PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kim, TJ; Sun, J; Lu, SY; Qi, YX; Wang, YX				Kim, Tae-Jin; Sun, Jie; Lu, Shaoying; Qi, Ying-Xin; Wang, Yingxiao			Prolonged Mechanical Stretch Initiates Intracellular Calcium Oscillations in Human Mesenchymal Stem Cells	PLOS ONE			English	Article							ION CHANNELS; ACTIVATION; TRPV4	Mesenchymal stem cells (MSCs) are a promising candidate for cell-based therapy in regenerative medicine. These stem cells can interact with their mechanical microenvironment to control their functions. External mechanical cues can be perceived and transmitted into intracellular calcium dynamics to regulate various cellular processes. Recent studies indicate that human MSCs (hMSCs) exhibit a heterogeneous nature with a subset of hMSCs lacking spontaneous calcium oscillations. In this study, we studied whether and how external mechanical tension can be applied to trigger and restore the intracellular calcium oscillation in these hMSCs lacking spontaneous activities. Utilizing the fluorescence resonance energy transfer (FRET) based calcium biosensor, we found that this subpopulation of hMSCs can respond to a prolonged mechanical stretch (PMS). Further results revealed that the triggering of calcium oscillations in these cells is dependent on the calcium influx across the plasma membrane, as well as on both cytoskeletal supports, myosin light chain kinase (MLCK)-driven actomyosin contractility, and phospholipase C (PLC) activity. Thus, our report confirmed that mechanical tension can govern the intracellular calcium oscillation in hMSCs, possibly via the control of the calcium permeability of channels at the plasma membrane. Our results also provide novel mechanistic insights into how hMSCs sense mechanical environment to regulate cellular functions.	[Kim, Tae-Jin; Wang, Yingxiao] Univ Illinois, Neurosci Program, Urbana, IL 61201 USA; [Kim, Tae-Jin; Sun, Jie; Wang, Yingxiao] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL USA; [Lu, Shaoying; Wang, Yingxiao] Univ Illinois, Dept Bioengn, Urbana, IL USA; [Lu, Shaoying; Wang, Yingxiao] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Lu, Shaoying; Wang, Yingxiao] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA; [Qi, Ying-Xin] Shanghai Jiao Tong Univ, Inst Mech & Med Engn, Shanghai 200030, Peoples R China	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California San Diego; University of California System; University of California San Diego; Shanghai Jiao Tong University	Wang, YX (corresponding author), Univ Illinois, Neurosci Program, Urbana, IL 61201 USA.	yiw015@eng.ucsd.edu		Sun, Jie/0000-0002-5642-0560	NIH [HL098472, HL109142, GM106403]; NSF CBET [0846429, 1344298]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098472, K02HL109142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM106403] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CBET(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in part by grants from NIH HL098472, HL109142, GM106403, NSF CBET 0846429 and 1344298 (Y.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandri-Haber N, 2009, J NEUROSCI, V29, P6217, DOI 10.1523/JNEUROSCI.0893-09.2009; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Campbell JJ, 2008, J APPL BIOMATER BIOM, V6, P9; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; Dupont G, 2011, COLD SPRING HARB PER, V3; Eijkelkamp N, 2013, ANNU REV NEUROSCI, V36, P519, DOI 10.1146/annurev-neuro-062012-170412; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Gees M, 2012, COMPR PHYSIOL, V2, P563, DOI 10.1002/cphy.c110026; Guo YJ, 2010, J BIOL CHEM, V285, P24999, DOI 10.1074/jbc.M110.132654; Jalali S, 2001, P NATL ACAD SCI USA, V98, P1042, DOI 10.1073/pnas.031562998; Kawano S, 2002, CELL CALCIUM, V32, P165, DOI 10.1016/S0143416002001240; Kim TJ, 2009, J CELL PHYSIOL, V218, P285, DOI 10.1002/jcp.21598; Kobayashi T, 2010, CURR OPIN CELL BIOL, V22, P669, DOI 10.1016/j.ceb.2010.08.023; Li GR, 2005, STEM CELLS, V23, P371, DOI 10.1634/stemcells.2004-0213; Li GR, 2006, STEM CELLS, V24, P1519, DOI 10.1634/stemcells.2005-0307; MacQueen L, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0179; Matthews BD, 2010, INTEGR BIOL-UK, V2, P435, DOI 10.1039/c0ib00034e; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Niessen CM, 2013, PHYSIOL REV, V91, P691; Nishitani WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026181; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Parker JC, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.121; Patel A, 2010, PFLUG ARCH EUR J PHY, V460, P571, DOI 10.1007/s00424-010-0847-8; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Sun S, 2007, FASEB J, V21, P1472, DOI 10.1096/fj.06-7153com; Thul R, 2008, ADV EXP MED BIOL, V641, P1; Torossian F, 2010, CELL MOL BIOL LETT, V15, P600, DOI 10.2478/s11658-010-0031-3; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; Uhlen P, 2010, BIOCHEM BIOPH RES CO, V396, P28, DOI 10.1016/j.bbrc.2010.02.117; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298	31	24	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e109378	10.1371/journal.pone.0109378	http://dx.doi.org/10.1371/journal.pone.0109378			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329052	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100023
J	Lee, YC; Chen, SS; Koh, CL; Hsueh, IP; Yao, KP; Hsieh, CL				Lee, Ya-Chen; Chen, Sheng-Shiung; Koh, Chia-Lin; Hsueh, I-Ping; Yao, Kai-Ping; Hsieh, Ching-Lin			Development of Two Barthel Index-Based Supplementary Scales for Patients with Stroke	PLOS ONE			English	Article							DAILY LIVING INDEX; PERCEIVED DIFFICULTY; OUTCOME MEASURES; PERFORMANCE; HEALTH; DISABILITY; REHABILITATION; RELIABILITY; LIFE; CONSTRUCTS	Background: The Barthel Index (BI) assesses actual performance of activities of daily living (ADL). However, comprehensive assessment of ADL functions should include two other constructs: self-perceived difficulty and ability. Objective: The aims of this study were to develop two BI-based Supplementary Scales (BI-SS), namely, the Self-perceived Difficulty Scale and the Ability Scale, and to examine the construct validity of the BI-SS in patients with stroke. Method: The BI-SS was first developed by consultation with experts and then tested on patients to confirm the clarity and feasibility of administration. A total of 306 participants participated in the construct validity study. Construct validity was investigated using Mokken scale analysis and analyzing associations between scales. The agreement between each pair of the scales' scores was further examined. Results: The Self-perceived Difficulty Scale consisted of 10 items, and the Ability Scale included 8 items (excluding both bladder and bowel control items). Items in each individual scale were unidimensional (H >= 0.5). The scores of the Self-perceived Difficulty and Ability Scales were highly correlated with those of the BI (rho = 0.78 and 0.90, respectively). The scores of the two BI-SS scales and BI were significantly different from each other (p<.001). These results indicate that both BI-SS scales assessed unique constructs. Conclusions: The BI-SS had overall good construct validity in patients with stroke. The BI-SS can be used as supplementary scales for the BI to comprehensively assess patients' ADL functions in order to identify patients' difficulties in performing ADL tasks, plan intervention strategies, and assess outcomes.	[Lee, Ya-Chen; Koh, Chia-Lin; Hsueh, I-Ping; Hsieh, Ching-Lin] Natl Taiwan Univ, Coll Med, Sch Occupat Therapy, Taipei 10764, Taiwan; [Chen, Sheng-Shiung] I Shou Univ, E Da Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Hsueh, I-Ping; Hsieh, Ching-Lin] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Yao, Kai-Ping] Natl Taiwan Univ, Coll Med, Dept Psychol, Taipei 10764, Taiwan	National Taiwan University; E-Da Hospital; I Shou University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Hsueh, IP (corresponding author), Natl Taiwan Univ, Coll Med, Sch Occupat Therapy, Taipei 10764, Taiwan.	iping@ntu.edu.tw	Koh, Chia-Lin/G-2127-2010; Hsieh, Ching-Lin/G-6057-2011	Koh, Chia-Lin/0000-0002-9927-2553; Hsieh, Ching-Lin/0000-0001-9468-9969; YAO, KAI-PING GRACE/0000-0003-0841-3507; HSUEH, I-PING/0000-0002-8852-8242	E-Da Hospital [EDAHT 101016]	E-Da Hospital	This study was supported by a research grant from the E-Da Hospital (EDAHT 101016), http://www.edah.org.tw/index.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkat-Masih M, 2011, J CHILD NEUROL, V26, P44, DOI 10.1177/0883073810372805; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chang HY, 2006, TAIWAN J PHYS MED RE, V34, P63; Chen HC, 2009, BRAIN INJURY, V23, P715, DOI 10.1080/02699050903013602; Collin C, 1988, Int Disabil Stud, V10, P61; Flansbjer UB, 2005, J REHABIL MED, V37, P75, DOI 10.1080/16501970410017215; Gill TM, 1998, ANN INTERN MED, V128, P96, DOI 10.7326/0003-4819-128-2-199801150-00004; Grimby G, 1998, STROKE, V29, P1843, DOI 10.1161/01.STR.29.9.1843; Holsbeeke L, 2009, ARCH PHYS MED REHAB, V90, P849, DOI 10.1016/j.apmr.2008.11.015; Hsieh CL, 2012, J REHABIL MED, V44, P720, DOI 10.2340/16501977-1008; Hsieh CL, 2002, STROKE, V33, P2626, DOI 10.1161/01.STR.0000033930.05931.93; Hsieh YW, 2007, NEUROREHAB NEURAL RE, V21, P233, DOI 10.1177/1545968306294729; Hsueh IP, 2001, J FORMOS MED ASSOC, V100, P526; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; JETTE AM, 1994, PHYS THER, V74, P380, DOI 10.1093/ptj/74.5.380; Koh CL, 2006, J REHABIL MED, V38, P375, DOI 10.1080/16501970600803252; Kwakkel G, 1996, AGE AGEING, V25, P479, DOI 10.1093/ageing/25.6.479; Laditka S B, 2001, J Health Soc Policy, V13, P1, DOI 10.1300/J045v13n03_01; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Lee YC, 2010, OCCUP THER INT, V17, P152, DOI 10.1002/oti.301; Michielsen ME, 2009, J REHABIL MED, V41, P327, DOI 10.2340/16501977-0351; Ostir GV, 2001, AGING CLIN EXP RES, V13, P465; Owens PL, 2002, ANN INTERN MED, V136, P802, DOI 10.7326/0003-4819-136-11-200206040-00008; Quinn TJ, 2011, STROKE, V42, P1146, DOI 10.1161/STROKEAHA.110.598540; Salter K, 2005, DISABIL REHABIL, V27, P507, DOI 10.1080/0963828040008552; Sangha H, 2005, INT J REHABIL RES, V28, P135, DOI 10.1097/00004356-200506000-00006; Schunemann HJ, 2005, HEALTH SERV RES, V40, P593, DOI 10.1111/j.1475-6773.2005.0k375.x; Sijtsma K, 2008, QUAL LIFE RES, V17, P275, DOI 10.1007/s11136-007-9281-6; Sinoff G, 1997, J AM GERIATR SOC, V45, P832, DOI 10.1111/j.1532-5415.1997.tb01510.x; SMITH DS, 1995, DISABIL REHABIL, V17, P15, DOI 10.3109/09638289509166623; Stochl J, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-74; Thoren-Jonsson AL, 2001, J REHABIL MED, V33, P4; van der Ark LA, 2012, J STAT SOFTW, V48, P1; van der Heijden PGM, 2003, QUAL LIFE RES, V12, P189, DOI 10.1023/A:1022269315437; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; Wade D T, 1988, Int Disabil Stud, V10, P64; Wade DT., 1992, MEASUREMENT NEUROLOG; WHO, 2001, WHO INT CLASS FUNCT; Williams LS, 1999, STROKE, V30, P1362, DOI 10.1161/01.STR.30.7.1362; Wilson R, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-68; Young NL, 1996, J CLIN EPIDEMIOL, V49, P1097, DOI 10.1016/0895-4356(96)00214-4; Yu WH, 2013, PHYS THER, V93, P798, DOI 10.2522/ptj.20120259	42	13	16	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110494	10.1371/journal.pone.0110494	http://dx.doi.org/10.1371/journal.pone.0110494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0AY	25329051	Green Submitted, gold, Green Published			2022-12-27	WOS:000343942100066
J	Brown, MG; Asbridge, M; Hicks, V; Kirby, S; Murray, TJ; Andreou, P; Lin, D				Brown, Murray G.; Asbridge, Mark; Hicks, Vern; Kirby, Sarah; Murray, Thomas J.; Andreou, Pantelis; Lin, Dong			Estimating Typical Multiple Sclerosis Disability Progression Speed from Clinical Observations	PLOS ONE			English	Article							DISEASE-MODIFYING DRUGS; NATURAL-HISTORY; DIAGNOSTIC-CRITERIA; INTERFERON-BETA; SCALE; PERSPECTIVES; SURVIVAL; ONSET; TIME	Introduction: Multiple sclerosis (MS) is a chronic disease of the central nervous system. Estimates of MS natural history (NH) disability progression speed from clinical observations vary worldwide. This may reflect, in part, variance in censoring-bias) (missing observations) and assumptions about when irreversible disability progression events occurred. We test whether estimates of progression speed which assume midpoint survival time at irreversible disability endpoints are significantly faster than estimates which assume maximum survival time, and are more stable across study groups and time periods. Methods: Our Nova Scotia NH study population includes 2,240 definite relapsing-onset multiple sclerosis (R-MS) natural history patients with 18,078 Expanded Disability Status Scale (EDSS) clinical observations in study period 1979-2010. Progression speed is measured by rate-of-change in range EDSS 0-6 and by survival time at irreversible endpoints EDSS 1-9. Midpoint censoring-bias-reduction methods are applied to clinical observations. Findings: Typical EDSS increase per year in range EDSS 0-6, assuming midpoint survival time, is estimated to be 0.168 for all R-MS, 0.204 for eventually-DMD-treated patients and 0.155 for never-DMD-treated patients. Estimates assuming midpoint rather than maximum survival time are significantly faster: 16% faster for all R-MS natural history patients, 6% faster for eventually-DMD-treated patients, and 21% faster for never-DMD-treated patients. The variability of estimates across study groups and time periods decreased when midpoint survival time was assumed. Conclusions: Estimates of typical disease progression speed from 1979-2010 Nova Scotia clinical observations are sensitive to censoring-bias and to analysts' survival time assumptions. Censoring-bias-adjusted estimates of typical natural history disability progression speed in relapsing-onset multiple sclerosis patients are significantly faster, and less variable within and across study groups and time periods, than unadjusted estimates, and are, arguably, more relevant for various stakeholders. The application of censoring-bias-reduction methods to other multiple sclerosis clinical databases may reduce variability in estimates of disability progression speed worldwide.	[Brown, Murray G.; Asbridge, Mark; Hicks, Vern; Murray, Thomas J.; Andreou, Pantelis] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada; [Brown, Murray G.] Capital Dist Hlth Author, Clin Res Ctr, Halifax, NS, Canada; [Asbridge, Mark] Dalhousie Univ, Dept Emergency Med, Halifax, NS, Canada; [Kirby, Sarah; Murray, Thomas J.] Dalhousie Univ, Div Neurol, Halifax, NS, Canada; [Lin, Dong] Dalhousie Univ, Dept Math & Stat, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University	Brown, MG (corresponding author), Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada.	murray.brown@dal.ca			Health Canada, Health Policy Research Program [QE-RW/2001-182]; Genzyme Canada Inc. [CDHA-RS2012-26]; Multiple Sclerosis Society of Canada; Capital District Health Authority, Department of Health and Wellness, Nova Scotia	Health Canada, Health Policy Research Program; Genzyme Canada Inc.; Multiple Sclerosis Society of Canada; Capital District Health Authority, Department of Health and Wellness, Nova Scotia	This work was supported by Health Canada, Health Policy Research Program, research grant QE-RW/2001-182; Genzyme Canada Inc. investigator-initiated research grant CDHA-RS2012-26; Multiple Sclerosis Society of Canada research grants in 2002 and 2003; Capital District Health Authority, Department of Health and Wellness, Nova Scotia, research support in kind. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banglmaier RF, 2006, INT J MATER PROD TEC, V25, P42, DOI 10.1504/IJMPT.2006.008273; Becker RV, 2011, J MANAGE CARE PHARM, V17, P377, DOI 10.18553/jmcp.2011.17.5.377; Bergamaschi R, 2012, MULT SCLER, V14; Bhan V, 2005, MULT SCLER S1, V11, pP406; Bronnum-Hansen H, 2004, BRAIN, V127, P844, DOI 10.1093/brain/awh104; Brown MG, 2007, NEUROLOGY, V69, P1498, DOI 10.1212/01.wnl.0000271884.11129.f3; Brown MG, 2013, COMPUTING EXPECTED S; Brown MT, 2004, ECOL MODEL, V178, P1, DOI 10.1016/j.ecolmodel.2003.12.001; CONFAVREUX C, 2006, MCALPINES MULTIPLE S; Costelloe L, 2008, J NEUROL NEUROSUR PS, V79, P1245, DOI 10.1136/jnnp.2008.143586; Debouverie M, 2007, J NEUROL, V254, P1370, DOI 10.1007/s00415-007-0554-3; Derfuss T, 2012, JAMA-J AM MED ASSOC, V308, P290, DOI 10.1001/jama.2012.8327; Ebers GC, 2005, J NEUROL, V252, P15, DOI 10.1007/s00415-005-2012-4; Eriksson M, 2003, MULT SCLER J, V9, P260, DOI 10.1191/1352458503ms914oa; Fisk JD, 2005, J NEUROL NEUROSUR PS, V76, P58, DOI 10.1136/jnnp.2003.017897; Fowke KR, 1996, LANCET, V348, P1347, DOI 10.1016/S0140-6736(95)12269-2; Herndon R.M., 2006, HDB NEUROLOGIC RATIN, V2nd edition; Hougaard, 2000, ANAL MULTIVARIATE SU; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Koch M, 2008, MULT SCLER J, V14, P300, DOI 10.1177/1352458507084269; Kremenchutzky M, 2006, BRAIN, V129, P584, DOI 10.1093/brain/awh721; Kurtzke JF, 2000, NEUROL SCI, V21, P339, DOI 10.1007/s100720070047; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; KURTZKE JF, 1955, NEUROLOGY, V5, P580, DOI 10.1212/WNL.5.8.580; Kurtzke JF, 2008, NEUROEPIDEMIOLOGY, V31, P1, DOI 10.1159/000136645; Lantz PM, 1998, SOC SCI MED, V46, P907, DOI 10.1016/S0277-9536(97)00218-9; Leung KM, 1997, ANNU REV PUBL HEALTH, V18, P83, DOI 10.1146/annurev.publhealth.18.1.83; Mallinckrodt CH, 2009, DRUG INF J, V43, P449, DOI 10.1177/009286150904300410; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McLeod JG, 2007, J NEUROL SCI, V256, P35, DOI 10.1016/j.jns.2007.02.004; Montalban X, 2006, J NEUROL, V253, P9, DOI 10.1007/s00415-006-6003-x; Murray TJ, 2009, J NEUROL SCI, V277, pS3, DOI 10.1016/S0022-510X(09)70003-6; PATY DW, 1998, MULTIPLE SCLEROSIS; Poser CM, 2004, CLIN NEUROL NEUROSUR, V106, P147, DOI 10.1016/j.clineuro.2004.02.004; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; SAMUELSEN SO, 1994, STAT MED, V13, P1771, DOI 10.1002/sim.4780131708; SAS Institute Inc, 2008, SAS STAT SOFTW COMP; Shirani A, 2012, JAMA-J AM MED ASSOC, V308, P247, DOI 10.1001/jama.2012.7625; Tan XM, 2011, SUBST USE MISUSE, V46, P758, DOI 10.3109/10826084.2010.537731; Torkildsen NG, 2008, MULT SCLER J, V14, P1191, DOI 10.1177/1352458508093890; Tremlett H, 2006, NEUROLOGY, V66, P172, DOI 10.1212/01.wnl.0000194259.90286.fe; Tremlett H, 2008, MULT SCLER J, V14, P1142, DOI 10.1177/1352458508095131; Tremlett H, 2010, NEUROLOGY, V74, P2004, DOI 10.1212/WNL.0b013e3181e3973f; Trojano M, 2007, NEUROLOGY, V69, P1478, DOI 10.1212/01.wnl.0000275545.08382.82; Trojano M, 2007, ANN NEUROL, V61, P300, DOI 10.1002/ana.21102; Veugelers PJ, 2009, MULT SCLER J, V15, P1286, DOI 10.1177/1352458509350307; Viel JF, 1997, ENVIRON HEALTH PERSP, V105, P1539, DOI 10.2307/3433667; Zhao YC, 2004, RISK ANAL, V24, P1019, DOI 10.1111/j.0272-4332.2004.00504.x	48	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e105123	10.1371/journal.pone.0105123	http://dx.doi.org/10.1371/journal.pone.0105123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329469	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204100001
J	Silva, WSE; Casarin, RCV; Nicolela, EL; Passos, HM; Sallum, AW; Goncalves, RB				Serra e Silva Filho, Wagner; Casarin, Renato C. V.; Nicolela Junior, Eduardo L.; Passos, Humberto M.; Sallum, Antonio W.; Goncalves, Reginaldo B.			Microbial Diversity Similarities in Periodontal Pockets and Atheromatous Plaques of Cardiovascular Disease Patients	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-HEART-DISEASE; ACINETOBACTER-BAUMANNII; MORAXELLA-OSLOENSIS; PATHOGENS; INFECTION; IDENTIFICATION; BACTERIA; BLOOD; DNA	Background and Objective: The immune and infectious alterations occurring in periodontitis have been shown to alter the development and severity of cardiovascular disease. One of these relationships is the translocation of oral bacteria to atheroma plaques, thereby promoting plaque development. Thus, the aim of this study was to assess, by 16s cloning and sequencing, the microbial diversity of the subgingival environment and atheroma plaques of patients concomitantly suffering from periodontitis and obstructive coronary artery atherosclerosis (OCAA). Methods: Subgingival biofilm and coronary balloons used in percutaneous transluminal coronary angioplasty were collected from 18 subjects presenting with generalized moderate to severe periodontitis and OCAA. DNA was extracted and the gene 16S was amplified, cloned and sequenced. Results: Significant differences in microbial diversity were observed between both environments. While subgingival samples mostly contained the phylum Firmicutes, in coronary balloons, Proteobacteria (p<0.05) was predominant. In addition, the most commonly detected genera in coronary balloons were Acinetobacter, Alloprevotella, Pseudomonas, Enterobacter, Sphingomonas and Moraxella, while in subgingival samples Porphyromonas, Filifactor, Veillonella, Aggregatibacter and Treponema (p<0.05) were found. Interestingly, 17 identical phylotypes were found in atheroma and subgingival samples, indicating possible bacterial translocation between periodontal pockets and coronary arteries. Conclusion: Periodontal pockets and atheromatous plaques of cardiovascular disease patients can present similarities in the microbial diversity.	[Serra e Silva Filho, Wagner] Univ Fed Piaui, Piaui, Brazil; [Casarin, Renato C. V.] Univ Paulista, Sao Paulo, Brazil; [Nicolela Junior, Eduardo L.; Passos, Humberto M.] Ctr Hemodynam, Emcor, Piracicaba, Brazil; [Sallum, Antonio W.] Univ Estadual Campinas, Piracicaba Dent Sch, Sao Paulo, Brazil; [Goncalves, Reginaldo B.] Univ Laval, Grp Rech Ecol Bucale, Quebec City, PQ, Canada	Universidade Federal do Piaui; Universidade Paulista; Universidade Estadual de Campinas; Laval University	Goncalves, RB (corresponding author), Univ Laval, Grp Rech Ecol Bucale, Quebec City, PQ, Canada.	reginaldo.goncalves@fmd.ulaval.ca	Sallum, Antonio Wilson/J-2984-2015	Casarin, Renato/0000-0003-1743-5855				Aimetti M, 2007, J PERIODONTOL, V78, P1718, DOI 10.1902/jop.2007.060473; AINAMO J, 1975, INT DENT J, V25, P229; Aquino ARL, 2011, J PERIODONTAL RES, V46, P303, DOI 10.1111/j.1600-0765.2010.01343.x; Bahekar AA, 2007, AM HEART J, V154, P830, DOI 10.1016/j.ahj.2007.06.037; Bahrani-Mougeot FK, 2007, J CLIN MICROBIOL, V45, P1588, DOI 10.1128/JCM.01963-06; Byakodi R, 2011, QUINTESSENCE INT, V42, pE118; Cairo F, 2004, J PERIODONTAL RES, V39, P442, DOI 10.1111/j.1600-0765.2004.00761.x; Calandrini CA, 2014, ORAL DIS, V20, pe128, DOI 10.1111/odi.12205; Casarin RCV, 2013, J PERIODONTAL RES, V48, P30, DOI 10.1111/j.1600-0765.2012.01498.x; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Chiu B, 1999, AM HEART J, V138, pS534, DOI 10.1016/S0002-8703(99)70294-2; Cisneros JM, 1996, CLIN INFECT DIS, V22, P1026, DOI 10.1093/clinids/22.6.1026; Cisneros-Herreros Jose Miguel, 2005, Enferm Infecc Microbiol Clin, V23 Suppl 3, P46; Epstein SE, 2000, ARTERIOSCL THROM VAS, V20, P1417, DOI 10.1161/01.ATV.20.6.1417; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fiehn NE, 2005, J PERIODONTOL, V76, P731, DOI 10.1902/jop.2005.76.5.731; Figuero E, 2011, J PERIODONTOL, V82, P1469, DOI 10.1902/jop.2011.100719; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; Garcia R I, 1998, Ann Periodontol, V3, P339, DOI 10.1902/annals.1998.3.1.339; Hadano Y, 2012, INT J GEN MED, V5, P875, DOI 10.2147/IJGM.S36919; Han XY, 2004, AM J CLIN PATHOL, V121, P581, DOI 10.1309/QBB3AVCMGWA3K1XK; Hanson M, 2005, HEART, V91, P864, DOI 10.1136/hrt.2004.047381; Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554; Ishihara K, 2004, J CLIN MICROBIOL, V42, P1313, DOI 10.1128/JCM.42.3.1313-1315.2004; Janket SJ, 2003, ORAL SURG ORAL MED O, V95, P559, DOI 10.1067/moe.2003.107; JUKES T H, 1969, P21; Khader YS, 2004, J PERIODONTOL, V75, P1046, DOI 10.1902/jop.2004.75.8.1046; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Libby P, 2009, J LIPID RES, V50, pS352, DOI 10.1194/jlr.R800099-JLR200; Linden GJ, 2012, J CLIN PERIODONTOL, V39, P940, DOI 10.1111/j.1600-051X.2012.01923.x; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Luepker RV, 2011, ANN EPIDEMIOL, V21, P824, DOI 10.1016/j.annepidem.2011.08.005; Mastragelopulos N, 2002, CHIRURG, V73, P585, DOI 10.1007/s00104-001-0385-1; Meulman Tatiana, 2013, J Int Acad Periodontol, V15, P83; Movahed M R, 1999, J S C Med Assoc, V95, P303; MUHLEMANN HR, 1971, HELV ODONTOL ACTA, V15, P107; Nabel EG, 2003, NEW ENGL J MED, V349, P60, DOI 10.1056/NEJMra035098; Ohki T, 2012, AM HEART J, V163, P164, DOI 10.1016/j.ahj.2011.10.012; Ozkan YK, 2012, GERODONTOLOGY, V29, P9, DOI 10.1111/j.1741-2358.2010.00381.x; Pollreisz A, 2010, J PERIODONTAL RES, V45, P239, DOI 10.1111/j.1600-0765.2009.01225.x; Rafferty B, 2011, J ATHEROSCLER THROMB, V18, P72, DOI 10.5551/jat.5207; Reyes L, 2013, J PERIODONTOL, V84, pS30, DOI [10.1902/jop.2013.1340012, 10.1111/jcpe.12079]; Romano F, 2007, Minerva Stomatol, V56, P169; Roth GA, 2006, J THROMB HAEMOST, V4, P2256, DOI 10.1111/j.1538-7836.2006.02128.x; Roth GA, 2007, ATHEROSCLEROSIS, V190, P271, DOI 10.1016/j.atherosclerosis.2006.03.018; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanders WE, 1997, CLIN MICROBIOL REV, V10, P220, DOI 10.1128/CMR.10.2.220; Scannapieco Frank A, 2003, Ann Periodontol, V8, P38, DOI 10.1902/annals.2003.8.1.38; Shchipkova AY, 2010, J DENT RES, V89, P1247, DOI 10.1177/0022034510377203; Stelzel M, 2002, J PERIODONTOL, V73, P868, DOI 10.1902/jop.2002.73.8.868; Thorstensson H, 2009, COMMUNITY DENT ORAL, V37, P325, DOI 10.1111/j.1600-0528.2009.00467.x; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; Vuori-Holopainen E, 2001, SCAND J INFECT DIS, V33, P625, DOI 10.1080/00365540110026737; Wisplinghoff H, 2012, J INFECTION, V64, P282, DOI 10.1016/j.jinf.2011.12.008; Yuan HP, 2013, P NATL ACAD SCI USA, V110, pE5059, DOI 10.1073/pnas.1320862110; Zaremba M, 2007, J PERIODONTOL, V78, P322, DOI 10.1902/jop.2006.060081; Zurawski DV, 2012, J BACTERIOL, V194, P1619, DOI 10.1128/JB.06749-11	58	40	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109761	10.1371/journal.pone.0109761	http://dx.doi.org/10.1371/journal.pone.0109761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329160	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210800039
J	Bass, MB; Yao, B; Hei, YJ; Ye, YN; Davis, GJ; Davis, MT; Kaesdorf, BA; Chan, SS; Patterson, SD				Bass, Michael B.; Yao, Bin; Hei, Yong-Jiang; Ye, Yining; Davis, Gerard J.; Davis, Michael T.; Kaesdorf, Barbara A.; Chan, Sabrina S.; Patterson, Scott D.			Challenges in Developing a Validated Biomarker for Angiogenesis Inhibitors: The Motesanib Experience	PLOS ONE			English	Article							CELL LUNG-CANCER; ENDOTHELIAL GROWTH-FACTOR; PHASE-II; MULTIKINASE INHIBITOR; THYROID-CANCER; SOLID TUMORS; BEVACIZUMAB; REVASCULARIZATION; CARBOPLATIN; COMBINATION	Purpose: We sought to develop placental growth factor as a predictive pharmacodynamic biomarker for motesanib efficacy as first-line therapy in patients with advanced nonsquamous non-small-cell lung cancer. Experimental Design: Placental growth factor was evaluated at baseline and study week 4 (after 3 weeks treatment) in an exploratory analysis of data from a randomized phase 2 study of motesanib 125 mg once daily plus carboplatin/paclitaxel and in a prespecified analysis of data from a randomized, double-blind phase 3 study of motesanib 125 mg once daily plus carboplatin/paclitaxel vs placebo plus carboplatin/paclitaxel (MONET1). Associations between fold-change from baseline in placental growth factor and overall survival were evaluated using Cox proportional hazards models. Results: In the phase 2 study, serum placental growth factor increased from baseline a mean 2.8-fold at study week 4. Patients with >= 2.2-fold change from baseline in placental growth factor (n = 18) had significantly longer overall survival than those with <2.2-fold change (n = 19; 22.9 vs 7.9 months; hazard ratio, 0.30; 95% CI, 0.12-0.74; P = 0.009). Consequently, placental growth factor was investigated as a pharmacodynamic biomarker in the phase 3 MONET1 study. There was no association between log-transformed placental growth factor fold-change from baseline to week 4 (continuous variable) and overall survival (hazard ratio, 0.98; 95% CI, 0.79-1.22; P = 0.868). MONET1 did not meet its primary endpoint of overall survival. Likewise, median overall survival was similar among patients with >= 2.0-fold change in placental growth factor (n = 229) compared with <2.0-fold change (n = 127; 14.8 vs 13.8 months; hazard ratio, 0.88; 95% CI, 0.67-1.15, P = 0.340). Conclusions: Our results illustrate the challenges of successfully translating phase 2 biomarker results into phase 3 studies.	[Bass, Michael B.; Davis, Michael T.] Amgen Inc, Mol Sci & Computat Biol, Thousand Oaks, CA 91320 USA; [Yao, Bin] Amgen Inc, Global Biostat Sci, Thousand Oaks, CA 91320 USA; [Hei, Yong-Jiang] Amgen Inc, Oncol Dev, Thousand Oaks, CA 91320 USA; [Ye, Yining] Amgen Inc, Global Biostat Sci, San Francisco, CA USA; [Davis, Gerard J.; Kaesdorf, Barbara A.; Chan, Sabrina S.] Abbott Labs, Diagnost Div Res & Dev, Abbott Pk, IL 60064 USA; [Patterson, Scott D.] Amgen Inc, Med Sci, Thousand Oaks, CA 91320 USA	Amgen; Amgen; Amgen; Amgen; Abbott Laboratories; Amgen	Bass, MB (corresponding author), Amgen Inc, Mol Sci & Computat Biol, Thousand Oaks, CA 91320 USA.	mbass@amgen.com			Amgen Inc.	Amgen Inc.(Amgen)	This study was funded by Amgen Inc. (http://www.amgen.com). Employees of Amgen Inc. participated in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Autiero M, 2003, J THROMB HAEMOST, V1, P1356, DOI 10.1046/j.1538-7836.2003.00263.x; Bass MB, 2010, J CLIN ONCOL, V28; Bass MB, 2010, J CLIN ENDOCR METAB, V95, P5018, DOI 10.1210/jc.2010-0947; Batchelor TT, 2010, J CLIN ONCOL, V28, P2817, DOI 10.1200/JCO.2009.26.3988; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blumenschein GR, 2011, ANN ONCOL, V22, P2057, DOI 10.1093/annonc/mdq731; Blumenschein GR, 2012, INVEST NEW DRUG, V30, P1802, DOI 10.1007/s10637-011-9750-1; Cao YH, 1996, J CLIN INVEST, V98, P2507, DOI 10.1172/JCI119069; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Cox D. R., 1984, ANAL SURVIVAL DATA; DePrimo SE, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-32; Freidlin B, 2012, J CLIN ONCOL, V30, P3304, DOI 10.1200/JCO.2012.43.3946; Green CJ, 2001, CANCER RES, V61, P2696; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hung HMJ, 2006, PHARM STAT, V5, P99, DOI 10.1002/pst.219; Kelly RJ, 2011, CLIN CANCER RES, V17, P1190, DOI 10.1158/1078-0432.CCR-10-2331; Kern SE, 2012, CANCER RES, V72, P6097, DOI 10.1158/0008-5472.CAN-12-3232; Korn EL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004018; Korpanty G, 2012, CURR PHARM DESIGN, V18, P2680, DOI 10.2174/138161212800626166; Kutner MH, 2005, APPL LINEAR STAT MOD, P1; Lambrechts D, 2013, J CLIN ONCOL, DOI [10.1200/JCO.2012.1246.2762, DOI 10.1200/JCO.2012.1246.2762]; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Metcalfe TA, 2010, SCAND J CLIN LAB INV, V70, P23, DOI 10.3109/00365513.2010.493361; MILLER R, 1982, BIOMETRICS, V38, P1011, DOI 10.2307/2529881; Mok T, 2014, J THORAC ONCOL, V9, P848, DOI 10.1097/JTO.0000000000000160; Nikolinakos PG, 2010, CANCER RES, V70, P2171, DOI 10.1158/0008-5472.CAN-09-2533; Patterson SD, 2010, J CLIN ONCOL, V28; Polverino A, 2006, CANCER RES, V66, P8715, DOI 10.1158/0008-5472.CAN-05-4665; Rini BI, 2008, J CLIN ONCOL, V26, P3743, DOI 10.1200/JCO.2007.15.5416; Rosen LS, 2007, J CLIN ONCOL, V25, P2369, DOI 10.1200/JCO.2006.07.8170; Russell Chris B., 2008, P1, DOI 10.1007/978-1-59745-463-6_1; Scagliotti GV, 2012, J CLIN ONCOL, V30, P2829, DOI 10.1200/JCO.2011.41.4987; Schlumberger MJ, 2009, J CLIN ONCOL, V27, P3794, DOI 10.1200/JCO.2008.18.7815; Sharma PS, 2011, CURR CANCER DRUG TAR, V11, P624; Sherman SI, 2008, NEW ENGL J MED, V359, P31, DOI 10.1056/NEJMoa075853; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; US Food and Drug Administration, 2010, GUID IND QUAL PROC D; Willett CG, 2009, J CLIN ONCOL, V27, P3020, DOI 10.1200/JCO.2008.21.1771; Zhang Lijian, 2005, World J Surg Oncol, V3, P68, DOI 10.1186/1477-7819-3-68	41	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e108048	10.1371/journal.pone.0108048	http://dx.doi.org/10.1371/journal.pone.0108048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314641	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662500009
J	Flechsig, H				Flechsig, Holger			TALEs from a Spring - Superelasticity of Tal Effector Protein Structures	PLOS ONE			English	Article							SINGLE-PARAMETER; DNA; DYNAMICS; MACHINES; MOTIONS; TARGET; CELL	Transcription activator-like effectors (TALEs) are DNA-related proteins that recognise and bind specific target sequences to manipulate gene expression. Recently determined crystal structures show that their common architecture reveals a superhelical overall structure that may undergo drastic conformational changes. To establish a link between structure and dynamics in TALE proteins we have employed coarse-grained elastic-network modelling of currently available structural data and implemented a force-probe setup that allowed us to investigate their mechanical behaviour in computer experiments. Based on the measured force-extension curves we conclude that TALEs exhibit superelastic dynamical properties allowing for large-scale global conformational changes along their helical axis, which represents the soft direction in such proteins. For moderate external forcing the TALE models behave like linear springs, obeying Hooke's law, and the investigated structures can be characterised and compared by a corresponding spring constant. We show that conformational flexibility underlying the large-scale motions is not homogeneously distributed over the TALE structure, but instead soft spot residues around which strain is accumulated and which turn out to represent key agents in the transmission of conformational motions are identified. They correspond to the RVD loop residues that have been experimentally determined to play an eminent role in the binding process of target DNA.	Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 724, Japan	Hiroshima University	Flechsig, H (corresponding author), Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 724, Japan.	holgerflechsig@hiroshima-u.ac.jp	Flechsig, Holger/C-3452-2011	Flechsig, Holger/0000-0003-4984-9294	Ministry of Education, Culture, Sports, Science and Technology, Japan [23115007]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas ''Spying minority in biological phenomena'' (23115007) and Platform for Dynamic Approaches to Living System of the Ministry of Education, Culture, Sports, Science and Technology, Japan. http://www.mext.go.jp/english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Boch J, 2011, NAT BIOTECHNOL, V29, P135, DOI 10.1038/nbt.1767; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Flechsig H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021809; Flechsig H, 2010, P NATL ACAD SCI USA, V107, P20875, DOI 10.1073/pnas.1014631107; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Murakami MT, 2010, PROTEINS, V78, P3386, DOI 10.1002/prot.22846; Scholze H, 2011, CURR OPIN MICROBIOL, V14, P47, DOI 10.1016/j.mib.2010.12.001; Schreiber T, 2014, NUCLEIC ACIDS RES, V42, P7160, DOI 10.1093/nar/gku341; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; Togashi Y, 2007, P NATL ACAD SCI USA, V104, P8697, DOI 10.1073/pnas.0702950104; Togashi Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000814; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Wan H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076045; Zheng WJ, 2003, P NATL ACAD SCI USA, V100, P13253, DOI 10.1073/pnas.2235686100	24	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109919	10.1371/journal.pone.0109919	http://dx.doi.org/10.1371/journal.pone.0109919			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313859	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500086
J	Hoxha, E; Harendza, S; Pinnschmidt, H; Panzer, U; Stahl, RAK				Hoxha, Elion; Harendza, Sigrid; Pinnschmidt, Hans; Panzer, Ulf; Stahl, Rolf A. K.			PLA(2)R Antibody Levels and Clinical Outcome in Patients with Membranous Nephropathy and Non-Nephrotic Range Proteinuria under Treatment with Inhibitors of the Renin-Angiotensin System	PLOS ONE			English	Article							PHOSPHOLIPASE-A2 RECEPTOR; CONTROLLED-TRIAL; AUTOANTIBODIES; RITUXIMAB	Patients with primary membranous nephropathy (MN) who experience spontaneous remission of proteinuria generally have an excellent outcome without need of immunosuppressive therapy. It is, however, unclear whether non-nephrotic proteinuria at the time of diagnosis is also associated with good prognosis since a reasonable number of these patients develop nephrotic syndrome despite blockade of the renin-angiotensin system. No clinical or laboratory parameters are available, which allow the assessment of risk for development of nephrotic proteinuria. Phospholipase A(2) Receptor antibodies (PLA(2)R-Ab) play a prominent role in the pathogenesis of primary MN and are associated with persistence of nephrotic proteinuria. In this study we analysed whether PLA(2)R-Ab levels might predict development of nephrotic syndrome and the clinical outcome in 33 patients with biopsy-proven primary MN and non-nephrotic proteinuria under treatment with blockers of the renin-angiotensin system. PLA(2)R-Ab levels, proteinuria and serum creatinine were measured every three months. Nephrotic-range proteinuria developed in 18 (55%) patients. At study start (1.2 +/- 1.5 months after renal biopsy and time of diagnosis), 16 (48%) patients were positive for PLA(2)R-Ab. A multivariate analysis showed that PLA(2)R-Ab levels were associated with an increased risk for development of nephrotic proteinuria (HR = 3.66; 95%CI: 1.39-9.64; p = 0.009). Immunosuppressive therapy was initiated more frequently in PLA(2)R-Ab positive patients (13 of 16 patients, 81%) compared to PLA(2)R-Ab negative patients (2 of 17 patients, 12%). PLA(2)R-Ab levels are associated with higher risk for development of nephrotic-range proteinuria in this cohort of non-nephrotic patients at the time of diagnosis and should be closely monitored in the clinical management.	[Hoxha, Elion; Harendza, Sigrid; Panzer, Ulf; Stahl, Rolf A. K.] Univ Klinikum Hamburg Eppendorf, Med Klin 3, Hamburg, Germany; [Pinnschmidt, Hans] Univ Klinikum Hamburg Eppendorf, Inst Med Biometrie & Epidemiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Stahl, RAK (corresponding author), Univ Klinikum Hamburg Eppendorf, Med Klin 3, Hamburg, Germany.	rstahl@uke.de	Hoxha, Elion/ABB-2981-2021		Else-Kroener-Fresenius Stiftung; Deutsche Forschungsgemeinschaft [KFO 228, STA193/9-1, STA193/9-2]	Else-Kroener-Fresenius Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work is supported by a grant from the Else-Kroener-Fresenius Stiftung to R.S. and the "Deutsche Forschungsgemeinschaft" KFO 228 (Z project (E.H.) and STA193/9-1 and and STA193/9-2). The funders had no role in study design, data collection analysis, decision to publish, or preparation of the manuscript.	Beck LH, 2011, J AM SOC NEPHROL, V22, P1543, DOI 10.1681/ASN.2010111125; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Cattran D, 2005, J AM SOC NEPHROL, V16, P1188, DOI 10.1681/ASN.2005010028; CATTRAN DC, 1995, KIDNEY INT, V47, P1130, DOI 10.1038/ki.1995.161; Dahnrich C, 2013, CLIN CHIM ACTA, V421, P213, DOI 10.1016/j.cca.2013.03.015; Hladunewich MA, 2009, CLIN J AM SOC NEPHRO, V4, P1417, DOI 10.2215/CJN.01330209; Howman A, 2013, LANCET, V381, P744, DOI 10.1016/S0140-6736(12)61566-9; Hoxha E, 2014, J AM SOC NEPHROL, V25, P1357, DOI 10.1681/ASN.2013040430; Hoxha E, 2012, KIDNEY INT, V82, P797, DOI 10.1038/ki.2012.209; Polanco N, 2010, J AM SOC NEPHROL, V21, P697, DOI 10.1681/ASN.2009080861; Ponticelli C, 1998, J AM SOC NEPHROL, V9, P444; Ruggenenti P, 2012, J AM SOC NEPHROL, V23, P1416, DOI 10.1681/ASN.2012020181; SCHIEPPATI A, 1993, NEW ENGL J MED, V329, P85, DOI 10.1056/NEJM199307083290203	13	64	70	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110681	10.1371/journal.pone.0110681	http://dx.doi.org/10.1371/journal.pone.0110681			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313791	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500121
J	Stoy, J; Grarup, N; Horlyck, A; Ibsen, L; Rungby, J; Poulsen, PL; Brandslund, I; Christensen, C; Hansen, T; Pedersen, O; Moller, N; Kampmann, U				Stoy, Julie; Grarup, Niels; Horlyck, Arne; Ibsen, Liselotte; Rungby, Jorgen; Poulsen, Per Logstrup; Brandslund, Ivan; Christensen, Cramer; Hansen, Torben; Pedersen, Oluf; Moller, Niels; Kampmann, Ulla			Blood Pressure Levels in Male Carriers of Arg82Cys in CD300LG	PLOS ONE			English	Article							SIALOMUCIN; RELEVANCE; LOCI	The genetics of hypertension has been scrutinized in large-scale genome-wide association studies (GWAS) with a large number of common genetic variants identified, each exerting subtle effects on disease susceptibility. An amino acid polymorphism, p.Arg82Cys, in CD300LG was recently found to be associated with fasting HDL-cholesterol and triglyceride levels. The polymorphism has not been detected in hypertension GWAS potentially due to its low frequency, but CD300LG has been linked to blood pressure as CD300LG knockout mice have changes in blood pressure. Twenty-four-hour ambulatory blood pressure was obtained in human CD300LG CT-carriers to follow up on these observations. Methods: Twenty healthy male CD300LG rs72836561 CT-carriers matched for age and BMI with 20 healthy male CC-carriers. Office blood pressure, 24-hour ambulatory blood pressure, carotid intima-media thickness (CIMT), and fasting blood samples were evaluated. The clinical study was combined with a genetic-epidemiological study to replicate the association between blood pressure and CD300LG Arg82Cys in 2,637 men and 3,249 women. Results: CT-carriers had a higher 24-hour ambulatory systolic blood pressure (122 mmHg versus 115; p = 0.01) and diastolic blood pressure (77 mmHg versus 72; p, 0.01) compared with CC-carriers. There were no differences in CIMT between the two groups. Metalloproteinase-9 level was higher in CT-carriers than in CC-carriers (P < 0.01). However, no association between office blood pressure and CD300LG genotype was detected in the genetic-epidemiological study. Conclusions: Although 24-hour blood pressure, measured with a sensitive method, in a small sample of CD300LG rs72836561 CT-carriers was higher than in CC-carriers, this did not translate into significant differences in office blood pressure in a larger cohort. This discrepancy which may reflect differences in methodological approach, underlines the importance of performing replication studies in a larger clinical context, but a formal rejection of a relation between blood pressure and CD300LG requires measurement of 24-hour ambulatory blood pressure in a larger cohort.	[Stoy, Julie; Rungby, Jorgen; Poulsen, Per Logstrup; Moller, Niels; Kampmann, Ulla] Aarhus Univ Hosp, Dept Internal Med & Endocrinol, DK-8000 Aarhus, Denmark; [Grarup, Niels; Hansen, Torben; Pedersen, Oluf] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Basic Metab Res, Novo Nordisk Fdn, Copenhagen, Denmark; [Horlyck, Arne; Ibsen, Liselotte] Aarhus Univ Hosp, Dept Radiol, DK-8000 Aarhus, Denmark; [Rungby, Jorgen] Rigshosp, Dept Endocrinol, DK-2100 Copenhagen, Denmark; [Brandslund, Ivan] Vejle Hosp, Dept Clin Biochem, Vejle, Denmark; [Christensen, Cramer] Vejle Hosp, Dept Med, Vejle, Denmark; [Moller, Niels] Aarhus Univ, Inst Clin Med, Med Res Labs, Aarhus, Denmark	Aarhus University; Novo Nordisk Foundation; University of Copenhagen; Aarhus University; Rigshospitalet; University of Copenhagen; University of Southern Denmark; Lillebaelt Hospital; University of Southern Denmark; Lillebaelt Hospital; Aarhus University	Stoy, J (corresponding author), Aarhus Univ Hosp, Dept Internal Med & Endocrinol, DK-8000 Aarhus, Denmark.	julistoe@rm.dk	Pedersen, Oluf/AAG-8015-2020; Dina, Christian R/D-3535-2015; Grarup, Niels/K-2807-2015; Pedersen, Oluf/Z-1731-2019; Moller, Niels/E-5091-2011; Rungby, Jørgen/AAQ-4332-2021	Dina, Christian R/0000-0002-7722-7348; Grarup, Niels/0000-0001-5526-1070; Pedersen, Oluf/0000-0002-3321-3972; Moller, Niels/0000-0001-5627-7322; Stoy, Julie/0000-0003-4698-0393; Horlyck, Arne/0000-0003-4624-6973; Brandslund, Ivan/0000-0002-4203-5442; Kampmann, Ulla/0000-0002-2234-7780; Hansen, Torben/0000-0001-8748-3831	Lundbeck Foundation; University of Aarhus; Novo Nordisk Foundation	Lundbeck Foundation(Lundbeckfonden); University of Aarhus; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The study was conducted by LuCamp investigators (www.lucamp.org) funded by the Lundbeck Foundation, and a full scholarship for JS from University of Aarhus. The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent Research Center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation (www.metabol.ku.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrechtsen A, 2012, DIABETOLOGIA; Cannon JP, 2012, IMMUNOGENETICS, V64, P39, DOI 10.1007/s00251-011-0562-4; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Engelen L, 2013, EUR HEART J, V34, P2368, DOI 10.1093/eurheartj/ehs380; Faraco G, 2013, HYPERTENSION, V62, P810, DOI 10.1161/HYPERTENSIONAHA.113.01063; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Jeppesen JL, 2012, AM J HYPERTENS, V25, P1095, DOI 10.1038/ajh.2012.96; Jin S, 2008, FEBS LETT, V582, P3018, DOI 10.1016/j.febslet.2008.07.041; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mancia G, 1995, J HYPERTENS, V13, P1377; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Takatsu H, 2006, BIOCHEM BIOPH RES CO, V348, P183, DOI 10.1016/j.bbrc.2006.07.047; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Umemoto E, 2006, J EXP MED, V203, P1603, DOI 10.1084/jem.20052543; Umemoto E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083681; Umemoto E, 2011, CRIT REV IMMUNOL, V31, P147, DOI 10.1615/CritRevImmunol.v31.i2.40	17	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109646	10.1371/journal.pone.0109646	http://dx.doi.org/10.1371/journal.pone.0109646			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314291	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500063
J	Zhou, HC; Tam, NFY; Lin, YM; Ding, ZH; Chai, WM; Wei, SD				Zhou, Hai-Chao; Tam, Nora Fung-yee; Lin, Yi-Ming; Ding, Zhen-Hua; Chai, Wei-Ming; Wei, Shu-Dong			Relationships between Degree of Polymerization and Antioxidant Activities: A Study on Proanthocyanidins from the Leaves of a Medicinal Mangrove Plant Ceriops tagal	PLOS ONE			English	Article							CONDENSED TANNINS; PHENOLIC-COMPOUNDS; PROTEIN PRECIPITATION; MASS-SPECTROMETRY; KANDELIA-CANDEL; PROCYANIDINS; ECOSYSTEMS; DITERPENES; DYNAMICS; ESTUARY	Tannins from the leaves of a medicinal mangrove plant, Ceriops tagal, were purified and fractionated on Sephadex LH-20 columns. C-13 nuclear magnetic resonance (C-13-NMR), reversed/normal high performance liquid chromatography electrospray ionization mass spectrometry (HPLC-ESI MS) and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDT-TOF MS) analysis showed that the tannins were predominantly B-type procyanidins with minor A-type linkages, galloyl and glucosyl substitutions, and a degree of polymerization (DP) up to 33. Thirteen subfractions of the procyanidins were successfully obtained by a modified fractionation method, and their antioxidant activities were investigated using 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging capacity and ferric reducing antioxidant power (FRAP) method. All these subfractions exhibited potent antioxidant activities, and eleven of them showed significantly different mean DP (mDP) ranging from 1.43 +/- 0.04 to 31.77 +/- 1.15. Regression analysis demonstrated that antioxidant activities were positively correlative with mDP when around mDP <10, while dropped and then remained at a level similar to mDP = 5 with around 95 mu g ml(-1) for DPPH scavenging activity and 4 mmol AAE g(-1) for FRAP value.	[Zhou, Hai-Chao; Lin, Yi-Ming; Ding, Zhen-Hua; Chai, Wei-Ming; Wei, Shu-Dong] Xiamen Univ, Key Lab, Minist Educ Coastal & Wetland Ecosyst, Xiamen, Peoples R China; [Zhou, Hai-Chao; Tam, Nora Fung-yee] City Univ Hong Kong, Dept Biol & Chem, Hong Kong, Hong Kong, Peoples R China; [Zhou, Hai-Chao; Tam, Nora Fung-yee] City Univ Hong Kong, Shenzhen Res Inst, Futian CityU Mangrove R&D Ctr, Shenzhen, Peoples R China	Xiamen University; City University of Hong Kong; City University of Hong Kong	Zhou, HC (corresponding author), Xiamen Univ, Key Lab, Minist Educ Coastal & Wetland Ecosyst, Xiamen, Peoples R China.	zhouhc2013@gmail.com; bhntam@cityu.edu.hk	Zhou, Haichao/ABA-1449-2021	Zhou, Haichao/0000-0003-2641-1273; TAM, Nora Fung-yee/0000-0003-2205-8775	National Natural Science Foundation of China [41306084, 41176090, 31070522]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This present work was supported by the National Natural Science Foundation of China (URL: http://isisn.nsfc.gov.cn/egrantweb/): no. 41306084 (Hai-Chao Zhou's funding), no. 41176090 (Zhen-Hua Ding's funding), and no. 31070522 (Yi-Ming Lin's funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasalvar C, 2009, J AGR FOOD CHEM, V57, P4645, DOI 10.1021/jf900489d; ARIGA T, 1990, AGR BIOL CHEM TOKYO, V54, P2499, DOI 10.1080/00021369.1990.10870369; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Cai YZ, 2006, LIFE SCI, V78, P2872, DOI 10.1016/j.lfs.2005.11.004; Cai YZ, 2004, LIFE SCI, V74, P2157, DOI 10.1016/j.lfs.2003.09.047; Castillo-Munoz N, 2009, J AGR FOOD CHEM, V57, P209, DOI 10.1021/jf802863g; Chacha M, 2008, NAT PROD COMMUN, V3, P17; Chai WM, 2012, J AGR FOOD CHEM, V60, P5013, DOI 10.1021/jf300740d; Chen JD, 2008, HELV CHIM ACTA, V91, P2292, DOI 10.1002/hlca.200890249; Chen XF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091830, 10.1371/journal.pone.0085716, 10.1371/journal.pone.0115462, 10.1371/journal.pone.0103330, 10.1371/journal.pone.0091809, 10.1371/journal.pone.0087752]; Chirinos R, 2007, SEP PURIF TECHNOL, V55, P217, DOI 10.1016/j.seppur.2006.12.005; CZOCHANSKA Z, 1980, J CHEM SOC PERK T 1, P2278, DOI 10.1039/p19800002278; de Gaulejac NSC, 1999, J SCI FOOD AGR, V79, P1081, DOI 10.1002/(SICI)1097-0010(199906)79:8&lt;1081::AID-JSFA330&gt;3.0.CO;2-G; Es-Safi NE, 2006, J AGR FOOD CHEM, V54, P6969, DOI 10.1021/jf061090f; Feller IC, 1999, ECOLOGY, V80, P2193, DOI 10.1890/0012-9658(1999)080[2193:EONEOW]2.0.CO;2; Fu C, 2007, J AGR FOOD CHEM, V55, P7689, DOI 10.1021/jf071166n; Gu LW, 2002, J AGR FOOD CHEM, V50, P4852, DOI 10.1021/jf020214v; Guyot S, 2001, J AGR FOOD CHEM, V49, P14, DOI 10.1021/jf000814z; Hagerman AE, 1998, J AGR FOOD CHEM, V46, P1887, DOI 10.1021/jf970975b; Hellstrom J, 2007, J AGR FOOD CHEM, V55, P157, DOI 10.1021/jf062441t; Hernes PJ, 2001, GEOCHIM COSMOCHIM AC, V65, P3109, DOI 10.1016/S0016-7037(01)00641-X; Jerez M, 2007, FOOD CHEM, V104, P518, DOI 10.1016/j.foodchem.2006.11.071; Khanbabaee K, 2001, NAT PROD REP, V18, P641, DOI 10.1039/b101061l; Kraus TEC, 2003, J CHEM ECOL, V29, P703, DOI 10.1023/A:1022876804925; Kraus TEC, 2003, PLANT SOIL, V256, P41, DOI 10.1023/A:1026206511084; Li CM, 2010, J AGR FOOD CHEM, V58, P9033, DOI 10.1021/jf102552b; Lin P, 2006, MARINE HIGHER PLANT, P76; Lin YM, 2006, BIOGEOCHEMISTRY, V78, P343, DOI 10.1007/s10533-005-4427-5; Lizcano LJ, 2010, FOOD CHEM, V119, P1566, DOI 10.1016/j.foodchem.2009.09.043; Maie N, 2008, LIMNOL OCEANOGR, V53, P160, DOI 10.4319/lo.2008.53.1.0160; Mainoya J. R., 1986, MAN MANGROVES, P87; MAKKAR HPS, 1993, J SCI FOOD AGR, V61, P161, DOI 10.1002/jsfa.2740610205; MEIR S, 1995, J AGR FOOD CHEM, V43, P1813, DOI 10.1021/jf00055a012; Monagas M, 2010, J PHARMACEUT BIOMED, V51, P358, DOI 10.1016/j.jpba.2009.03.035; Oo CW, 2008, J APPL POLYM SCI, V109, P963, DOI 10.1002/app.28135; Rastogi RP, 1991, COMPENDIUM INDIAN PL, P1; Reed JD, 2005, PHYTOCHEMISTRY, V66, P2248, DOI 10.1016/j.phytochem.2005.05.015; Silva EM, 2007, FOOD CHEM, V101, P1012, DOI 10.1016/j.foodchem.2006.02.055; Taylor AW, 2003, J AGR FOOD CHEM, V51, P4101, DOI 10.1021/jf0340409; TERRILL TH, 1992, J SCI FOOD AGR, V58, P321, DOI 10.1002/jsfa.2740580306; Wang Y, 2014, PLANT SOIL, V374, P549, DOI 10.1007/s11104-013-1912-9; Xiang P, 2007, J APPL POLYM SCI, V105, P859, DOI 10.1002/app.26373; Zhang LL, 2010, MOLECULES, V15, P420, DOI 10.3390/molecules15010420; Zhou HC, 2012, SOIL BIOL BIOCHEM, V44, P113, DOI 10.1016/j.soilbio.2011.09.015; Zhou HC, 2011, FOOD CHEM, V129, P1710, DOI 10.1016/j.foodchem.2011.06.036; Zhou HC, 2011, FOOD RES INT, V44, P613, DOI 10.1016/j.foodres.2010.12.016; Zhou HC, 2011, ACTA CHIM SINICA, V69, P2981	48	51	53	4	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e107606	10.1371/journal.pone.0107606	http://dx.doi.org/10.1371/journal.pone.0107606			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313980	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500005
J	Hongsuwan, M; Srisamang, P; Kanoksil, M; Luangasanatip, N; Jatapai, A; Day, NP; Peacock, SJ; Cooper, BS; Limmathurotsakul, D				Hongsuwan, Maliwan; Srisamang, Pramot; Kanoksil, Manas; Luangasanatip, Nantasit; Jatapai, Anchalee; Day, Nicholas P.; Peacock, Sharon J.; Cooper, Ben S.; Limmathurotsakul, Direk			Increasing Incidence of Hospital-Acquired and Healthcare-Associated Bacteremia in Northeast Thailand: A Multicenter Surveillance Study	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; CONTROL CONSORTIUM INICC; CENTRAL VENOUS CATHETER; LENGTH-OF-STAY; NOSOCOMIAL INFECTIONS; ATTRIBUTABLE COST; 8 CITIES; UNITS; RATES; MORTALITY	Background: Little is known about the epidemiology of nosocomial bloodstream infections in public hospitals in developing countries. We evaluated trends in incidence of hospital-acquired bacteremia (HAB) and healthcare-associated bacteremia (HCAB) and associated mortality in a developing country using routinely available databases. Methods: Information from the microbiology and hospital databases of 10 provincial hospitals in northeast Thailand was linked with the national death registry for 2004-2010. Bacteremia was considered hospital-acquired if detected after the first two days of hospital admission, and healthcare-associated if detected within two days of hospital admission with a prior inpatient episode in the preceding 30 days. Results: A total of 3,424 patients out of 1,069,443 at risk developed HAB and 2,184 out of 119,286 at risk had HCAB. Of these 1,559 (45.5%) and 913 (41.8%) died within 30 days, respectively. Between 2004 and 2010, the incidence rate of HAB increased from 0.6 to 0.8 per 1,000 patient-days at risk (p<0.001), and the cumulative incidence of HCAB increased from 1.2 to 2.0 per 100 readmissions (p<0.001). The most common causes of HAB were Acinetobacter spp. (16.2%), Klebsiella pneumoniae (13.9%), and Staphylococcus aureus (13.9%), while those of HCAB were Escherichia coli (26.3%), S. aureus (14.0%), and K. pneumoniae (9.7%). There was an overall increase over time in the proportions of ESBL-producing E. coli causing HAB and HCAB. Conclusions: This study demonstrates a high and increasing incidence of HAB and HCAB in provincial hospitals in northeast Thailand, increasing proportions of ESBL-producing isolates, and very high associated mortality.	[Hongsuwan, Maliwan; Luangasanatip, Nantasit; Jatapai, Anchalee; Day, Nicholas P.; Peacock, Sharon J.; Cooper, Ben S.; Limmathurotsakul, Direk] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Srisamang, Pramot] Sappasithiprasong Hosp, Dept Pediat, Ubon Ratchathani, Thailand; [Kanoksil, Manas] Udon Thani Hosp, Dept Pediat, Udon Thani, Thailand; [Day, Nicholas P.; Cooper, Ben S.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Peacock, Sharon J.] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Peacock, Sharon J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; [Limmathurotsakul, Direk] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Mahidol University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Mahidol University	Limmathurotsakul, D (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.	direk@tropmedres.ac	Cooper, Ben/HGC-7082-2022; Peacock, Sharon J/ABE-6331-2020	Peacock, Sharon/0000-0002-1718-2782; Limmathurotsakul, Direk/0000-0001-7240-5320; Cooper, Ben/0000-0002-9445-7217	Wellcome Trust of Great Britain [089275/Z/09/Z]; The Medical Research Council; Department for International Development [MR/K006924/1]; NIHR Cambridge Biomedical Research Centre; Intermediate Wellcome Trust Fellowship [101103/Z/13/Z]; MRC [MR/K006924/1] Funding Source: UKRI; Medical Research Council [MR/K006924/1] Funding Source: researchfish	Wellcome Trust of Great Britain(Wellcome Trust); The Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department for International Development; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Intermediate Wellcome Trust Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by the Wellcome Trust of Great Britain (grant number 089275/Z/09/Z). BSC was supported by The Medical Research Council and Department for International Development (grant number MR/K006924/1). SJP receives support from the NIHR Cambridge Biomedical Research Centre. DL is supported by an Intermediate Wellcome Trust Fellowship (grant number 101103/Z/13/Z). The funder has no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken AM, 2011, LANCET, V378, P2021, DOI 10.1016/S0140-6736(11)61622-X; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Askarian M, 2013, INT J PREVENTIVE MED, V4, P366; Baker OG, 1997, AM J INFECT CONTROL, V25, P96, DOI 10.1016/S0196-6553(97)90034-1; Cheng AC, 2008, PLOS MED, V5, P1173, DOI 10.1371/journal.pmed.0050175; Cuellar LE, 2008, REV PANAM SALUD PUBL, V24, P16, DOI 10.1590/S1020-49892008000700002; Rosenthal VD, 2013, INFECT CONT HOSP EP, V34, P229, DOI 10.1086/669511; Duennas L, 2011, J INFECT DEV COUNTR, V5, P445, DOI 10.3855/jidc.1319; Epidemiology BO, 2011, ANN EP SURV REP 2010; Fortin E, 2012, INFECT CONT HOSP EP, V33, P456, DOI 10.1086/665323; FRIEDMAN C, 1984, AM J INFECT CONTROL, V12, P228, DOI 10.1016/0196-6553(84)90113-5; Guanche-Garcell H, 2011, INT J INFECT DIS, V15, pE357, DOI 10.1016/j.ijid.2011.02.001; Hall KK, 2006, CLIN MICROBIOL REV, V19, P788, DOI 10.1128/CMR.00062-05; Higuera F, 2007, INFECT CONT HOSP EP, V28, P31, DOI 10.1086/510812; Higuera F, 2005, CRIT CARE MED, V33, P2022, DOI 10.1097/01.CCM.0000178190.89663.E5; Hu BJ, 2013, AM J INFECT CONTROL, V41, P301, DOI 10.1016/j.ajic.2012.03.037; Jaggi N, 2013, INT J INFECT DIS, V17, pE1218, DOI 10.1016/j.ijid.2013.07.007; Johnson AP, 2011, J ANTIMICROB CHEMOTH, V66, pIV43, DOI 10.1093/jac/dkr076; Kanoksil M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054714; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Kubler A, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.05.018; Leblebicioglu H, 2007, J HOSP INFECT, V65, P251, DOI 10.1016/j.jhin.2006.10.012; Leblebicioglu H, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-10; Lee Mao-Cheng, 2010, Can J Infect Dis Med Microbiol, V21, pe1; Madani Naoufel, 2009, Int Arch Med, V2, P29, DOI 10.1186/1755-7682-2-29; Mehta A, 2007, J HOSP INFECT, V67, P168, DOI 10.1016/j.jhin.2007.07.008; Mitt P, 2009, J HOSP INFECT, V71, P365, DOI 10.1016/j.jhin.2009.01.008; Moreno CA, 2006, INFECT CONT HOSP EP, V27, P349, DOI 10.1086/503341; Navoa-Ng JA, 2011, AM J INFECT CONTROL, V39, P548, DOI 10.1016/j.ajic.2010.10.018; Opartkiattikul Nisarat, 2002, Rinsho Byori, V50, P121; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Pereira CAP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068144; Barba EJR, 2006, AM J INFECT CONTROL, V34, P244, DOI 10.1016/j.ajic.2005.05/024; Rasslan Ossama, 2012, J Infect Public Health, V5, P394, DOI 10.1016/j.jiph.2012.07.002; Rodriguez-Bano J, 2010, CLIN MICROBIOL INFEC, V16, P1408, DOI [10.1111/j.1469-0691.2010.03089.x, 10.1111/j.1469-0691.2009.03089.x]; Rosenthal VD, 2012, INFECTION, V40, P415, DOI 10.1007/s15010-012-0246-5; Rosenthal VD, 2004, INFECT CONT HOSP EP, V25, P251, DOI 10.1086/502386; Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P475, DOI 10.1016/j.ajic.2003.03.002; Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P291, DOI 10.1067/mic.2003.1; Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P405, DOI 10.1067/mic.2003.52; Rosenthal VD, 2008, AM J INFECT CONTROL, V36, P627, DOI [10.1016/j.ajic.2008.10.009, 10.1016/j.ajic.2008.06.003]; Rosenthal VD, 2006, ANN INTERN MED, V145, P582, DOI 10.7326/0003-4819-145-8-200610170-00007; Rosenthal VD, 2012, AM J INFECT CONTROL, V40, P396, DOI 10.1016/j.ajic.2011.05.020; Rosenthal VD, 2010, INFECT CONT HOSP EP, V31, P1264, DOI 10.1086/657140; Salomao R, 2008, REV PANAM SALUD PUBL, V24, P195, DOI 10.1590/S1020-49892008000900006; Shorr AF, 2006, CRIT CARE MED, V34, P2588, DOI 10.1097/01.CCM.0000239121.09533.09; Son JS, 2010, J KOREAN MED SCI, V25, P992, DOI 10.3346/jkms.2010.25.7.992; Tao LL, 2011, INT J INFECT DIS, V15, pE774, DOI 10.1016/j.ijid.2011.06.009; Vrijens F, 2010, J HOSP INFECT, V75, P158, DOI 10.1016/j.jhin.2009.12.006; Wenzel RP, 2001, EMERG INFECT DIS, V7, P174, DOI 10.3201/eid0702.010203; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699	51	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109324	10.1371/journal.pone.0109324	http://dx.doi.org/10.1371/journal.pone.0109324			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310563	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210300046
J	Hsieh, IS; Yang, RS; Fu, WM				Hsieh, I-Shan; Yang, Rong-Sen; Fu, Wen-Mei			Osteopontin Upregulates the Expression of Glucose Transporters in Osteosarcoma Cells	PLOS ONE			English	Article							PHLORETIN-INDUCED APOPTOSIS; INDUCIBLE FACTOR 1-ALPHA; CANCER-CELLS; ERYTHROPOIETIN GENE; THERAPEUTIC TARGET; GLUT-1 EXPRESSION; PATIENT SURVIVAL; FACTOR-I; HYPOXIA; TUMOR	Osteosarcoma is the most common primary malignancy of bone. Even after the traditional standard surgical therapy, metastasis still occurs in a high percentage of patients. Glucose is an important source of metabolic energy for tumor proliferation and survival. Tumors usually overexpress glucose transporters, especially hypoxia-responsive glucose transporter 1 and glucose transporter 3. Osteopontin, hypoxia-responsive glucose transporter 1, and glucose transporter 3 are overexpressed in many types of tumors and have been linked to tumorigenesis and metastasis. In this study, we investigated the regulation of glucose transporters by osteopontin in osteosarcoma. We observed that both glucose transporters and osteopontin were upregulated in hypoxic human osteosarcoma cells. Endogenously released osteopontin regulated the expression of glucose transporter 1 and glucose transporter 3 in osteosarcoma and enhanced glucose uptake into cells via the alpha v beta 3 integrin. Knockdown of osteopontin induced cell death in 20% of osteosarcoma cells. Phloretin, a glucose transporter inhibitor, also caused cell death by treatment alone. The phloretin-induced cell death was significantly enhanced in osteopontin knockdown osteosarcoma cells. Combination of a low dose of phloretin and chemotherapeutic drugs, such as daunomycin, 5-Fu, etoposide, and methotrexate, exhibited synergistic cytotoxic effects in three osteosarcoma cell lines. Inhibition of glucose transporters markedly potentiated the apoptotic sensitivity of chemotherapeutic drugs in osteosarcoma. These results indicate that the combination of a low dose of a glucose transporter inhibitor with cytotoxic drugs may be beneficial for treating osteosarcoma patients.	[Hsieh, I-Shan; Fu, Wen-Mei] Natl Taiwan Univ, Coll Med, Dept Pharmacol, Taipei 10764, Taiwan; [Yang, Rong-Sen] Natl Taiwan Univ Hosp, Dept Orthoped Surg, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital	Yang, RS (corresponding author), Natl Taiwan Univ Hosp, Dept Orthoped Surg, Taipei, Taiwan.	rsyang@ntuh.gov.tw; wenmei@ntu.edu.tw		Yang, Rong-Sen/0000-0002-0553-4779; FU, WEN-MEI/0000-0003-4157-8987	Ministry of Science and Technology [NSC 101-2325-B-002-070]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was financially supported by Ministry of Science and Technology (NSC 101-2325-B-002-070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekola K, 2012, CURR OPIN ONCOL, V24, P650, DOI 10.1097/CCO.0b013e328356da72; Ahmed M, 2011, EXPERT OPIN THER TAR, V15, P1113, DOI 10.1517/14728222.2011.594438; Airley R, 2001, CLIN CANCER RES, V7, P928; Airley RE, 2007, CHEMOTHERAPY, V53, P233, DOI 10.1159/000104457; Cao XH, 2007, CANCER CHEMOTH PHARM, V59, P495, DOI 10.1007/s00280-006-0291-9; Carlos-Bregni R, 2008, ORAL SURG ORAL MED O, V105, pE47, DOI 10.1016/j.tripleo.2007.09.003; Clark JCM, 2008, J CANCER RES CLIN, V134, P281, DOI 10.1007/s00432-007-0330-x; Dalla-Torre CA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-237; Denhardt DT, 1998, J CELL BIOCHEM, P92, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<92::AID-JCB13>3.0.CO;2-A; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; Denhardt DT, 2001, ANNU REV PHARMACOL, V41, P723, DOI 10.1146/annurev.pharmtox.41.1.723; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dimova EY, 2006, ANN NY ACAD SCI, V1090, P355, DOI 10.1196/annals.1378.039; Egawa-Takata T, 2010, CANCER SCI, V101, P2171, DOI 10.1111/j.1349-7006.2010.01670.x; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Giachelli CM, 2000, MATRIX BIOL, V19, P615, DOI 10.1016/S0945-053X(00)00108-6; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ho VT, 1996, BIOCHEM BIOPH RES CO, V223, P175, DOI 10.1006/bbrc.1996.0865; Jain S, 2007, EXPERT OPIN THER TAR, V11, P81, DOI 10.1517/14728222.11.1.81; Kobori M, 1997, CANCER LETT, V119, P207, DOI 10.1016/S0304-3835(97)00271-1; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; Medina RA, 2002, BIOL RES, V35, P9, DOI 10.4067/S0716-97602002000100004; Meneses AM, 2008, J CELL PHYSIOL, V214, P110, DOI 10.1002/jcp.21166; O'Neil RG, 2005, MOL IMAGING BIOL, V7, P388, DOI 10.1007/s11307-005-0011-6; Park SY, 2007, J MED FOOD, V10, P581, DOI 10.1089/jmf.2007.116; Przybylska Katarzyna, 2007, Polish Journal of Food and Nutrition Sciences, V57, P307; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Rey S, 2010, CARDIOVASC RES, V86, P236, DOI 10.1093/cvr/cvq045; Sabzevari O, 2004, CHEM-BIOL INTERACT, V148, P57, DOI 10.1016/j.cbi.2004.04.004; Savitskaya YA, 2012, CLIN SARCOMA RES, V2, DOI 10.1186/2045-3329-2-9; Schwab JH, 2012, J BONE JOINT SURG AM, V94A, P1913, DOI 10.2106/JBJS.L.00955; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Tilli TM, 2011, MOL CANCER RES, V9, P280, DOI 10.1158/1541-7786.MCR-10-0463; Tsao R, 2003, J AGR FOOD CHEM, V51, P6347, DOI 10.1021/jf0346298; Vengellur A, 2004, TOXICOL SCI, V82, P638, DOI 10.1093/toxsci/kfh278; Wai PY, 2008, CANCER METAST REV, V27, P103, DOI 10.1007/s10555-007-9104-9; WANG GL, 1993, BLOOD, V82, P3610; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Weber GF, 2010, BRIT J CANCER, V103, P861, DOI 10.1038/sj.bjc.6605834; Weber GF, 2011, CANCER GENOM PROTEOM, V8, P263; Wittig JC, 2002, AM FAM PHYSICIAN, V65, P1123; Wu CH, 2009, INT J CANCER, V124, P2210, DOI 10.1002/ijc.24189; Yamamoto N, 2003, J CLIN INVEST, V112, P181, DOI 10.1172/JCI200317778; Younes M, 1997, CANCER-AM CANCER SOC, V80, P1046, DOI 10.1002/(SICI)1097-0142(19970915)80:6<1046::AID-CNCR6>3.0.CO;2-7; Younes M, 2001, ANTICANCER RES, V21, P575; Zhong H, 2000, CANCER RES, V60, P1541; Zou CH, 2005, J BIOCHEM BIOPH METH, V64, P207, DOI 10.1016/j.jbbm.2005.08.001	49	13	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109550	10.1371/journal.pone.0109550	http://dx.doi.org/10.1371/journal.pone.0109550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310823	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210300056
J	Pocock, T; Falk, S				Pocock, Tessa; Falk, Stefan			Negative Impact on Growth and Photosynthesis in the Green Alga Chlamydomonas reinhardtii in the Presence of the Estrogen 17 alpha-Ethynylestradiol	PLOS ONE			English	Article							CARBONIC-ANHYDRASE; EMBRYONIC EXPOSURE; SLUDGE TREATMENT; CHEMICALS; MUTANT; CAH3	It is well known that estrogenic compounds affect development of fertilized eggs of many species of birds, fish and amphibians through disrupted activity of carbonic anhydrase (CA). The most potent activity comes from the most commonly occurring synthetic sterol, 17 alpha-Ethynylestradiol (EE2). Less is known about the responses of aquatic phytoplankton to these compounds. Here we show for the first time that, in comparision to the control, the addition of 7 mu M EE2 reduced the growth rate of the green alga Chlamydomonas reinhardtii by 68% for cells grown at high CO2. When cells were grown in ambient air (low C-i) with a fully activated carbon concentrating mechanism through the induction of CA activity, the growth rates were reduced by as much as 119%. A reduced growth rate could be observed at EE2 concentrations as low as 10 pM. This was accompanied by a reduced maximum capacity for electron transport in photosystem II as determined by a lower F-V/F-M for low C-i-grown cells, which indicates the involvement of CAH3, a CA specifically located in the thylakoid lumen involved in proton pumping across the thylakoid membranes. These results were in agreement with an observed reduction in the chloroplastic affinity for C-i as shown by a strong increase in the Michaelis-Menten K-0.5 for HCO3-. In itself, a lowering of the growth rate of a green alga by addition of the sterol EE2 warrants further investigation into the potential environmental impact by the release of treated waste water.	[Pocock, Tessa; Falk, Stefan] Mid Sweden Univ, Dept Nat Sci, Sundsvall, Sweden	Mid-Sweden University	Falk, S (corresponding author), Mid Sweden Univ, Dept Nat Sci, Sundsvall, Sweden.	Stefan.Falk@miun.se						Berg C, 2004, REPRODUCTION, V128, P455, DOI 10.1530/rep.1.00211; Berg C, 2001, REPRODUCTION, V121, P155, DOI 10.1530/rep.0.1210155; Brown KH, 2008, P NATL ACAD SCI USA, V105, P19786, DOI 10.1073/pnas.0808333105; Chen X, 2010, WATER AIR SOIL POLL, V206, P251, DOI 10.1007/s11270-009-0102-0; de Mes Titia, 2005, Reviews in Environmental Science and Bio/Technology, V4, P275, DOI 10.1007/s11157-005-3216-x; Duanmu DQ, 2009, PLANT PHYSIOL, V149, P929, DOI 10.1104/pp.108.132456; European Commission, 1997, 17549 EUR ENV CLIM R; FALK S, 1992, PLANT PHYSIOL, V100, P685, DOI 10.1104/pp.100.2.685; Falk S, 1991, THESIS UMEA U SWEDEN; Gronlund E., 2004, VATTEN, V60, P239; Hamid H, 2012, WATER RES, V46, P5813, DOI 10.1016/j.watres.2012.08.002; Hanson DT, 2003, PLANT PHYSIOL, V132, P2267, DOI 10.1104/pp.103.023481; Holm L, 2001, ARCH TOXICOL, V75, P362, DOI 10.1007/s002040100241; Johnson AC, 2001, ENVIRON SCI TECHNOL, V35, P4697, DOI 10.1021/es010171j; Karlsson J, 1998, EMBO J, V17, P1208, DOI 10.1093/emboj/17.5.1208; LEGLER J, 2001, THESIS WAGENINGEN U; McConnell IL, 2007, BBA-BIOENERGETICS, V1767, P639, DOI 10.1016/j.bbabio.2007.01.019; Metcalfe CD, 2001, ENVIRON TOXICOL CHEM, V20, P297, DOI [10.1897/1551-5028(2001)020&lt;0297:EPOCDI&gt;2.0.CO;2, 10.1002/etc.5620200210]; Morgan RM, 1998, PHOTOSYNTH RES, V56, P303, DOI 10.1023/A:1006048519302; MORONEY JV, 1985, PLANT PHYSIOL, V79, P177, DOI 10.1104/pp.79.1.177; Perron MC, 2011, ENVIRON RES, V111, P520, DOI 10.1016/j.envres.2011.02.013; Pettersson I, 2007, ENVIRON TOXICOL CHEM, V26, P1005, DOI 10.1897/06-464R.1; Pocock T, 2011, J EXP BOT, V62, P1169, DOI 10.1093/jxb/erq347; Price GD, 2002, FUNCT PLANT BIOL, V29, P131, DOI 10.1071/PP01229; Shutova T, 2008, EMBO J, V27, P782, DOI 10.1038/emboj.2008.12; Spalding MH, 2008, J EXP BOT, V59, P1463, DOI 10.1093/jxb/erm128; Spalding MH, 2002, FUNCT PLANT BIOL, V29, P221, DOI 10.1071/PP01182; Thorpe KL, 2003, ENVIRON SCI TECHNOL, V37, P1142, DOI 10.1021/es0201348; United Nations Population Division, 2006, WORLD CONTR US 2005	29	14	14	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109289	10.1371/journal.pone.0109289	http://dx.doi.org/10.1371/journal.pone.0109289			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310092	gold, Green Submitted, Green Published			2022-12-27	WOS:000343210300042
J	Wilkosz, P; Greggains, GD; Tanbo, TG; Fedorcsak, P				Wilkosz, Pawel; Greggains, Gareth D.; Tanbo, Tom G.; Fedorcsak, Peter			Female Reproductive Decline Is Determined by Remaining Ovarian Reserve and Age	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; IN-VITRO FERTILIZATION; EXCESSIVE RESPONSE; FOLLICLE DYNAMICS; MENOPAUSE; WOMEN; MODEL; ENDOMETRIOSIS; POPULATION; COHORT	The early decline and loss of female fertility in humans and other species represents an evolutionary paradox. Despite being born with a vast stock of oocytes, females encounter an exhaustion of ovarian reserve and sterility half way through their natural lives. Female reproductive ageing has been proposed to proceed as an ongoing decline in ovarian reserve, determined by remaining ovarian follicle number. However, despite extensive modelling, the respective contributions of intra-, inter-, and extra-ovarian signalling have not been fully characterised. It remains unclear whether reproductive ageing progresses simply as a pre-determined function of remaining ovarian follicles, or as an age-dependent process in humans. Here, we have analysed ovarian response to hormonal stimulation in women who have undergone surgical removal of a single ovary, in order to investigate the relative contributions of intra-, inter, and extra-ovarian signalling on reproductive ageing. Our data show that in unilaterally oophorectomised women, ovarian response to follicle stimulating hormone (FSH) declines beyond levels predicted by a total ovarian follicle pool model of reproductive ageing. Maintenance of ovarian function later in reproductive life, despite the removal of half of the total ovarian reserve, suggests a role for an extra-ovarian age-dependent regulation of reproductive decline. This highlights the need for further work to identify signalling factors that communicate age-related signals between the soma and the germline.	[Wilkosz, Pawel; Greggains, Gareth D.; Tanbo, Tom G.; Fedorcsak, Peter] Oslo Univ Hosp, Rikshosp, Dept Gynecol, Sect Reprod Med, Oslo, Norway; [Wilkosz, Pawel; Tanbo, Tom G.] Univ Oslo, Inst Clin Med, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo	Wilkosz, P (corresponding author), Oslo Univ Hosp, Rikshosp, Dept Gynecol, Sect Reprod Med, Oslo, Norway.	sbwilp@ous-hf.no		Greggains, Gareth/0000-0003-2424-4694	Akershus University Hospital, Oslo, Norway; Norwegian Resource Centre for Women's Health	Akershus University Hospital, Oslo, Norway; Norwegian Resource Centre for Women's Health	PW received grants from Akershus University Hospital, Oslo, Norway (http://www.ahus.no/Sider/side.aspx) and the Norwegian Resource Centre for Women's Health (http://www.oslo-universitetssykehus.no/omoss/avdelinger/kvinnehelse/Sider/enhet.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER TG, 1976, CLIN OBSTET GYNAECOL, V3, P3; Bjelland EK, 2014, HUM REPROD, V29, P835, DOI 10.1093/humrep/deu026; Bjercke S, 2005, HUM REPROD, V20, P2441, DOI 10.1093/humrep/dei101; BLOCK E, 1953, ACTA ANAT, V17, P201; Broekmans FJ, 2009, ENDOCR REV, V30, P465, DOI 10.1210/er.2009-0006; Broer SL, 2011, HUM REPROD UPDATE, V17, P46, DOI 10.1093/humupd/dmq034; Broer SL, 2013, FERTIL STERIL, V100, P420, DOI 10.1016/j.fertnstert.2013.04.024; Broer SL, 2009, FERTIL STERIL, V91, P705, DOI 10.1016/j.fertnstert.2007.12.013; Byskov AG, 2011, HUM REPROD, V26, P2129, DOI 10.1093/humrep/der145; Carlsson IB, 2006, HUM REPROD, V21, P2223, DOI 10.1093/humrep/del165; Chen HX, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008018.pub2; Coccia ME, 2011, HUM REPROD, V26, P3000, DOI 10.1093/humrep/der286; FADDY MJ, 1995, HUM REPROD, V10, P770, DOI 10.1093/oxfordjournals.humrep.a136036; Faddy MJ, 1996, HUM REPROD, V11, P1484; FADDY MJ, 1992, HUM REPROD, V7, P1342, DOI 10.1093/oxfordjournals.humrep.a137570; Faddy MJ, 2000, MOL CELL ENDOCRINOL, V163, P43, DOI 10.1016/S0303-7207(99)00238-5; GOUGEON A, 1994, BIOL REPROD, V50, P653, DOI 10.1095/biolreprod50.3.653; Gougeon A, 1996, ENDOCR REV, V17, P121, DOI 10.1210/er.17.2.121; Hansen KR, 2008, HUM REPROD, V23, P699, DOI 10.1093/humrep/dem408; Hardy R, 1999, AM J EPIDEMIOL, V149, P612; Jaubert F, 2009, ROBBOYS PATHOLOGY FE, P1; Kenyon C, 2010, ANN NY ACAD SCI, V1204, P156, DOI 10.1111/j.1749-6632.2010.05640.x; Kirkwood TBL, 2010, ANN NY ACAD SCI, V1204, P21, DOI 10.1111/j.1749-6632.2010.05520.x; Kitajima M, 2011, FERTIL STERIL, V96, P685, DOI 10.1016/j.fertnstert.2011.06.064; Knowlton NS, 2014, FERTIL STERIL, V101, P851, DOI 10.1016/j.fertnstert.2013.12.008; Lei L, 2013, P NATL ACAD SCI USA, V110, P8585, DOI 10.1073/pnas.1306189110; Lemos NA, 2008, FERTIL STERIL, V89, P1064, DOI 10.1016/j.fertnstert.2007.04.048; Li HWR, 2011, CONTRACEPTION, V83, P582, DOI 10.1016/j.contraception.2010.09.007; Luo SJ, 2010, CELL, V143, P299, DOI 10.1016/j.cell.2010.09.013; Masse V, 2011, HUM REPROD, V26, P3431, DOI 10.1093/humrep/der320; Nelson SM, 2013, HUM REPROD UPDATE, V19, P67, DOI 10.1093/humupd/dms043; Opoien HK, 2012, FERTIL STERIL, V97, P912, DOI 10.1016/j.fertnstert.2012.01.112; Tatar M, 2010, ANN NY ACAD SCI, V1204, P149, DOI 10.1111/j.1749-6632.2010.05522.x; Thomas-Teinturier C, 2013, HUM REPROD, V28, P488, DOI 10.1093/humrep/des391; Velde ERT, 2002, HUM REPROD UPDATE, V8, P141, DOI 10.1093/humupd/8.2.141; Wallace WHB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008772; Yasui T, 2012, MATURITAS, V72, P249, DOI 10.1016/j.maturitas.2012.04.002; Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143; Zhang H, 2012, P NATL ACAD SCI USA, V109, P12580, DOI 10.1073/pnas.1206600109	39	39	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e108343	10.1371/journal.pone.0108343	http://dx.doi.org/10.1371/journal.pone.0108343			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310678	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210300015
J	Wang, XL; Ding, C; Wang, SH; Han, XG; Hou, WW; Yue, JP; Zou, JC; Yu, SQ				Wang, Xiaolan; Ding, Chan; Wang, Shaohui; Han, Xiangan; Hou, Wanwan; Yue, Jiaping; Zou, Jiechi; Yu, Shengqing			The AS87_04050 Gene Is Involved in Bacterial Lipopolysaccharide Biosynthesis and Pathogenicity of Riemerella anatipestifer	PLOS ONE			English	Article							MAJOR VIRULENCE FACTOR; ESCHERICHIA-COLI K-12; ABORTUS ROUGH MUTANTS; SERUM-RESISTANCE; BIOFILM FORMATION; HAEMOPHILUS-PARASUIS; CAMPYLOBACTER-JEJUNI; GLIDING MOTILITY; RFA LOCUS; IDENTIFICATION	Riemerella anatipestifer is reported worldwide as a cause of septicemic and exucitive diseases of domestic ducks. In this study, we identified a mutant strain RA2640 by Tn4351 transposon mutagenesis in which the AS87 04050 gene was inactivated by insertion of the transposon. Southern blot analysis indicated that only one insertion was found in the genome of the mutant strain RA2640. SDS-PAGE followed by silver staining showed that the lipopolysaccharide (LPS) pattern of mutant strain RA2640 was different from its wild-type strain Yb2, suggesting the LPS was defected. In addition, the phenotype of the mutant strain RA2640 was changed to roLigh-type, evident by altered colony morphology, autoaggregation ability and crystal violet staining characteristics. Bacterial LPS is a key factor in virulence as well as in both innate and acquired host responses to infection. The rough-type mutant strain RA2640 showed higher sensitivity to antibiotics, disinfectants and normal duck serum, and higher capability of adherence and invasion to Vero cells, compared to its wild type strain Yb2. Moreover, the mutant strain RA2640 lost the agglutination ability of its wild-type strain Yb2 to R. anatipestifer serotype 2 positive sera, suggesting that the 0-antigen is defected. Animal experiments indicated that the the mutant strain RA2640 was attenuated by more than 100,000-fold, compared to its wild-type strain Y132. suggested that the AS87_04050 gene in R. anatipestifer is associated with the LPS biosynthesis and bacterial pathogenicity.	[Wang, Xiaolan; Ding, Chan; Wang, Shaohui; Han, Xiangan; Hou, Wanwan; Yue, Jiaping; Zou, Jiechi; Yu, Shengqing] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS	Yu, SQ (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai, Peoples R China.	yus@shvri.ac.cn		Han, Xiangan/0000-0001-5625-637X	National Natural Science Foundation of China [31272591]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31272591). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez B, 2006, APPL ENVIRON MICROB, V72, P4044, DOI 10.1128/AEM.00128-06; AUSTIN EA, 1990, J BACTERIOL, V172, P5312, DOI 10.1128/jb.172.9.5312-5325.1990; Bouchet V, 2003, P NATL ACAD SCI USA, V100, P8898, DOI 10.1073/pnas.1432026100; Bravo D, 2008, J MED MICROBIOL, V57, P938, DOI 10.1099/jmm.0.47848-0; Cerda-Cuellar M, 2008, VET J, V175, P384, DOI 10.1016/j.tvjl.2007.01.016; Chang CF, 1998, AVIAN PATHOL, V27, P339, DOI 10.1080/03079459808419349; Crasta KC, 2002, J BACTERIOL, V184, P1932, DOI 10.1128/JB.184.7.1932-1939.2002; DeShazer D, 1998, MOL MICROBIOL, V30, P1081, DOI 10.1046/j.1365-2958.1998.01139.x; Ding JiaBo, 2008, Scientia Agricultura Sinica, V41, P2448; Fry BN, 2000, INFECT IMMUN, V68, P2594, DOI 10.1128/IAI.68.5.2594-2601.2000; GROSSMAN N, 1987, J BACTERIOL, V169, P856, DOI 10.1128/jb.169.2.856-863.1987; Grozdanov L, 2002, J BACTERIOL, V184, P5912, DOI 10.1128/JB.184.21.5912-5925.2002; Gu XX, 1998, INFECT IMMUN, V66, P1891, DOI 10.1128/IAI.66.5.1891-1897.1998; Harvill ET, 2000, INFECT IMMUN, V68, P6720, DOI 10.1128/IAI.68.12.6720-6728.2000; Hu QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039805; Hu QH, 2011, VET MICROBIOL, V150, P278, DOI 10.1016/j.vetmic.2011.01.022; Hu QH, 2010, VET MICROBIOL, V144, P429, DOI 10.1016/j.vetmic.2010.02.023; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Hunnicutt DW, 2002, J BACTERIOL, V184, P2370, DOI 10.1128/JB.184.9.2370-2378.2002; Lapaque N, 2005, CURR OPIN MICROBIOL, V8, P60, DOI 10.1016/j.mib.2004.12.003; MCSWEEGAN E, 1986, INFECT IMMUN, V53, P141, DOI 10.1128/IAI.53.1.141-148.1986; Merino S, 1996, MICROB PATHOGENESIS, V20, P325, DOI 10.1006/mpat.1996.0031; Nakao R, 2006, INFECT IMMUN, V74, P6145, DOI 10.1128/IAI.00261-06; Pei JW, 2006, INFECT IMMUN, V74, P2667, DOI 10.1128/IAI.74.5.2667-2675.2006; Pei JW, 2004, INFECT IMMUN, V72, P440, DOI 10.1128/IAI.72.1.440-450.2004; Penuelas-Urquides K, 2013, BRAZ J MICROBIOL, V44, P287, DOI 10.1590/S1517-83822013000100042; Pier GB, 2007, INT J MED MICROBIOL, V297, P277, DOI 10.1016/j.ijmm.2007.03.012; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; RONCERO C, 1992, J BACTERIOL, V174, P3250, DOI 10.1128/jb.174.10.3250-3260.1992; Sandhu TS., 1986, DUCK PRODUCTION SCI, P111; Thoden JB, 1998, BIOCHEMISTRY-US, V37, P11469, DOI 10.1021/bi9808969; Wang X, 2012, CHIN J ANIM INFECT D, V20, P54; Wang XY, 2010, PROG LIPID RES, V49, P97, DOI 10.1016/j.plipres.2009.06.002; Wells TJ, 2008, ENVIRON MICROBIOL, V10, P589, DOI 10.1111/j.1462-2920.2007.01479.x; Weng SC, 1999, FEMS MICROBIOL LETT, V179, P11, DOI 10.1111/j.1574-6968.1999.tb08701.x; Zhang B, 2012, VET MICROBIOL, V157, P237, DOI 10.1016/j.vetmic.2011.12.002; Zhang M, 2013, VET MICROBIOL, V164, P322, DOI 10.1016/j.vetmic.2013.02.017; Zuppardo AB, 1998, INFECT IMMUN, V66, P2601, DOI 10.1128/IAI.66.6.2601-2606.1998	39	23	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109962	10.1371/journal.pone.0109962	http://dx.doi.org/10.1371/journal.pone.0109962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303276	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400096
J	Igumbor, J; Pascoe, S; Rajap, S; Townsend, W; Sargent, J; Darkoh, E				Igumbor, Jude; Pascoe, Sophie; Rajap, Shuabe; Townsend, Wendy; Sargent, John; Darkoh, Ernest			A South African Public-Private Partnership HIV Treatment Model: Viability and Success Factors	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; ADHERENCE; CARE; MANAGEMENT; COUNTRIES; OUTCOMES; QUALITY; PROGRAM; HEALTH; SECTOR	Introduction: The increasing number of people requiring HIV treatment in South Africa calls for efficient use of its human resources for health in order to ensure optimum treatment coverage and outcomes. This paper describes an innovative public-private partnership model which uses private sector doctors to treat public sector patients and ascertains the model's ability to maintain treatment outcomes over time. Methods: The study used a retrospective design based on the electronic records of patients who were down-referred from government hospitals to selected private general medical practitioners (GPs) between November 2005 and October 2012. In total, 2535 unique patient records from 40 GPs were reviewed. The survival functions for mortality and attrition were calculated. Cumulative incidence of mortality for different time cohorts (defined by year of treatment initiation) was also established. Results: The median number of patients per GP was 143 (IQR: 66-246). At the time of down-referral to private GPs, 13.8% of the patients had CD4 count <200 cell/mm(3), this proportion reduced to 6.6% at 12 months and 4.1% at 48 months. Similarly, 88.4% of the patients had suppressed viral load (defined as HIV-1 RNA <400 copies/ml) at 48 months. The patients' probability of survival at 12 and 48 months was 99.0% (95% CI: 98.4%-99.3%) and 89.0% (95% CI: 87.1%-90.0%) respectively. Patient retention at 48 months remained high at 94.3% (95% CI: 93.0%-95.7%). Conclusions: The study findings demonstrate the ability of the GPs to effectively maintain patient treatment outcomes and potentially contribute to HIV treatment scale-up with the relevant support mechanism. The model demonstrates how an assisted private sector based programme can be effectively and efficiently used to either target specific health concerns, key populations or serve as a stop-gap measure to meet urgent health needs.	[Igumbor, Jude; Pascoe, Sophie] BroadReach Healthcare, Dept Res & Dev, Cape Town, South Africa; [Rajap, Shuabe] BroadReach Healthcare, Operat Dept, Cape Town, South Africa; [Townsend, Wendy; Sargent, John; Darkoh, Ernest] BroadReach Healthcare, Cape Town, South Africa		Igumbor, J (corresponding author), BroadReach Healthcare, Dept Res & Dev, Cape Town, South Africa.	jigumbor@brhc.com	Sargent, James D/I-2773-2013; Igumbor, Jude Ofuzinim/AAJ-2802-2020	Igumbor, Jude Ofuzinim/0000-0002-3324-7654; Pascoe, Sophie/0000-0002-9199-8333	U.S. Agency for International Development (USAID) [674-A-00-08-00008-00]	U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID))	This paper was developed using part of routinely collected data of a HIV treatment programme that is funded by the U.S. Agency for International Development (USAID) under the Cooperative Agreement No. 674-A-00-08-00008-00. The funding agency had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript, and the paper is not a requirement for the treatment programme funding. Beyond using the data of a funded programme, there was no external funding for this study.	Auer C, 2006, HEALTH POLICY, V77, P172, DOI 10.1016/j.healthpol.2005.07.004; Basu S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001244; Boulle A, 2008, B WORLD HEALTH ORGAN, V86, P678, DOI 10.2471/BLT.07.045294; Chabikuli N, 2002, HEALTH POLICY PLANN, V17, P40, DOI 10.1093/heapol/17.suppl_1.40; Chaix B, 2005, J EPIDEMIOL COMMUN H, V59, P517, DOI 10.1136/jech.2004.025478; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Dato María I, 2009, Rev. salud pública, V11, P370, DOI 10.1590/S0124-00642009000300006; Department of Health, 2011, 2011 NAT ANT SENT HI; Diabate S, 2007, AIDS, V21, P1799, DOI 10.1097/QAD.0b013e3282a5667b; Eholie SP, 2007, JAIDS-J ACQ IMM DEF, V45, P355; Enriquez M, 2011, HIV AIDS-RES PALLIAT, V3, P45, DOI 10.2147/HIV.S8993; Fatti G, 2011, J ACQ IMMUN DEF SYND, V58, P17; Gbotosho GO, 2009, MALARIA J, V8, P1; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Igumbor J, 2012, AFR J PHYS HLTH ED R, V18, P812; Igumbor JO, 2011, AIDS CARE, V23, P231, DOI 10.1080/09540121.2010.498909; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Johnson LF, 2012, S AFR J HIV MED, P22; Joint United Nations Programme on HIV/AIDS (UNAIDSb), 2012, WORLD AIDS DAY REP; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Lok JJ, 2010, AIDS, V24, P1867, DOI 10.1097/QAD.0b013e32833adbcf; MacPherson P, 2009, T ROY SOC TROP MED H, V103, P588, DOI 10.1016/j.trstmh.2008.10.001; Makuch MY, 2010, HUM REPROD, V25, P430, DOI 10.1093/humrep/dep405; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Navario P, 2009, THESIS U CAPE TOWN; Nglazi MD, 2011, JAIDS-J ACQ IMM DEF, V56, pE1, DOI 10.1097/QAI.0b013e3181ff0bdc; Pasquet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013414; Schneider H, 2005, SAMJ S AFR MED J, V95, P782; Shisana O., 2013, HIV AIDS S AFRICA LA; Stevens WS, 2010, J INFECT DIS, V201, pS78, DOI 10.1086/650383; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Vandan N, 2009, PUBLIC HEALTH, V123, P484, DOI 10.1016/j.puhe.2009.05.004	32	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110635	10.1371/journal.pone.0110635	http://dx.doi.org/10.1371/journal.pone.0110635			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0AY	25329384	Green Published, Green Submitted, gold			2022-12-27	WOS:000343942100077
J	Hoile, SP; Clarke-Harris, R; Huang, RC; Calder, PC; Mori, TA; Beilin, LJ; Lillycrop, KA; Burdge, GC				Hoile, Samuel P.; Clarke-Harris, Rebecca; Huang, Rae-Chi; Calder, Philip C.; Mori, Trevor A.; Beilin, Lawrence J.; Lillycrop, Karen A.; Burdge, Graham C.			Supplementation with N-3 Long-Chain Polyunsaturated Fatty Acids or Olive Oil in Men and Women with Renal Disease Induces Differential Changes in the DNA Methylation of FADS2 and ELOVL5 in Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							ALPHA-LINOLENIC ACID; EXPRESSION; EPIGENETICS; OMEGA-3-FATTY-ACIDS; METABOLISM; NUTRITION; PROTEIN; CLONING; HEALTH; SEX	Background: Studies in animal models and in cultured cells have shown that fatty acids can induce alterations in the DNA methylation of specific genes. There have been no studies of the effects of fatty acid supplementation on the epigenetic regulation of genes in adult humans. Methods and Results: We investigated the effect of supplementing renal patients with 4 g daily of either n-3 long-chain polyunsaturated fatty acids (n-3 LCPUFA) or olive oil (OO) for 8 weeks on the methylation status of individual CpG loci in the 59 regulatory region of genes involved in PUFA biosynthesis in peripheral blood mononuclear cells from men and women (aged 53 to 63 years). OO and n-3 LCPUFA each altered (>10% difference in methylation) 2/22 fatty acid desaturase (FADS)2 CpGs, while n-3 LCPUFA, but not OO, altered (>10%) 1/12 ELOVL5 CpGs in men. OO altered (>6%) 8/22 FADS2 CpGs and (>3%) 3/12 elongase (ELOVL)-5 CpGs, while n-3 LCPUFA altered (>5%) 3/22 FADS2 CpGs and 2/12 (>3%) ELOVL5 CpGs in women. FADS1 or ELOVL2 methylation was unchanged. The n-3 PUFA supplementation findings were replicated in blood DNA from healthy adults (aged 23 to 30 years). The methylation status of the altered CpGs in FADS2 and ELOVL5 was associated negatively with the level of their transcripts. Conclusions: These findings show that modest fatty acid supplementation can induce altered methylation of specific CpG loci in adult humans, contingent on the nature of the supplement and on sex. This has implications for understanding the effect of fatty acids on PUFA metabolism and cell function.	[Hoile, Samuel P.; Clarke-Harris, Rebecca; Calder, Philip C.; Burdge, Graham C.] Univ Southampton, Fac Med, Acad Unit Human Dev & Hlth, Southampton SO9 5NH, Hants, England; [Huang, Rae-Chi] Telethon Kids Inst, Perth, WA, Australia; [Calder, Philip C.] Univ Hosp Southampton NHS Fdn Trust, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Calder, Philip C.] Univ Southampton, Southampton, Hants, England; [Mori, Trevor A.; Beilin, Lawrence J.] Univ Western Australia, Sch Med & Pharmacol, Royal Perth Hosp Unit, Perth, WA 6009, Australia; [Lillycrop, Karen A.] Univ Southampton, Fac Nat & Environm Sci, Ctr Biol Sci, Southampton, Hants, England	University of Southampton; Telethon Kids Institute; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; Royal Perth Hospital; University of Western Australia; University of Southampton	Burdge, GC (corresponding author), Univ Southampton, Fac Med, Acad Unit Human Dev & Hlth, Southampton SO9 5NH, Hants, England.	g.c.burdge@soton.ac.uk	Huang, Rae-Chi/A-5841-2013; Mori, Trevor/H-5485-2014; Calder, Philip C/E-9739-2013; Burdge, Graham/A-2370-2014	Huang, Rae-Chi/0000-0002-8464-6639; Mori, Trevor/0000-0002-5264-9229; Calder, Philip C/0000-0002-6038-710X; Burdge, Graham/0000-0002-7665-2967; Lillycrop, Karen/0000-0001-7350-5489; Clarke-Harris, Rebecca/0000-0002-6888-9518	National Health and Medical Research Council of Australia [APP303151]; Hollywood Private Hospital Research Foundation; European Union [244995]; University of Southampton	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Hollywood Private Hospital Research Foundation; European Union(European Commission); University of Southampton	The generation of the samples used in Study 1 was supported by a grant from the National Health and Medical Research Council of Australia (APP303151) and the Hollywood Private Hospital Research Foundation to TAM. The generation of the samples used in Study 2 was funded by the European Union's Seventh Framework Programme FP7 2007-2013 under grant agreement number 244995 (BIOCLAIMS: Biomarkers of robustness of metabolic homeostasis for nutrigenomics-derived health claims made on food) awarded to PCC. All other analyses reported here were supported by departmental funds at the University of Southampton (GCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bester D, 2010, NUTR RES REV, V23, P334, DOI 10.1017/S0954422410000223; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Burdge GC, 2008, PROSTAG LEUKOTR ESS, V78, P73, DOI 10.1016/j.plefa.2007.10.028; Burdge GC, 2002, BRIT J NUTR, V88, P355, DOI 10.1079/BJN2002662; Burdge GC, 2002, BRIT J NUTR, V88, P411, DOI 10.1079/BJN2002689; Burdge GC, 2013, CLIN LIPIDOL, V8, P505, DOI 10.2217/clp.13.53; Burdge GC, 2010, GENOME MED, V2, DOI 10.1186/gm201; Burdge GC, 2010, ANNU REV NUTR, V30, P315, DOI 10.1146/annurev.nutr.012809.104751; Burdge GC, 2009, J NUTR, V139, P1054, DOI 10.3945/jn.109.104653; Burdge GC, 2009, BRIT J NUTR, V101, P619, DOI 10.1017/S0007114508145883; Calder PC, 2012, CURR OPIN CARDIOL, V27, P412, DOI 10.1097/HCO.0b013e328353febd; Ceccarelli V, 2011, J BIOL CHEM, V286, P27092, DOI 10.1074/jbc.M111.253609; Childs CE, 2012, PROSTAG LEUKOTR ESS, V86, P141, DOI 10.1016/j.plefa.2012.03.007; Cho HP, 1999, J BIOL CHEM, V274, P471, DOI 10.1074/jbc.274.1.471; Cho HP, 1999, J BIOL CHEM, V274, P37335, DOI 10.1074/jbc.274.52.37335; Cikos S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-113; Devlin AM, 2007, J BIOL CHEM, V282, P37082, DOI 10.1074/jbc.M704256200; GARG ML, 1988, BIOCHEM J, V249, P351, DOI 10.1042/bj2490351; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Haban P, 2004, MED SCI MONITOR, V10, pPI49; Hoile SP, 2013, J NUTR BIOCHEM, V24, P1213, DOI 10.1016/j.jnutbio.2012.09.005; Jacobsen SC, 2012, DIABETOLOGIA, V55, P3341, DOI 10.1007/s00125-012-2717-8; Kelsall CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034492; Lee HS, 2013, AM J CLIN NUTR; Lohner S, 2013, ANN NUTR METAB, V62, P98, DOI 10.1159/000345599; MORI TA, 1992, METABOLISM, V41, P1059, DOI 10.1016/0026-0495(92)90286-J; Mori TA, 2009, J HYPERTENS, V27, P1863, DOI 10.1097/HJH.0b013e32832e1bd9; Niculescu MD, 2013, FASEB J, V27, P350, DOI 10.1096/fj.12-210724; Niculescu MD, 2011, INT J DEV NEUROSCI, V29, P795, DOI 10.1016/j.ijdevneu.2011.09.006; Schwenk RW, 2013, HORM METAB RES, V45, P786, DOI 10.1055/s-0033-1348263; Sibbons CM, 2014, PROSTAG LEUKOTR ESS, V90, P47, DOI 10.1016/j.plefa.2013.12.006; Sijben JWC, 2007, P NUTR SOC, V66, P237, DOI 10.1017/S0029665107005472; Szyf M, 2007, TOXICOL SCI, V100, P7, DOI 10.1093/toxsci/kfm177; Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188; Visioli F, 2011, CURR PHARM DESIGN, V17, P786, DOI 10.2174/138161211795428885	35	64	65	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109896	10.1371/journal.pone.0109896	http://dx.doi.org/10.1371/journal.pone.0109896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329159	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000345204100034
J	Prasad, AA; McNally, GP				Prasad, Asheeta A.; McNally, Gavan P.			Effects of Vivo Morpholino Knockdown of Lateral Hypothalamus Orexin/Hypocretin on Renewal of Alcohol Seeking	PLOS ONE			English	Article							CONTEXT-INDUCED REINSTATEMENT; MEDIAL PREFRONTAL CORTEX; EXTINGUISHED REWARD SEEKING; NUCLEUS-ACCUMBENS CORE; VENTRAL TEGMENTAL AREA; D1 DOPAMINE-RECEPTORS; COCAINE-SEEKING; INDUCED RELAPSE; SPONTANEOUS-RECOVERY; HEROIN SEEKING	Two experiments used vivo morpholinos to assess the role of orexin/hypocretin in ABA renewal of extinguished alcohol seeking. Rats were trained to respond for alcoholic beer in a distinctive context, A, and then extinguished in a second distinctive context, B. When rats were tested in the extinction context, ABB, responding was low but when they were tested in the training context, ABA, responding was significantly higher. Microinjection of an orexin/hypocretin antisense vivo morpholino into LH significantly reduced orexin/hypocretin protein expression but had no effect on the ABA renewal of alcohol seeking (Experiment 1). Microinjection of a higher dose of the antisense vivo morpholino into LH also significantly reduced orexin/hypocretin protein expression but this was not selective and yielded significant reduction in melanin concentrating hormone (MCH) protein expression. This non-selective knockdown did significantly reduce ABA renewal as well as reduce the reacquisition of alcohol seeking. Taken together, these findings show an important role for LH in the ABA renewal of alcohol seeking but that orexin/hypocretin is not necessary for this renewal.	[Prasad, Asheeta A.; McNally, Gavan P.] UNSW Australia, Sch Psychol, Sydney, NSW, Australia	University of New South Wales Sydney	McNally, GP (corresponding author), UNSW Australia, Sch Psychol, Sydney, NSW, Australia.	g.mcnally@unsw.edu.au		prasad, asheeta/0000-0001-9752-8175; McNally, Gavan/0000-0001-9061-6463	National Health and Medical Research Council [1047899]; Australian Research Council [FT120100250]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by the National Health and Medical Research Council #1047899 (www.nhmrc.gov.au) and the Australian Research Council #FT120100250 (www.arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aston-Jones G, 2010, BRAIN RES, V1314, P74, DOI 10.1016/j.brainres.2009.09.106; Baldo BA, 2003, J COMP NEUROL, V464, P220, DOI 10.1002/cne.10783; Barson JR, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/983964; Bossert JM, 2007, J NEUROSCI, V27, P12655, DOI 10.1523/JNEUROSCI.3926-07.2007; Bossert JM, 2006, NEUROPSYCHOPHARMACOL, V31, P2197, DOI 10.1038/sj.npp.1300977; Bossert JM, 2011, NAT NEUROSCI, V14, P420, DOI 10.1038/nn.2758; Bossert JM, 2004, J NEUROSCI, V24, P10726, DOI 10.1523/JNEUROSCI.3207-04.2004; Bouton ME, 2014, BEHAV PROCESS, V104, P13, DOI 10.1016/j.beproc.2014.02.012; Bouton ME, 2011, LEARN BEHAV, V39, P57, DOI 10.3758/s13420-011-0018-6; Boutrel B, 2005, P NATL ACAD SCI USA, V102, P19168, DOI 10.1073/pnas.0507480102; Chaudhri N, 2008, EUR J NEUROSCI, V28, P2288, DOI 10.1111/j.1460-9568.2008.06517.x; Cippitelli A, 2010, PSYCHOPHARMACOLOGY, V211, P367, DOI 10.1007/s00213-010-1891-y; Collins BN, 2002, J CONSULT CLIN PSYCH, V70, P390, DOI 10.1037//0022-006X.70.2.390; Corcoran KA, 2004, LEARN MEMORY, V11, P598, DOI 10.1101/lm.78704; Corcoran KA, 2001, J NEUROSCI, V21, P1720, DOI 10.1523/JNEUROSCI.21-05-01720.2001; Crombag HS, 2008, PHILOS T R SOC B, V363, P3233, DOI 10.1098/rstb.2008.0090; Crombag HS, 2002, BEHAV NEUROSCI, V116, P169, DOI 10.1037//0735-7044.116.1.169; Cruz FC, 2014, J NEUROSCI, V34, P7437, DOI 10.1523/JNEUROSCI.0238-14.2014; de Lecea L, 1999, CELL MOL LIFE SCI, V56, P473, DOI 10.1007/s000180050446; Diergaarde L, 2008, NEUROPHARMACOLOGY, V55, P712, DOI 10.1016/j.neuropharm.2008.06.003; Fuchs RA, 2005, NEUROPSYCHOPHARMACOL, V30, P296, DOI 10.1038/sj.npp.1300579; George Paxinos CW, 2005, RAT BRAIN STEREOTAXI; Hamlin AS, 2008, NEUROSCIENCE, V151, P659, DOI 10.1016/j.neuroscience.2007.11.018; Hamlin AS, 2007, NEUROSCIENCE, V146, P525, DOI 10.1016/j.neuroscience.2007.01.063; Hamlin AS, 2006, NEUROSCIENCE, V143, P25, DOI 10.1016/j.neuroscience.2006.07.035; Hamlin AS, 2009, EUR J NEUROSCI, V29, P802, DOI 10.1111/j.1460-9568.2009.06623.x; Hanlon EC, 2004, PSYCHOPHARMACOLOGY, V172, P241, DOI 10.1007/s00213-003-1654-0; Harris JA, 2001, PSYCHOPHARMACOLOGY, V156, P92, DOI 10.1007/s002130100757; Holmes NM, 2013, J EXP PSYCHOL-ANIM B, V39, P208, DOI 10.1037/a0031986; James MH, 2011, INT J NEUROPSYCHOPH, V14, P684, DOI 10.1017/S1461145711000423; Lawrence AJ, 2006, BRIT J PHARMACOL, V148, P752, DOI 10.1038/sj.bjp.0706789; Leung HT, 2008, J EXP PSYCHOL-ANIM B, V34, P461, DOI 10.1037/0097-7403.34.4.461; Leung HT, 2012, J EXP PSYCHOL ANIM B, V38, P394, DOI 10.1037/a0030201; Marchant NJ, 2014, J NEUROSCI, V34, P7447, DOI 10.1523/JNEUROSCI.0256-14.2014; Marchant NJ, 2013, CURR OPIN NEUROBIOL, V23, P675, DOI 10.1016/j.conb.2013.01.003; Marchant NJ, 2009, J NEUROSCI, V29, P1331, DOI 10.1523/JNEUROSCI.5194-08.2009; Marinelli PW, 2007, EUR J NEUROSCI, V26, P2815, DOI 10.1111/j.1460-9568.2007.05898.x; Millan EZ, 2012, BEHAV NEUROSCI, V126, P690, DOI 10.1037/a0029953; Millan EZ, 2010, J NEUROSCI, V30, P4626, DOI 10.1523/JNEUROSCI.4933-09.2010; Nair SG, 2011, NEUROPSYCHOPHARMACOL, V36, P497, DOI 10.1038/npp.2010.181; Nunez A, 2009, CURR NEUROPHARMACOL, V7, P50, DOI 10.2174/157015909787602797; Perry CJ, 2013, EUR J NEUROSCI, V38, P2762, DOI 10.1111/ejn.12283; Peters J, 2008, PSYCHOPHARMACOLOGY, V197, P319, DOI 10.1007/s00213-007-1034-2; Reissner KJ, 2012, J NEUROSCI METH, V203, P354, DOI 10.1016/j.jneumeth.2011.10.009; Rescorla RA, 2006, LEARN BEHAV, V34, P13, DOI 10.3758/BF03192867; Richards JK, 2009, ADDICT BIOL, V14, P144, DOI 10.1111/j.1369-1600.2008.00139.x; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Sartor GC, 2012, J NEUROSCI, V32, P4623, DOI 10.1523/JNEUROSCI.4561-11.2012; Smith RJ, 2010, NEUROPHARMACOLOGY, V58, P179, DOI 10.1016/j.neuropharm.2009.06.042; Smith RJ, 2009, EUR J NEUROSCI, V30, P493, DOI 10.1111/j.1460-9568.2009.06844.x; Thewissen R, 2006, BEHAV RES THER, V44, P1441, DOI 10.1016/j.brat.2005.10.010; Todd TP, 2014, NEUROBIOL LEARN MEM, V108, P52, DOI 10.1016/j.nlm.2013.08.012; Willcocks AL, 2013, EUR J NEUROSCI, V37, P259, DOI 10.1111/ejn.12031; Winrow CJ, 2012, NEUROPHARMACOLOGY, V62, P978, DOI 10.1016/j.neuropharm.2011.10.003	55	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110385	10.1371/journal.pone.0110385	http://dx.doi.org/10.1371/journal.pone.0110385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329297	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204100070
J	Meristo, M; Surian, L				Meristo, Marek; Surian, Luca			Infants Distinguish Antisocial Actions Directed towards Fair and Unfair Agents	PLOS ONE			English	Article							PUNISHMENT; MORALITY; BEHAVIOR; REACT	Three experiments provide evidence of an incipient sense of fairness in preverbal infants. Ten-month-old infants were shown cartoon videos with two agents, the 'donors', who distributed resources to two identical recipients. One donor always distributed the goods equally, while the other performed unequal distributions by giving everything to one recipient. In the test phase, a third agent hit or took resources away from either the fair or the unfair donor. We found that infants looked longer when the antisocial actions were directed towards the unfair rather than the fair donor. These findings support the view that infants are able to evaluate agents based on their distributive actions and suggest that the foundations of human socio-moral competence are acquired independently of parental feedback and linguistic experience.	[Meristo, Marek] Univ Gothenburg, Dept Psychol, S-40020 Gothenburg, Sweden; [Surian, Luca] Univ Trento, Dept Psychol & Cognit Sci, Rovereto, Trento, Italy	University of Gothenburg; University of Trento	Meristo, M (corresponding author), Univ Gothenburg, Dept Psychol, Box 14158, S-40020 Gothenburg, Sweden.	marek.meristo@gu.se; luca.surian@unitn.it	Meristo, Marek/AAA-6556-2020; Surian, Luca/Q-2947-2019	Meristo, Marek/0000-0001-6792-3123; 	Swedish Research Council for Working Life and Social Research (FAS); Italian Government PRIN grants; EU Marie Curie International Postdoc Fellowship Programme	Swedish Research Council for Working Life and Social Research (FAS)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Italian Government PRIN grants; EU Marie Curie International Postdoc Fellowship Programme	This research was supported by The Swedish Research Council for Working Life and Social Research (FAS), by the Italian Government PRIN grants and by the EU Marie Curie International Postdoc Fellowship Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almas I, 2010, SCIENCE, V328, P1176, DOI 10.1126/science.1187300; Baumard N, 2013, BEHAV BRAIN SCI, V36, P59, DOI 10.1017/S0140525X11002202; Baumard N, 2012, DEV PSYCHOL, V48, P492, DOI 10.1037/a0026598; Benenson JF, 2007, EVOL HUM BEHAV, V28, P168, DOI 10.1016/j.evolhumbehav.2006.10.003; BLAIR RJR, 1995, COGNITION, V57, P1, DOI 10.1016/0010-0277(95)00676-P; Blake PR, 2011, COGNITION, V120, P215, DOI 10.1016/j.cognition.2011.04.006; Cushman F, 2013, COGNITION, V127, P6, DOI 10.1016/j.cognition.2012.11.008; Damon W., 1977, SOCIAL WORLD CHILD; Dwyer S., 1999, PHILOS LINGUISTICS, P169; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Geraci A, 2011, DEVELOPMENTAL SCI, V14, P1012, DOI 10.1111/j.1467-7687.2011.01048.x; Gredeback G, 2010, DEV NEUROPSYCHOL, V35, P1, DOI 10.1080/87565640903325758; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Hamlin JK, 2011, P NATL ACAD SCI USA, V108, P19931, DOI 10.1073/pnas.1110306108; Hamlin JK, 2010, DEVELOPMENTAL SCI, V13, P923, DOI 10.1111/j.1467-7687.2010.00951.x; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Hume D, 1777, ENQUIRY CONCERNING P; Johnson T, 2009, ECON LETT, V102, P192, DOI 10.1016/j.econlet.2009.01.003; Joyce R., 2007, EVOLUTION MORALITY; Kanngiesser P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043979; Kenward B, 2011, DEV PSYCHOL, V47, P1054, DOI 10.1037/a0023869; Kohlberg K, 1981, PHILOS MORAL DEV MOR; Kuhlmeier V, 2003, PSYCHOL SCI, V14, P402, DOI 10.1111/1467-9280.01454; Leman PJ, 2010, CHILD DEV, V81, P958, DOI 10.1111/j.1467-8624.2010.01445.x; Lisi AVMD, 2006, CHILD DEV, V77, P1063, DOI 10.1111/j.1467-8624.2006.00919.x; LoBue V, 2011, SOC DEV, V20, P154, DOI 10.1111/j.1467-9507.2009.00560.x; McCrink K, 2008, DEVELOPMENTAL SCI, V13, P37; Meristo M, 2013, COGNITION, V129, P102, DOI 10.1016/j.cognition.2013.06.006; Mikhail J, 2007, TRENDS COGN SCI, V11, P143, DOI 10.1016/j.tics.2006.12.007; Moore C, 2009, PSYCHOL SCI, V20, P944, DOI 10.1111/j.1467-9280.2009.02378.x; Nichols S, 2013, FUTURE PUNISHMENT; Olson KR, 2008, COGNITION, V108, P222, DOI 10.1016/j.cognition.2007.12.003; Piaget J., 1932, MORAL JUDGMENT CHILD; Prinz Jesse, 2007, EMOTIONAL CONSTRUCTI; Rochat P, 2009, J CROSS CULT PSYCHOL, V40, P416, DOI 10.1177/0022022109332844; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schmidt MFH, 2011, PLOS ONE, V6, DOI [10.1371/journal.-pone.0023223, DOI 10.1371/JOURNAL.-PONE.0023223]; Shaw A, 2014, J EXP PSYCHOL GEN, V143, P363, DOI 10.1037/a0031247; Shaw A, 2013, CURR DIR PSYCHOL SCI, V22, P413, DOI 10.1177/0963721413484467; Sloane S, 2012, PSYCHOL SCI, V23, P196, DOI 10.1177/0956797611422072; Smith CE, 2013, PLOS ONE, V8, DOI [10.1371/annotation/4b9340db-455b-4e0d-86e5-b6783747111f, 10.1371/journal.pone.0059510]; Sommerville JA, 2013, INFANCY, V18, P40, DOI 10.1111/j.1532-7078.2012.00129.x; Takagishi H, 2009, NEUROENDOCRINOL LETT, V30, P496	44	42	42	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110553	10.1371/journal.pone.0110553	http://dx.doi.org/10.1371/journal.pone.0110553			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ9XC	25329149	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210800094
J	Newton, VL; Ali, S; Duddy, G; Whitmarsh, AJ; Gardiner, NJ				Newton, Victoria L.; Ali, Sumia; Duddy, Graham; Whitmarsh, Alan J.; Gardiner, Natalie J.			Targeting Apoptosis Signalling Kinase-1 (ASK-1) Does Not Prevent the Development of Neuropathy in Streptozotocin-Induced Diabetic Mice	PLOS ONE			English	Article							REGULATING KINASE-1; PERIPHERAL NEUROPATHY; HETEROMERIC COMPLEX; PROTEIN-KINASES; MOUSE MODEL; STRESS; DISSOCIATION; ACTIVATION; PATHWAY; INHIBITION	Apoptosis signal-regulating kinase-1 (ASK1) is a mitogen-activated protein 3 kinase (MAPKKK/MAP3K) which lies upstream of the stress-activated MAPKs, JNK and p38. ASK1 may be activated by a variety of extracellular and intracellular stimuli. MAP kinase activation in the sensory nervous system as a result of diabetes has been shown in numerous preclinical and clinical studies. As a common upstream activator of both p38 and JNK, we hypothesised that activation of ASK1 contributes to nerve dysfunction in diabetic neuropathy. We therefore wanted to characterize the expression of ASK1 in sensory neurons, and determine whether the absence of functional ASK1 would protect against the development of neuropathy in a mouse model of experimental diabetes. ASK1 mRNA and protein is constitutively expressed by multiple populations of sensory neurons of the adult mouse lumbar DRG. Diabetes was induced in male C57BL/6 and transgenic ASK1 kinase-inactive (ASK1n) mice using streptozotocin. Levels of ASK1 do not change in the DRG, spinal cord, or sciatic nerve following induction of diabetes. However, levels of ASK2 mRNA increase in the spinal cord at 4 weeks of diabetes, which could represent a future target for this field. Neither motor nerve conduction velocity deficits, nor thermal or mechanical hypoalgesia were prevented or ameliorated in diabetic ASK1n mice. These results suggest that activation of ASK1 is not responsible for the nerve deficits observed in this mouse model of diabetic neuropathy.	[Newton, Victoria L.; Ali, Sumia; Whitmarsh, Alan J.; Gardiner, Natalie J.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Duddy, Graham] GlaxoSmithKline, Platform Technol & Sci, Stevenage, Herts, England	University of Manchester; GlaxoSmithKline	Gardiner, NJ (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	natalie.gardiner@manchester.ac.uk	Newton, Victoria/H-5566-2015	Newton, Victoria/0000-0001-5141-3970; Whitmarsh, Alan/0000-0003-1184-6610; Gardiner, Natalie/0000-0001-8287-1181	GlaxoSmithKline(GSK)-BBSRC(UK) [BB/J014478/1]	GlaxoSmithKline(GSK)-BBSRC(UK)	This work was supported by a GlaxoSmithKline(GSK)-BBSRC(UK) PhD studentship (VLN;BB/J014478/1). The authors thank GSK for advice, the supply of ASK1n mice and consumable support. The funders had no role in study design, data collection and analysis or preparation of the manuscript.	Averill S, 2004, EUR J NEUROSCI, V19, P1437, DOI 10.1111/j.1460-9568.2004.03241.x; Beiswenger KK, 2008, NEUROSCI LETT, V442, P267, DOI 10.1016/j.neulet.2008.06.079; Brownlees J, 2010, 13 WORLD C INT ASS S; Cheng HT, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-28; Cockrell LM, 2010, ONCOGENE, V29, P822, DOI 10.1038/onc.2009.382; Daulhac L, 2006, MOL PHARMACOL, V70, P1246, DOI 10.1124/mol.106.025478; Dorion S, 2002, J BIOL CHEM, V277, P30792, DOI 10.1074/jbc.M203642200; Drel VR, 2011, INT J MOL MED, V28, P629, DOI 10.3892/ijmm.2011.709; Fujii K, 2004, ONCOGENE, V23, P5099, DOI 10.1038/sj.onc.1207668; Fujino G, 2006, SEMIN CANCER BIOL, V16, P427, DOI 10.1016/j.semcancer.2006.09.003; Hsieh CC, 2006, FASEB J, V20, P259, DOI 10.1096/fj.05-4376com; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Iriyama T, 2009, EMBO J, V28, P843, DOI 10.1038/emboj.2009.32; Johnson MS, 2008, PAIN, V140, P35, DOI 10.1016/j.pain.2008.07.007; Kaji T, 2010, BIOCHEM BIOPH RES CO, V395, P213, DOI 10.1016/j.bbrc.2010.03.164; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Liu YM, 2001, J CLIN INVEST, V107, P917, DOI 10.1172/JCI11947; Lupachyk S, 2011, FREE RADICAL BIO MED, V50, P1400, DOI 10.1016/j.freeradbiomed.2011.01.037; Matsukawa J, 2004, J BIOCHEM, V136, P261, DOI 10.1093/jb/mvh134; Norman P, 2012, EXPERT OPIN THER PAT, V22, P1479, DOI 10.1517/13543776.2012.718760; Ortner E, 2007, BIOCHEM BIOPH RES CO, V362, P454, DOI 10.1016/j.bbrc.2007.08.006; Price SA, 2004, DIABETES, V53, P1851, DOI 10.2337/diabetes.53.7.1851; Purves T, 2001, FASEB J, V15, P2508, DOI 10.1096/fj.01-0253hyp; Sarker KP, 2003, J NEUROCHEM, V85, P50, DOI 10.1046/j.1471-4159.2003.01663.x; Stavniichuk R, 2011, EXP NEUROL, V230, P106, DOI 10.1016/j.expneurol.2011.04.002; Takeda K, 2008, ANNU REV PHARMACOL, V48, P199, DOI 10.1146/annurev.pharmtox.48.113006.094606; Takeda K, 2007, J BIOL CHEM, V282, P7522, DOI 10.1074/jbc.M607177200; Takizawa T, 2002, EUR J BIOCHEM, V269, P6126, DOI 10.1046/j.1432-1033.2002.03325.x; Thandavarayan RA, 2008, BIOCHEM PHARMACOL, V75, P1797, DOI 10.1016/j.bcp.2008.02.003; Tobiume K, 1997, BIOCHEM BIOPH RES CO, V239, P905, DOI 10.1006/bbrc.1997.7580; Tomlinson DR, 2008, J PERIPHER NERV SYST, V13, P112, DOI 10.1111/j.1529-8027.2008.00167.x; Toth CC, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-16; Wang XHSN, 1998, BIOCHEM BIOPH RES CO, V253, P33, DOI 10.1006/bbrc.1998.9749; Wodarski R, 2009, EUR J PAIN, V13, P807, DOI 10.1016/j.ejpain.2008.09.010; Wright DE, 2004, J PERIPHER NERV SYST, V9, P242, DOI 10.1111/j.1085-9489.2004.09404.x; Yamaguchi K, 2013, BBA-GEN SUBJECTS, V1830, P3656, DOI 10.1016/j.bbagen.2013.01.029; Yamakawa I, 2011, AM J PHYSIOL-ENDOC M, V301, pE844, DOI 10.1152/ajpendo.00029.2011; Zhan J, 2007, MOL CELL BIOL, V27, P3530, DOI 10.1128/MCB.00086-06	38	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e107437	10.1371/journal.pone.0107437	http://dx.doi.org/10.1371/journal.pone.0107437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329046	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210800004
J	Qiu, Q; Li, Y; Duan, XW; Yang, LK; Chen, Y; Li, H; Wang, L; Duan, ZP				Qiu, Qian; Li, Yan; Duan, Xiao-wan; Yang, Li-kun; Chen, Yu; Li, Hui; Wang, Li; Duan, Zhong-ping			Impact of a New Reimbursement Program on Hepatitis B Antiviral Medication Cost and Utilization in Beijing, China	PLOS ONE			English	Article							VIRUS-INFECTION; ENTECAVIR; MANAGEMENT	Background: Hepatitis B virus (HBV) infection is a significant clinical and financial burden for chronic hepatitis B (CHB) patients. In Beijing, China, partial reimbursement on antiviral agents was first implemented for the treatment of CHB patients in July 1, 2011. Aims: In this study, we describe the medical cost and utilization rates of antiviral therapy for CHB patients to explore the impact of the new partial reimbursement policy on the medical care cost, the composition, and antivirals utilization. Methods: Clinical and claims data of a retrospective cohort of 92,776 outpatients and 2,774 inpatients with non-cirrhotic CHB were retrieved and analyzed from You'an Hospital, Beijing between February 14, 2008 and December 31, 2012. The propensity score matching was used to adjust factors associated with the annual total cost, including age, gender, medical insurance type and treatment indicator. Results: Compared to patients who paid out-of-pocket, medical cost, especially antiviral costs increased greater among patients with medical insurance after July 1, 2011, the start date of reimbursement policy. Outpatients with medical insurance had 16% more antiviral utilization; usage increased 3% among those who paid out-of-pocket after the new partial reimbursement policy was implemented. Conclusions: Direct medical costs and antiviral utilization rates of CHB patients with medical insurance were higher than those from paid out-of-pocket payments, even after adjusting for inflation and other factors. Thus, a new partial reimbursement program may positively optimize the cost and standardization of antiviral treatment.	[Qiu, Qian; Li, Hui; Wang, Li] Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, Dept Epidemiol & Biostat,Inst Basic Med Sci, Beijing 100730, Peoples R China; [Li, Yan; Duan, Xiao-wan; Yang, Li-kun; Chen, Yu; Duan, Zhong-ping] Capital Med Univ, Beijing Youan Hosp, Ctr Liver, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Capital Medical University	Wang, L (corresponding author), Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, Dept Epidemiol & Biostat,Inst Basic Med Sci, Beijing 100730, Peoples R China.	liwang@ibms.pumc.edu.cn; duan2517@163.com			Ministry of National Science and Technology of China [2012ZX10004904]; Bristol-Myers Squibb Company [AI463-961]; Beijing Municipal and Technology Commission [Z131100004613030]; Innovative Foundation of Beijing Union Medical College	Ministry of National Science and Technology of China; Bristol-Myers Squibb Company(Bristol-Myers Squibb); Beijing Municipal and Technology Commission; Innovative Foundation of Beijing Union Medical College	This study was supported by the Ministry of National Science and Technology of China (2012ZX10004904), Bristol-Myers Squibb Company (AI463-961), Beijing Municipal and Technology Commission (Z131100004613030) and Innovative Foundation of Beijing Union Medical College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunetto MR, 2002, J HEPATOL, V36, P263, DOI 10.1016/S0168-8278(01)00266-5; Buti M, 2012, EUR J GASTROEN HEPAT, V24, P535, DOI 10.1097/MEG.0b013e3283511287; Chang TT, 2008, HEPATOL INT, V2, pS19, DOI 10.1007/s12072-008-9059-0; Chinese Society of Hepatology and Chinese Society of Infectious Diseases Chinese Medical Association, 2011, Zhonghua Gan Zang Bing Za Zhi, V19, P13, DOI 10.3760/cma.j.issn.1007-3418.2011.01.007; Fattovich G, 2003, SEMIN LIVER DIS, V23, P47, DOI 10.1055/s-2003-37590; Fattovich G, 2000, GUT, V46, P420, DOI 10.1136/gut.46.3.420; Janssen HLA, 2009, J HEPATOL, V51, P1, DOI 10.1016/j.jhep.2009.04.007; Keeffe EB, 2006, CLIN GASTROENTEROL H, V4, P936, DOI 10.1016/j.cgh.2006.05.016; Kobashi H, 2011, HEPATOL RES, V41, P405, DOI 10.1111/j.1872-034X.2011.00785.x; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Liaw YF, 2011, HEPATOLOGY, V53, P62, DOI 10.1002/hep.23952; Liaw YF, 2009, J HEPATOL, V51, P403, DOI 10.1016/j.jhep.2009.04.003; Lu FM, 2009, CHINESE MED J-PEKING, V122, P3, DOI 10.3760/cma.j.issn.0366-6999.2009.01.001; Lu JJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-37; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; Min H, 2009, VALUE HEALTH, V12, pS89; Osborn Melissa, 2011, Infect Drug Resist, V4, P55, DOI 10.2147/IDR.S4188; Yang BM, 2010, DIGEST DIS SCI, V55, P784, DOI 10.1007/s10620-009-0786-4; Yoon EL, 2011, J CLIN GASTROENTEROL, V45, P893, DOI 10.1097/MCG.0b013e31821f8bdf; Yuen MF, 2011, J GASTROEN HEPATOL, V26, P138, DOI 10.1111/j.1440-1746.2010.06545.x	22	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109652	10.1371/journal.pone.0109652	http://dx.doi.org/10.1371/journal.pone.0109652			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329072	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210800031
J	Abramoff, MD; Wu, XD; Lee, K; Tang, L				Abramoff, Michael D.; Wu, Xiaodong; Lee, Kyungmoo; Tang, Li			Subvoxel Accurate Graph Search Using Non-Euclidean Graph Space	PLOS ONE			English	Article							NET SURFACE PROBLEMS; IMAGE SEGMENTATION; ENERGY MINIMIZATION; FLOW; CUTS; OCT	Graph search is attractive for the quantitative analysis of volumetric medical images, and especially for layered tissues, because it allows globally optimal solutions in low-order polynomial time. However, because nodes of graphs typically encode evenly distributed voxels of the volume with arcs connecting orthogonally sampled voxels in Euclidean space, segmentation cannot achieve greater precision than a single unit, i.e. the distance between two adjoining nodes, and partial volume effects are ignored. We generalize the graph to non-Euclidean space by allowing non-equidistant spacing between nodes, so that subvoxel accurate segmentation is achievable. Because the number of nodes and edges in the graph remains the same, running time and memory use are similar, while all the advantages of graph search, including global optimality and computational efficiency, are retained. A deformation field calculated from the volume data adaptively changes regional node density so that node density varies with the inverse of the expected cost. We validated our approach using optical coherence tomography (OCT) images of the retina and 3-D MR of the arterial wall, and achieved statistically significant increased accuracy. Our approach allows improved accuracy in volume data acquired with the same hardware, and also, preserved accuracy with lower resolution, more cost-effective, image acquisition equipment. The method is not limited to any specific imaging modality and readily extensible to higher dimensions.	[Abramoff, Michael D.] Univ Iowa, Dept Biomed Engn, Dept Ophthalmol & Visual Sci, Stephen A Wynn Inst Vis Res, Iowa City, IA 52242 USA; [Abramoff, Michael D.; Lee, Kyungmoo] Univ Iowa, Dept Elect & Comp Engn, Iowa City, IA 52242 USA; [Abramoff, Michael D.] Iowa City Vet Adm Med Ctr, Iowa City, IA USA; [Wu, Xiaodong] Univ Iowa, Dept Elect & Comp Engn, Dept Radiat Oncol, Iowa City, IA 52242 USA; [Tang, Li] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Abramoff, MD (corresponding author), Univ Iowa, Dept Biomed Engn, Dept Ophthalmol & Visual Sci, Stephen A Wynn Inst Vis Res, Iowa City, IA 52242 USA.	michael-abramoff@uiowa.edu	Abramoff, Michael D/A-5836-2009	Abramoff, Michael D/0000-0002-3490-0037	National Institutes of Health [R01 EY019112, EY018853]; Arnold and Mabel Beckman Initiative for Macular Research; U.S. Department of Veterans Affairs [I01CX000119, IK2RX000728]; National Science Foundation [CCF-0844765, CCF-1318996]; Division of Computing and Communication Foundations [0844765] Funding Source: National Science Foundation; NATIONAL EYE INSTITUTE [R01EY018853, R01EY019112] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arnold and Mabel Beckman Initiative for Macular Research; U.S. Department of Veterans Affairs(US Department of Veterans Affairs); National Science Foundation(National Science Foundation (NSF)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by the National Institutes of Health R01 EY019112, EY018853, the Arnold and Mabel Beckman Initiative for Macular Research, the U.S. Department of Veterans Affairs I01CX000119, IK2RX000728 (MDA), and the National Science Foundation CCF-0844765, CCF-1318996 (XW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2002, IEEE T MED IMAGING, V21, P296, DOI 10.1109/TMI.2002.1000254; Abramoff MD, 2013, INVEST OPHTH VIS SCI, V54, P3721, DOI 10.1167/iovs.13-11812; Abramoff Michael D, 2010, IEEE Rev Biomed Eng, V3, P169, DOI 10.1109/RBME.2010.2084567; Abramoff MD, 2009, INVEST OPHTH VIS SCI, V50, P5778, DOI 10.1167/iovs.09-3790; Antony BJ, 2010, SPIE MEDICAL IMAGING; Boykov Y, 2001, IEEE T PATTERN ANAL, V23, P1222, DOI 10.1109/34.969114; Boykov Y, 2004, IEEE T PATTERN ANAL, V26, P1124, DOI 10.1109/TPAMI.2004.60; Boykov Y, 2006, INT J COMPUT VISION, V70, P109, DOI 10.1007/s11263-006-7934-5; Chen XJ, 2012, IEEE T MED IMAGING, V31, P1521, DOI 10.1109/TMI.2012.2191302; Dufour PA, 2013, IEEE T MED IMAGING, V32, P531, DOI 10.1109/TMI.2012.2225152; Filip M, 2011, THEORETICAL COMPUTER, V412, P1338; Garvin MK, 2008, IEEE T MED IMAGING, V27, P1495, DOI 10.1109/TMI.2008.923966; Garvin MK, 2009, IEEE T MED IMAGING, V28, P1436, DOI 10.1109/TMI.2009.2016958; KEYS RG, 1981, IEEE T ACOUST SPEECH, V29, P1153, DOI 10.1109/TASSP.1981.1163711; Lee K, 2012, THE IOWA REFERENCE A; Lee K, 2010, IEEE T MED IMAGING, V29, P159, DOI 10.1109/TMI.2009.2031324; Li K, 2006, IEEE T PATTERN ANAL, V28, P119, DOI 10.1109/TPAMI.2006.19; Liu XI, 2013, IEEE TRANSACTIONS ON, V32, P493; SHANNON CE, 1949, P IRE, V37, P10, DOI 10.1109/JRPROC.1949.232969; Song Q, 2013, IEEE T MED IMAGING, V32, P376, DOI 10.1109/TMI.2012.2227120; Trujillo-Pino A, 2013, IMAGE VISION COMPUT, V31, P72, DOI 10.1016/j.imavis.2012.10.005; Wu XD, 2002, LECT NOTES COMPUT SC, V2380, P1029; Wu XD, 2007, INT J COMPUT GEOM AP, V17, P261, DOI 10.1142/S0218195907002331; Wu XD, 2011, IEEE T MED IMAGING, V30, P814, DOI 10.1109/TMI.2010.2095870; Xu CY, 1998, IEEE T IMAGE PROCESS, V7, P359, DOI 10.1109/83.661186; Xu XY, 2011, IEEE T MED IMAGING, V30, P1184, DOI 10.1109/TMI.2010.2103566; Yin Y, 2010, IEEE T MED IMAGING, V29, P2023, DOI 10.1109/TMI.2010.2058861	27	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e107763	10.1371/journal.pone.0107763	http://dx.doi.org/10.1371/journal.pone.0107763			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314272	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500007
J	Branquinho, R; Sousa, C; Lopes, J; Pintado, ME; Peixe, LV; Osorio, H				Branquinho, Raquel; Sousa, Clara; Lopes, Joao; Pintado, Manuela E.; Peixe, Luisa V.; Osorio, Hugo			Differentiation of Bacillus pumilus and Bacillus safensis Using MALDI-TOF-MS	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; SPECIES IDENTIFICATION; RIBOSOMAL-PROTEINS; SUBTILIS; CLASSIFICATION; BACTERIA; CEREUS	Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) despite being increasingly used as a method for microbial identification, still present limitations in which concerns the differentiation of closely related species. Bacillus pumillus and Bacillus safensis, are species of biotechnological and pharmaceutical significance, difficult to differentiate by conventional methodologies. In this study, using a well-characterized collection of B. pumillus and B. safensis isolates, we demonstrated the suitability of MALDI-TOF-MS combined with chemometrics to accurately and rapidly identify them. Moreover, characteristic species-specific ion masses were tentatively assigned, using UniProtKB/Swiss-Prot and UniProtKB/TrEMBL databases and primary literature. Delineation of B. pumilus (ions at m/z 5271 and 6122) and B. safensis (ions at m/z 5288, 5568 and 6413) species were supported by a congruent characteristic protein pattern. Moreover, using a chemometric approach, the score plot created by partial least square discriminant analysis (PLSDA) of mass spectra demonstrated the presence of two individualized clusters, each one enclosing isolates belonging to a species-specific spectral group. The generated pool of species-specific proteins comprised mostly ribosomal and SASPs proteins. Therefore, in B. pumilus the specific ion at m/z 5271 was associated with a small acid-soluble spore protein (SASP O) or with 50S protein L35, whereas in B. safensis specific ions at m/z 5288 and 5568 were associated with SASP J and P, respectively, and an ion at m/z 6413 with 50S protein L32. Thus, the resulting unique protein profile combined with chemometric analysis, proved to be valuable tools for B. pumilus and B. safensis discrimination, allowing their reliable, reproducible and rapid identification.	[Branquinho, Raquel; Sousa, Clara; Peixe, Luisa V.] Univ Porto, Fac Farm, Dept Ciencias Biol, REQUIMTE,Lab Microbiol, P-4100 Porto, Portugal; [Sousa, Clara] Univ Minho, Ctr Engn Biol, Braga, Portugal; [Lopes, Joao] Univ Porto, Fac Farm, Dept Ciencias Quim, REQUIMTE,Lab Quim Aplicada, P-4100 Porto, Portugal; [Lopes, Joao] Univ Catolica Portuguesa, Escola Super Biotecnol, CBQF, Ctr Biotecnol & Quim Fina, Porto, Portugal; [Pintado, Manuela E.] Univ Lisbon, Fac Farm, Dept Tecnol Farmaceut, P-1699 Lisbon, Portugal; [Osorio, Hugo] Univ Porto, Inst Patol & Imunol Mol, IPATIMUP, P-4100 Porto, Portugal; [Osorio, Hugo] Univ Porto, Fac Med, P-4100 Porto, Portugal	Universidade do Porto; Universidade do Minho; Universidade do Porto; Universidade Catolica Portuguesa; Universidade de Lisboa; Universidade do Porto; Universidade do Porto	Osorio, H (corresponding author), Univ Porto, Inst Patol & Imunol Mol, IPATIMUP, Rua Campo Alegre 823, P-4100 Porto, Portugal.	hosorio@ipatimup.pt	Lopes, Joao A/H-1733-2011; Pintado, Maria Manuela/ABE-2085-2021; iMed.ULisboa, InTraCellADD/B-4826-2014; Pintado, Maria Manuela/AAW-6709-2021; Branquinho, Raquel/C-6789-2019; Osorio, Hugo/A-7847-2012; Sousa, Clara/S-6896-2019; Peixe, Luisa V/H-7347-2016; Sousa, Clara/D-5252-2013	Lopes, Joao A/0000-0002-1657-344X; Pintado, Maria Manuela/0000-0002-0760-3184; Branquinho, Raquel/0000-0002-1629-9292; Osorio, Hugo/0000-0002-6362-8255; Sousa, Clara/0000-0002-7206-8771; Peixe, Luisa V/0000-0001-5810-8215; Sousa, Clara/0000-0002-7206-8771	FCT (Fundacaopara a Ciencia e Tecnologia, Portugal) [SFRH/BD/61410/2009, SFRH/BPD/70548/2010]; QREN-FEDER through the Operational Program [ON. 2 - O Novo Norte]; Portuguese Foundation for Science and Technology	FCT (Fundacaopara a Ciencia e Tecnologia, Portugal)(Portuguese Foundation for Science and Technology); QREN-FEDER through the Operational Program; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	Dr. Kasthuri Venkateswaran, Dr. Irene Ouoba, Dr. Joseph W. Kloepper, Dr. Cecilie From and Dr. Maria Morea are gratefully acknowledged for providing isolates FO-36bT, SAFN-027, SAFN-037, KL-052, 51-3C and 82-2C; Bs31; SE 49 (AP3) and SE 52 (AP7); FEL 55, UNG22 and MIL46, respectively. Raquel Branquinho was supported by a PhD fellowship (Ref. SFRH/BD/61410/2009) and Clara Sousa by a post-doctoral fellowship (Ref. SFRH/BPD/70548/2010), from FCT (Fundacao para a Ciencia e Tecnologia, Portugal). Hugo Osorio acknowledges the funding from QREN-FEDER through the Operational Program ON. 2 - O Novo Norte. IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by the Portuguese Foundation for Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing	Arnold RJ, 1999, ANAL BIOCHEM, V269, P105, DOI 10.1006/abio.1998.3077; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Bentur HN, 2007, ANN CLIN MICROB ANTI, V6, P12, DOI DOI 10.1186/1476-0711-6-12; Bohme K, 2011, ELECTROPHORESIS, V32, P2951, DOI 10.1002/elps.201100217; Branquinho R, 2012, PLANTA MED, V78, pPA5, DOI [10.1055/s-0032-1320320, DOI 10.1055/S-0032-1320320]; Branquinho R, 2014, FEMS MICROBIOL ECOL, V90, P689, DOI 10.1111/1574-6941.12426; Clark AE, 2013, CLIN MICROBIOL REV, V26, P547, DOI 10.1128/CMR.00072-12; Dickinson DN, 2004, J MICROBIOL METH, V58, P1, DOI 10.1016/j.mimet.2004.02.011; Dieckmann R, 2011, APPL ENVIRON MICROB, V77, P4136, DOI 10.1128/AEM.02418-10; Driks A, 1999, MICROBIOL MOL BIOL R, V63, P1; Driks A., 2002, BACILLUS SUBTILIS IT, P527; Emonet S, 2010, CLIN MICROBIOL INFEC, V16, P1604, DOI 10.1111/j.1469-0691.2010.03368.x; Farfour E, 2012, J CLIN MICROBIOL, V50, P2702, DOI 10.1128/JCM.00368-12; Fernandez-No IC, 2013, FOOD MICROBIOL, V33, P235, DOI 10.1016/j.fm.2012.09.022; From C, 2005, APPL ENVIRON MICROB, V71, P1178, DOI 10.1128/AEM.71.3.1178-1183.2005; From C, 2007, INT J FOOD MICROBIOL, V115, P319, DOI 10.1016/j.ijfoodmicro.2006.11.005; Haymore BR, 2006, J INFECTION, V52, P154, DOI 10.1016/j.jinf.2005.05.007; Hong HA, 2005, FEMS MICROBIOL REV, V29, P813, DOI 10.1016/j.femsre.2004.12.001; Hotta Y, 2011, J AGR FOOD CHEM, V59, P5222, DOI 10.1021/jf2004095; Jetiyanon K, 1997, THESIS AUBURN U AUBU; Johnson BT, 2008, J MED MICROBIOL, V57, P643, DOI 10.1099/jmm.0.47754-0; Keys CJ, 2004, INFECT GENET EVOL, V4, P221, DOI 10.1016/j.meegid.2004.02.004; Lai EM, 2003, J BACTERIOL, V185, P1443, DOI 10.1128/JB.185.4.1443-1454.2003; Lasch P, 2008, ANAL CHEM, V80, P2026, DOI 10.1021/ac701822j; Lasch P, 2009, APPL ENVIRON MICROB, V75, P7229, DOI 10.1128/AEM.00857-09; Liu YF, 2013, STAT INTERFACE, V6, P1; Matarante A, 2004, APPL ENVIRON MICROB, V70, P5168, DOI 10.1128/AEM.70.9.5168-5176.2004; Mellmann A, 2009, J CLIN MICROBIOL, V47, P3732, DOI 10.1128/JCM.00921-09; Momo RA, 2013, ANAL BIOANAL CHEM, V405, P8251, DOI 10.1007/s00216-013-7245-y; Nas T., 2002, MULTIVARIATE CALIBRA, V2nd ed.; Ouoba LLI, 2004, INT J FOOD MICROBIOL, V90, P197, DOI 10.1016/S0168-1605(03)00302-7; Perez-Garcia A, 2011, CURR OPIN BIOTECH, V22, P187, DOI 10.1016/j.copbio.2010.12.003; Satomi M, 2006, INT J SYST EVOL MICR, V56, P1735, DOI 10.1099/ijs.0.64189-0; SHERMAN F, 1985, BIOESSAYS, V3, P27, DOI 10.1002/bies.950030108; Sousa C, 2014, J BIOPHOTONICS, V7, P287, DOI 10.1002/jbio.201200075; Tena D, 2007, CLIN INFECT DIS, V44, pE40, DOI 10.1086/511077; Wang LT, 2007, INT J SYST EVOL MICR, V57, P1846, DOI 10.1099/ijs.0.64685-0; Welker M, 2011, SYST APPL MICROBIOL, V34, P2, DOI 10.1016/j.syapm.2010.11.013	38	33	33	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110127	10.1371/journal.pone.0110127	http://dx.doi.org/10.1371/journal.pone.0110127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314655	gold, Green Submitted, Green Published			2022-12-27	WOS:000343662500099
J	Dhall, S; Do, D; Garcia, M; Wijesinghe, DS; Brandon, A; Kim, J; Sanchez, A; Lyubovitsky, J; Gallagher, S; Nothnagel, EA; Chalfant, CE; Patel, RP; Schiller, N; Martins-Green, M				Dhall, Sandeep; Do, Danh; Garcia, Monika; Wijesinghe, Dayanjan Shanaka; Brandon, Angela; Kim, Jane; Sanchez, Antonio; Lyubovitsky, Julia; Gallagher, Sean; Nothnagel, Eugene A.; Chalfant, Charles E.; Patel, Rakesh P.; Schiller, Neal; Martins-Green, Manuela			A Novel Model of Chronic Wounds: Importance of Redox Imbalance and Biofilm-Forming Bacteria for Establishment of Chronicity	PLOS ONE			English	Article							VENOUS LEG ULCERS; COAGULASE-NEGATIVE STAPHYLOCOCCI; OXIDATIVE-STRESS; NITRIC-OXIDE; HUMAN SKIN; PSEUDOMONAS-AERUGINOSA; OXYGEN; PH; MICROBIOLOGY; MECHANISMS	Chronic wounds have a large impact on health, affecting similar to 6.5 M people and costing similar to$ 25B/year in the US alone [1]. We previously discovered that a genetically modified mouse model displays impaired healing similar to problematic wounds in humans and that sometimes the wounds become chronic. Here we show how and why these impaired wounds become chronic, describe a way whereby we can drive impaired wounds to chronicity at will and propose that the same processes are involved in chronic wound development in humans. We hypothesize that exacerbated levels of oxidative stress are critical for initiation of chronicity. We show that, very early after injury, wounds with impaired healing contain elevated levels of reactive oxygen and nitrogen species and, much like in humans, these levels increase with age. Moreover, the activity of anti-oxidant enzymes is not elevated, leading to buildup of oxidative stress in the wound environment. To induce chronicity, we exacerbated the redox imbalance by further inhibiting the antioxidant enzymes and by infecting the wounds with biofilm-forming bacteria isolated from the chronic wounds that developed naturally in these mice. These wounds do not re-epithelialize, the granulation tissue lacks vascularization and interstitial collagen fibers, they contain an antibiotic-resistant mixed bioflora with biofilm-forming capacity, and they stay open for several weeks. These findings are highly significant because they show for the first time that chronic wounds can be generated in an animal model effectively and consistently. The availability of such a model will significantly propel the field forward because it can be used to develop strategies to regain redox balance that may result in inhibition of biofilm formation and result in restoration of healthy wound tissue. Furthermore, the model can lead to the understanding of other fundamental mechanisms of chronic wound development that can potentially lead to novel therapies.	[Dhall, Sandeep; Garcia, Monika; Martins-Green, Manuela] Univ Calif Riverside, Dept Cell Biol, Riverside, CA 92521 USA; [Dhall, Sandeep; Garcia, Monika; Martins-Green, Manuela] Univ Calif Riverside, Dept Neurosci, Riverside, CA 92521 USA; [Dhall, Sandeep; Martins-Green, Manuela] Univ Calif Riverside, Bioengn Interdept Grad Program, Riverside, CA 92521 USA; [Do, Danh; Schiller, Neal] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; [Kim, Jane; Nothnagel, Eugene A.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Lyubovitsky, Julia] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA; [Wijesinghe, Dayanjan Shanaka; Chalfant, Charles E.] Hunter Holmes McGuire Vet Adm Med Ctr, Richmond, VA USA; [Wijesinghe, Dayanjan Shanaka; Chalfant, Charles E.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA USA; [Wijesinghe, Dayanjan Shanaka; Chalfant, Charles E.] Virginia Commonwealth Univ, Reanimat Engn Sci Ctr, Richmond, VA USA; [Wijesinghe, Dayanjan Shanaka; Chalfant, Charles E.] Virginia Commonwealth Univ, Med Coll Virginia, Massey Canc Ctr, Richmond, VA 23298 USA; [Brandon, Angela; Patel, Rakesh P.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Sanchez, Antonio; Gallagher, Sean] UVP LLC, Prod Technol Dept, Upland, CA USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of Alabama System; University of Alabama Birmingham	Martins-Green, M (corresponding author), Univ Calif Riverside, Dept Cell Biol, Riverside, CA 92521 USA.	manuela.martins@ucr.edu	C, Danh/I-1527-2019	C, Danh/0000-0002-1065-7140; Patel, Rakesh/0000-0002-1526-4303	National Institutes of Health [5R21AI78208-2, AI078208-01, HL092624, HL072925, NH1C06-RR17393, S10RR031535]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development [BX001792]; US-Israel Binational Science Foundation (BSF) [2011380]; VCU Massey Cancer Center; NIH-NCI Cancer Center [P30 CA016059]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072925, R01HL092624, R01HL125353] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078208] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); US-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); VCU Massey Cancer Center; NIH-NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was partially supported by research grants from the National Institutes of Health to MMG (5R21AI78208-2), (AI078208-01); to RPP (HL092624); to CEC (HL072925); and to Virginia Commonwealth University for renovation of facilities (NH1C06-RR17393). These studies were also funded by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development (Career Development Award CDA1 to DSW, VA), a Merit Award to CEC (BX001792) and a Research Career Scientist Award to CEC. Funding also came from the US-Israel Binational Science Foundation to CEC (BSF#2011380). Services and products in support of the research project were generated by the VCU Massey Cancer Center Lipidomics Shared Resource (Developing Core), supported, in part, with funding from NIH-NCI Cancer Center Support Grant P30 CA016059 as well as a shared resource grant (S10RR031535 to CEC) from the National Institutes of Health. The contents of this manuscript do not represent the views of the Department of Veterans Affairs or the United States Government. Co-authors Antonio Sanchez and Sean Gallagher are employed by UVP, LLC, an Analytik Jena Company. UVP, LLC, an Analytik Jena Company provided support in the form of salaries for authors AS and SG, but did not have any additional role in the study design and decision to publish. They did, however, help in data collection and analysis, and helped write the pertinent Materials and Methods section related to image collection and data analysis. The specific roles of these authors are articulated in the "author contributions'' section.	Abd-El-Aleem SA, 2000, J PATHOL, V191, P434, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH654>3.0.CO;2-S; Bales PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067950; Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Berlett BS, 1996, P NATL ACAD SCI USA, V93, P1776, DOI 10.1073/pnas.93.5.1776; Boles BR, 2008, P NATL ACAD SCI USA, V105, P12503, DOI 10.1073/pnas.0801499105; Bowler PG, 2002, ANN MED, V34, P419, DOI 10.1080/078538902321012360; Britland S, 2012, BIOTECHNOL PROGR, V28, P917, DOI 10.1002/btpr.1561; Brook I, 1998, INT J DERMATOL, V37, P426, DOI 10.1046/j.1365-4362.1998.00445.x; Bryan N, 2012, EUR CELLS MATER, V24, P249, DOI 10.22203/eCM.v024a18; Cathie K., 2014, ARCH DIS CHILD, V99, pA159; CHAUDIERE J, 1984, J BIOL CHEM, V259, P1043; Chen CA, 2008, J BIOL CHEM, V283, P27038, DOI 10.1074/jbc.M802269200; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Clark RAF, 2008, J INVEST DERMATOL, V128, P2361, DOI 10.1038/jid.2008.257; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cui BT, 2013, J CLIN MICROBIOL, V51, P9, DOI 10.1128/JCM.05124-11; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dalben M, 2008, J HOSP INFECT, V70, P7, DOI 10.1016/j.jhin.2008.05.003; DeLoney CR, 1999, ANTIMICROB AGENTS CH, V43, P2702, DOI 10.1128/AAC.43.11.2702; Dovi JV, 2004, THROMB HAEMOSTASIS, V92, P275, DOI 10.1160/TH03-11-0720; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Erez A, 2011, NAT MED, V17, P1619, DOI 10.1038/nm.2544; Fazli M, 2011, WOUND REPAIR REGEN, V19, P387, DOI 10.1111/j.1524-475X.2011.00681.x; FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533; Freeman TA, 2009, FIBROGENESIS TISSUE, V2, DOI 10.1186/1755-1536-2-5; GERDING DN, 1995, CLIN INFECT DIS, V20, pS283, DOI 10.1093/clinids/20.Supplement_2.S283; Gethin G., 2007, WOUNDS UK, V3, P52; Gjodsbol Kristine, 2006, Int Wound J, V3, P225, DOI 10.1111/j.1742-481X.2006.00159.x; Goel A, 2012, J CELL BIOCHEM, V113, P419, DOI 10.1002/jcb.23387; Gonzalez FJ, 2005, MUTAT RES-FUND MOL M, V569, P101, DOI 10.1016/j.mrfmmm.2004.04.021; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; HANSSON C, 1995, ACTA DERM-VENEREOL, V75, P24; Heck DE, 2010, ANN NY ACAD SCI, V1203, P120, DOI 10.1111/j.1749-6632.2010.05603.x; Hopf HW, 2007, ANTIOXID REDOX SIGN, V9, P1183, DOI 10.1089/ars.2007.1641; Howell-Jones RS, 2005, J ANTIMICROB CHEMOTH, V55, P143, DOI 10.1093/jac/dkh513; Hunt T K, 2000, Adv Skin Wound Care, V13, P6; James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x; Kaplan JB, 2010, J DENT RES, V89, P205, DOI 10.1177/0022034509359403; Kikuchi S, 2012, FREE RADICAL BIO MED, V53, P643, DOI 10.1016/j.freeradbiomed.2012.06.006; KLOOS WE, 1975, INT J SYST BACTERIOL, V25, P62, DOI 10.1099/00207713-25-1-62; Kolodkin-Gal I, 2012, CELL, V149, P684, DOI 10.1016/j.cell.2012.02.055; Kuhlicke J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001364; Kundu TK, 2012, BIOCHEMISTRY-US, V51, P2930, DOI 10.1021/bi3000879; Lazarus Gerald S., 1994, Wound Repair and Regeneration, V2, P165, DOI 10.1046/j.1524-475X.1994.20305.x; Liu X, 2013, J BIOL CHEM, V288, P3739, DOI 10.1074/jbc.M112.426205; LOTITO S, 1989, NEUROSCI LETT, V97, P91, DOI 10.1016/0304-3940(89)90145-6; Luo JD, 2005, ACTA PHARMACOL SIN, V26, P259, DOI 10.1111/j.1745-7254.2005.00058.x; Madsen SM, 1996, APMIS, V104, P895, DOI 10.1111/j.1699-0463.1996.tb04955.x; Martin JM, 2010, J INVEST DERMATOL, V130, P38, DOI 10.1038/jid.2009.221; McCarty SM, 2012, WOUND REPAIR REGEN, V20, P125, DOI 10.1111/j.1524-475X.2012.00763.x; Messonnier L, 2007, J APPL PHYSIOL, V102, P1936, DOI 10.1152/japplphysiol.00691.2006; Miyazaki H, 1999, CIRCULATION, V99, P1141, DOI 10.1161/01.CIR.99.9.1141; Moor AN, 2014, AGE, V36, P733, DOI 10.1007/s11357-014-9617-4; Moseley R, 2004, WOUND REPAIR REGEN, V12, P419, DOI 10.1111/j.1067-1927.2004.12406.x; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Percival SL, 2011, WOUND REPAIR REGEN, V19, P1, DOI 10.1111/j.1524-475X.2010.00651.x; Petreaca ML, 2008, WOUND REPAIR REGEN, V16, P602, DOI 10.1111/j.1524-475X.2008.00411.x; Petreaca ML, 2012, WOUND REPAIR REGEN, V20, P353, DOI 10.1111/j.1524-475X.2012.00785.x; Qu Y, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-16; Rizk M, 2004, WORLD J SURG, V28, P301, DOI 10.1007/s00268-003-7396-7; Roy S, 2006, MOL THER, V13, P211, DOI 10.1016/j.ymthe.2005.07.684; Sapico FL, REV INFECT DIS S1, V6, pS171; Scales BS, 2013, J PATHOL, V229, P323, DOI 10.1002/path.4118; Schafer M, 2008, PHARMACOL RES, V58, P165, DOI 10.1016/j.phrs.2008.06.004; Schneider LA, 2007, ARCH DERMATOL RES, V298, P413, DOI 10.1007/s00403-006-0713-x; Schreiber F, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-111; Schreml S, 2010, BRIT J DERMATOL, V163, P257, DOI 10.1111/j.1365-2133.2010.09804.x; Sen CK, 2008, BBA-GEN SUBJECTS, V1780, P1348, DOI 10.1016/j.bbagen.2008.01.006; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Sharp CS, DIABETES CARE, V1, P289; SHAW S, 1992, LIFE SCI, V50, P2045, DOI 10.1016/0024-3205(92)90570-F; Shorrock SM, 2000, DETERMINATION RELATI, P117; Siddiqui AR, 2010, CLIN DERMATOL, V28, P519, DOI 10.1016/j.clindermatol.2010.03.009; Song L, 2009, CELL STRESS CHAPERON, V14, P417, DOI 10.1007/s12192-008-0095-4; Stapley R, 2012, BIOCHEM J, V446, P499, DOI 10.1042/BJ20120675; Stefaniak AB, 2013, SKIN RES TECHNOL, V19, P59, DOI 10.1111/srt.12016; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; STEVENS D, 1984, J CLIN MICROBIOL, V19, P942, DOI 10.1128/JCM.19.6.942-943.1984; Sullivan JC, 2006, CIRC RES, V98, P717, DOI 10.1161/01.RES.0000217594.97174.c2; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Wlaschek M, 2005, WOUND REPAIR REGEN, V13, P452, DOI 10.1111/j.1067-1927.2005.00065.x; Wong VW, 2012, EXP DERMATOL, V21, P729, DOI 10.1111/j.1600-0625.2012.01542.x; Yang QP, 2013, WOUND REPAIR REGEN, V21, P704, DOI 10.1111/wrr.12074; Yeoh-Ellerton S, 2003, J INVEST DERMATOL, V121, P918, DOI 10.1046/j.1523-1747.2003.12471.x; Youmans GP, 1980, JAMA-J AM MED ASSOC, V244, P849; Zhao G, 2012, WOUND REPAIR REGEN, V20, P342, DOI 10.1111/j.1524-475X.2012.00793.x	92	54	54	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109848	10.1371/journal.pone.0109848	http://dx.doi.org/10.1371/journal.pone.0109848			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313558	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662500083
J	Palmnas, MSA; Cowan, TE; Bomhof, MR; Su, J; Reimer, RA; Vogel, HJ; Hittel, DS; Shearer, J				Palmnaes, Marie S. A.; Cowan, Theresa E.; Bomhof, Marc R.; Su, Juliet; Reimer, Raylene A.; Vogel, Hans J.; Hittel, Dustin S.; Shearer, Jane			Low-Dose Aspartame Consumption Differentially Affects Gut Microbiota-Host Metabolic Interactions in the Diet-Induced Obese Rat	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; INTESTINAL MICROBIOTA; PROPIONIC-ACID; FATTY-ACIDS; RISK; ABSORPTION; PROFILES; ECOLOGY; PRODUCT; ADULTS	Aspartame consumption is implicated in the development of obesity and metabolic disease despite the intention of limiting caloric intake. The mechanisms responsible for this association remain unclear, but may involve circulating metabolites and the gut microbiota. Aims were to examine the impact of chronic low-dose aspartame consumption on anthropometric, metabolic and microbial parameters in a diet- induced obese model. Male Sprague-Dawley rats were randomized into a standard chow diet (CH, 12% kcal fat) or high fat (HF, 60% kcal fat) and further into ad libitum water control (W) or low-dose aspartame (A, 5-7 mg/kg/d in drinking water) treatments for 8 week (n = 10-12 animals/treatment). Animals on aspartame consumed fewer calories, gained less weight and had a more favorable body composition when challenged with HF compared to animals consuming water. Despite this, aspartame elevated fasting glucose levels and an insulin tolerance test showed aspartame to impair insulin-stimulated glucose disposal in both CH and HF, independently of body composition. Fecal analysis of gut bacterial composition showed aspartame to increase total bacteria, the abundance of Enterobacteriaceae and Clostridium leptum. An interaction between HF and aspartame was also observed for Roseburia ssp wherein HF-A was higher than HF-W (P<0.05). Within HF, aspartame attenuated the typical HF-induced increase in the Firmicutes:Bacteroidetes ratio. Serum metabolomics analysis revealed aspartame to be rapidly metabolized and to be associated with elevations in the short chain fatty acid propionate, a bacterial end product and highly gluconeogenic substrate, potentially explaining its negative affects on insulin tolerance. How aspartame influences gut microbial composition and the implications of these changes on the development of metabolic disease require further investigation.	[Palmnaes, Marie S. A.; Reimer, Raylene A.; Vogel, Hans J.; Hittel, Dustin S.; Shearer, Jane] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Palmnaes, Marie S. A.; Su, Juliet; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Cowan, Theresa E.; Bomhof, Marc R.; Reimer, Raylene A.; Hittel, Dustin S.; Shearer, Jane] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary	Palmnas, MSA (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	msapalmn@ucalgary.ca		Reimer, Raylene/0000-0001-5088-7947	National Science and Engineering Council of Canada Discovery Grant	National Science and Engineering Council of Canada Discovery Grant	Research was funded by a National Science and Engineering Council of Canada Discovery Grant. H.J.V. currently holds the Lance Armstrong Chair for Molecular Cancer Research. J.S. is an Alberta Innovates Health Solutions Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bleich SN, 2014, AM J PUBLIC HEALTH, V104, pE72, DOI 10.2105/AJPH.2013.301556; Bomhof MR, 2014, OBESITY, V22, P763, DOI 10.1002/oby.20632; CDC National Center for Health Statistics, 2012, BOD MEAS; Cowan TE, 2014, J NUTR BIOCHEM, V25, P489, DOI 10.1016/j.jnutbio.2013.12.009; de Koning L, 2011, AM J CLIN NUTR, V93, P1321, DOI 10.3945/ajcn.110.007922; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; Duggan GE, 2011, DIABETES OBES METAB, V13, P859, DOI 10.1111/j.1463-1326.2011.01410.x; Duggan GE, 2011, J APPL PHYSIOL, V110, P1311, DOI 10.1152/japplphysiol.00701.2010; Erces D, 2012, EUR J PHARMACOL, V691, P225, DOI 10.1016/j.ejphar.2012.06.044; Foley KA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087072, 10.1371/journal.pone.0108413]; Frye RE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.143; Gastaldelli A, 2001, DIABETES, V50, P1807, DOI 10.2337/diabetes.50.8.1807; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Johnston CA, 2014, TRENDS ENDOCRIN MET, V25, P1, DOI 10.1016/j.tem.2013.09.007; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Laerke HN, 1999, J NUTR, V129, P1002, DOI 10.1093/jn/129.5.1002; Larsson E, 2012, GUT, V61, P1124, DOI 10.1136/gutjnl-2011-301104; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lee KJ, 2010, NEUROGASTROENT MOTIL, V22, P493, DOI 10.1111/j.1365-2982.2010.01482.x; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067451; LIPTON WE, 1991, METABOLISM, V40, P1337, DOI 10.1016/0026-0495(91)90040-4; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; Macfabe Derrick, 2013, Glob Adv Health Med, V2, P52, DOI 10.7453/gahmj.2013.089; MacFabe DF, 2011, BEHAV BRAIN RES, V217, P47, DOI 10.1016/j.bbr.2010.10.005; Mackenzie T, 2006, ANN EPIDEMIOL, V16, P688, DOI 10.1016/j.annepidem.2005.11.009; Magnuson BA, 2007, CRIT REV TOXICOL, V37, P629, DOI 10.1080/10408440701516184; Nettleton JA, 2009, DIABETES CARE, V32, P688, DOI 10.2337/dc08-1799; OPPERMANN JA, 1973, J NUTR, V103, P1454, DOI 10.1093/jn/103.10.1454; Ossenkopp KP, 2012, BEHAV BRAIN RES, V227, P134, DOI 10.1016/j.bbr.2011.10.045; PANHOU H, 1990, BRAIN RES, V520, P351, DOI 10.1016/0006-8993(90)91729-Z; Puertollano E, 2014, CURR OPIN CLIN NUTR, V17, P139, DOI 10.1097/MCO.0000000000000025; Rahiman F, 2014, J Immunoassay Immunochem, V35, P26, DOI 10.1080/15321819.2013.784197; Ramsland PA, 1999, J MOL RECOGNIT, V12, P249, DOI 10.1002/(SICI)1099-1352(199907/08)12:4<249::AID-JMR463>3.0.CO;2-B; Reimer RA, 2012, J PROTEOME RES, V11, P4065, DOI 10.1021/pr300487s; Remely M, 2014, BENEF MICROBES, V5, P33, DOI 10.3920/BM2013.006; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Semova I, 2012, CELL HOST MICROBE, V12, P277, DOI 10.1016/j.chom.2012.08.003; Swithers SE, 2013, TRENDS ENDOCRIN MET, V24, P431, DOI 10.1016/j.tem.2013.05.005; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Verdam FJ, 2013, OBESITY, V21, pE607, DOI 10.1002/oby.20466; Zhao Y, 2013, J PROTEOME RES, V12, P2987, DOI 10.1021/pr400263n	48	158	168	5	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109841	10.1371/journal.pone.0109841	http://dx.doi.org/10.1371/journal.pone.0109841			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313461	Green Published, gold			2022-12-27	WOS:000343662500082
J	Tromme, I; Devleesschauwer, B; Beutels, P; Richez, P; Praet, N; Sacre, L; Marot, L; Van Eeckhout, P; Theate, I; Baurain, JF; Lambert, J; Legrand, C; Thomas, L; Speybroeck, N				Tromme, Isabelle; Devleesschauwer, Brecht; Beutels, Philippe; Richez, Pauline; Praet, Nicolas; Sacre, Laurine; Marot, Liliane; Van Eeckhout, Pascal; Theate, Ivan; Baurain, Jean-Francois; Lambert, Julien; Legrand, Catherine; Thomas, Luc; Speybroeck, Niko			Selective Use of Sequential Digital Dermoscopy Imaging Allows a Cost Reduction in the Melanoma Detection Process: A Belgian Study of Patients with a Single or a Small Number of Atypical Nevi	PLOS ONE			English	Article							MELANOCYTIC SKIN-LESIONS; FOLLOW-UP; IDENTIFICATION; METAANALYSIS; MANAGEMENT; DIAGNOSIS	Background: Dermoscopy is a technique which improves melanoma detection. Optical dermoscopy uses a handheld optical device to observe the skin lesions without recording the images. Sequential digital dermoscopy imaging (SDDI) allows storage of the pictures and their comparison over time. Few studies have compared optical dermoscopy and SDDI from an economic perspective. Objective: The present observational study focused on patients with one-to-three atypical melanocytic lesions, i.e. lesions considered as suspicious by optical dermoscopy. It aimed to calculate the "extra-costs" related to the process of melanoma detection. These extra-costs were defined as the costs of excision and pathology of benign lesions and/or the costs of follow-up by SDDI. The objective was to compare these extra-costs when using optical dermoscopy exclusively versus optical dermoscopy with selective use of SDDI. Methods: In a first group of patients, dermatologists were adequately trained in optical dermoscopy but worked without access to SDDI. They excised all suspicious lesions to rule out melanoma. In a second group, the dermatologists were trained in optical and digital dermoscopy. They had the opportunity of choosing between immediate excision or follow-up by SDDI (with delayed excision if significant change was observed). The comparison of extra-costs in both groups was made possible by a decision tree model and by the division of the extra-costs by the number of melanomas diagnosed in each group. Belgian official tariffs and charges were used. Results: The extra-costs in the first and in the second group were respectively (sic)1,613 and (sic)1,052 per melanoma excised. The difference was statistically significant. Conclusions: Using the Belgian official tariffs and charges, we demonstrated that the selective use of SDDI for patients with one-to-three atypical melanocytic lesions resulted in a significant cost reduction.	[Tromme, Isabelle; Richez, Pauline; Sacre, Laurine; Marot, Liliane; Van Eeckhout, Pascal; Theate, Ivan] Catholic Univ Louvain, Clin Univ St Luc, Ctr Canc, Dept Dermatol, B-1200 Brussels, Belgium; [Devleesschauwer, Brecht; Speybroeck, Niko] Catholic Univ Louvain, Fac Publ Hlth, Inst Hlth & Soc, B-1200 Brussels, Belgium; [Beutels, Philippe] Univ Antwerp, Fac Med & Hlth Sci, Vaccine & Infect Dis Inst, Ctr Hlth Econ Res & Modelling Infect Dis, B-2020 Antwerp, Belgium; [Praet, Nicolas] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Baurain, Jean-Francois] Catholic Univ Louvain, Clin Univ St Luc, Ctr Canc, Dept Med Oncol, B-1200 Brussels, Belgium; [Lambert, Julien] Univ Ziekenhuis, Dept Dermatol, Antwerp, Belgium; [Legrand, Catherine] Catholic Univ Louvain, Inst Stat Biostat & Actuarial Sci, Louvain La Neuve, Belgium; [Thomas, Luc] Univ Lyon 1, Ctr Hosp Lyon Sud, Dept Dermatol, Pierre Benite, France	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; University of Antwerp; Institute of Tropical Medicine (ITM); Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Tromme, I (corresponding author), Catholic Univ Louvain, Clin Univ St Luc, Ctr Canc, Dept Dermatol, B-1200 Brussels, Belgium.	isabelle.tromme@uclouvain.be	Beutels, Philippe/A-1919-2010; Devleesschauwer, Brecht/G-9895-2018	Beutels, Philippe/0000-0001-5034-3595; Devleesschauwer, Brecht/0000-0002-2867-6892; Thomas, Luc/0000-0003-1995-2434; Speybroeck, Niko/0000-0003-3322-3502	Nuovo-Soldati Foundation for Cancer Research	Nuovo-Soldati Foundation for Cancer Research	One of the authors (IT) was supported by the Nuovo-Soldati Foundation for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamura D, 2008, ARCH DERMATOL, V144, P502, DOI 10.1001/archderm.144.4.502; [Anonymous], TITLE ERROR; Argenziano G, 2008, BRIT J DERMATOL, V159, P331, DOI 10.1111/j.1365-2133.2008.08649.x; Argenziano G, 2010, BRIT J DERMATOL, V162, P267, DOI 10.1111/j.1365-2133.2009.09416.x; Belgian Health Care Knwoledge Center, 2012, REPORT 183C BELGIAN; BISHOP JAN, 1994, MELANOMA RES, V4, P199, DOI 10.1097/00008390-199408000-00001; Carli P, 2006, J AM ACAD DERMATOL, V55, P256, DOI 10.1016/j.jaad.2005.12.026; Dakin H, 2013, HEALTH ECON, V22, P22, DOI 10.1002/hec.1812; Duffy K, 2012, J AM ACAD DERMATOL, V67, P17; Erdmann F, 2013, INT J CANCER, V132, P385, DOI 10.1002/ijc.27616; Gimotty PA, 2007, J CLIN ONCOL, V25, P1129, DOI 10.1200/JCO.2006.08.1463; Gray A. M., 2011, APPL METHODS COST EF, P249; Gray AM, 2011, APPL METHODS COST EF, P179; Green AC, 2012, J CLIN ONCOL, V30, P1462, DOI 10.1200/JCO.2011.38.8561; Haenssle HA, 2010, ARCH DERMATOL, V146, P257, DOI 10.1001/archdermatol.2009.370; Kittler H, 2001, ARCH DERMATOL, V137, P1590; Kittler H, 2002, LANCET ONCOL, V3, P159, DOI 10.1016/S1470-2045(02)00679-4; Kittler H, 2006, ARCH DERMATOL, V142, P1113, DOI 10.1001/archderm.142.9.1113; Luo S, 2011, J AM ACAD DERMATOL, V65, P1087, DOI 10.1016/j.jaad.2011.06.045; Menzies SW, 2009, BRIT J DERMATOL, V161, P1270, DOI 10.1111/j.1365-2133.2009.09374.x; Menzies SW, 2001, ARCH DERMATOL, V137, P1583; R Foundation for Statistical Computing V Austria, 2013, R LANG ENV STAT COMP; Salerni G, 2013, J EUR ACAD DERMATOL, V27, P805, DOI 10.1111/jdv.12032; Schiffner R, 2003, BRIT J DERMATOL, V149, P79, DOI 10.1046/j.1365-2133.2003.05409.x; Tromme I, 2012, BRIT J DERMATOL, V167, P778, DOI 10.1111/j.1365-2133.2012.11042.x; Vestergaard ME, 2008, BRIT J DERMATOL, V159, P669, DOI 10.1111/j.1365-2133.2008.08713.x	26	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109339	10.1371/journal.pone.0109339	http://dx.doi.org/10.1371/journal.pone.0109339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313898	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500033
J	Yun, S; Lee, SU; Kim, JM; Lee, HJ; Song, HY; Kim, YK; Jung, H; Park, YJ; Yoon, SR; Oh, SR; Kim, TD; Choi, I				Yun, Sohyun; Lee, Su Ui; Kim, Jung Min; Lee, Hyun-Jun; Song, Hae Young; Kim, Young Kyeung; Jung, Haiyoung; Park, Young-Jun; Yoon, Suk Ran; Oh, Sei-Ryang; Kim, Tae-Don; Choi, Inpyo			Integrated mRNA-MicroRNA Profiling of Human NK Cell Differentiation Identifies MiR-583 as a Negative Regulator of IL2R gamma Expression	PLOS ONE			English	Article							NATURAL-KILLER-CELL; TRANSCRIPTION FACTOR; CYTOTOXIC ACTIVITY; GAMMA PRODUCTION; IMMUNE-SYSTEM; T-CELLS; B-CELL; MATURATION; PROMOTES; INTERLEUKIN-2	Natural killer (NK) cells are innate immune effector cells that protect against cancer and some viral infections. Until recently, most studies have investigated the molecular signatures of human or mouse NK cells to identify genes that are specifically expressed during NK cell development. However, the mechanism regulating NK cell development remains unclear. Here, we report a regulatory network of potential interactions during in vitro differentiation of human NK cells, identified using genome-wide mRNA and miRNA databases through hierarchical clustering analysis, gene ontology analysis and a miRNA target prediction program. The microRNA (miR)-583, which demonstrated the largest ratio change in mature NK cells, was highly correlated with IL2 receptor gamma (IL2R gamma) expression. The overexpression of miR-583 had an inhibitory effect on NK cell differentiation. In a reporter assay, the suppressive effect of miR-583 was ablated by mutating the putative miR-583 binding site of the IL2R gamma 3' UTR. Therefore, we show that miR-583 acts as a negative regulator of NK cell differentiation by silencing IL2R gamma. Additionally, we provide a comprehensive database of genome-wide mRNA and miRNA expression during human NK cell differentiation, offering a better understanding of basic human NK cell biology for the application of human NK cells in immunotherapy.	[Yun, Sohyun; Song, Hae Young; Kim, Young Kyeung; Jung, Haiyoung; Park, Young-Jun; Kim, Tae-Don; Choi, Inpyo] Korea Res Inst Biosci & Biotechnol, Immunotherapy Res Ctr, Taejon, South Korea; [Lee, Su Ui; Lee, Hyun-Jun; Oh, Sei-Ryang] Korea Res Inst Biosci & Biotechnol, Nat Med Res Ctr, Ochang Eup, South Korea; [Kim, Jung Min] Daejeon Univ, Daejeon Oriental Hosp, NAR Ctr Inc, Taejon, South Korea; [Kim, Tae-Don; Choi, Inpyo] Korea Univ Sci & Technol, Dept Funct Genom, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Daejeon University	Kim, TD (corresponding author), Korea Res Inst Biosci & Biotechnol, Immunotherapy Res Ctr, Taejon, South Korea.	tdkim@kribb.re.kr; ipchoi@kribb.re.kr		Kim, Jung Min/0000-0001-6319-0217; Kim, Tae-Don/0000-0002-5910-4264	GRL project [FGM1401223]; Ministry of Science, ICT & Future Planning, KRIBB Research Initiative Program; Korean Health Technology RD Project [A121934]; Basic Science Research Program through the National Research Foundation of Korea [RBM0261312]	GRL project; Ministry of Science, ICT & Future Planning, KRIBB Research Initiative Program; Korean Health Technology RD Project; Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported in part by grants from the GRL project (FGM1401223), the Ministry of Science, ICT & Future Planning, KRIBB Research Initiative Program, the Korean Health Technology R&D Project (A121934), and Basic Science Research Program through the National Research Foundation of Korea (RBM0261312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Barton K, 1998, IMMUNITY, V9, P555, DOI 10.1016/S1074-7613(00)80638-X; Becknell B, 2005, ADV IMMUNOL, V86, P209, DOI 10.1016/S0065-2776(04)86006-1; Bezman NA, 2011, J EXP MED, V208, P2717, DOI 10.1084/jem.20111386; Bezman NA, 2010, J IMMUNOL, V185, P3835, DOI 10.4049/jimmunol.1000980; Blom B, 2006, ANNU REV IMMUNOL, V24, P287, DOI 10.1146/annurev.immunol.24.021605.090612; Boggs SS, 1998, NAT IMMUN, V16, P137, DOI 10.1159/000069438; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Cichocki F, 2011, J IMMUNOL, V187, P6171, DOI 10.4049/jimmunol.1100835; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Colucci F, 2001, BLOOD, V97, P2625, DOI 10.1182/blood.V97.9.2625; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; Fehniger TA, 2010, GENOME RES, V20, P1590, DOI 10.1101/gr.107995.110; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hanna J, 2004, J IMMUNOL, V173, P6547, DOI 10.4049/jimmunol.173.11.6547; Horng T, 2007, NAT IMMUNOL, V8, P1345, DOI 10.1038/ni1524; Hosomi S, 2013, EUR J IMMUNOL, V43, P2473, DOI 10.1002/eji.201242676; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Kaisho T, 1999, J EXP MED, V190, P1573, DOI 10.1084/jem.190.11.1573; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kim TD, 2011, BLOOD, V118, P5476, DOI 10.1182/blood-2011-04-347526; Kim Tae-Don, 2009, Immune Netw, V9, P115, DOI 10.4110/in.2009.9.4.115; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Nandagopal N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00187; Ni F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2484; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; Samson SI, 2003, IMMUNITY, V19, P701, DOI 10.1016/S1074-7613(03)00294-2; Schietinger A, 2012, SCIENCE, V335, P723, DOI 10.1126/science.1214277; Shu F, 2007, P NATL ACAD SCI USA, V104, P9248, DOI 10.1073/pnas.0703327104; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Trotta R, 2013, BLOOD; Wang Jian, 2012, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V20, P731; Winchester B G, 2001, Eur J Paediatr Neurol, V5 Suppl A, P11, DOI 10.1053/ejpn.2000.0428; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yun S, 2011, IMMUNOL LETT, V136, P29, DOI 10.1016/j.imlet.2010.11.008; Yun S, 2010, INT IMMUNOPHARMACOL, V10, P481, DOI 10.1016/j.intimp.2010.01.009; Zawislak CL, 2013, P NATL ACAD SCI USA, V110, P6967, DOI 10.1073/pnas.1304410110	49	22	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e108913	10.1371/journal.pone.0108913	http://dx.doi.org/10.1371/journal.pone.0108913			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313504	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500019
J	Chang, DH; Wen, ZL; Wang, YH; Cai, WF; Wani, M; Paul, C; Okano, T; Millard, RW; Wang, YG				Chang, Dehua; Wen, Zhili; Wang, Yuhua; Cai, Wenfeng; Wani, Mashhood; Paul, Christian; Okano, Teruo; Millard, Ronald W.; Wang, Yigang			Ultrastructural Features of Ischemic Tissue following Application of a Bio-Membrane Based Progenitor Cardiomyocyte Patch for Myocardial Infarction Repair	PLOS ONE			English	Article							STEM-CELLS; TRANSPLANTATION; ANGIOMYOGENESIS; DELIVERY; SHEET	Background and Objective: Implantation of cell-sheets into damaged regions of the heart after myocardial infarction (MI) has been shown to improve heart function. However, the tissue morphology following application of induced pluripotent stem cell (iPSC)-derived cardiomyocytes (CM) has not been studied in detail at the level afforded by electron microscopy. We hypothesized that increasing the number of CM derived from iPSC would increase the effectiveness of cell-sheets used to treat ischemic cardiomyopathy. We report here on the ultrastructural features after application of a bio-membrane 'cell patch'. Methods: iPSC-derived progenitor cells were transduced using lentivirus vectors with or without NCX1 promoter. iPSC-CM sheets were transplanted over the transmural MI region in a mouse model of regional ischemic cardiomyopathy. Mice were divided into four groups, 1) Sham; 2) MI; 3) MI + iPSC without NCX1 treated cells (MI + iPSC(Null)) and 4) MI + iPSC receiving NCX1 promoter treated cells (MI + iPSC(NCX1)). Echocardiography was performed 4 weeks after cell patch application, followed by histological and transmission electron microscopy (TEM) analysis. Results: Large numbers of transplanted CM were observed with significant improvements in left ventricular performance and remodeling in group 4 as compared with group 3. No teratoma formation was detected in any of the treatment groups. Conclusion: Manipulation of iPSC yields large numbers of iPSC-CM and favorable morphological and ultrastructural tissue changes. These changes have the potential to enhance current methods used for restoration of cardiac function after MI.	[Chang, Dehua; Okano, Teruo] Tokyo Womens Med Univ, Dept Adv Biomed Engn & Sci, Tokyo, Japan; [Chang, Dehua; Wen, Zhili; Wang, Yuhua; Cai, Wenfeng; Wani, Mashhood; Paul, Christian; Wang, Yigang] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45220 USA; [Millard, Ronald W.] Univ Cincinnati, Dept Pharmacol & Cell Biophys, Cincinnati, OH USA	Tokyo Women's Medical University; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Wang, YG (corresponding author), Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45220 USA.	yi-gang.wang@uc.edu		Okano, Teruo/0000-0002-4470-9842	National Institutes of Health [HL1107401, HL107957]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110740, R01HL107957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health grants HL1107401 and HL107957 (YW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dai B, 2011, J AM COLL CARDIOL, V58, P2118, DOI 10.1016/j.jacc.2011.06.062; Grossman PM, 2002, CATHETER CARDIO INTE, V55, P392, DOI 10.1002/ccd.10136; Haider HK, 2009, ANTIOXID REDOX SIGN, V11, P1929, DOI [10.1089/ars.2009.2471, 10.1089/ARS.2009.2471]; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Inoue H, 2011, CLIN PHARMACOL THER, V89, P655, DOI 10.1038/clpt.2011.38; Kim SW, 2013, CARDIOVASC RES, V100, P241, DOI 10.1093/cvr/cvt192; Matsuura K, 2013, J CONTROL RELEASE, V169, P336, DOI 10.1016/j.jconrel.2013.03.003; Moelker AD, 2007, J MOL CELL CARDIOL, V42, P735, DOI 10.1016/j.yjmcc.2007.01.005; Pagidipati NJ, 2013, CIRCULATION, V127, P749, DOI 10.1161/CIRCULATIONAHA.112.128413; Pasha Z, 2008, CARDIOVASC RES, V77, P134, DOI 10.1093/cvr/cvm025; Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Wang Y, 2014, ANTIOXID REDOX SIGNA; Wu JX, 2011, BASIC RES CARDIOL, V106, P317, DOI 10.1007/s00395-011-0168-x; Zhang DS, 2010, AM J PHYSIOL-HEART C, V299, pH1339, DOI 10.1152/ajpheart.00592.2010; Zhao TM, 2009, AM J PHYSIOL-HEART C, V296, pH976, DOI 10.1152/ajpheart.01134.2008	16	4	4	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e107296	10.1371/journal.pone.0107296	http://dx.doi.org/10.1371/journal.pone.0107296			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310410	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210300005
J	Gottschlich, C; Schuhmacher, D				Gottschlich, Carsten; Schuhmacher, Dominic			The Shortlist Method for Fast Computation of the Earth Mover's Distance and Finding Optimal Solutions to Transportation Problems	PLOS ONE			English	Article							NUMERICAL-SOLUTION; ALGORITHM	Finding solutions to the classical transportation problem is of great importance, since this optimization problem arises in many engineering and computer science applications. Especially the Earth Mover's Distance is used in a plethora of applications ranging from content-based image retrieval, shape matching, fingerprint recognition, object tracking and phishing web page detection to computing color differences in linguistics and biology. Our starting point is the well-known revised simplex algorithm, which iteratively improves a feasible solution to optimality. The Shortlist Method that we propose substantially reduces the number of candidates inspected for improving the solution, while at the same time balancing the number of pivots required. Tests on simulated benchmarks demonstrate a considerable reduction in computation time for the new method as compared to the usual revised simplex algorithm implemented with state-of-the-art initialization and pivot strategies. As a consequence, the Shortlist Method facilitates the computation of large scale transportation problems in viable time. In addition we describe a novel method for finding an initial feasible solution which we coin Modified Russell's Method.	[Gottschlich, Carsten; Schuhmacher, Dominic] Univ Gottingen, Inst Math Stochast, D-37073 Gottingen, Germany; [Gottschlich, Carsten] Univ Gottingen, Felix Bernstein Inst Math Stat Biosci, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen	Gottschlich, C (corresponding author), Univ Gottingen, Inst Math Stochast, D-37073 Gottingen, Germany.	gottschlich@math.uni-goettingen.de	Gottschlich, Carsten/E-3948-2013	Gottschlich, Carsten/0000-0002-4118-012X	German Research Foundation; University of Goettingen; Felix-Bernstein-Institute for Mathematical Statistics in the Biosciences; Volkswagen Foundation	German Research Foundation(German Research Foundation (DFG)); University of Goettingen; Felix-Bernstein-Institute for Mathematical Statistics in the Biosciences; Volkswagen Foundation(Volkswagen)	CG and DS gratefully acknowledge support by the German Research Foundation and the Open Access Publication Funds of the University of Goettingen. CG gratefully acknowledges the support of the Felix-Bernstein-Institute for Mathematical Statistics in the Biosciences and the Volkswagen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angenent S, 2003, SIAM J MATH ANAL, V35, P61, DOI 10.1137/S0036141002410927; [Anonymous], 2010, CPLEX V12 5 1 HIGH P; Aurenhammer F, 1998, ALGORITHMICA, V20, P61, DOI 10.1007/PL00009187; Benamou JD, 2000, NUMER MATH, V84, P375, DOI 10.1007/s002119900117; Benamou JD, 2014, J COMPUT PHYS, V260, P107, DOI 10.1016/j.jcp.2013.12.015; Berkelaar M, 2014, IP SOLVE V5 5; Bertsekas D. P., 1989, Annals of Operations Research, V20, P67, DOI 10.1007/BF02216923; Bonabeau E, 2000, NATURE, V406, P39, DOI 10.1038/35017500; Dantzig G. B., 1963, LINEAR PROGRAMMING E; DANTZIG GB, 1990, INTERFACES, V20, P43, DOI 10.1287/inte.20.4.43; Faraway J., 2004, LINEAR MODELS R; Fu AY, 2006, IEEE T DEPEND SECURE, V3, P301, DOI 10.1109/TDSC.2006.50; GLOVER F, 1974, MANAGE SCI, V20, P793, DOI 10.1287/mnsc.20.5.783; Gottschlich C, IET BIOMETR IN PRESS; Gottschlich C., 2014, P IJCB CLEARW FL US; Gottschlich C, 2012, IEEE T IMAGE PROCESS, V21, P2220, DOI 10.1109/TIP.2011.2170696; Gottschlich C, 2011, IEEE T INF FOREN SEC, V6, P1165, DOI 10.1109/TIFS.2011.2143406; Grauman K, 2004, PROC CVPR IEEE, P220; Habr J, 1961, WISSENSCHAFTLICHE ZE, V10, P1069; Hoffman JR, 2004, IEEE T SYST MAN CY A, V34, P327, DOI 10.1109/TSMCA.2004.824848; HOUTHAKKER HS, 1955, J OPER RES SOC AM, V3, P210, DOI 10.1287/opre.3.2.210; Kendal D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072296; Li LX, 2014, P NATL ACAD SCI USA, V111, P8392, DOI 10.1073/pnas.1407083111; Ling H, 2007, IEEE T PATTERN ANAL, V29, P840, DOI 10.1109/TPAMI.2007.1058; Loeper G, 2005, CR MATH, V340, P319, DOI 10.1016/j.crma.2004.12.018; Lucic P, 2002, PROC INT C TOOLS ART, P216, DOI 10.1109/TAI.2002.1180807; Luenberg D.G., 2008, LINEAR NONLINEAR PRO; Lv Q., 2004, P 13 ACM INT C INF K, P208, DOI DOI 10.1145/1031171.1031213; Merigot Q, 2011, COMPUT GRAPH FORUM, V30, P1583, DOI 10.1111/j.1467-8659.2011.02032.x; Monge G., 1781, MEMOIRE THEORIE DEBL; Pele O, 2009, IEEE I CONF COMP VIS, P460, DOI 10.1109/ICCV.2009.5459199; Qiu P, 2013, PLOS ONE, V7; Reinfeld NV, 1958, MATH PROGRAMMING; Ricci E, 2013, IEEE T PATTERN ANAL, V35, P513, DOI 10.1109/TPAMI.2012.131; Rubner Y, 2000, INT J COMPUT VISION, V40, P99, DOI 10.1023/A:1026543900054; RUSSELL EJ, 1969, OPER RES, V17, P187, DOI 10.1287/opre.17.1.187; Schuhmacher D, 2008, IEEE T SIGNAL PROCES, V56, P3447, DOI 10.1109/TSP.2008.920469; Sedgewick R., 2003, ALGORITHMS JAVA; Spieksma FCR, 1996, EUR J OPER RES, V91, P611, DOI 10.1016/0377-2217(95)00003-8; SRINIVASAN V, 1973, J ACM, V20, P194, DOI 10.1145/321752.321754; Urbanek S, 2012, EMDIST R PACKAGE VER; Vejdemo-Johansson M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089184; Villani C., 2008, OPTIMAL TRANSPORT OL; Zhao Q, 2010, IEEE T PATTERN ANAL, V32, P274, DOI 10.1109/TPAMI.2008.299	44	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110214	10.1371/journal.pone.0110214	http://dx.doi.org/10.1371/journal.pone.0110214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310106	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210300098
J	Sukegawa, S; Sakuma, R; Ohmine, S; Takeuchi, H; Ikeda, Y; Yamaoka, S				Sukegawa, Sayaka; Sakuma, Ryuta; Ohmine, Seiga; Takeuchi, Hiroaki; Ikeda, Yasuhiro; Yamaoka, Shoji			Suppressor of Cytokine Signaling 1 Counteracts Rhesus Macaque TRIM5 alpha-Induced Inhibition of Human Immunodeficiency Virus Type-1 Production	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME PATHWAY; HIV-1 INFECTION; SOCS BOX; CELLS; DETERMINANTS; RESTRICTION; ASSOCIATION; DEGRADATION; PROTEOLYSIS; RETROVIRUS	Old world monkey TRIM5 alpha is a host factor that restricts human immunodeficiency virus type-1 (HIV-1) infection. Previously, we reported that rhesus macaque TRIM5 alpha (RhTRIM5 alpha) restricts HIV-1 production by inducing degradation of precursor Gag. Since suppressor of cytokine signaling 1 (SOCS1) is known to enhance HIV-1 production by rescuing Gag from lysosomal degradation, we examined if SOCS1 is involved in RhTRIM5 alpha-mediated late restriction. Over-expression of SOCS1 restored HIV-1 production in the presence of RhTRIM5 alpha to a level comparable to that in the absence of RhTRIM5 alpha in terms of titer and viral protein expression. Co-immunoprecipitation studies revealed that SOCS1 physically interacted with RhTRIM5 alpha. Over-expression of SOCS1 affected RhTRIM5 alpha expression in a dose-dependent manner, which was not reversed by proteasome inhibitors. In addition, SOCS1 and RhTRIM5 alpha were detected in virus-like particles. These results suggest that SOCS1 alleviates RhTRIM5 alpha-mediated regulation in the late phase of HIV-1 life cycle probably due to the destabilization of RhTRIM5 alpha.	[Sukegawa, Sayaka; Sakuma, Ryuta; Takeuchi, Hiroaki; Yamaoka, Shoji] Tokyo Med & Dent Univ, Dept Mol Virol, Tokyo, Japan; [Ohmine, Seiga; Ikeda, Yasuhiro] Mayo Clin, Dept Mol Med, Rochester, MN USA	Tokyo Medical & Dental University (TMDU); Mayo Clinic	Sakuma, R (corresponding author), Tokyo Med & Dent Univ, Dept Mol Virol, Tokyo, Japan.	ryuta.molv@tmd.ac.jp; shojmmb@tmd.ac.jp	Takeuchi, Hiroaki/F-9728-2012	Takeuchi, Hiroaki/0000-0002-5689-9858	Ministry of Health, Labor, and Welfare in Japan [H22-seisakusouyaku-ippan-015]; Takeda Science Foundation; Ministry of Education, Culture, Sports, Science, and Technology [21390136]	Ministry of Health, Labor, and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grant for Public-private sector joint research on Publicly Essential Drugs (H22-seisakusouyaku-ippan-015) from the Ministry of Health, Labor, and Welfare in Japan and research grant from Takeda Science Foundation to R. S. and grant 21390136 from the Ministry of Education, Culture, Sports, Science, and Technology to S.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Arhel NJ, 2008, BLOOD, V112, P3772, DOI 10.1182/blood-2008-04-151761; Biris N, 2012, P NATL ACAD SCI USA, V109, P13278, DOI 10.1073/pnas.1203536109; De Sepulveda P, 2000, J BIOL CHEM, V275, P14005, DOI 10.1074/jbc.C000106200; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Diaz-Griffero F, 2009, J VIROL, V83, P10737, DOI 10.1128/JVI.01307-09; Frantsve J, 2001, MOL CELL BIOL, V21, P3547, DOI 10.1128/MCB.21.10.3547-3557.2001; Fujimoto M, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/470468; Hinz M, 2012, IMMUNOL REV, V246, P59, DOI 10.1111/j.1600-065X.2012.01102.x; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Li SL, 2012, IMMUNITY, V37, P685, DOI 10.1016/j.immuni.2012.08.001; Li X, 2011, J BIOL CHEM, V286, P27959, DOI 10.1074/jbc.M111.260406; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Linossi EM, 2012, IUBMB LIFE, V64, P316, DOI 10.1002/iub.1011; Luban J., 2012, MOL BIOL INT, V2012; Miller RC, 2011, EUR J IMMUNOL, V41, P1058, DOI 10.1002/eji.201041198; Moutsopoulos NM, 2006, J LEUKOCYTE BIOL, V80, P1145, DOI 10.1189/jlb.0306142; Nishi M, 2009, FEBS LETT, V583, P1243, DOI 10.1016/j.febslet.2009.03.041; O'Brien M, 2011, J CLIN INVEST, V121, P1088, DOI 10.1172/JCI44960; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Platt EJ, 2009, J VIROL, V83, P8289, DOI 10.1128/JVI.00709-09; Qian YR, 2012, MOL MED REP, V5, P452, DOI 10.3892/mmr.2011.672; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Ryo A, 2008, P NATL ACAD SCI USA, V105, P294, DOI 10.1073/pnas.0704831105; Sakuma R, 2007, NAT MED, V13, P631, DOI 10.1038/nm1562; Sakuma R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00162; Sakuma R, 2010, J BIOL CHEM, V285, P3784, DOI 10.1074/jbc.M109.059063; Singh R, 2011, J VIROL, V85, P208, DOI 10.1128/JVI.01810-10; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; STRATTON MR, 1989, CARCINOGENESIS, V10, P899, DOI 10.1093/carcin/10.5.899; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Subramanya S, 2010, MOL THER, V18, P2028, DOI 10.1038/mt.2010.148; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; Tareen SU, 2011, CELL HOST MICROBE, V9, P349, DOI 10.1016/j.chom.2011.05.003; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; Uno M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088347; Wang YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031167; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Yadav A, 2009, VIROLOGY, V385, P126, DOI 10.1016/j.virol.2008.11.039; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; Zhang F, 2008, NAT MED, V14, P235, DOI 10.1038/nm0308-235; Zhang JG, 2001, P NATL ACAD SCI USA, V98, P13261, DOI 10.1073/pnas.231486498; Zhao GP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002009	47	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109640	10.1371/journal.pone.0109640	http://dx.doi.org/10.1371/journal.pone.0109640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310711	gold, Green Submitted, Green Published			2022-12-27	WOS:000343210300063
J	Wu, CD; McNeely, E; Cedeno-Laurent, JG; Pan, WC; Adamkiewicz, G; Dominici, F; Lung, SCC; Su, HJ; Spengler, JD				Wu, Chih-Da; McNeely, Eileen; Cedeno-Laurent, J. G.; Pan, Wen-Chi; Adamkiewicz, Gary; Dominici, Francesca; Lung, Shih-Chun Candice; Su, Huey-Jen; Spengler, John D.			Linking Student Performance in Massachusetts Elementary Schools with the "Greenness'' of School Surroundings Using Remote Sensing	PLOS ONE			English	Article							NEIGHBORHOOD GREENNESS; ACADEMIC-ACHIEVEMENT; ASSOCIATION; HEALTH; SPACE	Various studies have reported the physical and mental health benefits from exposure to "green'' neighborhoods, such as proximity to neighborhoods with trees and vegetation. However, no studies have explicitly assessed the association between exposure to "green'' surroundings and cognitive function in terms of student academic performance. This study investigated the association between the "greenness'' of the area surrounding a Massachusetts public elementary school and the academic achievement of the school's student body based on standardized tests with an ecological setting. Researchers used the composite school-based performance scores generated by the Massachusetts Comprehensive Assessment System (MCAS) to measure the percentage of 3rd-grade students (the first year of standardized testing for 8-9 years-old children in public school), who scored "Above Proficient'' (AP) in English and Mathematics tests (Note: Individual student scores are not publically available). The MCAS results are comparable year to year thanks to an equating process. Researchers included test results from 2006 through 2012 in 905 public schools and adjusted for differences between schools in the final analysis according to race, gender, English as a second language (proxy for ethnicity and language facility), parent income, student-teacher ratio, and school attendance. Surrounding greenness of each school was measured using satellite images converted into the Normalized Difference Vegetation Index (NDVI) in March, July and October of each year according to a 250-meter, 500-meter, 1,000-meter, and 2000-meter circular buffer around each school. Spatial Generalized Linear Mixed Models (GLMMs) estimated the impacts of surrounding greenness on school-based performance. Overall the study results supported a relationship between the "greenness'' of the school area and the school-wide academic performance. Interestingly, the results showed a consistently positive significant association between the greenness of the school in the Spring (when most Massachusetts students take the MCAS tests) and school-wide performance on both English and Math tests, even after adjustment for socio-economic factors and urban residency.	[Wu, Chih-Da] Natl Chiayi Univ, Coll Agr, Dept Forestry & Nat Resources, Chiayi, Taiwan; [Wu, Chih-Da; Cedeno-Laurent, J. G.; Adamkiewicz, Gary; Spengler, John D.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Exposure Epidemiol & Risk Program, Boston, MA 02115 USA; [McNeely, Eileen] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Environm Occupat Med & Epidemiol Program, Boston, MA 02115 USA; [Pan, Wen-Chi] Brown Univ, Dept Epidemiol, Providence, RI 02912 USA; [Dominici, Francesca] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Lung, Shih-Chun Candice] Acad Sinica, Res Ctr Environm Changes, Taipei 115, Taiwan; [Lung, Shih-Chun Candice] Natl Taiwan Univ, Dept Atmospher Sci, Taipei 10764, Taiwan; [Su, Huey-Jen] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan	National Chiayi University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Brown University; Harvard University; Harvard T.H. Chan School of Public Health; Academia Sinica - Taiwan; National Taiwan University; National Cheng Kung University	Su, HJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan.	hjsu@mail.ncku.edu.tw	Lung, Shih-Chun Candice/ABA-1011-2020; Lung, Shih-Chun Candice/GYD-5623-2022; Wu, Chih-Da/AAI-7384-2021	Lung, Shih-Chun Candice/0000-0002-4227-0469; Lung, Shih-Chun Candice/0000-0002-4227-0469; Wu, Chih-Da/0000-0001-9720-7937; Pan, Wen-Chi/0000-0002-0588-8083				Altschul I., 2012, J SOC SOC WORK RES, V3, P13, DOI [10.5243/jsswr.2012.2, 10.5243/jsswr, DOI 10.5243/JSSWR.2012.2]; [Anonymous], 2005, EC HUM WELL BEING SY; Bowler D, 2010, CEE REV; Breckle S.W, 2002, WALTERS VEGETATION E; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Capraro M.M., 2000, INVESTIGATION EFFECT; Carlsson M, 2012, 18484 NBER; Caro D.H., 2009, CANADIAN J ED, V32, P558; Chambers EA, 2004, GENDER EDUC, V16, P327, DOI 10.1080/09540250042000251470; Dadvand P, 2012, ENVIRON HEALTH PERSP, V120, P1286, DOI 10.1289/ehp.1104609; Dadvand P, 2012, ENVIRON INT, V40, P110, DOI 10.1016/j.envint.2011.07.004; Davies RG, 2006, P ROY SOC B-BIOL SCI, V273, P2127, DOI 10.1098/rspb.2006.3551; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Dormann CF, 2007, ECOL MODEL, V207, P234, DOI 10.1016/j.ecolmodel.2007.05.002; Eamon MK, 2005, J YOUTH ADOLESCENCE, V34, P163, DOI 10.1007/s10964-005-3214-x; Fan YL, 2011, HEALTH PLACE, V17, P1202, DOI 10.1016/j.healthplace.2011.08.008; Farooq M.S., 2011, J QUALITY TECHNOLOGY, V8, P1; Gill S.E., 2007, BUILT ENV, V33, P115, DOI [10.2148/benv.33.1.115, 10.2148/benv.33.1.115., DOI 10.2148/BENV.33.1.115]; Greenspace Scotland, 2008, HLTH IMP ASS GREENSP; Health Council of the Netherlands, 2004, NATURE HLTH INFLUENC; Kahlenberg RD, 2006, AM SCH BOARD J; Karjalainen Eeva, 2010, Environmental Health and Preventive Medicine, V15, P1, DOI 10.1007/s12199-008-0069-2; Kirkup. J, 2008, TELEGRAPH; Lee ACK, 2011, J PUBLIC HEALTH-UK, V33, P212, DOI 10.1093/pubmed/fdq068; Maas J, 2009, J EPIDEMIOL COMMUN H, V63, P967, DOI 10.1136/jech.2008.079038; Maas J., 2008, VITAMIN G GREEN ENV; Maas J, 2009, HEALTH PLACE, V15, P586, DOI 10.1016/j.healthplace.2008.09.006; McCoy LP, 2005, J EDUC RES, V98, P131, DOI 10.3200/JOER.98.3.131-135; Nowak David J., 2006, Urban Forestry & Urban Greening, V5, P93, DOI [10.1016/j.ufug.2006.04.002, 10.1016/j.ufug.2006.01.007]; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pereira G, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-49; Pereira G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-466; Pickering AJ, 2012, ENVIRON SCI TECHNOL, V46, P2391, DOI 10.1021/es203177v; PIRC (Massachusetts Parent Information & Resource Center), 2007, PARENTS PLACE B, V8, P4; Rouse CE, 2006, FUTURE CHILD, V16, P99, DOI 10.1353/foc.2006.0018; Solano R., 2010, MODIS VEGETATION IND; Stephenson CM, 2006, ECOL MODEL, V193, P747, DOI 10.1016/j.ecolmodel.2005.09.007; Townsend M., 2010, BLUE GREEN BENEFITS; U.S. Bureau of Labor Statistics, 2014, EARN UN RAT ED ATT; USGS, 2013, LAND PROC DISTR ACT; Uyar A., 2011, EUROPEAN J EC POLITI, V4, P139; Villeneuve PJ, 2012, ENVIRON RES, V115, P51, DOI 10.1016/j.envres.2012.03.003; Weier J, 2011, MEASURING VEGETATION; Whitford V, 2001, LANDSCAPE URBAN PLAN, V57, P91, DOI 10.1016/S0169-2046(01)00192-X; Zubrick SR, 2006, W AUSTR ABORIGINAL C, V3, P283	45	249	253	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e108548	10.1371/journal.pone.0108548	http://dx.doi.org/10.1371/journal.pone.0108548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ9WZ	25310542	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210300022
J	Derksen, A; Hensel, A; Hafezi, W; Herrmann, F; Schmidt, TJ; Ehrhardt, C; Ludwig, S; Kuhn, J				Derksen, Andrea; Hensel, Andreas; Hafezi, Wali; Herrmann, Fabian; Schmidt, Thomas J.; Ehrhardt, Christina; Ludwig, Stephan; Kuehn, Joachim			3-0-Galloylated Procyanidins from Rumex acetosa L. Inhibit the Attachment of Influenza A Virus	PLOS ONE			English	Article							ACTIVITY IN-VITRO; ANTIVIRAL ACTIVITY; GREEN TEA; COLORIMETRIC ASSAY; DERMAL FIBROBLASTS; SCREENING ASSAYS; B VIRUSES; POLYPHENOLS; AGENTS; RESISTANCE	Infections by influenza A viruses (IAV) are a major health burden to mankind. The current antiviral arsenal against IAV is limited and novel drugs are urgently required. Medicinal plants are known as an abundant source for bioactive compounds, including antiviral agents. The aim of the present study was to characterize the anti-IAV potential of a proanthocyanidinenriched extract derived from the aerial parts of Rumex acetosa (RA), and to identify active compounds of RA, their mode of action, and structural features conferring anti-AV activity. In a modified KU (MTTIAv) assay, RA was shown to inhibit growth of the IAV strain PR8 (H1N1) and a clinical isolate of lAV(H1N1)pdm09 with a half-maximal inhibitory concentration (IC50) of 2.5 pg/mL and 2.2;Ag/mL, and a selectivity index (SD (half-maximal cytotoxic concentration (CC50)/1(50)) of 32 and 36, respectively. At RA concentrations>1 pg/mL plaque formation of lAV(H1N1)pdm09 was abrogated. RA was also active against an oseltamivir-resistant isolate of lAV(H1N1)pdm09. TNF-iy. and EGF-induced signal transduction in A549 cells was not affected by RA. The dimeric proanthocyanidin epicatechin-3-0-gallate-(4f1 >8)-epicatechin-3'-0-gallate (procyanidin B2di-gallate) was identified as the main active principle of RA (IC50 approx. 15 uM, SI_?..13). RA and procyanidin B2-di-gallate blocked attachment of IAV and interfered with viral penetration at higher concentrations. Galloylation of the procyanidin core structure was shown to be a prerequisite for anti-AV activity; o-trihydroxylation in the B-ring increased the anti-IAV activity. In silico docking studies indicated that procyanidin B2-di-gallate is able to interact with the receptor binding site of IAV(H1N1)pdm09 hemagglutinin (HA). In conclusion, the proanthocyanidin-enriched extract RA and its main active constituent procyanidin B2-di-gallate protect cells from IAV infection by inhibiting viral entry into the host cell. RA and procyanidin B2-di-gallate appear to be a promising expansion of the currently available anti-influenza agents.	[Derksen, Andrea; Hensel, Andreas; Herrmann, Fabian; Schmidt, Thomas J.] Univ Munster, Inst Pharmaceut Biol & Phytochem, D-48149 Munster, Germany; [Hafezi, Wali; Kuehn, Joachim] Univ Hosp Munster, Inst Med Microbiol Clin Virol, Munster, Germany; [Ehrhardt, Christina; Ludwig, Stephan] Univ Munster, Inst Mol Virol, D-48149 Munster, Germany	University of Munster; University of Munster; University of Munster	Kuhn, J (corresponding author), Univ Hosp Munster, Inst Med Microbiol Clin Virol, Munster, Germany.	kuehnj@uni-muenster.de	Schmidt, Thomas J/M-1678-2016	Schmidt, Thomas J/0000-0003-2634-9705; Ludwig, Stephan/0000-0003-4490-3052; Herrmann, Fabian/0000-0002-2411-7671	Deutsche Forschungsgemeinschaft; University of Muenster	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Muenster	The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyare C, 2011, PHYTOMEDICINE, V18, P617, DOI 10.1016/j.phymed.2010.08.020; Beyleveld G, 2013, ANTIVIR RES, V100, P120, DOI 10.1016/j.antiviral.2013.07.018; Bicker J, 2009, FITOTERAPIA, V80, P483, DOI 10.1016/j.fitote.2009.08.015; Daglia M, 2012, CURR OPIN BIOTECH, V23, P174, DOI 10.1016/j.copbio.2011.08.007; DANNE A, 1994, PHYTOCHEMISTRY, V37, P533, DOI 10.1016/0031-9422(94)85094-1; De Bruyne T, 1999, J NAT PROD, V62, P954, DOI 10.1021/np980481o; De Clercq E, 2013, MED RES REV, V33, P1249, DOI 10.1002/med.21281; De Clercq E, 2013, BIOCHEM PHARMACOL, V85, P727, DOI 10.1016/j.bcp.2012.12.011; Dixit Rashmi, 2013, Infectious Disorders - Drug Targets, V13, P34; Ehrhardt C, 2007, ANTIVIR RES, V76, P38, DOI 10.1016/j.antiviral.2007.05.002; Ehrhardt C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063657; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Ge H, 2010, NAT PROD REP, V27, P1758, DOI 10.1039/c0np00005a; Gescher K, 2011, J ETHNOPHARMACOL, V134, P468, DOI 10.1016/j.jep.2010.12.038; Gescher K, 2011, ANTIVIR RES, V89, P9, DOI 10.1016/j.antiviral.2010.10.007; Glatthaar-Saalmuller B, 2011, PHYTOMEDICINE, V19, P1, DOI 10.1016/j.phymed.2011.10.010; Haidari M, 2009, PHYTOMEDICINE, V16, P1127, DOI 10.1016/j.phymed.2009.06.002; Haslam E, 1996, J NAT PROD, V59, P205, DOI 10.1021/np960040+; Hrincius ER, 2010, CELL MICROBIOL, V12, P831, DOI 10.1111/j.1462-5822.2010.01436.x; Imanishi N, 2002, MICROBIOL IMMUNOL, V46, P491, DOI 10.1111/j.1348-0421.2002.tb02724.x; Jassim SAA, 2003, J APPL MICROBIOL, V95, P412, DOI 10.1046/j.1365-2672.2003.02026.x; Kamali Amanda, 2013, Infect Drug Resist, V6, P187, DOI 10.2147/IDR.S36601; Karoline D, 2007, ANTIVIR RES, V76, P1, DOI 10.1016/j.antiviral.2007.04.001; Khandaker I, 2013, VIRUS GENES; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Laursen NS, 2013, ANTIVIR RES, V98, P476, DOI 10.1016/j.antiviral.2013.03.021; Liu G, 2011, ARCH VIROL, V156, P1359, DOI 10.1007/s00705-011-0989-9; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAKAYAMA M, 1993, ANTIVIR RES, V21, P289, DOI 10.1016/0166-3542(93)90008-7; Pabst D, 2011, EUR J INTERN MED, V22, pE119, DOI 10.1016/j.ejim.2011.08.014; Pariani E, 2013, HUM VACCIN IMMUNOTHE, V9; Park S, 2013, BIOCHEM BIOPH RES CO, V440, P14, DOI 10.1016/j.bbrc.2013.08.090; PAUWELS R, 1988, J VIROL METHODS, V20, P309, DOI 10.1016/0166-0934(88)90134-6; SAUTER NK, 1992, BIOCHEMISTRY-US, V31, P9609, DOI 10.1021/bi00155a013; Song JM, 2007, EXPERT REV ANTI-INFE, V5, P497, DOI 10.1586/14787210.5.3.497; Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010; Steinmann J, 2013, BRIT J PHARMACOL, V168, P1059, DOI 10.1111/bph.12009; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Theisen LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088062; Theisen LL, 2012, ANTIVIR RES, V94, P147, DOI 10.1016/j.antiviral.2012.03.006; Thorlund K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-134; Ubillas R, 1994, Phytomedicine, V1, P77, DOI 10.1016/S0944-7113(11)80026-7; Wang RX, 2013, FITOTERAPIA, V84, P308, DOI 10.1016/j.fitote.2012.12.020; Wang XY, 2006, PHYTOTHER RES, V20, P335, DOI 10.1002/ptr.1892; Williamson MP, 2006, J ALLERGY CLIN IMMUN, V118, P1369, DOI 10.1016/j.jaci.2006.08.016; Xu R, 2013, NAT STRUCT MOL BIOL, V20, P363, DOI 10.1038/nsmb.2500; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yang ZF, 2014, FITOTERAPIA, V93, P47, DOI 10.1016/j.fitote.2013.12.011; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zumdick S, 2012, FITOTERAPIA, V83, P1210, DOI 10.1016/j.fitote.2012.06.013	51	33	35	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110089	10.1371/journal.pone.0110089	http://dx.doi.org/10.1371/journal.pone.0110089			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303676	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400110
J	Zhang, ZJ; Ng, GYF; Lee, WC; Fu, SN				Zhang, Zhi Jie; Ng, Gabriel Yin-fat; Lee, Wai Chun; Fu, Siu Ngor			Changes in Morphological and Elastic Properties of Patellar Tendon in Athletes with Unilateral Patellar Tendinopathy and Their Relationships with Pain and Functional Disability	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; JUMPERS KNEE; VOLLEYBALL PLAYERS; ACHILLES-TENDON; SONOELASTOGRAPHY; ULTRASONOGRAPHY; PREVALENCE; STIFFNESS	Background: Patellar tendinopathy (PT) is one of the most common knee disorders among athletes. Changes in morphology and elasticity of the painful tendon and how these relate to the self-perceived pain and dysfunction remain unclear. Objectives: To compare the morphology and elastic properties of patellar tendons between athlete with and without unilateral PT and to examine its association with self-perceived pain and dysfunction. Methods: In this cross-sectional study, 33 male athletes (20 healthy and 13 with unilateral PT) were enrolled. The morphology and elastic properties of the patellar tendon were assessed by the grey and elastography mode of supersonic shear imaging (SSI) technique while the intensity of pressure pain, self-perceived pain and dysfunction were quantified with a 10-lb force to the most painful site and the Victorian Institute of Sport Assessment-patella (VISA-P) questionnaire, respectively. Results: In athletes with unilateral PT, the painful tendons had higher shear elastic modulus (SEM) and larger tendon than the non-painful side (p<0.05) or the dominant side of the healthy athletes (p<0.05). Significant correlations were found between tendon SEM ratio (SEM of painful over non-painful tendon) and the intensity of pressure pain (rho = 0.62; p = 0.024), VISA-P scores (rho = -0.61; p = 0.026), and the sub-scores of the VISA-P scores on going down stairs, lunge, single leg hopping and squatting (rho ranged from -0.63 to -0.67; p<0.05). Conclusions: Athletes with unilateral PT had stiffer and larger tendon on the painful side than the non-painful side and the dominant side of healthy athletes. No significant differences on the patellar tendon morphology and elastic properties were detected between the dominant and non-dominant knees of the healthy control. The ratio of the SEM of painful to non-painful sides was associated with pain and dysfunction among athletes with unilateral PT.	[Zhang, Zhi Jie; Ng, Gabriel Yin-fat; Lee, Wai Chun; Fu, Siu Ngor] Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China; [Zhang, Zhi Jie] Guangdong Prov Work Injury Rehabil Hosp, Guangdong Hongkong Joint Sports Rehabil & Res Ctr, Guangzhou, Guangdong, Peoples R China	Hong Kong Polytechnic University	Fu, SN (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China.	amy.fu@polyu.edu.hk		FU, Amy/0000-0003-4405-015X				Bensamoun SF, 2006, J MAGN RESON IMAGING, V23, P242, DOI 10.1002/jmri.20487; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Bjornaraa J, 2011, INT J SPORTS PHYS TH, V6, P271; Chen XM, 2013, J ULTRAS MED, V32, P449, DOI 10.7863/jum.2013.32.3.449; Cook JL, 2000, SCAND J MED SCI SPOR, V10, P216, DOI 10.1034/j.1600-0838.2000.010004216.x; Cook JL, 1998, CLIN J SPORT MED, V8, P73, DOI 10.1097/00042752-199804000-00001; Couppe C, 2008, J APPL PHYSIOL, V105, P805, DOI 10.1152/japplphysiol.90361.2008; Couppe C, 2013, SCAND J MED SCI SPOR, V23, pe89, DOI 10.1111/sms.12023; Crossley KM, 2004, ARCH PHYS MED REHAB, V85, P815, DOI 10.1016/S0003-9993(03)00613-0; De Zordo T, 2009, AM J ROENTGENOL, V193, P180, DOI 10.2214/AJR.08.2020; DeWall RJ, 2014, ULTRASOUND MED BIOL, V40, P158, DOI 10.1016/j.ultrasmedbio.2013.08.022; Fredberg U, 2008, SCAND J MED SCI SPOR, V18, P3, DOI 10.1111/j.1600-0838.2007.00746.x; Frohm A, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-49; Gisslen K, 2005, BRIT J SPORT MED, V39, P298, DOI 10.1136/bjsm.2004.014290; Goncalves-Neto J, 2002, JOINT BONE SPINE, V69, P189, DOI 10.1016/S1297-319X(02)00369-X; Helland C, 2013, BRIT J SPORT MED, V47, P862, DOI 10.1136/bjsports-2013-092275; HOOLEY CJ, 1979, INT J BIOL MACROMOL, V1, P123, DOI 10.1016/0141-8130(79)90028-X; Ireland D, 2001, MATRIX BIOL, V20, P159, DOI 10.1016/S0945-053X(01)00128-7; Itoh A, 2006, RADIOLOGY, V239, P341, DOI 10.1148/radiol.2391041676; Kader D, 2002, BRIT J SPORT MED, V36, P239, DOI 10.1136/bjsm.36.4.239; Khan KM, 1999, SPORTS MED, V27, P393, DOI 10.2165/00007256-199927060-00004; Klauser AS, 2010, SEMIN MUSCULOSKEL R, V14, P323, DOI 10.1055/s-0030-1254521; Kongsgaard M, 2009, SCAND J MED SCI SPOR, V19, P790, DOI 10.1111/j.1600-0838.2009.00949.x; Kongsgaard M, 2010, AM J SPORT MED, V38, P749, DOI 10.1177/0363546509350915; Kot BCW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044348; Kulig K, 2013, SCAND J MED SCI SPOR, V23, pe81, DOI 10.1111/sms.12021; Lian O, 1996, SCAND J MED SCI SPOR, V6, P291; Lian OB, 2005, AM J SPORT MED, V33, P561, DOI 10.1177/0363546504270454; Lichtwark GA, 2005, J EXP BIOL, V208, P4715, DOI 10.1242/jeb.01950; Maffulli N, 2004, MED SCI SPORT EXER, V36, P1470, DOI 10.1249/01.MSS.0000139895.94846.8D; Magnusson SP, 2003, SCAND J MED SCI SPOR, V13, P211, DOI 10.1034/j.1600-0838.2003.00308.x; Malliaras P, 2010, BRIT J SPORT MED, V44, P944, DOI 10.1136/bjsm.2008.054916; Nyland J, 2006, CLIN IMAG, V30, P335, DOI 10.1016/j.clinimag.2006.02.004; Royer D, 2011, J ACOUST SOC AM, V129, P2757, DOI 10.1121/1.3559681; Sconfienza LM, 2010, CLIN EXP RHEUMATOL, V28, P373; Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850; Visentini P J, 1998, J Sci Med Sport, V1, P22, DOI 10.1016/S1440-2440(98)80005-4; Warden SJ, 2007, AM J SPORT MED, V35, P427, DOI 10.1177/0363546506294858; Witvrouw E, 2001, AM J SPORT MED, V29, P190, DOI 10.1177/03635465010290021201; Zhang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066301; Zwerver J, 2011, AM J SPORT MED, V39, P1191, DOI 10.1177/0363546510395492	41	71	75	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108337	10.1371/journal.pone.0108337	http://dx.doi.org/10.1371/journal.pone.0108337			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303466	gold, Green Published, Green Submitted			2022-12-27	WOS:000343730400010
J	Chang, ZQ; Hou, TY; Xing, JC; Wu, XH; Jin, HY; Li, ZQ; Deng, MY; Xie, Z; Xu, JZ				Chang, Zhengqi; Hou, Tianyong; Xing, Junchao; Wu, Xuehui; Jin, Huiyong; Li, Zhiqiang; Deng, Moyuan; Xie, Zhao; Xu, Jianzhong			Umbilical Cord Wharton's Jelly Repeated Culture System: A New Device and Method for Obtaining Abundant Mesenchymal Stem Cells for Bone Tissue Engineering	PLOS ONE			English	Article							STROMAL CELLS; IN-VIVO; RECONSTRUCTION; EXPRESSION	To date, various types of cells for seeding regenerative scaffolds have been used for bone tissue engineering. Among seed cells, the mesenchymal stem cells derived from human umbilical cord Wharton's jelly (hUCMSCs) represent a promising candidate and hold potential for bone tissue engineering due to the the lack of ethical controversies, accessibility, sourced by non-invasive procedures for donors, a reduced risk of contamination, osteogenic differentiation capacities, and higher immunomodulatory capacity. However, the current culture methods are somewhat complicated and inefficient and often fail to make the best use of the umbilical cord (UC) tissues. Moreover, these culture processes cannot be performed on a large scale and under strict quality control. As a result, only a small quantity of cells can be harvested using the current culture methods. To solve these problems, we designed and evaluated an UC Wharton's jelly repeated culture device. Using this device, hUCMSCs were obtained from the repeated cultures and their quantities and biological characteristics were compared. We found that using our culture device, which retained all tissue blocks on the bottom of the dish, the total number of obtained cells increased 15-20 times, and the time required for the primary passage was reduced. Moreover, cells harvested from the repeated cultures exhibited no significant difference in their immunophenotype, potential for multilineage differentiation, or proliferative, osteoinductive capacities, and final osteogenesis. The application of the repeated culture frame (RCF) not only made full use of the Wharton's jelly but also simplified and specified the culture process, and thus, the culture efficiency was significantly improved. In summary, abundant hUCMSCs of dependable quality can be acquired using the RCF.	[Chang, Zhengqi; Hou, Tianyong; Xing, Junchao; Wu, Xuehui; Jin, Huiyong; Li, Zhiqiang; Deng, Moyuan; Xie, Zhao; Xu, Jianzhong] Third Mil Med Univ, Southwest Hosp, Dept Orthopaed, Natl & Reg United Engn Lab Tissue Engn, Chongqing, Peoples R China; [Chang, Zhengqi; Hou, Tianyong; Xing, Junchao; Wu, Xuehui; Jin, Huiyong; Li, Zhiqiang; Deng, Moyuan; Xie, Zhao; Xu, Jianzhong] Third Mil Med Univ, Ctr Tissue Engn Res & Applicat, Chongqing, Peoples R China; [Chang, Zhengqi; Hou, Tianyong; Xing, Junchao; Wu, Xuehui; Jin, Huiyong; Li, Zhiqiang; Deng, Moyuan; Xie, Zhao; Xu, Jianzhong] Lab Tissue Engn, Chongqing, Peoples R China; [Chang, Zhengqi] Gen Hosp Jinan Mil Commanding Reg, Dept Orthoped, Jinan, Peoples R China	Army Medical University; Army Medical University	Hou, TY (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Orthopaed, Natl & Reg United Engn Lab Tissue Engn, Chongqing, Peoples R China.	tianyonghou@126.com; jianzhong_xu@126.com	Xing, Junchao/GWN-0403-2022	Xu, Jianzhong/0000-0003-0434-5148	National Natural Science Foundation of China [81371975]; Foundation of Southwest Hospital [SWH2013JS07]; Military Foundation [BWS11C040]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Southwest Hospital; Military Foundation	This study was supported by the National Natural Science Foundation of China (81371975), the Foundation of Southwest Hospital (SWH2013JS07), and the Military Foundation (BWS11C040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzalone R, 2011, STEM CELL REV REP, V7, P342, DOI 10.1007/s12015-010-9196-4; Atala A., 2002, METHODS TISSUE ENG; Azari O, 2011, VET RES COMMUN, V35, P211, DOI 10.1007/s11259-011-9464-z; Baer PC, 2010, CYTOTHERAPY, V12, P96, DOI 10.3109/14653240903377045; Balasubramanian S, 2012, CYTOTHERAPY, V14, P26, DOI 10.3109/14653249.2011.605119; Corrao S, 2013, HISTOL HISTOPATHOL, V28, P1235, DOI 10.14670/HH-28.1235; De Bruyn C, 2011, STEM CELLS DEV, V20, P547, DOI 10.1089/scd.2010.0260; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Han D, 2013, CELL TISSUE RES, V352, P561, DOI 10.1007/s00441-013-1595-9; Hou TY, 2010, TISSUE ENG PT A, V16, P201, DOI [10.1089/ten.tea.2009.0291, 10.1089/ten.TEA.2009.0291]; Hou TY, 2009, TISSUE ENG PT A, V15, P2325, DOI 10.1089/ten.tea.2008.0402; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Ishige I, 2009, INT J HEMATOL, V90, P261, DOI 10.1007/s12185-009-0377-3; Kodama A, 2012, J BONE JOINT SURG BR, V94B, P998, DOI 10.1302/0301-620X.94B7.28521; Lee JH, 2011, BIOMATERIALS, V32, P5033, DOI 10.1016/j.biomaterials.2011.03.081; Leeb C, 2010, STEM CELL REV REP, V6, P15, DOI 10.1007/s12015-009-9102-0; Liu SY, 2012, CELL IMMUNOL, V278, P35, DOI 10.1016/j.cellimm.2012.06.010; Lonne M, 2013, CELL TISSUE RES, V353, P117, DOI 10.1007/s00441-013-1597-7; Longo UG, 2012, CURR STEM CELL RES T, V7, P272; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; Lu ZF, 2013, J CELL PHYSIOL, V228, P1737, DOI 10.1002/jcp.24330; Lushaj EB, 2011, CYTOTHERAPY, V13, P400, DOI 10.3109/14653249.2010.529890; Mankani MH, 2006, STEM CELLS, V24, P2140, DOI 10.1634/stemcells.2005-0567; Najar M, 2010, TISSUE ENG PT A, V16, P3537, DOI [10.1089/ten.tea.2010.0159, 10.1089/ten.TEA.2010.0159]; Romanov YA, 2003, STEM CELLS, V21, P105, DOI 10.1634/stemcells.21-1-105; Salehinejad P, 2012, IN VITRO CELL DEV-AN, V48, P75, DOI 10.1007/s11626-011-9480-x; Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166; Saward L, 1997, MOL CELL BIOCHEM, V176, P53, DOI 10.1023/A:1006870827516; Wang DA, 2005, TISSUE ENG, V11, P201, DOI 10.1089/ten.2005.11.201; Wang F, 2011, STEM CELLS DEV, V20, P2093, DOI 10.1089/scd.2010.0523; Wang LM, 2011, REGEN MED, V6, P95, DOI [10.2217/rme.10.98, 10.2217/RME.10.98]; Wegmeyer H, 2013, STEM CELLS DEV, V22, P2606, DOI 10.1089/scd.2013.0016; Xing JC, 2013, TISSUE ENG PT A, V19, P255, DOI [10.1089/ten.tea.2012.0262, 10.1089/ten.TEA.2012.0262]; Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705; Yoon JH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/428726	36	6	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110764	10.1371/journal.pone.0110764	http://dx.doi.org/10.1371/journal.pone.0110764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329501	gold, Green Submitted, Green Published			2022-12-27	WOS:000343942100093
J	Chen, W; Lewith, G; Wang, LQ; Ren, J; Xiong, WJ; Lu, F; Liu, JP				Chen, Wei; Lewith, George; Wang, Li-qiong; Ren, Jun; Xiong, Wen-jing; Lu, Fang; Liu, Jian-ping			Chinese Proprietary Herbal Medicine Listed in 'China National Essential Drug List' for Common Cold: A Systematic Literature Review	PLOS ONE			English	Review							PRESCRIBING STRATEGIES	Objective: Chinese proprietary herbal medicines (CPHMs) have long history in China for the treatment of common cold, and lots of them have been listed in the 'China national essential drug list' by the Chinese Ministry of Health. The aim of this review is to provide a well-round clinical evidence assessment on the potential benefits and harms of CPHMs for common cold based on a systematic literature search to justify their clinical use and recommendation. Methods: We searched CENTRAL, MEDLINE, EMBASE, SinoMed, CNKI, VIP, China Important Conference Papers Database, China Dissertation Database, and online clinical trial registry websites from their inception to 31 March 2013 for clinical studies of CPHMs listed in the 'China national essential drug list' for common cold. There was no restriction on study design. Results: A total of 33 CPHMs were listed in 'China national essential drug list 2012' for the treatment of common cold but only 7 had supportive clinical evidences. A total of 6 randomised controlled trials (RCTs) and 7 case series (CSs) were included; no other study design was identified. All studies were conducted in China and published in Chinese between 1995 and 2012. All included studies had poor study design and methodological quality, and were graded as very low quality. Conclusions: The use of CPHMs for common cold is not supported by robust evidence. Further rigorous well designed placebo-controlled, randomized trials are needed to substantiate the clinical claims made for CPHMs.	[Chen, Wei; Wang, Li-qiong; Ren, Jun; Xiong, Wen-jing; Lu, Fang; Liu, Jian-ping] Beijing Univ Chinese Med, Ctr Evidence Based Chinese Med, Beijing, Peoples R China; [Lewith, George] Univ Southampton, Sch Med, Southampton, Hants, England	Beijing University of Chinese Medicine; University of Southampton	Liu, JP (corresponding author), Beijing Univ Chinese Med, Ctr Evidence Based Chinese Med, Beijing, Peoples R China.	jianping_l@hotmail.com		Liu, Jianping/0000-0002-0320-061X	State Administration of Chinese Medicine [201207007]; Program for Innovative Research Team of Beijing University of Chinese Medicine [2011-CXTD-09]; research fund for the outstanding young teachers of Beijing University of Chinese Medicine	State Administration of Chinese Medicine; Program for Innovative Research Team of Beijing University of Chinese Medicine; research fund for the outstanding young teachers of Beijing University of Chinese Medicine	This work is supported by a research capacity establishment grant from the State Administration of Chinese Medicine (201207007), the Program for Innovative Research Team of Beijing University of Chinese Medicine (2011-CXTD-09), and research fund for the outstanding young teachers of Beijing University of Chinese Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An R., 2011, THESIS BEIJING U CHI; [Anonymous], 2000, BMJ-BRIT MED J, V320, P1623; Chen W, 2014, J ALTERN COMPLEM MED, V5, pA128; Dai LH, 1995, J HENAN COLL TRADITI, V10, P45; Di JH, 2012, CHIN PEDIAT INTEGR T, V4, P277; Eccles R, 2005, LANCET INFECT DIS, V5, P718, DOI 10.1016/S1473-3099(05)70270-X; Han M, 2013, MODERNIZATION TRADIT, V15, P1771; Ishizaki T, 1996, EUR RESPIR J, V9, P2691, DOI 10.1183/09031936.96.09122691; Jiang XQ, 2012, GUANGMING J CHINESE, V27, P386; Kenealy T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000247.pub3; Li QF, 2007, SHANDONG MED J, V47, P24; Li ZX, 1997, SHANXI J TRADITIONAL, V13, P16; Little P, 2001, BMJ-BRIT MED J, V322, P336, DOI 10.1136/bmj.322.7282.336; Little P, 2005, JAMA-J AM MED ASSOC, V293, P3029, DOI 10.1001/jama.293.24.3029; Lv GQ, 2010, INNER MONGOL J TRADI, V29, P151; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Melchart D, 1999, JAMA-J AM MED ASSOC, V282, P28, DOI 10.1001/jama.282.1.28; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; National Health and Family Planning Commission of the People's Republic of China, 2013, CHIN NAT ESS DRUG LI; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Simasek M, 2007, AM FAM PHYSICIAN, V75, P515; The Central People's Government of the People's Republic of China, 2009, HLTH MIN CHIN PROJ E; Turner LA, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-67; Turner RB, 2001, ANTIVIR RES, V49, P1, DOI 10.1016/S0166-3542(00)00135-2; Wang HR, 1997, QINGDAO MED J, V29, P40; Wang LZ, 1999, SHANDONG J TRADITION, V18, P282; Wang ZY, 2003, J EMERGENCY TRADITIO, V12, P503; Wells G.A., NEWCASTLE OTTAWA SCA; Williamson IG, 2007, JAMA-J AM MED ASSOC, V298, P2487, DOI 10.1001/jama.298.21.2487; Wu CF, 2012, STRAIT PHARM J, V24, P239; Wu T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004782.pub2; Xu HQ, 2010, MED J CHINESE PEOPLE, V22, P132; Yang SS, 1965, INNER CANON HUANGDI; Zhang HY, 2009, QINGDAO MED J, V36, P431; Zhang Y, 2010, INT J TRADTIONAL CHI, V32, P523; Zhao MD, 2012, CHINESE COMMUNITY DO, V14, P223	36	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110560	10.1371/journal.pone.0110560	http://dx.doi.org/10.1371/journal.pone.0110560			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329481	Green Submitted, gold, Green Published			2022-12-27	WOS:000343942100074
J	de Hoog, HPM; JieRong, EML; Banerjee, S; Decaillot, FM; Nallani, M				de Hoog, Hans-Peter M.; JieRong, Esther M. Lin; Banerjee, Sourabh; Decaillot, Fabien M.; Nallani, Madhavan			Conformational Antibody Binding to a Native, Cell-Free Expressed GPCR in Block Copolymer Membranes	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; CHEMOKINE; RECONSTITUTION; CHOLESTEROL; VESICLES; LIPIDS		[de Hoog, Hans-Peter M.; JieRong, Esther M. Lin; Banerjee, Sourabh; Nallani, Madhavan] ACM Biolabs Pte Ltd, Singapore, Singapore; [Decaillot, Fabien M.] ASTAR, Singapore Immunol Network, Singapore, Singapore; [Nallani, Madhavan] Nanyang Technol Univ, Sch Mat Sci & Engn, Ctr Biomimet Sensor Sci, Singapore 639798, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Nallani, M (corresponding author), ACM Biolabs Pte Ltd, Res Techno Pl XF-6, Singapore, Singapore.	mnallani@ntu.edu.sg	Nallani, Madhavan/D-6597-2014		Exploit Technologies, Agency for Science, Technology and Research (A*STAR), Singapore; SPRING Singapore PoV grant; ACM Biolabs	Exploit Technologies, Agency for Science, Technology and Research (A*STAR), Singapore; SPRING Singapore PoV grant; ACM Biolabs	The authors are grateful to Exploit Technologies, Agency for Science, Technology and Research (A*STAR), Singapore, for financial support. This project was partly funded by a SPRING Singapore PoV grant. ACM Biolabs provided support in the form of salaries for authors HH, ELJ and SB but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Baribaud F, 2001, J VIROL, V75, P8957, DOI 10.1128/JVI.75.19.8957-8967.2001; Carnec X, 2005, J VIROL, V79, P1930, DOI 10.1128/JVI.79.3.1930-1933.2005; Choi HJ, 2005, NANO LETT, V5, P2538, DOI 10.1021/nl051896e; Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143; Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hoffman TL, 2000, P NATL ACAD SCI USA, V97, P11215, DOI 10.1073/pnas.190274097; Karlsson OP, 2002, ANAL BIOCHEM, V300, P132, DOI 10.1006/abio.2001.5428; Kita-Tokarczyk K, 2005, POLYMER, V46, P3540, DOI 10.1016/j.polymer.2005.02.083; Knoll W, 1998, ANNU REV PHYS CHEM, V49, P569, DOI 10.1146/annurev.physchem.49.1.569; Kumar M, 2007, P NATL ACAD SCI USA, V104, P20719, DOI 10.1073/pnas.0708762104; May S, 2013, ANGEW CHEM INT EDIT, V52, P749, DOI 10.1002/anie.201204645; Nallani M, 2006, J BIOTECHNOL, V123, P50, DOI 10.1016/j.jbiotec.2005.10.025; Nallani M, 2011, BIOINTERPHASES, V6, P153, DOI 10.1116/1.3644384; Navratilova I, 2005, ANAL BIOCHEM, V339, P271, DOI 10.1016/j.ab.2004.12.017; Oates J, 2011, CURR OPIN STRUC BIOL, V21, P802, DOI 10.1016/j.sbi.2011.09.007; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Robertson N, 2011, NEUROPHARMACOLOGY, V60, P36, DOI 10.1016/j.neuropharm.2010.07.001; Stenlund P, 2003, ANAL BIOCHEM, V316, P243, DOI 10.1016/S0003-2697(03)00046-0; Strizki JM, 1997, J VIROL, V71, P5678, DOI 10.1128/JVI.71.7.5678-5683.1997; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Willis S, 2008, BIOCHEMISTRY-US, V47, P6988, DOI 10.1021/bi800540b; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Yasayan G, 2012, POLYM CHEM-UK, V3, P2596, DOI 10.1039/c2py20352a	25	14	14	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110847	10.1371/journal.pone.0110847	http://dx.doi.org/10.1371/journal.pone.0110847			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329156	Green Published, gold			2022-12-27	WOS:000343942100100
J	Fang, X; Tang, GA; Li, BC; Han, RM				Fang, Xuan; Tang, Guoan; Li, Bicheng; Han, Ruiming			Spatial and Temporal Variations of Ecosystem Service Values in Relation to Land Use Pattern in the Loess Plateau of China at Town Scale	PLOS ONE			English	Article							SOIL-EROSION; LANDSCAPE PATTERN; VALUATION; URBANIZATION; DIVERSITY; PROVINCE; INDEXES; REGION	Understanding the relationship between land use change and ecosystem service values (ESVs) is the key for improving ecosystem health and sustainability. This study estimated the spatial and temporal variations of ESVs at town scale in relation to land use change in the Loess Plateau which is characterized by its environmental vulnerability, then analyzed and discussed the relationship between ESVs and land use pattern. The result showed that ESVs increased with land use change from 1982 to 2008. The total ESVs increased by 16.17% from US$ 6.315 million at 1982 to US$ 7.336 million at 2002 before the start of the Grain to Green project, while increased significantly thereafter by 67.61% to US$ 11.275 million at 2008 along with the project progressed. Areas with high ESVs appeared mainly in the center and the east where largely distributing orchard and forestland, while those with low ESVs occurred mainly in the north and the south where largely distributing cropland. Correlation and regression analysis showed that land use pattern was significantly positively related with ESVs. The proportion of forestland had a positive effect on ESVs, however, that of cropland had a negative effect. Diversification, fragmentation and interspersion of landscape positively affected ESVs, while land use intensity showed a negative effect. It is concluded that continuing the Grain to Green project and encouraging diversified agriculture benefit to improve the ecosystem service.	[Fang, Xuan; Tang, Guoan] Nanjing Normal Univ, Sch Geog Sci, Minist Educ, Key Lab Virtual Geog Environm, Nanjing, Jiangsu, Peoples R China; [Li, Bicheng] Chinese Acad Sci, Res Ctr Soil & Water Conservat & Ecol Environm, Yangling, Shaanxi, Peoples R China; [Han, Ruiming] Nanjing Normal Univ, Sch Geog Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Nanjing Normal University	Tang, GA (corresponding author), Nanjing Normal Univ, Sch Geog Sci, Minist Educ, Key Lab Virtual Geog Environm, Nanjing, Jiangsu, Peoples R China.	tangguoan@njnu.edu.cn	Tang, Guo-An/W-3278-2017	Tang, Guoan/0000-0002-1443-6134	Jiangsu Planned Projects for Postdoctoral Research Funds [1401033C]; National Natural Science Foundation of China [41401441]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) [164320H101]	Jiangsu Planned Projects for Postdoctoral Research Funds; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was sponsored by the Jiangsu Planned Projects for Postdoctoral Research Funds (No. 1401033C), the National Natural Science Foundation of China (No. 41401441), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) (No. 164320H101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai YB, 2013, ENVIRON MONIT ASSESS, V185, P5111, DOI 10.1007/s10661-012-2929-x; Christine F, 2013, J ENVIRON MANAGE, V127, P96; Chu YF, 2007, HYDROGRAPHIC SURVEYI, V27, P47; Collin M.L., 2001, URBAN WATER, V3, P229, DOI [10.1016/S1462-0758(01)00049-8, DOI 10.1016/S1462-0758(01)00049-8]; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Costanza R., 2015, INTRO ECOLOGICAL EC; de Groot RS, 2002, ECOL ECON, V41, P393, DOI 10.1016/S0921-8009(02)00089-7; Deng L, 2012, INT J SEDIMENT RES, V27, P120, DOI 10.1016/S1001-6279(12)60021-3; Eliska L, 2013, LAND USE POLICY, V33, P183; Ernesto FV, 2006, ECOLOGICAL EC, V57, P140; Fu BJ, 2002, LOESS HILLY REGION L; Fu BJ, 2009, PROG PHYS GEOG, V33, P793, DOI 10.1177/0309133309350264; Hein L, 2006, ECOL ECON, V57, P209, DOI 10.1016/j.ecolecon.2005.04.005; Ignacio P, 2014, REG ENVIRON CHANGE, V14, P237; Jing L, 2011, INT J ENVIRON RES, V5, P109; Konarska KM, 2002, ECOL ECON, V41, P491, DOI 10.1016/S0921-8009(02)00096-4; Kreuter UP, 2001, ECOL ECON, V39, P333, DOI 10.1016/S0921-8009(01)00250-6; Li HB, 2004, LANDSCAPE ECOL, V19, P389, DOI 10.1023/B:LAND.0000030441.15628.d6; Li MS, 2011, APPL GEOGR, V31, P1026, DOI 10.1016/j.apgeog.2011.02.004; Li P, 2014, ENV SYSTEMS RES, V3, P1, DOI [10.1186/2193-2697-3-2, DOI 10.1186/2193-2697-3-2]; Li Q, 2002, B SURVEYING MAPPING, V9, P59; Li TH, 2010, ECOL ECON, V69, P1427, DOI 10.1016/j.ecolecon.2008.05.018; Limburg KE, 2002, ECOL ECON, V41, P409, DOI 10.1016/S0921-8009(02)00090-3; Liu DL, 2011, ENVIRON EARTH SCI, V64, P2229, DOI 10.1007/s12665-011-1051-7; Long JA, 2010, APPL GEOGR, V30, P426, DOI 10.1016/j.apgeog.2009.12.002; Mendoza-Gonzalez G, 2012, ECOL ECON, V82, P23, DOI 10.1016/j.ecolecon.2012.07.018; Nagendra H, 2002, APPL GEOGR, V22, P175, DOI 10.1016/S0143-6228(02)00002-4; Nasiri F, 2007, ECOL INFORM, V2, P128, DOI 10.1016/j.ecoinf.2007.05.003; Pan WKY, 2004, AGR ECOSYST ENVIRON, V101, P117, DOI 10.1016/j.agee.2003.09.022; Ribeiro SC, 2009, J ENVIRON MANAGE, V90, P2873, DOI 10.1016/j.jenvman.2008.02.014; Ritsema CJ, 2003, CATENA, V54, P1, DOI 10.1016/S0341-8162(03)00052-3; Ronald CE, 2013, LANDSCAPE URBAN PLAN, V116, P60; Schmidt JP, 2014, LANDSCAPE URBAN PLAN, V122, P56, DOI 10.1016/j.landurbplan.2013.11.008; Sherrouse BC, 2011, APPL GEOGR, V31, P748, DOI 10.1016/j.apgeog.2010.08.002; Shrestha RP, 2010, APPL GEOGR, V30, P606, DOI 10.1016/j.apgeog.2010.01.005; Su CH, 2013, GLOBAL PLANET CHANGE, V101, P119, DOI 10.1016/j.gloplacha.2012.12.014; Su SL, 2012, APPL GEOGR, V34, P295, DOI 10.1016/j.apgeog.2011.12.001; Su SL, 2011, APPL GEOGR, V31, P439, DOI 10.1016/j.apgeog.2010.10.008; Turner M.G., 2001, LANDSCAPE ECOLOGY TH; Turner RK, 2003, ECOL ECON, V46, P493, DOI 10.1016/S0921-8009(03)00189-7; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089174; Wu JG, 2011, ECOL COMPLEX, V8, P1, DOI 10.1016/j.ecocom.2010.03.002; [谢高地 Xie Gaodi], 2003, [山地学报, Journal of Mountain Science], V21, P50; Xie GD, 2008, J NATURAL RESOURCES, V18, P190; Zaehle S, 2007, ECOSYSTEMS, V10, P380, DOI 10.1007/s10021-007-9028-9; Zhang MY, 2011, CHINESE GEOGR SCI, V21, P446, DOI 10.1007/s11769-011-0486-9; Zhang TB, 2006, J EARTH SCI ENV, V28, P79	49	19	21	5	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110745	10.1371/journal.pone.0110745	http://dx.doi.org/10.1371/journal.pone.0110745			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0AY	25329311	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100091
J	Rangasamy, S; McGuire, PG; Nitta, CF; Monickaraj, F; Oruganti, SR; Das, A				Rangasamy, Sampathkumar; McGuire, Paul G.; Nitta, Carolina Franco; Monickaraj, Finny; Oruganti, Sreenivasa R.; Das, Arup			Chemokine Mediated Monocyte Trafficking into the Retina: Role of Inflammation in Alteration of the Blood-Retinal Barrier in Diabetic Retinopathy	PLOS ONE			English	Article							ENDOTHELIAL PERMEABILITY; ADHESION MOLECULE-1; MACULAR EDEMA; CELLS; EXPRESSION; PROTEIN-1; MICROGLIA; OCCLUDIN; INJURY; NEOVASCULARIZATION	Inflammation in the diabetic retina is mediated by leukocyte adhesion to the retinal vasculature and alteration of the blood-retinal barrier (BRB). We investigated the role of chemokines in the alteration of the BRB in diabetes. Animals were made diabetic by streptozotocin injection and analyzed for gene expression and monocyte/macrophage infiltration. The expression of CCL2 (chemokine ligand 2) was significantly up-regulated in the retinas of rats with 4 and 8 weeks of diabetes and also in human retinal endothelial cells treated with high glucose and glucose flux. Additionally, diabetes or intraocular injection of recombinant CCL2 resulted in increased expression of the macrophage marker, F4/80. Cell culture impedance sensing studies showed that purified CCL2 was unable to alter the integrity of the human retinal endothelial cell barrier, whereas monocyte conditioned medium resulted in significant reduction in cell resistance, suggesting the relevance of CCL2 in early immune cell recruitment for subsequent barrier alterations. Further, using Cx3cr1-GFP mice, we found that intraocular injection of CCL2 increased retinal GFP(+) monocyte/macrophage infiltration. When these mice were made diabetic, increased infiltration of monocytes/macrophages was also present in retinal tissues. Diabetes and CCL2 injection also induced activation of retinal microglia in these animals. Quantification by flow cytometry demonstrated a two-fold increase of CX3CR1(+)/CD11b(+) (monocyte/macrophage and microglia) cells in retinas of wildtype diabetic animals in comparison to control non-diabetic ones. Using CCL2 knockout (Ccl2(-/-)) mice, we show a significant reduction in retinal vascular leakage and monocyte infiltration following induction of diabetes indicating the importance of this chemokine in alteration of the BRB. Thus, CCL2 may be an important therapeutic target for the treatment of diabetic macular edema.	[Rangasamy, Sampathkumar; McGuire, Paul G.] Univ New Mexico, Sch Med, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA; [Nitta, Carolina Franco; Monickaraj, Finny; Das, Arup] Univ New Mexico, Sch Med, Dept Surg, Albuquerque, NM 87131 USA; [Nitta, Carolina Franco; Das, Arup] New Mexico VA Hlth Care Syst, Albuquerque, NM USA; [Oruganti, Sreenivasa R.] Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico; University of New Mexico	Das, A (corresponding author), Univ New Mexico, Sch Med, Dept Surg, Albuquerque, NM 87131 USA.	adas@unm.edu	Rangasamy, Sampathkumar/B-7510-2009	Rangasamy, Sampathkumar/0000-0003-2151-9162	National Institutes of Health [EY 022327]; NATIONAL EYE INSTITUTE [R01EY022327] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the National Institutes of Health EY 022327. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamis AP, 2008, SEMIN IMMUNOPATHOL, V30, P65, DOI 10.1007/s00281-008-0111-x; Adamis AP, 2002, BRIT J OPHTHALMOL, V86, P363, DOI 10.1136/bjo.86.4.363; Antonetti DA, 1998, DIABETES, V47, P1953, DOI 10.2337/diabetes.47.12.1953; Ayoub AE, 2003, J NEUROSCI, V23, P7759; Banerjee S, 2007, INVEST OPHTH VIS SCI, V48, P2203, DOI 10.1167/iovs.06-1358; Capeans C, 1998, RETINA-J RET VIT DIS, V18, P546; Ceriello A, 1998, HORM METAB RES, V30, P146, DOI 10.1055/s-2007-978854; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Davies MH, 2008, INVEST OPHTH VIS SCI, V49, P4195, DOI 10.1167/iovs.07-1491; Dimitrijevic OB, 2006, J CEREBR BLOOD F MET, V26, P797, DOI 10.1038/sj.jcbfm.9600229; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; Funk M, 2010, RETINA-J RET VIT DIS, V30, P1412, DOI 10.1097/IAE.0b013e3181e095c0; Harhaj NS, 2006, INVEST OPHTH VIS SCI, V47, P5106, DOI 10.1167/iovs.06-0322; Horuk R, 2009, NAT REV DRUG DISCOV, V8, P23, DOI 10.1038/nrd2734; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Katakami Naoto, 2010, Diabetes Res Clin Pract, V89, pe9, DOI 10.1016/j.diabres.2010.04.006; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Kim SY, 2005, DIABETES, V54, P1534, DOI 10.2337/diabetes.54.5.1534; Koenen RR, 2010, NAT REV DRUG DISCOV, V9, P141, DOI 10.1038/nrd3048; Lee JE, 2008, INVEST OPHTH VIS SCI, V49, P4169, DOI 10.1167/iovs.08-2076; LEONARD EJ, 1990, IMMUNOL TODAY, V11, P97, DOI 10.1016/0167-5699(90)90035-8; Li GY, 2012, DIABETES, V61, P3294, DOI 10.2337/db11-1249; Lutty GA, 1997, AM J PATHOL, V151, P707; MARTY S, 1991, NEUROSCIENCE, V45, P529, DOI 10.1016/0306-4522(91)90268-S; MCLEOD DS, 1995, AM J PATHOL, V147, P642; Meleth AD, 2005, INVEST OPHTH VIS SCI, V46, P4295, DOI 10.1167/iovs.04-1057; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Miyamoto K, 1998, INVEST OPHTH VIS SCI, V39, P2190; Mohamed MM, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-3; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; Navaratna D, 2007, DIABETES, V56, P2380, DOI 10.2337/db06-1694; Rangasamy S, 2011, INVEST OPHTH VIS SCI, V52, P3784, DOI 10.1167/iovs.10-6386; Rutar M, 2011, INVEST OPHTH VIS SCI, V52, P2379, DOI 10.1167/iovs.10-6010; SCHRODER S, 1991, AM J PATHOL, V139, P81; Serra AM, 2012, AM J PATHOL, V181, P719, DOI 10.1016/j.ajpath.2012.04.009; Stamatovic SM, 2006, J BIOL CHEM, V281, P8379, DOI 10.1074/jbc.M513122200; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Tashimo A, 2004, DIABETIC MED, V21, P1292, DOI 10.1111/j.1464-5491.2004.01334.x; Tesch GH, 2008, AM J PHYSIOL-RENAL, V294, pF697, DOI 10.1152/ajprenal.00016.2008; Tien T, 2013, INVEST OPHTH VIS SCI, V54, P6518, DOI 10.1167/iovs.13-11763; Zhang WB, 2009, INVEST OPHTH VIS SCI, V50, P3033, DOI 10.1167/iovs.08-2676	44	135	137	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e108508	10.1371/journal.pone.0108508	http://dx.doi.org/10.1371/journal.pone.0108508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329075	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100011
J	Griet, M; Zelaya, H; Mateos, MV; Salva, S; Juarez, GE; de Valdez, GF; Villena, J; Salvador, GA; Rodriguez, AV				Griet, Milagros; Zelaya, Hortensia; Valeria Mateos, Melina; Salva, Susana; Esteban Juarez, Guillermo; Font de Valdez, Graciela; Villena, Julio; Alejandra Salvador, Gabriela; Virginia Rodriguez, Ana			Soluble Factors from Lactobacillus reuteri CRL1098 Have Anti-Inflammatory Effects in Acute Lung Injury Induced by Lipopolysaccharide in Mice	PLOS ONE			English	Article							PNEUMOCOCCAL RESPIRATORY-INFECTION; NECROSIS-FACTOR-ALPHA; IMPROVES RESISTANCE; INFLAMMATION; MODULATION; PROTECTS; BACTERIA; PATHWAY; CANCER; CELLS	We have previously demonstrated that Lactobacillus reuteri CRL1098 soluble factors were able to reduce TNF-alpha production by human peripheral blood mononuclear cells. The aims of this study were to determine whether L. reuteri CRL1098 soluble factors were able to modulate in vitro the inflammatory response triggered by LPS in murine macrophages, to gain insight into the molecular mechanisms involved in the immunoregulatory effect, and to evaluate in vivo its capacity to exert anti-inflammatory actions in acute lung injury induced by LPS in mice. In vitro assays demonstrated that L. reuteri CRL1098 soluble factors significantly reduced the production of pro-inflammatory mediators (NO, COX-2, and Hsp70) and proinflammatory cytokines (TNF-alpha, and IL-6) caused by the stimulation of macrophages with LPS. NF-kB and PI3K inhibition by L. reuteri CRL1098 soluble factors contributed to these inhibitory effects. Inhibition of PI3K/Akt pathway and the diminished expression of CD14 could be involved in the immunoregulatory effect. In addition, our in vivo data proved that the LPS-induced secretion of the pro-inflammatory cytokines, inflammatory cells recruitment to the airways and inflammatory lung tissue damage were reduced in L. reuteri CRL1098 soluble factors treated mice, providing a new way to reduce excessive pulmonary inflammation.	[Griet, Milagros; Zelaya, Hortensia; Salva, Susana; Esteban Juarez, Guillermo; Font de Valdez, Graciela; Villena, Julio; Virginia Rodriguez, Ana] Ctr Referencia Lactobacilos CERELA CONICET, San Miguel De Tucuman, Tucuman, Argentina; [Valeria Mateos, Melina; Alejandra Salvador, Gabriela] Inst Invest Bioquim Bahi Blanca INIBIBB, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Rodriguez, AV (corresponding author), Ctr Referencia Lactobacilos CERELA CONICET, San Miguel De Tucuman, Tucuman, Argentina.	anavirr@cerela.org.ar	Salvador, Gabriela/GOJ-7718-2022	Mateos, Melina Valeria/0000-0003-0822-0975; Salva, Susana/0000-0001-9571-1259	National Scientific and Technical Research Council-Argentina [PIP 0077]	National Scientific and Technical Research Council-Argentina	Support was provided by the National Scientific and Technical Research Council-Argentina, grant numbers: PIP 0077; ( http://www.conicet.gov.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atabai K, 2002, THORAX, V57, P452, DOI 10.1136/thorax.57.5.452; Beck-Schimmer B, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-61; Chiba E, 2013, INT IMMUNOPHARMACOL, V17, P373, DOI 10.1016/j.intimp.2013.06.024; Chiu YH, 2010, CLIN NUTR, V29, P131, DOI 10.1016/j.clnu.2009.07.004; Findlay EG, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/140937; Gill SE, 2013, AM J RESP CELL MOL, V49, P768, DOI 10.1165/rcmb.2012-0377OC; Herrera M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090227; Hiroshima Y, 2014, J IMMUNOL, V192, P2800, DOI 10.4049/jimmunol.1302556; Juarez GE, 2013, J FUNCT FOODS, V5, P1761, DOI 10.1016/j.jff.2013.08.002; Kanwar JR, 2009, CURR MED CHEM, V16, P2373, DOI 10.2174/092986709788682155; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lei M, 2011, APPL MICROBIOL BIOT, V92, P115, DOI 10.1007/s00253-011-3371-7; Liu F, 2013, J SURG RES, V185, P300, DOI 10.1016/j.jss.2013.05.083; Matsuda A, 2014, ANN SURG; Matthay MA, 2012, EUR RESPIR J, V39, P1062, DOI 10.1183/09031936.00204211; Mechoud MA, 2012, INT IMMUNOPHARMACOL, V14, P446, DOI 10.1016/j.intimp.2012.08.020; Morjaria S, 2006, INT J IMMUNOPATH PH, V19, P525, DOI 10.1177/039463200601900308; Park CM, 2014, FOOD CHEM TOXICOL, V66, P56, DOI 10.1016/j.fct.2014.01.019; Remus DM, 2011, EUR J PHARMACOL, V668, pS33, DOI 10.1016/j.ejphar.2011.07.012; Ren WY, 2011, IMMUNOL LETT, V141, P94, DOI 10.1016/j.imlet.2011.07.010; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Salva S, 2013, PROBIOTICS IMMUNOBIO, P280; Sanchez B, 2010, MICROBIOL-SGM, V156, P3232, DOI 10.1099/mic.0.044057-0; Sarada S, 2008, EXP BIOL MED, V233, P1088, DOI 10.3181/0712-RM-337; Sharma S, 2011, FOOD CHEM TOXICOL, V49, P770, DOI 10.1016/j.fct.2010.11.041; Soria M, 2008, BIOSCI BIOTECH BIOCH, V72, P3293, DOI 10.1271/bbb.80445; Striz I, 2014, CLIN SCI, V126, P593, DOI 10.1042/CS20130497; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Tsatsanis C, 2006, INT J BIOCHEM CELL B, V38, P1654, DOI 10.1016/j.biocel.2006.03.021; Villena J, 2005, J NUTR, V135, P1462, DOI 10.1093/jn/135.6.1462; Villena J., 2013, PROBIOTICS, V1, P128; Villena J, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-53; Villena J, 2011, INT IMMUNOPHARMACOL, V11, P1633, DOI 10.1016/j.intimp.2011.06.004; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wu Q, 2014, INFLAMM RES; Yen YT, 2013, SURGERY, V153, P689, DOI 10.1016/j.surg.2012.11.021; Zelaya H, 2014, INT IMMUNOPHARMACOL, V19, P161, DOI 10.1016/j.intimp.2013.12.020; Zhang LJ, 2013, CELL SIGNAL, V25, P1310, DOI 10.1016/j.cellsig.2013.02.004	38	36	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110027	10.1371/journal.pone.0110027	http://dx.doi.org/10.1371/journal.pone.0110027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329163	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204100042
J	Liu, XP; Yin, FF; Zhu, Z; Hou, DH; Wang, J; Zhang, L; Wang, ML; Wang, HL; Hu, ZH; Deng, F				Liu, Xiaoping; Yin, Feifei; Zhu, Zheng; Hou, Dianhai; Wang, Jun; Zhang, Lei; Wang, Manli; Wang, Hualin; Hu, Zhihong; Deng, Fei			Genomic Sequencing and Analysis of Sucra jujuba Nucleopolyhedrovirus	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; BACULOVIRUS ALKALINE NUCLEASE; OS INFECTIVITY FACTOR; DNA; GENE; REPLICATION; BINDING; ORGANIZATION; PROTEINS; ENCODES	The complete nucleotide sequence of Sucra jujuba nucleopolyhedrovirus (SujuNPV) was determined by 454 pyrosequencing. The SujuNPV genome was 135,952 bp in length with an A+T content of 61.34%. It contained 131 putative open reading frames (ORFs) covering 87.9% of the genome. Among these ORFs, 37 were conserved in all baculovirus genomes that have been completely sequenced, 24 were conserved in lepidopteran baculoviruses, 65 were found in other baculoviruses, and 5 were unique to the SujuNPV genome. Seven homologous regions (hrs) were identified in the SujuNPV genome. SujuNPV contained several genes that were duplicated or copied multiple times: two copies of helicase, DNA binding protein gene (dbp), p26 and cg30, three copies of the inhibitor of the apoptosis gene (iap), and four copies of the baculovirus repeated ORF (bro). Phylogenetic analysis suggested that SujuNPV belongs to a subclade of group II alphabaculovirus, which differs from other baculoviruses in that all nine members of this subclade contain a second copy of dbp.	[Liu, Xiaoping; Yin, Feifei; Zhu, Zheng; Hou, Dianhai; Wang, Jun; Zhang, Lei; Wang, Manli; Wang, Hualin; Hu, Zhihong; Deng, Fei] Chinese Acad Sci, Wuhan Inst Virol, Virus Resource & Bioinformat Ctr, State Key Lab Virol, Wuhan, Hunan, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Deng, F (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Virus Resource & Bioinformat Ctr, State Key Lab Virol, Wuhan, Hunan, Peoples R China.	df@wh.iov.cn	Hu, Zhihong/AAS-2215-2020; ZHU, ZHENG/P-2173-2016	Hu, Zhihong/0000-0002-1560-0928; ZHU, ZHENG/0000-0002-2035-0804	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB11030400]; National Science Foundation of China [31130058, 31321001]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant No. XDB11030400), and the grants from the National Science Foundation of China (No. 31130058 and No. 31321001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aucoin MG, 2010, CURR GENE THER, V10, P174; AYRES MD, 1994, VIROLOGY, V202, P586, DOI 10.1006/viro.1994.1380; Bideshi DK, 2003, J GEN VIROL, V84, P2531, DOI 10.1099/vir.0.19256-0; BIRNBAUM MJ, 1994, J VIROL, V68, P2521, DOI 10.1128/JVI.68.4.2521-2528.1994; Chen XW, 2001, J GEN VIROL, V82, P241, DOI 10.1099/0022-1317-82-1-241; Evans JT, 1997, J VIROL, V71, P3114, DOI 10.1128/JVI.71.4.3114-3119.1997; Fang MG, 2009, J VIROL, V83, P12569, DOI 10.1128/JVI.01141-09; Fanren S, 1986, J VIROL, V6, P4; Fauquet CM, 2000, VIRUS TAXONOMY; Ferrelli ML, 2012, BACULOVIRAL GENOME; GORBALENYA AE, 1988, FEBS LETT, V235, P16, DOI 10.1016/0014-5793(88)81226-2; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guarino LA, 1998, J VIROL, V72, P7985, DOI 10.1128/JVI.72.10.7985-7991.1998; Guarino LA, 2002, J VIROL, V76, P12663, DOI 10.1128/JVI.76.24.12663-12675.2002; Haas AL, 1996, BIOCHEMISTRY-US, V35, P5385, DOI 10.1021/bi9524981; Hall MC, 1999, MOL MICROBIOL, V34, P867, DOI 10.1046/j.1365-2958.1999.01659.x; Hawtin RE, 1997, VIROLOGY, V238, P243, DOI 10.1006/viro.1997.8816; Herniou EA, 2003, ANNU REV ENTOMOL, V48, P211, DOI 10.1146/annurev.ento.48.091801.112756; Herniou EA, 2011, VIRUS TAXONOMY CLASS; HODGMAN TC, 1988, NATURE, V333, P22, DOI 10.1038/333022b0; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Garavaglia MJ, 2012, J VIROL, V86, P12069, DOI 10.1128/JVI.01873-12; Jehle JA, 2006, ARCH VIROL, V151, P1257, DOI 10.1007/s00705-006-0763-6; Ji WeiRong, 1999, Scientia Silvae Sinicae, V35, P81; Kuzio J, 1999, VIROLOGY, V253, P17, DOI 10.1006/viro.1998.9469; Ferrelli ML, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-548; Lu A., 1997, BACULOVIRUSES; Lu Albert, 1991, VIROLOGY, V181, P336; Lucarotti CJ, 2007, VIROLOGICA SINICA, V22, P10; Ma XC, 2007, VIROLOGY, V360, P235, DOI 10.1016/j.virol.2006.10.024; McDougal VV, 1999, J VIROL, V73, P4908, DOI 10.1128/JVI.73.6.4908-4918.1999; McDougal VV, 2000, J VIROL, V74, P5273, DOI 10.1128/JVI.74.11.5273-5279.2000; MCLACHLIN JR, 1994, J VIROL, V68, P7746, DOI 10.1128/JVI.68.12.7746-7756.1994; Mikhailov VS, 2004, J BIOL CHEM, V279, P14734, DOI 10.1074/jbc.M311658200; Mikhailov VS, 2003, MOL BIOL+, V37, P250, DOI 10.1023/A:1023349706186; Mikhailov VS, 2003, J VIROL, V77, P2436, DOI 10.1128/JVI.77.4.2436-2444.2003; Mitsuhashi W, 2007, J VIROL, V81, P4235, DOI 10.1128/JVI.02300-06; Nai YS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-116; Nie YC, 2012, J VIROL, V86, P3985, DOI 10.1128/JVI.06849-11; O'Reilly DR, 1992, BACULOVIRUS EXPRESSI, P368; OReilly D.R., 1997, BACULOVIRUSES, P267, DOI DOI 10.1007/978-1-4899-1834-5_11; OREILLY DR, 1989, SCIENCE, V245, P1110, DOI 10.1126/science.2505387; PEARSON MN, 1995, J VIROL, V69, P213, DOI 10.1128/JVI.69.1.213-221.1995; Peng K, 2010, J VIROL, V84, P9497, DOI 10.1128/JVI.00812-10; Rohrmann G.F., 2019, BACULOVIRUS MOL BIOL; Rohrmann GF, 2013, VIRUS GENES, V47, P357, DOI 10.1007/s11262-013-0951-x; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Solovyev VV, 1999, NUCLEIC ACIDS RES, V27, P248, DOI 10.1093/nar/27.1.248; Sparks WO, 2011, VIROLOGY, V409, P69, DOI 10.1016/j.virol.2010.09.027; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; Tang XD, 2009, VIRUS GENES, V38, P495, DOI 10.1007/s11262-009-0355-0; THEILMANN DA, 1992, VIROLOGY, V187, P97, DOI 10.1016/0042-6822(92)90298-4; THIEM SM, 1989, J VIROL, V63, P2008, DOI 10.1128/JVI.63.5.2008-2018.1989; Thumbi DK, 2011, VIRUSES-BASEL, V3, P2301, DOI 10.3390/v3112301; Tong DX, 2012, CHINA SERICULTURE, P29; Vanarsdall AL, 2007, CURR DRUG TARGETS, V8, P1096, DOI 10.2174/138945007782151397; Wang ML, 2010, J VIROL, V84, P8821, DOI 10.1128/JVI.00072-10; Yang S, 1998, VIROLOGY, V245, P99, DOI 10.1006/viro.1998.9152; Yin HY, 2010, WORLD J GASTROENTERO, V16, P5367, DOI 10.3748/wjg.v16.i42.5367; Zemskov EA, 2000, J VIROL, V74, P6784, DOI 10.1128/JVI.74.15.6784-6789.2000; Zhang ZY, 1986, J MICROBIOL, P6; Zhu SY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-91; Zhu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086450	63	8	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110023	10.1371/journal.pone.0110023	http://dx.doi.org/10.1371/journal.pone.0110023			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329074	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204100041
J	Rehan, M; Beg, MA; Parveen, S; Damanhouri, GA; Zaher, GF				Rehan, Mohd; Beg, Mohd A.; Parveen, Shadma; Damanhouri, Ghazi A.; Zaher, Galila F.			Computational Insights into the Inhibitory Mechanism of Human AKT1 by an Orally Active Inhibitor, MK-2206	PLOS ONE			English	Article							PROTEIN-KINASE B/AKT; SCORING FUNCTIONS; PATHWAY; STRATEGIES; DIAGRAMS; SYSTEM	The AKT signaling pathway has been identified as an important target for cancer therapy. Among small-molecule inhibitors of AKT that have shown tremendous potential in inhibiting cancer, MK-2206 is a highly potent, selective and orally active allosteric inhibitor. Promising preclinical anticancer results have led to entry of MK-2206 into Phase I/II clinical trials. Despite such importance, the exact binding mechanism and the molecular interactions of MK-2206 with human AKT are not available. The current study investigated the exact binding mode and the molecular interactions of MK-2206 with human AKT isoforms using molecular docking and (un)binding simulation analyses. The study also involved the docking analyses of the structural analogs of MK-2206 to AKT1 and proposed one as better inhibitor. The Dock was used for docking simulations of MK-2206 into the allosteric site of AKT isoforms. The Ligplot+ was used for analyses of polar and hydrophobic interactions between AKT isoforms and the ligands. The MoMa-LigPath web server was used to simulate the ligand (un)binding from the binding site to the surface of the protein. In the docking and (un)binding simulation analyses of MK-2206 with human AKT1, the Trp-80 was the key residue and showed highest decrease in the solvent accessibility, highest number of hydrophobic interactions, and the most consistent involvement in all (un)binding simulation phases. The number of molecular interactions identified and calculated binding energies and dissociation constants from the co-complex structures of these isoforms, clearly explained the varying affinity of MK-2206 towards these isoforms. The (un)binding simulation analyses identified various additional residues which despite being away from the binding site, play important role in initial binding of the ligand. Thus, the docking and (un)binding simulation analyses of MK-2206 with AKT isoforms and its structure analogs will provide a suitable model for studying drug-protein interaction and will help in designing better drugs.	[Rehan, Mohd; Beg, Mohd A.; Damanhouri, Ghazi A.] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21413, Saudi Arabia; [Parveen, Shadma] MJP Rohilkhand Univ, Bareilly Coll, Bareilly, Uttar Pradesh, India; [Zaher, Galila F.] King Abdulaziz Univ, Fac Med, Dept Haematol, Jeddah 21413, Saudi Arabia	King Abdulaziz University; Mahatma Jyotiba Phule Rohilkhand University; King Abdulaziz University	Rehan, M (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21413, Saudi Arabia.	mrehan786@gmail.com	Rehan, Mohd/H-9835-2012; Zaher, Galila/AAX-6601-2020; Damanhouri, Ghazi/Q-7901-2019; Beg, Mohd A/K-3366-2013	Zaher, Galila/0000-0003-3918-3273; Beg, Mohd A/0000-0002-8495-4738; Rehan, Mohd/0000-0003-4898-6043				Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Chen SF, 2014, J MOL GRAPH MODEL, V48, P36, DOI 10.1016/j.jmgm.2013.12.002; Cheng Y, 2012, MOL CANCER THER, V11, P154, DOI 10.1158/1535-7163.MCT-11-0606; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cortes J, 2005, BIOINFORMATICS, V21, pI116, DOI 10.1093/bioinformatics/bti1017; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Devaurs D, 2013, NUCLEIC ACIDS RES, V41, pW297, DOI 10.1093/nar/gkt380; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Ghosh KS, 2009, BIOPOLYMERS, V91, P737, DOI 10.1002/bip.21220; Green CJ, 2008, J BIOL CHEM, V283, P27653, DOI 10.1074/jbc.M802623200; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hubbard S. J., 1993, TECHNICAL REPORT; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Knowles JA, 2011, LARYNGOSCOPE, V121, P2359, DOI 10.1002/lary.22180; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lindsley CW, 2005, BIOORG MED CHEM LETT, V15, P761, DOI 10.1016/j.bmcl.2004.11.011; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Liu RX, 2011, J CLIN ENDOCR METAB, V96, pE577, DOI 10.1210/jc.2010-2644; Martelli AM, 2011, LEUKEMIA, V25, P1064, DOI 10.1038/leu.2011.46; Pal SK, 2010, EXPERT OPIN INV DRUG, V19, P1355, DOI 10.1517/13543784.2010.520701; Pant A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041593; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Polak R, 2012, BLOOD, V119, P911, DOI 10.1182/blood-2011-07-366203; Rao E, 2012, LEUKEMIA, V26, P1064, DOI 10.1038/leu.2011.305; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Simioni C, 2012, LEUKEMIA, V26, P2336, DOI 10.1038/leu.2012.136; Tan SX, 2011, BIOCHEM J, V435, P539, DOI 10.1042/BJ20110040; Tolcher AW, 2009, J CLIN ONCOL, V27; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang P, 2011, MINI-REV MED CHEM, V11, P1093, DOI 10.2174/138955711797655380; Wang RX, 2003, J MED CHEM, V46, P2287, DOI 10.1021/jm0203783; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winograd-Katz SE, 2006, ONCOGENE, V25, P7381, DOI 10.1038/sj.onc.1209737; Wu WT, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.5730; Yan L, 2009, P 100 ANN M AM ASS C; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263	42	35	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109705	10.1371/journal.pone.0109705	http://dx.doi.org/10.1371/journal.pone.0109705			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329478	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204100020
J	Eurlings, IMJ; Reynaert, NL; van den Beucken, T; Gosker, HR; de Theije, CC; Verhamme, FM; Bracke, KR; Wouters, EFM; Dentener, MA				Eurlings, Irene M. J.; Reynaert, Niki L.; van den Beucken, Twan; Gosker, Harry R.; de Theije, C. C.; Verhamme, Fien M.; Bracke, Ken R.; Wouters, Emiel F. M.; Dentener, Mieke A.			Cigarette Smoke Extract Induces a Phenotypic Shift in Epithelial Cells; Involvement of HIF1 alpha in Mesenchymal Transition	PLOS ONE			English	Article							GROWTH-FACTOR BETA(1); AIRWAY EPITHELIUM; MATRIX PROTEINS; LUNG-CANCER; EXPRESSION; ALVEOLAR; HYPOXIA; COPD; PATHWAY; HYALURONAN	In COPD, matrix remodeling contributes to airflow limitation. Recent evidence suggests that next to fibroblasts, the process of epithelial-mesenchymal transition can contribute to matrix remodeling. CSE has been shown to induce EMT in lung epithelial cells, but the signaling mechanisms involved are largely unknown and subject of this study. EMT was assessed in A549 and BEAS2B cells stimulated with CSE by qPCR, Western blotting and immunofluorescence for epithelial and mesenchymal markers, as were collagen production, cell adhesion and barrier integrity as functional endpoints. Involvement of TGF-beta and HIF1 alpha signaling pathways were investigated. In addition, mouse models were used to examine the effects of CS on hypoxia signaling and of hypoxia per se on mesenchymal expression. CSE induced EMT characteristics in A549 and BEAS2B cells, evidenced by decreased expression of epithelial markers and a concomitant increase in mesenchymal marker expression after CSE exposure. Furthermore cells that underwent EMT showed increased production of collagen, decreased adhesion and disrupted barrier integrity. The induction of EMT was found to be independent of TGF-beta signaling. On the contrary, CS was able to induce hypoxic signaling in A549 and BEAS2B cells as well as in mice lung tissue. Importantly, HIF1 alpha knock-down prevented induction of mesenchymal markers, increased collagen production and decreased adhesion after CSE exposure, data that are in line with the observed induction of mesenchymal marker expression by hypoxia in vitro and in vivo. Together these data provide evidence that both bronchial and alveolar epithelial cells undergo a functional phenotypic shift in response to CSE exposure which can contribute to increased collagen deposition in COPD lungs. Moreover, HIF1 alpha signaling appears to play an important role in this process.	[Eurlings, Irene M. J.; Reynaert, Niki L.; Gosker, Harry R.; de Theije, C. C.; Wouters, Emiel F. M.; Dentener, Mieke A.] Maastricht Univ, Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Dept Resp Med, Maastricht, Netherlands; [van den Beucken, Twan] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Radiat Oncol, Maastricht, Netherlands; [Verhamme, Fien M.; Bracke, Ken R.] Ghent Univ Hosp, Dept Resp Med, Lab Translat Res Obstruct Pulm Dis, Ghent, Belgium	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Ghent University; Ghent University Hospital	Dentener, MA (corresponding author), Maastricht Univ, Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Dept Resp Med, Maastricht, Netherlands.	mieke.dentener@maastrichtuniversity.nl	Bracke, Ken R/GSN-7630-2022; Wouters, Emiel/ABD-6200-2021; van den Beucken, Jeroen J. J. P./N-2910-2013; Reynaert, Niki L/C-5491-2014	Bracke, Ken R/0000-0001-5906-4605; van den Beucken, Jeroen J. J. P./0000-0002-0301-1966; Reynaert, Niki/0000-0002-8577-8094; Gosker, Harry/0000-0002-7659-0225				AUBERT JD, 1994, THORAX, V49, P225, DOI 10.1136/thx.49.3.225; Biselli PJC, 2011, BRAZ J MED BIOL RES, V44, P460, DOI 10.1590/S0100-879X2011007500040; Bracke KR, 2010, AM J RESP CELL MOL, V42, P753, DOI 10.1165/rcmb.2008-0424OC; Buhling F, 1999, J INTERF CYTOK RES, V19, P271, DOI 10.1089/107999099314207; CARP H, 1978, AM REV RESPIR DIS, V118, P617; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Churg A, 2006, AM J RESP CRIT CARE, V174, P1327, DOI 10.1164/rccm.200605-585OC; Cottin M, 1997, TOXICOL IN VITRO, V11, P399, DOI 10.1016/S0887-2333(97)00020-9; D'hulst AI, 2005, EUR RESPIR J, V26, P204, DOI 10.1183/09031936.05.00095204; de Boer WI, 1998, AM J RESP CRIT CARE, V158, P1951, DOI 10.1164/ajrccm.158.6.9803053; Dentener MA, 2005, THORAX, V60, P114, DOI 10.1136/thx.2003.020842; Dunsmore SE, 1996, AM J PHYSIOL-LUNG C, V270, pL3, DOI 10.1152/ajplung.1996.270.1.L3; Eurlings IMJ, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-90; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Hallgren O, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-55; Heijink IH, 2012, EUR RESPIR J, V39, P419, DOI 10.1183/09031936.00193810; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kokturk N, 2003, J ASTHMA, V40, P887, DOI 10.1081/JAS-120023580; Kranenburg AR, 2006, AM J CLIN PATHOL, V126, P725, DOI 10.1309/JC477FAEL1YKV54W; Krimmer DI, 2012, AM J RESP CELL MOL, V46, P34, DOI 10.1165/rcmb.2010-0426OC; LANG MR, 1994, THORAX, V49, P319, DOI 10.1136/thx.49.4.319; Merrilees MJ, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-41; Milara J, 2013, THORAX, V68, P410, DOI 10.1136/thoraxjnl-2012-201761; Nagathihalli NS, 2012, MOL CANCER THER, V11, P2362, DOI 10.1158/1535-7163.MCT-12-0107; Nakano Y, 2002, CHEST, V122, p271S, DOI 10.1378/chest.122.6_suppl.271S-a; Olea E, 2011, RESP PHYSIOL NEUROBI, V179, P305, DOI 10.1016/j.resp.2011.09.013; Papakonstantinou E, 2009, BRIT J PHARMACOL, V157, P1111, DOI 10.1111/j.1476-5381.2009.00279.x; Polosukhin VV, 2007, VIRCHOWS ARCH, V451, P793, DOI 10.1007/s00428-007-0469-5; Ramaekers CHMA, 2011, RADIOTHER ONCOL, V101, P190, DOI 10.1016/j.radonc.2011.05.059; Sakamoto O, 1997, J CLIN INVEST, V99, P701, DOI 10.1172/JCI119214; Sarker AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090261; Schamberger AC, 2014, AM J RESP CELL MOL, V50, P1040, DOI 10.1165/rcmb.2013-0090OC; Selman M, 2003, AM J RESP CELL MOL, V29, pS93; Shen HJ, 2014, BIOCH BIOPHYSICA ACT; Shibata T, 2000, GENE THER, V7, P493, DOI 10.1038/sj.gt.3301124; Sohal Sukhwinder S, 2011, Respir Res, V12, P130, DOI 10.1186/1465-9921-12-130; Takizawa H, 2001, AM J RESP CRIT CARE, V163, P1476, DOI 10.1164/ajrccm.163.6.9908135; van den Borst B, 2013, J APPL PHYSIOL, V114, P1619, DOI 10.1152/japplphysiol.00460.2012; Veljkovic E, 2011, TOXICOL IN VITRO, V25, P446, DOI 10.1016/j.tiv.2010.11.011; Xu XF, 2012, CHINESE MED J-PEKING, V125, P3312, DOI 10.3760/cma.j.issn.0366-6999.2012.18.021; Yang J, 2013, AM J PATHOL, V183, P1559, DOI 10.1016/j.ajpath.2013.07.016; Zandvoort A, 2006, EUR RESPIR J, V28, P533, DOI 10.1183/09031936.06.00078405; Zhang HQ, 2012, FREE RADICAL BIO MED, V52, P1437, DOI 10.1016/j.freeradbiomed.2012.01.024; Zhang QZ, 2007, CLIN CANCER RES, V13, P4686, DOI 10.1158/1078-0432.CCR-06-2898; Zhou GF, 2009, AM J PHYSIOL-LUNG C, V297, pL1120, DOI 10.1152/ajplung.00007.2009; Ziora D, 2007, J PHYSIOL PHARMACOL, V58, P791	47	35	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e107757	10.1371/journal.pone.0107757	http://dx.doi.org/10.1371/journal.pone.0107757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329389	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210800006
J	Navapour, L; Mogharrab, N; Amininasab, M				Navapour, Leila; Mogharrab, Navid; Amininasab, Mehriar			How Modification of Accessible Lysines to Phenylalanine Modulates the Structural and Functional Properties of Horseradish Peroxidase: A Simulation Study	PLOS ONE			English	Article							PHTHALIC-ANHYDRIDE MODIFICATION; CHEMICAL-MODIFICATION; MOLECULAR-DYNAMICS; SOLVENT TOLERANCE; HYDROGEN-PEROXIDE; STABILITY; RESIDUES; PROTEIN; ACID; THERMOSTABILITY	Horseradish Peroxidase (HRP) is one of the most studied peroxidases and a great number of chemical modifications and genetic manipulations have been carried out on its surface accessible residues to improve its stability and catalytic efficiency necessary for biotechnological applications. Most of the stabilized derivatives of HRP reported to date have involved chemical or genetic modifications of three surface-exposed lysines (K174, K232 and K241). In this computational study, we altered these lysines to phenylalanine residues to model those chemical modifications or genetic manipulations in which these positively charged lysines are converted to aromatic hydrophobic residues. Simulation results implied that upon these substitutions, the protein structure becomes less flexible. Stability gains are likely to be achieved due to the increased number of stable hydrogen bonds, improved heme-protein interactions and more integrated proximal Ca2+ binding pocket. We also found a new persistent hydrogen bond between the protein moiety (F174) and the heme prosthetic group as well as two stitching hydrogen bonds between the connecting loops GH and F'F '' in mutated HRP. However, detailed analysis of functionally related structural properties and dynamical features suggests reduced reactivity of the enzyme toward its substrates. Molecular dynamics simulations showed that substitutions narrow the bottle neck entry of peroxide substrate access channel and reduce the surface accessibility of the distal histidine (H42) and heme prosthetic group to the peroxide and aromatic substrates, respectively. Results also demonstrated that the area and volume of the aromatic-substrate binding pocket are significantly decreased upon modifications. Moreover, the hydrophobic patch functioning as a binding site or trap for reducing aromatic substrates is shrunk in mutated enzyme. Together, the results of this simulation study could provide possible structural clues to explain those experimental observations in which the protein stability achieved concurrent with a decrease in enzyme activity, upon manipulation of charge/hydrophobicity balance at the protein surface.	[Navapour, Leila; Mogharrab, Navid] Shiraz Univ, Coll Sci, Dept Biol, Biophys & Computat Biol Lab, Shiraz, Iran; [Mogharrab, Navid] Shiraz Univ, Inst Biotechnol, Shiraz, Iran; [Amininasab, Mehriar] Univ Tehran, Sch Biol, Coll Sci, Dept Cell & Mol Biol, Tehran, Iran	Shiraz University; Shiraz University; University of Tehran	Mogharrab, N (corresponding author), Shiraz Univ, Coll Sci, Dept Biol, Biophys & Computat Biol Lab, Shiraz, Iran.	mogharrab@shirazu.ac.ir	Mogharrab, Navid/W-6963-2018; Mogharrab, Navid/Y-7696-2019; Navapour, Leila/GPP-2922-2022	Mogharrab, Navid/0000-0001-9465-7422; Navapour, Leila/0000-0002-2513-9186	research council of Shiraz University; Shiraz University [88GCU1M143079]	research council of Shiraz University; Shiraz University	This research was financially supported by the research council of Shiraz University. The funder was Shiraz University, http://www.shirazu.ac.ir/. Grant number: 88GCU1M143079. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Azevedo AM, 2003, BIOTECHNOL ANN REV, V9, P199, DOI 10.1016/S1387-2656(03)09003-3; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Carlsson GH, 2005, BIOCHEMISTRY-US, V44, P635, DOI 10.1021/bi0483211; Colonna S, 1999, TRENDS BIOTECHNOL, V17, P163, DOI 10.1016/S0167-7799(98)01288-8; Cooper VA, 1996, WATER RES, V30, P954, DOI 10.1016/0043-1354(95)00237-5; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Duroux L, 2003, J MOL EVOL, V57, P397, DOI 10.1007/s00239-003-2489-3; Elsner C, 2000, J MOL CATAL B-ENZYM, V8, P193, DOI 10.1016/S1381-1177(99)00057-0; Filizola M, 2000, J AM CHEM SOC, V122, P18, DOI 10.1021/ja992793z; Gajhede M, 1997, NAT STRUCT BIOL, V4, P1032, DOI 10.1038/nsb1297-1032; Gazaryan I.G., 2006, USP BIOL KHIM, V46, P303; Hamid M, 2009, FOOD CHEM, V115, P1177, DOI 10.1016/j.foodchem.2009.02.035; Hassani L, 2006, ENZYME MICROB TECH, V38, P118, DOI 10.1016/j.enzmictec.2005.05.006; Hassani L, 2014, APPL BIOCHEM BIOTECH, V172, P3558, DOI 10.1007/s12010-014-0756-y; Hassani L, 2012, J MOL CATAL B-ENZYM, V80, P15, DOI 10.1016/j.molcatb.2012.04.002; Hassani L, 2012, APPL BIOCHEM BIOTECH, V167, P489, DOI 10.1007/s12010-012-9671-2; Henriksen A, 1999, J BIOL CHEM, V274, P35005, DOI 10.1074/jbc.274.49.35005; Henriksen A, 1998, BIOCHEMISTRY-US, V37, P8054, DOI 10.1021/bi980234j; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2000, PHYS REV E, V62, P8438, DOI 10.1103/PhysRevE.62.8438; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Howes BD, 2001, J BIOL CHEM, V276, P40704, DOI 10.1074/jbc.M107489200; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Khajeh K, 2001, ENZYME MICROB TECH, V28, P543, DOI 10.1016/S0141-0229(01)00296-4; Khajehpour M, 2003, PROTEINS, V53, P656, DOI 10.1002/prot.10475; Liu JZ, 2006, PROTEIN ENG DES SEL, V19, P169, DOI 10.1093/protein/gzj016; Liu JZ, 2002, J MOL CATAL B-ENZYM, V18, P225, DOI 10.1016/S1381-1177(02)00100-5; Miland E, 1996, ENZYME MICROB TECH, V19, P242, DOI 10.1016/0141-0229(95)00225-1; Miland E, 1996, ENZYME MICROB TECH, V19, P63, DOI 10.1016/0141-0229(95)00169-7; Mogharrab N, 2005, ELECTROCHEM COMMUN, V7, P466, DOI 10.1016/j.elecom.2005.02.025; Mogharrab N, 2007, BIOPHYS J, V92, P1192, DOI 10.1529/biophysj.106.092858; Moreno JM, 1997, J MOL CATAL B-ENZYM, V2, P271, DOI 10.1016/S1381-1177(96)00018-5; O'Brien AM, 2003, BIOTECHNOL BIOENG, V81, P233, DOI 10.1002/bit.10462; O'Brien AM, 2001, BIOTECHNOL BIOENG, V76, P277, DOI 10.1002/bit.1194; OBRIEN AM, 1997, THESIS DUBLIN CITY U; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; POULOS TL, 1980, J BIOL CHEM, V255, P8199; REGAN L, 1994, CURR BIOL, V4, P656, DOI 10.1016/S0960-9822(00)00147-0; Rodriguez-Lopez JN, 2001, J AM CHEM SOC, V123, P11838, DOI 10.1021/ja011853+; RodriguezLopez JN, 1996, J BIOL CHEM, V271, P4023; Ryan BJ, 2008, BIOCHIMIE, V90, P1414, DOI 10.1016/j.biochi.2008.05.008; Ryan BJ, 2007, BIOCHIMIE, V89, P1029, DOI 10.1016/j.biochi.2007.03.013; Ryan BJ, 2006, TRENDS BIOTECHNOL, V24, P355, DOI 10.1016/j.tibtech.2006.06.007; RYAN O, 1994, ENZYME MICROB TECH, V16, P501, DOI 10.1016/0141-0229(94)90021-3; Savenkova MI, 1996, J BIOL CHEM, V271, P24598, DOI 10.1074/jbc.271.40.24598; SMITH AT, 1992, EUR J BIOCHEM, V207, P507, DOI 10.1111/j.1432-1033.1992.tb17077.x; Song HY, 2005, ENZYME MICROB TECH, V36, P605, DOI 10.1016/j.enzmictec.2004.12.018; Street AG, 1999, P NATL ACAD SCI USA, V96, P9074, DOI 10.1073/pnas.96.16.9074; Szabo A, 2009, PROCESS BIOCHEM, V44, P199, DOI 10.1016/j.procbio.2008.10.008; Tatoli S, 2009, BIOPHYS CHEM, V141, P87, DOI 10.1016/j.bpc.2008.12.015; UGAROVA NN, 1979, BIOCHIM BIOPHYS ACTA, V570, P31, DOI 10.1016/0005-2744(79)90198-0; URRUTIGOITY M, 1991, BIOORG CHEM, V19, P66, DOI 10.1016/0045-2068(91)90044-P; Veitch NC, 2001, ADV INORG CHEM, V51, P107; Veitch NC, 2004, PHYTOCHEMISTRY, V65, P249, DOI 10.1016/j.phytochem.2003.10.022; WELINDER KG, 1979, EUR J BIOCHEM, V96, P483, DOI 10.1111/j.1432-1033.1979.tb13061.x; Xue Y, 2010, J MOL CATAL B-ENZYM, V63, P188, DOI 10.1016/j.molcatb.2010.01.018; Yang BY, 1996, CARBOHYD RES, V287, P203, DOI 10.1016/0008-6215(96)00073-0; Zakharova GS, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1391, DOI 10.1134/S0006297911130037; Ziemys A, 2005, COMPUT BIOL CHEM, V29, P83, DOI 10.1016/j.compbiolchem.2004.12.007	63	3	3	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109062	10.1371/journal.pone.0109062	http://dx.doi.org/10.1371/journal.pone.0109062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313804	gold, Green Submitted, Green Published			2022-12-27	WOS:000343662500022
J	Oujo, B; Munoz-Felix, JM; Arevalo, M; Nunez-Gomez, E; Perez-Roque, L; Pericacho, M; Gonzalez-Nunez, M; Langa, C; Martinez-Salgado, C; Perez-Barriocanal, F; Bernabeu, C; Lopez-Novoa, JM				Oujo, Barbara; Munoz-Felix, Jose M.; Arevalo, Miguel; Nunez-Gomez, Elena; Perez-Roque, Lucia; Pericacho, Miguel; Gonzalez-Nunez, Maria; Langa, Carmen; Martinez-Salgado, Carlos; Perez-Barriocanal, Fernando; Bernabeu, Carmelo; Lopez-Novoa, Jose M.			L-Endoglin Overexpression Increases Renal Fibrosis after Unilateral Ureteral Obstruction	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX SYNTHESIS; HUMAN MESANGIAL CELLS; DIABETIC-NEPHROPATHY; UP-REGULATION; BINDING PROTEIN; L6E9 MYOBLASTS; DIVERSE ROLES; EXPRESSION; FIBROBLASTS	Transforming growth factor-beta (TGF-beta) plays a pivotal role in renal fibrosis. Endoglin, a 180 KDa membrane glycoprotein, is a TGF-beta co-receptor overexpressed in several models of chronic kidney disease, but its function in renal fibrosis remains uncertain. Two membrane isoforms generated by alternative splicing have been described, L-Endoglin (long) and S-Endoglin (short) that differ from each other in their cytoplasmic tails, being L-Endoglin the most abundant isoform. The aim of this study was to assess the effect of L-Endoglin overexpression in renal tubulo-interstitial fibrosis. For this purpose, a transgenic mouse which ubiquitously overexpresses human L-Endoglin (L-ENG(+)) was generated and unilateral ureteral obstruction (UUO) was performed in L-ENG(+) mice and their wild type (WT) littermates. Obstructed kidneys from L-ENG(+) mice showed higher amounts of type I collagen and fibronectin but similar levels of alpha-smooth muscle actin (alpha-SMA) than obstructed kidneys from WT mice. Smad1 and Smad3 phosphorylation were significantly higher in obstructed kidneys from L-ENG(+) than in WT mice. Our results suggest that the higher increase of renal fibrosis observed in L-ENG(+) mice is not due to a major abundance of myofibroblasts, as similar levels of alpha-SMA were observed in both L-ENG(+) and WT mice, but to the higher collagen and fibronectin synthesis by these fibroblasts. Furthermore, in vivo L-Endoglin overexpression potentiates Smad1 and Smad3 pathways and this effect is associated with higher renal fibrosis development.	[Oujo, Barbara; Munoz-Felix, Jose M.; Nunez-Gomez, Elena; Perez-Roque, Lucia; Pericacho, Miguel; Gonzalez-Nunez, Maria; Martinez-Salgado, Carlos; Perez-Barriocanal, Fernando; Lopez-Novoa, Jose M.] Univ Salamanca, Dept Physiol & Pharmacol, Renal & Cardiovasc Res Unit, E-37008 Salamanca, Spain; [Oujo, Barbara; Munoz-Felix, Jose M.; Arevalo, Miguel; Nunez-Gomez, Elena; Perez-Roque, Lucia; Pericacho, Miguel; Gonzalez-Nunez, Maria; Martinez-Salgado, Carlos; Perez-Barriocanal, Fernando; Lopez-Novoa, Jose M.] Biomed Res Inst Salamanca IBSAL, Salamanca, Spain; [Oujo, Barbara; Munoz-Felix, Jose M.; Arevalo, Miguel; Nunez-Gomez, Elena; Perez-Roque, Lucia; Pericacho, Miguel; Gonzalez-Nunez, Maria; Martinez-Salgado, Carlos; Perez-Barriocanal, Fernando; Lopez-Novoa, Jose M.] Inst Queen Sophie Renal Res, Salamanca, Spain; [Arevalo, Miguel] Univ Salamanca, Dept Human Anat & Histol, E-37008 Salamanca, Spain; [Langa, Carmen; Bernabeu, Carmelo] CSIC, Ctr Invest Biol, Madrid, Spain; [Langa, Carmen; Bernabeu, Carmelo] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain; [Martinez-Salgado, Carlos] Hlth Sci Studies Inst Castilla & Leon IESCYL, Salamanca, Spain	University of Salamanca; University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Lopez-Novoa, JM (corresponding author), Univ Salamanca, Dept Physiol & Pharmacol, Renal & Cardiovasc Res Unit, E-37008 Salamanca, Spain.	jmlnovoa@usal.es	Muñoz-Félix, José M./AAH-9665-2019; Bernabeu, Carmelo/L-3226-2014; Pericacho, Miguel/H-1786-2016	Bernabeu, Carmelo/0000-0002-1563-6162; Pericacho, Miguel/0000-0003-0226-482X; Martinez-Salgado, Carlos/0000-0003-4641-6717	Ministerio de Economia y Competitividad of Spain [SAF2010-19222, SAF2010-15881]; Instituto de Salud Carlos III (Ministerio de Economia y Competitividad) [PS09/01067]; Junta de Castilla y Leon [GR100]; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER); Red de Investigacion Cooperativa en Enfermedades Renales (REDINREN) [RD12/0021/0032]; FEDER funds; European Regional Development Funds (FEDER); Ministerio de Economia y Competitividad; Junta de Castilla y Leon; Fondo Social Europeo	Ministerio de Economia y Competitividad of Spain(Spanish Government); Instituto de Salud Carlos III (Ministerio de Economia y Competitividad)(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER); Red de Investigacion Cooperativa en Enfermedades Renales (REDINREN); FEDER funds(European Commission); European Regional Development Funds (FEDER)(European Commission); Ministerio de Economia y Competitividad(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Fondo Social Europeo(European Social Fund (ESF)European Commission)	This study was supported by grants from Ministerio de Economia y Competitividad of Spain (SAF2010-19222 to CB and SAF2010-15881 to JML-N), Instituto de Salud Carlos III (Ministerio de Economia y Competitividad, PS09/01067 to CM-S), Junta de Castilla y Leon (GR100 to JML-N), Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER, CB) and Red de Investigacion Cooperativa en Enfermedades Renales (RD12/0021/0032; REDINREN, to JML-N). CIBERER and REDINREN are initiatives of the Instituto de Salud Carlos III (ISCIII) of Spain supported by FEDER funds. The Cardiovascular Phenotyping Unit of the University of Salamanca, including the telemetry equipment, was acquired with the support of the European Regional Development Funds (FEDER). BO and EN-G are supported by Ministerio de Economia y Competitividad; JMM-F and LP-R are supported by Junta de Castilla y Leon and Fondo Social Europeo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2012, J BIOL CHEM, V287, P20430, DOI 10.1074/jbc.M111.275610; Abe H, 2011, HISTOL HISTOPATHOL, V26, P531, DOI 10.14670/HH-26.531; Bascands JL, 2005, KIDNEY INT, V68, P925, DOI 10.1111/j.1523-1755.2005.00486.x; BELLON T, 1993, EUR J IMMUNOL, V23, P2340, DOI 10.1002/eji.1830230943; Bitzer M, 1998, KIDNEY BLOOD PRESS R, V21, P1, DOI 10.1159/000025837; BORDER WA, 1990, KIDNEY INT, V37, P689, DOI 10.1038/ki.1990.35; Burke JP, 2010, BRIT J SURG, V97, P892, DOI 10.1002/bjs.6996; Chen K, 2004, CIRC RES, V95, P1167, DOI 10.1161/01.RES.0000150369.68826.2f; Chung ACK, 2009, NEPHROL DIAL TRANSPL, V24, P1443, DOI 10.1093/ndt/gfn699; Diez-Marques L, 2002, BBA-MOL BASIS DIS, V1587, P36, DOI 10.1016/S0925-4439(02)00051-0; Docherty NG, 2009, KIDNEY INT, V75, P205, DOI 10.1038/ki.2008.482; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; Kapur NK, 2012, CIRCULATION, V125, P2728, DOI 10.1161/CIRCULATIONAHA.111.080002; Kulkarni O, 2009, J PHARMACOL EXP THER, V328, P371, DOI 10.1124/jpet.108.142711; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Lopez-Novoa JM, 2010, AM J PHYSIOL-HEART C, V299, pH959, DOI 10.1152/ajpheart.01251.2009; Manson SR, 2011, J UROLOGY, V185, P2523, DOI 10.1016/j.juro.2011.01.034; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Matsubara T, 2006, LAB INVEST, V86, P357, DOI 10.1038/labinvest.3700400; Meng XM, 2010, J AM SOC NEPHROL, V21, P1477, DOI 10.1681/ASN.2009121244; Meng XM, 2013, CLIN SCI, V124, P243, DOI 10.1042/CS20120252; Meng XM, 2012, J PATHOL, V227, P175, DOI 10.1002/path.3976; Meurer SK, 2011, CELL SIGNAL, V23, P683, DOI 10.1016/j.cellsig.2010.12.002; Mima A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017929; Moon JA, 2006, KIDNEY INT, V70, P1234, DOI 10.1038/sj.ki.5001775; Morris E, 2011, J CELL PHYSIOL, V226, P3340, DOI 10.1002/jcp.22690; Munoz-Felix JM, 2014, BBA-MOL CELL RES, V1843, P1111, DOI 10.1016/j.bbamcr.2014.02.017; Munoz-Felix JM, 2014, KIDNEY INT, V85, P319, DOI 10.1038/ki.2013.292; Obreo J, 2004, CELL PHYSIOL BIOCHEM, V14, P301, DOI 10.1159/000080340; Pannu J, 2008, ARTHRITIS RHEUM-US, V58, P2528, DOI 10.1002/art.23698; Perez-Gomez E, 2005, ONCOGENE, V24, P4450, DOI 10.1038/sj.onc.1208644; Prieto M, 2005, J PHYSIOL BIOCHEM, V61, P457, DOI 10.1007/BF03168452; Rodriguez-Barbero A, 2006, KIDNEY INT, V70, P901, DOI 10.1038/sj.ki.5001626; Rodriguez-Barbero A, 2006, CELL PHYSIOL BIOCHEM, V18, P135, DOI 10.1159/000095181; Rodriguez-Lopez AM, 1998, KIDNEY INT, V54, pS36, DOI 10.1046/j.1523-1755.1998.06810.x; Rodriguez-Pena A, 2001, NEPHROL DIAL TRANSPL, V16, P34, DOI 10.1093/ndt/16.suppl_1.34; Rodriguez-Pena A, 2002, HYPERTENSION, V40, P713, DOI 10.1161/01.HYP.0000037429.73954.27; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Scharpfenecker M, 2009, RADIOTHER ONCOL, V92, P484, DOI 10.1016/j.radonc.2009.06.013; Scherner O, 2007, J BIOL CHEM, V282, P13934, DOI 10.1074/jbc.M611062200; Schmidt M, 2008, EUR J OBSTET GYN R B, V139, P72, DOI 10.1016/j.ejogrb.2008.02.009; Segerer S, 2008, KIDNEY INT, V74, P37, DOI 10.1038/ki.2008.99; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Grande MT, 2010, KIDNEY INT, V77, P509, DOI 10.1038/ki.2009.498; Velasco S, 2008, J CELL SCI, V121, P913, DOI 10.1242/jcs.023283; Wang EH, 2011, EXP MOL PATHOL, V91, P368, DOI 10.1016/j.yexmp.2011.04.011; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhong X, 2011, J AM SOC NEPHROL, V22, P1668, DOI 10.1681/ASN.2010111168	50	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110365	10.1371/journal.pone.0110365	http://dx.doi.org/10.1371/journal.pone.0110365			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313562	gold, Green Submitted, Green Published			2022-12-27	WOS:000343662500110
J	Shaw, RJ; Benzeval, M; Popham, F				Shaw, Richard J.; Benzeval, Michaela; Popham, Frank			To What Extent Do Financial Strain and Labour Force Status Explain Social Class Inequalities in Self-Rated Health? Analysis of 20 Countries in the European Social Survey	PLOS ONE			English	Article							WELFARE-STATE; SOCIOECONOMIC CLASSIFICATION; REPORTED HEALTH; POVERTY; UNEMPLOYMENT; EXPLANATION; MORTALITY; POSITION; REGIMES; COHORT	Introduction: Nordic countries do not have the smallest health inequalities despite egalitarian social policies. A possible explanation for this is that drivers of class differences in health such as financial strain and labour force status remain socially patterned in Nordic countries. Methods: Our analyses used data for working age (25-59) men (n = 48,249) and women (n = 52,654) for 20 countries from five rounds (2002-2010) of the European Social Survey. The outcome was self-rated health in 5 categories. Stratified by gender we used fixed effects linear regression models and marginal standardisation to instigate how countries varied in the degree to which class inequalities were attenuated by financial strain and labour force status. Results and Discussion: Before adjustment, Nordic countries had large inequalities in self-rated health relative to other European countries. For example the regression coefficient for the difference in health between working class and professional men living in Norway was 0.34 (95% CI 0.26 to 0.42), while the comparable figure for Spain was 0.15 (95% CI 0.08 to 0.22). Adjusting for financial strain and labour force status led to attenuation of health inequalities in all countries. However, unlike some countries such as Spain, where after adjustment the regression coefficient for working class men was only 0.02 (95% CI -0.05 to 0.10), health inequalities persisted after adjustment for Nordic countries. For Norway the adjusted coefficient was 0.17 (95% CI 0.10 to 0.25). Results for women and men were similar. However, in comparison to men, class inequalities tended to be stronger for women and more persistent after adjustment. Conclusions: Adjusting for financial security and labour force status attenuates a high proportion of health inequalities in some counties, particularly Southern European countries, but attenuation in Nordic countries was modest and did not improve their relative position.	[Shaw, Richard J.; Popham, Frank] Univ Glasgow, MRC, Chief Scientist Off, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Benzeval, Michaela] Univ Essex, Inst Social & Econ Res, Colchester CO4 3SQ, Essex, England	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of Essex	Shaw, RJ (corresponding author), Univ Glasgow, MRC, Chief Scientist Off, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland.	richard.shaw@glasgow.ac.uk	Benzeval, Michaela/J-3163-2015; Shaw, Richard/X-8215-2019	Benzeval, Michaela/0000-0002-0372-2098; Shaw, Richard/0000-0002-7906-6066; Popham, Frank/0000-0002-7263-7954	United Kingdom's Medical Research Council [MC_UU12017/7]; United Kingdom Economic and Social Research Council for Understanding Society; University of Essex; ESRC [ES/L009153/1] Funding Source: UKRI; MRC [MC_UU_12017/7, MC_UP_A540_1021] Funding Source: UKRI; Economic and Social Research Council [ES/L009153/1] Funding Source: researchfish; Medical Research Council [MC_UU_12017/7, MC_UP_A540_1021] Funding Source: researchfish	United Kingdom's Medical Research Council; United Kingdom Economic and Social Research Council for Understanding Society; University of Essex; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	FP and RS are funded by the United Kingdom's Medical Research Council (MC_UU12017/7). MB is funded by the United Kingdom Economic and Social Research Council for Understanding Society and the University of Essex. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldabe B, 2011, J EPIDEMIOL COMMUN H, V65, P1123, DOI 10.1136/jech.2009.102517; d'Uva TB, 2008, INT J EPIDEMIOL, V37, P1375, DOI 10.1093/ije/dyn146; Bambra C, 2009, J EPIDEMIOL COMMUN H, V63, P92, DOI 10.1136/jech.2008.077354; Bambra C, 2007, J EPIDEMIOL COMMUN H, V61, P1098, DOI 10.1136/jech.2007.064295; Bambra C, 2011, J EPIDEMIOL COMMUN H, V65, P740, DOI 10.1136/jech.2011.136333; Bardage Carola, 2005, Eur J Ageing, V2, P149, DOI 10.1007/s10433-005-0032-7; Beckfield J, 2009, EPIDEMIOL REV, V31, P152, DOI 10.1093/epirev/mxp002; Beland D, 2014, SOC POLICY ADMIN, V48, P739, DOI 10.1111/spol.12064; Bergqvist K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1234; Blekesaune M, 2013, J SOC POLICY, V42, P57, DOI 10.1017/S0047279412000748; Dunn Nick, 2008, Ment Health Fam Med, V5, P15; Eikemo TA, 2008, J EPIDEMIOL COMMUN H, V62, P1072, DOI 10.1136/jech.2007.072470; Erlinghagen M, 2010, J SOC POLICY, V39, P71, DOI 10.1017/S0047279409990390; Esping-Andersen G, 1990, 3 WORLDS WELFARE CAP; Euopean Social Survey, 2012, SAMPL EUR SOC SURV R; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P7, DOI 10.1136/jech.2004.023531; Goldthorpe JH, 2004, EC BASIS SOCIAL CLAS; Harslof I., 2013, CHANGING SOCIAL RISK, P25; Hurrelmann K, 2011, J PUBLIC HEALTH-HEID, V19, P3, DOI 10.1007/s10389-010-0359-1; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jones C.I., 2010, GDP WELFARE COUNTRIE; Jurges H, 2007, HEALTH ECON, V16, P163, DOI 10.1002/hec.1134; Kawachi I, 2002, J EPIDEMIOL COMMUN H, V56, P647, DOI 10.1136/jech.56.9.647; Kovacs JM, 2002, WEST EUR POLIT, V25, P175, DOI 10.1080/713869590; Kunst AE, 1998, BMJ-BRIT MED J, V316, P1636, DOI 10.1136/bmj.316.7145.1636; Lynn P, 2007, JOS, V23, P107; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mackenbach JP, 2012, SOC SCI MED, V75, P761, DOI 10.1016/j.socscimed.2012.02.031; Manderbacka K, 1998, INT J EPIDEMIOL, V27, P208, DOI 10.1093/ije/27.2.208; Manor O, 1997, SOC SCI MED, V45, P761, DOI 10.1016/S0277-9536(96)00412-1; Marmot MG, 2006, JAMA-J AM MED ASSOC, V295, P1304, DOI 10.1001/jama.295.11.1304; Mcdonough P, 2003, J HEALTH SOC BEHAV, V44, P198, DOI 10.2307/1519808; McKee M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7973; McKee-Ryan FM, 2005, J APPL PSYCHOL, V90, P53, DOI 10.1037/0021-9010.90.1.53; Muller CJ, 2014, INT J EPIDEMIOL, V43, P962, DOI 10.1093/ije/dyu029; Power C, 1996, BRIT MED J, V313, P449; RINGEN S, 1988, J SOC POLICY, V17, P351, DOI 10.1017/S0047279400016858; Rose D, 2007, EUR SOC, V9, P459, DOI 10.1080/14616690701336518; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Schutte S, 2013, SCAND J PUBLIC HEALT, V41, P51, DOI 10.1177/1403494812469854; Thomas C, 2007, J EPIDEMIOL COMMUN H, V61, P48, DOI 10.1136/jech.2005.044206; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; Webster D, 2002, RADICAL STAT, V79, P96; Weich S, 1998, BMJ-BRIT MED J, V317, P115, DOI 10.1136/bmj.317.7151.115; Whelan CT, 2010, J EUR SOC POLICY, V20, P316, DOI 10.1177/0958928710374378; Wildman J, 2003, J HEALTH ECON, V22, P295, DOI 10.1016/S0167-6296(02)00101-7; Wilkinson RG, 1997, BRIT MED J, V314, P591, DOI 10.1136/bmj.314.7080.591	47	13	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110362	10.1371/journal.pone.0110362	http://dx.doi.org/10.1371/journal.pone.0110362			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR5ZW	25313462	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000343662500109
J	Shin, JY; Shim, HY; Jun, JK				Shin, Ji-Yeon; Shim, Hye Young; Jun, Jae Kwan			Comparison of Diabetes Management Status between Cancer Survivors and the General Population: Results from a Korean Population-Based Survey	PLOS ONE			English	Article							GLYCEMIC CONTROL; NATIONAL-HEALTH; SCREENING PRACTICES; FOLLOW-UP; MELLITUS; QUALITY; TYPE-2; RISK; CARE; SURVEILLANCE	Purpose: This study aimed to determine and compare the prevalences of diabetes awareness, treatment, and adequate glycemic control among cancer survivors in a Korean population and two non-cancer control groups, comprising individuals without a history of cancer but with other chronic diseases (non-cancer, chronic disease controls) and individuals without a history of cancer or any other chronic disease (non-cancer, non-chronic disease controls). Methods: We analyzed data from 2,660 subjects with prevalent diabetes (aged >= 30 years), who had participated in the 2007-2011 Korea National Health and Nutrition Examination Survey. Awareness was defined as a subject having been diagnosed with diabetes by a clinician. Treatment was defined as a subject who was taking anti-diabetic medicine. Adequate glycemic control was defined as a hemoglobin A1(c) level of <7%. Multivariable logistic regression and predictive margins were used to evaluate whether awareness, treatment, or adequate glycemic control differed among cancer survivors and the two non-cancer control groups. Results: Cancer survivors had greater awareness compared with the non-cancer, chronic disease and non-cancer, non-chronic disease control groups (85.1%, 80.4%, and 60.4%, respectively). Although the prevalences of treatment and adequate glycemic control were higher for survivors compared with the non-cancer, non-chronic disease controls, they were lower compared with the non-cancer, chronic disease controls. The prevalence of diabetes treatment was 67.5% for cancer survivors, 69.5% for non-cancer, chronic disease controls, and 46.7% for non-cancer, non-chronic disease controls; the prevalences of adequate glycemic control in these three groups were 31.7%, 34.6%, and 17.8%, respectively. Conclusions: Cancer survivors were less likely than the non-cancer chronic disease subjects to receive diabetes management and to achieve adequate glycemic targets. Special attention and education are required to ensure that this population receives optimal diabetes care, and the systematic roles for primary care and specialist physicians need to be determined.	[Shin, Ji-Yeon] Eulji Univ, Sch Med, Dept Prevent Med, Taejon, South Korea; [Shim, Hye Young; Jun, Jae Kwan] Natl Canc Ctr, Natl Canc Control Inst, Goyang, South Korea	Eulji University; National Cancer Center - Korea (NCC)	Jun, JK (corresponding author), Natl Canc Ctr, Natl Canc Control Inst, Goyang, South Korea.	jkjun@ncc.re.kr			National R&D Program for Cancer Control [1310231]	National R&D Program for Cancer Control(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant from the National R&D Program for Cancer Control, No. 1310231 (http://ncc.re.kr/english/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Barone BB, 2008, JAMA-J AM MED ASSOC, V300, P2754, DOI 10.1001/jama.2008.824; Bjornholt JV, 1999, DIABETES CARE, V22, P45, DOI 10.2337/diacare.22.1.45; Bowker SL, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-17; BROWN BW, 1993, J NATL CANCER I, V85, P979, DOI 10.1093/jnci/85.12.979; Byun SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062991; Cho J, 2010, CANCER CAUSE CONTROL, V21, P2203, DOI 10.1007/s10552-010-9640-4; CLAUSON P, 1994, DIABETIC MED, V11, P794, DOI 10.1111/j.1464-5491.1994.tb00355.x; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; de Haas EC, 2010, LANCET ONCOL, V11, P193, DOI 10.1016/S1470-2045(09)70287-6; Earle CC, 2004, CANCER, V101, P1712, DOI 10.1002/cncr.20560; Earle CC, 2003, J CLIN ONCOL, V21, P1447, DOI 10.1200/JCO.2003.03.060; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Harvey JN, 2009, DIABETIC MED, V26, P5, DOI 10.1111/j.1464-5491.2008.02628.x; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; Hu FB, 1999, JNCI-J NATL CANCER I, V91, P542, DOI 10.1093/jnci/91.6.542; Hudson MM, 2002, MED PEDIATR ONCOL, V39, P2, DOI 10.1002/mpo.10071; Jacobs LA, 2009, CA-CANCER J CLIN, V59, P391, DOI 10.3322/caac.20040; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Jung KW, 2013, CANCER RES TREAT, V45, P15, DOI 10.4143/crt.2013.45.1.15; Korea Centers for Disease Control and Prevention, 2009, QUAL CONTR DEV STAND; Korea Centers for Disease Control and Prevention, 2013, KOR NAT HLTH NUTR EX; Koro CE, 2004, DIABETES CARE, V27, P17, DOI 10.2337/diacare.27.1.17; Landier W, 2006, PEDIATR BLOOD CANCER, V46, P149, DOI 10.1002/pbc.20612; Lipscombe LL, 2008, BREAST CANCER RES TR, V109, P389, DOI 10.1007/s10549-007-9654-0; McCabe MS, 2013, J CLIN ONCOL, V31, P631, DOI 10.1200/JCO.2012.46.6854; Ong KL, 2008, ANN EPIDEMIOL, V18, P222, DOI 10.1016/j.annepidem.2007.10.007; Park SM, 2006, J CLIN ONCOL, V24, P5017, DOI 10.1200/JCO.2006.07.0243; SAS Institute, 2014, SAS SAS STAT R 9 22; Shaya FT, 2010, J CLIN HYPERTENS, V12, P826, DOI 10.1111/j.1751-7176.2010.00365.x; Shin DW, 2012, HYPERTENS RES, V35, P935, DOI 10.1038/hr.2012.54; Shin DW, 2011, SUPPORT CARE CANCER, V19, P211, DOI 10.1007/s00520-009-0802-4; Shin DW, 2010, CANCER CAUSE CONTROL, V21, P919, DOI 10.1007/s10552-010-9521-x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sim CS, 2014, ENVIRON RES, V130, P1, DOI 10.1016/j.envres.2014.01.004; Snyder CF, 2009, J CLIN ONCOL, V27, P1054, DOI 10.1200/JCO.2008.18.0950; Stattin P, 2007, DIABETES CARE, V30, P561, DOI 10.2337/dc06-0922; The Ministry of Health and Welfare, 2012, GUID US KOR NAT HLTH; Trask PC, 2005, AM J PREV MED, V28, P351, DOI 10.1016/j.amepre.2005.01.005	39	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110412	10.1371/journal.pone.0110412	http://dx.doi.org/10.1371/journal.pone.0110412			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313795	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500112
J	Abdel-Aziz, K; Solanky, BS; Yiannakas, MC; Altmann, DR; Wheeler-Kingshott, CAM; Thompson, AJ; Ciccarelli, O				Abdel-Aziz, Khaled; Solanky, Bhavana S.; Yiannakas, Marios C.; Altmann, Daniel R.; Wheeler-Kingshott, Claudia A. M.; Thompson, Alan J.; Ciccarelli, Olga			Age Related Changes in Metabolite Concentrations in the Normal Spinal Cord	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; CENTRAL-NERVOUS-SYSTEM; H-1 MR SPECTROSCOPY; UPPER CERVICAL CORD; N-ACETYL ASPARTATE; IN-VIVO; HUMAN BRAIN; GLUTAMATE LEVELS; GRAY-MATTER; LIPID-PEROXIDATION	Magnetic resonance spectroscopy (MRS) studies have previously described metabolite changes associated with aging of the healthy brain and provided insights into normal brain aging that can assist us in differentiating age-related changes from those associated with neurological disease. The present study investigates whether age-related changes in metabolite concentrations occur in the healthy cervical spinal cord. 25 healthy volunteers, aged 23-65 years, underwent conventional imaging and single-voxel MRS of the upper cervical cord using an optimised point resolved spectroscopy sequence on a 3T Achieva system. Metabolite concentrations normalised to unsuppressed water were quantified using LCModel and associations between age and spinal cord metabolite concentrations were examined using multiple regressions. A linear decline in total N-Acetyl-aspartate concentration (0.049 mmol/L lower per additional year of age, p = 0.010) and Glutamate-Glutamine concentration (0.054 mmol/L lower per additional year of age, p = 0.002) was seen within our sample age range, starting in the early twenties. The findings suggest that neuroaxonal loss and/or metabolic neuronal dysfunction, and decline in glutamate-glutamine neurotransmitter pool progress with aging.	[Abdel-Aziz, Khaled; Solanky, Bhavana S.; Yiannakas, Marios C.; Wheeler-Kingshott, Claudia A. M.; Thompson, Alan J.; Ciccarelli, Olga] UCL Inst Neurol, NMR Res Unit, London, England; [Abdel-Aziz, Khaled; Thompson, Alan J.; Ciccarelli, Olga] UCL Inst Neurol, Dept Brain Repair & Rehabil, London, England; [Solanky, Bhavana S.; Yiannakas, Marios C.; Wheeler-Kingshott, Claudia A. M.] UCL Inst Neurol, Dept Neuroinflammat, London, England; [Altmann, Daniel R.] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England; [Thompson, Alan J.; Ciccarelli, Olga] Univ Coll London Hosp, Biomed Res Ctr, Natl Inst Hlth Res, London, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University College London Hospitals NHS Foundation Trust; University of London; University College London	Abdel-Aziz, K (corresponding author), UCL Inst Neurol, NMR Res Unit, London, England.	k.abdel-aziz@ucl.ac.uk	Ciccarelli, Olga/AAY-3328-2020; Thompson, Alan J/C-2654-2008; Wheeler-Kingshott, Claudia A M Gandini/AAH-7480-2019	Thompson, Alan J/0000-0002-4333-8496; Wheeler-Kingshott, Claudia A M Gandini/0000-0002-4832-1300; Solanky, Bhavana/0000-0002-5946-7604; Ciccarelli, Olga/0000-0001-7485-1367	UK MS Society [984]	UK MS Society	This research was supported by the UK MS Society (Award Ref No: 984). http://www.mssociety.org.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2007, NEUROIMAGE, V36, P728, DOI 10.1016/j.neuroimage.2007.03.048; Aversa A, 2010, INT J UROL, V17, P38, DOI 10.1111/j.1442-2042.2009.02426.x; Baker EH, 2008, J MAGN RESON IMAGING, V27, P489, DOI 10.1002/jmri.21285; Bates TE, 1996, NEUROREPORT, V7, P1397, DOI 10.1097/00001756-199605310-00014; Batra NA, 2008, BIOL PSYCHIAT, V63, P1178, DOI 10.1016/j.biopsych.2007.10.007; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Bjartmar C, 2000, ANN NEUROL, V48, P893, DOI 10.1002/1531-8249(200012)48:6<893::AID-ANA10>3.3.CO;2-2; Brooks JCW, 2001, CEREB CORTEX, V11, P598, DOI 10.1093/cercor/11.7.598; BUREK JD, 1976, VET PATHOL, V13, P321, DOI 10.1177/030098587601300501; Butler D, 2006, ANTIOXID REDOX SIGN, V8, P185, DOI 10.1089/ars.2006.8.185; Carew JD, 2011, NEUROLOGY, V77, P1370, DOI 10.1212/WNL.0b013e318231526a; Chang L, 1996, LIFE SCI, V58, P2049, DOI 10.1016/0024-3205(96)00197-X; Chang L, 2009, MAGN RESON IMAGING, V27, P142, DOI 10.1016/j.mri.2008.06.002; CHARLES HC, 1994, PROG NEURO-PSYCHOPH, V18, P995, DOI 10.1016/0278-5846(94)90125-2; Choi CH, 2006, MAGN RESON MED, V56, P971, DOI 10.1002/mrm.21055; CHRISTIANSEN P, 1993, MAGN RESON IMAGING, V11, P799, DOI 10.1016/0730-725X(93)90197-L; Ciccarelli O, 2010, NEUROLOGY, V74, P721, DOI 10.1212/WNL.0b013e3181d26968; CLARKE DD, 1975, J NEUROCHEM, V24, P479, DOI 10.1111/j.1471-4159.1975.tb07665.x; Cooke FJ, 2004, MAGN RESON MED, V51, P1122, DOI 10.1002/mrm.20084; Corbin KB, 1937, ANAT REC, V68, P63, DOI 10.1002/ar.1090680105; Cruz-Sanchez FF, 1998, J NEURAL TRANSM, V105, P689, DOI 10.1007/s007020050088; Cudalbu C, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/10/104034; DENEELING JND, 1994, MUSCLE NERVE, V17, P454, DOI 10.1002/mus.880170414; Fan GG, 2003, CHINESE MED J-PEKING, V116, P400; FERRELL WR, 1992, NEUROREPORT, V3, P259, DOI 10.1097/00001756-199203000-00011; Gasparovic C, 2006, MAGN RESON MED, V55, P1219, DOI 10.1002/mrm.20901; Ge YL, 2002, AM J NEURORADIOL, V23, P1327; Gomez-Anson B, 2000, NEURORADIOLOGY, V42, P515, DOI 10.1007/s002340000323; Grillner S, 2008, BRAIN RES REV, V57, P2, DOI 10.1016/j.brainresrev.2007.06.027; GUPTA A, 1991, GERONTOLOGY, V37, P305, DOI 10.1159/000213277; Haga KK, 2009, NEUROBIOL AGING, V30, P353, DOI 10.1016/j.neurobiolaging.2007.07.005; Harris JL, 2014, NEUROBIOL AGING; Harting I, 2003, NEUROSCI LETT, V342, P163, DOI 10.1016/S0304-3940(03)00272-6; Henning A, 2008, MAGN RESON MED, V59, P1250, DOI 10.1002/mrm.21578; Holly LT, 2009, J NEUROSURG-SPINE, V10, P194, DOI 10.3171/2008.12.SPINE08367; Ishikawa M, 2003, SPINAL CORD, V41, P159, DOI 10.1038/sj.sc.3101375; Kachramanoglou C, 2013, NEUROREHAB NEURAL RE, V27, P118, DOI 10.1177/1545968312457825; Kadota T, 2001, AM J NEURORADIOL, V22, P128; Kaiser LG, 2005, NEUROBIOL AGING, V26, P665, DOI 10.1016/j.neurobiolaging.2004.07.001; Keller JN, 1998, REV NEUROSCIENCE, V9, P105; Kendi ATK, 2004, NEURORADIOLOGY, V46, P764, DOI 10.1007/s00234-004-1231-1; Lim KO, 1997, MAGNET RESON MED, V37, P372, DOI 10.1002/mrm.1910370313; Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133; MARCIO J, 1993, DIS COLON RECTUM, V36, P77; Marliani AF, 2010, AM J NEURORADIOL, V31, P180, DOI 10.3174/ajnr.A1738; Marliani AF, 2007, MAGN RESON MED, V57, P160, DOI 10.1002/mrm.21113; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Moreno-Torres A, 2005, NEUROBIOL AGING, V26, P1051, DOI 10.1016/j.neurobiolaging.2004.09.009; MUFSON EJ, 1980, EXP NEUROL, V70, P179, DOI 10.1016/0014-4886(80)90016-3; Muhlert N, 2014, J NEUROL NEUROSUR PS, V85, DOI 10.1136/jnnp-2014-308883.21; MURRAY MP, 1969, J GERONTOL, V24, P169, DOI 10.1093/geronj/24.2.169; Nijeholt GJLA, 1997, AM J NEURORADIOL, V18, P1041; Nonaka Naoko, 2008, Okajimas Folia Anatomica Japonica, V85, P103; O'Gorman RL, 2011, J MAGN RESON IMAGING, V33, P1262, DOI 10.1002/jmri.22520; PATEL TB, 1979, BIOCHEM J, V184, P539, DOI 10.1042/bj1840539; Phlips-Manual, 2009, ACH REL SER, V3; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Provencher SW., 2014, LCMODEL LCMGUI USERS; ROBBINS S, 1995, AGE AGEING, V24, P67, DOI 10.1093/ageing/24.1.67; Sailasuta N, 2008, MAGN RESON IMAGING, V26, P667, DOI 10.1016/j.mri.2007.06.007; Saunders DE, 1999, JMRI-J MAGN RESON IM, V9, P711, DOI 10.1002/(SICI)1522-2586(199905)9:5<711::AID-JMRI14>3.3.CO;2-V; Schubert F, 2004, NEUROIMAGE, V21, P1762, DOI 10.1016/j.neuroimage.2003.11.014; Schuff N, 2001, MAGN RESON MED, V45, P899, DOI 10.1002/mrm.1119; SHERMAN JL, 1990, AM J NEURORADIOL, V11, P369; Siroky M B, 2004, Rev Urol, V6 Suppl 1, pS3; SMITH SA, 1994, J MAGN RESON SER A, V106, P75, DOI 10.1006/jmra.1994.1008; Soher BJ, 1996, MAGNET RESON MED, V35, P356, DOI 10.1002/mrm.1910350313; Solanky BS, 2013, NMR BIOMED, V26, P357, DOI 10.1002/nbm.2867; Stroman PW, 2014, NEUROIMAGE, V84, P1070, DOI 10.1016/j.neuroimage.2013.04.124; Suzuki M, 1994, Nihon Seikeigeka Gakkai Zasshi, V68, P1; Tanaka Y, 1984, Nihon Seikeigeka Gakkai Zasshi, V58, P873; THORPE JW, 1993, NEUROLOGY, V43, P2625, DOI 10.1212/WNL.43.12.2625; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; TRUCKENMILLER ME, 1985, J NEUROCHEM, V45, P1658, DOI 10.1111/j.1471-4159.1985.tb07240.x; WOLFSON L, 1990, J GERONTOL, V45, pM12, DOI 10.1093/geronj/45.1.M12; Yiannakas MC, 2012, NEUROIMAGE, V63, P1054, DOI 10.1016/j.neuroimage.2012.07.048; Zahr NM, 2008, CEREB CORTEX, V18, P2241, DOI 10.1093/cercor/bhm250; Zahr NM, 2013, NEUROBIOL AGING, V34, P1265, DOI 10.1016/j.neurobiolaging.2012.09.014; Zlotnik A, 2011, BIOL REPROD, V84, P581, DOI 10.1095/biolreprod.110.088120	79	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e105774	10.1371/journal.pone.0105774	http://dx.doi.org/10.1371/journal.pone.0105774			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310093	Green Published, Green Accepted, gold			2022-12-27	WOS:000343210300002
J	Assareh, H; Ou, LX; Chen, J; Hillman, K; Flabouris, A; Hollis, SJ				Assareh, Hassan; Ou, Lixin; Chen, Jack; Hillman, Kenneth; Flabouris, Arthas; Hollis, Stephanie J.			Geographic Variation of Failure-to-Rescue in Public Acute Hospitals in New South Wales, Australia	PLOS ONE			English	Article							NESTED LAPLACE APPROXIMATIONS; SURGICAL-PATIENTS; PATIENT SAFETY; POSTOPERATIVE COMPLICATIONS; ADMINISTRATIVE DATA; INPATIENT SURGERY; ADVERSE EVENTS; CANCER-SURGERY; OLDER PATIENTS; MORTALITY	Despite the wide acceptance of Failure-to-Rescue (FTR) as a patient safety indicator (defined as the deaths among surgical patients with treatable complications), no study has explored the geographic variation of FTR in a large health jurisdiction. Our study aimed to explore the spatiotemporal variations of FTR rates across New South Wales (NSW), Australia. We conducted a population-based study using all admitted surgical patients in public acute hospitals during 2002-2009 in NSW, Australia. We developed a spatiotemporal Poisson model using Integrated Nested Laplace Approximation (INLA) methods in a Bayesian framework to obtain area-specific adjusted relative risk. Local Government Area (LGA) was chosen as the areal unit. LGA-aggregated covariates included age, gender, socio-economic and remoteness index scores, distance between patient residential postcode and the treating hospital, and a quadratic time trend. We studied 4,285,494 elective surgical admissions in 82 acute public hospitals over eight years in NSW. Around 14% of patients who developed at least one of the six FTR-related complications (58,590) died during hospitalization. Of 153 LGAs, patients who lived in 31 LGAs, accommodating 48% of NSW patients at risk, were exposed to an excessive adjusted FTR risk (10% to 50%) compared to the state-average. They were mostly located in state's centre and western Sydney. Thirty LGAs with a lower adjusted FTR risk (10% to 30%), accommodating 8% of patients at risk, were mostly found in the southern parts of NSW and Sydney east and south. There were significant spatiotemporal variations of FTR rates across NSW over an eight-year span. Areas identified with significantly high and low FTR risks provide potential opportunities for policy-makers, clinicians and researchers to learn from the success or failure of adopting the best care for surgical patients and build a self-learning organisation and health system.	[Assareh, Hassan; Ou, Lixin; Chen, Jack; Hillman, Kenneth; Hollis, Stephanie J.] Univ New S Wales, Australian Inst Hlth Innovat, Simpson Ctr Hlth Serv Res, Sydney, NSW, Australia; [Assareh, Hassan; Ou, Lixin; Chen, Jack; Hillman, Kenneth; Hollis, Stephanie J.] Univ New S Wales, South Western Sydney Clin Sch, Sydney, NSW, Australia; [Assareh, Hassan] Western Sydney Local Hlth Dist, Sydney, NSW, Australia; [Flabouris, Arthas] Royal Adelaide Hosp, Intens Care Unit, Adelaide, SA 5000, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Royal Adelaide Hospital	Assareh, H (corresponding author), Univ New S Wales, Australian Inst Hlth Innovat, Simpson Ctr Hlth Serv Res, Sydney, NSW, Australia.	h.assareh@unsw.edu.au	Flabouris, Arthas/AAF-9477-2019; Flabouris, Arthas/L-1347-2019; Hillman, Ken/P-6539-2015; Chen, Jack/AAR-7346-2020; Ou, Lixin/AAF-2698-2020	Flabouris, Arthas/0000-0002-1535-9441; Hillman, Ken/0000-0001-8241-0166; Chen, Jack/0000-0003-4693-5234	National Health And Medical Research Council-Australia [APP1009916, APP1020660]	National Health And Medical Research Council-Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work is supported by National Health And Medical Research Council Project grants-Australia (APP1009916 and APP1020660). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2009, AHRQ QUAL IND PAT SA; Almoudaris AM, 2013, JAMA SURG, V148, P272, DOI 10.1001/jamasurg.2013.791; [Anonymous], 2004, INT STAT CLASS DIS R; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Assuncao RM, 1999, STAT MED, V18, P2147, DOI 10.1002/(SICI)1097-0258(19990830)18:16<2147::AID-SIM179>3.0.CO;2-I; Australian Bureau of Statistics, 2006, LOC GOV AR POST AR 2; Australian Bureau of Statistics, 2011, SOCIO EC INDEXES ARE; Bellomo R, 2002, MED J AUSTRALIA, V176, P216, DOI 10.5694/j.1326-5377.2002.tb04376.x; Bellomo R, 2004, CRIT CARE MED, V32, P916, DOI 10.1097/01.CCM.0000119428.02968.9E; BERNARDINELLI L, 1995, STAT MED, V14, P2411, DOI 10.1002/sim.4780142111; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Blangiardo M, 2013, SPAT SPATIO-TEMPORAL, V4, P33, DOI 10.1016/j.sste.2012.12.001; Chen J, 2010, PUBLIC REPORTING HLT; Davis P, 2002, ADVERSE EVENTS NZ PU; Department of Health, 2006, AUSTR COMM SAF QUAL; Downey JR, 2012, HEALTH SERV RES, V47, P414, DOI 10.1111/j.1475-6773.2011.01361.x; Ghaferi AA, 2011, MED CARE, V49, P1076, DOI 10.1097/MLR.0b013e3182329b97; Ghaferi AA, 2009, ANN SURG, V250, P1029, DOI 10.1097/SLA.0b013e3181bef697; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Glance LG, 2011, ANN SURG, V253, P811, DOI 10.1097/SLA.0b013e318211d872; Griffiths P, 2013, INT J NURS STUD, V50, P292, DOI 10.1016/j.ijnurstu.2012.10.016; HealthGrades, 2013, AM HOSP QUAL OUTC HE; HealthGrades, 2013, VAR PAT SAF OUTC IMP; Henneman D, 2013, ANN SURG ONCOL, V20, P2117, DOI 10.1245/s10434-013-2896-7; Kable AK, 2002, INT J QUAL HEALTH C, V14, P269, DOI 10.1093/intqhc/14.4.269; Kammann EE, 2003, J R STAT SOC C-APPL, V52, P1, DOI 10.1111/1467-9876.00385; Khuri SF, 2005, ANN SURG, V242, P326, DOI 10.1097/01.sla.0000179621.33268.83; Martino S., 2009, IMPLEMENTING APPROXI; McNicol L, 2007, MED J AUSTRALIA, V186, P447, DOI 10.5694/j.1326-5377.2007.tb00994.x; MENG CYK, 1987, BIOMETRICS, V43, P301, DOI 10.2307/2531814; Moje Christine, 2006, Aust Health Rev, V30, P333; Needleman J, 2002, NEW ENGL J MED, V346, P1715, DOI 10.1056/NEJMsa012247; NSW Health, 2004, NSW CLIN EXC COMM DI; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Ou L, 2013, TRENDS RATES COMPLIC; Pasquali SK, 2012, PEDIATRICS, V129, pE370, DOI 10.1542/peds.2011-1188; Pearse RM, 2012, LANCET, V380, P1059, DOI 10.1016/S0140-6736(12)61148-9; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; RDC Team R, 2013, R LANG ENV STAT COMP; RUE H., 2005, GAUSSIAN MARKOV RAND; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Scarborough JE, 2012, ANN SURG, V256, P453, DOI 10.1097/SLA.0b013e31826578fb; Schmid A, 2007, J NURS ADMIN, V37, P188, DOI 10.1097/01.NNA.0000266838.23814.65; Schrodle B, 2011, COMPUTATION STAT, V26, P241, DOI 10.1007/s00180-010-0208-2; Schrodle B, 2011, J R STAT SOC C-APPL, V60, P261, DOI 10.1111/j.1467-9876.2010.00740.x; Schrodle B, 2011, ENVIRONMETRICS, V22, P725, DOI 10.1002/env.1065; Semel ME, 2012, SURGERY, V151, P171, DOI 10.1016/j.surg.2011.07.021; Sermeus W, 2011, BMC NURS, V10, DOI 10.1186/1472-6955-10-6; Sheetz KH, 2013, ANN SURG, V258, P614, DOI 10.1097/SLA.0b013e3182a5021d; Shelton A, 2013, CONTEMP NURSE, P2253; Silber JH, 2007, MED CARE, V45, P918, DOI 10.1097/MLR.0b013e31812e01cc; SILBER JH, 1992, MED CARE, V30, P615, DOI 10.1097/00005650-199207000-00004; Simpson KR, 2006, JOGNN-J OBST GYN NEO, V35, P432, DOI 10.1111/J.1552-6909.2006.00060.x; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; StataCorp, 2011, STAT STAT SOFTW REL, P173; Story DA, 2010, ANAESTHESIA, V65, P1022, DOI 10.1111/j.1365-2044.2010.06478.x; Talsma A, 2010, J NURS ADMIN, V40, P417, DOI 10.1097/NNA.0b013e3181f2eb5b; Tennant S.K., 2003, REMOTE AREAS STAT GE; Unruh LY, 2012, NURS RES, V61, P3, DOI 10.1097/NNR.0b013e3182358968; Victorian Government Health Information, 2006, PAT SAF IND TRANSL T; Welch HG, 2011, JAMA-J AM MED ASSOC, V305, P1113, DOI 10.1001/jama.2011.307; Wennberg JE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f549	64	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109807	10.1371/journal.pone.0109807	http://dx.doi.org/10.1371/journal.pone.0109807			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ9WZ	25310260	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210300075
J	Datovo, A; de Pinna, MCC; Johnson, GD				Datovo, Alessio; de Pinna, Mario C. C.; Johnson, G. David			The Infrabranchial Musculature and Its Bearing on the Phylogeny of Percomorph Fishes (Osteichthyes: Teleostei)	PLOS ONE			English	Article							RAY-FINNED FISH; MOLECULAR PHYLOGENY; COMPARATIVE ANATOMY; STRIATED-MUSCLES; HEAD-MUSCLES; GILL ARCHES; PERCIFORMES; MORPHOLOGY; ACTINOPTERYGII; ACANTHURIDAE	The muscles serving the ventral portion of the gill arches (= infrabranchial musculature) are poorly known in bony fishes. A comparative analysis of the infrabranchial muscles in the major percomorph lineages reveals a large amount of phylogenetically-relevant information. Characters derived from this anatomical system are identified and discussed in light of current hypotheses of phylogenetic relationships among percomorphs. New evidence supports a sister-group relationship between the Batrachoidiformes and Lophiiformes and between the Callionymoidei and Gobiesocoidei. Investigated data also corroborate the existence of two monophyletic groups, one including the Pristolepididae, Badidae, and Nandidae, and a second clade consisting of all non-amarsipid stromateiforms. New synapomorphies are proposed for the Atherinomorphae, Blenniiformes, Lophiiformes, Scombroidei (including Sphyraenidae), and Gobiiformes. Within the latter order, the Rhyacichthyidae and Odontobutidae are supported as the successive sister families of all remaining gobiiforms. The present analysis further confirms the validity of infrabranchial musculature characters previously proposed to support the grouping of the Mugiliformes with the Atherinomorphae and the monophyly of the Labriformes with the possible inclusion of the Pholidichthyiformes. Interestingly, most hypotheses of relationships supported by the infrabranchial musculature have been advanced by preceding anatomists on the basis of distinct data sources, but were never recovered in recent molecular phylogenies. These conflicts clearly indicate the current unsatisfactory resolution of the higher-level phylogeny of percomorphs.	[Datovo, Alessio; de Pinna, Mario C. C.] Univ Sao Paulo, Museu Zool, Lab Ictiol, Sao Paulo, Brazil; [Johnson, G. David] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Div Fishes,MRC 159, Washington, DC 20560 USA	Universidade de Sao Paulo; Smithsonian Institution; Smithsonian National Museum of Natural History	Datovo, A (corresponding author), Univ Sao Paulo, Museu Zool, Lab Ictiol, Sao Paulo, Brazil.	adatovo@usp.br	Fapesp, Biota/F-8655-2017; Datovo, Alessio/ABA-1945-2021; de pinna, mario c/L-8043-2017; Datovo, Alessio/K-7133-2016	Fapesp, Biota/0000-0002-9887-8449; Datovo, Alessio/0000-0001-9117-7343; Johnson, G D/0000-0003-4339-6589	Sao Paulo Research Foundation (FAPESP) [2010/18984-9]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was funded by a Postdoctoral Fellowship from Sao Paulo Research Foundation (FAPESP; grant #2010/18984-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILERA O, 1987, Revista Brasileira de Zoologia, V4, P89; Allis EP, 1903, J MORPHOL, V18, P45, DOI 10.1002/jmor.1050180103; ANKER G C, 1974, Transactions of the Zoological Society of London, V32, P311; ANKER GC, 1978, NETH J ZOOL, V28, P234, DOI 10.1163/002829678X00071; Baldwin CC, 2013, ZOOL J LINN SOC-LOND, V168, P496, DOI 10.1111/zoj.12033; Betancur RR, 2013, PLOS CURRENTS TREE L; Betancur-R R, 2013, NEW REVISED CLASSIFI; Borden W. Calvin, 2008, Bulletin of the Florida Museum of Natural History, V47, P109; Borden WC, 1999, J MORPHOL, V239, P191, DOI 10.1002/(SICI)1097-4687(199902)239:2<191::AID-JMOR6>3.0.CO;2-2; Britz R., 2006, COPEIA, P323; Britz R, 2003, GRZIMEKS ANIMAL LIFE, V5, P427; CARPENTER KE, 1995, B MAR SCI, V56, P379; Chakrabarty P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044083; Chanet B, 2013, CYBIUM, V37, P179; Chen WJ, 2003, MOL PHYLOGENET EVOL, V26, P262, DOI 10.1016/S1055-7903(02)00371-8; CLEMENTS KD, 1988, AUST J MAR FRESH RES, V39, P87; Collette B.B., 1984, American Society of Ichthyologists and Herpetologists Special Publication, P591; Datovo A, 2014, ZOOL J LINN SOC-LOND, V171, P554, DOI 10.1111/zoj12142; Datovo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060846; Datovo A, 2010, NEOTROP ICHTHYOL, V8, P193, DOI 10.1590/S1679-62252010000200001; de Schepper N, 2008, ZOOL J LINN SOC-LOND, V152, P717, DOI 10.1111/j.1096-3642.2008.00348.x; Dettai A, 2005, CR BIOL, V328, P674, DOI 10.1016/j.crvi.2005.04.002; Dietz P. A., 1914, Mitteilungen aus der Zoologischen Station zu Neapel, V22; Doiuchi R, 2004, ICHTHYOL RES, V51, P202, DOI 10.1007/s10228-004-0216-8; ELSHOUDOLDENHAVE MJW, 1979, ZOOMORPHOLOGIE, V93, P1, DOI 10.1007/BF02568672; Eschmeyer W. N., 2014, CATALOG FISHES ELECT; Eschmeyer WN, 2014, SPECIES FISHES FAMIL; Freihofer WC, 1963, STANFORD ICHTHYOL B, V8, P79; GOBALET KW, 1989, AM ZOOL, V29, P319; GOSLINE W A, 1970, Proceedings of the California Academy of Sciences, V38, P363; Gosline W. A, 1971, FUNCTIONAL MORPHOLOG; GOSLINE WA, 1985, ENVIRON BIOL FISH, V12, P161, DOI 10.1007/BF00005147; GOSLINE WILLIAM A., 1968, PROC US NAT MUS, V124, P1; Greenfield David W., 2008, Proceedings of the California Academy of Sciences, V59, P665; Greenwood P. H., 1966, Bulletin of the American Museum of Natural History, V131, P339; Hadley A., 2009, COMBINEZP GNU PUBLIC; Haedrich, 1969, DANA REP, V76, P1; HAEDRICH RICHARD L., 1967, BULL MUS COMP ZOOL HARVARD UNIV, V135, P31; HOESE DF, 1993, B MAR SCI, V52, P415; Horn M.H., 1984, American Society of Ichthyologists and Herpetologists Special Publication, P620; HOWES G J, 1976, Bulletin of the British Museum (Natural History) Zoology, V29, P203; Imamura H, 2005, ICHTHYOL RES, V52, P264, DOI 10.1007/s10228-005-0282-6; Imamura Hisashi, 1996, Species Diversity, V1, P123; Ishida Minoru, 1994, Bulletin of Nansei National Fisheries Research Institute, V27, P1; IUCN, 2012, IUCN RED LIST THREAT; JOHNSON GD, 1989, P ACAD NAT SCI PHILA, V141, P1; JOHNSON GD, 1993, B MAR SCI, V52, P441; JOHNSON GD, 1993, B MAR SCI, V52, P3; JOHNSON GD, 1993, B MAR SCI, V52, P554; JOHNSON GD, 1986, B MAR SCI, V39, P1; Jordan D.S., 1905, GUIDE STUDY FISHES, V2; Kaufman L.S., 1982, Breviora, P1; Kullander Sven O., 2002, Ichthyological Exploration of Freshwaters, V13, P295; LAUDER G V, 1983, Bulletin of the Museum of Comparative Zoology, V150, P95; Lauder G.V. Jr, 1980, Perspectives in Vertebrate Science, V1, P365; LAUDER GV, 1983, ZOOL J LINN SOC-LOND, V77, P1, DOI 10.1111/j.1096-3642.1983.tb01719.x; Li B, 2009, MOL PHYLOGENET EVOL, V50, P345, DOI 10.1016/j.ympev.2008.11.013; Miya M, 2005, BIOL J LINN SOC, V85, P289, DOI 10.1111/j.1095-8312.2005.00483.x; Miya M, 2003, MOL PHYLOGENET EVOL, V26, P121, DOI 10.1016/S1055-7903(02)00332-9; Miya M, 2001, MOL BIOL EVOL, V18, P1993, DOI 10.1093/oxfordjournals.molbev.a003741; Miya M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073535; Miya M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-58; Near TJ, 2013, P NATL ACAD SCI USA, V110, P12738, DOI 10.1073/pnas.1304661110; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; NELSON G J, 1970, Japanese Journal of Ichthyology, V17, P61; Nelson G.J., 1969, B AM MUS NAT HIST, V141, P475; NELSON GARETH J., 1967, ACTA ZOOL [STOCKHOLM], V48, P277; NELSON GARETH J., 1968, J LINN SOC LONDON ZOOL, V47, P261; NELSON GJ, 1967, PAC SCI, V21, P348; NELSON GJ, 1967, J ZOOL, V153, P71; NELSON GJ, 1967, J NAT HIST, V1, P289, DOI 10.1080/00222936700770231; NELSON GJ, 1966, PAC SCI, V20, P391; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; PARENTI LR, 1993, B MAR SCI, V52, P170; Parenti Lynne R., 2005, P13; Patterson C, 1989, PAPERS SYSTEMATICS G; Patterson C., 1995, SMITHSON CONTRIB ZOO, V559, P1, DOI [DOI 10.5479/SI.00810282.559, https://doi.org/10.5479/si.00810282.559]; Pietsch T. W., 1987, FROGFISHES WORLD SYS; Pietsch TW, 2007, COPEIA, P1; PIETSCH TW, 1981, FISH B-NOAA, V79, P387; Regan C. T., 1912, Annals & Magazine of Natural History Series 8, V9; Regan C. T., 1902, Annals of Natural History Ser 7, Vx, P115; Regan C.T, 1909, ANN MAG NAT HIST, V8, P66; Regan CT, 1909, ANN MAGAZINE NATURAL, V47, P75, DOI [DOI 10.1080/00222931108693067, 10.1080/00222931108693067]; Rosen D. E., 1964, Bulletin of the American Museum of Natural History, V127, P217; Rosen D. E., 1981, AM MUS NOVIT, V2719, P1; Rosen D. E., 1990, AM MUS NOVIT, V2983, P1; Rosen DE, 1969, B AM MUS NAT HIST, V141, P361; Sasaki K, 1989, MEMORIES FACULTY FIS, V36, P1, DOI DOI 10.1007/BF02905681; Setiamarga DHE, 2008, MOL PHYLOGENET EVOL, V49, P598, DOI 10.1016/j.ympev.2008.08.008; Shinohara Gento, 1994, Memoirs of the Faculty of Fisheries Hokkaido University, V41, P1; Springer, 1983, SMITHSON CONTRIB ZOO, V390, P1, DOI DOI 10.5479/SI.00810282.390; Springer V. G, 1976, SMITHSON CONTRIB ZOO, V216, P1; Springer VG, 2004, B BIOL SOC WASH, V11, P236; Springer VG, 2004, B BIOL SOC WASH, V11; Starks EC, 1909, SCIENCE, V30, P572, DOI 10.1126/science.30.773.572; STIASSNY M L J, 1987, Bulletin of the Museum of Comparative Zoology, V151, P269; STIASSNY MLJ, 1993, B MAR SCI, V52, P197; STIASSNY MLJ, 1987, J NAT HIST, V21, P1311, DOI 10.1080/00222938700770811; STIASSNY MLJ, 1992, NETH J ZOOL, V42, P260, DOI 10.1163/156854291X00324; Stiassny MLJ, 1996, INTERRELATIONSHIPS F, P333; STIASSNY MLJ, 1990, AM MUS NOVIT, P1; Takata Y, 2005, ICHTHYOL RES, V52, P33, DOI 10.1007/s10228-004-0251-5; Thacker CE, 2003, MOL PHYLOGENET EVOL, V26, P354, DOI 10.1016/S1055-7903(02)00361-5; Thacker CE, 2009, COPEIA, P93, DOI 10.1643/CI-08-004; Tyler J.C., 1989, SMITHSON CONTRIB ZOO, V485, P1, DOI 10.5479/si.00810282.485; VANDEWALLE P, 1995, J FISH BIOL, V46, P623, DOI 10.1111/j.1095-8649.1995.tb01101.x; Vandewalle P, 1998, EUR J MORPHOL, V36, P153, DOI 10.1076/ejom.36.3.153.4773; Wainwright PC, 2012, SYST BIOL, V61, P1001, DOI 10.1093/sysbio/sys060; Wiley E.O., 2010, P123; Winterbottom R., 1974, Smithsonian Contributions to Zoology, VNo. 155, P1; WINTERBOTTOM R, 1974, P ACAD NAT SCI PHILA, V125, P225; WINTERBOTTOM R, 1993, B MAR SCI, V52, P395; WINTERBOTTOM R, 1993, COPEIA, P21; Yabe M, 1996, B MAR SCI, V58, P494; YABE M, 1985, Memoirs of the Faculty of Fisheries Hokkaido University, V32, P1; Yagishita N, 2009, MOL PHYLOGENET EVOL, V53, P258, DOI 10.1016/j.ympev.2009.06.009	117	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110129	10.1371/journal.pone.0110129	http://dx.doi.org/10.1371/journal.pone.0110129			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310286	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210300092
J	Kim, YS; Kim, SH; Shin, J; Harikishore, A; Lim, JK; Jung, Y; Lyu, HN; Baek, NI; Choi, KY; Yoon, HS; Kim, KT				Kim, Ye Seul; Kim, Seong-Hoon; Shin, Joon; Harikishore, Amaravadhi; Lim, Jong-Kwan; Jung, Youngseob; Lyu, Ha-Na; Baek, Nam-In; Choi, Kwan Yong; Yoon, Ho Sup; Kim, Kyong-Tai			Luteolin Suppresses Cancer Cell Proliferation by Targeting Vaccinia-Related Kinase 1	PLOS ONE			English	Article							TO-AUTOINTEGRATION FACTOR; FLAVONOID LUTEOLIN; NUCLEAR-ENVELOPE; CYCLE ARREST; DNA-DAMAGE; VRK1; APOPTOSIS; BAF; PHOSPHORYLATION; ACCUMULATION	Uncontrolled proliferation, a major feature of cancer cells, is often triggered by the malfunction of cell cycle regulators such as protein kinases. Recently, cell cycle-related protein kinases have become attractive targets for anti-cancer therapy, because they play fundamental roles in cellular proliferation. However, the protein kinase-targeted drugs that have been developed so far do not show impressive clinical results and also display severe side effects; therefore, there is undoubtedly a need to investigate new drugs targeting other protein kinases that are critical in cell cycle progression. Vaccinia-related kinase 1 (VRK1) is a mitotic kinase that functions in cell cycle regulation by phosphorylating cell cycle-related substrates such as barrier-to-autointegration factor (BAF), histone H3, and the cAMP response element (CRE)-binding protein (CREB). In our study, we identified luteolin as the inhibitor of VRK1 by screening a small-molecule natural compound library. Here, we evaluated the efficacy of luteolin as a VRK1-targeted inhibitor for developing an effective anti-cancer strategy. We confirmed that luteolin significantly reduces VRK1-mediated phosphorylation of the cell cycle-related substrates BAF and histone H3, and directly interacts with the catalytic domain of VRK1. In addition, luteolin regulates cell cycle progression by modulating VRK1 activity, leading to the suppression of cancer cell proliferation and the induction of apoptosis. Therefore, our study suggests that luteolin-induced VRK1 inhibition may contribute to establish a novel cell cycle-targeted strategy for anticancer therapy.	[Kim, Ye Seul; Kim, Seong-Hoon; Lyu, Ha-Na; Choi, Kwan Yong; Kim, Kyong-Tai] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea; [Shin, Joon; Harikishore, Amaravadhi; Yoon, Ho Sup] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Lim, Jong-Kwan; Jung, Youngseob; Choi, Kwan Yong; Kim, Kyong-Tai] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, South Korea; [Baek, Nam-In] Kyung Hee Univ, Grad Sch Biotechnol, Suwon, South Korea; [Baek, Nam-In] Kyung Hee Univ, Plant Metab Res Ctr, Suwon, South Korea	Pohang University of Science & Technology (POSTECH); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Pohang University of Science & Technology (POSTECH); Kyung Hee University; Kyung Hee University	Kim, KT (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea.	ktk@postech.ac.kr	Yoon, Ho Sup/A-2193-2011; Baek, Nam-In/AAK-7447-2020; Amaravadhi, Harikishore/E-9294-2016	Yoon, Ho Sup/0000-0002-8243-3904; Amaravadhi, Harikishore/0000-0001-6552-1534; KIM, KYONG-TAI/0000-0001-7292-2627	National Research Foundation of Korea (NRF) [2013-056085]; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ009503]; Brain Korea 21 program of Korean Ministry of Education, Science and Technology	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea; Brain Korea 21 program of Korean Ministry of Education, Science and Technology	This work was supported by grants from the National Research Foundation of Korea (NRF) (2013-056085), the Next-Generation BioGreen 21 Program (No. PJ009503), Rural Development Administration, Republic of Korea. This work was also supported by the Brain Korea 21 program of the Korean Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell S, 2008, CLIN CANCER RES, V14, P4032, DOI 10.1158/1078-0432.CCR-07-5138; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Byun S, 2010, CANCER RES, V70, P2415, DOI 10.1158/0008-5472.CAN-09-4093; Cai XT, 2011, TOXICOL IN VITRO, V25, P1385, DOI 10.1016/j.tiv.2011.05.009; Chan KS, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.148; Chang JS, 2005, LIFE SCI, V76, P1883, DOI 10.1016/j.lfs.2004.11.003; Choi YH, 2012, NUCLEIC ACIDS RES, V40, P8499, DOI 10.1093/nar/gks634; Choi YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015254; Darvesh AS, 2013, NUTR CANCER, V65, P329, DOI 10.1080/01635581.2013.767367; George VC, 2013, ASIAN PAC J CANCER P, V14, P631, DOI 10.7314/APJCP.2013.14.2.631; Gorjanacz M, 2007, EMBO J, V26, P132, DOI 10.1038/sj.emboj.7601470; Haraguchi T, 2008, J CELL SCI, V121, P2540, DOI 10.1242/jcs.033597; Jeong MW, 2013, MOL BIOL CELL, V24, P373, DOI 10.1091/mbc.E12-06-0456; Kang TH, 2008, J CELL SCI, V121, P3035, DOI 10.1242/jcs.026757; Kang TH, 2007, MOL CELL BIOL, V27, P8533, DOI 10.1128/MCB.00018-07; Kim IJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2660; Kim J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00468; Kim S, 2014, MOL CELL BIOL, V34, P643, DOI 10.1128/MCB.00756-13; Kim W, 2013, MOL PHARMACOL, V83, P367, DOI 10.1124/mol.112.082578; Kim W, 2012, J BIOL CHEM, V287, P5278, DOI 10.1074/jbc.M111.281709; Korkina LG, 2013, CURR MED CHEM, V20, P852; Lancaster OM, 2007, J CELL BIOL, V179, P817, DOI 10.1083/jcb.200706067; Lim DY, 2007, AM J PHYSIOL-GASTR L, V292, pG66, DOI 10.1152/ajpgi.00248.2006; Lin Y, 2008, CURR CANCER DRUG TAR, V8, P634, DOI 10.2174/156800908786241050; Lin YS, 2011, CANCER SCI, V102, P1829, DOI 10.1111/j.1349-7006.2011.02035.x; Lopez-Lazaro M, 2009, MINI-REV MED CHEM, V9, P31, DOI 10.2174/138955709787001712; Lopez-Sanchez I, 2009, MOL CELL BIOL, V29, P1189, DOI 10.1128/MCB.01341-08; Manchado E, 2012, CELL DEATH DIFFER, V19, P369, DOI 10.1038/cdd.2011.197; Margalit A, 2005, P NATL ACAD SCI USA, V102, P3290, DOI 10.1073/pnas.0408364102; Martin KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002994; Molitor TP, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.11; Molitor TP, 2014, MOL BIOL CELL; Nezu J, 1997, GENOMICS, V45, P327, DOI 10.1006/geno.1997.4938; Nichols RJ, 2006, MOL BIOL CELL, V17, P2451, DOI 10.1091/mbc.E05-12-1179; Ong CS, 2010, CANCER LETT, V298, P167, DOI 10.1016/j.canlet.2010.07.001; Park CH, 2011, MOL BIOL CELL, V22, P1398, DOI 10.1091/mbc.E10-08-0717; Perez de Castro I, 2008, CURR OPIN PHARMACOL, V8, P375, DOI 10.1016/j.coph.2008.06.013; Santos CR, 2006, MOL CANCER RES, V4, P177, DOI 10.1158/1541-7786.MCR-05-0212; Sanz-Garcia M, 2012, J BIOL CHEM, V287, P23757, DOI 10.1074/jbc.M112.353102; Seelinger G, 2008, PLANTA MED, V74, P1667, DOI 10.1055/s-0028-1088314; Seelinger G, 2008, MOLECULES, V13, P2628, DOI 10.3390/molecules13102628; Segura-Totten M, 2002, J CELL BIOL, V158, P475, DOI 10.1083/jcb.200202019; Shin J, 2011, J BIOL CHEM, V286, P22131, DOI 10.1074/jbc.M110.200162; Valbuena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001642; Valbuena A, 2011, CELL SIGNAL, V23, P1267, DOI 10.1016/j.cellsig.2011.04.002; Vazquez-Cedeira M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023235; Vega FM, 2004, MOL CELL BIOL, V24, P10366, DOI 10.1128/MCB.24.23.10366-10380.2004; Weng CJ, 2012, CANCER METAST REV, V31, P323, DOI 10.1007/s10555-012-9347-y; Williams GH, 2012, J PATHOL, V226, P352, DOI 10.1002/path.3022; Xie F, 2012, EUR J PHARM SCI, V46, P388, DOI 10.1016/j.ejps.2012.03.002; Zhang B, 2008, J BIOMOL SCREEN, V13, P538, DOI 10.1177/1087057108318509	51	32	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109655	10.1371/journal.pone.0109655	http://dx.doi.org/10.1371/journal.pone.0109655			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310002	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210300065
J	Van Acker, A; Filtjens, J; Van Welden, S; Taveirne, S; Van Ammel, E; Vanhees, M; Devisscher, L; Kerre, T; Taghon, T; Vandekerckhove, B; Plum, J; Leclercq, G				Van Acker, Aline; Filtjens, Jessica; Van Welden, Sophie; Taveirne, Sylvie; Van Ammel, Els; Vanhees, Mandy; Devisscher, Lindsey; Kerre, Tessa; Taghon, Tom; Vandekerckhove, Bart; Plum, Jean; Leclercq, Georges			Ly49E Expression on CD8 alpha alpha-Expressing Intestinal Intraepithelial Lymphocytes Plays No Detectable Role in the Development and Progression of Experimentally Induced Inflammatory Bowel Diseases	PLOS ONE			English	Article							GAMMA-DELTA-T; NK CELLS; INDUCED COLITIS; CROHNS-DISEASE; RECEPTOR; MICE; PROTECTION; PATHOGENESIS; RECOGNITION; MODULATION	The Ly49E NK receptor is a unique inhibitory receptor, presenting with a high degree of conservation among mouse strains and expression on both NK cells and intraepithelial-localised T cells. Amongst intraepithelial-localised T cells, the Ly49E receptor is abundantly expressed on CD8 alpha alpha-expressing innate-like intestinal intraepithelial lymphocytes (iIELs), which contribute to front-line defense at the mucosal barrier. Inflammatory bowel diseases (IBDs), encompassing Crohn's disease and ulcerative colitis, have previously been suggested to have an autoreactive origin and to evolve from a dysbalance between regulatory and effector functions in the intestinal immune system. Here, we made use of Ly49E-deficient mice to characterize the role of Ly49E receptor expression on CD8 alpha alpha-expressing iIELs in the development and progression of IBD. For this purpose we used the dextran sodium sulphate (DSS)- and trinitrobenzenesulfonic-acid (TNBS)-induced colitis models, and the TNF Delta ARE ileitis model. We show that Ly49E is expressed on a high proportion of CD8 alpha alpha-positive iIELs, with higher expression in the colon as compared to the small intestine. However, Ly49E expression on small intestinal and colonic iIELs does not influence the development or progression of inflammatory bowel diseases.	[Van Acker, Aline; Filtjens, Jessica; Taveirne, Sylvie; Van Ammel, Els; Vanhees, Mandy; Kerre, Tessa; Taghon, Tom; Vandekerckhove, Bart; Plum, Jean; Leclercq, Georges] Univ Ghent, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium; [Van Welden, Sophie; Devisscher, Lindsey] Univ Ghent, Dept Gastroenterol, B-9000 Ghent, Belgium	Ghent University; Ghent University	Leclercq, G (corresponding author), Univ Ghent, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium.	georges.leclercq@ugent.be	Devisscher, Lindsey/AAD-5969-2021; Taghon, Tom/M-9111-2018; Leclercq, Georges/H-9659-2017; Kerre, Tessa CC/C-3226-2016; Plum, Jean/A-4357-2008; Van Welden, Sophie/AAL-6005-2020	Devisscher, Lindsey/0000-0003-4862-9580; Leclercq, Georges/0000-0002-1691-5294; Van Welden, Sophie/0000-0003-0037-796X; Vandekerckhove, Bart/0000-0003-3828-4195; Taghon, Tom/0000-0002-5781-0288	Foundation against Cancer, a foundation of public interest [2010-166]; Fund for Scientific Research (FWO) [G.0187.13]; BOF of Ghent University [BOF11/GOA/005]; Institute for the Promotion of Innovation through Science and Technology Flanders (IWT-Vlaanderen); FWO	Foundation against Cancer, a foundation of public interest; Fund for Scientific Research (FWO)(FWO); BOF of Ghent University(Ghent University); Institute for the Promotion of Innovation through Science and Technology Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); FWO(FWO)	This work was supported by grants from the Foundation against Cancer, a foundation of public interest (2010-166) (http://www.kanker.be/grants) (G. L.), by the Fund for Scientific Research (FWO) (G.0187.13) (http://www.fwo.be/en/fellowships-funding/research-projects/research-project/) (G. L.) and by the BOF of Ghent University (BOF11/GOA/005) (http://www.ugent.be/nl/onderzoek/financiering/bof/goa/overzicht.htm) (J.P, G. L., B. V, T. T.). A. V. A, J.F., M. V. are supported by the Institute for the Promotion of Innovation through Science and Technology Flanders (IWT-Vlaanderen) (http://www.iwt.be/subsidies/sb). S. T. is supported by the BOF of Ghent University. T. K. is supported by the FWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolaki M, 2008, GASTROENTEROLOGY, V134, P2025, DOI 10.1053/j.gastro.2008.02.085; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; Campbell KS, 2011, IMMUNOLOGY, V132, P315, DOI 10.1111/j.1365-2567.2010.03398.x; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Cheroutre H, 2004, NAT REV IMMUNOL, V4, P290, DOI 10.1038/nri1333; DEBRUIN PAF, 1988, THROMB HAEMOSTASIS, V60, P262; Denning TL, 2007, J IMMUNOL, V178, P4230, DOI 10.4049/jimmunol.178.7.4230; Dharmani P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025058; Dharmani Poonam, 2008, Curr Mol Pharmacol, V1, P195; Filtjens J, 2013, J LEUKOCYTE BIOL, V93, P699, DOI 10.1189/jlb.0812378; Fraser KP, 2002, EUR J IMMUNOL, V32, P868, DOI 10.1002/1521-4141(200203)32:3<868::AID-IMMU868>3.0.CO;2-A; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Hall LJ, 2013, MUCOSAL IMMUNOL, V6, P1016, DOI 10.1038/mi.2012.140; Hayday A, 2001, NAT IMMUNOL, V2, P997, DOI 10.1038/ni1101-997; Henderson P, 2011, INFLAMM BOWEL DIS, V17, P382, DOI 10.1002/ibd.21379; Hollenbach JA, 2009, IMMUNOGENETICS, V61, P663, DOI 10.1007/s00251-009-0396-5; Huybers S, 2008, INFLAMM BOWEL DIS, V14, P803, DOI 10.1002/ibd.20385; Inagaki-Ohara K, 2004, J IMMUNOL, V173, P1390, DOI 10.4049/jimmunol.173.2.1390; Jiang W, 2013, J EXP MED, V210, P2465, DOI 10.1084/jem.20122490; Jones DC, 2006, GENES IMMUN, V7, P576, DOI 10.1038/sj.gene.6364333; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; KOMANO H, 1995, P NATL ACAD SCI USA, V92, P6147, DOI 10.1073/pnas.92.13.6147; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; MacFarlane AW, 2008, BLOOD, V112, P131, DOI 10.1182/blood-2007-08-107847; Meehan TF, 2014, MUCOSAL IMMUNOL, V7, P134, DOI 10.1038/mi.2013.32; MISELJIC S, 1995, J CLIN LAB ANAL, V9, P413, DOI 10.1002/jcla.1860090613; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Olivares-Villagomez D, 2008, P NATL ACAD SCI USA, V105, P17931, DOI 10.1073/pnas.0808242105; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; ROBERTS AI, 1993, CLIN EXP IMMUNOL, V94, P527; Roselli M, 2009, INFLAMM BOWEL DIS, V15, P1526, DOI 10.1002/ibd.20961; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3; Taveirne S, 2011, BLOOD, V118, P339, DOI 10.1182/blood-2011-01-331124; Triantafillidis JK, 2011, DRUG DES DEV THER, V5, P185, DOI 10.2147/DDDT.S11290; Uhlig HH, 2009, EUR J IMMUNOL, V39, P2021, DOI 10.1002/eji.200939602; Van Beneden K, 2002, J IMMUNOL, V168, P3295, DOI 10.4049/jimmunol.168.7.3295; Van den Broeck T, 2013, J IMMUNOL, V190, P1982, DOI 10.4049/jimmunol.1200354; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Wilson TJ, 2010, HUM IMMUNOL, V71, P293, DOI 10.1016/j.humimm.2009.12.006; Yadav PK, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/348530; Yamagata T, 2004, NAT IMMUNOL, V5, P597, DOI 10.1038/ni1070; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055; Yusa S, 2002, J IMMUNOL, V168, P5047, DOI 10.4049/jimmunol.168.10.5047; Zhang Hui-Xia, 2008, Zhonghua Yi Xue Za Zhi, V88, P3108	49	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110015	10.1371/journal.pone.0110015	http://dx.doi.org/10.1371/journal.pone.0110015			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310588	gold, Green Published, Green Submitted			2022-12-27	WOS:000343210300086
J	De la Fuente, IM; Cortes, JM; Valero, E; Desroches, M; Rodrigues, S; Malaina, I; Martinez, L				De la Fuente, Ildefonso M.; Cortes, Jesus M.; Valero, Edelmira; Desroches, Mathieu; Rodrigues, Serafim; Malaina, Iker; Martinez, Luis			On the Dynamics of the Adenylate Energy System: Homeorhesis vs Homeostasis	PLOS ONE			English	Article							ADENINE-NUCLEOTIDE CONCENTRATIONS; EXTRACELLULAR ATP ACCUMULATION; LONG-RANGE CORRELATIONS; PANCREATIC BETA-CELL; INTRACELLULAR ATP; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; BIOCHEMICAL OSCILLATIONS; AUTONOMOUS OSCILLATIONS; MOLECULAR PHYSIOLOGY	Biochemical energy is the fundamental element that maintains both the adequate turnover of the biomolecular structures and the functional metabolic viability of unicellular organisms. The levels of ATP, ADP and AMP reflect roughly the energetic status of the cell, and a precise ratio relating them was proposed by Atkinson as the adenylate energy charge (AEC). Under growth-phase conditions, cells maintain the AEC within narrow physiological values, despite extremely large fluctuations in the adenine nucleotides concentration. Intensive experimental studies have shown that these AEC values are preserved in a wide variety of organisms, both eukaryotes and prokaryotes. Here, to understand some of the functional elements involved in the cellular energy status, we present a computational model conformed by some key essential parts of the adenylate energy system. Specifically, we have considered (I) the main synthesis process of ATP from ADP, (II) the main catalyzed phosphotransfer reaction for interconversion of ATP, ADP and AMP, (III) the enzymatic hydrolysis of ATP yielding ADP, and (IV) the enzymatic hydrolysis of ATP providing AMP. This leads to a dynamic metabolic model (with the form of a delayed differential system) in which the enzymatic rate equations and all the physiological kinetic parameters have been explicitly considered and experimentally tested in vitro. Our central hypothesis is that cells are characterized by changing energy dynamics (homeorhesis). The results show that the AEC presents stable transitions between steady states and periodic oscillations and, in agreement with experimental data these oscillations range within the narrow AEC window. Furthermore, the model shows sustained oscillations in the Gibbs free energy and in the total nucleotide pool. The present study provides a step forward towards the understanding of the fundamental principles and quantitative laws governing the adenylate energy system, which is a fundamental element for unveiling the dynamics of cellular life.	[De la Fuente, Ildefonso M.] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [De la Fuente, Ildefonso M.; Martinez, Luis] Univ Basque Country, UPV EHU, Dept Math, Leioa, Spain; [De la Fuente, Ildefonso M.] Univ Basque Country, Biophys Unit, CSIC, UPV EHU, Leioa, Spain; [De la Fuente, Ildefonso M.] Univ Basque Country, Dept Biochem & Mol Biol, Leioa, Spain; [De la Fuente, Ildefonso M.; Cortes, Jesus M.; Malaina, Iker; Martinez, Luis] Hosp Univ Cruces, Biocruces Hlth Res Inst, Baracaldo, Spain; [Cortes, Jesus M.] Ikerbasque, Basque Fdn Sci, Bilbao, Basque Country, Spain; [Valero, Edelmira] Univ Castilla La Mancha, Sch Ind Engn, Dept Phys Chem, Albacete, Spain; [Desroches, Mathieu] INRIA Paris Rocquencourt Ctr, Paris, France; [Rodrigues, Serafim] Univ Plymouth, Sch Comp & Math, Plymouth PL4 8AA, Devon, England; [Malaina, Iker] Univ Basque Country, UPV EHU, Dept Physiol, Bilbao, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Hospital Universitario Cruces; Basque Foundation for Science; Universidad de Castilla-La Mancha; University of Plymouth; University of Basque Country	De la Fuente, IM (corresponding author), CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain.	mtpmadei@ehu.es	Malaina, Iker/AAQ-1997-2020; Valero, Edelmira/M-7424-2014; Rodrigues, Serafim/M-7404-2016; Martínez, Luis/G-6266-2012; Cortes, Jesus/D-9949-2012	Malaina, Iker/0000-0002-1305-6623; Valero, Edelmira/0000-0001-8636-4574; Rodrigues, Serafim/0000-0002-3601-5760; Martínez, Luis/0000-0002-6297-1449; Cortes, Jesus/0000-0002-9059-8194; De la Fuente, Ildefonso/0000-0001-6548-7583	University of Basque Country (UPV/EHU): University-Society grant [US11/13]; Ministerio de Economia y Competitividad (Spain) [BFU2013-44095-P]	University of Basque Country (UPV/EHU): University-Society grant; Ministerio de Economia y Competitividad (Spain)(Spanish Government)	This study was funded by the University of Basque Country (UPV/EHU): University-Society grant US11/13 and Ministerio de Economia y Competitividad (Spain), Project No. BFU2013-44095-P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrusci P, 2007, EXP HEMATOL, V35, P1182, DOI 10.1016/j.exphem.2007.05.004; Aden J, 2013, BIOCHEMISTRY-US, V52, P1055, DOI 10.1021/bi301460k; Ainscow EK, 2002, DIABETES, V51, pS162, DOI 10.2337/diabetes.51.2007.S162; Ainscow EK, 2002, J PHYSIOL-LONDON, V544, P429, DOI 10.1113/jphysiol.2002.022434; AKITAYA T, 1985, J GEN MICROBIOL, V131, P195; ALBERTY RA, 1992, BIOCHEMISTRY-US, V31, P10610, DOI 10.1021/bi00158a025; Allegrini P, 1998, PHYS REV E, V57, P4558, DOI 10.1103/PhysRevE.57.4558; Aon MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003624; Ataullakhanov FI, 2002, BIOSCIENCE REP, V22, P501, DOI 10.1023/A:1022069718709; ATKINSON DE, 1967, J BIOL CHEM, V242, P3239; BALL WJ, 1975, J BACTERIOL, V121, P975, DOI 10.1128/JB.121.3.975-982.1975; BARIL EF, 1968, J NUTR, V95, P228, DOI 10.1093/jn/95.2.228; BARRETTE WC, 1988, J BACTERIOL, V170, P3655, DOI 10.1128/jb.170.8.3655-3659.1988; BEAMAN KD, 1981, J BACTERIOL, V146, P1055, DOI 10.1128/JB.146.3.1055-1058.1981; Bernard C., 1865, INTRO ETUDE MED EXPT; Bernard C., 1957, INTRO LIT CORRES TON; Bhatt DP, 2012, J CHROMATOGR B, V889, P110, DOI 10.1016/j.jchromb.2012.02.005; Biegniewska A, 2010, J APPL ICHTHYOL, V26, P674, DOI 10.1111/j.1439-0426.2010.01537.x; Blackwell KT, 2013, J NEUROSCI METH, V220, P131, DOI 10.1016/j.jneumeth.2013.05.008; BLANGY D, 1968, J MOL BIOL, V31, P13, DOI 10.1016/0022-2836(68)90051-X; Boender LGM, 2011, BBA-MOL CELL RES, V1813, P2133, DOI 10.1016/j.bbamcr.2011.07.008; Bonsdorff T, 2004, ANIM GENET, V35, P438, DOI 10.1111/j.1365-2052.2004.01201.x; BONZON M, 1981, PLANTA, V152, P189, DOI 10.1007/BF00385143; BRODSKY VY, 1992, J CELL SCI, V103, P363; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; BULTHUIS BA, 1993, ANTON LEEUW INT J G, V63, P1, DOI 10.1007/BF00871725; Burkeen JF, 2011, J NEUROSCI, V31, P8432, DOI 10.1523/JNEUROSCI.6576-10.2011; Burnstock G, 1999, PROG BRAIN RES, V120, P3; Burnstock G, 2012, BRIT J PHARMACOL, V167, P238, DOI 10.1111/j.1476-5381.2012.02008.x; Cannon W.B., 1932, WISDOM BODY; Chabot JR, 2007, NATURE, V450, P1249, DOI 10.1038/nature06395; Chapman A G, 1977, Adv Microb Physiol, V15, P253, DOI 10.1016/S0065-2911(08)60318-5; CHAPMAN AG, 1971, J BACTERIOL, V108, P1072, DOI 10.1128/JB.108.3.1072-1086.1971; Chen BS, 2009, MATH BIOSCI, V222, P92, DOI 10.1016/j.mbs.2009.09.004; Chen JQ, 2009, BBA-MOL CELL RES, V1793, P1540, DOI 10.1016/j.bbamcr.2009.06.001; Chen YY, 2007, BIOMED CHROMATOGR, V21, P628, DOI 10.1002/bmc.798; Chiam KH, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.061901; CHING TM, 1972, PLANT PHYSIOL, V50, P536, DOI 10.1104/pp.50.5.536; COHEN PF, 1972, BIOCHEMISTRY-US, V11, P1501, DOI 10.1021/bi00758a027; Curien G, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.29; Dai RH, 2008, TOXICON, V51, P649, DOI 10.1016/j.toxicon.2007.11.021; Das M, 2003, J NEUROPHYSIOL, V89, P833, DOI 10.1152/jn.00757.2002; De la Fuente IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058284; De la Fuente IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030162; De la Fuente IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027224; De la Fuente IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009484; De la Fuente IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007510; De La Fuente IM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003100; De la Fuente IM, 2006, ANN BIOMED ENG, V34, P295, DOI 10.1007/s10439-005-9026-z; De La Fuente IM, 1999, B MATH BIOL, V61, P573, DOI 10.1006/bulm.1999.0103; De la Fuente IM, 1999, BIOSYSTEMS, V50, P83, DOI 10.1016/S0303-2647(98)00094-X; De la Fuente IM, 1998, FRACTALS, V6, P95, DOI 10.1142/S0218348X98000110; de la Fuente IM, 1998, ACTA BIOTHEOR, V46, P37, DOI 10.1023/A:1000899820111; De La Fuente IM, 1998, B MATH BIOL, V60, P689; De la Fuentea IM, 1999, J BIOL SYST, V7, P113, DOI 10.1142/S0218339099000103; DelaFuente IM, 1996, BIOSYSTEMS, V39, P87, DOI 10.1016/0303-2647(95)01603-1; delaFuente IM, 1996, BIOPHYS J, V71, P2375, DOI 10.1016/S0006-3495(96)79431-6; DERR RF, 1972, BIOCHEM BIOPH RES CO, V49, P1385, DOI 10.1016/0006-291X(72)90492-5; Dinesh R, 2006, CURR SCI INDIA, V90, P1258; Dong K, 2012, EXP DERMATOL, V21, P231, DOI 10.1111/j.1600-0625.2011.01439.x; DOSPASSOS JB, 1992, BIOCHIM BIOPHYS ACTA, V1136, P57; Edwards JM, 2012, J EXP BOT, V63, P4389, DOI 10.1093/jxb/ers114; Eke A, 2002, PHYSIOL MEAS, V23, pR1, DOI 10.1088/0967-3334/23/1/201; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Ercan N, 1996, ARCH BIOCHEM BIOPHYS, V328, P255, DOI 10.1006/abbi.1996.0171; Ercan-Fang N, 2002, AM J PHYSIOL-ENDOC M, V283, pE29, DOI 10.1152/ajpendo.00425.2001; Erlinge D, 2010, EXTRACELLULAR ATP AND ADENOSINE AS REGULATORS OF ENDOTHELIAL CELL FUNCTION, P1, DOI 10.1007/978-90-481-3435-9_1; Falzoni S, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0101; Forsyth AM, 2011, P NATL ACAD SCI USA, V108, P10986, DOI 10.1073/pnas.1101315108; FUENTES JM, 1994, ARCH INT PHYSIOL BIO, V102, P237, DOI 10.3109/13813459409003936; GARCIAMUNOZ A, 1993, EXP BRAIN RES, V97, P325; Garmendia-Torres C, 2007, CURR BIOL, V17, P1044, DOI 10.1016/j.cub.2007.05.032; Geryk J, 2013, INT J DATA MIN BIOIN, V8, P188, DOI 10.1504/IJDMB.2013.055500; Getty L, 2000, J CLIN INVEST, V106, P421, DOI 10.1172/JCI7815; Getty-Kaushik L, 2005, DIABETES, V54, P629, DOI 10.2337/diabetes.54.3.629; Gilbert D. A., 2008, P105, DOI 10.1007/978-1-4020-8352-5_4; GOLDBETER A, 1972, BIOPHYS J, V12, P1302, DOI 10.1016/S0006-3495(72)86164-2; GOLDBETER A, 1974, FEBS LETT, V43, P327, DOI 10.1016/0014-5793(74)80672-1; Goldbeter A., 1990, RYTHMES CHAOS SYSTEM; GONZALEZ F, 1989, FEMS MICROBIOL LETT, V58, P21; Gottlieb A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020361; Guimaraes PMR, 2008, YEAST, V25, P47, DOI 10.1002/yea.1556; Hagen J, 2006, IND CATALYSIS PRACTI, V2nd; Haimovich AD, 2006, J COMPUT BIOL, V13, P1289, DOI 10.1089/cmb.2006.13.1289; HANHIJARVI AM, 1995, PHYSIOL PLANTARUM, V93, P493, DOI 10.1111/j.1399-3054.1995.tb06848.x; Hans MA, 2003, BIOTECHNOL BIOENG, V82, P143, DOI 10.1002/bit.10553; Hardie DG, 2011, NATURE, V472, P176, DOI 10.1038/472176a; Harold F. M., 1986, VITAL FORCE STUDY BI; Hartig K, 2005, PLANT BIOLOGY, V7, P33, DOI 10.1055/s-2004-830474; Hochachka PW, 1997, J EXP BIOL, V200, P381; Holert J, 2011, ENV MICROBIOL REP, V3, P136, DOI 10.1111/j.1758-2229.2010.00199.x; Holz GG, 2008, AM J PHYSIOL-CELL PH, V294, pC4, DOI 10.1152/ajpcell.00522.2007; Hungerbuehler AK, 2007, EUKARYOT CELL, V6, P473, DOI 10.1128/EC.00273-06; Hunken M, 2005, PHYCOLOGIA, V44, P249, DOI 10.2216/0031-8884(2005)44[249:DOTAEC]2.0.CO;2; Ishii K, 2006, EMBO REP, V7, P390, DOI 10.1038/sj.embor.7400620; Jacob T, 2005, EUR J VASC ENDOVASC, V29, P470, DOI 10.1016/j.ejvs.2005.01.030; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jin JP, 1998, J VIROL, V72, P10011, DOI 10.1128/JVI.72.12.10011-10019.1998; Jules M, 2005, FEBS J, V272, P1490, DOI 10.1111/j.1742-4658.2005.04588.x; KAHRU A, 1982, ARCH MICROBIOL, V133, P142, DOI 10.1007/BF00413528; Kazachenko VN, 2007, BIOL MEMBRANY, V24, P175; Kennedy RT, 2002, DIABETES, V51, pS152, DOI 10.2337/diabetes.51.2007.S152; Khakh BS, 2001, NAT REV NEUROSCI, V2, P165, DOI 10.1038/35058521; Kindzelskii AL, 1998, BIOPHYS J, V74, P90, DOI 10.1016/S0006-3495(98)77770-7; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; Klevecz RR, 2001, MOL BIOL REP, V28, P73, DOI 10.1023/A:1017909012215; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; Kwon HJ, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.20; Kwon HJ, 2013, CELL BIOCHEM FUNCT, V31, P75, DOI 10.1002/cbf.2862; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; LANGE G, 1988, EUR J BIOCHEM, V178, P61, DOI 10.1111/j.1432-1033.1988.tb14429.x; Lange PR, 2008, PLANT PHYSIOL, V146, P492, DOI 10.1104/pp.107.114702; Li JX, 2006, J THEOR BIOL, V242, P722, DOI 10.1016/j.jtbi.2006.04.002; Lim EL, 2010, NMR BIOMED, V23, P952, DOI 10.1002/nbm.1519; Lloyd D, 2005, TRENDS BIOCHEM SCI, V30, P373, DOI 10.1016/j.tibs.2005.05.005; Lloyd D, 2002, FEBS LETT, V519, P41, DOI 10.1016/S0014-5793(02)02704-7; Lloyd D, 2006, FEBS LETT, V580, P2830, DOI 10.1016/j.febslet.2006.02.066; Locasale JW, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-108; MacDonald MJ, 2003, J BIOL CHEM, V278, P51894, DOI 10.1074/jbc.M309038200; Mamontov E, 2007, MATH COMPUT MODEL, V45, P694, DOI 10.1016/j.mcm.2006.07.015; Mamontov E, 2006, ACTA BIOTHEOR, V54, P61, DOI 10.1007/s10441-006-8263-3; Mamontov E, 2006, MATH COMPUT MODEL, V44, P595, DOI 10.1016/j.mcm.2006.01.028; Mamontov E, 2011, PHYS LIFE REV, V8, P24, DOI 10.1016/j.plrev.2011.01.007; Manfredi G, 2002, METHODS, V26, P317, DOI 10.1016/S1046-2023(02)00037-3; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marquez S, 2004, FASEB J, V18, P519, DOI 10.1096/fj.03-0417fje; de la Fuente IM, 2010, INT J MOL SCI, V11, P3540, DOI 10.3390/ijms11093540; MCKEE KL, 1984, PHYSIOL PLANTARUM, V62, P1, DOI 10.1111/j.1399-3054.1984.tb05914.x; Mellon D, 1999, J NEUROPHYSIOL, V81, P1231, DOI 10.1152/jn.1999.81.3.1231; MILLS DCB, 1969, NATURE, V222, P991, DOI 10.1038/222991a0; Moller AC, 1998, BIOPHYS CHEM, V72, P63, DOI 10.1016/S0301-4622(98)00123-9; Moran LA, 2011, PRINCIPLES BIOCH; MORI Y, 1986, PROTOPLASMA, V135, P31, DOI 10.1007/BF01277050; de la Fuente IM, 2014, SPRINGER SER BIOPHYS, V16, P179, DOI 10.1007/978-3-642-38505-6_8; Murray DB, 2007, P NATL ACAD SCI USA, V104, P2241, DOI 10.1073/pnas.0606677104; Nath S, 2000, BIOCHEM BIOPH RES CO, V272, P629, DOI 10.1006/bbrc.2000.2774; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; Nelson SW, 2002, J BIOL CHEM, V277, P15539, DOI 10.1074/jbc.M112304200; Nenninger A, 2010, J BACTERIOL, V192, P4535, DOI 10.1128/JB.00284-10; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Oliva A, 2005, PLOS BIOL, V3, P1239, DOI 10.1371/journal.pbio.0030225; Ozalp VC, 2010, J BIOL CHEM, V285, P37579, DOI 10.1074/jbc.M110.155119; Peiying Z, 2007, MODELING AIRWAY SURF; Petty HR, 2001, P NATL ACAD SCI USA, V98, P3145, DOI 10.1073/pnas.061014298; Piotrowska MJ, 2008, MATH COMPUT MODEL, V48, P1122, DOI 10.1016/j.mcm.2007.12.020; Placantonakis DG, 2001, J PHYSIOL-LONDON, V534, P123, DOI 10.1111/j.1469-7793.2001.t01-1-00123.x; Plaideau C, 2012, FASEB J, V26, P2685, DOI 10.1096/fj.11-198168; POMEROY MK, 1986, PLANT PHYSIOL, V81, P361, DOI 10.1104/pp.81.2.361; PRADET A, 1983, ANNU REV PLANT PHYS, V34, P199, DOI 10.1146/annurev.pp.34.060183.001215; PRIVALLE LS, 1983, J BACTERIOL, V154, P351, DOI 10.1128/JB.154.1.351-355.1983; Psiuk-Maksymowicz K, 2008, MATH COMPUT MODEL, V47, P580, DOI 10.1016/j.mcm.2007.02.029; Rajab P, 2000, AM J PHYSIOL-REG I, V279, pR1076, DOI 10.1152/ajpregu.2000.279.3.R1076; Rakotonirainy MS, 2008, LUMINESCENCE, V23, P182, DOI 10.1002/bio.1021; Ramanujan VK, 2006, BIOPHYS J, V90, pL70, DOI 10.1529/biophysj.106.083501; RAPOPORT TA, 1976, BIOCHEM J, V154, P449, DOI 10.1042/bj1540449; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; REICH JG, 1974, FEBS LETT, V43, pS119; Rengan R, 1999, BIOCHEM BIOPH RES CO, V262, P479, DOI 10.1006/bbrc.1999.1222; Richard P, 1996, YEAST, V12, P731; Rosenspire AJ, 2001, J CELL SCI, V114, P1515; Samaey G, 2000, 305 TW; Sanchez-Armass S, 2006, AM J PHYSIOL-CELL PH, V290, pC524, DOI 10.1152/ajpcell.00290.2005; Sear RP, 2005, J PHYS-CONDENS MAT, V17, pS3587, DOI 10.1088/0953-8984/17/45/052; SELKOV E, 1975, EUR J BIOCHEM, V59, P151, DOI 10.1111/j.1432-1033.1975.tb02436.x; SELKOV EE, 1968, EUR J BIOCHEM, V4, P79, DOI 10.1111/j.1432-1033.1968.tb00175.x; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Shaul O, 1996, P NATL ACAD SCI USA, V93, P4868, DOI 10.1073/pnas.93.10.4868; Sheng XR, 1999, J BIOL CHEM, V274, P22238, DOI 10.1074/jbc.274.32.22238; SINGH J, 1981, PLANT PHYSIOL, V67, P906, DOI 10.1104/pp.67.5.906; SKJOLDAL HR, 1981, MAR BIOL, V62, P119, DOI 10.1007/BF00388173; SMITH BA, 1980, J BACTERIOL, V142, P1007, DOI 10.1128/JB.142.3.1007-1009.1980; Smrcinova M, 1998, INT J BIFURCAT CHAOS, V8, P2467, DOI 10.1142/S0218127498001984; Soga N, 2011, FEBS J, V278, P2647, DOI 10.1111/j.1742-4658.2011.08191.x; Srividhya J, 2007, BIOPHYS CHEM, V125, P286, DOI 10.1016/j.bpc.2006.09.001; Steigmiller S, 2008, P NATL ACAD SCI USA, V105, P3745, DOI 10.1073/pnas.0708356105; Steven WE, 1978, J GEN MICROBIOL, V108, P197; Sung MH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00616; Suska M, 2010, VET MED INT, V2010; SWEDES JS, 1975, J BIOL CHEM, V250, P6930; Tanaka K, 2010, TRENDS CELL BIOL, V20, P601, DOI 10.1016/j.tcb.2010.07.005; THUMA E, 1972, BIOCHIM BIOPHYS ACTA, V268, P81, DOI 10.1016/0005-2744(72)90200-8; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; Tonozuka H, 2001, J BIOCHEM-TOKYO, V130, P589, DOI 10.1093/oxfordjournals.jbchem.a003023; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; UEDA T, 1987, EXP CELL RES, V169, P191, DOI 10.1016/0014-4827(87)90237-0; Valero E, 2006, FEBS J, V273, P3598, DOI 10.1111/j.1742-4658.2006.05366.x; Versees W, 2003, CURR OPIN STRUC BIOL, V13, P731, DOI 10.1016/j.sbi.2003.10.002; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Waddington C H, 1957, STRATEGY GENES DISCU; WADDINGTON CH, 1968, NATURE, V218, P525, DOI 10.1038/218525a0; WALKERSIMMONS M, 1977, J BACTERIOL, V130, P676, DOI 10.1128/JB.130.2.676-683.1977; Weber J, 2005, MICROBIOL-SGM, V151, P707, DOI 10.1099/mic.0.27482-0; Weber J, 2006, BBA-BIOENERGETICS, V1757, P1162, DOI 10.1016/j.bbabio.2006.04.007; Wittmann C, 2005, BIOTECHNOL BIOENG, V89, P839, DOI 10.1002/bit.20408; Womac AD, 2009, EUR J NEUROSCI, V30, P869, DOI 10.1111/j.1460-9568.2009.06874.x; Xu Z, 2011, CHEM-ASIAN J, V6, P2113, DOI 10.1002/asia.201100120; Xu ZJ, 2004, BIOCHEM J, V383, P171, DOI 10.1042/BJ20040967; Yang JH, 2008, J BIOL CHEM, V283, P36321, DOI 10.1074/jbc.M804794200; Yildirim N, 2003, BIOPHYS J, V84, P2841, DOI 10.1016/S0006-3495(03)70013-7; YOSHIMOTO Y, 1981, PROTOPLASMA, V109, P159, DOI 10.1007/BF01287637; Ytting CK, 2012, INTEGR BIOL-UK, V4, P99, DOI 10.1039/c1ib00108f; Zubatkina IS, 2008, J EVOL BIOCHEM PHYS+, V44, P763, DOI 10.1134/S0022093008060136	204	51	52	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108676	10.1371/journal.pone.0108676	http://dx.doi.org/10.1371/journal.pone.0108676			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303477	Green Submitted, Green Published, gold			2022-12-27	WOS:000343730400021
J	Balzer, L; Pennino, D; Blank, S; Seismann, H; Darsow, U; Schnedler, M; McIntyre, M; Ollert, MW; Durham, SR; Spillner, E; Ring, J; Cifuentes, L				Balzer, Lukas; Pennino, Davide; Blank, Simon; Seismann, Henning; Darsow, Ulf; Schnedler, Mathias; McIntyre, Mareike; Ollert, Markus W.; Durham, Stephen R.; Spillner, Edzard; Ring, Johannes; Cifuentes, Liliana			Basophil Activation Test Using Recombinant Allergens: Highly Specific Diagnostic Method Complementing Routine Tests in Wasp Venom Allergy	PLOS ONE			English	Article							INSECT STING ALLERGY; RVES V 5; HYMENOPTERA VENOM; VESPULA VENOM; CD63 EXPRESSION; SENSITIZATION; SENSITIVITY; IGE; BEE	Background: Skin testing can expose allergic subjects to potential systemic reactions, sensitization against unrelated proteins, and increased risk of future sting reactions. Therefore the continuous improvement of in vitro diagnostic methods is desirable. Recombinant allergens have been shown to improve the sensitivity of specific IgE (sIgE) detection in vitro whilst no data is available regarding their application and reliability in basophil activation test (BAT). Here we aimed to compare the specificity and sensitivity of recombinant allergens Ves v 1, Ves v 2, Ves v 3 and Ves v 5 in both specific IgE (sIgE) detection in vitro and basophil activation test. Methods: sIgE detection by ELISA or ImmunoCAP and BAT towards the panel of recombinant allergens Ves v 1, Ves v 2, Ves v 3 and Ves v 5 were performed in 43 wasp venom allergic patients with a history of anaphylactic reaction and sIgE seropositivity, as well as 17 controls defined as subjects with a history of repetitive wasp stings but absence of any allergic symptom. Results: The BAT performed with the recombinant allergens Ves v 1, Ves v 2, Ves v 3 and Ves v 5 markedly improved the specificity of diagnosis in wasp venom allergic subjects when compared to the respective sIgE detection in serum. Conclusions: BAT performed with the recombinant allergens Ves v 5, Ves v 3 and Ves v 1 provides an emerging highly specific in vitro method for the detection of wasp venom allergy, compared to the sIgE detection. Recombinant allergens applied to BAT represent a step forward in developing reliable in vitro tests for specific diagnosis of allergy.	[Balzer, Lukas; Darsow, Ulf; Schnedler, Mathias; McIntyre, Mareike; Ollert, Markus W.; Ring, Johannes; Cifuentes, Liliana] Tech Univ Munich, Dept Dermatol & Allergy, D-80290 Munich, Germany; [Pennino, Davide; Blank, Simon] Tech Univ Munich, ZAUM Ctr Allergy & Environm, D-80290 Munich, Germany; [Pennino, Davide; Blank, Simon] Helmholtz Ctr Munich, Munich, Germany; [Seismann, Henning] Univ Hamburg, Inst Biochem & Mol Biol, Hamburg, Germany; [Durham, Stephen R.; Cifuentes, Liliana] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Allergy & Clin Immunol, London, England; [Spillner, Edzard] Aarhus Univ, Dept Engn, Aarhus, Denmark; [Ring, Johannes; Cifuentes, Liliana] CK CARE, Davos, Switzerland	Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Hamburg; Imperial College London; Aarhus University	Cifuentes, L (corresponding author), Tech Univ Munich, Dept Dermatol & Allergy, D-80290 Munich, Germany.	liliana.cifuentes@lrz.tu-muenchen.de	Ring, Johannes/GLN-4341-2022; Blank, Simon/M-7708-2013	Ring, Johannes/0000-0001-8236-3152; spillner, edzard/0000-0003-0999-5254; Ollert, Markus W./0000-0002-8055-0103	"Hochschulwissenschaftsprogramm" (HWP); "Kommission Klinische Forschung" (KKF) of the Technical University Munich; Christine Kuhne - Center for Allergy Research and Education (CK-CARE); "Bayerische Forschungsstiftung" (BFS)	"Hochschulwissenschaftsprogramm" (HWP); "Kommission Klinische Forschung" (KKF) of the Technical University Munich; Christine Kuhne - Center for Allergy Research and Education (CK-CARE); "Bayerische Forschungsstiftung" (BFS)	LC was supported by the "Hochschulwissenschaftsprogramm" (HWP), "Kommission Klinische Forschung" (KKF) of the Technical University Munich, the Christine Kuhne - Center for Allergy Research and Education (CK-CARE), and "Bayerische Forschungsstiftung" (BFS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilo BM, 2005, ALLERGY, V60, P1339, DOI 10.1111/j.1398-9995.2005.00963.x; Blank S, 2010, J IMMUNOL, V184, P5403, DOI 10.4049/jimmunol.0803709; Cifuentes L, 2013, J ALLERGY CLIN IMMUN; Eberlein-Konig B, 2006, J INVEST ALLERG CLIN, V16, P5; Eberlein-Konig B, 2004, J INVEST ALLERG CLIN, V14, P10; Erdmann SM, 2004, ALLERGY, V59, P1102, DOI 10.1111/j.1398-9995.2004.00624.x; Golden DBK, 2003, J ALLERGY CLIN IMMUN, V112, P495, DOI [10.1067/mai.2003.1606, 10.1016/S0091-6749(03)01537-9]; Golden DBK, 2003, AM FAM PHYSICIAN, V67, P2541; Golden DBK, 2001, J ALLERGY CLIN IMMUN, V107, P897, DOI 10.1067/mai.2001.114706; Grunwald T, 2006, J ALLERGY CLIN IMMUN, V117, P848, DOI 10.1016/j.jaci.2005.12.1331; Hofmann SC, 2011, J ALLERGY CLIN IMMUN, V127, P265, DOI 10.1016/j.jaci.2010.06.042; HUNT KJ, 1978, J ALLERGY CLIN IMMUN, V61, P48, DOI 10.1016/0091-6749(78)90473-6; King TP, 1996, J ALLERGY CLIN IMMUN, V98, P588, DOI 10.1016/S0091-6749(96)70093-3; Korosec P, 2012, J ALLERGY CLIN IMMUN, V129, P1406, DOI 10.1016/j.jaci.2011.12.975; LOCKEY RF, 1989, J ALLERGY CLIN IMMUN, V84, P967, DOI 10.1016/0091-6749(89)90396-5; Muller UR, 2009, ALLERGY, V64, P543, DOI 10.1111/j.1398-9995.2008.01794.x; REISMAN RE, 1979, J ALLERGY CLIN IMMUN, V64, P281, DOI 10.1016/0091-6749(79)90145-3; Reisman RE, 2001, J ALLERGY CLIN IMMUN, V107, P781, DOI 10.1067/mai.2001.115042; RING J, 1977, LANCET, V1, P466; SCHULLER DE, 1981, ANN ALLERGY, V47, P84; Seismann Henning, 2010, Clin Mol Allergy, V8, P7, DOI 10.1186/1476-7961-8-7; Seismann H, 2010, MOL IMMUNOL, V47, P799, DOI 10.1016/j.molimm.2009.10.005; Strohmeier B, 2013, ALLERGY, V68, P542, DOI 10.1111/all.12123; Sturm GJ, 2012, J ALLERGY CLIN IMMUN, V130, P817, DOI 10.1016/j.jaci.2012.05.047; Sturm GJ, 2009, INT ARCH ALLERGY IMM, V148, P261, DOI 10.1159/000161586; Vos B, 2013, J ALLERGY CLIN IMMUN, V131, P1225, DOI 10.1016/j.jaci.2012.07.041	26	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e108619	10.1371/journal.pone.0108619	http://dx.doi.org/10.1371/journal.pone.0108619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329342	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204100003
J	Jia, YL; Xu, G; Zhou, WJ; Wang, ZZ; Meng, LL; Zhou, SN; Xu, X; Yuan, HQ; Tian, KL				Jia, Yanglei; Xu, Gang; Zhou, Wenjing; Wang, Zhenzheng; Meng, Linlin; Zhou, Songnan; Xu, Xia; Yuan, Huiqing; Tian, Keli			Diabetes Promotes DMH-Induced Colorectal Cancer by Increasing the Activity of Glycolytic Enzymes in Rats	PLOS ONE			English	Article							ABERRANT CRYPT FOCI; HIGH-FAT DIET; INSULIN THERAPY; COLON-CANCER; RISK; MELLITUS; GROWTH; HYPERINSULINEMIA; OVEREXPRESSION; HYPERGLYCEMIA	The objective of the present study was to investigate the association between diabetes mellitus and colorectal carcinogenesis as well as the possible mechanism involved in this interaction. Diabetes rat models were induced with a low dose of STZ followed by a low dose of DMH to induce colorectal cancer. The formation of ACF in the colon and the incidence, number and size of tumors were measured. The activity of glycolytic enzymes in colonic tissues was also measured. The results demonstrated that both the total number of ACF and the number of foci that contain a different number of crypts were increased in diabetic rats. At the end of the experimental treatment, the incidence, number and size of tumors were also increased in diabetic rats. Overall, these data indicated that diabetes increased the risk of colorectal cancer. The activity of HK and PK in colonic tissues was increased in diabetic rats, whereas the activity of PDH was decreased. In addition, the activities of these enzymes in intratumor were higher than that of in peritumor. These data indicated that the high rate of glycolysis may play a role in colorectal carcinogenesis in diabetic rats.	[Jia, Yanglei; Zhou, Wenjing; Meng, Linlin; Zhou, Songnan; Xu, Xia; Yuan, Huiqing; Tian, Keli] Shandong Univ, Sch Med, Dept Biochem & Mol Biol, Jinan, Shandong, Peoples R China; [Xu, Gang] 456 Hosp PLA, Dept Gastroenterol, Jinan, Shandong, Peoples R China; [Wang, Zhenzheng] 456 Hosp PLA, Dept Pathol, Jinan, Shandong, Peoples R China	Shandong University	Tian, KL (corresponding author), Shandong Univ, Sch Med, Dept Biochem & Mol Biol, Jinan, Shandong, Peoples R China.	tiankeli@sdu.edu.cn	Zhou, Wenjing/O-5814-2018	Zhou, Wenjing/0000-0002-4932-9312	Natural Science Foundation of Shandong Province [2009ZRB01346]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by The Natural Science Foundation of Shandong Province (2009ZRB01346). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARORA KK, 1990, J BIOL CHEM, V265, P6481; Berster Jutta M., 2008, Archives of Physiology and Biochemistry, V114, P84, DOI [10.1080/13813450802008455, 10.1080/13813450802008455 ]; BIRD RP, 1987, CANCER LETT, V37, P147, DOI 10.1016/0304-3835(87)90157-1; BIRD RP, 1995, CANCER LETT, V93, P55, DOI 10.1016/0304-3835(95)03788-X; Bostick RM, 1997, CANCER EPIDEM BIOMAR, V6, P931; Bruce WR, 2000, NUTR CANCER, V37, P19, DOI 10.1207/S15327914NC3701_2; Bruce WR, 2000, CANCER EPIDEM BIOMAR, V9, P1271; BUSTAMANTE E, 1977, P NATL ACAD SCI USA, V74, P3735, DOI 10.1073/pnas.74.9.3735; Chang CK, 2003, DIABETOLOGIA, V46, P595, DOI 10.1007/s00125-003-1109-5; Deng LY, 2012, DIGEST DIS SCI, V57, P1576, DOI 10.1007/s10620-012-2055-1; GIOVANNUCCI E, 1995, CANCER CAUSE CONTROL, V6, P164, DOI 10.1007/BF00052777; Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S; Hou WR, 2011, GENET MOL RES, V10, P1576, DOI 10.4238/vol10-3gmr1159; Kerr DS, 2010, MOL GENET METAB, V99, P246, DOI 10.1016/j.ymgme.2009.11.005; LOPASCHUK GD, 1993, J PHARMACOL EXP THER, V264, P135; Mansor LS, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-136; MCLELLAN EA, 1991, CANCER RES, V51, P5270; Mohania D, 2013, AM J CANC THER PHARM, V1, P8; Nam SO, 2013, ANTICANCER RES, V33, P2855; Osawa H, 1996, J BIOL CHEM, V271, P16690, DOI 10.1074/jbc.271.28.16690; Potter JD, 1999, JNCI-J NATL CANCER I, V91, P916, DOI 10.1093/jnci/91.11.916; REAVEN GM, 1991, DIABETES CARE, V14, P195, DOI 10.2337/diacare.14.3.195; Rodrigues MAM, 2002, BRAZ J MED BIOL RES, V35, P351, DOI 10.1590/S0100-879X2002000300010; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Sridhar SS, 2009, J CLIN ONCOL, V27, P165, DOI 10.1200/JCO.2008.19.8937; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Srinivasan K, 2004, METHOD FIND EXP CLIN, V26, P327, DOI 10.1358/mf.2004.26.5.831322; Strickler H D, 2001, Diabetes Technol Ther, V3, P263, DOI 10.1089/152091501300209633; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Watts LM, 2005, DIABETES, V54, P1846, DOI 10.2337/diabetes.54.6.1846; WEINHOUSE S, 1956, SCIENCE, V124, P267, DOI 10.1126/science.124.3215.267; Whiteley LO, 1996, TOXICOL PATHOL, V24, P681, DOI 10.1177/019262339602400602; Wong P, 2012, CANCER EPIDEM BIOMAR, V21, P1833, DOI 10.1158/1055-9965.EPI-12-0771; Wu CA, 2013, BBA-MOL CELL RES, V1833, P1147, DOI 10.1016/j.bbamcr.2013.01.025; Xu G, 2010, FOOD CHEM TOXICOL, V48, P390, DOI 10.1016/j.fct.2009.10.027; Yang YX, 2004, GASTROENTEROLOGY, V127, P1044, DOI 10.1053/j.gastro.2004.07.011; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109; Zaafar DK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100562	38	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110455	10.1371/journal.pone.0110455	http://dx.doi.org/10.1371/journal.pone.0110455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329503	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204100077
J	Bermingham, EN; Thomas, DG; Cave, NJ; Morris, PJ; Butterwick, RF; German, AJ				Bermingham, Emma N.; Thomas, David G.; Cave, Nicholas J.; Morris, Penelope J.; Butterwick, Richard F.; German, Alexander J.			Energy Requirements of Adult Dogs: A Meta-Analysisle	PLOS ONE			English	Article							BODY-COMPOSITION; INDIRECT CALORIMETRY; NUTRIENT DIGESTIBILITY; PREDICTIVE EQUATION; WATER TURNOVER; HUNTING DOGS; WEIGHT-LOSS; FOOD-INTAKE; EXPENDITURE; OBESITY	A meta-analysis was conducted to determine the maintenance energy requirements of adult dogs. Suitable publications were first identified, and then used to generate relationships amongst energy requirements, husbandry, activity level, methodology, sex, neuter status, dog size, and age in healthy adult dogs. Allometric equations for maintenance energy requirements were determined using log-log linear regression. So that the resulting equations could readily be compared with equations reported by the National Research Council, maintenance energy requirements in the current study were determined in kcal/kg(0.75) body weight (BW). Ultimately, the data of 70 treatment groups from 29 publications were used, and mean (+/- standard deviation) maintenance energy requirements were 142.8 +/- 55.3 kcal. kgBW(-0.75).day(-1). The corresponding allometric equation was 81.5 kcal. kgBW(-0.93).day(-1) (adjusted R-2 = 0.64; 70 treatment groups). Type of husbandry had a significant effect on maintenance energy requirements (P<0.001): requirements were greatest in racing dogs, followed by working dogs and hunting dogs, whilst the energy requirements of pet dogs and kennel dogs were least. Maintenance energy requirements were less in neutered compared with sexually intact dogs (P<0.001), but there was no effect of sex. Further, reported activity level tended to effect the maintenance energy requirement of the dog (P = 0.09). This review suggests that estimating maintenance energy requirements based on BW alone may not be accurate, but that predictions that factor in husbandry, neuter status and, possibly, activity level might be superior. Additionally, more information on the nutrient requirements of older dogs, and those at the extremes of body size (i.e. giant and toy breeds) is needed.	[Bermingham, Emma N.] AgRes Grasslands, Food Nutr & Hlth Team, Food & Biobased Prod, Palmerston North, New Zealand; [Thomas, David G.] Massey Univ, Ctr Feline Nutr, Palmerston North, New Zealand; [Thomas, David G.; Cave, Nicholas J.] Massey Univ, Inst Vet Anim Biomed Sci, Palmerston North, New Zealand; [Morris, Penelope J.; Butterwick, Richard F.] WALTHAM Ctr Pet Nutr, Melton Mowbray, Leics, England; [German, Alexander J.] Univ Liverpool, Dept Obes & Endocrinol, Neston, Cheshire, England	AgResearch - New Zealand; Massey University; Massey University; Mars; WALTHAM Petcare Science Institute; University of Liverpool	German, AJ (corresponding author), Univ Liverpool, Dept Obes & Endocrinol, Neston, Cheshire, England.	ajgerman@liv.ac.uk	Cave, Nick/AAQ-9789-2021	Bermingham, Emma/0000-0003-0952-5260; Cave, Nick/0000-0002-6037-5942; German, Alexander/0000-0002-3017-7988	WALTHAM Centre of Pet Nutrition	WALTHAM Centre of Pet Nutrition	This review was funded by the WALTHAM Centre of Pet Nutrition (http://www.waltham.com). Further, employees of the funding body (RJB, PJM) are included authors. Although these authors participated in the initial discussions regarding the project, and reviewed the manuscript, they were not directly involved in performing the literature review, or in deciding on which publications and treatment groups to include.	Ahlstrom O, 2006, J NUTR, V136, p2063S, DOI 10.1093/jn/136.7.2063S; Ahlstrom O, 2011, BRIT J NUTR, V106, pS158, DOI 10.1017/S0007114511001838; Anantharaman-Barr G., 1990, Veterinary International, V2, P19; Association of American Feed Control Officials, 2010, AAFCO OFF PUBL, P169; Ballevre O, 1994, J NUTR, V124, p2594S; Bermingham EN, 2010, BRIT J NUTR, V103, P1083, DOI 10.1017/S000711450999290X; BLAZA SE, 1982, CANINE PRACT, V9, P10; Bouthegourd JC, 2006, P 2006 PUR NUTR FOR, V94; BURGER IH, 1991, J NUTR, V121, pS18, DOI 10.1093/jn/121.suppl_11.S18; Butterwick RF, 1998, J NUTR, V128, p2771S, DOI 10.1093/jn/128.12.2771S; Christian HE, 2012, J PHYS ACT HLTH; Decombaz J, 1995, ANN INT SLED DOG VET, V2, P113; EARLE KE, 1991, J NUTR, V121, pS45, DOI 10.1093/jn/121.suppl_11.S45; Euromonitor International, 2010, PET CAR EUR TRAD SOU; Finke Mark D., 1994, Journal of Nutrition, V124, p2604S, DOI 10.1093/jn/124.suppl_12.2604S; FINKE MD, 1991, J NUTR, V121, pS22, DOI 10.1093/jn/121.suppl_11.S22; FOLTIN RW, 1988, APPETITE, V11, P1, DOI 10.1016/S0195-6663(88)80017-5; Frankel TL, 1994, J NUTR, V124, p2614S; Galis F, 2007, J EXP ZOOL PART B, V308B, P119, DOI 10.1002/jez.b.21116; German AJ, 2008, VET REC, V163, P503, DOI 10.1136/vr.163.17.503; German AJ, 2011, J ANIM PHYSIOL AN N, V95, P368, DOI 10.1111/j.1439-0396.2010.01063.x; German AJ, 2007, J VET INTERN MED, V21, P1174, DOI 10.1892/06-280.1; German AJ, 2006, J NUTR, V136, p1940S, DOI 10.1093/jn/136.7.1940S; German AJ, 2011, BRIT J NUTR, V106, pS93, DOI 10.1017/S0007114511000584; Greer KA, 2007, RES VET SCI, V82, P208, DOI 10.1016/j.rvsc.2006.06.005; Harper EJ, 1997, FOCUS, V7, P32; Hawthorne AJ, 2004, J NUTR, V134, p2027S, DOI 10.1093/jn/134.8.2027S; Heitmann BL, 2000, INT J OBESITY, V24, P435, DOI 10.1038/sj.ijo.0801176; Hill RC, 2000, AM J VET RES, V61, P1566, DOI 10.2460/ajvr.2000.61.1566; Hill RC, 2001, AM J VET RES, V62, P440, DOI 10.2460/ajvr.2001.62.440; Hill RC, 2006, J NUTR, V136, p1967S, DOI 10.1093/jn/136.7.1967S; Hinchcliff KW, 1997, AM J VET RES, V58, P1457; Hosgood G, 2007, J VET EMERG CRIT CAR, V8, P222, DOI DOI 10.1111/J.1476-4431.1998.TB00128.X; Jeusette I, 2006, J ANIM PHYSIOL AN N, V90, P12, DOI 10.1111/j.1439-0396.2005.00612.x; Jeusette I, 2004, J ANIM PHYSIOL AN N, V88, P117, DOI 10.1111/j.1439-0396.2003.00467.x; Jeusette IC, 2005, RES VET SCI, V79, P169, DOI 10.1016/j.rvsc.2004.11.012; Jeusette IC, 2005, AM J VET RES, V66, P81, DOI 10.2460/ajvr.2005.66.81; Jewell DE, 2006, VET THER, V7, P78; KENDALL PT, 1983, J NUTR, V113, P1946, DOI 10.1093/jn/113.10.1946; Kienzle E, 2006, J NUTR, V136, p1973S, DOI 10.1093/jn/136.7.1973S; KIENZLE E, 1991, J NUTR, V121, pS39, DOI 10.1093/jn/121.suppl_11.S39; KIRKWOOD JK, 1985, J SMALL ANIM PRACT, V26, P97, DOI 10.1111/j.1748-5827.1985.tb02090.x; KLEIBER M, 1947, PHYSIOL REV, V27, P511, DOI 10.1152/physrev.1947.27.4.511; Kuzmuk KN, 2005, J NUTR, V135, P1940, DOI 10.1093/jn/135.8.1940; Laessle R, 2012, APPETITE, V58, P249, DOI 10.1016/j.appet.2011.10.004; Laflamme DP, 2000, COMP CONT ED SMA S9A, V22, P113; Larson BT, 2004, FASEB J, V18, pA378; Larsson C, 2010, ISOT ENVIRON HEALT S, V46, P432, DOI 10.1080/10256016.2010.521821; LEBLANC J, 1986, AM J PHYSIOL, V250, pE144, DOI 10.1152/ajpendo.1986.250.2.E144; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; NRC, 2006, NUTR REQ DOGS CATS, V2; O'Toole E, 2004, JAVMA-J AM VET MED A, V225, P58, DOI 10.2460/javma.2004.225.58; O'Toole E, 2001, AM J VET RES, V62, P1761, DOI 10.2460/ajvr.2001.62.1761; OGILVIE GK, 1993, CANCER, V71, P3146, DOI 10.1002/1097-0142(19930515)71:10<3146::AID-CNCR2820711041>3.0.CO;2-V; Ogilvie GK, 1996, AM J VET RES, V57, P1463; Owens SE, 1999, P 1999 PUR NUTR FOR, P112; Oxford Centre for Evidence-based Medicine, 2009, LEV EV; Patil AR, 2002, COMPEND CONTIN E S9A, V24, P81; Peachey SE, 1999, VET REC, V144, P420, DOI 10.1136/vr.144.15.420; Peachey SE, 2002, J NUTR, V132, p1735S, DOI 10.1093/jn/132.6.1735S; Peachey SE, 1999, GROWTH DEVELOP AGING, V63, P61; Perez-Camargo G, 2004, COMP CONT EDUC PRACT, P5; Phillips CJC, 2005, ANIM WELFARE, V14, P333; Poppitt SD, 1998, INT J OBESITY, V22, P303, DOI 10.1038/sj.ijo.0800584; Pouteau EB, 2002, AM J VET RES, V63, P111, DOI 10.2460/AJVR.2002.63.111; Rennie KL, 2007, BRIT J NUTR, V97, P1169, DOI 10.1017/S0007114507433086; Reynolds AJ, 1999, AM J VET RES, V60, P789; Rohlf VI, 2012, ANTHROZOOS, V25, P171, DOI 10.2752/175303712X13316289505341; Roudebush P, 2008, JAVMA-J AM VET MED A, V233, P717, DOI 10.2460/javma.233.5.717; Scientific Advisory Committee On Nutrition, 2011, REF VAL EN; Serisier S, 2013, J ANIM ANIMAL PHYSL, DOI 10.111/jpn.12044; Speakman JR, 2003, AGING CELL, V2, P265, DOI 10.1046/j.1474-9728.2003.00061.x; Sunvold GD, 2004, VET THER, V5, P82; Taylor EJ, 1995, P NUTR SOC, V54, P645, DOI 10.1079/PNS19950064; Teshima E, 2010, J ANIM PHYSIOL AN N, V94, pE251, DOI 10.1111/j.1439-0396.2009.00964.x; Thes M, 2013, P WALTHAM INT NUTR S, P107; WALTERS LM, 1993, AM J VET RES, V54, P1881; Weber MP, 2002, AM J VET RES, V63, P1323, DOI 10.2460/ajvr.2002.63.1323; Westerterp KR, 2002, CURR OPIN CLIN NUTR, V5, P489, DOI 10.1097/00075197-200209000-00006; Wrigglesworth DJ, 2011, AM J VET RES, V72, P1151, DOI 10.2460/ajvr.72.9.1151; Yoo S, 2006, J ANIM PHYSIOL AN N, V90, P185, DOI 10.1111/j.1439-0396.2005.00588.x	83	44	46	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109681	10.1371/journal.pone.0109681	http://dx.doi.org/10.1371/journal.pone.0109681			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313818	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500067
J	Sandoval, JR; Madsen, HO; De Stefano, G; Descailleaux-Dulanto, J; Velazquez-Reinoso, M; Nique, C; Fujita, R; Garred, P				Sandoval, Jose Raul; Madsen, Hans O.; De Stefano, Gianfranco; Descailleaux-Dulanto, Jaime; Velazquez-Reinoso, Margarita; Nique, Cesar; Fujita, Ricardo; Garred, Peter			Extreme High Prevalence of a Defective Mannose-Binding Lectin (MBL2) Genotype in Native South American West Andean Populations	PLOS ONE			English	Article							COMPLEMENT PATHWAY; PRISTINE MYTH; PROTEIN; SUSCEPTIBILITY; POLYMORPHISM; INFECTIONS; DEFICIENCY; INITIATION; MUTATIONS; EVOLUTION	Mannose-binding lectin (MBL) is one of the five recognition molecules in the lectin complement pathway. Common variant alleles in the promoter and structural regions of the human MBL gene (MBL2) influence the stability and serum concentration of the protein. Epidemiological studies have shown that MBL2 variant alleles are associated with susceptibility to and the course of different types of infectious and inflammatory conditions. However, it has been suggested that these alleles are maintained in different populations due to selected advantages for carriers. We investigated the MBL2 allelic variation in indigenous individuals from 12 different West Central South America localities spanning from the desert coast, high altitude Andean plates and the Amazon tropical forest within the territories of Peru (n = 249) (Departments of Loreto, Ucayali, Lambayeque, Junin, Ayacucho, Huancayo and Puno), and Ecuador (n = 182) (Region of Esmeraldas and Santo Domingo de los Colorados). The distribution of MBL2 genotypes among the populations showed that the defective variant LYPB haplotype was very common. It showed the highest frequencies in Puno (Taquile (0.80), Amantani (0.80) and Anapia (0.58) islander communities of the Lake Titicaca), but lower frequencies of 0.22 in Junin (Central Andean highland) and Ucayali (Central Amazonian forest), as well as 0.27 and 0.24 in the Congoma and Cayapa/Chachis populations in the Amazonian forest in Ecuador were also observed. Our results suggest that the high prevalence of the MBL2 LYPB variant causing low levels of functional MBL in serum may mainly reflect a random distribution due to a population bottleneck in the founder populations.	[Sandoval, Jose Raul; Fujita, Ricardo] Univ San Martin de Porres, Fac Med Humana, Ctr Genet & Biol Mol, Lima, Peru; [Madsen, Hans O.; Garred, Peter] Univ Copenhagen, Rigshosp, Mol Med Lab, Dept Clin Immunol,Sect 7631, DK-2100 Copenhagen, Denmark; [De Stefano, Gianfranco] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Descailleaux-Dulanto, Jaime; Velazquez-Reinoso, Margarita] Univ Nacl Mayor San Marcos, Fac Biol, Lab Genet Humana, Lima 14, Peru; [Nique, Cesar] Univ Catolica Santo Toribio de Mogrovejo, Fac Med Humana, Lambayeque, Peru	Universidad de San Martin de Porres; Rigshospitalet; University of Copenhagen; University of Rome Tor Vergata; Universidad Nacional Mayor de San Marcos	Garred, P (corresponding author), Univ San Martin de Porres, Fac Med Humana, Ctr Genet & Biol Mol, Lima, Peru.	garred@post5.tele.dk	Madsen, Hans O/Q-2035-2015	Madsen, Hans O/0000-0001-5551-4787; nique, cesar/0000-0002-9287-9387; Fujita, Ricardo/0000-0002-9617-5109; Sandoval, Jose/0000-0003-2673-4937; Garred, Peter/0000-0002-2876-8586	Novo Nordisk Research Foundation; Benzon Foundation; Danish Medical Research Council; Svend Andersen Research Foundation; Research Foundation of the Capital Region of Denmark; Rigshospitalet	Novo Nordisk Research Foundation(Novo Nordisk Foundation); Benzon Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Svend Andersen Research Foundation; Research Foundation of the Capital Region of Denmark; Rigshospitalet	This work was supported by The Novo Nordisk Research Foundation, The Benzon Foundation, the Danish Medical Research Council, The Svend Andersen Research Foundation, The Research Foundation of the Capital Region of Denmark and Rigshospitalet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AldenerCannava A, 1996, TISSUE ANTIGENS, V48, P153, DOI 10.1111/j.1399-0039.1996.tb02623.x; Bernig T, 2004, GENES IMMUN, V5, P461, DOI 10.1038/sj.gene.6364116; Boldt ABW, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-38; Denevan WM, 2011, GEOGR REV, V101, P576, DOI 10.1111/j.1931-0846.2011.00118.x; DENEVAN WM, 1992, ANN ASSOC AM GEOGR, V82, P369, DOI 10.1111/j.1467-8306.1992.tb01965.x; Eisen DP, 2003, CLIN INFECT DIS, V37, P1496, DOI 10.1086/379324; Espinoza-Avendano J, 1989, TAQUILE HIST EC ARTE, P148; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283; Garred P, 2003, J INFECT DIS, V188, P1394, DOI 10.1086/379044; Garred P, 2003, MOL IMMUNOL, V40, P73, DOI 10.1016/S0161-5890(03)00104-4; Garred P, 2003, INFECT IMMUN, V71, P5245, DOI 10.1128/IAI.71.9.5245-5253.2003; GARRED P, 1994, EUR J IMMUNOGENET, V21, P125, DOI 10.1111/j.1744-313X.1994.tb00183.x; GARRED P, 1992, EUR J IMMUNOGENET, V19, P403, DOI 10.1111/j.1744-313X.1992.tb00083.x; Garred P, 2010, J INNATE IMMUN, V2, P3, DOI 10.1159/000242419; Garred P, 2009, MOL IMMUNOL, V46, P2737, DOI 10.1016/j.molimm.2009.05.005; Gorsuch WB, 2012, IMMUNOBIOLOGY, V217, P1026, DOI 10.1016/j.imbio.2012.07.024; Jha AN, 2014, INFECT IMMUN, V82, P52, DOI 10.1128/IAI.01041-13; Jones DS, 2003, WILLIAM MARY QUART, V60, P703, DOI 10.2307/3491697; Koch A, 2001, JAMA-J AM MED ASSOC, V285, P1316, DOI 10.1001/jama.285.10.1316; Larsen F, 2004, J BIOL CHEM, V279, P21302, DOI 10.1074/jbc.M400520200; Lipscombe R. J., 1992, Human Molecular Genetics, V1, P709, DOI 10.1093/hmg/1.9.709; Ma YJ, 2013, J INNATE IMMUN, V5, P242, DOI 10.1159/000345356; Madsen HO, 1998, J IMMUNOL, V161, P3169; MADSEN HO, 1994, IMMUNOGENETICS, V40, P37, DOI 10.1007/BF00163962; Magner LN, 2005, HIST MED, P271; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; O'Fallon BD, 2011, P NATL ACAD SCI USA, V108, P20444, DOI 10.1073/pnas.1112563108; Ohlenschlaeger T, 2004, NEW ENGL J MED, V351, P260, DOI 10.1056/NEJMoa033122; Sandoval José, 2004, Rev. peru biol., V11, P161; Sandoval JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073006; Seyfarth J, 2005, HUM MOL GENET, V14, P2859, DOI 10.1093/hmg/ddi318; Verdu P, 2006, HUM MOL GENET, V15, P2650, DOI 10.1093/hmg/ddl193; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185	35	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e108943	10.1371/journal.pone.0108943	http://dx.doi.org/10.1371/journal.pone.0108943			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313559	Green Submitted, gold, Green Published			2022-12-27	WOS:000343662500020
J	Williams, DEJ; Wu, WL; Grotefend, CR; Radic, V; Chung, C; Chung, YH; Farzan, M; Huang, IC				Williams, David Evan Joseph; Wu, Wan-Lin; Grotefend, Christopher Robert; Radic, Vladimir; Chung, Changik; Chung, Young-Hwa; Farzan, Michael; Huang, I-Chueh			IFITM3 Polymorphism rs12252-C Restricts Influenza A Viruses	PLOS ONE			English	Article							DENGUE VIRUS; RECEPTOR; INFECTION; PROTEINS	IFITM3 The IFITM3 polymorphism rs12252-C, which encodes an IFITM3 isoform (Delta 21 IFITM3) lacking 21 amino acids at the amino terminus, has been controversially associated with poor clinical outcomes in patients with H1N1 influenza A virus (IAV) infections. In vitro studies have shown that Delta 21 IFITM3 loses its ability to restrict H1N1 IAV. Subsequent research has also revealed that tyrosine 20 is the key determinant for IFITM3 endocytic trafficking, which is essential for the efficient anti-viral activity of IFITM3. In contrast to previous studies, we demonstrated that both Delta 21 IFITM3 and an IFITM3 variant (Y20A IFITM3), in which tyrosine 20 is substituted with alanine, strongly restricted entry mediated by IAV H1, H3, H5, and H7 proteins. Delta 21 IFITM3 also efficiently suppressed replication of H1N1 and, to a lesser extent, H3N2 IAV. Delta 21 IFITM3 and Y20A IFITM3 had broader subcellular distributions than full-length IFITM3 but an abundant amount of both IFITM3 variants still localized to late endosomes and lysosomes. Our data indicate that tyrosine 20 partially regulates the subcellular localization of IFITM3 but is not functionally essential for IFITM3-mediated IAV restriction. They also suggested that mechanisms, other than viral entry restriction, might contribute to variations in clinical outcomes of H1N1 influenza associated with rs12252-C.	[Williams, David Evan Joseph; Wu, Wan-Lin; Grotefend, Christopher Robert; Radic, Vladimir; Huang, I-Chueh] Univ Calif Riverside, Dept Cell Biol & Neurosci, Coll Nat & Agr Sci, Riverside, CA 92521 USA; [Chung, Changik; Farzan, Michael] Scripps Res Inst, Dept Infect Dis, Jupiter, FL USA; [Chung, Young-Hwa] Pusan Natl Univ, Dept Cogno Mechatron Engn, BK21, Pusan, South Korea	University of California System; University of California Riverside; Scripps Research Institute; Pusan National University	Huang, IC (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Coll Nat & Agr Sci, Riverside, CA 92521 USA.	ichueh.huang@ucr.edu		Farzan, Michael/0000-0002-2990-5319	National Institutes of Health/National Institute of Allergy and Infectious Diseases [1R01AI100953-01A1, 5R00AI093679-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100953, R00AI093679] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is funded by National Institutes of Health/National Institute of Allergy and Infectious Diseases (1R01AI100953-01A1 and 5R00AI093679-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anafu AA, 2013, J BIOL CHEM, V288, P17261, DOI 10.1074/jbc.M112.438515; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Chen C, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00429.x; Chesarino NM, 2014, J BIOL CHEM; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Huang IC, 2008, J VIROL, V82, P4834, DOI 10.1128/JVI.00079-08; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Jia R., 2014, CELL MICROBIOL; Jia R, 2012, J VIROL, V86, P13697, DOI 10.1128/JVI.01828-12; John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13; Kuhn JH, 2006, J BIOL CHEM, V281, P15951, DOI 10.1074/jbc.M601796200; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Mills TC, 2014, J INFECT DIS, V209, P1028, DOI 10.1093/infdis/jit468; Mudhasani R, 2013, J VIROL, V87, P8451, DOI 10.1128/JVI.03382-12; Radoshitzky SR, 2007, NATURE, V446, P92, DOI 10.1038/nature05539; Wang ZF, 2014, P NATL ACAD SCI USA, V111, P769, DOI 10.1073/pnas.1321748111; Zhang YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2433	21	35	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110096	10.1371/journal.pone.0110096	http://dx.doi.org/10.1371/journal.pone.0110096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314048	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500096
J	Houghton, LC; Cooper, GD; Booth, M; Chowdhury, OA; Troisi, R; Ziegler, RG; Katki, HA; Hoover, RN; Bentley, GR				Houghton, Lauren C.; Cooper, Gillian D.; Booth, Mark; Chowdhury, Osul A.; Troisi, Rebecca; Ziegler, Regina G.; Katki, Hormuzd A.; Hoover, Robert N.; Bentley, Gillian R.			Childhood Environment Influences Adrenarcheal Timing among First-Generation Bangladeshi Migrant Girls to the UK	PLOS ONE			English	Article							ADRENAL ANDROGEN EXCRETION; FOR-GESTATIONAL-AGE; PREMATURE ADRENARCHE; BIRTH-WEIGHT; BODY-MASS; PUBERTAL DEVELOPMENT; PRECOCIOUS PUBERTY; NUTRITIONAL-STATUS; METABOLIC SYNDROME; UNITED-KINGDOM	Background: Adrenarche is a key early life event that marks middle childhood at approximately 7 years of age. Earlier work with British-Bangladeshi migrant women suggested that environmental conditions experienced before adrenarche influence adult reproductive function. We therefore investigated whether Bangladeshi children who migrate to the United Kingdom (UK) reach adrenarche earlier than non-migrants in Bangladesh or the United Kingdom. Methods and Findings: Healthy girls, aged 5-16 years, were recruited from schools in Sylhet, Bangladesh and London, England comprising four groups: Sylhetis (n = 165), first-generation migrants to the United Kingdom (n = 42), second-generation girls (n = 162), and British girls of European origin (n = 50). Anthropometric measurements were collected together with questionnaire data for migration and socioeconomic characteristics. Saliva samples were assayed for dehydroepiandrosterone (DHEAS) using enzyme-linked immunosorbent assays. Multiple linear regressions tested for group differences in anthropometric and socioeconomic variables and DHEAS levels. Median ages at adrenarche (DHEAS>400 pg/ml) were estimated using Weibull regression models for parametric survival analysis. Hazard ratios for reaching adrenarche earlier and 95% confidence intervals (CI), both unadjusted and adjusted for anthropometric variables, were estimated from the survival analyses. First-generation migrants had a median age at adrenarche (5.3 years) that was significantly earlier than Sylheti (7.2), second-generation (7.4), and European (7.1) girls. In univariate analyses, first-generation girls reached adrenarche significantly earlier than Sylhetis [HR (CI): 2.8 (1.4-5.5]. In multivariate models, first generation girls still reached adrenarche earlier than Sylhetis after adjusting for height [HR(CI): 1.9 (0.9-4.1)] and weight [HR(CI): 1.7 (0.8-3.8)], but these results were attenuated. Conclusions: We suggest that rapid catch-up growth experienced by first generation girls during early childhood may explain their advanced adrenarche. The environmental conditions leading to an earlier adrenarche, as well as the health implications of this early transition, merit further exploration.	[Houghton, Lauren C.; Troisi, Rebecca; Ziegler, Regina G.; Katki, Hormuzd A.; Hoover, Robert N.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Houghton, Lauren C.; Cooper, Gillian D.; Bentley, Gillian R.] Univ Durham, Dept Anthropol, Durham, England; [Houghton, Lauren C.; Cooper, Gillian D.; Bentley, Gillian R.] Univ Durham, Wolfson Res Inst Hlth & Wellbeing, Durham, England; [Booth, Mark] Univ Durham, Sch Med Pharm & Hlth, Durham, England; [Chowdhury, Osul A.] Sylhet MAG Osmani Med Coll, Sylhet, Bangladesh	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Durham University; Durham University; Durham University; Sylhet MAG Osmani Medical College	Houghton, LC (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	houghtonlc@mail.nih.gov	Booth, Mark/D-2266-2011; Katki, Hormuzd A/B-4003-2015; Houghton, Lauren C./ABC-8638-2021	Booth, Mark/0000-0002-5507-888X; Houghton, Lauren C./0000-0002-1432-1580	intramural division of the U.S. National Cancer Institute (NCI) at the National Institutes of Health; Wellcome Trust	intramural division of the U.S. National Cancer Institute (NCI) at the National Institutes of Health; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the intramural division of the U.S. National Cancer Institute (NCI) at the National Institutes of Health and the Wellcome Trust. Intramural investigators at the NCI designed and assisted in the analysis of the study. The Wellcome Trust had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLFSSON S, 1981, PEDIATR RES, V15, P82, DOI 10.1203/00006450-198101000-00068; Allahbadia Gautam N, 2008, Semin Reprod Med, V26, P22, DOI 10.1055/s-2007-992921; Amin M R, 1991, Indian J Pediatr, V58, P209, DOI 10.1007/BF02751122; Bansal N, 2008, J HYPERTENS, V26, P412, DOI 10.1097/HJH.0b013e3282f3168e; Begum K, FERTILITY STERILITY; Begum K, 2011, ENV EFFECTS OVARIAN; Belgorosky A, 2008, HORM RES, V70, P257, DOI 10.1159/000157871; Belgorosky A, 2009, REV ENDOCR METAB DIS, V10, P51, DOI 10.1007/s11154-008-9105-1; Bellary S, 2010, CURR MED RES OPIN, V26, P1873, DOI 10.1185/03007995.2010.490468; Biason-Lauber A, 2000, ENDOCRINOLOGY, V141, P1446, DOI 10.1210/en.141.4.1446; Bogin B, 2001, GROWTH HUMANITY; Campbell B, 2006, AM J HUM BIOL, V18, P569, DOI 10.1002/ajhb.20528; Campbell B, 2011, AM J HUM BIOL, V23, P44, DOI 10.1002/ajhb.21111; Campbell BC, 2011, HUM NATURE-INT BIOS, V22, P327, DOI 10.1007/s12110-011-9120-x; Cizza G, 2001, HORM METAB RES, V33, P138, DOI 10.1055/s-2001-14927; Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; Cooper C, 1996, BRIT J OBSTET GYNAEC, V103, P814, DOI 10.1111/j.1471-0528.1996.tb09879.x; Corvalan C, 2013, AM J CLIN NUTR, V97, P318, DOI 10.3945/ajcn.112.037325; Dhar B, 2002, J HEALTH POPUL NUTR, V20, P36; DHOM G, 1973, BEITR PATHOL, V150, P357; Domine F, 2006, EUR J ENDOCRINOL, V155, pS17, DOI 10.1530/eje.1.02252; Duggan MB, 1996, BRIT J NUTR, V76, P183, DOI 10.1079/BJN19960024; Gardner K., 1994, DESH PARDESH S ASIAN; Garnier D, 2005, AM J HUM BIOL, V17, P718, DOI 10.1002/ajhb.20435; GRUMBACH MM, 1980, HOSP PRACT, V15, P51, DOI 10.1080/21548331.1980.11946569; Harding S, 2004, INT J EPIDEMIOL, V33, P1279, DOI 10.1093/ije/dyh186; Havelock JC, 2004, SEMIN REPROD MED, V22, P337, DOI 10.1055/s-2004-861550; Hochberg Z, 2008, ARCH DIS CHILD, V93, P534, DOI 10.1136/adc.2008.137570; Houghton LC, 2013, JUVENILITY PUBERTY A; Huen KF, 1997, ACTA PAEDIATR, V86, P1121, DOI 10.1111/j.1651-2227.1997.tb14820.x; IBANEZ L, 1993, J CLIN ENDOCR METAB, V76, P1599, DOI 10.1210/jc.76.6.1599; Ibanez L, 1997, J CLIN ENDOCR METAB, V82, P2283, DOI 10.1210/jc.82.7.2283; Ibanez L, 2000, ENDOCR REV, V21, P671, DOI 10.1210/er.21.6.671; Idkowiak J, 2011, EUR J ENDOCRINOL, V165, P189, DOI 10.1530/EJE-11-0223; Hernandez MI, 2011, ARQ BRAS ENDOCRINOL, V55, P583, DOI 10.1590/S0004-27302011000800012; Islam A K M Monwarul, 2013, Indian Heart J, V65, P424, DOI 10.1016/j.ihj.2013.06.004; Jesmin S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-49; Juul A, 2006, INT J ANDROL, V29, P247, DOI 10.1111/j.1365-2605.2005.00556.x; Kelly AM, 1997, ARCH DIS CHILD, V77, P401, DOI 10.1136/adc.77.5.401; l'Allemand D, 2002, EUR J ENDOCRINOL, V146, P537, DOI 10.1530/eje.0.1460537; LAC G, 1993, ARCH INT PHYSIOL BIO, V101, P257, DOI 10.3109/13813459309003921; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Longo S, 2013, J MATERN-FETAL NEO M, V26, P222, DOI 10.3109/14767058.2012.715006; Magid KS, 2011, REPROD ECOLOGY LIFE; Mahachoklertwattana Pat, 2002, Journal of the Medical Association of Thailand, V85, pS1127; Margetts BM, 2002, J EPIDEMIOL COMMUN H, V56, P684, DOI 10.1136/jech.56.9.684; Martin DD, 2004, J CLIN ENDOCR METAB, V89, P1164, DOI 10.1210/jc.2003-031700; Mayhew L, 2010, COUNTING POPULATION; Murphy L, 2013, AM J HUM BIOL, V25, P83, DOI 10.1002/ajhb.22345; Nunez-De la Mora A, 2004, AM J HUM BIOL, V16, P216; Nunez-de la Mora A, 2008, HLTH RISK ADVERSITY, P129; Nunez-de la Mora A, 2007, PLOS MED, V4, P813, DOI 10.1371/journal.pmed.0040167; Ong KK, 2004, J CLIN ENDOCR METAB, V89, P2647, DOI 10.1210/jc.2003-031848; Palmert MR, 2001, J CLIN ENDOCR METAB, V86, P4536, DOI 10.1210/jc.86.9.4536; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; PRATT JH, 1994, METABOLISM, V43, P186, DOI 10.1016/0026-0495(94)90243-7; PRATT JH, 1990, HYPERTENSION, V16, P462, DOI 10.1161/01.HYP.16.4.462; PROKOPEC M, 1993, ANN HUM BIOL, V20, P517, DOI 10.1080/03014469300002922; Proos L A, 1991, Indian J Pediatr, V58, P105, DOI 10.1007/BF02810420; PROOS LA, 1991, ACTA PAEDIATR SCAND, V80, P852, DOI 10.1111/j.1651-2227.1991.tb11960.x; Proos L, 2012, INT J ENV RES PUB HE, V9, P1791, DOI 10.3390/ijerph9051791; Remer T, 1999, J CLIN ENDOCR METAB, V84, P3936, DOI 10.1210/jc.84.11.3936; Rolland-Cachera MF, 2006, INT J OBESITY, V30, pS11, DOI 10.1038/sj.ijo.0803514; Rolland-Cachera MF, 1999, ACTA PAEDIATR, V88, P365, DOI 10.1080/08035259950169701; ROLLANDCACHERA MF, 1984, AM J CLIN NUTR, V39, P129, DOI 10.1093/ajcn/39.1.129; SAENGER P, 1992, J CLIN ENDOCR METAB, V74, P236, DOI 10.1210/jc.74.2.236; Shalitin S, 2003, INT J OBESITY, V27, P869, DOI 10.1038/sj.ijo.0802328; Shams M, 1997, J BIOSOC SCI, V29, P101, DOI 10.1017/S0021932097001016; Shaw NJ, 2007, ARCH DIS CHILD, V92, P872, DOI 10.1136/adc.2007.117911; SIERVOGEL RM, 1991, INT J OBESITY, V15, P479; SKLAR CA, 1980, J CLIN ENDOCR METAB, V51, P548, DOI 10.1210/jcem-51-3-548; Stanfield KM, 2012, INT J EPIDEMIOL, V41, P1409, DOI 10.1093/ije/dys139; Suzuki T, 2000, CLIN ENDOCRINOL, V53, P739, DOI 10.1046/j.1365-2265.2000.01144.x; TANNER JM, 1968, J ENDOCRINOL, V41, P139, DOI 10.1677/joe.0.0410139; Teilmann G, 2007, J CLIN ENDOCR METAB, V92, P2538, DOI 10.1210/jc.2006-2096; [UNICEF BBoS Planning Division MoP], 2005, NAT LOW BIRTH WEIGHT; Verkauskiene R, 2013, HORM RES PAEDIAT, V80, P69, DOI 10.1159/000353759; Virdis R, 1998, ARCH DIS CHILD, V78, P152, DOI 10.1136/adc.78.2.152; Whitaker RC, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.3.e5; WIERMAN ME, 1986, J CLIN INVEST, V77, P121, DOI 10.1172/JCI112265; Wijeyaratne CN, 2002, CLIN ENDOCRINOL, V57, P343, DOI 10.1046/j.1365-2265.2002.01603.x; Worthman CM, 1999, EVOLUTIONARY MEDICI NE, P135; Yasmeen S, 2011, S E ASIA J PUBLIC HL, V1	83	16	16	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109200	10.1371/journal.pone.0109200	http://dx.doi.org/10.1371/journal.pone.0109200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25309977	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000343210300041
J	Laczka, OF; Labbate, M; Seymour, JR; Bourne, DG; Fielder, SS; Doblin, MA				Laczka, Olivier F.; Labbate, Maurizio; Seymour, Justin R.; Bourne, David G.; Fielder, Stewart S.; Doblin, Martina A.			Surface Immuno-Functionalisation for the Capture and Detection of Vibrio Species in the Marine Environment: A New Management Tool for Industrial Facilities	PLOS ONE			English	Article							PARAHAEMOLYTICUS; BACTERIA; VULNIFICUS; AVIDIN; ASSAY	Bacteria from the genus Vibrio are a common and environmentally important group of bacteria within coastal environments and include species pathogenic to aquaculture organisms. Their distribution and abundance are linked to specific environmental parameters, including temperature, salinity and nutrient enrichment. Accurate and efficient detection of Vibrios in environmental samples provides a potential important indicator of overall ecosystem health while also allowing rapid management responses for species pathogenic to humans or species implicated in disease of economically important aquacultured fish and invertebrates. In this study, we developed a surface immuno-functionalisation protocol, based on an avidin-biotin type covalent binding strategy, allowing specific sandwich-type detection of bacteria from the Vibrio genus. The assay was optimized on 12 diverse Vibrio strains, including species that have implications for aquaculture industries, reaching detection limits between 7x10(3) to 3x10(4) cells mL(-1). Current techniques for the detection of total Vibrios rely on laborious or inefficient analyses resulting in delayed management decisions. This work represents a novel approach for a rapid, accurate, sensitive and robust tool for quantifying Vibrios directly in industrial systems and in the environment, thereby facilitating rapid management responses.	[Laczka, Olivier F.; Seymour, Justin R.; Doblin, Martina A.] Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster C3, Sydney, NSW 2007, Australia; [Labbate, Maurizio] Univ Technol Sydney, Ithree Inst, Sydney, NSW 2007, Australia; [Bourne, David G.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Fielder, Stewart S.] New South Wales Dept Primary Ind, Port Stephens Fisheries Inst, Taylors Beach, NSW, Australia	University of Technology Sydney; University of Technology Sydney; Australian Institute of Marine Science; NSW Department of Primary Industries	Laczka, OF (corresponding author), Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster C3, Sydney, NSW 2007, Australia.	Olivier.Laczka@uts.edu.au	laczka, olivier/I-3817-2012; Doblin, Martina A/E-8719-2013; Bourne, David G/B-5073-2008; Doblin, Martina/L-1804-2019; Fielder, Donald/K-7911-2017	Doblin, Martina A/0000-0001-8750-3433; Bourne, David G/0000-0002-1492-8710; Doblin, Martina/0000-0001-8750-3433; laczka, olivier/0000-0003-0966-9897; Seymour, Justin/0000-0002-3745-6541; Labbate, Maurizio/0000-0003-1428-3382; Fielder, Donald/0000-0002-4519-2769	UTS chancellor's postdoctoral fellowship [2012000115]; Transfield foundation	UTS chancellor's postdoctoral fellowship; Transfield foundation	These 2 sources of funding have supported this work: 1. UTS chancellor's postdoctoral fellowship (grant number: 2012000115) and 2. The Transfield foundation (http://www.transfieldfoundation.org/index.php/grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker D., 2002, GUIDE ACCEPTABLE PRO; Boucher Y, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-3; Buchatipa S, 2009, SENSOR ACTUAT B-CHEM, V145, P259; Chatterjee S., 2012, J MAR SCI RES DEV, V1, P1, DOI DOI 10.4172/2155-9910.S1-002; Eilers H, 2000, APPL ENVIRON MICROB, V66, P4634, DOI 10.1128/AEM.66.11.4634-4640.2000; Elston RA, 2008, DIS AQUAT ORGAN, V82, P119, DOI 10.3354/dao01982; Fielder DS., 2011, HATCHERY MANUAL PROD; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; Islam A, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120181; Jones JL, 2012, FOOD MICROBIOL, V30, P105, DOI 10.1016/j.fm.2011.12.011; Jyoung JY, 2006, BIOSENS BIOELECTRON, V21, P2315, DOI 10.1016/j.bios.2005.10.015; Kimes NE, 2012, ISME J, V6, P835, DOI 10.1038/ismej.2011.154; Laczka O, 2008, ANAL BIOANAL CHEM, V391, P2825, DOI 10.1007/s00216-008-2199-1; Laczka O, 2014, ANAL METHODS-UK, V6, P2020, DOI 10.1039/c3ay42169d; Leyton Y, 2008, REV BIOL MAR OCEANOG, V43, P441; Morris JG, 2003, CLIN INFECT DIS, V37, P272, DOI 10.1086/375600; Niemi G, 2004, ENVIRON HEALTH PERSP, V112, P979, DOI 10.1289/ehp.6903; Nogales B, 2011, FEMS MICROBIOL REV, V35, P275, DOI 10.1111/j.1574-6976.2010.00248.x; Nordstrom JL, 2007, APPL ENVIRON MICROB, V73, P5840, DOI 10.1128/AEM.00460-07; Oberbeckmann S, 2011, FEMS MICROBIOL ECOL, V75, P145, DOI 10.1111/j.1574-6941.2010.00998.x; Oliver JD, 2005, EPIDEMIOL INFECT, V133, P383, DOI 10.1017/S0950268805003894; Percival SL., 2004, MICROBIOLOGY WATERBO; Pfeffer C, 2003, LETT APPL MICROBIOL, V36, P150, DOI 10.1046/j.1472-765X.2003.01280.x; Pfeffer CS, 2003, APPL ENVIRON MICROB, V69, P3526, DOI 10.1128/AEM.69.6.3526-3531.2003; Polysciences Inc, 2008, BEN NEUTR STREPT AV; Porter James W., 2008, P387; Ralston EP, 2011, J WATER HEALTH, V9, P680, DOI 10.2166/wh.2011.157; Rao VK, 2006, ANAL SCI, V22, P1207, DOI 10.2116/analsci.22.1207; Sainz-Hernandez JC, 2005, AQUAC RES, V36, P1611, DOI 10.1111/j.1365-2109.2005.01386.x; Senderovich Y, 2012, PLOS ONE, V5; Sherman K., 2009, SUSTAINING WORLDS LA; Subasinghe R.P., 2001, TECHN P C AQ 3 MILL, V167, P191; Thompson CC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-258; Traore SG, 2012, J FOOD PROTECT, V75, P1004, DOI 10.4315/0362-028X.JFP-11-472; Vezzulli L, 2012, ISME J, V6, P21, DOI 10.1038/ismej.2011.89; WOOD GS, 1981, J HISTOCHEM CYTOCHEM, V29, P1196, DOI 10.1177/29.10.7028859; Yu WT, 2013, INT J FOOD MICROBIOL, V160, P185, DOI 10.1016/j.ijfoodmicro.2012.11.002; Zhao XH, 2010, FOOD SCI BIOTECHNOL, V19, P1191, DOI 10.1007/s10068-010-0170-3	39	7	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e108387	10.1371/journal.pone.0108387	http://dx.doi.org/10.1371/journal.pone.0108387			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310801	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000343210300016
J	Vaicik, MK; Kortesmaa, JT; Moverare-Skrtic, S; Kortesmaa, J; Soininen, R; Bergstrom, G; Ohlsson, C; Chong, LY; Rozell, B; Emont, M; Cohen, RN; Brey, EM; Tryggvason, K				Vaicik, Marcella K.; Kortesmaa, Jill Thyboll; Moverare-Skrtic, Sofia; Kortesmaa, Jarkko; Soininen, Raija; Bergstrom, Goran; Ohlsson, Claes; Chong, Li Yen; Rozell, Bjorn; Emont, Margo; Cohen, Ronald N.; Brey, Eric M.; Tryggvason, Karl			Laminin alpha 4 Deficient Mice Exhibit Decreased Capacity for Adipose Tissue Expansion and Weight Gain	PLOS ONE			English	Article							BASEMENT-MEMBRANE; SKELETAL-MUSCLE; EXPRESSION; CHAINS; ADULT; DIFFERENTIATION; IDENTIFICATION; ADIPOGENESIS; PROTEINS; CLONING	Obesity is a global epidemic that contributes to the increasing medical burdens related to type 2 diabetes, cardiovascular disease and cancer. A better understanding of the mechanisms regulating adipose tissue expansion could lead to therapeutics that eliminate or reduce obesity-associated morbidity and mortality. The extracellular matrix (ECM) has been shown to regulate the development and function of numerous tissues and organs. However, there is little understanding of its function in adipose tissue. In this manuscript we describe the role of laminin alpha 4, a specialized ECM protein surrounding adipocytes, on weight gain and adipose tissue function. Adipose tissue accumulation, lipogenesis, and structure were examined in mice with a null mutation of the laminin alpha 4 gene (Lama4(+/+)) and compared to wild-type (Lama4(+/+)) control animals. Lama4(-/-) mice exhibited reduced weight gain in response to both age and high fat diet. Interestingly, the mice had decreased adipose tissue mass and altered lipogenesis in a depot-specific manner. In particular, epididymal adipose tissue mass was specifically decreased in knock-out mice, and there was also a defect in lipogenesis in this depot as well. In contrast, no such differences were observed in subcutaneous adipose tissue at 14 weeks. The results suggest that laminin alpha 4 influences adipose tissue structure and function in a depot-specific manner. Alterations in laminin composition offers insight into the roll the ECM potentially plays in modulating cellular behavior in adipose tissue expansion.	[Vaicik, Marcella K.; Brey, Eric M.] IIT, Dept Biomed Engn, Chicago, IL 60616 USA; [Kortesmaa, Jill Thyboll; Kortesmaa, Jarkko; Soininen, Raija; Tryggvason, Karl] Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, Stockholm, Sweden; [Moverare-Skrtic, Sofia; Ohlsson, Claes] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, Gothenburg, Sweden; [Bergstrom, Goran] Sahlgrens Univ Hosp, Dept Mol & Clin Med, Gothenburg, Sweden; [Chong, Li Yen; Tryggvason, Karl] Duke NUS Grad Med Sch, Cardiovasc & Metab Disorders Program, Singapore, Singapore; [Rozell, Bjorn] Huddinge Univ Hosp, Karolinska Inst, Dept Immunol Microbiol Pathol & Infect Dis, Clin Res Ctr, Stockholm, Sweden; [Rozell, Bjorn] Huddinge Univ Hosp, Karolinska Inst, Dept Immunol Microbiol Pathol & Infect Dis, Div Pathol, Stockholm, Sweden; [Emont, Margo; Cohen, Ronald N.] Univ Chicago, Dept Med, Endocrinol Sect, Chicago, IL 60637 USA; [Brey, Eric M.] Hines Vet Affairs Hosp, Res Serv, Hines, IL USA	Illinois Institute of Technology; Karolinska Institutet; University of Gothenburg; Sahlgrenska University Hospital; National University of Singapore; Karolinska Institutet; Karolinska Institutet; University of Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Brey, EM (corresponding author), IIT, Dept Biomed Engn, Chicago, IL 60616 USA.	brey@iit.edu	Vaicik, Marcella/AAC-7347-2020; Skrtic, Sofia/AAQ-1585-2020; Vaicik, Marcella/AAA-3052-2019; Ohlsson, Claes/AGP-3544-2022	Vaicik, Marcella/0000-0002-1679-1690; Ohlsson, Claes/0000-0002-9633-2805; Bergstrom, Goran/0000-0003-4289-5722; Emont, Margo/0000-0001-9873-2784	University of Chicago Diabetes Research and Training Center (DRTC) Pilot and Feasibility Grant Program DRTC grant [P30 DK020595]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF14OC0010513, NNF13OC0005785] Funding Source: researchfish	University of Chicago Diabetes Research and Training Center (DRTC) Pilot and Feasibility Grant Program DRTC grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Novo Nordisk Fonden(Novo Nordisk Foundation)	Funding support from University of Chicago Diabetes Research and Training Center (DRTC) Pilot and Feasibility Grant Program DRTC grant P30 DK020595. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abberton KM, 2008, CELLS TISSUES ORGANS, V188; ARATANI Y, 1988, J BIOL CHEM, V263, P16163; Aumailley M, 1998, J MOL MED-JMM, V76, P253, DOI 10.1007/s001090050215; Chavey C, 2003, J BIOL CHEM, V278; De Luca M, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-52; Domogatskaya A, 2012, ANNU REV CELL DEV BI, V28, P523, DOI 10.1146/annurev-cellbio-101011-155750; Frayn KN, 2000, BRIT J NUTR, V83, pS71, DOI 10.1017/S0007114500000982; Frieser M, 1997, EUR J BIOCHEM, V246, P727, DOI 10.1111/j.1432-1033.1997.t01-1-00727.x; Geberhiwot T, 1999, EXP CELL RES, V253, P723, DOI 10.1006/excr.1999.4653; Gu YC, 1999, BLOOD, V93, P2533, DOI 10.1182/blood.V93.8.2533.408k22_2533_2542; Hausman GJ, 1996, J ANIM SCI, V74; Kalluri R, 2003, NATURE REV CANC, V3; Kawaguchi N, 1998, P NATL ACAD SCI USA, V95, P1062, DOI 10.1073/pnas.95.3.1062; Kawaguchi N, 1999, CYTOTECHNOLOGY, V31, P215, DOI 10.1023/A:1008198731341; Kortesmaa J, 2002, MATRIX BIOL, V21, P483, DOI 10.1016/S0945-053X(02)00052-5; Kubo Y, 2000, IN VITRO CELL DEV, V36; Lefebvre O, 1999, DEV BIOL, V210, P135, DOI 10.1006/dbio.1999.9270; LIN CQ, 1993, FASEB J, V7, P737, DOI 10.1096/fasebj.7.9.8330681; Mariman ECM, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0399-1; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Neel BA, 2013, MOL ENDOCRINOL, V27, P394, DOI 10.1210/me.2012-1270; Nie J, 2009, J BIOL CHEM, V284, P1279, DOI 10.1074/jbc.M808285200; Niimi T, 1997, MATRIX BIOL, V16, P223, DOI 10.1016/S0945-053X(97)90011-1; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; PAULSSON M, 1992, CRIT REV BIOCHEM MOL, V27, P93; Petajaniemi N, 2002, J HISTOCHEM CYTOCHEM, V50, P1113, DOI 10.1177/002215540205000813; Ringelmann B, 1999, EXP CELL RES, V246, P165, DOI 10.1006/excr.1998.4244; Sasaki T, 2001, FEBS LETT, V505, P173, DOI 10.1016/S0014-5793(01)02812-5; Shoham N, 2012, J BIOMECH, V45; Shoham N, 2012, AM J PHYSIOL-CELL PH, V302, pC429, DOI 10.1152/ajpcell.00167.2011; Sorokin LM, 2000, EXP CELL RES, V256, P500, DOI 10.1006/excr.2000.4842; Sorokin LM, 1997, DEV DYNAM, V210, P446, DOI 10.1002/(SICI)1097-0177(199712)210:4<446::AID-AJA8>3.0.CO;2-G; Stewart ST, 2009, NEW ENGL J MED, V361, P2252, DOI 10.1056/NEJMsa0900459; Thyboll J, 2002, MOL CELL BIOL, V22, P1194, DOI 10.1128/MCB.22.4.1194-1202.2002; Uriel S, 2008, BIOMATERIALS, V29, P3712, DOI 10.1016/j.biomaterials.2008.05.028; Uriel S, 2009, TISSUE ENG PART C-ME, V15, P309, DOI 10.1089/ten.tec.2008.0309	37	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109854	10.1371/journal.pone.0109854	http://dx.doi.org/10.1371/journal.pone.0109854			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310607	gold, Green Submitted, Green Published			2022-12-27	WOS:000343210300078
J	Carvalho, N; Thacker, N; Gupta, SS; Salomon, JA				Carvalho, Natalie; Thacker, Naveen; Gupta, Subodh S.; Salomon, Joshua A.			More Evidence on the Impact of India's Conditional Cash Transfer Program, Janani Suraksha Yojana: Quasi-Experimental Evaluation of the Effects on Childhood Immunization and Other Reproductive and Child Health Outcomes	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; MORTALITY	Background: In 2005, India established a conditional cash transfer program called Janani Suraksha Yojana (JSY), to increase institutional delivery and encourage the use of reproductive and child health-related services. Objective: To assess the effect of maternal receipt of financial assistance from JSY on childhood immunizations, postpartum care, breastfeeding practices, and care-seeking behaviors. Methods: We use data from the latest district-level household survey (2007-2008) to conduct a propensity score matching analysis with logistic regression. We conduct the analyses at the national level as well as separately across groups of states classified as high-focus and non-high-focus. We carry out several sensitivity analyses including a subgroup analysis stratified by possession of an immunization card. Results: Receipt of financial assistance from JSY led to an increase in immunization rates ranging from 3.1 (95% CI 2.2-4.0) percentage points for one dose of polio vaccine to 9.1 (95% CI 7.5-10.7) percentage points in the proportion of fully vaccinated children. Our findings also indicate JSY led to increased post-partum check-up rates and healthy early breastfeeding practices around the time of childbirth. No effect of JSY was found on exclusive breastfeeding practices and care-seeking behaviors. Effect sizes were consistently larger in states identified as being a key focus for the program. In an analysis stratified by possession of an immunization card, there was little to no effect of JSY among those with vaccination cards, while the effect size was much larger than the base case results for those missing vaccination cards, across nearly all immunization outcomes. Conclusions: Early results suggest the JSY program led to a significant increase in childhood immunization rates and some healthy reproductive health behaviors, but the structuring of financial incentives to pregnant women and health workers warrants further review. Causal interpretation of our results relies on the assumption that propensity scores balance unobservable characteristics.	[Carvalho, Natalie] Melbourne Sch Populat & Global Hlth, Global Burden Dis Grp, Melbourne, Australia; [Carvalho, Natalie] Melbourne Sch Populat & Global Hlth, Ctr Hlth Policy, Melbourne, Australia; [Carvalho, Natalie; Salomon, Joshua A.] Harvard Univ, Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA 02115 USA; [Thacker, Naveen] Deep Children Hosp & Res Ctr, Gandhidham, Gujarat, India; [Gupta, Subodh S.] Mahatma Gandhi Inst Med Sci, Dept Community Med, Sevagram, Maharashtra, India; [Salomon, Joshua A.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Mahatma Gandhi Institute of Medical Sciences, Sevagram; Harvard University; Harvard T.H. Chan School of Public Health	Carvalho, N (corresponding author), Melbourne Sch Populat & Global Hlth, Global Burden Dis Grp, Melbourne, Australia.	natalie.carvalho@unimelb.edu.au	Gupta, Subodh S/K-4066-2014; Salomon, Joshua/S-1929-2019; Salomon, Joshua A/D-3898-2009; Carvalho, Natalie/AAD-4321-2022	Gupta, Subodh S/0000-0002-4412-9389; Salomon, Joshua/0000-0003-3929-5515; Salomon, Joshua A/0000-0003-3929-5515; Carvalho, Natalie/0000-0002-5599-2209	Harvard University Graduate Society Dissertation Completion Fellowship	Harvard University Graduate Society Dissertation Completion Fellowship	Natalie Carvalho was supported by the Harvard University Graduate Society Dissertation Completion Fellowship from September 2011 to May 2012. No other sources of funding were received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, Wkly Epidemiol Rec, V86, P509; [Anonymous], 2011, WORLD POP PROSP 2010; Arokiasamy P, 2011, HEALTH POLICY PLANN, V26, P429, DOI 10.1093/heapol/czq075; Banerjee AV, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2220; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; DEVADASAN N, 2008, STUDIES HLTH SERVICE, V24, P257; Gelman A, 2007, STAT SCI, V22, P153, DOI 10.1214/088342306000000691; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; India Ministry of Health and Family Welfare, 2013, IND MIN HLTH FAM WEL; India Ministry of Health and Family Welfare, 2006, JAN SUR YOJ FEAT FRE; India Ministry of Health and Family Welfare, 2013, ASHA ACCR SOC HLTH A; India Ministry of Health and Family Welfare, 2011, IND MIN HLTH FAM WEL; India Ministry of Health and Family Welfare, 2013, IND MIN HLTH FAM WEL; India Ministry of Health and Family Welfare, 2014, JAN SHISH SUR KAR BA; India Ministry of Health and Family Welfare, 2005, IND UN IMM PROGR REV; India Ministry of Health and Family Welfare, 2008, IMM HDB MED OFF; India Ministry of Health and Family Welfare, 2011, HOM BAS NEWB CAR OP; India Ministry of Health and Family Welfare, 2011, PROGR EV JAN SUR YOJ; India Ministry of Health and Family Welfare, 2011, HOM DEL CONTR COND O; India Ministry of Health and Family Welfare, 2011, NAT VACC POL; India Office of the Registrar General and Census Commissioner, 2014, SRS B YEARS 2008 200; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; Khan ME, 2010, J FAMILY WELFARE, V56; Lagarde M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008137; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Lim SS, 2008, LANCET, V372, P2031, DOI 10.1016/S0140-6736(08)61869-3; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Mazumdar S, 2011, FINANCIAL INCENTIVES; Planning Commission of India, 2011, REP WORK GROUP NAT R; Prinja S, 2010, B WORLD HEALTH ORGAN, V88, P97, DOI 10.2471/BLT.08.059543; Rainey JJ, 2009, B WORLD HEALTH ORGAN, V87, P955, DOI 10.2471/BLT.08.061556; Rajan VS, 2011, INDIA REPROD CHILD H; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Reddy Hanimi, 2012, WHO South East Asia J Public Health, V1, P279, DOI 10.4103/2224-3151.207024; Results-Based Financing for Health, 2012, BRED C IND JAN SUR Y; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Satapathy Dm, 2009, Indian J Community Med, V34, P351, DOI 10.4103/0970-0218.58398; Shukla S, 2012, LANCET, V379, P698, DOI 10.1016/S0140-6736(12)60293-1; Sidney K, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-2; *UNFPA, 2007, ASS ASHA JAN SUR YOJ; UNFPA, 2009, CONC ASS JAN SUR YOJ; Vora KS, 2009, J HEALTH POPUL NUTR, V27, P184, DOI 10.3329/jhpn.v27i2.3363	43	37	37	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109311	10.1371/journal.pone.0109311	http://dx.doi.org/10.1371/journal.pone.0109311			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6ZS	25303078	Green Published, gold			2022-12-27	WOS:000343730400050
J	Chan, LS; Moshkanbaryans, L; Xue, J; Graham, ME				Chan, Ling-Shan; Moshkanbaryans, Lia; Xue, Jing; Graham, Mark E.			The similar to 16 kDa C-Terminal Sequence of Clathrin Assembly Protein AP180 Is Essential for Efficient Clathrin Binding	PLOS ONE			English	Article							SYNAPTIC-VESICLE ENDOCYTOSIS; GENOME-WIDE ASSOCIATION; MYELOID-LEUKEMIA CALM; NUCLEAR EXPORT SIGNAL; COATED VESICLES; APPENDAGE DOMAIN; AP2; MODEL; GENE; AP-3	Brain-specific AP180 is present in clathrin coats at equal concentration to the adapter complex, AP2, and assembles clathrin faster than any other protein in vitro. Both AP180 and its ubiquitously expressed homolog clathrin assembly lymphoid myeloid leukemia protein (CALM) control vesicle size and shape in clathrin mediated endocytosis. The clathrin assembly role of AP180 is mediated by a long disordered C-terminal assembly domain. Within this assembly domain, a central acidic clathrin and adapter binding (CLAP) sub-domain contains all of the known short binding motifs for clathrin and AP2. The role of the remaining similar to 16 kDa C-terminal sequence has not been clear. We show that this sequence has a separate function in ensuring efficient binding of clathrin, based on in vitro binding and ex vivo transferrin uptake assays. Sequence alignment suggests the C-terminal sub-domain is conserved in CALM.	[Chan, Ling-Shan; Moshkanbaryans, Lia; Xue, Jing; Graham, Mark E.] Univ Sydney, Childrens Med Res Inst, Westmead, NSW 2145, Australia	Children's Medical Research Institute - Australia; University of Sydney	Graham, ME (corresponding author), Univ Sydney, Childrens Med Res Inst, Westmead, NSW 2145, Australia.	mgraham@cmri.org.au	Graham, Mark E/A-6480-2014	Graham, Mark E/0000-0002-7290-1217	National Health and Medical Research Council Biomedical (Dora Lush) Postgraduate Research Scholarship; University of Sydney Postgraduate Award; Children's Medical Research Institute PhD Scholarship; University of Sydney University Postgraduate Scholarship; Children's Medical Research Institute Postgraduate Scholarship; National Health and Medical Research Council; Australian Research Council	National Health and Medical Research Council Biomedical (Dora Lush) Postgraduate Research Scholarship(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney Postgraduate Award(University of Sydney); Children's Medical Research Institute PhD Scholarship; University of Sydney University Postgraduate Scholarship; Children's Medical Research Institute Postgraduate Scholarship; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	L.M. was funded by a National Health and Medical Research Council Biomedical (Dora Lush) Postgraduate Research Scholarship, a University of Sydney Postgraduate Award and Children's Medical Research Institute PhD Scholarship. L.-S.C. was funded by a University of Sydney University Postgraduate Scholarship and a Children's Medical Research Institute Postgraduate Scholarship. M. E. G. was funded by a National Health and Medical Research Council Project Grant and an Australian Research Council Discovery Project Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguet F, 2013, DEV CELL, V26, P279, DOI 10.1016/j.devcel.2013.06.019; AHLE S, 1986, EMBO J, V5, P3143, DOI 10.1002/j.1460-2075.1986.tb04621.x; Borner GHH, 2012, J CELL BIOL, V197, P141, DOI 10.1083/jcb.201111049; Chan LS, 2010, J PROTEOME RES, V9, P4028, DOI 10.1021/pr100223n; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Congar P, 2002, J PHYSIOL-LONDON, V542, P779, DOI 10.1113/jphysiol.2002.020222; Conway AE, 2013, BLOOD, V121, P4758, DOI 10.1182/blood-2012-06-435792; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deak F, 2004, NAT CELL BIOL, V6, P1102, DOI 10.1038/ncb1185; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; EMBL-EBI, 2014, EMBOSS NEEDL PAIRW S; Evans PR, 2002, CURR OPIN STRUC BIOL, V12, P814, DOI 10.1016/S0959-440X(02)00395-0; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Goes FS, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.106; Graham ME, 2012, ORG BIOMOL CHEM, V10, P2545, DOI 10.1039/c2ob07139h; Hao WH, 1999, J BIOL CHEM, V274, P22785, DOI 10.1074/jbc.274.32.22785; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Kalthoff C, 2002, J BIOL CHEM, V277, P8209, DOI 10.1074/jbc.M111587200; KEEN JH, 1987, J CELL BIOL, V105, P1989, DOI 10.1083/jcb.105.5.1989; Kelly BT, 2014, SCIENCE, V345, P459, DOI 10.1126/science.1254836; Koo SJ, 2011, P NATL ACAD SCI USA, V108, P13540, DOI 10.1073/pnas.1107067108; Kozlowski LP, 2013, CALCULATION PROTEIN; Kumon K, 1999, GENE CHROMOSOME CANC, V25, P33, DOI 10.1002/(SICI)1098-2264(199905)25:1<33::AID-GCC5>3.0.CO;2-3; LINDNER R, 1992, J BIOL CHEM, V267, P16567; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McMahon HT, 1999, CURR BIOL, V9, pR332, DOI 10.1016/S0960-9822(99)80206-1; Meyerholz A, 2005, TRAFFIC, V6, P1225, DOI 10.1111/j.1600-0854.2005.00355.x; Miller SE, 2011, CELL, V147, P1118, DOI 10.1016/j.cell.2011.10.038; Morgan JR, 2000, J NEUROSCI, V20, P8667; MORRIS SA, 1993, EMBO J, V12, P667, DOI 10.1002/j.1460-2075.1993.tb05700.x; Moshkanbaryans L, 2014, MEMBRANES, V4, P388, DOI 10.3390/membranes4030388; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; Pizzato M, 2007, P NATL ACAD SCI USA, V104, P6812, DOI 10.1073/pnas.0607622104; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Saheki Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005645; Sahlender DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064514; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Scotland PB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044252; Suzuki M, 2014, CANCER SCI, V105, P315, DOI 10.1111/cas.12347; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; UNANUE ER, 1981, CELL, V26, P439, DOI 10.1016/0092-8674(81)90213-0; Watanabe S, 2013, NATURE, V504, P242, DOI 10.1038/nature12809; Wechsler DS, 2003, GENE CHROMOSOME CANC, V36, P26, DOI 10.1002/gcc.10136; Wenzel EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038188; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; YE W, 1995, J NEUROSCI RES, V41, P15, DOI 10.1002/jnr.490410104; YE WL, 1995, J BIOL CHEM, V270, P10933, DOI 10.1074/jbc.270.18.10933; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zhao XH, 2001, J CELL SCI, V114, P353; ZHOU SB, 1993, J BIOL CHEM, V268, P12655; Zhuo Y, 2010, J MOL BIOL, V404, P274, DOI 10.1016/j.jmb.2010.09.044	55	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110557	10.1371/journal.pone.0110557	http://dx.doi.org/10.1371/journal.pone.0110557			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329427	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100073
J	Tomita, T; Nakamura, M; Sato, K; Takaoka, H; Toda, M; Kawauchi, J; Nakaya, K				Tomita, Taketeru; Nakamura, Masaru; Sato, Keiichi; Takaoka, Hiroko; Toda, Minoru; Kawauchi, Junro; Nakaya, Kazuhiro			Onset of Buccal Pumping in Catshark Embryos: How Breathing Develops in the Egg Capsule	PLOS ONE			English	Article							DOGFISH SCYLIORHINUS-CANICULA; EXTERNAL GILL FILAMENTS; LESSER SPOTTED DOGFISH; SHARK	Respiration in fishes involves buccal pumping, which is characterized by the generation of nearly continuous water flow over the gills because of the rhythmic expansion/compression of the pharyngeal cavity. This mechanism is achieved by the functions of the vascular, skeletal, and muscular systems. However, the process by which the embryo establishes the mechanism remains a mystery. Morphological and kinematical observations on captive cloudy catsharks, Scyliorhinus torazame, have suggested that the embryo starts buccal pumping just before the respiratory slits open on the egg capsule. During the pre-opening period, the embryo acquires oxygen mainly via the external gill filaments. After slit opening, respiration of the embryo involves buccal pumping to pass water over the "internal gills." The onset of buccal pumping accompanies four morphological changes: (1) regression of the external gill filaments, (2) development of blood vessels within the "internal gills," (3) completion of the development of hyoid skeletal and muscular elements, and (4) development of the oral valve. A previous study showed that buccal pumping allows the embryo to actively regulate oxygen intake by changing the pumping frequency. Thus, establishment of buccal pumping in the egg capsule is probably important for embryo survival in the unstable oxygen environment of the egg capsule after slit opening.	[Tomita, Taketeru] Hokkaido Univ Museum, Hakodate, Hokkaido, Japan; [Nakamura, Masaru; Sato, Keiichi; Toda, Minoru] Okinawa Churashima Fdn, Okinawa Churashima Res Ctr, Motobu, Okinawa, Japan; [Takaoka, Hiroko] Okinawa Churaumi Aquarium, Motobu, Okinawa, Japan; [Kawauchi, Junro] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido, Japan; [Nakaya, Kazuhiro] Hokkaido Univ, Hakodate, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Tomita, T (corresponding author), Hokkaido Univ Museum, Hakodate, Hokkaido, Japan.	teruteru-saurus@hotmail.co.jp			Japanese Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [23248034] Funding Source: KAKEN	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work project was supported by Japanese Society for the Promotion of Science (JSPS). http://www.jsps.go.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLARD WW, 1993, J EXP ZOOL, V267, P318, DOI 10.1002/jez.1402670309; BARANES A, 1981, J FISH BIOL, V18, P159, DOI 10.1111/j.1095-8649.1981.tb02811.x; Carrier JC, 2004, CRC MAR BIOL SER, P269; Castro J. I, 2011, SHARKS N AM; CASTRO JI, 1988, COPEIA, P740; Daniel J. F., 1922, ELASMOBRANCH FISHES; DIEZ JM, 1987, J MAR BIOL ASSOC UK, V67, P249, DOI 10.1017/S0025315400026576; Graham Jeffrey B., 2006, P85; GUDGER EW, 1946, J MORPHOL, V79, P263, DOI 10.1002/jmor.1050790203; Gudger EW, 1935, J MORPHOL, V57, P91, DOI 10.1002/jmor.1050570105; HAMLETT WC, 1985, J SUBMICR CYTOL PATH, V17, P31; Hamlett WC, 1999, SHARKS, SKATES, AND RAYS, P398; HUGHES GM, 1960, J EXP BIOL, V37, P11; HUGHES GM, 1965, J EXP BIOL, V43, P363; NAKAMURA M, 1973, Bulletin of the Faculty of Fisheries Hokkaido University, V24, P1; PELSTER B, 1992, RESP PHYSIOL, V89, P1, DOI 10.1016/0034-5687(92)90066-6; Pelster Bernd, 2008, P91; Richards S. W., 1963, Bulletin of the Bingham Oceanographic Collection, V18, P1; Rodda KR, 2008, J FISH BIOL, V72, P961, DOI 10.1111/j.1095-8649.2007.01777.x; Thomason JC, 1996, J FISH BIOL, V49, P965, DOI 10.1111/j.1095-8649.1996.tb00093.x; WOURMS JP, 1977, AM ZOOL, V17, P379; Wyffels J, 2006, KAIYOU MONTHLY, V45, P156; Wyffels Jennifer T., 2009, P1, DOI 10.1201/b10184-2	23	4	4	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e109504	10.1371/journal.pone.0109504	http://dx.doi.org/10.1371/journal.pone.0109504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329313	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100028
J	Roy, N; Chakraborty, S; Chowdhury, BP; Banerjee, S; Halder, K; Majumder, S; Majumdar, S; Sen, PC				Roy, Nivedita; Chakraborty, Supriya; Chowdhury, Bidisha Paul; Banerjee, Sayantan; Halder, Kuntal; Majumder, Saikat; Majumdar, Subrata; Sen, Parimal C.			Regulation of PKC Mediated Signaling by Calcium during Visceral Leishmaniasis	PLOS ONE			English	Article							PROTEIN-KINASE-C; INTRACELLULAR CA2+; MURINE MACROPHAGE; MEMBRANE ATPASE; IMMUNE-RESPONSE; ACTIVATION; DONOVANI; EXPRESSION; AMASTIGOTES; EVENTS	Calcium is an ubiquitous cellular signaling molecule that controls a variety of cellular processes and is strictly maintained in the cellular compartments by the coordination of various Ca2+ pumps and channels. Two such fundamental calcium pumps are plasma membrane calcium ATPase (PMCA) and Sarco/endoplasmic reticulum calcium ATPase (SERCA) which play a pivotal role in maintaining intracellular calcium homeostasis. This intracellular Ca2+ homeostasis is often disturbed by the protozoan parasite Leishmania donovani, the causative organism of visceral leishmaniasis. In the present study we have dileneated the involvement of PMCA4 and SERCA3 during leishmaniasis. We have observed that during leishmaniasis, intracellular Ca2+ concentration was up-regulated and was further controlled by both PMCA4 and SERCA3. Inhibition of these two Ca2+-ATPases resulted in decreased parasite burden within the host macrophages due to enhanced intracellular Ca2+. Contrastingly, on the other hand, activation of PMCA4 was found to enhance the parasite burden. Our findings also highlighted the importance of Ca2+ in the modulation of cytokine balance during leishmaniasis. These results thus cumulatively suggests that these two Ca2+-ATPases play prominent roles during visceral leishmaniasis.	[Roy, Nivedita; Chakraborty, Supriya; Chowdhury, Bidisha Paul; Banerjee, Sayantan; Halder, Kuntal; Majumder, Saikat; Majumdar, Subrata; Sen, Parimal C.] Bose Inst, Div Mol Med, Kolkata, W Bengal, India	Department of Science & Technology (India); Bose Institute	Majumdar, S (corresponding author), Bose Inst, Div Mol Med, Kolkata, W Bengal, India.	subrata@bic.boseinst.ernet.in; parimalsen.boseinst@gmail.com	Chakraborty, Supriya/GNP-4762-2022; Majumder, Saikat/ABC-2194-2020; BANERJEE, SAYANTAN/AAD-8420-2019; Chakraborty, Supriya/U-4306-2018	Chakraborty, Supriya/0000-0002-6517-0217; Majumder, Saikat/0000-0002-6591-9515; ROY, NIVEDITA/0000-0003-3908-0792; Chakraborty, Supriya/0000-0002-0800-5792	Department of Biotechnology, Government of India (NR); Bose Institute	Department of Biotechnology, Government of India (NR); Bose Institute(Department of Science & Technology (India))	This work has been supported by a post-doctoral fellowship from the Department of Biotechnology, Government of India (NR) and partly by Bose Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasthi A, 2004, INDIAN J MED RES, V119, P238; Benaim B, 2011, TROP BIOMED, V28, P471; Bhatnagar K, 2004, CURR MICROBIOL, V49, P28, DOI 10.1007/s00284-003-4261-8; Bhattacharyya S, 2001, MOL CELL BIOCHEM, V216, P47, DOI 10.1023/A:1011048210691; Bhattacharyya S, 2001, INFECT IMMUN, V69, P1499, DOI 10.1128/IAI.69.3.1499-1507.2001; BUCHMULLERROUILLER Y, 1991, J IMMUNOL, V146, P217; Christianse NO, 1988, BIOCH BIOPHYSICA ACT, V971, P317; DESCOTEAUX A, 1989, MOL CELL BIOL, V9, P5223, DOI 10.1128/MCB.9.11.5223; Faries MB, 2001, BLOOD, V98, P2489, DOI 10.1182/blood.V98.8.2489; Ghosh S, 2001, MOL CELL BIOCHEM, V223, P47, DOI 10.1023/A:1017996609928; Goto Y, 2008, EXP PARASITOL, V119, P80, DOI 10.1016/j.exppara.2007.12.019; Kress M, 2004, NEUROSCI LETT, V354, P127, DOI 10.1016/j.neulet.2003.10.003; Lanza H, 2004, BIOL RES, V37, P385, DOI 10.4067/S0716-97602004000300004; Lehmann MH, 1998, PFLUG ARCH EUR J PHY, V435, P868, DOI 10.1007/s004240050596; Lu HG, 1997, J BIOL CHEM, V272, P9464, DOI 10.1074/jbc.272.14.9464; LYTTON J, 1992, J BIOL CHEM, V267, P14483; Mishina YV, 2007, ANTIMICROB AGENTS CH, V51, P1852, DOI 10.1128/AAC.01544-06; MURRAY HW, 1985, J IMMUNOL, V134, P1619; Nishizuka, 1988, NIPPON KETSUEKI GAKK, V51, P1321; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Pandey D, 2011, MOL PHARMACOL, V80, P407, DOI 10.1124/mol.110.070193; PARKER PJ, 1989, MOL CELL ENDOCRINOL, V65, P1, DOI 10.1016/0303-7207(89)90159-7; Peiretti F, 1997, ARTERIOSCL THROM VAS, V17, P1550, DOI 10.1161/01.ATV.17.8.1550; Prasad A, 2001, MOL CELL BIOCHEM, V224, P39, DOI 10.1023/A:1011965109446; Robertson MJ, 1997, NAT IMMUN, V15, P213; Sambrook J., 2002, MOL CLONING LAB MANU; SARKADI B, 1992, J BIOL CHEM, V267, P4854; Schmitt JM, 2004, J BIOL CHEM, V279, P24064, DOI 10.1074/jbc.M401501200; Shaha C, 2006, INDIAN J MED RES, V123, P233; Sudhandiran G, 2003, J BIOL CHEM, V278, P25120, DOI 10.1074/jbc.M301975200; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Wilmanns M, 2000, CELL MOL BIOL, V46, P883; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147	33	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110843	10.1371/journal.pone.0110843	http://dx.doi.org/10.1371/journal.pone.0110843			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329062	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204100110
J	Yanagida, T; Carod, JF; Sako, Y; Nakao, M; Hoberg, EP; Ito, A				Yanagida, Tetsuya; Carod, Jean-Francois; Sako, Yasuhito; Nakao, Minoru; Hoberg, Eric P.; Ito, Akira			Genetics of the Pig Tapeworm in Madagascar Reveal a History of Human Dispersal and Colonization	PLOS ONE			English	Article							ISLAND SOUTHEAST-ASIA; TAENIA-SOLIUM; CYSTICERCOSIS; ORIGINS; AFRICA; NEUROCYSTICERCOSIS; ECHINOCOCCUS; HYPOTHESIS; PHYLOGENY; PARASITES	An intricate history of human dispersal and geographic colonization has strongly affected the distribution of human pathogens. The pig tapeworm Taenia solium occurs throughout the world as the causative agent of cysticercosis, one of the most serious neglected tropical diseases. Discrete genetic lineages of T. solium in Asia and Africa/Latin America are geographically disjunct; only in Madagascar are they sympatric. Linguistic, archaeological and genetic evidence has indicated that the people in Madagascar have mixed ancestry from Island Southeast Asia and East Africa. Hence, anthropogenic introduction of the tapeworm from Southeast Asia and Africa had been postulated. This study shows that the major mitochondrial haplotype of T. solium in Madagascar is closely related to those from the Indian Subcontinent. Parasitological evidence presented here, and human genetics previously reported, support the hypothesis of an Indian influence on Malagasy culture coinciding with periods of early human migration onto the island. We also found evidence of nuclear-mitochondrial discordance in single tapeworms, indicating unexpected cross-fertilization between the two lineages of T. solium. Analyses of genetic and geographic populations of T. solium in Madagascar will shed light on apparently rapid evolution of this organism driven by recent (<2,000 yr) human migrations, following tens of thousands of years of geographic isolation.	[Yanagida, Tetsuya; Sako, Yasuhito; Nakao, Minoru; Ito, Akira] Asahikawa Med Univ, Dept Parasitol, Asahikawa, Hokkaido, Japan; [Carod, Jean-Francois] Inst Pasteur Madagascar, Antananarivo, Madagascar; [Hoberg, Eric P.] ARS, USDA, US Natl Parasite Collect, Anim Parasit Dis Lab, Beltsville, MD USA	Asahikawa Medical College; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; United States Department of Agriculture (USDA)	Yanagida, T (corresponding author), Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Parasitol, Yamaguchi, Japan.	yanagi-t@yamaguchi-u.ac.jp	Ito, A./E-9377-2014	Ito, A./0000-0002-5070-9187	Institut Pasteur de Madagascar; Japan Society for Promotion of Science (JSPS) Asia/Africa Scientific platform; JSPS [21256003, 24256002]; Special Coordination Fund for Promoting Science and Technology from the Ministry of Education, Japan	Institut Pasteur de Madagascar; Japan Society for Promotion of Science (JSPS) Asia/Africa Scientific platform(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Special Coordination Fund for Promoting Science and Technology from the Ministry of Education, Japan	This study was supported by the Institut (http://www.pasteur.mg/) Pasteur de Madagascar and by the Japan Society for Promotion of Science (JSPS: http://www.jsps.go.jp/) Asia/Africa Scientific platform (2006-2011), the Grant-in-Aid for Scientific Research from JSPS (21256003, 24256002) and the Special Coordination Fund for Promoting Science and Technology from the Ministry of Education, Japan (2010-2012) to A. Ito. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo A, 2008, TRENDS PARASITOL, V24, P112, DOI 10.1016/j.pt.2007.11.007; Campbell G, 2006, PARASITOL INT, V55, pS121, DOI 10.1016/j.parint.2005.11.019; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; DEWAR RE, 1993, J WORLD PREHIST, V7, P417, DOI 10.1007/BF00997802; Dubut V, 2009, HUM BIOL, V81, P495, DOI 10.3378/027.081.0407; Haag KL, 2011, PARASITOLOGY, V138, P298, DOI 10.1017/S0031182010001307; Hoberg EP, 2006, PARASITOL INT, V55, pS23, DOI 10.1016/j.parint.2005.11.049; Hoberg EP, 2001, P ROY SOC B-BIOL SCI, V268, P781, DOI 10.1098/rspb.2000.1579; Hurles ME, 2005, AM J HUM GENET, V76, P894, DOI 10.1086/430051; Ito A, 2013, TROP BIOMED, V30, P164; Ito A, 2003, LANCET, V362, P1918, DOI 10.1016/S0140-6736(03)14965-3; Knapp J, 2011, MOL PHYLOGENET EVOL, V61, P628, DOI 10.1016/j.ympev.2011.07.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Larson G, 2007, P NATL ACAD SCI USA, V104, P4834, DOI 10.1073/pnas.0607753104; Mafojane NA, 2003, ACTA TROP, V87, P25, DOI 10.1016/S0001-706X(03)00052-4; Maravilla P, 2008, INFECT GENET EVOL, V8, P213, DOI 10.1016/j.meegid.2007.11.006; Martinez-Hernandez F, 2009, INFECT GENET EVOL, V9, P1108, DOI 10.1016/j.meegid.2009.09.005; MCCAULEY DE, 1985, AM J BOT, V72, P1978, DOI 10.2307/2443614; Michelet L, 2012, BIOL REV, V87, P731, DOI 10.1111/j.1469-185X.2012.00217.x; Michelet L, 2010, MOL PHYLOGENET EVOL, V55, P744, DOI 10.1016/j.ympev.2010.01.008; Nakao M, 2002, PARASITOLOGY, V124, P657, DOI 10.1017/S0031182002001725; Nakao M, 2000, MOL BIOCHEM PARASIT, V111, P415, DOI 10.1016/S0166-6851(00)00334-0; Ndimubanzi PC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000870; Rasamoelina-Andriamanivo H, 2013, TRENDS PARASITOL, V29, P538, DOI 10.1016/j.pt.2013.09.002; Robertson LJ, 2013, TRENDS PARASITOL, V29, P101, DOI 10.1016/j.pt.2012.12.004; Sato MO, 2011, PARASITOL INT, V60, P108, DOI 10.1016/j.parint.2010.11.004; Swastika K, 2012, PARASITOL INT, V61, P378, DOI 10.1016/j.parint.2011.11.004; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TEMPLETON AR, 1992, GENETICS, V132, P619; Terefe Y, 2014, INT J PARASITOL, V44, P533, DOI 10.1016/j.ijpara.2014.03.013; Yanagida T, 2010, J TRAVEL MED, V17, P206, DOI 10.1111/j.1708-8305.2010.00409.x	32	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109002	10.1371/journal.pone.0109002	http://dx.doi.org/10.1371/journal.pone.0109002			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AX2IH	25329310	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200014
J	Heylen, M; Ruyssers, NE; De Man, JG; Timmermans, JP; Pelckmans, PA; Moreels, TG; De Winter, BY				Heylen, Marthe; Ruyssers, Nathalie E.; De Man, Joris G.; Timmermans, Jean-Pierre; Pelckmans, Paul A.; Moreels, Tom G.; De Winter, Benedicte Y.			Worm Proteins of Schistosoma mansoni Reduce the Severity of Experimental Chronic Colitis in Mice by Suppressing Colonic Proinflammatory Immune Responses	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TRICHURIS-SUIS THERAPY; T-CELL RESPONSES; HELMINTH-PARASITES; CROHNS-DISEASE; IMMUNODEFICIENT MICE; EXPRESSION; INFECTION; INTESTINE; MODEL	Although helminthic therapy as a possible new option to treat inflammatory bowel disease is a well-established concept by now, the search for immunomodulatory helminth-derived compounds and their mechanisms of action is still ongoing. We investigated the therapeutic potential and the underlying immunological mechanisms of Schistosoma mansoni soluble worm proteins (SmSWP) in an adoptive T cell transfer mouse model of chronic colitis. Both a curative and a preventive treatment protocol were included in this study. The curative administration of SmSWP (started when colitis was established), resulted in a significant improvement of the clinical disease score, colonoscopy, macroscopic and microscopic inflammation score, colon length and myeloperoxidase activity. The therapeutic potential of the preventive SmSWP treatment (started before colitis was established), was less pronounced compared with the curative SmSWP treatment but still resulted in an improved clinical disease score, body weight loss, colon length and microscopic inflammation score. Both the curative and preventive SmSWP treatment downregulated the mRNA expression of the proinflammatory cytokines IFN-gamma and IL-17A and upregulated the mRNA expression of the anti-inflammatory cytokine IL-4 in the colon at the end of the experiment. This colonic immunomodulatory effect of SmSWP could not be confirmed at the protein level. Moreover, the effect of SmSWP appeared to be a local colonic phenomenon, since the flow cytometric T cell characterization of the mesenteric lymph nodes and the cytokine measurements in the serum did not reveal any effect of SmSWP treatment. In conclusion, SmSWP treatment reduced the severity of colitis in the adoptive transfer mouse model via the suppression of proinflammatory cytokines and the induction of an anti-inflammatory response in the colon.	[Heylen, Marthe; Ruyssers, Nathalie E.; De Man, Joris G.; Pelckmans, Paul A.; Moreels, Tom G.; De Winter, Benedicte Y.] Univ Antwerp, Lab Expt Med & Pediat, Div Gastroenterol, B-2020 Antwerp, Belgium; [Timmermans, Jean-Pierre] Univ Antwerp, Dept Vet Sci, Lab Cell Biol & Histol, B-2020 Antwerp, Belgium; [Pelckmans, Paul A.; Moreels, Tom G.] Univ Antwerp Hosp, Div Gastroenterol & Hepatol, Antwerp, Belgium	University of Antwerp; University of Antwerp; University of Antwerp	De Winter, BY (corresponding author), Univ Antwerp, Lab Expt Med & Pediat, Div Gastroenterol, B-2020 Antwerp, Belgium.	benedicte.dewinter@uantwerpen.be	De Winter, Benedicte Y/G-2616-2011	De Winter, Benedicte Y/0000-0003-0327-6304; Timmermans, Jean-Pierre/0000-0003-2506-6252	Belgian IBD Research and Development (BIRD) group (BIRD Research Grant)	Belgian IBD Research and Development (BIRD) group (BIRD Research Grant)	This work was supported by a grant from the Belgian IBD Research and Development (BIRD) group (BIRD Research Grant 2012A) to Marthe Heylen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Blum AM, 2012, J IMMUNOL, V189, P2512, DOI 10.4049/jimmunol.1102892; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; Boukli NM, 2011, J PARASITOL, V97, P852, DOI 10.1645/GE-2495.1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broadhurst MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003000; Cools N, 2007, CLIN DEV IMMUNOL, DOI 10.1155/2007/89195; Donskow-Lysoniewska K, 2012, PARASITE IMMUNOL, V34, P536, DOI 10.1111/pim.12003; Du LL, 2011, DIGEST DIS SCI, V56, P2810, DOI 10.1007/s10620-011-1689-8; Elliott DE, 2012, CURR OPIN GASTROEN, V28, P551, DOI 10.1097/MOG.0b013e3283572f73; Elliott DE, 2000, FASEB J, V14, P1848, DOI 10.1096/fj.99-0885hyp; Ferreira I, 2013, INFECT IMMUN, V81, P2104, DOI 10.1128/IAI.00563-12; Gyires K, 2014, CURR PHARM DESIGN, V20, P1063, DOI 10.2174/13816128113199990417; Hang L, 2010, J IMMUNOL, V185, P3184, DOI 10.4049/jimmunol.1000941; Heylen M, 2014, PHARMACOL THERAPEUT, V143, P153, DOI 10.1016/j.pharmthera.2014.02.011; Heylen M, 2013, INFLAMM BOWEL DIS, V19, P967, DOI 10.1097/MIB.0b013e3182802c7c; Hunter MM, 2010, GASTROENTEROLOGY, V138, P1395, DOI 10.1053/j.gastro.2009.12.041; Jang SW, 2011, KOREAN J PARASITOL, V49, P245, DOI 10.3347/kjp.2011.49.3.245; Jones LJ, 2003, BIOTECHNIQUES, V34, P850, DOI 10.2144/03344pt03; Jurjus Abdo R., 2004, Journal of Pharmacological and Toxicological Methods, V50, P81, DOI 10.1016/j.vascn.2003.12.002; Khan AR, 2013, INT J PARASITOL, V43, P293, DOI 10.1016/j.ijpara.2012.12.002; Knights D, 2013, GUT, V62, P1505, DOI 10.1136/gutjnl-2012-303954; Ledeganck KJ, 2011, AM J PHYSIOL-RENAL, V301, pF486, DOI 10.1152/ajprenal.00116.2011; Leithauser F, 2006, AM J PATHOL, V168, P1898, DOI 10.2353/ajpath.2006.050228; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald TT, 2011, GASTROENTEROLOGY, V140, P1768, DOI 10.1053/j.gastro.2011.02.047; Maizels RM, 2012, CURR OPIN IMMUNOL, V24, P459, DOI 10.1016/j.coi.2012.06.003; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; McSorley HJ, 2013, INT J PARASITOL, V43, P301, DOI 10.1016/j.ijpara.2012.11.011; McSorley HJ, 2012, CLIN MICROBIOL REV, V25, P585, DOI 10.1128/CMR.05040-11; Moreels TG, 2004, GUT, V53, P99, DOI 10.1136/gut.53.1.99; MORRISSEY PJ, 1993, J EXP MED, V178, P237, DOI 10.1084/jem.178.1.237; Ostanin DV, 2006, AM J PHYSIOL-GASTR L, V290, pG109, DOI 10.1152/ajpgi.00214.2005; Pastorelli L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00280; RATCLIFFE EC, 1991, PARASITOLOGY, V103, P65, DOI 10.1017/S0031182000059308; Ruyssers NE, 2009, INFLAMM BOWEL DIS, V15, P491, DOI 10.1002/ibd.20787; Sandborn WJ, 2013, ALIMENT PHARM THER, V38, P255, DOI 10.1111/apt.12366; Schnoeller C, 2008, J IMMUNOL, V180, P4265, DOI 10.4049/jimmunol.180.6.4265; Smith P, 2007, J IMMUNOL, V178, P4557, DOI 10.4049/jimmunol.178.7.4557; Speight RA, 2013, CLIN MED, V13, P378, DOI 10.7861/clinmedicine.13-4-378; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; Summers RW, 2003, AM J GASTROENTEROL, V98, P2034, DOI [10.1016/S0002-9270(03)00623-3, 10.1111/j.1572-0241.2003.07660.x]; Weinstock JV, 2013, INT J PARASITOL, V43, P245, DOI 10.1016/j.ijpara.2012.10.016; Weinstock JV, 2012, NATURE, V491, P183, DOI 10.1038/491183a; Zaccone P, 2003, EUR J IMMUNOL, V33, P1439, DOI 10.1002/eji.200323910	48	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110002	10.1371/journal.pone.0110002	http://dx.doi.org/10.1371/journal.pone.0110002			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313594	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500092
J	Li, YR; Bailey, DH; Winegard, B; Puts, DA; Welling, LLM; Geary, DC				Li, Yaoran; Bailey, Drew H.; Winegard, Benjamin; Puts, David A.; Welling, Lisa L. M.; Geary, David C.			Women's Preference for Masculine Traits Is Disrupted by Images of Male-on-Female Aggression	PLOS ONE			English	Article							MALE-MALE COMPETITION; SEXUAL SELECTION; FACIAL APPEARANCE; MATE CHOICE; VISUAL CUES; TESTOSTERONE; PERCEPTION; DOMINANCE; EXPOSURE; SIGNALS	Women's preferences for men's masculinized faces and voices were assessed after women (n = 331) were primed with images of male-on-male aggression, male-on-female aggression, pathogens, and neutral scenes. Male-on-male aggression and pathogen primes were associated with increased preference for masculine traits, but the same effect emerged in the neutral condition. We show the increased preference for masculine traits was due to repeated exposure to these traits, not the priming images themselves. Images of male-on-female aggression were an exception; these elicited feelings of disgust and anger appeared to disrupt the preference for masculinized traits. The results suggest women process men's facial and vocal traits as signals of aggressive potential and lose any preference for these traits with cues indicating men might direct this aggression toward them.	[Li, Yaoran] Univ Missouri, Dept Educ, Sch & Counseling Psychol, Columbia, MO USA; [Bailey, Drew H.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Winegard, Benjamin; Geary, David C.] Univ Missouri, Dept Psychol Sci, Columbia, MO 65211 USA; [Puts, David A.] Penn State Univ, Dept Anthropol, State Coll, PA USA; [Welling, Lisa L. M.] Oakland Univ, Dept Psychol, Auburn Hills, MI USA; [Geary, David C.] Univ Missouri, Interdisciplinary Neurosci Program, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; Carnegie Mellon University; University of Missouri System; University of Missouri Columbia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Oakland University; University of Missouri System; University of Missouri Columbia	Geary, DC (corresponding author), Univ Missouri, Dept Psychol Sci, Columbia, MO 65211 USA.	GearyD@Missouri.edu	Puts, David A/E-5453-2011	Puts, David/0000-0002-6478-1980				Andersson Malte, 1994; BalshineEarn S, 1996, BEHAV ECOL SOCIOBIOL, V39, P107, DOI 10.1007/s002650050272; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; CUNNINGHAM MR, 1990, J PERS SOC PSYCHOL, V59, P61, DOI 10.1037/0022-3514.59.1.61; Dabbs JM, 1999, PERS INDIV DIFFER, V27, P801, DOI 10.1016/S0191-8869(98)00272-4; Darwin C., 1871, P423; DeBruine LM, 2006, P ROY SOC B-BIOL SCI, V273, P1355, DOI 10.1098/rspb.2005.3445; Fairbanks G, 1960, VOICE ARTICULATION D; Fink B, 2007, AM J HUM BIOL, V19, P82, DOI 10.1002/ajhb.20583; Gangestad SW, 2013, BEHAV ECOL, V24, P594, DOI 10.1093/beheco/ars096; Jirotkul M, 1999, ANIM BEHAV, V58, P287, DOI 10.1006/anbe.1999.1149; Jones BC, 2008, VIS COGN, V16, P849, DOI 10.1080/13506280701760811; Lang P.J., 2008, A8 U FLOR; Little AC, 2013, EVOL HUM BEHAV, V34, P193, DOI 10.1016/j.evolhumbehav.2012.11.008; Little AC, 2011, P ROY SOC B-BIOL SCI, V278, P2032, DOI 10.1098/rspb.2010.1925; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; McKibbin WF, 2014, EVOL PSYCHOL-SER, P209, DOI 10.1007/978-1-4939-0314-6_11; Pound N, 2009, P ROY SOC B-BIOL SCI, V276, P153, DOI 10.1098/rspb.2008.0990; Puts DA, 2012, J SEX RES, V49, P227, DOI 10.1080/00224499.2012.658924; Puts DA, 2012, P ROY SOC B-BIOL SCI, V279, P601, DOI 10.1098/rspb.2011.0829; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Puts DA, 2007, EVOL HUM BEHAV, V28, P340, DOI 10.1016/j.evolhumbehav.2007.05.002; ROWLAND DA, 1995, IEEE COMPUT GRAPH, V15, P70, DOI 10.1109/38.403830; Scott IML, 2013, BEHAV ECOL, V24, P579, DOI 10.1093/beheco/ars092; Thornhill R., 2001, NATURAL HIST RAPE BI; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Watkins CD, 2012, ANIM BEHAV, V83, P545, DOI 10.1016/j.anbehav.2011.12.002; Welling LLM, 2007, HORM BEHAV, V52, P156, DOI 10.1016/j.yhbeh.2007.01.010; Welling LLM, 2013, PERS INDIV DIFFER, V54, P414, DOI 10.1016/j.paid.2012.10.014; Wong BBM, 2005, BIOL REV, V80, P559, DOI 10.1017/S1464793105006809	31	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110497	10.1371/journal.pone.0110497	http://dx.doi.org/10.1371/journal.pone.0110497			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR5ZW	25314277	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662500117
J	Morales-Buenrostro, LE; Salas-Nolasco, OI; Barrera-Chimal, J; Casas-Aparicio, G; Irizar-Santana, S; Perez-Villalva, R; Bobadilla, NA				Morales-Buenrostro, Luis E.; Salas-Nolasco, Omar I.; Barrera-Chimal, Jonatan; Casas-Aparicio, Gustavo; Irizar-Santana, Sergio; Perez-Villalva, Rosalba; Bobadilla, Norma A.			Hsp72 Is a Novel Biomarker to Predict Acute Kidney Injury in Critically Ill Patients	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; GELATINASE-ASSOCIATED LIPOCALIN; ADULT CARDIAC-SURGERY; URINARY BIOMARKERS; POOR OUTCOMES; MORTALITY; DISEASE; ASSOCIATION; MOLECULE-1; RECOVERY	Background and Objectives: Acute kidney injury (AKI) complicates the course of disease in critically ill patients. Efforts to change its clinical course have failed because of the fail in the early detection. This study was designed to assess whether heat shock protein (Hsp72) is an early and sensitive biomarker of acute kidney injury (AKI) compared with kidney injury molecule (Kim-1), neutrophil gelatinase-associated lipocalin (NGAL), and interleukin-18 (IL-18) biomarkers. Methods: A total of 56 critically ill patients fulfilled the inclusion criteria. From these patients, 17 developed AKI and 20 were selected as controls. In AKI patients, Kim-1, IL-18, NGAL, and Hsp72 were measured from 3 days before and until 2 days after the AKI diagnosis and in no-AKI patients at 1, 5 and 10 days after admission. Biomarker sensitivity and specificity were determined. To validate the results obtained with ROC curves for Hsp72, a new set of critically ill patients was included, 10 with AKI and 12 with no-AKI patients. Results: Urinary Hsp72 levels rose since 3 days before the AKI diagnosis in critically ill patients; this early increase was not seen with any other tested biomarkers. Kim-1, IL-18, NGAL, and Hsp72 significantly increased from 2 days before AKI and remained elevated during the AKI diagnosis. The best sensitivity/specificity was observed in Kim-1 and Hsp72: 83/95% and 100/90%, respectively, whereas 1 day before the AKI diagnosis, the values were 100/100% and 100/90%, respectively. The sensibility, specificity and accuracy in the validation test for Hsp72 were 100%, 83.3% and 90.9%, respectively. Conclusions: The biomarker Hsp72 is enough sensitive and specific to predict AKI in critically ill patients up to 3 days before the diagnosis.	[Morales-Buenrostro, Luis E.; Salas-Nolasco, Omar I.; Barrera-Chimal, Jonatan; Casas-Aparicio, Gustavo; Irizar-Santana, Sergio; Perez-Villalva, Rosalba; Bobadilla, Norma A.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Nephrol Nefrol & Metab Mineral, Mexico City, DF, Mexico; [Barrera-Chimal, Jonatan; Perez-Villalva, Rosalba; Bobadilla, Norma A.] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Unidad Fisiol Mol, Mexico City 04510, DF, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico	Morales-Buenrostro, LE (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Nephrol Nefrol & Metab Mineral, Mexico City, DF, Mexico.	luis_buenrostro@yahoo.com; nab@biomedicas.unam.mx	Barrera-Chimal, Jonatan/AAC-1380-2020	Barrera-Chimal, JONATAN/0000-0002-0711-5092	Mexican Council of Science and Technology (CONACyT) [181267]; National University of Mexico [IN203412-3]	Mexican Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National University of Mexico	This project was supported by grants from the Mexican Council of Science and Technology (CONACyT) (181267 to NAB), http://www.conacyt.mx/ And from the National University of Mexico (IN203412-3 to NAB), http://dgapa.unam.mx/html/papiit/papit.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagshaw SM, 2010, NAT REV NEPHROL, V6, P71, DOI 10.1038/nrneph.2009.225; Barrera-Chimal J, 2011, EMBO MOL MED, V3, P5, DOI 10.1002/emmm.201000105; Bennett M, 2008, CLIN J AM SOC NEPHRO, V3, P665, DOI 10.2215/CJN.04010907; Bucaloiu ID, 2012, KIDNEY INT, V81, P477, DOI 10.1038/ki.2011.405; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Cruz DN, 2011, SEMIN DIALYSIS, V24, P124, DOI 10.1111/j.1525-139X.2011.00830.x; Endre ZH, 2011, KIDNEY INT, V79, P1119, DOI 10.1038/ki.2010.555; Gonzalez F, 2012, MINERVA ANESTESIOL, V78, P1394; Haase M, 2008, CRIT CARE, V12, DOI 10.1186/cc6972; Hsu CY, 2012, J AM SOC NEPHROL, V23, P967, DOI 10.1681/ASN.2012030222; Jones J, 2012, AM J KIDNEY DIS, V60, P402, DOI 10.1053/j.ajkd.2012.03.014; Kelly KJ, 2006, SEMIN NEPHROL, V26, P105, DOI 10.1016/j.semnephrol.2005.09.003; Lafrance JP, 2010, J AM SOC NEPHROL, V21, P345, DOI 10.1681/ASN.2009060636; Lameire NH, 2013, LANCET, V382, P170, DOI 10.1016/S0140-6736(13)60647-9; Lewington AJP, 2013, KIDNEY INT, V84, P457, DOI 10.1038/ki.2013.153; Liano F, 1996, KIDNEY INT, V50, P811, DOI 10.1038/ki.1996.380; Lopes JA, 2008, CRIT CARE, V12, DOI 10.1186/cc6997; Matsui K, 2012, CIRC J, V76, P213, DOI 10.1253/circj.CJ-11-0342; Melnikov VY, 2001, J CLIN INVEST, V107, P1145, DOI 10.1172/JCI12089; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Molitoris BA, 2008, NAT CLIN PRACT NEPHR, V4, P154, DOI 10.1038/ncpneph0723; Munshi R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-11; Murugan R, 2011, NAT REV NEPHROL, V7, P209, DOI 10.1038/nrneph.2011.13; Parikh CR, 2006, KIDNEY INT, V70, P199, DOI 10.1038/sj.ki.5001527; Parikh CR, 2011, J AM SOC NEPHROL, V22, P1748, DOI 10.1681/ASN.2010121302; Parikh CR, 2011, J AM SOC NEPHROL, V22, P1737, DOI 10.1681/ASN.2010111163; Sanchez-Pozos K, 2012, NEPHROL DIAL TRANSPL, V27, P3160, DOI 10.1093/ndt/gfs014; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Torregrosa I, 2012, NEFROLOGIA, V32, P44, DOI 10.3265/Nefrologia.pre2011.Sep.10988; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; Vaidya VS, 2009, KIDNEY INT, V76, P108, DOI 10.1038/ki.2009.96; Vaidya VS, 2006, AM J PHYSIOL-RENAL, V290, pF517, DOI 10.1152/ajprenal.00291.2005; Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010; Wagener G, 2008, AM J KIDNEY DIS, V52, P425, DOI 10.1053/j.ajkd.2008.05.018; Wagener G, 2006, ANESTHESIOLOGY, V105, P485, DOI 10.1097/00000542-200609000-00011; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; Wu I, 2008, CLIN J AM SOC NEPHRO, V3, P1895, DOI 10.2215/CJN.02030408	39	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109407	10.1371/journal.pone.0109407	http://dx.doi.org/10.1371/journal.pone.0109407			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313566	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662500038
J	Wang, S; Dong, ZY; Yan, YB				Wang, Sha; Dong, Zhi-Yang; Yan, Yong-Bin			Formation of High-Order Oligomers by a Hyperthemostable Fe-Superoxide Dismutase (tcSOD)	PLOS ONE			English	Article							HYPERTHERMOPHILIC ARCHAEON; AQUIFEX-PYROPHILUS; CRYSTAL-STRUCTURE; SULFOLOBUS-SOLFATARICUS; THERMOPHILIC PROTEINS; PYROCOCCUS-FURIOSUS; ANGSTROM RESOLUTION; LENS CRYSTALLINS; CROSS-LINKING; ION-PAIRS	Hyperthermostable proteins are highly resistant to various extreme conditions. Many factors have been proposed to contribute to their ultrahigh structural stability. Some thermostable proteins have larger oligomeric size when compared to their mesophilic homologues. The formation of compact oligomers can minimize the solvent accessible surface area and increase the changes of Gibbs free energy for unfolding. Similar to mesophilic proteins, hyperthermostable proteins also face the problem of unproductive aggregation. In this research, we investigated the role of high-order oligomerization in the fight against aggregation by a hyperthermostable superoxide dismutase identified from Tengchong, China (tcSOD). Besides the predominant tetramers, tcSOD could also form active high-order oligomers containing at least eight subunits. The dynamic equilibrium between tetramers and high-order oligomers was not significantly affected by pH, salt concentration or moderate temperature. The secondary and tertiary structures of tcSOD remained unchanged during heating, while cross-linking experiments showed that there were conformational changes or structural fluctuations at high temperatures. Mutational analysis indicated that the last helix at the C-terminus was involved in the formation of high-order oligomers, probably via domain swapping. Based on these results, we proposed that the reversible conversion between the active tetramers and high-order oligomers might provide a buffering system for tcSOD to fight against the irreversible protein aggregation pathway. The formation of active high-order oligomers not only increases the energy barrier between the native state and unfolded/aggregated state, but also provides the enzyme the ability to reproduce the predominant oligomers from the active high-order oligomers.	[Wang, Sha; Dong, Zhi-Yang] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China; [Wang, Sha; Yan, Yong-Bin] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Tsinghua University	Dong, ZY (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China.	dongzy@sun.im.ac.cn; ybyan@tsinghua.edu.cn	Yan, Yong-Bin/A-4282-2008	Yan, Yong-Bin/0000-0002-8565-3558	Ministry of Science and Technology of China [2010CB912402]; National Natural Science Foundation of China [30970559]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grant 2010CB912402 from the Ministry of Science and Technology of China and grant 30970559 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Rahman RNZ, 1997, BIOCHEM BIOPH RES CO, V241, P646; Arnott MA, 2000, J MOL BIOL, V304, P657, DOI 10.1006/jmbi.2000.4240; Bafana A, 2011, CRIT REV BIOTECHNOL, V31, P65, DOI 10.3109/07388551.2010.490937; Batinic-Haberle I, 2010, ANTIOXID REDOX SIGN, V13, P877, DOI 10.1089/ars.2009.2876; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Collins T, 2003, J MOL BIOL, V328, P419, DOI 10.1016/S0022-2836(03)00287-0; Culotta VC, 2000, CURR TOP CELL REGUL, V36, P117; D'Abusco A.S., 2005, ARCHAEA, V1, P411, DOI [10.1155/2005/543789, DOI 10.1155/2005/543789]; Dhar SK, 2012, FREE RADICAL BIO MED, V52, P2209, DOI 10.1016/j.freeradbiomed.2012.03.009; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; FALKE JJ, 1987, SCIENCE, V237, P1596, DOI 10.1126/science.2820061; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Fu XM, 2003, BIOCHEM BIOPH RES CO, V310, P412, DOI 10.1016/j.bbrc.2003.09.027; Galvagnion C, 2009, BIOCHEMISTRY-US, V48, P2891, DOI 10.1021/bi801784d; Grabarse W, 1999, STRUCTURE, V7, P1257, DOI 10.1016/S0969-2126(00)80059-3; Gromiha MM, 2013, PROTEINS, V81, P715, DOI 10.1002/prot.24232; Guidry JJ, 2002, ARCH BIOCHEM BIOPHYS, V405, P280, DOI 10.1016/S0003-9861(02)00406-X; Haslbeck M, 2008, J MOL BIOL, V378, P362, DOI 10.1016/j.jmb.2008.01.095; He YZ, 2007, APPL MICROBIOL BIOT, V75, P367, DOI 10.1007/s00253-006-0834-3; Holley AK, 2012, AMINO ACIDS, V42, P139, DOI 10.1007/s00726-010-0600-9; Huang BX, 2005, BIOCHEM J, V387, P695, DOI 10.1042/BJ20041624; Jaenicke R, 1996, FASEB J, V10, P84, DOI 10.1096/fasebj.10.1.8566552; Jiang JS, 2008, P NATL ACAD SCI USA, V105, P11939, DOI 10.1073/pnas.0805464105; Jiao WW, 2005, J MOL BIOL, V347, P871, DOI 10.1016/j.jmb.2005.01.029; Karshikoff A, 2001, TRENDS BIOCHEM SCI, V26, P550, DOI 10.1016/S0968-0004(01)01918-1; Knapp S, 1999, J MOL BIOL, V285, P689, DOI 10.1006/jmbi.1998.2344; Kumar S, 2001, CELL MOL LIFE SCI, V58, P1216, DOI 10.1007/PL00000935; LADERMAN KA, 1993, J BIOL CHEM, V268, P24394; Lee JR, 2009, P NATL ACAD SCI USA, V106, P5978, DOI 10.1073/pnas.0811231106; Libonati M, 2004, BIOCHEM J, V380, P311, DOI 10.1042/BJ20031922; Lim JH, 1997, J MOL BIOL, V270, P259, DOI 10.1006/jmbi.1997.1105; Lim JH, 1997, FEBS LETT, V406, P142, DOI 10.1016/S0014-5793(97)00262-7; Lim JH, 2001, BIOCHEM BIOPH RES CO, V288, P263, DOI 10.1006/bbrc.2001.5752; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Luke KA, 2007, FEBS J, V274, P4023, DOI 10.1111/j.1742-4658.2007.05955.x; MARKLUND S, 1974, European Journal of Biochemistry, V47, P469, DOI 10.1111/j.1432-1033.1974.tb03714.x; Matsui I, 2007, FEBS J, V274, P4012, DOI 10.1111/j.1742-4658.2007.05956.x; Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018; Miller AF, 2004, CURR OPIN CHEM BIOL, V8, P162, DOI 10.1016/j.cbpa.2004.02.011; Minamino T, 2006, J MOL BIOL, V360, P510, DOI 10.1016/j.jmb.2006.05.010; Raab-Graham KF, 1998, J BIOL CHEM, V273, P19699, DOI 10.1074/jbc.273.31.19699; Rabbani G, 2014, APPL MICROBIOL BIOT, V98, P2533, DOI 10.1007/s00253-013-5123-3; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Secundo F, 2005, BIOCHEMISTRY-US, V44, P11040, DOI 10.1021/bi050469c; Tanaka Y, 2004, J BIOL CHEM, V279, P32957, DOI 10.1074/jbc.M404405200; Thoma R, 2000, STRUCTURE, V8, P265, DOI 10.1016/S0969-2126(00)00106-4; Unsworth LD, 2007, FEBS J, V274, P4044, DOI 10.1111/j.1742-4658.2007.05954.x; Ursby T, 1999, J MOL BIOL, V286, P189, DOI 10.1006/jmbi.1998.2471; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Wang S, 2008, BBA-PROTEINS PROTEOM, V1784, P445, DOI 10.1016/j.bbapap.2007.12.001; Wang S, 2009, INT J MOL SCI, V10, P5498, DOI 10.3390/ijms10125498; Whittaker MM, 2000, J BIOL INORG CHEM, V5, P402; Xu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051200; Zhang K, 2014, BBA-MOL BASIS DIS, V1842, P44, DOI 10.1016/j.bbadis.2013.10.001; Zhao TJ, 2005, J BIOL CHEM, V280, P13470, DOI 10.1074/jbc.M413882200	57	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109657	10.1371/journal.pone.0109657	http://dx.doi.org/10.1371/journal.pone.0109657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313557	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662500065
J	Zhang, XX; Shi, YY; Weng, YY; Lai, Q; Luo, TB; Zhao, J; Ren, GP; Li, WD; Pan, HY; Ke, YH; Zhang, W; He, Q; Wang, QQ; Zhou, R				Zhang, Xinxia; Shi, Yaoyao; Weng, Yuanyuan; Lai, Qian; Luo, Taobo; Zhao, Jing; Ren, Guoping; Li, Wande; Pan, Hongyang; Ke, Yuehai; Zhang, Wei; He, Qiang; Wang, Qingqing; Zhou, Ren			The Truncate Mutation of Notch2 Enhances Cell Proliferation through Activating the NF-kappa B Signal Pathway in the Diffuse Large B-Cell Lymphomas	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GAMMA-SECRETASE INHIBITORS; MARGINAL ZONE LYMPHOMA; IMMUNE-SYSTEM; CROSS-TALK; RBP-J; GROWTH; EXPRESSION; SURVIVAL; GENE	The Notch2 is a critical membrane receptor for B-cell functions, and also displays various biological roles in lymphoma pathogenesis. In this article, we reported that 3 of 69 (4.3%) diffuse large B-cell lymphomas (DLBCLs) exhibited a truncate NOTCH2 mutation at the nucleotide 7605 (G/A) in the cDNA sequence, which led to partial deletion of the C-terminal of PEST (proline-, glutamic acid-, serine- and threonine-rich) domain. The truncate Notch2 activated both the Notch2 and the NF-kappa B signals and promoted the proliferation of B-cell lymphoma cell lines, including DLBCL and Burkitt's lymphoma cell lines. Moreover, the ectopic proliferation was completely inhibited by ammonium pyrrolidinedithiocarbamate (PDTC), an NF-kappa B inhibitor. Simultaneously, PDTC also reduced the expression level of Notch2. Based on these results, we conclude that the Notch2 receptor with PEST domain truncation enhances cell proliferation which may be associated with the activation of the Notch2 and the NF-kappa B signaling. Our results are expected to provide a possible target for new DLBCL therapies by suppressing the Notch2 and the NF-kappa B signaling.	[Zhang, Xinxia; Shi, Yaoyao; Weng, Yuanyuan; Lai, Qian; Luo, Taobo; Pan, Hongyang; Ke, Yuehai; Zhang, Wei; Zhou, Ren] Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, Inst Pathol & Forens Med, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Qingqing] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Jing; Ren, Guoping] Zhejiang Univ, Sch Med, Dept Pathol, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Wande] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Pan, Hongyang] Epit Hangzhou Inc, Hangzhou, Zhejiang, Peoples R China; [He, Qiang] Zhejiang Prov Peoples Hosp, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Boston University; Zhejiang Provincial People's Hospital	Zhou, R (corresponding author), Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, Inst Pathol & Forens Med, Hangzhou 310003, Zhejiang, Peoples R China.	zhouren@zju.edu.cn			Science Foundation of the National Program on Key Basic Research Project (973) [2014CB542101]; Zhejiang Province [Y2090167, 2009C33039]; National Science Foundation of China [30670810]	Science Foundation of the National Program on Key Basic Research Project (973); Zhejiang Province; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Science Foundation of the National Program on Key Basic Research Project (973) (No. 2014CB542101) who played an important role in data collection and analysis, decision to publish and preparation of the manuscript; by Zhejiang Province (No. Y2090167 and No. 2009C33039) who had a role in study design, data collection and analysis; and by the National Science Foundation of China (No. 30670810) who had a role in study design, data collection and analysis.	Adams J, 1999, CANCER RES, V59, P2615; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Barth TFE, 2002, LANCET ONCOL, V3, P229, DOI 10.1016/S1470-2045(02)00714-3; Bash J, 1999, EMBO J, V18, P2803, DOI 10.1093/emboj/18.10.2803; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Del Giudice I, 2012, HAEMATOL-HEMATOL J, V97, P437, DOI 10.3324/haematol.2011.060129; Espinosa L, 2003, MOL BIOL CELL, V14, P491, DOI 10.1091/mbc.E02-07-0404; Espinosa L, 2011, AM J CANCER RES, V1, P446; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Fukushima H, 2008, MOL CELL BIOL, V28, P6402, DOI 10.1128/MCB.00299-08; Groth C, 2012, SEMIN CELL DEV BIOL, V23, P465, DOI 10.1016/j.semcdb.2012.01.016; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Johnson SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039093; Kanarek N, 2012, IMMUNOL REV, V246, P77, DOI 10.1111/j.1600-065X.2012.01098.x; Kato H, 1997, DEVELOPMENT, V124, P4133; Keller CE, 2008, AM J CLIN PATHOL, V130, P193, DOI 10.1309/ELPKF130Q0MCMWU8; Kiel MJ, 2012, J EXP MED, V209, P1553, DOI 10.1084/jem.20120910; Kogoshi H, 2007, ONCOL REP, V18, P77; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Koprivnikar JL, 2012, FUTURE ONCOL, V8, P359, DOI [10.2217/FON.12.23, 10.2217/fon.12.23]; Krikelis D, 2012, CLIN EXP METASTAS, V29, P603, DOI 10.1007/s10585-012-9474-4; Lee SY, 2009, CANCER SCI, V100, P920, DOI 10.1111/j.1349-7006.2009.01130.x; Lee SH, 2007, APMIS, V115, P1357, DOI 10.1111/j.1600-0463.2007.00751.x; Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570; Moran ST, 2007, J IMMUNOL, V179, P195, DOI 10.4049/jimmunol.179.1.195; Morgan TH, 1917, AM NAT, V51, P513, DOI 10.1086/279629; Nefedova Y, 2008, DRUG RESIST UPDATE, V11, P210, DOI 10.1016/j.drup.2008.09.002; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Olivier S, 2006, BIOCHEM PHARMACOL, V72, P1054, DOI 10.1016/j.bcp.2006.07.023; Osipo C, 2008, LAB INVEST, V88, P11, DOI 10.1038/labinvest.3700700; Oswald F, 1998, MOL CELL BIOL, V18, P2077, DOI 10.1128/MCB.18.4.2077; Pancewicz J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-502; Poellinger L, 2008, CURR OPIN GENET DEV, V18, P449, DOI 10.1016/j.gde.2008.07.013; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Real PJ, 2009, LEUKEMIA, V23, P1374, DOI 10.1038/leu.2009.75; Real PJ, 2009, NAT MED, V15, P50, DOI 10.1038/nm.1900; Rohn JL, 1996, J VIROL, V70, P8071, DOI 10.1128/JVI.70.11.8071-8080.1996; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Rossi D, 2012, J EXP MED, V209, P1537, DOI 10.1084/jem.20120904; Salles G, 2011, BLOOD, V117, P7070, DOI 10.1182/blood-2011-04-345256; Sanchez M, 2013, ONCOGENE, V32, P117, DOI 10.1038/onc.2012.19; Schwarzer R, 2012, LEUKEMIA, V26, P806, DOI 10.1038/leu.2011.265; Shin HM, 2006, EMBO J, V25, P129, DOI 10.1038/sj.emboj.7600902; Singh NK, 2014, MOL BIOTECHNOL, V56, P91, DOI 10.1007/s12033-013-9685-1; Swerdlow SH, 2008, WHO CLASSIFICATION T, P179; Tanigaki K, 2007, NAT IMMUNOL, V8, P451, DOI 10.1038/ni1453; Tohda S, 2006, LEUKEMIA RES, V30, P1385, DOI 10.1016/j.leukres.2006.05.003; Troen G, 2008, HAEMATOL-HEMATOL J, V93, P1107, DOI 10.3324/haematol.11635; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yuan JS, 2010, ANNU REV IMMUNOL, V28, P343, DOI 10.1146/annurev.immunol.021908.132719	55	7	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e108747	10.1371/journal.pone.0108747	http://dx.doi.org/10.1371/journal.pone.0108747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314575	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662500018
J	Huang, CY; Huang, HY; Forrest, MD; Pan, YR; Wu, WJ; Chen, HM				Huang, Chih-Yu; Huang, Hsuan-Yu; Forrest, Michael D.; Pan, Yun-Ru; Wu, Wei-Jen; Chen, Hueih-Min			Inhibition Effect of a Custom Peptide on Lung Tumors	PLOS ONE			English	Article							SMALL-CELL; CECROPIN B; LYTIC PEPTIDES; CANCER; CHEMOTHERAPY; MEMBRANE; STABILITY; LIPOSOMES; BACTERIAL; SURVIVAL	Cecropin B is a natural antimicrobial peptide and CB1a is a custom, engineered modification of it. In vitro, CB1a can kill lung cancer cells at concentrations that do not kill normal lung cells. Furthermore, in vitro, CB1a can disrupt cancer cells from adhering together to form tumor-like spheroids. Mice were xenografted with human lung cancer cells; CB1a could significantly inhibit the growth of tumors in this in vivo model. Docetaxel is a drug in present clinical use against lung cancers; it can have serious side effects because its toxicity is not sufficiently limited to cancer cells. In our studies in mice: CB1a is more toxic to cancer cells than docetaxel, but dramatically less toxic to healthy cells.	[Huang, Chih-Yu; Huang, Hsuan-Yu; Pan, Yun-Ru; Wu, Wei-Jen; Chen, Hueih-Min] Natl Appl Res Labs, Natl Nano Device Labs, Nano Biomed Grp, Hsinchu, Taiwan; [Forrest, Michael D.] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England	National Applied Research Laboratories - Taiwan; University of Warwick	Chen, HM (corresponding author), Natl Appl Res Labs, Natl Nano Device Labs, Nano Biomed Grp, Hsinchu, Taiwan.	hmchen@narlabs.org.tw	Huang, Chih-Yu/AAS-3695-2021	Forrest, Michael/0000-0002-0648-7468	Ministry of Science and Technology [MOST 103-2221-E-492-032]; National Nano Device Laboratories	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Nano Device Laboratories	This work was partly supported from Ministry of Science and Technology (MOST 103-2221-E-492-032) and National Nano Device Laboratories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alan AR, 2002, MOL PLANT MICROBE IN, V15, P701, DOI 10.1094/MPMI.2002.15.7.701; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Chen HM, 1997, BBA-GEN SUBJECTS, V1336, P171, DOI 10.1016/S0304-4165(97)00024-X; Chen HM, 2001, J BIOMOL STRUCT DYN, V19, P193, DOI 10.1080/07391102.2001.10506731; Chen HM, 2001, EUR J BIOCHEM, V268, P1659, DOI 10.1046/j.1432-1033.2001.02039.x; CRUCIANI RA, 1991, P NATL ACAD SCI USA, V88, P3792, DOI 10.1073/pnas.88.9.3792; Del Duca D, 2004, J NEURO-ONCOL, V67, P295, DOI 10.1023/B:NEON.0000024220.07063.70; Deslauriers J, 2002, EUR RESPIR J, V19, p61S, DOI 10.1183/09031936.02.00271302; Desoize B, 2000, CRIT REV ONCOL HEMAT, V36, P193, DOI 10.1016/S1040-8428(00)00086-X; DURAND RE, 1973, RADIAT RES, V56, P513, DOI 10.2307/3573721; Earle Craig C, 2004, J Natl Cancer Inst Monogr, P56; Golden R, 2011, CRIT REV TOXICOL, V41, P672, DOI 10.3109/10408444.2011.573467; Gomperts BN, 2011, SEMIN RESP CRIT CARE, V32, P32, DOI 10.1055/s-0031-1272867; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; HULTMARK D, 1982, EUR J BIOCHEM, V127, P207, DOI 10.1111/j.1432-1033.1982.tb06857.x; Jan PS, 2010, APPL ENVIRON MICROB, V76, P769, DOI 10.1128/AEM.00698-09; Jina XT, 2014, TOXICOLOGY, V322, P99, DOI 10.1016/j.tox.2014.05.002; Kao FS, 2012, BBA-BIOMEMBRANES, V1818, P2927, DOI 10.1016/j.bbamem.2012.07.019; Kiyohara Chikako, 2004, Rev Environ Health, V19, P15; Klein R, 2003, FDA APPROVES FUZEON; Kobayashi M, 2002, CHRONOBIOL INT, V19, P237, DOI 10.1081/CBI-120002600; Kratz JR, 2012, LANCET, V379, P823, DOI 10.1016/S0140-6736(11)61941-7; Meanwell C, 2000, ANGIOMAX PRESCRIBING; MOORE AJ, 1994, PEPTIDE RES, V7, P265; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Mourgues F, 1998, PLANT SCI, V139, P83, DOI 10.1016/S0168-9452(98)00178-2; Murray N, 1997, LUNG CANCER, V17, pS75, DOI 10.1016/S0169-5002(97)00641-7; Nildtovic D, 2014, BBA-GEN SUBJECTS, V1840, P2471, DOI 10.1016/j.bbagen.2014.01.031; Oard S, 2004, J APPL MICROBIOL, V97, P169, DOI 10.1111/j.1365-2672.2004.02291.x; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Patel N, 2007, BRIT J CANCER, V96, P886, DOI 10.1038/sj.bjc.6603659; Riedl S, 2011, CHEM PHYS LIPIDS, V164, P766, DOI 10.1016/j.chemphyslip.2011.09.004; Ross RW, 2002, J UROLOGY, V167, P1952, DOI 10.1016/S0022-5347(05)65060-4; Sakata I, 2012, ONCOL LETT, V3, P297, DOI 10.3892/ol.2011.492; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Schiller JH, 2001, ONCOLOGY-BASEL, V61, P3, DOI 10.1159/000055386; Sehouli J, 2002, GYNECOL ONCOL, V85, P321, DOI 10.1006/gyno.2002.6623; Srisailam S, 2001, EUR J BIOCHEM, V268, P4278, DOI 10.1046/j.1432-1327.2001.02345.x; Srisailam S, 2000, BBA-PROTEIN STRUCT M, V1479, P275, DOI 10.1016/S0167-4838(00)00008-X; Suthar M, 2009, PHARM TIMES, V41, P15; Suzuki H, 2011, PATHOL RES PRACT, V207, P111, DOI 10.1016/j.prp.2010.11.006; Tieleman DP, 2001, PROTEINS, V44, P63, DOI 10.1002/prot.1073; Todd K, 2005, HOSP PHARM, V12, P137; TRAVIS WD, 1995, CANCER-AM CANCER SOC, V75, P191, DOI 10.1002/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-Y; VANZANDWIJK N, 1995, LUNG CANCER-J IASLC, V12, pS27, DOI 10.1016/0169-5002(95)00418-Z; Varlotto JM, 2011, J THORAC ONCOL, V6, P1050, DOI 10.1097/JTO.0b013e318217b6f8; Wagner KW, 2012, CLIN CANCER RES, V18, P585, DOI 10.1158/1078-0432.CCR-11-2087; Wahba HA, 2012, MED ONCOL, V29, P199, DOI 10.1007/s12032-010-9772-0; Wang W, 1998, J BIOL CHEM, V273, P27438, DOI 10.1074/jbc.273.42.27438; Wang W, 1999, BBA-GEN SUBJECTS, V1473, P418, DOI 10.1016/S0304-4165(99)00200-7; Wild C, 2014, WORLD CANC REPORT 20; Worden FP, 2000, EXPERT OPIN INV DRUG, V9, P565, DOI 10.1517/13543784.9.3.565; Wu GQ, 2011, PEPTIDES, V32, P1484, DOI 10.1016/j.peptides.2011.05.009; Wu JM, 2009, PEPTIDES, V30, P839, DOI 10.1016/j.peptides.2009.02.004; Xu Y, 2012, TUMOR BIOL, V33, P475, DOI 10.1007/s13277-011-0276-0; Yin M, 2012, CANCER-AM CANCER SOC, V118, P528, DOI 10.1002/cncr.26214	58	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109174	10.1371/journal.pone.0109174	http://dx.doi.org/10.1371/journal.pone.0109174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310698	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210300039
J	Markun, S; Holzer, BM; Rodak, R; Kaplan, V; Wagner, CC; Battegay, E; Zimmerli, L				Markun, Stefan; Holzer, Barbara M.; Rodak, Roksana; Kaplan, Vladimir; Wagner, Claudia C.; Battegay, Edouard; Zimmerli, Lukas			Therapeutic Conflicts in Emergency Department Patients with Multimorbidity: A Cross-Sectional Study	PLOS ONE			English	Article							INAPPROPRIATE MEDICATION USE; RANDOMIZED CONTROLLED-TRIALS; CLINICAL-PRACTICE GUIDELINES; MULTIPLE CHRONIC CONDITIONS; DRUG-DISEASE INTERACTIONS; ACUTELY ILL POPULATION; BEERS CRITERIA; EXPLICIT CRITERIA; ELDERLY-PATIENTS; CONSENSUS PANEL	Background: Patients with multimorbidity are an increasing concern in healthcare. Clinical practice guidelines, however, do not take into account potential therapeutic conflicts caused by co-occurring medical conditions. This makes therapeutic decisions complex, especially in emergency situations. Objective: The aim of this study was to identify and quantify therapeutic conflicts in emergency department patients with multimorbidity. Methods: We reviewed electronic records of all patients >= 18 years with two or more concurrent active medical conditions, admitted from the emergency department to the hospital ward of the University Hospital Zurich in January 2009. We cross-tabulated all active diagnoses with treatments recommended by guidelines for each diagnosis. Then, we identified potential therapeutic conflicts and classified them as either major or minor conflicts according to their clinical significance. Results: 166 emergency inpatients with multimorbidity were included. The mean number of active diagnoses per patient was 6.6 (SD +/- 3.4). We identified a total of 239 therapeutic conflicts in 49% of the of the study population. In 29% of the study population major therapeutic conflicts, in 41% of the patients minor therapeutic conflicts occurred. Conclusions: Therapeutic conflicts are common among multimorbid patients, with one out of two experiencing minor, and one out of three experiencing major therapeutic conflicts. Clinical practice guidelines need to address frequent therapeutic conflicts in patients with co-morbid medical conditions.	[Markun, Stefan; Holzer, Barbara M.; Rodak, Roksana; Kaplan, Vladimir; Wagner, Claudia C.; Battegay, Edouard; Zimmerli, Lukas] Univ Zurich Hosp, Div Internal Med, CH-8091 Zurich, Switzerland; [Markun, Stefan] Univ Zurich, Univ Zurich Hosp, Inst Gen Practice & Hlth Serv Res, Zurich, Switzerland; [Holzer, Barbara M.; Kaplan, Vladimir; Battegay, Edouard; Zimmerli, Lukas] Univ Zurich, Ctr Competence Multimorbid, Zurich, Switzerland; [Battegay, Edouard] Univ Zurich, Univ Res Prior Program Dynam Hlth Aging, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich	Zimmerli, L (corresponding author), Univ Zurich Hosp, Div Internal Med, CH-8091 Zurich, Switzerland.	lukas.zimmerli@usz.ch		Markun, Stefan/0000-0003-3317-0957				Barry PJ, 2006, J CLIN PHARM THER, V31, P617, DOI 10.1111/j.1365-2710.2006.00783.x; Basow DS, 2009, UPTODATE; BEERS M H, 1991, Archives of Internal Medicine, V151, P1825, DOI 10.1001/archinte.151.9.1825; Beers MH, 1997, ARCH INTERN MED, V157, P1531, DOI 10.1001/archinte.157.14.1531; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Boyd CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041601; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; Fried TR, 2011, ARCH INTERN MED, V171, P75, DOI 10.1001/archinternmed.2010.318; Gallagher P, 2011, EUR J CLIN PHARMACOL, V67, P1175, DOI 10.1007/s00228-011-1061-0; Gallagher PF, 2008, AGE AGEING, V37, P96, DOI 10.1093/ageing/afm116; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Goldberg RM, 1996, AM J EMERG MED, V14, P447, DOI 10.1016/S0735-6757(96)90147-3; Gross CP, 2002, ANN INTERN MED, V137, P10, DOI 10.7326/0003-4819-137-1-200207020-00007; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lindblad CI, 2005, ANN PHARMACOTHER, V39, P412, DOI 10.1345/aph.1E467; McLeod PJ, 1997, CAN MED ASSOC J, V156, P385; Mutasingwa DR, 2011, CAN FAM PHYSICIAN, V57, pE253; Naugler C T, 2000, Can J Clin Pharmacol, V7, P103; Onder G, 2005, EUR J CLIN PHARMACOL, V61, P453, DOI 10.1007/s00228-005-0928-3; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; van den Bussche H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-101; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; World Health Organization, 1992, ICD 10 CLASSIFICATIO	28	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110309	10.1371/journal.pone.0110309	http://dx.doi.org/10.1371/journal.pone.0110309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310005	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000343210300105
J	McLean, NA; Popescu, BF; Gordon, T; Zochodne, DW; Verge, VMK				McLean, Nikki A.; Popescu, Bogdan F.; Gordon, Tessa; Zochodne, Douglas W.; Verge, Valerie M. K.			Delayed Nerve Stimulation Promotes Axon-Protective Neurofilament Phosphorylation, Accelerates Immune Cell Clearance and Enhances Remyelination In Vivo in Focally Demyelinated Nerves	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; GENE-RELATED PEPTIDE; SPINAL-CORD-INJURY; NEUROTROPHIC FACTOR; PERIPHERAL-NERVE; SCHWANN-CELLS; SCIATIC-NERVE; WHITE-MATTER; LYSOPHOSPHATIDYL CHOLINE; CNS REMYELINATION	Rapid and efficient axon remyelination aids in restoring strong electrochemical communication with end organs and in preventing axonal degeneration often observed in demyelinating neuropathies. The signals from axons that can trigger more effective remyelination in vivo are still being elucidated. Here we report the remarkable effect of delayed brief electrical nerve stimulation (ES; 1 hour @ 20 Hz 5 days post-demyelination) on ensuing reparative events in a focally demyelinated adult rat peripheral nerve. ES impacted many parameters underlying successful remyelination. It effected increased neurofilament expression and phosphorylation, both implicated in axon protection. ES increased expression of myelin basic protein (MBP) and promoted node of Ranvier re-organization, both of which coincided with the early reappearance of remyelinated axons, effects not observed at the same time points in non-stimulated demyelinated nerves. The improved ES-associated remyelination was accompanied by enhanced clearance of ED-1 positive macrophages and attenuation of glial fibrillary acidic protein expression in accompanying Schwann cells, suggesting a more rapid clearance of myelin debris and return of Schwann cells to a nonreactive myelinating state. These benefits of ES correlated with increased levels of brain derived neurotrophic factor (BDNF) in the acute demyelination zone, a key molecule in the initiation of the myelination program. In conclusion, the tremendous impact of delayed brief nerve stimulation on enhancement of the innate capacity of a focally demyelinated nerve to successfully remyelinate identifies manipulation of this axis as a novel therapeutic target for demyelinating pathologies.	[McLean, Nikki A.; Popescu, Bogdan F.; Verge, Valerie M. K.] Univ Saskatchewan, Cameco MS Neurosci Res Ctr, Saskatoon, SK, Canada; [McLean, Nikki A.; Popescu, Bogdan F.; Verge, Valerie M. K.] Univ Saskatchewan, Dept Anat & Cell Biol, Saskatoon, SK, Canada; [Gordon, Tessa] Univ Toronto, Dept Surg, Div Plast Reconstruct Surg, Toronto, ON, Canada; [Zochodne, Douglas W.] Univ Alberta, Dept Med, Div Neurol, Edmonton, AB, Canada	University of Saskatchewan; University of Saskatchewan; University of Toronto; University of Alberta	Verge, VMK (corresponding author), Univ Saskatchewan, Cameco MS Neurosci Res Ctr, Saskatoon, SK, Canada.	valerie.verge@usask.ca			Canadian Institutes of Health Research [RMF82496DZ, MOP74747]; University of Saskatchewan; University of Saskatchewan College of Medicine	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan; University of Saskatchewan College of Medicine	This research was supported by Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) Regenerative Medicine and Nanomedicine Program grant RMF82496DZ to VMKV, TG and DZ; and Canadian Institutes of Health Research operating grant MOP74747 to VMKV. NAM is supported by University of Saskatchewan Graduate and University of Saskatchewan College of Medicine Scholarship programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Majed AA, 2000, EUR J NEUROSCI, V12, P4381, DOI 10.1046/j.1460-9568.2000.01341.x; Al-Majed AA, 2000, J NEUROSCI, V20, P2602; ALLT G, 1988, ACTA NEUROPATHOL, V75, P456, DOI 10.1007/BF00687132; Arroyo EJ, 2004, J COMP NEUROL, V479, P424, DOI 10.1002/cne.20321; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Barouch R, 2001, J NEUROIMMUNOL, V112, P72, DOI 10.1016/S0165-5728(00)00408-2; Bernardini N, 2004, NEUROSCIENCE, V126, P585, DOI 10.1016/j.neuroscience.2004.03.017; Bouhy D, 2006, FASEB J, V20, P1239, DOI 10.1096/fj.05-4382fje; Bruck W, 1997, BRAIN PATHOL, V7, P741, DOI 10.1111/j.1750-3639.1997.tb01060.x; Brushart TM, 2005, EXP NEUROL, V194, P221, DOI 10.1016/j.expneurol.2005.02.007; Camara J, 2009, J CELL BIOL, V185, P699, DOI 10.1083/jcb.200807010; Chan JR, 2006, SCIENCE, V314, P832, DOI 10.1126/science.1134069; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Chan JR, 2001, P NATL ACAD SCI USA, V98, P14661, DOI 10.1073/pnas.251543398; Cheng C, 2002, NEUROSCIENCE, V115, P321, DOI 10.1016/S0306-4522(02)00291-9; Chio A, 2003, NEUROLOGY, V60, P1146, DOI 10.1212/01.WNL.0000055091.96905.D0; Clerico M, 2008, CLIN NEUROL NEUROSUR, V110, P878, DOI 10.1016/j.clineuro.2007.10.020; COLELLO RJ, 1995, J NEUROSCI, V15, P7665; Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595; Cui QL, 2010, J NEUROPATH EXP NEUR, V69, P930, DOI 10.1097/NEN.0b013e3181ef3be4; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Dieni S, 2012, J CELL BIOL, V196, P775, DOI 10.1083/jcb.201201038; Dougherty KD, 2000, NEUROBIOL DIS, V7, P574, DOI 10.1006/nbdi.2000.0318; Drenthen J, 2013, NEUROLOGY, V81, P1827, DOI 10.1212/01.wnl.0000436073.21406.e6; DYCK PJ, 1989, NEUROLOGY, V39, P1302, DOI 10.1212/WNL.39.10.1302; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; English AW, 2007, DEV NEUROBIOL, V67, P158, DOI 10.1002/dneu.20339; English AW, 2013, P NATL ACAD SCI USA, V110, P16217, DOI 10.1073/pnas.1303646110; FITZGERALD M, 1987, NATURE, V326, P603, DOI 10.1038/326603a0; FRIEDE RL, 1970, ANAT REC, V167, P379, DOI 10.1002/ar.1091670402; Fry EJ, 2007, NEURON, V53, P649, DOI 10.1016/j.neuron.2007.02.009; Geremia NM, 2007, EXP NEUROL, V205, P347, DOI 10.1016/j.expneurol.2007.01.040; Geremia NM, 2010, EXP NEUROL, V223, P128, DOI 10.1016/j.expneurol.2009.07.022; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; GOLDSTEIN ME, 1987, J NEUROIMMUNOL, V14, P149, DOI 10.1016/0165-5728(87)90049-X; GREENWOOD JA, 1993, J NEUROCHEM, V61, P191, DOI 10.1111/j.1471-4159.1993.tb03555.x; GRIFFIN JW, 1992, J NEUROIMMUNOL, V40, P153, DOI 10.1016/0165-5728(92)90129-9; GRIFFIN JW, 1990, J NEUROCYTOL, V19, P367, DOI 10.1007/BF01188405; HALL SM, 1972, J CELL SCI, V10, P535; HALL SM, 1971, J CELL SCI, V9, P769; HOFFMAN PN, 1987, P NATL ACAD SCI USA, V84, P3472, DOI 10.1073/pnas.84.10.3472; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; KAMAKURA K, 1983, J NEUROCHEM, V40, P908, DOI 10.1111/j.1471-4159.1983.tb08072.x; Karimi-Abdolrezaee S, 2004, EUR J NEUROSCI, V19, P577, DOI 10.1111/j.0953-816X.2004.03164.x; Kiefer R, 2001, PROG NEUROBIOL, V64, P109, DOI 10.1016/S0301-0082(00)00060-5; Koda M, 2002, J NEUROTRAUM, V19, P777, DOI 10.1089/08977150260139147; Kotter MR, 2001, GLIA, V35, P204, DOI 10.1002/glia.1085; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Kotter MR, 2005, NEUROBIOL DIS, V18, P166, DOI 10.1016/j.nbd.2004.09.019; Kuhlmann T, 2001, J NEUROSCI, V21, P3401, DOI 10.1523/JNEUROSCI.21-10-03401.2001; LEE VMY, 1987, J NEUROSCI, V7, P3474; Mannion RJ, 1999, P NATL ACAD SCI USA, V96, P9385, DOI 10.1073/pnas.96.16.9385; Martini R, 2008, GLIA, V56, P1566, DOI 10.1002/glia.20766; McTigue DM, 1998, J NEUROSCI, V18, P5354, DOI 10.1523/JNEUROSCI.18-14-05354.1998; MEYER M, 1992, J CELL BIOL, V119, P45, DOI 10.1083/jcb.119.1.45; Michael GJ, 1997, J NEUROSCI, V17, P8476; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Nakahara J, 2009, EXPERT OPIN THER TAR, V13, P1375, DOI 10.1517/14728220903307491; Ng BK, 2007, J NEUROSCI, V27, P7597, DOI 10.1523/JNEUROSCI.0563-07.2007; Pant HC, 1995, BIOCHEM CELL BIOL, V73, P575, DOI 10.1139/o95-063; PANT HC, 1988, BIOCHEM J, V256, P665, DOI 10.1042/bj2560665; Pavelko KD, 1998, J NEUROSCI, V18, P2498; Plemel JR, 2013, GLIA, V61, P1471, DOI 10.1002/glia.22535; Rasband M, 1998, J NEUROSCI, V18, P36; RUBINSTEIN CT, 1990, BRAIN RES, V524, P303, DOI 10.1016/0006-8993(90)90705-G; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; SAKAGUCHI T, 1993, NEUROSCI LETT, V153, P65, DOI 10.1016/0304-3940(93)90078-Y; Sampaio-Baptista C, 2013, J NEUROSCI, V33, P19499, DOI 10.1523/JNEUROSCI.3048-13.2013; Sauer SK, 1999, NEUROSCIENCE, V92, P319, DOI 10.1016/S0306-4522(98)00731-3; Schafer DP, 2006, NEURON GLIA BIOL, V2, P69, DOI 10.1017/S1740925X06000093; Scherer SS, 2001, GLIAL CELL DEV; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Silber E, 1999, J NEUROL SCI, V170, P11, DOI 10.1016/S0022-510X(99)00178-1; Singh B, 2012, J NEUROSURG, V116, P498, DOI 10.3171/2011.10.JNS11612; Starr R, 1996, J NEUROSCI RES, V44, P328; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Stevens B, 1998, J NEUROSCI, V18, P9303; Tokuoka H, 2000, J CELL SCI, V113, P1059; Tolwani RJ, 2004, J NEUROSCI RES, V77, P662, DOI 10.1002/jnr.20181; Tonra JR, 1998, J NEUROSCI, V18, P4374; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Verderio C, 2006, BRAIN CELL BIOL, V35, P187, DOI 10.1007/s11068-007-9011-6; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Wan LD, 2010, J NEUROSCI RES, V88, P2578, DOI 10.1002/jnr.22426; Wang J, 2010, ARTIF CELL BLOOD SUB, V38, P24, DOI 10.3109/10731190903495736; WEINBERG HJ, 1976, BRAIN RES, V113, P363, DOI 10.1016/0006-8993(76)90947-1; WINER JB, 1988, J NEUROL NEUROSUR PS, V51, P605, DOI 10.1136/jnnp.51.5.605; Wong I, 2010, BRAIN BEHAV IMMUN, V24, P585, DOI 10.1016/j.bbi.2010.01.001; YAGIHASHI S, 1990, AM J PATHOL, V136, P1365; Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525; Zhang JY, 2000, EUR J NEUROSCI, V12, P4171, DOI 10.1046/j.1460-9568.2000.01312.x; Zhou XF, 1999, NEUROSCIENCE, V92, P841, DOI 10.1016/S0306-4522(99)00027-5; Zhou XF, 1996, NEUROSCIENCE, V74, P945, DOI 10.1016/S0306-4522(96)00237-0	96	17	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110174	10.1371/journal.pone.0110174	http://dx.doi.org/10.1371/journal.pone.0110174			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310564	gold, Green Published, Green Submitted			2022-12-27	WOS:000343210300094
J	Ding, XX; Li, XF; Deng, YQ; Guo, YH; Hao, W; Che, XY; Qin, CF; Fu, N				Ding, Xi-Xia; Li, Xiao-Feng; Deng, Yong-Qiang; Guo, Yong-Hui; Hao, Wei; Che, Xiao-Yan; Qin, Cheng-Feng; Fu, Ning			Development of a Double Antibody Sandwich ELISA for West Nile Virus Detection Using Monoclonal Antibodies against Non-Structural Protein 1	PLOS ONE			English	Article							ANTIGEN CAPTURE IMMUNOASSAY; DENGUE VIRUS; JAPANESE ENCEPHALITIS; GUANGDONG PROVINCE; CELL-CULTURE; NS1 PROTEIN; ACUTE-PHASE; DEAD BIRDS; INFECTION; ASSAY	The early diagnosis of West Nile virus (WNV) infection is important for successful clinical management and epidemiological control. The non-structural protein 1 (NS1) of flavivirus, a highly conserved and secreted glycoprotein, is abundant in the serum of flavivirus-infected patients and represents a useful early diagnostic marker. We developed a WNV-specific NS1 antigen-capture ELISA using two mouse monoclonal antibodies (MAbs) that recognised distinct epitopes of the NS1 protein of WNV as capture and detection antibodies. The antigen-capture ELISA displayed exclusive specificity to WNV without cross-reaction with other related members of the flavivirus family, including the dengue virus, yellow fever virus, Japanese encephalitis virus, and tick-borne encephalitis virus. Additionally, the specificity was presented as no false positive in normal (0/1003) and DENV-infected (0/107) human serum specimens. The detection limit of the antigen-capture ELISA was as low as 15 pg/ml of recombinant WNV NS1 protein (rWNV-NS1) and 6.1 plaque-forming units (PFU)/0.1 ml of WNV-infected culture supernatant. In mice infected with WNV, the NS1 protein was readily detected in serum as early as one day after WNV infection, prior to the development of clinical signs of the disease. The sensitivity of the NS1 capture ELISA (93.7%) was significantly higher (79.4%) than that of real-time reverse transcription polymerase chain reaction in 63 serum samples from WNV-infected mice (p = 0.035). This newly developed NS1 antigen-capture ELISA with high sensitivity and specificity could be used as an efficient method for the early diagnosis of WNV infection in animals or humans.	[Ding, Xi-Xia; Guo, Yong-Hui; Hao, Wei; Che, Xiao-Yan; Fu, Ning] Southern Med Univ, Zhujiang Hosp, Lab Emerging Infect Dis, Guangzhou, Guangdong, Peoples R China; [Ding, Xi-Xia; Guo, Yong-Hui; Hao, Wei; Che, Xiao-Yan; Fu, Ning] Southern Med Univ, Zhujiang Hosp, Div Lab Med, Guangzhou, Guangdong, Peoples R China; [Li, Xiao-Feng; Deng, Yong-Qiang; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Southern Medical University - China; Southern Medical University - China; Beijing Institute of Microbiology & Epidemiology	Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	chengfeng_qin@126.com; zfzn2013@126.com	Qin, Cheng-Feng/I-6839-2019	Qin, Cheng-Feng/0000-0002-0632-2807	National Projects of Major Infectious Disease Control and Prevention [2012ZX10004213, 2013ZX10004-805]; National High Technology Research and Development Program of China (863 Program) [2011AA02A116]; GDUPS	National Projects of Major Infectious Disease Control and Prevention; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); GDUPS	This work was supported by grant Nos. 2012ZX10004213 and 2013ZX10004-805 of the National Projects of Major Infectious Disease Control and Prevention and 2011AA02A116 of the National High Technology Research and Development Program of China (863 Program) and grant 2009 GDUPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002; Bai ZJ, 2008, J MED MICROBIOL, V57, P1547, DOI 10.1099/jmm.0.2008/003418-0; Ben-Nathan D, 2003, J INFECT DIS, V188, P5, DOI 10.1086/376870; Burkhalter KL, 2006, J AM MOSQUITO CONTR, V22, P64, DOI 10.2987/8756-971X(2006)22[64:EOCAFD]2.0.CO;2; Busch MP, 2005, NEW ENGL J MED, V353, P460, DOI 10.1056/NEJMoa044029; Busch MP, 2005, TRANSFUSION, V45, P492, DOI 10.1111/j.0041-1132.2005.04382.x; Castillo-Olivares J, 2004, VET RES, V35, P467, DOI 10.1051/vetres:2004022; Chung KM, 2008, J MED VIROL, V80, P547, DOI 10.1002/jmv.21091; Ding Xi-xia, 2010, Zhonghua Weishengwuxue He Mianyixue Zazhi, V30, P566, DOI 10.3760/cma.j.issn.0254-5101.2010.06.018; Ding XX, 2011, CLIN VACCINE IMMUNOL, V18, P430, DOI 10.1128/CVI.00462-10; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Hu DM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-47; Julander JG, 2005, ANTIVIR RES, V65, P79, DOI 10.1016/j.antiviral.2004.10.005; Kitai Y, 2011, J VIROL METHODS, V171, P123, DOI 10.1016/j.jviromet.2010.10.012; Li SH, 2013, J VIROL, V87, P5812, DOI 10.1128/JVI.02806-12; Li SH, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-64; Li XF, 2010, J GEN VIROL, V91, P1218, DOI 10.1099/vir.0.013854-0; Lindsay R, 2003, EMERG INFECT DIS, V9, P1406, DOI 10.3201/eid0911.030318; Macdonald J, 2005, J VIROL, V79, P13924, DOI 10.1128/JVI.79.22.13924-13933.2005; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Padgett KA, 2006, VECTOR-BORNE ZOONOT, V6, P183, DOI 10.1089/vbz.2006.6.183; PORSTMANN T, 1992, J IMMUNOL METHODS, V150, P5, DOI 10.1016/0022-1759(92)90061-W; Qiu LW, 2009, CLIN VACCINE IMMUNOL, V16, P88, DOI 10.1128/CVI.00212-08; Ratterree MS, 2004, J INFECT DIS, V189, P669, DOI 10.1086/381461; Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007; Saxena D, 2013, J CLIN VIROL, V58, P528, DOI 10.1016/j.jcv.2013.08.033; Siirin M, 2004, VECTOR-BORNE ZOONOT, V4, P204, DOI 10.1089/vbz.2004.4.204; Stone WB, 2004, EMERG INFECT DIS, V10, P2175, DOI 10.3201/eid1012.040836; Tardei G, 2000, J CLIN MICROBIOL, V38, P2232; Xu H, 2006, J CLIN MICROBIOL, V44, P2872, DOI 10.1128/JCM.00777-06; Yong-hui G, 2009, CHINESE J ZOONOSES, V25, P545; Yong-qiang D, 2005, CHINESE J MICROBIOLO, V25, P519; Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000; Zeller HG, 2004, EUR J CLIN MICROBIOL, V23, P147, DOI 10.1007/s10096-003-1085-1; Zheng K, 2009, EPIDEMIOL INFECT, V137, P73, DOI 10.1017/S0950268808000617	36	6	8	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108623	10.1371/journal.pone.0108623	http://dx.doi.org/10.1371/journal.pone.0108623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303282	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400019
J	Kiss, T; Krajcs, N; Pirger, Z; Hernadi, L				Kiss, Tibor; Krajcs, Nora; Pirger, Zsolt; Hernadi, Laszlo			Nicotinic Acetylcholine Receptors Containing the alpha 7-Like Subunit Mediate Contractions of Muscles Responsible for Space Positioning of the Snail, Helix pomatia L. Tentacle	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SALIVARY-GLAND CELLS; APLYSIA NEURONS; CAENORHABDITIS-ELEGANS; SYNAPTIC TRANSMISSION; SEPIA-OFFICINALIS; LYMNAEA-STAGNALIS; FLEXOR MUSCLES; BUCCAL MUSCLES; SMOOTH-MUSCLE	Three recently discovered tentacle muscles are crucial to perform patterned movements of upper tentacles of the terrestrial snail, Helix pomatia. The muscles receive central and peripheral excitatory cholinergic innervation lacking inhibitory innervation. Here, we investigate the pharmacology of acetylcholine (ACh) responses in muscles to determine the properties of the ACh receptor (AChR), the functional availability of which was assessed using isotonic contraction measurement. Using broad spectrum of nicotinic and muscarinic ligands, we provide the evidence that contractions in the muscles are attributable to the activation of nAChRs that contain the alpha 7-like subunit. Contractions could be evoked by nicotine, carbachol, succinylchloride, TMA, the selective alpha 7-nAChR agonist choline chloride, 3-Bromocytisine and PNU-282987, and blocked by nAChR selective antagonists such as mytolon, hexamethonium, succinylchloride, d-tubocurarine, hemicholinium, DMDA (decamethonium), methyllycaconitine, alpha-Bungarotoxin (alpha BgTx) and alpha-Conotoxin IMI. The specific muscarinic agonist oxotremorine and arecoline failed to elicit contractions. Based on these pharmacological properties we conclude that the Na+ and Ca2+ permeable AChRs of the flexor muscle are nicotinic receptors that contain the alpha 7-like subunit. Immunodetection experiments confirmed the presence of alpha 7-or alpha 7-like AChRs in muscle cells, and alpha 4-AChRs in nerves innervating the muscle. These results support the conclusion that the slowly desensitizing alpha BgTx-sensitive responses obtained from flexor muscles are produced by activation of alpha 7- like AChRs. This is the first demonstration of postsynaptic expression and an obligatory role for a functional alpha 7-like nAChR in the molluscan periphery.	[Kiss, Tibor; Krajcs, Nora; Hernadi, Laszlo] MTA Ctr Ecol Res, Balaton Limnol Inst, Dept Expt Zool, Chem Ecol & Neurobiol Grp, Tihany, Hungary; [Pirger, Zsolt] Natl Brain Project Team, Adapt Neuroetol MTA CER, Tihany, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Hungarian Balaton Limnological Research Institute	Kiss, T (corresponding author), MTA Ctr Ecol Res, Balaton Limnol Inst, Dept Expt Zool, Chem Ecol & Neurobiol Grp, Tihany, Hungary.	kiss.tibor@okologia.mta.hu	Pirger, Zsolt/AAH-7907-2021; PIRGER, Zsolt/AAH-4045-2020; Krajcs, Nora/O-2617-2019	PIRGER, Zsolt/0000-0001-9039-6966; 	 [TAMOP-4.2.2.A-/11/1 KONV-2012-0024]		TAMOP-4.2.2.A-/11/1 KONV-2012-0024 grant to T. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJIMAL GS, 1981, COMP BIOCHEM PHYS C, V68, P133, DOI 10.1016/0306-4492(81)90007-1; Alkondon M, 1997, EUR J NEUROSCI, V9, P2734, DOI 10.1111/j.1460-9568.1997.tb01702.x; ALKONDON M, 1993, J PHARMACOL EXP THER, V265, P1455; ASCHER P, 1978, J PHYSIOL-LONDON, V278, P177, DOI 10.1113/jphysiol.1978.sp012299; BAHLS F, 1987, CELL MOL NEUROBIOL, V7, P35, DOI 10.1007/BF00734988; Ballivet M, 1996, J MOL BIOL, V258, P261, DOI 10.1006/jmbi.1996.0248; BARBER A, 1985, COMP BIOCHEM PHYS C, V80, P175, DOI 10.1016/0742-8413(85)90151-3; Bellanger C, 2005, NEUROSCI LETT, V387, P162, DOI 10.1016/j.neulet.2005.06.017; BUCKETT KJ, 1990, J NEUROPHYSIOL, V63, P1426, DOI 10.1152/jn.1990.63.6.1426; CAREW TJ, 1974, J NEUROPHYSIOL, V37, P1020, DOI 10.1152/jn.1974.37.5.1020; COHEN JL, 1978, J NEUROPHYSIOL, V41, P157, DOI 10.1152/jn.1978.41.1.157; COTTRELL GA, 1968, COMP BIOCHEM PHYSIOL, V27, P787, DOI 10.1016/0010-406X(68)90618-X; CRAVEIRO JPM, 1990, COMP BIOCHEM PHYS C, V95, P91, DOI 10.1016/0742-8413(90)90087-P; D'Este L, 2008, J COMP NEUROL, V509, P566, DOI 10.1002/cne.21761; De La Porte S, 1998, EUR J NEUROSCI, V10, P1631; EVANS T G, 1971, Comparative and General Pharmacology, V2, P5, DOI 10.1016/0010-4035(71)90062-0; Francis MM, 1996, NEUROPHARMACOLOGY, V35, P1547, DOI 10.1016/S0028-3908(96)00103-7; Gebauer M, 1998, COMP BIOCHEM PHYS C, V119, P13, DOI 10.1016/S0742-8413(97)00162-X; GERSCHENFELD HM, 1973, PHYSIOL REV, V53, P1, DOI 10.1152/physrev.1973.53.1.1; Herber DL, 2004, J HISTOCHEM CYTOCHEM, V52, P1367, DOI 10.1369/jhc.4A6319.2004; Hernadi L, 2012, ACTA BIOL HUNG, V63, P123, DOI 10.1556/ABiol.63.2012.Suppl.2.16; HILL RB, 1974, J EXP BIOL, V61, P629; Holden-Dye L, 2013, PARASITOL INT, V62, P606, DOI 10.1016/j.parint.2013.03.004; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; JORDAN R, 1993, J EXP ZOOL, V265, P496, DOI 10.1002/jez.1402650505; KEHOE J, 1972, J PHYSIOL-LONDON, V225, P115, DOI 10.1113/jphysiol.1972.sp009931; Kehoe J, 1998, J NEUROSCI, V18, P8198; KEHOE J, 1972, J PHYSIOL-LONDON, V225, P147, DOI 10.1113/jphysiol.1972.sp009932; KELLY JS, 1985, NEUROTRANSMITTER ACT, P143; Kelly JS, 1985, ACETYLCHOLINE; KISS I, 1978, COMP BIOCHEM PHYS C, V60, P89, DOI 10.1016/0306-4492(78)90033-3; KISS T, 1972, Annales Instituti Biologici (Tihany) Hungaricae Academiae Scientiarum, V39, P29; Kobayashi M, 1977, COMP BIOCH PHYSL C, V60C, P115; Kozak JA, 1996, J NEUROPHYSIOL, V75, P660, DOI 10.1152/jn.1996.75.2.660; Krajcs N, 2014, INVERTEBR NEUROSCI, V14, P59, DOI 10.1007/s10158-013-0164-y; Krajcs N, 2012, ACTA BIOL HUNG, V63, P129, DOI 10.1556/ABiol.63.2012.Suppl.2.17; Laurienti PJ, 1999, J NEUROPHYSIOL, V82, P778, DOI 10.1152/jn.1999.82.2.778; LINDSTROM J, 1995, ANN NY ACAD SCI, V757, P100, DOI 10.1111/j.1749-6632.1995.tb17467.x; Moser N, 2007, J NEUROCHEM, V102, P479, DOI 10.1111/j.1471-4159.2007.04498.x; MURRAY TF, 1988, BRAIN RES BULL, V21, P181, DOI 10.1016/0361-9230(88)90230-4; NELSON ID, 1992, GEN PHARMACOL, V23, P317, DOI 10.1016/0306-3623(92)90089-3; PANCHIN YV, 1995, J NEUROPHYSIOL, V73, P1924, DOI 10.1152/jn.1995.73.5.1924; PETERS M, 1979, COMP BIOCHEM PHYS C, V62, P181, DOI 10.1016/0306-4492(79)90007-8; RAM JL, 1983, BRAIN RES, V288, P177, DOI 10.1016/0006-8993(83)90092-6; RAM JL, 1994, COMP BIOCHEM PHYS C, V107, P235, DOI 10.1016/1367-8280(94)90046-9; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; TWAROG BM, 1960, J PHYSIOL-LONDON, V152, P236, DOI 10.1113/jphysiol.1960.sp006484; van Nierop P, 2006, J BIOL CHEM, V281, P1680, DOI 10.1074/jbc.M508571200; van Nierop P, 2005, J NEUROSCI, V25, P10617, DOI 10.1523/JNEUROSCI.2015-05.2005; Vulfius CA, 2005, NEUROSCI LETT, V373, P232, DOI 10.1016/j.neulet.2004.10.010; Vulfius CA, 2001, NEUROSCI LETT, V309, P189, DOI 10.1016/S0304-3940(01)02081-X; Walker RJ, 1996, PARASITOLOGY, V113, pS3, DOI 10.1017/S0031182000077878; WELLS DW, 1980, COMP BIOCHEM PHYS C, V67, P97, DOI 10.1016/0306-4492(80)90003-9; Wright TJ, 2002, J COMP PHYSIOL B, V172, P237, DOI 10.1007/s00360-001-0248-6; YAROWSKY PJ, 1978, J NEUROPHYSIOL, V41, P531	55	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109538	10.1371/journal.pone.0109538	http://dx.doi.org/10.1371/journal.pone.0109538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303328	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400064
J	Brozynska, M; Furtado, A; Henry, RJ				Brozynska, Marta; Furtado, Agnelo; Henry, Robert James			Direct Chloroplast Sequencing: Comparison of Sequencing Platforms and Analysis Tools for Whole Chloroplast Barcoding	PLOS ONE			English	Article							GENOME SEQUENCES; DNA; IDENTIFICATION; MUTANT	Direct sequencing of total plant DNA using next generation sequencing technologies generates a whole chloroplast genome sequence that has the potential to provide a barcode for use in plant and food identification. Advances in DNA sequencing platforms may make this an attractive approach for routine plant identification. The HiSeq (Illumina) and Ion Torrent (Life Technology) sequencing platforms were used to sequence total DNA from rice to identify polymorphisms in the whole chloroplast genome sequence of a wild rice plant relative to cultivated rice (cv. Nipponbare). Consensus chloroplast sequences were produced by mapping sequence reads to the reference rice chloroplast genome or by de novo assembly and mapping of the resulting contigs to the reference sequence. A total of 122 polymorphisms (SNPs and indels) between the wild and cultivated rice chloroplasts were predicted by these different sequencing and analysis methods. Of these, a total of 102 polymorphisms including 90 SNPs were predicted by both platforms. Indels were more variable with different sequencing methods, with almost all discrepancies found in homopolymers. The Ion Torrent platform gave no apparent false SNP but was less reliable for indels. The methods should be suitable for routine barcoding using appropriate combinations of sequencing platform and data analysis.	[Brozynska, Marta; Furtado, Agnelo; Henry, Robert James] Univ Queensland, Brisbane, Qld, Australia	University of Queensland	Henry, RJ (corresponding author), Univ Queensland, Brisbane, Qld, Australia.	robert.henry@uq.edu.au	Henry, Robert J/B-5824-2008	Henry, Robert J/0000-0002-4060-0292; Furtado, Agnelo/0000-0001-6130-9026; Brozynska, Marta/0000-0002-8930-2683	Rural Industries Research and Development Corporation (Australia)	Rural Industries Research and Development Corporation (Australia)	The research was funded by Rural Industries Research and Development Corporation (Australia). The funders played no role in study design, data collection, decision to publish or preparation of the manuscript.	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Bragg LM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003031; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Diaz-Sanchez S, 2013, POULTRY SCI, V92, P562, DOI 10.3382/ps.2012-02741; Ferrarini M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-670; Furtado A, 2014, METHODS MOL BIOL, V1099, P1, DOI 10.1007/978-1-62703-715-0_1; Galimberti A, 2013, FOOD RES INT, V50, P55, DOI 10.1016/j.foodres.2012.09.036; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Hartwig B, 2012, PLANT PHYSIOL, V160, P591, DOI 10.1104/pp.112.200311; Henry R. J., 2013, MOL MARKERS PLANTS; Henry R. J., 2001, PLANT GENOTYPING DNA; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lang BF, 2007, NAT PROTOC, V2, P652, DOI 10.1038/nprot.2007.58; Lee KH, 2013, PLANT J, V73, P720, DOI 10.1111/tpj.12055; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; McPherson H, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-8; Meacham F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-451; Nock CJ, 2011, PLANT BIOTECHNOL J, V9, P328, DOI 10.1111/j.1467-7652.2010.00558.x; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Sotowa M, 2013, RICE, V6, DOI 10.1186/1939-8433-6-26; Straub SCK, 2012, AM J BOT, V99, P349, DOI 10.3732/ajb.1100335; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x	29	13	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110387	10.1371/journal.pone.0110387	http://dx.doi.org/10.1371/journal.pone.0110387			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329378	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204100071
J	Peyton, KA; Valentino, LM; Maruska, KP				Peyton, Kimberly A.; Valentino, Lauren M.; Maruska, Karen P.			Dual Roles of an Algal Farming Damselfish as a Cultivator and Opportunistic Browser of an Invasive Seaweed	PLOS ONE			English	Article							ACANTHOPHORA-SPICIFERA RHODOPHYTA; MARINE PROTECTED AREAS; TURTLES CHELONIA-MYDAS; KANEOHE BAY; TERRITORIAL DAMSELFISH; BENTHIC COMMUNITIES; PHASE-SHIFTS; CORAL; DIVERSITY; HERBIVORY	Herbivory is a fundamental process determining reef resilience, and while algal farming damselfishes can help shape benthic assemblages, an understanding of their contribution to areas outside of defended territories is relatively unexplored. Here, we demonstrate how the farming damselfish Stegastes marginatus plays a dual role in benthic structuring by 1) contributing to persistence of the invasive macroalga Acanthophora spicifera within a Hawaiian marine protected area, where the macroalga occurred exclusively inside Stegastes territories, and 2) behaving as an opportunistic browser of the exotic alga outside their territorial borders. Greater than 50% of the biomass of tethered A. spicifera was consumed within one-hour when placed outside Stegastes territories, compared to <5% lost from tethers within territories or herbivore exclusion cages. In situ remote video revealed that tethered A. spicifera located outside territories was grazed primarily by the surgeonfish Acanthurus nigrofuscus (similar to 68% of total bites) and, surprisingly, by S. marginatus (similar to 27% of total bites) that left their territories to feed on this resource on 107 occasions during 400 min of filming. Further, for over half of those occurrences where S. marginatus grazed on the tethered macroalga outside of territories, they fed alongside conspecifics and other species, displaying little of the aggressiveness that characterizes this damselfish. These results show that S. marginatus plays a wider role in determining benthic assemblages than previously recognized, acting both as cultivators of a canopy-forming invasive macroalga within their territories, and as opportunistic browsers in neighboring sites. Consequently, S. marginatus can affect benthic species composition across their territory borders. These results provide a rare example of interspecific facilitation of an exotic alga by an indigenous marine fish. Accounting for fish behaviors more broadly is important to further our understanding of ecological processes that shape reef ecosystems to improve management of MPAs that often support extensive farming damselfish populations.	[Peyton, Kimberly A.; Valentino, Lauren M.] Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Maruska, Karen P.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	University of Hawaii System; University of Hawaii Manoa; Louisiana State University System; Louisiana State University	Peyton, KA (corresponding author), State Hawaii, Dept Land & Nat Resources, Div Aquat Resources, Honolulu, HI 96815 USA.	peyton@hawaii.edu	Valentino, Lauren/A-3068-2017	Valentino, Lauren/0000-0002-8748-9050	Hawaii Coral Reef Initiative [NA09NOS4260242]; Department of Biological Sciences in the College of Science at Louisiana State University	Hawaii Coral Reef Initiative; Department of Biological Sciences in the College of Science at Louisiana State University	K.A.P was supported by Hawaii Coral Reef Initiative Grant Number: NA09NOS4260242 awarded to F. Thomas. K.P.M. was supported by start-up funds from the Department of Biological Sciences in the College of Science at Louisiana State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur KE, 2008, PAC SCI, V62, P205, DOI 10.2984/1534-6188(2008)62[205:ACOIGT]2.0.CO;2; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Burkepile DE, 2011, CORAL REEFS, V30, P351, DOI 10.1007/s00338-011-0726-6; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Ceccarelli DM, 2007, CORAL REEFS, V26, P853, DOI 10.1007/s00338-007-0275-1; Ceccarelli DM, 2005, CORAL REEFS, V24, P606, DOI 10.1007/s00338-005-0035-z; Ceccarelli DM, 2005, OECOLOGIA, V145, P445, DOI 10.1007/s00442-005-0144-y; Ceccarelli DM, 2001, OCEANOGR MAR BIOL, V39, P355; Cheal AJ, 2010, CORAL REEFS, V29, P1005, DOI 10.1007/s00338-010-0661-y; Cheal AJ, 2013, ECOL APPL, V23, P174, DOI 10.1890/11-2253.1; Conklin EJ, 2005, BIOL INVASIONS, V7, P1029, DOI 10.1007/s10530-004-3125-x; Dailer ML, 2012, HARMFUL ALGAE, V17, P111, DOI 10.1016/j.hal.2012.03.008; DOTY MAXWELL S., 1961, PACIFIC SCI, V15, P547; Friedlander AM, 2007, MAR ECOL PROG SER, V351, P221, DOI 10.3354/meps07112; Gobler CJ, 2006, J EXP MAR BIOL ECOL, V336, P135, DOI 10.1016/j.jembe.2006.04.012; HARTWICK EB, 1978, WILSON BULL, V90, P650; Hata H, 2006, BIOL LETT-UK, V2, P593, DOI 10.1098/rsbl.2006.0528; HINDS PA, 1987, AQUAT BOT, V27, P299, DOI 10.1016/0304-3770(87)90070-2; Hixon MA, 1996, ECOL MONOGR, V66, P67, DOI 10.2307/2963481; HIXON MA, 1983, SCIENCE, V220, P511, DOI 10.1126/science.220.4596.511; Hoey AS, 2010, MAR ECOL PROG SER, V411, P299, DOI 10.3354/meps08660; Hoey AS, 2010, CORAL REEFS, V29, P107, DOI 10.1007/s00338-009-0567-8; Hoey AS, 2011, ECOL LETT, V14, P267, DOI 10.1111/j.1461-0248.2010.01581.x; Hoey AS, 2009, ECOSYSTEMS, V12, P1316, DOI 10.1007/s10021-009-9291-z; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; KILAR JA, 1986, J EXP MAR BIOL ECOL, V104, P1, DOI 10.1016/0022-0981(86)90094-8; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Lapointe BE, 2011, HARMFUL ALGAE, V10, P310, DOI 10.1016/j.hal.2010.11.004; LOSEY GS, 1982, BEHAVIOUR, V81, P14, DOI 10.1163/156853982X00508; Mallet D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084344; Mantyka CS, 2007, MAR ECOL PROG SER, V352, P177, DOI 10.3354/meps07055; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; O'Doherty DC, 2007, PAC SCI, V61, P223, DOI 10.2984/1534-6188(2007)61[223:GPSOTH]2.0.CO;2; Preskitt Linda B., 2004, Pacific Science, V58, P201, DOI 10.1353/psc.2004.0021; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Rogers S, 1999, PAC SCI, V53, P232; RUSS GR, 1987, J EXP MAR BIOL ECOL, V110, P1, DOI 10.1016/0022-0981(87)90062-1; Russell DF, 2009, PAC SCI, V63, P181, DOI 10.2984/049.063.0202; RUSSELL DJ, 1992, ICES MAR SC, V194, P110; SAMMARCO PW, 1983, MAR ECOL PROG SER, V13, P1, DOI 10.3354/meps013001; SANTELICES B, 1990, OCEANOGR MAR BIOL, V28, P177; Schacter CR, 2014, ENVIRON BIOL FISH, V97, P813, DOI 10.1007/s10641-013-0181-z; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; Smith Jennifer E., 2002, Pacific Science, V56, P299, DOI 10.1353/psc.2002.0030; Stimson J, 2001, CORAL REEFS, V19, P343, DOI 10.1007/s003380000123; Stimson J, 2007, MAR BIOL, V151, P1761, DOI 10.1007/s00227-007-0628-x; Tsukada H, 1997, J ETHOL, V15, P27, DOI 10.1007/BF02767323; Weijerman M, 2008, PAC SCI, V62, P517, DOI 10.2984/1534-6188(2008)62[517:ATCTIR]2.0.CO;2	51	3	3	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109007	10.1371/journal.pone.0109007	http://dx.doi.org/10.1371/journal.pone.0109007			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25329385	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766200015
J	Chi, S; Wu, SX; Yu, J; Wang, XM; Tang, XX; Liu, T				Chi, Shan; Wu, Shuangxiu; Yu, Jun; Wang, Xumin; Tang, Xuexi; Liu, Tao			Phylogeny of C-4-Photosynthesis Enzymes Based on Algal Transcriptomic and Genomic Data Supports an Archaeal/Proteobacterial Origin and Multiple Duplication for Most C-4-Related Genes	PLOS ONE			English	Article							C4 PHOSPHOENOLPYRUVATE CARBOXYLASE; PHOSPHATE DIKINASE; CALVIN CYCLE; CARBON; EVOLUTION; PLANT; PHOTOSYNTHESIS; FIXATION; SEQUENCE; INSIGHTS	Both Calvin-Benson-Bassham (C-3) and Hatch-Slack (C-4) cycles are most important autotrophic CO2 fixation pathways on today's Earth. C-3 cycle is believed to be originated from cyanobacterial endosymbiosis. However, studies on evolution of different biochemical variants of C-4 photosynthesis are limited to tracheophytes and origins of C-4-cycle genes are not clear till now. Our comprehensive analyses on bioinformatics and phylogenetics of novel transcriptomic sequencing data of 21 rhodophytes and 19 Phaeophyceae marine species and public genomic data of more algae, tracheophytes, cyanobacteria, proteobacteria and archaea revealed the origin and evolution of C-4 cycle-related genes. Almost all of C-4-related genes were annotated in extensive algal lineages with proteobacterial or archaeal origins, except for phosphoenolpyruvate carboxykinase (PCK) and aspartate aminotransferase (AST) with both cyanobacterial and archaeal/proteobacterial origin. Notably, cyanobacteria may not possess complete C-4 pathway because of the flawed annotation of pyruvate orthophosphate dikinase (PPDK) genes in public data. Most C-4 cycle-related genes endured duplication and gave rise to functional differentiation and adaptation in different algal lineages. C-4-related genes of NAD-ME (NAD-malic enzyme) and PCK subtypes exist in most algae and may be primitive ones, while NADP-ME (NADP-malic enzyme) subtype genes might evolve from NAD-ME subtype by gene duplication in chlorophytes and tracheophytes.	[Chi, Shan; Tang, Xuexi; Liu, Tao] Ocean Univ China, Qingdao, Shandong, Peoples R China; [Wu, Shuangxiu; Yu, Jun; Wang, Xumin] Chinese Acad Sci, Beijing Inst Genom, Beijing Key Lab Genome & Precis Med Technol, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Wu, Shuangxiu; Yu, Jun; Wang, Xumin] Chinese Acad Sci, Beijing Inst Genom, Beijing Key Lab Funct Genom Dao Di Herbs, Beijing, Peoples R China	Ocean University of China; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Wang, XM (corresponding author), Chinese Acad Sci, Beijing Inst Genom, Beijing Key Lab Genome & Precis Med Technol, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.	wangxm@big.ac.cn; liutao@ouc.edu.cn	wang, xumin/HII-8627-2022	Wu, Shuangxiu/0000-0001-8307-298X	National Natural Science Foundation of China (NSFC) [41206116, 31271397]; China Postdoctoral Science Foundation [2011M501167]; National Public Benefit Research Foundation of China [201105021]; 1KP Project	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Public Benefit Research Foundation of China; 1KP Project	This work was supported by the National Natural Science Foundation of China (NSFC No. 41206116 and No. 31271397, China Postdoctoral Science Foundation (No. 2011M501167), National Public Benefit Research Foundation of China ( No. 201105021). The algal transcriptome sequencing was supported by 1KP Project (www.onekp.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya D, 2004, BIOESSAYS, V26, P50, DOI 10.1002/bies.10376; Brown JR, 1997, MICROBIOL MOL BIOL R, V61, P456, DOI 10.1128/.61.4.456-502.1997; Brown R.H., 1999, C4 PLANT BIOL, P473, DOI DOI 10.1016/B978-012614440-6/50015-X; Dorrell RG, 2011, EUKARYOT CELL, V10, P856, DOI 10.1128/EC.00326-10; Engelmann S, 2002, FEBS LETT, V524, P11, DOI 10.1016/S0014-5793(02)02975-7; Falkowski P.G., 2013, AQUATIC PHOTOSYNTHES; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Fan XL, 2007, J PHYCOL, V43, P1287, DOI 10.1111/j.1529-8817.2007.00415.x; Fravolinil A, 2002, J EXP BOT, V53, P2261, DOI 10.1093/jxb/erf084; Gennidakis S, 2007, PLANT J, V52, P839, DOI 10.1111/j.1365-313X.2007.03274.x; HATCH MD, 1966, BIOCHEM J, V101, P103, DOI 10.1042/bj1010103; Hatch MD., 1975, AUST J PLANT PHYSIOL, V2, P111, DOI [DOI 10.1071/PP9750111, 10.1071/PP9750111]; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; Johnson MTJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050226; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; [李天勇 Li Tianyong], 2012, [海洋湖沼通报, Transactions of Oceanology and Limnology], P64; Martin W, 1997, CURR GENET, V32, P1, DOI 10.1007/s002940050241; Matsuoka M, 2001, ANNU REV PLANT PHYS, V52, P297, DOI 10.1146/annurev.arplant.52.1.297; O'Leary B, 2011, BIOCHEM J, V436, P15, DOI 10.1042/BJ20110078; Patel HM, 2004, J BACTERIOL, V186, P5129, DOI 10.1128/jb.186.15.5129-5137.2004; Qiu H, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00366; Qiu YL, 1999, TRENDS PLANT SCI, V4, P26, DOI 10.1016/S1360-1385(98)01361-2; Raven JA, 2009, AQUAT MICROB ECOL, V56, P177, DOI 10.3354/ame01315; REEVES RE, 1968, J BIOL CHEM, V243, P5486; Reinfelder JR, 2000, NATURE, V407, P996, DOI 10.1038/35039612; Reinfelder JR, 2004, PLANT PHYSIOL, V135, P2106, DOI 10.1104/pp.104.041319; REISKIND JB, 1991, P NATL ACAD SCI USA, V88, P2883, DOI 10.1073/pnas.88.7.2883; Reyes-Prieto A, 2007, MOL PHYLOGENET EVOL, V45, P384, DOI 10.1016/j.ympev.2007.02.026; Stirewalt VL, 1995, PLANT MOL BIOL REP, V13, P327, DOI 10.1007/BF02669186; Tabita FR, 2004, PHOTOSYNTH RES, V80, P315; Tachibana M, 2011, PHOTOSYNTH RES, V109, P205, DOI 10.1007/s11120-011-9634-4; TANIGUCHI M, 1995, ARCH BIOCHEM BIOPHYS, V318, P295, DOI 10.1006/abbi.1995.1233; Taub DR, 2000, AM J BOT, V87, P1211, DOI 10.2307/2656659; Tjaden B, 2006, MOL MICROBIOL, V60, P287, DOI 10.1111/j.1365-2958.2006.05098.x; Tsuji Y, 2009, PLANT CELL PHYSIOL, V50, P318, DOI 10.1093/pcp/pcn200; Ueno O, 1996, PLANTA, V199, P382; Ueno O, 2011, J EXP BOT, V62, P5347, DOI 10.1093/jxb/err187; Wang CL, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S2-S9; Westhoff P, 2004, ANN BOT-LONDON, V93, P13, DOI 10.1093/aob/mch003	39	11	11	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110154	10.1371/journal.pone.0110154	http://dx.doi.org/10.1371/journal.pone.0110154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313828	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500102
J	Ohfuji, S; Fukushima, W; Watanabe, K; Sasaki, S; Yamagami, H; Nagahori, M; Watanabe, M; Hirota, Y				Ohfuji, Satoko; Fukushima, Wakaba; Watanabe, Kenji; Sasaki, Satoshi; Yamagami, Hirokazu; Nagahori, Masakazu; Watanabe, Mamoru; Hirota, Yoshio		Japanese Case-Control Study Grp Ul	Pre-Illness Isoflavone Consumption and Disease Risk of Ulcerative Colitis: A Multicenter Case-Control Study in Japan	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; DIET HISTORY QUESTIONNAIRES; ESTROGEN-RECEPTOR-BETA; BARRIER FUNCTION; BREAST-CANCER; CHINESE WOMEN; SOY; METAANALYSIS; HEALTH; CONTRACEPTIVES	Introduction: Previous studies have suggested that estrogens play a role in the development of ulcerative colitis (UC). Because isoflavones have a similar structure to 17 beta-estradiol, dietary consumption of isoflavones may have similar influences on the development of UC. We examined the association between pre-illness isoflavone consumption and the risk of UC. Materials and Methods: We conducted a hospital-based case control study, and compared the dietary habits of 126 newly diagnosed UC cases with those of 170 age- and gender-matched hospital controls. Information on dietary factors was collected using a self-administered diet history questionnaire. To consider potential changes in dietary habits due to disease symptoms, the habits were assessed separately during the previous 1 month and at 1 year before the recruitment. Results: In the assessment of dietary habits during the previous 1 month, the highest tertile of isoflavone consumption revealed an increased odds ratio (OR) for UC (OR = 2.79; 95% confidence interval (CI), 1.39-5.59; Trend P = 0.004). A significant association was also observed for the dietary assessment at 1 year before, when most UC cases had not yet experienced their first disease symptoms (OR = 2.06; 95% CI, 1.05-4.04; Trend P = 0.04). Associations were more pronounced in females (OR in highest tertile of isoflavone consumption at 1 year before = 4.76; 95% CI, 1.30-17.5; Trend P = 0.02) but were obscured in males (corresponding OR = 1.21; 95% CI, 0.49-3.01; Trend P = 0.63). Conclusions: Dietary isoflavone consumption may be associated with an increased risk of UC, particularly in females. Prospective cohort studies are warranted to confirm these findings.	[Ohfuji, Satoko; Fukushima, Wakaba; Hirota, Yoshio] Osaka City Univ, Fac Med, Dept Publ Hlth, Osaka 558, Japan; [Watanabe, Kenji; Yamagami, Hirokazu] Osaka City Univ, Fac Med, Dept Gastroenterol, Osaka 558, Japan; [Sasaki, Satoshi] Univ Tokyo, Sch Publ Hlth, Dept Social & Prevent Epidemiol, Tokyo, Japan; [Nagahori, Masakazu; Watanabe, Mamoru] Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Hirota, Yoshio] Med Co LTA, Clin Epidemiol Res Ctr, Fukuoka, Japan	Osaka Metropolitan University; Osaka Metropolitan University; University of Tokyo; Tokyo Medical & Dental University (TMDU)	Ohfuji, S (corresponding author), Osaka City Univ, Fac Med, Dept Publ Hlth, Osaka 558, Japan.	satop@med.osaka-cu.ac.jp	Ohfuji, Satoko/AHB-4998-2022; Watanabe, Mamoru/AHE-0489-2022		Health and Labour Sciences Research Grants from the Ministry of Health, Labor and Welfare, Japan	Health and Labour Sciences Research Grants from the Ministry of Health, Labor and Welfare, Japan	This study was supported by a research grant for Research on Intractable Diseases, Health and Labour Sciences Research Grants from the Ministry of Health, Labor and Welfare, Japan (http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hokabunya/kenkyujigyou/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Y, 2000, J NUTR, V130, P2243; Asakura K, 2009, J GASTROENTEROL, V44, P659, DOI 10.1007/s00535-009-0057-3; Bingham SA, 1998, BRIT J NUTR, V79, P393, DOI 10.1079/BJN19980068; Braniste V, 2010, P NATL ACAD SCI USA, V107, P448, DOI 10.1073/pnas.0907697107; BYERS T, 1987, AM J EPIDEMIOL, V125, P999, DOI 10.1093/oxfordjournals.aje.a114638; Cooke PS, 2006, J NUTR, V136, P704, DOI 10.1093/jn/136.3.704; Cornish JA, 2008, AM J GASTROENTEROL, V103, P2394, DOI 10.1111/j.1572-0241.2008.02064.x; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; GODET PG, 1995, GUT, V37, P668, DOI 10.1136/gut.37.5.668; Gomes MPV, 2004, ARCH INTERN MED, V164, P1965, DOI 10.1001/archinte.164.18.1965; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Hibi T, 2010, IBD RES, V4, P189; Japan Intractable Diseases Information Center, 2013, NUMB INFL BOW DIS PA; Khalili H, 2012, GASTROENTEROLOGY, V143, P1199, DOI 10.1053/j.gastro.2012.07.096; KITAHORA T, 1995, J GASTROENTEROL, V30, P5; Kobayashi S, 2012, J EPIDEMIOL, V22, P151, DOI 10.2188/jea.JE20110075; Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200, DOI 10.1017/S1368980011000504; Kokubo Y, 2007, CIRCULATION, V116, P2553, DOI 10.1161/CIRCULATIONAHA.106.683755; Koutroubakis IE, 2000, AM J GASTROENTEROL, V95, P171; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kuwahara E, 2012, J GASTROENTEROL, V47, P961, DOI 10.1007/s00535-012-0558-3; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Looijer-van Langen M, 2011, AM J PHYSIOL-GASTR L, V300, pG621, DOI 10.1152/ajpgi.00274.2010; Mahid SS, 2006, MAYO CLIN PROC, V81, P1462, DOI 10.4065/81.11.1462; Messina MJ, 1999, AM J CLIN NUTR, V70, p439S, DOI 10.1093/ajcn/70.3.439s; Miyake Y, 2005, J ALLERGY CLIN IMMUN, V115, P1176, DOI 10.1016/j.jaci.2005.02.016; Nechuta SJ, 2012, AM J CLIN NUTR, V96, P123, DOI 10.3945/ajcn.112.035972; Nikov GN, 2000, ENVIRON HEALTH PERSP, V108, P867, DOI 10.2307/3434995; Oswald E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031066; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Sasaki S, 2000, J NUTR SCI VITAMINOL, V46, P285, DOI 10.3177/jnsv.46.285; Sasaki S, 1998, J Epidemiol, V8, P203; Shimazu T, 2011, CANCER EPIDEM BIOMAR, V20, P419, DOI 10.1158/1055-9965.EPI-10-1025; Tanaka K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-39; Wu AH, 2002, CANCER EPIDEM BIOMAR, V11, P844; WU ML, 1988, AM J EPIDEMIOL, V128, P1137; Yamamoto S, 2003, J NATL CANCER I, V95, P906, DOI 10.1093/jnci/95.12.906	38	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110270	10.1371/journal.pone.0110270	http://dx.doi.org/10.1371/journal.pone.0110270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314032	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662500105
J	Camelo, LV; Giatti, L; Neves, JAB; Lotufo, PA; Bensenor, IM; Chor, D; Griep, RH; da Fonseca, MDM; Vidigal, PG; Kawachi, I; Schmidt, MI; Barreto, SM				Camelo, Lidyane V.; Giatti, Luana; Barbosa Neves, Jorge Alexandre; Lotufo, Paulo A.; Bensenor, Isabela M.; Chor, Dora; Griep, Rosane Haerter; Mendes da Fonseca, Maria de Jesus; Vidigal, Pedro Guatimosim; Kawachi, Ichiro; Schmidt, Maria Ines; Barreto, Sandhi Maria			Life Course Socioeconomic Position and C-Reactive Protein: Mediating Role of Health-Risk Behaviors and Metabolic Alterations. The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; BIRTH COHORT; SEX-DIFFERENCES; YOUNG-ADULTS; MARKERS; CHILDHOOD; INFLAMMATION; OBESITY; STRESS	Background: Chronic inflammation has been postulated to be one mediating mechanism explaining the association between low socioeconomic position (SEP) and cardiovascular disease (CVD). We sought to examine the association between life course SEP and C-reactive protein (CRP) levels in adulthood, and to evaluate the extent to which health-risk behaviors and metabolic alterations mediate this association. Additionally, we explored the possible modifying influence of gender. Methods and Findings: Our analytical sample comprised 13,371 participants from ELSA-Brasil baseline, a multicenter prospective cohort study of civil servants. SEP during childhood, young adulthood, and adulthood were considered. The potential mediators between life course SEP and CRP included clusters of health-risk behaviors (smoking, low leisure time physical activity, excessive alcohol consumption), and metabolic alterations (obesity, hypertension, low HDL, hypertriglyceridemia, and diabetes). Linear regression models were performed and structural equation modeling was used to evaluate mediation. Although lower childhood SEP was associated with higher levels of CRP in adult life, this association was not independent of adulthood SEP. However, CRP increased linearly with increasing number of unfavorable social circumstances during the life course (p trend <0.001). The metabolic alterations were the most important mediator between cumulative SEP and CRP. This mediation path accounted for 49.5% of the total effect of cumulative SEP on CRP among women, but only 20.2% among men. In consequence, the portion of the total effect of cumulative SEP on CRP that was mediated by risk behaviors and metabolic alterations was higher among women (55.4%) than among men (36.8%). Conclusions: Cumulative SEP across life span was associated with elevated systemic inflammation in adulthood. Although health-risk behaviors and metabolic alterations were important mediators of this association, a sizable fraction of this association was not mediated by these factors, suggesting that other pathways might play a role, especially among men.	[Camelo, Lidyane V.; Giatti, Luana; Barreto, Sandhi Maria] Univ Fed Minas Gerais, Fac Med, Postgrad Program Publ Hlth, Belo Horizonte, MG, Brazil; [Camelo, Lidyane V.; Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Giatti, Luana] Univ Fed Ouro Preto, Sch Nutr, Ouro Preto, MG, Brazil; [Barbosa Neves, Jorge Alexandre] Univ Fed Minas Gerais, Fac Philosophy & Human Sci, Belo Horizonte, MG, Brazil; [Lotufo, Paulo A.; Bensenor, Isabela M.] Univ Sao Paulo, Univ Hosp, Ctr Clin & Epidemiol Res, Sao Paulo, Brazil; [Chor, Dora] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, RJ, Brazil; [Griep, Rosane Haerter] Fundacao Oswaldo Cruz, Lab Hlth & Environm Educ, Rio De Janeiro, RJ, Brazil; [Mendes da Fonseca, Maria de Jesus] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Dept Epidemiol & Quantitat Methods Hlth, Rio De Janeiro, RJ, Brazil; [Vidigal, Pedro Guatimosim] Univ Fed Minas Gerais, Fac Med, Dept Lab Med, Belo Horizonte, MG, Brazil; [Schmidt, Maria Ines] Univ Fed Rio Grande do Sul, Sch Med, Postgrad Studies Program Epidemiol, Porto Alegre, RS, Brazil	Universidade Federal de Minas Gerais; Harvard University; Harvard T.H. Chan School of Public Health; Universidade Federal de Ouro Preto; Universidade Federal de Minas Gerais; Universidade de Sao Paulo; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Universidade Federal do Rio Grande do Sul	Camelo, LV (corresponding author), Univ Fed Minas Gerais, Fac Med, Postgrad Program Publ Hlth, Belo Horizonte, MG, Brazil.	lidyanecamelo@gmail.com	Lotufo, Paulo/A-9843-2008; Bensenor, Isabela Judith Martins/L-3306-2017; Vidigal, Pedro G/K-4834-2016; Griep, Rosane Härter/ABB-4509-2020; Barreto, Sandhi M/D-2855-2014; Schmidt, Maria Inês/AGP-6441-2022; Camelo, Lidyane V./H-7893-2016; Schmidt, Maria/V-3196-2019; Griep, Rosane H/E-3763-2013; Schmidt, Maria Inês/AGT-5691-2022	Lotufo, Paulo/0000-0002-4856-8450; Vidigal, Pedro G/0000-0001-8035-1350; Barreto, Sandhi M/0000-0001-7383-7811; Schmidt, Maria Inês/0000-0002-3837-0731; Camelo, Lidyane V./0000-0001-7471-7547; Griep, Rosane H/0000-0002-6250-2036; 	Brazilian Ministry of Health (Department of Science and Technology); Ministry of Science, Technology and Innovation (FINEP, Financiadora de Estudos e Projetos) [01 06 0010.00, 01 06 0212.00, 01 06 0300.00, 01 06 0278.00, 01 06 0115.00, 01 06 0071.00]; CNPq (the National Council for Scientific and Technological Development); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); CAPES - Brazilian Ministry of Education [99999.012455/2013-00]; National Research Council (CNPq) [300159/99-4]	Brazilian Ministry of Health (Department of Science and Technology); Ministry of Science, Technology and Innovation (FINEP, Financiadora de Estudos e Projetos)(Financiadora de Inovacao e Pesquisa (Finep)); CNPq (the National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES - Brazilian Ministry of Education(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study is supported by the Brazilian Ministry of Health (Department of Science and Technology) and Ministry of Science, Technology and Innovation (FINEP, Financiadora de Estudos e Projetos), grants no. 01 06 0010.00, 01 06 0212.00, 01 06 0300.00, 01 06 0278.00, 01 06 0115.00 and 01 06 0071.00 and CNPq (the National Council for Scientific and Technological Development). LVC received a doctoral scholarship from Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) and is a research fellow of CAPES - Brazilian Ministry of Education (grant nu 99999.012455/2013-00). SMB is a research fellow of the National Research Council (CNPq, grant nu 300159/99-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acock A., 2013, DISCOVERING STRUTURA; Aiello AE, 2009, BIODEMOGR SOC BIOL, V55, P178, DOI 10.1080/19485560903382304; [Anonymous], 2005, IPAC GUID DAT PROC A; Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294; Batty GD, 2012, INT J PUBLIC HEALTH, V57, P119, DOI 10.1007/s00038-011-0270-8; Baum A, 1999, ANN NY ACAD SCI, V896, P131, DOI 10.1111/j.1749-6632.1999.tb08111.x; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; Bisoendial RJ, 2010, EUR HEART J, V31, P2087, DOI 10.1093/eurheartj/ehq238; Blane D, 1996, BMJ-BRIT MED J, V313, P1434, DOI 10.1136/bmj.313.7070.1434; Borghol N, 2012, INT J EPIDEMIOL, V41, P62, DOI 10.1093/ije/dyr147; Choi J, 2013, OBES REV, V14, P232, DOI 10.1111/obr.12003; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Galobardes B, 2006, ANN EPIDEMIOL, V16, P91, DOI 10.1016/j.annepidem.2005.06.053; Galobardes B, 2007, BRIT MED BULL, V81-82, P21, DOI 10.1093/bmb/ldm001; Hansel A, 2010, NEUROSCI BIOBEHAV R, V35, P115, DOI 10.1016/j.neubiorev.2009.12.012; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th; Harper S, 2011, ANNU REV PUBL HEALTH, V32, P39, DOI 10.1146/annurev-publhealth-031210-101234; Hermeto A, 2014, APRESENTACA IN PRESS; Huang CJ, 2013, SCI WORLD J, DOI 10.1155/2013/752071; Imhof A, 2001, LANCET, V357, P763, DOI 10.1016/S0140-6736(00)04170-2; Instituto Brasileiro de Geografia e Estatistica, 2012, PESQ NAC AM DOM 2012; Ishii S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036062; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kershaw KN, 2010, HEALTH PSYCHOL, V29, P307, DOI 10.1037/a0019286; Khera A, 2009, J CLIN ENDOCR METAB, V94, P3251, DOI 10.1210/jc.2008-2406; Kiggundu MN, 2012, INT REV ADM SCI, V78, P733, DOI 10.1177/0020852312455553; Kivimaki M, 2005, ARTERIOSCL THROM VAS, V25, P2197, DOI 10.1161/01.ATV.0000183729.91449.6e; Kuh D, 2003, J EPIDEMIOL COMMUN H, V57, P778, DOI 10.1136/jech.57.10.778; Lawlor DA, 2005, THROMB HAEMOSTASIS, V93, P955, DOI 10.1160/TH04-12-0805; Loucks EB, 2010, SOC SCI MED, V71, P187, DOI 10.1016/j.socscimed.2010.03.012; Marmot MG, 1997, LANCET, V350, P235, DOI 10.1016/S0140-6736(97)04244-X; Matthews KA, 2010, ANN NY ACAD SCI, V1186, P146, DOI 10.1111/j.1749-6632.2009.05332.x; McEwen BS, 1999, ANN NY ACAD SCI, V896, P30, DOI 10.1111/j.1749-6632.1999.tb08103.x; McGuinness D, 2012, INT J EPIDEMIOL, V41, P151, DOI 10.1093/ije/dyr215; Mendall MA, 2000, EUR HEART J, V21, P1584, DOI 10.1053/euhj.1999.1982; Miller GE, 2011, PSYCHOL BULL, V137, P959, DOI 10.1037/a0024768; Miller GE, 2009, P NATL ACAD SCI USA, V106, P14716, DOI 10.1073/pnas.0902971106; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Monteiro CA, 2007, AM J PUBLIC HEALTH, V97, P1808, DOI 10.2105/AJPH.2006.099630; Nazmi A, 2010, SOC SCI MED, V70, P1229, DOI 10.1016/j.socscimed.2009.12.014; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Pollitt RA, 2008, J EPIDEMIOL COMMUN H, V62, P484, DOI 10.1136/jech.2006.054106; Pollitt RA, 2007, EUR J EPIDEMIOL, V22, P55, DOI 10.1007/s10654-006-9082-1; Power C, 2005, INT J EPIDEMIOL, V34, P335, DOI 10.1093/ije/dyh394; Rasella D, 2013, LANCET, V382, P57, DOI 10.1016/S0140-6736(13)60715-1; Rudnicka AR, 2011, J THROMB HAEMOST, V9, P2337, DOI 10.1111/j.1538-7836.2011.04517.x; Schmidt MI, 2015, INT J EPIDEMIOL, V44, P68, DOI 10.1093/ije/dyu027; Sorensen CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088196; Stringhini S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001479; Szyf M, 2008, ENVIRON MOL MUTAGEN, V49, P46, DOI 10.1002/em.20357; Tabassum F, 2008, AM J EPIDEMIOL, V167, P1332, DOI 10.1093/aje/kwn055; Tracy RP, 2001, ARTERIOSCL THROM VAS, V21, P881, DOI 10.1161/01.ATV.21.6.881; Vineis P, 2014, ENVIRON RES, V133, P424, DOI 10.1016/j.envres.2014.02.002; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Wensley F, 2011, BMJ-BRIT MED J, V15, pd548; Wilkinson RG, 1997, BRIT MED J, V314, P591, DOI 10.1136/bmj.314.7080.591	56	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e108426	10.1371/journal.pone.0108426	http://dx.doi.org/10.1371/journal.pone.0108426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ9WZ	25309988	Green Published, gold			2022-12-27	WOS:000343210300017
J	Diallo, D; Sall, AA; Diagne, CT; Faye, O; Faye, O; Ba, Y; Hanley, KA; Buenemann, M; Weaver, SC; Diallo, M				Diallo, Diawo; Sall, Amadou A.; Diagne, Cheikh T.; Faye, Oumar; Faye, Ousmane; Ba, Yamar; Hanley, Kathryn A.; Buenemann, Michaela; Weaver, Scott C.; Diallo, Mawlouth			Zika Virus Emergence in Mosquitoes in Southeastern Senegal, 2011	PLOS ONE			English	Article							YELLOW-FEVER VIRUS; CHIKUNGUNYA VIRUS; AEDES; TRANSMISSION; ISOLATIONS; CULICIDAE; DIPTERA; VECTOR; AMPLIFICATION; SURVEILLANCE	Background: Zika virus (ZIKV; genus Flavivirus, family Flaviviridae) is maintained in a zoonotic cycle between arboreal Aedes spp. mosquitoes and nonhuman primates in African and Asian forests. Spillover into humans has been documented in both regions and the virus is currently responsible for a large outbreak in French Polynesia. ZIKV amplifications are frequent in southeastern Senegal but little is known about their seasonal and spatial dynamics. The aim of this paper is to describe the spatio-temporal patterns of the 2011 ZIKV amplification in southeastern Senegal. Methodology/Findings: Mosquitoes were collected monthly from April to December 2011 except during July. Each evening from 18: 00 to 21: 00 hrs landing collections were performed by teams of 3 persons working simultaneously in forest (canopy and ground), savannah, agriculture, village (indoor and outdoor) and barren land cover sites. Mosquitoes were tested for virus infection by virus isolation and RT-PCR. ZIKV was detected in 31 of the 1,700 mosquito pools (11,247 mosquitoes) tested: Ae. furcifer (5), Ae. luteocephalus (5), Ae. africanus (5), Ae. vittatus (3), Ae. taylori, Ae. dalzieli, Ae. hirsutus and Ae. metallicus (2 each) and Ae. aegypti, Ae. unilinaetus, Ma. uniformis, Cx. perfuscus and An. coustani (1 pool each) collected in June (3), September (10), October (11), November (6) and December (1). ZIKV was detected from mosquitoes collected in all land cover classes except indoor locations within villages. The virus was detected in only one of the ten villages investigated. Conclusions/Significance: This ZIKV amplification was widespread in the Kedougou area, involved several mosquito species as probable vectors, and encompassed all investigated land cover classes except indoor locations within villages. Aedes furcifer males and Aedes vittatus were found infected within a village, thus these species are probably involved in the transmission of Zika virus to humans in this environment.	[Diallo, Diawo; Diagne, Cheikh T.; Ba, Yamar; Diallo, Mawlouth] Inst Pasteur, Unite Entomol Med, Dakar, Senegal; [Sall, Amadou A.; Faye, Oumar; Faye, Ousmane] Inst Pasteur, Unite Arbovirus & Virus Fievres Hemorrag, Dakar, Senegal; [Hanley, Kathryn A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Buenemann, Michaela] New Mexico State Univ, Dept Geog, Las Cruces, NM 88003 USA; [Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Ctr Trop Dis, Galveston, TX 77555 USA; [Weaver, Scott C.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; New Mexico State University; New Mexico State University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Diallo, D (corresponding author), Inst Pasteur, Unite Entomol Med, Dakar, Senegal.	ddiallo@pasteur.sn	DIAGNE, Tidiane/AAY-9686-2020; faye, Ousmane/GMW-6500-2022; Weaver, Scott C/D-6490-2011; Faye, Oumar/T-7168-2019	Weaver, Scott C/0000-0001-8016-8556; Faye, Oumar/0000-0002-3478-1322; DIAGNE, Cheikh Tidiane/0000-0002-3499-4934; DIALLO, Diawo/0000-0002-7478-5248	National Center for Research Resources [5P20RR016480-12]; National Institutes of Health [AI069145]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069145] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from the National Center for Research Resources (5P20RR016480-12) and the National Institutes of Health (AI069145). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam F, CTR COLLBAORATEUR OM; Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227; BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3; BRES P, 1970, B WORLD HEALTH ORGAN, V43, P223; Cornet M, 1979, ENT MED PARASITOL OR, V17, P149; Cornet M, 1979, ENTOMOL MED PARASITO, V17, P47; Cornet M, 1973, ENTOMOL MED PARASIT, V11, P175; DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P446, DOI 10.1016/0035-9203(83)90108-6; DIAGNE N, 1994, B SOC PATHOL EXOT, V87, P267; Diallo D, 2014, AM J TROP MED HYG, V90, P1003, DOI 10.4269/ajtmh.13-0404; Diallo D, 2013, T ROY SOC TROP MED H, V107, P200, DOI 10.1093/trstmh/trs095; Diallo D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-286; Diallo D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001649; Diallo M, 2003, EMERG INFECT DIS, V9, P362, DOI 10.3201/eid0903.020219; DIGOUTTE JP, 1992, RES VIROLOGY, V143, P417, DOI 10.1016/S0923-2516(06)80135-4; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Duong V, 2009, Med Trop (Mars), V69, P339; Edwards F, 1941, MOSQUITOES ETHIPIAN; FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997; Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311; Ferrara L, 1984, ENTOMOL MED PARASITO, V22, P95; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57; Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442; Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224; Huang Y-M, 1981, PICTORIAL KEY IDENTI; HUANG YM, 1986, J MED ENTOMOL, V23, P196, DOI 10.1093/jmedent/23.2.196; JOHNSON BK, 1977, T ROY SOC TROP MED H, V71, P512, DOI 10.1016/0035-9203(77)90146-8; Jupp PG, 1997, MOSQUITOES SO AFRIC; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792; MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411; Mavale M, 2010, AM J TROP MED HYG, V83, P1242, DOI 10.4269/ajtmh.2010.09-0577; MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4; MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21; OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0; R Development Core Team, 2012, R LANG ENV STAT COMP; Rickenbach A, 1969, Bull. Soc. Path. exot., V62, P266; SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9; Tewari SC, 2004, TROP MED INT HEALTH, V9, P499, DOI 10.1111/j.1365-3156.2004.01103.x; TraoreLamizana M, 1996, J MED ENTOMOL, V33, P760, DOI 10.1093/jmedent/33.5.760; TRAORELAMIZANA M, 1994, J MED ENTOMOL, V31, P623, DOI 10.1093/jmedent/31.4.623; Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310	43	213	223	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109442	10.1371/journal.pone.0109442	http://dx.doi.org/10.1371/journal.pone.0109442			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310102	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210300050
J	Xu, K; Ma, C; Lian, JJ; Bin, LL				Xu, Kui; Ma, Chao; Lian, Jijian; Bin, Lingling			Joint Probability Analysis of Extreme Precipitation and Storm Tide in a Coastal City under Changing Environment	PLOS ONE			English	Article							FLOOD FREQUENCY; CLIMATE-CHANGE; RAINFALL; COPULA; DEPENDENCE; IMPACT; RISK; URBANIZATION; PATTERNS; NETWORK	Catastrophic flooding resulting from extreme meteorological events has occurred more frequently and drawn great attention in recent years in China. In coastal areas, extreme precipitation and storm tide are both inducing factors of flooding and therefore their joint probability would be critical to determine the flooding risk. The impact of storm tide or changing environment on flooding is ignored or underestimated in the design of drainage systems of today in coastal areas in China. This paper investigates the joint probability of extreme precipitation and storm tide and its change using copula-based models in Fuzhou City. The change point at the year of 1984 detected by Mann-Kendall and Pettitt's tests divides the extreme precipitation series into two subsequences. For each subsequence the probability of the joint behavior of extreme precipitation and storm tide is estimated by the optimal copula. Results show that the joint probability has increased by more than 300% on average after 1984 (alpha = 0.05). The design joint return period (RP) of extreme precipitation and storm tide is estimated to propose a design standard for future flooding preparedness. For a combination of extreme precipitation and storm tide, the design joint RP has become smaller than before. It implies that flooding would happen more often after 1984, which corresponds with the observation. The study would facilitate understanding the change of flood risk and proposing the adaption measures for coastal areas under a changing environment.	[Xu, Kui; Ma, Chao; Lian, Jijian] Tianjin Univ, State Key Lab Hydraul Engn Simulat & Safety, Tianjin 300072, Peoples R China; [Bin, Lingling] Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China	Tianjin University; Beijing Normal University	Ma, C (corresponding author), Tianjin Univ, State Key Lab Hydraul Engn Simulat & Safety, Tianjin 300072, Peoples R China.	mac_tju@126.com		Xu, Kui/0000-0001-9371-0340	Science Fund for Creative Research Groups of the National Natural Science Foundation of China [51021004]; National Natural Science Foundation of China [51109156]; Major National Science and Technology Project [2012ZX07205005]; Tianjin Research Program of Application Foundation and Advanced Technology (The Key Program of National Natural Science Foundation) [13JCZDJC36200]; Programme of Introducing Talents of Discipline to Universities [B14012]	Science Fund for Creative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major National Science and Technology Project; Tianjin Research Program of Application Foundation and Advanced Technology (The Key Program of National Natural Science Foundation); Programme of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project)	This study was financed by the Science Fund for Creative Research Groups of the National Natural Science Foundation of China (51021004), National Natural Science Foundation of China (51109156), Major National Science and Technology Project (2012ZX07205005), Tianjin Research Program of Application Foundation and Advanced Technology (The Key Program of National Natural Science Foundation) (13JCZDJC36200), the Programme of Introducing Talents of Discipline to Universities (B14012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RP, 2008, SCIENCE, V321, P1481, DOI 10.1126/science.1160787; Archetti R, 2011, HYDROL EARTH SYST SC, V15, P3115, DOI 10.5194/hess-15-3115-2011; Balistrocchi M, 2011, HYDROL EARTH SYST SC, V15, P1959, DOI 10.5194/hess-15-1959-2011; Bardossy A, 2009, HYDROL EARTH SYST SC, V13, P2299, DOI 10.5194/hess-13-2299-2009; Bouwer LM, 2013, RISK ANAL, V33, P915, DOI 10.1111/j.1539-6924.2012.01880.x; Chadwick R, 2013, J CLIMATE, V26, P3803, DOI 10.1175/JCLI-D-12-00543.1; Crossman J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074054; [董锁成 Dong Suocheng], 2010, [气候变化研究进展, Advances in Climate Change Research], V6, P284; Du J, 2011, STOCH ENV RES RISK A, V25, P1013, DOI 10.1007/s00477-010-0453-5; Fan XH, 2012, THEOR APPL CLIMATOL, V109, P283, DOI 10.1007/s00704-011-0577-7; Goda K, 2010, RISK ANAL, V30, P1076, DOI 10.1111/j.1539-6924.2010.01408.x; Grimaldi S, 2006, ADV WATER RESOUR, V29, P1155, DOI 10.1016/j.advwatres.2005.09.005; Grundfest E., 2000, FLOODS, V1, P377; Gyasi-Agyei Y, 2012, J HYDROL, V464, P249, DOI 10.1016/j.jhydrol.2012.07.014; KENDALL M. G., 1948, Rank correlation methods.; Kysely J, 2011, THEOR APPL CLIMATOL, V104, P529, DOI 10.1007/s00704-010-0362-z; Li BF, 2013, THEOR APPL CLIMATOL, V112, P589, DOI 10.1007/s00704-012-0753-4; Li LJ, 2007, HYDROL PROCESS, V21, P3485, DOI 10.1002/hyp.6485; Li N, 2013, RISK ANAL, V33, P134, DOI 10.1111/j.1539-6924.2012.01838.x; Lian JJ, 2013, HYDROL EARTH SYST SC, V17, P679, DOI 10.5194/hess-17-679-2013; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; MCELROY FW, 1967, J AM STAT ASSOC, V62, P1302, DOI 10.2307/2283779; Milly PCD, 2002, NATURE, V415, P514, DOI 10.1038/415514a; Min SK, 2011, NATURE, V470, P378, DOI 10.1038/nature09763; Moraes JM, 1998, WATER RESOUR MANAG, V12, P295, DOI 10.1023/A:1008048212420; Muller CJ, 2011, NAT CLIM CHANGE, V1, P266, DOI 10.1038/NCLIMATE1169; Nelsen RB, 2006, INTRO COPULAS, DOI [10.1007/978-1-4757-3076-0, 10.1007/0-387-28678-0]; Nicholls RJ, 2010, SCIENCE, V328, P1517, DOI 10.1126/science.1185782; Pettitt A. N., 1979, Applied Statistics, V28, P126, DOI 10.2307/2346729; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; Ranger N, 2011, CLIMATIC CHANGE, V104, P139, DOI 10.1007/s10584-010-9979-2; Rouge C, 2013, ADV WATER RESOUR, V53, P33, DOI 10.1016/j.advwatres.2012.09.008; Salvadori G, 2004, WATER RESOUR RES, V40, DOI 10.1029/2004WR003133; Sang YF, 2013, HYDROL PROCESS, V27, P175, DOI 10.1002/hyp.9202; Sklar A., 1959, PUBLICATIONS I STAT, V8, P229, DOI DOI 10.1007/BF01544178; Sneyers R., 1977, CIEL TERRE, V93, P186; Suriya S, 2012, J HYDROL, V412, P210, DOI 10.1016/j.jhydrol.2011.05.008; Tao YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078805; Wang C, 2009, HYDROL PROCESS, V23, P1471, DOI 10.1002/hyp.7273; Wang XJ, 2010, J HYDROL, V390, P108, DOI 10.1016/j.jhydrol.2010.06.039; Xiao MZ, 2013, THEOR APPL CLIMATOL, V114, P203, DOI 10.1007/s00704-013-0832-1; Xu YP, 2010, WATER SCI TECHNOL, V62, P1221, DOI 10.2166/wst.2010.391; Zhang L, 2007, J HYDROL, V332, P93, DOI 10.1016/j.jhydrol.2006.06.033; Zhang Q, 2012, THEOR APPL CLIMATOL, V107, P255, DOI 10.1007/s00704-011-0476-y; Zhang Q, 2013, INT J CLIMATOL, V33, P1140, DOI 10.1002/joc.3499; Zhang Q, 2012, J HYDROL, V440, P113, DOI 10.1016/j.jhydrol.2012.03.037; Zheng FF, 2013, J HYDROL, V505, P172, DOI 10.1016/j.jhydrol.2013.09.054; Zhong H, 2012, WATER-SUI, V4, P474, DOI 10.3390/w4020474	49	43	44	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109341	10.1371/journal.pone.0109341	http://dx.doi.org/10.1371/journal.pone.0109341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310006	gold, Green Submitted, Green Published			2022-12-27	WOS:000343210300049
J	Cappi, C; Hounie, AG; Mariani, DB; Diniz, JB; Silva, ART; Reis, VNS; Busso, AF; Silva, AG; Fidalgo, F; Rogatto, SR; Miguel, EC; Krepischi, AC; Brentani, H				Cappi, Carolina; Hounie, Ana Gabriela; Mariani, Daniel B.; Diniz, Juliana Belo; Silva, Aderbal R. T.; Reis, Viviane N. S.; Busso, Ariane F.; Silva, Amanda Goncalves; Fidalgo, Felipe; Rogatto, Silvia Regina; Miguel, Euripedes C.; Krepischi, Ana C.; Brentani, Helena			An Inherited Small Microdeletion at 15q13.3 in a Patient with Early- Onset Obsessive-Compulsive Disorder	PLOS ONE			English	Article							COPY NUMBER VARIATION; DE-NOVO CNVS; TOURETTE SYNDROME; STRUCTURAL VARIATION; AUTISM; VARIANTS; GENES; CHROMOSOMES; DNA; SCHIZOPHRENIA	Copy number variations (CNVs) have been previously associated with several different neurodevelopmen al psychiatric disorders, such as autism, schizophrenia, and attention deficit hyperactivity disorder (ADHD). The present study consisted of pilot genorne-wide screen for CNVs in a cohort of 16 patients with early-onset obsessive-compulsive disorder (OCD) and 2 mentally healthy individuals, using array-based comparative enomic hybridization (aCGH) on 44K arrays. A small rare nal inherited microdeletion (-64 kb) was identified in chromosome 15q13.3 of one male patient with very early onset have OCD. The deletion encompassed part of the FA/IN1 gene, which is involved with the glutamatergic system This finding supports the hypothesis of a complex network of several genes expressed in the brain cant ibuting for h genetic risk of OCD, and also supports the glutamatergic involvement in OCD, which has been previsously reported in the literature.	[Cappi, Carolina; Hounie, Ana Gabriela; Diniz, Juliana Belo; Silva, Aderbal R. T.; Reis, Viviane N. S.; Miguel, Euripedes C.; Brentani, Helena] Univ Sao Paulo, Sch Med, Inst & Dept Psychiat, Sao Paulo, Brazil; [Mariani, Daniel B.] Univ Sao Paulo, Inst Math & Stat, Inter Inst Grad Program Bioinformat, Sao Paulo, Brazil; [Silva, Amanda Goncalves; Fidalgo, Felipe; Krepischi, Ana C.] AC Camargo Canc Ctr, Int Res Ctr, Sao Paulo, Brazil; [Rogatto, Silvia Regina] Sao Paulo State Univ, Sch Med, Sao Paulo, Brazil; [Hounie, Ana Gabriela] Univ Fed Sao Paulo, UPIA, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; A.C.Camargo Cancer Center; Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP)	Cappi, C (corresponding author), Univ Sao Paulo, Sch Med, Inst & Dept Psychiat, Sao Paulo, Brazil.	carolinacappi@gmail.com	Diniz, Juliana Belo/D-2503-2011; Krepischi, Ana C V/E-4976-2012; Rogatto, Silvia R/E-6535-2012; Brentani, Helena/G-6839-2011; Reis, Viviane/J-3996-2014; Busso-Lopes, Ariane Fidelis/K-1383-2015; Miguel, Euripedes C/B-2871-2008; Hounie, Ana G/D-2931-2014; Cappi, Carolina/P-1811-2017; Ruy T. Silva, Aderbal/K-6503-2012	Diniz, Juliana Belo/0000-0001-9486-3779; Krepischi, Ana C V/0000-0003-2931-8605; Brentani, Helena/0000-0001-5192-4682; Reis, Viviane/0000-0002-4959-2954; Busso-Lopes, Ariane Fidelis/0000-0003-2280-1848; Hounie, Ana G/0000-0002-5026-2880; Rogatto, Silvia/0000-0003-4637-5687; Cappi, Carolina/0000-0001-6661-3756; Ruy T. Silva, Aderbal/0000-0003-1158-5617	Foundation for Research Support of the State of Sao Paulo (FAPESP) [2008/11537-7]; Brazilian National Council for Scientific and Technological Development (CNPq) [MCT/CNPq 14/2008]	Foundation for Research Support of the State of Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by grants to Dras Cappi and Brentani from the Foundation for Research Support of the State of Sao Paulo (FAPESP); grant number 2008/11537-7, and from the Brazilian National Council for Scientific and Technological Development (CNPq; protocol number MCT/CNPq 14/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2013, MOL PSYCHIAT; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arnold PD, 2009, BRAIN IMAGING BEHAV, V3, P64, DOI 10.1007/s11682-008-9050-3; Barrett MT, 2004, P NATL ACAD SCI USA, V101, P17765, DOI 10.1073/pnas.0407979101; Ben-Shachar S, 2009, J MED GENET, V46, P382, DOI 10.1136/jmg.2008.064378; Coe BP, 2012, CURR OPIN NEUROBIOL; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Coppola A, 2013, EPILEPSIA, V54, pe69, DOI 10.1111/epi.12130; Crespi B, 2010, P NATL ACAD SCI USA, V107, P1736, DOI 10.1073/pnas.0906080106; Crespi BJ, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-15; Delorme R, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-100; Derwinska K, 2009, CLIN GENET, V75, P199, DOI 10.1111/j.1399-0004.2008.01077.x; Engels H, 2007, NEUROLOGY, V68, P743, DOI 10.1212/01.wnl.0000256367.70365.e0; Fernandez TV, 2012, BIOL PSYCHIAT, V71, P392, DOI 10.1016/j.biopsych.2011.09.034; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Hoexter MQ, 2009, REV BRAS PSIQUIATR, V31, P345; Hooper SD, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-123; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Le Pichon JB, 2013, EUR J HUM GENET; Lesch KP, 2011, MOL PSYCHIATR, V16, P491, DOI 10.1038/mp.2010.29; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Malhotra D, 2011, NEURON, V72, P951, DOI 10.1016/j.neuron.2011.11.007; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McGrath LM, 2014, J AM ACAD CHILD PSY, V53, P910, DOI 10.1016/j.jaac.2014.04.022; Melchior L, 2013, AM J MED GENET B, V162, P825, DOI 10.1002/ajmg.b.32186; Merikangas AK, 2009, TRENDS GENET, V25, P536, DOI 10.1016/j.tig.2009.10.006; Miguel EC, 2008, REV BRAS PSIQUIATR, V30, P185, DOI 10.1590/S1516-44462008000300003; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nestadt G, 2012, AM J MED GENET B, V159B, P53, DOI 10.1002/ajmg.b.32001; Pagnamenta AT, 2009, EUR J HUM GENET, V17, P687, DOI 10.1038/ejhg.2008.228; Pauls DL, 2008, AM J MED GENET C, V148C, P133, DOI 10.1002/ajmg.c.30168; Pauls DL, 2014, NAT REV NEUROSCI, V15, P410, DOI 10.1038/nrn3746; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Ross J, 2011, HUM GENET, V130, P795, DOI 10.1007/s00439-011-1033-6; Rucker JJH, 2012, DEV PSYCHOPATHOL, V24, P1335, DOI 10.1017/S0954579412000740; Salama-Cohen P, 2006, J NEUROCHEM, V97, P1269, DOI 10.1111/j.1471-4159.2006.03783.x; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, NAT GENET, V39, pS3, DOI 10.1038/ng2095; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sebat J, 2009, TRENDS GENET, V25, P528, DOI 10.1016/j.tig.2009.10.004; Shugart YY, 2006, MOL PSYCHIATR, V11, P763, DOI 10.1038/sj.mp.4001847; Simon-Areces J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021825; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stewart SE, 2013, AM J MED GENET B; Stewart SE, 2012, MOL PSYCHIAT; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Taylor S, 2012, MOL PSYCHIAT; Ting Jonathan T, 2008, Curr Chem Genomics, V2, P62; Veenstra-VanderWeele J, 2012, PSYCHIAT GENET, V22, P256, DOI 10.1097/YPG.0b013e328353fb63; Walitza S, 2012, J NEURAL TRANSM, V119, P507, DOI 10.1007/s00702-011-0699-1; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Williams NM, 2010, LANCET, V376, P1401, DOI 10.1016/S0140-6736(10)61109-9; Xu B, 2009, P NATL ACAD SCI USA, V106, P16746, DOI 10.1073/pnas.0908584106	58	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110198	10.1371/journal.pone.0110198	http://dx.doi.org/10.1371/journal.pone.0110198			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303678	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400121
J	Fletcher, TL; Kolias, AG; Hutchinson, PJ; Sutcliffe, MPF				Fletcher, Tim L.; Kolias, Angelos G.; Hutchinson, Peter J.; Sutcliffe, Michael P. F.			A New Improved Method for Assessing Brain Deformation after Decompressive Craniectomy	PLOS ONE			English	Article							INJURY; PLATFORM	Background: Decompressive craniectomy (DC) is a surgical intervention used following traumatic brain injury to prevent or alleviate raised intracranial pressure. However the clinical effectiveness of the intervention remains in doubt. The location of the craniectomy (unilateral or bifrontal) might be expected to change the brain deformation associated with the operation and hence the clinical outcome. As existing methods for assessing brain deformation have several limitations, we sought to develop and validate a new improved method. Methods: Computed tomography (CT) scans were taken from 27 patients who underwent DC (17 bifrontal patients and 10 unilateral patients). Pre-operative and post-operative images were processed and registered to determine the change in brain position associated with the operation. The maximum deformation in the herniated brain, the change in volume and estimates of the craniectomy area were determined from the images. Statistical comparison was made using the Pearson's correlation coefficient r and a Welch's two-tailed T-test, with statistical significance reported at the 5% level. Results: There was a reasonable correlation between the volume increase and the maximum brain displacement (r = 0.64), a low correlation between the volume increase and the craniectomy area (r = 0.30) and no correlation between the maximum displacement and the craniectomy area (r = -0.01). The maximum deformation was significantly lower (P = 0.023) in the bifrontal patients (mean = 22.5 mm) compared with the unilateral patients (mean = 29.8 mm). Herniation volume was significantly lower (P = 0.023) in bifrontal (mean = 50.0 ml) than unilateral patients (mean = 107.3 ml). Craniectomy area was not significantly different for the two craniectomy locations (P = 0.29). Conclusions: A method has been developed to quantify changes in brain deformation due to decompressive craniectomy from CT images and allow comparison between different craniectomy locations. Measured displacement is a reasonable way to characterise volume changes.	[Fletcher, Tim L.; Sutcliffe, Michael P. F.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Kolias, Angelos G.; Hutchinson, Peter J.] Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge, England; [Kolias, Angelos G.; Hutchinson, Peter J.] Univ Cambridge, Cambridge, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Sutcliffe, MPF (corresponding author), Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England.	mpfs@eng.cam.ac.uk		Hutchinson, Peter/0000-0002-2796-1835; Sutcliffe, Michael/0000-0001-9729-4460; Kolias, Angelos/0000-0003-3992-0587	Engineering and Physical Sciences Research Council (EPSRC); Royal College of Surgeons of England Research Fellowship - Freemasons and the Rosetrees Trust; National Institute of Health Research (NIHR) Academic Clinical Fellowship; Raymond and Beverly Sackler Studentship; NIHR Research Professorship; NIHR Cambridge Biomedical Research Centre; Medical Research Council [G0601025] Funding Source: researchfish; National Institute for Health Research [12/35/57, NIHR-RP-R3-12-013] Funding Source: researchfish; MRC [G0601025] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal College of Surgeons of England Research Fellowship - Freemasons and the Rosetrees Trust; National Institute of Health Research (NIHR) Academic Clinical Fellowship(National Institute for Health Research (NIHR)); Raymond and Beverly Sackler Studentship; NIHR Research Professorship; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	TLF acknowledges funding from the Engineering and Physical Sciences Research Council (EPSRC). AGK is supported by a Royal College of Surgeons of England Research Fellowship (funded by the Freemasons and the Rosetrees Trust), a National Institute of Health Research (NIHR) Academic Clinical Fellowship and a Raymond and Beverly Sackler Studentship. PJH is supported by a NIHR Research Professorship and the NIHR Cambridge Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Frise E, 2008, LEVEL SETS FAST MARC; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson Peter, 2007, Neurosurg Focus, V22, pE14; Hutchinson PJ, 2011, BRIT J NEUROSURG, V25, P441, DOI 10.3109/02688697.2011.583366; Johnson H., 2007, INSIGHT JOUR, P2, DOI [10.54294/hmb052, DOI 10.54294/HMB052]; Kenning TJ, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0960; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Pieper S, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P632; Pieper S, 2006, I S BIOMED IMAGING, P698; Quinn TM, 2011, ACTA NEUROL SCAND, V123, P239, DOI 10.1111/j.1600-0404.2010.01397.x; Quintus K, 2010, MODULES LABELSTATIST; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Timofeev I, 2012, Adv Tech Stand Neurosurg, V38, P115, DOI 10.1007/978-3-7091-0676-1_6; Unser M, 1999, IEEE SIGNAL PROC MAG, V16, P22, DOI 10.1109/79.799930; Vashu R, 2011, ACTA NEUROCHIR, V153, P2065, DOI 10.1007/s00701-011-1101-7; von Holst H, 2012, ACTA NEUROCHIR, V154, P1583, DOI 10.1007/s00701-012-1393-2; Wirtz CR, 1997, NEUROSURG FOCUS, V2	22	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110408	10.1371/journal.pone.0110408	http://dx.doi.org/10.1371/journal.pone.0110408			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303305	gold, Green Published, Green Submitted			2022-12-27	WOS:000343730400129
J	Li, B; Yang, JX; Wei, DP; Chen, SB; Li, JM; Ma, YB				Li, Bo; Yang, Junxing; Wei, Dongpu; Chen, Shibao; Li, Jumei; Ma, Yibing			Field Evidence of Cadmium Phytoavailability Decreased Effectively by Rape Straw and/or Red Mud with Zinc Sulphate in a Cd-Contaminated Calcareous Soil	PLOS ONE			English	Article							GENOTYPIC VARIATIONS; POLLUTED SOIL; ZN; PB; ACCUMULATION; VEGETABLES; METALS; CU; MOBILITY; PHYTOREMEDIATION	To reduce Cd phytoavailability in calcareous soils, the effects of soil amendments ed mud, rape straw, and corn s combination with zinc fertilization on Cd extractability and phytoavailability to spinach, tomato, Chinese cabbage and dish were investigated in a calcareous soil with added Cd at 1.5 mg kg(-1). The results showed that water soluble and exchangeable Cd in soils was significantly decreased by the amendments themselves from 26% to 70%, which resulted in arked decrease by approximately from 34% to 77% in Cd concentration in vegetables. The amendments plus Zn lization further decreased the Cd concentration in vegetables. Also cruciferous rape straw was more effective than ramineous corn straw. In all treatments, rape straw piLls red mLld combined with Zn fertilization was most effective in decreasing Cd phytoavailabill y in soils and it is potential to be an efficient and cost-effective measure to ensure food safety or vegetable production in mildly Cd-contaminated calcareous sods	[Li, Bo; Yang, Junxing; Wei, Dongpu; Chen, Shibao; Li, Jumei; Ma, Yibing] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Soil Fertil & Fertilizer Effects Long Term M, Beijing 100193, Peoples R China; [Li, Bo] Liaoning Acad Agr Sci, Inst Plant Nutr & Environm Resources, Shenyang, Peoples R China; [Yang, Junxing] Chinese Acad Agr Sci, Inst Geog Sci & Nat Resources Res, Ctr Environm Remediat, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Chinese Academy of Agricultural Sciences; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Ma, YB (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Soil Fertil & Fertilizer Effects Long Term M, Beijing 100193, Peoples R China.	ybma@caas.ac.cn		Ma, Yibing/0000-0002-9340-8181; chen, shibao/0000-0003-0159-2434	Special Fund for Public Industry in China (Agriculture) [200903015]; Natural Science Foundation of China [41201312, 41401361]	Special Fund for Public Industry in China (Agriculture); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank the Special Fund for Public Industry in China (Agriculture, 200903015) and the Natural Science Foundation of China (41201312 and 41401361) for financial supports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELSABOUR MF, 1988, SOIL SCI, V145, P424, DOI 10.1097/00010694-198806000-00004; Alexander PD, 2006, ENVIRON POLLUT, V144, P736, DOI 10.1016/j.envpol.2006.03.001; Almas A, 1999, J ENVIRON QUAL, V28, P1742, DOI 10.2134/jeq1999.00472425002800060008x; Basta N, 2000, J SOIL CONTAM, V9, P149, DOI 10.1080/10588330008984181; Castaldi P, 2005, CHEMOSPHERE, V60, P365, DOI 10.1016/j.chemosphere.2004.11.098; Castaldi P, 2009, GEODERMA, V151, P241, DOI 10.1016/j.geoderma.2009.04.009; Chen S B, 2012, CHINA ENV SCI, V32, P1309; Cui YS, 2008, GEODERMA, V146, P370, DOI 10.1016/j.geoderma.2008.06.010; Demirezen D, 2006, J FOOD QUALITY, V29, P252, DOI 10.1111/j.1745-4557.2006.00072.x; Friesl W, 2006, ENVIRON POLLUT, V144, P40, DOI 10.1016/j.envpol.2006.01.012; Friesl W, 2003, J PLANT NUTR SOIL SC, V166, P191, DOI 10.1002/jpln.200390028; Friesl-Hanl W, 2009, ENVIRON GEOCHEM HLTH, V31, P581, DOI 10.1007/s10653-009-9256-3; Garau G, 2011, J HAZARD MATER, V185, P1241, DOI 10.1016/j.jhazmat.2010.10.037; Giordani C, 2005, ENVIRON MANAGE, V36, P675, DOI 10.1007/s00267-004-0171-1; Harada E, 2002, J PLANT PHYSIOL, V159, P445, DOI 10.1078/0176-1617-00733; Herbette S, 2006, BIOCHIMIE, V88, P1751, DOI 10.1016/j.biochi.2006.04.018; Hooda Peter S., 2010, TRACE ELEMENTS SOILS; Jackson M.L., 1958, SOIL CHEM ANAL, DOI DOI 10.1002/JPLN.19590850311; Jones MG, 2004, J EXP BOT, V55, P1903, DOI 10.1093/jxb/erh138; Koleli N, 2004, ENVIRON POLLUT, V131, P453, DOI 10.1016/j.envpol.2004.02.012; KUBOI T, 1986, PLANT SOIL, V92, P405, DOI 10.1007/BF02372488; Lee SH, 2011, GEODERMA, V161, P1, DOI 10.1016/j.geoderma.2010.11.008; Li B, 2010, THESIS CHINESE ACAD; Li J, 2006, ENVIRON GEOCHEM HLTH, V28, P37, DOI 10.1007/s10653-005-9009-x; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Liu YJ, 2011, GEODERMA, V163, P1, DOI 10.1016/j.geoderma.2011.04.002; Lombi E, 2003, ENVIRON SCI TECHNOL, V37, P979, DOI 10.1021/es026083w; Lombi E, 2002, ENVIRON POLLUT, V118, P445, DOI 10.1016/S0269-7491(01)00295-0; Lombi E, 2002, ENVIRON POLLUT, V118, P135; Luo L, 2011, ENVIRON POLLUT, V159, P1108, DOI 10.1016/j.envpol.2011.02.019; Marchiol L, 2004, WATER AIR SOIL POLL, V158, P345, DOI 10.1023/B:WATE.0000044862.51031.fb; McLaughlin MJ, 1999, FIELD CROP RES, V60, P143, DOI 10.1016/S0378-4290(98)00137-3; OLIVER DP, 1994, J ENVIRON QUAL, V23, P705, DOI 10.2134/jeq1994.00472425002300040013x; Satarug S, 2003, TOXICOL LETT, V137, P65, DOI 10.1016/S0378-4274(02)00381-8; Tandy S, 2009, ENVIRON POLLUT, V157, P690, DOI 10.1016/j.envpol.2008.08.006; TLUSTOS P, 1995, ROST VYROBA, V41, P31; Wang G, 2006, ENVIRON POLLUT, V144, P127, DOI 10.1016/j.envpol.2005.12.023; Wang L Q, 2009, THESIS CAPITAL NORMA; Wu FL, 2011, AGR SCI CHINA, V10, P267, DOI 10.1016/S1671-2927(11)60004-7; Yang JX, 2011, SOIL SEDIMENT CONTAM, V20, P400, DOI 10.1080/15320383.2011.571314; Yang JX, 2010, J ENVIRON SCI, V22, P1246, DOI 10.1016/S1001-0742(09)60245-X; Yang JX, 2014, FRONT ENV S IN PRESS	42	14	17	9	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109967	10.1371/journal.pone.0109967	http://dx.doi.org/10.1371/journal.pone.0109967			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303439	Green Submitted, gold, Green Published			2022-12-27	WOS:000343730400098
J	Li, TT; Hu, YY; Du, XH; Tang, H; Shen, CH; Wu, JS				Li, Tingting; Hu, Yuanyuan; Du, Xuhua; Tang, Hui; Shen, Chaohua; Wu, Jiasheng			Salicylic Acid Alleviates the Adverse Effects of Salt Stress in Torreya grandis cv. Merrillii Seedlings by Activating Photosynthesis and Enhancing Antioxidant Systems	PLOS ONE			English	Article							CARBON ASSIMILATION; OSMOTIC-STRESS; GAS-EXCHANGE; SALINITY; TOLERANCE; GROWTH; PLANTS; NACL; ADAPTATION; CULTIVARS	Background: Salt stress is a major factor limiting plant growth and productivity. Salicylic acid (SA) has been shown to ameliorate the adverse effects of environmental stress on plants. To investigate the protective role of SA in ameliorating salt stress on Torreya grandis (T. grandis) trees, a pot experiment was conducted to analyze the biomass, relative water content (RWC), chlorophyll content, net photosynthesis (Pn), gas exchange parameters, relative leakage conductivity (REC), malondialdehyde (MDA) content, and activities of superoxide dismutase (SOD) and peroxidase (POD) of T. grandis under 0.2% and 0.4% NaCl conditions with and without SA. Methodology/Principal Findings: The exposure of T. grandis seedlings to salt conditions resulted in reduced growth rates, which were associated with decreases in RWC and Pn and increases in REC and MDA content. The foliar application of SA effectively increased the chlorophyll (chl (a+b)) content, RWC, net CO2 assimilation rates (Pn), and proline content, enhanced the activities of SOD, CAT and POD, and minimized the increases in the REC and MDA content. These changes increased the capacity of T. grandis in acclimating to salt stress and thus increased the shoot and root dry matter. However, when the plants were under 0% and 0.2% NaCl stress, the dry mass of the shoots and roots did not differ significantly between SA-treated plants and control plants. Conclusions: SA induced the salt tolerance and increased the biomass of T. grandis cv. by enhancing the chlorophyll content and activity of antioxidative enzymes, activating the photosynthetic process, and alleviating membrane injury. A better understanding about the effect of salt stress in T. grandis is vital, in order gain knowledge over expanding the plantations to various regions and also for the recovery of T. grandis species in the future.	[Li, Tingting; Hu, Yuanyuan; Tang, Hui; Shen, Chaohua; Wu, Jiasheng] Zhejiang A&F Univ, Nurturing Stn State Key Lab Subtrop Silviculture, Hangzhou, Zhejiang, Peoples R China; [Li, Tingting; Hu, Yuanyuan; Tang, Hui; Shen, Chaohua; Wu, Jiasheng] Zhejiang A&F Univ, Sch Forestry & Biotechnol, Hangzhou, Zhejiang, Peoples R China; [Du, Xuhua] China Natl Bamboo Res Ctr, Hangzhou, Zhejiang, Peoples R China	Zhejiang A&F University; Zhejiang A&F University; Chinese Academy of Forestry; China National Bamboo Research Center, CAF	Wu, JS (corresponding author), Zhejiang A&F Univ, Nurturing Stn State Key Lab Subtrop Silviculture, Hangzhou, Zhejiang, Peoples R China.	wujs@zafu.edu.cn	du, xuhua/L-3423-2013; xuhua, du/AAE-2404-2021	du, xuhua/0000-0003-3156-3968; 	Fruit Innovation Team Project of Zhejiang Province [2009R50033-7]; Major Project of National Spark Plan of China [2012GA700001]	Fruit Innovation Team Project of Zhejiang Province; Major Project of National Spark Plan of China	This project was supported in part by the Fruit Innovation Team Project of Zhejiang Province (2009R50033-7) and the Major Project of National Spark Plan of China (2012GA700001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdiev SI, 2000, PLANT PHYSIOL, V123, P1047, DOI 10.1104/pp.123.3.1047; Arfan M, 2007, J PLANT PHYSIOL, V164, P685, DOI 10.1016/j.jplph.2006.05.010; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Borsani O, 2001, PLANT PHYSIOL, V126, P1024, DOI 10.1104/pp.126.3.1024; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUGNOLI E, 1992, PLANTA, V187, P335, DOI 10.1007/BF00195657; Chen BQ, 2006, FITOTERAPIA, V77, P262, DOI 10.1016/j.fitote.2006.03.019; Cheng XiaoJian, 2007, Journal of Zhejiang Forestry College, V24, P383; Costa H, 2002, PLANT SCI, V162, P939, DOI 10.1016/S0168-9452(02)00051-1; El-Tayeb MA, 2005, PLANT GROWTH REGUL, V45, P215, DOI 10.1007/s10725-005-4928-1; Fariduddin Q, 2003, PHOTOSYNTHETICA, V41, P281, DOI 10.1023/B:PHOT.0000011962.05991.6c; Fu JM, 2001, ENVIRON EXP BOT, V45, P105, DOI 10.1016/S0098-8472(00)00084-8; Gonzalez L, 2001, HANDBOOK OF PLANT ECOPHYSIOLOGY TECHNIQUES, P207; GOSSETT DR, 1994, CROP SCI, V34, P706, DOI 10.2135/cropsci1994.0011183X003400030020x; Gunes A, 2007, J PLANT PHYSIOL, V164, P728, DOI 10.1016/j.jplph.2005.12.009; Gutierrez-Coronado MA, 1998, PLANT PHYSIOL BIOCH, V36, P563, DOI 10.1016/S0981-9428(98)80003-X; Hayat Q, 2010, ENVIRON EXP BOT, V68, P14, DOI 10.1016/j.envexpbot.2009.08.005; He Y, 2014, PLANT PHYSIOL BIOCH, V74, P118, DOI 10.1016/j.plaphy.2013.11.008; Huang YJ, 2001, FEMS IMMUNOL MED MIC, V31, P163, DOI 10.1111/j.1574-695X.2001.tb00513.x; Idrees M, 2011, ACTA PHYSIOL PLANT, V33, P987, DOI 10.1007/s11738-010-0631-6; Iqbal M, 2006, J INTEGR PLANT BIOL, V48, P181, DOI 10.1111/j.1744-7909.2006.00181.x; Jaleel CA, 2008, TURK J BIOL, V32, P79; KAISER WM, 1981, PLANTA, V153, P423, DOI 10.1007/BF00394980; Kaydan D, 2007, J AGR SCI-TARIM BILI, V13, P114, DOI 10.1501/Tarimbil_0000000444; Khan MIR, 2014, PLANT PHYSIOL BIOCH, V80, P67, DOI 10.1016/j.plaphy.2014.03.026; Khedr AHA, 2003, J EXP BOT, V54, P2553, DOI 10.1093/jxb/erg277; Khodary S. E. A., 2004, International Journal of Agriculture and Biology, V6, P5; Lawlor DW, 2002, PLANT CELL ENVIRON, V25, P275, DOI 10.1046/j.0016-8025.2001.00814.x; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Liu AiRong, 2013, Transactions of the Chinese Society of Agricultural Engineering, V29, P126; Mishra A, 1999, BIOL PLANTARUM, V42, P409, DOI 10.1023/A:1002469303670; Misra N, 2009, PLANT SCI, V177, P181, DOI 10.1016/j.plantsci.2009.05.007; Nazar R, 2011, J PLANT PHYSIOL, V168, P807, DOI 10.1016/j.jplph.2010.11.001; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Saeed MK, 2007, EX LINDL J APP SCI, V7, P269; Saleh B, 2012, SOIL ENVRON, V31, P113; Senaratna T, 2000, PLANT GROWTH REGUL, V30, P157, DOI 10.1023/A:1006386800974; Shi Q, 2006, PLANT GROWTH REGUL, V48, P127, DOI 10.1007/s10725-005-5482-6; Steduto P, 2000, ENVIRON EXP BOT, V44, P243, DOI 10.1016/S0098-8472(00)00071-X; Stevens J, 2006, PLANT GROWTH REGUL, V49, P77, DOI 10.1007/s10725-006-0019-1; Sudhir P, 2004, PHOTOSYNTHETICA, V42, P481, DOI 10.1007/S11099-005-0001-6; Syeed S, 2011, ACTA PHYSIOL PLANT, V33, P877, DOI 10.1007/s11738-010-0614-7; Tang D, 2007, J ARID ENVIRON, V71, P312, DOI 10.1016/j.jaridenv.2007.05.004; Wang LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-34; Wolff RL, 1998, J AM OIL CHEM SOC, V75, P1637, DOI 10.1007/s11746-998-0105-9; Yusuf M, 2008, J INTEGR PLANT BIOL, V50, P1096, DOI 10.1111/j.1744-7909.2008.00697.x; Zheng B, 2006, RES METHODOLOGY MODE, P189; Zhou XianRong, 2012, Journal of Northeast Forestry University, V40, P42	49	136	152	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109492	10.1371/journal.pone.0109492	http://dx.doi.org/10.1371/journal.pone.0109492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302987	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400060
J	Nair, ADS; Cheng, CM; Jaworski, DC; Willard, LH; Sanderson, MW; Ganta, RR				Nair, Arathy D. S.; Cheng, Chuanmin; Jaworski, Deborah C.; Willard, Lloyd H.; Sanderson, Michael W.; Ganta, Roman R.			Ehrlichia chaffeensis Infection in the Reservoir Host (White-Tailed Deer) and in an Incidental Host (Dog) Is Impacted by Its Prior Growth in Macrophage and Tick Cell Environments	PLOS ONE			English	Article							AMBLYOMMA-AMERICANUM ACARI; ODOCOILEUS-VIRGINIANUS; PERSISTENT INFECTION; NATURAL-HISTORY; ETIOLOGIC AGENT; MEMBRANE; TRANSMISSION; PATHOGEN; IXODIDAE; MOUSE	Ehrlichia chaffeensis, transmitted from Amblyomma americanum ticks, causes human monocytic ehrlichiosis. It also infects white-tailed deer, dogs and several other vertebrates. Deer are its reservoir hosts, while humans and dogs are incidental hosts. E. chaffeensis protein expression is influenced by its growth in macrophages and tick cells. We report here infection progression in deer or dogs infected intravenously with macrophage- or tick cell-grown E. chaffeensis or by tick transmission in deer. Deer and dogs developed mild fever and persistent rickettsemia; the infection was detected more frequently in the blood of infected animals with macrophage inoculum compared to tick cell inoculum or tick transmission. Tick cell inoculum and tick transmission caused a drop in tick infection acquisition rates compared to infection rates in ticks fed on deer receiving macrophage inoculum. Independent of deer or dogs, IgG antibody response was higher in animals receiving macrophage inoculum against macrophage- derived Ehrlichia antigens, while it was significantly lower in the same animals against tick cell-derived Ehrlichia antigens. Deer infected with tick cell inoculum and tick transmission caused a higher antibody response to tick cell cultured bacterial antigens compared to the antibody response for macrophage cultured antigens for the same animals. The data demonstrate that the host cell-specific E. chaffeensis protein expression influences rickettsemia in a host and its acquisition by ticks. The data also reveal that tick cell-derived inoculum is similar to tick transmission with reduced rickettsemia, IgG response and tick acquisition of E. chaffeensis.	[Nair, Arathy D. S.; Cheng, Chuanmin; Jaworski, Deborah C.; Willard, Lloyd H.; Sanderson, Michael W.; Ganta, Roman R.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Jaworski, Deborah C.] Oklahoma State Univ, Noble Res Ctr, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA	Kansas State University; Oklahoma State University System; Oklahoma State University - Stillwater	Ganta, RR (corresponding author), Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.	rganta@vet.ksu.edu			National Institutes of Health, USA [AI070908]; Oklahoma Agricultural Experiment Station [OKL02623]; Kansas State University Open Access Publishing Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI070908, R01AI070908] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Agricultural Experiment Station; Kansas State University Open Access Publishing Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by the National Institutes of Health, USA grant #AI070908 and the Oklahoma Agricultural Experiment Station #OKL02623. Publication of this article was supported in part by the Kansas State University Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON BE, 1993, AM J TROP MED HYG, V49, P239, DOI 10.4269/ajtmh.1993.49.239; Breitschwerdt EB, 1998, J CLIN MICROBIOL, V36, P2645, DOI 10.1128/JCM.36.9.2645-2651.1998; Chapes SK, 2008, VET PARASITOL, V158, P344, DOI 10.1016/j.vetpar.2008.09.028; CHEN SM, 1995, INFECT IMMUN, V63, P647, DOI 10.1128/IAI.63.2.647-655.1995; Cheng C, 2008, CURR PROTOC MICROBIO, V3; Cheng CM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003171; Cohen SB, 2010, VECTOR-BORNE ZOONOT, V10, P435, DOI 10.1089/vbz.2009.0058; Davidson WR, 2001, J WILDLIFE DIS, V37, P538, DOI 10.7589/0090-3558-37.3.538; DAWSON JE, 1994, J CLIN MICROBIOL, V32, P2725, DOI 10.1128/JCM.32.11.2725-2728.1994; Dawson JE, 1996, AM J VET RES, V57, P1175; Dedonder SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036749; Dugan VG, 2000, J CLIN MICROBIOL, V38, P448; Dumler JS, 2007, CLIN INFECT DIS, V45, pS45, DOI 10.1086/518146; DUMLER JS, 1995, CLIN INFECT DIS, V20, P1102, DOI 10.1093/clinids/20.5.1102; DUMLER JS, 1993, CLIN INFECT DIS, V17, P903, DOI 10.1093/clinids/17.5.903; EWING SA, 1995, J MED ENTOMOL, V32, P368, DOI 10.1093/jmedent/32.3.368; Faburay B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-83; Fritzen CM, 2011, AM J TROP MED HYG, V85, P718, DOI 10.4269/ajtmh.2011.10-0583; Gaines DN, 2014, VECTOR-BORNE ZOONOT, V14, P307, DOI 10.1089/vbz.2013.1509; Ganta RR, 2007, INFECT IMMUN, V75, P135, DOI 10.1128/IAI.01127-06; Ganta RR, 2002, INFECT IMMUN, V70, P380, DOI 10.1128/IAI.70.1.380-388.2002; Gratz NG, 1999, ANNU REV ENTOMOL, V44, P51, DOI 10.1146/annurev.ento.44.1.51; Ismail N, 2010, CLIN LAB MED, V30, P261, DOI 10.1016/j.cll.2009.10.004; Jaworski DC, 2013, VECTOR-BORNE ZOONOT, V13, P193, DOI 10.1089/vbz.2011.0868; Kocan A, 2000, EMERG INFECT DIS, V6, P477, DOI 10.3201/eid0605.000505; Kumar DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003666; Kuriakose JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024136; Li JSY, 2001, J IMMUNOL, V166, P1855; Lockhart JM, 1997, J PARASITOL, V83, P887, DOI 10.2307/3284284; McQuiston JH, 2003, J AM VET MED ASSOC, V223, P1750, DOI 10.2460/javma.2003.223.1750; Miura K, 2011, INFECT IMMUN, V79, P4947, DOI 10.1128/IAI.05640-11; Mixson TR, 2006, J MED ENTOMOL, V43, P1261, DOI 10.1603/0022-2585(2006)43[1261:POEBAR]2.0.CO;2; Munderloh UG, 1999, J CLIN MICROBIOL, V37, P2518, DOI 10.1128/JCM.37.8.2518-2524.1999; Paddock CD, 1997, J CLIN MICROBIOL, V35, P2496, DOI 10.1128/JCM.35.10.2496-2502.1997; Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003; PATRICK CD, 1975, J MED ENTOMOL, V12, P389, DOI 10.1093/jmedent/12.3.389; Pavelites JJ, 2011, FORENSIC SCI MED PAT, V7, P287, DOI 10.1007/s12024-010-9219-0; SAMBROOK J, 2000, MOL CLONING LAB MANU; Seo GM, 2008, INFECT IMMUN, V76, P4823, DOI 10.1128/IAI.00484-08; Singu V, 2005, INFECT IMMUN, V73, P79, DOI 10.1128/IAI.73.1.79-87.2005; Singu V, 2006, CELL MICROBIOL, V8, P1475, DOI 10.1111/j.1462-5822.2006.00727.x; Stone JH, 2004, JAMA-J AM MED ASSOC, V292, P2263, DOI 10.1001/jama.292.18.2263; Telford SR, 1996, VET MICROBIOL, V52, P103, DOI 10.1016/0378-1135(96)00064-8; Varela AS, 2005, VECTOR-BORNE ZOONOT, V5, P48, DOI 10.1089/vbz.2005.5.48; Varela AS, 2003, J WILDLIFE DIS, V39, P881, DOI 10.7589/0090-3558-39.4.881; Varela-Stokes AS, 2006, VECTOR-BORNE ZOONOT, V6, P140, DOI 10.1089/vbz.2006.6.140; Walker DH, 1996, EMERG INFECT DIS, V2, P18, DOI 10.3201/eid0201.960102; Winslow GM, 2005, ANN NY ACAD SCI, V1063, P395, DOI 10.1196/annals.1355.071; Winslow GM, 2005, CURR OPIN INFECT DIS, V18, P217, DOI 10.1097/01.qco.0000168381.86024.cf; Winslow GM, 1998, INFECT IMMUN, V66, P3892, DOI 10.1128/IAI.66.8.3892-3899.1998; Yabsley MJ, 2010, VET PARASITOL, V167, P136, DOI 10.1016/j.vetpar.2009.09.015; Yu DH, 2008, VECTOR-BORNE ZOONOT, V8, P355, DOI 10.1089/vbz.2007.0226; Zhang HZ, 2004, INFECT IMMUN, V72, P498, DOI 10.1128/IAI.72.1.498-507.2004; Zhang XF, 2003, J MED MICROBIOL, V52, P1021, DOI 10.1099/jmm.0.05234-0; ZUBLER MA, 1987, ARCH INTERN MED, V147, P197, DOI 10.1001/archinte.1987.00370020017008	55	25	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109056	10.1371/journal.pone.0109056	http://dx.doi.org/10.1371/journal.pone.0109056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303515	Green Submitted, Green Published, gold			2022-12-27	WOS:000343730400043
J	Olle-Monge, M; Munoz, X; Vanoirbeek, JAJ; Gomez-Olles, S; Morell, F; Cruz, MJ				Olle-Monge, Marta; Munoz, Xavier; Vanoirbeek, Jeroen A. J.; Gomez-Olles, Susana; Morell, Ferran; Cruz, Maria-Jesus			Persistence of Asthmatic Response after Ammonium Persulfate-Induced Occupational Asthma in Mice	PLOS ONE			English	Article							AIRWAY INFLAMMATION; TRIMELLITIC ANHYDRIDE; MOUSE MODELS; EXPOSURE; SENSITIZATION; CELLS; SALTS; HAIRDRESSERS; ALLERGEN; AGENTS	Introduction:Since persulfate salts are an important cause of occupational asthma (OA), we aimed to study the persistence of respiratory symptoms after a single exposure to ammonium persulfate (AP) in AP-sensitized mice. Material and Methods: BALB/c mice received dermal applications of AP or dimethylsulfoxide (DMSO) on days 1 and 8. On day 15, they received a single nasal instillation of AP or saline. Airway hyperresponsiveness (AHR) was assessed using methacholine provocation, while pulmonary inflammation was evaluated in bronchoalveolar lavage (BAL), and total serum immunoglobulin E (IgE), IgG1 and IgG2a were measured in blood at 1, 4, 8, 24 hours and 4, 8, 15 days after the single exposure to the causal agent. Histological studies of lungs were assessed. Results: AP-treated mice showed a sustained increase in AHR, lasting up to 4 days after the challenge. There was a significant increase in the percentage of neutrophils 8 hours after the challenge, which persisted for 24 hours in AP-treated mice. The extent of airway inflammation was also seen in the histological analysis of the lungs from challenged mice. Slight increases in total serum IgE 4 days after the challenge were found, while IgG gradually increased further 4 to 15 days after the AP challenge in AP-sensitized mice. Conclusions: In AP-sensitized mice, an Ig-independent response is induced after AP challenge. AHR appears immediately, but airway neutrophil inflammation appears later. This response decreases in time; at early stages only respiratory and inflammatory responses decrease, but later on immunological response decreases as well.	[Olle-Monge, Marta; Munoz, Xavier; Gomez-Olles, Susana; Morell, Ferran; Cruz, Maria-Jesus] Hosp Univ Vall Hebron, Serv Neumol, Barcelona, Spain; [Olle-Monge, Marta; Munoz, Xavier; Gomez-Olles, Susana; Morell, Ferran; Cruz, Maria-Jesus] CIBER Enfermedades Resp CibeRes, Barcelona, Spain; [Olle-Monge, Marta] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain; [Vanoirbeek, Jeroen A. J.] Katholieke Univ Leuven, Ctr Environm & Hlth, Leuven, Belgium; [Munoz, Xavier] Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, E-08193 Barcelona, Spain	Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Autonomous University of Barcelona; KU Leuven; Autonomous University of Barcelona	Cruz, MJ (corresponding author), Hosp Univ Vall Hebron, Serv Neumol, Barcelona, Spain.	mj.cruz@vhir.org	Vanoirbeek, Jeroen/D-5183-2016; Cruz, Maria Jesus/I-9073-2014	Vanoirbeek, Jeroen/0000-0001-5508-3518; Cruz, Maria Jesus/0000-0001-9759-5466; Munoz, Xavier/0000-0002-8693-022X; Morell Brotad, Ferran/0000-0002-7206-4543	Miguel Servet programme from Instituto de Salud Carlos III [CP12/03101]; Fundacio Catalana de Pneumologia (FUCAP); FIS [PI10/00782]	Miguel Servet programme from Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fundacio Catalana de Pneumologia (FUCAP); FIS(Instituto de Salud Carlos III)	MJC is a researcher supported by the Miguel Servet programme from Instituto de Salud Carlos III (CP12/03101). This project was supported by the Fundacio Catalana de Pneumologia (FUCAP) and FIS PI10/00782. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto-Korte K, 2003, CONTACT DERMATITIS, V49, P22, DOI 10.1111/j.0105-1873.2003.00134.x; Barrett NA, 2009, IMMUNITY, V31, P425, DOI 10.1016/j.immuni.2009.08.014; Bettiol J, 2002, ALLERGY, V57, P1145, DOI 10.1034/j.1398-9995.2002.23586.x; BLAINEY AD, 1986, THORAX, V41, P42, DOI 10.1136/thx.41.1.42; Cruz MJ, 2009, CONTACT DERMATITIS, V60, P85, DOI 10.1111/j.1600-0536.2008.01477.x; de Groene GJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006308.pub3; De Vooght V, 2010, THORAX, V65, P252, DOI 10.1136/thx.2009.121293; FISHER AA, 1976, ARCH DERMATOL, V112, P1407, DOI 10.1001/archderm.112.10.1407; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Hawrylowicz CM, 2005, J EXP MED, V202, P1459, DOI 10.1084/jem.20052211; Hox V, 2014, ALLERGY, V69, P282, DOI 10.1111/all.12347; Hox V, 2013, AM J RESP CRIT CARE, V187, P486, DOI 10.1164/rccm.201208-1358OC; Janssenheininger YM, 2012, J ALLERGY THER S1, V2012; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kariyawasam HH, 2007, AM J RESP CRIT CARE, V175, P896, DOI 10.1164/rccm.200609-1260OC; Kogevinas M, 2007, LANCET, V370, P336, DOI 10.1016/S0140-6736(07)61164-7; Lemiere C, 2003, ANN ALLERG ASTHMA IM, V90, P52, DOI 10.1016/S1081-1206(10)61650-X; Letourneau S, 2009, J ALLERGY CLIN IMMUN, V123, P758, DOI 10.1016/j.jaci.2009.02.011; Maes T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-7; Maghni K, 2004, AM J RESP CRIT CARE, V169, P367, DOI 10.1164/rccm.200309-1238OC; Mapp CE, 2005, AM J RESP CRIT CARE, V172, P280, DOI 10.1164/rccm.200311-1575SO; Moscato G, 2005, CHEST, V128, P3590, DOI 10.1378/chest.128.5.3590; Munoz X, 2003, CHEST, V123, P2124, DOI 10.1378/chest.123.6.2124; Munoz X, 2008, ARCH BRONCONEUMOL, V44, P140, DOI 10.1016/S1579-2129(08)60028-2; Nicholson PJ, 2005, OCCUP ENVIRON MED, V62, P290, DOI 10.1136/oem.2004.016287; Park HS, 1999, J ALLERGY CLIN IMMUN, V104, P847, DOI 10.1016/S0091-6749(99)70297-6; PEPYS J, 1976, CLIN ALLERGY, V6, P399, DOI 10.1111/j.1365-2222.1976.tb01922.x; Perzanowski MS, 2002, AM J RESP CRIT CARE, V166, P696, DOI 10.1164/rccm.2201035; Platts-Mills T, 2001, LANCET, V357, P752, DOI 10.1016/S0140-6736(00)04168-4; Pralong JA, 2012, J ALLERGY, V2012; Redlich CA, 2002, AM J RESP CELL MOL, V27, P385, DOI 10.1165/rcmb.F249; Sehra S, 2003, J IMMUNOL, V171, P2080, DOI 10.4049/jimmunol.171.4.2080; Tarlo SA, 2003, ANN ALLERG ASTHMA IM, V90, P19, DOI 10.1016/S1081-1206(10)61643-2; Toren Kjell, 2009, BMC Pulm Med, V9, P7, DOI 10.1186/1471-2466-9-7; Uter W, 2003, CONTACT DERMATITIS, V49, P236, DOI 10.1111/j.0105-1873.2003.0233.x; Vanoirbeek JAJ, 2008, J ALLERGY CLIN IMMUN, V121, P456, DOI 10.1016/j.jaci.2007.09.006; Vanoirbeek JAJ, 2006, J ALLERGY CLIN IMMUN, V117, P1090, DOI 10.1016/j.jaci.2006.01.027; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; Yawalkar N, 1999, ANN ALLERG ASTHMA IM, V82, P401, DOI 10.1016/S1081-1206(10)63291-7; Zhang XD, 2002, ALLERGY, V57, P620, DOI 10.1034/j.1398-9995.2002.03548.x	40	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109000	10.1371/journal.pone.0109000	http://dx.doi.org/10.1371/journal.pone.0109000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303285	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400041
J	Tseng, CH				Tseng, Chin-Hsiao			Metformin Reduces Thyroid Cancer Risk in Taiwanese Patients with Type 2 Diabetes	PLOS ONE			English	Article							NATIONAL-HEALTH INSURANCE; POPULATION-BASED COHORT; 12-YEAR FOLLOW-UP; BLADDER-CANCER; INSULIN USE; PANCREATIC-CANCER; INHIBITS GROWTH; MORTALITY; SMOKING; CARCINOMA	Background: Whether metformin may affect thyroid cancer risk has not been studied. This study investigated the association between metformin use and thyroid cancer risk in Taiwanese patients with type 2 diabetes mellitus. Methods: The reimbursement databases of all diabetic patients from 1996 to 2009 were retrieved from the National Health Insurance. An entry date was set at 1 January 2006 and 1,414,723 patients with type 2 diabetes were followed for thyroid cancer incidence until the end of 2009. Incidences for ever-users, never-users and subgroups of metformin exposure using tertile cutoffs for cumulative duration of therapy and cumulative dose were calculated and adjusted hazard ratios were estimated by Cox regression. Additional sensitivity analyses were conducted. Results: There were 795,321 ever-users and 619,402 never-users, with respective numbers of incident thyroid cancer of 683 (0.09%) and 1,614 (0.26%), and respective incidence of 24.09 and 87.33 per 100,000 person-years. The overall fully adjusted hazard ratio (95% confidence interval) was 0.683 (0.598-0.780), and all categories of the dose-response parameters showed significantly lower risk with P-trends <0.0001. The protective effect of metformin on thyroid cancer incidence was also supported by sensitivity analyses, disregarding age (<50 or >= 50 years) and sex; and was not affected by excluding users of insulin, sulfonylurea, and insulin and/or sulfonylurea respectively, by previous diagnosis of other cancers or by potential detection examinations that might lead to differential diagnosis of thyroid cancer. Conclusions: This study provides evidence for the first time that metformin use in patients with type 2 diabetes may reduce the risk of thyroid cancer.	[Tseng, Chin-Hsiao] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Tseng, Chin-Hsiao] Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei 100, Taiwan; [Tseng, Chin-Hsiao] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan	Tseng, CH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan.	ccktsh@ms6.hinet.net		TSENG, CHIN-HSIAO/0000-0001-9545-7123	National Science Council of Taiwan [NSC102-2314-B-002-067]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	The study was supported by the National Science Council (NSC102-2314-B-002-067) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljada A, 2012, PHARMACOL THERAPEUT, V133, P108, DOI 10.1016/j.pharmthera.2011.09.004; Arcidiacono B, 2012, EXP DIABETES RES, DOI 10.1155/2012/789174; Cappelli C, EUR J ENDOCRINOL, V167, P261; Chen GF, 2012, J CLIN ENDOCR METAB, V97, pE510, DOI 10.1210/jc.2011-1754; Diez JJ, 2013, CLIN ENDOCRINOL, V78, P505, DOI 10.1111/j.1365-2265.2012.04468.x; Dong XQ, 2012, CANCER EPIDEMIOL, V36, P206, DOI 10.1016/j.canep.2011.05.013; Franciosi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071583; Gursoy A, 2010, MED HYPOTHESES, V74, P35, DOI 10.1016/j.mehy.2009.08.021; Ittermann T, 2013, EUR J ENDOCRINOL, V169, P9, DOI 10.1530/EJE-13-0101; Klubo-Gwiezdzinska J, 2013, J CLIN ENDOCR METAB, V98, P3269, DOI 10.1210/jc.2012-3799; Klubo-Gwiezdzinska J, 2012, ENDOCR-RELAT CANCER, V19, P447, DOI 10.1530/ERC-12-0046; Kourelis TV, 2012, MED ONCOL, V29, P1314, DOI 10.1007/s12032-011-9846-7; Malaguarnera R, 2011, J CLIN ENDOCR METAB, V96, P766, DOI 10.1210/jc.2010-1255; Margel D, 2013, J CLIN ONCOL, V31, P3069, DOI 10.1200/JCO.2012.46.7043; Nar A, 2009, ACTA DIABETOL, V46, P113, DOI 10.1007/s00592-008-0067-2; Nicolucci A, 2010, ACTA DIABETOL, V47, P87, DOI 10.1007/s00592-010-0187-3; Rezzonico J, 2011, METAB SYNDR RELAT D, V9, P69, DOI 10.1089/met.2010.0026; Rizos CV, 2013, EUR J PHARMACOL, V705, P96, DOI 10.1016/j.ejphar.2013.02.038; Shih SR, 2012, EXP DIABETES RES, DOI 10.1155/2012/578285; Tseng CH, 2012, ANN ONCOL, V23, P153, DOI 10.1093/annonc/mdr334; Tseng CH, 2011, DIABETOLOGIA, V54, P2009, DOI 10.1007/s00125-011-2171-z; Tseng CH, 2014, EUR J CLIN INVEST, V44, P736, DOI 10.1111/eci.12290; Tseng CH, 2014, BREAST CANCER RES TR, V145, P785, DOI 10.1007/s10549-014-2985-8; Tseng CH, 2014, ACTA DIABETOL, V51, P295, DOI 10.1007/s00592-014-0562-6; Tseng CH, 2014, J ENVIRON SCI HEAL C, V32, P1, DOI 10.1080/10590501.2014.877645; Tseng CH, 2013, ACTA DIABETOL, V50, P879, DOI 10.1007/s00592-013-0471-0; Tseng CH, 2013, CLIN GENITOURIN CANC, V11, P508, DOI 10.1016/j.clgc.2013.04.019; Tseng CH, 2013, HEPATOL INT, V7, P693, DOI 10.1007/s12072-012-9405-0; Tseng CH, 2013, CANCER EPIDEMIOL, V37, P385, DOI 10.1016/j.canep.2013.03.013; Tseng CH, 2013, EUR J CLIN INVEST, V43, P595, DOI 10.1111/eci.12086; Tseng CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053096; Tseng CH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-7; Tseng CH, 2013, PANCREAS, V42, P42, DOI 10.1097/MPA.0b013e3182571ba9; Tseng CH, 2012, J ENVIRON SCI HEAL C, V30, P368, DOI 10.1080/10590501.2012.735519; Tseng CH, 2012, EUR J ENDOCRINOL, V167, P409, DOI 10.1530/EJE-12-0369; Tseng CH, 2012, METABOLISM, V61, P1003, DOI 10.1016/j.metabol.2011.11.015; Tseng CH, 2012, DIABETES CARE, V35, P278, DOI 10.2337/dc11-1449; Tseng CH, 2011, GUT, V60, P774, DOI 10.1136/gut.2010.226522; Tseng CH, 2009, ANN MED, V41, P371, DOI 10.1080/07853890902729778; Vigersky RA, 2006, J CLIN ENDOCR METAB, V91, P225, DOI 10.1210/jc.2005-1210; Willey CJ, 2006, AM J MANAG CARE, V12, P435; Wurth R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/126586; Wurth R, 2013, CELL CYCLE, V12, P145, DOI 10.4161/cc.23050	43	50	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109852	10.1371/journal.pone.0109852	http://dx.doi.org/10.1371/journal.pone.0109852			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303400	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400087
J	Xie, ZZ; Ling, X; Wang, DD; Fang, C; Liu, QY; Li, ZH; Liu, XC; Zhang, Y; Li, SS; Lin, HR				Xie Zhenzhen; Xiao Ling; Wang Dengdong; Fang Chao; Liu Qiongyu; Li Zihao; Liu Xiaochun; Zhang Yong; Li Shuisheng; Lin Haoran			Transcriptome Analysis of the Trachinotus ovatus: Identification of Reproduction, Growth and Immune-Related Genes and Microsatellite Markers	PLOS ONE			English	Article							DISEASE RESISTANCE; SEX DETERMINATION; FISH; TOOL; POLYMORPHISM; ASSOCIATION; EXPRESSION; DISCOVERY; MYOSTATIN; ENHANCE	Background: The Trachinotus ovatus (Teleostei, Carangidae) is an economically important marine fish species in the world. However, the lack of genomic information regarding this species limits our understanding of the genetics and biological mechanisms in Trachinotus ovatus. In this study, high throughput transcriptome sequencing was used to obtain comprehensive genomic information in Trachinotus ovatus. Principal Findings: Transcriptome sequencing was performed by using Illumina paired-end sequencing technology. The 98,534,862 high quality reads were yielded, and were de novo assembled into 156,094 unigenes with an average sequence length of 1179 bp. Transcriptome annotation revealed that 75,586 and 67,923 unigenes were functionally annotated in the NCBI non-redundant database and Swiss-Prot protein database, respectively. Functional analysis demonstrated that 67,923 unigenes were grouped into 25 Cluster of Orthologous Groups (COG) functional categories, 37,976 unigenes were clustered into 61 Gene Ontology (GO) terms, and 38,172 unigenes were assigned to 275 different Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. Based on the transcriptome dataset, a large number of unigenes associated with reproduction, growth and immunity were identified. Furthermore, a total number of 38,794 simple sequence repeats (SSRs) were discovered and 16 polymorphic loci were characterized in Trachinotus ovatus. Conclusion/Significance: The present study is the first transcriptome analysis of a fish species belonging to the genus Trachinotus and provides a valuable genomic resource for novel gene discovery, gene expression and regulation studies, and the identification of genetic markers in Trachinotus ovatus and the other fish of the genus Trachinotus.	[Xie Zhenzhen; Xiao Ling; Wang Dengdong; Fang Chao; Liu Qiongyu; Li Zihao; Liu Xiaochun; Zhang Yong; Li Shuisheng; Lin Haoran] Sun Yat Sen Univ, Sch Life Sci, Inst Aquat Econ Anim, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Xie Zhenzhen; Xiao Ling; Wang Dengdong; Fang Chao; Liu Qiongyu; Li Zihao; Liu Xiaochun; Zhang Yong; Li Shuisheng; Lin Haoran] Sun Yat Sen Univ, Sch Life Sci, Guangdong Prov Key Lab Aquat Econ Anim, Guangzhou 510275, Guangdong, Peoples R China; [Lin Haoran] Coll Ocean, Haikou, Hainan, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, Y (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Inst Aquat Econ Anim, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	lshuish@mail.sysu.edu.cn; lsszy@mail.sysu.edu.cn	lin, haoran/GXH-3030-2022; Wang, Dengdong/Y-1351-2019	Wang, Dengdong/0000-0002-6026-2083	National 863 Program of China [2012AA10A407]; Special Fund for Agro-scientific Research in the Public Interest [201403008]	National 863 Program of China(National High Technology Research and Development Program of China); Special Fund for Agro-scientific Research in the Public Interest	This work was supported by the National 863 Program of China (No. 2012AA10A407) and Special Fund for Agro-scientific Research in the Public Interest (201403008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baroiller JF, 2009, SEX DEV, V3, P118, DOI 10.1159/000223077; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bradley KM, 2011, G3-GENES GENOM GENET, V1, P3, DOI 10.1534/g3.111.000190; Campion CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095087; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; DiSepio D, 1998, P NATL ACAD SCI USA, V95, P14811, DOI 10.1073/pnas.95.25.14811; Duan CM, 2005, GEN COMP ENDOCR, V142, P44, DOI 10.1016/j.ygcen.2004.12.022; FAO, GLOB AQ PROD ONL QUE; Froese R, 2014, FISHBASE GLOBAL INFO; Gabillard JC, 2013, GEN COMP ENDOCR, V194, P45, DOI 10.1016/j.ygcen.2013.08.012; Gao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042637; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo YQ, 2005, BIOCHEM BIOPH RES CO, V330, P950, DOI 10.1016/j.bbrc.2005.03.066; Howe JR, 1997, HISTOL HISTOPATHOL, V12, P595; Ijiri S, 2008, BIOL REPROD, V78, P333, DOI 10.1095/biolreprod.107.064246; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; JORY D, 1985, J WORLD MARIC SOC, V16, P87, DOI DOI 10.1111/J.1749-7345.1985.TB00190.X; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Langefors A, 2001, P ROY SOC B-BIOL SCI, V268, P479, DOI 10.1098/rspb.2000.1378; Levavi-Sivan B, 2010, GEN COMP ENDOCR, V165, P412, DOI 10.1016/j.ygcen.2009.07.019; Li P, 2013, GENE, V532, P63, DOI 10.1016/j.gene.2013.09.014; Li WS, 2010, SCI CHINA LIFE SCI, V53, P462, DOI 10.1007/s11427-010-0084-6; Lin SM, 2012, FISH SHELLFISH IMMUN, V32, P909, DOI 10.1016/j.fsi.2012.02.019; Lind CE, 2009, AQUACULTURE, V286, P12, DOI 10.1016/j.aquaculture.2008.09.009; Long Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056998; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Ma ZH, 2014, FISH PHYSL IN PRESS; Meng ZN, 2012, GENET MOL RES, V11, P3869, DOI 10.4238/2012.November.12.4; Morton GJ, 2011, PHYSIOL REV, V91, P389, DOI 10.1152/physrev.00007.2010; Mylonas CC, 2010, GEN COMP ENDOCR, V165, P516, DOI 10.1016/j.ygcen.2009.03.007; Nadjar-Boger E, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-22; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Ou YouJun, 2013, Journal of Fisheries of China, V37, P961; [彭敏 PENG Min], 2011, [西南农业学报, Southwest China Journal of Agricultural Sciences], V24, P1152; Pereiro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035369; Rance NE, 2013, FRONT NEUROENDOCRIN, V34, P211, DOI 10.1016/j.yfrne.2013.07.003; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousseau K, 2007, NEUROENDOCRINOLOGY, V86, P165, DOI 10.1159/000101029; Rozen S, 2000, Methods Mol Biol, V132, P365; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Sirko A, 2011, INT J MOL SCI, V12, P3536, DOI 10.3390/ijms12063536; Sun LY, 2011, CONSER GENET RES, V5, P1107; Sun YH, 2012, INT J MOL SCI, V13, P14956, DOI 10.3390/ijms131114956; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Valassi E, 2008, NUTR METAB CARDIOVAS, V18, P158, DOI 10.1016/j.numecd.2007.06.004; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Veith AM, 2006, ZEBRAFISH, V3, P325, DOI 10.1089/zeb.2006.3.325; Wagh V, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.273; Wang DS, 2010, ENDOCRINOLOGY, V151, P1331, DOI 10.1210/en.2009-0999; Wang RX, 2013, VET MICROBIOL, V162, P957, DOI 10.1016/j.vetmic.2012.09.020; Xie FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026980; Xu TJ, 2009, FISH SHELLFISH IMMUN, V27, P192, DOI 10.1016/j.fsi.2009.04.009; Yaron Z, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P1500; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zhang Q, 2014, FISH SHELLFISH IMMUN, V38, P7, DOI 10.1016/j.fsi.2014.02.008; Zhang YX, 2006, MAR BIOTECHNOL, V8, P600, DOI 10.1007/s10126-005-6185-8; Zhou YC, 2001, MAR SCI, V25, P40	66	46	51	5	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109419	10.1371/journal.pone.0109419	http://dx.doi.org/10.1371/journal.pone.0109419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303650	gold, Green Published, Green Submitted			2022-12-27	WOS:000343730400055
J	Benzina, O; Cloitre, T; Martin, M; Raoul, C; Gergely, C; Scamps, F				Benzina, Ouafa; Cloitre, Thierry; Martin, Marta; Raoul, Cedric; Gergely, Csilla; Scamps, Frederique			Morphology and Intrinsic Excitability of Regenerating Sensory and Motor Neurons Grown on a Line Micropattern	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ROOT GANGLION NEURONS; SCIATIC-NERVE; CALCIUM CURRENT; MOUSE MODEL; IN-VITRO; CHANNELS; AXOTOMY; CELLS; MECHANISMS	Axonal regeneration is one of the greatest challenges in severe injuries of peripheral nerve. To provide the bridge needed for regeneration, biological or synthetic tubular nerve constructs with aligned architecture have been developed. A key point for improving axonal regeneration is assessing the effects of substrate geometry on neuronal behavior. In the present study, we used an extracellular matrix-micropatterned substrate comprising 3 mm wide lines aimed to physically mimic the in vivo longitudinal axonal growth of mice peripheral sensory and motor neurons. Adult sensory neurons or embryonic motoneurons were seeded and processed for morphological and electrical activity analyses after two days in vitro. We show that micropattern-guided sensory neurons grow one or two axons without secondary branching. Motoneurons polarity was kept on micropattern with a long axon and small dendrites. The micro-patterned substrate maintains the growth promoting effects of conditioning injury and demonstrates, for the first time, that neurite initiation and extension could be differentially regulated by conditioning injury among DRG sensory neuron subpopulations. The micro-patterned substrate impacts the excitability of sensory neurons and promotes the apparition of firing action potentials characteristic for a subclass of mechanosensitive neurons. The line pattern is quite relevant for assessing the regenerative and developmental growth of sensory and motoneurons and offers a unique model for the analysis of the impact of geometry on the expression and the activity of mechanosensitive channels in DRG sensory neurons.	[Raoul, Cedric; Scamps, Frederique] St Eloi Hosp, Neurosci Inst Montpellier, INSERM, UMR1051, Montpellier, France; [Benzina, Ouafa; Cloitre, Thierry; Martin, Marta; Gergely, Csilla] Univ Montpellier 2, Lab Charles Coulomb, UMR 5221, Montpellier, France; [Benzina, Ouafa; Cloitre, Thierry; Martin, Marta; Gergely, Csilla] CNRS, Lab Charles Coulomb, UMR 5221, Montpellier, France; [Raoul, Cedric; Scamps, Frederique] Univ Montpellier I, Univ Montpellier 2, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Montpellier; Universite de Montpellier	Scamps, F (corresponding author), St Eloi Hosp, Neurosci Inst Montpellier, INSERM, UMR1051, Montpellier, France.	frederique.scamps@inserm.fr	cloitre, thierry/M-1976-2018; Scamps, Frédérique/M-5268-2018; Raoul, Cedric/H-6517-2016	cloitre, thierry/0000-0001-6058-4050; Scamps, Frédérique/0000-0001-9545-407X; Raoul, Cedric/0000-0003-0561-6851; Gergely, Csilla/0000-0003-1229-6761	Institut National de la Sante et de la Recherche Medicale (Inserm); Association Francaise contre les Myopathies (AFM); LABEX NUMEV	Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); LABEX NUMEV	This work was supported by grants from the Institut National de la Sante et de la Recherche Medicale (Inserm), Association Francaise contre les Myopathies (AFM). The authors are grateful for the financial support obtained from the LABEX NUMEV for the Ph.D fellowship of OB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla FA, 2001, J NEUROPHYSIOL, V85, P630, DOI 10.1152/jn.2001.85.2.630; Andre S, 2003, J NEUROPHYSIOL, V90, P3764, DOI 10.1152/jn.00449.2003; Benzina O, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.10.106014; Camu W, 2014, NEUROBIOL AGING, V35, P1198, DOI 10.1016/j.neurobiolaging.2013.11.005; Chang Q, 2011, J NEUROSCI, V31, P2815, DOI 10.1523/JNEUROSCI.2475-10.2011; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Coste B, 2007, J GEN PHYSIOL, V129, P57, DOI 10.1085/jgp.200609665; Dubreuil AS, 2004, J NEUROSCI, V24, P8480, DOI 10.1523/JNEUROSCI.1598-04.2004; Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9; Fricke R, 2011, BIOMATERIALS, V32, P2070, DOI 10.1016/j.biomaterials.2010.11.036; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Gauthier NC, 2012, TRENDS CELL BIOL, V22, P527, DOI 10.1016/j.tcb.2012.07.005; Griffin JW, 2010, EXP NEUROL, V223, P60, DOI 10.1016/j.expneurol.2009.12.033; Hao JZ, 2010, J NEUROSCI, V30, P13384, DOI 10.1523/JNEUROSCI.2926-10.2010; Hilaire C, 2005, NEUROSCI LETT, V380, P330, DOI 10.1016/j.neulet.2005.01.068; Hilaire C, 2012, BIOCHEM J, V441, P463, DOI 10.1042/BJ20111147; JACOB JM, 1993, J NEUROBIOL, V24, P356, DOI 10.1002/neu.480240308; Kim YT, 2008, BIOMATERIALS, V29, P3117, DOI 10.1016/j.biomaterials.2008.03.042; Lankford KL, 1998, J COMP NEUROL, V391, P11, DOI 10.1002/(SICI)1096-9861(19980202)391:1<11::AID-CNE2>3.0.CO;2-U; Lauer L, 2001, BIOMATERIALS, V22, P1925, DOI 10.1016/S0142-9612(00)00379-3; LAWSON SN, 1991, J PHYSIOL-LONDON, V435, P41, DOI 10.1113/jphysiol.1991.sp018497; Lawson SN., 1992, SENSORY NEURONS DIVE, P27; Lechner SG, 2009, EMBO J, V28, P1479, DOI 10.1038/emboj.2009.73; Macefield VG, 2005, CLIN EXP PHARMACOL P, V32, P135, DOI 10.1111/j.1440-1681.2005.04143.x; Magnusson AK, 2008, J NEUROSCI RES, V86, P2363, DOI 10.1002/jnr.21688; Martin E, 2013, NEUROBIOL DIS, V54, P116, DOI 10.1016/j.nbd.2013.02.011; Martin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056286; MCQUARRIE IG, 1978, BRAIN RES, V152, P597, DOI 10.1016/0006-8993(78)91116-2; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Poudel I, 2013, ACTA BIOMATER, V9, P4592, DOI 10.1016/j.actbio.2012.08.039; Raivich G, 2007, BRAIN RES REV, V53, P287, DOI 10.1016/j.brainresrev.2006.09.005; Ramachandra R, 2012, J NEUROPHYSIOL, V108, P2230, DOI 10.1152/jn.00219.2012; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Recknor JB, 2006, BIOMATERIALS, V27, P4098, DOI 10.1016/j.biomaterials.2006.03.029; Schmalenberg KE, 2005, BIOMATERIALS, V26, P1423, DOI 10.1016/j.biomaterials.2004.04.046; Smith DS, 1997, J NEUROSCI, V17, P646; Stenger DA, 1998, J NEUROSCI METH, V82, P167, DOI 10.1016/S0165-0270(98)00047-8; TANAKA K, 1992, EXP NEUROL, V118, P53, DOI 10.1016/0014-4886(92)90022-I; Thery M, 2009, COLD SPRING HARB PRO, V2009; Wang HB, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016001; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Ylera B, 2009, CURR BIOL, V19, P930, DOI 10.1016/j.cub.2009.04.017; Yucel D, 2010, BIOMATERIALS, V31, P1596, DOI 10.1016/j.biomaterials.2009.11.013	43	4	4	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110687	10.1371/journal.pone.0110687	http://dx.doi.org/10.1371/journal.pone.0110687			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329060	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100082
J	Huang, HP; Jiang, XF; Dong, YB; Zhang, XF; Ding, N; Liu, JN; Hutchinson, SZ; Lu, G; Zhang, XL				Huang, Hanpeng; Jiang, Xiufeng; Dong, Yanbin; Zhang, Xiaofeng; Ding, Ning; Liu, Jiannan; Hutchinson, Sean Z.; Lu, Gan; Zhang, Xilong			Adiponectin Alleviates Genioglossal Mitochondrial Dysfunction in Rats Exposed to Intermittent Hypoxia	PLOS ONE			English	Article							SKELETAL-MUSCLE; SERUM ADIPONECTIN; SLEEP; PGC-1-ALPHA; ACTIVATION; PROTEIN; ADIPOR1	Background: Genioglossal dysfunction is involved in the pathophysiology of obstructive sleep apnea hypoxia syndrome (OSAHS) characterized by nocturnal chronic intermittent hypoxia (CIH). The pathophysiology of genioglossal dysfunction and possible targeted pharmacotherapy for alleviation of genioglossal injury in CIH require further investigation. Methodology/Principal Findings: Rats in the control group were exposed to normal air, while rats in the CIH group and CIH+adiponectin (AD) group were exposed to the same CIH condition (CIH 8 hr/day for 5 successive weeks). Furthermore, rats in CIH+AD group were administrated intravenous AD supplementation at the dosage of 10 mu g, twice a week for 5 consecutive weeks. We found that CIH-induced genioglossus (GG) injury was correlated with mitochondrial dysfunction, reduction in the numbers of mitochondrias, impaired mitochondrial ultrastructure, and a reduction in type I fibers. Compared with the CIH group, impaired mitochondrial structure and function was significantly improved and a percentage of type I fiber was elevated in the CIH+AD group. Moreover, compared with the control group, the rats' GG in the CIH group showed a significant decrease in phosphorylation of LKB1, AMPK, and PGC1-alpha, whereas there was significant rescue of such reduction in phosphorylation within the CIH+AD group. Conclusions: CIH exposure reduces mitochondrial biogenesis and impairs mitochondrial function in GG, while AD supplementation increases mitochondrial contents and alleviates CIH-induced mitochondrial dysfunction possibly through the AMPK pathway.	[Huang, Hanpeng] Jiangsu Univ, Affiliated Hosp, Dept Respirol, Zhenjiang, Peoples R China; [Jiang, Xiufeng] Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Dept Respirol, Wuxi, Peoples R China; [Dong, Yanbin; Zhang, Xiaofeng; Ding, Ning; Zhang, Xilong] Nanjing Med Univ, Affiliated Hosp 1, Dept Respirol, Nanjing, Jiangsu, Peoples R China; [Liu, Jiannan; Lu, Gan] Jangsu Geriatr Hosp, Dept Resp Dis, Nanjing, Jiangsu, Peoples R China; [Hutchinson, Sean Z.] Morsani Coll Med, Tampa, FL USA	Jiangsu University; Nanjing Medical University	Lu, G (corresponding author), Jangsu Geriatr Hosp, Dept Resp Dis, Nanjing, Jiangsu, Peoples R China.	lugan0121@163.com; zhangxilong1952@163.com			National Natural Science Foundation of China [81370184, 81400066]; Chinese Jiangsu Provincial Program of Medical Science [81400066, BL2012012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Jiangsu Provincial Program of Medical Science	This work is supported by National Natural Science Foundation of China 81370184, 81400066 and Chinese Jiangsu Provincial Program of Medical Science (BL2012012), 81400066. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Bailey EF, 2011, RESP PHYSIOL NEUROBI, V179, P14, DOI 10.1016/j.resp.2011.04.018; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Bonneau GA, 2014, DIABETES METAB SYND, V8, P3, DOI 10.1016/j.dsx.2013.10.005; Boyd JH, 2004, AM J RESP CRIT CARE, V170, P541, DOI 10.1164/rccm.200308-1100OC; Carrera M, 1999, AM J RESP CRIT CARE, V159, P1960, DOI 10.1164/ajrccm.159.6.9809052; Civitarese AE, 2006, CELL METAB, V4, P75, DOI 10.1016/j.cmet.2006.05.002; de Almeida AR, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-25; Douglas RM, 2010, AM J PHYSIOL-CELL PH, V298, pC1594, DOI 10.1152/ajpcell.00298.2009; Fritah A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032520; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Huang HP, 2012, SLEEP BREATH, V16, P505, DOI 10.1007/s11325-011-0532-y; Illan-Gomez F, 2012, OBES SURG, V22, P950, DOI 10.1007/s11695-012-0643-y; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Ix JH, 2010, J AM SOC NEPHROL, V21, P406, DOI 10.1681/ASN.2009080820; Jordan AS, 2010, J APPL PHYSIOL, V109, P469, DOI 10.1152/japplphysiol.00373.2010; Kadi F, 2002, J MUSCLE RES CELL M, V23, P335, DOI 10.1023/A:1022071114344; Kanbay A, 2008, RESPIRATION, V76, P324, DOI 10.1159/000134010; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Lee SD, 2007, INT J CARDIOL, V116, P348, DOI 10.1016/j.ijcard.2006.03.064; Li L, 2011, BASIC RES CARDIOL, V106, P1221, DOI 10.1007/s00395-011-0213-9; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Miniello VL, 2014, INT J CARDIOL, V174, P343, DOI 10.1016/j.ijcard.2014.04.115; NACHLAS MM, 1957, J HISTOCHEM CYTOCHEM, V5, P420, DOI 10.1177/5.4.420; Ohashi K, 2012, BIOCHIMIE, V94, P2137, DOI 10.1016/j.biochi.2012.06.008; Oliven A, 2007, EUR RESPIR J, V30, P748, DOI 10.1183/09031936.00131106; Qiao LP, 2012, DIABETES, V61, P1463, DOI 10.2337/db11-1475; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1; Shehzad A, 2012, HORM-INT J ENDOCRINO, V11, P8, DOI 10.1007/BF03401534; Sutlive TG, 2000, MUSCLE NERVE, V23, P416, DOI 10.1002/(SICI)1097-4598(200003)23:3<416::AID-MUS14>3.0.CO;2-#; Trinder J, 2011, SLEEP, V34, P983, DOI 10.5665/SLEEP.1144; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Zhang XL, 2004, CHINESE MED J-PEKING, V117, P1603; Zhu XD, 2011, J BIOL CHEM, V286, P8231, DOI 10.1074/jbc.M110.145888	37	12	13	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e109284	10.1371/journal.pone.0109284	http://dx.doi.org/10.1371/journal.pone.0109284			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329318	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100018
J	Kim, B; Lee, S; Jeong, D; Yang, J; Oh, MK; Lee, J				Kim, Borim; Lee, Soojin; Jeong, Daun; Yang, Jeongmo; Oh, Min-Kyu; Lee, Jinwon			Redistribution of Carbon Flux toward 2,3-Butanediol Production in Klebsiella pneumoniae by Metabolic Engineering	PLOS ONE			English	Article							ESCHERICHIA-COLI; OXYTOCA; STRAIN; MESO-2,3-BUTANEDIOL; PATHWAY; GENE	Klebsiella pneumoniae KCTC2242 has high potential in the production of a high-value chemical, 2,3-butanediol (2,3-BDO). However, accumulation of metabolites such as lactate during cell growth prevent large-scale production of 2,3-BDO. Consequently, we engineered K. pneumoniae to redistribute its carbon flux toward 2,3-BDO production. The ldhA gene deletion and gene overexpression (budA and budB) were conducted to block a pathway that competitively consumes reduced nicotinamide adenine dinucleotide and to redirect carbon flux toward 2,3-BDO biosynthesis, respectively. These steps allowed efficient glucose conversion to 2,3-BDO under slightly acidic conditions (pH 5.5). The engineered strain SGSB105 showed a 40% increase in 2,3-BDO production from glucose compared with that of the host strain, SGSB100. Genes closely related to 2,3-BDO biosynthesis were observed at the gene transcription level by cultivating the SGSB100, SGSB103, SGSB104, and SGSB105 strains under identical growth conditions. Transcription levels for budA, budB, and budC increased approximately 10% during the log phase of cell growth relative to that of SGSB100. Transcription levels of 2,3-BDO genes in SGSB105 remained high during the log and stationary phases. Thus, the carbon flux was redirected toward 2,3-BDO production. Data on batch culture and gene transcription provide insight into improving the metabolic network for 2,3-BDO biosynthesis for industrial applications.	[Kim, Borim; Lee, Soojin; Jeong, Daun; Yang, Jeongmo; Lee, Jinwon] Sogang Univ, Dept Chem & Biomol Engn, Seoul, South Korea; [Oh, Min-Kyu] Korea Univ, Dept Chem & Biol Engn, Seoul, South Korea	Sogang University; Korea University	Lee, J (corresponding author), Sogang Univ, Dept Chem & Biomol Engn, Seoul, South Korea.	jinwonlee@sogang.ac.kr	Oh, Min-Kyu/F-6933-2013	Oh, Min-Kyu/0000-0001-6406-3930; Lee, Jinwon/0000-0003-4153-0609	R&D Program of MOTIE/KEIT [10035578]; Graduate School of Specialization for Biotechnology Program of the Ministry of Knowledge Economy	R&D Program of MOTIE/KEIT; Graduate School of Specialization for Biotechnology Program of the Ministry of Knowledge Economy	This work was supported by the R&D Program of MOTIE/KEIT (No. 10035578, Development of 2,3-Butanediol and Derivative Production Technology for C-Zero Bio-Platform Industry). This work was also supported by the Graduate School of Specialization for Biotechnology Program of the Ministry of Knowledge Economy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cho S, 2013, APPL BIOCHEM BIOTECH, V170, P1922, DOI 10.1007/s12010-013-0291-2; GARG SK, 1995, BIORESOURCE TECHNOL, V51, P103, DOI 10.1016/0960-8524(94)00136-O; Ji XJ, 2008, BIOTECHNOL LETT, V30, P731, DOI 10.1007/s10529-007-9599-8; Ji XJ, 2011, BIOTECHNOL ADV, V29, P351, DOI 10.1016/j.biotechadv.2011.01.007; Ji XJ, 2010, APPL MICROBIOL BIOT, V85, P1751, DOI 10.1007/s00253-009-2222-2; Jung MY, 2012, APPL MICROBIOL BIOT, V95, P461, DOI 10.1007/s00253-012-3883-9; Jung SG, 2013, APPL MICROBIOL BIOT, V97, P1997, DOI 10.1007/s00253-012-4284-9; Kim B, 2012, J MICROBIOL BIOTECHN, V22, P1258, DOI 10.4014/jmb.1201.01044; Kim DK, 2013, J BIOSCI BIOENG, V116, P186, DOI 10.1016/j.jbiosc.2013.02.021; Kim SJ, 2013, BIORESOURCE TECHNOL, V146, P274, DOI 10.1016/j.biortech.2013.07.081; Lee S, 2012, APPL BIOCHEM BIOTECH, V166, P1801, DOI 10.1007/s12010-012-9593-z; Lu M, 2014, BIOPROC BIOSYST ENG, V37, P343, DOI 10.1007/s00449-013-0999-y; Ma CQ, 2009, APPL MICROBIOL BIOT, V82, P49, DOI 10.1007/s00253-008-1732-7; Qin JY, 2006, CHINESE J CHEM ENG, V14, P132, DOI 10.1016/S1004-9541(06)60050-5; Shin SH, 2012, J BACTERIOL, V194, P2736, DOI 10.1128/JB.00027-12; Sun LH, 2009, APPL MICROBIOL BIOT, V82, P847, DOI 10.1007/s00253-008-1823-5; Syu MJ, 2001, APPL MICROBIOL BIOT, V83, P358; Wong CL, 2014, BIORESOURCE TECHNOL, V152, P169, DOI 10.1016/j.biortech.2013.10.101; Xu YQ, 2014, METAB ENG, V23, P22, DOI 10.1016/j.ymben.2014.02.004; Xu YZ, 2009, BIOTECHNOL BIOENG, V104, P965, DOI 10.1002/bit.22455; Yan YJ, 2009, ORG BIOMOL CHEM, V7, P3914, DOI 10.1039/b913501d; Yang TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076149; Zhang GL, 2012, BIOTECHNOL LETT, V34, P1519, DOI 10.1007/s10529-012-0933-4; Zhang LY, 2010, BIORESOURCE TECHNOL, V101, P1961, DOI 10.1016/j.biortech.2009.10.052	24	15	16	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e105322	10.1371/journal.pone.0105322	http://dx.doi.org/10.1371/journal.pone.0105322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329548	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100003
J	Salerno, M; Avnet, S; Bonuccelli, G; Hosogi, S; Granchi, D; Baldini, N				Salerno, Manuela; Avnet, Sofia; Bonuccelli, Gloria; Hosogi, Shigekuni; Granchi, Donatella; Baldini, Nicola			Impairment of Lysosomal Activity as a Therapeutic Modality Targeting Cancer Stem Cells of Embryonal Rhabdomyosarcoma Cell Line RD	PLOS ONE			English	Article							SIDE POPULATION CELLS; ACRIDINE-ORANGE; V-ATPASE; ACIDIC VESICLES; P-GLYCOPROTEIN; IDENTIFICATION; EXPRESSION; RESISTANCE; TUMORS; AXIS	Rhabdomyosarcoma is the most frequent soft tissue sarcoma in children and adolescents, with a high rate of relapse that dramatically affects the clinical outcome. Multiagent chemotherapy, in combination with surgery and/or radiation therapy, is the treatment of choice. However, the relapse rate is disappointingly high and identification of new therapeutic tools is urgently needed. Under this respect, the selective block of key features of cancer stem cells (CSC) appears particularly promising. In this study, we isolated rhabdomyosarcoma CSC with stem-like features (high expression of NANOG and OCT3/4, self-renewal ability, multipotency). Rhabdomyosarcoma CSC showed higher invasive ability and a reduced cytotoxicity to doxorubicin in comparison to native cells, through a mechanism unrelated to the classical multidrug resistance process. This was dependent on a high level of lysosome acidity mediated by a high expression of vacuolar ATPase (V-ATPase). Since it was not associated with other paediatric cancers, like Ewing's sarcoma and neuroblastoma, V-ATPase higher expression in CSC was rhabdomyosarcoma specific. Inhibition of lysosomal acidification by the V-ATPase inhibitor omeprazole, or by specific siRNA silencing, significantly enhanced doxorubicin cytoxicity. Unexpectedly, lysosomal targeting also blocked cell growth and reduced the invasive potential of rhabdomyosarcoma CSC, even at very low doses of omeprazole (10 and 50 mu M, respectively). Based on these observations, we propose lysosome acidity as a valuable target to enhance chemosensitivity of rhabdomyosarcoma CSC, and suggest the use of anti-V-ATPase agents in combination with standard regimens as a promising tool for the eradication of minimal residual disease or the prevention of metastatic disease.	[Salerno, Manuela; Avnet, Sofia; Bonuccelli, Gloria; Hosogi, Shigekuni; Granchi, Donatella; Baldini, Nicola] Ist Ortoped Rizzoli, Orthopaed Pathophysiol & Regenerat Med Unit, Bologna, Italy; [Salerno, Manuela; Bonuccelli, Gloria; Baldini, Nicola] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Hosogi, Shigekuni] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Cell Physiol, Kyoto, Japan	IRCCS Istituto Ortopedico Rizzoli; University of Bologna; Kyoto Prefectural University of Medicine	Salerno, M (corresponding author), Ist Ortoped Rizzoli, Orthopaed Pathophysiol & Regenerat Med Unit, Bologna, Italy.	manuela.salerno@ior.it	Baldini, Nicola/J-4806-2016; Granchi, Donatella/ABD-5402-2021; Granchi, Donatella/J-3647-2016; Avnet, Sofia/B-3220-2018	Baldini, Nicola/0000-0003-2228-3833; Granchi, Donatella/0000-0001-7225-0023; Avnet, Sofia/0000-0002-7843-0591; Bonuccelli, Gloria/0000-0001-7576-5508	FIRB from the Italian Ministry of Education, University and Research [RBAP10447J]; Italian Association for Cancer Research [AIRC 11426]; Italian Ministry of the Health	FIRB from the Italian Ministry of Education, University and Research; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of the Health(Ministry of Health, Italy)	This work was supported by a FIRB grant (RBAP10447J to N.B.) from the Italian Ministry of Education, University and Research; from the Italian Association for Cancer Research (AIRC 11426 to N.B.); and by the Italian Ministry of the Health, Financial Support for Scientific Research "5 per mille 2010". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari AS, 2010, CANCER RES, V70, P4602, DOI 10.1158/0008-5472.CAN-09-3463; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Avnet S, 2013, BBA-MOL BASIS DIS, V1832, P1105, DOI 10.1016/j.bbadis.2013.04.003; BALDINI N, 1995, NEW ENGL J MED, V333, P1380, DOI 10.1056/NEJM199511233332103; BALDINI N, 1992, J CANCER RES CLIN, V119, P121, DOI 10.1007/BF01209668; Bell C, 2013, CELL BIOCHEM BIOPHYS, V66, P499, DOI 10.1007/s12013-012-9497-0; Castino R, 2003, J MOL RECOGNIT, V16, P337, DOI 10.1002/jmr.643; Cyranoski D, 2014, NATURE, V505, P596, DOI 10.1038/505596a; De Milito A, 2007, CANCER RES, V67, P5408, DOI 10.1158/0008-5472.CAN-06-4095; Deleyrolle LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015844; Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005; Ghiaur G, 2012, STEM CELLS, V30, P89, DOI 10.1002/stem.769; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Glunde K, 2003, NEOPLASIA, V5, P533, DOI 10.1016/S1476-5586(03)80037-4; Guan JL, 2013, AUTOPHAGY, V9, P830, DOI 10.4161/auto.24132; Jefferies KC, 2008, ARCH BIOCHEM BIOPHYS, V476, P33, DOI 10.1016/j.abb.2008.03.025; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Komuro H, 2007, J PEDIATR SURG, V42, P2040, DOI 10.1016/j.jpedsurg.2007.08.026; Kusuzaki K, 2000, ANTICANCER RES, V20, P965; Kusuzaki K, 2007, IN VIVO, V21, P205; Kusuzaki K, 2012, CURR PHARM DESIGN, V18, P1414, DOI 10.2174/138161212799504812; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Libura J, 2002, BLOOD, V100, P2597, DOI 10.1182/blood-2002-01-0031; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long HX, 2012, STEM CELLS, V30, P2309, DOI 10.1002/stem.1194; Luciani F, 2004, JNCI-J NATL CANCER I, V96, P1702, DOI 10.1093/jnci/djh305; Mahoney BP, 2003, BIOCHEM PHARMACOL, V66, P1207, DOI 10.1016/S0006-2952(03)00467-2; Millot C, 1997, J HISTOCHEM CYTOCHEM, V45, P1255, DOI 10.1177/002215549704500909; MORIYAMA Y, 1993, BIOCHEM BIOPH RES CO, V196, P699, DOI 10.1006/bbrc.1993.2306; Murase M, 2009, BRIT J CANCER, V101, P1425, DOI 10.1038/sj.bjc.6605330; Nakanishi H, 1997, J CANCER RES CLIN, V123, P352, DOI 10.1007/BF01438312; Ndolo RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049366; Ognjanovic S, 2009, CANCER-AM CANCER SOC, V115, P4218, DOI 10.1002/cncr.24465; Perut F, 2014, EXP CELL RES, V320, P21, DOI 10.1016/j.yexcr.2013.10.011; Raghunand N, 1999, BIOCHEM PHARMACOL, V57, P1047, DOI 10.1016/S0006-2952(99)00021-0; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Roncuzzi L, 2014, ONCOL REP, V32, P389, DOI 10.3892/or.2014.3181; Sakhrani NM, 2013, DRUG DES DEV THER, V7, P585, DOI 10.2147/DDDT.S45614; Salerno M, 2013, INT J ONCOL, V43, P95, DOI 10.3892/ijo.2013.1927; Singh SK, 2003, CANCER RES, V63, P5821; Spugnini EP, 2010, J EXP CLIN CANC RES, V8, P29; Stiller CA, 2004, ONCOGENE, V23, P6429, DOI 10.1038/sj.onc.1207717; Strahm B, 2008, CLIN EXP METASTAS, V25, P1, DOI 10.1007/s10585-007-9094-6; Suva ML, 2009, CANCER RES, V69, P1776, DOI 10.1158/0008-5472.CAN-08-2242; Swietach P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035949; Tirino V, 2011, FASEB J, V25, P2022, DOI 10.1096/fj.10-179036; Walter D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019506; Wang L, 2009, CANCER BIOL THER, V8, P543, DOI 10.4161/cbt.8.6.7695; You HY, 2009, CANCER LETT, V280, P110, DOI 10.1016/j.canlet.2009.02.023	50	40	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110340	10.1371/journal.pone.0110340	http://dx.doi.org/10.1371/journal.pone.0110340			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329465	Green Published, Green Submitted, gold			2022-12-27	WOS:000343942100055
J	Pulcherio, JOB; Bittencourt, AG; Burke, PR; Monsanto, RD; de Brito, R; Tsuji, RK; Bento, RF				Bentivi Pulcherio, Janaina Oliveira; Bittencourt, Aline Gomes; Burke, Patrick Rademaker; Monsanto, Rafael da Costa; de Brito, Rubens; Tsuji, Robinson Koji; Bento, Ricardo Ferreira			Carina (R) and Esteem (R): A Systematic Review of Fully Implantable Hearing Devices	PLOS ONE			English	Article							MIDDLE-EAR DEVICE; ROUND WINDOW; ENVOY ESTEEM; EXPERIENCE; TRIAL; REHABILITATION; SAFETY; AIDS	Objective: To review the outcomes of the fully implantable middle ear devices Carina and Esteem regarding the treatment of hearing loss. Data Sources: PubMed, Embase, Scielo, and Cochrane Library databases were searched. Study Selection: Abstracts of 77 citations were screened, and 43 articles were selected for full review. From those, 22 studies and two literature reviews in English directly demonstrating the results of Carina and Esteem were included. Data Extraction: There were a total of 244 patients ranging from 18 to 88 years. One hundred and 10 patients were implanted with Carina and with 134 Esteem. There were registered 92 males and 67 females. Five studies provided no information about patients' age or gender. From the data available, the follow-up ranged from 2 to 29.4 months. Data Synthesis: The comparison of the results about word recognition is difficult as there was no standardization of measurement. The results were obtained from various sound intensities and different frequencies. The outcomes comparing to conventional HAs were conflicting. Nevertheless, all results comparing to unaided condition showed improvement and showed a subjective improvement of quality of life. Conclusion: There are still some problems to be solved, mainly related to device functioning and price. Due to the relatively few publications available and small sample sizes, we must be careful in extrapolating these results to a broader population. Additionally, none of all these studies represented level high levels of evidence (i.e. randomized controlled trials).	[Bentivi Pulcherio, Janaina Oliveira] Hosp Cent Policia Militar, Dept Otolaryngol, Rio De Janeiro, Brazil; [Bittencourt, Aline Gomes; Burke, Patrick Rademaker; de Brito, Rubens; Tsuji, Robinson Koji; Bento, Ricardo Ferreira] Univ Sao Paulo, Sch Med, Dept Otolaryngol, Sao Paulo, Brazil; [Monsanto, Rafael da Costa] Banco Olhos Sorocaba Hosp, Dept Otolaryngol, Sao Paulo, Brazil	Universidade de Sao Paulo	Bittencourt, AG (corresponding author), Univ Sao Paulo, Sch Med, Dept Otolaryngol, Sao Paulo, Brazil.	alinebittencourt@hotmail.com	de Brito Neto, Rubens Vuono/D-4475-2013; da Costa Monsanto, Rafael/P-3930-2017; Monsanto, Rafael/S-8605-2017; Brito Neto, Rubens Vuono de/J-7204-2015	da Costa Monsanto, Rafael/0000-0002-9124-593X; Monsanto, Rafael/0000-0002-9124-593X; Bento, Ricardo/0000-0003-3749-4684; Brito Neto, Rubens Vuono de/0000-0001-5313-5214				Barbara M, 2011, ACTA OTO-LARYNGOL, V131, P399, DOI 10.3109/00016489.2010.536994; Barbara M, 2009, ACTA OTO-LARYNGOL, V129, P429, DOI 10.1080/00016480802593505; Bruschini L, 2009, ACTA OTORHINOLARYNGO, V29, P79; Bruschini L, 2010, ACTA OTO-LARYNGOL, V130, P1147, DOI 10.3109/00016481003671244; Butler CL, 2013, J LARYNGOL OTOL, V127, pS8, DOI 10.1017/S0022215113001151; Chen DA, 2004, OTOLARYNG HEAD NECK, V131, P904, DOI 10.1016/j.otohns.2004.05.027; Chung J, 2013, HEARING RES, V301, P137, DOI 10.1016/j.heares.2013.01.007; Deveze A, 2010, AURIS NASUS LARYNX, V37, P631, DOI 10.1016/j.anl.2010.01.005; Gerard JM, 2012, AUDIOL NEURO-OTOL, V17, P267, DOI 10.1159/000338689; Jenkins HA, 2008, OTOL NEUROTOL, V29, P534, DOI 10.1097/MAO.0b013e3181656969; Jenkins HA, 2007, OTOLARYNG HEAD NECK, V137, P206, DOI 10.1016/j.otohns.2007.03.012; Kam ACS, 2012, CLIN OTOLARYNGOL, V37, P240, DOI 10.1111/j.1749-4486.2012.02492.x; Klein K, 2012, OTOL NEUROTOL, V33, P916, DOI 10.1097/MAO.0b013e31825f230d; Kraus EM, 2011, OTOLARYNG HEAD NECK, V145, P100, DOI 10.1177/0194599811401709; Lachowska M, 2012, ARCH MED SCI, V8, P736, DOI 10.5114/aoms.2012.30299; Lefebvre PP, 2009, AUDIOL NEURO-OTOL, V14, P172, DOI 10.1159/000171479; Leuwer R, 2005, GMS Curr Top Otorhinolaryngol Head Neck Surg, V4, pDoc03; Martin C, 2009, OTOL NEUROTOL, V30, P1196, DOI 10.1097/MAO.0b013e3181c34898; Memari F, 2011, EUR ARCH OTO-RHINO-L, V268, P1421, DOI 10.1007/s00405-011-1507-0; Monini S, 2013, EUR ARCH OTO-RHINO-L, V270, P2027, DOI 10.1007/s00405-012-2252-8; Murali S, 2009, INDIAN J OTOLARYNGOL, V61, P245, DOI 10.1007/s12070-009-0076-7; Shohet JA, 2011, OTOL NEUROTOL, V32, P1428, DOI 10.1097/MAO.0b013e3182382bc8; Siegert R, 2007, LARYNGOSCOPE, V117, P336, DOI 10.1097/MLG.0b013e31802b6561; Tringali S, 2008, INT J PEDIATR OTORHI, V72, P513, DOI 10.1016/j.ijporl.2007.12.002; Tringali S, 2009, AURIS NASUS LARYNX, V36, P353, DOI 10.1016/j.anl.2008.09.003; Zenner HP, 2010, ADV OTO-RHINO-LARYNG, V69, P72, DOI 10.1159/000318524	26	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110636	10.1371/journal.pone.0110636	http://dx.doi.org/10.1371/journal.pone.0110636			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329463	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204100098
J	Padhi, A; Ma, L				Padhi, Abinash; Ma, Li			Molecular Evolutionary and Epidemiological Dynamics of Genotypes 1G and 2B of Rubella Virus	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; SURVEILLANCE; STRAINS; VACCINATION; RATES	Rubella Virus (RV), which causes measles-like rashes in children, puts millions of infants at risk of congenital defects across the globe. Employing phylogenetic approaches to the whole genome sequence data and E1 glycoprotein sequence data, the present study reports the substitution rates and dates of emergence of all thirteen previously described rubella genotypes, and gains important insights into the epidemiological dynamics of two geographically widely distributed genotypes 1G and 2B. The overall nucleotide substitution rate of this non-vector-borne RV is in the order of 10(-3) substitutions/site/year, which is considerably higher than the substitution rates previously reported for the vector-borne alphaviruses within the same family. Currently circulating strains of RV share a common ancestor that existed within the last 150 years, with 95% Highest Posterior Density values ranging from 1868 to 1926 AD. Viral strains within the respective genotypes began diverging between the year 1930 s and 1980 s. Both genotype 1G and 2B have shown a decline in effective number of infections since 1990 s, a period during which mass immunization programs against RV were adapted across the globe. Although both genotypes showed some extent of spatial genetic structuring, the analyses also depicted an inter-continental viral dispersal. Such a viral dispersal pattern could be related to the migration of infected individuals across the regions coupled with a low coverage of MMR vaccination.	[Padhi, Abinash; Ma, Li] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Padhi, A (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.	abinash74@gmail.com; lima@umd.edu	ma, li/C-1585-2014		University of Maryland	University of Maryland	LM and AP were supported by startup grant from the University of Maryland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernathy E, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-32; Abernathy ES, 2011, J INFECT DIS, V204, pS524, DOI 10.1093/infdis/jir099; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P301; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P337; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P474; [Anonymous], 2012, PHARM DRINK WAT; Banatvala JE, 2004, LANCET, V363, P1127, DOI 10.1016/S0140-6736(04)15897-2; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; de Filippis AMB, 2011, J INFECT DIS, V204, pS652, DOI 10.1093/infdis/jir405; Chen M, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-122; Chen MH, 2007, PERSP MED V, V15, P1, DOI 10.1016/S0168-7069(06)15001-6; Cheng WY, 2013, J MED VIROL, V85, P745, DOI 10.1002/jmv.23451; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; DuBois RM, 2013, NATURE, V493, P552, DOI 10.1038/nature11741; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Figueiredo CA, 2012, J MED VIROL, V84, P1831, DOI 10.1002/jmv.23393; FREY TK, 1994, ADV VIRUS RES, V44, P69, DOI 10.1016/S0065-3527(08)60328-0; Grabowsky M, 2014, JAMA PEDIATR, V168, P108, DOI 10.1001/jamapediatrics.2013.4603; Gray RR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-131; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Holmes E. C., 2009, EVOLUTION EMERGENCE; Hubschen JM, 2007, J GEN VIROL, V88, P1960, DOI 10.1099/vir.0.82580-0; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Knobler S, 2006, IMPACT GLOBALIZATION; Lee JY, 2000, CLIN MICROBIOL REV, V13, P571, DOI 10.1128/CMR.13.4.571-587.2000; Martinez-Torres AO, 2009, J CLIN MICROBIOL, V47, P158, DOI 10.1128/JCM.00469-08; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Mongua-Rodriguez N, 2013, VACCINE, V31, P2145, DOI 10.1016/j.vaccine.2013.02.047; Muller CP, 2007, VACCINE, V25, P1, DOI 10.1016/j.vaccine.2006.07.039; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Muscat M, 2014, CLIN MICROBIOL INFEC; Padhi A, 2008, J GEN VIROL, V89, P2122, DOI 10.1099/vir.0.2008/001719-0; Papania MJ, 2014, JAMA PEDIATR, V168, P148, DOI 10.1001/jamapediatrics.2013.4342; Pomeroy LW, 2008, J MOL EVOL, V66, P98, DOI 10.1007/s00239-007-9040-x; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Sugishita Y, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2013.4.2.011, 10.5365/WPSAR.2013.4.2.011]; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vauloup-Fellous C, 2010, J CLIN MICROBIOL, V48, P2530, DOI 10.1128/JCM.00181-10; Wang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042013; World Health Organization, 2012, WORLD HLTH STAT; Zheng DP, 2003, EMERG INFECT DIS, V9, P1523; Zheng DP, 2003, J INFECT DIS, V187, P1587, DOI 10.1086/374972; Zhou YM, 2007, J GEN VIROL, V88, P932, DOI 10.1099/vir.0.82495-0; Zhu Z, 2012, J CLIN MICROBIOL, V50, P353, DOI 10.1128/JCM.01264-11	48	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110082	10.1371/journal.pone.0110082	http://dx.doi.org/10.1371/journal.pone.0110082			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329480	gold, Green Submitted, Green Published			2022-12-27	WOS:000345204100043
J	Borges, AV; Morana, C; Bouillon, S; Servais, P; Descy, JP; Darchambeau, F				Borges, Alberto V.; Morana, Cedric; Bouillon, Steven; Servais, Pierre; Descy, Jean-Pierre; Darchambeau, Francois			Carbon Cycling of Lake Kivu (East Africa): Net Autotrophy in the Epilimnion and Emission of CO2 to the Atmosphere Sustained by Geogenic Inputs	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; HARD-WATER LAKES; SURFACE WATERS; ISOTOPE FRACTIONATION; NORTHERN WISCONSIN; INORGANIC CARBON; DIOXIDE; PHYTOPLANKTON; METHANE; FLUXES	We report organic and inorganic carbon distributions and fluxes in a large (>2000 km(2)) oligotrophic, tropical lake (Lake Kivu, East Africa), acquired during four field surveys, that captured the seasonal variations (March 2007-mid rainy season, September 2007-late dry season, June 2008-early dry season, and April 2009-late rainy season). The partial pressure of CO2 (pCO(2)) in surface waters of the main basin of Lake Kivu showed modest spatial (coefficient of variation between 3% and 6%), and seasonal variations with an amplitude of 163 ppm (between 579 +/- 23 ppm on average in March 2007 and 742 +/- 28 ppm on average in September 2007). The most prominent spatial feature of the pCO(2) distribution was the very high pCO(2) values in Kabuno Bay (a small sub-basin with little connection to the main lake) ranging between 11213 ppm and 14213 ppm (between 18 and 26 times higher than in the main basin). Surface waters of the main basin of Lake Kivu were a net source of CO2 to the atmosphere at an average rate of 10.8 mmol m(-2) d(-1), which is lower than the global average reported for freshwater, saline, and volcanic lakes. In Kabuno Bay, the cbCO(2) emission to the atmosphere was on average 500.7 mmol m(-2) d(-1) (similar to 46 times higher than in the main basin). Based on whole-lake mass balance of dissolved inorganic carbon (DIC) bulk concentrations and of its stable carbon isotope composition, we show that the epilimnion of Lake Kivu was net autotrophic. This is due to the modest river inputs of organic carbon owing to the small ratio of catchment area to lake surface area (2.15). The carbon budget implies that the CO2 emission to the atmosphere must be sustained by DIC inputs of geogenic origin from deep geothermal springs.	[Borges, Alberto V.; Darchambeau, Francois] Univ Liege, Chem Oceanog Unit, Liege, Belgium; [Morana, Cedric; Bouillon, Steven] Katholieke Univ Leuven, Dept Earth & Environm Sci, Leuven, Belgium; [Servais, Pierre] Univ Libre Bruxelles, Brussels, Belgium; [Descy, Jean-Pierre] Univ Namur, Res Unit Environm & Evolutionary Biol, Namur, Belgium	University of Liege; KU Leuven; Universite Libre de Bruxelles; University of Namur	Borges, AV (corresponding author), Univ Liege, Chem Oceanog Unit, Liege, Belgium.	alberto.borges@ulg.ac.be	Borges, Alberto Vieira/C-4989-2008; Bouillon, Steven/C-5177-2011; Morana, Cedric/AAL-5025-2021; Darchambeau, Francois/AAX-1206-2021	Borges, Alberto Vieira/0000-0002-5434-2247; Bouillon, Steven/0000-0001-7669-2929; Morana, Cedric/0000-0002-5521-0414; Descy, Jean-Pierre/0000-0003-1649-7800	Fonds National de la Recherche Scientifique (FNRS) [2.4.598.07, 1715859]; European Research Council [240002, SD/AR/02A]; Natural Environment Research Council [NE/I003266/1] Funding Source: researchfish; NERC [NE/I003266/1] Funding Source: UKRI	Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); European Research Council(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Fonds National de la Recherche Scientifique (FNRS) under the CAKI (Cycle du carbone et des nutriments au Lac Kivu, 2.4.598.07) and the MICKI (Microbial diversity and processes in Lake Kivu, 1715859) projects, and contributes to the European Research Council Starting Grant AFRIVAL (African river basins: catchment-scale carbon fluxes and transformations, 240002) and to the Belgian Federal Science Policy Office EAGLES (East African Great Lake Ecosystem Sensitivity to changes, SD/AR/02A) projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algesten G, 2004, GLOBAL CHANGE BIOL, V10, P141, DOI 10.1111/j.1365-2486.2003.00721.x; Alin SR, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002881; Atilla N, 2011, LIMNOL OCEANOGR, V56, P775, DOI 10.4319/lo.2011.56.3.0775; Aufdenkampe AK, 2011, FRONT ECOL ENVIRON, V9, P53, DOI 10.1890/100014; BAINES SB, 1994, LIMNOL OCEANOGR, V39, P213, DOI 10.4319/lo.1994.39.2.0213; BAINES SB, 1991, LIMNOL OCEANOGR, V36, P1078, DOI 10.4319/lo.1991.36.6.1078; Balmer MB, 2011, INLAND WATERS, V1, P125, DOI 10.5268/IW-1.2.366; Battin TJ, 2008, NAT GEOSCI, V1, P95, DOI 10.1038/ngeo101; Borges AV, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001673; Broecker W.S., 1982, TRACERS SEA; Butman D, 2011, NAT GEOSCI, V4, P839, DOI [10.1038/ngeo1294, 10.1038/NGEO1294]; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Cole JJ, 1998, LIMNOL OCEANOGR, V43, P647, DOI 10.4319/lo.1998.43.4.0647; COLE JJ, 1994, SCIENCE, V265, P1568, DOI 10.1126/science.265.5178.1568; Cole JJ, 2001, MAR FRESHWATER RES, V52, P101, DOI 10.1071/MF00084; Damas H., 1937, VERH INT VER LIMNOL, V8, P51; Darchambeau F, 2014, SCI TOTAL ENVIRON, V473, P178, DOI 10.1016/j.scitotenv.2013.12.036; Degens ET, 1973, GEOL RUNDSCH, V62, P245, DOI DOI 10.1007/BF01826830; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; Del Giorgio PA, 1999, ECOLOGY, V80, P1422, DOI 10.1890/0012-9658(1999)080[1422:LPBAMT]2.0.CO;2; Descy JP, 2000, J PHYCOL, V36, P274, DOI 10.1046/j.1529-8817.2000.99063.x; Dittrich M, 2004, AMBIO, V33, P559, DOI 10.1639/0044-7447(2004)033[0559:APRFCP]2.0.CO;2; Duarte CM, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000637; Dubois K, 2009, APPL GEOCHEM, V24, P988, DOI 10.1016/j.apgeochem.2009.03.001; Einola E, 2011, J GEOPHYS RES-BIOGEO, V116, DOI [10.1029/2010JG001636, 10.1029/2010)G001636]; EMRICH K, 1970, EARTH PLANET SC LETT, V8, P363, DOI 10.1016/0012-821X(70)90109-3; Finlay K, 2010, LIMNOL OCEANOGR, V55, P1551, DOI 10.4319/lo.2010.55.4.1551; Finlay K, 2009, LIMNOL OCEANOGR, V54, P2553, DOI 10.4319/lo.2009.54.6_part_2.2553; Frankignoulle M, 2001, AQUAT GEOCHEM, V7, P267, DOI 10.1023/A:1015251010481; Frankignoulle M, 2001, WATER RES, V35, P1344, DOI 10.1016/S0043-1354(00)00369-9; FUHRMAN JA, 1982, MAR BIOL, V66, P109, DOI 10.1007/BF00397184; Gelbrecht J, 1998, FRESEN J ANAL CHEM, V361, P47, DOI 10.1007/s002160050832; Gran G, 1952, OCEANOL ACTA, V5, P209; Hanson PC, 2003, LIMNOL OCEANOGR, V48, P1112, DOI 10.4319/lo.2003.48.3.1112; Hope D, 1996, J ENVIRON QUAL, V25, P1442, DOI 10.2134/jeq1996.00472425002500060039x; Humborg C, 2010, GLOBAL CHANGE BIOL, V16, P1966, DOI 10.1111/j.1365-2486.2009.02092.x; Karim A, 2011, CHEM GEOL, V281, P133, DOI 10.1016/j.chemgeo.2010.12.006; Kelly CA, 2001, LIMNOL OCEANOGR, V46, P1054, DOI 10.4319/lo.2001.46.5.1054; KEMPE S, 1984, J GEOPHYS RES-ATMOS, V89, P4657, DOI 10.1029/JD089iD03p04657; Kortelainen P, 2006, GLOBAL CHANGE BIOL, V12, P1554, DOI 10.1111/j.1365-2486.2006.01167.x; Kortelainen P, 2013, GLOBAL BIOGEOCHEM CY, V27, P363, DOI 10.1002/gbc.20036; Kosten S, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003618; Lapierre JF, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001945; Lehmann MF, 2004, LIMNOL OCEANOGR, V49, P415, DOI 10.4319/lo.2004.49.2.0415; Lehner B, 2004, J HYDROL, V296, P1, DOI 10.1016/j.jhydrol.2004.03.028; Ludwig W, 1996, GLOBAL BIOGEOCHEM CY, V10, P23, DOI 10.1029/95GB02925; Maberly SC, 2012, NAT CLIM CHANGE, DOI [10.1038/NCLI- MATE1748, DOI 10.1038/NCLI-MATE1748]; Marotta H, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003434; MCCONNAUGHEY TA, 1994, LIMNOL OCEANOGR, V39, P1319, DOI 10.4319/lo.1994.39.6.1319; McDonald CP, 2013, GLOBAL BIOGEOCHEM CY, V27, P285, DOI 10.1002/gbc.20032; Millero FJ, 2006, MAR CHEM, V100, P80, DOI 10.1016/j.marchem.2005.12.001; MIYAJIMA T, 1995, LIMNOL OCEANOGR, V40, P994, DOI 10.4319/lo.1995.40.5.0994; Moran XAG, 2002, MICROBIAL ECOL, V44, P217, DOI 10.1007/s00248-002-1026-z; Moran XAG, 2001, MAR ECOL PROG SER, V222, P25, DOI 10.3354/meps222025; Morana C, 2014, LIMNOL OCEANOGR, V59, P1364, DOI 10.4319/lo.2014.59.4.1364; Muvundja FA, 2009, J GREAT LAKES RES, V35, P406, DOI 10.1016/j.jglr.2009.06.002; Nayar A, 2009, NATURE, V460, P321, DOI 10.1038/460321a; Nimick DA, 2011, CHEM GEOL, V283, P3, DOI 10.1016/j.chemgeo.2010.08.017; Obst M, 2009, GEOBIOLOGY, V7, P324, DOI 10.1111/j.1472-4669.2009.00200.x; Pasche N, 2010, J PALEOLIMNOL, V44, P931, DOI 10.1007/s10933-010-9465-x; Perez NM, 2011, GEOLOGY, V39, P235, DOI 10.1130/G31586.1; Pilskaln CH, 2004, LIMNOL OCEANOGR, V49, P964, DOI 10.4319/lo.2004.49.4.0964; Prairie YT, 2002, LIMNOL OCEANOGR, V47, P316, DOI 10.4319/lo.2002.47.1.0316; Quay P, 2003, DEEP-SEA RES PT I, V50, P1045, DOI 10.1016/S0967-0637(03)00116-X; Quay PD, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003193; Rantakari M, 2008, BIOGEOCHEMISTRY, V91, P151, DOI 10.1007/s10533-008-9266-8; Raymond PA, 2013, NATURE, V503, P355, DOI 10.1038/nature12760; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; Riera JL, 1999, CAN J FISH AQUAT SCI, V56, P265, DOI 10.1139/cjfas-56-2-265; Roehm CL, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003297; Sarmento H, 2006, J PLANKTON RES, V28, P815, DOI 10.1093/plankt/fbl017; Sarmento H, 2012, AQUAT ECOL SER, V5, P67, DOI 10.1007/978-94-007-4243-7_5; Schmid M, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000892; Schmid M, 2002, ACTA VULCANOL, V14, P115, DOI DOI 10.1400/19084; Schmid M, 2012, AQUAT ECOL SER, V5, P13, DOI 10.1007/978-94-007-4243-7_2; Schmid M, 2010, LIMNOL OCEANOGR, V55, P225, DOI 10.4319/lo.2010.55.1.0225; SCHOELL M, 1988, CHEM GEOL, V71, P257, DOI 10.1016/0009-2541(88)90119-2; Shaffer G., 1993, GLOBAL CARBON CYCLE, V15, P431; Sobek S, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002264; Solomon S., 2007, 4 ASS REP INT PAN CL, P1; Spigel RH, 1996, LIMNOLOGY CLIMATOLOG, P103; STEEMANNIELSEN E, 1951, NATURE, V167, P684, DOI DOI 10.1038/167684B0; Stenuite S, 2009, FRESHWATER BIOL, V54, P1300, DOI 10.1111/j.1365-2427.2009.02177.x; Stets EG, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000783; Striegl RG, 1998, LIMNOL OCEANOGR, V43, P1519, DOI 10.4319/lo.1998.43.7.1519; Takahashi T, 2009, DEEP-SEA RES PT II, V56, P554, DOI 10.1016/j.dsr2.2008.12.009; Tamooh F, 2012, BIOGEOSCIENCES, V9, P2905, DOI 10.5194/bg-9-2905-2012; Thiery W, 2014, TELLUS A, V66, DOI 10.3402/tellusa.v66.21390; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; Weiss R.F., 1974, MAR CHEM, V2, P203, DOI DOI 10.1016/0304-4203(74)90015-2; WEISS RF, 1980, MAR CHEM, V8, P347, DOI 10.1016/0304-4203(80)90024-9; Whitfield PH, 2009, CAN WATER RESOUR J, V34, P303, DOI 10.4296/cwrj3404303; Wuest A, 2012, AQUAT ECOL SER, V5, P165, DOI 10.1007/978-94-007-4243-7_10; Yamanaka Y, 1996, GLOBAL BIOGEOCHEM CY, V10, P361, DOI 10.1029/96GB00634; ZHANG J, 1995, GEOCHIM COSMOCHIM AC, V59, P107, DOI 10.1016/0016-7037(95)91550-D	96	30	30	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109500	10.1371/journal.pone.0109500	http://dx.doi.org/10.1371/journal.pone.0109500			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314144	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500044
J	Cardelli, M; Aubin, JE				Cardelli, Marco; Aubin, Jane E.			ERR gamma Is Not Required for Skeletal Development but Is a RUNX2-Dependent Negative Regulator of Postnatal Bone Formation in Male Mice	PLOS ONE			English	Article							ESTROGEN-RELATED RECEPTOR; OSTEOBLAST DIFFERENTIATION; CELL-PROLIFERATION; HORMONE-RECEPTORS; COACTIVATOR PGC-1; BREAST-CANCER; IN-VITRO; ALPHA; ORPHAN; EXPRESSION	To assess the effects of the orphan nuclear Estrogen receptor-related receptor gamma (ERR gamma) deficiency on skeletal development and bone turnover, we utilized an ERR gamma global knockout mouse line. While we observed no gross morphological anomalies or difference in skeletal length in newborn mice, by 8 weeks of age ERR gamma +/- males but not females exhibited increased trabecular bone, which was further increased by 14 weeks. The increase in trabecular bone was due to an increase in active osteoblasts on the bone surface, without detectable alterations in osteoclast number or activity. Consistent with the histomorphometric results, we observed an increase in gene expression of the bone formation markers alkaline phosphatase (Alp) and bone sialoprotein (Bsp) in bone and increase in serum ALP, but no change in the osteoclast regulators receptor activator of NF-kappa B ligand (RANKL) and osteoprotegerin (OPG) or the resorption marker carboxy-terminal collagen crosslinks (CTX). More colony forming units-alkaline phosphatase and - osteoblast (CFU-ALP, CFU-O respectively) but not CFU-fibroblast (CFU-F) formed in ERR gamma +/- versus ERR gamma +/+ stromal cell cultures, suggesting that ERR gamma negatively regulates osteoblast differentiation and matrix mineralization but not mesenchymal precursor number. By co-immunoprecipitation experiments, we found that ERR gamma and RUNX2 interact in an ERR gamma DNA binding domain (DBD)dependent manner. Treatment of post-confluent differentiating bone marrow stromal cell cultures with Runx2 antisense oligonucleotides resulted in a reduction of CFU-ALP/CFU-O in ERR gamma +/- but not ERR gamma +/+ mice compared to their corresponding sense controls. Our data indicate that ERR gamma is not required for skeletal development but is a sex-dependent negative regulator of postnatal bone formation, acting in a RUNX2-and apparently differentiation stage-dependent manner.	[Cardelli, Marco; Aubin, Jane E.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Aubin, Jane E.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University of Toronto	Aubin, JE (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	jane.aubin@utoronto.ca		Aubin, Jane E./0000-0002-7268-5235	Canadian Institutes of Health Research [FRN 88104]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The work was supported by the following: Canadian Institutes of Health Research operating grant (FRN 88104) JEA; and Canadian Institutes of Health Research Doctoral Research Award MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Bonnelye E, 1997, MOL ENDOCRINOL, V11, P905, DOI 10.1210/me.11.7.905; Bonnelye E, 2001, J CELL BIOL, V153, P971, DOI 10.1083/jcb.153.5.971; Bonnelye E, 2013, J BONE MINER RES, V28, P225, DOI 10.1002/jbmr.1836; Delhon I, 2009, ENDOCRINOLOGY, V150, P4463, DOI 10.1210/en.2009-0121; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Elfassihi L, 2010, J BONE MINER RES, V25, P901, DOI 10.1359/jbmr.091014; Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6; Hentschke M, 2002, BIOCHEM BIOPH RES CO, V299, P872, DOI 10.1016/S0006-291X(02)02753-5; Hentschke M, 2002, EUR J BIOCHEM, V269, P4086, DOI 10.1046/j.1432-1033.2002.03102.x; Huppunen J, 2004, BIOCHEM BIOPH RES CO, V314, P964, DOI 10.1016/j.bbrc.2003.12.194; Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005; Ijichi N, 2011, J STEROID BIOCHEM, V123, P1, DOI 10.1016/j.jsbmb.2010.09.002; Jeong BC, 2009, J BIOL CHEM, V284, P14211, DOI 10.1074/jbc.M808345200; Johnston SD, 1997, MOL ENDOCRINOL, V11, P342, DOI 10.1210/me.11.3.342; Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100; Khalid O, 2008, ENDOCRINOLOGY, V149, P5984, DOI 10.1210/en.2008-0680; Kim EJ, 2013, LIFE SCI, V92, P562, DOI 10.1016/j.lfs.2013.01.015; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Luo JM, 2003, MOL CELL BIOL, V23, P7947, DOI 10.1128/MCB.23.22.7947-7956.2003; MALAVAL L, 1994, J CELL PHYSIOL, V158, P555, DOI 10.1002/jcp.1041580322; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; Perlmann T, 1996, MOL ENDOCRINOL, V10, P958, DOI 10.1210/me.10.8.958; Pirih FQ, 2008, J CELL BIOCHEM, V105, P1316, DOI 10.1002/jcb.21931; Rajalin AM, 2010, BIOCHEM BIOPH RES CO, V396, P477, DOI 10.1016/j.bbrc.2010.04.120; Roforth MM, 2012, J BONE MINER RES, V27, P891, DOI 10.1002/jbmr.1502; ROSSERT J, 1995, J CELL BIOL, V129, P1421, DOI 10.1083/jcb.129.5.1421; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Scutt Andrew, 2004, BMC Pharmacology, V4, P10, DOI 10.1186/1471-2210-4-10; Sims NA, 2002, BONE, V30, P18, DOI 10.1016/S8756-3282(01)00643-3; Sims NA, 2003, J CLIN INVEST, V111, P1319, DOI 10.1172/JCI200317246; Takarada T, 2013, J BONE MINER RES, V28, P2064, DOI 10.1002/jbmr.1945; Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200; Teyssier C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007942; Vanacker JM, 1999, EMBO J, V18, P4270, DOI 10.1093/emboj/18.15.4270; Vanacker JM, 1999, MOL ENDOCRINOL, V13, P764, DOI 10.1210/me.13.5.764; Vidal O, 2000, P NATL ACAD SCI USA, V97, P5474, DOI 10.1073/pnas.97.10.5474; Wai PY, 2006, J BIOL CHEM, V281, P18973, DOI 10.1074/jbc.M511962200; Xie W, 1999, MOL ENDOCRINOL, V13, P2151, DOI 10.1210/me.13.12.2151; Yamamoto T, 2012, INT J GYNECOL CANCER, V22, P1509, DOI 10.1097/IGC.0b013e31826fd623; Yang NY, 1996, J BIOL CHEM, V271, P5795, DOI 10.1074/jbc.271.10.5795; Yu SA, 2007, CANCER RES, V67, P4904, DOI 10.1158/0008-5472.CAN-06-3855; Zirngibl RA, 2013, J CELL BIOCH	46	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109592	10.1371/journal.pone.0109592	http://dx.doi.org/10.1371/journal.pone.0109592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313644	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662500057
J	Marti-Solano, M; Sanz, F; Pastor, M; Selent, J				Marti-Solano, Maria; Sanz, Ferran; Pastor, Manuel; Selent, Jana			A Dynamic View of Molecular Switch Behavior at Serotonin Receptors: Implications for Functional Selectivity	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; BETA(2)-ADRENERGIC RECEPTOR; DRUG DISCOVERY; CRYSTAL-STRUCTURE; BIASED AGONISM; SIGNALING BIAS; TIME-SCALE; ACTIVATION; MECHANISM; SIMULATIONS	Functional selectivity is a property of G protein-coupled receptors that allows them to preferentially couple to particular signaling partners upon binding of biased agonists. Publication of the X-ray crystal structure of serotonergic 5-HT1B and 5-HT2B receptors in complex with ergotamine, a drug capable of activating G protein coupling and beta-arrestin signaling at the 5-HT1B receptor but clearly favoring beta-arrestin over G protein coupling at the 5-HT2B subtype, has recently provided structural insight into this phenomenon. In particular, these structures highlight the importance of specific residues, also called micro-switches, for differential receptor activation. In our work, we apply classical molecular dynamics simulations and enhanced sampling approaches to analyze the behavior of these micro-switches and their impact on the stabilization of particular receptor conformational states. Our analysis shows that differences in the conformational freedom of helix 6 between both receptors could explain their different G protein-coupling capacity. In particular, as compared to the 5-HT1B receptor, helix 6 movement in the 5-HT2B receptor can be constrained by two different mechanisms. On the one hand, an anchoring effect of ergotamine, which shows an increased capacity to interact with the extracellular part of helices 5 and 6 and stabilize them, hinders activation of a hydrophobic connector region at the center of the receptor. On the other hand, this connector region in an inactive conformation is further stabilized by unconserved contacts extending to the intracellular part of the 5-HT2B receptor, which hamper opening of the G protein binding site. This work highlights the importance of considering receptor capacity to adopt different conformational states from a dynamic perspective in order to underpin the structural basis of functional selectivity.	[Marti-Solano, Maria; Sanz, Ferran; Pastor, Manuel; Selent, Jana] Univ Pompeu Fabra, IMIM, Hosp del Mar,Dept Expt & Hlth Sci,Med Res Inst, Res Programme Biomed Informat GRIB, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University	Pastor, M (corresponding author), Univ Pompeu Fabra, IMIM, Hosp del Mar,Dept Expt & Hlth Sci,Med Res Inst, Res Programme Biomed Informat GRIB, Barcelona, Spain.	manuel.pastor@upf.edu; jana.selent@upf.edu	Selent, Jana/E-6912-2015; Gasull, Martina/J-4076-2019; Pastor, Manuel/A-1566-2010; Sanz, Ferran/B-3852-2009	Selent, Jana/0000-0002-1844-4449; Pastor, Manuel/0000-0001-8850-1341; Sanz, Ferran/0000-0002-7534-7661; Marti-Solano, Maria/0000-0003-0373-8927	Ministerio de Educacion y Ciencia [SAF2009-13609-C04-04]; La MARATO de TV3 Foundation [091010]; University and Research Secretariat of the Catalan Government; European Social Fund [2013FI_B 00143]; Instituto de Salud Carlos III FEDER [CP12/03139]; GLISTEN European Research Network	Ministerio de Educacion y Ciencia(Spanish Government); La MARATO de TV3 Foundation; University and Research Secretariat of the Catalan Government; European Social Fund(European Social Fund (ESF)); Instituto de Salud Carlos III FEDER(Instituto de Salud Carlos IIIEuropean Commission); GLISTEN European Research Network	This work was funded by the Ministerio de Educacion y Ciencia, grant number SAF2009-13609-C04-04, and La MARATO de TV3 Foundation, grant number 091010. MM-S is supported by a doctoral fellowship from the University and Research Secretariat of the Catalan Government and the European Social Fund (2013FI_B 00143). JS acknowledges support from the Instituto de Salud Carlos III FEDER (CP12/03139) and the GLISTEN European Research Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Bock A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2028; Bonomi M, 2009, PLUMED PORTABLE PLUG, P1; Case D, 2012, AMBER 12 AMBER MOL D; Chemical Computing Group, 2014, MOL OP ENV MOE SOFW; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Dror RO, 2011, P NATL ACAD SCI USA, V108, P1; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Gregory KJ, 2010, J BIOL CHEM, V285, P7459, DOI 10.1074/jbc.M109.094011; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; Harvey MJ, 2012, DRUG DISCOV TODAY, V17, P1059, DOI 10.1016/j.drudis.2012.03.017; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Marti-Solano M, 2013, CURR PHARM DESIGN, V19, P5156, DOI 10.2174/1381612811319280014; Mezei M, 2006, J COMPUT AID MOL DES, V20, P97, DOI 10.1007/s10822-006-9039-1; Mezei M, 2010, J COMPUT CHEM, V31, P2658, DOI 10.1002/jcc.21551; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Park PSH, 2012, CURR MED CHEM, V19, P1146; Preininger AM, 2013, J MOL BIOL, V425, P2288, DOI 10.1016/j.jmb.2013.04.011; Raiteri P, 2006, J PHYS CHEM B, V110, P3533, DOI 10.1021/jp054359r; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosas MBR, 2013, EXPERT OPIN PHARMACO, V14, P1599, DOI 10.1517/14656566.2013.806487; Roth BL, 2007, NEW ENGL J MED, V356, P6, DOI 10.1056/NEJMp068265; Sherwood CC, 2011, P NATL ACAD SCI USA, V108, P13029, DOI 10.1073/pnas.1016709108; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807; Williams T, 2014, GNUPLOT 4 5 INTERACT; Wisler JW, 2014, CURR OPIN CELL BIOL, V27, P18, DOI 10.1016/j.ceb.2013.10.008; Yuan SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047114	42	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109312	10.1371/journal.pone.0109312	http://dx.doi.org/10.1371/journal.pone.0109312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313636	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500030
J	Song, JG; Gao, LC; Yang, G; Tang, SH; Xie, HH; Wang, YJ; Wang, JB; Zhang, YP; Jin, J; Gou, YW; Yang, ZP; Chen, Z; Wu, KC; Liu, J; Fan, DM				Song, Jiugang; Gao, Liucun; Yang, Guang; Tang, Shanhong; Xie, Huahong; Wang, Yongji; Wang, Jingbo; Zhang, Yanping; Jin, Jiang; Gou, Yawen; Yang, Zhiping; Chen, Zheng; Wu, Kaichun; Liu, Jie; Fan, Daiming			MiR-199a Regulates Cell Proliferation and Survival by Targeting FZD7	PLOS ONE			English	Article							MICRORNA EXPRESSION; HEPATOCELLULAR-CARCINOMA; THERAPEUTIC TARGET; GENE-EXPRESSION; CATENIN PATHWAY; SUPPRESSOR GENE; WILMS-TUMOR; HUMAN LIVER; FRIZZLED-7; IDENTIFICATION	A growing amount of evidence indicates that miRNAs are important regulators of multiple cellular processes and, when expressed aberrantly in different types of cancer such as hepatocellular carcinoma (HCC), play significant roles in tumorigenesis and progression. Aberrant expression of miR-199a-5p (also called miR-199a) was found to contribute to carcinogenesis in different types of cancer, including HCC. However, the precise molecular mechanism is not yet fully understood. The present study showed that miR-199a is frequently down-regulated in HCC tissues and cells. Importantly, lower expression of miR-199a was significantly correlated with the malignant potential and poor prognosis of HCC, and restoration of miR-199a in HCC cells led to inhibition of the cell proliferation and cell cycle in vitro and in vivo. Furthermore, Frizzled type 7 receptor (FZD7), the most important Wnt receptor involved in cancer development and progression, was identified as a functional target of miR-199a. In addition, these findings were further strengthened by results showing that expression of FZD7 was inversely correlated with miR-199a in both HCC tissues and cells and that over-expression of miR-199a could significantly down-regulate the expression of genes downstream of FZD7, including beta-catenin, Jun, Cyclin D1 and Myc. In conclusion, these findings not only help us to better elucidate the molecular mechanisms of hepatocarcinogenesis from a fresh perspective but also provide a new theoretical basis to further investigate miR-199a as a potential biomarker and a promising approach for HCC treatment.	[Song, Jiugang] 309th Hosp Chinese Peoples Liberat Army, Dept Gastroenterol, Beijing, Peoples R China; [Song, Jiugang; Gao, Liucun; Tang, Shanhong; Xie, Huahong; Wang, Jingbo; Jin, Jiang; Gou, Yawen; Yang, Zhiping; Chen, Zheng; Wu, Kaichun; Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp Digest, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Gao, Liucun] Beijing Inst Radiat Med, Dept Pharmacol & Toxicol, Beijing, Peoples R China; [Yang, Guang] 309th Hosp Chinese Peoples Liberat Army, Dept XiShan, Outpatient Clin, Beijing, Peoples R China; [Tang, Shanhong] Gen Hosp Chengdu Mil Command, Dept Digest, Chengdu, Sichuan Provinc, Peoples R China; [Wang, Yongji] 309th Hosp Chinese Peoples Liberat Army, Dept Med, Beijing, Peoples R China; [Zhang, Yanping] Gen Armament Dept PLA, Asian Games Village Clin, Logist Dept, Beijing, Peoples R China; [Liu, Jie] Fudan Univ, Huashan Hosp, Dept Digest Dis, Shanghai 200433, Peoples R China	Air Force Military Medical University; Academy of Military Medical Sciences - China; Fudan University	Fan, DM (corresponding author), Fourth Mil Med Univ, Xijing Hosp Digest, State Key Lab Canc Biol, Xian 710032, Peoples R China.	fandaim@fmmu.edu.cn	gao, Liu/AAH-5970-2019; wang, jing/GRS-7509-2022; WANG, JINGYI/GSJ-1241-2022		National Natural Science Foundation of China [81101852]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant 81101852 from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Braconi C, 2011, SEMIN ONCOL, V38, P752, DOI 10.1053/j.seminoncol.2011.08.001; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fujii N, 2007, CANCER RES, V67, P573, DOI 10.1158/0008-5472.CAN-06-2726; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Gullberg D, 2011, PLOS ONE, V6; He XJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-218; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Huang S, 2011, BRIT J CANCER, V104, P235, DOI 10.1038/sj.bjc.6606010; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Kim M, 2008, J HEPATOL, V48, P780, DOI 10.1016/j.jhep.2007.12.020; Kirikoshi H, 2001, INT J ONCOL, V19, P111; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Li CM, 2002, AM J PATHOL, V160, P2181, DOI 10.1016/S0002-9440(10)61166-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mascaux C, 2009, EUR RESPIR J, V33, P352, DOI 10.1183/09031936.00084108; Melchior K, 2008, BIOL CHEM, V389, P897, DOI 10.1515/BC.2008.108; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Merle P, 2005, J HEPATOL, V43, P854, DOI 10.1016/j.jhep.2005.05.018; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Nambotin SB, 2011, J HEPATOL, V54, P288, DOI 10.1016/j.jhep.2010.06.033; Negrini M, 2011, ANTI-CANCER AGENT ME, V11, P500, DOI 10.2174/187152011796011037; Nelson KM, 2008, MOL CANCER THER, V7, P3655, DOI 10.1158/1535-7163.MCT-08-0586; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Pode-Shakked N, 2011, ONCOGENE, V30, P1664, DOI 10.1038/onc.2010.549; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Sagara N, 1998, BIOCHEM BIOPH RES CO, V252, P117, DOI 10.1006/bbrc.1998.9607; Sanyal AJ, 2010, ONCOLOGIST, V15, P14, DOI 10.1634/theoncologist.2010-S4-14; Schwartz M, 2007, NAT CLIN PRACT ONCOL, V4, P424, DOI 10.1038/ncponc0844; Song JG, 2006, NEOPLASIA, V8, P995, DOI 10.1593/neo.06592; Su SF, 2013, ONCOGENE, V32, P4694, DOI 10.1038/onc.2012.483; Tanaka S, 1998, P NATL ACAD SCI USA, V95, P10164, DOI 10.1073/pnas.95.17.10164; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Tsukigi M, 2012, CANCER LETT, V315, P189, DOI 10.1016/j.canlet.2011.10.008; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Ueno K, 2009, BRIT J CANCER, V101, P1374, DOI 10.1038/sj.bjc.6605307; Ueno K, 2008, NEOPLASIA, V10, P697, DOI 10.1593/neo.08320; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yang L, 2011, ONCOGENE, V30, P4437, DOI 10.1038/onc.2011.145; Yates LA, 2013, CELL, V153, P516, DOI 10.1016/j.cell.2013.04.003; Yu T, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-64	51	53	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110074	10.1371/journal.pone.0110074	http://dx.doi.org/10.1371/journal.pone.0110074			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313882	Green Submitted, gold, Green Published			2022-12-27	WOS:000343662500095
J	Xiao, S; Caglar, E; Maldonado, P; Das, D; Nadeem, Z; Chi, A; Trinite, B; Li, X; Saxena, A				Xiao, Shu; Caglar, Elif; Maldonado, Priscilla; Das, Dibash; Nadeem, Zaineb; Chi, Angela; Trinite, Benjamin; Li, Xin; Saxena, Anjana			Induced Expression of Nucleolin Phosphorylation-Deficient Mutant Confers Dominant-Negative Effect on Cell Proliferation	PLOS ONE			English	Article							REPLICATION PROTEIN-A; CASEIN KINASE-II; MESSENGER-RNA; DNA-DAMAGE; TRANSCRIPTION FACTOR; COMPLEX-FORMATION; S-PHASE; P53; BINDING; IDENTIFICATION	Nucleolin (NCL) is a major nucleolar phosphoprotein that has pleiotropic effects on cell proliferation and is elevated in a variety of tumors. NCL is highly phosphorylated at the N-terminus by two major kinases: interphase casein kinase 2 (CK2) and mitotic cyclin-dependent kinase 1 (CDK1). Earlier we demonstrated that a NCL-mutant that is partly defective in undergoing phosphorylation by CK2 inhibits chromosomal replication through its interactions with Replication Protein A, mimicking the cellular response to DNA damage. We further delineated that the N-terminus of NCL associates with Hdm2, the most common E3 ubiquitin ligase of p53. We reported that NCL antagonizes Hdm2 to stabilize p53 and stimulates p53 transcriptional activity. Although NCL-phosphorylation by CK2 and ribosomal DNA transcription are closely coordinated during interphase, the role of NCL phosphorylation in regulating cell proliferation remains unexplored. We have therefore engineered unique human cells that specifically induce expression of NCL-wild type (WT) or a phosphorylation-deficient NCL-mutant, 6/S*A where all the six CK2 consensus serine sites residing in the N-terminus NCL were mutated to alanine. Here we show that this NCL-mutant is defective in undergoing phosphorylation by CK2. We also demonstrate that NCL-phosphorylation by CK2 is required through the S-phase progression in cell cycle and hence proliferation. Induced expression of NCL with mutated CK2 phosphorylation sites stabilizes p53, results in higher expression of Bcl2 (B-cell lymphoma 2) homology 3 (BH3)-only apoptotic markers and causes a dominant-negative effect on cell viability. Our unique cellular system thus provides the first evidential support to delineate phospho-specific functions of NCL on cell proliferation.	[Xiao, Shu; Caglar, Elif; Das, Dibash; Nadeem, Zaineb; Saxena, Anjana] CUNY Brooklyn Coll, Dept Biol, Brooklyn, NY 11210 USA; [Xiao, Shu; Das, Dibash; Saxena, Anjana] CUNY, Grad Ctr, New York, NY USA; [Maldonado, Priscilla] NYU, Sch Med, New York, NY USA; [Chi, Angela] Great Neck South High Sch, Great Neck, NY USA; [Trinite, Benjamin; Li, Xin] NYU, Coll Dent, New York, NY USA	City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System; New York University; New York University	Saxena, A (corresponding author), CUNY Brooklyn Coll, Dept Biol, Brooklyn, NY 11210 USA.	asaxena@brooklyn.cuny.edu	Saxena, Anjana/AAZ-5244-2020; Ogunwobi, Olorunseun/F-3172-2010	Saxena, Anjana/0000-0001-8884-5179; Das, Dibash/0000-0002-1643-3287; Li, Xin/0000-0002-7414-5734	National Institutes of Health (NIH) (National Cancer Institute (NCI)) [CA175794]; PSC-CUNY Awards [60040-39 40, 80209-07 19]; NIH (NCI) [CA172894, CA180277]; NIH [5R01AI029963]; NATIONAL CANCER INSTITUTE [R03CA172894, R01CA180277, R21CA175794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029963] Funding Source: NIH RePORTER	National Institutes of Health (NIH) (National Cancer Institute (NCI))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PSC-CUNY Awards; NIH (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by National Institutes of Health (NIH) (National Cancer Institute (NCI)) grant CA175794 & PSC-CUNY Awards # 60040-39 40, # 80209-07 19 to A. Saxena, NIH (NCI) grants CA172894 & CA180277 to X. Li and by NIH grant 5R01AI029963. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2012, RNA BIOL, V9, P799, DOI 10.4161/rna.19718; Abdelmohsen K, 2011, NUCLEIC ACIDS RES, V39, P8513, DOI 10.1093/nar/gkr488; Anantha RW, 2007, J BIOL CHEM, V282, P35910, DOI 10.1074/jbc.M704645200; Angelov D, 2006, EMBO J, V25, P1669, DOI 10.1038/sj.emboj.7601046; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Becherel OJ, 2006, HUM MOL GENET, V15, P2239, DOI 10.1093/hmg/ddl149; BELENGUER P, 1990, MOL CELL BIOL, V10, P3607, DOI 10.1128/MCB.10.7.3607; Bhatt P, 2012, FEBS J, V279, P370, DOI 10.1111/j.1742-4658.2011.08430.x; Bonnet H, 1996, J BIOL CHEM, V271, P24781, DOI 10.1074/jbc.271.40.24781; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Carpentier M, 2005, BIOCHEMISTRY-US, V44, P5804, DOI 10.1021/bi047831s; Chen J, 2012, J BIOL CHEM, V287, P16467, DOI 10.1074/jbc.M112.349274; Cong R, 2012, NUCLEIC ACIDS RES, V40, P9441, DOI 10.1093/nar/gks720; Daniely Y, 2000, J CELL BIOL, V149, P799, DOI 10.1083/jcb.149.4.799; Daniely Y, 2002, MOL CELL BIOL, V22, P6014, DOI 10.1128/MCB.22.16.6014-6022.2002; Das S, 2013, FEBS LETT, V587, P417, DOI 10.1016/j.febslet.2013.01.035; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; ERARD MS, 1988, EUR J BIOCHEM, V175, P525, DOI 10.1111/j.1432-1033.1988.tb14224.x; Fujiki H, 2014, J CANC RES CLIN ONCO; GEAHLEN RL, 1984, BIOCHIM BIOPHYS ACTA, V804, P169, DOI 10.1016/0167-4889(84)90146-0; Giorgianni F, 2007, ELECTROPHORESIS, V28, P2027, DOI 10.1002/elps.200600782; Goodman T, 2004, ELECTROPHORESIS, V25, P2533, DOI 10.1002/elps.200406008; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; Hanakahi LA, 1997, P NATL ACAD SCI USA, V94, P3605, DOI 10.1073/pnas.94.8.3605; Happo L, 2010, BLOOD, V116, P5256, DOI 10.1182/blood-2010-04-280818; Iliakis G, 2004, INT J HYPERTHER, V20, P240, DOI 10.1080/02656730310001656379; Ishimaru D, 2010, J BIOL CHEM, V285, P27182, DOI 10.1074/jbc.M109.098830; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; JORDAN P, 1994, BIOCHEMISTRY-US, V33, P14696, DOI 10.1021/bi00253a007; KHARRAT A, 1991, BIOCHEMISTRY-US, V30, P10329, DOI 10.1021/bi00106a034; Kim K, 2005, MOL CELL BIOL, V25, P2463, DOI 10.1128/MCB.25.6.2463-2474.2005; Kobayashi J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049245; Lee JH, 2014, HISTOCHEM CELL BIOL, V141, P137, DOI 10.1007/s00418-013-1166-x; LEITINGER N, 1993, J CELL BIOCHEM, V52, P153, DOI 10.1002/jcb.240520207; Lopez MF, 2000, ELECTROPHORESIS, V21, P3673, DOI 10.1002/1522-2683(200011)21:17<3673::AID-ELPS3673>3.3.CO;2-D; Maggi LB, 2005, CANCER INVEST, V23, P599, DOI 10.1080/07357900500283085; Masuda K, 2011, EMBO J, V30, P1040, DOI 10.1038/emboj.2011.24; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Negi SS, 2006, J CELL SCI, V119, P3676, DOI 10.1242/jcs.03090; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olson Mark O J, 2004, Sci STKE, V2004, ppe10; OLSON MOJ, 1990, BIOCHEMISTRY-US, V29, P5682, DOI 10.1021/bi00476a006; Otake Y, 2007, BLOOD, V109, P3069, DOI 10.1182/blood-2006-08-043257; PETER M, 1990, CELL, V60, P791, DOI 10.1016/0092-8674(90)90093-T; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Saxena A, 2006, ONCOGENE, V25, P7274, DOI 10.1038/sj.onc.1209714; SCHNEIDER HR, 1989, BIOCHIM BIOPHYS ACTA, V1014, P98, DOI 10.1016/0167-4889(89)90246-2; Schwab MS, 1997, EUR J CELL BIOL, V73, P287; Smetana K, 2006, EUR J HISTOCHEM, V50, P119; Storck S, 2009, BIOL CELL, V101, P153, DOI 10.1042/BC20080054; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; TAWFIC S, 1994, PROSTATE, V24, P101, DOI 10.1002/pros.2990240208; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; Villunger A, 2011, CELL DEATH DIFFER, V18, P1545, DOI 10.1038/cdd.2011.100; WEISENBERGER D, 1995, J CELL BIOL, V129, P561, DOI 10.1083/jcb.129.3.561; Yang C, 2002, NUCLEIC ACIDS RES, V30, P2251, DOI 10.1093/nar/30.10.2251; Yang Chonglin, 2009, Mol Cell Pharmacol, V1, P130; Yang L, 2008, J BIOL CHEM, V283, P11823, DOI 10.1074/jbc.M800308200; Ying GG, 2000, J BIOL CHEM, V275, P4152, DOI 10.1074/jbc.275.6.4152; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45	64	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109858	10.1371/journal.pone.0109858	http://dx.doi.org/10.1371/journal.pone.0109858			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313645	Green Published, gold			2022-12-27	WOS:000343662500084
J	Bloch, S; Nejman-Falenczyk, B; Dydecka, A; Los, JM; Felczykowska, A; Wegrzyn, A; Wegrzyn, G				Bloch, Sylwia; Nejman-Falenczyk, Bozena; Dydecka, Aleksandra; Los, Joanna M.; Felczykowska, Agnieszka; Wegrzyn, Alicja; Wegrzyn, Grzegorz			Different Expression Patterns of Genes from the Exo-Xis Region of Bacteriophage lambda and Shiga Toxin-Converting Bacteriophage Phi 24(B) following Infection or Prophage Induction in Escherichia coli	PLOS ONE			English	Article							PCR DATA; ENCODING BACTERIOPHAGES; REGULATORY CIRCUITS; O104/H4 OUTBREAK; RNA; VIRUS; PHAGE; STEC; QUANTIFICATION; IDENTIFICATION	Lambdoid bacteriophages serve as useful models in microbiological and molecular studies on basic biological process. Moreover, this family of viruses plays an important role in pathogenesis of enterohemorrhagic Escherichia coli (EHEC) strains, as they are carriers of genes coding for Shiga toxins. Efficient expression of these genes requires lambdoid prophage induction and multiplication of the phage genome. Therefore, understanding the mechanisms regulating these processes appears essential for both basic knowledge and potential anti-EHEC applications. The exo-xis region, present in genomes of lambdoid bacteriophages, contains highly conserved genes of largely unknown functions. Recent report indicated that the Ea8.5 protein, encoded in this region, contains a newly discovered fused homeodomain/zinc-finger fold, suggesting its plausible regulatory role. Moreover, subsequent studies demonstrated that overexpression of the exo-xis region from a multicopy plasmid resulted in impaired lysogenization of E. coli and more effective induction of lambda and Phi 24(B) prophages. In this report, we demonstrate that after prophage induction, the increase in phage DNA content in the host cells is more efficient in E. coli bearing additional copies of the exo-xis region, while survival rate of such bacteria is lower, which corroborated previous observations. Importantly, by using quantitative real-time reverse transcription PCR, we have determined patterns of expressions of particular genes from this region. Unexpectedly, in both phages lambda and Phi 24(B), these patterns were significantly different not only between conditions of the host cells infection by bacteriophages and prophage induction, but also between induction of prophages with various agents (mitomycin C and hydrogen peroxide). This may shed a new light on our understanding of regulation of lambdoid phage development, depending on the mode of lytic cycle initiation.	[Bloch, Sylwia; Nejman-Falenczyk, Bozena; Dydecka, Aleksandra; Los, Joanna M.; Felczykowska, Agnieszka; Wegrzyn, Grzegorz] Univ Gdansk, Dept Mol Biol, PL-80952 Gdansk, Poland; [Wegrzyn, Alicja] Univ Szczecin, Dept Microbiol, PL-70453 Szczecin, Poland	Fahrenheit Universities; University of Gdansk; University of Szczecin	Wegrzyn, G (corresponding author), Univ Gdansk, Dept Mol Biol, PL-80952 Gdansk, Poland.	grzegorz.wegrzyn@biol.ug.edu.pl	Wegrzyn, Grzegorz/ABD-6699-2020; Nejman-Falenczyk, Bozena/AAA-1961-2021; Wegrzyn, Grzegorz/AAL-1179-2020	Wegrzyn, Grzegorz/0000-0003-4042-7466; Nejman-Falenczyk, Bozena/0000-0003-4468-0733; Dydecka, Aleksandra/0000-0003-1248-3508; Wegrzyn, Alicja/0000-0002-3073-2814; Bloch, Sylwia/0000-0002-3451-3619	National Science Center (Poland) [N N301 192439, 2013/09/B/NZ2/02366]; University of Gdansk - Faculty of Biology [538-L140-B571-14]	National Science Center (Poland); University of Gdansk - Faculty of Biology	Support was provided by the National Science Center (Poland) (http://www.ncn.gov.pl/?language=en) grant no. N N301 192439 to AW; National Science Center (Poland) (http://www.ncn.gov.pl/?language=en) grant no. 2013/09/B/NZ2/02366 to AW; University of Gdansk - Faculty of Biology (http://en.ug.edu.pl/) grant no. 538-L140-B571-14 to SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglawe S. B., 2012, Physiology and Molecular Biology of Plants, V18, P287, DOI 10.1007/s12298-012-0135-5; Allison HE, 2003, INFECT IMMUN, V71, P3409, DOI 10.1128/IAI.71.6.3409-3418.2003; Allison HE, 2007, FUTURE MICROBIOL, V2, P165, DOI 10.2217/17460913.2.2.165; Beutin L, 2012, J FOOD PROTECT, V75, P408, DOI 10.4315/0362-028X.JFP-11-452; Bloch S, 2013, ARCH MICROBIOL, V195, P693, DOI 10.1007/s00203-013-0920-8; Bloch SK, 2012, ACTA BIOCHIM POL, V59, P483; Borges A, 2012, PLANT CELL REP, V31, P827, DOI 10.1007/s00299-011-1204-x; Cikos S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-113; Feng JL, 2008, BIOTECHNIQUES, V44, P901, DOI 10.2144/000112750; Gautheret D, 2001, J MOL BIOL, V313, P1003, DOI 10.1006/jmbi.2001.5102; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Hemm MR, 2008, MOL MICROBIOL, V70, P1487, DOI 10.1111/j.1365-2958.2008.06495.x; Herold S, 2004, INT J MED MICROBIOL, V294, P115, DOI 10.1016/j.ijmm.2004.06.023; Hobbs EC, 2011, CURR OPIN MICROBIOL, V14, P167, DOI 10.1016/j.mib.2011.01.007; Hoerr V, 2007, ANAL CHEM, V79, P7510, DOI 10.1021/ac071117+; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hunt JM, 2010, CLIN LAB MED, V30, P21, DOI 10.1016/j.cll.2009.11.001; Ibrahim M, 2007, MICROBIOL-SGM, V153, P3631, DOI 10.1099/mic.0.2007/006205-0; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; Karch H, 2012, EMBO MOL MED, V4, P841, DOI 10.1002/emmm.201201662; Kwan JJ, 2013, BIOCHEMISTRY-US, V52, P3612, DOI 10.1021/bi400543w; Lesnik EA, 2001, NUCLEIC ACIDS RES, V29, P3583, DOI 10.1093/nar/29.17.3583; Liu XQ, 2013, P NATL ACAD SCI USA, V110, P11928, DOI 10.1073/pnas.1309739110; Los JM, 2008, FOLIA MICROBIOL, V53, P443, DOI 10.1007/s12223-008-0068-0; Los JM, 2008, APPL ENVIRON MICROB, V74, P5113, DOI 10.1128/AEM.00306-08; Los JM, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2012.00166; Los JM, 2011, FUTURE MICROBIOL, V6, P909, DOI 10.2217/FMB.11.70; Los JM, 2010, FEMS IMMUNOL MED MIC, V58, P322, DOI 10.1111/j.1574-695X.2009.00644.x; Los JM, 2009, MICROB PATHOGENESIS, V47, P289, DOI 10.1016/j.micpath.2009.09.006; Macke TJ, 2001, NUCLEIC ACIDS RES, V29, P4724, DOI 10.1093/nar/29.22.4724; MARUYAMA A, 1993, APPL ENVIRON MICROB, V59, P712, DOI 10.1128/AEM.59.3.712-717.1993; Mauro SA, 2011, TOXINS, V3, P608, DOI 10.3390/toxins3060608; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Nowicki D, 2014, ANTIMICROB AGENTS CH, V58, P2304, DOI 10.1128/AAC.02515-13; Nowicki D, 2013, J BACTERIOL, V195, P5007, DOI 10.1128/JB.00592-13; Ptashne M, 2004, GENETIC SWITCH PHAGE; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Regier N, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-57; Riley LM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-42; Roche, 2009, LIGHTCYCLER REAL TIM; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sergueev K, 2002, J MOL BIOL, V324, P297, DOI 10.1016/S0022-2836(02)01037-9; Strauch E, 2008, INFECT IMMUN, V76, P5466, DOI 10.1128/IAI.00875-08; Waldor MK, 2005, CURR OPIN MICROBIOL, V8, P459, DOI 10.1016/j.mib.2005.06.001; Wegrzyn G, 2005, PROG NUCLEIC ACID RE, V79, P1, DOI 10.1016/S0079-6603(04)79001-7; Wegrzyn G, 2012, ADV VIRUS RES, V82, P155, DOI 10.1016/B978-0-12-394621-8.00016-9; Werber D, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-11	47	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e108233	10.1371/journal.pone.0108233	http://dx.doi.org/10.1371/journal.pone.0108233			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310402	gold, Green Published, Green Submitted			2022-12-27	WOS:000343210300013
J	Christofferson, RC; Chisenhall, DM; Wearing, HJ; Mores, CN				Christofferson, Rebecca C.; Chisenhall, Daniel M.; Wearing, Helen J.; Mores, Christopher N.			Chikungunya Viral Fitness Measures within the Vector and Subsequent Transmission Potential	PLOS ONE			English	Article							AEDES-ALBOPICTUS DIPTERA; REPRODUCTION NUMBER R-0; DENGUE OUTBREAK; BORNE DISEASES; VIRUS; AEGYPTI; MOSQUITO; SUSCEPTIBILITY; FEVER; EMERGENCE	Given the recent emergence of chikungunya in the Americas, the accuracy of forecasting and prediction of chikungunya transmission potential in the U.S. requires urgent assessment. The La Reunion-associated sub-lineage of chikungunya (with a valine substitution in the envelope protein) was shown to increase viral fitness in the secondary vector, Ae. albopictus. Subsequently, a majority of experimental and modeling efforts focused on this combination of a sub-lineage of the East-Central-South African genotype (ECSA-V) - Ae. albopictus, despite the Asian genotype being the etiologic agent of recent chikungunya outbreaks world-wide. We explore a collection of data to investigate relative transmission efficiencies of the three major genotypes/sub-lineages of chikungunya and found difference in the extrinsic incubation periods to be largely overstated. However, there is strong evidence supporting the role of Ae. albopictus in the expansion of chikungunya that our R0 calculations cannot attribute to fitness increases in one vector over another. This suggests other ecological factors associated with the Ae. albopictus-ECSA-V cycle may drive transmission intensity differences. With the apparent bias in literature, however, we are less prepared to evaluate transmission where Ae. aegypti plays a significant role. Holistic investigations of CHIKV transmission cycle(s) will allow for more complete assessment of transmission risk in areas affected by either or both competent vectors.	[Christofferson, Rebecca C.; Chisenhall, Daniel M.; Mores, Christopher N.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA; [Wearing, Helen J.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Wearing, Helen J.] Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; University of New Mexico; University of New Mexico	Christofferson, RC (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.	rcarri1@lsu.edu		Wearing, Helen/0000-0002-9837-9797; Mores, Christopher/0000-0001-6678-9049	National Institutes of Health/NIGMS [U01GM097661]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM097661] Funding Source: NIH RePORTER	National Institutes of Health/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by the National Institutes of Health/NIGMS U01GM097661. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelz A., 2007, Morbidity and Mortality Weekly Report, V56, P785; Appassakij H, 2013, TRANSFUSION, V53, P2567, DOI 10.1111/j.1537-2995.2012.03960.x; Bacaer N, 2007, B MATH BIOL, V69, P1067, DOI 10.1007/s11538-006-9166-9; Beasley DWC, 2013, ANTIVIR RES, V99, P1, DOI 10.1016/j.antiviral.2013.04.015; Bellan SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010165; Bellini R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028360; Boelle PY, 2008, VECTOR-BORNE ZOONOT, V8, P207, DOI 10.1089/vbz.2006.0620; Bonilauri P, 2008, EMERG INFECT DIS, V14, P852, DOI 10.3201/eid1405.071144; Brunkard JM, 2007, EMERG INFECT DIS, V13, P1477, DOI 10.3201/eid1310.061586; Carrieri M, 2012, J MED ENTOMOL, V49, P388, DOI 10.1603/ME10259; Casas-Martinez M, 2013, J VECTOR ECOL, V38, P277, DOI 10.1111/j.1948-7134.2013.12041.x; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P281; Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972; Chowell G, 2013, MATH BIOSCI ENG, V10, P1455, DOI 10.3934/mbe.2013.10.1455; Christofferson RC, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-282; Christofferson RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016298; de Moor P P, 1970, Trans R Soc Trop Med Hyg, V64, P927, DOI 10.1016/0035-9203(70)90114-8; Delatte H, 2008, PARASITE, V15, P3, DOI 10.1051/parasite/2008151003; Dommar CJ, 2014, ACTA TROP, V129, P61, DOI 10.1016/j.actatropica.2013.08.004; Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895; Dumont Y, 2008, MATH BIOSCI, V213, P80, DOI 10.1016/j.mbs.2008.02.008; Dumont Y, 2012, J MATH BIOL, V65, P809, DOI 10.1007/s00285-011-0477-6; Dumont Y, 2010, MATH BIOSCI ENG, V7, P313, DOI 10.3934/mbe.2010.7.313; Dupont-Rouzeyrol M, 2012, VECTOR-BORNE ZOONOT, V12, P1036, DOI 10.1089/vbz.2011.0937; Effler PV, 2005, EMERG INFECT DIS, V11, P742; Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500; Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11; Girod R, 2011, TROP MED INT HEALTH, V16, P134, DOI 10.1111/j.1365-3156.2010.02613.x; Hapuarachchi HC, 2010, J GEN VIROL, V91, P1067, DOI 10.1099/vir.0.015743-0; Kumar NP, 2008, J GEN VIROL, V89, P1945, DOI 10.1099/vir.0.83628-0; Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9; Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033; Martin Estelle, 2010, BMC Ecology, V10, P8, DOI 10.1186/1472-6785-10-8; Massad E, 2008, J TRAVEL MED, V15, P147, DOI 10.1111/j.1708-8305.2008.00186.x; McTighe SP, 2012, VECTOR-BORNE ZOONOT, V12, P867, DOI 10.1089/vbz.2012.0978; Mecoli M, 2013, COMPUT OPER RES, V40, P2219, DOI 10.1016/j.cor.2012.03.007; MOURYA DT, 1994, AM J TROP MED HYG, V51, P295, DOI 10.4269/ajtmh.1994.51.295; Moutailler S, 2009, TROP MED INT HEALTH, V14, P1105, DOI 10.1111/j.1365-3156.2009.02320.x; Nasci RS, 2014, EMERGING INFECT DIS, V20; Ng LC, 2009, EMERG INFECT DIS, V15, P1243, DOI 10.3201/eid1508.081486; Nguyen NM, 2013, P NATL ACAD SCI USA, V110, P9072, DOI 10.1073/pnas.1303395110; Novoseltsev VN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039479; Oki M, 2013, EPIDEMIOL INFECT, V141, P2612, DOI 10.1017/S0950268813000447; Paaijmans KP, 2012, BIOL LETTERS, V8, P465, DOI 10.1098/rsbl.2011.1075; Pages F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004691; Paquet C, 2006, EUROSURVEILLANCE, V11; Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005; Pesko K, 2009, J MED ENTOMOL, V46, P395, DOI 10.1603/033.046.0228; Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860; Pongsumpun P, 2013, J BASIC APPL SCI RES, V3, P302; Pongsumpun P., 2010, WORLD ACAD SCI ENG T, V4, P969; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; Reiskind MH, 2008, AM J TROP MED HYG, V78, P422, DOI 10.4269/ajtmh.2008.78.422; Ritchie SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068137; Ruiz-Moreno D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001918; Sam IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050476; Singh P, 2012, J INFECT DEV COUNTR, V6, P563; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; Talbalaghi A, 2010, MED VET ENTOMOL, V24, P83, DOI 10.1111/j.1365-2915.2009.00853.x; TESH RB, 1976, AM J TROP MED HYG, V25, P326, DOI 10.4269/ajtmh.1976.25.326; Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108; TURELL MJ, 1992, J MED ENTOMOL, V29, P49, DOI 10.1093/jmedent/29.1.49; Van Bortel W, 2014, EURO SURVEILL, V19; van den Hurk AF, 2010, VECTOR-BORNE ZOONOT, V10, P489, DOI 10.1089/vbz.2009.0106; Vazeille M, 2008, TROP MED INT HEALTH, V13, P1176, DOI 10.1111/j.1365-3156.2008.02123.x; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; Vazeille M, 2013, VECTOR-BORNE ZOONOT, V13, P37, DOI 10.1089/vbz.2012.0982; Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14; Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716; Yakob L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057448	72	22	22	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110538	10.1371/journal.pone.0110538	http://dx.doi.org/10.1371/journal.pone.0110538			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310016	gold, Green Published, Green Submitted			2022-12-27	WOS:000343210300121
J	Kim, JH; Cheong, HS; Sul, JH; Seo, JM; Kim, DY; Oh, JT; Park, KW; Kim, HY; Jung, SM; Jung, K; Cho, MJ; Bae, JS; Shin, HD				Kim, Jeong-Hyun; Cheong, Hyun Sub; Sul, Jae Hoon; Seo, Jeong-Meen; Kim, Dae-Yeon; Oh, Jung-Tak; Park, Kwi-Won; Kim, Hyun-Young; Jung, Soo-Min; Jung, Kyuwhan; Cho, Min Jeng; Bae, Joon Seol; Shin, Hyoung Doo			A Genome-Wide Association Study Identifies Potential Susceptibility Loci for Hirschsprung Disease	PLOS ONE			English	Article							NERVOUS-SYSTEM; RET; EXPRESSION; MUTATION; PROLINE; GENE; TRANSPORTER; PROTEIN-1; SOX10; RISK	Hirschsprung disease (HSCR) is a congenital and heterogeneous disorder characterized by the absence of intramural nervous plexuses along variable lengths of the hindgut. Although RET is a well-established risk factor, a recent genome-wide association study (GWAS) of HSCR has identified NRG1 as an additional susceptibility locus. To discover additional risk loci, we performed a GWAS of 123 sporadic HSCR patients and 432 unaffected controls using a large-scale platform with coverage of over 1 million polymorphic markers. The result was that our study replicated the findings of RET-CSGALNACT2-RASGEF1A genomic region (P-raw = 5.69x10(-19) before a Bonferroni correction; P-corr = 4.31x10(-13) after a Bonferroni correction) and NRG1 as susceptibility loci. In addition, this study identified SLC6A20 (P-adj = 2.71x10(-6)), RORA (P-adj = 1.26x10(-5)), and ABCC9 (P-adj = 1.86x10(-5)) as new potential susceptibility loci under adjusting the already known loci on the RET-CSGALNACT2-RASGEF1A and NRG1 regions, although none of the SNPs in these genes passed the Bonferroni correction. In further subgroup analysis, the RET-CSGALNACT2-RASGEF1A genomic region was observed to have different significance levels among subgroups: short-segment (S-HSCR, P-corr = 1.71x10(-5)), long-segment (L-HSCR, P-corr = 6.66x10(-4)), and total colonic aganglionosis (TCA, P-corr>0.05). This differential pattern in the significance level suggests that other genomic loci or mechanisms may affect the length of aganglionosis in HSCR subgroups during enteric nervous system (ENS) development. Although functional evaluations are needed, our findings might facilitate improved understanding of the mechanisms of HSCR pathogenesis.	[Kim, Jeong-Hyun; Shin, Hyoung Doo] Sogang Univ, Res Inst Basic Sci, Seoul, South Korea; [Kim, Jeong-Hyun; Shin, Hyoung Doo] Sogang Univ, Dept Life Sci, Seoul, South Korea; [Cheong, Hyun Sub; Shin, Hyoung Doo] SNP Genet Inc, Dept Genet Epidemiol, Seoul, South Korea; [Sul, Jae Hoon] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90024 USA; [Seo, Jeong-Meen; Jung, Soo-Min] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pediat Surg,Dept Surg, Seoul, South Korea; [Kim, Dae-Yeon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pediat Surg, Seoul, South Korea; [Oh, Jung-Tak] Yonsei Univ, Coll Med, Severance Childrens Hosp, Dept Pediat Surg, Seoul, South Korea; [Park, Kwi-Won; Kim, Hyun-Young] Seoul Natl Univ, Childrens Hosp, Dept Pediat Surg, Seoul, South Korea; [Jung, Kyuwhan] Seoul Natl Univ, Bundang Hosp, Dept Surg, Songnam, Gyeonggi, South Korea; [Cho, Min Jeng] Konkuk Univ, Med Ctr, Dept Surg, Seoul, South Korea; [Bae, Joon Seol] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Lab Translat Genom,Samsung Genome Inst, Seoul, South Korea	Sogang University; Sogang University; SNP Genetics; University of California System; University of California Los Angeles; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Ulsan; Asan Medical Center; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Konkuk University; Konkuk University Medical Center; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center	Shin, HD (corresponding author), Sogang Univ, Res Inst Basic Sci, Seoul, South Korea.	hdshin@sogang.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2010-0007857, 2012-0006690]; Ministry of Education [2013R1A1A2008335]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Ministry of Education	This work was supported by grants from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0007857 and 2012-0006690) and the Ministry of Education (2013R1A1A2008335). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Bai SW, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-54; Broer S, 2008, J CLIN INVEST, V118, P3881, DOI 10.1172/JCI36625; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; Dierking K, 2011, CELL HOST MICROBE, V9, P425, DOI 10.1016/j.chom.2011.04.011; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Evangelisti C, 2012, NEUROGASTROENT MOTIL, V24, pe497, DOI 10.1111/j.1365-2982.2012.01998.x; Fernandez RM, 2008, J PEDIATR SURG, V43, P2042, DOI 10.1016/j.jpedsurg.2008.05.018; Garcia-Barcelo M, 2003, GUT, V52, P563, DOI 10.1136/gut.52.4.563; Garcia-Barcelo MM, 2009, P NATL ACAD SCI USA, V106, P2694, DOI 10.1073/pnas.0809630105; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; Jannot AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062519; Jannot AS, 2012, EUR J HUM GENET, V20, P917, DOI 10.1038/ejhg.2012.35; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/nmeth.1681, 10.1038/NMETH.1681]; Menashe I, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-36; Miao XP, 2010, HUM MOL GENET, V19, P1461, DOI 10.1093/hmg/ddq020; Pan ZW, 2011, J PEDIATR SURG, V46, P1930, DOI 10.1016/j.jpedsurg.2011.05.017; Panza E, 2012, PROG NEUROBIOL, V96, P176, DOI 10.1016/j.pneurobio.2012.01.001; PROCOPIS PG, 1971, J PEDIATR-US, V79, P419, DOI 10.1016/S0022-3476(71)80150-6; Raab M, 2010, NEUROSCIENCE, V171, P421, DOI 10.1016/j.neuroscience.2010.08.041; Saeed A, 2012, J PEDIATR SURG, V47, P303, DOI 10.1016/j.jpedsurg.2011.11.017; Sham MH, 2001, GUT, V49, P220, DOI 10.1136/gut.49.2.220; Shen L, 2002, AM J HUM GENET, V70, P435, DOI 10.1086/338712; Takanaga H, 2005, J BIOL CHEM, V280, P8974, DOI 10.1074/jbc.M413027200; Tang ChengCai, 2012, Journal of Resources and Ecology, V3, P8; Tang CSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016181; Tang WB, 2012, J PEDIATR SURG, V47, P1694, DOI 10.1016/j.jpedsurg.2012.03.061; Tse MT, 2012, NAT REV DRUG DISCOV, V11, DOI 10.1038/nrd3780; Yamada K, 2001, AM J HUM GENET, V69, P1178, DOI 10.1086/324343	30	30	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110292	10.1371/journal.pone.0110292	http://dx.doi.org/10.1371/journal.pone.0110292			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310821	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210300104
J	Stanczyk, NE; Smit, ES; Schulz, DN; de Vries, H; Bolman, C; Muris, JWM; Evers, SMAA				Stanczyk, Nicola E.; Smit, Eline S.; Schulz, Daniela N.; de Vries, Hein; Bolman, Catherine; Muris, Jean W. M.; Evers, Silvia M. A. A.			An Economic Evaluation of a Video- and Text-Based Computer-Tailored Intervention for Smoking Cessation: A Cost-Effectiveness and Cost-Utility Analysis of a Randomized Controlled Trial	PLOS ONE			English	Article							QUALITY-OF-LIFE; FAGERSTROM TEST; HEALTH; INTENTION; SUPPORT	Background: Although evidence exists for the effectiveness of web-based smoking cessation interventions, information about the cost-effectiveness of these interventions is limited. Objective: The study investigated the cost-effectiveness and cost-utility of two web-based computer-tailored (CT) smoking cessation interventions (video-vs. text-based CT) compared to a control condition that received general text-based advice. Methods: In a randomized controlled trial, respondents were allocated to the video-based condition (N = 670), the text-based condition (N = 708) or the control condition (N = 721). Societal costs, smoking status, and quality-adjusted life years (QALYs; EQ-5D-3L) were assessed at baseline, six-and twelve-month follow-up. The incremental costs per abstinent respondent and per QALYs gained were calculated. To account for uncertainty, bootstrapping techniques and sensitivity analyses were carried out. Results: No significant differences were found in the three conditions regarding demographics, baseline values of outcomes and societal costs over the three months prior to baseline. Analyses using prolonged abstinence as outcome measure indicated that from a willingness to pay of (sic)1,500, the video-based intervention was likely to be the most cost-effective treatment, whereas from a willingness to pay of (sic)50,400, the text-based intervention was likely to be the most cost-effective. With regard to cost-utilities, when quality of life was used as outcome measure, the control condition had the highest probability of being the most preferable treatment. Sensitivity analyses yielded comparable results. Conclusion: The video-based CT smoking cessation intervention was the most cost-effective treatment for smoking abstinence after twelve months, varying the willingness to pay per abstinent respondent from (sic)0 up to (sic)80,000. With regard to cost-utility, the control condition seemed to be the most preferable treatment. Probably, more time will be required to assess changes in quality of life. Future studies with longer follow-up periods are needed to investigate whether cost-utility results regarding quality of life may change in the long run.	[Stanczyk, Nicola E.; Smit, Eline S.; Schulz, Daniela N.; de Vries, Hein] Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, Dept Hlth Promot, Maastricht, Netherlands; [Smit, Eline S.] Univ Amsterdam, Amsterdam Sch Commun Res ASCoR, Dept Commun Sci, Amsterdam, Netherlands; [Bolman, Catherine] Open Univ Netherlands, Dept Psychol & Educ Sci, Heerlen, Netherlands; [Muris, Jean W. M.] Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, Dept Family Practice, Maastricht, Netherlands; [Evers, Silvia M. A. A.] Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, Dept Hlth Serv Res, Maastricht, Netherlands; [Evers, Silvia M. A. A.] Netherlands Inst Mental Hlth & Addict, Trimbos Inst, Utrecht, Netherlands	Maastricht University; University of Amsterdam; Open University Netherlands; Maastricht University; Maastricht University; Trimbos Institute	Stanczyk, NE (corresponding author), Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, Dept Hlth Promot, Maastricht, Netherlands.	nicola.stanczyk@maastrichtuniversity.nl	Evers, Silvia MAA/K-9720-2015; Evers, Silvia/ABG-2128-2020; Smit, Eline/A-9081-2011	Evers, Silvia MAA/0000-0003-1026-570X; Evers, Silvia/0000-0003-1026-570X; Schulz, Daniela/0000-0002-1016-432X; Muris, Jean/0000-0002-8780-476X	ZonMw, the Netherlands Organisation for Health Research and Development [20011007]	ZonMw, the Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	This work was supported by ZonMw, the Netherlands Organisation for Health Research and Development (grant number 20011007, http://www.zonmw.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, AM PSYCHOL, V57, P1060, DOI DOI 10.1037/0003-066X.57.12.1060; [Anonymous], HANDLEIDING KOSTENON; Balmford J, 2013, HEALTH EDUC RES, V28, P288, DOI 10.1093/her/cys104; Brouwer W, 2010, HEALTH EDUC RES, V25, P585, DOI 10.1093/her/cyp063; Casparie A F, 1998, Ned Tijdschr Geneeskd, V142, P2075; Centraal Bureau voor de Statistiek (CBS), 2013, INT MIGR 2006 2011; Chalkidou K, 2008, HEALTH ECON, V17, P441, DOI 10.1002/hec.1277; Chen YF, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16380; Civliak M, 2010, COCHRANE DATABASE SY, V9; Dijkstra A, 2005, HEALTH EDUC RES, V20, P527, DOI 10.1093/her/cyh014; Drummond M, 2001, ANN MED, V33, P344, DOI 10.3109/07853890109002088; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Elfeddali I, 2012, J MED INTERNET RES, V14, P87, DOI 10.2196/jmir.2057; Eysenbach G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e11; Fagerstrom K, 2012, NICOTINE TOB RES, V14, P75, DOI 10.1093/ntr/ntr137; Feenstra TL, 2005, VALUE HEALTH, V8, P178, DOI 10.1111/j.1524-4733.2005.04008.x; Fidler JA, 2008, CANCER EPIDEM BIOMAR, V17, P3331, DOI 10.1158/1055-9965.EPI-08-0296; Gerhards SAH, 2010, BRIT J PSYCHIAT, V196, P310, DOI 10.1192/bjp.bp.109.065748; Glick H, 2007, EC EVALUATION CLIN T; Gold M, 1996, MED CARE, V34, pDS197; Gregorio DI, 1997, AM J PUBLIC HEALTH, V87, P1472, DOI 10.2105/AJPH.87.9.1472; Guimaraes N, 2000, COGNITIVE MAPS HYPER; Hassan E, 2006, INTERNET J EPIDEMIOL, V3; Hays JT, 2012, EUR J PUBLIC HEALTH, V22, P224, DOI 10.1093/eurpub/ckq137; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hendriks MR, 2013, MED DECIS MAKING; Heritier SR, 2003, MED J AUSTRALIA, V179, P438, DOI 10.5694/j.1326-5377.2003.tb05627.x; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Hughes JR, 2004, ADDICTION, V99, P29, DOI 10.1111/j.1360-0443.2004.00540.x; Kotz D, 2009, TOB CONTROL, V18, P43, DOI 10.1136/tc.2008.025981; Kreuter MW, 2003, AM J HEALTH BEHAV, V27, pS227; Laaksonen M, 2003, J EPIDEMIOL COMMUN H, V57, P711, DOI 10.1136/jech.57.9.711; Ladapo JA, 2011, ARCH INTERN MED, V171, P39, DOI 10.1001/archinternmed.2010.479; Lamers LM, 2005, NED TIJDSCHR GENEES, V149, P1574; Lancaster T, 2005, COCHRANE DB SYST REV, P1; Lorgelly PK, 2010, INT J ENV RES PUB HE, V7, P2274, DOI 10.3390/ijerph7052274; Margetts BM, 2003, S AFRICAN J CLIN NUT, V16, P78; Mudde AN, 1996, PREV MED, V25, P708, DOI 10.1006/pmed.1996.0110; Office of Applied Studies, 2002, NHSDA REP TOB US INC; OSE, 2012, OVERNITE SOFTW EUR B; Park AL, 2013, BMC PUBLIC HEALTH, V13, P787, DOI DOI 10.1186/1471-2458-13-787; Parrott S, 1998, Thorax, V53 Suppl 5 Pt 2, pS1; Poel FT, 2009, HEALTH EDUC RES, V24, P930, DOI 10.1093/her/cyp036; Quist-Paulsen P, 2006, EUR J CARDIOV PREV R, V13, P274, DOI 10.1097/01.hjr.0000192742.81231.91; Raad voor de Volksgezondheid en Zorg (RVZ), 2006, ZINN DUURZ ZORG; Salize HJ, 2009, ARCH INTERN MED, V169, P230, DOI 10.1001/archinternmed.2008.556; Sculpher M, 2008, PHARMACOECONOMICS, V26, P721, DOI 10.2165/00019053-200826090-00001; Shahab L, 2009, ADDICTION, V104, P1792, DOI 10.1111/j.1360-0443.2009.02710.x; Shiffman S, 2006, ADDICTION, V101, P1822, DOI 10.1111/j.1360-0443.2006.01635.x; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Smit ES, 2013, J MED INTERNET RES, V15, P55, DOI 10.2196/jmir.2059; Smit ES, 2012, J MED INTERNET RES, V14, P136, DOI 10.2196/jmir.1812; Song FJ, 2002, MED DECIS MAKING, V22, pS26, DOI 10.1107/027298902237708; Stanczyk NE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-847; Steunbijstoppen.nl, 2012, ONL STOPP MET ROK IN; Stinnett AA, 1998, MED DECIS MAKING, V18, pS68, DOI 10.1177/0272989X98018002S09; Tate DF, 2009, ANN BEHAV MED, V38, P40, DOI 10.1007/s12160-009-9131-6; Sales MPU, 2009, J BRAS PNEUMOL, V35, P436, DOI 10.1590/S1806-37132009000500008; Wiggers LCW, 2006, NICOTINE TOB RES, V8, P581, DOI 10.1080/14622200600790005; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Woolacott N F, 2002, Health Technol Assess, V6, P1	61	33	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110117	10.1371/journal.pone.0110117	http://dx.doi.org/10.1371/journal.pone.0110117			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ9WZ	25310007	Green Published, gold			2022-12-27	WOS:000343210300089
J	Frochaux, V; Hildebrand, D; Talke, A; Linscheid, MW; Schluter, H				Frochaux, Violette; Hildebrand, Diana; Talke, Anja; Linscheid, Michael W.; Schlueter, Hartmut			Alpha-1-Antitrypsin: A Novel Human High Temperature Requirement Protease A1 (HTRA1) Substrate in Human Placental Tissue	PLOS ONE			English	Article							SERINE-PROTEASE; ALPHA-1-PROTEINASE INHIBITOR; SERPIN; INACTIVATION; MECHANISM; PROTEINS; GENE; CLEAVAGE; DATABASE; FAMILY	The human serine protease high temperature requirement A1 (HTRA1) is highly expressed in the placental tissue, especially in the last trimester of gestation. This suggests that HTRA1 is involved in placental formation and function. With the aim of a better understanding of the role of HTRA1 in the placenta, candidate substrates were screened in a placenta protein extract using a gel-based mass spectrometric approach. Protease inhibitor alpha-1-antitrypsin, actin cytoplasmic 1, tropomyosin beta chain and ten further proteins were identified as candidate substrates of HTRA1. Among the identified candidate substrates, alpha-1-antitrypsin (A1AT) was considered to be of particular interest because of its important role as protease inhibitor. For investigation of alpha-1-antitrypsin as substrate of HTRA1 synthetic peptides covering parts of the sequence of alpha-1-antitrypsin were incubated with HTRA1. By mass spectrometry a specific cleavage site was identified after met-382 (AIPM(382) down arrow (SIPP)-S-383) within the reactive centre loop of alpha-1-antitrypsin, resulting in a C-terminal peptide comprising 36 amino acids. Proteolytic removal of this peptide from alpha-1-antitrypsin results in a loss of its inhibitor function. Beside placental alpha-1-antitrypsin the circulating form in human plasma was also significantly degraded by HTRA1. Taken together, our data suggest a link between the candidate substrates alpha-1-antitrypsin and the function of HTRA1 in the placenta in the syncytiotrophoblast, the cell layer attending to maternal blood in the villous tree of the human placenta. Data deposition: Mass spectrometry (MS) data have been deposited to the ProteomeXchange with identifier PXD000473.	[Frochaux, Violette; Linscheid, Michael W.] Humboldt Univ, Dept Chem, D-10099 Berlin, Germany; [Hildebrand, Diana; Schlueter, Hartmut] Univ Med Ctr Hamburg Eppendorf, Dept Clin Chem, Hamburg, Germany; [Talke, Anja] ProteaImmun GmbH, Berlin, Germany	Humboldt University of Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf	Schluter, H (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Clin Chem, Hamburg, Germany.	hschluet@uke.de	Linscheid, Michael W/D-2125-2009; Schluter, Hartmut/D-1371-2015; Linscheid, Michael/ABB-7808-2020	Linscheid, Michael W/0000-0002-8902-1734; Schluter, Hartmut/0000-0002-9358-7036; 	BMBF (Bundesministerium fur Forschung und Technologie) [031U216A, 0313694 A, 0313842A]	BMBF (Bundesministerium fur Forschung und Technologie)(Federal Ministry of Education & Research (BMBF))	This work was supported by the BMBF (Bundesministerium fur Forschung und Technologie. Grants: 031U216A, 0313694 A & 0313842A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayi F, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.046; An E, 2010, INVEST OPHTHALMOL VI; Baldi A, 2002, ONCOGENE, V21, P6684, DOI 10.1038/sj.onc.1205911; Benirschke K., 2000, PATHOLOGY HUMAN PLAC; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASTELLUCCI M, 1994, CELL TISSUE RES, V278, P283, DOI 10.1007/s004410050219; Chang WSW, 1996, BIOCHEM J, V314, P647, DOI 10.1042/bj3140647; Chien J, 2004, ONCOGENE, V23, P1636, DOI 10.1038/sj.onc.1207271; Chien J, 2009, MOL CELL BIOL, V29, P4177, DOI 10.1128/MCB.00035-09; Chien J, 2009, J CELL BIOCHEM, V107, P253, DOI 10.1002/jcb.22121; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; De Luca A, 2003, J HISTOCHEM CYTOCHEM, V51, P1279, DOI 10.1177/002215540305101004; De Luca A, 2004, J HISTOCHEM CYTOCHEM, V52, P885, DOI 10.1369/jhc.3A6186.2004; Dunstone MA, 2000, PROTEIN SCI, V9, P417; Gettins PGW, 2000, GENOME RES, V10, P1833, DOI 10.1101/gr.168900; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; He X, 2011, INT J CANC; He XP, 2010, CANCER RES, V70, P3109, DOI 10.1158/0008-5472.CAN-09-3557; Hu SI, 1998, J BIOL CHEM, V273, P34406, DOI 10.1074/jbc.273.51.34406; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Huppertz B, 2003, PLACENTA, V24, P181, DOI 10.1053/plac.2002.0903; JOHNSON DA, 1986, J BIOL CHEM, V261, P4748; KLOSE J, 1995, ELECTROPHORESIS, V16, P1034, DOI 10.1002/elps.11501601175; KNAUPER V, 1990, FEBS LETT, V263, P355, DOI 10.1016/0014-5793(90)81412-H; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIPINSKA B, 1988, NUCLEIC ACIDS RES, V16, P10053, DOI 10.1093/nar/16.21.10053; Lisowska-Myjak B, 2005, CLIN CHIM ACTA, V352, P1, DOI 10.1016/j.cccn.2004.03.012; LOBERMANN H, 1982, H-S Z PHYSIOL CHEM, V363, P1377, DOI 10.1515/bchm2.1982.363.2.1377; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Lorenzi T, 2009, PLACENTA, V30, P35, DOI 10.1016/j.placenta.2008.10.016; Marzioni D, 2009, HISTOL HISTOPATHOL, V24, P1213, DOI 10.14670/HH-24.1213; MAST AE, 1991, BIOCHEMISTRY-US, V30, P1723, DOI 10.1021/bi00220a039; Mills K, 2003, GLYCOBIOLOGY, V13, P73, DOI 10.1093/glycob/cwg026; Nelson D, 1999, J BIOL CHEM, V274, P12245, DOI 10.1074/jbc.274.18.12245; Nelson D, 1998, ANAL BIOCHEM, V260, P230, DOI 10.1006/abio.1998.2708; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; PATSTON PA, 1991, BIOCHEMISTRY-US, V30, P8876, DOI 10.1021/bi00100a022; PEI DQ, 1994, J BIOL CHEM, V269, P25849; PERLMUTTER DH, 1990, J BIOL CHEM, V265, P16713; Petrache L, 2006, AM J RESP CRIT CARE, V173, P1222, DOI 10.1164/rccm.200512-1842OC; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Potgens AJG, 2004, HUM REPROD UPDATE, V10, P487, DOI 10.1093/humupd/dmh039; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Tennstaedt A, 2012, J BIOL CHEM, V287, P20931, DOI 10.1074/jbc.M111.316232; Truebestein L, 2011, NAT STRUCT MOL BIOL, V18, P386, DOI 10.1038/nsmb.2013; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vierkotten S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022959; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Zhang L, 2012, J BIOL CHEM, V287, P1520, DOI 10.1074/jbc.M111.275990; Zumbrunn J, 1996, FEBS LETT, V398, P187, DOI 10.1016/S0014-5793(96)01229-X	53	21	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e109483	10.1371/journal.pone.0109483	http://dx.doi.org/10.1371/journal.pone.0109483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329061	gold, Green Published, Green Submitted			2022-12-27	WOS:000343942100027
J	Chen, DS; Jin, PY; Zhang, KJ; Ding, XL; Yang, SX; Ju, JF; Zhao, JY; Hong, XY				Chen, Da-Song; Jin, Peng-Yu; Zhang, Kai-Jun; Ding, Xiu-Lei; Yang, Si-Xia; Ju, Jia-Fei; Zhao, Jing-Yu; Hong, Xiao-Yue			The Complete Mitochondrial Genomes of Six Species of Tetranychus Provide Insights into the Phylogeny and Evolution of Spider Mites	PLOS ONE			English	Article							RIBOSOMAL ITS2 SEQUENCES; TRANSFER-RNA GENES; CYTOPLASMIC INCOMPATIBILITY; ACARI TETRANYCHIDAE; PARALLEL EVOLUTION; LEVEL CHARACTERS; CONTROL REGION; URTICAE ACARI; ARRANGEMENT; RESISTANCE	Many spider mites belonging to the genus Tetranychus are of agronomical importance. With limited morphological characters, Tetranychus mites are usually identified by a combination of morphological characteristics and molecular diagnostics. To clarify their molecular evolution and phylogeny, the mitochondrial genomes of the green and red forms of Tetranychus urticae as well as T. kanzawai, T. ludeni, T. malaysiensis, T. phaselus, T. pueraricola were sequenced and compared. The seven mitochondrial genomes are typical circular molecules of about 13,000 bp encoding and they are composed of the complete set of 37 genes that are usually found in metazoans. The order of the mitochondrial (mt) genes is the same as that in the mt genomes of Panonychus citri and P. ulmi, but very different from that in other Acari. The J-strands of the mitochondrial genomes have high (similar to 84%) A+T contents, negative GC-skews and positive AT-skews. The nucleotide sequence of the cox1 gene, which is commonly used as a taxon barcode and molecular marker, is more highly conserved than the nucleotide sequences of other mitochondrial genes in these seven species. Most tRNA genes in the seven genomes lose the D-arm and/or the T-arm. The functions of these tRNAs need to be evaluated. The mitochondrial genome of T. malaysiensis differs from the other six genomes in having a slightly smaller genome size, a slight difference in codon usage, and a variable loop in place of the T-arm of some tRNAs by a variable loop. A phylogenic analysis shows that T. malaysiensis first split from other Tetranychus species and that the clade of the family Tetranychoidea occupies a basal position in the Trombidiformes. The mt genomes of the green and red forms of T. urticae have limited divergence and short evolutionary distance.	[Chen, Da-Song; Jin, Peng-Yu; Ding, Xiu-Lei; Yang, Si-Xia; Ju, Jia-Fei; Zhao, Jing-Yu; Hong, Xiao-Yue] Nanjing Agr Univ, Coll Plant Protect, Dept Entomol, Nanjing, Jiangsu, Peoples R China; [Zhang, Kai-Jun] Southwest Univ, Coll Plant Protect, Dept Entomol, Chongqing, Peoples R China	Nanjing Agricultural University; Southwest University - China	Hong, XY (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Dept Entomol, Nanjing, Jiangsu, Peoples R China.	xyhong@njau.edu.cn	Hong, Xiao-Yue/AAF-4759-2020		Ministry of Agriculture of China [201103020]; National Natural Science Foundation of China [31172131, 31371944]	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by a grant-in-aid from the Science and Technology Program of the National Public Welfare Professional Fund (no. 201103020) from the Ministry of Agriculture of China (www.moa.gov.cn), and a grant-in-aid for Scientific Research (nos. 31172131 and 31371944) from the National Natural Science Foundation of China (www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abascal F, 2006, PLOS BIOL, V4, P711, DOI 10.1371/journal.pbio.0040127; Adachi J, 1996, J MOL EVOL, V42, P459; Arimoto M, 2013, J ECON ENTOMOL, V106, P661, DOI 10.1603/EC12440; Black WC, 1998, MOL BIOL EVOL, V15, P1772, DOI 10.1093/oxfordjournals.molbev.a025903; Boore JL, 2008, PHILOS T R SOC B, V363, P1445, DOI 10.1098/rstb.2007.2234; Boore JL, 2006, TRENDS ECOL EVOL, V21, P439, DOI 10.1016/j.tree.2006.05.009; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; Breeuwer JAJ, 1997, HEREDITY, V79, P41, DOI 10.1038/hdy.1997.121; Cui P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-241; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davila S, 2005, GENE, V360, P92, DOI 10.1016/j.gene.2005.06.008; de Mendonca RS, 2011, EXP APPL ACAROL, V55, P1, DOI 10.1007/s10493-011-9453-5; De Rijk P, 1999, NUCLEIC ACIDS RES, V27, P174, DOI 10.1093/nar/27.1.174; De Rijk P, 2003, BIOINFORMATICS, V19, P299, DOI 10.1093/bioinformatics/19.2.299; DEBOER R, 1982, GENETICA, V58, P23, DOI 10.1007/BF00055999; Dekeyser MA, 2005, PEST MANAG SCI, V61, P103, DOI 10.1002/ps.994; Dermauw W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-317; Dermauw W, 2013, P NATL ACAD SCI USA, V110, pE113, DOI 10.1073/pnas.1213214110; Dermauw W, 2010, GENOME, V53, P285, DOI [10.1139/g10-004, 10.1139/G10-004]; Dermauw W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-107; Domes K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-532; Dowton M, 1999, MOL BIOL EVOL, V16, P298, DOI 10.1093/oxfordjournals.molbev.a026111; Dowton M, 2002, INVERTEBR SYST, V16, P345, DOI 10.1071/IS02003; Edwards DD, 2011, EXP APPL ACAROL, V54, P105, DOI 10.1007/s10493-011-9433-9; Ehara Shozo, 1999, Species Diversity, V4, P63; Ernsting BR, 2009, EXP APPL ACAROL, V49, P305, DOI 10.1007/s10493-009-9263-1; Gotoh T, 2007, HEREDITY, V98, P13, DOI 10.1038/sj.hdy.6800881; Gotoh T, 2007, EXP APPL ACAROL, V42, P1, DOI 10.1007/s10493-007-9072-3; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; Hassanin A, 2006, MOL PHYLOGENET EVOL, V38, P100, DOI 10.1016/j.ympev.2005.09.012; Hayashi N, 2013, PEST MANAG SCI, V69, P1080, DOI 10.1002/ps.3470; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Jeyaprakash A, 2007, GENE, V391, P264, DOI 10.1016/j.gene.2007.01.012; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klimov PB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-598; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mans BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049461; Masta SE, 2010, GENE, V449, P9, DOI 10.1016/j.gene.2009.09.009; Migeon A, 2010, TRENDS IN ACAROLOGY, P557, DOI 10.1007/978-90-481-9837-5_96; Navajas M, 1998, HEREDITY, V80, P742, DOI 10.1046/j.1365-2540.1998.00349.x; Navajas M, 2001, B ENTOMOL RES, V91, P117; Nei M, 2000, MOL EVOLUTION PHYLOG; Osakabe M, 2010, PSYCHE, V2009, P1; Osakabe M, 2008, J ECON ENTOMOL, V101, P1167, DOI 10.1603/0022-0493(2008)101[1167:RFLPCF]2.0.CO;2; Ros VID, 2007, EXP APPL ACAROL, V42, P239, DOI 10.1007/s10493-007-9092-z; Shao RF, 2006, J MOL EVOL, V63, P251, DOI 10.1007/s00239-005-0196-y; Shao RF, 2005, J MOL EVOL, V60, P764, DOI 10.1007/s00239-004-0226-1; Sugasawa J, 2002, APPL ENTOMOL ZOOL, V37, P127, DOI 10.1303/aez.2002.127; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vala F, 2000, P ROY SOC B-BIOL SCI, V267, P1931, DOI 10.1098/rspb.2000.1232; Van de Peer Y, 1999, NUCLEIC ACIDS RES, V27, P179, DOI 10.1093/nar/27.1.179; Van Leeuwen T, 2011, INSECT MOL BIOL, V20, P135, DOI 10.1111/j.1365-2583.2010.01040.x; Van Leeuwen T, 2008, P NATL ACAD SCI USA, V105, P5980, DOI 10.1073/pnas.0802224105; Van Leeuwen T, 2010, INSECT BIOCHEM MOLEC, V40, P563, DOI 10.1016/j.ibmb.2010.05.008; Wei SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012708; Wuyts J, 2000, NUCLEIC ACIDS RES, V28, P4698, DOI 10.1093/nar/28.23.4698; Xie RR, 2011, APPL ENTOMOL ZOOL, V46, P95, DOI 10.1007/s13355-010-0014-x; Yuan ML, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-597; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7; ZHANG DX, 1995, J MOL EVOL, V40, P382, DOI 10.1007/BF00164024; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	70	25	27	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110625	10.1371/journal.pone.0110625	http://dx.doi.org/10.1371/journal.pone.0110625			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329165	gold, Green Published, Green Submitted			2022-12-27	WOS:000343210800099
J	Davuluri, G; Augoff, K; Schiemann, WP; Plow, EF; Sossey-Alaoui, K				Davuluri, Gangarao; Augoff, Katarzyna; Schiemann, William P.; Plow, Edward F.; Sossey-Alaoui, Khalid			WAVE3-NF kappa B Interplay Is Essential for the Survival and Invasion of Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; LAMELLIPODIA FORMATION; WAVE3; METASTASIS; EXPRESSION; INVADOPODIA; PROTEIN; GENE; PHOSPHORYLATION	The WAVE3 cytoskeletal protein promotes cancer invasion and metastasis. We have shown that the WAVE3-mediated activation of cancer cell invasion is due, in part, to its regulation of expression and activity of key metalloproteinases (MMPs), including MMP9, which is centrally involved in invadopodia-mediated degradation of the extracellular matrix (ECM). MMP9 is also a major NF kappa B target gene, suggesting a potential linkage of WAVE3 to this pathway, which we sought to investigate. Mechanistically, we found that loss of WAVE3 in cancer cells leads to inhibition of NF kappa B signaling as a result of a decrease in the nuclear translocation of NF kappa B and therefore loss of activation of NF kappa B target genes. Conversely, overexpression of WAVE3 was sufficient to enhance NF kappa B activity. Both pharmacologic and genetic manipulations of NF kappa B effector molecules show that the biological consequence of loss of WAVE3 function in the NF kappa B pathway result the inhibition of invadopodia formation and ECM degradation by cancer cells, and these changes are a consequence of decreased MMP9 expression and activity. Loss of WAVE3 also sensitized cancer cells to apoptosis and cell death driven by TNF alpha, through the inhibition of the AKT pro-survival pathway. Our results identify a novel function of WAVE3 in NF kappa B signaling, where its activity is essential for the regulation of invadopodia and ECM degradation. Therefore, targeted therapeutic inhibition of WAVE3 will sensitize cancer cells to apoptosis and cell death, and suppress cancer invasion and metastasis.	[Davuluri, Gangarao; Augoff, Katarzyna; Plow, Edward F.; Sossey-Alaoui, Khalid] Cleveland Clin, Lerner Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA; [Schiemann, William P.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University	Sossey-Alaoui, K (corresponding author), Cleveland Clin, Lerner Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA.	sosseyk@ccf.org		Augoff, Katarzyna/0000-0002-6133-3621	National Institute of Health, NIH.gov [P01 HL073311, R01 HL096062]; Case Comprehensive Cancer Center, Case.edu [P30 CA43703]; NATIONAL CANCER INSTITUTE [P30CA043703, R01CA129359] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073311, R01HL096062] Funding Source: NIH RePORTER	National Institute of Health, NIH.gov; Case Comprehensive Cancer Center, Case.edu; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work received support from grants P01 HL073311 and R01 HL096062, National Institute of Health, NIH.gov, EFP; and grant P30 CA43703, Case Comprehensive Cancer Center, Case.edu, to KS-A and WPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal E, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-145; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Bialkowska K, 2010, J BIOL CHEM, V285, P18640, DOI 10.1074/jbc.M109.085746; Caldieri G, 2009, INT REV CEL MOL BIO, V275, P1, DOI 10.1016/S1937-6448(09)75001-4; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Cheng Y, 2012, MOL CANCER THER, V11, P154, DOI 10.1158/1535-7163.MCT-11-0606; Cho SG, 2009, J CELL BIOCHEM, V107, P1139, DOI 10.1002/jcb.22216; Deorukhkar A, 2010, BIOCHEM PHARMACOL, V80, P1904, DOI 10.1016/j.bcp.2010.06.039; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Fernando HS, 2010, UROL ONCOL-SEMIN ORI, V28, P320, DOI 10.1016/j.urolonc.2008.12.022; Fortunato SJ, 2002, AM J OBSTET GYNECOL, V187, P1159, DOI 10.1067/mob.2002.127457; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kant S, 2011, GENE DEV, V25, P2069, DOI 10.1101/gad.17224711; Kulkarni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042895; Kurisu S, 2010, CANCER SCI, V101, P2093, DOI 10.1111/j.1349-7006.2010.01654.x; Kurisu S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-226; Lai YC, 2012, BIOCHEM J, V447, P137, DOI 10.1042/BJ20120772; Liu RX, 2011, J CLIN ENDOCR METAB, V96, pE577, DOI 10.1210/jc.2010-2644; Mattioli I, 2004, J IMMUNOL, V172, P6336, DOI 10.4049/jimmunol.172.10.6336; Mizutani K, 2005, J BIOCHEM, V138, P639, DOI 10.1093/jb/mvi160; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nagasaki K, 2003, INT J CANCER, V105, P454, DOI 10.1002/ijc.11122; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; O'Dea E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000216; O'Dea E, 2009, WIRES SYST BIOL MED, V1, P107, DOI 10.1002/wsbm.30; Oner C, 2008, J CLIN ENDOCR METAB, V93, P252, DOI 10.1210/jc.2007-1538; SATO H, 1993, J BIOL CHEM, V268, P23460; Scott JD, 2003, BIOCHEM SOC T, V31, P87, DOI 10.1042/bst0310087; Sossey-Alaoui K, 2005, EXP CELL RES, V308, P135, DOI 10.1016/j.yexcr.2005.04.011; Sossey-Alaoui K, 2005, J BIOL CHEM, V280, P21748, DOI 10.1074/jbc.M500503200; Sossey-Alaoui K, 2007, J BIOL CHEM, V282, P26257, DOI 10.1074/jbc.M701484200; Sossey-Alaoui K, 2007, AM J PATHOL, V170, P2112, DOI 10.2353/ajpath.2007.060975; Sossey-Alaoui K, 2014, FASEB J, V28, P2260, DOI 10.1096/fj.13-244004; Sossey-Alaoui K, 2013, SEMIN CELL DEV BIOL, V24, P287, DOI 10.1016/j.semcdb.2012.10.006; Sossey-Alaoui K, 2011, INT J CANCER, V129, P1331, DOI 10.1002/ijc.25793; Sossey-Alaoui K, 2009, J BIOL CHEM, V284, P33019, DOI 10.1074/jbc.M109.034553; Stovold CF, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-11; Taylor MA, 2013, BREAST CANCER RES TR, V142, P341, DOI 10.1007/s10549-013-2753-1; Teng Y, 2010, BRIT J CANCER, V103, P1066, DOI 10.1038/sj.bjc.6605850; Teng Y, 2011, INT J CANCER, V129, P2825, DOI 10.1002/ijc.25964; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530; Yamaguchi H, 2012, EUR J CELL BIOL, V91, P902, DOI 10.1016/j.ejcb.2012.04.005; Yamaguchi H, 2011, J CELL BIOL, V193, P1275, DOI 10.1083/jcb.201009126; Zhang Y, 2012, J CANCER RES CLIN, V138, P2035, DOI 10.1007/s00432-012-1274-3	45	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110627	10.1371/journal.pone.0110627	http://dx.doi.org/10.1371/journal.pone.0110627			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329315	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210800100
J	Farooq, S; Shakeel-u-Rehman; Dangroo, NA; Priya, D; Banday, JA; Sangwan, PL; Qurishi, MA; Koul, S; Saxena, AK				Farooq, Saleem; Shakeel-u-Rehman; Dangroo, Nisar Ahmad; Priya, Dev; Banday, Javid Ahmad; Sangwan, Pyare Lal; Qurishi, Mushtaq Ahmad; Koul, Surrinder; Saxena, Ajit Kumar			Isolation, Cytotoxicity Evaluation and HPLC-Quantification of the Chemical Constituents from Prangos pabularia	PLOS ONE			English	Article							ESSENTIAL OIL; COUMARINS; DERIVATIVES; ANTIBACTERIAL; INHIBITION; OSTHOLE; PLANTS; BARK	Phytochemical analysis of the dichloromethane: methanol (1: 1) extract of root parts of Prangos pabularia led to the isolation of twelve cytotoxic constituents, viz., 6-hydroxycoumarin (1), 7-hydroxycoumarin (2), heraclenol-glycoside (3), xanthotoxol (4), heraclenol (5), oxypeucedanin hydrate (6), 8-((3,3-dimethyloxiran-2-yl) methyl)-7-methoxy-2H-chromen-2-one (7), oxypeucedanin hydrate monoacetate (8), xanthotoxin (9), 4-((2-hydroxy-3-methylbut-3-en-1-yl) oxy)-7H-furo[3,2-g]chromen-7-one (10), imperatorin (11) and osthol (12). The isolates were identified using spectral techniques in the light of literature. 3-(4,5-dimethyl thiazol-2yl)-2,5-diphenyltetrazolium bromide (MTT) cytotoxicity screening of the isolated constituents was carried out against six human cancer cell lines including lung (A549 and NCI-H322), epidermoid carcinoma (A431), melanoma (A375), prostate (PC-3) and Colon (HCT-116) cell lines. Osthol (12) exhibited the highest cytotoxicity with IC50 values of 3.2, 6.2, 10.9, 14.5, 24.8, and 30.2 mu M against epidermoid carcinoma (A431), melanoma (A375), lung (NCI-H322), lung (A549), prostate (PC-3) and colon (HCT-116) cell lines respectively. Epidermoid carcinoma cell line A431 was sensitive to most of the compounds followed by lung (A549) cancer cell line. Finally a simple and reliable HPLC method was developed (RP-HPLC-DAD) and validated for the simultaneous quantification of these cytotoxic constituents in Prangos pabularia. The extract was analyzed using a reversed-phase Agilent ZORBAX eclipse plus column C-18 (4.6x250 mm, 5 mu m) at 250 nm wavelength using a gradient water-methanol solvent system at a flow rate of 0.8 ml/min. The RP-HPLC method is validated in terms of recovery, linearity, accuracy and precision (intra and inter-day validation). This method, because of shorter analysis time, makes it valuable for the commercial quality control of Prangos pabularia extracts and its future pharmaceutical preparations.	[Farooq, Saleem; Dangroo, Nisar Ahmad; Sangwan, Pyare Lal; Koul, Surrinder] CSIR, Indian Inst Integrat Med, Bioorgan Chem Sect, Jammu, India; [Shakeel-u-Rehman] CSIR, Indian Inst Integrat Med, Bioorgan Chem Sect, Srinagar, Jammu & Kashmir, India; [Shakeel-u-Rehman; Banday, Javid Ahmad; Qurishi, Mushtaq Ahmad] Univ Kashmir, Dept Chem, Srinagar 190006, Jammu & Kashmir, India; [Priya, Dev; Saxena, Ajit Kumar] CSIR, Indian Inst Integrat Med, Canc Pharmacol Div, Jammu, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); University of Kashmir; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM)	Farooq, S (corresponding author), CSIR, Indian Inst Integrat Med, Bioorgan Chem Sect, Jammu, India.	farooqprince100@yahoo.in; skoul@iiim.ac.in	Banday, Javid/ABB-7348-2020; Banday, Javid/AAT-4684-2020	Banday, Javid/0000-0003-0339-4781; Dangroo, Dr Nisar Ahmad/0000-0003-4880-1408	CSIR India	CSIR India(Council of Scientific & Industrial Research (CSIR) - India)	The authors have received fellowship/funding from CSIR India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banday JA., 2012, AM J ANAL CHEM, V3, P204, DOI [10.4236/ajac.2012.33029, DOI 10.4236/AJAC.2012.33029]; Baser KHC, 2000, PLANTA MED, V66, P674, DOI 10.1055/s-2000-8627; Cao XW, 2010, J SEP SCI, V33, P1587, DOI 10.1002/jssc.200900866; CHATTERJEE A, 1972, TETRAHEDRON, V28, P5175, DOI 10.1016/S0040-4020(01)88937-7; Chopra R, 1986, GLOSSARY INDIAN MED; Ding Y, 2014, INT J CLIN PHARM TH, V52, P112, DOI 10.5414/CP201923; Dokovic DD, 2004, CHEM PHARM BULL, V52, P853, DOI 10.1248/cpb.52.853; Dongmo AB, 2007, J ETHNOPHARMACOL, V111, P329, DOI 10.1016/j.jep.2006.11.026; Farooq S, 2014, EUR J MED CHEM, V84, P545, DOI 10.1016/j.ejmech.2014.07.069; GUPTA BK, 1964, INDIAN J CHEM, V2, P464; Hata K, 1963, J PHARM SOC JPN, V83, P611; Iqbal PF, 2009, EUR J MED CHEM, V44, P2252, DOI 10.1016/j.ejmech.2008.06.003; JAMWAL KS, 1964, ARCH INT PHARMACOD T, V147, P351; Kawaii S, 2001, ANTICANCER RES, V21, P1905; KIRTIKAR KR, 1980, INDIAN MED PLANTS, V1; Kogure K, 2004, PHYTOMEDICINE, V11, P645, DOI 10.1016/j.phymed.2003.09.004; KOUL SK, 1979, PHYTOCHEMISTRY, V18, P1762, DOI 10.1016/0031-9422(79)80213-7; Koul SK, 1978, INDIAN PERFUMER, V22, P284; Lake B., 1999, FOOD CHEM TOXICOL, V3, P412; Mavi A, 2004, BIOL PHARM BULL, V27, P702, DOI 10.1248/bpb.27.702; Mazloomifar H, 2004, J ESSENT OIL RES, V16, P415, DOI 10.1080/10412905.2004.9698758; Nimisha S, 2012, J PHARMACOGN PHYTOCH, V1, P48; Okamoto T, 2007, MED CHEM, V3, P35, DOI 10.2174/157340607779317607; Piao XL, 2004, J ETHNOPHARMACOL, V93, P243, DOI 10.1016/j.jep.2004.03.054; Ramanitrahasimbola D, 2005, J ETHNOPHARMACOL, V102, P400, DOI 10.1016/j.jep.2005.06.037; Razavi SM, 2008, PHYTOCHEM LETT, V1, P159, DOI 10.1016/j.phytol.2008.07.009; Razavi SM, 2008, REV BRAS FARMACOGN, V18, P1, DOI 10.1590/S0102-695X2008000100002; Rosselli S, 2007, PLANTA MED, V73, P116, DOI 10.1055/s-2006-951772; Shakeel-u-Rehman, 2014, BIOORG MED CHEM LETT, V24, P4243, DOI 10.1016/j.bmcl.2014.07.031; Siskos EP, 2008, J AGR FOOD CHEM, V56, P5577, DOI 10.1021/jf800446t; Stein AC, 2006, J ETHNOPHARMACOL, V107, P95, DOI 10.1016/j.jep.2006.02.009; Tada Y, 2002, PHYTOCHEMISTRY, V59, P649, DOI 10.1016/S0031-9422(02)00023-7; Tawaha K., 2001, ALEX J PHARM SCI, V15, P89; Torres R, 2006, PHYTOCHEMISTRY, V67, P984, DOI 10.1016/j.phytochem.2006.03.016; Xu XM, 2012, MOL MED REP, V6, P1018, DOI 10.3892/mmr.2012.1044	35	18	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e108713	10.1371/journal.pone.0108713	http://dx.doi.org/10.1371/journal.pone.0108713			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314269	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500017
J	Goyal, A; Murray, JM				Goyal, Ashish; Murray, John M.			The Impact of Vaccination and Antiviral Therapy on Hepatitis B and Hepatitis D Epidemiology	PLOS ONE			English	Article							DELTA-VIRUS; NATURAL-HISTORY; MOLECULAR-BIOLOGY; DISEASE BURDEN; CHINA; LONG; TRANSMISSION; PATHOGENESIS; INFECTIONS; PREVALENCE	The major cause of liver cancer around the globe is hepatitis B virus (HBV), which also contributes to a large number of deaths due to liver failure alone. Hepatitis delta virus (HDV) is as potentially alarming as HBV since life threatening cases are 10 times more likely with HBV-HDV dual infection compared to HBV monoinfection. So far, there is no established effective treatment against HDV and the only preventive action suggested by the World Health Organization is to introduce HBV vaccination for children immediately after birth (newborns) and thus reduce the available pool for HDV infection. Here the main objective is to understand the complex dynamics of HBV-HDV infection in a human population that can inform public health policy makers on the level of different preventive measures required to eliminate HBV and HDV infections. Model simulations suggest that HBV vertical transmission and HBV vaccination rates for newborns are instrumental in determining HBV and HDV prevalence. A decrease in HBV prevalence is observed as vaccination coverage increases and it is possible to eradicate both HBV and HDV using high vaccination coverage of >= 80% in the long term. We further found that HDV presence results in lower HBV prevalence. An application of our model to China revealed that vaccinating every newborn in China will further prevent 1.69 million new infections by 2028 as compared to the current 90% vaccination coverage. Although, higher vaccination coverage of newborns should eliminate both HBV and HDV over a long time period, any short term strategy to eradicate HDV must include additional preventive measures such as HBV adult vaccination. Implementation of HBV adult vaccination programs at a rate of 10% per year over 15 years will further prevent 39 thousand new HDV infections in China by 2028 as compared to HBV vaccination programs solely for newborns.	[Goyal, Ashish; Murray, John M.] Univ New S Wales, Sch Math & Stat, Sydney, NSW, Australia	University of New South Wales Sydney	Goyal, A (corresponding author), Univ New S Wales, Sch Math & Stat, Sydney, NSW, Australia.	ashish.goyal@student.unsw.edu.au	Goyal, Ashish/AAE-9948-2022; Murray, John/B-5481-2009; Goyal, Ashish/AFF-7955-2022; Goyal, Ashish/E-9727-2013	Murray, John/0000-0001-9314-2283; Goyal, Ashish/0000-0003-1582-3379				Abbas Z, 2010, WORLD J GASTROENTERO, V16, P554, DOI 10.3748/wjg.v16.i5.554; Alter MJ, 2003, J HEPATOL, V39, pS64, DOI 10.1016/S0168-8278(03)00141-7; Bonino F., 1989, MODERN CONCEPTS ACUT, P113; Bordier BB, 2003, J CLIN INVEST, V112, P407, DOI 10.1172/JCI200317704; Bordier BB, 2002, J VIROL, V76, P10465, DOI 10.1128/JVI.76.20.10465-10472.2002; Bordier Bruno B, 2004, Methods Mol Med, V96, P539; BUREAU OF DEMOCRACY HR AND LABOR, 2010, 2009 HUM RIGHTS REP; Buti M, 2011, J VIRAL HEPATITIS, V18, P434, DOI 10.1111/j.1365-2893.2010.01324.x; Chen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056444; Chu CJ, 2003, GASTROENTEROLOGY, V125, P444, DOI 10.1016/S0016-5085(03)00895-3; Edmunds WJ, 1996, T ROY SOC TROP MED H, V90, P436, DOI 10.1016/S0035-9203(96)90539-8; Elgolihari HM, 2008, CLEV CLIN J MED, V75, P881, DOI 10.3949/ccjm.75a.07019; Fattovich G, 2002, AM J GASTROENTEROL, V97, P2886, DOI 10.1111/j.1572-0241.2002.07057.x; Fattovich G, 2003, SEMIN LIVER DIS, V23, P47, DOI 10.1055/s-2003-37590; Fattovich Giovanna, 2003, Journal of Hepatology, V39, pS50; FitzSimons D, 2005, VACCINE, V23, P4158, DOI 10.1016/j.vaccine.2005.03.017; Fung SK, 2004, CLIN GASTROENTEROL H, V2, P839, DOI 10.1016/S1542-3565(04)00386-6; Gomaa AI, 2008, WORLD J GASTROENTERO, V14, P4300, DOI 10.3748/wjg.14.4300; Hui AY, 2002, J CLIN GASTROENTEROL, V34, P569, DOI 10.1097/00004836-200205000-00018; Kao JH, 2002, J CLIN MICROBIOL, V40, P3047, DOI 10.1128/JCM.40.8.3047-3049.2002; LAI MMC, 1995, ANNU REV BIOCHEM, V64, P259, DOI 10.1146/annurev.bi.64.070195.001355; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Lu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008467; Lutgehetmann M, 2012, HEPATOLOGY, V55, P685, DOI 10.1002/hep.24758; Medley GF, 2001, NAT MED, V7, P619, DOI 10.1038/87953; Niro GA, 2005, J VIRAL HEPATITIS, V12, P2, DOI 10.1111/j.1365-2893.2005.00601.x; Niro GA, 2012, FUTURE VIROL, V7, P709, DOI 10.2217/FVL.12.61; Pang JH, 2010, J THEOR BIOL, V265, P572, DOI 10.1016/j.jtbi.2010.05.038; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Perz JF, 2006, PEDIATRICS, V118, P1403, DOI 10.1542/peds.2006-0724; POLISH LB, 1993, CLIN MICROBIOL REV, V6, P211, DOI 10.1128/CMR.6.3.211-229.1993; Purcell RH, 1996, FIELDS VIROLOGY, P2819; Rizzetto M, 2012, SEMIN LIVER DIS, V32, P211, DOI 10.1055/s-0032-1323626; Shen LP, 2012, J MED VIROL, V84, P445, DOI 10.1002/jmv.23212; The World Bank, 2013, PREG WOM REC PREN CA; UNICEF, 2013, CHINA STAT; Wedemeyer H, 2010, NAT REV GASTRO HEPAT, V7, P31, DOI 10.1038/nrgastro.2009.205; World Health Organization, 2001, HEP D; Xiridou M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005247; Yang SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047808; Zhao SJ, 2000, INT J EPIDEMIOL, V29, P744, DOI 10.1093/ije/29.4.744; Zou L, 2010, J THEOR BIOL, V262, P330, DOI 10.1016/j.jtbi.2009.09.035	44	34	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110143	10.1371/journal.pone.0110143	http://dx.doi.org/10.1371/journal.pone.0110143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313681	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500101
J	Li, SY; Hu, B; Wang, Y; Wu, D; Jin, L; Wang, XF				Li, Shuyuan; Hu, Bin; Wang, Yi; Wu, Di; Jin, Li; Wang, Xiaofeng			Influences of APOA5 Variants on Plasma Triglyceride Levels in Uyghur Population	PLOS ONE			English	Article							APOLIPOPROTEIN A5 GENE; CORONARY-ARTERY-DISEASE; SERUM-LIPID LEVELS; METABOLIC SYNDROME; ETHNIC-GROUPS; POLYMORPHISMS; ASSOCIATION; RISK; HYPERTRIGLYCERIDEMIA; CLUSTER	Objective: Single nucleotide polymorphisms (SNPs) in apolipoprotein A5 (APOA5) gene are associated with triglyceride (TG) levels. However, the minor allele frequencies and linkage disequilibriums (LDs) of the SNPs in addition to their effects on TG levels vary greatly between Caucasians and East Asians. The distributions of the SNPs/haplotypes and their associations with TG levels in Uyghur population, an admixture population of Caucasians and East Asians, have not been reported to date. Here, we performed a cross-sectional study to address these. Methods: Genotyping of four SNPs in APOA5 (rs662799, rs3135506, rs2075291, and rs2266788) was performed in 1174 unrelated Uyghur subjects. SNP/haplotype and TG association analyses were conducted. Results: The frequencies of the SNPs in Uyghurs were in between those in Caucasians and East Asians. The LD between rs662799 and rs2266788 in Uyghurs was stronger than that in East Asians but weaker than that in Caucasians, and the four SNPs resulted in four haplotypes (TGGT, CGGC, TCGT, and CGTT arranged in the order of rs662799, rs3135506, rs2075291, and rs2266788) representing 99.2% of the population. All the four SNPs were significantly associated with TG levels. Compared with non-carriers, carriers of rs662799-C, rs3135506-C, rs2075291-T, and rs2266788-C alleles had 16.0%, 15.1%, 17.1%, and 12.4% higher TG levels, respectively. When haplotype TGGT was defined as the reference, the haplotypes CGGC, TCGT, and CGTT resulted in 16.1%, 19.0%, and 19.8% higher TG levels, respectively. The proportions of variance in TG explained by APOA5 locus were 2.5%, 0.3%, 0.4%, and 1.9% for single SNP rs662799, rs3135506, rs2075291, and rs2266788, respectively, and 3.0% for the haplotypes constructed by them. Conclusions: The association profiles between the SNPs and haplotypes at APOA5 locus and TG levels in this admixture population differed from those in Caucasians and East Asians. The functions of these SNPs and haplotypes need to be elucidated comprehensively.	[Li, Shuyuan; Hu, Bin; Wang, Yi; Wu, Di; Jin, Li; Wang, Xiaofeng] Fudan Univ, Sch Life Sci, Minist Educ, Collaborat Innovat Ctr Genet & Dev,Key Lab Contem, Shanghai 200433, Peoples R China; [Li, Shuyuan; Hu, Bin; Wang, Yi; Wu, Di; Jin, Li; Wang, Xiaofeng] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Li, Shuyuan; Hu, Bin; Wang, Yi; Jin, Li; Wang, Xiaofeng] Fudan Taizhou Inst Hlth Sci, Taizhou, Jiangsu, Peoples R China	Fudan University; Fudan University	Wang, XF (corresponding author), Fudan Univ, Sch Life Sci, Minist Educ, Collaborat Innovat Ctr Genet & Dev,Key Lab Contem, Shanghai 200433, Peoples R China.	xiaofengautomatic@gmail.com	Jin, Li/M-5063-2019; Jin, Li/C-1468-2009	Jin, Li/0000-0002-4546-2415	National Science and Technology Supporting Program [2011BAI09B02]; National Natural Science Foundation [311712160, 30890034]; National Basic Research Program [2012CB944600]	National Science and Technology Supporting Program; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China)	This work was supported by grants-in-aids from National Science and Technology Supporting Program (2011BAI09B02), National Natural Science Foundation (311712160 and 30890034), and grants from and National Basic Research Program (2012CB944600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouizerat BE, 2003, J LIPID RES, V44, P1167, DOI 10.1194/jlr.M200480-JLR200; Bacanu SA, 2002, GENET EPIDEMIOL, V22, P78, DOI 10.1002/gepi.1045; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Caussy C, 2014, AM J HUM GENET, V94, P129, DOI 10.1016/j.ajhg.2013.12.001; Chandak GR, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-76; Chien KL, 2008, CLIN CHIM ACTA, V390, P56, DOI 10.1016/j.cca.2007.12.014; Eichenbaum-Voline S, 2004, ARTERIOSCL THROM VAS, V24, P167, DOI 10.1161/01.ATV.0000099881.83261.D4; Hodoglugil U, 2006, J LIPID RES, V47, P144, DOI 10.1194/jlr.M500343-JLR200; Ishihara M, 2005, J LIPID RES, V46, P2015, DOI 10.1194/jlr.D500018-JLR200; Kao JT, 2003, HUM MOL GENET, V12, P2533, DOI 10.1093/hmg/ddg255; Lai CQ, 2005, CURR OPIN LIPIDOL, V16, P153, DOI 10.1097/01.mol.0000162320.54795.68; Lai CQ, 2004, J LIPID RES, V45, P2096, DOI 10.1194/jlr.M400192-JLR200; Lai CQ, 2003, J LIPID RES, V44, P2365, DOI 10.1194/jlr.M300251-JLR200; Lee KWJ, 2004, ATHEROSCLEROSIS, V176, P165, DOI 10.1016/j.atherosclerosis.2004.04.024; Li YY, 2011, NUTR METAB CARDIOVAS, V21, P947, DOI 10.1016/j.numecd.2010.04.004; Lin R, 2009, HUM MUTAT, V30, P609, DOI 10.1002/humu.20895; Liu ZK, 2010, ATHEROSCLEROSIS, V208, P427, DOI 10.1016/j.atherosclerosis.2009.08.013; Martinelli N, 2007, ATHEROSCLEROSIS, V191, P409, DOI 10.1016/j.atherosclerosis.2006.04.009; Matsunaga A, 2007, CIRC J, V71, P746, DOI 10.1253/circj.71.746; Merkel M, 2005, J CLIN INVEST, V115, P2694, DOI 10.1172/JCI26712; Olivier M, 2004, GENOMICS, V83, P912, DOI 10.1016/j.ygeno.2003.11.016; Pennacchio LA, 2002, HUM MOL GENET, V11, P3031, DOI 10.1093/hmg/11.24.3031; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Talmud PJ, 2004, J LIPID RES, V45, P750, DOI 10.1194/jlr.M300458-JLR200; Talmud PJ, 2002, HUM MOL GENET, V11, P3039, DOI 10.1093/hmg/11.24.3039; Tang YB, 2006, ATHEROSCLEROSIS, V185, P433, DOI 10.1016/j.atherosclerosis.2005.06.026; van der Vliet HN, 2002, BIOCHEM BIOPH RES CO, V295, P1156, DOI 10.1016/S0006-291X(02)00808-2; van Dijk KW, 2004, CURR OPIN LIPIDOL, V15, P239, DOI [10.1097/01.mol.00001300096.77252.1f, 10.1097/00041433-200406000-00002]; Wang J, 2008, HUM MOL GENET, V17, P2894, DOI 10.1093/hmg/ddn188; Wang LF, 2010, J CLIN HYPERTENS, V12, P741, DOI 10.1111/j.1751-7176.2010.00349.x; Wright WT, 2006, ATHEROSCLEROSIS, V185, P353, DOI 10.1016/j.atherosclerosis.2005.06.043; Xu CX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056216; Xu SH, 2008, AM J HUM GENET, V82, P883, DOI 10.1016/j.ajhg.2008.01.017; Yamada Y, 2008, J MED GENET, V45, P22, DOI 10.1136/jmg.2007.052415; Yao YG, 2004, MOL BIOL EVOL, V21, P2265, DOI 10.1093/molbev/msh238; Yin RX, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-140	36	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110258	10.1371/journal.pone.0110258	http://dx.doi.org/10.1371/journal.pone.0110258			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313938	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662500104
J	Bajracharya, P; Lu, HL; Pietrantonio, PV				Bajracharya, Prati; Lu, Hsiao-Ling; Pietrantonio, Patricia V.			The Red Imported Fire Ant (Solenopsis invicta Buren) Kept Y not F: Predicted sNPY Endogenous Ligands Deorphanize the Short NPF (sNPF) Receptor	PLOS ONE			English	Article							SHORT NEUROPEPTIDE-F; BOOPHILUS-MICROPLUS ACARI; SOUTHERN CATTLE TICK; FUNCTIONAL-ANALYSIS; AMERICAN COCKROACH; MOLECULAR-CLONING; FEEDING-BEHAVIOR; PEPTIDE; IDENTIFICATION; GENE	Neuropeptides and their receptors play vital roles in controlling the physiology and behavior of animals. Short neuropeptide F (sNPF) signaling regulates several physiological processes in insects such as feeding, locomotion, circadian rhythm and reproduction, among others. Previously, the red imported fire ant (Solenopsis invicta) sNPF receptor (S. invicta sNPFR), a G protein-coupled receptor, was immunolocalized in queen and worker brain and queen ovaries. Differential distribution patterns of S. invicta sNPFR protein in fire ant worker brain were associated both with worker subcastes and with presence or absence of brood in the colony. However, the cognate ligand for this sNPFR has not been characterized and attempts to deorphanize the receptor with sNPF peptides from other insect species which ended in the canonical sequence LRLRF amide, failed. Receptor deorphanization is an important step to understand the neuropeptide receptor downstream signaling cascade. We cloned the full length cDNA of the putative S. invicta sNPF prepropeptide and identified the putative "sNPF" ligand within its sequence. The peptide ends with an amidated Tyr residue whereas in other insect species sNPFs have an amidated Phe or Trp residue at the C-terminus. We stably expressed the HA-tagged S. invicta sNPFR in CHO-K1 cells. Two S. invicta sNPFs differing at their N-terminus were synthesized that equally activated the sNPFR, SLRSALAAGHLRYa (EC50 = 3.2 nM) and SALAAGHLRYa (EC50 = 8.6 nM). Both peptides decreased the intracellular cAMP concentration, indicating signaling through the Gai-subunit. The receptor was not activated by sNPF peptides from other insect species, honey bee long NPF (NPY) or mammalian PYY. Further, a synthesized peptide otherwise identical to the fire ant sequence but in which the C-terminal amidated amino acid residue 'Y' was switched to 'F', failed to activate the sNPFR. This discovery will now allow us to investigate the function of sNPY and its cognate receptor in fire ant biology.	[Bajracharya, Prati; Lu, Hsiao-Ling; Pietrantonio, Patricia V.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Pietrantonio, PV (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	p-pietrantonio@tamu.edu			National Science Foundation [NSF-IOS 1257837]; Texas AgriLife Research	National Science Foundation(National Science Foundation (NSF)); Texas AgriLife Research	This research was funded by grants from the National Science Foundation NSF-IOS 1257837 and the Texas invasive ant research and management seed grant program from Texas AgriLife Research to P.V.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ament SA, 2011, INSECT MOL BIOL, V20, P335, DOI 10.1111/j.1365-2583.2011.01068.x; Ascunce MS, 2011, SCIENCE, V331, P1066, DOI 10.1126/science.1198734; Beck B, 2001, NEUROSCI BIOBEHAV R, V25, P143, DOI 10.1016/S0149-7634(01)00003-3; Boerjan B, 2010, NEUROPHARMACOLOGY, V58, P248, DOI 10.1016/j.neuropharm.2009.06.026; Brockmann A, 2009, P NATL ACAD SCI USA, V106, P2383, DOI 10.1073/pnas.0813021106; Broeck JV, 2001, PEPTIDES, V22, P241, DOI 10.1016/S0196-9781(00)00376-4; Brown MR, 1999, PEPTIDES, V20, P1035, DOI 10.1016/S0196-9781(99)00097-2; Caers Jelle, 2012, Front Endocrinol (Lausanne), V3, P151, DOI 10.3389/fendo.2012.00151; Castillo P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083966; Chen A, 2004, INSECT MOL BIOL, V13, P45, DOI 10.1111/j.1365-2583.2004.00457.x; Chen ME, 2006, ARCH INSECT BIOCHEM, V61, P195, DOI 10.1002/arch.20103; Chen WF, 2013, INSECT BIOCHEM MOLEC, V43, P809, DOI 10.1016/j.ibmb.2013.06.003; Chirino MG, 2012, ANN ENTOMOL SOC AM, V105, P740, DOI 10.1603/AN11073; Clynen E, 2009, ANN NY ACAD SCI, V1163, P60, DOI 10.1111/j.1749-6632.2008.03624.x; de Jong-Brink M, 2001, PEPTIDES, V22, P309, DOI 10.1016/S0196-9781(01)00332-1; De Jong-Brink M, 1999, FASEB J, V13, P1972, DOI 10.1096/fasebj.13.14.1972; De Loof A, 2001, ARCH INSECT BIOCHEM, V47, P129, DOI 10.1002/arch.1044; DECKER CJ, 1995, CURR OPIN CELL BIOL, V7, P386, DOI 10.1016/0955-0674(95)80094-8; Dillen S, 2014, PEPTIDES, V53, P134, DOI 10.1016/j.peptides.2013.09.018; Dillen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053604; Dumont Y, 2004, PEPTIDES, V25, P365, DOI 10.1016/j.peptides.2004.01.013; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; Fukuda N, 2008, J PHYSIOL SCI, V58, P151, DOI 10.2170/physiolsci.RV005408; Garczynski SF, 2006, PEPTIDES, V27, P575, DOI 10.1016/j.peptides.2005.06.029; Garczynski SF, 2007, PEPTIDES, V28, P109, DOI 10.1016/j.peptides.2006.09.019; Gruber CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032559; Hokfelt T, 2008, NUTRITION, V24, P860, DOI 10.1016/j.nut.2008.06.010; Holmes SP, 2003, INSECT MOL BIOL, V12, P27, DOI 10.1046/j.1365-2583.2003.00384.x; Hong SH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002857; Huang YC, 2014, BIOESSAYS, V36, P200, DOI 10.1002/bies.201300103; Hummon AB, 2006, SCIENCE, V314, P647, DOI 10.1126/science.1124128; JACKSON RJ, 1993, CELL, V74, P9, DOI 10.1016/0092-8674(93)90290-7; Johard HAD, 2009, J COMP NEUROL, V516, P59, DOI 10.1002/cne.22099; Kahsai L, 2010, J EXP BIOL, V213, P2256, DOI 10.1242/jeb.043190; Koller KJ, 1997, ANAL BIOCHEM, V250, P51, DOI 10.1006/abio.1997.2190; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; Langkilde T, 2009, ECOLOGY, V90, P208, DOI 10.1890/08-0355.1; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; Ligon RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022578; Liu Huiqing, 2003, Genome Inform, V14, P84; Lu HL, 2011, JOVE-J VIS EXP, DOI 10.3791/2732; Lu HL, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-57; Lu HL, 2009, FEBS J, V276, P3110, DOI 10.1111/j.1742-4658.2009.07029.x; Meer RV, 2012, J CHEM ECOL, V38, P728, DOI 10.1007/s10886-012-0140-8; Mercier J, 2007, J PESTIC SCI, V32, P345, DOI 10.1584/jpestics.R07-04; Mertens I, 2002, BIOCHEM BIOPH RES CO, V297, P1140, DOI 10.1016/S0006-291X(02)02351-3; Mikani A, 2012, PEPTIDES, V34, P135, DOI 10.1016/j.peptides.2011.10.028; Munding EM, 2013, MOL CELL, V51, P338, DOI 10.1016/j.molcel.2013.06.012; Munoz-Torres MC, 2011, NUCLEIC ACIDS RES, V39, pD658, DOI 10.1093/nar/gkq1145; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; Nguyen AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040191; Ons S, 2011, INSECT MOL BIOL, V20, P29, DOI 10.1111/j.1365-2583.2010.01050.x; RAJPARA SM, 1992, NEURON, V9, P505, DOI 10.1016/0896-6273(92)90188-J; Riehle MA, 2002, SCIENCE, V298, P172, DOI 10.1126/science.1076827; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Shang YH, 2013, NEURON, V80, P171, DOI 10.1016/j.neuron.2013.07.029; Southey BR, 2008, BIOINFORMATICS, V24, P815, DOI 10.1093/bioinformatics/btn044; Spittaels K, 1996, INSECT BIOCHEM MOLEC, V26, P375, DOI 10.1016/0965-1748(95)00104-2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tschinkel WR, 2006, FIRE ANTS; Vecsey CG, 2014, J NEUROPHYSIOL, V111, P1033, DOI 10.1152/jn.00712.2013; VEENSTRA JA, 1995, BIOCHEM BIOPH RES CO, V213, P519, DOI 10.1006/bbrc.1995.2162; Wilder SM, 2013, OECOLOGIA, V172, P197, DOI 10.1007/s00442-012-2477-7; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048; Yang YL, 2013, GEN COMP ENDOCR, V194, P142, DOI 10.1016/j.ygcen.2013.09.001; Zimanyi IA, 1998, CURR PHARM DESIGN, V4, P349	70	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109590	10.1371/journal.pone.0109590	http://dx.doi.org/10.1371/journal.pone.0109590			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310341	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210300060
J	Lin, XC; Li, JY; Ma, S; Liu, GS; Yang, K; Tong, MP; Lin, DH				Lin, Xiuchun; Li, Jingyi; Ma, Si; Liu, Gesheng; Yang, Kun; Tong, Meiping; Lin, Daohui			Toxicity of TiO2 Nanoparticles to Escherichia coli: Effects of Particle Size, Crystal Phase and Water Chemistry	PLOS ONE			English	Article							TITANIUM-DIOXIDE NANOPARTICLES; PHOTOCATALYTIC DISINFECTION; ZNO NANOPARTICLES; HUMIC-ACID; PHOTOTOXICITY; NANOMATERIALS; EXPOSURE; ANTIBACTERIAL; INACTIVATION; NANO-TIO2	Controversial and inconsistent results on the eco-toxicity of TiO2 nanoparticles (NPs) are commonly found in recorded studies and more experimental works are therefore warranted to elucidate the nanotoxicity and its underlying precise mechanisms. Toxicities of five types of TiO2 NPs with different particle sizes (10 similar to 50 nm) and crystal phases were investigated using Escherichia coli as a test organism. The effect of water chemistry on the nanotoxicity was also examined. The antibacterial effects of TiO2 NPs as revealed by dose-effect experiments decreased with increasing particle size and rutile content of the TiO2 NPs. More bacteria could survive at higher solution pH (5.0-10.0) and ionic strength (50-200 mg L-1 NaCl) as affected by the anatase TiO2 NPs. The TiO2 NPs with anatase crystal structure and smaller particle size produced higher content of intracellular reactive oxygen species and malondialdehyde, in line with their greater antibacterial effect. Transmission electron microscopic observations showed the concentration buildup of the anatase TiO2 NPs especially those with smaller particle sizes on the cell surfaces, leading to membrane damage and internalization. These research results will shed new light on the understanding of ecological effects of TiO2 NPs.	[Lin, Xiuchun] Putian Univ, Coll Environm & Biol Engn, Putian, Fujian, Peoples R China; [Lin, Xiuchun; Li, Jingyi; Ma, Si; Liu, Gesheng; Yang, Kun; Lin, Daohui] Zhejiang Univ, Dept Environm Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Kun; Lin, Daohui] Zhejiang Univ, Zhejiang Prov Key Lab Organ Pollut Proc & Control, Hangzhou 310003, Zhejiang, Peoples R China; [Tong, Meiping] Peking Univ, Coll Environm Sci & Engn, Beijing 100871, Peoples R China	Putian University; Zhejiang University; Zhejiang University; Peking University	Lin, DH (corresponding author), Zhejiang Univ, Dept Environm Sci, Hangzhou 310003, Zhejiang, Peoples R China.	lindaohui@zju.edu.cn	yang, kun/B-3141-2014		973 Program of China [2014CB441104]; National Natural Science Foundation of China [21337004, 21477107]; Natural Science Foundation of Zhejiang Province of China [LR12B07001]; Natural Science Foundation of Fujian Province of China [2014J01053]	973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province of China(Natural Science Foundation of Zhejiang Province); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province)	This work was supported by the 973 Program of China (2014CB441104), National Natural Science Foundation of China (21337004, 21477107), Natural Science Foundations of Zhejiang Province (LR12B07001) and Fujian Province (2014J01053) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085981; Adams LK, 2006, WATER RES, V40, P3527, DOI 10.1016/j.watres.2006.08.004; Barnes RJ, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1432-9; Batley GE, 2013, ACCOUNTS CHEM RES, V46, P854, DOI 10.1021/ar2003368; Battin TJ, 2009, ENVIRON SCI TECHNOL, V43, P8098, DOI 10.1021/es9017046; Bokare A, 2013, COLLOID SURFACE B, V102, P273, DOI 10.1016/j.colsurfb.2012.08.030; Brunet L, 2009, ENVIRON SCI TECHNOL, V43, P4355, DOI 10.1021/es803093t; Chen X, 2007, CHEM REV, V107, P2891, DOI 10.1021/cr0500535; Chowdhury I, 2012, ENVIRON SCI TECHNOL, V46, P6968, DOI 10.1021/es2034747; Clement L, 2013, CHEMOSPHERE, V90, P1083, DOI 10.1016/j.chemosphere.2012.09.013; Dalai S, 2012, TOXICOL RES-UK, V1, P116, DOI 10.1039/c2tx00012a; Dastjerdi R, 2010, COLLOID SURFACE B, V79, P5, DOI 10.1016/j.colsurfb.2010.03.029; Foster HA, 2011, APPL MICROBIOL BIOT, V90, P1847, DOI 10.1007/s00253-011-3213-7; French RA, 2009, ENVIRON SCI TECHNOL, V43, P1354, DOI 10.1021/es802628n; Griffitt RJ, 2008, ENVIRON TOXICOL CHEM, V27, P1972, DOI 10.1897/08-002.1; Ji J, 2011, CHEM ENG J, V170, P525, DOI 10.1016/j.cej.2010.11.026; Jiang GX, 2011, J ENVIRON MONITOR, V13, P42, DOI 10.1039/c0em00499e; Jiang JK, 2009, J NANOPART RES, V11, P77, DOI 10.1007/s11051-008-9446-4; Jiang W, 2009, ENVIRON POLLUT, V157, P1619, DOI 10.1016/j.envpol.2008.12.025; Jin C, 2011, BIOL TRACE ELEM RES, V141, P3, DOI 10.1007/s12011-010-8707-0; Johnson AC, 2011, SCI TOTAL ENVIRON, V409, P2503, DOI 10.1016/j.scitotenv.2011.03.040; Kaegi R, 2008, ENVIRON POLLUT, V156, P233, DOI 10.1016/j.envpol.2008.08.004; Kelly SA, 1998, ENVIRON HEALTH PERSP, V106, P375, DOI 10.2307/3434064; Kim DS, 2009, ENVIRON SCI TECHNOL, V43, P148, DOI 10.1021/es801029h; Kim J, 2014, ECOTOX ENVIRON SAFE, V101, P240, DOI 10.1016/j.ecoenv.2014.01.002; Kim SW, 2012, APPL MICROBIOL BIOT, V95, P243, DOI 10.1007/s00253-012-4153-6; Kumar A, 2011, FREE RADICAL BIO MED, V51, P1872, DOI 10.1016/j.freeradbiomed.2011.08.025; Li M, 2013, ENVIRON POLLUT, V173, P97, DOI 10.1016/j.envpol.2012.10.026; Li M, 2011, ENVIRON SCI TECHNOL, V45, P1977, DOI 10.1021/es102624t; Li SB, 2014, CHEMOSPHERE, V112, P62, DOI 10.1016/j.chemosphere.2014.03.058; Li SB, 2014, ENVIRON TOXICOL CHEM, V33, P1563, DOI 10.1002/etc.2583; Li SB, 2014, SCI TOTAL ENVIRON, V466, P800, DOI 10.1016/j.scitotenv.2013.07.059; Lin DH, 2012, WATER RES, V46, P4477, DOI 10.1016/j.watres.2012.05.035; Lin DH, 2010, J ENVIRON QUAL, V39, P1896, DOI 10.2134/jeq2009.0423; LINSEBIGLER AL, 1995, CHEM REV, V95, P735, DOI 10.1021/cr00035a013; Long ZF, 2012, ENVIRON SCI TECHNOL, V46, P8458, DOI 10.1021/es301802g; Ma S, 2013, ENVIRON SCI-PROC IMP, V15, P145, DOI 10.1039/c2em30637a; Markowska-Szczupak A, 2011, CATAL TODAY, V169, P249, DOI 10.1016/j.cattod.2010.11.055; McWhirter MJ, 2002, COLLOID SURFACE B, V26, P365, DOI 10.1016/S0927-7765(02)00017-6; Menard A, 2011, ENVIRON POLLUT, V159, P677, DOI 10.1016/j.envpol.2010.11.027; Musee N, 2011, J ENVIRON MONITOR, V13, P1164, DOI 10.1039/c1em10023h; Neal AL, 2008, ECOTOXICOLOGY, V17, P362, DOI 10.1007/s10646-008-0217-x; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Ng AMC, 2013, APPL MICROBIOL BIOT, V97, P5565, DOI 10.1007/s00253-013-4889-7; Pagnout C, 2012, COLLOID SURFACE B, V92, P315, DOI 10.1016/j.colsurfb.2011.12.012; Park S, 2012, BIOTECHNOL BIOPROC E, V17, P276, DOI 10.1007/s12257-010-0251-4; Planchon M, 2013, COLLOID SURFACE B, V102, P158, DOI 10.1016/j.colsurfb.2012.08.034; Rincon AG, 2004, APPL CATAL B-ENVIRON, V51, P283, DOI 10.1016/j.apcatb.2004.03.007; Robichaud CO, 2009, ENVIRON SCI TECHNOL, V43, P4227, DOI 10.1021/es8032549; Schwegmann H, 2013, WATER RES, V47, P1503, DOI 10.1016/j.watres.2012.11.030; Simon-Deckers A, 2009, ENVIRON SCI TECHNOL, V43, P8423, DOI 10.1021/es9016975; Suresh AK, 2013, NANOSCALE, V5, P463, DOI 10.1039/c2nr32447d; Tong TZ, 2013, WATER RES, V47, P2352, DOI 10.1016/j.watres.2013.02.008; Wang ZP, 2010, CHEMOSPHERE, V80, P525, DOI 10.1016/j.chemosphere.2010.04.047; Xiong SJ, 2013, ARCH TOXICOL, V87, P99, DOI 10.1007/s00204-012-0912-5	55	31	33	5	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110247	10.1371/journal.pone.0110247	http://dx.doi.org/10.1371/journal.pone.0110247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310452	gold, Green Published, Green Submitted			2022-12-27	WOS:000343210300101
J	Chessa, A; Crimaldi, I; Riccaboni, M; Trapin, L				Chessa, Alessandro; Crimaldi, Irene; Riccaboni, Massimo; Trapin, Luca			Cluster Analysis of Weighted Bipartite Networks: A New Copula-Based Approach	PLOS ONE			English	Article							COMMUNITY STRUCTURE; 2-MODE; EVOLUTION	In this work we are interested in identifying clusters of "positional equivalent" actors, i.e. actors who play a similar role in a system. In particular, we analyze weighted bipartite networks that describes the relationships between actors on one side and features or traits on the other, together with the intensity level to which actors show their features. We develop a methodological approach that takes into account the underlying multivariate dependence among groups of actors. The idea is that positions in a network could be defined on the basis of the similar intensity levels that the actors exhibit in expressing some features, instead of just considering relationships that actors hold with each others. Moreover, we propose a new clustering procedure that exploits the potentiality of copula functions, a mathematical instrument for the modelization of the stochastic dependence structure. Our clustering algorithm can be applied both to binary and real-valued matrices. We validate it with simulations and applications to real-world data.	[Chessa, Alessandro; Crimaldi, Irene; Riccaboni, Massimo; Trapin, Luca] IMT Inst Adv Studies, Lucca, Italy	IMT School for Advanced Studies Lucca	Trapin, L (corresponding author), IMT Inst Adv Studies, Lucca, Italy.	luca.trapin@imtlucca.it	Trapin, Luca/AAI-3733-2020	Trapin, Luca/0000-0001-8613-0962; RICCABONI, Massimo/0000-0003-4979-8933	CNR PNR Project "CRISIS Lab"; MIUR (FIRB) [RBFR12BA3Y]	CNR PNR Project "CRISIS Lab"(Consiglio Nazionale delle Ricerche (CNR)); MIUR (FIRB)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	The authors acknowledge support from CNR PNR Project "CRISIS Lab" and from the MIUR (FIRB project RBFR12BA3Y). Moreover, Irene Crimaldi is a member of the "Gruppo Nazionale per l'Analisi Matematica, la Probabilita e le loro Applicazioni (GNAMPA)" of the "Istituto Nazionale di Alta Matematica (INdAM)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agliari E, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/10002; Agliari E, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.268101; Aicher C, 2014, ARXIV14040431V1; Asratian A.S, 1998, BIPARTITE GRAPHS THE; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barber MJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066102; Barigozzi M, 2011, PHYSICA A, V390, P2051, DOI 10.1016/j.physa.2011.02.004; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Borgatti SP, 1997, SOC NETWORKS, V19, P243, DOI 10.1016/S0378-8733(96)00301-2; Borgatti SP, 2008, ENCY COMPLEXITY SYST; Borgatti Stephen P., 2011, SAGE HDB SOCIAL NETW, P417, DOI DOI 10.4135/9781446294413.N28; Brandes U, 2007, ICFCA SAT WORKSH SOC; Breiger RL, 1982, CONTINUITIES STRUCTU, P353; Brusco M, 2007, J MATH PSYCHOL, V51, P325, DOI 10.1016/j.jmp.2007.07.001; Brusco M, 2006, J MATH PSYCHOL, V50, P468, DOI 10.1016/j.jmp.2006.05.005; Brusco M, 2011, SOC NETWORKS, V33, P201, DOI 10.1016/j.socnet.2011.05.001; Cerina F, 2014, WORLD INPUT OUTPUT N; Cerina F, 2014, SCI REP-UK, V4, DOI 10.1038/srep04546; Davis GF, 1997, AM J SOCIOL, V103, P1, DOI 10.1086/231170; Dhillon I. S., 2001, P 7 ACM SIGKDD INT C, P269, DOI DOI 10.1145/502512.502550; Di Lascio FML, 2012, J CLASSIF, V29, P50, DOI 10.1007/s00357-012-9099-y; Doreian P, 2004, SOC NETWORKS, V26, P29, DOI 10.1016/j.socnet.2004.01.002; Everett MG, 2013, SOC NETWORKS, V35, P204, DOI 10.1016/j.socnet.2012.05.004; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Good BH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046106; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; Guimera R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036102; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hoeffding W., 1994, COLLECTED WORKS WASS, P57, DOI DOI 10.1007/978-1-4612-0865-5_4; Joe H., 1997, MULTIVARIATE MODELS; Larremore DB, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003268; Larremore DB, 2014, ARXIV14032933; MARIOLIS P, 1975, SOC SCI QUART, V56, P425; Mrvar A, 2009, J MATH SOCIOL, V33, P196, DOI 10.1080/00222500902946210; Nelsen RB, 2006, INTRO COPULAS, DOI [10.1007/978-1-4757-3076-0, 10.1007/0-387-28678-0]; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Sklar A., 1959, PUBL I STAT U PARIS, V8, P229, DOI DOI 10.1007/978-3-642-33590-7; Trivedi P.K., 2005, FDN TRENDS ECONOMETR, V1, P1, DOI DOI 10.1561/0800000005; Tzekina I, 2008, EUR PHYS J B, V63, P541, DOI 10.1140/epjb/e2008-00181-2; Wasserman F., 1994, SOCIAL NETWORK ANAL; Zhou T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046115; Zhu Z, 2014, PLOS ONE IN PRESS; Ziberna A, 2007, SOC NETWORKS, V29, P105, DOI 10.1016/j.socnet.2006.04.002	44	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109507	10.1371/journal.pone.0109507	http://dx.doi.org/10.1371/journal.pone.0109507			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303095	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000343730400061
J	Froese, T; Gershenson, C; Manzanilla, LR				Froese, Tom; Gershenson, Carlos; Manzanilla, Linda R.			Can Government Be Self-Organized? A Mathematical Model of the Collective Social Organization of Ancient Teotihuacan, Central Mexico	PLOS ONE			English	Article							EVOLUTION; OPTIMIZATION; STATE; CITY; DEMOGRAPHY; NETWORKS; COLLAPSE; VICTIMS; SYSTEM; VALLEY	Teotihuacan was the first urban civilization of Mesoamerica and one of the largest of the ancient world "adition in archaeology to equate social complexity with centralized hierarchy, it is widely believed that the origin and rowth was controlled by a lineage of powerful individuals. However, much data is ndicative of a government of co-rulers, and artistic traditions expressed an egalitarian ideology. Yet this alternative keeps being marginalized because the problems of collective action make it difficult to conceive how such a coalition could have functioned in principle. We therefore devised a mathematical model of the city's hypothetical network of representatives as a formal proof of concept that idespread cooperation was realizable in a fLilly distribLited manner. In the model, decisions become self-organized into lobally optimal configurations even though local representatives behave and modify their relations in a rational and selfish anner. This self-optimization crucially depends on occasional communal interruptions of normal activity, and it is impeded hen sections of the network are too independent. We relate these insights to theories aboLit community-wide nituals at Teotihuacan and the citys eventual disitegratin	[Froese, Tom; Gershenson, Carlos] Univ Nacl Autonoma Mexico, Inst Invest Matemat Aplicadas & Siste, Mexico City 04510, DF, Mexico; [Froese, Tom; Gershenson, Carlos] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Mexico City 04510, DF, Mexico; [Manzanilla, Linda R.] Univ Nacl Autonoma Mexico, Inst Invest Antropol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Froese, T (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Matemat Aplicadas & Siste, Ciudad Univ, Mexico City 04510, DF, Mexico.	t.froese@gmail.com	Gershenson, Carlos/F-2241-2010; Froese, Tom/B-3301-2012	Gershenson, Carlos/0000-0003-0193-3067; Froese, Tom/0000-0002-9899-5274	UNAM PAPIIT [IN113013]; SNI of CONACyT, Mexico [47907]; project "Guiando Comportamientos para Mejorar la Movilidad Urbana" [CONACyT 212802]	UNAM PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); SNI of CONACyT, Mexico; project "Guiando Comportamientos para Mejorar la Movilidad Urbana"	TF was partially supported by UNAM PAPIIT grant number IN113013. CG was partially supported by SNI membership 47907 of CONACyT, Mexico. The work was partially funded by the project "Guiando Comportamientos para Mejorar la Movilidad Urbana" (CONACyT 212802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul JH, 1987, TEOTIHUACAN NUEVOS D, P191; Angulo J., 2007, POLITICAL EC ANCIENT, P83; Aveni Anthony F., 2001, SKYWATCHERS REVISED; Axtell RL, 2002, P NATL ACAD SCI USA, V99, P7275, DOI 10.1073/pnas.092080799; Beramendi-Orosco LE, 2009, QUATERNARY RES, V71, P99, DOI 10.1016/j.yqres.2008.10.003; Berrin, 1988, FEATHERED SERPENTS F, P114; Berrin K., 1993, TEOTIHUACAN ART CITY, P16; Berrin K, 1993, TEOTIHUACAN ART CITY, P74; Blanton RE, 1996, CURR ANTHROPOL, V37, P1, DOI 10.1086/204471; Blanton RE, 2012, NEIGHBORHOOD SOCIAL, P26; Brughmans T, 2013, J ARCHAEOL METHOD TH, V20, P623, DOI 10.1007/s10816-012-9133-8; Burtsev M, 2006, NATURE, V440, P1041, DOI 10.1038/nature04470; Cabrera Castro R., 2007, MUSEO TEOTIHUACANOS, P229; Cabrera Castro R, 1991, ANCIENT MESOAM, V2, P77; Cabrera Castro Ruben., 1993, TEOTIHUACAN ART CITY, P101; Cowgill GL, 2008, ANTIQUITY, V82, P962, DOI 10.1017/S0003598X00097714; Cowgill George L., 2008, URBANISMO MESOAMERIC, V2, P85; Cowgill GL, 1997, ANNU REV ANTHROPOL, V26, P129, DOI 10.1146/annurev.anthro.26.1.129; Cowgill GL, 2000, CAMB ARCHAEOL J, V10, P358; Cowgill GL, 1974, MESOAMERICAN ARCHAEO, P363; Crumley C., 1995, ARCHAEOLOGICAL PAPER, V6, P1, DOI [10.1525/ap3a.1995.6.1.1, DOI 10.1525/AP3A.1995.6.1.1]; Davies AP, 2011, ARTIF LIFE, V17, P167, DOI 10.1162/artl_a_00030; De la Garza Mercedes, 2012, SUENO EXTASIS VISION; de Tapia Emily McClung, 1987, TEOTIHUACAN NUEVOS D, P115; Flannery KV, 2003, P NATL ACAD SCI USA, V100, P11801, DOI 10.1073/pnas.1934526100; Flores JC, 2011, J THEOR BIOL, V291, P29, DOI 10.1016/j.jtbi.2011.09.018; Gershenson C, 2010, PALADYN J BEHAV ROBO, V1, P147, DOI DOI 10.2478/S13230-010-0015-Z]; Gomez-Chavez S., 2012, NEIGHBORHOOD SOCIAL, P74; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Headrick A., 2007, TEOTIHUACAN TRINITY; HOPFIELD JJ, 1983, NATURE, V304, P158, DOI 10.1038/304158a0; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; HOPKINS MR, 1987, ENVIRON PLANN B, V14, P387, DOI 10.1068/b140387; Koontz R., 2013, MEXICO OLMECS AZTECS; Kryzhanovsky B, 2008, LECT NOTES ARTIF INT, V5097, P89, DOI 10.1007/978-3-540-69731-2_10; Langley JC, 1993, TEOTIHUACAN ART CITY, P128; Lopez Austin A, 1989, HIST TEOTIHUACAN TEO, P13; Manzanilla L, 1997, FUND ISS ARCH, P109; Manzanilla L.R., 2009, DOMESTIC LIFE PREHIS, V46, P21; Manzanilla Linda, 1996, LAT AM ANTIQ, V7, P228, DOI DOI 10.2307/971576; Manzanilla Linda, 2005, MEMORIA TERCERA MESA, P185; Manzanilla Linda R., 2012, NEIGHBORHOOD SOCIAL, P74; Manzanilla LR, 2012, ESTUDIOS ARQUEOMETRI, P17; Manzanilla LR, 1992, ART IDEOLOGY CITY TE, P321; Manzanilla LR, 2007, ARCHAEOLOGY MILLENNI, P381; Marcus J., 1993, MESOAMERICAN WRITING; Matos Moctezuma Eduardo, 1993, TEOTIHUACAN ART CITY, P156; MILLON C, 1973, AM ANTIQUITY, V38, P294, DOI 10.2307/279716; MILLON R, 1970, SCIENCE, V170, P1077, DOI 10.1126/science.170.3962.1077; Millon R., 1976, VALLEY MEXICO, P205; Millon Rene, 1988, FEATHERED SERPENTS F, P78; Morton SG, 2012, CAMB ARCHAEOL J, V22, P387, DOI 10.1017/S0959774312000467; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ostrom E., 1990, GOVERNING COMMONS EV; PARSONS JR, 1968, SCIENCE, V162, P872, DOI 10.1126/science.162.3856.872; Pasztory Esther, 1997, TEOTIHUACAN EXPT LIV; Pasztory Esther., 1988, FEATHERED SERPENTS F, P45; Pasztory Esther, 1993, TEOTIHUACAN ART CITY, P44; Paulinyi Z., 1981, ACTA ORIENT ACAD, V35, P315; Paulinyi Zoltan., 2001, ANCIENT MESOAM, V12, P1; Plunket P, 2005, J ARCHAEOL RES, V13, P89, DOI 10.1007/s10804-005-2485-5; Price TD, 2007, INTERD CONTRIB ARCH, P263, DOI 10.1007/978-0-387-48871-4_12; Price TD, 2000, J ARCHAEOL SCI, V27, P903, DOI 10.1006/jasc.1999.0504; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; Siebe C, 2004, B VOLCANOL, V66, P203, DOI 10.1007/s00445-003-0304-z; Siebe C, 2000, J VOLCANOL GEOTH RES, V104, P45, DOI 10.1016/S0377-0273(00)00199-2; Sload R, 1987, TEOTIHUACAN NUEVOS D, P219; Smith Monica L., 2003, SOCIAL CONSTRUCTION, P37; Spence MW, 2007, ANCIENT MESOAM, V18, P147, DOI 10.1017/S0956536107000090; Spencer CS, 2004, ANNU REV ANTHROPOL, V33, P173, DOI 10.1146/annurev.anthro.33.070203.143823; Sprajc I, 2000, LAT AM ANTIQ, V11, P403, DOI 10.2307/972004; Stone Elizabeth C., 2007, SETTLEMENT SOC ESSAY, P261; Sugiyama N, 2013, LAT AM ANTIQ, V24, P403, DOI 10.7183/1045-6635.24.4.403; Sugiyama Saburo, 2005, HUMAN SACRIFICE MILI; Taube Karl, 2000, WRITING SYSTEM ANCIE; Turchin P, 2013, P NATL ACAD SCI USA, V110, P16384, DOI 10.1073/pnas.1308825110; TURNER V, 1977, DAEDALUS, V106, P61; Turner Victor, 1969, RITUAL PROCESS; Uriarte MT, 2007, MUSEO MURALES TEOTIH, P181; Vasconcelos VV, 2013, NAT CLIM CHANGE, V3, P797, DOI [10.1038/nclimate1927, 10.1038/NCLIMATE1927]; Watson RA, 2011, ADAPT BEHAV, V19, P227, DOI 10.1177/1059712311412797; Watson RA, 2011, ARTIF LIFE, V17, P147, DOI 10.1162/artl_a_00029; Watson RA, 2011, COMPLEXITY, V16, P17, DOI 10.1002/cplx.20346; White CD, 2004, J ANTHROPOL ARCHAEOL, V23, P385, DOI 10.1016/j.jaa.2004.08.002; White CD, 2002, LAT AM ANTIQ, V13, P217, DOI 10.2307/971915; Widmer Randolph J., 1993, PREHISPANIC DOMESTIC, P87; Yoffee Norman, 1988, COLLAPSE ANCIENT STA, P102	87	20	20	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109966	10.1371/journal.pone.0109966	http://dx.doi.org/10.1371/journal.pone.0109966			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AR6ZS	25303308	Green Published, gold			2022-12-27	WOS:000343730400097
J	Reinwarth, M; Avrutina, O; Fabritz, S; Kolmar, H				Reinwarth, Michael; Avrutina, Olga; Fabritz, Sebastian; Kolmar, Harald			Fragmentation Follows Structure: Top-Down Mass Spectrometry Elucidates the Topology of Engineered Cystine-Knot Miniproteins	PLOS ONE			English	Article							COLLISION-INDUCED DISSOCIATION; ELECTRON-CAPTURE DISSOCIATION; PROTONATED PEPTIDES; TRYPSIN-INHIBITOR; QUADRUPOLE-TIME; DRUG DESIGN; DISULFIDE; PROTEINS; SCAFFOLD; IDENTIFICATION	Over the last decades the field of pharmaceutically relevant peptides has enormously expanded. Among them, several peptide families exist that contain three or more disulfide bonds. In this context, elucidation of the disulfide patterns is extremely important as these motifs are often prerequisites for folding, stability, and activity. An example of this structure-determining pattern is a cystine knot which comprises three constrained disulfide bonds and represents a core element in a vast number of mechanically interlocked peptidic structures possessing different biological activities. Herein, we present our studies on disulfide pattern determination and structure elucidation of cystine-knot miniproteins derived from Momordica cochinchinensis peptide MCoTI-II, which act as potent inhibitors of human matriptase-1. A top-down mass spectrometric analysis of the oxidised and bioactive peptides is described. Following the detailed sequencing of the peptide backbone, interpretation of the MS3 spectra allowed for the verification of the knotted topology of the examined miniproteins. Moreover, we found that the fragmentation pattern depends on the knottin's folding state, hence, tertiary structure, which to our knowledge has not been described for a top-down MS approach before.	[Reinwarth, Michael; Avrutina, Olga; Kolmar, Harald] Tech Univ Darmstadt, Inst Organ Chem & Biochem, Darmstadt, Germany; [Fabritz, Sebastian] AB Sciex Germany GmbH, Darmstadt, Germany	Technical University of Darmstadt	Fabritz, S (corresponding author), AB Sciex Germany GmbH, Darmstadt, Germany.	Sebastian.Fabritz@absciex.com; Kolmar@Biochemie-TUD.de	Kolmar, Harald/AAK-8316-2021	Kolmar, Harald/0000-0002-8210-1993				Aina OH, 2007, MOL PHARMACEUT, V4, P631, DOI 10.1021/mp700073y; ATHERTON E, 1975, J AM CHEM SOC, V97, P6584, DOI 10.1021/ja00855a053; Berkowitz SA, 2012, NAT REV DRUG DISCOV, V11, P527, DOI 10.1038/nrd3746; Boyd R, 2010, J AM SOC MASS SPECTR, V21, P1275, DOI 10.1016/j.jasms.2010.04.017; Castagnola M, 2012, J MATERN-FETAL NEO M, V25, P27, DOI 10.3109/14767058.2012.714647; Chait BT, 2006, SCIENCE, V314, P65, DOI 10.1126/science.1133987; Chen JZ, 2012, J AM SOC MASS SPECTR, V23, P225, DOI 10.1007/s13361-011-0294-6; Chen JZ, 2010, ANAL CHEM, V82, P6079, DOI 10.1021/ac1006766; Cheng CF, 2000, MASS SPECTROM REV, V19, P398; Chiche L, 2004, CURR PROTEIN PEPT SC, V5, P341, DOI 10.2174/1389203043379477; Choi S, 2010, J PROTEOME RES, V9, P626, DOI 10.1021/pr900771r; Chrisman PA, 2005, J AM SOC MASS SPECTR, V16, P1020, DOI 10.1016/j.jasms.2005.02.010; Chrisman PA, 2002, J PROTEOME RES, V1, P549, DOI 10.1021/pr025561z; Combes A, 2009, EUR J MASS SPECTROM, V15, P517, DOI 10.1255/ejms.1000; Craik DJ, 2006, BIOPOLYMERS, V84, P250, DOI 10.1002/bip.20451; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Engen JR, 2009, ANAL CHEM, V81, P7870, DOI 10.1021/ac901154s; Felizmenio-Quimio ME, 2001, J BIOL CHEM, V276, P22875, DOI 10.1074/jbc.M101666200; Gelly JC, 2004, NUCLEIC ACIDS RES, V32, pD156, DOI 10.1093/nar/gkh015; Giang KTN, 2011, J BIOL CHEM, V286, P44833, DOI 10.1074/jbc.M111.290296; Ginter JM, 2004, J AM SOC MASS SPECTR, V15, P1478, DOI 10.1016/j.jasms.2004.07.004; Glotzbach B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076956; Goransson U, 2003, J BIOL CHEM, V278, P48188, DOI 10.1074/jbc.M308771200; Goyder MS, 2013, EXPERT REV PROTEOMIC, V10, P489, DOI 10.1586/14789450.2013.837663; Gracy J, 2008, NUCLEIC ACIDS RES, V36, pD314, DOI 10.1093/nar/gkm939; Gundry Rebekah L, 2009, Curr Protoc Mol Biol, VChapter 10, DOI 10.1002/0471142727.mb1025s88; Gupta K, 2010, ANAL CHEM, V82, P8313, DOI 10.1021/ac101867e; Guthals A, 2012, MOL CELL PROTEOMICS, V11, P550, DOI 10.1074/mcp.R112.018556; Heck AJR, 2008, NAT METHODS, V5, P927, DOI 10.1038/nmeth.1265; Heitz A, 2001, BIOCHEMISTRY-US, V40, P7973, DOI 10.1021/bi0106639; Heitz A, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-54; Hofmeyer T, 2013, MOL BIOTECHNOL; Kellie JF, 2010, MOL BIOSYST, V6, P1532, DOI 10.1039/c000896f; Kimura RH, 2009, CANCER RES, V69, P2435, DOI 10.1158/0008-5472.CAN-08-2495; Klotz U, 2006, INT J CLIN PHARM TH, V44, P478; Korner R, 1996, J AM SOC MASS SPECTR, V7, P150, DOI 10.1016/1044-0305(95)00626-5; Lam KS, 2003, ACCOUNTS CHEM RES, V36, P370, DOI 10.1021/ar0201299; Lanucara F, 2013, MASS SPECTROM REV, V32, P27, DOI 10.1002/mas.21348; Lioe H, 2007, J AM SOC MASS SPECTR, V18, P1109, DOI 10.1016/j.jasms.2007.03.003; Macht M, 2009, BIOANALYSIS, V1, P1131, DOI [10.4155/bio.09.93, 10.4155/BIO.09.93]; Paizs B, 2005, MASS SPECTROM REV, V24, P508, DOI 10.1002/mas.20024; Pan JX, 2013, PROTEOMICS, V13, P974, DOI 10.1002/pmic.201200246; PAPAYANNOPOULOS IA, 1995, MASS SPECTROM REV, V14, P49, DOI 10.1002/mas.1280140104; Peng Y, 2013, J MUSCLE RES CELL MO; Raska CS, 2002, J AM SOC MASS SPECTR, V13, P1034, DOI 10.1016/S1044-0305(02)00433-6; Reinwarth M, 2013, CHEMBIOCHEM, V14, P137, DOI 10.1002/cbic.201200604; Reinwarth M, 2012, MOLECULES, V17, P12533, DOI 10.3390/molecules171112533; Seidler J, 2010, PROTEOMICS, V10, P634, DOI 10.1002/pmic.200900459; Sommerhoff CP, 2010, J MOL BIOL, V395, P167, DOI 10.1016/j.jmb.2009.10.028; Switzar L, 2013, J PROTEOME RES, V12, P1067, DOI 10.1021/pr301201x; Thongyoo P, 2008, ORG BIOMOL CHEM, V6, P1462, DOI 10.1039/b801667d; Wang CK, 2009, J BIOL CHEM, V284, P10672, DOI 10.1074/jbc.M900021200; Wells JM, 2000, INT J MASS SPECTROM, V203, pA1, DOI 10.1016/S1387-3806(00)00389-4; Werle M, 2007, INT J PHARMACEUT, V332, P72, DOI 10.1016/j.ijpharm.2006.09.028; Werle M, 2006, J DRUG TARGET, V14, P137, DOI 10.1080/10611860600648254; Wu SL, 2009, ANAL CHEM, V81, P112, DOI 10.1021/ac801560k; Wysocki VH, 2000, J MASS SPECTROM, V35, P1399, DOI 10.1002/1096-9888(200012)35:12<1399::AID-JMS86>3.0.CO;2-R; Zhang H, 2011, CIRC-CARDIOVASC GENE, V4, P711, DOI 10.1161/CIRCGENETICS.110.957829; Zubarev RA, 1999, J AM CHEM SOC, V121, P2857, DOI 10.1021/ja981948k	59	4	4	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108626	10.1371/journal.pone.0108626	http://dx.doi.org/10.1371/journal.pone.0108626			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303319	gold, Green Published, Green Submitted			2022-12-27	WOS:000343730400020
J	Stone, KD; Gonzalez, CLR				Stone, Kayla D.; Gonzalez, Claudia L. R.			Grasping without Sight: Insights from the Congenitally Blind	PLOS ONE			English	Article							PREHENSION MOVEMENTS; TACTILE PERCEPTION; HAND PREFERENCE; HEMISPHERIC-SPECIALIZATION; CEREBRAL COMMISSUROTOMY; HAPTIC DISCRIMINATION; VISUAL FEEDBACK; REACHING TASK; CHILDREN; RECOGNITION	We reach for and grasp different sized objects numerous times per day. Most of these movements are visually-guided, but some are guided by the sense of touch (i.e. haptically-guided), such as reaching for your keys in a bag, or for an object in a dark room. A marked right-hand preference has been reported during visually-guided grasping, particularly for small objects. However, little is known about hand preference for haptically-guided grasping. Recently, a study has shown a reduction in right-hand use in blindfolded individuals, and an absence of hand preference if grasping was preceded by a short haptic experience. These results suggest that vision plays a major role in hand preference for grasping. If this were the case, then one might expect congenitally blind (CB) individuals, who have never had a visual experience, to exhibit no hand preference. Two novel findings emerge from the current study: first, the results showed that contrary to our expectation, CB individuals used their right hand during haptically-guided grasping to the same extent as visually-unimpaired (VU) individuals did during visually-guided grasping. And second, object size affected hand use in an opposite manner for haptically-versus visually-guided grasping. Big objects were more often picked up with the right hand during haptically-guided, but less often during visually-guided grasping. This result highlights the different demands that object features pose on the two sensory systems. Overall the results demonstrate that hand preference for grasping is independent of visual experience, and they suggest a left-hemisphere specialization for the control of grasping that goes beyond sensory modality.	[Stone, Kayla D.; Gonzalez, Claudia L. R.] Univ Lethbridge, Dept Kinesiol, Brain Act Lab, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	Stone, KD (corresponding author), Univ Lethbridge, Dept Kinesiol, Brain Act Lab, Lethbridge, AB T1K 3M4, Canada.	kayla.stone@uleth.ca	Stone, Kayla/AAD-3525-2020	Stone, Kayla/0000-0001-9212-2782	Natural Sciences and Engineering Research Council of Canada (NSERC Fund) [14367]; University of Lethbridge	Natural Sciences and Engineering Research Council of Canada (NSERC Fund); University of Lethbridge	The current study was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC Fund # 14367) and the University of Lethbridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begliomini C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003388; Bennett KM, 1994, INSIGHTS REACH GRASP, P390; BENTON AL, 1973, NEUROLOGY, V23, P1248, DOI 10.1212/WNL.23.11.1248; BENTON AL, 1978, NEUROPSYCHOLOGIA, V16, P109, DOI 10.1016/0028-3932(78)90049-0; Bishop DVM, 1996, BRIT J PSYCHOL, V87, P269, DOI 10.1111/j.2044-8295.1996.tb02590.x; Brown S, 2006, MAMM GENOME, V17, P1, DOI 10.1007/s00335-005-0900-7; Bryden PJ, 2006, DEV PSYCHOBIOL, V48, P121, DOI 10.1002/dev.20120; Caliskan E, 2009, LATERALITY, V14, P205, DOI 10.1080/13576500802586251; Calvert G A, 1998, Laterality, V3, P255, DOI 10.1080/135765098397287; Carlier M, 2006, BRAIN COGNITION, V61, P255, DOI 10.1016/j.bandc.2006.01.007; CASTIELLO U, 1993, EXP BRAIN RES, V96, P152, DOI 10.1007/BF00230448; Collignon O, 2009, CAN J EXP PSYCHOL, V63, P287, DOI 10.1037/a0015415; Connolly JD, 1999, EXP BRAIN RES, V125, P281, DOI 10.1007/s002210050684; Cormier JM, 2013, LATERALITY, V18, P365, DOI 10.1080/1357650X.2012.701631; DODDS AG, 1978, NEUROPSYCHOLOGIA, V16, P247, DOI 10.1016/0028-3932(78)90115-X; FAGOT J, 1993, BRAIN COGNITION, V21, P212, DOI 10.1006/brcg.1993.1017; FAGOT J, 1994, PERCEPT PSYCHOPHYS, V56, P347, DOI 10.3758/BF03209768; FAGOT J, 1993, PERCEPTION, V22, P847, DOI 10.1068/p220847; Fiehler K, 2009, CEREB CORTEX, V19, P1, DOI 10.1093/cercor/bhn067; Gabbard C, 2003, INT J NEUROSCI, V113, P143, DOI 10.1080/00207450390161994; Gabbard C, 2001, DEV NEUROPSYCHOL, V19, P41, DOI 10.1207/S15326942DN1901_4; GENTILUCCI M, 1991, NEUROPSYCHOLOGIA, V29, P361, DOI 10.1016/0028-3932(91)90025-4; Gonzalez CLR, 2007, EXP BRAIN RES, V182, P275, DOI 10.1007/s00221-007-1090-1; Gonzalez CLR, 2009, NEUROPSYCHOLOGIA, V47, P3182, DOI 10.1016/j.neuropsychologia.2009.07.019; Grant AC, 2000, PERCEPT PSYCHOPHYS, V62, P301, DOI 10.3758/BF03205550; Harada T, 2004, J NEUROSCI, V24, P7524, DOI 10.1523/JNEUROSCI.1395-04.2004; Heath M, 1998, CAN J EXP PSYCHOL, V52, P163, DOI 10.1037/h0087289; Heller MA, 1996, PERCEPT PSYCHOPHYS, V58, P310, DOI 10.3758/BF03211884; HELLER MA, 1993, PERCEPT PSYCHOPHYS, V53, P422, DOI 10.3758/BF03206785; HERMELIN B, 1971, NEUROPSYCHOLOGIA, V9, P431, DOI 10.1016/0028-3932(71)90007-8; ITTYERAH M, 1993, Q J EXP PSYCHOL-A, V46, P35, DOI 10.1080/14640749308401066; Ittyerah M, 2000, LATERALITY, V5, P221, DOI 10.1080/713754379; Ittyerah M, 2009, J DEV PHYS DISABIL, V21, P329, DOI 10.1007/s10882-009-9146-8; JACKSON SR, 1995, EXP BRAIN RES, V102, P519; JAKOBSON LS, 1991, EXP BRAIN RES, V86, P199; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Karl JM, 2013, EXP BRAIN RES, V225, P465, DOI 10.1007/s00221-012-3386-z; Kudoh N, 1997, EXP BRAIN RES, V117, P457, DOI 10.1007/s002210050241; KUMAR S, 1977, CORTEX, V13, P55, DOI 10.1016/S0010-9452(77)80053-1; LEDERMAN SJ, 1990, PERCEPT PSYCHOPHYS, V47, P54, DOI 10.3758/BF03208164; MARTENIUK RG, 1990, HUM MOVEMENT SCI, V9, P149, DOI 10.1016/0167-9457(90)90025-9; MILLAR S, 1987, CORTEX, V23, P111, DOI 10.1016/S0010-9452(87)80023-0; MILNER B, 1972, NEUROPSYCHOLOGIA, V10, P1, DOI 10.1016/0028-3932(72)90038-3; OBOYLE MW, 1987, BRAIN COGNITION, V6, P474, DOI 10.1016/0278-2626(87)90141-2; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Overvliet KE, 2011, EXP BRAIN RES, V208, P245, DOI 10.1007/s00221-010-2475-0; Paulignan Y, 1997, EXP BRAIN RES, V114, P226, DOI 10.1007/PL00005631; Pettypiece CE, 2009, EXP BRAIN RES, V195, P473, DOI 10.1007/s00221-009-1807-4; Pietrini P, 2004, P NATL ACAD SCI USA, V101, P5658, DOI 10.1073/pnas.0400707101; Rand MK, 2007, EXP BRAIN RES, V181, P447, DOI 10.1007/s00221-007-0945-9; Ricciardi E, 2013, NEUROSCI BIOBEHAV RE; RIEGE WH, 1980, NEUROPSYCHOLOGIA, V18, P707, DOI 10.1016/0028-3932(80)90112-8; Sacrey LAR, 2012, INFANT BEHAV DEV, V35, P543, DOI 10.1016/j.infbeh.2012.05.006; Schettino LF, 2003, EXP BRAIN RES, V151, P158, DOI 10.1007/s00221-003-1435-3; Squeri V, 2012, J NEUROPHYSIOL, V107, P544, DOI 10.1152/jn.00756.2010; Stone KD, 2014, EXP BRAIN RES, V232, P385, DOI 10.1007/s00221-013-3746-3; Stone KD, 2013, EXP BRAIN RES, V224, P455, DOI 10.1007/s00221-012-3325-z; Theurel A, 2013, J EXP PSYCHOL-APPL, V19, P233, DOI 10.1037/a0034255; Theurel A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040251; ThinusBlanc C, 1997, PSYCHOL BULL, V121, P20, DOI 10.1037/0033-2909.121.1.20; Tomlinson SP, 2011, NEUROPSYCHOLOGIA, V49, P2703, DOI 10.1016/j.neuropsychologia.2011.05.018; Vainio L, 2006, EXP BRAIN RES, V173, P395, DOI 10.1007/s00221-006-0378-x; VARNEY NR, 1975, NEUROPSYCHOLOGIA, V13, P449, DOI 10.1016/0028-3932(75)90068-8; Winges SA, 2003, EXP BRAIN RES, V152, P489, DOI 10.1007/s00221-003-1571-9; Withagen A, 2013, ATTEN PERCEPT PSYCHO; Woods AT, 2004, J PHYSIOL-PARIS, V98, P147, DOI 10.1016/j.jphysparis.2004.03.006	66	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110175	10.1371/journal.pone.0110175	http://dx.doi.org/10.1371/journal.pone.0110175			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303211	Green Published, gold, Green Submitted			2022-12-27	WOS:000343730400117
J	Thorbjornsen, GH; Riise, T; Oyen, J				Thorbjornsen, Gunhild Hervik; Riise, Trond; Oyen, Jannike			Bodyweight Changes Are Associated with Reduced Health Related Quality of Life: The Hordaland Health Study	PLOS ONE			English	Article							JOLLY FAT HYPOTHESIS; BODY-MASS INDEX; WEIGHT-LOSS; PHYSICAL-ACTIVITY; DEPRESSIVE SYMPTOMS; STYLE FACTORS; OBESITY; WOMEN; OVERWEIGHT; ADULTS	There is lack of studies investigating the association between bodyweight changes and health related quality of life (HRQL). The aim was to study the effect of relative changes in bodyweight over time on HRQL. In the Hordaland Health Study, 9276 men and 10433 women aged 40-47 years were included. Weight and height were measured and information on bodyweight changes during the last 5 years, physical activity and smoking was obtained from self-administered questionnaires including the Medical Outcomes Study MOS short form-12 including a Physical health Composite Score (PCS) and a Mental health Composite Score (MCS). Increasing bodyweight changes were associated with marked reduced scores in PCS and MCS also after adjustment for body mass index (BMI), physical activity and smoking. Men and women with a variation in weight with more than 15% during the last 5 years reported a mean score of MCS that was 0.48 standard deviation (SD) (3.9/8.1) and 0.35 SD (3.1/8.9) lower than those reporting a variation in weight less than 5%. No major differences were found between those who at date of examination were at the lower and higher end of the reported weight interval. There were no significant differences in the associations between men and women. Our findings confirm that increasing bodyweight changes are associated with reduced physical and mental health beyond what is related to BMI itself.	[Thorbjornsen, Gunhild Hervik; Riise, Trond; Oyen, Jannike] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Oyen, Jannike] Haukeland Hosp, Dept Rheumatol, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital	Oyen, J (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.	jannike.oyen@igs.uib.no	Øyen, Jannike/H-9857-2018; Riise, Trond/H-1390-2018; Øyen, Jannike/G-4156-2017	Øyen, Jannike/0000-0002-5590-5136; Riise, Trond/0000-0001-9644-5140; Øyen, Jannike/0000-0002-5590-5136	Research Council of Norway; Western Norway Regional Health Authority	Research Council of Norway(Research Council of Norway); Western Norway Regional Health Authority	The Hordaland Health Study was funded by the Research Council of Norway. JO was supported by the Western Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abildso CG, 2010, PREV CHRONIC DIS, V7; Arrebola E, 2011, NUTR CLIN PRACT, V26, P316, DOI 10.1177/0884533611405993; Bize R, 2007, PREV MED, V45, P401, DOI 10.1016/j.ypmed.2007.07.017; Cash SW, 2013, QUAL LIFE RES, V22, P2381, DOI 10.1007/s11136-013-0389-6; Coakley EH, 1998, INT J OBESITY, V22, P89, DOI 10.1038/sj.ijo.0800549; Coakley EH, 1998, INT J OBESITY, V22, P958, DOI 10.1038/sj.ijo.0800698; Dishman RK, 2003, QUAL LIFE RES, V12, P43, DOI 10.1023/A:1023517303411; Fine JT, 1999, JAMA-J AM MED ASSOC, V282, P2136, DOI 10.1001/jama.282.22.2136; Ford ES, 2001, OBES RES, V9, P21, DOI 10.1038/oby.2001.4; Hainer V, 2008, DIABETES CARE, V31, pS269, DOI 10.2337/dc08-s265; Hassan MK, 2003, INT J OBESITY, V27, P1227, DOI 10.1038/sj.ijo.0802396; Herman KM, 2012, MED SCI SPORT EXER, V44, P625, DOI 10.1249/MSS.0b013e31823a90ae; Hurst NP, 1998, BRIT J RHEUMATOL, V37, P862; Hwu CM, 2011, J CHIN MED ASSOC, V74, P149, DOI 10.1016/j.jcma.2011.01.033; Jasienska G, 2005, WOMEN HEALTH ISS, V15, P145, DOI 10.1016/j.whi.2005.02.002; Kalter-Leibovici O, 2010, ARCH INTERN MED, V170, P970, DOI 10.1001/archinternmed.2010.103; Kruger J, 2007, INT J OBESITY, V31, P321, DOI 10.1038/sj.ijo.0803386; Lasikiewicz N, 2014, APPETITE, V72, P123, DOI 10.1016/j.appet.2013.09.017; Lee PH, 2006, J ADV NURS, V53, P295, DOI 10.1111/j.1365-2648.2006.03726.x; Lemon SC, 2009, BODY IMAGE, V6, P90, DOI 10.1016/j.bodyim.2008.11.004; Manini TM, 2010, AGEING RES REV, V9, P1, DOI 10.1016/j.arr.2009.08.002; Morimoto T, 2006, QUAL LIFE RES, V15, P537, DOI 10.1007/s11136-005-3033-2; Palinkas LA, 1996, J PSYCHOSOM RES, V40, P59, DOI 10.1016/0022-3999(95)00542-0; Pan A, 2014, AM J EPIDEMIOL, V180, P254, DOI 10.1093/aje/kwu136; Pan HJ, 2011, J CHIN MED ASSOC, V74, P169, DOI 10.1016/j.jcma.2011.01.038; Perusse-Lachance E, 2010, APPL PHYSIOL NUTR ME, V35, P498, DOI 10.1139/H10-035; Riise T, 2003, J OCCUP ENVIRON MED, V45, P324, DOI 10.1097/01.jom.0000052965.43131.c3; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Rippe JM, 1998, J AM DIET ASSOC, V98, pS31, DOI 10.1016/S0002-8223(98)00708-1; Ross R, 2009, NAT REV ENDOCRINOL, V5, P319, DOI 10.1038/nrendo.2009.78; Samsa GP, 2001, AM J MANAG CARE, V7, P875; Soltoft F, 2009, QUAL LIFE RES, V18, P1293, DOI 10.1007/s11136-009-9541-8; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wu CH, 2009, ASIA PAC J CLIN NUTR, V18, P423	34	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110173	10.1371/journal.pone.0110173	http://dx.doi.org/10.1371/journal.pone.0110173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6ZS	25303082	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400116
J	Jie, M; Cheung, WM; Yu, V; Zhou, YL; Tong, PH; Ho, JWS				Jie, Meng; Cheung, Wan Man; Yu, Vivian; Zhou, Yanling; Tong, Pak Ho; Ho, John W. S.			Anti-Proliferative Activities of Sinigrin on Carcinogen-Induced Hepatotoxicity in Rats	PLOS ONE			English	Article							ALLYL ISOTHIOCYANATE; GLUCOSINOLATE; INDUCTION; ENZYMES; CELLS	Liver cancer is one of the leading causes of cancer death worldwide. A very high incidence of new liver cancer cases is diagnosed every year, and metastasis has been found to correlate to poor prognoses in humans. Better treatments for liver cancer are thus clearly needed. Sinigrin is one of the major ingredients present in Brassica nigra, which has been used in combination with other herbs for treatment of various diseases. The anti-proliferative activities of sinigrin were studied in a model of carcinogen-induced hepatotoxicity in rats. Rats were orally administered with sinigrin on a daily basis for three months before sacrifice. Sinigrin was found to significantly inhibit the proliferation of liver tumor cells; the number of surface tumors in the rat liver was dramatically reduced. Sinigrin induced apoptosis of liver cancer cells through up-regulation of p53 and down-regulation of Bcl-2 family members and caspases. Our findings indicated that the liver functions were gradually restored after treatment with sinigrin and that the agent did not cause liver toxicity. Cell cycle analysis indicated that sinigrin caused cell cycle arrest in G0/G1 phase. The results suggest that sinigrin exerts important anti-proliferative activities in carcinogen-induced hepatocarcinogenesis in rats, and highlight the potential of sinigrin as an anticancer agent for liver cancer.	[Jie, Meng; Cheung, Wan Man; Yu, Vivian; Zhou, Yanling; Tong, Pak Ho; Ho, John W. S.] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Ho, JWS (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	ws203ho@cuhk.edu.gk						Krul C, 2002, CARCINOGENESIS, V23, P1009, DOI 10.1093/carcin/23.6.1009; Mays JR, 2008, CHEMBIOCHEM, V9, P729, DOI 10.1002/cbic.200700586; MCGEE JOD, 1969, BRIT J EXP PATHOL, V50, P521; Munday R, 2002, NUTR CANCER, V44, P52, DOI 10.1207/S15327914NC441_7; Navarro-Yepes J, 2014, ANTIOXID RE IN PRESS; Okulicz M, 2010, PLANT FOOD HUM NUTR, V65, P217, DOI 10.1007/s11130-010-0183-3; Ostrakhovitch EA, 2005, APOPTOSIS, V10, P111, DOI 10.1007/s10495-005-6066-7; PITOT HC, 1990, ANNU REV PHARMACOL, V30, P465; POWER C, 1987, CARCINOGENESIS, V8, P797, DOI 10.1093/carcin/8.6.797; Rocha NS, 2002, TERATOGEN CARCIN MUT, V22, P129, DOI 10.1002/tcm.10005; Rungapamestry V, 2008, BRIT J NUTR, V99, P773, DOI 10.1017/S0007114507841134; Slamenova D, 2013, MUTAT RES-GEN TOX EN, V757, P15, DOI 10.1016/j.mrgentox.2013.03.014; Smith TK, 2005, J AGR FOOD CHEM, V53, P3895, DOI 10.1021/jf048025v; TANAKA T, 1990, CARCINOGENESIS, V11, P1403, DOI 10.1093/carcin/11.8.1403; TAWFIQ N, 1995, CARCINOGENESIS, V16, P1191, DOI 10.1093/carcin/16.5.1191; Vines G, 1996, NEW SCI, V152, P46	16	27	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110145	10.1371/journal.pone.0110145	http://dx.doi.org/10.1371/journal.pone.0110145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329483	Green Submitted, gold, Green Published			2022-12-27	WOS:000343942100041
J	van Leeuwen, EM; Smouter, FAS; Kam-Thong, T; Karbalai, N; Smith, AV; Harris, TB; Launer, LJ; Sitlani, CM; Li, G; Brody, JA; Bis, JC; White, CC; Jaiswal, A; Oostra, BA; Hofman, A; Rivadeneira, F; Uitterlinden, AG; Boerwinkle, E; Ballantyne, CM; Gudnason, V; Psaty, BM; Cupples, LA; Jarvelin, MR; Ripatti, S; Isaacs, A; Muller-Myhsok, B; Karssen, LC; van Duijn, CM				van Leeuwen, Elisabeth M.; Smouter, Francoise A. S.; Kam-Thong, Tony; Karbalai, Nazanin; Smith, Albert V.; Harris, Tamara B.; Launer, Lenore J.; Sitlani, Colleen M.; Li, Guo; Brody, Jennifer A.; Bis, Joshua C.; White, Charles C.; Jaiswal, Alok; Oostra, Ben A.; Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre G.; Boerwinkle, Eric; Ballantyne, Christie M.; Gudnason, Vilmundur; Psaty, Bruce M.; Cupples, L. Adrienne; Jaervelin, Marjo-Riitta; Ripatti, Samuli; Isaacs, Aaron; Mueller-Myhsok, Bertram; Karssen, Lennart C.; van Duijn, Cornelia M.			The Challenges of Genome-Wide Interaction Studies: Lessons to Learn from the Analysis of HDL Blood Levels	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; DNA METHYLATION; LOCI; RISK	Genome-wide association studies (GWAS) have revealed 74 single nucleotide polymorphisms (SNPs) associated with high-density lipoprotein cholesterol (HDL) blood levels. This study is, to our knowledge, the first genome-wide interaction study (GWIS) to identify SNPxSNP interactions associated with HDL levels. We performed a GWIS in the Rotterdam Study (RS) cohort I (RS-I) using the GLIDE tool which leverages the massively parallel computing power of Graphics Processing Units (GPUs) to perform linear regression on all genome-wide pairs of SNPs. By performing a meta-analysis together with Rotterdam Study cohorts II and III (RS-II and RS-III), we were able to filter 181 interaction terms with a p-value<1 . 10(-8) that replicated in the two independent cohorts. We were not able to replicate any of these interaction term in the AGES, ARIC, CHS, ERF, FHS and NFBC-66 cohorts (N-total = 30,011) when adjusting for multiple testing. Our GWIS resulted in the consistent finding of a possible interaction between rs774801 in ARMC8 (ENSG00000114098) and rs12442098 in SPATA8 (ENSG00000185594) being associated with HDL levels. However, p-values do not reach the preset Bonferroni correction of the p-values. Our study suggest that even for highly genetically determined traits such as HDL the sample sizes needed to detect SNPxSNP interactions are large and the 2-step filtering approaches do not yield a solution. Here we present our analysis plan and our reservations concerning GWIS.	[van Leeuwen, Elisabeth M.; Smouter, Francoise A. S.; Isaacs, Aaron; Karssen, Lennart C.; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Genet Epidemiol Unit, Rotterdam, Netherlands; [Kam-Thong, Tony; Karbalai, Nazanin; Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Smith, Albert V.; Gudnason, Vilmundur] Iceland & Univ Iceland, Iceland Heart Assoc, Reykjavik, Iceland; [Harris, Tamara B.; Launer, Lenore J.] Natl Inst Aging, Lab Epidemiol Demog & Biometry, NIH, Bethesda, MD USA; [Sitlani, Colleen M.; Li, Guo; Brody, Jennifer A.; Bis, Joshua C.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Sitlani, Colleen M.; Li, Guo; Brody, Jennifer A.; Bis, Joshua C.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [White, Charles C.; Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Jaiswal, Alok; Ripatti, Samuli] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Oostra, Ben A.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Sch Publ Hlth, Houston, TX 77030 USA; [Ballantyne, Christie M.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Med, Hlth Serv, Seattle, WA USA; [Psaty, Bruce M.] Grp Hlth Res Inst, Grp Hlth, Seattle, WA USA; [Cupples, L. Adrienne] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Jaervelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, MRC Hlth Protect Agcy HPA Ctr Environm & Hlth, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Jaervelin, Marjo-Riitta] Natl Inst Hlth & Welf, Oulu, Finland; [Jaervelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jaervelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jaervelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu, Finland; [Ripatti, Samuli] Wellcome Trust Sanger Inst, Cambridge, England; [Ripatti, Samuli] Univ Helsinki, Hjelt Inst, Helsinki, Finland; [Mueller-Myhsok, Bertram] Munich Cluster Syst Neurol Synergy, Munich, Germany; [Mueller-Myhsok, Bertram] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England	Erasmus University Rotterdam; Erasmus MC; Max Planck Society; Icelandic Heart Association; University of Iceland; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Boston University; University of Helsinki; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baylor College of Medicine; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Framingham Heart Study; Imperial College London; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Oulu; Wellcome Trust Sanger Institute; University of Helsinki; University of Munich; University of Liverpool	van Duijn, CM (corresponding author), Erasmus MC, Dept Epidemiol, Genet Epidemiol Unit, Rotterdam, Netherlands.	c.vanduijn@erasmusmc.nl	Ballantyne, Christie/A-6599-2008; Rivadeneira, Fernando/O-5385-2015; Mirza-Schreiber, Nazanin/AAD-1563-2022; Gudnason, Vilmundur/AAE-7126-2019; Smith, Albert Vernon/K-5150-2015; Mirza-Schreiber, Nazanin/AAD-1558-2022; Ripatti, Samuli/H-9446-2014; van Leeuwen, Elisabeth/G-3382-2017; Gudnason, Vilmundur/K-6885-2015	Rivadeneira, Fernando/0000-0001-9435-9441; Mirza-Schreiber, Nazanin/0000-0003-0836-8267; Gudnason, Vilmundur/0000-0001-5696-0084; Smith, Albert Vernon/0000-0003-1942-5845; Ripatti, Samuli/0000-0002-0504-1202; Gudnason, Vilmundur/0000-0001-5696-0084; Van Duijn, Cornelia/0000-0002-2374-9204; Ballantyne, Christie/0000-0002-6432-1730; Cupples, L. Adrienne/0000-0003-0273-7965; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Karssen, Lennart C./0000-0002-1959-342X	CHANCES project [242244]; BBMRI-NL, a Research Infrastructure - Dutch government [NWO 184.021.007]; Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; Research Institute for Diseases in the Elderly [014-93-015, RIDE2]; Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) project [050-060-810]; European Commission FP6 STRP grant [018947 (LSHG-CT-2006-01947)]; European Community by the European Commission [HEALTH-F4-2007-201413, similar toQLG2-CT-2002-01254]; ENGAGE consortium; CMSB; Netherlands Organisation for Scientific Research; Russian Foundation for Basic Research [NWO-RFBR 047.017.043]; NHLBI [HHSN268201200036C, HHSN268200800007C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, HL080295, HL087652, HL105756]; National Institute of Neurological Disorders and Stroke (NINDS); National Institute on Aging (NIA) [AG023629]; National Center for Research Resources [UL1RR033176]; National Center for Advancing Translational Sciences, CTSI grant [UL1TR000124]; National Institute of Diabetes and Digestive and Kidney Disease grant [DK063491]; Southern California Diabetes Endocrinology Research Center; Academy of Finland [251217]; Finnish foundation for Cardiovascular Research; Sigrid Juselius Foundation; NIH; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055222, N01HC085080, N01HC085083, N01HC085079, N01HC085086, N01HC085082, N01HC085081] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033176] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080295, R01HL105756, U01HL080295, R01HL087652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG023629, R01AG023629] Funding Source: NIH RePORTER	CHANCES project; BBMRI-NL, a Research Infrastructure - Dutch government; Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) project(Netherlands Organization for Scientific Research (NWO)); European Commission FP6 STRP grant; European Community by the European Commission; ENGAGE consortium; CMSB; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, CTSI grant; National Institute of Diabetes and Digestive and Kidney Disease grant; Southern California Diabetes Endocrinology Research Center; Academy of Finland(Academy of Finland); Finnish foundation for Cardiovascular Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was supported by the CHANCES project funded in the FP7 framework programme of DG-RESEARCH in the European Commission (grant no. 242244) and by BBMRI-NL, a Research Infrastructure financed by the Dutch government (NWO 184.021.007). The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The generation and management of GWAS genotype data for the Rotterdam Study is supported by the Netherlands Organisation of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) project nr. 050-060-810. The ERF study as a part of EuroSPAN (European Special Populations Research Network) was supported by European Commission FP6 STRP grant number 018947 (LSHG-CT-2006-01947) and also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013)/grant agreement HEALTH-F4-2007-201413 by the European Commission under the programme "Quality of Life and Management of the Living Resources'' of 5th Framework Programme (no.similar to QLG2-CT-2002-01254). The ERF study was further supported by ENGAGE consortium and CMSB. High-throughput analysis of the ERF data was supported by a joint grant from the Netherlands Organisation for Scientific Research and the Russian Foundation for Basic Research (NWO-RFBR 047.017.043). This CHS research was supported by NHLBI contracts HHSN268201200036C, HHSN268200800007C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086; and NHLBI grants HL080295, HL087652, HL105756, with additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS). Additional support was provided through AG023629 from the National Institute on Aging (NIA). DNA handling and genotyping at Cedars-Sinai Medical Center was supported in part by the National Center for Research Resources, grant UL1RR033176, and is now at the National Center for Advancing Translational Sciences, CTSI grant UL1TR000124, in addition to the National Institute of Diabetes and Digestive and Kidney Disease grant DK063491 to the Southern California Diabetes Endocrinology Research Center. Samuli Ripatti was supported by Academy of Finland (251217), the Finnish foundation for Cardiovascular Research and the Sigrid Juselius Foundation. Christie M. Ballantyne was funded by the NIH. None of the funders had a role in study design, data analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Becker T, 2011, ANN HUM GENET, V75, P29, DOI 10.1111/j.1469-1809.2010.00610.x; Brockmann GA, 2007, MAMM GENOME, V18, P757, DOI 10.1007/s00335-007-9068-7; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Guay SP, 2013, ATHEROSCLEROSIS, V228, P413, DOI 10.1016/j.atherosclerosis.2013.03.033; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Kam-Thong T, 2012, HUM HERED, V73, P220, DOI 10.1159/000341885; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Ma L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002714; Pardo LM, 2005, ANN HUM GENET, V69, P288, DOI 10.1046/j.1529-8817.2005.00162.x; Pearce MS, 2012, INT J EPIDEMIOL, V41, P210, DOI 10.1093/ije/dys020; RANTAKALLIO P, 1969, ACTA PAEDIATR SC S, V0193; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Surakka I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002333; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Turner SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019586; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797	22	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e109290	10.1371/journal.pone.0109290	http://dx.doi.org/10.1371/journal.pone.0109290			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329471	Green Submitted, Green Published, gold			2022-12-27	WOS:000343942100019
J	Mordukhova, EA; Pan, JG				Mordukhova, Elena A.; Pan, Jae-Gu			Stabilization of Homoserine-O-Succinyltransferase (MetA) Decreases the Frequency of Persisters in Escherichia coli under Stressful Conditions	PLOS ONE			English	Article							HEAT-SHOCK; BACTERIAL PERSISTENCE; ACETIC-ACID; METHIONINE BIOSYNTHESIS; MULTIDRUG TOLERANCE; GROWTH-RATE; IN-VIVO; GENE; AGGREGATION; EXPRESSION	Bacterial persisters are a small subpopulation of cells that exhibit multi-drug tolerance without genetic changes. Generally, persistence is associated with a dormant state in which the microbial cells are metabolically inactive. The bacterial response to unfavorable environmental conditions (heat, oxidative, acidic stress) induces the accumulation of aggregated proteins and enhances formation of persister cells in Escherichia coli cultures. We have found that methionine supplementation reduced the frequency of persisters at mild (37 degrees C) and elevated (42 degrees C) temperatures, as well as in the presence of acetate. Homoserine-o-succinyltransferase (MetA), the first enzyme in the methionine biosynthetic pathway, is prone to aggregation under many stress conditions, resulting in a methionine limitation in E. coli growth. Overexpression of MetA induced the greatest number of persisters at 42 degrees C, which is correlated to an increased level of aggregated MetA. Substitution of the native metA gene on the E. coli K-12 WE chromosome by a mutant gene encoding the stabilized MetA led to reduction in persisters at the elevated temperature and in the presence of acetate, as well as lower aggregation of the mutated MetA. Decreased persister formation at 42 degrees C was confirmed also in E. coli K-12 W3110 and a fast-growing WErph+ mutant harboring the stabilized MetA. Thus, this is the first study to demonstrate manipulation of persister frequency under stressful conditions by stabilization of a single aggregation-prone protein, MetA.	[Mordukhova, Elena A.; Pan, Jae-Gu] Korea Res Inst Biosci & Biotechnol KRIBB, Superbacteria Res Ctr, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Pan, JG (corresponding author), Korea Res Inst Biosci & Biotechnol KRIBB, Superbacteria Res Ctr, Taejon, South Korea.	jgpan@kribb.re.kr			Superbacteria Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB) Innovation Grant	Superbacteria Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB) Innovation Grant	This work was financially supported by the Superbacteria Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB) Innovation Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold CN, 2001, J BACTERIOL, V183, P2178, DOI 10.1128/JB.183.7.2178-2186.2001; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Barat S, 2013, PLOS ONE, V7; Barth VC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084361; Bigger JW, 1944, LANCET, V2, P497; Biran D, 2000, MOL MICROBIOL, V37, P1436, DOI 10.1046/j.1365-2958.2000.02097.x; BIRAN D, 1995, J BACTERIOL, V177, P1374, DOI 10.1128/jb.177.5.1374-1379.1995; Cardoso K, 2010, J MED MICROBIOL, V59, P1061, DOI 10.1099/jmm.0.020339-0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377, DOI 10.1128/.61.3.377-392.1997; ENG RHK, 1991, ANTIMICROB AGENTS CH, V35, P1824, DOI 10.1128/AAC.35.9.1824; FLAVIN M, 1967, BIOCHIM BIOPHYS ACTA, V132, P400, DOI 10.1016/0005-2744(67)90158-1; Gefen O, 2009, FEMS MICROBIOL REV, V33, P704, DOI 10.1111/j.1574-6976.2008.00156.x; GILBERT P, 1990, ANTIMICROB AGENTS CH, V34, P1865, DOI 10.1128/AAC.34.10.1865; GREENE RC, 1996, ESCHERICHIA COLI SAL, P542; Gur E, 2002, MOL MICROBIOL, V46, P1391, DOI 10.1046/j.1365-2958.2002.03257.x; HAN K, 1993, BIOTECHNOL BIOENG, V41, P316, DOI 10.1002/bit.260410305; Hansen S, 2008, ANTIMICROB AGENTS CH, V52, P2718, DOI 10.1128/AAC.00144-08; Jenkins SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066177; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; KADNER RJ, 1974, J BACTERIOL, V119, P401, DOI 10.1128/JB.119.2.401-409.1974; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Laskowska E, 1996, MOL MICROBIOL, V22, P555, DOI 10.1046/j.1365-2958.1996.1231493.x; Leszczynska D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054737; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Luidalepp H, 2011, J BACTERIOL, V193, P3598, DOI 10.1128/JB.00085-11; MAGER WH, 1995, MICROBIOL REV, V59, P506, DOI 10.1128/MMBR.59.3.506-531.1995; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Merlin C, 2002, J BACTERIOL, V184, P5513, DOI 10.1128/JB.184.19.5513-5517.2002; MICHAELI S, 1984, J BACTERIOL, V160, P1158, DOI 10.1128/JB.160.3.1158-1162.1984; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Mordukhova EA, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-179; Mordukhova EA, 2008, APPL ENVIRON MICROB, V74, P7660, DOI 10.1128/AEM.00654-08; Murakami K, 2005, FEMS MICROBIOL LETT, V242, P161, DOI 10.1016/j.femsle.2004.11.005; Orman MA, 2013, ANTIMICROB AGENTS CH, V57, P3230, DOI 10.1128/AAC.00243-13; PAEK KH, 1987, J BACTERIOL, V169, P283, DOI 10.1128/jb.169.1.283-290.1987; PHILLIPS TA, 1984, J BACTERIOL, V159, P283, DOI 10.1128/JB.159.1.283-287.1984; Poole K, 2012, J ANTIMICROB CHEMOTH, V67, P2069, DOI 10.1093/jac/dks196; Price-Carter M, 2005, J BACTERIOL, V187, P3088, DOI 10.1128/JB.187.9.3088-3099.2005; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Roe AJ, 2002, MICROBIOL-SGM, V148, P2215, DOI 10.1099/00221287-148-7-2215; RON EZ, 1971, J BACTERIOL, V107, P391, DOI 10.1128/JB.107.2.391-396.1971; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; TUOMANEN E, 1986, J GEN MICROBIOL, V132, P1297; Vazquez-Laslop N, 2006, J BACTERIOL, V188, P3494, DOI 10.1128/JB.188.10.3494-3497.2006; Winkler J, 2010, EMBO J, V29, P910, DOI 10.1038/emboj.2009.412; Wood TK, 2013, APPL ENVIRON MICROB, V79, P7116, DOI 10.1128/AEM.02636-13; Zelazny AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065102	55	17	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110504	10.1371/journal.pone.0110504	http://dx.doi.org/10.1371/journal.pone.0110504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329174	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204100085
J	Castellanos-Martinez, S; Arteta, D; Catarino, S; Gestal, C				Castellanos-Martinez, Sheila; Arteta, David; Catarino, Susana; Gestal, Camino			De Novo Transcriptome Sequencing of the Octopus vulgaris Hemocytes Using Illumina RNA-Seq Technology: Response to the Infection by the Gastrointestinal Parasite Aggregate octopiana	PLOS ONE			English	Article							NF-KAPPA-B; PEPTIDOGLYCAN RECOGNITION PROTEINS; MOLECULAR CHARACTERIZATION; EXPRESSION ANALYSIS; PROTEASE INHIBITORS; EUPRYMNA-SCOLOPES; GENE-EXPRESSION; HOST HEMOCYTES; PACIFIC OYSTER; COMPLETE CDS	Background: Octopus vulgaris is a highly valuable species of great commercial interest and excellent candidate for aquaculture diversification; however, the octopus' well-being is impaired by pathogens, of which the gastrointestinal coccidian parasite Aggregata octopiana is one of the most important. The knowledge of the molecular mechanisms of the immune response in cephalopods, especially in octopus is scarce. The transcriptome of the hemocytes of O. vulgaris was de novo sequenced using the high-throughput paired-end Illumina technology to identify genes involved in immune defense and to understand the molecular basis of octopus tolerance/resistance to coccidiosis. Results: A bi-directional mRNA library was constructed from hemocytes of two groups of octopus according to the infection by A. octopiana, sick octopus, suffering coccidiosis, and healthy octopus, and reads were de novo assembled together. The differential expression of transcripts was analysed using the general assembly as a reference for mapping the reads from each condition. After sequencing, a total of 75,571,280 high quality reads were obtained from the sick octopus group and 74,731,646 from the healthy group. The general transcriptome of the O. vulgaris hemocytes was assembled in 254,506 contigs. A total of 48,225 contigs were successfully identified, and 538 transcripts exhibited differential expression between groups of infection. The general transcriptome revealed genes involved in pathways like NF-kB, TLR and Complement. Differential expression of TLR-2, PGRP, C1q and PRDX genes due to infection was validated using RT-qPCR. In sick octopuses, only TLR-2 was up-regulated in hemocytes, but all of them were up-regulated in caecum and gills. Conclusion: The transcriptome reported here de novo establishes the first molecular clues to understand how the octopus immune system works and interacts with a highly pathogenic coccidian. The data provided here will contribute to identification of biomarkers for octopus resistance against pathogens, which could improve octopus farming in the near future.	[Castellanos-Martinez, Sheila; Gestal, Camino] CSIC, Inst Invest Marinas, Dept Biotecnol & Acuicultura, Vigo, Spain; [Arteta, David; Catarino, Susana] PROGENIKA Biopharma, Derio, Bizkaia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Gestal, C (corresponding author), CSIC, Inst Invest Marinas, Dept Biotecnol & Acuicultura, Vigo, Spain.	cgestal@iim.csic.es		Gestal, Camino/0000-0003-1931-9567	Xunta de Galicia [10PXIB402116PR]; CONACyT (Mexico)	Xunta de Galicia(Xunta de GaliciaEuropean Commission); CONACyT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work has been funded by Xunta de Galicia (10PXIB402116PR). SCM wishes to acknowledge additional funding from CONACyT (Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 2004, COMP BIOCHEM PHYS A, V138, P405, DOI 10.1016/j.cbpb.2004.05.013; Al-Sharif WZ, 1998, J IMMUNOL, V160, P2983; Albertin CB, 2012, STAND GENOMIC SCI, V7, P175, DOI 10.4056/sigs.3136559; Alpuche J, 2010, COMP BIOCHEM PHYS B, V156, P1, DOI 10.1016/j.cbpb.2010.01.006; Altura MA, 2011, CELL MICROBIOL, V13, P527, DOI 10.1111/j.1462-5822.2010.01552.x; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anthony BJ, 2012, PPAR RES, V2012, DOI 10.1155/2012/128068; Armstrong PB, 2006, IMMUNOBIOLOGY, V211, P263, DOI 10.1016/j.imbio.2006.01.002; Bandyopadhyay U, 1999, CURR SCI INDIA, V77, P658; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boyle P, 2005, CEPHALOPODS: ECOLOGY AND FISHERIES, P1, DOI 10.1002/9780470995310; Candia E, 2012, IMMUNOBIOLOGY, V217, P634, DOI 10.1016/j.imbio.2011.10.023; Canesi L, 2002, MICROSC RES TECHNIQ, V57, P469, DOI 10.1002/jemt.10100; Canny G, 2008, TRENDS IMMUNOL, V29, P541, DOI 10.1016/j.it.2008.07.012; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Castellanos-Martinez S, 2014, DEV COMP IMMUNOL, V44, P50, DOI 10.1016/j.dci.2013.11.013; Castellanos-Martinez S, J EXP MAR BIOL ECOL, V447, P14; Castellanos-Martinez S, 2014, J PROTEOMICS, V105, P151, DOI 10.1016/j.jprot.2013.12.008; Castillo MG, 2009, DEV COMP IMMUNOL, V33, P69, DOI 10.1016/j.dci.2008.07.013; Chapela A, 2006, SCI MAR, V70, P121, DOI 10.3989/scimar.2006.70n1121; CHENG TC, 1975, ANN NY ACAD SCI, V266, P343, DOI 10.1111/j.1749-6632.1975.tb35116.x; Chu FLE, 2000, RE ADV MAR BIOTECHNO, V5, P1; Chun CK, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-154; Collins AJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00091; Comesana P, 2012, J INVERTEBR PATHOL, V109, P274, DOI 10.1016/j.jip.2011.12.007; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Davidson SK, 2004, CELL MICROBIOL, V6, P1139, DOI 10.1111/j.1462-5822.2004.00429.x; De Zoysa M, 2009, FISH SHELLFISH IMMUN, V26, P625, DOI 10.1016/j.fsi.2008.10.004; Dodd RB, 2001, GLYCOBIOLOGY, V11, p71R, DOI 10.1093/glycob/11.5.71R; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Engelmann P, 2005, MOL IMMUNOL, V42, P931, DOI 10.1016/j.molimm.2004.09.038; Engelmann P, 2002, ZOOLOGY, V105, P257, DOI 10.1078/0944-2006-00068; Engelmann P, 2011, SOIL BIOL, V24, P229, DOI 10.1007/978-3-642-14636-7_14; Estefanell J, 2011, AQUACULTURE, V322, P91, DOI 10.1016/j.aquaculture.2011.09.027; Estevez-Calvar N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061502; Faisal M, 1998, COMP BIOCHEM PHYS B, V121, P161, DOI 10.1016/S0305-0491(98)10084-6; Feldmeyer B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-317; FISHER WS, 1991, J INVERTEBR PATHOL, V57, P380, DOI 10.1016/0022-2011(91)90142-D; Ford Larisa A., 1992, Annual Review of Fish Diseases, V2, P25, DOI 10.1016/0959-8030(92)90054-2; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Garcia-Garcia B, 2006, AQUACULTURE, V211, P171; Gestal C, 2002, DIS AQUAT ORGAN, V50, P45, DOI 10.3354/dao050045; Gestal C, 2002, DIS AQUAT ORGAN, V51, P61, DOI 10.3354/dao051061; Gestal C, 2000, THESIS U VIGO; Gestal C, 2007, ICES J MAR SCI, V64, P1743, DOI 10.1093/icesjms/fsm154; Goodson MS, 2005, APPL ENVIRON MICROB, V71, P6934, DOI 10.1128/AEM.71.11.6934-6946.2005; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grant P, 2006, BIOL BULL-US, V210, P318, DOI 10.2307/4134568; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; Hatada EN, 2000, CURR OPIN IMMUNOL, V12, P52, DOI 10.1016/S0952-7915(99)00050-3; Hochberg F.G., 1990, P47; Huang WB, 2010, FISH SHELLFISH IMMUN, V28, P587, DOI 10.1016/j.fsi.2009.12.016; Humason L. G., 1979, ANIMAL TISSUE TECHNI; ICES, 2012, REP WORK GROUP CEPH; Iglesias J, 2007, AQUACULTURE, V266, P1, DOI 10.1016/j.aquaculture.2007.02.019; Jiang YS, 2007, DEV COMP IMMUNOL, V31, P121, DOI 10.1016/j.dci.2006.05.014; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Koropatnick TA, 2007, BIOL BULL-US, V212, P29, DOI 10.2307/25066578; Krasity BC, 2011, BIOL BULL, V212, P29; Lacy P, 2011, BLOOD, V118, P9, DOI 10.1182/blood-2010-08-265892; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Li J, 2013, FISH SHELLFISH IMMUN, V34, P365, DOI 10.1016/j.fsi.2012.11.012; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li WY, 2001, J EXP ZOOL, V290, P741, DOI 10.1002/jez.1124; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Macagno ER, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-407; Malagoli D, 2010, ISJ-INVERT SURVIV J, V7, P1; Malham Shelagh K., 1997, Iberus, V15, P1; Malham SK, 2002, AQUAT LIVING RESOUR, V15, P187, DOI 10.1016/S0990-7440(02)01173-7; Malham SK, 1998, DEV COMP IMMUNOL, V22, P27, DOI 10.1016/S0145-305X(97)00045-1; McDaniel DO, 2012, J CLIN EXP CARDIOL S, V11; MESSENGER JB, 1985, COMP BIOCHEM PHYS C, V82, P203, DOI 10.1016/0742-8413(85)90230-0; MIYAJIMA A, 1992, TRENDS BIOCHEM SCI, V17, P378, DOI 10.1016/0968-0004(92)90004-S; Mladineo I, 2007, J INVERTEBR PATHOL, V96, P261, DOI 10.1016/j.jip.2007.05.010; Moltschaniwskyj NA, 2007, REV FISH BIOL FISHER, V17, P455, DOI 10.1007/s11160-007-9056-8; Montagnani C, 2004, FEBS LETT, V561, P75, DOI 10.1016/S0014-5793(04)00124-3; Moreira R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035009; Munoz-Chapuli R, 2011, INT J DEV BIOL, V55, P345, DOI 10.1387/ijdb.103212rm; Novoa B, 2002, J SHELLFISH RES, V21, P243; Nyholm SV, 2009, J BACTERIOL, V191, P1997, DOI 10.1128/JB.01801-08; Ogura A, 2004, GENOME RES, V14, P1555, DOI 10.1101/gr.2268104; Ospelt C, 2010, INT J BIOCHEM CELL B, V42, P495, DOI 10.1016/j.biocel.2009.10.010; Otero J, 2005, SCI MAR, V69, P577, DOI 10.3989/scimar.2005.69n4577; Ovando F, 2012, J SHELLFISH RES, V31, P875, DOI 10.2983/035.031.0336; Parcellier A, 2003, MOL CELL BIOL, V23, P5790, DOI 10.1128/MCB.23.16.5790-5802.2003; Park EM, 2008, FISH SHELLFISH IMMUN, V24, P11, DOI 10.1016/j.fsi.2007.07.003; Pascual S, 2006, AQUACULTURE, V254, P21, DOI 10.1016/j.aquaculture.2005.10.014; Pascual S, 1996, AQUACULTURE, V142, P1, DOI 10.1016/0044-8486(96)01254-9; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philipp EER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033091; PIPE RK, 1992, DEV COMP IMMUNOL, V16, P111, DOI 10.1016/0145-305X(92)90012-2; Prado-Alvarez M, 2009, FISH SHELLFISH IMMUN, V26, P305, DOI 10.1016/j.fsi.2008.11.015; Prato E, 2010, AQUACULTURE, V309, P203, DOI 10.1016/j.aquaculture.2010.09.036; Riesgo A, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-33; Roberts S, 2008, DEV COMP IMMUNOL, V32, P1099, DOI 10.1016/j.dci.2008.02.006; Robertson DJ, 2006, P ROY SOC LOND B BIO, V263, P1739, DOI DOI 10.1098/RSPB.1996.0254; ROBERTSON JD, 1994, P ROY SOC B-BIOL SCI, V256, P269, DOI 10.1098/rspb.1994.0080; Rodriguez-Dominguez H, 2006, AQUACULTURE, V254, P563, DOI 10.1016/j.aquaculture.2005.10.005; ROGENER W, 1985, DEV COMP IMMUNOL, V9, P605, DOI 10.1016/0145-305X(85)90026-6; Romero A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017003; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; Sahtout AH, 2001, DIS AQUAT ORGAN, V44, P155, DOI 10.3354/dao044155; Schleicher TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025649; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; SENDAO JC, 1998, 6 C NAC AQ VIAN CAST; Smeds L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026314; Sokolova IM, 2009, ISJ-INVERT SURVIV J, V6, P49; Steiner H, 2004, IMMUNOL REV, V198, P83, DOI 10.1111/j.0105-2896.2004.0120.x; TOMAREV SI, 1993, GENE, V132, P219, DOI 10.1016/0378-1119(93)90199-D; Toubiana M, 2014, DEV COMP IMMUNOL, V45, P300, DOI 10.1016/j.dci.2014.03.021; Toubiana M, 2013, DEV COMP IMMUNOL, V40, P158, DOI 10.1016/j.dci.2013.02.006; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vasselon T, 2002, INFECT IMMUN, V70, P1033, DOI 10.1128/IAI.70.3.1033-1041.2002; Vasta GR, 1999, DEV COMP IMMUNOL, V23, P401, DOI 10.1016/S0145-305X(99)00020-8; Wang LL, 2009, FISH SHELLFISH IMMUN, V26, P744, DOI 10.1016/j.fsi.2009.03.002; WELLS MJ, 1987, EXPERIENTIA, V43, P487, DOI 10.1007/BF02143577; Witowski J, 2004, CELL MOL LIFE SCI, V61, P567, DOI 10.1007/s00018-003-3228-z; Xian JA, 2013, COMP BIOCHEM PHYS A, V164, P301, DOI 10.1016/j.cbpa.2012.10.008; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang DC, 2009, FISH SHELLFISH IMMUN, V26, P84, DOI 10.1016/j.fsi.2008.10.009; Zhang X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040320, 10.1371/journal.pone.0042529]; Zhou ZC, 2011, FISH SHELLFISH IMMUN, V31, P540, DOI 10.1016/j.fsi.2011.06.023; Zhu BJ, 2012, AFR J MICROBIOL RES, V6, P4169, DOI 10.5897/AJMR12.010; Zhu Y, 2005, EMBO J, V24, P382, DOI 10.1038/sj.emboj.7600533	132	43	43	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e107873	10.1371/journal.pone.0107873	http://dx.doi.org/10.1371/journal.pone.0107873			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329466	gold, Green Published, Green Submitted			2022-12-27	WOS:000343210800007
J	Li, HWR; Lee, VCY; Lau, EYL; Yeung, WSB; Ho, PC; Ng, EHY				Li, Hang Wun Raymond; Lee, Vivian Chi Yan; Lau, Estella Yee Lan; Yeung, William Shu Biu; Ho, Pak Chung; Ng, Ernest Hung Yu			Ovarian Response and Cumulative Live Birth Rate of Women Undergoing In-Vitro Fertilisation Who Had Discordant Anti-Mullerian Hormone and Antral Follicle Count Measurements: A Retrospective Study	PLOS ONE			English	Article							ANTIMULLERIAN HORMONE; MLLERIAN HORMONE; AMH; STIMULATION; PREDICTION; SERUM; FSH	Objective: To evaluate ovarian response and cumulative live birth rate of women undergoing in-vitro fertilization (IVF) treatment who had discordant baseline serum anti-Mullerian hormone (AMH) level and antral follicle count (AFC). Methods: This is a retrospective cohort study on 1,046 women undergoing the first IVF cycle in Queen Mary Hospital, Hong Kong. Subjects receiving standard IVF treatment with the GnRH agonist long protocol were classified according to their quartiles of baseline AMH and AFC measurements after GnRH agonist down-regulation and before commencing ovarian stimulation. The number of retrieved oocytes, ovarian sensitivity index (OSI) and cumulative live-birth rate for each classification category were compared. Results: Among our studied subjects, 32.2% were discordant in their AMH and AFC quartiles. Among them, those having higher AMH within the same AFC quartile had higher number of retrieved oocytes and cumulative live-birth rate. Subjects discordant in AMH and AFC had intermediate OSI which differed significantly compared to those concordant in AMH and AFC on either end. OSI of those discordant in AMH and AFC did not differ significantly whether either AMH or AFC quartile was higher than the other. Conclusions: When AMH and AFC are discordant, the ovarian responsiveness is intermediate between that when both are concordant on either end. Women having higher AMH within the same AFC quartile had higher number of retrieved oocytes and cumulative live-birth rate.	[Li, Hang Wun Raymond; Lee, Vivian Chi Yan; Lau, Estella Yee Lan; Yeung, William Shu Biu; Ho, Pak Chung; Ng, Ernest Hung Yu] Univ Hong Kong, Queen Mary Hosp, Ctr Assisted Reprod & Embryol, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Li, HWR (corresponding author), Univ Hong Kong, Queen Mary Hosp, Ctr Assisted Reprod & Embryol, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China.	raymondli@hku.hk	Li, H.W. Raymond/H-4442-2012	Li, H.W. Raymond/0000-0002-7957-7798; Ng, Ernest/0000-0002-7688-4557; Yeung, Shu Biu William/0000-0003-0670-0879	The University of Hong Kong [200607176062]	The University of Hong Kong(University of Hong Kong)	The study was supported by small project funding (200607176062), The University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anckaert E, 2012, HUM REPROD, V27, P1829, DOI 10.1093/humrep/des101; Andersen CY, 2010, HUM REPROD, V25, P1282, DOI 10.1093/humrep/deq019; Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034; Broer SL, 2011, HUM REPROD UPDATE, V17, P46, DOI 10.1093/humupd/dmq034; Broer SL, 2010, CURR OPIN OBSTET GYN, V22, P193, DOI 10.1097/GCO.0b013e3283384911; Broer SL, 2009, FERTIL STERIL, V91, P705, DOI 10.1016/j.fertnstert.2007.12.013; Ferraretti AP, 2011, HUM REPROD, V26, P1616, DOI 10.1093/humrep/der092; Gleicher N, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-64; Hansen KR, 2011, FERTIL STERIL, V95, P170, DOI 10.1016/j.fertnstert.2010.04.006; Jeppesen JV, 2013, MOL HUM REPROD, V19, P519, DOI 10.1093/molehr/gat024; Leader B, 2012, FERTIL STERIL, V98, P1037, DOI 10.1016/j.fertnstert.2012.06.006; Li HWR, 2014, J ASSIST REPROD GEN, V31, P199, DOI 10.1007/s10815-013-0144-5; Li HWR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061095; Nelson SM, 2007, HUM REPROD, V22, P2414, DOI 10.1093/humrep/dem204; Nelson SM, 2012, HUM REPROD, V27, P631, DOI 10.1093/humrep/der446; Ng EHY, 2004, HUM REPROD, V19, P2811, DOI 10.1093/humrep/deh500; Veeck LL., 1999, ATLAS HUMAN GAMETES; Yeung William S. B., 2009, Hong Kong Medical Journal, V15, P420	18	20	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e108493	10.1371/journal.pone.0108493	http://dx.doi.org/10.1371/journal.pone.0108493			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313856	Green Published, gold			2022-12-27	WOS:000343662500014
J	Zhao, WJ; Wei, LR; Tan, DM; Su, GS; Zheng, YW; He, C; Mao, ZWJ; Singleton, TP; Yin, B				Zhao, Wenjun; Wei, Lirong; Tan, Dongming; Su, Guangsong; Zheng, Yanwen; He, Chao; Mao, Zhengwei J.; Singleton, Timothy P.; Yin, Bin			Cellular Intrinsic Mechanism Affecting the Outcome of AML Treated with Ara-C in a Syngeneic Mouse Model	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; IN-VITRO; BCL-2 INHIBITION; NPM1 MUTATION; RESISTANCE; ABT-737; CANCER; CELLS; CHEMOTHERAPY	The mechanisms underlying acute myeloid leukemia (AML) treatment failure are not clear. Here, we established a mouse model of AML by syngeneic transplantation of BXH-2 derived myeloid leukemic cells and developed an efficacious Ara-C-based regimen for treatment of these mice. We proved that leukemic cell load was correlated with survival. We also demonstrated that the susceptibility of leukemia cells to Ara-C could significantly affect the survival. To examine the molecular alterations in cells with different sensitivity, genome-wide expression of the leukemic cells was profiled, revealing that overall 366 and 212 genes became upregulated or downregulated, respectively, in the resistant cells. Many of these genes are involved in the regulation of cell cycle, cellular proliferation, and apoptosis. Some of them were further validated by quantitative PCR. Interestingly, the Ara-C resistant cells retained the sensitivity to ABT-737, an inhibitor of anti-apoptosis proteins, and treatment with ABT-737 prolonged the life span of mice engrafted with resistant cells. These results suggest that leukemic load and intrinsic cellular resistance can affect the outcome of AML treated with Ara-C. Incorporation of apoptosis inhibitors, such as ABT-737, into traditional cytotoxic regimens merits consideration for the treatment of AML in a subset of patients with resistance to Ara-C. This work provided direct in vivo evidence that leukemic load and intrinsic cellular resistance can affect the outcome of AML treated with Ara-C, suggesting that incorporation of apoptosis inhibitors into traditional cytotoxic regimens merits consideration for the treatment of AML in a subset of patients with resistance to Ara-C.	[Zhao, Wenjun; Wei, Lirong; Tan, Dongming; Su, Guangsong; Zheng, Yanwen; He, Chao; Yin, Bin] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Cyrus Tang Hematol Ctr, Suzhou, Jiangsu, Peoples R China; [Mao, Zhengwei J.] Univ Minnesota, Dept Lab Med & Pathol, Med Ctr Fairview, Div Hematopathol, Minneapolis, MN 55455 USA; [Singleton, Timothy P.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Yin, Bin] Soochow Univ, Minist Hlth, Thrombosis & Hemostasis Key Lab, Suzhou, Jiangsu, Peoples R China; [Yin, Bin] Soochow Univ, Collaborat Innovat Ctr Hematol, Suzhou, Jiangsu, Peoples R China	Soochow University - China; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Soochow University - China; Soochow University - China	Yin, B (corresponding author), Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Cyrus Tang Hematol Ctr, Suzhou, Jiangsu, Peoples R China.	yinbin@hotmail.com			National Key Scientific Project of China ("973 Program") [2011CB933501]; NSFC Project [81070417]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD program)	National Key Scientific Project of China ("973 Program"); NSFC Project(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD program)	This study is supported by the National Key Scientific Project of China ("973 Program", No. 2011CB933501), the NSFC Project (No. 81070417), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; Beran M, 2000, INT J HEMATOL, V72, P139; Beurlet S, 2013, BLOOD, V122, P2864, DOI 10.1182/blood-2012-07-445635; Coenen EA, 2011, BLOOD, V117, P7102, DOI 10.1182/blood-2010-12-328302; Connelly P, 2011, SCIENCE, V333, P156, DOI 10.1126/science.333.6039.156-b; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Gillies RJ, 2012, NAT REV CANCER, V12, P487, DOI 10.1038/nrc3298; High LM, 2010, MOL PHARMACOL, V77, P483, DOI 10.1124/mol.109.060780; Ipek Y, 2012, CASE REP MED, V2012, DOI 10.1155/2012/236174; JENKINS NA, 1982, J VIROL, V42, P379, DOI 10.1128/JVI.42.2.379-388.1982; Kaiser J, 2011, SCIENCE, V332, P523, DOI 10.1126/science.332.6029.523; Kang MH, 2007, BLOOD, V110, P2057, DOI 10.1182/blood-2007-03-080325; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Konoplev S, 2009, CANCER-AM CANCER SOC, V115, P4737, DOI 10.1002/cncr.24543; Kumar AR, 2010, BLOOD, V115, P3642, DOI 10.1182/blood-2010-01-264564; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; LARGAESPADA DA, 1995, J VIROL, V69, P5095, DOI 10.1128/JVI.69.8.5095-5102.1995; Liu P, 2003, INT J HEMATOL, V78, P32, DOI 10.1007/BF02983237; Malaise M, 2011, LEUKEMIA, V25, P1635, DOI 10.1038/leu.2011.121; Marcucci G, 2005, J CLIN ONCOL, V23, P5705, DOI 10.1200/JCO.2005.15.610; Moore VD, 2008, BLOOD, V111, P2300, DOI 10.1182/blood-2007-06-098012; Nardi V, 2009, BLOOD, V113, P3813, DOI 10.1182/blood-2008-07-167189; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Omidvar N, 2013, HAEMATOLOGICA, V98, P424, DOI 10.3324/haematol.2011.057067; Perez-Simon JA, 2002, LEUKEMIA, V16, P1423, DOI 10.1038/sj.leu.2402550; Pratcorona M, 2013, BLOOD, V121, P2734, DOI 10.1182/blood-2012-06-431122; Pulte D, 2010, ANN ONCOL, V21, P335, DOI 10.1093/annonc/mdp309; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Szymanska B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033894; Uy GL, 2012, BLOOD, V119, P3917, DOI 10.1182/blood-2011-10-383406; Vandenberg CJ, 2013, BLOOD, V121, P2285, DOI 10.1182/blood-2013-01-475855; Wunderlich M, 2013, BLOOD, V121, pE90, DOI 10.1182/blood-2012-10-464677; Xu ZJ, 2013, BIOLOGIA, V68, P766, DOI 10.2478/s11756-013-0214-2; Yin B, 2006, LEUKEMIA, V20, P151, DOI 10.1038/sj.leu.2404033; YIN B, 2006, DRUG DISCOV TODAY, V3, P137; Yin B, 2006, EXP HEMATOL, V34, P631, DOI 10.1016/j.exphem.2006.01.015; Yu JL, 2002, SCIENCE, V295, P1526, DOI 10.1126/science.1068327; Zhang B, 2013, BLOOD, V121, P1824, DOI 10.1182/blood-2012-02-412890; Zhu HH, 2013, BLOOD, V121, P4056, DOI 10.1182/blood-2012-11-468348	41	1	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109198	10.1371/journal.pone.0109198	http://dx.doi.org/10.1371/journal.pone.0109198			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314317	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500027
J	Heaslip, AT; Nelson, SR; Lombardo, AT; Previs, SB; Armstrong, J; Warshaw, DM				Heaslip, Aoife T.; Nelson, Shane R.; Lombardo, Andrew T.; Previs, Samantha Beck; Armstrong, Jessica; Warshaw, David M.			Cytoskeletal Dependence of Insulin Granule Movement Dynamics in INS-1 Beta-Cells in Response to Glucose	PLOS ONE			English	Article							SINGLE KINESIN MOLECULES; SECRETORY GRANULES; PLASMA-MEMBRANE; ACTIN MICROFILAMENTS; BINDING PROTEIN; HEAVY-CHAIN; RANDOM-WALK; EXOCYTOSIS; TRACKING; VESICLE	For pancreatic beta-cells to secrete insulin in response to elevated blood glucose, insulin granules retained within the subplasmalemmal space must be transported to sites of secretion on the plasma membrane. Using a combination of super-resolution STORM imaging and live cell TIRF microscopy we investigate how the organization and dynamics of the actin and microtubule cytoskeletons in INS-1 beta-cells contribute to this process. GFP-labeled insulin granules display 3 different modes of motion (stationary, diffusive-like, and directed). Diffusive-like motion dominates in basal, low glucose conditions. Upon glucose stimulation no gross rearrangement of the actin cytoskeleton is observed but there are increases in the 1) rate of microtubule polymerization; 2) rate of diffusive-like motion; and 3) proportion of granules undergoing microtubule-based directed motion. By pharmacologically perturbing the actin and microtubule cytoskeletons, we determine that microtubule-dependent granule transport occurs within the subplasmalemmal space and that the actin cytoskeleton limits this transport in basal conditions, when insulin secretion needs to be inhibited.	[Heaslip, Aoife T.; Nelson, Shane R.; Lombardo, Andrew T.; Previs, Samantha Beck; Armstrong, Jessica; Warshaw, David M.] Univ Vermont, Dept Mol Physiol & Biophys, Hlth Sci Res Facil, Burlington, VT 05405 USA	University of Vermont	Warshaw, DM (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, Hlth Sci Res Facil, Burlington, VT 05405 USA.	david.warshaw@uvm.edu		Lombardo, Andrew/0000-0002-1814-5748; Heaslip, Aoife/0000-0002-7838-3617	National Institutes of Health [GM094229]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094229] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institutes of Health (GM094229 to D.M.W.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Balamatsias D, 2011, J BIOL CHEM, V286, P43229, DOI 10.1074/jbc.M111.306621; Brozzi F, 2012, TRAFFIC, V13, P54, DOI 10.1111/j.1600-0854.2011.01301.x; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Burke NV, 1997, NEURON, V19, P1095, DOI 10.1016/S0896-6273(00)80400-6; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Cai DW, 2007, BIOPHYS J, V92, P4137, DOI 10.1529/biophysj.106.100206; Dawicki-McKenna JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043662; Del Prato S, 2002, DIABETES, V51, pS109, DOI 10.2337/diabetes.51.2007.S109; Del Prato S, 2001, DIABETES-METAB RES, V17, P164, DOI 10.1002/dmrr.198; Desnos C, 2007, J NEUROSCI, V27, P10636, DOI 10.1523/JNEUROSCI.1228-07.2007; Donelan MJ, 2002, J BIOL CHEM, V277, P24232, DOI 10.1074/jbc.M203345200; FARSHORI PQ, 1994, J SUBMICR CYTOL PATH, V26, P137; Grigoriev I, 2011, CURR BIOL, V21, P967, DOI 10.1016/j.cub.2011.04.030; Gupta D, 2012, CURR DIABETES REV, V8, P76, DOI 10.2174/157339912799424564; HAMILTON JD, 1989, ECONOMETRICA, V57, P357, DOI 10.2307/1912559; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; Hao MM, 2005, J CELL SCI, V118, P5873, DOI 10.1242/jcs.02684; Heaslip AT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007406; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Henquin JC, 2012, FEBS LETT, V586, P89, DOI 10.1016/j.febslet.2011.11.030; HOWELL SL, 1982, BIOSCIENCE REP, V2, P795, DOI 10.1007/BF01114939; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Ivarsson R, 2004, TRAFFIC, V5, P750, DOI 10.1111/j.1600-0854.2004.00216.x; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; KANAZAWA Y, 1980, DIABETES, V29, P953, DOI 10.2337/diabetes.29.12.953; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; LACY PE, 1975, LAB INVEST, V33, P570; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Lawrence JTR, 2003, P NATL ACAD SCI USA, V100, P13320, DOI 10.1073/pnas.2232129100; Li CH, 2004, CELL RES, V14, P480, DOI 10.1038/sj.cr.7290251; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Meng YX, 1997, ENDOCRINOLOGY, V138, P1979, DOI 10.1210/en.138.5.1979; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Mizuno K, 2011, MOL BIOL CELL, V22, P1716, DOI 10.1091/mbc.E10-05-0404; Mourad NI, 2011, AM J PHYSIOL-CELL PH, V300, pC697, DOI 10.1152/ajpcell.00329.2010; Mourad NI, 2010, AM J PHYSIOL-CELL PH, V299, pC389, DOI 10.1152/ajpcell.00138.2010; Nelson SR, 2009, BIOPHYS J, V97, P509, DOI 10.1016/j.bpj.2009.04.052; Nevins AK, 2003, AM J PHYSIOL-CELL PH, V285, pC698, DOI 10.1152/ajpcell.00093.2003; Oheim M, 2000, EUR BIOPHYS J BIOPHY, V29, P67, DOI 10.1007/s002490050253; Park JJ, 2008, MOL ENDOCRINOL, V22, P2583, DOI 10.1210/me.2008-0209; Porat-Shliom N., 2012, CELL MOL LIFE SCI; Rausand M, 2003, SYSTEM RELIABILITY T, V2nd, DOI DOI 10.1002/9780470316900; Rizzo MA, 2002, J BIOL CHEM, V277, P34168, DOI 10.1074/jbc.M112478200; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Tabei SMA, 2013, P NATL ACAD SCI USA, V110, P4911, DOI 10.1073/pnas.1221962110; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Tsuboi T, 2003, J BIOL CHEM, V278, P52042, DOI 10.1074/jbc.M307800200; Uenishi E, 2013, J BIOL CHEM, V288, P25851, DOI 10.1074/jbc.M113.464420; Varadi A, 2003, BIOCHEM BIOPH RES CO, V311, P272, DOI 10.1016/j.bbrc.2003.09.208; Varadi A, 2005, MOL BIOL CELL, V16, P2670, DOI 10.1091/mbc.e04-11-1001; Varadi A, 2002, J CELL SCI, V115, P4177, DOI 10.1242/jcs.00083; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Wilson JR, 2001, FEBS LETT, V492, P101, DOI 10.1016/S0014-5793(01)02241-4; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/NMETH.1841, 10.1038/nmeth.1841]; Ybo J, 2008, EXP CELL RES, V314, P3563, DOI 10.1016/j.yexcr.2008.09.014; Zajac AL, 2013, CURR BIOL, V23, P1173, DOI 10.1016/j.cub.2013.05.015	62	40	41	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109082	10.1371/journal.pone.0109082	http://dx.doi.org/10.1371/journal.pone.0109082			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310693	Green Submitted, gold, Green Published			2022-12-27	WOS:000343210300031
J	He, LJ; Lou, WJ; Ji, LH; Liang, W; Zhou, ML; Xu, GS; Zhao, LJ; Huang, C; Li, R; Wang, HM; Chen, XM; Sun, SR				He, Lijie; Lou, Weijuan; Ji, Lihua; Liang, Wei; Zhou, Meilan; Xu, Guoshang; Zhao, Lijuan; Huang, Chen; Li, Rong; Wang, Hanmin; Chen, Xiangmei; Sun, Shiren			Serum Response Factor Accelerates the High Glucose-Induced Epithelial-to-Mesenchymal Transition (EMT) via Snail Signaling in Human Peritoneal Mesothelial Cells	PLOS ONE			English	Article							MYOFIBROBLAST DIFFERENTIATION; DIALYSIS; EXPRESSION; MECHANISM; CARCINOMA; MEMBRANE; OVEREXPRESSION; RESISTANCE	Background: Epithelial-to-Mesenchymal Transition (EMT) induced by glucose in human peritoneal mesothelial cells (HPMCs) is a major cause of peritoneal membrane (PM) fibrosis and dysfunction. Methods: To investigate serum response factor (SRF) impacts on EMT-derived fibrosis in PM, we isolated HPMCs from the effluents of patients with end-stage renal disease (ESRD) to analyze alterations during peritoneal dialysis (PD) and observe the response of PM to SRF in a rat model. Results: Our results demonstrated the activation and translocation of SRF into the nuclei of HPMCs under extensive periods of PD. Accordingly, HPMCs lost their epithelial morphology with a decrease in E-cadherin expression and an increase in alpha-smooth muscle actin (alpha-SMA) expression, implying a transition in phenotype. PD with 4.25% glucose solution significantly induced SRF up-regulation and increased peritoneal thickness. In immortal HPMCs, high glucose (HG, 60 mmol/L) stimulated SRF overexpression in transformed fibroblastic HPMCs. SRF-siRNA preserved HPMC morphology, while transfection of SRF plasmid into HPMCs caused the opposite effects. Evidence from electrophoretic mobility shift, chromatin immunoprecipitation and reporter assays further supported that SRF transcriptionally regulated Snail, a potent inducer of EMT, by directly binding to its promoter. Conclusions: Our data suggested that activation of SRF/Snail pathway might contribute to the progressive PM fibrosis during PD.	[He, Lijie; Lou, Weijuan; Ji, Lihua; Liang, Wei; Zhou, Meilan; Xu, Guoshang; Zhao, Lijuan; Huang, Chen; Li, Rong; Wang, Hanmin; Chen, Xiangmei; Sun, Shiren] Fourth Mil Med Univ, Xijing Hosp, Dept Nephrol, Xian 710032, Shaan Xi, Peoples R China; [He, Lijie; Lou, Weijuan; Ji, Lihua; Liang, Wei; Wang, Hanmin; Sun, Shiren] Fourth Mil Med Univ, Xijing Hosp, State Key Lab Canc Biol, Xian 710032, Shaan Xi, Peoples R China; [Ji, Lihua] Fourth Hosp Yulin, Xingyuan Hosp, Dept Nephrol, Yulin, Shaan Xi, Peoples R China; [Liang, Wei] Ninth Hosp Xian, Dept Nephrol, Xian, Shaan Xi, Peoples R China; [Chen, Xiangmei] Chinese PLA Gen Hosp & Med Coll, Dept Nephrol, State Key Lab Kidney Dis, Beijing, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Chen, XM (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Nephrol, Xian 710032, Shaan Xi, Peoples R China.	xmchen301@126.com; sunshiren@gmail.com	Xu, Guoshuang/GQH-0472-2022		National Scientific Foundation of China [81270849, 81270768, 2012K16-08-05, 81170670, 2011BAI10B08]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Scientific Foundation of China (81270849, 81270768, 2012K16-08-05, 81170670, 2011BAI10B08). All of the funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroeira LS, 2005, AM J KIDNEY DIS, V46, P938, DOI 10.1053/j.ajkd.2005.08.011; Aroeira LS, 2007, J AM SOC NEPHROL, V18, P2004, DOI 10.1681/ASN.2006111292; Arva NC, 2005, J BIOL CHEM, V280, P26776, DOI 10.1074/jbc.M505203200; Bezdekova M, 2012, INT J MOL SCI, V13, P1632, DOI 10.3390/ijms13021632; Bidmon B, 2004, KIDNEY INT, V66, P2300, DOI 10.1111/j.1523-1755.2004.66040.x; Choi HN, 2009, ONCOL REP, V21, P57, DOI 10.3892/or_00000189; del Peso G, 2008, KIDNEY INT, V73, pS26, DOI 10.1038/sj.ki.5002598; Dennis M, 2012, OTOLARYNG HEAD NECK, V147, P726, DOI 10.1177/0194599812446407; Dong C, 2012, ONCOGENE; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Foubert E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2585; Harney AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032318; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jain AK, 2012, J AM SOC NEPHROL, V23, P533, DOI 10.1681/ASN.2011060607; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kuwahara K, 2005, MOL CELL BIOL, V25, P3173, DOI 10.1128/MCB.25.8.3173-3181.2005; Li CX, 2012, NEPHROL DIAL TRANSPL, V27, P4119, DOI 10.1093/ndt/gfs049; Lopez-Cabrera M, 2006, PERITON DIALYSIS INT, V26, P26; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Niu Z, 2008, P NATL ACAD SCI USA, V105, P17824, DOI 10.1073/pnas.0805491105; Park MY, 2007, INT J ONCOL, V31, P1309; Peinado H, NAT REV CANC, V7, P415; Saka M, 2006, CLIN EXP PHARMACOL P, V33, P1164, DOI 10.1111/j.1440-1681.2006.04508.x; Sandbo N, 2009, AM J RESP CELL MOL, V41, P332, DOI 10.1165/rcmb.2008-0288OC; STYLIANOU E, 1990, KIDNEY INT, V37, P1563, DOI 10.1038/ki.1990.150; Sun SR, 2009, KIDNEY INT, V75, P1278, DOI 10.1038/ki.2009.62; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Weber CE, 2012, J BURN CARE RES, V33, P311, DOI 10.1097/BCR.0b013e318240541e; Williams JD, 2002, J AM SOC NEPHROL, V13, P470, DOI 10.1681/ASN.V132470; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Yang Y, 2003, AM J RESP CELL MOL, V29, P583, DOI 10.1165/rcmb.2002-0315OC; Yu MA, 2009, J AM SOC NEPHROL, V20, P567, DOI 10.1681/ASN.2008040424; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang SX, 2005, J BIOL CHEM, V280, P19115, DOI 10.1074/jbc.M413793200	35	22	30	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108593	10.1371/journal.pone.0108593	http://dx.doi.org/10.1371/journal.pone.0108593			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303231	Green Submitted, Green Published, gold			2022-12-27	WOS:000343730400018
J	Rottinghaus, EK; Beard, RS; Bile, E; Modukanele, M; Maruping, M; Mine, M; Nkengasong, J; Yang, CF				Rottinghaus, Erin K.; Beard, R. Suzanne; Bile, Ebi; Modukanele, Mosetsanagape; Maruping, Maruping; Mine, Madisa; Nkengasong, John; Yang, Chunfu			Evaluation of Dried Blood Spots Collected on Filter Papers from Three Manufacturers Stored at Ambient Temperature for Application in HIV-1 Drug Resistance Monitoring	PLOS ONE			English	Article							VIRAL LOAD; GENOTYPING ASSAY; PLASMA; SURVEILLANCE; SPECIMENS	As more HIV-infected people gain access to antiretroviral therapy (ART), monitoring HIV drug resistance (HIVDR) becomes essential to combat both acquired and transmitted HIVDR. Studies have demonstrated dried blood spots (DBS) are a suitable alternative in HIVDR monitoring using DBS collected on Whatman 903 (W-903). In this study, we sought to evaluate two other commercially available filter papers, Ahlstrom 226 (A-226) and Munktell TFN (M-TFN), for HIVDR genotyping following ambient temperature storage. DBS were prepared from remnant blood specimens collected from 334 ART patients and stored at ambient temperature for a median time of 30 days. HIV-1 viral load was determined using NucliSENS EasyQ (R) HIV-1 v2.0 RUO test kits prior to genotyping of the protease and reverse transcriptase regions of the HIV-1 pol gene using an in-house assay. Among the DBS tested, 26 specimens had a viral load >= 1000 copies/mL in all three types of filter paper and were included in the genotyping analysis. Genotyping efficiencies were similar between DBS collected on W-903 (92.3%), A-226 (88.5%), and M-TFN (92.3%) filter papers (P = 1.00). We identified 50 DR-associated mutations in DBS collected on W-903, 33 in DBS collected on A-226, and 48 in DBS collected on M-TFN, resulting in mutation detection sensitivities of 66.0% for A-226 and 88.0% for M-TFN when compared to W-903. Our data indicate that differences among filter papers may exist at this storage condition and warrant further studies evaluating filter paper type for HIVDR monitoring.	[Rottinghaus, Erin K.; Beard, R. Suzanne; Nkengasong, John; Yang, Chunfu] Ctr Dis Control & Prevent, Int Lab Branch, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA 30329 USA; [Bile, Ebi; Modukanele, Mosetsanagape; Maruping, Maruping] CDC Botswana, Gaborone, Botswana; [Mine, Madisa] Botswana Minist Hlth, Gaborone, Botswana	Centers for Disease Control & Prevention - USA	Yang, CF (corresponding author), Ctr Dis Control & Prevent, Int Lab Branch, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA 30329 USA.	CYang1@cdc.gov	Yang, Chunfu/G-6890-2013	Bile, Ebi Celestin/0000-0003-1930-7443	American Public Health Laboratory (APHL); U.S. Centers for Disease Control and Prevention (CDC); President's Emergency Plan for AIDS Relief (PEPFAR) through The Centers for Disease Control and Prevention	American Public Health Laboratory (APHL); U.S. Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); President's Emergency Plan for AIDS Relief (PEPFAR) through The Centers for Disease Control and Prevention(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	ER and RSB were the recipients of the 2009-2011 and 2012-2014, respectively, Emerging Infectious Disease (EID) Fellowship sponsored by American Public Health Laboratory (APHL) and the U.S. Centers for Disease Control and Prevention (CDC). This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through The Centers for Disease Control and Prevention. The sponsors and funding agency had no role in the study design, in the collection, analysis and interpretation of data or in the writing of the report.	Bertagnolio S, 2007, ANTIVIR THER, V12, P107; Bertagnolio S, 2010, AIDS REV, V12, P195; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Garcia-Lerma JG, 2009, J ANTIMICROB CHEMOTH, V64, P33, DOI 10.1093/jac/dkp150; Garrido C, 2008, J ANTIMICROB CHEMOTH, V61, P694, DOI 10.1093/jac/dkm515; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamers RL, 2009, ANTIVIR THER, V14, P619; Inzaule S, 2013, J CLIN MICROBIOL, V51, P529, DOI 10.1128/JCM.02347-12; Johannessen A, 2009, CLIN INFECT DIS, V49, P976, DOI 10.1086/605502; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Masciotra S, 2007, AIDS, V21, P2503, DOI 10.1097/QAD.0b013e3281c618db; McNulty A, 2007, J CLIN MICROBIOL, V45, P517, DOI 10.1128/JCM.02016-06; Rottinghaus E, 2013, J CLIN MICROBIOL, V51, P55, DOI 10.1128/JCM.02002-12; Rottinghaus EK, 2012, CLIN INFECT DIS, V54, P1187, DOI 10.1093/cid/cis015; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Woods CK, 2012, J CLIN MICROBIOL, V50, P1936, DOI 10.1128/JCM.06689-11; World Health Organization, 2010, WHO MAN HIV DRUG RES; Yang CF, 2010, J CLIN MICROBIOL, V48, P3158, DOI 10.1128/JCM.00564-10; Youngpairoj AS, 2008, J ANTIMICROB CHEMOTH, V61, P1217, DOI 10.1093/jac/dkn100; Zhou ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028184	20	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109060	10.1371/journal.pone.0109060	http://dx.doi.org/10.1371/journal.pone.0109060			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303690	gold, Green Published, Green Submitted			2022-12-27	WOS:000343730400044
J	Murtola, TJ; Visvanathan, K; Artama, M; Vainio, H; Pukkala, E				Murtola, Teemu J.; Visvanathan, Kala; Artama, Miia; Vainio, Harri; Pukkala, Eero			Statin Use and Breast Cancer Survival: A Nationwide Cohort Study from Finland	PLOS ONE			English	Article							RISK; RECURRENCE; MORTALITY; SIMVASTATIN; ADHERENCE; P53	Recent studies have suggested that statins, an established drug group in the prevention of cardiovascular mortality, could delay or prevent breast cancer recurrence but the effect on disease-specific mortality remains unclear. We evaluated risk of breast cancer death among statin users in a population-based cohort of breast cancer patients. The study cohort included all newly diagnosed breast cancer patients in Finland during 1995-2003 (31,236 cases), identified from the Finnish Cancer Registry. Information on statin use before and after the diagnosis was obtained from a national prescription database. We used the Cox proportional hazards regression method to estimate mortality among statin users with statin use as time-dependent variable. A total of 4,151 participants had used statins. During the median follow-up of 3.25 years after the diagnosis (range 0.08-9.0 years) 6,011 participants died, of which 3,619 (60.2%) was due to breast cancer. After adjustment for age, tumor characteristics, and treatment selection, both post-diagnostic and pre-diagnostic statin use were associated with lowered risk of breast cancer death (HR 0.46, 95% CI 0.38-0.55 and HR 0.54, 95% CI 0.44-0.67, respectively). The risk decrease by post-diagnostic statin use was likely affected by healthy adherer bias; that is, the greater likelihood of dying cancer patients to discontinue statin use as the association was not clearly dose-dependent and observed already at low-dose/short-term use. The dose-and time-dependence of the survival benefit among pre-diagnostic statin users suggests a possible causal effect that should be evaluated further in a clinical trial testing statins' effect on survival in breast cancer patients.	[Murtola, Teemu J.] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Murtola, Teemu J.] Tampere Univ Hosp, Dept Urol, Tampere, Finland; [Visvanathan, Kala] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Visvanathan, Kala] Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Artama, Miia] Univ Helsinki, Helsinki, Finland; [Vainio, Harri] Finnish Inst Occupat Hlth, Helsinki, Finland; [Pukkala, Eero] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland; [Pukkala, Eero] Finnish Canc Registry, Inst Stat & Epidemiol Canc Res, FIN-00170 Helsinki, Finland	Tampere University; Tampere University; Tampere University Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; University of Helsinki; Finnish Institute of Occupational Health; Tampere University; Finnish Cancer Registry	Murtola, TJ (corresponding author), Univ Tampere, Sch Med, FIN-33101 Tampere, Finland.	teemu.murtola@uta.fi	Visvanathan, Kala/AAE-4396-2021		Finnish Cultural Foundation; Finnish Surgical Society; Finnish Medical Association	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Surgical Society; Finnish Medical Association	This work was supported by a post-doctoral research grant from the Finnish Cultural Foundation (http://www.skr.fi/en), a traveling grant from the Finnish Surgical Society (http://www.kirurgiyhdistys.fi/), and a working grant from the Finnish Medical Association (http://www.laaketieteensaatio.fi/fin/in_english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern TP, 2011, JNCI-J NATL CANCER I, V103, P1461, DOI 10.1093/jnci/djr291; Berard E, 2011, CURR MED RES OPIN, V27, P1963, DOI 10.1185/03007995.2011.616191; Bjarnadottir O, 2013, BREAST CANCER RES TR, V138, P499, DOI 10.1007/s10549-013-2473-6; Brookhart MA, 2007, AM J EPIDEMIOL, V166, P348, DOI 10.1093/aje/kwm070; Chae YK, 2011, CANCER INVEST, V29, P585, DOI 10.3109/07357907.2011.616252; Demierre MF, 2005, NAT REV CANCER, V5, P930, DOI 10.1038/nrc1751; Dormuth CR, 2009, CIRCULATION, V119, P2051, DOI 10.1161/CIRCULATIONAHA.108.824151; Eichholzer M, 2000, AM J CLIN NUTR, V71, P569; Eindhoven JA, 2012, EUROINTERVENTION, V7, P1420, DOI 10.4244/EIJV7I12A222; Emberson JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029849; Ferlay J, 2010, IARC CANCERBASE, V2; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Frohlich GM, 2012, CIRCULATION, V126, P440, DOI 10.1161/CIRCULATIONAHA.111.081059; Garcia-Ruiz C, 2012, ANTI-CANCER AGENT ME, V12, P303, DOI 10.2174/187152012800228715; Garwood ER, 2010, BREAST CANCER RES TR, V119, P137, DOI 10.1007/s10549-009-0507-x; Haukka J, 2012, PHARMACOEPIDEM DR S, V21, P61, DOI 10.1002/pds.2255; Higgins MJ, 2012, BREAST CANCER RES TR, V131, P915, DOI 10.1007/s10549-011-1858-7; Hilvo M, 2011, CANCER RES, V71, P3236, DOI 10.1158/0008-5472.CAN-10-3894; Koyuturk M, 2007, CANCER LETT, V250, P220, DOI 10.1016/j.canlet.2006.10.009; Kubatka P, 2011, Klin Onkol, V24, P41; Kwan ML, 2008, BREAST CANCER RES TR, V109, P573, DOI 10.1007/s10549-007-9683-8; Makela M, 2005, 162000 NAT RES DEV C; Martikainen J, 2002, SOCIAL SECURITY HLTH, V54, P130; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Nickels S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075088; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; TEPPO L, 1994, ACTA ONCOL, V33, P365, DOI 10.3109/02841869409098430; Undela K, 2012, BREAST CANCER RES TR, V135, P261, DOI 10.1007/s10549-012-2154-x; World Health Organization, ATC DDD IND DAT	31	100	101	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110231	10.1371/journal.pone.0110231	http://dx.doi.org/10.1371/journal.pone.0110231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329299	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100044
J	Roka, JL; Van den Bergh, R; Au, S; De Plecker, E; Zachariah, R; Manzi, M; Lambert, V; Abi-Aad, E; Nanan-N'Zeth, K; Nzuya, S; Omba, B; Shako, C; MuishaBaroki, D; Basimuoneye, JP; Moke, DA; Lampaert, E; Masangu, L; De Weggheleire, A				Roka, Jerlie Loko; Van den Bergh, Rafael; Au, Sokhieng; De Plecker, Eva; Zachariah, Rony; Manzi, Marcel; Lambert, Vincent; Abi-Aad, Elias; Nanan-N'Zeth, Kassi; Nzuya, Serge; Omba, Brigitte; Shako, Charly; MuishaBaroki, Derick; Basimuoneye, Jean Paul; Moke, Didier Amudiandroy; Lampaert, Emmanuel; Masangu, Lucien; De Weggheleire, Anja			One Size Fits All? Standardised Provision of Care for Survivors of Sexual Violence in Conflict and Post-Conflict Areas in the Democratic Republic of Congo	PLOS ONE			English	Article								Background: Outcomes of sexual violence care programmes may vary according to the profile of survivors, type of violence suffered, and local context. Analysis of existing sexual violence care services could lead to their better adaptation to the local contexts. We therefore set out to compare the Medecins Sans Frontieres sexual violence programmes in the Democratic Republic of Congo (DRC) in a zone of conflict (Masisi, North Kivu) and post-conflict (Niangara, Haut-Uele). Methods: A retrospective descriptive cohort study, using routine programmatic data from the MSF sexual violence programmes in Masisi and Niangara, DRC, for 2012. Results: In Masisi, 491 survivors of sexual violence presented for care, compared to 180 in Niangara. Niangara saw predominantly sexual violence perpetrated by civilians who were known to the victim (48%) and directed against children and adolescents (median age 15 (IQR 13-17)), while sexual violence in Masisi was more directed towards adults (median age 26 (IQR 20-35)), and was characterised by marked brutality, with higher levels of gang rape, weapon use, and associated violence; perpetrated by the military (51%). Only 60% of the patients in Masisi and 32% of those in Niangara arrived for a consultation within the critical timeframe of 72 hours, when prophylaxis for HIV and sexually transmitted infections is most effective. Survivors were predominantly referred through community programmes. Treatment at first contact was typically efficient, with high (>95%) coverage rates of prophylaxes. However, follow-up was poor, with only 49% of all patients in Masisi and 61% in Niangara returning for follow-up, and consequently low rates of treatment and/or vaccination completion. Conclusion: This study has identified a number of weak and strong points in the sexual violence programmes of differing contexts, indicating gaps which need to be addressed, and strengths of both programmes that may contribute to future models of context-specific sexual violence programmes.	[Roka, Jerlie Loko; Abi-Aad, Elias; Nanan-N'Zeth, Kassi; Nzuya, Serge; Omba, Brigitte; Shako, Charly; Lampaert, Emmanuel; Masangu, Lucien; De Weggheleire, Anja] Med Sans Frontieres, Operat Ctr Brussels, Kinshasa, DEM REP CONGO; [Van den Bergh, Rafael; Au, Sokhieng; Zachariah, Rony; Manzi, Marcel] Med Sans Frontieres, Operat Ctr Brussels, Operat Res Unit LuxOR, Luxembourg, Luxembourg; [De Plecker, Eva] Med Sans Frontieres, Operat Ctr Brussels, Dept Med, Brussels, Belgium; [Lambert, Vincent] Med Sans Frontieres, Operat Ctr Brussels, Operat Dept, Brussels, Belgium; [MuishaBaroki, Derick; Basimuoneye, Jean Paul] Minist Sante, Bur Cent Zone St Masisi, Masisi, DEM REP CONGO; [Moke, Didier Amudiandroy] Minist Sante, Bur Cent Zone St Niangara, Niangara, DEM REP CONGO	Doctors Without Borders; Doctors Without Borders; Doctors Without Borders	Van den Bergh, R (corresponding author), Med Sans Frontieres, Operat Ctr Brussels, Operat Res Unit LuxOR, Luxembourg, Luxembourg.	rafael.van.den.bergh@brussels.msf.org	De Weggheleire, Anja/C-7345-2018	De Weggheleire, Anja/0000-0001-9377-4766; zachariah, rony/0000-0002-2915-9328; Van den Bergh, Rafael/0000-0001-6277-8713				Ahonsi B, 2010, POLICY NOTES, V2, P1; Bartels S, 2012, J INTERPERS VIOLENCE; Bartels SA, 2012, DISASTER MED PUBLIC, V6, P393, DOI 10.1001/dmp.2012.66; Brown Carly, 2012, Torture, V22, P24; Christian Mervyn, 2011, Med Confl Surviv, V27, P227, DOI 10.1080/13623699.2011.645144; Daru PH, 2011, NIGER J CLIN PRACT, V14, P47, DOI 10.4103/1119-3077.79240; Johnson K, 2010, JAMA-J AM MED ASSOC, V304, P553, DOI 10.1001/jama.2010.1086; Kalonda J C Omba, 2012, Rev Med Brux, V33, P482; Kohli Anjalee, 2012, Confl Health, V6, P6, DOI 10.1186/1752-1505-6-6; MSF, 2014, MAN ACC EXP BLOOD BO; Nelson Brett D, 2011, Med Confl Surviv, V27, P211, DOI 10.1080/13623699.2011.645148; Peterman A, 2011, AM J PUBLIC HEALTH, V101, P1060, DOI 10.2105/AJPH.2010.300070; Spangaro J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062600; Tayler-Smith K, 2012, TROP MED INT HLTH; Wakabi W, 2008, LANCET, V371, P15, DOI 10.1016/S0140-6736(08)60051-3; WHO, 2002, GLOB REP VIOL HLTH; WHO, 2013, WORLD HLTH STAT COUN; World Health Organization, 2003, GUID MED LEG CAR VIC; World Health Organization United Nations Population Fund United Nations High Commission for Refugees, 2004, CLIN MAN RAP SURV DE	19	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e111096	10.1371/journal.pone.0111096	http://dx.doi.org/10.1371/journal.pone.0111096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0AY	25329482	Green Published, gold			2022-12-27	WOS:000343942100112
J	Singh, V; Tchernookov, M; Butterfield, R; Nemenman, I				Singh, Vijay; Tchernookov, Martin; Butterfield, Rebecca; Nemenman, Ilya			Director Field Model of the Primary Visual Cortex for Contour Detection	PLOS ONE			English	Article							OBJECT RECOGNITION; RECEPTIVE-FIELDS; ORGANIZATION; ARCHITECTURE; CONNECTIONS; CURVE	We aim to build the simplest possible model capable of detecting long, noisy contours in a cluttered visual scene. For this, we model the neural dynamics in the primate primary visual cortex in terms of a continuous director field that describes the average rate and the average orientational preference of active neurons at a particular point in the cortex. We then use a linear-nonlinear dynamical model with long range connectivity patterns to enforce long-range statistical context present in the analyzed images. The resulting model has substantially fewer degrees of freedom than traditional models, and yet it can distinguish large contiguous objects from the background clutter by suppressing the clutter and by filling-in occluded elements of object contours. This results in high-precision, high-recall detection of large objects in cluttered scenes. Parenthetically, our model has a direct correspondence with the Landau - de Gennes theory of nematic liquid crystal in two dimensions.	[Singh, Vijay; Tchernookov, Martin; Nemenman, Ilya] Emory Univ, Dept Phys, Atlanta, GA 30322 USA; [Butterfield, Rebecca; Nemenman, Ilya] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University; Emory University	Nemenman, I (corresponding author), Emory Univ, Dept Phys, Atlanta, GA 30322 USA.	ilya.nemenman@emory.edu	Singh, Vijay/AAU-7018-2020	Singh, Vijay/0000-0002-7886-9190	Army Research Office [60704-NS-II]; James S. McDonnell Foundation [220020321]; NIH [R90DA033462]; NATIONAL INSTITUTE ON DRUG ABUSE [R90DA033462] Funding Source: NIH RePORTER	Army Research Office; James S. McDonnell Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by Army Research Office, 60704-NS-II (V. S., I.N.), James S. McDonnell Foundation, 220020321 (M. T., I.N.), and NIH, R90DA033462 (R. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann CF, 2003, CURR BIOL, V13, P342, DOI 10.1016/S0960-9822(03)00052-6; Angelucci A, 2002, J NEUROSCI, V22, P8633; Boureau YL, 2010, PROC CVPR IEEE, P2559, DOI 10.1109/CVPR.2010.5539963; Bressloff PC, 2003, J PHYSIOL-PARIS, V97, P221, DOI 10.1016/j.jphysparis.2003.09.017; Colonnier M, 1981, NUMBER NEURONS SYNAP, V40; CREUTZFELDT OD, 1978, NATURWISSENSCHAFTEN, V65, P307, DOI 10.1007/BF00368371; Dayan P., 2005, THEORETICAL NEUROSCI; de Gennes P.G., 1995, PHYS TODAY, V48, P70, DOI [10.1063/1.2808028, DOI 10.1063/1.2808028]; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; GILBERT CD, 1989, J NEUROSCI, V9, P2432; Gintautas V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002162; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hubel DH, 1968, J PHYSL, V195; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; KOVACS I, 1993, P NATL ACAD SCI USA, V90, P7495, DOI 10.1073/pnas.90.16.7495; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; LeCun Y, 2004, P 2004 IEEE COMP SOC, V2, pII; Miconi T, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00205; PARENT P, 1989, IEEE T PATTERN ANAL, V11, P823, DOI 10.1109/34.31445; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Riesenhuber M, 2000, NAT NEUROSCI, V3, P1199, DOI 10.1038/81479; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; Stettler DD, 2002, NEURON, V36, P739, DOI 10.1016/S0896-6273(02)01029-2; Thorpe S, 2001, NEURAL NETWORKS, V14, P715, DOI 10.1016/S0893-6080(01)00083-1; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; Wolf F, 1998, NATURE, V395, P73, DOI 10.1038/25736; Wolf F, 2003, J PHYSIOL-PARIS, V97, P253, DOI 10.1016/j.jphysparis.2003.09.018; Zweck J, 2004, J MATH IMAGING VIS, V21, P135, DOI 10.1023/B:JMIV.0000035179.47895.bc	32	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e108991	10.1371/journal.pone.0108991	http://dx.doi.org/10.1371/journal.pone.0108991			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329158	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204100008
J	Morishima, T; Mori, A; Sasaki, H; Goto, K				Morishima, Takuma; Mori, Ayaka; Sasaki, Hiroto; Goto, Kazushige			Impact of Exercise and Moderate Hypoxia on Glycemic Regulation and Substrate Oxidation Pattern	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN SKELETAL-MUSCLE; INSULIN SENSITIVITY; GLUCOSE-TRANSPORT; ALTITUDE; ACCLIMATIZATION; FAT; MEN; METABOLISM; INGESTION	Objective: We examined metabolic and endocrine responses during rest and exercise in moderate hypoxia over a 7.5 h time courses during daytime. Methods: Eight sedentary, overweight men (28.6 +/- 0.8 kg/m(2)) completed four experimental trials: a rest trial in normoxia (FiO(2) = 20.9%, NOR-Rest), an exercise trial in normoxia (NOR-Ex), a rest trial in hypoxia (FiO(2) = 15.0%, HYP-Rest), and an exercise trial in hypoxia (HYP-Ex). Experimental trials were performed from 8: 00 to 15:30 in an environmental chamber. Blood and respiratory gas samples were collected over 7.5 h. In the exercise trials, subjects performed 30 min of pedaling exercise at 60% of VO(2)max at 8:00, 10:30, and 13:00, and rested during the remaining period in each environment. Standard meals were provided at 8:30, 11:00, and 13:30. Results: The areas under the curves for blood glucose and serum insulin concentrations over 7.5 h did not differ among the four trials. At baseline, %carbohydrate contribution was significantly higher in the hypoxic trials than in the normoxic trials (P<0.05). Although exercise promoted carbohydrate oxidation in the NOR-Ex and HYP-Ex trials, %carbohydrate contribution during each exercise and post-exercise period were significantly higher in the HYP-Ex trial than in the NOR-Ex trial (P<0.05). Conclusion: Three sessions of 30 min exercise (60% of VO(2)max) in moderate hypoxia over 7.5 h did not attenuate postprandial glucose and insulin responses in young, overweight men. However, carbohydrate oxidation was significantly enhanced when the exercise was conducted in moderate hypoxia.	[Morishima, Takuma; Mori, Ayaka; Sasaki, Hiroto; Goto, Kazushige] Ritsumeikan Univ, Grad Sch Sport & Hlth Sci, Kusatsu, Shiga, Japan; [Goto, Kazushige] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga, Japan	Ritsumeikan University; Ritsumeikan University	Goto, K (corresponding author), Ritsumeikan Univ, Grad Sch Sport & Hlth Sci, Kusatsu, Shiga, Japan.	kagoto@fc.ritsumei.ac.jp			Ritsumeikan University; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [26282180, 14J09537] Funding Source: KAKEN	Ritsumeikan University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was supported by a research grant from Ritsumeikan University, and a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beidleman BA, 2002, MED SCI SPORT EXER, V34, P430, DOI 10.1097/00005768-200203000-00008; BROOKS GA, 1992, J APPL PHYSIOL, V72, P2435, DOI 10.1152/jappl.1992.72.6.2435; BROOKS GA, 1991, J APPL PHYSIOL, V70, P919, DOI 10.1152/jappl.1991.70.2.919; CARTEE GD, 1991, J APPL PHYSIOL, V70, P1593, DOI 10.1152/jappl.1991.70.4.1593; de Glisezinski I, 1999, PFLUG ARCH EUR J PHY, V439, P134, DOI 10.1007/s004240051137; DELA F, 1993, J PHYSIOL-LONDON, V469, P615, DOI 10.1113/jphysiol.1993.sp019833; DEMPSEY JA, 1982, PHYSIOL REV, V62, P262, DOI 10.1152/physrev.1982.62.1.262; EASTON PA, 1986, J APPL PHYSIOL, V61, P906, DOI 10.1152/jappl.1986.61.3.906; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; Friedmann B, 2004, MED SCI SPORT EXER, V36, P1737, DOI 10.1249/01.MSS.0000142307.62181.37; Fujii N, 2006, AM J PHYSIOL-ENDOC M, V291, pE867, DOI 10.1152/ajpendo.00207.2006; Gamboa JL, 2011, AM J PHYSIOL-REG I, V300, pR85, DOI 10.1152/ajpregu.00078.2010; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Haufe S, 2008, MED SCI SPORT EXER, V40, P1939, DOI 10.1249/MSS.0b013e31817f1988; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Katayama K, 2010, METABOLISM, V59, P959, DOI 10.1016/j.metabol.2009.10.017; Kelly KR, 2010, METABOLISM, V59, P200, DOI 10.1016/j.metabol.2009.07.014; Koopman R, 2005, EUR J APPL PHYSIOL, V94, P180, DOI 10.1007/s00421-004-1307-y; Lee WC, 2004, PREV MED, V39, P681, DOI 10.1016/j.ypmed.2004.02.035; Lee WC, 2003, HIGH ALT MED BIOL, V4, P81, DOI 10.1089/152702903321489013; Mackenzie R, 2011, DIABETES-METAB RES, V27, P94, DOI 10.1002/dmrr.1156; Manetta J, 2002, MED SCI SPORT EXER, V34, P423, DOI 10.1097/00005768-200203000-00007; Mazzeo RS, 2008, SPORTS MED, V38, P1, DOI 10.2165/00007256-200838010-00001; MIKINES KJ, 1988, AM J PHYSIOL, V254, pE248, DOI 10.1152/ajpendo.1988.254.3.E248; Morishima T, 2014, CLIN PHYSIOL FUNCT I, V34, P90, DOI 10.1111/cpf.12069; Musi N, 2003, ACTA PHYSIOL SCAND, V178, P337, DOI 10.1046/j.1365-201X.2003.01168.x; O'Connor AM, 2006, AM J PHYSIOL-ENDOC M, V290, pE1155, DOI 10.1152/ajpendo.00500.2005; O'Gorman DJ, 2000, J APPL PHYSIOL, V89, P1412, DOI 10.1152/jappl.2000.89.4.1412; Ohkawara K, 2013, OBESITY, V21, P336, DOI 10.1002/oby.20032; Peronnet F, 2006, EUR J APPL PHYSIOL, V97, P527, DOI 10.1007/s00421-006-0164-2; PESTELL RG, 1993, METABOLISM, V42, P277, DOI 10.1016/0026-0495(93)90074-X; RICHTER EA, 1989, J APPL PHYSIOL, V66, P876; RICHTER EA, 1982, J CLIN INVEST, V69, P785, DOI 10.1172/JCI110517; Roberts AC, 1996, J APPL PHYSIOL, V80, P605, DOI 10.1152/jappl.1996.80.2.605; Roberts AC, 1996, J APPL PHYSIOL, V81, P1762, DOI 10.1152/jappl.1996.81.4.1762; Rose AJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE766, DOI 10.1152/ajpendo.2001.281.4.E766; Schobersberger W, 2003, EUR J APPL PHYSIOL, V88, P506, DOI 10.1007/s00421-002-0736-8; Short KR, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/278678; Sriwijitkamol A, 2007, DIABETES, V56, P836, DOI 10.2337/db06-1119; Tuominen JA, 1997, CLIN PHYSIOL, V17, P19, DOI 10.1046/j.1365-2281.1997.01717.x	40	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e108629	10.1371/journal.pone.0108629	http://dx.doi.org/10.1371/journal.pone.0108629			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329405	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210800010
J	Chao, CT; Lee, SY; Yang, WS; Chen, HW; Fang, CC; Yen, CJ; Chiang, CK; Hung, KY; Huang, JW				Chao, Chia-Ter; Lee, Szu-Ying; Yang, Wei-Shun; Chen, Huei-Wen; Fang, Cheng-Chung; Yen, Chung-Jen; Chiang, Chih-Kang; Hung, Kuan-Yu; Huang, Jenq-Wen			Acinetobacter Peritoneal Dialysis Peritonitis: A Changing Landscape over Time	PLOS ONE			English	Article							INFECTIONS RECOMMENDATIONS; MATCHED COHORT; BAUMANNII; MORTALITY; RISK	Background: Acinetobacter species are assuming an increasingly important role in modern medicine, with their persistent presence in health-care settings and antibiotic resistance. However, clinical reports addressing this issue in patients with peritoneal dialysis (PD) peritonitis are rare. Methods: All PD peritonitis episodes caused by Acinetobacter that occurred between 1985 and 2012 at a single centre were retrospectively reviewed. Clinical features, microbiological data, and outcomes were analysed, with stratifications based upon temporal periods (before and after 2000). Results: Acinetobacter species were responsible for 26 PD peritonitis episodes (3.5% of all episodes) in 25 patients. A. baumannii was the most common pathogen (54%), followed by A. iwoffii (35%), with the former being predominant after 2000. Significantly more episodes resulted from breaks in exchange sterility after 2000, while those from exit site infections decreased (P=0.01). The interval between the last and current peritonitis episodes lengthened significantly after 2000 (5 vs. 13.6 months; P=0.05). All the isolates were susceptible to cefepime, fluoroquinolone, and aminoglycosides, with a low ceftazidime resistance rate (16%). Nearly half of the patients (46%) required hospitalisation for their Acinetobacter PD-associated peritonitis, and 27% required an antibiotic switch. The overall outcome was fair, with no mortality and a 12% technique failure rate, without obvious interval differences. Conclusions: The temporal change in the microbiology and origin of Acinetobacter PD-associated peritonitis in our cohort suggested an important evolutional trend. Appropriate measures, including technique re-education and sterility maintenance, should be taken to decrease the Acinetobacter peritonitis incidence in PD patients.	[Chao, Chia-Ter] Natl Taiwan Univ Hosp, Dept Internal Med, Jin Shan Branch, Div Nephrol, New Taipei City, Taiwan; [Chao, Chia-Ter] Natl Taiwan Univ, Grad Inst Toxicol, Taipei 10764, Taiwan; [Lee, Szu-Ying] Natl Taiwan Univ Hosp, Dept Internal Med, Div Nephrol, Yun Lin Branch, Taipei, Taiwan; [Yang, Wei-Shun] Natl Taiwan Univ Hosp, Dept Internal Med, Div Nephrol, Hsin Chu Branch, Taipei, Hsin Chu County, Taiwan; [Chen, Huei-Wen; Hung, Kuan-Yu; Huang, Jenq-Wen] Natl Taiwan Univ Hosp, Dept Internal Med, Div Nephrol, Taipei 100, Taiwan; [Fang, Cheng-Chung] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei 100, Taiwan; [Yen, Chung-Jen] Natl Taiwan Univ Hosp, Dept Geriatr & Gerontol, Taipei 100, Taiwan; [Chiang, Chih-Kang] Natl Taiwan Univ Hosp, Dept Integrat Diagnost & Therapeut, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Huang, JW (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Nephrol, Taipei 100, Taiwan.	007378@ntuh.gov.tw	Yang, Weishun/AAR-6218-2020; Chao, Chia-Ter/H-7994-2019	Yang, Weishun/0000-0002-3249-280X; Chao, Chia-Ter/0000-0003-2892-7986; CHEN, HUEI-WEN/0000-0001-5051-9896; CHIANG, CHIH-KANG/0000-0001-9021-4616; HUANG, JENQ-WEN/0000-0001-8011-2317; FANG, CHENG-CHUNG/0000-0001-5386-6674; HUNG, KUAN-YU/0000-0003-3472-5512; YEN, CHUNG-JEN/0000-0001-5372-3657	National Taiwan University Hospital intramural fund [102-N2249]	National Taiwan University Hospital intramural fund	This study is financially supported by National Taiwan University Hospital intramural fund (project NO. 102-N2249). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbo A, 2007, EUR J CLIN MICROBIOL, V26, P793, DOI 10.1007/s10096-007-0371-8; Baboolal K, 2008, NEPHROL DIAL TRANSPL, V23, P1982, DOI 10.1093/ndt/gfm870; Barraclough K, 2010, AM J KIDNEY DIS, V55, P121, DOI 10.1053/j.ajkd.2009.08.020; Chao CT, 2013, J AM COLL SURGEONS, V217, P240, DOI 10.1016/j.jamcollsurg.2013.03.024; Chao CT, 2013, INT J MED SCI, V10, P1092, DOI 10.7150/ijms.6251; Chao CT, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-111; Chao CT, 2012, KIDNEY INT, V82, P920, DOI 10.1038/ki.2012.237; Falagas ME, 2006, CRIT CARE, V10, DOI [10.1186/cc4910, 10.1186/cc4869]; Falagas ME, 2006, J ANTIMICROB CHEMOTH, V57, P1251, DOI 10.1093/jac/dkl130; Friedman O, 2008, PERITON DIALYSIS INT, V28, P195; GALVAO C, 1989, AM J KIDNEY DIS, V14, P101, DOI 10.1016/S0272-6386(89)80184-2; GERNERSMIDT P, 1991, J CLIN MICROBIOL, V29, P277, DOI 10.1128/JCM.29.2.277-282.1991; Jarvis EM, 2010, KIDNEY INT, V78, P408, DOI 10.1038/ki.2010.149; Keane WF, 2000, PERITON DIALYSIS INT, V20, P396; Kern EO, 2002, PERITON DIALYSIS INT, V22, P323; Lafrance JP, 2012, CLIN J AM SOC NEPHRO, V7, P1598, DOI 10.2215/CJN.00440112; Li PKT, 2013, AM J KIDNEY DIS, V62, P993, DOI 10.1053/j.ajkd.2013.03.038; Li PKT, 2010, PERITON DIALYSIS INT, V30, P393, DOI 10.3747/pdi.2010.00049; LYE WC, 1991, ADV PERIT D, V7, P176; LYE WC, 1994, PERITON DIALYSIS INT, V14, P174; McConnell MJ, 2013, FEMS MICROBIOL REV, V37, P130, DOI 10.1111/j.1574-6976.2012.00344.x; Najafi I, 2013, PERIT DIAL INT; Piraino B, 2005, PERITON DIALYSIS INT, V25, P107; PROWANT B, 1986, NEPHRON, V43, P105, DOI 10.1159/000183807; Szeto CC, 2005, CLIN MICROBIOL INFEC, V11, P837, DOI 10.1111/j.1469-0691.2005.01222.x; Towner KJ, 2009, J HOSP INFECT, V73, P355, DOI 10.1016/j.jhin.2009.03.032; Zarrilli R, 2013, INT J ANTIMICROB AG, V41, P11, DOI 10.1016/j.ijantimicag.2012.09.008; Zelenitsky S, 2000, AM J KIDNEY DIS, V36, P1009, DOI 10.1053/ajkd.2000.19103	28	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110315	10.1371/journal.pone.0110315	http://dx.doi.org/10.1371/journal.pone.0110315			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314341	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500107
J	Dublan, MD; Ortiz-Marquez, JCF; Lett, L; Curatti, L				de los Angeles Dublan, Maria; Federico Ortiz-Marquez, Juan Cesar; Lett, Lina; Curatti, Leonardo			Plant-Adapted Escherichia coli Show Increased Lettuce Colonizing Ability, Resistance to Oxidative Stress and Chemotactic Response	PLOS ONE			English	Article							SALMONELLA-TYPHIMURIUM; O157-H7; QUANTIFICATION; CONTAMINATION; LOCALIZATION; SURVIVAL; ENTERICA; MUTANTS; GROWTH	Background: Escherichia coli is a widespread gut commensal and often a versatile pathogen of public health concern. E. coli are also frequently found in different environments and/or alternative secondary hosts, such as plant tissues. The lifestyle of E. coli in plants is poorly understood and has potential implications for food safety. Methods/Principal Findings: This work shows that a human commensal strain of E. coli K12 readily colonizes lettuce seedlings and produces large microcolony-like cell aggregates in leaves, especially in young leaves, in proximity to the vascular tissue. Our observations strongly suggest that those cell aggregates arise from multiplication of single bacterial cells that reach those spots. We showed that E. coli isolated from colonized leaves progressively colonize lettuce seedlings to higher titers, suggesting a fast adaptation process. E. coli cells isolated from leaves presented a dramatic rise in tolerance to oxidative stress and became more chemotactic responsive towards lettuce leaf extracts. Mutant strains impaired in their chemotactic response were less efficient lettuce colonizers than the chemotactic isogenic strain. However, acclimation to oxidative stress and/or minimal medium alone failed to prime E. coli cells for enhanced lettuce colonization efficiency. Conclusion/Significance: These findings help to understand the physiological adaptation during the alternative lifestyle of E. coli in/on plant tissues.	[de los Angeles Dublan, Maria; Federico Ortiz-Marquez, Juan Cesar; Curatti, Leonardo] Consejo Nacl Invest Cient & Tecn, Inst Invest Biodiversidad & Biotecnol, Buenos Aires, DF, Argentina; [de los Angeles Dublan, Maria; Federico Ortiz-Marquez, Juan Cesar; Curatti, Leonardo] Fdn Invest Biol Aplicadas, Buenos Aires, DF, Argentina; [de los Angeles Dublan, Maria; Lett, Lina] Univ Nacl Ctr Prov Buenos Aires, Fac Agron, Lab Integrado Microbiol Agr & Alimentos, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Comision Nacional de Energia Atomica (CNEA)	Dublan, MD (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Biodiversidad & Biotecnol, Buenos Aires, DF, Argentina.	mdublan@faa.unicen.edu.ar; lcuratti@fiba.org.ar						ADLER J, 1973, J GEN MICROBIOL, V74, P77, DOI 10.1099/00221287-74-1-77; Bacilio-Jimenez M, 2003, PLANT SOIL, V249, P271, DOI 10.1023/A:1022888900465; Buchanan RL, 1999, J FOOD PROTECT, V62, P444, DOI 10.4315/0362-028X-62.5.444; Cooley MB, 2003, APPL ENVIRON MICROB, V69, P4915, DOI 10.1128/AEM.69.8.4915-4926.2003; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; de Weert S, 2002, MOL PLANT MICROBE IN, V15, P1173, DOI 10.1094/MPMI.2002.15.11.1173; Deering AJ, 2011, J FOOD PROTECT, V74, P1224, DOI 10.4315/0362-028X.JFP-11-015; Eblen BS, 2004, J FOOD PROTECT, V67, P1578, DOI 10.4315/0362-028X-67.8.1578; Erickson MC, 2010, J FOOD PROTECT, V7, P500; Franz E, 2007, FOOD MICROBIOL, V24, P106, DOI 10.1016/j.fm.2006.03.002; Holden NJ, 2013, MECH PLANT COLONIZAT; Islam M, 2004, J FOOD PROTECT, V67, P574, DOI 10.4315/0362-028X-67.3.574; Jablasone J, 2005, INT J FOOD MICROBIOL, V99, P7, DOI 10.1016/j.ijfoodmicro.2004.06.011; JIMENEZ L, 1989, J APPL BACTERIOL, V67, P61, DOI 10.1111/j.1365-2672.1989.tb04955.x; Kyle JL, 2010, APPL ENVIRON MICROB, V76, P1375, DOI 10.1128/AEM.02461-09; Monier JM, 2004, APPL ENVIRON MICROB, V70, P346, DOI 10.1128/AEM.70.1.346-355.2004; PARKINSON JS, 1982, J BACTERIOL, V151, P106, DOI 10.1128/JB.151.1.106-113.1982; Queval G, 2008, J EXP BOT, V59, P135, DOI 10.1093/jxb/erm193; Reinhold-Hurek B, 2011, CURR OPIN PLANT BIOL, V14, P435, DOI 10.1016/j.pbi.2011.04.004; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; SANATINIA H, 1995, J BACTERIOL, V177, P2713, DOI 10.1128/jb.177.10.2713-2720.1995; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; van Baarlen P, 2007, FEMS MICROBIOL REV, V31, P239, DOI 10.1111/j.1574-6976.2007.00065.x; Walk ST, 2009, APPL ENVIRON MICROB, V75, P6534, DOI 10.1128/AEM.01262-09; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003; Wright KM, 2013, PHYTOPATHOLOGY, V103, P333, DOI 10.1094/PHYTO-08-12-0209-FI; Zaragoza WJ, 2012, ENV MICROBIOL REP, V4, P453, DOI 10.1111/j.1758-2229.2012.00364.x	27	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110416	10.1371/journal.pone.0110416	http://dx.doi.org/10.1371/journal.pone.0110416			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313845	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662500113
J	Lee, Y; Koay, EJ; Zhang, WJ; Qin, LD; Kirui, DK; Hussain, F; Shen, HF; Ferrari, M				Lee, Yeonju; Koay, Eugene J.; Zhang, Weijia; Qin, Lidong; Kirui, Dickson K.; Hussain, Fazle; Shen, Haifa; Ferrari, Mauro			Human Equilibrative Nucleoside Transporter-1 Knockdown Tunes Cellular Mechanics through Epithelial-Mesenchymal Transition in Pancreatic Cancer Cells	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; FOCAL ADHESION; TUMOR-CELLS; GEMCITABINE; DISEASE; DEFORMABILITY; DYNAMICS; SURVIVAL; EMT; ADENOCARCINOMA	We report cell mechanical changes in response to alteration of expression of the human equilibrative nucleoside transporter-1 (hENT1), a most abundant and widely distributed plasma membrane nucleoside transporter in human cells and/or tissues. Modulation of hENT1 expression level altered the stiffness of pancreatic cancer Capan-1 and Panc 03.27 cells, which was analyzed by atomic force microscopy (AFM) and correlated to microfluidic platform. The hENT1 knockdown induced reduction of cellular stiffness in both of cells up to 70%. In addition, cellular phenotypic changes such as cell morphology, migration, and expression level of epithelial-mesenchymal transition (EMT) markers were observed after hENT1 knockdown. Cells with suppressed hENT1 became elongated, migrated faster, and had reduced E-cadherin and elevated N-cadherin compared to parental cells which are consistent with epithelial-mesenchymal transition (EMT). Those cellular phenotypic changes closely correlated with changes in cellular stiffness. This study suggests that hENT1 expression level affects cellular phenotype and cell elastic behavior can be a physical biomarker for quantify hENT1 expression and detect phenotypic shift. Furthermore, cell mechanics can be a critical tool in detecting disease progression and response to therapy.	[Lee, Yeonju; Koay, Eugene J.; Zhang, Weijia; Qin, Lidong; Kirui, Dickson K.; Shen, Haifa; Ferrari, Mauro] Houston Methodist Res Inst, Dept Nanomed, Houston, TX 77030 USA; [Koay, Eugene J.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Hussain, Fazle] Texas Tech Univ, Dept Mech Engn, Lubbock, TX 79409 USA; [Qin, Lidong; Shen, Haifa] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA; [Ferrari, Mauro] Weill Cornell Med Coll, Dept Med, New York, NY USA	The Methodist Hospital System; The Methodist Hospital - Houston; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Texas Tech University System; Texas Tech University; Cornell University; Cornell University	Ferrari, M (corresponding author), Houston Methodist Res Inst, Dept Nanomed, Houston, TX 77030 USA.	mferrari@HoustonMethodist.org	Qin, Lidong/Q-1198-2015		Department of Defense [W81XWH-09-1-0212, W81XWH-12-1-0414]; National Institute of Health [U54CA143837, U54CA151668]; CPRIT grant from the State of Texas [RP121071]; Ernest Cockrell Jr. Distinguished Endowed Chair; NATIONAL CANCER INSTITUTE [U54CA151668, U54CA143837] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT grant from the State of Texas; Ernest Cockrell Jr. Distinguished Endowed Chair; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors gratefully acknowledge funding support from the following sources: Department of Defense grants W81XWH-09-1-0212 and W81XWH-12-1-0414, National Institute of Health grants U54CA143837 and U54CA151668, the CPRIT grant RP121071 from the State of Texas, and the Ernest Cockrell Jr. Distinguished Endowed Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Buckley ST, 2012, NANOMED-NANOTECHNOL, V8, P355, DOI 10.1016/j.nano.2011.06.021; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Giovannetti E, 2006, CANCER RES, V66, P3928, DOI 10.1158/0008-5472.CAN-05-4203; Gjorevski N, 2012, CANCER MICROENVIRON, V5, P29, DOI 10.1007/s12307-011-0076-5; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Hou HW, 2009, BIOMED MICRODEVICES, V11, P557, DOI 10.1007/s10544-008-9262-8; Indra I, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015015; IZZARD CS, 1980, J CELL SCI, V42, P81; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Kamm R., 2010, SPRINGER HDB NANOTEC, P1171; Kim DH, 2013, FASEB J, V27, P1351, DOI 10.1096/fj.12-220160; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lee S, 2013, J PHYS CHEM B, V117, P9233, DOI 10.1021/jp4055186; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Mori R, 2007, ONCOL REP, V17, P1201; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Shah AN, 2007, ANN SURG ONCOL, V14, P3629, DOI 10.1245/s10434-007-9583-5; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Sirghi L, 2008, EUR BIOPHYS J BIOPHY, V37, P935, DOI 10.1007/s00249-008-0311-2; Spratlin J, 2004, CLIN CANCER RES, V10, P6956, DOI 10.1158/1078-0432.CCR-04-0224; Suresh S, 2005, ACTA BIOMATER, V1, P15, DOI 10.1016/j.actbio.2004.09.001; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Swaminathan V, 2011, CANCER RES, V71, P5075, DOI 10.1158/0008-5472.CAN-11-0247; Wang R, 2014, CURR CANCER DRUG TAR, V14, P407, DOI 10.2174/1568009614666140226114015; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Xu WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046609; Yaron RS, 2009, NANOTECHNOLOGY, V20; Zhang WJ, 2012, P NATL ACAD SCI USA, V109, P18707, DOI 10.1073/pnas.1209893109	33	3	3	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e107973	10.1371/journal.pone.0107973	http://dx.doi.org/10.1371/journal.pone.0107973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314577	Green Submitted, gold, Green Published			2022-12-27	WOS:000343662500008
J	Maschietto, M; Williams, RD; Chagtai, T; Popov, SD; Sebire, NJ; Vujanic, G; Perlman, E; Anderson, JR; Grundy, P; Dome, JS; Pritchard-Jones, K				Maschietto, Mariana; Williams, Richard D.; Chagtai, Tasnim; Popov, Sergey D.; Sebire, Neil J.; Vujanic, Gordan; Perlman, Elizabeth; Anderson, James R.; Grundy, Paul; Dome, Jeffrey S.; Pritchard-Jones, Kathy			TP53 Mutational Status Is a Potential Marker for Risk Stratification in Wilms Tumour with Diffuse Anaplasia	PLOS ONE			English	Article							CIRCULAR BINARY SEGMENTATION; P53 GENE-MUTATIONS; CANCER-STUDY-GROUP; ARRAY CGH DATA; FAVORABLE HISTOLOGY; GENOMIC INSTABILITY; PROGNOSTIC-FACTOR; POOR-PROGNOSIS; MUTANT P53; STAGE-I	Purpose: The presence of diffuse anaplasia in Wilms tumours (DAWT) is associated with TP53 mutations and poor outcome. As patients receive intensified treatment, we sought to identify whether TP53 mutational status confers additional prognostic information. Patients and Methods: We studied 40 patients with DAWT with anaplasia in the tissue from which DNA was extracted and analysed for TP53 mutations and 17p loss. The majority of cases were profiled by copy number (n = 32) and gene expression (n = 36) arrays. TP53 mutational status was correlated with patient event-free and overall survival, genomic copy number instability and gene expression profiling. Results: From the 40 cases, 22 (55%) had TP53 mutations (2 detected only after deep-sequencing), 20 of which also had 17p loss (91%); 18 (45%) cases had no detectable mutation but three had 17p loss. Tumours with TP53 mutations and/or 17p loss (n = 25) had an increased risk of recurrence as a first event (p = 0.03, hazard ratio (HR), 3.89; 95% confidence interval (CI), 1.26-16.0) and death (p = 0.04, HR, 4.95; 95% CI, 1.36-31.7) compared to tumours lacking TP53 abnormalities. DAWT carrying TP53 mutations showed increased copy number alterations compared to those with wild-type, suggesting a more unstable genome (p = 0.03). These tumours showed deregulation of genes associated with cell cycle and DNA repair biological processes. Conclusion: This study provides evidence that TP53 mutational analysis improves risk stratification in DAWT. This requires validation in an independent cohort before clinical use as a biomarker.	[Maschietto, Mariana; Williams, Richard D.; Chagtai, Tasnim; Pritchard-Jones, Kathy] UCL, Inst Child Hlth, Canc Sect, London, England; [Popov, Sergey D.] Inst Canc Res, Div Mol Pathol, London SW3 6JB, England; [Popov, Sergey D.] Inst Canc Res, Div Canc Therapeut, London SW3 6JB, England; [Sebire, Neil J.] Great Ormond St Hosp Sick Children, Dept Histopathol, London, England; [Vujanic, Gordan] Cardiff Univ, Sch Med, Dept Pathol, Cardiff CF10 3AX, S Glam, Wales; [Perlman, Elizabeth] Ann & Robert H Lurie Childrens Hosp, Dept Pathol, Chicago, IL USA; [Anderson, James R.] Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Biostat, Omaha, NE USA; [Grundy, Paul] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Grundy, Paul] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Dome, Jeffrey S.] Childrens Natl Med Ctr, Div Pediat Hematol Oncol, Washington, DC 20010 USA	University of London; University College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Cardiff University; Ann & Robert H. Lurie Children's Hospital of Chicago; University of Nebraska System; University of Nebraska Medical Center; University of Alberta; University of Alberta; Children's National Health System	Pritchard-Jones, K (corresponding author), UCL, Inst Child Hlth, Canc Sect, London, England.	k.pritchard-jones@ucl.ac.uk	Dome, Jeffrey/AAH-7825-2019; Maschietto, Mariana/G-4999-2010; Vujanic, Gordan M./AFS-3176-2022; Vujanic, Gordan M./AAW-4712-2020; Pritchard-Jones, Kathryn/F-4286-2014	Maschietto, Mariana/0000-0003-2589-3186; Vujanic, Gordan M./0000-0003-0726-6939; Vujanic, Gordan M./0000-0003-0726-6939; Pritchard-Jones, Kathryn/0000-0002-2384-9475; Perlman, Elizabeth/0000-0001-6853-6221; Sebire, Neil/0000-0001-5348-9063	Cancer Research UK [C1188/A11859]; European Commission [FP7-ICT-2009-6]; National Institute for Health Research Great Ormond Street Hospital UCL Biomedical Research Centre award; Great Ormond Street Hospital for Children's Charitable funds; Cancer Research UK; CCLG; National Institutes of Health [CA-42326]; National Wilms Tumor Study Group Late Effects Study [CA-54498]; Children's Oncology Group [CA-98543, CA-98413]; NATIONAL CANCER INSTITUTE [R01CA054498, U10CA098543, U10CA098413, U10CA042326] Funding Source: NIH RePORTER; Cancer Research UK [17297] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1303, W1090] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); European Commission(European CommissionEuropean Commission Joint Research Centre); National Institute for Health Research Great Ormond Street Hospital UCL Biomedical Research Centre award; Great Ormond Street Hospital for Children's Charitable funds; Cancer Research UK(Cancer Research UK); CCLG; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Wilms Tumor Study Group Late Effects Study; Children's Oncology Group; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Great Ormond Street Hospital Childrens Charity	This study was funded by Cancer Research UK (Grant No. C1188/A11859) and the European Commission Framework Programme 7 P-medicine integrated project (Grant No. FP7-ICT-2009-6) and supported by the National Institute for Health Research Great Ormond Street Hospital UCL Biomedical Research Centre award and Great Ormond Street Hospital for Children's Charitable funds. The Children's Cancer and Leukaemia Group (CCLG) Tissue Bank is funded by Cancer Research UK and CCLG (www.cclg.org.uk). The research was also supported by grants from the National Institutes of Health to the National Wilms Tumor Study Group (CA-42326), the National Wilms Tumor Study Group Late Effects Study (CA-54498), and the Children's Oncology Group (CA-98543 and CA-98413). The funders had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARDEESY N, 1995, CANCER RES, V55, P215; BARDEESY N, 1994, NAT GENET, V7, P91, DOI 10.1038/ng0594-91; BECKWITH JB, 1978, CANCER-AM CANCER SOC, V41, P1937, DOI 10.1002/1097-0142(197805)41:5<1937::AID-CNCR2820410538>3.0.CO;2-U; Breslow NE, 2004, CANCER-AM CANCER SOC, V101, P1072, DOI 10.1002/cncr.20433; Breslow NE, 2010, INT J CANCER, V127, P657, DOI 10.1002/ijc.25067; de Kraker J, 2004, LANCET, V364, P1229, DOI 10.1016/S0140-6736(04)17139-0; Diniz G, 2013, PEDIATR HEMAT ONCOL, V30, P273, DOI 10.3109/08880018.2013.780274; Dome JS, 2006, J CLIN ONCOL, V24, P2352, DOI 10.1200/JCO.2005.04.7852; Dome JS, 2013, PEDIATR BLOOD CANCER, V60, P994, DOI 10.1002/pbc.24419; Dome JS, 2002, J PEDIAT HEMATOL ONC, V24, P192, DOI 10.1097/00043426-200203000-00007; ElBahtimi R, 1996, MODERN PATHOL, V9, P238; Faria P, 1996, AM J SURG PATHOL, V20, P909, DOI 10.1097/00000478-199608000-00001; Franken J, 2013, J UROLOGY, V189, P664, DOI 10.1016/j.juro.2012.09.115; Green DM, 1998, J CLIN ONCOL, V16, P3744, DOI 10.1200/JCO.1998.16.12.3744; Green DM, 2004, J CLIN ONCOL, V22, P1366, DOI 10.1200/JCO.2004.08.008; Green DM, 2001, J CLIN ONCOL, V19, P3719, DOI 10.1200/JCO.2001.19.17.3719; Hanel W, 2012, J CELL BIOCHEM, V113, P433, DOI 10.1002/jcb.23400; Hill DA, 2003, CANCER-AM CANCER SOC, V97, P2318, DOI 10.1002/cncr.11325; Jadali F, 2011, IRAN J KIDNEY DIS, V5, P149; MALKIN D, 1994, CANCER RES, V54, P2077; Malogolowkin M, 2008, PEDIATR BLOOD CANCER, V50, P236, DOI 10.1002/pbc.21267; Miller MA, 2005, J PEDIAT HEMATOL ONC, V27, P11, DOI 10.1097/01.mph.0000149961.71266.27; Mitchell C, 2006, EUR J CANCER, V42, P2554, DOI 10.1016/j.ejca.2006.05.026; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Overholtzer M, 2003, P NATL ACAD SCI USA, V100, P11547, DOI 10.1073/pnas.1934852100; Parikh N, 2013, J PATHOL; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pfeifer GP, 2011, CURR OPIN ONCOL, V23, P62, DOI 10.1097/CCO.0b013e3283414d00; Pritchard-Jones K, 2012, ANN ONCOL, V23, P2457, DOI 10.1093/annonc/mds025; Pritchard-Jones K, 2003, J CLIN ONCOL, V21, P3269, DOI 10.1200/JCO.2003.01.062; Pritchard-Jones K, 2013, LANCET ONCOL, V14, pE95, DOI 10.1016/S1470-2045(13)70010-X; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Reinhard H, 2008, ONCOL REP, V20, P463, DOI 10.3892/or_00000029; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Scott RH, 2006, J MED GENET, V43, P705, DOI 10.1136/jmg.2006.041723; Segers H, 2012, PEDIAT DEV PATHOL; Smets AMJB, 2012, EUR J CANCER, V48, P1060, DOI 10.1016/j.ejca.2011.05.025; TAKEUCHI S, 1995, MODERN PATHOL, V8, P483; Termuhlen AM, 2011, PEDIATR BLOOD CANCER, V57, P1210, DOI 10.1002/pbc.23090; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Willenbrock H, 2005, BIOINFORMATICS, V21, P4084, DOI 10.1093/bioinformatics/bti677; Williams RD, 2011, GENE CHROMOSOME CANC, V50, P982, DOI 10.1002/gcc.20907; Zenz T, 2008, BLOOD, V112, P3322, DOI 10.1182/blood-2008-04-154070	47	46	49	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109924	10.1371/journal.pone.0109924	http://dx.doi.org/10.1371/journal.pone.0109924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313908	gold, Green Submitted, Green Published			2022-12-27	WOS:000343662500087
J	Hosaka, H; Haruki, R; Yamada, K; Bottcher, C; Komatsu, T				Hosaka, Hitomi; Haruki, Risa; Yamada, Kana; Boettcher, Christoph; Komatsu, Teruyuki			Hemoglobin-Albumin Cluster Incorporating a Pt Nanoparticle: Artificial O-2 Carrier with Antioxidant Activities	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; SUPEROXIDE-DISMUTASE; HYDROGEN-PEROXIDE; BLOOD SUBSTITUTE; CROSS-LINKING; FREE-RADICALS; BINDING; AUTOXIDATION; PROTECTION; COMPLEXES	A covalent core-shell structured protein cluster composed of hemoglobin (Hb) at the center and human serum albumins (HSA) at the periphery, Hb-HSA(m), is an artificial O-2 carrier that can function as a red blood cell substitute. Here we described the preparation of a novel Hb-HSA(3) cluster with antioxidant activities and its O-2 complex stable in aqueous H2O2 solution. We used an approach of incorporating a Pt nanoparticle (PtNP) into the exterior HSA unit of the cluster. A citrate reduced PtNP (1.8 nm diameter) was bound tightly within the cleft of free HSA with a binding constant (K) of 1.1x10(7) M-1, generating a stable HSA-PtNP complex. This platinated protein showed high catalytic activities for dismutations of superoxide radical anions (O-2(center dot-)) and hydrogen peroxide (H2O2), i.e., superoxide dismutase and catalase activities. Also, Hb-HSA(3) captured PtNP into the external albumin unit (K = 1.1x10(7) M-1), yielding an Hb-HSA(3)(PtNP) cluster. The association of PtNP caused no alteration of the protein surface net charge and O-2 binding affinity. The peripheral HSA-PtNP shell prevents oxidation of the core Hb, which enables the formation of an extremely stable O-2 complex, even in H2O2 solution.	[Hosaka, Hitomi; Haruki, Risa; Yamada, Kana; Komatsu, Teruyuki] Chuo Univ Tokyo, Fac Sci & Engn, Dept Appl Chem, Tokyo, Japan; [Boettcher, Christoph] Free Univ Berlin, Res Ctr Elect Microscopy, Inst Chem & Biochem, Berlin, Germany	Free University of Berlin	Komatsu, T (corresponding author), Chuo Univ Tokyo, Fac Sci & Engn, Dept Appl Chem, Tokyo, Japan.	komatsu@kc.chuo-u.ac.jp			MEXT (Ministry of Education, Culture, Sports, Science and Technology) Japan [21108013]; Chuo University Grant for Special Research; Institute of Science and Engineering, Chuo University	MEXT (Ministry of Education, Culture, Sports, Science and Technology) Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Chuo University Grant for Special Research; Institute of Science and Engineering, Chuo University	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Area ("Coordination Programming" Area 2107, No. 21108013) from MEXT (Ministry of Education, Culture, Sports, Science and Technology) Japan, Chuo University Grant for Special Research, and Joint Research Grant from the Institute of Science and Engineering, Chuo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagic A, 2005, J AM CHEM SOC, V127, P8036, DOI 10.1021/ja050339r; Antonini E., 1971, N HOLLAND RES MONOGR, V21, P13; Bhattacharya AA, 2000, J BIOL CHEM, V275, P38731, DOI 10.1074/jbc.M005460200; BOND GC, 1956, T FARADAY SOC, V52, P1235, DOI 10.1039/tf9565201235; Bourdon E, 2001, ANTIOXID REDOX SIGN, V3, P293, DOI 10.1089/152308601300185241; Buehler PW, 2005, ANAL CHEM, V77, P3466, DOI 10.1021/ac050064y; Canaveras F, 2012, J PHYS CHEM C, V116, P10430, DOI 10.1021/jp3021497; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; D'Agnillo F, 1998, NAT BIOTECHNOL, V16, P667, DOI 10.1038/nbt0798-667; Day BJ, 1997, ARCH BIOCHEM BIOPHYS, V347, P256, DOI 10.1006/abbi.1997.0341; Doherty DH, 1998, NAT BIOTECHNOL, V16, P672, DOI 10.1038/nbt0798-672; Elmer J, 2010, BIOTECHNOL BIOENG, V106, P76, DOI 10.1002/bit.22659; EVENSON MA, 1978, CLIN CHIM ACTA, V89, P341, DOI 10.1016/0009-8981(78)90333-9; FAULKNER KM, 1994, J BIOL CHEM, V269, P23471; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Halliwell B, 2000, FEBS LETT, V486, P10, DOI 10.1016/S0014-5793(00)02197-9; Hamasaki T, 2008, LANGMUIR, V24, P7354, DOI 10.1021/la704046f; Hathazi D, 2014, BIOMACROMOLECULES, V15, P1920, DOI 10.1021/bm5004256; Hu T, 2008, BIOCHEMISTRY-US, V47, P10981, DOI 10.1021/bi800906z; Intaglietta M, 1996, CARDIOVASC RES, V32, P632; Iwao Y, 2012, IUBMB LIFE, V64, P450, DOI 10.1002/iub.567; Jahr JS, 2011, CHEMISTRY AND BIOCHEMISTRY OF OXYGEN THERAPEUTICS: FROM TRANSFUSION TO ARTIFICIAL BLOOD, P301; Kajita M, 2007, FREE RADICAL RES, V41, P615, DOI 10.1080/10715760601169679; Kato R, 2014, CHEM-ASIAN J, V9, P83, DOI 10.1002/asia.201301285; Kluger R., 2013, HEMOGLOBIN BASED OXY, P159, DOI DOI 10.1007/978-3-642-40717-8_10; Kluger R, 2010, CURR OPIN CHEM BIOL, V14, P538, DOI 10.1016/j.cbpa.2010.03.021; McCord JM, 2005, BIOMED PHARMACOTHER, V59, P139, DOI 10.1016/j.biopha.2005.03.005; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; Michel CC, 1996, CARDIOVASC RES, V32, P644, DOI 10.1016/0008-6363(96)00064-8; Mondery-Pawlowski CL, 2013, BIOMACROMOLECULES, V14, P939; Nagababu E, 2002, BIOCHEMISTRY-US, V41, P7407, DOI 10.1021/bi0121048; Natanson C, 2008, JAMA-J AM MED ASSOC, V299, P2304, DOI 10.1001/jama.299.19.jrv80007; Ohtsu H, 2000, J AM CHEM SOC, V122, P5733, DOI 10.1021/ja994050j; PEARCE LB, 2006, BLOOD SUBSTITUTES, P437, DOI DOI 10.1016/B978-012759760-7/50047-0; Rohlfs RJ, 1998, J BIOL CHEM, V273, P12128, DOI 10.1074/jbc.273.20.12128; SALIN ML, 1975, J CLIN INVEST, V56, P1319, DOI 10.1172/JCI108208; San BH, 2012, J MATER CHEM, V22, P1774, DOI 10.1039/c1jm14581a; SCHULTZ SC, 1993, J LAB CLIN MED, V122, P301; Squires JE, 2002, SCIENCE, V295, P1002, DOI 10.1126/science.1068443; Tomita D, 2013, BIOMACROMOLECULES, V14, P1816, DOI 10.1021/bm400204y; Tsuruga M, 1998, J BIOL CHEM, V273, P8607, DOI 10.1074/jbc.273.15.8607; WESER U, 1981, J MOL CATAL, V13, P249, DOI 10.1016/0304-5102(81)85025-0; Winslow RM, 2003, J INTERN MED, V253, P508, DOI 10.1046/j.1365-2796.2003.01150.x	43	40	41	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110541	10.1371/journal.pone.0110541	http://dx.doi.org/10.1371/journal.pone.0110541			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310133	gold, Green Submitted, Green Published			2022-12-27	WOS:000343210300122
J	Jayachandran, D; Rundell, AE; Hannemann, RE; Vik, TA; Ramkrishna, D				Jayachandran, Devaraj; Rundell, Ann E.; Hannemann, Robert E.; Vik, Terry A.; Ramkrishna, Doraiswami			Optimal Chemotherapy for Leukemia: A Model-Based Strategy for Individualized Treatment	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CHILDHOOD-CANCER SURVIVOR; INFLAMMATORY-BOWEL-DISEASE; MEAN CORPUSCULAR VOLUME; LONG-TERM SURVIVORS; MAINTENANCE THERAPY; THIOPURINE METHYLTRANSFERASE; CYCLICAL NEUTROPENIA; MATHEMATICAL-MODELS; PREDICTIVE CONTROL	Acute Lymphoblastic Leukemia, commonly known as ALL, is a predominant form of cancer during childhood. With the advent of modern healthcare support, the 5-year survival rate has been impressive in the recent past. However, long-term ALL survivors embattle several treatment-related medical and socio-economic complications due to excessive and inordinate chemotherapy doses received during treatment. In this work, we present a model-based approach to personalize 6-Mercaptopurine (6-MP) treatment for childhood ALL with a provision for incorporating the pharmacogenomic variations among patients. Semi-mechanistic mathematical models were developed and validated for i) 6-MP metabolism, ii) red blood cell mean corpuscular volume (MCV) dynamics, a surrogate marker for treatment efficacy, and iii) leukopenia, a major side-effect. With the constraint of getting limited data from clinics, a global sensitivity analysis based model reduction technique was employed to reduce the parameter space arising from semi-mechanistic models. The reduced, sensitive parameters were used to individualize the average patient model to a specific patient so as to minimize the model uncertainty. Models fit the data well and mimic diverse behavior observed among patients with minimum parameters. The model was validated with real patient data obtained from literature and Riley Hospital for Children in Indianapolis. Patient models were used to optimize the dose for an individual patient through nonlinear model predictive control. The implementation of our approach in clinical practice is realizable with routinely measured complete blood counts (CBC) and a few additional metabolite measurements. The proposed approach promises to achieve model-based individualized treatment to a specific patient, as opposed to a standard-dose-for-all, and to prescribe an optimal dose for a desired outcome with minimum side-effects.	[Jayachandran, Devaraj; Hannemann, Robert E.; Ramkrishna, Doraiswami] Purdue Univ, Sch Chem Engn, W Lafayette, IN 47907 USA; [Rundell, Ann E.; Hannemann, Robert E.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Vik, Terry A.] Riley Hosp Children, Indianapolis, IN USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; James Whitcomb Riley Hospital Children	Ramkrishna, D (corresponding author), Purdue Univ, Sch Chem Engn, W Lafayette, IN 47907 USA.	ramkrish@purdue.edu	Rundell, Ann/P-1822-2014; Vik, Terry Allan/AAG-9422-2019	Vik, Terry Allan/0000-0002-9883-0568	NSF; American Recovery and Reinvestment Act (ARRA) [ECCS-0846572]; Directorate For Engineering [0846572] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); American Recovery and Reinvestment Act (ARRA); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by an NSF CAREER Award and funded under the American Recovery and Reinvestment Act of 2009 (ARRA) under the grant ECCS-0846572. D.J. would like to acknowledge the Lynn Fellowship for computational life sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimy M, 2005, SIAM J APPL MATH, V65, P1328, DOI 10.1137/040604698; Arico M, 2005, Leukemia, V19, P1145, DOI 10.1038/sj.leu.2403783; Armstrong GT, 2009, J CLIN ONCOL, V27, P2328, DOI 10.1200/JCO.2008.21.1425; Armstrong L, 2011, ALIMENT PHARM THER, V34, P1106, DOI 10.1111/j.1365-2036.2011.04848.x; Balis FM, 1998, BLOOD, V92, P3569, DOI 10.1182/blood.V92.10.3569.422k16_3569_3577; Bell BA, 2004, PEDIATR BLOOD CANCER, V43, P105, DOI 10.1002/pbc.20089; Bernard S, 2003, J THEOR BIOL, V223, P283, DOI 10.1016/S0022-5193(03)00090-0; Brandalise SR, 2010, J CLIN ONCOL, V28, P1911, DOI 10.1200/JCO.2009.25.6115; Campo PJ, 1987, ROBUST MODEL PREDICT, P1021; Cave H, 1998, NEW ENGL J MED, V339, P591, DOI 10.1056/NEJM199808273390904; Chan K., 2000, SENSITIVITY ANAL; Chessells JM, 1997, BRIT J HAEMATOL, V98, P945, DOI 10.1046/j.1365-2141.1997.3113127.x; Childhood A, 1996, LANCET, V347, P1783, DOI DOI 10.1016/S0140-6736(96)91615-3; Decaux G, 2000, J LAB CLIN MED, V135, P256, DOI 10.1067/mlc.2000.105215; Deisboeck T.S., 2011, ANN REV BIOMEDICAL E, V13; Dickerman JD, 2007, PEDIATRICS, V119, P554, DOI 10.1542/peds.2006-2826; Doyle III F, 2011, DYNAMICS CONTROL ART; Evans WE, 1998, NEW ENGL J MED, V338, P499, DOI 10.1056/NEJM199802193380803; Foley C, 2009, J MATH BIOL, V58, P285, DOI 10.1007/s00285-008-0165-3; Fransson M, 2007, STATISTICS, V2009, P04; Gearry RB, 2005, INTERN MED J, V35, P580, DOI 10.1111/j.1445-5994.2005.00904.x; Harila MJ, 2010, PEDIATR BLOOD CANCER, V55, P331, DOI 10.1002/pbc.22531; HAUPT R, 1994, JAMA-J AM MED ASSOC, V272, P1427, DOI 10.1001/jama.272.18.1427; Haurie C, 1998, BLOOD, V92, P2629, DOI 10.1182/blood.V92.8.2629.420a35_2629_2640; Hawwa AF, 2008, BRIT J CLIN PHARMACO, V66, P517, DOI 10.1111/j.1365-2125.2008.03248.x; Hawwa AF, 2008, BRIT J CLIN PHARMACO, V66, P826, DOI 10.1111/j.1365-2125.2008.03281.x; Hillman R., 1996, RED CELL MANUAL; Hindorf U, 2006, GUT, V55, P1423, DOI 10.1136/gut.2005.074930; Hindorf U, 2004, THER DRUG MONIT, V26, P673, DOI 10.1097/00007691-200412000-00014; Innocenti F, 1999, CANCER CHEMOTH PHARM, V43, P133, DOI 10.1007/s002800050873; Jemal A, 2010, CA CANC J CLIN CAAC; Kiran KL, 2009, IFMBE PROC, V23, P1337; Kiran KL, 2009, CAN J CHEM ENG, V87, P732, DOI 10.1002/cjce.20204; KOREN G, 1990, NEW ENGL J MED, V323, P17, DOI 10.1056/NEJM199007053230104; KRYNETSKI EY, 1995, MOL PHARMACOL, V47, P1141; Lainez JM, 2011, IND ENG CHEM RES; LENNARD L, 1992, EUR J CLIN PHARMACOL, V43, P329, DOI 10.1007/BF02220605; LENNARD L, 1990, LANCET, V336, P225, DOI 10.1016/0140-6736(90)91745-V; LENNARD L, 1993, BRIT J CLIN PHARMACO, V36, P277, DOI 10.1111/j.1365-2125.1993.tb00365.x; LILLEYMAN JS, 1994, LANCET, V343, P1188, DOI 10.1016/S0140-6736(94)92400-7; LOHRMANN HP, 1982, RECENT RES CANCER, V80, P192; MACKEY MC, 1978, BLOOD, V51, P941; Mody R, 2008, BLOOD, V111, P5515, DOI 10.1182/blood-2007-10-117150; Morari M, 1999, COMPUT CHEM ENG, V23, P667, DOI 10.1016/S0098-1354(98)00301-9; Noble SL, 2010, J THEOR BIOL, V264, P990, DOI 10.1016/j.jtbi.2010.01.031; Nowak MA., 2000, VIRUS DYNAMICS MATH; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Rombout F, 2004, J PHARMACOKINET PHAR, V31, P419, DOI 10.1007/s10928-005-5910-2; Schmiegelow K, 2009, LEUKEMIA, V23, P557, DOI 10.1038/leu.2008.316; Schmiegelow K, 2009, BLOOD, V113, P6077, DOI 10.1182/blood-2008-11-187880; Sklar CA, 2002, J CLIN ENDOCR METAB, V87, P3136, DOI 10.1210/jc.87.7.3136; Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6; Stefanini MO, 2012, MATH MED BIOL, V29, P85, DOI 10.1093/imammb/dqq025; Terashi K, 1999, ANTIMICROB AGENTS CH, V43, P21, DOI 10.1128/AAC.43.1.21; Testart-Paillet D, 2007, CRIT REV ONCOL HEMAT, V63, P1, DOI 10.1016/j.critrevonc.2007.01.005; Thomas CW, 2003, INFLAMM BOWEL DIS, V9, P237, DOI 10.1097/00054725-200307000-00004; Tolar J, 2000, J PEDIAT HEMATOL ONC, V22, P378; TUCKER MA, 1987, J NATL CANCER I, V78, P459, DOI 10.1093/jnci/78.3.459	59	31	31	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109623	10.1371/journal.pone.0109623	http://dx.doi.org/10.1371/journal.pone.0109623			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310465	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210300061
J	Kaveri, S; Nakahara, H				Kaveri, Sivaramakrishnan; Nakahara, Hiroyuki			Dual Reward Prediction Components Yield Pavlovian Sign- and Goal-Tracking	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; ORBITOFRONTAL CORTEX; DOPAMINE NEURONS; ACCUMBENS CORE; SUCCESSOR REPRESENTATION; NUCLEUS-ACCUMBENS; LATERAL HABENULA; DECISION-MAKING; SYSTEMS; MODELS	Reinforcement learning (RL) has become a dominant paradigm for understanding animal behaviors and neural correlates of decision-making, in part because of its ability to explain Pavlovian conditioned behaviors and the role of midbrain dopamine activity as reward prediction error (RPE). However, recent experimental findings indicate that dopamine activity, contrary to the RL hypothesis, may not signal RPE and differs based on the type of Pavlovian response (e. g. sign-and goal-tracking responses). In this study, we address this discrepancy by introducing a new neural correlate for learning reward predictions; the correlate is called "cue-evoked reward''. It refers to a recall of reward evoked by the cue that is learned through simple cue-reward associations. We introduce a temporal difference learning model, in which neural correlates of the cue itself and cue-evoked reward underlie learning of reward predictions. The animal's reward prediction supported by these two correlates is divided into sign and goal components respectively. We relate the sign and goal components to approach responses towards the cue (i.e. sign-tracking) and the food-tray (i.e. goal-tracking) respectively. We found a number of correspondences between simulated models and the experimental findings (i.e. behavior and neural responses). First, the development of modeled responses is consistent with those observed in the experimental task. Second, the model's RPEs were similar to dopamine activity in respective response groups. Finally, goal-tracking, but not sign-tracking, responses rapidly emerged when RPE was restored in the simulated models, similar to experiments with recovery from dopamine-antagonist. These results suggest two complementary neural correlates, corresponding to the cue and its evoked reward, form the basis for learning reward predictions in the sign-and goal-tracking rats.	[Kaveri, Sivaramakrishnan; Nakahara, Hiroyuki] RIKEN BSI, Lab Integrated Theoret Neurosci, Wako, Saitama, Japan; [Kaveri, Sivaramakrishnan] Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 227, Japan	RIKEN; Tokyo Institute of Technology	Kaveri, S (corresponding author), RIKEN BSI, Lab Integrated Theoret Neurosci, Wako, Saitama, Japan.	siva@brain.riken.jp	Nakahara, Hiroyuki/N-5411-2015	Nakahara, Hiroyuki/0000-0001-6891-1175; Kaveri, Srini/0000-0002-0837-4053	KAKENHI (Ministry of Education, Cultures, Sports, Science and Technology) [24120523]; Grants-in-Aid for Scientific Research [26120732] Funding Source: KAKEN	KAKENHI (Ministry of Education, Cultures, Sports, Science and Technology); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI grant 24120523 (Ministry of Education, Cultures, Sports, Science and Technology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselme P, 2012, BEHAV BRAIN RES; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Boakes RA, 1977, OPERANT PAVLOVIAN IN, V1st, P35; Bromberg-Martin ES, 2010, NEURON, V67, P499, DOI 10.1016/j.neuron.2010.06.031; Bromberg-Martin ES, 2010, NEURON, V67, P144, DOI 10.1016/j.neuron.2010.06.016; Clark JJ, 2012, CURR OPIN NEUROBIOL, V22, P1054, DOI 10.1016/j.conb.2012.06.004; Corbit LH, 2011, J NEUROSCI, V31, P11786, DOI 10.1523/JNEUROSCI.2711-11.2011; Corbit LH, 2001, J NEUROSCI, V21, P3251, DOI 10.1523/JNEUROSCI.21-09-03251.2001; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Dayan P, 2009, PHARMACOPSYCHIATRY, V42, pS56, DOI 10.1055/s-0028-1124107; DAYAN P, 1993, NEURAL COMPUT, V5, P613, DOI 10.1162/neco.1993.5.4.613; Dayan P, 2008, COGN AFFECT BEHAV NE, V8, P429, DOI 10.3758/CABN.8.4.429; Doll BB, 2011, J NEUROSCI, V31, P6188, DOI 10.1523/JNEUROSCI.6486-10.2011; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Flagel SB, 2010, NEUROPSYCHOPHARMACOL, V35, P388, DOI 10.1038/npp.2009.142; Flagel SB, 2009, NEUROPHARMACOLOGY, V56, P139, DOI 10.1016/j.neuropharm.2008.06.027; Frank MJ, 2009, NAT NEUROSCI, V12, P1062, DOI 10.1038/nn.2342; Gershman SJ, 2012, NEURAL COMPUT, V24, P1553, DOI 10.1162/NECO_a_00282; HOLLAND PC, 1990, COGNITION, V37, P105, DOI 10.1016/0010-0277(90)90020-K; HOLLAND PC, 1985, J EXP PSYCHOL ANIM B, V11, P367, DOI 10.1037/0097-7403.11.3.367; Khamassi M, 2008, EUR J NEUROSCI, V28, P1849, DOI 10.1111/j.1460-9568.2008.06480.x; KONORSKI JERZY, 1967; Lesaint F, 2014, PLOS COMPUTATIONAL B, V10; Maia TV, 2011, NAT NEUROSCI, V14, P154, DOI 10.1038/nn.2723; McDannald MA, 2012, EUR J NEUROSCI, V35, P991, DOI 10.1111/j.1460-9568.2011.07982.x; Meyer PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038987; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Nakahara H, 2014, CURR OPIN NEUROBIOL, V25, P123, DOI 10.1016/j.conb.2014.01.001; Nakahara H, 2012, NEUROSCI RES, V74, P177, DOI 10.1016/j.neures.2012.09.007; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Pickens CL, 2004, NEUROSCI BIOBEHAV R, V28, P651, DOI 10.1016/j.neubiorev.2004.09.003; Ratcliff R, 2012, NEURAL COMPUT, V24, P1186, DOI 10.1162/NECO_a_00270; RESCORLA RA, 1988, AM PSYCHOL, V43, P151, DOI 10.1037/0003-066X.43.3.151; Rolls ET, 2000, ANNU REV PSYCHOL, V51, P599, DOI 10.1146/annurev.psych.51.1.599; Rolls ET, 1999, J NEUROSCI, V19, P1532; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Samejima K, 2007, ANN NY ACAD SCI, V1104, P213, DOI 10.1196/annals.1390.024; Saunders BT, 2012, EUR J NEUROSCI, V36, P2521, DOI 10.1111/j.1460-9568.2012.08217.x; Saunders BT, 2012, EUROPEAN J NEUROSCIE; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Sutton R.S., 1990, LEARNING COMPUTATION, P497; Takahashi YK, 2011, NAT NEUROSCI, V14, P1590, DOI 10.1038/nn.2957; Tomie A, 2000, PHARMACOL BIOCHEM BE, V65, P509, DOI 10.1016/S0091-3057(99)00241-5; YAXLEY S, 1988, PHYSIOL BEHAV, V42, P223, DOI 10.1016/0031-9384(88)90074-1	49	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e108142	10.1371/journal.pone.0108142	http://dx.doi.org/10.1371/journal.pone.0108142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ9WZ	25310184	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210300011
J	Larcher, T; Lafoux, A; Tesson, L; Remy, S; Thepenier, V; Francois, V; Le Guiner, C; Goubin, H; Dutilleul, M; Guigand, L; Toumaniantz, G; De Cian, A; Boix, C; Renaud, JB; Cherel, Y; Giovannangeli, C; Concordet, JP; Anegon, I; Huchet, C				Larcher, Thibaut; Lafoux, Aude; Tesson, Laurent; Remy, Severine; Thepenier, Virginie; Francois, Virginie; Le Guiner, Caroline; Goubin, Helicia; Dutilleul, Maeva; Guigand, Lydie; Toumaniantz, Gilles; De Cian, Anne; Boix, Charlotte; Renaud, Jean-Baptiste; Cherel, Yan; Giovannangeli, Carine; Concordet, Jean-Paul; Anegon, Ignacio; Huchet, Corinne			Characterization of Dystrophin Deficient Rats: A New Model for Duchenne Muscular Dystrophy	PLOS ONE			English	Article							ZINC-FINGER; EMBRYO MICROINJECTION; KNOCKOUT RATS; MDX; GENE; GENERATION; ZEBRAFISH; EVOLUTION; PREDICTS; CALCIUM	A few animal models of Duchenne muscular dystrophy (DMD) are available, large ones such as pigs or dogs being expensive and difficult to handle. Mdx (X-linked muscular dystrophy) mice only partially mimic the human disease, with limited chronic muscular lesions and muscle weakness. Their small size also imposes limitations on analyses. A rat model could represent a useful alternative since rats are small animals but 10 times bigger than mice and could better reflect the lesions and functional abnormalities observed in DMD patients. Two lines of Dmd mutated-rats (Dmd(mdx)) were generated using TALENs targeting exon 23. Muscles of animals of both lines showed undetectable levels of dystrophin by western blot and less than 5% of dystrophin positive fibers by immunohistochemistry. At 3 months, limb and diaphragm muscles from Dmd(mdx) rats displayed severe necrosis and regeneration. At 7 months, these muscles also showed severe fibrosis and some adipose tissue infiltration. Dmd(mdx) rats showed significant reduction in muscle strength and a decrease in spontaneous motor activity. Furthermore, heart morphology was indicative of dilated cardiomyopathy associated histologically with necrotic and fibrotic changes. Echocardiography showed significant concentric remodeling and alteration of diastolic function. In conclusion, Dmd(mdx) rats represent a new faithful small animal model of DMD.	[Larcher, Thibaut; Goubin, Helicia; Dutilleul, Maeva; Guigand, Lydie; Cherel, Yan] Univ Nantes, Oniris, Ecole Natl Vet Agroalimentaire & Alimentat, INRA,APEX UMR703, Nantes, France; [Lafoux, Aude; Toumaniantz, Gilles; Huchet, Corinne] Univ Nantes, Inst Thorax, Fac Sci & Tech, CNRS 6291,INSERM,UMR 1087, Nantes, France; [Tesson, Laurent; Remy, Severine; Thepenier, Virginie; Anegon, Ignacio] Univ Nantes, CHU Nantes, Fac Med,INSERM,ITUN, UMR Ctr Res Transplantat & Immunol 1064, Nantes, France; [Francois, Virginie; Le Guiner, Caroline] Univ Nantes, Fac Med, INSERM, UMR 1089, Nantes, France; [Le Guiner, Caroline] Genethon, Evry, France; [De Cian, Anne; Boix, Charlotte; Renaud, Jean-Baptiste; Giovannangeli, Carine; Concordet, Jean-Paul] Museum Natl Hist Nat, CNRS, INSERM, U1154,UMR 7196, Paris, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Nantes Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); Museum National d'Histoire Naturelle (MNHN)	Anegon, I (corresponding author), Univ Nantes, CHU Nantes, Fac Med,INSERM,ITUN, UMR Ctr Res Transplantat & Immunol 1064, Nantes, France.	ianegon@inserm.fr; corinne.huchet2@univ-nantes.fr	Anegon, Ignacio/I-7760-2018; Larcher, Thibaut/X-8500-2019; Anegon, Ignacio/I-7498-2018; concordet, jean-paul/C-3417-2015; Larcher, Thibaut/M-9160-2013	Larcher, Thibaut/0000-0002-0396-3190; DE CIAN, Anne/0000-0002-1737-2543; Concordet, Jean-Paul/0000-0001-8924-4316	Region Pays de la Loire through Biogenouest; IBiSA program; Fondation Progreffe; TEFOR (Infrastructures d'Avenir of the French goverment)	Region Pays de la Loire through Biogenouest(Region Pays de la Loire); IBiSA program; Fondation Progreffe; TEFOR (Infrastructures d'Avenir of the French goverment)	Funding was provided by Region Pays de la Loire through Biogenouest, IBiSA program, Fondation Progreffe and TEFOR (Infrastructures d'Avenir of the French goverment), and the integrative genomic facility of Nantes for sequencing experiments. The authors thank the Wolfson Centre for Inherited Neuromuscular Disease for kindly supplying dystrophin monoclonal antibody. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allen DG, 2010, CAN J PHYSIOL PHARM, V88, P83, DOI 10.1139/Y09-058; Arechavala-Gomeza V, 2010, NEUROMUSCULAR DISORD, V20, P295, DOI 10.1016/j.nmd.2010.03.007; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Bartlett RJ, 2000, NAT BIOTECHNOL, V18, P615, DOI 10.1038/76448; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Carre-Pierrat M, 2011, NEUROMUSCULAR DISORD, V21, P313, DOI 10.1016/j.nmd.2011.01.005; De Luca A, 2008, IEEE T ROBOT, V24, P1, DOI 10.1109/TRO.2008.918243; Desguerre I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004347; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Dubowitz V, 1985, MUSCLE BIOPSY MODERN, P335; Fine EJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1326; Geurts AM, 2010, METHODS MOL BIOL, V597, P211, DOI 10.1007/978-1-60327-389-3_15; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hollinger K, 2014, FASEB J, V28, P1600, DOI 10.1096/fj.13-241141; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Jarmin S, 2014, EXPERT OPIN BIOL TH, V14, P209, DOI 10.1517/14712598.2014.866087; Kanneboyinna N, 2008, BEHAV LOCOMOTOR MEAS; Kieny P., 2013, Annals of Physical and Rehabilitation Medicine, V56, P443, DOI 10.1016/j.rehab.2013.06.002; Klingler Werner, 2012, Acta Myol, V31, P184; Klymiuk N, 2013, HUM MOL GENET, V22, P4368, DOI 10.1093/hmg/ddt287; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Lin S, 1998, J NEUROPATH EXP NEUR, V57, P780, DOI 10.1097/00005072-199808000-00007; Menoret S, 2013, FASEB J, V27, P703, DOI 10.1096/fj.12-219907; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mourkioti F, 2013, NAT CELL BIOL, V15, P895, DOI 10.1038/ncb2790; Muller J, 2001, J MUSCLE RES CELL M, V22, P133, DOI 10.1023/A:1010305801236; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Nakamura A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/184393; Nakamura K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05635; Nowak KJ, 2004, EMBO REP, V5, P872, DOI 10.1038/sj.embor.7400221; Partridge TA, 2013, FEBS J, V280, P4177, DOI 10.1111/febs.12267; Piganeau M, 2013, GENOME RES, V23, P1182, DOI 10.1101/gr.147314.112; Remy S, 2014, GENOME RES IN PRESS; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; SHARP NJH, 1992, GENOMICS, V13, P115, DOI 10.1016/0888-7543(92)90210-J; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Whitehead NP, 2006, CLIN EXP PHARMACOL P, V33, P657, DOI 10.1111/j.1440-1681.2006.04394.x	40	104	109	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110371	10.1371/journal.pone.0110371	http://dx.doi.org/10.1371/journal.pone.0110371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310701	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210300111
J	Mudaliar, H; Pollock, C; Ma, J; Wu, HL; Chadban, S; Panchapakesan, U				Mudaliar, Harshini; Pollock, Carol; Ma, Jin; Wu, Huiling; Chadban, Steven; Panchapakesan, Usha			The Role of TLR2 and 4-Mediated Inflammatory Pathways in Endothelial Cells Exposed to High Glucose	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; DIABETIC-NEPHROPATHY; ADHESION MOLECULES; HYPERGLYCEMIA; EXPRESSION; DYSFUNCTION; ACTIVATION; PROGRESSION; TYPE-1; ICAM-1	Postprandial hyperglycemia induces inflammation and endothelial dysfunction resulting in vascular complications in patients with diabetes. Toll-like receptors (TLRs) are central to the regulation of inflammatory responses through activation of nuclear factor-kappa B (NF-kappa B). This study examined the role of TLR2 and 4 in regulating inflammation and endothelial dysfunction when exposed to fluctuating glucose concentrations. HMEC-1 cells (a human microvascular endothelial cell line) were exposed to control (5 mM), 30 mM (high), fluctuating (5/30 mM) and 11.2 mM glucose (approximate glycaemic criteria for the diagnosis of diabetes mellitus) for 72 h. Cells were assessed for TLR2, 4, high mobility group box -1 (HMGB1), NF-kappa B, monocyte chemoattractant protein-1 (MCP-1), interleukin-8 (IL-8), intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1). Fluctuating glucose concentrations maximally upregulated TLR4 but not TLR2 expression with increased NF-kappa B activation, IL-8 and ICAM-1 expression. HMGB1 was increased in the supernatants of cells exposed to 30 mM and 11.2 mM glucose compared to control. The addition of recombinant HMGB1 induced NF-kappa B activation and synthesis of proinflammatory cytokines and chemokines, which were prevented by TLR2 or 4 signalling inhibition. An additive effect when both TLR2 and 4 signalling pathways were inhibited was observed. However, only inhibition of TLR4 signalling suppressed the synthesis of MCP-1, IL-8 and ICAM-1. In vivo, streptozotocin-induced diabetic mice exhibited an increase in glomerular ICAM-1 which was not evident in TLR2(-/-) or TLR4(-/-) diabetic mice. Collectively, our results suggest that targeting the signalling pathway of TLR2 and 4 may be of therapeutic benefit in attenuating vascular inflammation in diabetic microangiopathy.	[Mudaliar, Harshini; Pollock, Carol; Panchapakesan, Usha] Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Renal Res Grp, St Leonards, NSW 2065, Australia; [Ma, Jin; Wu, Huiling; Chadban, Steven] Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia; [Ma, Jin; Wu, Huiling; Chadban, Steven] Univ Sydney, Collaborat Transplant Res Grp, Camperdown, NSW, Australia	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; University of Sydney; University of Sydney	Panchapakesan, U (corresponding author), Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Renal Res Grp, St Leonards, NSW 2065, Australia.	usha.panchapakesan@sydney.edu.au			National Health and Medical Research Council, Australia	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by National Health and Medical Research Council, Australia. URL http://purl.org/au-research/grants/nhmrc/632673. UP, CP, HW and SC received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Azuma K, 2006, ARTERIOSCL THROM VAS, V26, P2275, DOI 10.1161/01.ATV.0000239488.05069.03; Bae JS, 2011, BLOOD, V118, P3952, DOI 10.1182/blood-2011-06-360701; Ceriello A, 2004, DIABETES, V53, P701, DOI 10.2337/diabetes.53.3.701; Ceriello A, 2008, US ENDOCRINOL, P63; Chow FY, 2005, J AM SOC NEPHROL, V16, P1711, DOI 10.1681/ASN.2004070612; Devaraj S, 2011, METABOLISM, V60, P256, DOI 10.1016/j.metabol.2010.01.005; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300; Gluba A, 2010, NAT REV NEPHROL, V6, P224, DOI 10.1038/nrneph.2010.16; Gu Harvest F, 2012, Front Endocrinol (Lausanne), V3, P179, DOI 10.3389/fendo.2012.00179; Hak AE, 2001, J CLIN ENDOCR METAB, V86, P4398, DOI 10.1210/jc.86.9.4398; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Kahn R, 2001, DIABETES CARE, V24, P775; Kaur H, 2012, AM J PHYSIOL-RENAL, V303, pF1145, DOI 10.1152/ajprenal.00319.2012; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawano H, 1999, J AM COLL CARDIOL, V34, P146, DOI 10.1016/S0735-1097(99)00168-0; Li JL, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-90; Matsui H, 1996, DIABETES RES CLIN PR, V32, P1, DOI 10.1016/0168-8227(96)01209-0; Morioka T, 2001, DIABETES CARE, V24, P909, DOI 10.2337/diacare.24.5.909; Mudaliar H, 2013, AM J PHYSIOL-RENAL, V305, pF143, DOI 10.1152/ajprenal.00398.2012; Mullins GE, 2004, SCAND J IMMUNOL, V60, P566, DOI 10.1111/j.0300-9475.2004.01518.x; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Okada S, 2003, DIABETES, V52, P2586, DOI 10.2337/diabetes.52.10.2586; Panchapakesan U, 2005, AM J PHYSL RENAL PHY, V289; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Paulis LEM, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-25; Rudofsky G, 2004, DIABETES CARE, V27, P179, DOI 10.2337/diacare.27.1.179; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shichiri M, 2000, DIABETES CARE, V23, pB21; Skrha J, 2012, EXP CLIN ENDOCR DIAB, V120, P277, DOI 10.1055/s-0031-1283161; Stehouwer CDA, 2004, NEPHROL DIAL TRANSPL, V19, P778, DOI 10.1093/ndt/gfh015; Takata S, 2013, ACTA HISTOCHEM CYTOC, V46, P35, DOI 10.1267/ahc.13002; Tang SCW, 2006, J AM SOC NEPHROL, V17, P1633, DOI 10.1681/ASN.2005101113; Tang SCW, 2011, CONTRIB NEPHROL, V170, P124, DOI 10.1159/000325647; Taslipinar A, 2011, SCAND J CLIN LAB INV, V71, P606, DOI 10.3109/00365513.2011.598944; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Tuttle K, 2005, J AM SOC NEPHROL, V16, P5; Wang JJ, 2008, AM J PHYSIOL-RENAL, V294, pF1166, DOI 10.1152/ajprenal.00375.2007; Yang J, 2010, MOL CELL BIOCHEM, V345, P189, DOI 10.1007/s11010-010-0572-9; Yao DC, 2010, DIABETES, V59, P249, DOI 10.2337/db09-0801; Zafiriou S, 2004, KIDNEY INT, V65, P1647, DOI 10.1111/j.1523-1755.2004.00574.x; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554	45	75	80	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108844	10.1371/journal.pone.0108844	http://dx.doi.org/10.1371/journal.pone.0108844			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303153	Green Published, gold, Green Submitted			2022-12-27	WOS:000343730400029
J	Wong, AJ; Planck, SR; Choi, DS; Harrington, CA; Troxell, ML; Houghton, DC; Stauffer, P; Wilson, DJ; Grossniklaus, HE; Dailey, RA; Ng, JD; Steele, EA; Harris, GJ; Czyz, C; Foster, JA; White, VA; Dolman, PJ; Kazim, M; Patel, PJ; Edward, DP; al Katan, H; al Hussain, H; Selva, D; Yeatts, RP; Korn, BS; Kikkawa, DO; Rosenbaum, JT				Wong, Amanda J.; Planck, Stephen R.; Choi, Dongseok; Harrington, Christina A.; Troxell, Megan L.; Houghton, Donald C.; Stauffer, Patrick; Wilson, David J.; Grossniklaus, Hans E.; Dailey, Roger A.; Ng, John D.; Steele, Eric A.; Harris, Gerald J.; Czyz, Craig; Foster, Jill A.; White, Valerie A.; Dolman, Peter J.; Kazim, Michael; Patel, Payal J.; Edward, Deepak P.; al Katan, Hind; al Hussain, Hailah; Selva, Dinesh; Yeatts, R. Patrick; Korn, Bobby S.; Kikkawa, Don O.; Rosenbaum, James T.			IgG4 Immunostaining and Its Implications in Orbital Inflammatory Disease	PLOS ONE			English	Article							IGG4-POSITIVE PLASMA-CELLS; IGG4-RELATED SYSTEMIC-DISEASE; TUBULOINTERSTITIAL NEPHRITIS; SCLEROSING DISEASE; RITUXIMAB THERAPY; NOMENCLATURE; LUNG	Objective: IgG4-related disease is an emerging clinical entity which frequently involves tissue within the orbit. In order to appreciate the implications of IgG4 immunostaining, we analyzed gene expression and the prevalence of IgG4-immunostaining among subjects with orbital inflammatory diseases. Methods: We organized an international consortium to collect orbital biopsies from 108 subjects including 22 with no known orbital disease, 42 with nonspecific orbital inflammatory disease (NSOI), 26 with thyroid eye disease (TED), 12 with sarcoidosis, and 6 with granulomatosis with polyangiitis (GPA). Lacrimal gland and orbital adipose tissue biopsies were immunostained for IgG4 or IgG secreting plasma cells. RNA transcripts were quantified by Affymetrix arrays. Results: None of the healthy controls or subjects with TED had substantial IgG4 staining. Among the 63 others, the prevalence of significant IgG4-immunostaining ranged from 11 to 39% depending on the definition for significant. IgG4 staining was detectable in the majority of tissues from subjects with GPA and less commonly in tissue from subjects with sarcoidosis or NSOI. The detection of IgG4+ cells correlated with inflammation in the lacrimal gland based on histology. IgG4 staining tissue expressed an increase in transcripts associated with inflammation, especially B cell-related genes. Functional annotation analysis confirmed this. Conclusion: IgG4+ plasma cells are common in orbital tissue from patients with sarcoidosis, GPA, or NSOI. Even using the low threshold of 10 IgG4+ cells/high powered field, IgG4 staining correlates with increased inflammation in the lacrimal gland based on histology and gene expression.	[Wong, Amanda J.; Planck, Stephen R.; Choi, Dongseok; Stauffer, Patrick; Wilson, David J.; Dailey, Roger A.; Ng, John D.; Steele, Eric A.; Rosenbaum, James T.] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA; [Planck, Stephen R.; Rosenbaum, James T.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; [Planck, Stephen R.; Rosenbaum, James T.] Legacy Hlth Syst, Devers Eye Inst, Portland, OR USA; [Choi, Dongseok] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA; [Houghton, Donald C.] Oregon Hlth & Sci Univ, Integrated Genom Lab, Portland, OR 97201 USA; [Troxell, Megan L.; Houghton, Donald C.] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Grossniklaus, Hans E.] Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA; [Harris, Gerald J.] Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA; [Czyz, Craig] Ohio Univ, Div Ophthalmol, Columbus, OH USA; [Foster, Jill A.] Ohio State Univ, Dept Ophthalmol, Columbus, OH 43210 USA; [White, Valerie A.; Dolman, Peter J.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 1M9, Canada; [Kazim, Michael; Patel, Payal J.] Columbia Univ, Dept Ophthalmol, New York, NY 10027 USA; [Edward, Deepak P.; al Katan, Hind; al Hussain, Hailah] King Khalid Eye Specialist Hosp, Res Dept, Riyadh, Saudi Arabia; [Selva, Dinesh] Royal Adelaide Hosp, Ophthalmol Network, Adelaide, SA 5000, Australia; [Yeatts, R. Patrick] Wake Forest Univ, Dept Ophthalmol, Winston Salem, NC 27109 USA; [Korn, Bobby S.; Kikkawa, Don O.] Univ Calif San Diego, Dept Ophthalmol, San Diego, CA 92103 USA	Oregon Health & Science University; Oregon Health & Science University; Devers Eye Institute; Legacy Health; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Emory University; Medical College of Wisconsin; University System of Ohio; Ohio University; University System of Ohio; Ohio State University; University of British Columbia; Columbia University; King Khaled Eye Specialist Hospital; Royal Adelaide Hospital; Wake Forest University; University of California System; University of California San Diego	Rosenbaum, JT (corresponding author), Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA.	Rosenbaj@ohsu.edu	ALKATAN, HIND M/AAU-3752-2021	ALKATAN, HIND M/0000-0002-9968-4099; Czyz, Craig/0000-0001-6357-8019; Choi, Dongseok/0000-0002-1552-4072	National Institutes of Health [EY020249, EY010572, RR024140]; Research to Prevent Blindness (Casey Eye Institute, OHSU); Stan and Madelle Rosenfeld Family Trust; William and Mary Bauman Foundation; MAS Family Foundation; NATIONAL CANCER INSTITUTE [P30CA069533] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY020249, P30EY010572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (Casey Eye Institute, OHSU); Stan and Madelle Rosenfeld Family Trust; William and Mary Bauman Foundation; MAS Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by funding from National Institutes of Health Grants (www.nih.gov), EY020249 (JTR), EY010572 (JTR) and RR024140 (E.S.Orwoll); and Research to Prevent Blindness (www.rpbusa.org) (Casey Eye Institute, OHSU), the Stan and Madelle Rosenfeld Family Trust (JTR), the William and Mary Bauman Foundation (JTR), the MAS Family Foundation (JTR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara Y, 2013, JPN J OPHTHALMOL, V57, P573, DOI 10.1007/s10384-013-0266-4; Andrew N, 2013, ACTA OPHTHALMOL, V91, P694, DOI 10.1111/j.1755-3768.2012.02526.x; Chang SY, 2013, HUM PATHOL, V44, P2432, DOI 10.1016/j.humpath.2013.05.023; Cheuk W, 2007, AM J SURG PATHOL, V31, P643, DOI 10.1097/01.pas.0000213445.08902.11; Cornell LD, 2007, AM J SURG PATHOL, V31, P1586, DOI 10.1097/PAS.0b013e318059b87c; Deshpande V, 2012, MODERN PATHOL, V25, P1181, DOI 10.1038/modpathol.2012.72; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Hamed G, 2007, RESPIROLOGY, V12, P455, DOI 10.1111/j.1440-1843.2007.01053.x; Houghton DC, 2011, MODERN PATHOL, V24, P1480, DOI 10.1038/modpathol.2011.101; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kamisawa T, 2003, J GASTROENTEROL, V38, P982, DOI 10.1007/s00535-003-1175-y; Karamchandani JR, 2012, AM J CLIN PATHOL, V137, P699, DOI 10.1309/AJCPE1G8DRHXRPIH; Khosroshahi A, 2012, MEDICINE, V91, P57, DOI 10.1097/MD.0b013e3182431ef6; Khosroshahi A, 2011, AM J MED, V124, pE7, DOI 10.1016/j.amjmed.2011.03.011; Khosroshahi A, 2010, ARTHRITIS RHEUM-US, V62, P1755, DOI 10.1002/art.27435; Lehman JS, 2014, AM J CLIN PATHOL, V141, P234, DOI 10.1309/AJCPTMWTCN04GSJH; Lindfield D, 2012, EYE, V26, P623, DOI 10.1038/eye.2012.4; Matsuo T, 2010, J CLIN EXP HEMATOP, V50, P129, DOI 10.3960/jslrt.50.129; Mehta M, 2009, ARCH PATHOL LAB MED, V133, P1251, DOI 10.1043/1543-2165-133.8.1251; Plaza JA, 2011, ARCH OPHTHALMOL-CHIC, V129, P421, DOI 10.1001/archophthalmol.2011.16; Rispens T, 2009, J IMMUNOL, V182, P4275, DOI 10.4049/jimmunol.0804338; Sato Y, 2008, PATHOL INT, V58, P465, DOI 10.1111/j.1440-1827.2008.02257.x; Stone JH, 2012, SEMIN DIAGN PATHOL, V29, P177, DOI 10.1053/j.semdp.2012.08.002; Stone JH, 2012, ARTHRITIS RHEUM-US, V64, P3061, DOI 10.1002/art.34593; Strehl JD, 2011, J CLIN PATHOL, V64, P237, DOI 10.1136/jcp.2010.085613; Suhler EB, 2014, JAMA OPHTHALMOL, V132, P572, DOI 10.1001/jamaophthalmol.2013.8179; van de Stadt LA, 2013, ARTHRITIS RHEUM; Wallace ZS, 2013, MEDICINE, V92, P206, DOI 10.1097/MD.0b013e31829cce35; Wallace ZS, 2012, SURV OPHTHALMOL, V57, P26, DOI 10.1016/j.survophthal.2011.07.004; Zen Y, 2005, HUM PATHOL, V36, P710, DOI 10.1016/j.humpath.2005.05.011	30	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109847	10.1371/journal.pone.0109847	http://dx.doi.org/10.1371/journal.pone.0109847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303270	Green Submitted, Green Published, gold			2022-12-27	WOS:000343730400085
J	Lee, WC; Tsai, TH; Chen, YL; Yang, CH; Chen, SM; Chen, CJ; Lin, CJ; Cheng, CI; Hang, CL; Wu, CJ; Yip, HK				Lee, Wei-Chieh; Tsai, Tzu-Hsien; Chen, Yung-Lung; Yang, Cheng-Hsu; Chen, Shyh-Ming; Chen, Chien-Jen; Lin, Cheng-Jei; Cheng, Cheng-I; Hang, Chi-Ling; Wu, Chiung-Jen; Yip, Hon-Kan			Safety and Feasibility of Coronary Stenting in Unprotected Left Main Coronary Artery Disease in the Real World Clinical Practice-A Single Center Experience	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; BYPASS GRAFT-SURGERY; LONG-TERM OUTCOMES; INTERVENTION; STENOSIS; SURVIVAL; IMPACT; REVASCULARIZATION; ANGIOPLASTY	Background: This study evaluated the feasibility, safety, and prognostic outcome in patients with significant unprotected left main coronary artery (ULMCA) disease undergoing stenting. Method and Results: Between January 2010 and December 2012, totally 309 patients, including those with stable angina [13.9% (43/309)], unstable angina [59.2% (183/309)], acute non-ST-segment elevation myocardial infarction (NSTEMI) [24.3% (75/309)], and post-STEMI angina (i.e., onset of STEMI<7 days) [2.6% (8/309)] with significant ULMCA disease (>50%) undergoing stenting using transradial arterial approach, were consecutively enrolled. The patients' mean age was 68.9 +/- 10.8 yrs. Incidences of advance congestive heart failure (CHF) (defined as >= NYHA Fc 3) and multi-vessel disease were 16.5% (51/309) and 80.6% (249/309), respectively. Mechanical supports, including IABP for critical patients (defined as LVEF <35%, advanced CHF, or hemodynamically unstable) and extra-corporeal membrane oxygenator (ECMO) for hemodynamically collapsed patients, were utilized in 17.2% (53/309) and 2.6% (8/409) patients, respectively. Stent implantation was successfully performed in all patients. Thirty-day mortality rate was 4.5% (14/309) [cardiac death: 2.9% (9/309) vs. non-cardiac death: 1.6% (5/309)] without significant difference among four groups [2.3% (1) vs. 2.7% (5) vs. 9.3% (7) vs. 12.5% (1), p = 0.071]. Multivariate analysis identified acute kidney injury (AKI) as the strongest independent predictor of 30-day mortality (p<0.0001), while body mass index (BMI) and white blood cell (WBC) count were independently predictive of 30-day mortality (p = 0.003 and 0.012, respectively). Conclusion: Catheter-based LM stenting demonstrated high rates of procedural success and excellent 30-day clinical outcomes. AKI, BMI, and WBC count were significantly and independently predictive of 30-day mortality.	[Lee, Wei-Chieh; Tsai, Tzu-Hsien; Chen, Yung-Lung; Yang, Cheng-Hsu; Chen, Shyh-Ming; Chen, Chien-Jen; Lin, Cheng-Jei; Cheng, Cheng-I; Hang, Chi-Ling; Wu, Chiung-Jen; Yip, Hon-Kan] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Lee, Wei-Chieh; Tsai, Tzu-Hsien; Chen, Yung-Lung; Yang, Cheng-Hsu; Chen, Shyh-Ming; Chen, Chien-Jen; Lin, Cheng-Jei; Cheng, Cheng-I; Hang, Chi-Ling; Wu, Chiung-Jen; Yip, Hon-Kan] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Yip, Hon-Kan] Kaohsiung Chang Gung Mem Hosp, Ctr Translat Res Biomed Sci, Kaohsiung, Taiwan; [Yip, Hon-Kan] Kaohsiung Chang Gung Mem Hosp, Inst Shock Wave Med & Tissue Engn, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Yip, HK (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan.	han.gung@msa.hinet.net	Sun, Cheuk-Kwan/K-5723-2012	Chen, Shyh-Ming/0000-0001-5256-7429				Buszman PE, 2008, J AM COLL CARDIOL, V51, P538, DOI 10.1016/j.jacc.2007.09.054; Buszman PP, 2009, J INVASIVE CARDIOL, V21, P564; CARACCIOLO EA, 1995, CIRCULATION, V91, P2335, DOI 10.1161/01.CIR.91.9.2335; Carrie D, 2009, EUROINTERVENTION, V4, P449, DOI 10.4244/EIJV4I4A78; CHAITMAN BR, 1981, AM J CARDIOL, V48, P765, DOI 10.1016/0002-9149(81)90156-9; Cheng CI, 2009, CIRC J, V73, P705, DOI 10.1253/circj.CJ-08-0804; Chieffo A, 2007, CIRCULATION, V116, P158, DOI 10.1161/CIRCULATIONAHA.107.692178; Chung SY, 2012, CIRC J, V76, P1385, DOI 10.1253/circj.CJ-11-1015; COHEN MV, 1975, CIRCULATION, V52, P275, DOI 10.1161/01.CIR.52.2.275; Eagle KA, 2004, CIRCULATION, V110, pe340; Fajadet J, 2012, EUR HEART J, V33, P36, DOI 10.1093/eurheartj/ehr426; HERMILLER JB, 1992, CATHETER CARDIO DIAG, V25, P110, DOI 10.1002/ccd.1810250207; Kappetein AP, 2011, EUR HEART J, V32, P2125, DOI 10.1093/eurheartj/ehr213; Kragelund C, 2005, INT J CARDIOL, V98, P123, DOI 10.1016/j.ijcard.2004.03.042; Lee SH, 2008, AM J CARDIOL, V102, P957, DOI 10.1016/j.amjcard.2008.06.022; Park SJ, 2011, NEW ENGL J MED, V364, P1718, DOI 10.1056/NEJMoa1100452; Park SJ, 2003, AM J CARDIOL, V91, P12, DOI 10.1016/S0002-9149(02)02990-9; Rastan AJ, 2006, CIRCULATION, V114, pI477, DOI 10.1161/CIRCULATIONHA.105.001545; Rodes-Cabau J, 2008, CIRCULATION, V118, P2374, DOI 10.1161/CIRCULATIONAHA.107.727099; Sadeghi HM, 2003, CIRCULATION, V108, P2769, DOI 10.1161/01.CIR.0000103623.63687.21; Sheu JJ, 2010, CRIT CARE MED, V38, P1810, DOI 10.1097/CCM.0b013e3181e8acf7; Silvestri M, 2000, J AM COLL CARDIOL, V35, P1543, DOI 10.1016/S0735-1097(00)00588-X; Smith SC, 2006, CIRCULATION, V113, pE166, DOI 10.1161/CIRCULATIONAHA.106.173220; Taggart DP, 2008, J AM COLL CARDIOL, V51, P885, DOI 10.1016/j.jacc.2007.09.067; TAKARO T, 1982, CIRCULATION, V66, P14, DOI 10.1161/01.CIR.66.1.14; TAYLOR HA, 1989, CIRCULATION, V79, P1171, DOI 10.1161/01.CIR.79.6.1171; Tsai TH, 2013, AM J MED SCI, V345, P104, DOI 10.1097/MAJ.0b013e318258f482; Tsai TH, 2011, CRIT CARE MED, V39, P436, DOI 10.1097/CCM.0b013e318206ccc3; Vaquerizo B, 2009, CIRCULATION, V119, P2349, DOI 10.1161/CIRCULATIONAHA.108.804930; Yip HK, 2003, AM J CARDIOL, V92, P1331, DOI 10.1016/j.amjcard.2003.08.019; Yip HK, 2009, CIRC J, V73, P2050, DOI 10.1253/circj.CJ-09-0334; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1	32	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e109281	10.1371/journal.pone.0109281	http://dx.doi.org/10.1371/journal.pone.0109281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329166	gold, Green Published, Green Submitted			2022-12-27	WOS:000343942100017
J	Shimko, TC; Andersen, EC				Shimko, Tyler C.; Andersen, Erik C.			COPASutils: An R Package for Reading, Processing, and Visualizing Data from COPAS Large-Particle Flow Cytometers	PLOS ONE			English	Article								The R package COPASutils provides a logical workflow for the reading, processing, and visualization of data obtained from the Union Biometrica Complex Object Parametric Analyzer and Sorter (COPAS) or the BioSorter large-particle flow cytometers. Data obtained from these powerful experimental platforms can be unwieldy, leading to difficulties in the ability to process and visualize the data using existing tools. Researchers studying small organisms, such as Caenorhabditis elegans, Anopheles gambiae, and Danio rerio, and using these devices will benefit from this streamlined and extensible R package. COPASutils offers a powerful suite of functions for the rapid processing and analysis of large high-throughput screening data sets.	[Shimko, Tyler C.; Andersen, Erik C.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	Northwestern University	Andersen, EC (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	erik.andersen@northwestern.edu		Andersen, Erik/0000-0003-0229-9651	Northwestern University	Northwestern University	This work was supported by start-up funds provided by Northwestern University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardini F, 2014, P NATL ACAD SCI USA, V111, P7600, DOI 10.1073/pnas.1404996111; Boyd WA, 2010, TOXICOL APPL PHARM, V245, P153, DOI 10.1016/j.taap.2010.02.014; Boyd WA, 2010, NEUROTOXICOL TERATOL, V32, P68, DOI 10.1016/j.ntt.2008.12.004; Elizabeth M, 2010, BIOTECHNIQUES, DOI [10.2144/000113427, DOI 10.2144/000113427.]; Giacomotto J, 2010, BRIT J PHARMACOL, V160, P204, DOI 10.1111/j.1476-5381.2010.00725.x; Karatzoglou A, 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i09, DOI 10.18637/JSS.V011.I09]; Veneman WJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-255; Wickham H, 2014, DPLYR GRAMMAR DATA M; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zhang XHD, 2006, PHARMACOGENOMICS, V7, P299, DOI 10.2217/14622416.7.3.299; Zhang XD, 2013, BIOINFORMATICS, V29, P794, DOI 10.1093/bioinformatics/btt060	11	23	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e111090	10.1371/journal.pone.0111090	http://dx.doi.org/10.1371/journal.pone.0111090			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329171	gold, Green Published			2022-12-27	WOS:000343942100109
J	Little, VL; McGuirk, TE; Patten, C				Little, Virginia L.; McGuirk, Theresa E.; Patten, Carolynn			Impaired Limb Shortening following Stroke: What's in a Name?	PLOS ONE			English	Article							POSTSTROKE HEMIPARESIS; HEMIPLEGIC GAIT; WALKING SPEED; TOE CLEARANCE; REHABILITATION; LEG; ABNORMALITIES; KINEMATICS; PARAMETERS; VARIABLES	Background: Difficulty advancing the paretic limb during the swing phase of gait is a prominent manifestation of walking dysfunction following stroke. This clinically observable sign, frequently referred to as 'foot drop', ostensibly results from dorsiflexor weakness. Objective: Here we investigated the extent to which hip, knee, and ankle motions contribute to impaired paretic limb advancement. We hypothesized that neither: 1) minimal toe clearance and maximal limb shortening during swing nor, 2) the pattern of multiple joint contributions to toe clearance and limb shortening would differ between post-stroke and non-disabled control groups. Methods: We studied 16 individuals post-stroke during overground walking at self-selected speed and nine non-disabled controls who walked at matched speeds using 3D motion analysis. Results: No differences were detected with respect to the ankle dorsiflexion contribution to toe clearance post-stroke. Rather, hip flexion had a greater relative influence, while the knee flexion influence on producing toe clearance was reduced. Conclusions: Similarity in the ankle dorsiflexion, but differences in the hip and knee, contributions to toe clearance between groups argues strongly against dorsiflexion dysfunction as the fundamental impairment of limb advancement post-stroke. Marked reversal in the roles of hip and knee flexion indicates disruption of inter-joint coordination, which most likely results from impairment of the dynamic contribution to knee flexion by the gastrocnemius muscle in preparation for swing. These findings suggest the need to reconsider the notion of foot drop in persons post-stroke. Redirecting the focus of rehabilitation and restoration of hemiparetic walking dysfunction appropriately, towards contributory neuromechanical impairments, will improve outcomes and reduce disability.	[Little, Virginia L.; McGuirk, Theresa E.; Patten, Carolynn] Univ Florida, Dept Phys Therapy, Gainesville, FL 32611 USA; [Little, Virginia L.; Patten, Carolynn] Univ Florida, Rehabil Sci Doctoral Program, Gainesville, FL USA; [Little, Virginia L.; McGuirk, Theresa E.; Patten, Carolynn] Malcolm Randall VA Med Ctr, Brain Rehabil Res & Dev Ctr, Gainesville, FL USA; [Patten, Carolynn] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Patten, C (corresponding author), Univ Florida, Dept Phys Therapy, Gainesville, FL 32611 USA.	patten@phhp.ufl.edu	Patten, Carolynn/B-4804-2009	Patten, Carolynn/0000-0002-9948-0045	Department of Veterans Affairs, Rehabilitation Research & Development Service [B540231, F7823S]; VA Brain Rehabilitation Research Center of Excellence [B6793C]; Foundation for Physical Therapy; NIH [5 T32 HD043730-08]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD043730] Funding Source: NIH RePORTER	Department of Veterans Affairs, Rehabilitation Research & Development Service(US Department of Veterans Affairs); VA Brain Rehabilitation Research Center of Excellence; Foundation for Physical Therapy; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Department of Veterans Affairs, Rehabilitation Research & Development Service, Project #B540231 (CP) and Research Career Scientist Award #F7823S (CP) and the VA Brain Rehabilitation Research Center of Excellence (B6793C). Dr. Little received support from the Foundation for Physical Therapy and NIH T32 Neuromuscular Plasticity Training Grant (No. 5 T32 HD043730-08, K Vandenborne, PI). The funding source played no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Begg R, 2007, GAIT POSTURE, V25, P191, DOI 10.1016/j.gaitpost.2006.03.008; Blaya JA, 2004, IEEE T NEUR SYS REH, V12, P24, DOI 10.1109/TNSRE.2003.823266; BOHANNON RW, 1987, ARCH PHYS MED REHAB, V68, P777; Burridge JH, 2001, NEUROMODULATION, V4, P77, DOI 10.1046/j.1525-1403.2001.00077.x; Burridge JH, 2001, MED ENG PHYS, V23, P427, DOI 10.1016/S1350-4533(01)00061-3; Chen G, 2005, GAIT POSTURE, V22, P51, DOI 10.1016/j.gaitpost.2004.06.009; Chen G, 2008, J BIOMECH, V41, P877, DOI 10.1016/j.jbiomech.2007.10.017; Clark DJ, 2006, CLIN NEUROPHYSIOL, V117, P2328, DOI 10.1016/j.clinph.2006.07.131; De Bujanda Eva, 2004, J Stroke Cerebrovasc Dis, V13, P58; Den Otter AR, 2007, GAIT POSTURE, V25, P342, DOI 10.1016/j.gaitpost.2006.04.007; Dodd KJ, 2003, ARCH PHYS MED REHAB, V84, P1200, DOI 10.1016/S0003-9993(03)00142-4; Duncan PW, 2011, NEW ENGL J MED, V364, P2026, DOI 10.1056/NEJMoa1010790; Forrester LW, 2011, NEUROREHAB NEURAL RE, V25, P369, DOI 10.1177/1545968310388291; Goldberg SR, 2004, J BIOMECH, V37, P1189, DOI 10.1016/j.jbiomech.2003.12.005; Hand Brittany, 2014, Stroke Res Treat, V2014, P462681, DOI 10.1155/2014/462681; Jonkers I, 2009, GAIT POSTURE, V29, P129, DOI 10.1016/j.gaitpost.2008.07.010; Kafri M, 2013, J NEUROIMAGING, V23, P39, DOI 10.1111/j.1552-6569.2012.00734.x; Kautz SA, 2006, J NEUROPHYSIOL, V95, P3154, DOI 10.1152/jn.00951.2005; Kautz SA, 2005, J NEUROPHYSIOL, V93, P2460, DOI 10.1152/jn.00963.2004; Kesar TM, 2010, PHYS THER, V90, P55, DOI 10.2522/ptj.20090140; Kesar TM, 2009, STROKE, V40, P3821, DOI 10.1161/STROKEAHA.109.560375; Lamontagne A, 2000, J ELECTROMYOGR KINES, V10, P407, DOI 10.1016/S1050-6411(00)00028-6; Lamontagne A, 2002, GAIT POSTURE, V15, P244, DOI 10.1016/S0966-6362(01)00190-4; LEHMANN JF, 1986, ARCH PHYS MED REHAB, V67, P380; Mills PM, 2008, GAIT POSTURE, V28, P101, DOI 10.1016/j.gaitpost.2007.10.006; Moosabhoy MA, 2006, GAIT POSTURE, V24, P493, DOI 10.1016/j.gaitpost.2005.12.004; Mulroy SJ, 2010, PHYS THER, V90, P209, DOI 10.2522/ptj.20090141; Murray M P, 1966, Phys Ther, V46, P585; Murray M P, 1966, Phys Ther, V46, P590; Nadeau S, 1999, CLIN BIOMECH, V14, P125, DOI 10.1016/S0268-0033(98)00062-X; OLNEY SJ, 1994, PHYS THER, V74, P872, DOI 10.1093/ptj/74.9.872; OLNEY SJ, 1996, GAIT POSTURE, V4, P136, DOI 10.1016/0966-6362(96)01063-6; Pereira S, 2014, J ELECTROMYOGR KINES, V24, P165, DOI 10.1016/j.jelekin.2013.10.001; Perry J., 1992, GAIT ANAL NORMAL PAT; Pollock A, 2012, LANCET NEUROL, V11, P209, DOI 10.1016/S1474-4422(12)70029-7; Rancho Los Amigos Medical Center Pathokinesiology Service Rancho Los Amigos Medical Center Physical Therapy Dept, 2001, OBS GAIT AN; Roy A, 2009, IEEE T ROBOT, V25, P569, DOI 10.1109/TRO.2009.2019783; Silva-Couto MD, 2014, PHYS THER; Stokic DS, 2009, AM J PHYS MED REHAB, V88, P437, DOI 10.1097/PHM.0b013e3181a5b1ec; SUTHERLAND DH, 1980, J BONE JOINT SURG AM, V62, P354, DOI 10.2106/00004623-198062030-00005; Tyson SF, 1999, CLIN REHABIL, V13, P295, DOI 10.1191/026921599666307333; WAGENAAR RC, 1992, J BIOMECH, V25, P1007, DOI 10.1016/0021-9290(92)90036-Z; WINTER DA, 1984, CRIT REV BIOMED ENG, V9, P287; WINTER DA, 1992, PHYS THER, V72, P55, DOI 10.1093/ptj/72.1.55; Yavuzer G, 2008, GAIT POSTURE, V27, P31, DOI 10.1016/j.gaitpost.2006.12.016	45	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110140	10.1371/journal.pone.0110140	http://dx.doi.org/10.1371/journal.pone.0110140			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329317	Green Submitted, gold, Green Published			2022-12-27	WOS:000343210800062
J	Srisuwan, S; Tongtawe, P; Srimanote, P; Voravuthikunchai, SP				Srisuwan, Sutthirat; Tongtawe, Pongsri; Srimanote, Potjanee; Voravuthikunchai, Supayang Piyawan			Rhodomyrtone Modulates Innate Immune Responses of THP-1 Monocytes to Assist in Clearing Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							PGG-GLUCAN; PHAGOCYTOSIS; MACROPHAGES; SUPPRESSION; ENHANCEMENT; RECOGNITION; ACTIVATION; PREVENTION; INDUCTION; EFFICACY	Background: The increasing resistance of Staphylococcus aureus to conventional antibiotics poses a major health problem. Moreover, S. aureus can survive within phagocytes, thus evading some antibiotics and the innate immune response. Rhodomyrtone, a bioactive compound from the leaves of Rhodomyrtus tomentosa, possesses potent antibacterial activity against methicillin-resistant S. aureus (MRSA). This study was to investigate the immunomodulatory effects of rhodomyrtone on THP-1 monocytes in response to MRSA. Methods: THP-1 monocytes were stimulated with heat-killed MRSA, followed by treatment with rhodomyrtone. The cell pellets were prepared to detect pro-inflammatory molecules using real-time PCR. The supernatants were collected to assess nitric oxide production using Griess assay. Assays for phagocytosis and bacterial killing by THP-1 monocytes were performed to determine if they were affected by rhodomyrtone. Results: Expression of pro-inflammatory molecules including IL-1 beta, TNF-alpha, IL-6, and iNOS was enhanced in THP-1 monocytes stimulated with high doses of heat-killed MRSA (10(8) to 10(9) cfu/ml). In contrast, monocytes stimulated with MRSA at lower doses (10(6) to 10(7) cfu/ml) did not induce the expression of these cytokines. However, rhodomyrtone significantly increased the expression of pro-inflammatory mediators, IL-6 and iNOS in monocytes stimulated with heat-killed MRSA at low doses, and displayed some anti-inflammatory activity by reducing TNF-alpha expression in monocytes stimulated with heat-killed MRSA at high doses. Treatment with rhodomyrtone also significantly up-regulated the expression of the key pattern recognition receptors, TLR2 and CD14, in THP-1 monocytes stimulated with heat-killed MRSA at 10(6) to 10(9) cfu/ml, while heat-killed MRSA alone did not induce the expression of these molecules. The ability of rhodomyrtone to eliminate MRSA from the monocytes was observed within 24 h after treatment. Conclusion: Rhodomyrtone enhanced the expression of pattern recognition receptors by monocytes in response to MRSA. Increased expression of these receptors might improve MRSA clearance by modulating pro- and anti-inflammatory cytokine responses.	[Srisuwan, Sutthirat; Voravuthikunchai, Supayang Piyawan] Prince Songkla Univ, Fac Sci, Dept Microbiol, Hat Yai, Thailand; [Srisuwan, Sutthirat; Voravuthikunchai, Supayang Piyawan] Prince Songkla Univ, Fac Sci, Nat Prod Res Ctr Excellence, Hat Yai, Thailand; [Tongtawe, Pongsri; Srimanote, Potjanee] Thammasat Univ, Fac Allied Hlth Sci, Grad Program Biomed Sci, Pathumtanee, Thailand	Prince of Songkla University; Prince of Songkla University; Thammasat University	Voravuthikunchai, SP (corresponding author), Prince Songkla Univ, Fac Sci, Dept Microbiol, Hat Yai, Thailand.	supayang.v@psu.ac.th	Srimanote, Potjanee/W-2221-2019		Thailand Research Fund [BRG 5580015]; Royal Golden Jubilee Ph.D. Program [PHD/0293/2552]	Thailand Research Fund(Thailand Research Fund (TRF)); Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF))	This work was supported by the Thailand Research Fund (Grant number BRG 5580015) and the Royal Golden Jubilee Ph.D. Program (Grant number PHD/0293/2552). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Dachriyanus, 2002, AUST J CHEM, V55, P229, DOI 10.1071/CH01194; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Davis KM, 2011, INFECT IMMUN, V79, P562, DOI 10.1128/IAI.00651-10; Diao H, 2005, INFECT IMMUN, V73, P3745, DOI 10.1128/IAI.73.6.3745-3748.2005; El-Obeid A, 2006, BIOCHEM BIOPH RES CO, V344, P1200, DOI 10.1016/j.bbrc.2006.04.035; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Geetha K. M., 2010, Journal of Pharmacy Research, V3, P2860; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hiranrat A, 2008, TETRAHEDRON, V64, P11193, DOI 10.1016/j.tet.2008.09.054; Imbuluzqueta E, 2012, J ANTIMICROB CHEMOTH, V67, P2158, DOI 10.1093/jac/dks172; Jeong D, 2013, J ETHNOPHARMACOL, V146, P205, DOI 10.1016/j.jep.2012.12.034; Jiang WW, 2011, INT IMMUNOPHARMACOL, V11, P1065, DOI 10.1016/j.intimp.2011.02.028; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kolodziej H, 2005, BIOORGAN MED CHEM, V13, P6470, DOI 10.1016/j.bmc.2005.07.012; Lambert JD, 2007, CHEM RES TOXICOL, V20, P583, DOI 10.1021/tx7000515; Liang JS, 1998, INT J IMMUNOPHARMACO, V20, P595, DOI 10.1016/S0192-0561(98)00007-1; Limsuwan S, 2009, PHYTOMEDICINE, V16, P645, DOI 10.1016/j.phymed.2009.01.010; de Oliveira FFM, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/291592; McKay DL, 2007, PHYTOTHER RES, V21, P1, DOI 10.1002/ptr.1992; Miller LS, 2011, NAT REV IMMUNOL, V11, P505, DOI 10.1038/nri3010; Miller M, 2011, J PROTEOME RES, V10, P4018, DOI 10.1021/pr200224x; Oberg F, 2009, PHYTOMEDICINE, V16, P477, DOI 10.1016/j.phymed.2008.10.008; Ramstead AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050546; Rockel C, 2011, IMMUNOBIOLOGY, V216, P316, DOI 10.1016/j.imbio.2010.08.001; Saising J, 2008, J HEALTH SCI, V54, P589, DOI 10.1248/jhs.54.589; Schmaler M, 2010, INT J MED MICROBIOL, V300, P155, DOI 10.1016/j.ijmm.2009.08.018; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Shimada T, 2010, CELL HOST MICROBE, V7, P38, DOI 10.1016/j.chom.2009.12.008; Sinha B, 2010, INT J MED MICROBIOL, V300, P170, DOI 10.1016/j.ijmm.2009.08.019; Sulemankhil I, 2012, ANTIMICROB AGENTS CH, V56, P6095, DOI 10.1128/AAC.01173-12; Sullivan AM, 2008, IMMUNOPHARM IMMUNOT, V30, P553, DOI 10.1080/08923970802135534; Tanioka A, 2013, SCAND J IMMUNOL, V78, P61, DOI 10.1111/sji.12067; Thurlow LR, 2011, J IMMUNOL, V186, P6585, DOI 10.4049/jimmunol.1002794; TILG H, 1994, BLOOD, V83, P113; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Tuchscherr L, 2011, EMBO MOL MED, V3, P129, DOI 10.1002/emmm.201000115; Tuchscherr L, 2010, J INFECT DIS, V202, P1031, DOI 10.1086/656047; Tzianabos AO, 1996, ANN NY ACAD SCI, V797, P285, DOI 10.1111/j.1749-6632.1996.tb52980.x; Verma RK, 2013, TUBERCULOSIS, V93, P412, DOI 10.1016/j.tube.2013.02.012; Waihenya RK, 2002, J ETHNOPHARMACOL, V79, P317, DOI 10.1016/S0378-8741(01)00397-X; Wei F., 2006, People's Republic of China patent CN, Patent No. 1853687; Xu Q, 2006, CLIN EXP ALLERGY, V36, P94, DOI 10.1111/j.1365-2222.2006.02401.x; Yoon YD, 2003, INT IMMUNOPHARMACOL, V3, P1873, DOI 10.1016/j.intimp.2003.09.005; Zhang XL, 2010, BBA-GEN SUBJECTS, V1800, P1262, DOI 10.1016/j.bbagen.2010.08.005	45	28	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110321	10.1371/journal.pone.0110321	http://dx.doi.org/10.1371/journal.pone.0110321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329066	gold, Green Published, Green Submitted			2022-12-27	WOS:000343210800075
J	Tuomarila, M; Luostari, K; Soini, Y; Kataja, V; Kosma, VM; Mannermaa, A				Tuomarila, Marie; Luostari, Kaisa; Soini, Ylermi; Kataja, Vesa; Kosma, Veli-Matti; Mannermaa, Arto			Overexpression of MicroRNA-200c Predicts Poor Outcome in Patients with PR-Negative Breast Cancer	PLOS ONE			English	Article							PROGESTERONE-RECEPTOR; ESTROGEN-RECEPTOR; MIR-200 FAMILY; MESENCHYMAL TRANSITION; REPRESSORS ZEB1; DOWN-REGULATION; EXPRESSION; TARGETS; INVASION; SUBTYPES	Micro-RNAs are small, noncoding RNAs that act as tumor suppressors or oncogenes. MiR-200c is a member of the miR-200 family; it is known to be dysregulated in invasive breast carcinoma. MiR-200c maintains the epithelial-mesenchymal transition and inhibits cell migration and invasion. Recent studies showed that miR-200c regulated steroid hormone receptors, estrogen receptors (ER), and progesterone receptors (PR). The present study aimed to detect miR-200c in 172 invasive breast carcinoma cases selected from a prospective cohort enrolled in Kuopio, Eastern Finland, between 1990 and 1995. MiR-200c expression was determined with relative q-PCR, and results were compared to clinicopathological variables and patient outcome. We found that PR status combined with miR-200c expression was a significant marker of outcome. High miR-200c expression was associated with reduced survival in PR-negative cases (n = 68); low miR-200c expression indicated reduced survival in PR-positive cases (n = 86) (Cox regression: P = 0.002, OR = 3.433; and P = 0.004, OR = 4.176, respectively). In PR-negative cases, high miR-200c expression was associated with shortened relapse-free survival (Cox regression: P = 0.001, OR = 3.613); increased local/distant recurrence (Logistic regression: P = 0.006, OR = 3.965); and more frequent distant metastasis (Logistic regression: P = 0.015, OR = 3.390). We also found that high grade and low stage tumors were positively correlated with high miR-200c expression (Logistic regression for high grade tumors: P = 0.002, OR = 2.791 and for high stage tumors: P = 0.035, OR = 0.285). Our results indicated that miR-200c may play a role in invasive breast carcinoma. Furthermore, miR-200c combined with PR status provided a refined predictor of outcome. In future, a larger study is required to confirm our results. This data may provide a basis for new research target-progesterone receptor-regulated microRNAs in breast cancer.	[Tuomarila, Marie; Luostari, Kaisa; Soini, Ylermi; Kosma, Veli-Matti; Mannermaa, Arto] Univ Eastern Finland, Inst Clin Med Clin Pathol & Forens Med, Kuopio, Finland; [Kataja, Vesa] Univ Eastern Finland, Inst Clin Med, Kuopio, Finland	University of Eastern Finland; University of Eastern Finland	Mannermaa, A (corresponding author), Univ Eastern Finland, Inst Clin Med Clin Pathol & Forens Med, Kuopio, Finland.	arto.mannermaa@uef.fi		Kataja, Vesa/0000-0003-4846-4843	Special Government Funding (EVO) of Kuopio University Hospital; Finnish Cancer Organisations; University of Eastern Finland (Cancer center of Eastern Finland)	Special Government Funding (EVO) of Kuopio University Hospital; Finnish Cancer Organisations; University of Eastern Finland (Cancer center of Eastern Finland)	This study was supported by grants from Special Government Funding (EVO) of Kuopio University Hospital (www.psshp.fi), the Finnish Cancer Organisations (www.cancer.fi), and the strategic funding of the University of Eastern Finland (Cancer center of Eastern Finland; www.uef.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Castilla MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047709; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bhat-Nakshatri P, 2009, NUCLEIC ACIDS RES, V37, P4850, DOI 10.1093/nar/gkp500; Bockmeyer CL, 2011, BREAST CANCER RES TR, V130, P735, DOI 10.1007/s10549-010-1303-3; BRADSHAW MS, 1991, J BIOL CHEM, V266, P16684; Braun L, 2013, MODERN PATHOL, V26, P1161, DOI 10.1038/modpathol.2013.60; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Cittelly DM, 2013, ONCOGENE, V32, P2555, DOI 10.1038/onc.2012.275; Cochrane DR, 2012, MOL CELL ENDOCRINOL, V355, P15, DOI 10.1016/j.mce.2011.12.020; Cochrane Dawn R., 2010, Hormones & Cancer, V1, P306, DOI 10.1007/s12672-010-0043-5; Cochrane DR, 2009, MOL CANCER THER, V8, P1055, DOI 10.1158/1535-7163.MCT-08-1046; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Di Leva G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003311; Feeley LP, 2014, MODERN PATHOL, V27, P554, DOI 10.1038/modpathol.2013.153; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gravgaard KH, 2012, BREAST CANCER RES TR, V134, P207, DOI 10.1007/s10549-012-1969-9; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hartikainen JM, 2005, CANCER EPIDEM BIOMAR, V14, P75; Howe EN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049987; Howe EN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2867; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Karaayvaz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035158; Karakatsanis A, 2013, MOL CARCINOGEN, V52, P297, DOI 10.1002/mc.21864; Klinge CM, 2009, CURR GENOMICS, V10, P169, DOI 10.2174/138920209788185289; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kuokkanen S, 2010, BIOL REPROD, V82, P791, DOI 10.1095/biolreprod.109.081059; Leskela S, 2011, ENDOCR-RELAT CANCER, V18, P85, DOI 10.1677/ERC-10-0148; Liu XG, 2012, MED ONCOL, V29, P618, DOI 10.1007/s12032-011-9923-y; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Marchini S, 2011, LANCET ONCOL, V12, P273, DOI 10.1016/S1470-2045(11)70012-2; Panda H, 2012, REPROD SCI, V19, P786, DOI 10.1177/1933719112438448; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pellikainen MJ, 2003, J CLIN PATHOL, V56, P214, DOI 10.1136/jcp.56.3.214; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Petz LN, 2004, J STEROID BIOCHEM, V88, P113, DOI 10.1016/j.jsbmb.2003.11.008; Renthal NE, 2010, P NATL ACAD SCI USA, V107, P20828, DOI 10.1073/pnas.1008301107; Rivas MA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3187; Schickel R, 2010, MOL CELL, V38, P908, DOI 10.1016/j.molcel.2010.05.018; Soini Y, 2011, BMC CANCER, V11; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sossey-Alaoui K, 2009, J BIOL CHEM, V284, P33019, DOI 10.1074/jbc.M109.034553; Tessel MA, 2010, CURR OPIN ONCOL, V22, P592, DOI 10.1097/CCO.0b013e32833ea80c; Vares G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077124; Williams KC, 2012, MOL ENDOCRINOL, V26, P1857, DOI 10.1210/me.2012-1199; Williams KC, 2012, P NATL ACAD SCI USA, V109, P7529, DOI 10.1073/pnas.1200650109; Wright JA, 2010, J MAMMARY GLAND BIOL, V15, P213, DOI 10.1007/s10911-010-9183-z; Yu J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-169	54	36	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109508	10.1371/journal.pone.0109508	http://dx.doi.org/10.1371/journal.pone.0109508			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329395	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210800026
J	Wang, G; Qu, XH; Yu, ZF				Wang, Gang; Qu, Xinhua; Yu, Zhifeng			Changes in the Mechanical Properties and Composition of Bone during Microdamage Repair	PLOS ONE			English	Article							ELASTIC-MODULUS; FATIGUE; MICROCRACKS; ACCUMULATION; HARDNESS; STRAIN; GOATS	Under normal conditions, loading activities result in microdamage in the living skeleton, which is repaired by bone remodeling. However, microdamage accumulation can affect the mechanical properties of bone and increase the risk of fracture. This study aimed to determine the effect of microdamage on the mechanical properties and composition of bone. Fourteen male goats aged 28 months were used in the present study. Cortical bone screws were placed in the tibiae to induce microdamage around the implant. The goats were euthanized, and 3 bone segments with the screws in each goat were removed at 0 days, 21 days, 4 months, and 8 months after implantation. The bone segments were used for observing microdamage and bone remodeling, as well as nanoindentation and bone composition, separately. Two regions were measured: the first region (R1), located> 1.5 mm from the interface between the screw hole and bone; and the second region (R2), located. 1.5 mm from the bone-screw interface. Both diffuse and linear microdamage decreased significantly with increasing time after surgery, with the diffuse microdamage disappearing after 8 months. Thus, screw implantation results in increased bone remodeling either in the proximal or distal cortical bone, which repairs the microdamage. Moreover, bone hardness and elastic modulus decreased with microdamage repair, especially in the proximal bone tissue. Bone composition changed greatly during the production and repair of microdamage, especially for the C (Carbon) and Ca (Calcium) in the R1 region. In conclusion, the presence of mechanical microdamage accelerates bone remodeling either in the proximal or distal cortical bone. The bone hardness and elastic modulus decreased with microdamage repair, with the micromechanical properties being restored on complete repair of the microdamage. Changes in bone composition may contribute to changes in bone mechanical properties.	[Wang, Gang; Qu, Xinhua; Yu, Zhifeng] Shanghai Jiao Tong Univ, Shanghai Key Lab Orthopaed Implants, Dept Orthopaed Surg, Shanghai Peoples Hosp 9,Sch Med, Shanghai 200030, Peoples R China; [Wang, Gang] Nanjing Med Univ, Affiliated Hosp 2, Dept Orthoped Surg, Nanjing, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Nanjing Medical University	Yu, ZF (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Lab Orthopaed Implants, Dept Orthopaed Surg, Shanghai Peoples Hosp 9,Sch Med, Shanghai 200030, Peoples R China.	zhifengyu@gmail.com	Yu, Zhifeng/L-2248-2017; Qu, Xinhua/Q-3950-2016	Yu, Zhifeng/0000-0002-2224-8344; Qu, Xinhua/0000-0002-8889-0890	National Natural Science Foundation for Youth [11002090]; Shanghai Natural Science Foundation [10ZR1417900]; Program for Key Disciplines of the Shanghai Municipal Education Commission [J50206]	National Natural Science Foundation for Youth; Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Program for Key Disciplines of the Shanghai Municipal Education Commission	This research was supported by grants from the National Natural Science Foundation for Youth (11002090), the Shanghai Natural Science Foundation (10ZR1417900), and the Program for Key Disciplines of the Shanghai Municipal Education Commission (J50206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agholme F, 2012, J MATER SCI-MATER M, V23, P743, DOI 10.1007/s10856-011-4539-5; Allen MR, 2007, J BONE MINER RES, V22, P1759, DOI 10.1359/JBMR.070720; Bentolila V, 1998, BONE, V23, P275, DOI 10.1016/S8756-3282(98)00104-5; Boyde A, 2003, J ANAT, V203, P173, DOI 10.1046/j.1469-7580.2003.00213.x; Brennan O, 2012, CALCIFIED TISSUE INT, V91, P440, DOI 10.1007/s00223-012-9657-7; Burr D, 2003, OSTEOPOROSIS INT, V14, pS67, DOI 10.1007/s00198-003-1476-2; Burr DB, 1998, J BIOMECH, V31, P337, DOI 10.1016/S0021-9290(98)00016-5; BURR DB, 1995, BONE, V17, P431, DOI 10.1016/S8756-3282(95)00241-3; Currey J., 2002, BONES STRUCTURE MECH, P54; Donahue SW, 2000, BONE, V27, P827, DOI 10.1016/S8756-3282(00)00402-6; FROST HM, 1960, J BONE JOINT SURG AM, V42, P144, DOI 10.2106/00004623-196042010-00012; Herman BC, 2010, BONE, V47, P766, DOI 10.1016/j.bone.2010.07.006; Huja SS, 1999, BONE, V25, P217, DOI 10.1016/S8756-3282(99)00151-9; Leung KS, 2001, J BONE MINER RES, V16, P2348, DOI 10.1359/jbmr.2001.16.12.2348; Martin RB, 2003, CALCIFIED TISSUE INT, V73, P101, DOI 10.1007/s00223-002-1059-9; Mashiba T, 2001, BONE, V29, P271, DOI 10.1016/S8756-3282(01)00575-0; Norman TL, 1998, BONE, V23, P303, DOI 10.1016/S8756-3282(98)00103-3; O'Brien Fergal J, 2005, Curr Osteoporos Rep, V3, P39, DOI 10.1007/s11914-005-0002-1; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Qiu SJ, 2005, BONE, V37, P10, DOI 10.1016/j.bone.2005.01.023; SCHAFFLER MB, 1989, BONE, V10, P207, DOI 10.1016/8756-3282(89)90055-0; Schaffler MB, 2003, OSTEOPOROSIS INT, V14, pS73; Smith LJ, 2010, J BIOMECH, V43, P3144, DOI 10.1016/j.jbiomech.2010.07.038; Sobelman OS, 2004, J BIOMECH, V37, P1295, DOI 10.1016/j.jbiomech.2003.12.034; Wang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089343; Wang L, 2012, MICROSC MICROANAL, V18, P1106, DOI 10.1017/S1431927612001286; Wang X, 2008, J BIOMED MATER RES B, V85B, P68, DOI 10.1002/jbm.b.30918; Yu Z, 2014, OSTEOPOROSIS INT, V25, P897, DOI 10.1007/s00198-013-2496-1	28	3	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e108324	10.1371/journal.pone.0108324	http://dx.doi.org/10.1371/journal.pone.0108324			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313565	Green Submitted, gold, Green Published			2022-12-27	WOS:000343662500011
J	Gramaje, D; Leon, M; Santana, M; Crous, PW; Armengol, J				Gramaje, David; Leon, Maela; Santana, Marcela; Crous, Pedro W.; Armengol, Josep			Multilocus ISSR Markers Reveal Two Major Genetic Groups in Spanish and South African Populations of the Grapevine Fungal Pathogen Cadophora luteo-olivacea	PLOS ONE			English	Article							R-PACKAGE; TRUNK DISEASES; PETRI DISEASE; INTER-SIMPLE; BLACK-FOOT; CLONALITY; DIVERSITY; NURSERIES; GROWTH	Cadophora luteo-olivacea is a lesser-known fungal trunk pathogen of grapevine which has been recently isolated from vines showing decline symptoms in grape growing regions worldwide. In this study, 80 C. luteo-olivacea isolates (65 from Spain and 15 from South Africa) were studied. Inter-simple-sequence repeat-polymerase chain reaction (ISSR-PCR) generated 55 polymorphic loci from four ISSR primers selected from an initial screen of 13 ISSR primers. The ISSR markers revealed 40 multilocus genotypes (MLGs) in the global population. Minimum spanning network analysis showed that the MLGs from South Africa clustered around the most frequent genotype, while the genotypes from Spain were distributed all across the network. Principal component analysis and dendrograms based on genetic distance and bootstrapping identified two highly differentiated genetic clusters in the Spanish and South African C. luteo-olivacea populations, with no intermediate genotypes between these clusters. Movement within the Spanish provinces may have occurred repeatedly given the frequent retrieval of the same genotype in distant locations. The results obtained in this study provide new insights into the population genetic structure of C. luteo-olivacea in Spain and highlights the need to produce healthy and quality planting material in grapevine nurseries to avoid the spread of this fungus throughout different grape growing regions.	[Gramaje, David; Leon, Maela; Santana, Marcela; Armengol, Josep] Univ Politecn Valencia, Inst Agroforestal Mediterraneo, E-46071 Valencia, Spain; [Crous, Pedro W.] CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands	Universitat Politecnica de Valencia; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW)	Gramaje, D (corresponding author), Univ Politecn Valencia, Inst Agroforestal Mediterraneo, E-46071 Valencia, Spain.	dagrape@hotmail.com	Crous, Pedro W/H-1489-2012; Gramaje, David/M-7006-2017	Crous, Pedro W/0000-0001-9085-8825; Gramaje, David/0000-0003-1755-3413; Armengol, Josep/0000-0003-3815-8578				Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Agusti-Brisach C, 2011, PLANT DIS, V95, P803, DOI 10.1094/PDIS-12-10-0888; Agusti-Brisach C, 2013, PLANT SOIL, V364, P5, DOI 10.1007/s11104-012-1333-1; Alaniz S, 2009, MYCOL RES, V113, P16, DOI 10.1016/j.mycres.2008.07.002; ANDERSON JB, 1995, ANNU REV PHYTOPATHOL, V33, P369, DOI 10.1146/annurev.py.33.090195.002101; Armengol J, 2010, PLANT PATHOL, V59, P179, DOI 10.1111/j.1365-3059.2009.02150.x; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Aroca A, 2010, EUR J PLANT PATHOL, V126, P165, DOI 10.1007/s10658-009-9530-3; Bahri B, 2009, MOL ECOL, V18, P4165, DOI 10.1111/j.1365-294X.2009.04267.x; Berbegal M, 2013, PHYTOPATHOLOGY, V103, P851, DOI 10.1094/PHYTO-11-12-0281-R; Bertsch C, 2013, PLANT PATHOL, V62, P243, DOI 10.1111/j.1365-3059.2012.02674.x; BROWN AHD, 1980, GENETICS, V96, P523; Brown JKM, 1996, NEW PHYTOL, V133, P183, DOI 10.1111/j.1469-8137.1996.tb04353.x; BURDON JJ, 1993, CURR PLANT SCI BIOT, V18, P41; Comont G, 2010, EUR J PLANT PATHOL, V127, P451, DOI 10.1007/s10658-010-9611-3; Dhingra OD, 1995, BASIC PLANT PATHOLOG, P434; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fincham JRS, 1963, FUNGAL GENETICS; Fourie PH, 2001, WYNBOER, V149, P19; Goncalves VN, 2012, FEMS MICROBIOL ECOL, V82, P459, DOI 10.1111/j.1574-6941.2012.01424.x; GOODWIN SB, 1994, P NATL ACAD SCI USA, V91, P11591, DOI 10.1073/pnas.91.24.11591; Goss EM, 2009, MOL ECOL, V18, P1161, DOI 10.1111/j.1365-294X.2009.04089.x; Gramaje D, 2011, PLANT DIS, V95, P1040, DOI 10.1094/PDIS-01-11-0025; Gramaje D, 2010, ANN APPL BIOL, V156, P231, DOI 10.1111/j.1744-7348.2009.00382.x; Gramaje D, 2009, CROP PROT, V28, P280, DOI 10.1016/j.cropro.2008.11.002; Gramaje D, 2011, PHYTOPATHOL MEDITERR, V50, pS112; Gramaje D, 2010, AM J ENOL VITICULT, V61, P512, DOI 10.5344/ajev.2010.10021; Grunwald NJ, 2003, PHYTOPATHOLOGY, V93, P738, DOI 10.1094/PHYTO.2003.93.6.738; Halleen F, 2007, AUSTRALAS PLANT PATH, V36, P277, DOI 10.1071/AP07019; Halleen F, 2003, AUSTRALAS PLANT PATH, V32, P47, DOI 10.1071/AP02062; Held BW, 2005, INT BIODETER BIODEGR, V55, P45, DOI 10.1016/j.ibiod.2004.06.011; Hujslova M, 2010, MYCOL PROG, V9, P1, DOI 10.1007/s11557-009-0611-7; Jombart T, 2009, HEREDITY, V102, P330, DOI 10.1038/hdy.2008.130; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Milgroom MG, 1997, ADV BOT RES, V24, P1; Navarrete F, 2011, PHYTOPATHOL MEDITERR, V50, pS166; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pearson RC, 1988, COMPENDIUM GRAPE DIS, P128; PIELOU E C, 1969, P286; Potter D, 2002, J AM SOC HORTIC SCI, V127, P75, DOI 10.21273/JASHS.127.1.75; R Core Team, 2021, R LANGUAGE ENV STAT; Rampersad SN, 2013, PHYTOPATHOLOGY, V103, P182, DOI 10.1094/PHYTO-07-12-0160-R; Riccioni L, 2007, ACTA HORTIC, P669, DOI 10.17660/ActaHortic.2007.753.88; Rooney-Latham S, 2005, THESIS U CALIFORNIA; Smart R, 2013, WINE VITICULT J  JUL, P16; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TIBAYRENC M, 1991, P NATL ACAD SCI USA, V88, P5129, DOI 10.1073/pnas.88.12.5129; Unwin T, 1996, WINE WINE HIST GEOGR, P389; Urbez-Torres JR, 2014, PLANT DIS, V98, P469, DOI 10.1094/PDIS-05-13-0523-RE; Wolfe A, 1998, PLANT MOL SYSTEMATIC, DOI [10.1007/978-1-4615-5419-6, DOI 10.1007/978-1-4615-5419-6]; Zhou SG, 2001, MYCOL RES, V105, P919, DOI 10.1016/S0953-7562(08)61947-4	55	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110417	10.1371/journal.pone.0110417	http://dx.doi.org/10.1371/journal.pone.0110417			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310345	Green Submitted, gold, Green Published			2022-12-27	WOS:000343210300116
J	Horan, WP; Wynn, JK; Mathis, I; Miller, GA; Green, MF				Horan, William P.; Wynn, Jonathan K.; Mathis, Ian; Miller, Gregory A.; Green, Michael F.			Approach and Withdrawal Motivation in Schizophrenia: An Examination of Frontal Brain Asymmetric Activity	PLOS ONE			English	Article							PSYCHIATRIC RATING-SCALE; EEG-ALPHA ASYMMETRY; INDIVIDUAL-DIFFERENCES; BEHAVIORAL ACTIVATION; AVOIDANCE MOTIVATION; EMOTION REGULATION; QUALITY-ASSURANCE; ANXIETY; LATERALIZATION; CONSISTENCY	Although motivational disturbances are common in schizophrenia, their neurophysiological and psychological basis is poorly understood. This electroencephalography (EEG) study examined the well-established motivational direction model of asymmetric frontal brain activity in schizophrenia. According to this model, relative left frontal activity in the resting EEG reflects enhanced approach motivation tendencies, whereas relative right frontal activity reflects enhanced withdrawal motivation tendencies. Twenty-five schizophrenia outpatients and 25 healthy controls completed resting EEG assessments of frontal asymmetry in the alpha frequency band (8-12 Hz), as well as a self-report measure of behavioral activation and inhibition system (BIS/BAS) sensitivity. Patients showed an atypical pattern of differences from controls. On the EEG measure patients failed to show the left lateralized activity that was present in controls, suggesting diminished approach motivation. On the self-report measure, patients reported higher BIS sensitivity than controls, which is typically interpreted as heightened withdrawal motivation. EEG asymmetry scores did not significantly correlate with BIS/BAS scores or with clinical symptom ratings among patients. The overall pattern suggests a motivational disturbance in schizophrenia characterized by elements of both diminished approach and elevated withdrawal tendencies.	[Horan, William P.; Wynn, Jonathan K.; Mathis, Ian; Green, Michael F.] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA; [Horan, William P.; Wynn, Jonathan K.; Mathis, Ian; Miller, Gregory A.; Green, Michael F.] Univ Calif Los Angeles, Los Angeles, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles	Horan, WP (corresponding author), VA Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA.	horan@ucla.edu	Wynn, Jonathan/H-3749-2014; Horan, William/V-7495-2019	Wynn, Jonathan/0000-0002-1763-8540; 	NARSAD; NIMH [MH043292, MH065707]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065707, R01MH043292, R29MH043292] Funding Source: NIH RePORTER	NARSAD(NARSAD); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work received support from a NARSAD Young Investigator Award (WPH), NIMH Grant MH043292 (MFG), and NIMH Grant MH065707 (MFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JJB, 2004, BIOL PSYCHOL, V67, P183, DOI 10.1016/j.biopsycho.2004.03.007; Barch DM, 2008, SCHIZOPHRENIA BULL, V34, P816, DOI 10.1093/schbul/sbn092; Blanchard JJ, 2011, SCHIZOPHR B, V37, P91; Britton WB, 2012, BEHAV THER, V43, P365, DOI 10.1016/j.beth.2011.08.006; Carver CS, 2009, PSYCHOL BULL, V135, P183, DOI 10.1037/a0013965; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Coan JA, 2004, BIOL PSYCHOL, V67, P7, DOI 10.1016/j.biopsycho.2004.03.002; Coan JA, 2006, BIOL PSYCHOL, V72, P198, DOI 10.1016/j.biopsycho.2005.10.003; Corr PJ, 2008, REINFORCEMENT SENSITIVITY THEORY OF PERSONALITY, P155; Davidson RJ, 1998, COGNITION EMOTION, V12, P307, DOI 10.1080/026999398379628; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Davidson RJ, 2003, PSYCHOSOM MED, V65, P564, DOI 10.1097/01.PSY.0000077505.67574.E3; De Pascalis V, 2013, BIOL PSYCHOL, V94, P198, DOI 10.1016/j.biopsycho.2013.05.016; Elliot AJ, 2002, J PERS SOC PSYCHOL, V82, P804, DOI 10.1037/0022-3514.82.5.804; Engels AS, 2007, PSYCHOPHYSIOLOGY, V44, P352, DOI 10.1111/j.1469-8986.2007.00518.x; Engels AS, 2010, COGN AFFECT BEHAV NE, V10, P141, DOI 10.3758/CABN.10.1.141; First M.B., 2014, STRUCTURED CLIN INTE; Gable SL, 2013, EMOT REV, V5, P269, DOI 10.1177/1754073913477513; Gordon E, 2010, CLIN EEG NEUROSCI, V41, P178, DOI 10.1177/155005941004100404; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Gray J.A., 1987, PSYCHOL FEAR STRESS, V2nd, P422; Green MF, 2012, ARCH GEN PSYCHIAT, V69, P1216, DOI 10.1001/archgenpsychiatry.2012.652; Heller W, 1998, CURR DIR PSYCHOL SCI, V7, P26, DOI 10.1111/1467-8721.ep11521823; Herrington JD, 2010, PSYCHOPHYSIOLOGY, V47, P442, DOI 10.1111/j.1469-8986.2009.00958.x; Horan WP, 2013, PSYCHOL MED, V43, P2377, DOI 10.1017/S0033291713000019; Horan WP, 2008, SCHIZOPHRENIA BULL, V34, P856, DOI 10.1093/schbul/sbn083; Horan WP, 2006, J ABNORM PSYCHOL, V115, P496, DOI 10.1037/0021-843X.115.3.496; Jetha MK, 2009, INT J NEUROSCI, V119, P847, DOI 10.1080/00207450701242966; Jetha MK, 2009, INT J PSYCHOPHYSIOL, V72, P228, DOI 10.1016/j.ijpsycho.2008.12.011; Kern RS, 2013, SCHIZOPHRENIA BULL, V39, P1201, DOI 10.1093/schbul/sbt127; Kopelowicz A, 2008, PSYCHOPATHOLOGY, V41, P77, DOI 10.1159/000111551; Kraepelin E, 1919, DEMENTIA PRAECOX PAR; LUKOFF D, 1986, SCHIZOPHRENIA BULL, V12, P578, DOI 10.1093/schbul/12.4.578; Medalia A, 2010, SCHIZOPHRENIA BULL, V36, P912, DOI 10.1093/schbul/sbq073; Miller G.A., 1991, J PSYCHOPHYSIOL, V5, P273; MILLER GA, 1988, PSYCHOPHYSIOLOGY, V25, P241, DOI 10.1111/j.1469-8986.1988.tb00999.x; Miller GA, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00002; Moscovitch DA, 2011, BIOL PSYCHOL, V87, P379, DOI 10.1016/j.biopsycho.2011.04.009; Nusslock R, 2012, J ABNORM PSYCHOL, V121, P592, DOI 10.1037/a0028973; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Peterson CK, 2008, SOC NEUROSCI, V3, P113, DOI 10.1080/17470910701612736; Scholten MRM, 2006, J PSYCHIAT RES, V40, P638, DOI 10.1016/j.jpsychires.2006.03.005; Spielberg JM, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00284; Spielberg JM, 2012, PSYCHOPHYSIOLOGY, V49, P1200, DOI 10.1111/j.1469-8986.2012.01443.x; Spielberg JM, 2012, COGN AFFECT BEHAV NE, V12, P308, DOI 10.3758/s13415-012-0088-8; Spielberg JM, 2011, NEUROIMAGE, V54, P661, DOI 10.1016/j.neuroimage.2010.08.037; SPITZER R. L., 1994, STRUCTURED CLIN INTE; Strauss GP, 2013, SCHIZOPHRENIA BULL, V39, P872, DOI 10.1093/schbul/sbs186; Thibodeau R, 2006, J ABNORM PSYCHOL, V115, P715, DOI 10.1037/0021-843X.115.4.715; TOMARKEN AJ, 1992, J PERS SOC PSYCHOL, V62, P676, DOI 10.1037/0022-3514.62.4.676; Tomarken AJ, 2009, PSYCHOL BULL, V135, P209, DOI 10.1037/a0014735; Towers DN, 2009, PSYCHOPHYSIOLOGY, V46, P132, DOI 10.1111/j.1469-8986.2008.00759.x; van Honk J, 2006, PSYCHOL SCI, V17, P963, DOI 10.1111/j.1467-9280.2006.01813.x; VENTURA J, 1993, INT J METH PSYCH RES, V3, P221; Ventura J, 1998, PSYCHIAT RES, V79, P163, DOI 10.1016/S0165-1781(98)00038-9; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8	56	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110007	10.1371/journal.pone.0110007	http://dx.doi.org/10.1371/journal.pone.0110007			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ9WZ	25310340	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210300084
J	Singh, W; Ornolfsdottir, EB; Stefansson, G				Singh, Warsha; Ornolfsdottir, Erla B.; Stefansson, Gunnar			A Small-Scale Comparison of Iceland Scallop Size Distributions Obtained from a Camera Based Autonomous Underwater Vehicle and Dredge Survey	PLOS ONE			English	Article							PLACOPECTEN-MAGELLANICUS; CHLAMYS-ISLANDICA; SEA SCALLOP; JUVENILE; GULF; EFFICIENCY; ABUNDANCE; ATLANTIC; SOUTHERN; FISHERY	An approach is developed to estimate size of Iceland scallop shells from AUV photos. A small-scale camera based AUV survey of Iceland scallops was conducted at a defined site off West Iceland. Prior to height estimation of the identified shells, the distortions introduced by the vehicle orientation and the camera lens were corrected. The average AUV pitch and roll was 1.3 and 2.3 deg that resulted in <2% error in ground distance rendering these effects negligible. A quadratic polynomial model was identified for lens distortion correction. This model successfully predicted a theoretical grid from a frame photographed underwater, representing the inherent lens distortion. The predicted shell heights were scaled for the distance from the bottom at which the photos were taken. This approach was validated by height estimation of scallops of known sizes. An underestimation of approximately 0.5 cm was seen, which could be attributed to pixel error, where each pixel represented 0.24 x 0.27 cm. After correcting for this difference the estimated heights ranged from 3.8-9.3 cm. A comparison of the height-distribution from a small-scale dredge survey carried out in the vicinity showed non-overlapping peaks in size distribution, with scallops of a broader size range visible in the AUV survey. Further investigations are necessary to evaluate any underlying bias and to validate how representative these surveys are of the true population. The low resolution images made identification of smaller scallops difficult. Overall, the observations of very few small scallops in both surveys could be attributed to low recruitment levels in the recent years due to the known scallop parasite outbreak in the region.	[Singh, Warsha; Stefansson, Gunnar] Univ Iceland, Inst Sci, IS-107 Reykjavik, Iceland; [Ornolfsdottir, Erla B.] Holar Univ Coll, Holar, Iceland	University of Iceland	Singh, W (corresponding author), Univ Iceland, Inst Sci, Dunhaga 3, IS-107 Reykjavik, Iceland.	singh.warsha@gmail.com	Stefansson, Gunnar/AAV-9432-2020; Stefansson, Gunnar/A-2209-2008	Stefansson, Gunnar/0000-0002-2693-9142; Stefansson, Gunnar/0000-0002-2693-9142; Singh, Warsha/0000-0002-8302-984X	Icelandic Research Fund, Rannis [110209023]; United Nations University - Fisheries Training Programme	Icelandic Research Fund, Rannis; United Nations University - Fisheries Training Programme	This research work was funded by the Icelandic Research Fund, Rannis (grant number 110209023 http://www.rannis.is/) and the United Nations University - Fisheries Training Programme (http://www.unuftp.is/). Grants were received by WS, EBO and GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenault DJ, 1996, MAR ECOL PROG SER, V140, P115, DOI 10.3354/meps140115; Arsenault DJ, 1996, CAN J FISH AQUAT SCI, V53, P884, DOI 10.1139/f95-234; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Carbines G, 2009, FISH RES, V96, P230, DOI 10.1016/j.fishres.2008.11.007; Carey JD, 2011, J SHELLFISH RES, V30, P569, DOI 10.2983/035.030.0301; Collie JS, 2000, ICES J MAR SCI, V57, P987, DOI 10.1006/jmsc.2000.0584; Fifas S, 1999, ICES J MAR SCI, V56, P489, DOI 10.1006/jmsc.1999.0482; Galand PE, 2000, SARSIA, V85, P183, DOI 10.1080/00364827.2000.10414570; Garcia EG, 2006, ADV MAR BIOL, V51, P1, DOI 10.1016/S0065-2881(06)51001-6; Gavia T, 2010, TECHNICAL REPORT; GIGUERE M, 1994, J SHELLFISH RES, V13, P25; Harris BP, 2006, ICES J MAR SCI, V63, P811, DOI 10.1016/j.icesjms.2006.02.003; Heikkila J, 1997, PROC CVPR IEEE, P1106, DOI 10.1109/CVPR.1997.609468; Hrafnkelsson B, 2004, CAN J FISH AQUAT SCI, V61, P1135, DOI 10.1139/F04-049; Jacobson LD, 2010, FISH B-NOAA, V108, P233; Jenkins SR, 2001, MAR ECOL PROG SER, V215, P297, DOI 10.3354/meps215297; Jonasson JP, 2007, ICES J MAR SCI, V64, P298, DOI 10.1093/icesjms/fsl028; Kutner M., 2005, APPL LINEAR STAT MOD; MCLOUGHLIN RJ, 1991, FISH RES, V11, P1, DOI 10.1016/0165-7836(91)90030-J; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rosenkranz GE, 2004, FISH RES, V69, P131, DOI 10.1016/j.fishres.2004.01.007; Rosenkranz GE, 2008, FISH RES, V92, P340, DOI 10.1016/j.fishres.2008.03.014; Seiler J, 2012, FISH RES, V129, P64, DOI 10.1016/j.fishres.2012.06.011; Singh W, 2013, J SHELLFISH RES, V32, P725, DOI 10.2983/035.032.0314; Sklyar O., 2011, EBIMAGE IMAGE PROCES; Stokesbury KDE, 2010, J SHELLFISH RES, V29, P369, DOI 10.2983/035.029.0212; Stokesburys KDE, 2002, T AM FISH SOC, V131, P1081, DOI 10.1577/1548-8659(2002)131<1081:EOSSAI>2.0.CO;2; TAYLOR R, 2008, OCEANS, V2008, P1, DOI DOI 10.1109/OCEANS.2008.5152032; Tolimieri Nick, 2008, Alaska Sea Grant Report, V08-03, P129	29	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109369	10.1371/journal.pone.0109369	http://dx.doi.org/10.1371/journal.pone.0109369			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303243	Green Submitted, gold, Green Published			2022-12-27	WOS:000343730400052
J	Qiu, SH; Cai, X; Schumann, U; Velders, M; Sun, ZL; Steinacker, JM				Qiu, Shanhu; Cai, Xue; Schumann, Uwe; Velders, Martina; Sun, Zilin; Steinacker, Juergen Michael			Impact of Walking on Glycemic Control and Other Cardiovascular Risk Factors in Type 2 Diabetes: A Meta-Analysis	PLOS ONE			English	Article							RESTING BLOOD-PRESSURE; PHYSICAL-ACTIVITY; HEMOGLOBIN A(1C); US ADULTS; EXERCISE; FITNESS; COMPLICATIONS; CHOLESTEROL; POPULATION; PEDOMETER	Background: Walking is the most popular and most preferred exercise among type 2 diabetes patients, yet compelling evidence regarding its beneficial effects on cardiovascular risk factors is still lacking. The aim of this meta-analysis of randomized controlled trials (RCTs) was to evaluate the association between walking and glycemic control and other cardiovascular risk factors in type 2 diabetes patients. Methods: Three databases were searched up to August 2014. English-language RCTs were eligible for inclusion if they had assessed the walking effects (duration >= 8 weeks) on glycemic control or other cardiovascular risk factors among type 2 diabetes patients. Data were pooled using a random-effects model. Subgroup analyses based on supervision status and meta-regression analyses of variables regarding characteristics of participants and walking were performed to investigate their association with glycemic control. Results: Eighteen studies involving 20 RCTs (866 participants) were included. Walking significantly decreased glycosylated haemoglobin A1c (HbA1c) by 0.50% (95% confidence intervals [CI]: -0.78% to -0.21%). Supervised walking was associated with a pronounced decrease in HbA1c (WMD -0.58%, 95% CI: -0.93% to -0.23%), whereas non-supervised walking was not. Further subgroup analysis suggested non-supervised walking using motivational strategies is also effective in decreasing HbA1c (WMD -0.53%, 95% CI: -1.05% to -0.02%). Effects of covariates on HbA1c change were generally unclear. For other cardiovascular risk factors, walking significantly reduced body mass index (BMI) and lowered diastolic blood pressure (DBP), but non-significantly lowered systolic blood pressure (SBP), or changed high-density or low-density lipoprotein cholesterol levels. Conclusions: This meta-analysis supports that walking decreases HbA1c among type 2 diabetes patients. Supervision or the use of motivational strategies should be suggested when prescribed walking to ensure optimal glycemic control. Walking also reduces BMI and lowers DBP, however, it remains insufficient regarding the association of walking with lowered SBP or improved lipoprotein profiles.	[Qiu, Shanhu; Schumann, Uwe; Velders, Martina; Steinacker, Juergen Michael] Univ Ulm, Dept Med 2, Div Sports & Rehabil Med, D-89069 Ulm, Germany; [Qiu, Shanhu; Cai, Xue; Sun, Zilin] Southeast Univ, Sch Med, Inst Diabet, Dept Endocrinol,Zhongda Hosp, Nanjing, Jiangsu, Peoples R China	Ulm University; Southeast University - China	Sun, ZL (corresponding author), Southeast Univ, Sch Med, Inst Diabet, Dept Endocrinol,Zhongda Hosp, Nanjing, Jiangsu, Peoples R China.	sunzilin1963@126.com	Qiu, Shanhu/AAI-1318-2019; Steinacker, Juergen M. M/E-6876-2015; 李, 伟/J-5211-2016	Qiu, Shanhu/0000-0003-2597-3856; Steinacker, Juergen M. M/0000-0001-8901-9450; 				Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Arora E, 2009, INDIAN J MED RES, V129, P515; Belli T, 2011, DIABETES RES CLIN PR, V93, P337, DOI 10.1016/j.diabres.2011.05.007; Chudyk A, 2011, DIABETES CARE, V34, P1228, DOI 10.2337/dc10-1881; Church TS, 2010, JAMA-J AM MED ASSOC, V304, P2253, DOI 10.1001/jama.2010.1710; Dale JR, 2012, DIABETIC MED, V29, P1361, DOI 10.1111/j.1464-5491.2012.03749.x; Dixit S, 2014, J DIABETES COMPLICAT, V28, P332, DOI 10.1016/j.jdiacomp.2013.12.006; Espeland M, 2007, DIABETES CARE, V30, P1374; FORD ES, 1995, DIABETES CARE, V18, P27, DOI 10.2337/diacare.18.1.27; GOLDBERG AP, 1989, MED SCI SPORT EXER, V21, P669, DOI 10.1249/00005768-198912000-00008; Goldhaber-Fiebert JD, 2003, DIABETES CARE, V26, P24, DOI 10.2337/diacare.26.1.24; Gram B, 2010, CLIN J SPORT MED, V20, P355, DOI 10.1227/NEU.0b013e3181e56e0a; Gregg EW, 2003, ARCH INTERN MED, V163, P1440, DOI 10.1001/archinte.163.12.1440; Gusso S, 2008, DIABETOLOGIA, V51, P1317, DOI 10.1007/s00125-008-1012-1; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hootman JM, 2001, AM J EPIDEMIOL, V154, P251, DOI 10.1093/aje/154.3.251; Hu FB, 2003, ARCH INTERN MED, V163, P1397, DOI 10.1001/archinte.163.12.1397; KAPLAN RM, 1985, DIABETES CARE, V8, P343, DOI 10.2337/diacare.8.4.343; Karstoft K, 2013, DIABETES CARE, V36, P228, DOI 10.2337/dc12-0658; Kelley GA, 2001, PREV MED, V33, P120, DOI 10.1006/pmed.2001.0860; Kelley George A, 2005, Prev Cardiol, V8, P102; Koo BK, 2010, DIABETIC MED, V27, P1088, DOI 10.1111/j.1464-5491.2010.03045.x; Kravitz RL, 2000, MED CARE, V38, P728, DOI 10.1097/00005650-200007000-00005; Ku YH, 2010, J INT MED RES, V38, P782, DOI 10.1177/147323001003800305; Kurban S, 2011, ENDOCR RES, V36, P116, DOI 10.3109/07435800.2011.566236; Kwon Hwi Ryun, 2010, Korean Diabetes J, V34, P23, DOI 10.4093/kdj.2010.34.1.23; Makura CBT, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-37; Mitranun W, 2014, SCAND J MED SCI SPOR, V24, pE69, DOI 10.1111/sms.12112; Moghadasi M, 2013, EUR J SPORT SCI, V13, P378, DOI 10.1080/17461391.2011.635701; Morrato EH, 2007, DIABETES CARE, V30, P203, DOI 10.2337/dc06-1128; Murphy MH, 2007, PREV MED, V44, P377, DOI 10.1016/j.ypmed.2006.12.008; Murtagh EM, 2002, PREV MED, V35, P397, DOI 10.1006/pmed.2002.1090; Negri C, 2010, DIABETES CARE, V33, P2333, DOI 10.2337/dc10-0877; Qiu SH, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-36; RE RN, 1994, HYPERTENSION, V23, P159; Schellenberg ES, 2013, ANN INTERN MED, V159, P543, DOI 10.7326/0003-4819-159-8-201310150-00007; Shenoy S, 2010, PRIM CARE DIABETES, V4, P41, DOI 10.1016/j.pcd.2009.10.004; Sigal RJ, 2010, DIABETES CARE, V33, P147, DOI DOI 10.2337/DC10-9990; Sigal RJ, 2007, ANN INTERN MED, V147, P357, DOI 10.7326/0003-4819-147-6-200709180-00005; Snowling NJ, 2006, DIABETES CARE, V29, P2518, DOI 10.2337/dc06-1317; SOWERS JR, 1994, HYPERTENSION, V23, P145; Spence JC, 2009, PSYCHOL HEALTH, V24, P777, DOI 10.1080/08870440801989938; Sung K, 2012, NURS HEALTH SCI, V14, P438, DOI 10.1111/j.1442-2018.2012.00690.x; Thomas N, 2004, POSTGRAD MED J, V80, P287, DOI 10.1136/pgmj.2003.010553; Umpierre D, 2013, DIABETOLOGIA, V56, P242, DOI 10.1007/s00125-012-2774-z; van Rooijen AJ, 2004, QJM-INT J MED, V97, P343, DOI 10.1093/qjmed/hch061; Weinstock RS, 2011, AGE AGEING, V40, P98, DOI 10.1093/ageing/afq147; Williams PT, 2013, ARTERIOSCL THROM VAS, V33, P1085, DOI 10.1161/ATVBAHA.112.300878; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118	49	62	66	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109767	10.1371/journal.pone.0109767	http://dx.doi.org/10.1371/journal.pone.0109767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329391	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100026
J	Fontanari, JF				Fontanari, Jose F.			Imitative Learning as a Connector of Collective Brains	PLOS ONE			English	Article							CULTURE; INFORMATION; CONSTRAINT; MODEL	The notion that cooperation can aid a group of agents to solve problems more efficiently than if those agents worked in isolation is prevalent in computer science and business circles. Here we consider a primordial form of cooperation - imitative learning - that allows an effective exchange of information between agents, which are viewed as the processing units of a social intelligence system or collective brain. In particular, we use agent-based simulations to study the performance of a group of agents in solving a cryptarithmetic problem. An agent can either perform local random moves to explore the solution space of the problem or imitate a model agent - the best performing agent in its influence network. There is a trade-off between the number of agents N and the imitation probability p, and for the optimal balance between these parameters we observe a thirtyfold diminution in the computational cost to find the solution of the cryptarithmetic problem as compared with the independent search. If those parameters are chosen far from the optimal setting, however, then imitative learning can impair greatly the performance of the group.	Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil	Universidade de Sao Paulo	Fontanari, JF (corresponding author), Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil.	fontanari@ifsc.usp.br	Fontanari, Jose/GNP-7589-2022; Fontanari, José F/A-4511-2008	Fontanari, Jose/0000-0001-9413-1922; Fontanari, José F/0000-0001-9413-1922	Sao Paulo Research Foundation (FAPESP) [2013/17131-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [303979/2013-5]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding provided by grant 2013/17131-0, Sao Paulo Research Foundation (FAPESP) and grant 303979/2013-5, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasian R, 2009, INT C COMP ELEC ENG, P308, DOI 10.1109/ICCEE.2009.25; Averbach B., 1980, PROBLEM SOLVING RECR; Axelrod R, 1997, J CONFLICT RESOLUT, V41, P203, DOI 10.1177/0022002797041002001; Bandura A., 1962, NEBRASKA S MOTIVATIO, P211; Bandura Albert, 1977, SOCIAL LEARNING THEO; Bloom H., 2001, GLOBAL BRAIN EVOLUTI; Bonabeau E DdRDF, 1999, SWARM INTELLIGENCE N; CLEARWATER SH, 1991, SCIENCE, V254, P1181, DOI 10.1126/science.254.5035.1181; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; FIORITO G, 1992, SCIENCE, V256, P545, DOI 10.1126/science.256.5056.545; Fontanari JF, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.056118; Gonzalez-Avella JC, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/1/013010; Heyes C, 2012, PHILOS T R SOC B, V367, P2181, DOI 10.1098/rstb.2012.0120; HUBERMAN BA, 1990, PHYSICA D, V42, P38, DOI 10.1016/0167-2789(90)90065-W; Hunter JA, 1976, MATH BRAIN TEASERS; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kennedy J, 1999, ADAPT BEHAV, V7, P269, DOI 10.1177/105971239900700304; Kennedy J, 1998, J CONFLICT RESOLUT, V42, P56, DOI 10.1177/0022002798042001003; Laland KN, 2011, PHILOS T R SOC B, V366, P958, DOI 10.1098/rstb.2010.0328; Laland KN, 1998, BEHAV ECOL, V9, P493, DOI 10.1093/beheco/9.5.493; LEVINE JM, 1993, ANNU REV PSYCHOL, V44, P585, DOI 10.1146/annurev.psych.44.1.585; Moore Bruce R., 1996, P245, DOI 10.1016/B978-012273965-1/50013-3; Morgan T, 1988, BLACKBOARD SYSTEMS; Nehaniv CL, 2007, IMITATION AND SOCIAL LEARNING IN ROBOTS, HUMANS AND ANIMALS: BEHAVIOURAL, SOCIAL AND COMMUNICATIVE DIMENSIONS, P1, DOI 10.1017/CBO9780511489808.001; Newell A., 1972, HUMAN PROBLEM SOLVIN; Peres LR, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/38004; Shibanai Y, 2001, J CONFLICT RESOLUT, V45, P80, DOI 10.1177/0022002701045001004; Wilson E.O., 1975, P1	29	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110517	10.1371/journal.pone.0110517	http://dx.doi.org/10.1371/journal.pone.0110517			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ9XC	25329400	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210800090
J	Nishida, Y; Aida, K; Kihara, M; Kobayashi, T				Nishida, Yoriko; Aida, Kaoru; Kihara, Makoto; Kobayashi, Tetsuro			Antibody-Validated Proteins in Inflamed Islets of Fulminant Type 1 Diabetes Profiled by Laser-Capture Microdissection Followed by Mass Spectrometry	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASE; INTERFERON-GAMMA; GROWTH-FACTOR; CELL; ACTIN; EXPRESSION; ACTIVATION; CYTOKINES; RESPONSES; DYNAMICS	Background: There are no reports of proteomic analyses of inflamed islets in type 1 diabetes. Procedures: Proteins expressed in the islets of enterovirus-associated fulminant type 1 diabetes (FT1DM) with extensive insulitis were identified by laser-capture microdissection mass spectrometry using formalin-fixed paraffin-embedded pancreatic tissues. Results: Thirty-eight proteins were identified solely in FT1DM islets, most of which have not been previously linked to type 1 diabetes. Five protein-protein interacting clusters were identified, and the cellular localization of selected proteins was validated immunohistochemically. Migratory activity-related proteins, including plastin-2 (LCP1), moesin (MSN), lamin-B1 (LMNB1), Ras GTPase-activating-like protein (IQGAP1) and others, were identified in CD8(+) T cells and CD68(+) macrophages infiltrated to inflamed FT1DM islets. Proteins involved in successive signaling in innate/adaptive immunity were identified, including SAM domain and HD domain-containing protein 1 (SAMHD1), Ras GTPase-activating-like protein (IQGAP1), proteasome activator complex subunit 1 (PSME1), HLA class I histocompatibility antigen (HLA-C), and signal transducer and activator of transcription 1-alpha/beta (STAT1). Angiogenic (thymidine phosphorylase (TYMP)) and anti-angiogenic (tryptophan-tRNA ligase (WARS)) factors were identified in migrating CD8(+) T cells and CD68(+) macrophages. Proteins related to virus replication and cell proliferation, including probable ATP-dependent RNA helicase DEAD box helicase 5 (DDX5) and heterogeneous nuclear ribonucleoprotein H (HNRNPH1), were identified. The anti-apoptotic protein T-complex protein 1 subunit epsilon (CCT5), the anti-oxidative enzyme 6-phosphogluconate dehydrogenase (PDG), and the anti-viral and antiapoptotic proteins serpin B6 (SERPINB6) and heat shock 70 kDa protein1-like (HSPA1L), were identified in FT1DM-affected islet cells. Conclusion: The identified FT1DM-characterizing proteins include those involved in aggressive beta cell destruction through massive immune cell migration and proteins involved in angiogenesis and islet vasculature bleeding, cell repair, and anti-inflammatory processes. Several target proteins for future type 1 diabetes interventions were identified.	[Nishida, Yoriko] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Nursing, Chuo Ku, Kofu, Yamanashi, Japan; [Aida, Kaoru; Kobayashi, Tetsuro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Internal Med 3, Chuo Ku, Kofu, Yamanashi, Japan; [Kihara, Makoto] Med ProteoScope Co Ltd, Yokohama, Kanagawa, Japan; [Kobayashi, Tetsuro] Okinaka Mem Inst Med Res, Tokyo, Japan	University of Yamanashi; University of Yamanashi	Kobayashi, T (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Nursing, Chuo Ku, Kofu, Yamanashi, Japan.	tetsurou@yamanashi.ac.jp			University of Yamanashi; Ministry of Education, Culture, Science and Technology of Japan [245991321, 24591319]	University of Yamanashi(University of Yamanashi); Ministry of Education, Culture, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the University of Yamanashi to professor Tetsuro Kobayashi and by Grant-in-Aid from the Ministry of Education, Culture, Science and Technology of Japan for Scientific Research (C) (245991321) (KA), and (24591319) (TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida K, 2011, DIABETES, V60, P884, DOI 10.2337/db10-0795; Amrani A, 2000, NATURE, V406, P739, DOI 10.1038/35021081; Barrie MB, 2004, J IMMUNOL, V172, P6453, DOI 10.4049/jimmunol.172.10.6453; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; Brandt DT, 2007, EMBO REP, V8, P1019, DOI 10.1038/sj.embor.7401089; Chen F W, 1999, Int Rev Immunol, V18, P429, DOI 10.3109/08830189909088492; Chen JY, 2009, ARCH VIROL, V154, P507, DOI 10.1007/s00705-009-0323-y; Dechat T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000547; Delanote V, 2005, ACTA PHARMACOL SIN, V26, P769, DOI 10.1111/j.1745-7254.2005.00145.x; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; FLECKNER J, 1995, CYTOKINE, V7, P70, DOI 10.1006/cyto.1995.1009; Freeley M, 2012, J IMMUNOL, V188, P6357, DOI 10.4049/jimmunol.1103242; Frigerio S, 2002, NAT MED, V8, P1414, DOI 10.1038/nm792; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Goto H, 2001, CANCER RES, V61, P469; Hsu YA, 2011, DNA CELL BIOL, V30, P671, DOI 10.1089/dna.2010.1149; Imagawa A, 2000, NEW ENGL J MED, V342, P301, DOI 10.1056/NEJM200002033420501; Kawamura T, 2010, J PROTEOMICS, V73, P1089, DOI 10.1016/j.jprot.2009.11.011; Kobayashi T, 1990, IDF B, V35, P34; Kotani R, 2004, DIABETOLOGIA, V47, P1285, DOI 10.1007/s00125-004-1441-4; Kruger E, 2012, CURR OPIN IMMUNOL, V24, P77, DOI 10.1016/j.coi.2012.01.005; Lee JW, 2011, J PROTEOME RES, V10, P4522, DOI 10.1021/pr200338d; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; Liao W, 2011, J CELL PHYSIOL, V226, P397, DOI 10.1002/jcp.22345; Lu YQ, 2006, HUM GENE THER, V17, P625, DOI 10.1089/hum.2006.17.625; Naji S, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015313; Nakamura F, 2013, BIOCHEM J, V453, P17, DOI 10.1042/BJ20130290; Palmer AM, 1999, J NEURAL TRANSM, V106, P317, DOI 10.1007/s007020050161; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Samstag Y, 2003, J LEUKOCYTE BIOL, V73, P30, DOI 10.1189/jlb.0602272; SAPPERSTEIN SK, 1995, P NATL ACAD SCI USA, V92, P522, DOI 10.1073/pnas.92.2.522; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Serrador JM, 1997, J CELL BIOL, V138, P1409, DOI 10.1083/jcb.138.6.1409; Shimada A, 2002, DIABETES CARE, V25, P635, DOI 10.2337/diacare.25.3.635; Tanaka S, 2000, NEW ENGL J MED, V342, P1835; Tanaka S, 2009, DIABETES, V58, P2285, DOI 10.2337/db09-0091; Toi M, 2005, LANCET ONCOL, V6, P158, DOI 10.1016/S1470-2045(05)01766-3; Tzima E, 2003, P NATL ACAD SCI USA, V100, P14903, DOI 10.1073/pnas.2436330100; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; von Herrath M, 2009, NAT IMMUNOL, V10, P129, DOI 10.1038/ni0209-129; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Yao YX, 2005, J NEURO-ONCOL, V72, P217, DOI 10.1007/s11060-004-3012-4; Zhang JY, 2013, J VIROL, V87, P7608, DOI 10.1128/JVI.03186-12; Zhao DC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-114	44	22	25	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e107664	10.1371/journal.pone.0107664	http://dx.doi.org/10.1371/journal.pone.0107664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329145	gold, Green Submitted, Green Published			2022-12-27	WOS:000343210800005
J	Purcaru, D; Preda, A; Popa, D; Moga, MA; Rogozea, L				Purcaru, Daniel; Preda, Adrian; Popa, Daniela; Moga, Marius Alexandru; Rogozea, Liliana			Informed Consent: How Much Awareness Is There?	PLOS ONE			English	Article							BIOMEDICAL-RESEARCH; CHILDHOOD LEUKEMIA; CLINICAL-TRIALS; COMPREHENSION; IMPROVEMENT	Improving the informed consent process in clinical research is of constant concern to regulatory authorities in the field and presents a challenge for both the specialists and patients involved. Informed consent is a process that should adequately match the complexity of clinical research. In analyzing the behaviour of 68 patients during the informed consent process related to the clinical research performed at Neomed Clinical Center in Brasov, we found that many patients do not ask any questions (35.3%). From those who do, part of the questions (20,6%) referred to general aspects (addressed the form but not the gist) of the clinical trial, some (72,8%) referred to specific aspects of the clinical trial they will attend and others (6,6%) unrelated to the clinical trial. These results suggest a lack of interest, awareness, and understanding of the information presented in the informed consent form. The possible underlying causes of this attitude and its bureaucratic, ethic, and legal implications are discussed.	[Purcaru, Daniel] Transilvania Univ, Dept Med Eth, Brasov, Romania; [Purcaru, Daniel] Neomed Med Ctr, Dept Clin Res, Brasov, Romania; [Preda, Adrian] Univ Calif Irvine, Sch Med, Dept Psychiat & Human Behav, Irvine, CA USA; [Preda, Adrian] Univ Calif Irvine, Neuropsychiat Ctr, Orange, CA 92668 USA; [Popa, Daniela] Transilvania Univ, Fac Psychol & Sci Educ, Brasov, Romania; [Moga, Marius Alexandru] Transilvania Univ, Fac Med, Dept Med & Surg Specialties, Brasov, Romania; [Rogozea, Liliana] Transilvania Univ, Fac Med, Dept Fundamental Disciplines & Clin Prevent, Brasov, Romania	Transylvania University of Brasov; University of California System; University of California Irvine; University of California System; University of California Irvine; Transylvania University of Brasov; Transylvania University of Brasov; Transylvania University of Brasov	Purcaru, D (corresponding author), Transilvania Univ, Dept Med Eth, Brasov, Romania.	dpurcaru@gmail.com	Popa, Daniela/N-2657-2014; Preda, Adrian/K-8889-2013; Rogozea, Liliana/U-2809-2017; MOGA, MARIUS ALEXANDRU/AHC-2310-2022; Popa, Daniela/AAN-6969-2020	Preda, Adrian/0000-0003-3373-2438; Rogozea, Liliana/0000-0001-9551-9910; Popa, Daniela/0000-0002-4538-7136	European Social Fund [ID76945]; Romanian Government; Sectoral Operation Programme Human Resources Development (SOP HRD)	European Social Fund(European Social Fund (ESF)); Romanian Government(Romanian Government); Sectoral Operation Programme Human Resources Development (SOP HRD)	This paper is supported by the Sectoral Operation Programme Human Resources Development (SOP HRD), ID76945 financed from the European Social Fund and by the Romanian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors received no specific funding for this work.	Angiolillo AL, 2004, PEDIATR BLOOD CANCER, V42, P433, DOI 10.1002/pbc.20010; Barfield RC, 2005, CURR OPIN PEDIATR, V17, P20, DOI 10.1097/01.mop.0000145718.77939.b1; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593; HOWARD JM, 1981, CONTROL CLIN TRIALS, V2, P287, DOI 10.1016/0197-2456(81)90019-2; Joffe S, 2001, J NATL CANCER I, V93, P139, DOI 10.1093/jnci/93.2.139; Kim L, 2008, TECH COMMUN Q, V17, P335, DOI 10.1080/10572250802100451; Kodish E, 2004, JAMA-J AM MED ASSOC, V291, P470, DOI 10.1001/jama.291.4.470; Kodish Eric, 2003, Account Res, V10, P17, DOI 10.1080/08989620300502; Lavori PW, 1999, CONTROL CLIN TRIALS, V20, P187, DOI 10.1016/S0197-2456(98)00064-6; MILLER C, 1994, J CLIN RES DRUG DEV, V8, P237; Paris A, 2007, FUND CLIN PHARMACOL, V21, P207, DOI 10.1111/j.1472-8206.2007.00472.x; Paris A, 2010, BRIT J CLIN PHARMACO, V69, P231, DOI 10.1111/j.1365-2125.2009.03565.x; Sharp SM, 2004, AM J CLIN ONCOL-CANC, V27, P570, DOI 10.1097/01.coc.0000135925.83221.b3; Vollmann J, 1996, BRIT MED J, V313, P1445, DOI 10.1136/bmj.313.7070.1445; Wright Patricia, 2003, J Audiov Media Med, V26, P6, DOI 10.1080/0140511031000091211	21	43	43	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110139	10.1371/journal.pone.0110139	http://dx.doi.org/10.1371/journal.pone.0110139			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329168	Green Published, gold			2022-12-27	WOS:000343210800061
J	Csabi, E; Varszegi-Schulz, M; Janacsek, K; Malecek, N; Nemeth, D				Csabi, Eszter; Varszegi-Schulz, Maria; Janacsek, Karolina; Malecek, Nick; Nemeth, Dezso			The Consolidation of Implicit Sequence Memory in Obstructive Sleep Apnea	PLOS ONE			English	Article							SHORT-TERM-MEMORY; INDIVIDUAL-DIFFERENCES; PRIMARY INSOMNIA; CAPACITY; FORMS; OSAS; AGE	Obstructive Sleep Apnea (OSA) Syndrome is a relatively frequent sleep disorder characterized by disrupted sleep patterns. It is a well-established fact that sleep has beneficial effect on memory consolidation by enhancing neural plasticity. Implicit sequence learning is a prominent component of skill learning. However, the formation and consolidation of this fundamental learning mechanism remains poorly understood in OSA. In the present study we examined the consolidation of different aspects of implicit sequence learning in patients with OSA. We used the Alternating Serial Reaction Time task to measure general skill learning and sequence-specific learning. There were two sessions: a learning phase and a testing phase, separated by a 10-hour offline period with sleep. Our data showed differences in offline changes of general skill learning between the OSA and control group. The control group demonstrated offline improvement from evening to morning, while the OSA group did not. In contrast, we did not observe differences between the groups in offline changes in sequence-specific learning. Our findings suggest that disrupted sleep in OSA differently affects neural circuits involved in the consolidation of sequence learning.	[Csabi, Eszter] Univ Szeged, Inst Psychol, Szeged, Hungary; [Varszegi-Schulz, Maria] Somnocenter, Szeged, Hungary; [Janacsek, Karolina; Nemeth, Dezso] Eotvos Lorand Univ, Dept Clin Psychol & Addict, Budapest, Hungary; [Malecek, Nick; Nemeth, Dezso] Univ Texas Austin, Imaging Res Ctr, Austin, TX 78712 USA	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Szeged University; Eotvos Lorand University; University of Texas System; University of Texas Austin	Nemeth, D (corresponding author), Eotvos Lorand Univ, Dept Clin Psychol & Addict, Budapest, Hungary.	nemethd@gmail.com	Janacsek, Karolina/H-8639-2017; Janacsek, Karolina/P-2957-2019; Nemeth, Dezso/B-9142-2009; Lang, Steven/AAE-8102-2021	Janacsek, Karolina/0000-0001-7829-8220; Janacsek, Karolina/0000-0001-7829-8220; Nemeth, Dezso/0000-0002-9629-5856; Lang, Steven/0000-0003-1669-9146	Hungarian Scientific Research Fund [OTKA NF105878, OTKA MB 84743]; Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	The authors are grateful to the Hungarian Scientific Research Fund (OTKA NF105878 and OTKA MB 84743) and Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences (to K. J.) for supporting their work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archbold KH, 2009, J CLIN SLEEP MED, V5, P21; Axmacher N, 2009, CELL MOL LIFE SCI, V66, P2285, DOI 10.1007/s00018-009-0019-1; Backhaus J, 2006, BIOL PSYCHIAT, V60, P1324, DOI 10.1016/j.biopsych.2006.03.051; Banno K, 2007, SLEEP MED, V8, P400, DOI 10.1016/j.sleep.2007.03.003; BEDARD MA, 1991, J CLIN EXP NEUROPSYC, V13, P950, DOI 10.1080/01688639108405110; Bo J, 2011, EXP BRAIN RES, V214, P73, DOI 10.1007/s00221-011-2807-8; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Cosentino FII, 2008, SLEEP MED, V9, P831, DOI 10.1016/j.sleep.2007.10.015; Csabi E, 2013, J CLIN EXP NEUROPSYC, V35, P677, DOI 10.1080/13803395.2013.815693; DANEMAN M, 1984, J EDUC PSYCHOL, V76, P1372, DOI 10.1037/0022-0663.76.6.1372; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; Djonlagic I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034106; Engleman HM, 2000, SLEEP, V23, pS102; Ficca G, 2004, SLEEP MED, V5, P225, DOI 10.1016/j.sleep.2004.01.018; Fischer S, 2005, J NEUROSCI, V25, P11248, DOI 10.1523/JNEUROSCI.1743-05.2005; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; FRENSCH PA, 1994, MEM COGNITION, V22, P95, DOI 10.3758/BF03202765; Gais J, 2004, LEARN MEMORY, V13, P259; Gais S, 2004, LEARN MEMORY, V11, P679, DOI 10.1101/lm.80504; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; Howard DV, 2004, PSYCHOL AGING, V19, P79, DOI 10.1037/0882-7974.19.1.79; Howard JH, 1997, PSYCHOL AGING, V12, P634, DOI 10.1037/0882-7974.12.4.634; Janacsek K., 2009, MAGYAR PSZICHOLOGIAI, V64, P385; Janacsek K, 2013, CORTEX, V49, P2001, DOI 10.1016/j.cortex.2013.02.012; Kaufman SB, 2010, COGNITION, V116, P321, DOI 10.1016/j.cognition.2010.05.011; Kloepfer C, 2009, J CLIN SLEEP MED, V5, P540; Krakauer JW, 2006, TRENDS NEUROSCI, V29, P58, DOI 10.1016/j.tins.2005.10.003; Lojander J, 1999, J SLEEP RES, V8, P71, DOI 10.1046/j.1365-2869.1999.00141.x; Macey PM, 2008, SLEEP, V31, P967; McGeorge P, 1997, J EXP PSYCHOL LEARN, V23, P239, DOI 10.1037/0278-7393.23.1.239; Meier B, 2014, CORTEX, V57, P156, DOI 10.1016/j.cortex.2014.03.009; NAEGELE B, 1995, SLEEP, V18, P43; Nemeth D, 2012, J SLEEP RES, V21, P396, DOI 10.1111/j.1365-2869.2011.00983.x; Nemeth D, 2010, EXP BRAIN RES, V201, P351, DOI 10.1007/s00221-009-2024-x; Nissen C, 2006, SLEEP, V29, P1068, DOI 10.1093/sleep/29.8.1068; Orth M, 2005, EUR RESPIR J, V26, P898, DOI 10.1183/09031936.05.00054704; Pierobon A, 2008, SLEEP MED, V9, P882, DOI 10.1016/j.sleep.2007.10.017; Remillard G, 2008, Q J EXP PSYCHOL, V61, P400, DOI 10.1080/17470210701210999; Richardson JTE, 2007, CORTEX, V43, P635, DOI 10.1016/S0010-9452(08)70493-3; Rickard TC, 2008, J EXP PSYCHOL LEARN, V34, P834, DOI 10.1037/0278-7393.34.4.834; Rouleau I, 2007, SLEEP, V25, P398; Song S, 2014, NAT COMMUN, V5; Song SB, 2007, J NEUROSCI, V27, P12475, DOI 10.1523/JNEUROSCI.2062-07.2007; Unsworth N, 2005, MEM COGNITION, V33, P213, DOI 10.3758/BF03195310; Urbain C, 2013, J COGNITIVE NEUROSCI, V25, P2003, DOI 10.1162/jocn_a_00439; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012	48	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109010	10.1371/journal.pone.0109010	http://dx.doi.org/10.1371/journal.pone.0109010			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25329462	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000346766200016
J	Tuk, B; Tong, M; Fijneman, EMG; van Neck, JW				Tuk, Bastiaan; Tong, Miao; Fijneman, Esther M. G.; van Neck, Johan W.			Hyperbaric Oxygen Therapy to Treat Diabetes Impaired Wound Healing in Rats	PLOS ONE			English	Article								Wound healing in diabetes is frequently impaired and its treatment remains a challenge. Hyperbaric oxygen therapy (HBOT) receives a wide attendance and is often used as a last resort treatment option, however, its effectiveness for many conditions is unproven. We tested the effect of HBOT on healing of diabetic ulcers in an animal experimental setting. Experimental diabetes was induced by intraperitoneal injection of streptozotocin. Four weeks after diabetes induction, rats were ulcerated by clamping a pair of magnet disks on the dorsal skin for 16 h. After magnet removal, the animals received HBOT, daily on weekdays, for 4 weeks. To examine the effect of HBOT on diabetes impaired wound healing, the degree of wound tissue perfusion, inflammation, angiogenesis, and tissue breaking strength were evaluated. HBOT effects on the degree of inflammation and number of blood vessels could not be observed. HBOT improved the tissue breaking strength of the wound, however, this did not reach statistical significance. Twenty hours after ending the HBOT, a significantly improved oxygen saturation of the hemoglobin at the venous end of the capillaries and the quantity of hemoglobin in the micro-blood vessels was measured.	[Tuk, Bastiaan; Tong, Miao; Fijneman, Esther M. G.; van Neck, Johan W.] Erasmus MC, Univ Med Ctr, Dept Plast & Reconstruct Surg, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	van Neck, JW (corresponding author), Erasmus MC, Univ Med Ctr, Dept Plast & Reconstruct Surg, Rotterdam, Netherlands.	j.vanneck@erasmusmc.nl			Nuts Ohra Foundation (the Netherlands) [1103-055]	Nuts Ohra Foundation (the Netherlands)(Netherlands Government)	This research was supported by grant 1103-055 from the Nuts Ohra Foundation (the Netherlands). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brimson CH, 2013, J EUR ACAD DERMATOL, V27, P411, DOI 10.1111/j.1468-3083.2012.04650.x; Calvert JW, 2007, NEUROL RES, V29, P132, DOI 10.1179/016164107X174156; Djasim UM, 2012, INT J ORAL MAX SURG, V41, P271, DOI 10.1016/j.ijom.2011.10.007; Fife CE, 2002, WOUND REPAIR REGEN, V10, P198, DOI 10.1046/j.1524-475X.2002.10402.x; Hunter S, 2010, ADV SKIN WOUND CARE, V23, P115, DOI 10.1097/01.ASW.0000363517.55135.c2; Kikkawa R, 2000, BRIT J NUTR, V84, pS183; Klemetti E, 2005, LAB ANIM-UK, V39, P116, DOI 10.1258/0023677052886529; Kranke P, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004123.pub3, 10.1002/14651858.CD004123.pub4]; Niinikoski JHA, 2004, WORLD J SURG, V28, P307, DOI 10.1007/s00268-003-7401-1; Perez-Amodio S, 2011, TISSUE ENG PT A, V17, P1583, DOI 10.1089/ten.tea.2010.0429; Sheikh AY, 2000, ARCH SURG-CHICAGO, V135, P1293, DOI 10.1001/archsurg.135.11.1293; Thom SR, 2011, PLAST RECONSTR SURG, V127, p131S, DOI 10.1097/PRS.0b013e3181fbe2bf; Thom SR, 2009, J APPL PHYSIOL, V106, P988, DOI 10.1152/japplphysiol.91004.2008; Tong M, 2008, WOUND REPAIR REGEN, V16, P294, DOI 10.1111/j.1524-475X.2008.00368.x; Tong M, 2012, DIABETES, V61, P2633, DOI 10.2337/db11-1329; Tong M, 2011, WOUND REPAIR REGEN, V19, P505, DOI 10.1111/j.1524-475X.2011.00704.x; Yuan J, 2009, BBA-BIOENERGETICS, V1787, P828, DOI 10.1016/j.bbabio.2009.03.009	17	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e108533	10.1371/journal.pone.0108533	http://dx.doi.org/10.1371/journal.pone.0108533			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25329176	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766200011
J	Almagro, L; Carbonell-Bejerano, P; Belchi-Navarro, S; Bru, R; Martinez-Zapater, JM; Lijavetzky, D; Pedreno, MA				Almagro, Lorena; Carbonell-Bejerano, Pablo; Belchi-Navarro, Sarai; Bru, Roque; Martinez-Zapater, Jose M.; Lijavetzky, Diego; Pedreno, Maria A.			Dissecting the Transcriptional Response to Elicitors in Vitis vinifera Cells	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; RESVERATROL PRODUCTION; SALICYLIC-ACID; ANTHOCYANIN TRANSPORT; GRAPEVINE CELLS; UV-C; ARABIDOPSIS; CULTURES; CYCLODEXTRINS; CYTOSKELETON	The high effectiveness of cyclic oligosaccharides like cyclodextrins in the production of trans-resveratrol in Vitis vinifera cell cultures is enhanced in the presence of methyl jasmonate. In order to dissect the basis of the interactions among the elicitation responses triggered by these two compounds, a transcriptional analysis of grapevine cell cultures treated with cyclodextrins and methyl jasmonate separately or in combination was carried out. The results showed that the activation of genes encoding enzymes from phenylpropanoid and stilbene biosynthesis induced by cyclodextrins alone was partially enhanced in the presence of methyl jasmonate, which correlated with their effects on trans-resveratrol production. In addition, protein translation and cell cycle regulation were more highly repressed in cells treated with cyclodextrins than in those treated with methyl jasmonate, and this response was enhanced in the combined treatment. Ethylene signalling was activated by all treatments, while jasmonate signalling and salicylic acid conjugation were activated only in the presence of methyl jasmonate and cyclodextrins, respectively. Moreover, the combined treatment resulted in a crosstalk between the signalling cascades activated by cyclodextrins and methyl jasmonate, which, in turn, provoked the activation of additional regulatory pathways involving the up-regulation of MYB15, NAC and WRKY transcription factors, protein kinases and calcium signal transducers. All these results suggest that both elicitors cause an activation of the secondary metabolism in detriment of basic cell processes like the primary metabolism or cell division. Crosstalk between cyclodextrins and methyl jasmonate-induced signalling provokes an intensification of these responses resulting in a greater trans-resveratrol production.	[Almagro, Lorena; Belchi-Navarro, Sarai; Pedreno, Maria A.] Univ Murcia, Dept Plant Biol, Fac Biol, Murcia, Spain; [Carbonell-Bejerano, Pablo; Martinez-Zapater, Jose M.] Univ La Rioja Gobierno La Rioja, CSIC, Inst Ciencias Vid & Vino, Logrono, Spain; [Bru, Roque] Univ Alicante, Dept Agrochem & Biochem, Fac Sci, E-03080 Alicante, Spain; [Lijavetzky, Diego] Univ Nacl Cuyo, Fac Ciencias Agr, Inst Biol Agr Mendoza, CONICET, RA-5500 Mendoza, Argentina	University of Murcia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-CAR-UR - Instituto de Ciencias de la Vid y del Vino (ICVV); Universidad de La Rioja; Universitat d'Alacant; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Almagro, L (corresponding author), Univ Murcia, Dept Plant Biol, Fac Biol, Murcia, Spain.	lorena.almagro@um.es	Carbonell-Bejerano, Pablo/AAX-3509-2021; Pedreno, Maria A/S-1478-2019; Lijavetzky, Diego/AAF-1557-2020; Carbonell-Bejerano, Pablo/L-6699-2017; Bru-Martinez, Roque/L-5713-2014; Martinez Zapater, Jose Miguel/I-4892-2012	Carbonell-Bejerano, Pablo/0000-0002-7266-9665; Pedreno, Maria A/0000-0001-6195-6418; Carbonell-Bejerano, Pablo/0000-0002-7266-9665; Bru-Martinez, Roque/0000-0003-3465-3766; Lijavetzky, Diego/0000-0003-4207-3067; Almagro, Lorena/0000-0001-8393-2943; Martinez Zapater, Jose Miguel/0000-0001-7217-4454	Fundacion Seneca, Agencia de Ciencia y Tecnologia de la Region de Murcia en el marco de II PCTRM [08799/PI/08]; Ministerio de Economia y Competitividad-Fondo Europeo de Desarrollo Regional [BIO2008-03892, BIO2011-29856-C02-02]; Agencia Nacional de Promocion Cientifica y Tecnologica-MINCYT-Argentina [PAE-PICT 2360]	Fundacion Seneca, Agencia de Ciencia y Tecnologia de la Region de Murcia en el marco de II PCTRM(Fundacion Seneca); Ministerio de Economia y Competitividad-Fondo Europeo de Desarrollo Regional; Agencia Nacional de Promocion Cientifica y Tecnologica-MINCYT-Argentina	This work was supported by the Fundacion Seneca, Agencia de Ciencia y Tecnologia de la Region de Murcia en el marco de II PCTRM 2007-10 (08799/PI/08) and Ministerio de Economia y Competitividad-Fondo Europeo de Desarrollo Regional (BIO2008-03892 and BIO2011-29856-C02-02); Agencia Nacional de Promocion Cientifica y Tecnologica-MINCYT-Argentina (PAE-PICT 2360). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian M, 2012, FITOTERAPIA, V83, P1345, DOI 10.1016/j.fitote.2012.04.004; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Almagro L, 2011, PLANTS ENV, P115; Almagro L., 2013, HDB NATURAL PRODUCTS, P1683, DOI [10.1007/978-3-642-22144-6_54, DOI 10.1007/978-3-642-22144-6]; Beckers GJM, 2006, PLANT BIOLOGY, V8, P1, DOI 10.1055/s-2005-872705; Belchi-Navarro S, 2013, PLANT PHYSIOL BIOCH, V62, P107, DOI 10.1016/j.plaphy.2012.11.001; Belchi-Navarro S, 2012, PLANT CELL REP, V31, P81, DOI 10.1007/s00299-011-1141-8; Belhadj A, 2008, J AGR FOOD CHEM, V56, P5781, DOI 10.1021/jf800578c; Bradamante S, 2004, CARDIOVASC DRUG REV, V22, P169; Bru R, 2006, J AGR FOOD CHEM, V54, P65, DOI 10.1021/jf051485j; CALDERON AA, 1993, NEW PHYTOL, V124, P455, DOI 10.1111/j.1469-8137.1993.tb03836.x; Cantos E, 2003, J AGR FOOD CHEM, V51, P1208, DOI 10.1021/jf020939z; Carbonell-Bejerano P, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-78; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chong JL, 2009, PLANT SCI, V177, P143, DOI 10.1016/j.plantsci.2009.05.012; Conesa A, 2006, BIOINFORMATICS, V22, P1096, DOI 10.1093/bioinformatics/btl056; Conn S, 2008, J EXP BOT, V59, P3621, DOI 10.1093/jxb/ern217; Czemmel S, 2012, PROTOPLASMA, V249, P109, DOI 10.1007/s00709-012-0380-z; Dash S, 2012, NUCLEIC ACIDS RES, V40, pD1194, DOI 10.1093/nar/gkr938; de la Lastra CA, 2005, MOL NUTR FOOD RES, V49, P405; Dean JV, 2005, PLANTA, V221, P287, DOI 10.1007/s00425-004-1430-3; Dean JV, 2004, PHYSIOL PLANTARUM, V120, P603, DOI 10.1111/j.0031-9317.2004.0263.x; Donnez D, 2011, PROCESS BIOCHEM, V46, P1056, DOI 10.1016/j.procbio.2011.01.019; Ebel C, 2001, PLANT PHYSIOL, V126, P87, DOI 10.1104/pp.126.1.87; Edwards R, 2000, TRENDS PLANT SCI, V5, P193, DOI 10.1016/S1360-1385(00)01601-0; Fernandez-Perez F, 2012, PLANT FOOD HUM NUTR, V67, P422, DOI 10.1007/s11130-012-0327-8; Ferri M, 2009, PROTEOMICS, V9, P610, DOI 10.1002/pmic.200800386; Gfeller A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3109cm4; Gomez C, 2011, PLANT J, V67, P960, DOI 10.1111/j.1365-313X.2011.04648.x; Grimplet Jerome, 2012, BMC Res Notes, V5, P213, DOI 10.1186/1756-0500-5-213; Guo CL, 2014, J EXP BOT, V65, P1513, DOI 10.1093/jxb/eru007; Guo MR, 2012, J PLANT PHYSIOL, V169, P1511, DOI 10.1016/j.jplph.2012.06.019; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; Holl J, 2013, PLANT CELL, V25, P4135, DOI 10.1105/tpc.113.117127; Hou XL, 2010, DEV CELL, V19, P884, DOI 10.1016/j.devcel.2010.10.024; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kiselev KV, 2011, APPL MICROBIOL BIOT, V90, P417, DOI 10.1007/s00253-011-3184-8; Kitamura S, 2004, PLANT J, V37, P104, DOI 10.1046/j.1365-313X.2003.01943.x; Li KP, 2008, PLANT J, V55, P927, DOI 10.1111/j.1365-313X.2008.03561.x; Lijavetzky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039547; Lijavetzky Diego, 2008, BMC Res Notes, V1, P132, DOI 10.1186/1756-0500-1-132; Liu Q, 2013, BBA-BIOMEMBRANES, V1828, P2111, DOI 10.1016/j.bbamem.2013.04.027; Ludwig A, 2001, PLANTA, V212, P792, DOI 10.1007/s004250000427; Martinez-Esteso MJ, 2011, J PROTEOMICS, V74, P1421, DOI 10.1016/j.jprot.2011.02.035; Martinez-Esteso MJ, 2009, J PROTEOMICS, V73, P331, DOI 10.1016/j.jprot.2009.10.001; Matsumura H, 2003, PLANT J, V33, P425, DOI 10.1046/j.1365-313X.2003.01639.x; Matus JT, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-83; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Morales M, 1998, PLANT CELL TISS ORG, V53, P179, DOI 10.1023/A:1006027410575; Okawara M, 2007, BIOCHEM PHARMACOL, V73, P550, DOI 10.1016/j.bcp.2006.11.003; Pauwels L, 2008, P NATL ACAD SCI USA, V105, P1380, DOI 10.1073/pnas.0711203105; Pauwels L, 2011, PLANT CELL, V23, P3089, DOI 10.1105/tpc.111.089300; Pedreno MA, 2009, Patent, Patent No. [WO2009106662, 2009106662]; Peer WA, 2011, PLANT CELL MONOGR, V19, P31, DOI 10.1007/978-3-642-13431-9_2; Pezet R, 2004, VITIS, V43, P145; Pontin MA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-224; Qing J, 2004, CHINESE SCI BULL, V49, P535, DOI 10.1360/03wc0541; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Saito K, 2013, PLANT PHYSIOL BIOCH, V72, P21, DOI 10.1016/j.plaphy.2013.02.001; Santamaria AR, 2011, J AGR FOOD CHEM, V59, P9094, DOI 10.1021/jf201181n; Sasaki Y, 2001, DNA RES, V8, P153, DOI 10.1093/dnares/8.4.153; Staiger CJ, 2000, ANNU REV PLANT PHYS, V51, P257, DOI 10.1146/annurev.arplant.51.1.257; Tassoni A, 2005, NEW PHYTOL, V166, P895, DOI 10.1111/j.1469-8137.2005.01383.x; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Toronen P, 1999, FEBS LETT, V451, P142, DOI 10.1016/S0014-5793(99)00524-4; Vang O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019881; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang W, 2010, PLANT PHYSIOL BIOCH, V48, P142, DOI 10.1016/j.plaphy.2009.12.002; Wasteneys GO, 2003, ANNU REV PLANT BIOL, V54, P691, DOI 10.1146/annurev.arplant.54.031902.134818; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; Wild M, 2012, PLANT CELL, V24, P3307, DOI 10.1105/tpc.112.101428; Zamboni A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-363	76	40	41	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109777	10.1371/journal.pone.0109777	http://dx.doi.org/10.1371/journal.pone.0109777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314001	Green Published, gold			2022-12-27	WOS:000343662500077
J	Boll, T; von Haaren, C; von Ruschkowski, E				Boll, Thiemen; von Haaren, Christina; von Ruschkowski, Eick			The Preference and Actual Use of Different Types of Rural Recreation Areas by Urban Dwellers-The Hamburg Case Study	PLOS ONE			English	Article							ECOSYSTEM SERVICES; LANDSCAPE; PERCEPTIONS; PARKS	In the wake of urbanisation processes and the constitution of metropolitan regions, the role of the city's rural surroundings is receiving more attention from researchers and planners as rural areas offer various (cultural) ecosystem services for the urban population. Urban dwellers increasingly desire recreation and landscape experience. Although this need for recreation is generally recognized, few studies have focused on the question of people's preferences for certain types and characteristics of outdoor recreation areas in relation to the frequency of use. In order to acquire baseline data on this subject, the main objectives of this study were to explore recreation preferences of urban dwellers and the relation between actual use and perceived value of recreation areas in a case study in the Hamburg Metropolitan Region (Germany). In a social survey, Hamburg residents (n = 400) were asked about their preferences and use of four important regional recreation areas with different landscape characteristics in face-to-face interviews in different locations in the city. We found that both outdoor recreation within and outside of the city were fairly or very important for more than 70% of the questioned urban dwellers. Interestingly, the preference for a recreation area outside of the city did not depend on the frequency of use, which indicates that certain recreation areas had a symbolic value besides their use value. When people were questioned on the characteristics of recreation areas, perceived naturalness was found to be strongly related to preference. Respondents considered the diversity, uniqueness, and naturalness of the landscape to be far more important than the accessibility of the recreation areas and the provision of service facilities.	[Boll, Thiemen; von Haaren, Christina] Leibniz Univ Hannover, Inst Environm Planning, Hannover, Germany; [von Ruschkowski, Eick] Nat & Biodivers Conservat Union Germany NABU, Dept Nat Conservat & Environm Policy, Berlin, Germany	Leibniz University Hannover	Boll, T (corresponding author), Leibniz Univ Hannover, Inst Environm Planning, Hannover, Germany.	boll@umwelt.uni-hannover.de		von Ruschkowski, Eick/0000-0001-7662-0888	German Federal Ministry of Education and Research; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Leibniz Universitat Hannover	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Leibniz Universitat Hannover	The research is part of the project AgroForNet, which was funded by the German Federal Ministry of Education and Research. AgroForNet will develop regional value creation networks for the sustainable and efficient production and supply of dendromass from agriculture, forestry, and the open landscape. More information on AgroForNet is available on the German-language website www.agrofornet.de. We acknowledge support by Deutsche Forschungsgemeinschaft and the Open Access Publishing Fund of Leibniz Universitat Hannover. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammer U, 1991, FREIZEIT NATUR PROBL; Bastian O, 2012, OKOSYSTEMDIENSTLEIST; Bateman IJ, 2013, SCIENCE, V341, P45, DOI 10.1126/science.1234379; Baur JWR, 2013, LANDSCAPE URBAN PLAN, V117, P100, DOI 10.1016/j.landurbplan.2013.04.015; Boll T, 2014, IFOREST, V7, P423, DOI 10.3832/ifor1173-007; Bundesnaturschutzgesetz, 2010, 12542 BGBI; Burggraaff P, 1998, ANGEW LANDSCHAFTSOKO, V20; Chiesura A, 2004, LANDSCAPE URBAN PLAN, V68, P129, DOI 10.1016/j.landurbplan.2003.08.003; Croucher K., 2007, LINKS GREENSPACE HLT; Dockerty T, 2009, PUBLIC ATTITUDES BIO; Federal Statistical Office, 2010, DEST REG ATL JOINT P; Florek M., 2011, J TOWN CITY MANAG, V1; Gruehn D, 2008, INT LANDSCAPE ARCHIT; Hadler Markus, 2005, QUANTITATIVE DATENAN; Hunziker M, 2010, FORUM WISSEN, P33; Hunziker M, 2008, MT RES DEV, V28, P140, DOI 10.1659/mrd.0952; Ift Freizeit und Tourismus GmbH Metropolregion Hamburg, 2011, TAG BEW METR HAMB EN; Kowarik I, 1988, LANDSCHAFTSENTWICKLU, V56; Kretschmer H, 2007, NATUR LANDSCHAFT, V82, P6; Kumar P., 2012, EC ECOSYSTEMS BIODIV; LAMB RJ, 1990, LANDSCAPE URBAN PLAN, V19, P333, DOI 10.1016/0169-2046(90)90041-Y; Mann C, 2006, ALLG FORST JAGDZTG, V177, P224; Matsuoka RH, 2008, LANDSCAPE URBAN PLAN, V84, P7, DOI 10.1016/j.landurbplan.2007.09.009; Ministry of Economic Affairs Employment and Traffic in Lower Saxony, 2007, WETTB STEIG ZUK GEST; OECD, 2007, RUR POL REV; Plieninger T, 2013, LAND USE POLICY, V33, P118, DOI 10.1016/j.landusepol.2012.12.013; Probstl U, 2010, MANAGEMENT OF RECREATION AND NATURE BASED TOURISM IN EUROPEAN FORESTS, P1; Scannell L, 2010, J ENVIRON PSYCHOL, V30, P1, DOI 10.1016/j.jenvp.2009.09.006; Schipperijn J, 2010, URBAN FOR URBAN GREE, V9, P25, DOI 10.1016/j.ufug.2009.09.002; Soini K, 2012, LANDSCAPE URBAN PLAN, V104, P124, DOI 10.1016/j.landurbplan.2011.10.002; Van den Berg AE, 2006, LANDSCAPE URBAN PLAN, V78, P362, DOI 10.1016/j.landurbplan.2005.11.006; von Ruschkowski E, 2013, J PARK RECREAT ADM, V31, P95; Vries S., 2008, RECREATIONAL ACCESSI; Waltert F, 2011, LAND USE POLICY, V28, P748, DOI 10.1016/j.landusepol.2011.01.002; White MP, 2013, PSYCHOL SCI, V24, P920, DOI 10.1177/0956797612464659; Wobse HH, 2003, LANDSCHAFTSASTHETIK	36	26	26	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e108638	10.1371/journal.pone.0108638	http://dx.doi.org/10.1371/journal.pone.0108638			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR5ZW	25314002	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662500016
J	Cashin, K; Sterjovski, J; Harvey, KL; Ramsland, PA; Churchill, MJ; Gorry, PR				Cashin, Kieran; Sterjovski, Jasminka; Harvey, Katherine L.; Ramsland, Paul A.; Churchill, Melissa J.; Gorry, Paul R.			Covariance of Charged Amino Acids at Positions 322 and 440 of HIV-1 Env Contributes to Coreceptor Specificity of Subtype B Viruses, and Can Be Used to Improve the Performance of V3 Sequence-Based Coreceptor Usage Prediction Algorithms	PLOS ONE			English	Article							TREATMENT-NAIVE PATIENTS; TYPE-1 GP120; VIROLOGICAL RESPONSE; PHENOTYPIC ASSAY; VIRAL TROPISM; MARAVIROC; CCR5; MUTATIONS; LOOP; REGION	The ability to determine coreceptor usage of patient-derived human immunodeficiency virus type 1 (HIV-1) strains is clinically important, particularly for the administration of the CCR5 antagonist maraviroc. The envelope glycoprotein (Env) determinants of coreceptor specificity lie primarily within the gp120 V3 loop region, although other Env determinants have been shown to influence gp120-coreceptor interactions. Here, we determined whether conserved amino acid alterations outside the V3 loop that contribute to coreceptor usage exist, and whether these alterations improve the performance of V3 sequence-based coreceptor usage prediction algorithms. We demonstrate a significant covariant association between charged amino acids at position 322 in V3 and position 440 in the C4 Env region that contributes to the specificity of HIV-1 subtype B strains for CCR5 or CXCR4. Specifically, positively charged Lys/Arg at position 322 and negatively charged Asp/Glu at position 440 occurred more frequently in CXCR4-using viruses, whereas negatively charged Asp/Glu at position 322 and positively charged Arg at position 440 occurred more frequently in R5 strains. In the context of CD4-bound gp120, structural models suggest that covariation of amino acids at Env positions 322 and 440 has the potential to alter electrostatic interactions that are formed between gp120 and charged amino acids in the CCR5 N-terminus. We further demonstrate that inclusion of a ''440 rule'' can improve the sensitivity of several V3 sequence-based genotypic algorithms for predicting coreceptor usage of subtype B HIV-1 strains, without compromising specificity, and significantly improves the AUROC of the geno2pheno algorithm when set to its recommended false positive rate of 5.75%. Together, our results provide further mechanistic insights into the intra-molecular interactions within Env that contribute to coreceptor specificity of subtype B HIV-1 strains, and demonstrate that incorporation of Env determinants outside V3 can improve the reliability of coreceptor usage prediction algorithms.	[Cashin, Kieran; Sterjovski, Jasminka; Harvey, Katherine L.; Ramsland, Paul A.; Churchill, Melissa J.; Gorry, Paul R.] Burnet Inst, Ctr Biomed Res, Melbourne, Australia; [Cashin, Kieran; Harvey, Katherine L.; Gorry, Paul R.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Churchill, Melissa J.] Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia; [Ramsland, Paul A.] Univ Melbourne, Dept Surg, Austin Hlth, Melbourne, Vic, Australia; [Ramsland, Paul A.] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia; [Ramsland, Paul A.] Curtin Univ, Sch Biomed Sci, CHIRI Biosci, Fac Hlth Sci, Perth, WA 6845, Australia; [Churchill, Melissa J.] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Gorry, Paul R.] Monash Univ, Dept Infect Dis, Melbourne, Vic 3004, Australia	Burnet Institute; University of Melbourne; Monash University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Monash University; Curtin University; Monash University; Monash University	Gorry, PR (corresponding author), Burnet Inst, Ctr Biomed Res, Melbourne, Australia.	gorry@burnet.edu.au		Sterjovski, Jasminka/0000-0002-2471-3000; Ramsland, Paul/0000-0002-2107-2738; Churchill, Melissa/0000-0001-5510-7954	Australian National Health and Medical Research Council (NHMRC) [1022066]; Australian Research Council (ARC) [FT120100389]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council)	This study was supported by a grant from the Australian National Health and Medical Research Council (NHMRC) to PRG, MJC and PAR (Grant number 1022066; (www.nhmrc.gov.au)). PRG is supported by an Australian Research Council (ARC) Future Fellowship (Grant number FT120100389; (www.arc.gov.au)). The authors gratefully acknowledge the contribution toward this study from the Victorian Operational Infrastructure Support Program received by the Burnet Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Biscone MJ, 2006, VIROLOGY, V351, P226, DOI 10.1016/j.virol.2006.03.017; Carrillo A, 1996, J VIROL, V70, P1301, DOI 10.1128/JVI.70.2.1301-1309.1996; Carrillo A, 1996, J VIROL, V70, P1310, DOI 10.1128/JVI.70.2.1310-1316.1996; Cashin K, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-24; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Cimbro R, 2014, P NATL ACAD SCI USA, V111, P3152, DOI 10.1073/pnas.1314718111; Coetzer M, 2011, JAIDS-J ACQ IMM DEF, V56, P9, DOI 10.1097/QAI.0b013e3181f63906; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; DEJONG JJ, 1992, J VIROL, V66, P6777, DOI 10.1128/JVI.66.11.6777-6780.1992; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Garrido C, 2008, J CLIN MICROBIOL, V46, P887, DOI 10.1128/JCM.01611-07; Gorry PR, 2010, KUCERS USE ANTIBIOTI, P2869; Groot F, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-52; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hoffman NG, 2002, J VIROL, V76, P3852, DOI 10.1128/JVI.76.8.3852-3864.2002; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Hunt JS, 2009, PHARMACOTHERAPY, V29, P295, DOI 10.1592/phco.29.3.295; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Jakobsen MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065950; Jakobsen MR, 2010, FUTURE VIROL, V5, P219, DOI 10.2217/FVL.09.77; Jensen MA, 2006, J VIROL, V80, P4698, DOI 10.1128/JVI.80.10.4698-4704.2006; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Labrosse B, 2001, J VIROL, V75, P5457, DOI 10.1128/JVI.75.12.5457-5464.2001; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McGovern RA, 2009, 12 EUR AIDS C COL GE, P11; McGovern RA, 2012, JAIDS-J ACQ IMM DEF, V61, P279, DOI 10.1097/QAI.0b013e31826249cf; McGovern RA, 2010, AIDS, V24, P2512, DOI 10.1097/QAD.0b013e32833e6cfb; Melby T, 2006, J INFECT DIS, V194, P238, DOI 10.1086/504693; MOORE JP, 1993, J VIROL, V67, P4785, DOI 10.1128/JVI.67.8.4785-4796.1993; Mulinge M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060566; Nabatov AA, 2004, J VIROL, V78, P524, DOI 10.1128/JVI.78.1.524-530.2004; Pastore C, 2006, J VIROL, V80, P750, DOI 10.1128/JVI.80.2.750-758.2006; Raymond S, 2008, AIDS, V22, pF11, DOI 10.1097/QAD.0b013e32830ebcd4; Raymond S, 2010, JAIDS-J ACQ IMM DEF, V53, P167, DOI 10.1097/QAI.0b013e3181c8413b; Recordon-Pinson P, 2010, ANTIMICROB AGENTS CH, V54, P3335, DOI 10.1128/AAC.00148-10; Roche M, 2011, J VIROL, V85, P4330, DOI 10.1128/JVI.00106-11; Rosen O, 2008, PROTEINS, V71, P1066, DOI 10.1002/prot.21982; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schnur E, 2011, J MOL BIOL, V410, P778, DOI 10.1016/j.jmb.2011.04.023; Shaw GM, 2012, COLD SPRING HARB PER, V2; SHIODA T, 1992, P NATL ACAD SCI USA, V89, P9434, DOI 10.1073/pnas.89.20.9434; Suphaphiphat P, 2007, VIROLOGY, V360, P182, DOI 10.1016/j.virol.2006.10.019; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Swenson LC, 2011, J INFECT DIS, V203, P237, DOI 10.1093/infdis/jiq030; Thielen A, 2011, ANTIVIR THER, V16, P319, DOI 10.3851/IMP1769; Tsuchiya K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02389; Vergis EN, 2000, INFECT DIS CLIN N AM, V14, P809, DOI 10.1016/S0891-5520(05)70135-5; Whitcomb JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06; Wilkin TJ, 2011, CLIN INFECT DIS, V52, P925, DOI 10.1093/cid/cir072; Yamaguchi-Kabata Y, 2004, J MOL EVOL, V58, P333, DOI 10.1007/s00239-003-2555-x	59	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109771	10.1371/journal.pone.0109771	http://dx.doi.org/10.1371/journal.pone.0109771			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313689	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662500075
J	Liu, X; Gan, XL; Chen, JX; Lv, LS; Li, M; Lou, TQ				Liu, Xun; Gan, Xiaoliang; Chen, Jinxia; Lv, Linsheng; Li, Ming; Lou, Tanqi			A New Modified CKD-EPI Equation for Chinese Patients with Type 2 Diabetes	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; RENAL-DISEASE; DIET; EPIDEMIOLOGY	Objective: To improve the performance of glomerular filtration rate (GFR) estimating equation in Chinese type 2 diabetic patients by modification of the CKD-EPI equation. Design and patients: A total of 1196 subjects were enrolled. Measured GFR was calibrated to the dual plasma sample Tc-99m-DTPA-GFR. GFRs estimated by the re-expressed 4-variable MDRD equation, the CKD-EPI equation and the Asian modified CKD-EPI equation were compared in 351 diabetic/non-diabetic pairs. And a new modified CKD-EPI equation was reconstructed in a total of 589 type 2 diabetic patients. Results: In terms of both precision and accuracy, GFR estimating equations all achieved better results in the non-diabetic cohort comparing with those in the type 2 diabetic cohort (30% accuracy, P <= 0.01 for all comparisons). In the validation data set, the new modified equation showed less bias (median difference, 2.3 ml/min/1.73 m(2) for the new modified equation vs. ranged from -3.8 to -7.9 ml/min/1.73 m(2) for the other 3 equations [P < 0.001 for all comparisons]), as was precision (IQR of the difference, 24.5ml/min/1.73 m(2) vs. ranged from 27.3 to 30.7 ml/min/1.73 m(2)), leading to a greater accuracy (30% accuracy, 71.4% vs. 55.2% for the re-expressed 4 variable MDRD equation and 61.0% for the Asian modified CKD-EPI equation [P = 0.001 and P = 0.02]). Conclusion: A new modified CKD-EPI equation for type 2 diabetic patients was developed and validated. The new modified equation improves the performance of GFR estimation.	[Liu, Xun; Chen, Jinxia; Li, Ming; Lou, Tanqi] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Internal Med, Div Nephrol, Guangzhou 510275, Guangdong, Peoples R China; [Gan, Xiaoliang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Dept Anesthesiol, Guangzhou 510275, Guangdong, Peoples R China; [Lv, Linsheng] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Lou, TQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Internal Med, Div Nephrol, Guangzhou 510275, Guangdong, Peoples R China.	liuxun@medmail.com.cn			National Natural Science Foundation of China [81070612, 81370866]; China Postdoctoral Science Foundation [201104335]; Guangdong Science and Technology Plan [2011B031800084, 2013B021800190]; Fundamental Research Funds for the Central Universities [11ykpy38]; National Project of Scientific and Technical Supporting Programs - Ministry of Science & Technology of China [2011BAI10B05]; China Scholarship Council [201308440060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Guangdong Science and Technology Plan; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Project of Scientific and Technical Supporting Programs - Ministry of Science & Technology of China(Ministry of Science and Technology, China); China Scholarship Council(China Scholarship Council)	This work was supported by the National Natural Science Foundation of China (Grant No. 81070612 and 81370866), the China Postdoctoral Science Foundation (Grant No. 201104335), Guangdong Science and Technology Plan (Grant No. 2011B031800084 and 2013B021800190), the Fundamental Research Funds for the Central Universities (Grant No. 11ykpy38), the National Project of Scientific and Technical Supporting Programs Funded by Ministry of Science & Technology of China (Grant No. 2011BAI10B05) and China Scholarship Council (Grant No. 201308440060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Bjornstad P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096264; de Boer IH, 2007, J AM SOC NEPHROL, V18, P235, DOI 10.1681/ASN.2006040394; Earley A, 2012, ANN INTERN MED, V156, P785, DOI 10.7326/0003-4819-156-11-201203200-00391; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Heikkinen JO, 2001, NUCL MED COMMUN, V22, P987, DOI 10.1097/00006231-200109000-00008; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; Kawamoto R, 2008, HYPERTENS RES, V31, P1559, DOI 10.1291/hypres.31.1559; Kim TN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100118; Lee CS, 2010, J KOREAN MED SCI, V25, P1616, DOI 10.3346/jkms.2010.25.11.1616; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079675; Liu X, 2013, CLIN INTERV AGING, V8, P1387, DOI [10.2147/CIA.S47009, 10.2147/CIA.S52774]; Liu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058242; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Nair S, 2011, DIABETOLOGIA, V54, P1304, DOI 10.1007/s00125-011-2085-9; Pei XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057852; Praditpornsilpa K, 2011, NEPHROL DIAL TRANSPL, V26, P2780, DOI 10.1093/ndt/gfq815; Rigalleau V, 2005, DIABETES CARE, V28, P838, DOI 10.2337/diacare.28.4.838; Rigalleau V, 2006, DIABETES CARE, V29, P1491, DOI 10.2337/dc06-0407; Rognant N, 2011, DIABETES CARE, V34, P1320, DOI 10.2337/dc11-0203; Silveiro SP, 2011, DIABETES CARE, V34, P2353, DOI 10.2337/dc11-1282; Stevens LA, 2011, KIDNEY INT, V79, P555, DOI 10.1038/ki.2010.462; Teo BW, 2011, AM J KIDNEY DIS, V58, P56, DOI 10.1053/j.ajkd.2011.02.393; Tonelli M, 2012, LANCET, V380, P807, DOI 10.1016/S0140-6736(12)60572-8; van Deventer HE, 2008, CLIN CHEM, V54, P1197, DOI 10.1373/clinchem.2007.099085	29	19	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109743	10.1371/journal.pone.0109743	http://dx.doi.org/10.1371/journal.pone.0109743			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313918	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662500069
J	Mossenbock, K; Vegiopoulos, A; Rose, AJ; Sijmonsma, TP; Herzig, S; Schafmeier, T				Moessenboeck, Karin; Vegiopoulos, Alexandros; Rose, Adam J.; Sijmonsma, Tjeerd P.; Herzig, Stephan; Schafmeier, Tobias			Browning of White Adipose Tissue Uncouples Glucose Uptake from Insulin Signaling	PLOS ONE			English	Article							DIET-INDUCED OBESITY; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; ADULT HUMANS; FAT-CELL; ADIPOCYTES; MICE; THERMOGENESIS; ADIPOGENESIS; ACTIVATION	Presence of thermogenically active adipose tissue in adult humans has been inversely associated with obesity and type 2 diabetes. While it had been shown that insulin is crucial for the development of classical brown fat, its role in development and function of inducible brown-in-white (brite) adipose tissue is less clear. Here we show that insulin deficiency impaired differentiation of brite adipocytes. However, adrenergic stimulation almost fully induced the thermogenic program under these settings. Although brite differentiation of adipocytes as well as browning of white adipose tissue entailed substantially elevated glucose uptake by adipose tissue, the capacity of insulin to stimulate glucose uptake surprisingly was not higher in the brite state. Notably, in line with the insulin-independent stimulation of glucose uptake, our data revealed that brite recruitment results in induction of solute carrier family 2 (GLUT-1) expression in adipocytes and inguinal WAT. These results for the first time demonstrate that insulin signaling is neither essential for brite recruitment, nor is it improved in cells or tissues upon browning.	[Moessenboeck, Karin; Vegiopoulos, Alexandros; Rose, Adam J.; Sijmonsma, Tjeerd P.; Herzig, Stephan; Schafmeier, Tobias] Heidelberg Univ, Joint Div Mol Metab Control, DKFZ ZMBH Alliance & Network Aging Res, German Canc Res Ctr DKFZ Heidelberg,Ctr Mol Biol, Heidelberg, Germany; [Moessenboeck, Karin; Vegiopoulos, Alexandros; Rose, Adam J.; Sijmonsma, Tjeerd P.; Herzig, Stephan; Schafmeier, Tobias] Heidelberg Univ, Univ Hosp, Heidelberg, Germany; [Vegiopoulos, Alexandros] German Canc Res Ctr, Jr Res Grp Metab & Stem Cell Plast, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Herzig, S (corresponding author), Heidelberg Univ, Joint Div Mol Metab Control, DKFZ ZMBH Alliance & Network Aging Res, German Canc Res Ctr DKFZ Heidelberg,Ctr Mol Biol, Heidelberg, Germany.	s.herzig@dkfz.de	Rose, Adam John/AAC-6274-2019	Rose, Adam John/0000-0001-9132-8244; Herzig, Stephan/0000-0003-3950-3652	Reinhart Koselleck Grant of the Deutsche Forschungsgemeinschaft [HE-3260/8-1]; EU FP7 Collaborative Project DIABAT [HEALTH-F2-2011-278373]; Helmholtz Alliance ICEMED	Reinhart Koselleck Grant of the Deutsche Forschungsgemeinschaft; EU FP7 Collaborative Project DIABAT; Helmholtz Alliance ICEMED	This work was funded by a Reinhart Koselleck Grant of the Deutsche Forschungsgemeinschaft (HE-3260/8-1), the EU FP7 Collaborative Project DIABAT (HEALTH-F2-2011-278373) and the Helmholtz Alliance ICEMED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admiraal WM, 2013, DIABETOLOGIA; Algire C, 2013, BBA-MOL CELL BIOL L, V1831, P896, DOI 10.1016/j.bbalip.2012.10.001; Barnett AH, 2006, DIABETOLOGIA, V49, P2234, DOI 10.1007/s00125-006-0325-1; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Boucher J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1905; Boucher J, 2010, J BIOL CHEM, V285, P17235, DOI 10.1074/jbc.M110.118620; Chan DA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002394; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dallner OS, 2006, ENDOCRINOLOGY, V147, P5730, DOI 10.1210/en.2006-0242; Elias I, 2012, DIABETES, V61, P1801, DOI 10.2337/db11-0832; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fueger PT, 2004, AM J PHYSIOL-ENDOC M, V286, pE77, DOI 10.1152/ajpendo.00309.2003; Ge X, 2011, J BIOL CHEM, V286, P34533, DOI 10.1074/jbc.M111.248591; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Haas B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000511; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Harper J A, 2001, Obes Rev, V2, P255, DOI 10.1046/j.1467-789X.2001.00043.x; Hsieh WP, 2003, GENETICS, V165, P747; Ikeda Y, 2011, BIOL PHARM BULL, V34, P865, DOI 10.1248/bpb.34.865; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; KRAEGEN EW, 1985, AM J PHYSIOL, V248, pE353; Lazar MA, 2008, SCIENCE, V321, P1048, DOI 10.1126/science.1164094; Lee P, 2014, DIABETES; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Maarbjerg SJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE924, DOI 10.1152/ajpendo.90653.2008; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Mercader J, 2009, AM J PHYSIOL-ENDOC M, V297, pE184, DOI 10.1152/ajpendo.00163.2009; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Nicholls D G, 1978, Experientia Suppl, V32, P89; Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012; Ouellet V, 2011, J CLIN ENDOCR METAB, V96, P192, DOI 10.1210/jc.2010-0989; Peirce V, 2014, NATURE, V510, P76, DOI 10.1038/nature13477; Peirce V, 2013, LANCET DIABETES ENDO, V1, P353, DOI 10.1016/S2213-8587(13)70055-X; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rohm M, 2013, CELL METAB, V17, P575, DOI 10.1016/j.cmet.2013.02.010; Rose AJ, 2005, PHYSIOLOGY, V20, P260, DOI 10.1152/physiol.00012.2005; Rosen ED, 2000, GENE DEV, V14, P1293; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Roy J, 2007, J BIOPHARM STAT, V17, P363, DOI DOI 10.1080/10543400601001600; Saladin R, 1999, CELL GROWTH DIFFER, V10, P43; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Shi Jun, 2008, V456, P307, DOI 10.1007/978-1-59745-245-8_23; Sun K, 2012, P NATL ACAD SCI USA, V109, P5874, DOI 10.1073/pnas.1200447109; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Villarroya F, 2013, CELL METAB, V17, P638, DOI 10.1016/j.cmet.2013.02.020; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xue Y, 2009, CELL METAB, V9, P99, DOI 10.1016/j.cmet.2008.11.009	55	37	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110428	10.1371/journal.pone.0110428	http://dx.doi.org/10.1371/journal.pone.0110428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313899	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500114
J	Montalto, A; Faes, L; Marinazzo, D				Montalto, Alessandro; Faes, Luca; Marinazzo, Daniele			MuTE: A MATLAB Toolbox to Compare Established and Novel Estimators of the Multivariate Transfer Entropy	PLOS ONE			English	Article							INFORMATION; CAUSALITY	A challenge for physiologists and neuroscientists is to map information transfer between components of the systems that they study at different scales, in order to derive important knowledge on structure and function from the analysis of the recorded dynamics. The components of physiological networks often interact in a nonlinear way and through mechanisms which are in general not completely known. It is then safer that the method of choice for analyzing these interactions does not rely on any model or assumption on the nature of the data and their interactions. Transfer entropy has emerged as a powerful tool to quantify directed dynamical interactions. In this paper we compare different approaches to evaluate transfer entropy, some of them already proposed, some novel, and present their implementation in a freeware MATLAB toolbox. Applications to simulated and real data are presented.	[Montalto, Alessandro; Marinazzo, Daniele] Univ Ghent, Data Anal Dept, B-9000 Ghent, Belgium; [Faes, Luca] Univ Trento, Dept Ind Engn, BIOtech, Trento, Italy; [Faes, Luca] IRCS PAT FBK, Trento, Italy	Ghent University; University of Trento; Fondazione Bruno Kessler	Montalto, A (corresponding author), Univ Ghent, Data Anal Dept, B-9000 Ghent, Belgium.	alessandro.montalto@ugent.be	Faes, Luca/E-5156-2012; Marinazzo, Daniele/H-4793-2019	Faes, Luca/0000-0002-3271-5348; Marinazzo, Daniele/0000-0002-9803-0122	Belgian Science Policy [CEREBNET P7 11]; University of Gent	Belgian Science Policy(Belgian Federal Science Policy Office); University of Gent	This work is supported by: the Belgian Science Policy (IUAP VII project CEREBNET P7 11); the University of Gent (Special Research Funds for visiting researchers). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Barnett L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238701; Barrett AB, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041907; Brandt P.T., 2007, MULTIPLE TIME SERIES, V148; Chicharro D, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.041901; Cohen MA, 2002, J PHYSIOL-LONDON, V542, P669, DOI 10.1113/jphysiol.2002.017483; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Faes L, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00080; Faes L, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051112; Faes L, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026201; Gourevitch B, 2007, J NEUROPHYSIOL, V97, P2533, DOI 10.1152/jn.01106.2006; Hlavackova-Schindler K, 2007, PHYS REP, V441, P1, DOI 10.1016/j.physrep.2006.12.004; Kramer MA, 2008, EPILEPSY RES, V79, P173, DOI 10.1016/j.eplepsyres.2008.02.002; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Kugiumtzis D, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062918; Marinazzo D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.144103; Merkwirth C., 2009, OPENTSTOOL USER MANU; Nollo G, 2009, PHILOS T R SOC A, V367, P1423, DOI 10.1098/rsta.2008.0275; Quiroga RQ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041903; Schindler K., 2011, APPL MATH SCI, V5, P3637; Schneider T, 2001, ACM T MATH SOFTWARE, V27, P58, DOI 10.1145/382043.382316; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Vakorin VA, 2010, NEUROIMAGE, V49, P1593, DOI 10.1016/j.neuroimage.2009.08.027; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Vlachos I, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.016207; Wibral M, 2011, BMC NEUROSCI, V12, pP200; Wibral M, 2011, PROG BIOPHYS MOL BIO, V105, P80, DOI 10.1016/j.pbiomolbio.2010.11.006	28	113	114	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109462	10.1371/journal.pone.0109462	http://dx.doi.org/10.1371/journal.pone.0109462			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314003	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500043
J	Roet, KCD; Wirz, KTS; Franssen, EHP; Verhaagen, J				Roet, Kasper C. D.; Wirz, Kerstin T. S.; Franssen, Elske H. P.; Verhaagen, Joost			A Role for Neuropilins in the Interaction between Schwann Cells and Meningeal Cells	PLOS ONE			English	Article							SPINAL-CORD-INJURY; OLFACTORY ENSHEATHING CELLS; PERIPHERAL NERVOUS-SYSTEM; NEURAL CREST MIGRATION; FUNCTIONAL RECOVERY; SEMAPHORIN-III; WHITE-MATTER; AXON GROWTH; TRANSPLANTATION; ADULT	In their natural habitat, the peripheral nerve, Schwann cells (SCs) form nicely aligned pathways (also known as the bands of Bungner) that guide regenerating axons to their targets. Schwann cells that are implanted in the lesioned spinal cord fail to align in pathways that could support axon growth but form cellular clusters that exhibit only limited intermingling with the astrocytes and meningeal cells (MCs) that are present in the neural scar. The formation of cell clusters can be studied in co-cultures of SCs and MCs. In these co-cultures SCs form cluster-like non-overlapping cell aggregates with well-defined boundaries. There are several indications that neuropilins (NRPs) play an important role in MC-induced SC aggregation. Both SCs and MCs express NRP1 and NRP2 and SCs express the NRP ligands Sema3B, C and E while MCs express Sema3A, C, E and F. We now demonstrate that in SC-MC co-cultures, siRNA mediated knockdown of NRP2 in SCs decreased the formation of SC clusters while these SCs maintained their capacity to align in bands of Bungner-like columnar arrays. Unexpectedly, knockdown of NRP1 expression resulted in a significant increase in SC aggregation. These results suggest that a reduction in NRP2 expression may enhance the capacity of implanted SCs to interact with MCs that invade a neural scar formed after a lesion of the spinal cord.	[Roet, Kasper C. D.; Wirz, Kerstin T. S.; Franssen, Elske H. P.; Verhaagen, Joost] Royal Acad Arts & Sci, Netherlands Inst Neurosci, Lab Neuroregenerat, Amsterdam, Netherlands; [Verhaagen, Joost] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Mol & Cellular Neurobiol, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Vrije Universiteit Amsterdam	Roet, KCD (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02163 USA.	kasperroet@gmail.com; j.verhaagen@nin.knaw.nl	Verhaagen, Joost/G-4773-2012					Afshari FT, 2010, GLIA, V58, P857, DOI 10.1002/glia.20970; Afshari FT, 2010, J NEUROSCI, V30, P4246, DOI 10.1523/JNEUROSCI.3351-09.2010; Ara J, 2005, J NEUROSCI RES, V79, P468, DOI 10.1002/jnr.20370; Ara J, 2004, NEUROCHEM RES, V29, P1153, DOI 10.1023/B:NERE.0000023602.72354.82; Bannerman P, 2008, J NEUROSCI RES, V86, P3163, DOI 10.1002/jnr.21766; Bielenberg DR, 2004, J CLIN INVEST, V114, P1260, DOI 10.1172/JCI200421378; Bregman BS, 2002, PROG BRAIN RES, V137, P257; Bunge MB, 2008, J SPINAL CORD MED, V31, P262, DOI 10.1080/10790268.2008.11760720; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Cheng HJ, 2001, NEURON, V32, P249, DOI 10.1016/S0896-6273(01)00478-0; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; De Winter F, 2002, EXP NEUROL, V175, P61, DOI 10.1006/exnr.2002.7884; DUNCAN ID, 1981, J NEUROL SCI, V49, P241, DOI 10.1016/0022-510X(81)90082-4; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Fairless R, 2005, MOL CELL NEUROSCI, V28, P253, DOI 10.1016/j.mcn.2004.09.009; Favier B, 2006, BLOOD, V108, P1243, DOI 10.1182/blood-2005-11-4447; Franssen EHP, 2009, J NEUROSCI RES, V87, P1556, DOI 10.1002/jnr.21979; Gammill LS, 2007, DEV NEUROBIOL, V67, P47, DOI 10.1002/dneu.20326; Gammill LS, 2006, DEVELOPMENT, V133, P99, DOI 10.1242/dev.02187; Garcia-Alias G, 2004, J NEUROSCI RES, V75, P632, DOI 10.1002/jnr.20029; Golden KL, 2007, EXP NEUROL, V207, P203, DOI 10.1016/j.expneurol.2007.06.023; Guest JD, 1997, EXP NEUROL, V148, P502, DOI 10.1006/exnr.1997.6693; Iwashita Y, 2000, EXP NEUROL, V164, P292, DOI 10.1006/exnr.2000.7440; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Lakatos A, 2000, GLIA, V32, P214, DOI 10.1002/1098-1136(200012)32:3<214::AID-GLIA20>3.0.CO;2-7; Lakatos A, 2003, EXP NEUROL, V184, P237, DOI 10.1016/S0014-4886(03)00270-X; Luo JA, 2011, GLIA, V59, P424, DOI 10.1002/glia.21111; MORRISSEY TK, 1991, J NEUROSCI, V11, P2433; Nasarre P, 2005, NEOPLASIA, V7, P180, DOI 10.1593/neo.04481; Niclou SP, 2003, MOL CELL NEUROSCI, V24, P902, DOI 10.1016/S1044-7431(03)00243-4; Oudega M, 2006, J NEUROTRAUM, V23, P453, DOI 10.1089/neu.2006.23.453; Oudega M, 2005, BRAZ J MED BIOL RES, V38, P825, DOI 10.1590/S0100-879X2005000600003; Pasterkamp RJ, 1999, MOL CELL NEUROSCI, V13, P143, DOI 10.1006/mcne.1999.0738; Pearse DD, 2007, GLIA, V55, P976, DOI 10.1002/glia.20490; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; Saberi H, 2008, NEUROSCI LETT, V443, P46, DOI 10.1016/j.neulet.2008.07.041; Scarlato M, 2003, EXP NEUROL, V183, P489, DOI 10.1016/S0014-4886(03)00046-3; Schwarz Q, 2009, DEVELOPMENT, V136, P1785, DOI 10.1242/dev.034322; Shimizu M, 2000, J CELL BIOL, V148, P1283, DOI 10.1083/jcb.148.6.1283; TAKAGI S, 1995, DEV BIOL, V170, P207, DOI 10.1006/dbio.1995.1208; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Tuszynski MH, 1998, CELL TRANSPLANT, V7, P187, DOI 10.1016/S0963-6897(97)00166-8; Wilby MJ, 1999, MOL CELL NEUROSCI, V14, P66, DOI 10.1006/mcne.1999.0766	47	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109401	10.1371/journal.pone.0109401	http://dx.doi.org/10.1371/journal.pone.0109401			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314276	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500036
J	Uhlig, CE; Seitz, B; Eter, N; Promesberger, J; Busse, H				Uhlig, Constantin E.; Seitz, Berthold; Eter, Nicole; Promesberger, Julia; Busse, Holger			Efficiencies of Internet-Based Digital and Paper-Based Scientific Surveys and the Estimated Costs and Time for Different-Sized Cohorts	PLOS ONE			English	Article							HEALTH; RECRUITMENT	Aims: To evaluate the relative efficiencies of five Internet-based digital and three paper-based scientific surveys and to estimate the costs for different-sized cohorts. Methods: Invitations to participate in a survey were distributed via e-mail to employees of two university hospitals (E-1 and E-2) and to members of a medical association (E-3), as a link placed in a special text on the municipal homepage regularly read by the administrative employees of two cities (H-1 and H-2), and paper-based to workers at an automobile enterprise (P-1) and college (P-2) and senior (P-3) students. The main parameters analyzed included the numbers of invited and actual participants, and the time and cost to complete the survey. Statistical analysis was descriptive, except for the Kruskal-Wallis-H-test, which was used to compare the three recruitment methods. Cost efficiencies were compared and extrapolated to different-sized cohorts. Results: The ratios of completely answered questionnaires to distributed questionnaires were between 81.5% (E-1) and 97.4% (P-2). Between 6.4% (P-1) and 57.0% (P-2) of the invited participants completely answered the questionnaires. The costs per completely answered questionnaire were $0.57-$1.41 (E1-3), $1.70 and $0.80 for H-1 and H-2, respectively, and $3.36-$ 4.21 (P1-3). Based on our results, electronic surveys with 10, 20, 30, or 42 questions would be estimated to be most cost (and time) efficient if more than 101.6-225.9 (128.2-391.7), 139.8-229.2 (93.8-193.6), 165.8-230.6 (68.7-115.7), or 188.2-231.5 (44.4-72.7) participants were required, respectively. Conclusions: The study efficiency depended on the technical modalities of the survey methods and engagement of the participants. Depending on our study design, our results suggest that in similar projects that will certainly have more than two to three hundred required participants, the most efficient way of conducting a questionnaire-based survey is likely via the Internet with a digital questionnaire, specifically via a centralized e-mail.	[Uhlig, Constantin E.; Eter, Nicole; Promesberger, Julia; Busse, Holger] Univ Munster, Dept Ophthalmol, Med Ctr, D-48149 Munster, Germany; [Seitz, Berthold] Univ Saarland, Dept Ophthalmol, Med Ctr, Homburg, Germany	University of Munster; Saarland University	Uhlig, CE (corresponding author), Univ Munster, Dept Ophthalmol, Med Ctr, D-48149 Munster, Germany.	uhligc@uni-muenster.de	Seitz, Berthold/AAB-8546-2019	Seitz, Berthold/0000-0001-9701-8204				Bock BC, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.989; Chen YF, 2010, INT J MED INFORM, V79, P167, DOI 10.1016/j.ijmedinf.2009.12.006; de Vries H, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1902; Etter JF, 2001, INT J EPIDEMIOL, V30, P521, DOI 10.1093/ije/30.3.521; Eysenbach G, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.2.e13; Fritz F, 2012, INT J MED INFORM, V81, P303, DOI 10.1016/j.ijmedinf.2011.12.008; Galliber JM, 2008, ANN FAM MED, V6, P154, DOI 10.1370/afm.762; Graham AL, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1001; Hohwu L, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2595; Hunter J, 2012, J EVAL CLIN PRACT, V19, P20; Koo M, 2007, J MED INTERNET RES, V7, pe6; Le Jeannic A, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-7; Marks L, 2002, TRENDS BIOTECHNOL, V20, P105, DOI 10.1016/S0167-7799(02)01881-4; Pavlovic I, 2009, CONTEMP CLIN TRIALS, V30, P300, DOI 10.1016/j.cct.2009.03.008; Postel MG, 2010, J MED INTERNET RES, V12, P11, DOI 10.2196/jmir.1642; Purvis S, 2010, CLIN NURSE SPEC, V24, P289, DOI 10.1097/NUR.0b013e3181f8724c; Reips UD, 2002, EXP PSYCHOL, V49, P243, DOI 10.1027//1618-3169.49.4.243; Robinson KM, 2001, QUAL HEALTH RES, V11, P706, DOI 10.1177/104973201129119398; Smith MA, 1997, BEHAV RES METH INS C, V29, P496, DOI 10.3758/BF03210601; Tingling P, 2003, INTERNET RES, V13, P223, DOI 10.1108/10662240310478231; Townsend A, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1752; Uhlig CE, 2012, OPHTHALMOLOGE, V109, P1198, DOI 10.1007/s00347-012-2626-8; Walther B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025348	23	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e108441	10.1371/journal.pone.0108441	http://dx.doi.org/10.1371/journal.pone.0108441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313672	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662500012
J	Armitage, SAO; Sun, W; You, XT; Kurtz, J; Schmucker, D; Chen, W				Armitage, Sophie A. O.; Sun, Wei; You, Xintian; Kurtz, Joachim; Schmucker, Dietmar; Chen, Wei			Quantitative Profiling of Drosophila melanogaster Dscam1 Isoforms Reveals No Changes in Splicing after Bacterial Exposure	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTOR; DROSOPHILA-DSCAM; IMMUNE-SYSTEM; AXON GUIDANCE; HOST-DEFENSE; INSECT IMMUNITY; SELF-AVOIDANCE; DIVERSITY; GENES; EXPRESSION	The hypervariable Dscam1 (Down syndrome cell adhesion molecule 1) gene can produce thousands of different ectodomain isoforms via mutually exclusive alternative splicing. Dscam1 appears to be involved in the immune response of some insects and crustaceans. It has been proposed that the diverse isoforms may be involved in the recognition of, or the defence against, diverse parasite epitopes, although evidence to support this is sparse. A prediction that can be generated from this hypothesis is that the gene expression of specific exons and/or isoforms is influenced by exposure to an immune elicitor. To test this hypothesis, we for the first time, use a long read RNA sequencing method to directly investigate the Dscam1 splicing pattern after exposing adult Drosophila melanogaster and a S2 cell line to live Escherichia coli. After bacterial exposure both models showed increased expression of immune-related genes, indicating that the immune system had been activated. However there were no changes in total Dscam1 mRNA expression. RNA sequencing further showed that there were no significant changes in individual exon expression and no changes in isoform splicing patterns in response to bacterial exposure. Therefore our studies do not support a change of D. melanogaster Dscam1 isoform diversity in response to live E. coli. Nevertheless, in future this approach could be used to identify potentially immune-related Dscam1 splicing regulation in other host species or in response to other pathogens.	[Armitage, Sophie A. O.; Kurtz, Joachim] Univ Munster, Inst Evolut & Biodivers, D-48149 Munster, Germany; [Sun, Wei; You, Xintian; Chen, Wei] Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, Lab Novel Sequencing Technol Funct & Med Genom, Berlin, Germany; [Schmucker, Dietmar] Univ Leuven, Dept Oncol, VIB, Lab Neuronal Wiring,Vesalius Res Ctr, Leuven, Belgium	University of Munster; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Flanders Institute for Biotechnology (VIB); KU Leuven	Armitage, SAO (corresponding author), Univ Munster, Inst Evolut & Biodivers, D-48149 Munster, Germany.	sophie.armitage@uni-muenster.de; dietmar.schmucker@vib-kuleuven.be; Wei.Chen@mdc-berlin.de	Armitage, Sophie AO/A-6961-2012; Sun, Wei/A-4417-2018; Chen, Wei/C-1273-2011; Kurtz, Joachim/A-9678-2008	Armitage, Sophie AO/0000-0002-5561-9543; Sun, Wei/0000-0001-9607-1361; Kurtz, Joachim/0000-0002-7258-459X; YOU, Xintian/0000-0002-1684-7084	Fonds Wetenschappelijk Onderzoek - Vlaanderen (FWO) [G059611N]; BELSPO IUAP VII-20 "WIBRAIN project"; Volkswagen Foundation Postdoctoral Fellowship [83516, 86020]; German Research Foundation (DFG) within SPP 1399 [AR 872/1-1]; Berlin Institute for Medical Systems Biology of the Federal Ministry for Education and Research (BMBF); Senate of Berlin [0315362]; China Scholarship Council (CSC) [2010623030]	Fonds Wetenschappelijk Onderzoek - Vlaanderen (FWO)(FWO); BELSPO IUAP VII-20 "WIBRAIN project"; Volkswagen Foundation Postdoctoral Fellowship; German Research Foundation (DFG) within SPP 1399; Berlin Institute for Medical Systems Biology of the Federal Ministry for Education and Research (BMBF); Senate of Berlin; China Scholarship Council (CSC)(China Scholarship Council)	Support was provided to DS by Fonds Wetenschappelijk Onderzoek - Vlaanderen (FWO), (http://www.fwo.be/en/) (G059611N) BELSPO IUAP VII-20 "WIBRAIN project", to SAOA by Volkswagen Foundation Postdoctoral Fellowship (http://www.volkswagenstiftung.de/) Grant numbers: 83516 and 86020; German Research Foundation (DFG) (http://www.dfg.de/en/) Grant number: AR 872/1-1 within SPP 1399, to WC by Berlin Institute for Medical Systems Biology of the Federal Ministry for Education and Research (BMBF) and Senate of Berlin (www.bmbf.de, www.berlin.de/sen/wtf) Grant number: 0315362, and to WS by the China Scholarship Council (CSC) (http://en.csc.edu.cn/) Grant number: 2010623030. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERS S, 2010, GENOME BIOL, V11; Armitage SAO, DEV COMP IM IN PRESS; Armitage SAO, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-53; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brites D, 2008, MOL BIOL EVOL, V25, P1429, DOI 10.1093/molbev/msn087; Bulet P, 2005, PROTEIN PEPTIDE LETT, V12, P3, DOI 10.2174/0929866053406011; Chiang YA, 2013, FISH SHELLFISH IMMUN, V34, P209, DOI 10.1016/j.fsi.2012.10.021; Chou PH, 2009, DEV COMP IMMUNOL, V33, P1258, DOI 10.1016/j.dci.2009.07.006; Clancy David J., 2001, Drosophila Information Service, V84, P168; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Dong YM, 2012, CELL HOST MICROBE, V12, P521, DOI 10.1016/j.chom.2012.09.004; Douglas AE, 2011, P ROY SOC B-BIOL SCI, V278, P333, DOI 10.1098/rspb.2010.1563; FEHLBAUM P, 1994, J BIOL CHEM, V269, P33159; Fellous S, 2011, MOL ECOL, V20, P1558, DOI 10.1111/j.1365-294X.2011.05006.x; Hattori D, 2007, NATURE, V449, P223, DOI 10.1038/nature06099; Hattori D, 2009, NATURE, V461, P644, DOI 10.1038/nature08431; He HH, 2014, SCIENCE, V344, P1182, DOI 10.1126/science.1251852; Hung HY, 2013, FISH SHELLFISH IMMUN, V35, P1272, DOI 10.1016/j.fsi.2013.07.045; Kallio J, 2005, MICROBES INFECT, V7, P811, DOI 10.1016/j.micinf.2005.03.014; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Luu-The V, 2005, BIOTECHNIQUES, V38, P287, DOI 10.2144/05382RR05; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Malagoli D, 2012, CYTOKINE, V58, P280, DOI 10.1016/j.cyto.2012.02.002; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Meijers R, 2007, NATURE, V449, P487, DOI 10.1038/nature06147; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Rogers SL, 2008, NAT PROTOC, V3, P606, DOI 10.1038/nprot.2008.18; Romeo Yves, 2008, V415, P379, DOI 10.1007/978-1-59745-570-1_22; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Schmucker D, 2009, GENE DEV, V23, P147, DOI 10.1101/gad.1752909; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Smith PJ, 2011, FILM QUART, V65, P10, DOI 10.1525/FQ.2011.65.2.10; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Sun W, 2013, EMBO J, V32, P2029, DOI 10.1038/emboj.2013.144; Tanji T, 2007, MOL CELL BIOL, V27, P4578, DOI 10.1128/MCB.01814-06; Team RC, 2014, LANG ENV STAT COMP; Valanne S, 2007, DEV COMP IMMUNOL, V31, P991, DOI 10.1016/j.dci.2007.01.004; Von Ohlen T, 2012, INFECT IMMUN, V80, P3576, DOI 10.1128/IAI.00670-12; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Watthanasurorot A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002062; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; WICKER C, 1990, J BIOL CHEM, V265, P22493; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wojtowicz WM, 2007, CELL, V130, P1134, DOI 10.1016/j.cell.2007.08.026; Wu W, 2012, NEURON, V74, P261, DOI 10.1016/j.neuron.2012.02.029; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zipursky SL, 2006, TRENDS BIOCHEM SCI, V31, P581, DOI 10.1016/j.tibs.2006.08.003; Zipursky SL, 2013, ANNU REV NEUROSCI, V36, P547, DOI 10.1146/annurev-neuro-062111-150414	56	23	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e108660	10.1371/journal.pone.0108660	http://dx.doi.org/10.1371/journal.pone.0108660			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310676	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000343210300023
J	Juel, C				Juel, Carsten			Oxidative Stress (Glutathionylation) and Na,K-ATPase Activity in Rat Skeletal Muscle	PLOS ONE			English	Article							NA+-K+ PUMP; S-GLUTATHIONYLATION; INHIBITION; SUBUNIT; ATPASE	Background: Changes in ion distribution across skeletal muscle membranes during muscle activity affect excitability and may impair force development. These changes are counteracted by the Na,K-ATPase. Regulation of the Na, K-ATPase is therefore important for skeletal muscle function. The present study investigated the presence of oxidative stress (glutathionylation) on the Na,K-ATPase in rat skeletal muscle membranes. Results: Immunoprecipitation with an anti-glutathione antibody and subsequent immunodetection of Na, K-ATPase protein subunits demonstrated 9.0 +/- 1.3% and 4.1 +/- 1.0% glutathionylation of the alpha isoforms in oxidative and glycolytic skeletal muscle, respectively. In oxidative muscle, 20.0 +/- 6.1% of the beta 1 units were glutathionylated, whereas 14.8 +/- 2.8% of the beta 2-subunits appear to be glutathionylated in glycolytic muscle. Treatment with the reducing agent dithiothreitol (DTT, 1 mM) increased the in vitro maximal Na,K-ATPase activity by 19% (P < 0.05) in membranes from glycolytic muscle. Oxidized glutathione (GSSG, 0-10 mM) increased the in vitro glutathionylation level detected with antibodies, and decreased the in vitro maximal Na,K-ATPase activity in a dose-dependent manner, and with a larger effect in oxidative compared to glycolytic skeletal muscle. Conclusion: This study demonstrates the existence of basal glutathionylation of both the alpha and the beta units of rat skeletal muscle Na,K-ATPase. In addition, the study suggests a negative correlation between glutathionylation levels and maximal Na,K-ATPase activity. Perspective: Glutathionylation likely contributes to the complex regulation of Na,K-ATPase function in skeletal muscle. Especially, glutathionylation induced by oxidative stress may have a role in Na,K-ATPase regulation during prolonged muscle activity.	Univ Copenhagen, Dept Biol, Copenhagen, Denmark	University of Copenhagen	Juel, C (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	cjuel@bio.ku.dk	Juel, Carsten/J-5328-2014	Juel, Carsten/0000-0002-2373-6358				Bailey DM, 2003, J APPL PHYSIOL, V94, P1714, DOI 10.1152/japplphysiol.01024.2002; Bibert S, 2011, J BIOL CHEM, V286, P18562, DOI 10.1074/jbc.M110.184101; Clausen T, 2003, PHYSIOL REV, V83, P1269, DOI 10.1152/physrev.00011.2003; Figtree GA, 2009, CIRC RES, V105, P185, DOI 10.1161/CIRCRESAHA.109.199547; Juel C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091175; Juel C, 2013, AM J PHYSIOL-REG I, V304, pR1161, DOI 10.1152/ajpregu.00591.2012; Juel C, 2009, AM J PHYSIOL-REG I, V296, pR125, DOI 10.1152/ajpregu.90760.2008; Liu CC, 2013, J MOL CELL CARDIOL, V61, P94, DOI 10.1016/j.yjmcc.2013.05.013; Liu CC, 2012, J BIOL CHEM, V287, P12353, DOI 10.1074/jbc.M112.340893; Meng XY, 2014, BIOCHEMISTRY-MOSCOW+, V79, P158, DOI 10.1134/S0006297914020096; Mollica JP, 2012, J PHYSIOL-LONDON, V590, P1443, DOI 10.1113/jphysiol.2011.224535; Petrushanko IY, 2012, J BIOL CHEM, V287, P32195, DOI 10.1074/jbc.M112.391094; Reid MB, 2001, J APPL PHYSIOL, V90, P724, DOI 10.1152/jappl.2001.90.2.724; SHATTOCK MJ, 1993, CIRC RES, V72, P91, DOI 10.1161/01.RES.72.1.91	14	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110514	10.1371/journal.pone.0110514	http://dx.doi.org/10.1371/journal.pone.0110514			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310715	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210300119
J	Debruin, EJ; Hughes, MR; Sina, C; Liu, A; Cait, J; Jian, ZQ; Lopez, M; Lo, B; Abraham, T; McNagny, KM				Debruin, Erin J.; Hughes, Michael R.; Sina, Christina; Liu, Alex; Cait, Jessica; Jian, Zhiqi; Lopez, Martin; Lo, Bernard; Abraham, Thomas; McNagny, Kelly M.			Podocalyxin Regulates Murine Lung Vascular Permeability by Altering Endothelial Cell Adhesion	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; IMPAIRS ALVEOLARIZATION; MAJOR SIALOPROTEIN; MOLECULAR-BASIS; MOUSE MODEL; EMPHYSEMA; COLLAGEN; MICE; ELASTIN; MORPHOGENESIS	Despite the widespread use of CD34-family sialomucins (CD34, podocalyxin and endoglycan) as vascular endothelial cell markers, there is remarkably little known of their vascular function. Podocalyxin (gene name Podxl), in particular, has been difficult to study in adult vasculature as germ-line deletion of podocalyxin in mice leads to kidney malformations and perinatal death. We generated mice that conditionally delete podocalyxin in vascular endothelial cells (Podxl(Delta EC) mice) to study the homeostatic role of podocalyxin in adult mouse vessels. Although Podxl(Delta EC) adult mice are viable, their lungs display increased lung volume and changes to the matrix composition. Intriguingly, this was associated with increased basal and inflammation-induced pulmonary vascular permeability. To further investigate the etiology of these defects, we isolated mouse pulmonary endothelial cells. Podxl(Delta EC) endothelial cells display mildly enhanced static adhesion to fibronectin but spread normally when plated on fibronectin-coated transwells. In contrast, Podxl(Delta EC) endothelial cells exhibit a severely impaired ability to spread on laminin and, to a lesser extent, collagen I coated transwells. The data suggest that, in endothelial cells, podocalyxin plays a previously unrecognized role in maintaining vascular integrity, likely through orchestrating interactions with extracellular matrix components and basement membranes, and that this influences downstream epithelial architecture.	[Debruin, Erin J.; Hughes, Michael R.; Sina, Christina; Liu, Alex; Cait, Jessica; Jian, Zhiqi; Lopez, Martin; Lo, Bernard; McNagny, Kelly M.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada; [Abraham, Thomas] UBC James Hogg Res Ctr, Inst Heart Lung Hlth, Vancouver, BC, Canada; [Abraham, Thomas] Penn State Univ, Penn State Coll Med, Hershey, PA USA	University of British Columbia; University of British Columbia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	McNagny, KM (corresponding author), Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada.	kelly@brc.ubc.ca	Abraham, Thomas/J-7080-2014; McNagny, Kelly/P-5239-2014; Abraham, Thomas/AAJ-7950-2020; Hughes, Michael/N-6039-2015	Abraham, Thomas/0000-0003-0750-8774; McNagny, Kelly/0000-0003-4737-3499; Hughes, Michael/0000-0002-7925-6070	Canadian Institutes for Health Research [MOP-84545]; Heart and Stroke Foundation of BC; National Science & Engineering Research Council; UBC	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of BC; National Science & Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); UBC	This research was funded by the following sources by a Canadian Institutes for Health Research grant MOP-84545 (http://www.cihr-irsc.gc.ca/e/193.html), & Heart and Stroke Foundation of BC and Yukon Grant in Aid (http://www.hsf.ca/research/en/whats-new). EJD was supported through a National Science & Engineering Research Council Postgraduate Scholarship and a UBC 4-Year Fellowship; KMM is a Michael Smith Foundation for Health Research Senior Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham T, 2011, RESPIROLOGY, V16, P22, DOI 10.1111/j.1440-1843.2010.01898.x; Abraham T, 2010, J STRUCT BIOL, V171, P189, DOI 10.1016/j.jsb.2010.04.006; Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Balasubramaniam V, 2003, AM J PHYSIOL-LUNG C, V284, pL964, DOI 10.1152/ajplung.00421.2002; Blanchet MR, 2010, J IMMUNOL, V184, P1292, DOI 10.4049/jimmunol.0900808; Bou-harios G, 2004, CELL PROLIFERAT, V37, P207, DOI [10.1111/j.1365-2184.2004.00306.x, DOI 10.1111/J.1365-2184.2004.00306.X]; Bridges JP, 2006, ILAR J, V47, P22, DOI 10.1093/ilar.47.1.22; CARDOSO WV, 1993, AM REV RESPIR DIS, V147, P975, DOI 10.1164/ajrccm/147.4.975; Chapman HA, 2004, J CLIN INVEST, V113, P148, DOI 10.1172/JCI200420729; Chen WC, 2010, CELL TISSUE RES, V342, P75, DOI 10.1007/s00441-010-1035-z; Cipollone JA, 2012, CLIN EXP METASTAS, V29, P239, DOI 10.1007/s10585-011-9446-0; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; DeLisser HM, 2006, J BIOL CHEM, V281, P8724, DOI 10.1074/jbc.M511798200; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Doyonnas R, 2005, BLOOD, V105, P4170, DOI 10.1182/blood-2004-10-4077; Doyonnas R, 2001, J EXP MED, V194, P13, DOI 10.1084/jem.194.1.13; Finlay GA, 1996, AM J PATHOL, V149, P1405; Galambos C, 2007, PEDIATR DEVEL PATHOL, V10, P1, DOI 10.2350/06-06-0122.1; Goncalves C, 2001, EXP LUNG RES, V27, P533; Grutzmacher C, 2010, AM J PHYSIOL-LUNG C, V299, pL607, DOI 10.1152/ajplung.00390.2009; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Hamakawa H, 2011, AM J RESP CELL MOL, V45, P517, DOI 10.1165/rcmb.2010-0473OC; Han RNN, 2004, CIRC RES, V94, P1115, DOI 10.1161/01.RES.0000125624.85852.1E; Hara T, 1999, IMMUNITY, V11, P567, DOI 10.1016/S1074-7613(00)80132-6; Hogg JC, 2002, THORAX, V57, P830, DOI 10.1136/thorax.57.9.830; HORVAT R, 1986, J CELL BIOL, V102, P484, DOI 10.1083/jcb.102.2.484; Humphries Martin J., 2009, V522, P203, DOI 10.1007/978-1-59745-413-1_14; Ito S, 2005, J APPL PHYSIOL, V98, P503, DOI 10.1152/japplphysiol.00590.2004; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Kerosuo L, 2004, BRIT J HAEMATOL, V124, P809, DOI 10.1111/j.1365-2141.2004.04840.x; LANG MR, 1994, THORAX, V49, P319, DOI 10.1136/thx.49.4.319; Lucey EC, 1998, AM J RESP CRIT CARE, V158, P555, DOI 10.1164/ajrccm.158.2.9705021; Mahabeleshwar Ganapati H., 2006, V129, P197; Maltby S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018160; Maltby S, 2009, EXP HEMATOL, V37, P10, DOI 10.1016/j.exphem.2008.09.006; Maniatis NA, 2008, VASC PHARMACOL, V49, P119, DOI 10.1016/j.vph.2008.06.009; MCGOWAN SE, 1992, FASEB J, V6, P2895, DOI 10.1096/fasebj.6.11.1644255; McNagny KM, 1997, J CELL BIOL, V138, P1395, DOI 10.1083/jcb.138.6.1395; McNagny KM., 2012, PODOCALYXIN DIAGNOSI; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Moitra J, 2007, TRANSL RES, V150, P253, DOI 10.1016/j.trsl.2007.03.013; Nielsen JS, 2008, J CELL SCI, V121, P3683, DOI 10.1242/jcs.037507; Nielsen JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000237; Orfanos SE, 2004, INTENS CARE MED, V30, P1702, DOI 10.1007/s00134-004-2370-x; Pena AM, 2007, MICROSC RES TECHNIQ, V70, P162, DOI 10.1002/jemt.20400; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; SCHERLE W, 1970, Mikroskopie, V26, P57; Schneider CA, 2013, SERIES CELLULAR CLIN, P373; Strilic B, 2009, DEV CELL, V17, P505, DOI 10.1016/j.devcel.2009.08.011; Tang KC, 2004, J APPL PHYSIOL, V97, P1559, DOI 10.1152/japplphysiol.00221.2004; Thebaud B, 2007, AM J RESP CRIT CARE, V175, P978, DOI 10.1164/rccm.200611-1660PP; THURLBECK WM, 1994, CAN RESPIR J, V1, P21; Tuder RM, 2003, AM J RESP CELL MOL, V29, P88, DOI 10.1165/rcmb.2002-0228OC; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; Vitureira N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012003; Voelkel Norbert, 2005, Proc Am Thorac Soc, V2, P23, DOI 10.1513/pats.200405-033MS; Voelkel Norbert F, 2011, Pulm Circ, V1, P320, DOI 10.4103/2045-8932.87295; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Weinstein M, 1998, DEVELOPMENT, V125, P3615	60	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108881	10.1371/journal.pone.0108881	http://dx.doi.org/10.1371/journal.pone.0108881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303643	gold, Green Submitted, Green Published			2022-12-27	WOS:000343730400033
J	Gaudio, S; Brooks, SJ; Riva, G				Gaudio, Santino; Brooks, Samantha Jane; Riva, Giuseppe			Nonvisual Multisensory Impairment of Body Perception in Anorexia Nervosa: A Systematic Review of Neuropsychological Studies	PLOS ONE			English	Article							EATING-DISORDERS; HAPTIC PERCEPTION; NEURAL BASIS; BODILY SELF; IMAGE DISTURBANCE; ALLOCENTRIC LOCK; BULIMIA-NERVOSA; RISK-FACTORS; THETA-POWER; WEIGHT	Background: Body image distortion is a central symptom of Anorexia Nervosa (AN). Even if corporeal awareness is multisensory majority of AN studies mainly investigated visual misperception. We systematically reviewed AN studies that have investigated different nonvisual sensory inputs using an integrative multisensory approach to body perception. We also discussed the findings in the light of AN neuroimaging evidence. Methods: Pub Med and PsycINFO were searched until March, 2014. To be included in the review, studies were mainly required to: investigate a sample of patients with current or past AN and a control group and use tasks that directly elicited one or more nonvisual sensory domains. Results:Thirteen studies were included. They studied a total of 223 people with current or past AN and 273 control subjects. Overall, results show impairment in tactile and proprioceptive domains of body perception in AN patients. lnteroception and multisensory integration have been poorly explored directly in AN patients. A limitation of this review is the relatively small amount of literature available. Conclusions: Our results showed that AN patients had a multisensory impairment of body perception that goes beyond visual misperception and involves tactile and proprioceptive sensory components. Furthermore, impairment of tactile and proprioceptive components may be associated with parietal cortex alterations in AN patients. Interoception and multisensory integration have been weakly explored directly. Further research, using multisensory approaches as well as neuroimaging techniques, is needed to better define the complexity of body image distortion in AN. Key Findings: The review suggests an altered capacity of AN patients in processing and integration of bodily signals: body parts are experienced as dissociated from their holistic and perceptive dimensions. Specifically, it is likely that not only perception but memory, and in particular sensorimotor/proprioceptive memory, probably shapes bodily experience in patients with AN.	[Gaudio, Santino] Univ Campus Biomed Roma, CIR, Area Diagnost Imaging, Rome, Italy; [Brooks, Samantha Jane] Univ Cape Town, Groote Schuur Hosp, Dept Psychiat & Mental Hlth, ZA-7925 Cape Town, South Africa; [Brooks, Samantha Jane] Uppsala Univ, BMC, Dept Neurosci, Uppsala, Sweden; [Riva, Giuseppe] Ist Auxol Italiano, Appl Technol Neuro Psychol Lab, Milan, Italy; [Riva, Giuseppe] Univ Cattolica Sacro Cuore, Dept Psychol, I-20123 Milan, Italy	University Campus Bio-Medico - Rome Italy; University of Cape Town; Uppsala University; IRCCS Istituto Auxologico Italiano; Catholic University of the Sacred Heart	Gaudio, S (corresponding author), Univ Campus Biomed Roma, CIR, Area Diagnost Imaging, Rome, Italy.	santino.gaudio@libero.it	Riva, Giuseppe/C-5917-2008; Brooks, Samantha/AAJ-2159-2020	Riva, Giuseppe/0000-0003-3657-106X; Brooks, Samantha/0000-0002-9146-6257				Akatsuka K, 2008, NEUROIMAGE, V40, P852, DOI 10.1016/j.neuroimage.2007.12.013; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Arcelus J, 2011, ARCH GEN PSYCHIAT, V68, P724, DOI 10.1001/archgenpsychiatry.2011.74; Banfield SS, 2002, ADOLESCENCE, V37, P373; Beato-Fernandez L, 2004, EUR CHILD ADOLES PSY, V13, P287, DOI 10.1007/s00787-004-0407-x; Berlucchi G, 2010, EXP BRAIN RES, V200, P25, DOI 10.1007/s00221-009-1970-7; Blanke O, 2012, NAT REV NEUROSCI, V13, P556, DOI 10.1038/nrn3292; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Botvinick M, 2004, SCIENCE, V305, P782, DOI 10.1126/science.1101836; Buckingham G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009709; Cardini F, 2013, COGNITION, V127, P84, DOI 10.1016/j.cognition.2012.12.010; Case LK, 2012, EXP BRAIN RES, V217, P79, DOI 10.1007/s00221-011-2974-7; CASH TF, 1986, J PERS ASSESS, V50, P290, DOI 10.1207/s15327752jpa5002_15; Cash TF, 1997, INT J EAT DISORDER, V22, P107, DOI 10.1002/(SICI)1098-108X(199709)22:2&lt;107::AID-EAT1&gt;3.0.CO;2-J; CASH TF, 1991, PERCEPT MOTOR SKILL, V73, P235, DOI 10.2466/PMS.73.4.235-241; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; de Vignemont F, 2010, NEUROPSYCHOLOGIA, V48, P669, DOI 10.1016/j.neuropsychologia.2009.09.022; Dyde RT, 2006, EXP BRAIN RES, V173, P612, DOI 10.1007/s00221-006-0405-y; Epstein J, 2001, Eat Weight Disord, V6, P140; Eshkevari E, 2012, PSYCHOL MED, V42, P819, DOI 10.1017/S0033291711002091; Eshkevari E, 2014, INT J EAT DISORDER, V47, P400, DOI 10.1002/eat.22219; Flanagan JR, 2000, NAT NEUROSCI, V3, P737, DOI 10.1038/76701; Fruhstorfer H, 2001, EUR J PAIN-LONDON, V5, P341, DOI 10.1053/eujp.2001.0250; Funk J, 2011, NEUROSCIENCE, V173, P124, DOI 10.1016/j.neuroscience.2010.10.067; Funk J, 2010, NEUROPSYCHOLOGIA, V48, P1616, DOI 10.1016/j.neuropsychologia.2010.01.029; Gaudio S, 2013, BIOL PSYCHIAT, V73, pE25, DOI 10.1016/j.biopsych.2012.08.028; Gaudio S, 2012, NEUROSCI BIOBEHAV R, V36, P1839, DOI 10.1016/j.neubiorev.2012.05.003; Goldzak-Kunik G, 2012, AM J CLIN NUTR, V95, P272, DOI 10.3945/ajcn.111.020131; Grunwald M, 2004, J CLIN EXP NEUROPSYC, V26, P608, DOI 10.1080/13803390490504407; Grunwald M, 2001, J CLIN EXP NEUROPSYC, V23, P520, DOI 10.1076/jcen.23.4.520.1229; Grunwald M, 2001, INT J EAT DISORDER, V29, P417, DOI 10.1002/eat.1038; Guardia D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054928; Guardia D, 2012, PSYCHIAT RES, V195, P56, DOI 10.1016/j.psychres.2011.08.003; Hodzic A, 2009, NEUROIMAGE, V45, P1264, DOI 10.1016/j.neuroimage.2009.01.027; Hodzic A, 2009, HUM BRAIN MAPP, V30, P951, DOI 10.1002/hbm.20558; Howard I. P., 1982, HUMAN VISUAL ORIENTA; Jacobi C, 2004, PSYCHOL BULL, V130, P19, DOI 10.1037/0033-2909.130.1.19; Kaye WH, 2013, TRENDS NEUROSCI, V36, P110, DOI 10.1016/j.tins.2013.01.003; Kaye WH, 2009, NAT REV NEUROSCI, V10, P573, DOI 10.1038/nrn2682; Keizer A, 2012, PSYCHIAT RES, V200, P530, DOI 10.1016/j.psychres.2012.05.001; Keizer A, 2011, PSYCHIAT RES, V190, P115, DOI 10.1016/j.psychres.2011.04.031; Kerkhoff G, 1999, NEUROPSYCHOLOGIA, V37, P1387, DOI 10.1016/S0028-3932(99)00031-7; Lackner JR, 2005, CURR OPIN NEUROBIOL, V15, P653, DOI 10.1016/j.conb.2005.10.012; Lay B, 1999, Z KINDER JUG-PSYCH, V27, P207, DOI 10.1024//1422-4917.27.3.207; Legrand D, 2010, NEUROPSYCHOLOGIA, V48, P726, DOI 10.1016/j.neuropsychologia.2009.08.026; Li Y, 2007, NEUROSCI LETT, V426, P187, DOI 10.1016/j.neulet.2007.09.008; Longo MR, 2010, NEUROPSYCHOLOGIA, V48, P655, DOI 10.1016/j.neuropsychologia.2009.08.022; Longo MR, 2009, ACTA PSYCHOL, V132, P166, DOI 10.1016/j.actpsy.2009.02.003; MITTELSTAEDT H, 1983, NATURWISSENSCHAFTEN, V70, P272, DOI 10.1007/BF00404833; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mohr HM, 2010, PSYCHOL MED, V40, P1519, DOI 10.1017/S0033291709991826; Mussap AJ, 2006, J HEALTH PSYCHOL, V11, P627, DOI 10.1177/1359105306065022; Pollatos Olga, 2008, Eat Behav, V9, P381, DOI 10.1016/j.eatbeh.2008.02.001; Riva G, 2012, MED HYPOTHESES, V79, P113, DOI 10.1016/j.mehy.2012.03.036; Riva G, 2012, MED HYPOTHESES, V78, P254, DOI 10.1016/j.mehy.2011.10.039; Sachdev P, 2008, NEUROPSYCHOLOGIA, V46, P2161, DOI 10.1016/j.neuropsychologia.2008.02.031; Schwoebel J, 2005, J COGNITIVE NEUROSCI, V17, P543, DOI 10.1162/0898929053467587; SLADE PD, 1994, BEHAV RES THER, V32, P497, DOI 10.1016/0005-7967(94)90136-8; Spitoni GF, 2010, EXP BRAIN RES, V207, P185, DOI 10.1007/s00221-010-2446-5; Strigo IA, 2013, INT J EAT DISORDER, V46, P23, DOI 10.1002/eat.22045; Titova OE, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-110; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Utz KS, 2011, NEUROSCIENCE, V188, P68, DOI 10.1016/j.neuroscience.2011.04.068; Vocks S, 2010, J PSYCHIATR NEUROSCI, V35, P163, DOI 10.1503/jpn.090048; Zaehle T, 2007, BRAIN RES, V1137, P92, DOI 10.1016/j.brainres.2006.12.044	65	82	82	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110087	10.1371/journal.pone.0110087	http://dx.doi.org/10.1371/journal.pone.0110087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6ZS	25303480	gold, Green Published, Green Submitted			2022-12-27	WOS:000343730400109
J	Wipasa, J; Wongkulab, P; Chawansuntati, K; Chaiwarit, R; Supparatpinyo, K				Wipasa, Jiraprapa; Wongkulab, Panuwat; Chawansuntati, Kriangkrai; Chaiwarit, Romanee; Supparatpinyo, Khuanchai			Cellular Immune Responses in HIV-Negative Immunodeficiency with Anti-Interferon-gamma Antibodies and Opportunistic Intracellular Microorganisms	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; ACQUIRED-IMMUNODEFICIENCY; INFECTION; PATIENT; AUTOANTIBODIES; INTERLEUKIN-2; RESPONSIVENESS; EXPRESSION; PNEUMONIA	Background: Cell-mediated immunity plays a crucial role in resistance to intracellular infection. We previously reported antibodies against interferon-gamma (IFN-gamma) in HIV- negative (HIV-) patients with acquired immunodeficiency presenting with repeated episodes of disseminated infection caused by uncommon opportunistic intracellular fungal, bacterial, and viral pathogens. This follow-up study aimed to investigate cellular immune responses in these unusual patients. Methods: Twenty HIV- patients presenting with >= 2 episodes of culture-or histopathologic-proven opportunistic infections were enrolled along with age- and sex-matched controls comprised of 20 HIV+ patients plus 20 healthy adults. Monocyte phenotyping and intracellular cytokine production were determined by staining with specific antibodies followed by flow cytometry. Anti-interferon-gamma antibodies were measured by enzyme-linked immunosorbent assay, and inducible nitric oxide synthase by reverse-transcription polymerase chain reaction. Results: There were no differences among cases, HIV+, and healthy controls in the percentage of monocytes, or CD68 and HLA-DR expression on their surfaces. FcR1 (CD119) expression on monocytes was significantly higher in cases than in HIV+ (p<0.05) and healthy controls (p<0.01), suggesting the presence of activated monocytes in the circulation. Interleukin (IL)-2 and tumor necrosis factor (TNF)-alpha production in CD4 cells were significantly lower in cases than in healthy controls (p<0.01 and p<0.001, respectively). CD8 production of TNF-alpha among cases was significantly lower than that of healthy controls (p<0.05). Conclusion: Immunodeficiency in HIV- individuals with repeated infections with intracellular pathogens may be associated with one or more of the abnormal immune responses reflected by the reduced production of both IL-2 by CD4 T cells and TNF-alpha by CD4 T cells and CD8 T cells, as well as presence of anti-IFN-gamma antibody, as previously reported.	[Wipasa, Jiraprapa; Chawansuntati, Kriangkrai; Supparatpinyo, Khuanchai] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand; [Wongkulab, Panuwat; Chaiwarit, Romanee; Supparatpinyo, Khuanchai] Chiang Mai Univ, Dept Med, Chiang Mai 50000, Thailand	Chiang Mai University; Chiang Mai University	Supparatpinyo, K (corresponding author), Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand.	khuanchai.s@gmail.com			National Research University Project under Thailand's Office of the Higher Education Commission	National Research University Project under Thailand's Office of the Higher Education Commission	This work was supported by the National Research University Project under Thailand's Office of the Higher Education Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu C, 2013, J CROHNS COLITIS, V7, P175, DOI [10.1016/j.crohns.2012.04.018, 10.1016/j.crohns.2013.03.004]; Aikio O, 2000, PEDIATRICS, V105, P1013, DOI 10.1542/peds.105.5.1013; Bassetti M, 2010, CLIN MICROBIOL INFEC, V16, P84, DOI 10.1111/j.1469-0691.2009.02961.x; Bourre-Tessier J, 2009, SCAND J RHEUMATOL, V38, P311, DOI 10.1080/03009740902776935; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Browne SK, 2012, NEW ENGL J MED, V367, P725, DOI 10.1056/NEJMoa1111160; BURMESTER GR, 1984, CLIN IMMUNOL IMMUNOP, V30, P279, DOI 10.1016/0090-1229(84)90062-X; Chi CY, 2013, BLOOD, V121, P1357, DOI 10.1182/blood-2012-08-452482; Cox MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/159152; Danko JR, 2009, SCAND J INFECT DIS, V41, P252, DOI 10.1080/00365540902774599; Fuller MJ, 2004, J IMMUNOL, V172, P4204, DOI 10.4049/jimmunol.172.7.4204; Fuller MJ, 2003, J IMMUNOL, V170, P477, DOI 10.4049/jimmunol.170.1.477; GALLIN M, 1988, J IMMUNOL, V140, P1999; Haverkamp MH, 2006, MICROBES INFECT, V8, P1157, DOI 10.1016/j.micinf.2005.10.029; Hoflich C, 2004, BLOOD, V103, P673, DOI 10.1182/blood-2003-04-1065; Idh J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039891; Juang YT, 2005, J CLIN INVEST, V115, P996, DOI 10.1172/JCI22854; Kaku N, 2013, J INFECT CHEMOTHER, V19, P166, DOI 10.1007/s10156-012-0459-7; Kalyoncu U, 2007, SCAND J INFECT DIS, V39, P475, DOI 10.1080/00365540601071867; Kampmann B, 2005, J CLIN INVEST, V115, P2480, DOI 10.1172/JCI19316; Khaitan Alka, 2011, Curr HIV/AIDS Rep, V8, P4, DOI 10.1007/s11904-010-0066-0; Koosirirat C, 2010, INT IMMUNOPHARMACOL, V10, P815, DOI 10.1016/j.intimp.2010.04.021; Koya T, 2009, J INFECT CHEMOTHER, V15, P118, DOI 10.1007/s10156-008-0662-8; Kurushima H, 2000, J LEUKOCYTE BIOL, V67, P104, DOI 10.1002/jlb.67.1.104; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Lieberman LA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/740619; Maimon N, 2007, THORAX, V62, P739, DOI 10.1136/thx.2005.056952; Mokrzycka M, 2010, FOLIA HISTOCHEM CYTO, V48, P191, DOI 10.2478/v10042-008-0111-7; Nobre CA, 2012, RHEUMATOL INT, V32, P2769, DOI 10.1007/s00296-011-2017-5; Patel SY, 2005, J IMMUNOL, V175, P4769, DOI 10.4049/jimmunol.175.7.4769; Pena-Sagredo JL, 2009, CLIN EXP RHEUMATOL, V27, P920; Poulin S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-24; Rieper CD, 2009, CYTOKINE GROWTH F R, V20, P61, DOI 10.1016/j.cytogfr.2009.01.003; Rodrigues V, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002567; SORENSEN RU, 1992, J PEDIATR-US, V121, P873, DOI 10.1016/S0022-3476(05)80331-2; Swart RM, 2009, EMERG INFECT DIS, V15, P1700, DOI 10.3201/eid1510.090110; Tang BSF, 2010, CLIN VACCINE IMMUNOL, V17, P1132, DOI 10.1128/CVI.00053-10; Thomas John E, 2006, Hawaii Med J, V65, P12; TOOSSI Z, 1986, J EXP MED, V163, P1162, DOI 10.1084/jem.163.5.1162; TSUYUGUCHI I, 1988, CHEST, V94, P822, DOI 10.1378/chest.94.4.822; Tu WW, 2004, J IMMUNOL, V172, P3260, DOI 10.4049/jimmunol.172.5.3260; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; van de Vosse E, 2004, LANCET INFECT DIS, V4, P739, DOI 10.1016/S1473-3099(04)01203-4; Watanabe M, 2007, FEBS LETT, V581, P2017, DOI 10.1016/j.febslet.2007.04.029; Waters JP, 2013, J PATHOL, V230, P132, DOI 10.1002/path.4187; Weiner SM, 2011, RHEUMATOL INT, V31, P1399, DOI 10.1007/s00296-010-1570-7; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wipasa J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001281; Wongkulab P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076371; Wuerz TC, 2012, EMERG INFECT DIS, V18, P1872, DOI 10.3201/eid1811.111505; Yang Chul-Su, 2009, Immune Netw, V9, P46, DOI 10.4110/in.2009.9.2.46; Yi JS, 2010, IMMUNOLOGY, V129, P474, DOI 10.1111/j.1365-2567.2010.03255.x	52	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110276	10.1371/journal.pone.0110276	http://dx.doi.org/10.1371/journal.pone.0110276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329064	Green Published, Green Submitted, gold			2022-12-27	WOS:000343942100049
J	Winitthana, T; Lawanprasert, S; Chanvorachote, P				Winitthana, Thidarat; Lawanprasert, Somsong; Chanvorachote, Pithi			Triclosan Potentiates Epithelial-To-Mesenchymal Transition in Anoikis-Resistant Human Lung Cancer Cells	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; METASTASIS; CYTOTOXICITY; BIOMARKERS; INHIBITOR; ADHESION; INVASION; HEALTH; GROWTH; SAFETY	Alteration of cancer cell toward mesenchymal phenotype has been shown to potentiate tumor aggressiveness by increasing cancer cell metastasis. Herein, we report the effect of triclosan, a widely used antibacterial agent found in many daily products, in enhancing the epithelial-to-mesenchymal transition (EMT) in aggressive anoikis resistant human H460 lung cancer cells. EMT has been long known to increase abilities of the cells to increase migration, invasion, and survival in circulating system. The present study reveals that treatment of the cancer cells with triclosan at the physiologically related concentrations significantly increased the colony number of the cancer cells assessed by tumor formation assay. Also, the mesenchymal-like morphology and decrease in cell-to-cell adhesion were observed in triclosan-treated cells. Importantly, western blot analysis revealed that triclosan-treated cells exhibited decreased E-cadherin, while the levels of EMT markers, namely N-cadherin, vimentin, snail and slug were found to be significantly up-regulated. Furthermore, EMT induced by triclosan treatment was accompanied by the activation of focal adhesion kinase/ATP dependent tyrosine kinase (FAK/Akt) and Ras-related C3 botulinum toxin substrate 1 (Rac1), which enhanced the ability of the cells to migrate and invade. In conclusion, we demonstrated for the first time that triclosan may potentiate cancer cells survival in detached condition and motility via the process of EMT. As mentioned capabilities are required for success in metastasis, the present study provides the novel toxicological information and encourages the awareness of triclosan use in cancer patients.	[Winitthana, Thidarat; Lawanprasert, Somsong; Chanvorachote, Pithi] Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Physiol & Pharmacol, Bangkok, Thailand; [Chanvorachote, Pithi] Chulalongkorn Univ, Fac Pharmaceut Sci, Cell Based Drug & Hlth Prod Dev Res Unit, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University	Chanvorachote, P (corresponding author), Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Physiol & Pharmacol, Bangkok, Thailand.	pithi.c@chula.ac.th		chanvorachote, pithi/0000-0002-3103-3249	Thailand Research Fund; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University [RES560530132-HR]; 90th Anniversary of Chulalongkorn University Fund (Ratchadapiseksomphot Endowment Fund); Chulalongkorn University Graduate Scholarship	Thailand Research Fund(Thailand Research Fund (TRF)); Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University(Chulalongkorn University); 90th Anniversary of Chulalongkorn University Fund (Ratchadapiseksomphot Endowment Fund); Chulalongkorn University Graduate Scholarship(Chulalongkorn University)	This research was supported by the Thailand Research Fund (to PC) (http://www.trf.or.th), Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (RES560530132-HR), the 90th Anniversary of Chulalongkorn University Fund (Ratchadapiseksomphot Endowment Fund), and the Chulalongkorn University Graduate Scholarship to Commemorate the 72nd Anniversary of His Majesty King Bhumibol Adulyadej (http://www.grad.chula.ac.th/eng/scholarships). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong AJ, 2011, MOL CANCER RES, V9, P997, DOI 10.1158/1541-7786.MCR-10-0490; Barriere Guislaine, 2012, ISRN Oncol, V2012, P382010, DOI 10.5402/2012/382010; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Cheng JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034071; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Chunhacha P, 2013, ONCOL LETT, V5, P1043, DOI 10.3892/ol.2013.1108; Chunhacha Preedakorn, 2012, Int J Physiol Pathophysiol Pharmacol, V4, P149; Ciniglia C, 2005, J HAZARD MATER, V122, P227, DOI 10.1016/j.jhazmat.2005.03.002; Dauphin M, 2013, LUNG CANCER, V81, P117, DOI 10.1016/j.lungcan.2013.03.011; Dayan AD, 2007, FOOD CHEM TOXICOL, V45, P125, DOI 10.1016/j.fct.2006.08.009; Ding SZ, 2013, TOXICOL APPL PHARM, V269, P61, DOI 10.1016/j.taap.2013.03.006; Fang JL, 2010, J ENVIRON SCI HEAL C, V28, P147, DOI 10.1080/10590501.2010.504978; Fenouille N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040378; Fidler IJ, 2002, DIFFERENTIATION, V70, P498, DOI 10.1046/j.1432-0436.2002.700904.x; Franco R, 2012, J THORAC DIS, V4, P438, DOI 10.3978/j.issn.2072-1439.2012.08.23; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gorges TM, 2013, CANCER IMMUNOL IMMUN, V62, P931, DOI 10.1007/s00262-012-1387-1; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; Henry ND, 2013, J APPL TOXICOL, V33, P265, DOI 10.1002/jat.1736; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hou Jian-Mei, 2010, Cancers (Basel), V2, P1236, DOI 10.3390/cancers2021236; Hou JM, 2011, AM J PATHOL, V178, P989, DOI 10.1016/j.ajpath.2010.12.003; Jones RD, 2000, AM J INFECT CONTROL, V28, P184, DOI 10.1016/S0196-6553(00)90027-0; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kawata M, 2012, J BIOCHEM, V151, P205, DOI 10.1093/jb/mvr136; Khongmanee A, 2013, PROTEOMICS, V13, P3157, DOI 10.1002/pmic.201300219; Kim Yu-Kyoung, 2012, ISRN Microbiol, V2012, P650563, DOI 10.5402/2012/650563; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; KOLESKE AJ, 1995, P NATL ACAD SCI USA, V92, P1381, DOI 10.1073/pnas.92.5.1381; Kowitdamrong A, 2013, BIOMED RES INT, V2013, P1; Larsen M, 2003, NAT REV MOL CELL BIO, V4, P700, DOI 10.1038/nrm1199; Liberko M, 2013, CRIT REV ONCOL HEMAT, V88, P338, DOI 10.1016/j.critrevonc.2013.05.002; Ma HM, 2013, CHEMOSPHERE, V90, P1023, DOI 10.1016/j.chemosphere.2012.07.063; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nurwidya F, 2012, CANCER RES TREAT, V44, P151, DOI 10.4143/crt.2012.44.3.151; O'Flaherty JD, 2012, LUNG CANCER, V76, P19, DOI 10.1016/j.lungcan.2011.10.018; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Paterlini-Brechot P, 2007, CANCER LETT, V253, P180, DOI 10.1016/j.canlet.2006.12.014; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Rho JK, 2009, LUNG CANCER, V63, P219, DOI 10.1016/j.lungcan.2008.05.017; Rodricks JV, 2010, CRIT REV TOXICOL, V40, P422, DOI 10.3109/10408441003667514; Sakuma Y, 2012, LAB INVEST, V92, P371, DOI 10.1038/labinvest.2011.187; Shi Y, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-9; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sun YF, 2011, J CANCER RES CLIN, V137, P1151, DOI 10.1007/s00432-011-0988-y; Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wang Y, 2013, EXP CELL RES, V319, P160, DOI 10.1016/j.yexcr.2012.07.019; Wang ZL, 2013, CARCINOGENESIS, V34, P638, DOI 10.1093/carcin/bgs367; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zhang SM, 2013, J BIOL CHEM, V288, P1469, DOI 10.1074/jbc.M112.438341; Zhang ZY, 2008, FOLIA HISTOCHEM CYTO, V46, P331, DOI 10.2478/v10042-008-0042-3	59	35	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110851	10.1371/journal.pone.0110851	http://dx.doi.org/10.1371/journal.pone.0110851			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329306	gold, Green Published, Green Submitted			2022-12-27	WOS:000343210800111
J	Zaric, G; Gonzalez, GF; Tijms, J; van der Molen, MW; Blomert, L; Bonte, M				Zaric, Gojko; Gonzalez, Gorka Fraga; Tijms, Jurgen; van der Molen, Maurits W.; Blomert, Leo; Bonte, Milene			Reduced Neural Integration of Letters and Speech Sounds in Dyslexic Children Scales with Individual Differences in Reading Fluency	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MISMATCH NEGATIVITY MMN; INDEPENDENT COMPONENT ANALYSIS; SUPERIOR TEMPORAL SULCUS; DEVELOPMENTAL DYSLEXIA; HUMAN BRAIN; PHONOLOGICAL REPRESENTATIONS; INTERINDIVIDUAL DIFFERENCES; AUDIOVISUAL INTEGRATION; PERCEPTION	The acquisition of letter-speech sound associations is one of the basic requirements for fluent reading acquisition and its failure may contribute to reading difficulties in developmental dyslexia. Here we investigated event-related potential (ERP) measures of letter-speech sound integration in 9-year-old typical and dyslexic readers and specifically test their relation to individual differences in reading fluency. We employed an audiovisual oddball paradigm in typical readers (n = 20), dysfluent (n = 18) and severely dysfluent (n = 18) dyslexic children. In one auditory and two audiovisual conditions the Dutch spoken vowels/a/and/o/were presented as standard and deviant stimuli. In audiovisual blocks, the letter 'a' was presented either simultaneously (AV0), or 200 ms before (AV200) vowel sound onset. Across the three children groups, vowel deviancy in auditory blocks elicited comparable mismatch negativity (MMN) and late negativity (LN) responses. In typical readers, both audiovisual conditions (AV0 and AV200) led to enhanced MMN and LN amplitudes. In both dyslexic groups, the audiovisual LN effects were mildly reduced. Most interestingly, individual differences in reading fluency were correlated with MMN latency in the AV0 condition. A further analysis revealed that this effect was driven by a short-lived MMN effect encompassing only the N1 window in severely dysfluent dyslexics versus a longer MMN effect encompassing both the N1 and P2 windows in the other two groups. Our results confirm and extend previous findings in dyslexic children by demonstrating a deficient pattern of letter-speech sound integration depending on the level of reading dysfluency. These findings underscore the importance of considering individual differences across the entire spectrum of reading skills in addition to group differences between typical and dyslexic readers.	[Zaric, Gojko; Blomert, Leo; Bonte, Milene] Univ Maastricht, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [Zaric, Gojko; Blomert, Leo] Maastricht Brain Imaging Ctr M BIC, Maastricht, Netherlands; [Gonzalez, Gorka Fraga; Tijms, Jurgen; van der Molen, Maurits W.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Tijms, Jurgen] IWAL Inst Dyslexia, Amsterdam, Netherlands; [van der Molen, Maurits W.] Rudolf Berlin Ctr, Amsterdam, Netherlands; [van der Molen, Maurits W.] Univ Amsterdam, Amsterdam Brain & Cognit, Amsterdam, Netherlands	Maastricht University; Maastricht University; University of Amsterdam; University of Amsterdam	Zaric, G (corresponding author), Univ Maastricht, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands.	gojko.zaric@maastrichtuniversity.nl	van der Molen, Maurits W/B-7543-2014	Tijms, Jurgen/0000-0002-9080-8569; Bonte, Milene/0000-0002-0203-8913	Netherlands Initiative Brain and Cognition, a program of the Organization for Scientific Research (NWO), as a part of the "Fluent reading neurocognitively decomposed: The case of dyslexia - HCMI 10-59'' research program [056-14-015]	Netherlands Initiative Brain and Cognition, a program of the Organization for Scientific Research (NWO), as a part of the "Fluent reading neurocognitively decomposed: The case of dyslexia - HCMI 10-59'' research program	This project is funded by the Netherlands Initiative Brain and Cognition, a program of the Organization for Scientific Research (NWO), as a part of the "Fluent reading neurocognitively decomposed: The case of dyslexia - HCMI 10-59'' research program under grant number 056-14-015. http://www.nwo.nl/en/research-and-results/research-projects/97/2300163097.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T. M., 2003, HDB PSYCHOL ED ASSES, V2, P406; Andres AJD, 2011, INT J PSYCHOPHYSIOL, V79, P137, DOI 10.1016/j.ijpsycho.2010.09.012; ANNETT M, 1979, ANN HUM GENET, V42, P479, DOI 10.1111/j.1469-1809.1979.tb00681.x; [Anonymous], 1973, EEN MINUUT TEST VORM; Aravena S, 2013, J EXP CHILD PSYCHOL, V115, P691, DOI 10.1016/j.jecp.2013.03.009; Baart M, 2014, NEUROPSYCHOLOGIA, V53, P115, DOI 10.1016/j.neuropsychologia.2013.11.011; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blau V, 2010, BRAIN, V133, P868, DOI 10.1093/brain/awp308; Blau V, 2009, CURR BIOL, V19, P503, DOI 10.1016/j.cub.2009.01.065; Blomert L, 2009, 3DM DIFFERENTIAL DIA; Blomert L., 2005, DYSLEXIE NEDERLAND; Blomert L, 2011, NEUROIMAGE, V57, P695, DOI 10.1016/j.neuroimage.2010.11.003; Boersma P., 2002, PRAAT DOING PHONETIC; Bonte ML, 2007, NEUROPSYCHOLOGIA, V45, P1427, DOI 10.1016/j.neuropsychologia.2006.11.009; Bonte ML, 2005, CLIN NEUROPHYSIOL, V116, P2765, DOI 10.1016/j.clinph.2005.08.012; Bonte ML, 2004, COGNITIVE BRAIN RES, V21, P360, DOI 10.1016/j.cogbrainres.2004.06.010; Booth JR, 2001, CHILD NEUROPSYCHOL, V7, P119, DOI 10.1076/chin.7.3.119.8740; Bus AG, 1999, J EDUC PSYCHOL, V91, P403, DOI 10.1037/0022-0663.91.3.403; Cheour M, 2002, NEUROSCI LETT, V325, P187, DOI 10.1016/S0304-3940(02)00269-0; Cheour M, 2001, AUDIOL NEURO-OTOL, V6, P2, DOI 10.1159/000046804; CHEOURLUHTANEN M, 1995, HEARING RES, V82, P53, DOI 10.1016/0378-5955(94)00164-L; Colin C, 2002, CLIN NEUROPHYSIOL, V113, P495, DOI 10.1016/S1388-2457(02)00024-X; CSEPE V, 1995, EAR HEARING, V16, P91, DOI 10.1097/00003446-199502000-00007; Csepe V, 2003, NEUROPS COG, V23, P81; Czamara D, 2011, BEHAV GENET, V41, P110, DOI 10.1007/s10519-010-9413-6; De Vos, 2011, SCHOOLVAARDIGHEIDSTO; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Ehri LC, 2005, SCI STUD READ, V9, P167, DOI 10.1207/s1532799xssr0902_4; Eulitz C, 2004, J COGNITIVE NEUROSCI, V16, P577, DOI 10.1162/089892904323057308; Faulkner HJ, 1999, PSYCHON B REV, V6, P111, DOI 10.3758/BF03210817; Froyen D, 2008, NEUROSCI LETT, V430, P23, DOI 10.1016/j.neulet.2007.10.014; Froyen D, 2011, DEVELOPMENTAL SCI, V14, P635, DOI 10.1111/j.1467-7687.2010.01007.x; Froyen DJW, 2009, J COGNITIVE NEUROSCI, V21, P567, DOI 10.1162/jocn.2009.21061; Fuchs D, 2004, LEARN DISABILITY Q, V27, P216, DOI 10.2307/1593674; Grainger J, 2009, LANG LINGUIST COMPAS, V3, P128, DOI 10.1111/j.1749-818x.2008.00121.x; Hasko S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00570; Hasko S, 2012, NEUROPSYCHOLOGIA, V50, P640, DOI 10.1016/j.neuropsychologia.2012.01.001; Holloway I, 2013, CEREB CORTEX; Hommet C, 2009, NEUROPSYCHOLOGIA, V47, P761, DOI 10.1016/j.neuropsychologia.2008.12.010; Jost LB, 2013, BRAIN TOPOGR; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kasai K, 2002, COGNITIVE BRAIN RES, V13, P305, DOI 10.1016/S0926-6410(01)00125-2; Katzir T, 2008, J LEARN DISABIL-US, V41, P47, DOI 10.1177/0022219407311325; Knowland VCP, 2014, DEVELOPMENTAL SCI, V17, P110, DOI 10.1111/desc.12098; Lafontaine H, 2012, NEUROPSYCHOLOGIA, V50, P2897, DOI 10.1016/j.neuropsychologia.2012.08.020; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Leinonen S, 2001, READ WRIT, V14, P265, DOI 10.1023/A:1011117620895; Liebenthal E, 2010, CEREB CORTEX, V20, P2958, DOI 10.1093/cercor/bhq045; Lohvansuu K, 2013, PSYCHOPHYSIOLOGY, V50, P640, DOI 10.1111/psyp.12048; Luck S.J., 2005, INTRO EVENT RELATED; Lyon GR, 2003, ANN DYSLEXIA, V53, P1, DOI 10.1007/s11881-003-0001-9; Maurer U, 2005, J COGNITIVE NEUROSCI, V17, P1532, DOI 10.1162/089892905774597218; Maurer U, 2006, NEUROIMAGE, V33, P749, DOI 10.1016/j.neuroimage.2006.06.025; McNorgan C, 2013, CEREB CORTEX; McNorgan C, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00388; Mittag M, 2013, PSYCHOPHYSIOLOGY, V50, P1034, DOI 10.1111/psyp.12085; Mittag M, 2013, CLIN NEUROPHYSIOL, V124, P315, DOI 10.1016/j.clinph.2012.08.003; Mittag M, 2011, EXP BRAIN RES, V211, P287, DOI 10.1007/s00221-011-2686-z; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naatanen R, 2001, PSYCHOPHYSIOLOGY, V38, P1, DOI 10.1017/S0048577201000208; Nath AR, 2012, NEUROIMAGE, V59, P781, DOI 10.1016/j.neuroimage.2011.07.024; Nath AR, 2011, J NEUROSCI, V31, P13963, DOI 10.1523/JNEUROSCI.2605-11.2011; Neuhoff N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034909; Oades RD, 1997, PSYCHOPHYSIOLOGY, V34, P677, DOI 10.1111/j.1469-8986.1997.tb02143.x; Pattamadilok C, 2011, BRAIN LANG, V116, P116, DOI 10.1016/j.bandl.2010.12.002; Pilling M, 2009, J SPEECH LANG HEAR R, V52, P1073, DOI [10.1044/1092-4388(2009/07-0276), 10.1044/1092-4388]; Ponton CW, 2000, CLIN NEUROPHYSIOL, V111, P220, DOI 10.1016/S1388-2457(99)00236-9; Raij T, 2000, NEURON, V28, P617, DOI 10.1016/S0896-6273(00)00138-0; Ramus F, 2008, Q J EXP PSYCHOL, V61, P129, DOI 10.1080/17470210701508822; Ramus F, 2012, COGN NEUROPSYCHOL, V29, P104, DOI 10.1080/02643294.2012.677420; Raven J., 1998, COLOURED PROGR MATRI; Roeske D, 2011, MOL PSYCHIATR, V16, P97, DOI 10.1038/mp.2009.102; Savill NJ, 2012, NEUROPSYCHOLOGIA, V50, P1553, DOI 10.1016/j.neuropsychologia.2012.03.008; Savill NJ, 2011, BRAIN RES, V1385, P192, DOI 10.1016/j.brainres.2011.02.012; Schulte-Korne G, 1998, NEUROREPORT, V9, P337, DOI 10.1097/00001756-199801260-00029; Shafer VL, 2000, EAR HEARING, V21, P242, DOI 10.1097/00003446-200006000-00008; SHARE DL, 1995, COGNITION, V55, P151, DOI 10.1016/0010-0277(94)00645-2; Shaywitz SE, 2008, ANNU REV PSYCHOL, V59, P451, DOI 10.1146/annurev.psych.59.103006.093633; Shestakova A, 2003, CLIN NEUROPHYSIOL, V114, P1507, DOI 10.1016/S1388-2457(03)00134-2; Snowling M., 1998, CHILD PSYCHOL PSYCHI, V3, P4, DOI [10.1111/1475-3588.00201, DOI 10.1017/S1360641797001366, DOI 10.1111/1475-3588.00201]; STANOVICH KE, 1983, B PSYCHONOMIC SOC, V21, P199; Stekelenburg JJ, 2004, NEUROSCI LETT, V357, P163, DOI 10.1016/j.neulet.2003.12.085; Tijms J, 2005, DYSLEXIA, V11, P22, DOI 10.1002/dys.283; Vaessen A, 2010, J EDUC PSYCHOL, V102, P827, DOI 10.1037/a0019465; van Atteveldt N, 2004, NEURON, V43, P271, DOI 10.1016/j.neuron.2004.06.025; van Atteveldt NM, 2007, NEUROIMAGE, V36, P1345, DOI 10.1016/j.neuroimage.2007.03.065; van Atteveldt NM, 2007, CEREB CORTEX, V17, P962, DOI 10.1093/cercor/bhl007; van Atteveldt NM, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-11; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; Wimmer H, 2010, DYSLEXIA, V16, P283, DOI 10.1002/dys.411; Winkler I, 1999, PSYCHOPHYSIOLOGY, V36, P638, DOI 10.1111/1469-8986.3650638	92	50	51	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110337	10.1371/journal.pone.0110337	http://dx.doi.org/10.1371/journal.pone.0110337			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ9XC	25329388	Green Published, gold			2022-12-27	WOS:000343210800076
J	Crowder, CM; Liang, WL; Weis, VM; Fan, TY				Crowder, Camerron M.; Liang, Wei-Lo; Weis, Virginia M.; Fan, Tung-Yung			Elevated Temperature Alters the Lunar Timing of Planulation in the Brooding Coral Pocillopora damicornis	PLOS ONE			English	Article							LARVAL SETTLEMENT; REEF; RELEASE; PERIODICITY; SURVIVORSHIP; REPRODUCTION; PLASTICITY	Reproductive timing in corals is associated with environmental variables including temperature, lunar periodicity, and seasonality. Although it is clear that these variables are interrelated, it remains unknown if one variable in particular acts as the proximate signaler for gamete and or larval release. Furthermore, in an era of global warming, the degree to which increases in ocean temperatures will disrupt normal reproductive patterns in corals remains unknown. Pocillopora damicornis, a brooding coral widely distributed in the Indo-Pacific, has been the subject of multiple reproductive ecology studies that show correlations between temperature, lunar periodicity, and reproductive timing. However, to date, no study has empirically measured changes in reproductive timing associated with increased seawater temperature. In this study, the effect of increased seawater temperature on the timing of planula release was examined during the lunar cycles of March and June 2012. Twelve brooding corals were removed from Hobihu reef in Nanwan Bay, southern Taiwan and placed in 23 and 28 degrees C controlled temperature treatment tanks. For both seasons, the timing of planulation was found to be plastic, with the high temperature treatment resulting in significantly earlier peaks of planula release compared to the low temperature treatment. This suggests that temperature alone can influence the timing of larval release in Pocillopora damicornis in Nanwan Bay. Therefore, it is expected that continued increases in ocean temperature will result in earlier timing of reproductive events in corals, which may lead to either variations in reproductive success or phenotypic acclimatization.	[Crowder, Camerron M.; Weis, Virginia M.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Liang, Wei-Lo; Fan, Tung-Yung] Natl Dong Hwa Univ, Inst Marine Biol, Pingtung, Taiwan; [Fan, Tung-Yung] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan	Oregon State University; National Dong Hwa University; National Museum of Marine Biology & Aquarium	Crowder, CM (corresponding author), Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA.	Crowderc@onid.oregonstate.edu; tyfan@nmmba.gov.tw	Weis, Virginia/T-5095-2019	Crowder, Camerron/0000-0002-3517-0697; Weis, Virginia/0000-0002-1826-2848	Ministry of Science and Technology grant [NSC-101-2611-M0291-002]; National Science Foundation East Asian and Pacific Summer Institute grant; National Science Foundation OISE award [1042509]	Ministry of Science and Technology grant; National Science Foundation East Asian and Pacific Summer Institute grant; National Science Foundation OISE award	This research was supported by a Ministry of Science and Technology grant NSC-101-2611-M0291-002 awarded to T-Y.F., a National Science Foundation East Asian and Pacific Summer Institute grant awarded to C.M.C., and a National Science Foundation OISE award (#1042509) awarded to V.M.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Brady AK, 2009, CORAL REEFS, V28, P677, DOI 10.1007/s00338-009-0498-4; de Putron SJ, 2009, INVERTEBR BIOL, V128, P213, DOI 10.1111/j.1744-7410.2009.00170.x; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Edmunds PJ, 2011, J EXP BIOL, V214, P2783, DOI 10.1242/jeb.055343; Edmunds PJ, 2005, INVERTEBR BIOL, V124, P185, DOI 10.1111/j.1744-7410.2005.00018.x; Fan T-Y, 2006, MARINE ECOLOGY PROGR, V321, P42; Fan TY, 2002, ZOOL STUD, V41, P288; Fan TY, 1999, MAR ECOL PROG SER, V190, P297, DOI 10.3354/meps190297; Goodbody-Gringley G, 2009, CORAL REEFS, V28, P959, DOI 10.1007/s00338-009-0539-z; Goodbody-Gringley G, 2010, J EXP MAR BIOL ECOL, V389, P70, DOI 10.1016/j.jembe.2010.03.016; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Harrison PL, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P59, DOI 10.1007/978-94-007-0114-4_6; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Howells EJ, 2013, ECOLOGY, V94, P1078, DOI 10.1890/12-1257.1; JOKIEL PL, 1985, MAR BIOL, V88, P167, DOI 10.1007/BF00397164; JOKIEL PL, 1978, B MAR SCI, V28, P786; Mayfield AB, 2013, CORAL REEFS, V32, P909, DOI 10.1007/s00338-013-1067-4; McClanahan T., 2009, CONSEQUENCES CORAL B; McGuire MP, 1998, CORAL REEFS, V17, P369, DOI 10.1007/s003380050141; Michalek-Wagner K, 2001, CORAL REEFS, V19, P231, DOI 10.1007/s003380170003; Nozawa Y, 2007, MAR BIOL, V152, P1181, DOI 10.1007/s00227-007-0765-2; Randall CJ, 2009, BIOL BULL-US, V217, P269, DOI 10.1086/BBLv217n3p269; RICHMOND RH, 1984, B MAR SCI, V34, P280; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; Schnitzler CE, 2012, MAR BIOL, V159, P633, DOI 10.1007/s00227-011-1842-0; Tanner JE, 1996, CORAL REEFS, V15, P59, DOI 10.1007/s003380050028; Vermeij MJA, 2004, CORAL REEFS, V23, P206, DOI 10.1007/s00338-004-0368-z; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Villanueva RD, 2008, MAR ECOL PROG SER, V370, P111, DOI 10.3354/meps07659; Villanueva RD, 2011, HYDROBIOLOGIA, V673, P273, DOI 10.1007/s10750-011-0771-8; Yakovleva IM, 2009, MAR ECOL PROG SER, V378, P105, DOI 10.3354/meps07857; Zar JH, 1999, BIOSTAT ANAL, P422	33	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e107906	10.1371/journal.pone.0107906	http://dx.doi.org/10.1371/journal.pone.0107906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25329546	gold, Green Submitted, Green Published			2022-12-27	WOS:000346766200006
J	Sant'Anna, RTP; Faria, RB				Sant'Anna, Rafaela T. P.; Faria, Roberto B.			The Chlorate-Iodine-Nitrous Acid Clock Reaction	PLOS ONE			English	Article							MECHANISM; KINETICS; SYSTEM; ION	A new clock reaction based on chlorate, iodine and nitrous acid is presented. The induction period of this new clock reaction decreases when the initial concentrations of chlorate, nitrous acid and perchloric acid increase, but it is independent on the initial iodine concentration. The proposed mechanism is based on the LLKE autocatalytic mechanism for the chlorite-iodide reaction and the initial reaction between chlorate and nitrous acid to produce nitrate and chlorite. This new clock reaction opens the possibility for a new family of oscillating reactions containing chlorate or nitrous acid, which in both cases has not been observed until now.	[Sant'Anna, Rafaela T. P.; Faria, Roberto B.] Univ Fed Rio de Janeiro, Inst Quim, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro	Faria, RB (corresponding author), Univ Fed Rio de Janeiro, Inst Quim, Rio De Janeiro, RJ, Brazil.	faria@iq.ufrj.br	Faria, Roberto B./B-5455-2013	FARIA, ROBERTO/0000-0001-9337-4324	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [303988/2009-6, 308497/2013-9]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ [E29-111749/2011]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	RTPS received a scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES; RTPS received a scholarship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; RBF was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, #303988/2009-6 and #308497/2013-9; this research was funded by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ, #E29-111749/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOISSONADE J, 1980, J PHYS CHEM-US, V84, P501, DOI 10.1021/j100442a009; EMEISH SS, 1980, CAN J CHEM, V58, P902, DOI 10.1139/v80-142; Galajda M, 2007, J AM CHEM SOC, V129, P7738, DOI 10.1021/ja072361l; GOMES MD, 1993, ANAL CHIM ACTA, V282, P81; Jowza M, 2005, J PHYS CHEM A, V109, P1873, DOI 10.1021/jp0457895; KAPS P, 1979, NUMER MATH, V33, P55, DOI 10.1007/BF01396495; Lengyel I, 1996, J AM CHEM SOC, V118, P3708, DOI 10.1021/ja953938e; Oliveira AP, 2005, J AM CHEM SOC, V127, P18022, DOI 10.1021/ja0570537; RABAI G, 1987, INORG CHEM, V26, P1195, DOI 10.1021/ic00255a004; Sant'Anna RTP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083706; Sant'Anna RTP, 2012, J BRAZIL CHEM SOC, V23, P1543, DOI 10.1590/S0103-50532012005000017	11	5	5	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109899	10.1371/journal.pone.0109899	http://dx.doi.org/10.1371/journal.pone.0109899			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313803	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662500085
J	Seng, LG; Daly, J; Chang, KC; Kuchipudi, SV				Seng, Lai-Giea; Daly, Janet; Chang, Kin-Chow; Kuchipudi, Suresh V.			High Basal Expression of Interferon-Stimulated Genes in Human Bronchial Epithelial (BEAS-2B) Cells Contributes to Influenza A Virus Resistance	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; REAL-TIME PCR; LUNG; REPLICATION; INFECTION; PATHWAY; H5N1; RECEPTORS; AIRWAY	Respiratory epithelial cells play a key role in influenza A virus (IAV) pathogenesis and host innate response. Transformed human respiratory cell lines are widely used in the study of IAV-host interactions due to their relative convenience, and inherent difficulties in working with primary cells. Transformed cells, however, may have altered susceptibility to virus infection. Proper characterization of different respiratory cell types in their responses to IAV infection is therefore needed to ensure that the cell line chosen will provide results that are of relevance in vivo. We compared replication kinetics of human H1N1 (A/USSR/77) IAVs in normal primary human bronchial epithelial (NHBE) and two commonly used respiratory epithelial cell lines namely BEAS-2B and A549 cells. We found that IAV replication was distinctly poor in BEAS-2B cells in comparison with NHBE, A549 and Madin-Darby canine kidney (MDCK) cells. IAV resistance in BEAS-2B cells was accompanied by an activated antiviral state with high basal expression of interferon (IFN) regulatory factor-7 (IRF-7), stimulator of IFN genes (STING) and IFN stimulated genes (ISGs). Treatment of BEAS-2B cells with a pan-Janus-activated-kinase (JAK) inhibitor decreased IRF-7 and ISG expression and resulted in increased IAV replication. Therefore, the use of highly resistant BEAS-2B cells in IAV infection may not reflect the cytopathogenicity of IAV in human epithelial cells in vivo.	[Seng, Lai-Giea; Daly, Janet; Chang, Kin-Chow; Kuchipudi, Suresh V.] Univ Nottingham, Sch Vet Med & Sci, Nottingham NG7 2RD, Leics, England	University of Nottingham	Kuchipudi, SV (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Sutton Bonington Campus, Nottingham NG7 2RD, Leics, England.	suresh.kuchipudi@nottingham.ac.uk	Kuchipudi, Suresh/AAC-5016-2021; Daly, Janet/G-9797-2011	Kuchipudi, Suresh/0000-0002-8640-254X; Daly, Janet/0000-0002-1912-4500; Chang, Kin-Chow/0000-0002-6602-7447	Ministry of Higher Education, Government of Malaysia; BBSRC [BB/I024704/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I024704/1] Funding Source: researchfish	Ministry of Higher Education, Government of Malaysia; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project is funded by a Ministry of Higher Education, Government of Malaysia PhD scholarship awarded to LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buggele WA, 2012, J BIOL CHEM, V287, P31027, DOI 10.1074/jbc.M112.387670; Chakrabarti AK, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-219; Dienz O, 2012, MUCOSAL IMMUNOL, V5, P258, DOI 10.1038/mi.2012.2; Fernandez M, 2002, J VIROL, V76, P895, DOI 10.1128/JVI.76.2.895-904.2002; Gagneux P, 2003, J BIOL CHEM, V278, P48245, DOI 10.1074/jbc.M309813200; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Hamamoto I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059892; Ilyushina NA, 2012, J VIROL, V86, P11725, DOI 10.1128/JVI.01477-12; Kuchipudi SV, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-230; Kuchipudi SV, 2012, IMMUNOL CELL BIOL, V90, P116, DOI 10.1038/icb.2011.17; Kuchipudi Suresh V, 2009, J Mol Genet Med, V3, P143; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Matrosovich M, 2009, REV SCI TECH OIE, V28, P203, DOI 10.20506/rst.28.1.1870; Moerdyk-Schauwecker M, 2013, VIROLOGY, V436, P221, DOI 10.1016/j.virol.2012.11.014; Munday DC, 2010, MOL CELL PROTEOMICS, V9, P2438, DOI 10.1074/mcp.M110.001859; Nakhaei P, 2010, J MOL CELL BIOL, V2, P110, DOI 10.1093/jmcb/mjp048; Nelli RK, 2012, J VIROL, V86, P9201, DOI 10.1128/JVI.00244-12; Nelli RK, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-4; Nelli RK, 2012, J VIROL; Nelli RK, 2012, J VIROLOGY; Pedranzini L, 2006, CANCER RES, V66, P9714, DOI 10.1158/0008-5472.CAN-05-4280; Perwitasari O, 2013, J VIROL, V87, P13775, DOI 10.1128/JVI.01509-13; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Samson M, 2013, ANTIVIR RES, V98, P174, DOI 10.1016/j.antiviral.2013.03.014; Satkunanathan S, 2014, J VIROL, V88, P2366, DOI 10.1128/JVI.02789-13; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; Thitithanyanont A, 2010, BIOCHEM BIOPH RES CO, V398, P752, DOI 10.1016/j.bbrc.2010.07.017; Toyoda T, 1996, Uirusu, V46, P131; van den Elsen PJ, 2003, CLIN IMMUNOL, V109, P46, DOI 10.1016/S1521-6616(03)00200-6; Wang HL, 2008, AM J EMERG MED, V26, P711, DOI 10.1016/j.ajem.2007.10.031; Youil R, 2004, J VIROL METHODS, V120, P23, DOI 10.1016/j.jviromet.2004.03.011; Zhao C, 2013, TRENDS MICROBIOL, V21, P181, DOI 10.1016/j.tim.2013.01.005	34	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109023	10.1371/journal.pone.0109023	http://dx.doi.org/10.1371/journal.pone.0109023			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313647	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500021
J	Al-Aidaroos, AM; El-Sherbiny, MMO; Satheesh, S; Mantha, G; Agusti, S; Carreja, B; Duarte, CM				Al-Aidaroos, Ali M.; El-Sherbiny, Mohsen M. O.; Satheesh, Sathianeson; Mantha, Gopikrishna; Agusti, Susana; Carreja, Beatriz; Duarte, Carlos M.			High Mortality of Red Sea Zooplankton under Ambient Solar Radiation	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION; VERTICAL-DISTRIBUTION; MIGRATION; SURVIVAL; BEHAVIOR; COPEPOD; OCEAN; BIOTA	High solar radiation along with extreme transparency leads to high penetration of solar radiation in the Red Sea, potentially harmful to biota inhabiting the upper water column, including zooplankton. Here we show, based on experimental assessments of solar radiation dose-mortality curves on eight common taxa, the mortality of zooplankton in the oligotrophic waters of the Red Sea to increase steeply with ambient levels of solar radiation in the Red Sea. Responses curves linking solar radiation doses with zooplankton mortality were evaluated by exposing organisms, enclosed in quartz bottles, allowing all the wavelengths of solar radiation to penetrate, to five different levels of ambient solar radiation (100%, 21.6%, 7.2%, 3.2% and 0% of solar radiation). The maximum mortality rates under ambient solar radiation levels averaged (+/- standard error of the mean, SEM) 18.4 +/- 5.8% h(-1), five-fold greater than the average mortality in the dark for the eight taxa tested. The UV-B radiation required for mortality rates to reach 1/2of maximum values averaged (+/- SEM) 12 +/- 5.6 h(-1)% of incident UVB radiation, equivalent to the UV-B dose at 19.2 +/- 2.7 m depth in open coastal Red Sea waters. These results confirm that Red Sea zooplankton are highly vulnerable to ambient solar radiation, as a consequence of the combination of high incident radiation and high water transparency allowing deep penetration of damaging UV-B radiation. These results provide evidence of the significance of ambient solar radiation levels as a stressor of marine zooplankton communities in tropical, oligotrophic waters. Because the oligotrophic ocean extends across 70% of the ocean surface, solar radiation can be a globally-significant stressor for the ocean ecosystem, by constraining zooplankton use of the upper levels of the water column and, therefore, the efficiency of food transfer up the food web in the oligotrophic ocean.	[Al-Aidaroos, Ali M.; El-Sherbiny, Mohsen M. O.; Satheesh, Sathianeson; Mantha, Gopikrishna; Duarte, Carlos M.] King Abdulaziz Univ, Fac Marine Sci, Dept Marine Biol, Jeddah 21413, Saudi Arabia; [El-Sherbiny, Mohsen M. O.] Suez Canal Univ, Fac Sci, Dept Marine Sci, Ismailia, Egypt; [Agusti, Susana; Duarte, Carlos M.] Univ Western Australia, UWA Oceans Inst, Crawley, WA, Australia; [Agusti, Susana; Duarte, Carlos M.] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia; [Agusti, Susana; Carreja, Beatriz; Duarte, Carlos M.] IMEDEA CSIC UIB, Inst Mediterraneo Estudios Avanzados, Dept Global Change Res, Miquel Marques, Esporles, Spain; [Agusti, Susana; Carreja, Beatriz; Duarte, Carlos M.] IMEDEA CSIC UIB, Inst Mediterraneo Estudios Avanzados, LINC Global, Miquel Marques, Esporles, Spain	King Abdulaziz University; Egyptian Knowledge Bank (EKB); Suez Canal University; University of Western Australia; University of Western Australia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears	Al-Aidaroos, AM (corresponding author), King Abdulaziz Univ, Fac Marine Sci, Dept Marine Biol, Jeddah 21413, Saudi Arabia.	aaidaroos@kau.edu.sa	Duarte Quesada, Carlos Manuel/ABD-6208-2021; Satheesh, Sathianeson/D-4692-2012; El-Sherbiny, Mohsen M/H-8171-2012; Agusti, Susana/G-2864-2017; عمر, محسن محمد الشربيني/T-7129-2019; Duarte, Carlos M/A-7670-2013; Mantha, Gopikrishna/H-6752-2012	Satheesh, Sathianeson/0000-0001-7809-720X; El-Sherbiny, Mohsen M/0000-0003-3040-3575; Agusti, Susana/0000-0003-0536-7293; Duarte, Carlos M/0000-0002-1213-1361; Mantha, Gopikrishna/0000-0002-7200-5105	Deanship of Scientific Research (DSR), King Abdulaziz University [1-150/1433 HiCi]	Deanship of Scientific Research (DSR), King Abdulaziz University	This project was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University (grant no. 1-150/1433 HiCi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti S, 2015, ESTUAR COAST, V38, P1126, DOI 10.1007/s12237-014-9790-9; Boelen P, 2002, MICROBIAL ECOL, V44, P164, DOI 10.1007/s00248-002-1002-7; BOLLENS SM, 1990, J EXP MAR BIOL ECOL, V137, P89, DOI 10.1016/0022-0981(90)90062-H; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Browman HI, 2003, MAR ECOL PROG SER, V247, P297, DOI 10.3354/meps247297; CHALKERSCOTT L, 1995, MAR BIOL, V123, P799; CULLEN JJ, 1992, SCIENCE, V258, P646, DOI 10.1126/science.258.5082.646; Dachs J, 2010, ESTUAR COAST, V33, P1, DOI 10.1007/s12237-009-9255-8; DAMKAER DM, 1980, OECOLOGIA, V44, P149, DOI 10.1007/BF00572672; ELHADIDY MA, 1990, SOL ENERGY, V44, P315, DOI 10.1016/0038-092X(90)90135-Y; Hader DP, 2007, PHOTOCH PHOTOBIO SCI, V6, P267, DOI 10.1039/b700020k; Hansson LA, 2007, ECOLOGY, V88, P1932, DOI 10.1890/06-2038.1; Hansson LA, 2009, PHOTOCH PHOTOBIO SCI, V8, P1266, DOI 10.1039/b908825c; Hylander S, 2014, FUNCT ECOL, V28, P149, DOI 10.1111/1365-2435.12159; Hylander S, 2010, J PLANKTON RES, V32, P971, DOI 10.1093/plankt/fbq037; Hylander S, 2009, LIMNOL OCEANOGR, V54, P1883, DOI 10.4319/lo.2009.54.6.1883; KHOGALI A, 1992, SOL ENERGY, V48, P79, DOI 10.1016/0038-092X(92)90036-A; Llabres M, 2006, LIMNOL OCEANOGR, V51, P21, DOI 10.4319/lo.2006.51.1.0021; Llabres M, 2013, GLOBAL ECOL BIOGEOGR, V22, P131, DOI 10.1111/j.1466-8238.2012.00784.x; Llabres M, 2010, MAR ECOL PROG SER, V399, P27, DOI 10.3354/meps08332; Ma ZL, 2013, HYDROBIOLOGIA, V701, P209, DOI 10.1007/s10750-012-1275-x; Mackas DL, 2007, PROG OCEANOGR, V75, P223, DOI 10.1016/j.pocean.2007.08.010; MAILLARD C, 1986, OCEANOL ACTA, V9, P249; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Raitsos DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064909; Rautio M, 2009, AQUAT BIOL, V7, P93, DOI 10.3354/ab00184; Riebesell U., 2011, OCEAN ACIDIFICATION, P99, DOI [10.1093/oso/9780199591091.003.0011, DOI 10.1093/OSO/9780199591091.003.0011]; Souza MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032046; Sommaruga R, 2010, HYDROBIOLOGIA, V648, P143, DOI 10.1007/s10750-010-0141-y; Speekmann CL, 2000, J PLANKTON RES, V22, P2325, DOI 10.1093/plankt/22.12.2325; Tedetti M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029823; Valiela I., 1995, MARINE ECOLOGICAL PR, V1, P686; Weatherhead EC, 2006, NATURE, V441, P39, DOI 10.1038/nature04746; Williamson CE, 2011, LIMNOL OCEANOGR, V56, P1603, DOI 10.4319/lo.2011.56.5.1603; WILSON DL, 1994, MECH AGEING DEV, V74, P15, DOI 10.1016/0047-6374(94)90095-7; Zengling MA, 2010, J PHOTOCH PHOTOBIO B, V101, P233, DOI 10.1016/j.jphotobiol.2010.07.008	36	11	11	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e108778	10.1371/journal.pone.0108778	http://dx.doi.org/10.1371/journal.pone.0108778			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25309996	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210300025
J	Fizel'ova, M; Cederberg, H; Stancakova, A; Jauhiainen, R; Vangipurapu, J; Kuusisto, J; Laakso, M				Fizel'ova, Maria; Cederberg, Henna; Stancakova, Alena; Jauhiainen, Raimo; Vangipurapu, Jagadish; Kuusisto, Johanna; Laakso, Markku			Markers of Tissue-Specific Insulin Resistance Predict the Worsening of Hyperglycemia, Incident Type 2 Diabetes and Cardiovascular Disease	PLOS ONE			English	Article							GLUCOSE-TOLERANCE; SURROGATE MEASURES; SENSITIVITY; LIVER; SECRETION; MELLITUS; RELEASE; MUSCLE	We investigated the ability of surrogate markers of tissue-specific insulin resistance (IR, Matsuda IR, Adipocyte IR, Liver IR) to predict deterioration of hyperglycemia, incident type 2 diabetes and cardiovascular events in the Metabolic Syndrome in Men (METSIM) Study. The METSIM Study includes 10,197 Finnish men, aged 45-73 years, and examined in 2005-2010. A total of 558 of 8,749 non-diabetic participants at baseline were diagnosed with new-onset diabetes and 239 with a new CVD event during a 5.9-year follow-up of this cohort (2010-2013). Compared to fasting plasma insulin level, Matsuda IR (IR in skeletal muscle) and Adipocyte IR were significantly better predictors of 2-hour plasma glucose and glucose area under the curve after adjustment for confounding factors. Liver IR was the strongest predictor of both incident type 2 diabetes (hazard ratio = 1.83, 95% confidence interval: 1.68-1.98) and cardiovascular events (hazard ratio = 1.31, 95% confidence interval: 1.15-1.48). Hazard ratios for fasting insulin were 1.37 (95% confidence interval: 1.32-1.42) and 1.11 (95% confidence interval: 1.00-1.24), respectively. Tissue-specific markers of IR, Matsuda IR and Adipocyte IR, were superior to fasting plasma insulin level in predicting worsening of hyperglycemia, and Liver IR was superior to fasting insulin level in predicting incident type 2 diabetes and cardiovascular events.	[Fizel'ova, Maria; Cederberg, Henna; Stancakova, Alena; Jauhiainen, Raimo; Vangipurapu, Jagadish; Kuusisto, Johanna; Laakso, Markku] Univ Eastern Finland, Dept Med, Kuopio, Finland; [Cederberg, Henna; Jauhiainen, Raimo; Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Laakso, M (corresponding author), Univ Eastern Finland, Dept Med, Kuopio, Finland.	markku.laakso@kuh.fi	Stancakova, Alena/AAN-6723-2020	Stancakova, Alena/0000-0002-1375-0252; Cederberg, Henna/0000-0003-2901-9373	Academy of Finland; Finnish Diabetes Research Foundation; Finnish Cardiovascular Research Foundation; University of eastern Finland, Kuopio, Finland; Kuopio University Hospital [5263]	Academy of Finland(Academy of Finland); Finnish Diabetes Research Foundation; Finnish Cardiovascular Research Foundation; University of eastern Finland, Kuopio, Finland; Kuopio University Hospital	This work has been supported by the grants from the Academy of Finland, the Finnish Diabetes Research Foundation, the Finnish Cardiovascular Research Foundation, the Strategic Research Funding from the University of eastern Finland, Kuopio, Finland, and EVO Grant 5263 from the Kuopio University Hospital to M. L. The funding bodies named above had no role in the design and conduct of the study; collection management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Abdul-Ghani MA, 2008, DIABETIC MED, V25, P1289, DOI 10.1111/j.1464-5491.2008.02597.x; Abdul-Ghani MA, 2008, ACTA DIABETOL, V45, P147, DOI 10.1007/s00592-008-0033-z; Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519; Amer Diabet Assoc, 2006, DIABETES CARE, V29, pS43; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; Bressler P, 1996, DIABETOLOGIA, V39, P1345, DOI 10.1007/s001250050581; Cherrington AD, 1999, DIABETES, V48, P1198, DOI 10.2337/diabetes.48.5.1198; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; DEFRONZO RA, 1982, CLIN RES, V30, pA523; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Ferrannini E, 2013, DIABETES, V62, P1730, DOI 10.2337/db12-0707; Gast KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052036; Gastaldelli A, 2010, DIGEST LIVER DIS, V42, P310, DOI 10.1016/j.dld.2010.01.013; GROOP LC, 1989, J CLIN INVEST, V84, P205, DOI 10.1172/JCI114142; Hacke W, 2003, CEREBROVASC DIS, V16, P311, DOI 10.1159/000072554; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kuusisto J, 2001, DIABETES CARE, V24, P1629, DOI 10.2337/diacare.24.9.1629; LAAKSO M, 1993, AM J EPIDEMIOL, V137, P959, DOI 10.1093/oxfordjournals.aje.a116768; LAAKSO M, 1991, ARTERIOSCLER THROMB, V11, P1068, DOI 10.1161/01.ATV.11.4.1068; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; Lorenzo C, 2010, J CLIN ENDOCR METAB, V95, P5082, DOI 10.1210/jc.2010-1144; Lorenzo C, 2010, DIABETES CARE, V33, P67, DOI 10.2337/dc09-1115; Lyssenko V, 2005, DIABETES, V54, P166, DOI 10.2337/diabetes.54.1.166; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Stancakova A, 2009, DIABETES, V58, P1212, DOI 10.2337/db08-1607; Stumvoll M, 2000, DIABETES CARE, V23, P1440, DOI 10.2337/diacare.23.9.1440; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Tripathy D, 2004, DIABETES CARE, V27, P2204, DOI 10.2337/diacare.27.9.2204; Vangipurapu J, 2011, DIABETOLOGIA, V54, P540, DOI 10.1007/s00125-010-1966-7; Walker M, 2005, DIABETOLOGIA, V48, P2470, DOI 10.1007/s00125-005-0004-7; Zierath JR, 2003, BEST PRACT RES CL EN, V17, P385, DOI 10.1016/S1521-690X(03)00040-X	32	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109772	10.1371/journal.pone.0109772	http://dx.doi.org/10.1371/journal.pone.0109772			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310839	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210300072
J	Schuck, RN; Zha, WB; Edin, ML; Gruzdev, A; Vendrov, KC; Miller, TM; Xu, ZH; Lih, FB; DeGraff, LM; Tomer, KB; Jones, HM; Makowski, L; Huang, L; Poloyac, SM; Zeldin, DC; Lee, CR				Schuck, Robert N.; Zha, Weibin; Edin, Matthew L.; Gruzdev, Artiom; Vendrov, Kimberly C.; Miller, Tricia M.; Xu, Zhenghong; Lih, Fred B.; DeGraff, Laura M.; Tomer, Kenneth B.; Jones, H. Michael; Makowski, Liza; Huang, Leaf; Poloyac, Samuel M.; Zeldin, Darryl C.; Lee, Craig R.			The Cytochrome P450 Epoxygenase Pathway Regulates the Hepatic Inflammatory Response in Fatty Liver Disease	PLOS ONE			English	Article							SOLUBLE EPOXIDE HYDROLASE; HYDRODYNAMICS-BASED TRANSFECTION; LARGE GENE LISTS; NONALCOHOLIC STEATOHEPATITIS; ENDOTHELIAL EXPRESSION; EICOSANOID METABOLISM; ARACHIDONIC-ACID; ATHEROGENIC DIET; MICE; MOUSE	Fatty liver disease is an emerging public health problem without effective therapies, and chronic hepatic inflammation is a key pathologic mediator in its progression. Cytochrome P450 (CYP) epoxygenases metabolize arachidonic acid to biologically active epoxyeicosatrienoic acids (EETs), which have potent anti-inflammatory effects. Although promoting the effects of EETs elicits anti-inflammatory and protective effects in the cardiovascular system, the contribution of CYP-derived EETs to the regulation of fatty liver disease-associated inflammation and injury is unknown. Using the atherogenic diet model of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH), our studies demonstrated that induction of fatty liver disease significantly and preferentially suppresses hepatic CYP epoxygenase expression and activity, and both hepatic and circulating levels of EETs in mice. Furthermore, mice with targeted disruption of Ephx2 (the gene encoding soluble epoxide hydrolase) exhibited restored hepatic and circulating EET levels and a significantly attenuated induction of hepatic inflammation and injury. Collectively, these data suggest that suppression of hepatic CYP-mediated EET biosynthesis is an important pathological consequence of fatty liver disease-associated inflammation, and that the CYP epoxygenase pathway is a central regulator of the hepatic inflammatory response in NAFLD/NASH. Future studies investigating the utility of therapeutic strategies that promote the effects of CYP-derived EETs in NAFLD/NASH are warranted.	[Schuck, Robert N.; Zha, Weibin; Vendrov, Kimberly C.; Lee, Craig R.] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC 27515 USA; [Edin, Matthew L.; Gruzdev, Artiom; Lih, Fred B.; DeGraff, Laura M.; Tomer, Kenneth B.; Zeldin, Darryl C.] NIEHS, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA; [Miller, Tricia M.; Poloyac, Samuel M.] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Xu, Zhenghong; Huang, Leaf] Univ N Carolina, Eshelman Sch Pharm, Div Mol Pharmaceut, Chapel Hill, NC USA; [Jones, H. Michael] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Makowski, Liza] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Lee, CR (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC 27515 USA.	craig_lee@unc.edu	, Histology Research Core Facility/ABF-6317-2021; Edin, Matthew/AAI-1934-2019; Zeldin, Darryl C/Y-7091-2018	Zeldin, Darryl C/0000-0002-2087-7307; Lee, Craig/0000-0003-3595-5301; Vendrov, Kimberly/0000-0002-9131-5272; Makowski, Liza/0000-0002-5337-8037; Edin, Matthew/0000-0002-7042-500X	NIH/NIGMS [R01GM088199]; NIH/NHLBI [T32HL069768]; American Heart Association [11PRE7240059]; NIH/NINDS [R01NS052315]; NIH/NCRR [S10RR023461]; NIH/NIAAA [AA017376]; NIH/NIDDK [P30DK34987]; UNC Nutrition Obesity Research Center [P30DK056350]; Intramural Research Program of the NIH/NIEHS [Z01ES050167, Z01ES025034]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023461] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987, P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102546, Z01ES025034, Z01ES050167, ZICES102425, ZIAES025034, ZIAES103005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R00AA017376, K99AA017376] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); UNC Nutrition Obesity Research Center; Intramural Research Program of the NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This publication was made possible by a grant from the NIH/NIGMS (R01GM088199) to Dr. Lee, a predoctoral training program in Integrative Vascular Biology supported by the NIH/NHLBI (T32HL069768) and a predoctoral fellowship from the American Heart Association (11PRE7240059) to Dr. Schuck, grants from the NIH/NINDS (R01NS052315) and NIH/NCRR (S10RR023461) to Dr. Poloyac, NIH/NIAAA (AA017376) to Dr. Makowski, NIH/NIDDK to the UNC Center for Gastrointestinal Biology and Disease (P30DK34987) and UNC Nutrition Obesity Research Center (P30DK056350), and funds from the Intramural Research Program of the NIH/NIEHS to Dr. Tomer (Z01ES050167) and Dr. Zeldin (Z01ES025034). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Deng YM, 2010, J MOL CELL CARDIOL, V48, P331, DOI 10.1016/j.yjmcc.2009.10.022; Desai MS, 2008, J LEUKOCYTE BIOL, V83, P1336, DOI 10.1189/jlb.0607390; Edin ML, 2011, FASEB J, V25, P3436, DOI 10.1096/fj.11-188300; EnayetAllah AE, 2008, J BIOL CHEM, V283, P36592, DOI 10.1074/jbc.M806315200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iber H, 2000, ARCH BIOCHEM BIOPHYS, V377, P187, DOI 10.1006/abbi.2000.1772; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lee CR, 2010, FASEB J, V24, P3770, DOI 10.1096/fj.10-160119; Lichtman AH, 1999, ARTERIOSCL THROM VAS, V19, P1938, DOI 10.1161/01.ATV.19.8.1938; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039165; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luria A, 2011, P NATL ACAD SCI USA, V108, P9038, DOI 10.1073/pnas.1103482108; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; Merrell MD, 2011, DRUG METAB REV, V43, P317, DOI 10.3109/03602532.2011.577781; Morgan ET, 2001, DRUG METAB DISPOS, V29, P207; Newman JW, 2003, P NATL ACAD SCI USA, V100, P1558, DOI 10.1073/pnas.0437724100; NISHINA PM, 1990, J LIPID RES, V31, P859; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Oni-Orisan A, 2013, PROSTAG OTH LIPID M, V104, P67, DOI 10.1016/j.prostaglandins.2012.09.003; Poloyac SM, 2004, DRUG METAB DISPOS, V32, P727, DOI 10.1124/dmd.32.7.727; Puri P, 2009, HEPATOLOGY, V50, P1827, DOI 10.1002/hep.23229; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18; Schmelzer KR, 2005, P NATL ACAD SCI USA, V102, P9772, DOI 10.1073/pnas.0503279102; Schuck RN, 2013, ATHEROSCLEROSIS, V227, P442, DOI 10.1016/j.atherosclerosis.2013.01.034; Seubert JM, 2006, CIRC RES, V99, P442, DOI 10.1161/01.RES.0000237390.92932.37; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Song YK, 2002, METHOD ENZYMOL, V346, P92; Suda T, 2007, GENE THER, V14, P129, DOI 10.1038/sj.gt.3302865; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Theken KN, 2012, AM J PHYSIOL-ENDOC M, V302, pE500, DOI 10.1152/ajpendo.00370.2011; Theken KN, 2011, DRUG METAB DISPOS, V39, P22, DOI 10.1124/dmd.110.035287; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Yang SL, 2007, AM J PHYSIOL-HEART C, V293, pH142, DOI 10.1152/ajpheart.00783.2006; Ye DW, 2012, GUT, V61, P1058, DOI 10.1136/gutjnl-2011-300269; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200; Zhao G, 2012, HUM GENE THER, V23, P688, DOI 10.1089/hum.2011.135	44	56	58	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110162	10.1371/journal.pone.0110162	http://dx.doi.org/10.1371/journal.pone.0110162			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310404	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000343210300093
J	Yang, M; Fu, ZK; Zhang, QJ; Xin, Y; Chen, YJ; Tian, Y				Yang, Mao; Fu, Zhenkun; Zhang, Qingjiang; Xin, Yu; Chen, Yanjun; Tian, Ye			Association between the Polymorphisms in Intercellular Adhesion Molecule-1 and the Risk of Coronary Atherosclerosis: A Case-Controlled Study	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR RISK; DIABETIC-PATIENTS; HEART-DISEASE; YOUNG FINNS; GENE; INTERVENTION; METAANALYSIS; PROGRESSION; MECHANISMS	Intercellular adhesion molecule-1 (ICAM-1), an important immune adhesion molecule, is related to the atherosclerosis. We explored the association between the polymorphisms of the ICAM-1 gene and coronary atherosclerotic stenosis to determine whether any risk factors correlate with genetic polymorphisms in Chinese patients with coronary atherosclerosis. Using the SNaPshot assay, we examined six SNPs of rs5491, rs281428, rs281432, rs5496, rs5498 and rs281437 in 604 patients diagnosed with coronary atherosclerotic stenosis by angiography and in 468 controls. We found that AG genotype of rs5498 had higher frequency in the coronary atherosclerotic stenosis patients (41.56% to 34.19%, P = 0.017, OR = 1.368,95% CI 1.057-1.770) and that the haplotype Ars(5491)Crs(281428)Grs(281432) had higher frequency in patients (13.8% to 12.1%, P = 0.048). When analyzing the clinical risk factors for coronary atherosclerosis, we found that the rs5498 locus was associated with the levels of apolipoprotein A (APOA) (P = 0.0002) and triglycerides (TG) (P = 0.002). Furthermore, the levels of triglycerides (TG) were also associated with rs281432 (P = 0.040). Additionally, the TT genotype of rs281437 was associated with a higher level of apolipoprotein A (APOA) (P = 0.039) and apolipoprotein B (APOB) (P = 0.003). Finally, among those with coronary atherosclerosis, we found no differences in the haplotype analysis of polymorphisms of the ICAM-1 gene from individuals with hypertension or those who smoked. According to our results, the ICAM-1 polymorphisms were associated with risk of coronary atherosclerotic stenosis in Chinese individuals.	[Yang, Mao; Chen, Yanjun] Harbin Med Univ, Affiliated Hosp 4, Dept Cardiol, Harbin, Peoples R China; [Fu, Zhenkun] Harbin Med Univ, Dept Immunol, Harbin, Peoples R China; [Tian, Ye] Harbin Med Univ, Affiliated Hosp 1, Dept Cardiol, Harbin, Peoples R China; [Tian, Ye] Dept Pathophysiol, Harbin, Peoples R China; [Zhang, Qingjiang] Heilongjiang Univ Chinese Med, Affiliated Hosp 2, Dept Cardiol, Harbin, Peoples R China; [Xin, Yu] Harbin Med Univ, Affiliated Hosp 4, Dept Lab Med, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Heilongjiang University of Chinese Medicine; Harbin Medical University	Chen, YJ (corresponding author), Harbin Med Univ, Affiliated Hosp 4, Dept Cardiol, Harbin, Peoples R China.	hmuchenyj@126.com; hmutianye@126.com			National Natural Science Foundation of China [81171483]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (No. 81171483). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers JJ, 2013, J AM COLL CARDIOL, V62, P1575, DOI 10.1016/j.jacc.2013.06.051; Banks K, 2011, JACC-CARDIOVASC IMAG, V4, P65, DOI 10.1016/j.jcmg.2010.10.006; Baralle D, 2005, J MED GENET, V42, P737, DOI 10.1136/jmg.2004.029538; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Blankenberg S, 2001, CIRCULATION, V104, P1336, DOI 10.1161/hc3701.095949; Boumil RM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001046; Chen JM, 2006, HUM GENET, V120, P1, DOI 10.1007/s00439-006-0180-7; Cui YD, 2009, AM J CARDIOL, V104, P829, DOI 10.1016/j.amjcard.2009.05.020; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Gazzaruso C, 2006, INT J CARDIOL, V108, P354, DOI 10.1016/j.ijcard.2005.05.022; Giacconi R, 2007, INT J CARDIOL, V120, P45, DOI 10.1016/j.ijcard.2006.08.035; Giannoglou GD, 2009, ANGIOLOGY, V60, P676, DOI 10.1177/0003319709337307; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Gu Y, 2013, CELL PHYSIOL BIOCHEM, V31, P143, DOI 10.1159/000343356; Guray U, 2004, INT J CARDIOL, V96, P235, DOI 10.1016/j.ijcard.2003.07.014; Haim M, 2002, J AM COLL CARDIOL, V39, P1133, DOI 10.1016/S0735-1097(02)01728-X; Hernesniemi JA, 2010, ANN MED, V42, P223, DOI 10.3109/07853891003769940; Hoke M, 2012, EUR J CLIN INVEST, V42, P921, DOI 10.1111/j.1365-2362.2012.02669.x; Hulkkonen J, 2009, ATHEROSCLEROSIS, V203, P454, DOI 10.1016/j.atherosclerosis.2008.07.014; Inwald D, 2001, J CLIN PATHOL-MOL PA, V54, P1; Ji YN, 2012, MOL BIOL REP, V39, P6043, DOI 10.1007/s11033-011-1418-6; Krauss V, 2005, MOL BIOL EVOL, V22, P74, DOI 10.1093/molbev/msh255; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Nicholls SJ, 2011, J AM COLL CARDIOL, V57, P153, DOI 10.1016/j.jacc.2010.06.055; Rifai N, 2004, CLIN CHEM, V50, P1364, DOI 10.1373/clinchem.2003.030031; ROSS R, 1995, ANN NY ACAD SCI, V748, P1; Smith SC, 2001, CIRCULATION, V103, P3019, DOI 10.1161/01.CIR.103.24.3019; Taylor AJ, 2008, ATHEROSCLEROSIS, V197, P339, DOI 10.1016/j.atherosclerosis.2007.05.027; Volcik KA, 2010, STROKE, V41, P1038, DOI 10.1161/STROKEAHA.109.575563; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Zhang K, 2012, THROMB RES, V130, pE203, DOI 10.1016/j.thromres.2012.07.008	33	9	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109658	10.1371/journal.pone.0109658	http://dx.doi.org/10.1371/journal.pone.0109658			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310099	gold, Green Published, Green Submitted			2022-12-27	WOS:000343210300066
J	Chen, QQ; Wang, H; Schwender, H; Zhang, TS; Hetmanski, JB; Chou, YHW; Ye, XQ; Yeow, V; Chong, SS; Zhang, B; Jabs, EW; Parker, MM; Scott, AF; Beaty, TH				Chen, Qianqian; Wang, Hong; Schwender, Holger; Zhang, Tianxiao; Hetmanski, Jacqueline B.; Chou, Yah-Huei Wu; Ye, Xiaoqian; Yeow, Vincent; Chong, Samuel S.; Zhang, Bo; Jabs, Ethylin Wang; Parker, Margaret M.; Scott, Alan F.; Beaty, Terri H.			Joint Testing of Genotypic and Gene-Environment Interaction Identified Novel Association for BMP4 with Non-Syndromic CL/P in an Asian Population Using Data from an International Cleft Consortium	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CANDIDATE GENES; RISK VARIANTS; LIP; PALATE; POLYMORPHISMS; LIP/PALATE; FAMILY; LOCUS; TDT	Background: Non-syndromic cleft lip with or without cleft palate (NSCL/P) is a common disorder with complex etiology. The Bone Morphogenetic Protein 4 gene (BMP4) has been considered a prime candidate gene with evidence accumulated from animal experimental studies, human linkage studies, as well as candidate gene association studies. The aim of the current study is to test for linkage and association between BMP4 and NSCL/P that could be missed in genome-wide association studies (GWAS) when genotypic (G) main effects alone were considered. Methodology/Principal Findings: We performed the analysis considering G and interactions with multiple maternal environmental exposures using additive conditional logistic regression models in 895 Asian and 681 European complete NSCL/P trios. Single nucleotide polymorphisms (SNPs) that passed the quality control criteria among 122 genotyped and 25 imputed single nucleotide variants in and around the gene were used in analysis. Selected maternal environmental exposures during 3 months prior to and through the first trimester of pregnancy included any personal tobacco smoking, any environmental tobacco smoke in home, work place or any nearby places, any alcohol consumption and any use of multivitamin supplements. A novel significant association held for rs7156227 among Asian NSCL/P and non-syndromic cleft lip and palate (NSCLP) trios after Bonferroni correction which was not seen when G main effects alone were considered in either allelic or genotypic transmission disequilibrium tests. Odds ratios for carrying one copy of the minor allele without maternal exposure to any of the four environmental exposures were 0.58 (95% CI = 0.44, 0.75) and 0.54 (95% CI = 0.40, 0.73) for Asian NSCL/P and NSCLP trios, respectively. The Bonferroni P values corrected for the total number of 117 tested SNPs were 0.0051 (asymptotic P = 4.39*10(-5)) and 0.0065 (asymptotic P = 5.54*10(-5)), accordingly. In European trios, no significant association was seen for any SNPs after Bonferroni corrections for the total number of 120 tested SNPs. Conclusions/Significance: Our findings add evidence from GWAS to support the role of BMP4 in susceptibility to NSCL/P originally identified in linkage and candidate gene association studies.	[Chen, Qianqian; Wang, Hong] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China; [Chen, Qianqian; Wang, Hong] Minist Hlth, Key Lab Reprod Hlth, Beijing, Peoples R China; [Schwender, Holger] Univ Dusseldorf, Math Inst, Dusseldorf, Germany; [Zhang, Tianxiao] Washington Univ, Div Biol & Biomed Sci, St Louis, MO USA; [Hetmanski, Jacqueline B.; Parker, Margaret M.; Beaty, Terri H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Chou, Yah-Huei Wu] Chang Gung Mem Hosp, Dept Med Res, Taipei 10591, Taiwan; [Ye, Xiaoqian] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Yeow, Vincent] KK Womens & Childrens Hosp, Dept Plast Surg, Singapore, Singapore; [Chong, Samuel S.] Natl Univ Singapore, Dept Pediat, Singapore 117548, Singapore; [Zhang, Bo] Xi An Jiao Tong Univ, Dept Engn, Xian 710049, Peoples R China; [Jabs, Ethylin Wang] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Jabs, Ethylin Wang] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Scott, Alan F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Peking University; Heinrich Heine University Dusseldorf; Washington University (WUSTL); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Chang Gung Memorial Hospital; Icahn School of Medicine at Mount Sinai; KK Women's & Children's Hospital; National University of Singapore; Xi'an Jiaotong University; Johns Hopkins University; Icahn School of Medicine at Mount Sinai; Johns Hopkins University	Wang, H (corresponding author), Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China.	hwang2010@aliyun.com	Zhang, Tianshu/K-6837-2015; Chong, Samuel S./D-8098-2015	Jabs, Ethylin/0000-0001-8983-5466; Chong, Samuel S./0000-0002-1872-5937; Parker, PhD, Margaret/0000-0001-6368-5033	National Natural Science Foundation of China [81273164]; National Institute of Dental & Craniofacial Research [R21-DE-013707, R01-DE-014581]; Fogarty Institution [D43-TW006176]; FOGARTY INTERNATIONAL CENTER [D43TW006176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE013707] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Dental & Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Fogarty Institution; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants from the National Natural Science Foundation of China(No. 81273164, HW, http://www.nsfc.gov.cn/), the National Institute of Dental & Craniofacial Research (No. R21-DE-013707 and R01-DE-014581, THB, http://www.nidcr.nih.gov/), and Fogarty Institution (No. D43-TW006176, EWJ http://www.fic.nih.gov/Pages/Default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agopian AJ, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-88; Antunes LS, 2013, CLEFT PALATE-CRAN J, V50, P633, DOI 10.1597/12-048; Araujo TK, 2012, PLAST SURG INT, V2012; Ashique AM, 2002, DEVELOPMENT, V129, P4647; Barlow AJ, 1997, DEVELOPMENT, V124, P391; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beaty TH, 2013, HUM GENET, V132, P771, DOI 10.1007/s00439-013-1283-6; Beaty TH, 2011, GENET EPIDEMIOL, V35, P469, DOI 10.1002/gepi.20595; Beaty TH, 2010, NAT GENET, V42, P525, DOI 10.1038/ng.580; Birnbaum S, 2009, NAT GENET, V41, P473, DOI 10.1038/ng.333; Butali A, 2011, CLEFT PALATE-CRAN J, V48, P646, DOI 10.1597/10-133; Chen QQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035347; Cordell HJ, 2009, GENOMICS, V93, P5, DOI 10.1016/j.ygeno.2008.05.002; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Fallin D, 2002, GENET EPIDEMIOL, V23, P458, DOI 10.1002/gepi.10192; Fontoura C, 2012, EUR J ORAL SCI, V120, P553, DOI 10.1111/eos.12001; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Grant SFA, 2009, J PEDIATR-US, V155, P909, DOI 10.1016/j.jpeds.2009.06.020; Hancock DB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003098; Hobbs CA, 2010, OBSTET GYNECOL, V116, P316, DOI 10.1097/AOG.0b013e3181e80979; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jugessur A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005385; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Lennon CJ, 2012, LARYNGOSCOPE, V122, P2082, DOI 10.1002/lary.23394; Lin JY, 2008, DNA CELL BIOL, V27, P601, DOI 10.1089/dna.2008.0777; Liu W, 2005, DEVELOPMENT, V132, P1453, DOI 10.1242/dev.01676; Ludwig KU, 2012, NAT GENET, V44, P968, DOI 10.1038/ng.2360; Mangold E, 2010, NAT GENET, V42, P24, DOI 10.1038/ng.506; Marazita ML, 2012, ANNU REV GENOM HUM G, V13, P263, DOI 10.1146/annurev-genom-090711-163729; Marazita ML, 2009, HUM HERED, V68, P151, DOI 10.1159/000224636; Marazita ML, 2004, AM J HUM GENET, V75, P161, DOI 10.1086/422475; Mostowska A, 2012, BIRTH DEFECTS RES A, V94, P42, DOI 10.1002/bdra.22862; Schaid DJ, 1999, GENET EPIDEMIOL, V16, P250, DOI 10.1002/(SICI)1098-2272(1999)16:3<250::AID-GEPI2>3.0.CO;2-T; Schwender H, 2012, BIOMETRICS, V68, P766, DOI 10.1111/j.1541-0420.2011.01713.x; Shi M, 2007, AM J HUM GENET, V80, P76, DOI 10.1086/510518; Paiva KBS, 2010, ACTA HISTOCHEM, V112, P508, DOI 10.1016/j.acthis.2009.05.007; Suazo J, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-163; Suazo J, 2010, DNA CELL BIOL, V29, P59, DOI 10.1089/dna.2009.0944; Suzuki S, 2009, AM J HUM GENET, V84, P406, DOI 10.1016/j.ajhg.2009.02.002; Taghavi N, 2012, IRAN RED CRESCENT ME, V14, P25; Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764; Wang H, 2013, CLEFT PALATE-CRAN J, V50, P96, DOI 10.1597/11-132; Zhang TX, 2012, STAT APPL GENET MOL, V11, DOI 10.2202/1544-6115.1717	43	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109038	10.1371/journal.pone.0109038	http://dx.doi.org/10.1371/journal.pone.0109038			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303326	gold, Green Published, Green Submitted			2022-12-27	WOS:000343730400042
J	Tang, ZX; Li, M; Chen, L; Wang, YY; Ren, ZL; Fu, SL				Tang, Zongxiang; Li, Meng; Chen, Lei; Wang, Yangyang; Ren, Zhenglong; Fu, Shulan			New Types of Wheat Chromosomal Structural Variations NE in Derivatives of Wheat-Rye Hybrids	PLOS ONE			English	Article							TANDEM REPEATS; ADDITION LINES; HETEROCHROMATIN; TRANSLOCATIONS; REARRANGEMENTS; INSTABILITY; SEQUENCES; PATTERNS; SECALE	Background: Chromosomal rearrangements induced by wheat-rye hybridization is a very well investigated research topic. However, the structural alterations of wheat chromosomes in wheat-rye hybrids are seldom reported. Methodology/Principal Findings: Octoploid triticale lines were derived from common wheat Triticum. aestivum L. 'Mianyang11'xrye Seca le cereale L. 'Kustro'. Some progeny were obtained by the controlled backcrossing of triticale with 'Mianyang11' and common wheat T. aestivum L. 'Chuannong27' followed by self-fertilization. Fluorescence in situ hybridization (FISH) and genomic in situ hybridization (GISH) using Oligo-pSc119.2-1, Oligo-pTa535-1 and rye genomic DNA as probes were used to analyze the mitotic chromosomes of these progeny. Alterations of wheat chromosomes including 5A, 6A, 1B, 2B, 6B, 7B, 1D, 3D and 7D were observed. SAL arm carrying intercalary Oligo-pSc119.2-1, Oligo-pTa535-1 or both Oligo-pSc119.2-1 and Oligo-pTa535-1 signals, 6A5, 1BS and 1DL arms containing terminal Oligo-pSc119.2-1 signal, 6B5 and 3D5 arms without terminal Oligo-pSc119.2-1 signal, 785 without subtelomeric Oligo-pSc119.2-1 signal and 7DL with intercalary Oligo-pSc119.2-1 signal have been observed. However, these changed wheat chromosomes have not been detected in 'Mianyang11' and Chuannong 27. The altered 5A, 6A, 7B and 7D chromosomes in this study have not been reported and represent several new karyotype structures of common wheat chromosomes. Conclusions/Significance:These rearranged wheat chromosomes in the present study afford some new genetic variations for wheat breeding program and are valuable materials for studying the biological function of tandem repetitive DNA sequences.	[Tang, Zongxiang; Li, Meng; Chen, Lei; Wang, Yangyang; Ren, Zhenglong; Fu, Shulan] Sichuan Agr Univ, Agron Coll, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University	Fu, SL (corresponding author), Sichuan Agr Univ, Agron Coll, Chengdu, Sichuan, Peoples R China.	fushulan@sicau.edu.cn			National High Technology Research and Development Program ("863" Program) of China [2011AA100101, 2011AA100103]	National High Technology Research and Development Program ("863" Program) of China(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development Program ("863" Program) of China (No. 2011AA100101; 2011AA100103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhimova AG, 1999, CHROMOSOME RES, V7, P205, DOI 10.1023/A:1009299300018; Alkhimova OG, 2004, CHROMOSOMA, V113, P42, DOI 10.1007/s00412-004-0294-4; APPELS R, 1982, THEOR APPL GENET, V63, P235, DOI 10.1007/BF00304002; Badaeva ED, 2007, GENOME, V50, P907, DOI 10.1139/G07-072; Bento M, 2010, THEOR APPL GENET, V121, P489, DOI 10.1007/s00122-010-1325-6; Berkman PJ, 2012, THEOR APPL GENET, V124, P423, DOI 10.1007/s00122-011-1717-2; Feuillet C, 2008, TRENDS GENET, V24, P24, DOI 10.1016/j.tig.2007.11.001; Fu SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070483; Fu SL, 2013, J GENET GENOMICS, V40, P413, DOI 10.1016/j.jgg.2013.05.005; GUSTAFSON JP, 1983, CHROMOSOMA, V88, P293, DOI 10.1007/BF00292906; Han FP, 2006, P NATL ACAD SCI USA, V103, P3238, DOI 10.1073/pnas.0509650103; Han FP, 2005, GENETICS, V170, P1239, DOI 10.1534/genetics.104.039263; Hao M, 2013, GENOME, V56, P303, DOI 10.1139/gen-2013-0049; Komuro S, 2013, GENOME, V56, P131, DOI 10.1139/gen-2013-0003; KOTA RS, 1988, GENETICS, V120, P1085; LAPITAN NLV, 1984, THEOR APPL GENET, V68, P547, DOI 10.1007/BF00285012; MCCLINTOCK B, 1978, STADLER GENET S, V10, P25; REN ZL, 1990, PLANT BREEDING, V105, P257, DOI 10.1111/j.1439-0523.1990.tb01283.x; Salina EA, 2004, GENOME, V47, P860, DOI 10.1139/G04-044; Schneider A, 2003, PLANT BREEDING, V122, P396, DOI 10.1046/j.1439-0523.2003.00891.x; Szakacs E, 2010, J APPL GENET, V51, P149, DOI 10.1007/BF03195723; Tang ZX, 2008, GENOME, V51, P399, DOI 10.1139/G08-027; Tang ZX, 2014, J APPL GENET, V55, P313, DOI 10.1007/s13353-014-0215-z; Zhang HK, 2013, P NATL ACAD SCI USA, V110, P19466, DOI 10.1073/pnas.1319598110	24	27	35	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110282	10.1371/journal.pone.0110282	http://dx.doi.org/10.1371/journal.pone.0110282			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302962	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400126
J	Zhen, Z; Liu, HT; Wang, N; Guo, LY; Meng, J; Ding, N; Wu, GL; Jiang, GM				Zhen, Zhen; Liu, Haitao; Wang, Na; Guo, Liyue; Meng, Jie; Ding, Na; Wu, Guanglei; Jiang, Gaoming			Effects of Manure Compost Application on Soil Microbial Community Diversity and Soil Microenvironments in a Temperate Cropland in China	PLOS ONE			English	Article							LONG-TERM APPLICATION; ORGANIC-MATTER; FUMIGATION-EXTRACTION; LAND MANAGEMENT; BIOMASS; FERTILIZER; DYNAMICS; RHIZOSPHERE; NITROGEN; RESIDUE	The long-term application of excessive chemical fertilizers has resulted in the degeneration of soil quality parameters such as soil microbial biomass, communities, and nutrient content, which in turn affects crop health, productivity, and soil sustainable productivity. The objective of this study was to develop a rapid and efficient solution for rehabilitating degraded cropland soils by precisely quantifying soil quality parameters through the application of manure compost and bacteria fertilizers or its combination during maize growth. We investigated dynamic impacts on soil microbial count, biomass, basal respiration, community structure diversity, and enzyme activity using six different treatments [no fertilizer (CK), N fertilizer (N), N fertilizer + bacterial fertilizer (NB), manure compost (M), manure compost + bacterial fertilizer (MB), and bacterial fertilizer (B)] in the plowed layer (0-20 cm) of potted soil during various maize growth stages in a temperate cropland of eastern China. Denaturing gradient electrophoresis (DGGE) fingerprinting analysis showed that the structure and composition of bacterial and fungi communities in the six fertilizer treatments varied at different levels. The Shannon index of bacterial and fungi communities displayed the highest value in the MB treatments and the lowest in the N treatment at the maize mature stage. Changes in soil microorganism community structure and diversity after different fertilizer treatments resulted in different microbial properties. Adding manure compost significantly increased the amount of cultivable microorganisms and microbial biomass, thus enhancing soil respiration and enzyme activities (p<0.01), whereas N treatment showed the opposite results (p<0.01). However, B and NB treatments minimally increased the amount of cultivable microorganisms and microbial biomass, with no obvious influence on community structure and soil enzymes. Our findings indicate that the application of manure compost plus bacterial fertilizers can immediately improve the microbial community structure and diversity of degraded cropland soils.	[Zhen, Zhen; Liu, Haitao; Guo, Liyue; Meng, Jie; Wu, Guanglei; Jiang, Gaoming] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Zhen, Zhen] Guangdong Ocean Univ, Lab Crop, Zhanjiang, Peoples R China; [Zhen, Zhen] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Na] Dev & Promot Ctr, Jinan, Peoples R China; [Ding, Na] Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Guangdong Ocean University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shandong Agricultural University	Jiang, GM (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	jianggm@126.com	Wu, Guanglei/GXN-0325-2022	Wu, Guanglei/0000-0001-6145-3415	Chinese Academy of Sciences [KSZD-EW-Z-012-2]; State Key Laboratory of Vegetation and Environmental Change [2014ZDFX04]	Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Vegetation and Environmental Change	This research was jointly supported by the Key Strategic Project of the Chinese Academy of Sciences (No. KSZD-EW-Z-012-2) and State Key Laboratory of Vegetation and Environmental Change (2014ZDFX04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2007, ANN MICROBIOL, V57, P471, DOI 10.1007/BF03175343; Anderson J.P.E., 1982, METHODS SOIL ANAL 2, Vsecond, P831; Bending GD, 2002, SOIL BIOL BIOCHEM, V34, P1073, DOI 10.1016/S0038-0717(02)00040-8; Bhandari AL, 2002, SOIL SCI SOC AM J, V66, P162, DOI 10.2136/sssaj2002.0162; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Chaudhry AN, 2009, ASIAN J CHEM, V21, P4997; Dijkstra FA, 2009, SOIL BIOL BIOCHEM, V41, P1080, DOI 10.1016/j.soilbio.2009.02.013; Dinesh R, 2010, BIORESOURCE TECHNOL, V101, P4697, DOI 10.1016/j.biortech.2010.01.108; Drenovsky RE, 2004, MICROB ECOL, V48, P424, DOI 10.1007/s00248-003-1063-2; Francis I, 2010, ENVIRON MICROBIOL, V12, P1, DOI 10.1111/j.1462-2920.2009.01989.x; Ge Y, 2008, J SOIL SEDIMENT, V8, P43, DOI 10.1065/jss2008.01.270; Gregorich EG, 1996, SOIL SCI SOC AM J, V60, P472, DOI 10.2136/sssaj1996.03615995006000020019x; Guan S., 1986, SOIL ENZYME ITS RES, V1986, P274; Hao XH, 2008, NUTR CYCL AGROECOSYS, V81, P17, DOI 10.1007/s10705-007-9145-z; Hedlund K, 2002, SOIL BIOL BIOCHEM, V34, P1299, DOI 10.1016/S0038-0717(02)00073-1; Helgason BL, 2010, APPL SOIL ECOL, V46, P390, DOI 10.1016/j.apsoil.2010.10.002; Hsu SF, 2009, ISME J, V3, P124, DOI 10.1038/ismej.2008.82; Hu JL, 2011, J SOIL SEDIMENT, V11, P271, DOI 10.1007/s11368-010-0308-1; Inselsbacher E, 2010, SOIL BIOL BIOCHEM, V42, P360, DOI 10.1016/j.soilbio.2009.11.019; Jenkinson DS, 2004, SOIL BIOL BIOCHEM, V36, P5, DOI 10.1016/j.soilbio.2003.10.002; Joergensen RG, 1996, SOIL BIOL BIOCHEM, V28, P33, DOI 10.1016/0038-0717(95)00101-8; Kaur T, 2008, NUTR CYCL AGROECOSYS, V81, P59, DOI 10.1007/s10705-007-9152-0; Leita L, 1999, BIOL FERT SOILS, V28, P371, DOI 10.1007/s003740050506; Leite LFC, 2010, AUST J SOIL RES, V48, P258, DOI 10.1071/SR09122; Li XZ, 2014, SOIL BIOL BIOCHEM, V68, P392, DOI 10.1016/j.soilbio.2013.10.017; Liu EK, 2010, GEODERMA, V158, P173, DOI 10.1016/j.geoderma.2010.04.029; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; Mandal A, 2007, BIORESOURCE TECHNOL, V98, P3585, DOI 10.1016/j.biortech.2006.11.027; McCaig AE, 2001, FEMS MICROBIOL ECOL, V35, P37, DOI 10.1111/j.1574-6941.2001.tb00786.x; Paul EA., 2006, SOIL MICROBIOLOGY EC, V3rd; Pengthamkeerati P, 2011, APPL SOIL ECOL, V48, P71, DOI 10.1016/j.apsoil.2011.01.005; Philippot L, 2011, GLOBAL CHANGE BIOL, V17, P1497, DOI 10.1111/j.1365-2486.2010.02334.x; Qiu MH, 2012, BIOL FERT SOILS, V48, P807, DOI 10.1007/s00374-012-0675-4; Saha S, 2008, EUR J SOIL BIOL, V44, P309, DOI 10.1016/j.ejsobi.2008.02.004; Stark CH, 2008, SOIL BIOL BIOCHEM, V40, P1352, DOI 10.1016/j.soilbio.2007.09.025; Tilman D, 1998, NATURE, V396, P211, DOI 10.1038/24254; Tu C, 2006, SOIL BIOL BIOCHEM, V38, P247, DOI 10.1016/j.soilbio.2005.05.002; Wang WW, 2011, POL J ECOL, V59, P37; Wardle DA, 1999, SOIL BIOL BIOCHEM, V31, P1707, DOI 10.1016/S0038-0717(99)00090-5; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; Wu T, 2008, MICROB ECOL, V55, P293, DOI 10.1007/s00248-007-9276-4; Xu G.H., 1986, HDB ANAL METHODS SOI; Zhang QC, 2012, APPL SOIL ECOL, V57, P1, DOI 10.1016/j.apsoil.2012.02.012	43	145	152	12	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108555	10.1371/journal.pone.0108555	http://dx.doi.org/10.1371/journal.pone.0108555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302996	Green Submitted, Green Published, gold			2022-12-27	WOS:000343730400016
J	Videnska, P; Rahman, MM; Faldynova, M; Babak, V; Matulova, ME; Prukner-Radovcic, E; Krizek, I; Smole-Mozina, S; Kovac, J; Szmolka, A; Nagy, B; Sedlar, K; Cejkova, D; Rychlik, I				Videnska, Petra; Rahman, Md. Masudur; Faldynova, Marcela; Babak, Vladimir; Matulova, Marta Elsheimer; Prukner-Radovcic, Estella; Krizek, Ivan; Smole-Mozina, Sonja; Kovac, Jasna; Szmolka, Ama; Nagy, Bela; Sedlar, Karel; Cejkova, Darina; Rychlik, Ivan			Characterization of Egg Laying Hen and Broiler Fecal Microbiota in Poultry Farms in Croatia, Czech Republic, Hungary and Slovenia	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE GENES; REAL-TIME PCR; CHICKEN; BACTERIA; TETRACYCLINE; STREPTOMYCIN; ENTERITIDIS; DIVERSITY; COMMUNITY; REVEALS	Poultry meat is the most common protein source of animal origin for humans. However, intensive breeding of animals in confined spaces has led to poultry colonisation by microbiota with a zoonotic potential or encoding antibiotic resistances. In this study we were therefore interested in the prevalence of selected antibiotic resistance genes and microbiota composition in feces of egg laying hens and broilers originating from 4 different Central European countries determined by real-time PCR and 16S rRNA gene pyrosequencing, respectively. strA gene was present in 1 out of 10,000 bacteria. The prevalence of sul1, sul2 and tet(B) in poultry microbiota was approx. 6 times lower than that of the strA gene. tet(A) and cat were the least prevalent being present in around 3 out of 10,000,000 bacteria forming fecal microbiome. The core chicken fecal microbiota was formed by 26 different families. Rather unexpectedly, representatives of Desulfovibrionaceae and Campylobacteraceae, both capable of hydrogen utilisation in complex microbial communities, belonged among core microbiota families. Understanding the roles of individual population members in the total metabolism of the complex community may allow for interventions which might result in the replacement of Campylobacteraceae with Desulfovibrionaceae and a reduction of Campylobacter colonisation in broilers, carcasses, and consequently poultry meat products.	[Videnska, Petra; Rahman, Md. Masudur; Faldynova, Marcela; Babak, Vladimir; Matulova, Marta Elsheimer; Cejkova, Darina; Rychlik, Ivan] Vet Res Inst, CS-62132 Brno, Czech Republic; [Prukner-Radovcic, Estella; Krizek, Ivan] Univ Zagreb, Fac Vet Med, Zagreb 41000, Croatia; [Smole-Mozina, Sonja; Kovac, Jasna] Univ Ljubljana, Biotech Fac, Ljubljana, Slovenia; [Szmolka, Ama; Nagy, Bela] Hungarian Acad Sci, Vet Med Res Inst, H-1581 Budapest, Hungary; [Sedlar, Karel] Brno Univ Technol, Dept Biomed Engn, CS-61090 Brno, Czech Republic	Czech Veterinary Research Institute; University of Zagreb; University of Ljubljana; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute; Brno University of Technology	Rychlik, I (corresponding author), Vet Res Inst, CS-62132 Brno, Czech Republic.	rychlik@vri.cz	Szmolka, Ama/Z-4598-2019; Prukner-Radovcic, Estella/AAB-3271-2019; Sedlar, Karel/K-1120-2014; , Ivan/GPS-9674-2022; RAHMAN, MASUDUR M/M-2636-2013; Cejkova, Darina/AAA-5820-2022	Sedlar, Karel/0000-0002-8269-4020; , Ivan/0000-0001-7995-6483; RAHMAN, MASUDUR M/0000-0001-7095-9303; Cejkova, Darina/0000-0002-6989-6330	PROMISE project 7th Framework Programme; AdmireVet project from the Czech Ministry of Education [CZ.1.05/2.1.00/01.0006-ED0006/01/01]; Hungarian Academy of Sciences	PROMISE project 7th Framework Programme; AdmireVet project from the Czech Ministry of Education; Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This study was supported by PROMISE project 7th Framework Programme and AdmireVet project CZ.1.05/2.1.00/01.0006-ED0006/01/01 from the Czech Ministry of Education. A. Szmolka is holder of a Bolyai Janos Stipend from the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjdia A, 2011, J BIOL CHEM, V286, P25973, DOI 10.1074/jbc.M111.228841; Callaway TR, 2009, POULTRY SCI, V88, P298, DOI 10.3382/ps.2008-00222; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cheng WX, 2013, ENVIRON INT, V61, P1, DOI 10.1016/j.envint.2013.08.023; Cressman MD, 2010, APPL ENVIRON MICROB, V76, P6572, DOI 10.1128/AEM.00180-10; Czekalski N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00106; Faldynova M, 2013, VET MED-CZECH, V58, P298, DOI 10.17221/6865-VETMED; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Gerzova L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103865; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Ismail AS, 2009, J IMMUNOL, V182, P3047, DOI 10.4049/jimmunol.0802705; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; Kim T, 2011, METHODS MOL BIOL, V733, P185, DOI 10.1007/978-1-61779-089-8_13; LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185; LILLEHOJ HS, 1993, POULTRY SCI, V72, P1306, DOI 10.3382/ps.0721306; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Nordentoft S, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-187; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Qu A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002945; Rastogi R, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-208; Rey FE, 2013, P NATL ACAD SCI USA, V110, P13582, DOI 10.1073/pnas.1312524110; Sekelja M, 2012, APPL ENVIRON MICROB, V78, P2941, DOI 10.1128/AEM.05391-11; Sergeant MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091941; Stanley D, 2012, VET MICROBIOL, V159, P155, DOI 10.1016/j.vetmic.2012.03.032; Szmolka A, 2012, VET MICROBIOL, V156, P110, DOI 10.1016/j.vetmic.2011.09.030; Tseng CP, 2003, CLIN CHEM, V49, P306, DOI 10.1373/49.2.306; Videnska P, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-140; Videnska P, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-30; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Walsh F, 2011, J MICROBIOL METH, V86, P150, DOI 10.1016/j.mimet.2011.04.011	32	54	55	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110076	10.1371/journal.pone.0110076	http://dx.doi.org/10.1371/journal.pone.0110076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329397	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000343210800053
J	Watanabe, T; Tanigawa, T; Kobata, A; Takeda, S; Nadatani, Y; Otani, K; Yamagami, H; Shiba, M; Tominaga, K; Fujiwara, Y; Arakawa, T				Watanabe, Toshio; Tanigawa, Tetsuya; Kobata, Atsushi; Takeda, Shogo; Nadatani, Yuji; Otani, Koji; Yamagami, Hirokazu; Shiba, Masatsugu; Tominaga, Kazunari; Fujiwara, Yasuhiro; Arakawa, Tetsuo			Toll-Like Receptor 2 Mediates Ischemia-Reperfusion Injury of the Small Intestine in Adult Mice	PLOS ONE			English	Article							GASTRIC-ULCER RECURRENCE; INFLAMMATORY RESPONSES; RAT MODEL; ACTIVATION; EXPRESSION; ACID; INDUCTION; INTEGRITY; PROTECTS; PATHWAY	Toll-like receptor 2 (TLR2) recognizes conserved molecular patterns associated with both gram-negative and gram-positive bacteria, and detects some endogenous ligands. Previous studies demonstrated that in ischemia-reperfusion (I/R) injury of the small intestine, the TLR2-dependent signaling exerted preventive effects on the damage in young mice, but did not have a significant effect in neonatal mice. We investigated the role of TLR2 in adult ischemia-reperfusion injury in the small intestine. Wild-type and TLR2 knockout mice at 16 weeks of age were subjected to intestinal I/R injury. Some wild-type mice received anti-Ly-6G antibodies to deplete circulating neutrophils. In wild-type mice, I/R induced severe small intestinal injury characterized by infiltration by inflammatory cells, disruption of the mucosal epithelium, and mucosal bleeding. Compared to wild-type mice, TLR2 knockout mice exhibited less severe mucosal injury induced by I/R, with a 35%, 33%, and 43% reduction in histological grading score and luminal concentration of hemoglobin, and the numbers of apoptotic epithelial cells, respectively. The I/R increased the activity of myeloperoxidase (MPO), a marker of neutrophil infiltration, and the levels of mRNA expression of tumor necrosis factor-alpha (TNF-alpha), intercellular adhesion molecule-1 (ICAM-1), and cyclooxygenase-2 (COX-2) in the small intestine of the wild-type mice by 3.3-, 3.2-, and 13.0-fold, respectively. TLR2 deficiency significantly inhibited the I/R-induced increase in MPO activity and the expression of mRNAs for TNF-alpha and ICAM-1, but did not affect the expression of COX-2 mRNA. I/R also enhanced TLR2 mRNA expression by 2.9-fold. TLR2 proteins were found to be expressed in the epithelial cells, inflammatory cells, and endothelial cells. Neutrophil depletion prevented intestinal I/R injury in wildtype mice. These findings suggest that TLR2 may mediate I/R injury of the small intestine in adult mice via induction of inflammatory mediators such as TNF-alpha and ICAM-1.	[Watanabe, Toshio; Tanigawa, Tetsuya; Takeda, Shogo; Nadatani, Yuji; Otani, Koji; Yamagami, Hirokazu; Shiba, Masatsugu; Tominaga, Kazunari; Fujiwara, Yasuhiro; Arakawa, Tetsuo] Osaka City Univ, Dept Gastroenterol, Sch Med, Osaka 558, Japan; [Kobata, Atsushi] Kyoto Pharmaceut Univ, Dept Pharmacol & Expt Therapeut, Kyoto 607, Japan	Osaka Metropolitan University; Kyoto Pharmaceutical University	Watanabe, T (corresponding author), Osaka City Univ, Dept Gastroenterol, Sch Med, Osaka 558, Japan.	watanabet@med.osaka-cu.ac.jp	Tanigawa, Tetsuya/J-6131-2019	Tanigawa, Tetsuya/0000-0002-9305-1637				Adlerberth I, 2009, ACTA PAEDIATR, V98, P229, DOI 10.1111/j.1651-2227.2008.01060.x; Aprahamian CJ, 2008, PEDIATR CRIT CARE ME, V9, P105, DOI 10.1097/01.PCC.0000288717.44702.C0; Arslan F, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/704202; Arumugam TV, 2009, SHOCK, V32, P4, DOI 10.1097/SHK.0b013e318193e333; Cario E, 2008, MUCOSAL IMMUNOL, V1, pS62, DOI 10.1038/mi.2008.47; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; Ciorba MA, 2012, GUT, V61, P829, DOI 10.1136/gutjnl-2011-300367; Feinman R, 2010, AM J PHYSIOL-GASTR L, V299, pG833, DOI 10.1152/ajpgi.00065.2010; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Gibson DL, 2008, CELL MICROBIOL, V10, P388, DOI 10.1111/j.1462-5822.2007.01052.x; Goldsmith JR, 2013, AM J PATHOL, V182, P776, DOI 10.1016/j.ajpath.2012.11.021; Hierholzer C, 1999, TRANSPLANTATION, V68, P1244, DOI 10.1097/00007890-199911150-00006; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Ilhan H, 2003, J PEDIATR SURG, V38, P1591, DOI 10.1016/S0022-3468(03)00568-2; Iram N, 2012, DEVELOPMENT, V139, P4210, DOI 10.1242/dev.083477; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lee HT, 2013, AM J PHYSIOL-GASTR L, V304, pG12, DOI 10.1152/ajpgi.00201.2012; Lee IT, 2008, J IMMUNOL, V181, P5098, DOI 10.4049/jimmunol.181.7.5098; Lenaerts K, 2013, CURR OPIN ORGAN TRAN, V18, P298, DOI 10.1097/MOT.0b013e32835ef1eb; Lu C, 2011, J IMMUNOL, V187, P1458, DOI 10.4049/jimmunol.1003428; MAGGI CA, 1986, EXPERIENTIA, V42, P531; MAGGI CA, 1986, EXPERIENTIA, V42, P109, DOI 10.1007/BF01952426; Mallick IH, 2004, DIGEST DIS SCI, V49, P1359, DOI 10.1023/B:DDAS.0000042232.98927.91; Martinez FE, 2000, INFLAMM RES, V49, P727, DOI 10.1007/s000110050653; Matsumoto C, 2012, BIOCHEM BIOPH RES CO, V428, P110, DOI 10.1016/j.bbrc.2012.10.016; Mogami S, 2012, AM J PHYSIOL-GASTR L, V302, pG359, DOI 10.1152/ajpgi.00297.2011; Nadatani Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080130; Nadatani Y, 2012, AM J PATHOL, V181, P98, DOI 10.1016/j.ajpath.2012.03.039; Otani K, 2012, BIOCHEM BIOPH RES CO, V426, P342, DOI 10.1016/j.bbrc.2012.08.080; Piccinini AM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/672395; Pope MR, 2010, MOL IMMUNOL, V48, P356, DOI 10.1016/j.molimm.2010.07.004; Riehl TE, 2012, AM J PHYSIOL-GASTR L, V302, pG309, DOI 10.1152/ajpgi.00248.2011; Roebuck KA, 1999, J LEUKOCYTE BIOL, V66, P876, DOI 10.1002/jlb.66.6.876; Suzuki S, 2010, NEUROGASTROENT MOTIL, V22, P585, DOI 10.1111/j.1365-2982.2009.01444.x; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; Tatum PM, 2010, J PEDIATR SURG, V45, P1246, DOI 10.1016/j.jpedsurg.2010.02.093; Watanabe T, 2008, GUT, V57, P181, DOI 10.1136/gut.2007.125963; Watanabe T, 2004, AM J PHYSIOL-GASTR L, V287, pG919, DOI 10.1152/ajpgi.00372.2003; Watanabe T, 1997, AM J PATHOL, V150, P971; Watanabe T, 2001, GUT, V48, P774, DOI 10.1136/gut.48.6.774; Watanabe T, 2012, AM J PHYSIOL-GASTR L, V303, pG324, DOI 10.1152/ajpgi.00075.2012; Watanabe T, 2009, AM J PHYSIOL-GASTR L, V297, pG506, DOI 10.1152/ajpgi.90553.2008; Wilhelmsen K, 2012, INNATE IMMUN-LONDON, V18, P602, DOI 10.1177/1753425911429336; Yuan ZH, 2013, J IMMUNOL, V191, P3810, DOI 10.4049/jimmunol.1300883; Zheng L, 2009, GASTROENTEROLOGY, V137, P2041, DOI 10.1053/j.gastro.2009.08.055; Zhong X, 2012, BIOCHEM BIOPH RES CO, V425, P401, DOI 10.1016/j.bbrc.2012.07.110	46	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110441	10.1371/journal.pone.0110441	http://dx.doi.org/10.1371/journal.pone.0110441			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329155	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210800086
J	Cho, FN; Chang, TH; Shu, CW; Ko, MC; Liao, SK; Wu, KH; Yu, MS; Lin, SJ; Hong, YC; Chen, CH; Hung, CH; Chang, YH				Cho, Fu-Nan; Chang, Tsung-Hsien; Shu, Chih-Wen; Ko, Ming-Chin; Liao, Shuen-Kuei; Wu, Kang-Hsi; Yu, Ming-Sun; Lin, Shyh-Jer; Hong, Ying-Chung; Chen, Chien-Hsun; Hung, Chien-Hui; Chang, Yu-Hsiang			Enhanced Cytotoxicity of Natural Killer Cells following the Acquisition of Chimeric Antigen Receptors through Trogocytosis	PLOS ONE			English	Article							T-CELLS; RESIDUAL DISEASE; IMMUNE SYNAPSE; NKG2D; ACTIVATION; PROTEINS; LEUKEMIA	Natural killer (NK) cells have the capacity to target tumors and are ideal candidates for immunotherapy. Viral vectors have been used to genetically modify in vitro expanded NK cells to express chimeric antigen receptors (CARs), which confer cytotoxicity against tumors. However, use of viral transduction methods raises the safety concern of viral integration into the NK cell genome. In this study, we used trogocytosis as a non-viral method to modify NK cells for immunotherapy. A K562 cell line expressing high levels of anti-CD19 CARs was generated as a donor cell to transfer the anti-CD19 CARs onto NK cells via trogocytosis. Anti-CD19 CAR expression was observed in expanded NK cells after these cells were co-cultured for one hour with freeze/thaw-treated donor cells expressing anti-CD19 CARs. Immunofluorescence analysis confirmed the localization of the anti-CD19 CARs on the NK cell surface. Acquisition of anti-CD19 CARs via trogocytosis enhanced NK cell-mediated cytotoxicity against the B-cell acute lymphoblastic leukemia (B-ALL) cell lines and primary B-ALL cells derived from patients. To our knowledge, this is the first report that describes the increased cytotoxicity of NK cells following the acquisition of CARs via trogocytosis. This novel strategy could be a potential valuable therapeutic approach for the treatment of B-cell tumors.	[Cho, Fu-Nan] Kaohsiung Vet Gen Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan; [Chang, Tsung-Hsien; Shu, Chih-Wen] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan; [Ko, Ming-Chin; Hung, Chien-Hui; Chang, Yu-Hsiang] Kaohsiung Vet Gen Hosp, Dept Pediat, Kaohsiung, Taiwan; [Liao, Shuen-Kuei] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Liao, Shuen-Kuei] Taipei Med Univ, Ctr Excellence Canc Res, Taipei, Taiwan; [Wu, Kang-Hsi] China Med Univ Hosp, Childrens Hosp, Dept Pediat, Taichung, Taiwan; [Wu, Kang-Hsi] China Med Univ Hosp, Sch Chinese Med, Taichung, Taiwan; [Yu, Ming-Sun; Lin, Shyh-Jer; Hong, Ying-Chung] Kaohsiung Vet Gen Hosp, Dept Med, Haematol Oncol Sect, Kaohsiung, Taiwan; [Chen, Chien-Hsun] Kaohsiung Vet Gen Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan; [Chang, Yu-Hsiang] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan; [Chang, Yu-Hsiang] Tajen Univ, Dept Nursing, Yanpu Township, Pingtung County, Taiwan	Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; Taipei Medical University; Taipei Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University	Chang, YH (corresponding author), Kaohsiung Vet Gen Hosp, Dept Pediat, Kaohsiung, Taiwan.	yhchang@vghks.gov.tw	Shu, Chih-Wen/AAE-9652-2019; Chang, Tsung-Hsien/AAG-9384-2019	Chang, Tsung-Hsien/0000-0003-4806-7864; Yu, Ming-Sun/0000-0002-7548-4279; Shu, Chih-Wen/0000-0002-7774-0002	National Health Research Institutes [PS9808]; Kaohsiung Veterans General Hospital [VGHKS 102-104, 103-123]; Ministry of Health and Welfare of Taiwan [MOHW103-TD-B-111-01]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan); Kaohsiung Veterans General Hospital; Ministry of Health and Welfare of Taiwan	This study was supported by grants from National Health Research Institutes (PS9808, http://english.nhri.org.tw/NHRI_WEB/nhriw001Action.do), and Kaohsiung Veterans General Hospital (VGHKS 102-104 and 103-123, http://www.vghks.gov.tw/English/) to YHC. This work is also supported in part by the Ministry of Health and Welfare of Taiwan (MOHW103-TD-B-111-01), http://www.mohw.gov.tw/EN/Ministry/Index.aspx) to SKL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altvater B, 2009, CLIN CANCER RES, V15, P4857, DOI 10.1158/1078-0432.CCR-08-2810; Bene MC, 2009, HAEMATOL-HEMATOL J, V94, P1135, DOI 10.3324/haematol.2008.004267; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Carlin LM, 2001, J EXP MED, V194, P1507, DOI 10.1084/jem.194.10.1507; Caumartin J, 2006, TRANSPL IMMUNOL, V17, P20, DOI 10.1016/j.trim.2006.09.032; Caumartin J, 2007, EMBO J, V26, P1423, DOI 10.1038/sj.emboj.7601570; Chang YH, 2013, CANCER RES, V73, P1777, DOI 10.1158/0008-5472.CAN-12-3558; Denman CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030264; Domaica CI, 2009, EMBO REP, V10, P908, DOI 10.1038/embor.2009.92; Fujisaki H, 2009, CANC RES; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Imai C, 2005, BLOOD, V106, P376, DOI 10.1182/blood-2004-12-4797; Imai C, 2004, LEUKEMIA, V18, P676, DOI 10.1038/sj.leu.2403302; Lapteva N, 2012, CYTOTHERAPY, V14, P1131, DOI 10.3109/14653249.2012.700767; Li L, 2009, CANC GENE THER; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; Luchetti F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035766; MANABE A, 1994, BLOOD, V83, P1731, DOI 10.1182/blood.V83.7.1731.bloodjournal8371731; Marcenaro E, 2009, BLOOD, V114, P4108, DOI 10.1182/blood-2009-05-222265; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Poupot M, 2008, J LEUKOCYTE BIOL, V84, P1298, DOI 10.1189/jlb.0508278; Rawstron AC, 2007, LEUKEMIA, V21, P956, DOI 10.1038/sj.leu.2404584; Rechavi O, 2009, FEBS LETT, V583, P1792, DOI 10.1016/j.febslet.2009.03.014; Roda-Navarro P, 2007, FASEB J, V21, P1636, DOI 10.1096/fj.06-7488rev; Roda-Navarro P, 2006, P NATL ACAD SCI USA, V103, P11258, DOI 10.1073/pnas.0600721103; Sadelain M, 2009, CURR OPIN IMMUNOL, V21, P215, DOI 10.1016/j.coi.2009.02.009; Shimasaki N, 2012, CYTOTHERAPY, V14, P830, DOI 10.3109/14653249.2012.671519; Somanchi SS, 2012, BLOOD, V119, P5164, DOI 10.1182/blood-2011-11-389924; Williams GS, 2007, TRAFFIC, V8, P1190, DOI 10.1111/j.1600-0854.2007.00603.x; Wu KH, 2013, TRANSPLANTATION, V95, P773, DOI 10.1097/TP.0b013e31827a93dd	33	29	31	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109352	10.1371/journal.pone.0109352	http://dx.doi.org/10.1371/journal.pone.0109352			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313995	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662500034
J	Gonzalez-Vicente, A; Cabral, PD; Garvin, JL				Gonzalez-Vicente, Agustin; Cabral, Pablo D.; Garvin, Jeffrey L.			Resveratrol Increases Nitric Oxide Production in the Rat Thick Ascending Limb via Ca2+/Calmodulin	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; CIS-RESVERATROL; L-ARGININE; TRANS-RESVERATROL; CARDIAC-HYPERTROPHY; HYPERTENSIVE-RATS; OXIDATIVE STRESS; RED WINE; PREVENTS; ENOS	The thick ascending limb of the loop of Henle reabsorbs 30% of the NaCl filtered through the glomerulus. Nitric oxide (NO) produced by NO synthase 3 (NOS3) inhibits NaCl absorption by this segment. Resveratrol, a polyphenol, has beneficial cardiovascular and renal effects, many of which are mediated by NO. Resveratrol increases intracellular Ca2+ (Ca-i) and AMP kinase (AMPK) and NAD-dependent deacetylase sirtuin1 (SIRT1) activities, all of which could activate NO production. We hypothesized that resveratrol stimulates NO production by thick ascending limbs via a Ca2+/calmodulin-dependent mechanism. To test this, the effect of resveratrol on NO bioavailability was measured in thick ascending limb suspensions. Ca-i was measured in single perfused thick ascending limbs. SIRT1 activity and expression were measured in thick ascending limb lysates. Resveratrol (100 mu M) increased NO bioavailability in thick ascending limb suspensions by 1.3 +/- 0.2 AFU/mg/min (p < 0.03). The NOS inhibitor L-NAME blunted resveratrol-stimulated NO bioavailability by 96 +/- 11% (p < 0.03). The superoxide scavenger tempol had no effect. Resveratrol elevated Cai from 48 +/- 7 to 135 +/- 24 nM (p < 0.01) in single tubules. In Ca2+-free media, the resveratrol-induced increase in NO was blunted by 60 +/- 20% (p < 0.05) and the rise in Ca-i reduced by 80%. Calmodulin inhibition prevented the resveratrol-induced increase in NO (p < 0.002). AMPK inhibition had no effect. Resveratrol did not increase SIRT1 activity. We conclude that resveratrol increases NO production in thick ascending limbs via a Ca2+/calmodulin dependent mechanism, and SIRT1 and AMPK do not participate. Resveratrol-stimulated NO production in thick ascending limbs may account for part of its beneficial effects.	[Gonzalez-Vicente, Agustin; Cabral, Pablo D.; Garvin, Jeffrey L.] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Gonzalez-Vicente, Agustin] Univ Buenos Aires, Fac Farm & Bioquim, RA-1113 Buenos Aires, DF, Argentina; [Cabral, Pablo D.] Univ Buenos Aires, Fac Med, Buenos Aires, DF, Argentina; [Garvin, Jeffrey L.] Henry Ford Hosp, Dept Internal Med, Detroit, MI 48202 USA	Case Western Reserve University; University of Buenos Aires; University of Buenos Aires; Henry Ford Health System; Henry Ford Hospital	Garvin, JL (corresponding author), Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	jeffrey.garvin@case.edu	Gonzalez-Vicente, Agustin/K-2773-2018	Gonzalez-Vicente, Agustin/0000-0002-3682-0815	 [HL 07985];  [13POST16280001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL007985] Funding Source: NIH RePORTER	; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by Grant 1: HL 07985, http://www.nih.gov/, and Grant 2: 13POST16280001, http://my.americanheart.org/professional/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arunachalam G, 2010, BIOCHEM BIOPH RES CO, V393, P66, DOI 10.1016/j.bbrc.2010.01.080; Bertelli AAE, 1996, INT J CLIN PHARM RES, V16, P77; Bertelli AAE, 2002, ANN NY ACAD SCI, V957, P230, DOI 10.1111/j.1749-6632.2002.tb02919.x; Bertelli AAE, 1998, DRUG EXP CLIN RES, V24, P51; Bhatt JK, 2012, NUTR RES, V32, P537, DOI 10.1016/j.nutres.2012.06.003; Bhatt SR, 2011, EUR J PHARMACOL, V667, P258, DOI 10.1016/j.ejphar.2011.05.026; Cabral PD, 2012, AM J PHYSIOL-RENAL, V303, pF194, DOI 10.1152/ajprenal.00504.2011; Cabral PD, 2010, AM J PHYSIOL-RENAL, V299, pF1185, DOI 10.1152/ajprenal.00112.2010; Campos-Toimil M, 2007, EUR J PHARMACOL, V577, P91, DOI 10.1016/j.ejphar.2007.08.003; Carnpos-Toimll M, 2005, MOL NUTR FOOD RES, V49, P396, DOI 10.1002/mnfr.200400108; Catalgol B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00141; Chander V, 2006, ARCH MED RES, V37, P19, DOI 10.1016/j.arcmed.2005.05.018; Chander V, 2005, J VASC SURG, V42, P1198, DOI 10.1016/j.jvs.2005.08.032; Chang HT, 2013, J RECEPT SIG TRANSD, V33, P298, DOI 10.3109/10799893.2013.822886; CHEN PY, 1991, J CLIN INVEST, V88, P1559, DOI 10.1172/JCI115467; Csiszar A, 2009, AM J PHYSIOL-HEART C, V297, pH13, DOI 10.1152/ajpheart.00368.2009; Di Paola-Naranjo RD, 2011, J AGR FOOD CHEM, V59, P7854, DOI 10.1021/jf2007419; Ding DF, 2010, AM J NEPHROL, V31, P363, DOI 10.1159/000300388; Do Amaral CL, 2008, ARCH TOXICOL, V82, P363, DOI 10.1007/s00204-007-0262-x; Dolinsky VW, 2013, BBA-MOL BASIS DIS, V1832, P1723, DOI 10.1016/j.bbadis.2013.05.018; Dolinsky VW, 2009, CIRCULATION, V119, P1643, DOI 10.1161/CIRCULATIONAHA.108.787440; El-Mohsen MA, 2006, BRIT J NUTR, V96, P62, DOI 10.1079/BJN20061810; Elesgaray R, 2008, REGUL PEPTIDES, V151, P130, DOI 10.1016/j.regpep.2008.05.008; Elies J, 2011, MOL NUTR FOOD RES, V55, P1237, DOI 10.1002/mnfr.201100240; Juan ME, 2010, J PHARMACEUT BIOMED, V51, P391, DOI 10.1016/j.jpba.2009.03.026; Farci P, 2010, P NATL ACAD SCI USA, V107, P8766, DOI [10.1073/pnas.1003854107, 10.1073/pnas.1003833107]; Padin JF, 2012, EUR J PHARMACOL, V685, P99, DOI 10.1016/j.ejphar.2012.03.040; Fleming I, 2010, PFLUG ARCH EUR J PHY, V459, P793, DOI 10.1007/s00424-009-0767-7; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Ford RJ, 2011, AM J PHYSIOL-HEART C, V300, pH64, DOI 10.1152/ajpheart.00597.2010; Galletti P, 2005, NEPHROL DIAL TRANSPL, V20, P1551, DOI 10.1093/ndt/gfh846; Giovannini L, 2001, J CARDIOVASC PHARM, V37, P262, DOI 10.1097/00005344-200103000-00004; Gonzalez-Vicente A, 2013, AM J PHYSIOL-RENAL, V305, pF1306, DOI 10.1152/ajprenal.00064.2013; Gordish KL, 2014, AM J PHYSIOL-RENAL, V306, pF542, DOI 10.1152/ajprenal.00437.2013; Herrera M, 2005, HYPERTENSION, V45, P1062, DOI 10.1161/01.HYP.0000159760.88697.1e; Hong NJ, 2012, HYPERTENSION, V60, P765, DOI 10.1161/HYPERTENSIONAHA.112.199216; Inanaga K, 2009, HYPERTENS RES, V32, P466, DOI 10.1038/hr.2009.47; Kim MY, 2013, DIABETOLOGIA, V56, P204, DOI 10.1007/s00125-012-2747-2; Kurus M, 2009, TOXICOL IND HEALTH, V25, P539, DOI 10.1177/0748233709346755; Li HF, 2006, PHYSIOL RES, V55, P365, DOI 10.33549/physiolres.930826; Li HG, 2012, NITRIC OXIDE-BIOL CH, V26, P102, DOI 10.1016/j.niox.2011.12.006; Li W, 2013, CURR MED CHEM, V20, P4185; Massey KJ, 2012, AM J PHYSIOL-CELL PH, V303, pC781, DOI 10.1152/ajpcell.00457.2011; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Miyata N, 1999, HYPERTENSION, V33, P446, DOI 10.1161/01.HYP.33.1.446; Mizutani K, 2001, CLIN EXP PHARMACOL P, V28, P55, DOI 10.1046/j.1440-1681.2001.03415.x; Movahed A, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/851267; Nicholson SK, 2008, P NUTR SOC, V67, P42, DOI 10.1017/S0029665108006009; Nihei T, 2001, LIFE SCI, V68, P2845, DOI 10.1016/S0024-3205(01)01061-X; Orallo F, 2006, CURR MED CHEM, V13, P87, DOI 10.2174/092986706775197953; Orallo F, 2002, MOL PHARMACOL, V61, P294, DOI 10.1124/mol.61.2.294; Ortiz PA, 2003, HYPERTENSION, V42, P674, DOI 10.1161/01.HYP.0000085561.00001.81; Palsamy P, 2011, BBA-MOL BASIS DIS, V1812, P719, DOI 10.1016/j.bbadis.2011.03.008; Perez-Rojas JM, 2010, AM J PHYSIOL-REG I, V298, pR1050, DOI 10.1152/ajpregu.00181.2009; Plato CF, 2000, HYPERTENSION, V35, P319, DOI 10.1161/01.HYP.35.1.319; Rimbaud S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026391; Rius C, 2010, J IMMUNOL, V185, P3718, DOI 10.4049/jimmunol.1001043; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Rush JWE, 2007, EXP BIOL MED, V232, P814; Schmitt CA, 2010, BIOFACTORS, V36, P342, DOI 10.1002/biof.109; Thandapilly SJ, 2010, AM J HYPERTENS, V23, P192, DOI 10.1038/ajh.2009.228; Wallerath T, 2002, CIRCULATION, V106, P1652, DOI 10.1161/01.CIR.0000029925.18593.5C; Xiang LM, 2014, FOOD CHEM, V156, P258, DOI 10.1016/j.foodchem.2014.01.006; Xu Q, 2009, BIOCHEM BIOPH RES CO, V388, P389, DOI 10.1016/j.bbrc.2009.08.021; Yar AS, 2010, MOL BIOL REP, V37, P2323, DOI 10.1007/s11033-009-9737-6	65	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110487	10.1371/journal.pone.0110487	http://dx.doi.org/10.1371/journal.pone.0110487			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314136	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500116
J	Lohiniva, AL; Barakat, A; Dueger, E; Restrepo, S; El Aouad, R				Lohiniva, Anna-Leena; Barakat, Amal; Dueger, Erica; Restrepo, Suzanne; El Aouad, Rajae			A Qualitative Study of Vaccine Acceptability and Decision Making among Pregnant Women in Morocco during the A (H1N1) pdm09 Pandemic	PLOS ONE			English	Article							INFLUENZA VACCINE; PERCEPTIONS; ACCEPTANCE; KNOWLEDGE; RISK	Vaccination uptake of pregnant women in Morocco during the A (H1N1) pdm09 pandemic was lower than expected. A qualitative study using open-ended questions was developed to explore the main determinants of acceptance and nonacceptance of the monovalent A (H1N1) pdm09 vaccine among pregnant women in Morocco and to identify information sources that influenced their decision-making process. The study sample included 123 vaccinated and unvaccinated pregnant women who were in their second or third trimester between December 2009 and March 2010. They took part in 14 focus group discussions and eight in-depth interviews in the districts of Casablanca and Kenitra. Thematic qualitative analysis identified reasons for vaccine non-acceptance: (1) fear of the monovalent A (H1N1) pdm09 vaccine, (2) belief in an A (H1N1) pdm09 pandemic conspiracy, (3) belief in the inapplicability of the monovalent A (H1N1) pdm09 vaccine to Moroccans, (4) lack of knowledge of the monovalent A (H1N1) pdm09 vaccine, and (5) challenges of vaccination services/logistics. Reasons for vaccine acceptance included: (1) perceived benefits and (2) modeling. Decision-making was strongly influenced by family, community, mass media, religious leaders and health providers suggesting that broad communication efforts should also be used to advocate for vaccination. Meaningful communication for future vaccine campaigns must consider these context-specific findings. As cultural and religious values are shared across many Arab countries, these findings may also provide valuable insights for seasonal influenza vaccine planning in the Middle East and North Africa region at large.	[Lohiniva, Anna-Leena; Dueger, Erica; Restrepo, Suzanne] US Naval Med Res Unit 3, Global Dis Detect Ctr Egypt, Cairo, Egypt; [Barakat, Amal; El Aouad, Rajae] Minist Hlth, Natl Inst Hyg, Ctr Natl Reference Grippe, Rabat, Morocco; [Dueger, Erica] Ctr Dis Control & Prevent, Atlanta, GA USA	Naval Medical Research Center (NMRC); Naval Medical Research Unit - No. 3 (NAMRU-3); Centers for Disease Control & Prevention - USA	Lohiniva, AL (corresponding author), US Naval Med Res Unit 3, Global Dis Detect Ctr Egypt, Cairo, Egypt.	anna.leena.lohiniva@hotmail.com		EL AOUAD, Rajae/0000-0002-2686-6924; Lohiniva, Anna-Leena/0000-0003-3169-5872	Centers for Disease Control and Prevention Influenza Division	Centers for Disease Control and Prevention Influenza Division	This study was funded by the Centers for Disease Control and Prevention Influenza Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhaskar E, 2012, LUNG INDIA, V29, P232, DOI 10.4103/0970-2113.99105; Bish A, 2011, VACCINE, V29, P6472, DOI 10.1016/j.vaccine.2011.06.107; Brown V, 2006, QUAL RES PSYCHOL, V3, P77, DOI DOI 10.1191/1478088706QP063OA; Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947; d'Alessandro E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034054; Davis MM, 2002, J GEN INTERN MED, V17, P670, DOI 10.1046/j.1525-1497.2002.11040.x; Dlugacz Y, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.027; Drees M, 2012, AM J PERINAT, V29, P289, DOI 10.1055/s-0031-1295660; Eppes C, 2012, VACCINE, V30, P5782, DOI 10.1016/j.vaccine.2012.06.032; Fabry P, 2011, VACCINE, V29, P1824, DOI 10.1016/j.vaccine.2010.12.109; Fisher BM, 2011, AM J OBSTET GYNECOL, V204, pS107, DOI 10.1016/j.ajog.2011.02.041; Fridman D, 2011, AM J OBSTET GYNECOL, V204, pS124, DOI 10.1016/j.ajog.2011.04.011; Goldfarb I, 2011, AM J OBSTET GYNECOL, V204, pS112, DOI 10.1016/j.ajog.2011.01.007; Hewagama S, 2010, CLIN INFECT DIS, V50, P686, DOI 10.1086/650460; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Liao QY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017713; Lynch MM, 2012, MATERN CHILD HLTH J, V16, P1657, DOI 10.1007/s10995-011-0865-y; Mirdamadi K, 2011, CAN FAM PHYSICIAN, V57, P1003; Myers LB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-15; Naleway AL, 2007, AM J EPIDEMIOL, V165, P352, DOI 10.1093/aje/kwk104; Nguyen Trang, 2011, Infect Drug Resist, V4, P197, DOI 10.2147/IDR.S23174; Nichol KL, 2001, ARCH INTERN MED, V161, P2702, DOI 10.1001/archinte.161.22.2702; Ozer A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014177; Rodriguez-Rieiro C, 2011, VACCINE, V29, P1332, DOI 10.1016/j.vaccine.2010.10.061; Sakaguchi S, 2011, J OBSTET GYNAECOL CA, V33, P460, DOI 10.1016/S1701-2163(16)34879-4; Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99; Sim JA, 2011, PUBLIC HEALTH, V125, P505, DOI 10.1016/j.puhe.2011.05.005; Sinuff T, 2007, J CRIT CARE, V22, P104, DOI 10.1016/j.jcrc.2007.03.001; SteelFisher Gillian K, 2010, N Engl J Med, V362, pe65, DOI 10.1056/NEJMp1005102; Tamma PD, 2009, AM J OBSTET GYNECOL, V201, P547, DOI 10.1016/j.ajog.2009.09.034; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; White SW, 2010, MED J AUSTRALIA, V193, P405, DOI 10.5694/j.1326-5377.2010.tb03970.x; World Health Organization, WHO REC PAND H1N1 20; Young ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003552; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	35	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e96244	10.1371/journal.pone.0096244	http://dx.doi.org/10.1371/journal.pone.0096244			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313555	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500001
J	Petkeviciene, J; Klumbiene, J; Simonyte, S; Ceponiene, I; Jureniene, K; Kriaucioniene, V; Raskiliene, A; Smalinskiene, A; Lesauskaite, V				Petkeviciene, Janina; Klumbiene, Jurate; Simonyte, Sandrita; Ceponiene, Indre; Jureniene, Kristina; Kriaucioniene, Vilma; Raskiliene, Asta; Smalinskiene, Alina; Lesauskaite, Vaiva			Physical, Behavioural and Genetic Predictors of Adult Hypertension: The Findings of the Kaunas Cardiovascular Risk Cohort Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BLOOD-PRESSURE; ALCOHOL-CONSUMPTION; CHILDHOOD; POPULATION; DISEASE; POLYMORPHISMS; OVERWEIGHT; MORTALITY; OBESITY	Background: The roots of adult hypertension go back to childhood. This study aimed to examine the independent effects of physical, behavioural and genetic factors identified in childhood and mid-adulthood for prediction of adult hypertension. Methods: The study subjects were participants of the Kaunas Cardiovascular Risk Cohort study started in 1977 (n = 1082, age 12-13 years). In 2012, a total of 507 individuals (63.9% of eligible sample) participated in the 35-year follow-up survey. Health examination involved measurements of blood pressure (BP), anthropometric parameters, and interview about health behaviours. Subjects were genotyped for AGT (M235T), ACE (I/D, rs4340), ADM (rs7129220), and CACNB2 (rs12258967) genes polymorphisms. A genetic risk score was calculated as the sum of the number of risk alleles at each of four single nucleotide polymorphisms. Results: AGT TT genotype male carriers had the highest mean values of systolic BP in childhood. In females, ADM genotype AA was associated with the highest values of systolic and diastolic BP, while CACNB2 genotype CC carriers had the highest values of diastolic BP in childhood. Systolic and diastolic BP in childhood, gain in BMI from childhood to adulthood, and risky alcohol consumption predicted hypertension in middle-aged men. In women, genetic risk score together with diastolic BP in childhood and gain in BMI were significant predictors of adult hypertension. The comparison of four nested logistic regression models showed that the prediction of hypertension improved significantly after the addition of BMI gain. Genetic risk score had a relatively weak effect on the improvement of the model performance in women. Conclusions: BP in childhood and the gain in BMI from childhood to adulthood were significant predictors of adult hypertension in both genders. Genetic risk score in women and risky alcohol consumption in men were independently related with the risk of adult hypertension.	[Petkeviciene, Janina; Klumbiene, Jurate; Kriaucioniene, Vilma; Raskiliene, Asta] Lithuanian Univ Hlth Sci, Med Acad, Fac Publ Hlth, Kaunas, Lithuania; [Simonyte, Sandrita] Lithuanian Univ Hlth Sci, Inst Microbiol & Virol, Vet Acad, Kaunas, Lithuania; [Ceponiene, Indre] Lithuanian Univ Hlth Sci, Med Acad, Dept Cardiol, Kaunas, Lithuania; [Jureniene, Kristina; Smalinskiene, Alina; Lesauskaite, Vaiva] Lithuanian Univ Hlth Sci, Med Acad, Inst Cardiol, Kaunas, Lithuania	Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; Lithuanian University of Health Sciences	Petkeviciene, J (corresponding author), Lithuanian Univ Hlth Sci, Med Acad, Fac Publ Hlth, Kaunas, Lithuania.	janina.petkeviciene@lsmuni.lt	Kriaucioniene, Vilma/AAW-5543-2020	Kriaucioniene, Vilma/0000-0001-5269-2895; Lesauskaite, Vaiva/0000-0003-2736-3111; Ceponiene, Indre/0000-0003-1975-8412	Research Council of Lithuania for National Research Programme "Chronic Noncommunicable Diseases'' [LIG-12019]	Research Council of Lithuania for National Research Programme "Chronic Noncommunicable Diseases''(Research Council of Lithuania (LMTLT))	The study was supported by a research grant from the Research Council of Lithuania for National Research Programme "Chronic Noncommunicable Diseases'' (LIG-12019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm-Larsen B, 2000, ARTERIOSCL THROM VAS, V20, P484, DOI 10.1161/01.ATV.20.2.484; Bunton DC, 2004, PHARMACOL THERAPEUT, V103, P179, DOI 10.1016/j.pharmthera.2004.07.002; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Carnethon MR, 2010, HYPERTENSION, V56, P49, DOI 10.1161/HYPERTENSIONAHA.109.147603; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cornelissen VA, 2005, HYPERTENSION, V46, P667, DOI 10.1161/01.HYP.0000184225.05629.51; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Ehret GB, 2013, EUR HEART J, V34, P951, DOI 10.1093/eurheartj/ehs455; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Field AE, 2005, OBES RES, V13, P163, DOI 10.1038/oby.2005.21; Frisoli TM, 2011, EUR HEART J, V32, P3081, DOI 10.1093/eurheartj/ehr379; Grabauskas V, 2013, HLTH BEHAV LITHUANIA; Grabauskas V, 2008, MEDICINA-LITHUANIA, V44, P633, DOI 10.3390/medicina44080082; He QF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075870; Ji LD, 2010, J HYPERTENS, V28, P419, DOI 10.1097/HJH.0b013e32833456b9; Juhola J, 2012, CIRCULATION, V126, P402, DOI 10.1161/CIRCULATIONAHA.111.085977; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Kim DH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059316, 10.1371/journal.pone.0070684]; Klatsky AL, 2008, J AM SOC HYPERTENS, V2, P307, DOI 10.1016/j.jash.2008.03.010; Klumbiene J, 2000, J HYPERTENS, V18, P531, DOI 10.1097/00004872-200018050-00004; Klumbiene J, 2012, SCI WORLD J, DOI 10.1100/2012/615183; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li L, 2007, J HYPERTENS, V25, P1215, DOI 10.1097/HJH.0b013e3280f3c01a; Lloyd LJ, 2010, INT J OBESITY, V34, P18, DOI 10.1038/ijo.2009.61; Mayer NJ, 2002, J CLIN PATHOL-MOL PA, V55, P29, DOI 10.1136/mp.55.1.29; Mendis S., 2011, GLOB ATL CARD DIS PR; Moreira LB, 1998, J HYPERTENS, V16, P175, DOI 10.1097/00004872-199816020-00007; O'Donnell CJ, 1998, CIRCULATION, V97, P1766, DOI 10.1161/01.CIR.97.18.1766; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pereira AC, 2003, HYPERTENSION, V41, P25, DOI 10.1161/01.HYP.0000047465.97065.15; Radisauskas R, 2011, ALCOHOL ALCOHOLISM, V46, P614, DOI 10.1093/alcalc/agr068; Reklaitiene R, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-68; Rosito GA, 1999, AM J HYPERTENS, V12, P236; Sesso HD, 2008, HYPERTENSION, V51, P1080, DOI 10.1161/HYPERTENSIONAHA.107.104968; Sethi AA, 2001, HYPERTENSION, V37, P875, DOI 10.1161/01.HYP.37.3.875; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; Sun SS, 2007, PEDIATRICS, V119, P237, DOI 10.1542/peds.2006-2543; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; WHO, 2012, GUID SOD INT AD CHIL	40	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109974	10.1371/journal.pone.0109974	http://dx.doi.org/10.1371/journal.pone.0109974			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313554	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500091
J	Baitharu, I; Jain, V; Deep, SN; Shroff, S; Sahu, JK; Naik, PK; Ilavazhagan, G				Baitharu, Iswar; Jain, Vishal; Deep, Satya Narayan; Shroff, Sabita; Sahu, Jayanta Kumar; Naik, Pradeep Kumar; Ilavazhagan, Govindasamy			Withanolide A Prevents Neurodegeneration by Modulating Hippocampal Glutathione Biosynthesis during Hypoxia	PLOS ONE			English	Article							INDUCED MEMORY IMPAIRMENT; SOMNIFERA ROOT EXTRACT; HYPOBARIC HYPOXIA; WITHANIA-SOMNIFERA; OXIDATIVE STRESS; LIPID-PEROXIDATION; BRAIN GLUTATHIONE; NITRIC-OXIDE; S-NITROSOGLUTATHIONE; CELL-DAMAGE	Withania somnifera root extract has been used traditionally in ayurvedic system of medicine as a memory enhancer. Present study explores the ameliorative effect of withanolide A, a major component of withania root extract and its molecular mechanism against hypoxia induced memory impairment. Withanolide A was administered to male Sprague Dawley rats before a period of 21 days pre-exposure and during 07 days of exposure to a simulated altitude of 25,000 ft. Glutathione level and glutathione dependent free radicals scavenging enzyme system, ATP, NADPH level, c-glutamylcysteinyl ligase (GCLC) activity and oxidative stress markers were assessed in the hippocampus. Expression of apoptotic marker caspase 3 in hippocampus was investigated by immunohistochemistry. Transcriptional alteration and expression of GCLC and Nuclear factor (erythroid-derived 2)-related factor 2 (Nrf2) were investigated by real time PCR and immunoblotting respectively. Exposure to hypobaric hypoxia decreased reduced glutathione (GSH) level and impaired reduced gluatathione dependent free radical scavenging system in hippocampus resulting in elevated oxidative stress. Supplementation of withanolide A during hypoxic exposure increased GSH level, augmented GSH dependent free radicals scavenging system and decreased the number of caspase and hoescht positive cells in hippocampus. While withanolide A reversed hypoxia mediated neurodegeneration, administration of buthionine sulfoximine along with withanolide A blunted its neuroprotective effects. Exogenous administration of corticosterone suppressed Nrf2 and GCLC expression whereas inhibition of corticosterone synthesis upregulated Nrf2 as well as GCLC. Thus present study infers that withanolide A reduces neurodegeneration by restoring hypoxia induced glutathione depletion in hippocampus. Further, Withanolide A increases glutathione biosynthesis in neuronal cells by upregulating GCLC level through Nrf2 pathway in a corticosterone dependenet manner.	[Baitharu, Iswar; Naik, Pradeep Kumar] Guru Ghasidas Cent Univ, Dept Zool, Bilaspur, Chattishgarh, India; [Baitharu, Iswar; Jain, Vishal; Deep, Satya Narayan] Def Res Dev Org, Def Inst Physiol & Allied Sci, Dept Neurobiol, Delhi, India; [Ilavazhagan, Govindasamy] Hindustan Univ, Dept Res, Madras, Tamil Nadu, India; [Sahu, Jayanta Kumar] Natl Inst Technol, Dept Life Sci, Rourkela, India; [Shroff, Sabita] Sambalpur Univ, Dept Chem, Burla, India	Guru Ghasidas Vishwavidyalaya; Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS); Hindustan Institute of Technology & Science; National Institute of Technology (NIT System); National Institute of Technology Rourkela; Sambalpur University	Ilavazhagan, G (corresponding author), Hindustan Univ, Dept Res, Madras, Tamil Nadu, India.	govindasamyilavazhagan@gmail.com	Baitharu, Iswar/AAM-3530-2021	Baitharu, Iswar/0000-0002-3046-2076	Defense Research Development Organisation	Defense Research Development Organisation	The study was funded by Defense Research Development Organisation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando Daisuke, 2009, Journal of Physiological Anthropology, V28, P211, DOI 10.2114/jpa2.28.211; Anwer T, 2012, ACTA POL PHARM, V69, P1095; BAHRKE MS, 1993, SPORTS MED, V16, P97, DOI 10.2165/00007256-199316020-00003; Bains JS, 1997, BRAIN RES REV, V25, P335, DOI 10.1016/S0165-0173(97)00045-3; Baitharu I, 2013, J BEHAV BRAIN SCI, V3, P591, DOI 10.4236/jbbs.2013.38063; Baitharu I, 2013, J ETHNOPHARMACOL, V145, P431, DOI 10.1016/j.jep.2012.10.063; Baitharu I, 2013, BEHAV BRAIN RES, V240, P76, DOI 10.1016/j.bbr.2012.11.005; Baitharu I, 2012, BEHAV BRAIN RES, V228, P53, DOI 10.1016/j.bbr.2011.11.030; Barhwal K, 2009, NEUROBIOL DIS, V34, P230, DOI 10.1016/j.nbd.2009.01.008; Barker JE, 1996, BRAIN RES, V716, P118, DOI 10.1016/0006-8993(96)00003-0; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bhatnagar M, 2009, NEUROCHEM RES, V34, P1975, DOI 10.1007/s11064-009-9987-7; Bhattacharya A, 2001, J ETHNOPHARMACOL, V74, P1, DOI 10.1016/S0378-8741(00)00309-3; BLUM J, 1985, ARCH BIOCHEM BIOPHYS, V240, P500, DOI 10.1016/0003-9861(85)90056-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Choy KHC, 2010, EUR J PHARMACOL, V649, P224, DOI 10.1016/j.ejphar.2010.09.035; CLANCY RM, 1994, P NATL ACAD SCI USA, V91, P3680, DOI 10.1073/pnas.91.9.3680; Colado MI, 1997, BRIT J PHARMACOL, V121, P889, DOI 10.1038/sj.bjp.0701213; Cooper AJL, 1997, BIOL CHEM, V378, P793; CORNFORD EM, 1978, ENDOCRINOLOGY, V103, P1297, DOI 10.1210/endo-103-4-1297; DAS NP, 1987, BIOCHEM MED METAB B, V37, P258, DOI 10.1016/0885-4505(87)90035-1; Dhuley JN, 1998, J ETHNOPHARMACOL, V60, P173, DOI 10.1016/S0378-8741(97)00151-7; Dringen R, 2000, EUR J BIOCHEM, V267, P4903, DOI 10.1046/j.1432-1327.2000.01651.x; FERRARI R, 1991, AM J MED, V91, pS95, DOI 10.1016/0002-9343(91)90291-5; Garcia-Ruiz C, 2007, J GASTROEN HEPATOL, V22, pS38, DOI 10.1111/j.1440-1746.2006.04644.x; Giustarini D, 2004, J CELL MOL MED, V8, P201, DOI 10.1111/j.1582-4934.2004.tb00275.x; Gupta A, 2000, MOL CELL BIOCHEM, V209, P55, DOI 10.1023/A:1007000430394; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Hota SK, 2007, NEUROCHEM INT, V51, P384, DOI 10.1016/j.neuint.2007.04.003; Hota SK, 2009, NEUROBIOL DIS, V34, P23, DOI 10.1016/j.nbd.2008.12.006; Hussain S, 1996, NEUROCHEM INT, V29, P145, DOI 10.1016/0197-0186(95)00114-X; Janaky R, 1999, J NEUROCHEM, V73, P889, DOI 10.1046/j.1471-4159.1999.0730889.x; Jayalakshmi K, 2007, PHYSIOL BEHAV, V92, P643, DOI 10.1016/j.physbeh.2007.05.051; Kannan R, 1996, J BIOL CHEM, V271, P9754, DOI 10.1074/jbc.271.16.9754; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Ki SH, 2005, MOL CELL BIOL, V25, P4150, DOI 10.1128/MCB.25.10.4150-4165.2005; Kim JY, 2006, ENDOCRINOLOGY, V147, P1357, DOI 10.1210/en.2005-0895; Kratschmar DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036774; Kuboyama T, 2002, NEUROREPORT, V13, P1715, DOI 10.1097/00001756-200210070-00005; LEBEL CP, 1990, TOXICOL APPL PHARM, V104, P17, DOI 10.1016/0041-008X(90)90278-3; Maiti P, 2006, NEUROCHEM INT, V49, P709, DOI 10.1016/j.neuint.2006.06.002; Maiti P, 2008, J CHEM NEUROANAT, V36, P227, DOI 10.1016/j.jchemneu.2008.07.003; MIKI N, 1977, BIOCHEM BIOPH RES CO, V75, P851, DOI 10.1016/0006-291X(77)91460-7; Mishra A, 2006, J ENDOCRINOL, V189, P341, DOI 10.1677/joe.1.06686; MIZUI T, 1992, AM J PHYSIOL, V262, pH313, DOI 10.1152/ajpheart.1992.262.2.H313; Moller P, 2001, FASEB J, V15, P1181, DOI 10.1096/fj.00-0703com; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Myhre O, 2003, BIOCHEM PHARMACOL, V65, P1575, DOI 10.1016/S0006-2952(03)00083-2; Naidu PS, 2006, PHYTOTHER RES, V20, P140, DOI 10.1002/ptr.1823; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Parihar MS, 2003, J BIOSCIENCES, V28, P121, DOI 10.1007/BF02970142; PILEBLAD E, 1989, J NEUROCHEM, V52, P978, DOI 10.1111/j.1471-4159.1989.tb02550.x; PINTO RE, 1969, BIOCHEM J, V112, P109, DOI 10.1042/bj1120109; Prasad J, 2013, HIGH ALT MED BIOL, V14, P383, DOI 10.1089/ham.2013.1014; Rauhala P, 1998, FASEB J, V12, P165, DOI 10.1096/fasebj.12.2.165; RICHMAN PG, 1975, J BIOL CHEM, V250, P1422; Schliebs R, 1997, NEUROCHEM INT, V30, P181, DOI 10.1016/S0197-0186(96)00025-3; SEELIG GF, 1984, J BIOL CHEM, V259, P3534; Sharma R, 2004, ANTIOXID REDOX SIGN, V6, P289, DOI 10.1089/152308604322899350; Shih AY, 2005, J BIOL CHEM, V280, P22925, DOI 10.1074/jbc.M414635200; Singh RJ, 1996, J BIOL CHEM, V271, P18596, DOI 10.1074/jbc.271.31.18596; SmithSwintosky VL, 1996, J CEREBR BLOOD F MET, V16, P585, DOI 10.1097/00004647-199607000-00008; Tohda C, 2000, NEUROREPORT, V11, P1981, DOI 10.1097/00001756-200006260-00035; WINTERBOURN CC, 1994, ARCH BIOCHEM BIOPHYS, V314, P284, DOI 10.1006/abbi.1994.1444; Won SJ, 2002, J BIOCHEM MOL BIOL, V35, P67, DOI 10.5483/BMBRep.2002.35.1.067; Wullner U, 1999, BRAIN RES, V826, P53, DOI 10.1016/S0006-8993(99)01228-7; Yang YC, 2011, FREE RADICAL BIO MED, V51, P2073, DOI 10.1016/j.freeradbiomed.2011.09.007	68	40	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e105311	10.1371/journal.pone.0105311	http://dx.doi.org/10.1371/journal.pone.0105311			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310001	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210300001
J	Balsanelli, E; de Baura, VA; Pedrosa, FD; de Souza, EM; Monteiro, RA				Balsanelli, Eduardo; de Baura, Valter Antonio; Pedrosa, Fabio de Oliveira; de Souza, Emanuel Maltempi; Monteiro, Rose Adele			Exopolysaccharide Biosynthesis Enables Mature Biofilm Formation on Abiotic Surfaces by Herbaspirillum seropedicae	PLOS ONE			English	Article							CALCOFLUOR-BINDING EXOPOLYSACCHARIDE; LEGUMINOSARUM BV TRIFOLII; SP STRAIN 12S; RHIZOBIUM-MELILOTI; BACTERIAL BIOFILMS; NIF GENES; EXTRACELLULAR POLYSACCHARIDES; PSEUDOMONAS-SOLANACEARUM; AZOSPIRILLUM-BRASILENSE; XANTHOMONAS-CAMPESTRIS	H. seropedicae associates endophytically and epiphytically with important poaceous crops and is capable of promoting their growth. The molecular mechanisms involved in plant colonization by this microrganism are not fully understood. Exopolysaccharides (EPS) are usually necessary for bacterial attachment to solid surfaces, to other bacteria, and to form biofilms. The role of H. seropedicae SmR1 exopolysaccharide in biofilm formation on both inert and plant substrates was assessed by characterization of a mutant in the espB gene which codes for a glucosyltransferase. The mutant strain was severely affected in EPS production and biofilm formation on glass wool. In contrast, the plant colonization capacity of the mutant strain was not altered when compared to the parental strain. The requirement of EPS for biofilm formation on inert surface was reinforced by the induction of eps genes in biofilms grown on glass and polypropylene. On the other hand, a strong repression of eps genes was observed in H. seropedicae cells adhered to maize roots. Our data suggest that H. seropedicae EPS is a structural component of mature biofilms, but this development stage of biofilm is not achieved during plant colonization.	[Balsanelli, Eduardo; de Baura, Valter Antonio; Pedrosa, Fabio de Oliveira; de Souza, Emanuel Maltempi; Monteiro, Rose Adele] Univ Fed Parana, Dept Biochem & Mol Biol, BR-80060000 Curitiba, Parana, Brazil	Universidade Federal do Parana	Monteiro, RA (corresponding author), Univ Fed Parana, Dept Biochem & Mol Biol, BR-80060000 Curitiba, Parana, Brazil.	rose.adele@ufpr.br	Balsanelli, Eduardo/O-8831-2014; Pedrosa, Fabio 0/C-1938-2013	Monteiro, Rose Adele/0000-0001-8226-0700	CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [484309/2012-9]	CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (484309/2012-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsanelli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077001; Balsanelli E, 2010, ENVIRON MICROBIOL, V12, P2233, DOI 10.1111/j.1462-2920.2010.02187.x; BARANY F, 1985, P NATL ACAD SCI USA, V82, P4202, DOI 10.1073/pnas.82.12.4202; Bogino PC, 2013, INT J MOL SCI, V14, P15838, DOI 10.3390/ijms140815838; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burdman S, 2000, CRIT REV MICROBIOL, V26, P91, DOI 10.1080/10408410091154200; Chapman MR, 1998, J BACTERIOL, V180, P27, DOI 10.1128/JB.180.1.27-34.1998; Cheng HP, 1998, J BACTERIOL, V180, P5183, DOI 10.1128/JB.180.19.5183-5191.1998; Chou FL, 1997, BIOCHEM BIOPH RES CO, V233, P265, DOI 10.1006/bbrc.1997.6365; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Dalton HM, 1996, J IND MICROBIOL, V17, P228, DOI 10.1007/BF01574697; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; DENNY TP, 1995, ANNU REV PHYTOPATHOL, V33, P173, DOI 10.1146/annurev.py.33.090195.001133; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Egener T, 1999, MOL PLANT MICROBE IN, V12, P813, DOI 10.1094/MPMI.1999.12.9.813; Flemming HC, 2001, WATER SCI TECHNOL, V43, P1; Fujishige NA, 2006, FEMS MICROBIOL ECOL, V56, P195, DOI 10.1111/j.1574-6941.2005.00044.x; Gonzalez JE, 1996, P NATL ACAD SCI USA, V93, P8636, DOI 10.1073/pnas.93.16.8636; Gyaneshwar P, 2002, NEW PHYTOL, V154, P131, DOI 10.1046/j.1469-8137.2002.00371.x; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; HAYWARD AC, 1991, ANNU REV PHYTOPATHOL, V29, P65, DOI 10.1146/annurev.py.29.090191.000433; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Hussain A, 1958, PHYTOPATHOLOGY, V48, P155; Janczarek M, 2013, INT J MOL SCI, V14, P23711, DOI 10.3390/ijms141223711; Janczarek M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-284; Jofre E, 2004, FEMS MICROBIOL LETT, V231, P267, DOI 10.1016/S0378-1097(04)00003-5; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Killiny N, 2013, MOL PLANT MICROBE IN, V26, P1044, DOI 10.1094/MPMI-09-12-0211-R; Klassen G, 1997, CAN J MICROBIOL, V43, P887, DOI 10.1139/m97-129; Koczan JM, 2009, PHYTOPATHOLOGY, V99, P1237, DOI 10.1094/PHYTO-99-11-1237; Koutsoudis MD, 2006, P NATL ACAD SCI USA, V103, P5983, DOI 10.1073/pnas.0509860103; Lappin-Scott HM., 1995, MICROBIAL BIOFILMS, P15, DOI [10.1017/CBO9780511525353.003, DOI 10.1017/CBO9780511525353, DOI 10.1017/CBO9780511525353.003]; Laus MC, 2005, MOL PLANT MICROBE IN, V18, P1123, DOI 10.1094/MPMI-18-1123; LEIGH JA, 1987, CELL, V51, P579, DOI 10.1016/0092-8674(87)90127-9; LEIGH JA, 1992, ANNU REV MICROBIOL, V46, P307, DOI 10.1146/annurev.mi.46.100192.001515; LEIGH JA, 1994, TRENDS GENET, V10, P63, DOI 10.1016/0168-9525(94)90151-1; LONG S, 1988, J BACTERIOL, V170, P4239, DOI 10.1128/jb.170.9.4239-4248.1988; Meneses CHSG, 2011, MOL PLANT MICROBE IN, V24, P1448, DOI 10.1094/MPMI-05-11-0127; Miller J.H., 1972, EXPT MOL GENETICS; Monteiro RA, 2012, PLANT SOIL, V356, P175, DOI 10.1007/s11104-012-1125-7; Muller D, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030053; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Pedrosa FO, 1997, SOIL BIOL BIOCHEM, V29, P843, DOI 10.1016/S0038-0717(96)00206-4; Perez-Gimenez Julieta, 2009, Int J Microbiol, V2009, P719367, DOI 10.1155/2009/719367; Rinaudi LV, 2010, FEMS MICROBIOL LETT, V304, P1, DOI 10.1111/j.1574-6968.2009.01840.x; Rinaudi LV, 2009, J BACTERIOL, V191, P7216, DOI 10.1128/JB.01063-09; ROBERSON EB, 1992, APPL ENVIRON MICROB, V58, P1284, DOI 10.1128/AEM.58.4.1284-1291.1992; Rolfe BG, 1996, AUST J PLANT PHYSIOL, V23, P285, DOI 10.1071/PP9960285; Roncato-Maccari LDB, 2003, FEMS MICROBIOL ECOL, V45, P39, DOI 10.1016/S0168-6496(03)00108-9; Roper MC, 2007, APPL ENVIRON MICROB, V73, P7252, DOI 10.1128/AEM.00895-07; Saile E, 1997, PHYTOPATHOLOGY, V87, P1264, DOI 10.1094/PHYTO.1997.87.12.1264; Sambrook J., 2002, MOL CLONING LAB MANU; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Skorupska A, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-7; Smol'kina ON, 2012, MICROBIOLOGY+, V81, P317, DOI 10.1134/S0026261712030113; Staehelin C, 2006, J BACTERIOL, V188, P6168, DOI 10.1128/JB.00365-06; Steenhoudt O, 2000, FEMS MICROBIOL REV, V24, P487, DOI 10.1111/j.1574-6976.2000.tb00552.x; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; SUTHERLAND IW, 1982, ADV MICROB PHYSIOL, V23, P79, DOI 10.1016/S0065-2911(08)60336-7; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; Sutherland IW, 1980, ANNU REV MICROBIOL, V34, P79; Tadra-Sfeir MZ, 2011, APPL ENVIRON MICROB, V77, P2180, DOI 10.1128/AEM.02071-10; Tolker-Nielsen T, 2000, J BACTERIOL, V182, P6482, DOI 10.1128/JB.182.22.6482-6489.2000; Tomlinson AD, 2010, MICROBIOL-SGM, V156, P2670, DOI 10.1099/mic.0.039032-0; Torres PS, 2007, ENVIRON MICROBIOL, V9, P2101, DOI 10.1111/j.1462-2920.2007.01332.x; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; van Workum WAT, 1998, MOL PLANT MICROBE IN, V11, P1233, DOI 10.1094/MPMI.1998.11.12.1233; Wang P, 2008, ARCH MICROBIOL, V189, P525, DOI 10.1007/s00203-007-0345-3; Yoshida T, 2000, APPL MICROBIOL BIOT, V54, P341, DOI 10.1007/s002530000407; Yoshida T, 2003, MICROBIOL-SGM, V149, P431, DOI 10.1099/mic.0.25913-0; Zhang A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080969, 10.1371/journal.pone.0063486, 10.1371/journal.pone.0059428, 10.1371/journal.pone.0059254, 10.1371/journal.pone.0064689]	73	37	37	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110392	10.1371/journal.pone.0110392	http://dx.doi.org/10.1371/journal.pone.0110392			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310013	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210300113
J	Onoda, K; Yamaguchi, S				Onoda, Keiichi; Yamaguchi, Shuhei			Revision of the Cognitive Assessment for Dementia, iPad Version (CADi2)	PLOS ONE			English	Article							MINI-MENTAL-STATE; ALZHEIMERS-DISEASE; IMPAIRMENT	Early detection of dementia is crucial because it is the time when intervention is most effective. Therefore, a simple and short test is necessary for primary mass screening in community-based medical facilities. We developed the Cognitive Assessment for Dementia, iPad version (CADi) which consists of 10 simple questions and is self-administered. In this paper we present a revised version which improves the detection of dementia. Two questions of the CADi were replaced in the latest version (CADi2). We examined the validity and reliability of the CADi2 in 27 Alzheimer's disease patients and age-matched healthy controls. The Alzheimer's disease patients had lower CADi2 scores and longer total response times to questions compared to the controls. The CADi2 had high sensitivity (0.85-0.96) and specificity (0.81-0.93), and showed significant correlations with existing standard neuropsychological tests. Cronbach's alpha analysis revealed moderate consistency of the CADi2. These results support the utility of the CADi2 for primary screening for dementia.	[Onoda, Keiichi; Yamaguchi, Shuhei] Shimane Univ, Dept Neurol, Izumo, Shimane, Japan	Shimane University	Yamaguchi, S (corresponding author), Shimane Univ, Dept Neurol, Izumo, Shimane, Japan.	yamagu3n@med.shimane-u.ac.jp	Onoda, Keiichi/N-2944-2019	Onoda, Keiichi/0000-0002-3882-3446				Ashendorf L, 2008, ARCH CLIN NEUROPSYCH, V23, P129, DOI 10.1016/j.acn.2007.11.005; Atri Alireza, 2011, Am J Manag Care, V17 Suppl 13, pS346; BECHTOLDT HP, 1962, PSYCHOL REC, V12, P147, DOI 10.1007/BF03393452; Boustani M, 2003, ANN INTERN MED, V138, P927, DOI 10.7326/0003-4819-138-11-200306030-00015; Cherbuin N, 2008, INT PSYCHOGERIATR, V20, P431, DOI 10.1017/S104161020800673X; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Harrison J, 2013, MED CLIN N AM, V97, P425, DOI 10.1016/j.mcna.2012.12.014; Junkkila J, 2012, DEMENT GERIATR COGN, V34, P83, DOI 10.1159/000342116; Kobayashi S, 1987, JPN J NEUROPSYCHOL, V3, P67; Ober BA, 2002, J CLIN EXP NEUROPSYC, V24, P883, DOI 10.1076/jcen.24.7.883.8384; Okada K., 1998, JPN J STROKE, V20, P318, DOI [DOI 10.3995/JSTR0KE.20.318, DOI 10.3995/JSTROKE.20.318]; Onoda K, 2013, CLIN INTERV AGING, V8, P353, DOI 10.2147/CIA.S42342; Phillips M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065712; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Vapnik V., 2013, NATURE STAT LAERNING; Wild K, 2008, ALZHEIMERS DEMENT, V4, P428, DOI 10.1016/j.jalz.2008.07.003; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	20	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109931	10.1371/journal.pone.0109931	http://dx.doi.org/10.1371/journal.pone.0109931			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ9WZ	25310860	gold, Green Published, Green Submitted			2022-12-27	WOS:000343210300080
J	Tran, NM; Dufresne, M; Helle, F; Hoffmann, TW; Francois, C; Brochot, E; Paullier, P; Legallais, C; Duverlie, G; Castelain, S				Tran, Nhu-Mai; Dufresne, Murielle; Helle, Francois; Hoffmann, Thomas Walter; Francois, Catherine; Brochot, Etienne; Paullier, Patrick; Legallais, Cecile; Duverlie, Gilles; Castelain, Sandrine			Alginate Hydrogel Protects Encapsulated Hepatic HuH-7 Cells against Hepatitis C Virus and Other Viral Infections	PLOS ONE			English	Article							SULFATED POLYSACCHARIDES; ANTIVIRAL ACTIVITY; LIVER-FAILURE; STEM-CELLS; HEPATOCYTES; CULTURE; SYSTEM; REPLICATION; TRANSPLANTATION; COENCAPSULATION	Cell microencapsulation in alginate hydrogel has shown interesting applications in regenerative medicine and the biomedical field through implantation of encapsulated tissue or for bioartificial organ development. Although alginate solution is known to have low antiviral activity, the same property regarding alginate gel has not yet been studied. The aim of this work is to investigate the potential protective effect of alginate encapsulation against hepatitis C virus (HCV) infection for a hepatic cell line (HuH-7) normally permissive to the virus. Our results showed that alginate hydrogel protects HuH-7 cells against HCV when the supernatant was loaded with HCV. In addition, alginate hydrogel blocked HCV particle release out of the beads when the HuH-7 cells were previously infected and encapsulated. There was evidence of interaction between the molecules of alginate hydrogel and HCV, which was dose-and incubation time-dependent. The protective efficiency of alginate hydrogel towards HCV infection was confirmed against a variety of viruses, whether or not they were enveloped. This promising interaction between an alginate matrix and viruses, whose chemical mechanisms are discussed, is of great interest for further medical therapeutic applications based on tissue engineering.	[Tran, Nhu-Mai; Dufresne, Murielle; Paullier, Patrick; Legallais, Cecile] Univ Technol, UMR CNRS Biomech & Bioingn 7338, Compiegne, France; [Helle, Francois; Hoffmann, Thomas Walter; Francois, Catherine; Brochot, Etienne; Duverlie, Gilles; Castelain, Sandrine] Univ Picardie Jules Verne, Dept Fundamental & Clin Virol, EA4294, Amiens, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Dufresne, M (corresponding author), Univ Technol, UMR CNRS Biomech & Bioingn 7338, Compiegne, France.	murielle.dufresne@utc.fr	Castelain, Sandrine/AAA-6344-2019; BROCHOT, ETIENNE/I-5318-2012; FRANCOIS, Catherine/AAJ-8289-2020; CASTELAIN, SANDRINE/AAJ-7506-2020; HELLE, Francois/G-7427-2011	BROCHOT, ETIENNE/0000-0002-8677-6349; CASTELAIN, SANDRINE/0000-0002-2670-3148; HELLE, Francois/0000-0001-6884-2456; FRANCOIS, Catherine/0000-0002-1797-4253; Legallais, Cecile/0000-0002-8061-906X	FEDER Program; Picardy Region, France	FEDER Program(European Commission); Picardy Region, France(Region Hauts-de-France)	The authors would like to thank the FEDER Program and the Picardy Region, France for providing financial support for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouna GM, 2008, TRANSPL P, V40, P34, DOI 10.1016/j.transproceed.2007.11.067; Ananthanarayanan A, 2014, MOL PHARMACEUT, V11, P2106, DOI 10.1021/mp500063y; Aoki T, 2005, TRANSPLANTATION, V79, P783, DOI 10.1097/01.TP.0000156319.47645.3B; Araya N, 2011, ANTIVIR THER, V16, P89, DOI 10.3851/IMP1699; Bandyopadhyaya SS, 2011, PHYTOCHEMISTRY, V72, P276, DOI 10.1016/j.phytochem.2010.11.006; Blandino A, 1999, J BIOSCI BIOENG, V88, P686, DOI 10.1016/S1389-1723(00)87103-0; Buck CB, 2006, PLOS PATHOG, V2, P671, DOI 10.1371/journal.ppat.0020069; Calafiore R, 2014, ADV DRUG DELIVER REV, V67-68, P84, DOI 10.1016/j.addr.2013.09.020; Capone SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062032; Castelain S, 2004, J CLIN VIROL, V31, P227, DOI 10.1016/j.jcv.2004.03.009; Cermelli C, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-141; David B, 2004, BIOTECHNOL PROGR, V20, P1204, DOI 10.1021/bp034301z; de Vos P, 2006, BIOMATERIALS, V27, P5603, DOI 10.1016/j.biomaterials.2006.07.010; Delgrange D, 2007, J GEN VIROL, V88, P2495, DOI 10.1099/vir.0.82872-0; Fitton JH, 2011, MAR DRUGS, V9, P1731, DOI 10.3390/md9101731; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Ghosh T, 2009, GLYCOBIOLOGY, V19, P2, DOI 10.1093/glycob/cwn092; GIROND S, 1991, RES VIROLOGY, V142, P261, DOI 10.1016/0923-2516(91)90011-Q; Helle F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070809; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Kam N, 2011, CAN J MICROBIOL, V57, P1032, DOI [10.1139/w11-106, 10.1139/W11-106]; KIM JH, 2009, BEIH Z ALTTEST WISS, V394, P1; Kurosaki T, 2009, BIOMATERIALS, V30, P4427, DOI 10.1016/j.biomaterials.2009.04.041; LaBarre DD, 2001, J VIROL METHODS, V96, P107, DOI 10.1016/S0166-0934(01)00316-0; Mei J, 2009, CELL TRANSPLANT, V18, P101, DOI 10.3727/096368909788237168; Miao BC, 2004, BIOCHEM PHARMACOL, V68, P641, DOI 10.1016/j.bcp.2004.04.009; Molina-Jimenez F, 2012, VIROLOGY, V425, P31, DOI 10.1016/j.virol.2011.12.021; Ngo DH, 2013, INT J BIOL MACROMOL, V62, P70, DOI 10.1016/j.ijbiomac.2013.08.036; Tran NM, 2013, TISSUE ENG PT A, V19, P103, DOI [10.1089/ten.TEA.2012.0139, 10.1089/ten.tea.2012.0139]; Nimtrakul P, 2015, DRUG DEV IND PHARM, V41, P423, DOI 10.3109/03639045.2013.873448; Opara Emmanuel C, 2013, Methods Mol Biol, V1001, P261, DOI 10.1007/978-1-62703-363-3_21; Orive G, 2006, BIOMATERIALS, V27, P3691, DOI 10.1016/j.biomaterials.2006.02.048; Queiroz KCS, 2008, BIOMED PHARMACOTHER, V62, P303, DOI 10.1016/j.biopha.2008.03.006; Revie D, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-346; Sainz B, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-103; Saitoh S, 2000, Dent Mater J, V19, P396; Shi XL, 2009, TRANSPLANTATION, V88, P1178, DOI 10.1097/TP.0b013e3181bc288b; Sinha S, 2010, PHYTOCHEMISTRY, V71, P235, DOI 10.1016/j.phytochem.2009.10.014; Steele JAM, 2014, ADV DRUG DELIVER REV, V67-68, P74, DOI 10.1016/j.addr.2013.09.015; STEENSON LR, 1987, J DAIRY SCI, V70, P1121, DOI 10.3168/jds.S0022-0302(87)80121-2; Sun JC, 2013, MATERIALS, V6, P1285, DOI 10.3390/ma6041285; Talarico LB, 2007, VIROLOGY, V363, P473, DOI 10.1016/j.virol.2007.01.043; Tengdelius M, 2014, BIOMACROMOLECULES, V15, P2359, DOI 10.1021/bm5002312; Tonnesen HH, 2002, DRUG DEV IND PHARM, V28, P621, DOI 10.1081/DDC-120003853; Vo TS, 2010, MAR DRUGS, V8, P2871, DOI 10.3390/md8122871; Wang W, 2012, MAR DRUGS, V10, P2795, DOI 10.3390/md10122795; Wilson GK, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/292591; Zhang Y, 2014, INT J ARTIF ORGANS, V37, P133, DOI 10.5301/ijao.5000284	48	30	30	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109969	10.1371/journal.pone.0109969	http://dx.doi.org/10.1371/journal.pone.0109969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310111	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210300082
J	Cao, X; Irwin, DM; Liu, YH; Cheng, LG; Wang, L; Wang, GD; Zhang, YP				Cao, Xue; Irwin, David M.; Liu, Yan-Hu; Cheng, Lu-Guang; Wang, Lu; Wang, Guo-Dong; Zhang, Ya-Ping			Balancing Selection on CDH2 May Be Related to the Behavioral Features of the Belgian Malinois	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; BINDING-PROTEIN-BETA; HAPLOTYPE RECONSTRUCTION; VARIANTS; MUTATION; GENES; MODEL	The Belgian Malinois (BM) is an excellent working dog that typically shows a circling behavior when placed in a confined space. Moreover, individuals showing moderate running in circles (one kind of obsessive compulsive behavior) in confined spaces typically performance compared to those without the circling behavior or to those with a serious circling behavior (which can be defined as an obsessive compulsive disorder (OCD)). To determine whether the candidate gene CDH2, Cadherin , which is associated with OCD in the Doberman pinscher breed of dogs and in humans was linked with this behavioral character in the BM, population genetic analyses were performed on a BM population and a natural population of the Chinese indigenous dog (CID). Many genetic signals of balancing selection were detected for one specific region of the CDH2 gene, which suggests that a genomic block, which is included in the CDH2 gene, experienced balancing selection in the BM, and that the CDH2 gene might be associated with the behavioral characteristics of the BM dog la balance between circling behavior and work performance). Moreover one specific variant, G63913941A, which creates a predicted transcription factor-binding site, may be the key mutation in the CDH2 gene affecting the behavior of by allowing the binding of a transcription factor and increasing CDH2 expression.	[Cao, Xue; Irwin, David M.; Wang, Guo-Dong; Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Cao, Xue; Irwin, David M.; Wang, Guo-Dong; Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, Yunnan Lab Mol Biol Domest Animals, Kunming, Peoples R China; [Cao, Xue] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Peoples R China; [Irwin, David M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Liu, Yan-Hu; Wang, Lu] Yunnan Univ, Lab Conservat & Utilizat Bioresource, Kunming, Peoples R China; [Liu, Yan-Hu; Wang, Lu] Yunnan Univ, Key Lab Microbial Resources, Minist Educ, Kunming, Peoples R China; [Cheng, Lu-Guang] Minist Publ Secur, Kunming Police Dog Base, Kunming, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Toronto; Yunnan University; Yunnan University; Ministry of Public Security (China)	Wang, GD (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	wanggd@mail.kiz.ac.cn; zhangyp@mail.kiz.ac.cn		Irwin, David/0000-0001-6131-4933	Natural Science Foundation of China [31201712]; 973 program [2013CB835200, 2013CB835202]; ministry of public security science and technology special project [2013YYCXKMJQ121]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); ministry of public security science and technology special project	This work was supported by grants from the Natural Science Foundation of China (31201712), the 973 program (2013CB835200 and 2013CB835202), and the ministry of public security science and technology special project 2013YYCXKMJQ121. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON AC, 1956, ANN HUM GENET, V21, P67, DOI 10.1111/j.1469-1809.1971.tb00266.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cortes-Canteli M, 2002, J BIOL CHEM, V277, P5460, DOI 10.1074/jbc.M108761200; Dodman NH, 2010, MOL PSYCHIATR, V15, P8, DOI 10.1038/mp.2009.111; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Khiari HM, 2011, NEUROL SCI, V32, P959, DOI 10.1007/s10072-011-0480-0; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Moya PR, 2013, EUR J HUM GENET, V21, P850, DOI 10.1038/ejhg.2012.245; Overall KL, 2002, J AM VET MED ASSOC, V221, P1445, DOI 10.2460/javma.2002.221.1445; Quardokus E, 2000, SCIENCE, V288, P458, DOI 10.1126/science.288.5465.458; Reilly TJ, 2011, BEHAV BRAIN RES, V222, P375, DOI 10.1016/j.bbr.2011.04.003; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sterneck E, 1998, J NEUROCHEM, V70, P2424; Strohmeyer R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086617; Tang RQ, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r25; Wang GD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2814; Wang GD, 2014, ANNU REV ANIM BIOSCI, V2, P65, DOI 10.1146/annurev-animal-022513-114129; Wang GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055469; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	29	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110075	10.1371/journal.pone.0110075	http://dx.doi.org/10.1371/journal.pone.0110075			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303325	Green Published, gold, Green Submitted			2022-12-27	WOS:000343730400108
J	Sun, YQ; Tong, T; Cai, SJ; Bi, R; Xin, C; Gu, YJ				Sun, Yiqun; Tong, Tong; Cai, Sanjun; Bi, Rui; Xin, Chao; Gu, Yajia			Apparent Diffusion Coefficient (ADC) Value: A Potential Imaging Biomarker That Reflects the Biological Features of Rectal Cancer	PLOS ONE			English	Article							CLINICAL-SIGNIFICANCE; PROGNOSTIC-FACTORS; WEIGHTED MRI; SURVIVAL; PREDICTION; EXPRESSION; TUMORS; STAGE; P53	Objective: We elected to analyze the correlation between the pre-treatment apparent diffusion coefficient (ADC) and the clinical, histological, and immunohistochemical status of rectal cancers. Materials and Methods: Forty-nine rectal cancer patients who received surgical resection without neoadjuvant therapy were selected that underwent primary MRI and diffusion-weighted imaging (DWI). Tumor ADC values were determined and analyzed to identify any correlations between these values and pre-treatment CEA or CA19-9 levels, and/or the histological and immunohistochemical properties of the tumor. Results: Inter-observer agreement of confidence levels from two separate observers was suitable for ADC measurement (k = 0.775). The pre-treatment ADC values of different T stage tumors were not equal (p = 0.003). The overall trend was that higher T stage values correlated with lower ADC values. ADC values were also significantly lower for the following conditions: tumors with the presence of extranodal tumor deposits (p = 0.006) and tumors with CA19-9 levels >= 35 g/ml (p = 0.006). There was a negative correlation between Ki-67 LI and the ADC value (r = -0.318, p = 0.026) and between the AgNOR count and the ADC value (r = -0.310, p = 0.030). Conclusion: Significant correlations were found between the pre-treatment ADC values and T stage, extranodal tumor deposits, CA19-9 levels, Ki-67 LI, and AgNOR counts in our study. Lower ADC values were associated with more aggressive tumor behavior. Therefore, the ADC value may represent a useful biomarker for assessing the biological features and possible relationship to the status of identified rectal cancers.	[Sun, Yiqun; Tong, Tong; Xin, Chao; Gu, Yajia] Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Dept Radiol,Dept Oncol, Shanghai 200433, Peoples R China; [Cai, Sanjun] Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Dept Colorectal Surg,Dept Oncol, Shanghai 200433, Peoples R China; [Bi, Rui] Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Dept Pathol,Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Gu, YJ (corresponding author), Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Dept Radiol,Dept Oncol, Shanghai 200433, Peoples R China.	cjr.guyajia@vip.163.com			Shanghai Science and Technology planning fund [13140902103]; Shanghai Science and Technology guiding fund [124119a0201]; Shanghai Municipal Health Bureau Foundation for youths [20124y099]	Shanghai Science and Technology planning fund; Shanghai Science and Technology guiding fund; Shanghai Municipal Health Bureau Foundation for youths	This study was supported by grants from Shanghai Science and Technology planning fund (No. 13140902103); Shanghai Science and Technology guiding fund (No. 124119a0201); Shanghai Municipal Health Bureau Foundation for youths (No. 20124y099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae H, 2014, INT UROL NEPHROL, V46, P555, DOI 10.1007/s11255-013-0557-1; Boras Z, 2012, COLLEGIUM ANTROPOL, V36, P1355; Chen ZY, 2010, J MAGN RESON IMAGING, V31, P1331, DOI 10.1002/jmri.22175; Choi SY, 2012, BRIT J RADIOL, V85, pE474, DOI 10.1259/bjr/79381464; Curvo-Semedo L, 2012, J MAGN RESON IMAGING, V35, P1365, DOI 10.1002/jmri.23589; Higano S, 2006, RADIOLOGY, V241, P839, DOI 10.1148/radiol.2413051276; Huh JW, 2009, VIRCHOWS ARCH, V454, P381, DOI 10.1007/s00428-009-0752-8; Jeh SK, 2011, J MAGN RESON IMAGING, V33, P102, DOI 10.1002/jmri.22400; Jurach Márcia Teresinha, 2006, Arq. Gastroenterol., V43, P14, DOI 10.1590/S0004-28032006000100006; Kim MS, 2013, J SURG ONCOL, V107, P835, DOI 10.1002/jso.23327; Kobayashi S, 2014, J MAGN RESON IMAGING, V39, P172, DOI 10.1002/jmri.24148; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Kozak KR, 2008, J SURG ONCOL, V98, P161, DOI 10.1002/jso.21107; Lebe B, 2005, APPL IMMUNOHISTO M M, V13, P38, DOI 10.1097/00129039-200503000-00007; Lee YC, 2013, DIS COLON RECTUM, V56, P1093, DOI 10.1097/DCR.0b013e318298e36b; Martincich L, 2012, EUR RADIOL, V22, P1519, DOI 10.1007/s00330-012-2403-8; Mesko S, 2013, PROSTATE CANCER, V2013, DOI 10.1155/2013/717080; MINSKY BD, 1989, INT J RADIAT ONCOL, V17, P311, DOI 10.1016/0360-3016(89)90445-8; Ritu G, 2012, J OBSTET GYN INDIA, V62, P437, DOI 10.1007/s13224-012-0300-3; Schnapauff D, 2009, J MAGN RESON IMAGING, V29, P1355, DOI 10.1002/jmri.21755; Tarantino I, 2012, BRIT J CANCER, V107, P266, DOI 10.1038/bjc.2012.267; Tsigris C, 2002, CANCER LETT, V184, P215, DOI 10.1016/S0304-3835(02)00205-7; Zhang XY, 2011, J MAGN RESON IMAGING, V33, P1171, DOI 10.1002/jmri.22558	23	22	35	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109371	10.1371/journal.pone.0109371	http://dx.doi.org/10.1371/journal.pone.0109371			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303288	gold, Green Submitted, Green Published			2022-12-27	WOS:000343730400053
J	Tumber, AK; Scheerer, NE; Jones, JA				Tumber, Anupreet K.; Scheerer, Nichole E.; Jones, Jeffery A.			Attentional Demands Influence Vocal Compensations to Pitch Errors Heard in Auditory Feedback	PLOS ONE			English	Article							SELECTIVE ATTENTION; DIVIDED ATTENTION; SPATIAL ATTENTION; SPEECH MOTOR; VOICE; RESPONSES; PERFORMANCE; POTENTIALS; MECHANISMS; MAGNITUDE	Auditory feedback is required to maintain fluent speech. At present, it is unclear how attention modulates auditory feedback processing during ongoing speech. In this event-related potential (ERP) study participants vocalized/a/ while they heard their vocal pitch suddenly shifted downward a 1/2 semitone in both single and dual-task conditions. During the single task condition participants passively viewed a visual stream for cues to start and stop vocalizing. In the dual-task condition, participants vocalized while they identified target stimuli in a visual stream of letters. The presentation rate of the visual stream of letters. The presentation rate of the visual stimuli was manipulated in the dual-task condition in order to produce a low, intermediate, and high attentional load. Visual target identification accuracy was lowest in the high attentional load condition, indicating that attentional successfully manipulated. Results further showed that participants who were exposed to the single-task condition prior to the dual-task condition produced target local compensations during the single task condition. Thus, when participants attention was divided less attention was available for the monitoring of their auditory feedback, resulting in smaller compensatory vocal responses. However, P1-N1-P2 ERP responses were not affected by divided attention, suggesting that the effect of attentional load was not on the auditory processing of pitch altered feedback, but instead it interfered with the integration of auditory and motor information, or motor control itself.	[Jones, Jeffery A.] Wilfrid Laurier Univ, Dept Psychol, Waterloo, ON N2L 3C5, Canada; Wilfrid Laurier Univ, Laurier Ctr Cognit Neurosci, Waterloo, ON N2L 3C5, Canada	Wilfrid Laurier University; Wilfrid Laurier University	Jones, JA (corresponding author), Wilfrid Laurier Univ, Dept Psychol, Waterloo, ON N2L 3C5, Canada.	jjones@wlu.ca	Scheerer, Nichole E./Y-5522-2019	Scheerer, Nichole/0000-0003-0070-6559	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was funded by a Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) Discovery Grant awarded to JAJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2006, P R SOC B, V273, P1339, DOI 10.1098/rspb.2005.3420; Bays PM, 2007, J PHYSIOL-LONDON, V578, P387, DOI 10.1113/jphysiol.2006.120121; Behroozmand R, 2011, J COGNITIVE NEUROSCI, V23, P1205, DOI 10.1162/jocn.2010.21447; Behroozmand R, 2009, CLIN NEUROPHYSIOL, V120, P1303, DOI 10.1016/j.clinph.2009.04.022; Burnett TA, 1997, J VOICE, V11, P202, DOI 10.1016/S0892-1997(97)80079-3; Burnett TA, 1998, J ACOUST SOC AM, V103, P3153, DOI 10.1121/1.423073; Camacho A, 2007, J ACOUST SOC AM, V122, P2960, DOI [10.1121/1.2942550, DOI 10.1121/1.2942550]; Chen ZC, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-55; Choi I, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00115; Chun MM, 2008, BLACKWELL HDB PERCEP, P272; Civier O, 2010, J FLUENCY DISORD, V35, P246, DOI 10.1016/j.jfludis.2010.05.002; Coch D, 2005, CLIN NEUROPHYSIOL, V116, P2184, DOI 10.1016/j.clinph.2005.06.005; DAI HP, 1991, J ACOUST SOC AM, V89, P2837, DOI 10.1121/1.400721; Delano PH, 2007, J NEUROSCI, V27, P4146, DOI 10.1523/JNEUROSCI.3702-06.2007; Dromey C, 2003, J SPEECH LANG HEAR R, V46, P1234, DOI 10.1044/1092-4388(2003/096); Dromey C, 2008, J SPEECH LANG HEAR R, V51, P1171, DOI 10.1044/1092-4388(2008/06-0221); ELMAN JL, 1981, J ACOUST SOC AM, V70, P45, DOI 10.1121/1.386580; Ferlazzo F, 2002, Q J EXP PSYCHOL-A, V55, P937, DOI 10.1080/02724980143000569; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Guenther FH, 2006, J COMMUN DISORD, V39, P350, DOI 10.1016/j.jcomdis.2006.06.013; Hain TC, 2000, EXP BRAIN RES, V130, P133, DOI 10.1007/s002219900237; Hawco CS, 2009, BRAIN RES, V1276, P131, DOI 10.1016/j.brainres.2009.04.033; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; HINK RF, 1977, NEUROPSYCHOLOGIA, V15, P597, DOI 10.1016/0028-3932(77)90065-3; HINK RF, 1978, BIOL PSYCHOL, V6, P1, DOI 10.1016/0301-0511(78)90002-9; Johnson JA, 2005, CEREB CORTEX, V15, P1609, DOI 10.1093/cercor/bhi039; Korzyukov O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041216; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Liu HJ, 2011, CLIN NEUROPHYSIOL, V122, P951, DOI 10.1016/j.clinph.2010.08.010; Macdonald JSP, 2011, ATTEN PERCEPT PSYCHO, V73, P1780, DOI 10.3758/s13414-011-0144-4; NAATANEN R, 1991, BEHAV BRAIN SCI, V14, P761; PARASURAMAN R, 1980, BIOL PSYCHOL, V11, P217, DOI 10.1016/0301-0511(80)90057-5; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Scheerer NE, 2013, NEUROSCIENCE, V240, P176, DOI 10.1016/j.neuroscience.2013.02.054; Scheerer NE, 2013, EUR J NEUROSCI, V38, P3189, DOI 10.1111/ejn.12301; Schneider W, 2003, COGNITIVE SCI, V27, P525, DOI 10.1016/S0364-0213(03)00011-9; Spence C, 1996, J EXP PSYCHOL HUMAN, V22, P1005, DOI 10.1037/0096-1523.22.4.1005; WALDSTEIN RS, 1990, J ACOUST SOC AM, V88, P2099, DOI 10.1121/1.400107; Wickens C. D., 2002, THEORETICAL ISSUES E, V3, P159, DOI [10.1080/14639220210123806, DOI 10.1080/14639220210123806]; Wickens CD, 2007, IRAL-INT REV APPL LI, V45, DOI [10.1515/iral.2007.008, DOI 10.1515/IRAL.2007.008]; Zenger-Landolt B, 2003, J NEUROSCI, V23, P6884	42	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109968	10.1371/journal.pone.0109968	http://dx.doi.org/10.1371/journal.pone.0109968			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6ZS	25303649	Green Submitted, Green Published, gold			2022-12-27	WOS:000343730400099
J	Clarke, K; Azad, K; Kuddus, A; Shaha, S; Nahar, T; Aumon, BH; Hossen, MM; Beard, J; Costello, A; Houweling, TAJ; Prost, A; Fottrell, E				Clarke, Kelly; Azad, Kishwar; Kuddus, Abdul; Shaha, Sanjit; Nahar, Tasmin; Aumon, Bedowra Haq; Hossen, Mohammed Munir; Beard, James; Costello, Anthony; Houweling, Tanja A. J.; Prost, Audrey; Fottrell, Edward			Impact of a Participatory Intervention with Women's Groups on Psychological Distress among Mothers in Rural Bangladesh: Secondary Analysis of a Cluster-Randomised Controlled Trial	PLOS ONE			English	Article							POSTNATAL DEPRESSION; MENTAL-HEALTH; PRIMARY-CARE; SYMPTOMS; DISORDERS; SANTIAGO; UGANDA; CHILE	Background: Perinatal common mental disorders (PCMDs) are a major cause of disability among women and disproportionately affect lower income countries. Interventions to address PCMDs are urgently needed in these settings, and group-based and peer-led approaches are potential strategies to increase access to mental health interventions. Participatory women's health groups led by local women previously reduced postpartum psychological distress in eastern India. We assessed the effect of a similar intervention on postpartum psychological distress in rural Bangladesh. Method: We conducted a secondary analysis of data from a cluster-randomised controlled trial with 18 clusters and an estimated population of 532,996. Nine clusters received an intervention comprising monthly meetings during which women's groups worked through a participatory learning and action cycle to develop strategies for improving women's and children's health. There was one group for every 309 individuals in the population, 810 groups in total. Mothers in nine control clusters had access to usual perinatal care. Postpartum psychological distress was measured with the 20-item Self Reporting Questionnaire (SRQ-20) between six and 52 weeks after delivery, during the months of January to April, in 2010 and 2011. Results: We analysed outcomes for 6275 mothers. Although the cluster mean SRQ-20 score was lower in the intervention arm (mean 5.2, standard deviation 1.8) compared to control (5.3, 1.2), the difference was not significant (beta 1.44, 95% CI 0.28, 3.08). Conclusions: Despite promising results in India, participatory women's groups focused on women's and children's health had no significant effect on postpartum psychological distress in rural Bangladesh.	[Clarke, Kelly; Beard, James; Costello, Anthony; Houweling, Tanja A. J.; Prost, Audrey; Fottrell, Edward] UCL, Inst Global Hlth, London, England; [Azad, Kishwar; Kuddus, Abdul; Shaha, Sanjit; Nahar, Tasmin; Aumon, Bedowra Haq; Hossen, Mohammed Munir] Diabet Assoc Bangladesh, Perinatal Care Project, Dhaka, Bangladesh; [Houweling, Tanja A. J.] Erasmus MC Univ, Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands	University of London; University College London; Erasmus University Rotterdam; Erasmus MC	Clarke, K (corresponding author), UCL, Inst Global Hlth, London, England.	k.clarke.09@ucl.ac.uk	Houweling, Tanja/GRF-6127-2022	Houweling, Tanja AJ/0000-0001-6090-4376; Fottrell, Edward/0000-0003-0518-7161	Big Lottery Fund International Strategic Grant [IS/2/010281409]; Wellcome Trust [085417ma/Z/08/Z]; Economic and Social Research Council [ES/I033572/1] Funding Source: researchfish; ESRC [ES/I033572/1] Funding Source: UKRI	Big Lottery Fund International Strategic Grant; Wellcome Trust(Wellcome TrustEuropean Commission); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	A Big Lottery Fund International Strategic Grant (IS/2/010281409) funded the implementation and evaluation of the women's groups. The study was also supported by funds from a Wellcome Trust Strategic Award (085417ma/Z/08/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2010, ENVIRON MONIT ASSESS, V164, P263, DOI 10.1007/s10661-009-0890-0; Araya R, 2003, LANCET, V361, P995, DOI 10.1016/S0140-6736(03)12825-5; Azad K, 2010, LANCET, V375, P1193, DOI 10.1016/S0140-6736(10)60142-0; Beusenberg M., 1994, WHOMNHPSF948; Black MM, 2007, J CHILD PSYCHOL PSYC, V48, P764, DOI 10.1111/j.1469-7610.2007.01752.x; Bolton P, 2003, JAMA-J AM MED ASSOC, V289, P3117, DOI 10.1001/jama.289.23.3117; Bolton P, 2007, JAMA-J AM MED ASSOC, V298, P519, DOI 10.1001/jama.298.5.519; Choudhury WA, 2006, INT REV PSYCHIATR, V18, P529, DOI 10.1080/09540260601037896; Chowdhury M. A. I., 2011, Journal of Environmental Science and Natural Resources, V4, P13, DOI 10.3329/jesnr.v4i2.10125; Clarke K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001541; Cooper PJ, 1999, BRIT J PSYCHIAT, V175, P554, DOI 10.1192/bjp.175.6.554; Cooper PJ, 2009, BMJ-BRIT MED J, V338, P997, DOI [10.2307/20512727, DOI 10.2307/20512727]; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Fottrell E, 2013, JAMA PEDIAT, V20, P1; Gao LL, 2010, INT J NURS STUD, V47, P1208, DOI 10.1016/j.ijnurstu.2010.03.002; Gausia K, 2009, PSYCHOL MED, V39, P999, DOI 10.1017/S0033291708004455; Gausia K, 2009, ARCH WOMEN MENT HLTH, V12, P351, DOI 10.1007/s00737-009-0080-7; Goldberg DP., 1992, COMMON MENTAL DISORD; Hanlon C, 2013, INT HEALTH, V5, P4, DOI 10.1093/inthealth/ihs003; Harpham T, 2003, HEALTH POLICY PLANN, V18, P344, DOI 10.1093/heapol/czg041; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Hayes RJ, 2009, INTERD STAT, P3; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Houweling TAJ, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-208; Islam MM, 2000, BANGLADESH J PSYCHIA, V14, P31; Mao HJ, 2012, PERSPECT PSYCHIATR C, V48, P218, DOI 10.1111/j.1744-6163.2012.00331.x; Nasreen HE, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-22; Parsons CE, 2012, BRIT MED BULL, V101, P57, DOI 10.1093/bmb/ldr047; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Rahman A, 2004, ARCH GEN PSYCHIAT, V61, P946, DOI 10.1001/archpsyc.61.9.946; Rahman A, 2013, B WHO; Rahman A, 2008, LANCET, V372, P902, DOI 10.1016/S0140-6736(08)61400-2; Rath S, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-25; Rojas G, 2007, LANCET, V370, P1629, DOI 10.1016/S0140-6736(07)61685-7; Senturk V, 2012, J AFFECT DISORDERS, V136, P340, DOI 10.1016/j.jad.2011.11.028; StataCorp, 2011, STAT STAT SOFTW REL, P173; Surkan P. J., 2011, B WHO, P89; Tripathy P, 2010, LANCET, V375, P1182, DOI 10.1016/S0140-6736(09)62042-0; World Health Organisation, 2007, WHO AIMS REP MENT HL; Zug S, 2006, J SOCIAL STUDIES, V11	41	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110697	10.1371/journal.pone.0110697	http://dx.doi.org/10.1371/journal.pone.0110697			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ9XC	25329470	Green Published, gold			2022-12-27	WOS:000343210800106
J	Ruiz-Gonzalez, A; Gurrutxaga, M; Cushman, SA; Madeira, MJ; Randi, E; Gomez-Moliner, BJ				Ruiz-Gonzalez, Aritz; Gurrutxaga, Mikel; Cushman, Samuel A.; Jose Madeira, Maria; Randi, Ettore; Gomez-Moliner, Benjamin J.			Landscape Genetics for the Empirical Assessment of Resistance Surfaces: The European Pine Marten (Martes martes) as a Target-Species of a Regional Ecological Network	PLOS ONE			English	Article							POPULATION CONNECTIVITY; GENOTYPING ERRORS; HABITAT SELECTION; COMPUTER-PROGRAM; CLIMATE-CHANGE; FLOW; SCALE; DIFFERENTIATION; FRAGMENTATION; DISPERSAL	Coherent ecological networks (EN) composed of core areas linked by ecological corridors are being developed worldwide with the goal of promoting landscape connectivity and biodiversity conservation. However, empirical assessment of the performance of EN designs is critical to evaluate the utility of these networks to mitigate effects of habitat loss and fragmentation. Landscape genetics provides a particularly valuable framework to address the question of functional connectivity by providing a direct means to investigate the effects of landscape structure on gene flow. The goals of this study are (1) to evaluate the landscape features that drive gene flow of an EN target species (European pine marten), and (2) evaluate the optimality of a regional EN design in providing connectivity for this species within the Basque Country (North Spain). Using partial Mantel tests in a reciprocal causal modeling framework we competed 59 alternative models, including isolation by distance and the regional EN. Our analysis indicated that the regional EN was among the most supported resistance models for the pine marten, but was not the best supported model. Gene flow of pine marten in northern Spain is facilitated by natural vegetation, and is resisted by anthropogenic landcover types and roads. Our results suggest that the regional EN design being implemented in the Basque Country will effectively facilitate gene flow of forest dwelling species at regional scale.	[Ruiz-Gonzalez, Aritz; Jose Madeira, Maria; Gomez-Moliner, Benjamin J.] Univ Basque Country, UPV EHU, Dept Zool & Anim Cell Biol, Vitoria, Spain; [Ruiz-Gonzalez, Aritz; Gurrutxaga, Mikel; Jose Madeira, Maria; Gomez-Moliner, Benjamin J.] Univ Basque Country, UPV EHU, Lascaray Res Ctr, Systemat Biogeog & Populat Dynam Res Grp, Vitoria, Spain; [Ruiz-Gonzalez, Aritz; Randi, Ettore] ISPRA, Natl Inst Environm Protect & Res, Conservat Genet Lab, Bologna, Italy; [Gurrutxaga, Mikel] Univ Basque Country, UPV EHU, Dept Geog, Vitoria, Spain; [Cushman, Samuel A.] US Forest Serv, Rocky Mt Res Stn, Flagstaff, AZ USA; [Randi, Ettore] Aalborg Univ, Dept 18, Sect Environm Engn, Aalborg, Denmark	University of Basque Country; University of Basque Country; Italian Institute for Environmental Protection & Research (ISPRA); University of Basque Country; United States Department of Agriculture (USDA); United States Forest Service; Aalborg University	Ruiz-Gonzalez, A (corresponding author), Univ Basque Country, UPV EHU, Dept Zool & Anim Cell Biol, Vitoria, Spain.	aritz.ruiz@ehu.es	GONZALEZ, ARITZ RUIZ/P-3384-2019; Gurrutxaga, Mikel/A-2085-2012; Ruiz-Gonzalez, Aritz/A-1613-2013; MADEIRA, MARÍA JOSÉ/L-7556-2014; Gomez, Benjamin/AAA-4119-2019	GONZALEZ, ARITZ RUIZ/0000-0001-7409-4634; Gurrutxaga, Mikel/0000-0001-5464-7318; MADEIRA, MARÍA JOSÉ/0000-0002-7357-7228; GOMEZ MOLINER, BENJAMIN JUAN/0000-0002-3054-8806	Basque Government through the Research group on "Systematics, Biogeography and Population Dynamics'' [IT317-10, GIC10/76, IT575/13]; University of the Basque Country (UPV-EHU); Department of Environment, Territorial Planning, Agriculture and Fisheries (Basque Government) through IKT S.A [UE07/02]; Dept. of Education Universities and Research of the Basque Government [DKR-2012-64]; Spanish Ministry of Environment; Regional Government of Navarre; Regional Government of Aragon; Alava Provincial Council	Basque Government through the Research group on "Systematics, Biogeography and Population Dynamics''; University of the Basque Country (UPV-EHU); Department of Environment, Territorial Planning, Agriculture and Fisheries (Basque Government) through IKT S.A; Dept. of Education Universities and Research of the Basque Government; Spanish Ministry of Environment(Spanish Government); Regional Government of Navarre; Regional Government of Aragon(Gobierno de Aragon); Alava Provincial Council	This study has been funded by the Basque Government through the Research group on "Systematics, Biogeography and Population Dynamics'' (Ref. IT317-10; GIC10/76; IT575/13) and by the University of the Basque Country (UPV-EHU) and the Department of Environment, Territorial Planning, Agriculture and Fisheries (Basque Government) through IKT S.A under the University-Enterprise research program (Ref. UE07/02). Ruiz-Gonzalez holds a Post doc fellowship awarded by the Dept. of Education Universities and Research of the Basque Government (Ref. DKR-2012-64). Several samples analysed in this study have been obtained in the framework of different carnivore surveys funded by regional or national administrations (Spanish Ministry of Environment, Regional Governments of Navarre and Aragon, Alava Provincial Council). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; Anderson CD, 2010, MOL ECOL, V19, P3565, DOI 10.1111/j.1365-294X.2010.04757.x; Balestrieri A, 2010, MAMM BIOL, V75, P412, DOI 10.1016/j.mambio.2009.05.003; Balkenhol N, 2009, MOL ECOL, V18, P4151, DOI 10.1111/j.1365-294X.2009.04322.x; Balkenhol N, 2009, LANDSCAPE ECOL, V24, P455, DOI 10.1007/s10980-009-9334-z; Beier P, 2008, CONSERV BIOL, V22, P836, DOI 10.1111/j.1523-1739.2008.00942.x; Beja-Pereira A, 2009, MOL ECOL RESOUR, V9, P1279, DOI 10.1111/j.1755-0998.2009.02699.x; Belkhir K, 2004, GENETIX 4 02 LOGICIE; Bennett G., 2001, DEV APPL ECOLOGICAL; Blair C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057433; Blair C, 2012, MOL ECOL RESOUR, V12, P822, DOI 10.1111/j.1755-0998.2012.03151.x; Blair ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043027; Boitani L, 2007, CONSERV BIOL, V21, P1414, DOI 10.1111/j.1523-1739.2007.00828.x; Brainerd SM, 2002, WILDLIFE BIOL, V8, P289, DOI 10.2981/wlb.2002.026; Bright PW, 2000, MAMMAL REV, V30, P217, DOI 10.1046/j.1365-2907.2000.00068.x; Brooks CP, 2003, OIKOS, V102, P433; Broquet T, 2006, LANDSCAPE ECOL, V21, P877, DOI 10.1007/s10980-005-5956-y; Brzeski KE, 2013, J WILDLIFE MANAGE, V77, P1523, DOI 10.1002/jwmg.610; Bull RAS, 2011, MOL ECOL, V20, P1092, DOI 10.1111/j.1365-294X.2010.04944.x; Caryl FM, 2012, J MAMMALOGY, V93; Castillo JA, 2014, MOL ECOL, V23, P843, DOI 10.1111/mec.12650; Centeno-Cuadros A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024613; Coulon A, 2006, MOL ECOL, V15, P1669, DOI 10.1111/j.1365-294X.2006.02861.x; Coulon A, 2004, MOL ECOL, V13, P2841, DOI 10.1111/j.1365-294X.2004.02253.x; Cushman S, 2013, CONSERVATION THEORY, P32; Cushman SA, 2011, LANDSCAPE ECOL, V26, P1137, DOI 10.1007/s10980-011-9645-8; Cushman SA, 2013, MOVEMENT ECOLOGY, V1, P1, DOI DOI 10.1186/2051-3933-1-12.ARTICLE; Cushman SA, 2006, AM NAT, V168, P486, DOI 10.1086/506976; Cushman SA, 2014, ECOL APPL, V24, P1000, DOI 10.1890/13-1612.1; Cushman Samuel A., 2013, Diversity-Basel, V5, P51; Cushman SA, 2013, CONSERV GENET, V14, P263, DOI 10.1007/s10592-012-0396-0; Cushman SA, 2012, ECOL MODEL, V231, P101, DOI 10.1016/j.ecolmodel.2012.02.011; Cushman SA, 2010, LANDSCAPE ECOL, V25, P1613, DOI 10.1007/s10980-010-9534-6; Cushman SA, 2010, MOL ECOL, V19, P3592, DOI 10.1111/j.1365-294X.2010.04656.x; Cushman SA, 2010, SPATIAL COMPLEXITY, INFORMATICS, AND WILDLIFE CONSERVATION, P349, DOI 10.1007/978-4-431-87771-4_19; Cushman SA, 2010, SPATIAL COMPLEXITY, INFORMATICS, AND WILDLIFE CONSERVATION, P369, DOI 10.1007/978-4-431-87771-4_20; Cushman SA, 2009, CONSERV BIOL, V23, P368, DOI 10.1111/j.1523-1739.2008.01111.x; Davison A, 2002, J ZOOL, V257, P141, DOI 10.1017/S0952836902000730; Dudaniec RY, 2013, MOL ECOL, V22, P3752, DOI 10.1111/mec.12359; Epps CW, 2007, J APPL ECOL, V44, P714, DOI 10.1111/j.1365-2664.2007.01325.x; ESRI, 2009, ARCMAP VERS 9 3; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; Frantz AC, 2003, MOL ECOL, V12, P1649, DOI 10.1046/j.1365-294X.2003.01848.x; Garroway CJ, 2011, MOL ECOL, V20, P3978, DOI 10.1111/j.1365-294X.2011.05243.x; Graves TA, 2013, MOL ECOL, V22, P3888, DOI 10.1111/mec.12348; Guillot G, 2013, METHODS ECOL EVOL, V4, P336, DOI 10.1111/2041-210x.12018; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Gurrutxaga M, 2011, LANDSCAPE URBAN PLAN, V101, P310, DOI 10.1016/j.landurbplan.2011.02.036; Gurrutxaga M, 2010, J NAT CONSERV, V18, P318, DOI 10.1016/j.jnc.2010.01.005; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Institut SNG, 2008, BAS CART NUM BCN200; Jackson ND, 2011, BIOL CONSERV, V144, P3143, DOI 10.1016/j.biocon.2011.09.010; Jenkins DG, 2010, ECOGRAPHY, V33, P315, DOI 10.1111/j.1600-0587.2010.06285.x; Jongman R, 2004, ECOLOGICAL NETWORKS, P368; Jongman R. H. G., 2006, INDICATIVE MAP PAN E; Jongman RHG, 2002, LANDSCAPE URBAN PLAN, V58, P211, DOI 10.1016/S0169-2046(01)00222-5; Koen EL, 2012, LANDSCAPE ECOL, V27, P29, DOI 10.1007/s10980-011-9675-2; Kurki S, 1998, J ANIM ECOL, V67, P874, DOI 10.1046/j.1365-2656.1998.6760874.x; Latch EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027794; Luque S, 2012, LANDSCAPE ECOL, V27, P153, DOI 10.1007/s10980-011-9700-5; Mallarach J. M., 2010, CONNECTIVITY CONSERV, P269; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Manel S, 2013, TRENDS ECOL EVOL, V28, P614, DOI 10.1016/j.tree.2013.05.012; MANTEL N, 1967, CANCER RES, V27, P209; Mergey M, 2012, EUR J WILDLIFE RES, V58, P909, DOI 10.1007/s10344-012-0634-2; Mergey M, 2011, J MAMMAL, V92, P328, DOI 10.1644/09-MAMM-A-366.1; Miller CR, 2002, GENETICS, V160, P357; Mills LS, 2000, ECOL APPL, V10, P283, DOI 10.2307/2641002; Opdam P, 2004, BIOL CONSERV, V117, P285, DOI 10.1016/j.biocon.2003.12.008; Pereboom V, 2008, CAN J ZOOL, V86, P983, DOI 10.1139/Z08-076; Perez-Espona S, 2012, MOL ECOL, V21, P5969, DOI 10.1111/mec.12088; Piggott MP, 2003, WILDLIFE RES, V30, P1, DOI 10.1071/WR02077; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Proulx G, 2004, MARTENS AND FISHERS (MARTES) IN HUMAN-ALTERED ENVIRONMENTS: AN INTERNATIONAL PERSPECTIVE, P21; Quemere E, 2010, MOL ECOL, V19, P1606, DOI 10.1111/j.1365-294X.2010.04581.x; Ray N, 2005, MOL ECOL NOTES, V5, P177, DOI 10.1111/j.1471-8286.2004.00843.x; Rayfield B, 2010, LANDSCAPE ECOL, V25, P519, DOI 10.1007/s10980-009-9436-7; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; Row JR, 2010, MOL ECOL, V19, P5157, DOI 10.1111/j.1365-294X.2010.04872.x; Ruiz-Gonzalez A, 2008, EUR J WILDLIFE RES, V54, P253, DOI 10.1007/s10344-007-0138-7; Ruiz-Gonzalez A, 2013, EUR J WILDLIFE RES, V59, P371, DOI 10.1007/s10344-012-0683-6; Schwartz MK, 2009, ECOLOGY, V90, P3222, DOI 10.1890/08-1287.1; Schwartz MK, 2012, BIOL CONSERVATION MA, P398; Schwartz MK, 2008, NONINVASIVE SURVEY M, P228; Segelbacher G, 2010, CONSERV GENET, V11, P375, DOI 10.1007/s10592-009-0044-5; Shirk AJ, 2010, MOL ECOL, V19, P3603, DOI 10.1111/j.1365-294X.2010.04745.x; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Spear SF, 2010, MOL ECOL, V19, P3576, DOI 10.1111/j.1365-294X.2010.04657.x; Stenglein JL, 2010, J WILDLIFE MANAGE, V74, P1050, DOI 10.2193/2009-305; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2; Wang YH, 2008, LANDSCAPE ECOL, V23, P989, DOI 10.1007/s10980-008-9262-3; Wasserman TN, 2013, CONSERV GENET, V14, P529, DOI 10.1007/s10592-012-0336-z; Wasserman TN, 2010, LANDSCAPE ECOL, V25, P1601, DOI 10.1007/s10980-010-9525-7; Watts PC, 2007, MOL ECOL, V16, P737, DOI 10.1111/j.1365-294X.2006.03184.x; Wright S, 1943, GENETICS, V28, P114; Zalewski A, 2006, ECOGRAPHY, V29, P31, DOI 10.1111/j.2005.0906-7590.04313.x; Zalewski A, 2009, MOL ECOL, V18, P1601, DOI 10.1111/j.1365-294X.2009.04131.x; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0	108	39	40	1	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110552	10.1371/journal.pone.0110552	http://dx.doi.org/10.1371/journal.pone.0110552			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329047	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210800093
J	Kitaura, Y; Hojo, H; Komiyama, Y; Takato, T; Chung, UI; Ohba, S				Kitaura, Yoshiaki; Hojo, Hironori; Komiyama, Yuske; Takato, Tsuyoshi; Chung, Ung-il; Ohba, Shinsuke			Gli1 Haploinsufficiency Leads to Decreased Bone Mass with an Uncoupling of Bone Metabolism in Adult Mice	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; MEDIATED DOWN-REGULATION; MORPHOGENETIC-PROTEIN; INDIAN HEDGEHOG; OSTEOBLAST DIFFERENTIATION; OSTEOCLAST DIFFERENTIATION; ENDOCHONDRAL OSSIFICATION; RANKL EXPRESSION; FRACTURE REPAIR; STEM-CELLS	Hedgehog (Hh) signaling plays important roles in various development processes. This signaling is necessary for osteoblast formation during endochondral ossification. In contrast to the established roles of Hh signaling in embryonic bone formation, evidence of its roles in adult bone homeostasis is not complete. Here we report the involvement of Gli1, a transcriptional activator induced by Hh signaling activation, in postnatal bone homeostasis under physiological and pathological conditions. Skeletal analyses of Gli1(+/-) adult mice revealed that Gli1 haploinsufficiency caused decreased bone mass with reduced bone formation and accelerated bone resorption, suggesting an uncoupling of bone metabolism. Hh-mediated osteoblast differentiation was largely impaired in cultures of Gli1(+/-) precursors, and the impairment was rescued by Gli1 expression via adenoviral transduction. In addition, Gli1(+/-) precursors showed premature differentiation into osteocytes and increased ability to support osteoclastogenesis. When we compared fracture healing between wild-type and Gli1(+/-) adult mice, we found that the Gli1(+/-) mice exhibited impaired fracture healing with insufficient soft callus formation. These data suggest that Gli1, acting downstream of Hh signaling, contributes to adult bone metabolism, in which this molecule not only promotes osteoblast differentiation but also represses osteoblast maturation toward osteocytes to maintain normal bone homeostasis.	[Kitaura, Yoshiaki; Hojo, Hironori; Komiyama, Yuske; Takato, Tsuyoshi] Univ Tokyo, Grad Sch Med, Dept Sensory & Motor Syst Med, Bunkyo Ku, Tokyo, Japan; [Kitaura, Yoshiaki; Hojo, Hironori; Komiyama, Yuske; Chung, Ung-il; Ohba, Shinsuke] Univ Tokyo, Grad Sch Med, Div Clin Biotechnol, Bunkyo Ku, Tokyo, Japan; [Chung, Ung-il; Ohba, Shinsuke] Univ Tokyo, Dept Bioengn, Grad Sch Engn, Bunkyo Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Ohba, S (corresponding author), Univ Tokyo, Grad Sch Med, Div Clin Biotechnol, Bunkyo Ku, Tokyo, Japan.	ohba@bioeng.t.u-tokyo.ac.jp		Hojo, Hironori/0000-0003-2245-6853; Ohba, Shinsuke/0000-0002-6874-8539	Center for Medical System Innovation; Graduate Program for Leaders in Life Innovation, Core-to-Core Program A (Advanced Research Networks); Funding Program for World-Leading Innovative R&D on Science and Technology; Center for NanoBio Integration; S-innovation Program;  [23689079]	Center for Medical System Innovation; Graduate Program for Leaders in Life Innovation, Core-to-Core Program A (Advanced Research Networks); Funding Program for World-Leading Innovative R&D on Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center for NanoBio Integration; S-innovation Program; 	This work was supported by a Grant-in-Aid for Young Scientists (#23689079), the Center for Medical System Innovation, the Graduate Program for Leaders in Life Innovation, Core-to-Core Program A (Advanced Research Networks), the Funding Program for World-Leading Innovative R&D on Science and Technology, the Center for NanoBio Integration, and the S-innovation Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akune T, 2002, J CELL BIOL, V159, P147, DOI 10.1083/jcb.200204046; Chung UI, 2001, J CLIN INVEST, V107, P295, DOI 10.1172/JCI11706; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Heller E, 2012, CANCER RES, V72, P897, DOI 10.1158/0008-5472.CAN-11-2681; Hilton MJ, 2005, DEVELOPMENT, V132, P4339, DOI 10.1242/dev.02025; Hojo H, 2013, J BIOL CHEM, V288, P9924, DOI 10.1074/jbc.M112.409342; Hojo H, 2012, J BIOL CHEM, V287, P17860, DOI 10.1074/jbc.M112.347716; Horikiri Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076785; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Joeng KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055134; Joeng KS, 2009, DEVELOPMENT, V136, P4177, DOI 10.1242/dev.041624; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kugimiya F, 2005, J BIOL CHEM, V280, P35704, DOI 10.1074/jbc.M505166200; Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006; Long FX, 2001, DEVELOPMENT, V128, P5099; Maeda Y, 2007, P NATL ACAD SCI US; Mak KK, 2008, DEV CELL, V14, P674, DOI 10.1016/j.devcel.2008.02.003; Miyaji T, 2003, HISTOCHEM CELL BIOL, V119, P233, DOI 10.1007/s00418-003-0501-z; Murao H, 2013, J BONE MINER METAB, V31, P390, DOI 10.1007/s00774-013-0429-x; Nakase T, 2001, HISTOCHEM CELL BIOL, V116, P277, DOI 10.1007/s004180100320; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Ogasawara T, 2004, MOL CELL BIOL, V24, P6560, DOI 10.1128/mcb.24.15.6560-6568.2004; Ogasawara T, 2004, J BONE MINER RES, V19, P1128, DOI 10.1359/jbmr.2004.19.7.1128; Ogata N, 2000, J CLIN INVEST, V105, P935, DOI 10.1172/JCI9017; Ohba S, 2008, DEV CELL, V14, P689, DOI 10.1016/j.devcel.2008.03.007; Ohba S, 2007, FASEB J, V21, P1777, DOI 10.1096/fj.06-7571com; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Park HL, 2000, DEVELOPMENT, V127, P1593; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Shimoaka T, 2004, J BIOL CHEM, V279, P15314, DOI 10.1074/jbc.M312525200; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Udagawa N, 2000, ENDOCRINOLOGY, V141, P3478, DOI 10.1210/en.141.9.3478; Vortkamp A, 1998, MECH DEVELOP, V71, P65, DOI 10.1016/S0925-4773(97)00203-7; Wang Q, 2010, AM J PATHOL, V177, P3100, DOI 10.2353/ajpath.2010.100060; Yamamoto A, 2002, J BONE MINER RES, V17, P612, DOI 10.1359/jbmr.2002.17.4.612; Zhang XX, 2013, STEM CELLS, V31, P2667, DOI 10.1002/stem.1371	41	27	32	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109597	10.1371/journal.pone.0109597	http://dx.doi.org/10.1371/journal.pone.0109597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313900	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500060
J	Vasconcellos, SEG; Acosta, CC; Gomes, LL; Conceicao, EC; Lima, KV; de Araujo, MI; Leite, MD; Tannure, F; Caldas, PCD; Gomes, HM; Santos, AR; Gomgnimbou, MK; Sola, C; Couvin, D; Rastogi, N; Boechat, N; Suffys, PN				Vasconcellos, Sidra E. G.; Acosta, Chyntia Carolina; Gomes, Lia Lima; Conceicao, Emilyn Costa; Lima, Karla Valeria; de Araujo, Marcelo Ivens; Leite, Maria de Lourdes; Tannure, Flavio; de Souza Caldas, Paulo Cesar; Gomes, Harrison M.; Santos, Adalberto Rezende; Gomgnimbou, Michel K.; Sola, Christophe; Couvin, David; Rastogi, Nalin; Boechat, Neio; Suffys, Philip Noel			Strain Classification of Mycobacterium tuberculosis Isolates in Brazil Based on Genotypes Obtained by Spoligotyping, Mycobacterial Interspersed Repetitive Unit Typing and the Presence of Large Sequence and Single Nucleotide Polymorphism	PLOS ONE			English	Article							AMERICAN-MEDITERRANEAN FAMILY; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; GLOBAL DISSEMINATION; POPULATION-STRUCTURE; SOUTHERN BRAZIL; COMPLEX; DATABASE; SUBLINEAGE; PHYLOGENY	Rio de Janeiro is endemic for tuberculosis (TB) and presents the second largest prevalence of the disease in Brazil. Here, we present the bacterial population structure of 218 isolates of Mycobacterium tuberculosis, derived from 186 patients that were diagnosed between January 2008 and December 2009. Genotypes were generated by means of spoligotyping, 24 MIRU-VNTR typing and presence of fbpC(103), RDRio and RD174. The results confirmed earlier data that predominant genotypes in Rio de Janeiro are those of the Euro American Lineages (99%). However, we observed differences between the classification by spoligotyping when comparing to that of 24 MIRU-VNTR typing, being respectively 43.6% vs. 62.4% of LAM, 34.9% vs. 9.6% of T and 18.3% vs. 21.5% of Haarlem. Among isolates classified as LAM by MIRU typing, 28.0% did not present the characteristic spoligotype profile with absence of spacers 21 to 24 and 32 to 36 and we designated these conveniently as "LAM-like", 79.3% of these presenting the LAM-specific SNP fbpC(103). The frequency of RDRio and RD174 in the LAM strains, as defined both by spoligotyping and 24 MIRU-VNTR loci, were respectively 11% and 15.4%, demonstrating that RD174 is not always a marker for LAM/RDRio strains. We conclude that, although spoligotyping alone is a tool for classification of strains of the Euro-American lineage, when combined with MIRU-VNTRs, SNPs and RD typing, it leads to a much better understanding of the bacterial population structure and phylogenetic relationships among strains of M. tuberculosis in regions with high incidence of TB.	[Vasconcellos, Sidra E. G.; Gomes, Lia Lima; de Araujo, Marcelo Ivens; Gomes, Harrison M.; Santos, Adalberto Rezende; Suffys, Philip Noel] Fiocruz MS, Inst Oswaldo Cruz, Lab Mol Biol Appl Mycobacteria, BR-21045900 Rio De Janeiro, Brazil; [Acosta, Chyntia Carolina] Fiocruz MS, Inst Oswaldo Cruz, Lab Cellular Microbiol, BR-21045900 Rio De Janeiro, Brazil; [Conceicao, Emilyn Costa; Lima, Karla Valeria] Inst Evandro Chagas, Sect Bacteriol & Mycol, Belem, Para, Brazil; [Leite, Maria de Lourdes; Tannure, Flavio] Municipal Secretary Hlth, Hosp Municipal Rafael de Paula Souza, Rio De Janeiro, Brazil; [de Souza Caldas, Paulo Cesar] Fiocruz MS, Escola Nacl Saude Publ Sergio Arouca, Ctr Referencia Prof Helio Fraga, BR-21045900 Rio De Janeiro, Brazil; [Gomgnimbou, Michel K.; Sola, Christophe] Univ Paris 11, CNRS, Inst Genet & Microbiol, Infect Genet Emerging Pathogens Evolut Team, F-91405 Orsay, France; [Couvin, David; Rastogi, Nalin] Inst Pasteur Guadeloupe, Supranatl TB Reference Lab, Unite TB & Mycobacteries, Abymes, Guadeloupe, France; [Vasconcellos, Sidra E. G.; Boechat, Neio] Univ Fed Rio de Janeiro, Univ Hosp Clementino Fraga Filho HUCFF, Multidisciplinary Res Lab, Rio De Janeiro, Brazil; [Boechat, Neio] Univ Hosp Clementino Fraga Filho, Fac Med, Grad Program Clin Med, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Instituto Evandro Chagas; Fundacao Oswaldo Cruz; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Universidade Federal do Rio de Janeiro	Suffys, PN (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Mol Biol Appl Mycobacteria, BR-21045900 Rio De Janeiro, Brazil.	psuffys@gmail.com	CONCEICAO, EMILYN COSTA/K-1170-2015; Sola, Christophe/A-7992-2016; Lima, Karla Valéria/AAF-8256-2021; vasconcellos, Sidra E G Ezidio gonçalves/H-9651-2014; suffys, philip/E-3009-2013; Lima, Karla Valeria Batista/N-6531-2016; RASTOGI, NALIN/AAP-1958-2020; DIAZ ACOSTA, CHYNTIA CAROLINA/GNP-0468-2022	CONCEICAO, EMILYN COSTA/0000-0002-7445-6620; Sola, Christophe/0000-0003-4672-2140; Lima, Karla Valéria/0000-0001-5807-0392; vasconcellos, Sidra E G Ezidio gonçalves/0000-0001-6983-1310; Lima, Karla Valeria Batista/0000-0001-5807-0392; RASTOGI, NALIN/0000-0002-7199-7747; Couvin, David/0000-0002-7897-9023; DIAZ ACOSTA, CHYNTIA CAROLINA/0000-0002-8541-8312	PAPES/CNPq [407624/2012-0]; PROEP/CNPq of the Oswaldo Cruz Institute (IOC); CNPq [142958/2008-5]	PAPES/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PROEP/CNPq of the Oswaldo Cruz Institute (IOC); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by funding by Brazilian funding agencies PAPES/CNPq (407624/2012-0), PROEP/CNPq of the Oswaldo Cruz Institute (IOC), and CNPq PhD grant (142958/2008-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia E, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-122; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P1398, DOI 10.1128/JCM.02089-07; Borile C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-224; Brudey K, 2006, J CLIN MICROBIOL, V44, P183, DOI 10.1128/JCM.44.1.183-191.2006; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Cerezo I, 2012, INFECT GENET EVOL, V12, P657, DOI 10.1016/j.meegid.2011.07.006; Chacon-Salinas R, 2005, CLIN EXP IMMUNOL, V140, P443, DOI 10.1111/j.1365-2249.2005.02797.x; Chuang PC, 2010, INFECT GENET EVOL, V10, P459, DOI 10.1016/j.meegid.2010.03.003; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cowan LS, 2005, J CLIN MICROBIOL, V43, P688, DOI 10.1128/JCM.43.2.688-695.2005; Dale JW, 1999, J CLIN MICROBIOL, V37, P1265, DOI 10.1128/JCM.37.5.1265-1268.1999; Costa ERD, 2013, J CLIN MICROBIOL, V51, P1071, DOI 10.1128/JCM.01511-12; David S, 2012, INFECT GENET EVOL, V12, P1362, DOI 10.1016/j.meegid.2012.04.021; de Jong BC, 2009, J CLIN MICROBIOL, V47, P994, DOI 10.1128/JCM.01216-08; de Miranda SS, 2011, MEM I OSWALDO CRUZ, V106, P267, DOI 10.1590/S0074-02762011000300003; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Dos Vultos T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001538; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Filliol I, 2002, EMERG INFECT DIS, V8, P1347, DOI 10.3201/eid0811.020125; Ford C, 2012, TUBERCULOSIS, V92, P194, DOI 10.1016/j.tube.2011.11.003; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; de Viedma DG, 2011, ENFERM INFEC MICR CL, V29, P8, DOI 10.1016/S0213-005X(11)70012-X; Gibson AL, 2008, J CLIN MICROBIOL, V46, P1259, DOI 10.1128/JCM.02231-07; Goh KS, 2005, J CLIN MICROBIOL, V43, P4010, DOI 10.1128/JCM.43.8.4010-4014.2005; Gomes HM, 2012, INFECT GENET EVOL, V12, P649, DOI 10.1016/j.meegid.2011.08.027; Gonzalo X, 2011, EMERG INFECT DIS, V17, P528, DOI 10.3201/eid1703.100394; Graur D, 2000, FUNDAMENTALS MOL EVO, P58; Hill V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041991; Homolka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039855; Huard RC, 2006, J BACTERIOL, V188, P4271, DOI 10.1128/JB.01783-05; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kato-Maeda M, 2011, INT J TUBERC LUNG D, V15, P131; Lazzarini LCO, 2012, INFECT GENET EVOL, V12, P798, DOI 10.1016/j.meegid.2011.08.028; Lopes JS, 2013, INFECT GENET EVOL, V18, P238, DOI 10.1016/j.meegid.2013.04.028; Mendes Natalia H, 2011, BMC Res Notes, V4, P269, DOI 10.1186/1756-0500-4-269; Mokrousov I, 2014, J BACTERIOL, V196, P1833, DOI 10.1128/JB.01485-13; Musser JM, 2000, GENETICS, V155, P7; Nakanishi N, 2013, INFECT GENET EVOL, V16, P174, DOI 10.1016/j.meegid.2013.02.007; Noguti EN, 2010, MEM I OSWALDO CRUZ, V105, P779, DOI 10.1590/S0074-02762010000600008; Oelemann MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018256; Lazzarini LCO, 2008, J CLIN MICROBIOL, V46, P2175, DOI 10.1128/JCM.00065-08; Lazzarini LCO, 2007, J CLIN MICROBIOL, V45, P3891, DOI 10.1128/JCM.01394-07; Perizzolo PF, 2012, TUBERCULOSIS, V92, P56, DOI 10.1016/j.tube.2011.09.008; Rindi L, 2012, INFECT GENET EVOL, V12, P1551, DOI 10.1016/j.meegid.2012.06.008; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Secretaria de Vigilancia em Saude - Ministerio da Saude Especial Tuberculose, 2012, B EPIDEMIOLOGICO, V43; Luiz RDS, 2013, BRAZ J INFECT DIS, V17, P338, DOI 10.1016/j.bjid.2012.10.019; Sola C, 2001, EMERG INFECT DIS, V7, P390; Sola C, 2003, INFECT GENET EVOL, V3, P125, DOI 10.1016/S1567-1348(03)00011-X; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Stavrum R, 2009, J CLIN MICROBIOL, V47, P1848, DOI 10.1128/JCM.02167-08; Stucki D, 2013, TUBERCULOSIS, V93, P30, DOI 10.1016/j.tube.2012.11.002; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Vasconcellos SEG, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-80; Vinhas SA, 2013, TUBERCULOSIS, V93, P207, DOI 10.1016/j.tube.2012.09.001; Von Groll A, 2010, FEMS IMMUNOL MED MIC, V58, P119, DOI 10.1111/j.1574-695X.2009.00611.x; Warren RM, 2002, J CLIN MICROBIOL, V40, P4457, DOI 10.1128/JCM.40.12.4457-4465.2002; Weisenberg SA, 2012, INFECT GENET EVOL, V12, P664, DOI 10.1016/j.meegid.2011.07.018; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; Zhang J, 2010, J MED MICROBIOL, V59, P285, DOI 10.1099/jmm.0.016949-0	62	28	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e107747	10.1371/journal.pone.0107747	http://dx.doi.org/10.1371/journal.pone.0107747			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314118	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500006
J	Aresti, U; Carrera, S; Iruarrizaga, E; Fuente, N; Marrodan, I; de Lobera, AR; Munoz, A; Buque, A; Condori, E; Ugalde, I; Calvo, B; Vivanco, G				Aresti, Unai; Carrera, Sergio; Iruarrizaga, Eluska; Fuente, Natalia; Marrodan, Ines; Ruiz de Lobera, Abigail; Munoz, Alberto; Buque, Aitziber; Condori, Elizabeth; Ugalde, Irene; Calvo, Begona; Lopez Vivanco, Guillermo			Estrogen Receptor 1 Gene Expression and Its Combination with Estrogen Receptor 2 or Aromatase Expression Predicts Survival in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							IMMUNOHISTOCHEMICAL EXPRESSION; BREAST-CANCER; MESSENGER-RNA; COLON-CANCER; BETA; ALPHA; GROWTH; WOMEN; TISSUE; EGFR	The biological roles of estrogen receptor 1 (ERS1), estrogen receptor 2 (ERS2), and aromatase (CYP19A1) genes in the development of non-small cell lung cancer (NSCLC) is unclear, as is the use of their expression as a prognostic factor. The aim of this study was to investigate the prognostic value of estrogen receptors and aromatase mRNA expression, along with aromatase protein concentration, in resected NSCLC patients. Tumor and non-tumor lung tissue samples were analyzed for the mRNA expression of ERS1, ERS2 and CYP19A1 by RT-PCR. Aromatase concentration was measured with an ELISA. A total of 96 patients were included. ERS1 expression was significantly higher in non-tumor tissue than in tumor samples. Two gene expression categories were created for each gene (and protein): high and low. ERS1 high category showed increased overall survival (OS) when compared to the low expression category. Aromatase protein concentration was significantly higher in tumor samples. Higher ERS1 expression in tumor tissues was related to longer overall survival. The analysis of gene expression combinations provides evidence for longer OS when both ERS1 and ERS2 are highly expressed. ESR1, alone or in combination with ERS2 or CYP19A1, is the most determining prognostic factor within the analyzed 3 genes. It seems that ERS1 can play a role in NSCLC prognosis, alone or in combination with other genes such as ERS2 or Cyp19a1. ERS2 in combination with aromatase concentration could have a similar function.	[Aresti, Unai; Buque, Aitziber; Calvo, Begona] Cruces Univ Hosp, BioCruces Hlth Res Inst, Oncol Res Lab, Baracaldo, Bizkaia, Spain; [Carrera, Sergio; Iruarrizaga, Eluska; Fuente, Natalia; Marrodan, Ines; Ruiz de Lobera, Abigail; Munoz, Alberto; Condori, Elizabeth; Ugalde, Irene; Lopez Vivanco, Guillermo] Cruces Univ Hosp, Dept Med Oncol, Baracaldo, Bizkaia, Spain	Hospital Universitario Cruces; Hospital Universitario Cruces	Aresti, U (corresponding author), Cruces Univ Hosp, BioCruces Hlth Res Inst, Oncol Res Lab, Baracaldo, Bizkaia, Spain.	unai.arestigoiriena@osakidetza.net		, Aitziber/0000-0002-7698-8778	Basque Broadcasting Corporation (EITB) Cancer Marathon [PROYECT BIO07/CA/012]; Instituto de Salud Carlos III of the Spanish Ministry of Economy and Competitiveness (ISCIII) [RD06/0020/0067]	Basque Broadcasting Corporation (EITB) Cancer Marathon; Instituto de Salud Carlos III of the Spanish Ministry of Economy and Competitiveness (ISCIII)	This study was supported by a grant (PROYECT BIO07/CA/012) from the Basque Broadcasting Corporation (EITB; www.eitb.com) Cancer Marathon. Funding to pay the Open Access publication charges for this article was provided by the Instituto de Salud Carlos III of the Spanish Ministry of Economy and Competitiveness (grant: RD06/0020/0067, ISCIII). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2010, HUM PATHOL, V41, P190, DOI 10.1016/j.humpath.2009.07.010; American Cancer Society, 2014, CANC FACTS FIG 2014; Arai N, 2000, BIOCHEM BIOPH RES CO, V270, P425, DOI 10.1006/bbrc.2000.2444; Atmaca A, 2014, INT J CANCER, V134, P2314, DOI 10.1002/ijc.28571; Brueckl WM, 2013, INT J CANCER, V133, P1825, DOI 10.1002/ijc.28209; Campbell-Thompson M, 2001, CANCER RES, V61, P632; Chen GG, 2008, MED RES REV, V28, P954, DOI 10.1002/med.20131; Fasco MJ, 2002, MOL CELL ENDOCRINOL, V188, P125, DOI 10.1016/S0303-7207(01)00750-X; Foster PA, 2008, MINERVA ENDOCRINOL, V33, P27; Gomez-Fernandez C, 2010, APPL IMMUNOHISTO M M, V18, P137, DOI 10.1097/PAI.0b013e3181bec23b; Hershberger PA, 2005, CANCER RES, V65, P1598, DOI 10.1158/0008-5472.CAN-04-2694; Kawai H, 2005, ANTICANCER RES, V25, P4693; Kawai H, 2005, CLIN CANCER RES, V11, P5084, DOI 10.1158/1078-0432.CCR-05-0200; Mah V, 2007, CANCER RES, V67, P10484, DOI 10.1158/0008-5472.CAN-07-2607; Mah V, 2011, LUNG CANCER, V74, P318, DOI 10.1016/j.lungcan.2011.03.009; Marquez-Garban DC, 2007, STEROIDS, V72, P135, DOI 10.1016/j.steroids.2006.11.019; Marquez-Garban DC, 2009, ANN NY ACAD SCI, V1155, P194, DOI 10.1111/j.1749-6632.2009.04116.x; Miki Y, 2011, MOL CELL ENDOCRINOL, V340, P168, DOI 10.1016/j.mce.2011.02.018; Mollerup S, 2002, LUNG CANCER, V37, P153, DOI 10.1016/S0169-5002(02)00039-9; Olivo-Marston SE, 2010, CARCINOGENESIS, V31, P1778, DOI 10.1093/carcin/bgq156; Oyama T, 2009, FRONT BIOSCI-LANDMRK, V14, P2285, DOI 10.2741/3379; Pearce ST, 2004, CRIT REV ONCOL HEMAT, V50, P3, DOI 10.1016/j.critrevonc.2003.09.003; Pietras RJ, 2005, STEROIDS, V70, P372, DOI 10.1016/j.steroids.2005.02.017; Rades D, 2012, CANCER-AM CANCER SOC, V118, P157, DOI 10.1002/cncr.26282; Raso MG, 2009, CLIN CANCER RES, V15, P5359, DOI 10.1158/1078-0432.CCR-09-0033; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Skov BG, 2008, LUNG CANCER, V59, P88, DOI 10.1016/j.lungcan.2007.07.025; Stabile Laura P, 2004, Curr Oncol Rep, V6, P259, DOI 10.1007/s11912-004-0033-2; Stabile LP, 2011, CLIN CANCER RES, V17, P154, DOI 10.1158/1078-0432.CCR-10-0992; Stabile LP, 2002, CANCER RES, V62, P2141; TAIOLI E, 1994, J NATL CANCER I, V86, P869, DOI 10.1093/jnci/86.11.869; Verma MK, 2012, LIFE SCI, V91, P800, DOI 10.1016/j.lfs.2012.08.029; Wu CT, 2005, J THORAC CARDIOV SUR, V130, P979, DOI 10.1016/j.jtcvs.2005.06.012; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Zeng Q, 2007, CELL PROLIFERAT, V40, P921, DOI 10.1111/j.1365-2184.2007.00471.x	35	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109659	10.1371/journal.pone.0109659	http://dx.doi.org/10.1371/journal.pone.0109659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310221	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210300067
J	Chen, QY; Lee, CE; Denard, B; Ye, J				Chen, Qiuyue; Lee, Ching-En; Denard, Bray; Ye, Jin			Sustained Induction of Collagen Synthesis by TGF-beta Requires Regulated Intramembrane Proteolysis of CREB3L1	PLOS ONE			English	Article							AORTIC-ANEURYSM; MICE; TRANSITION; MECHANISMS; PATHWAY; GROWTH; OASIS	CREB3L1 (cAMP response element binding protein 3-like 1), a transcription factor synthesized as a membrane-bound precursor and activated through Regulated Intramembrane Proteolysis (RIP), is essential for collagen production by osteoblasts during bone development. Here, we show that TGF-beta (transforming growth factor-beta), a cytokine known to stimulate production of collagen during wound healing and fibrotic diseases, induces proteolytic activation of CREB3L1 in human A549 cells. This activation results from inhibition of expression of TM4SF20 (transmembrane 4 L6 family member 20), which normally inhibits RIP of CREB3L1. Cleavage of CREB3L1 releases its NH2-terminal domain from membranes, allowing it to enter the nucleus where it binds to Smad4 to activate transcription of genes encoding proteins required for assembly of collagen-containing extracellular matrix. Our findings raise the possibility that inhibition of RIP of CREB3L1 could prevent excess deposition of collagen in certain fibrotic diseases.	[Chen, Qiuyue; Lee, Ching-En; Denard, Bray; Ye, Jin] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Ye, J (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	jin.ye@utsouthwestern.edu			National Institutes of Health [AI-090119, HL-20948, AI-70116]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090119, T32AI070116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health AI-090119 (JY), National Institutes of Health HL-20948 (JY), and National Institutes of Health AI-70116 (BD, www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Burch ML, 2011, CELL MOL LIFE SCI, V68, P97, DOI 10.1007/s00018-010-0514-4; Denard B, 2012, ELIFE, V1, DOI 10.7554/eLife.00090; Denard B, 2011, CELL HOST MICROBE, V10, P65, DOI 10.1016/j.chom.2011.06.006; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Egeblad M, 2010, CURR OPIN CELL BIOL, V22, P697, DOI 10.1016/j.ceb.2010.08.015; Habashi JP, 2011, SCIENCE, V332, P361, DOI 10.1126/science.1192152; Hawkins JL, 2008, J PHARMACOL EXP THER, V326, P801, DOI 10.1124/jpet.108.139626; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Iverson C, 2009, CANCER RES, V69, P6839, DOI 10.1158/0008-5472.CAN-09-0679; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Loeys BL, 2013, PEDIATR ENDOCR REV P, V10, P417; Martinek N, 2007, J DENT RES, V86, P296, DOI 10.1177/154405910708600402; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nguyen VT, 2000, AM J PATHOL, V157, P1377, DOI 10.1016/S0002-9440(10)64651-2; Olmstead AD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002468; Qi B, 2009, CURR PHARM DESIGN, V15, P2336, DOI 10.2174/138161209788682352; Rosenbloom J, 2010, ANN INTERN MED, V152, P159, DOI 10.7326/0003-4819-152-3-201002020-00007; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Thompson N, 2005, CURR OPIN PHARMACOL, V5, P350, DOI 10.1016/j.coph.2005.04.007; Tsukita S, 2002, CURR OPIN CELL BIOL, V14, P531, DOI 10.1016/S0955-0674(02)00362-9; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang CF, 2005, MOL CELL, V18, P425, DOI 10.1016/j.molcel.2005.04.004; Wright MD, 2000, PROTEIN SCI, V9, P1594, DOI 10.1110/ps.9.8.1594	35	33	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e108528	10.1371/journal.pone.0108528	http://dx.doi.org/10.1371/journal.pone.0108528			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310401	gold, Green Published, Green Submitted			2022-12-27	WOS:000343210300021
J	Kim, H; Kim, K; Jin, J; Park, J; Yu, SJ; Yoon, JH; Kim, Y				Kim, Hyunsoo; Kim, Kyunggon; Jin, Jonghwa; Park, Jiyoung; Yu, Su Jong; Yoon, Jung-Hwan; Kim, Youngsoo			Measurement of Glycosylated Alpha-Fetoprotein Improves Diagnostic Power over the Native Form in Hepatocellular Carcinoma	PLOS ONE			English	Article							GAMMA-CARBOXY PROTHROMBIN; PROTEIN GLYCOSYLATION; FUCOSYLATION INDEX; REACTIVE FRACTION; BIOMARKERS; MARKER; ULTRASONOGRAPHY; RECURRENCE; CIRRHOSIS; DISEASE	Serum alpha-fetoprotein (AFP) has long been used as a diagnostic marker for hepatocellular carcinoma (HCC), albeit controversially. Although it remains widely used in clinics, the value of AFP in HCC diagnosis has recently been challenged due to its significant rates of false positive and false negative findings. To improve the efficacy of AFP as HCC diagnostic marker, we developed a method of measuring total and glycosylated AFP by multiple reaction monitoring (MRM)-MS. In this study, we verified the total amount of AFP (nonglycopeptide levels) and the degree of glycosylated AFP (deglycopeptide levels) in 60 normal (41 men and 19 women; mean age 53 years; range 32-74 years), 35 LC (23 men and 12 women; mean age 56 years; range 43-78 years; HBV-related), and 60 HCC subjects (42 men and 18 women; mean age 58 years; range 38-76 years; HBV-related; 30 stage I, 15 stage II, and 10 stage III). By MRM-MS analysis, the nonglycopeptide had 56.7% sensitivity, 68.3% specificity, and an AUC of 0.687 [cutoff value: >= 0.02 (light/heavy ratio)], comparing the normal and HCC group, whereas the deglycopeptide had 93.3% sensitivity, 68.3% specificity, and an AUC of 0.859 [cutoff value: >= 0.02 (light/heavy ratio)]. In comparing the stage I HCC subgroup with the LC group, the nonglycopeptide had a sensitivity of 66.7%, specificity of 80.0%, and an AUC of 0.712 [cutoff value: >= 0.02 (light/heavy ratio)], whereas the deglycopeptide had a sensitivity of 96.7%, specificity of 80.0%, and an AUC of 0.918 [cutoff value: >= 0.02 (light/heavy ratio)]. These data demonstrate that the discriminatory power of the deglycopeptide is greater than that of the nonglycopeptide. We conclude that deglycopeptide can distinguish cancer status between normal subjects and HCC patients better than nonglycopeptide.	[Kim, Hyunsoo; Park, Jiyoung; Kim, Youngsoo] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Kim, Kyunggon; Jin, Jonghwa; Kim, Youngsoo] Seoul Natl Univ, Coll Med, Dept Biomed Engn, Seoul, South Korea; [Yu, Su Jong; Yoon, Jung-Hwan] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, Y (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.	biolab@snu.ac.kr	Kim, Youngsoo/D-6046-2012	Yoon, Jung-Hwan/0000-0002-9128-3610; Yu, Su Jong/0000-0001-8888-7977; Kim, Hyunsoo/0000-0002-8441-3376	National Research Foundation of Korea grant [2011-0030740]; Proteogenomic Research Program - Korea government [MISP]; Industrial Strategic Technology Development Program - Ministry of Knowledge Economy (MKE, Korea) [10045352]	National Research Foundation of Korea grant(National Research Foundation of Korea); Proteogenomic Research Program - Korea government [MISP]; Industrial Strategic Technology Development Program - Ministry of Knowledge Economy (MKE, Korea)	This work was supported by a National Research Foundation of Korea grant (No. 2011-0030740) and the Proteogenomic Research Program, funded by the Korea government [MISP]. This work was also supported by the Industrial Strategic Technology Development Program (#10045352), funded by the Ministry of Knowledge Economy (MKE, Korea). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi A, 2008, DIS MARKERS, V25, P193, DOI 10.1155/2008/863032; An HJ, 2009, CURR OPIN CHEM BIOL, V13, P601, DOI 10.1016/j.cbpa.2009.08.015; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; AOYAGI Y, 1988, CANCER-AM CANCER SOC, V61, P769, DOI 10.1002/1097-0142(19880215)61:4<769::AID-CNCR2820610422>3.0.CO;2-M; AOYAGI Y, 1993, HEPATOLOGY, V17, P50, DOI 10.1002/hep.1840170110; Bertozzi C.R., 2009, ESSENTIALS GLYCOBIOL; Boja E, 2010, BIOMARK MED, V4, P799, DOI 10.2217/BMM.10.92; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chu CW, 2001, J CLIN GASTROENTEROL, V32, P240, DOI 10.1097/00004836-200103000-00014; Colli A, 2006, AM J GASTROENTEROL, V101, P513, DOI 10.1111/j.1572-0241.2006.00467.x; Cui RT, 2002, CHINESE MED J-PEKING, V115, P42; Daniele B, 2004, GASTROENTEROLOGY, V127, pS108, DOI 10.1053/j.gastro.2004.09.023; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Drake PM, 2010, CLIN CHEM, V56, P223, DOI 10.1373/clinchem.2009.136333; Durand G, 2000, CLIN CHEM, V46, P795; Farinati F, 2006, AM J GASTROENTEROL, V101, P524, DOI 10.1111/j.1572-0241.2006.00443.x; Hayashi K, 1999, AM J GASTROENTEROL, V94, P3028, DOI 10.1016/S0002-9270(99)00434-7; Hua S, 2012, BMB REP, V45, P323, DOI 10.5483/BMBRep.2012.45.6.132; Kamoto T, 2002, JPN J CLIN ONCOL, V32, P472, DOI 10.1093/jjco/hyf094; Khan KN, 2000, J HEPATOL, V32, P269, DOI 10.1016/S0168-8278(00)80072-0; Khien VV, 2001, INT J BIOL MARKER, V16, P105, DOI 10.1177/172460080101600204; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063468; Koike Y, 2001, CANCER, V91, P561, DOI 10.1002/1097-0142(20010201)91:3<561::AID-CNCR1035>3.0.CO;2-N; Kulik LM, 2007, CURR OPIN GASTROEN, V23, P268, DOI 10.1097/MOG.0b013e3280ec5113; Lai Q, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/893103; Lee JY, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.009290-1, 10.1074/mcp.M111.009290]; Li D, 2001, CLIN CHIM ACTA, V313, P15, DOI 10.1016/S0009-8981(01)00644-1; Malaguarnera G, 2010, DIGEST DIS SCI, V55, P2744, DOI 10.1007/s10620-010-1184-7; Marrero JA, 2003, HEPATOLOGY, V37, P1114, DOI 10.1053/jhep.2003.50195; Miyoshi E, 1999, BBA-GEN SUBJECTS, V1473, P9, DOI 10.1016/S0304-4165(99)00166-X; Nagaoka S, 2003, CANCER, V98, P2671, DOI 10.1002/cncr.11839; Oda K, 2011, ONCOL REP, V26, P1227, DOI 10.3892/or.2011.1425; Peracaula R, 2008, DIS MARKERS, V25, P207, DOI 10.1155/2008/797629; Qin LX, 2014, CLIN CANCER RES, V20, P3371, DOI 10.1158/1078-0432.CCR-13-3155; Reis CA, 2010, J CLIN PATHOL, V63, P322, DOI 10.1136/jcp.2009.071035; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; TAKETA K, 1993, CANCER RES, V53, P5419; Wang BH, 2012, J PROTEOME RES, V11, P1217, DOI 10.1021/pr2009252; Witjes CDM, 2013, HEPATOL INT, V7, P59, DOI 10.1007/s12072-012-9374-3; Yamashiki N, 1999, ONCOL REP, V6, P1229; Zhou L, 2012, HEPATO-GASTROENTEROL, V59, P840, DOI 10.5754/hge10404	41	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110366	10.1371/journal.pone.0110366	http://dx.doi.org/10.1371/journal.pone.0110366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310463	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210300109
J	Lamarre, NS; Braverman, AS; Malykhina, AP; Barbe, MF; Ruggieri, MR				Lamarre, Neil S.; Braverman, Alan S.; Malykhina, Anna P.; Barbe, Mary F.; Ruggieri, Michael R., Sr.			Alterations in Nerve-Evoked Bladder Contractions in a Coronavirus-Induced Mouse Model of Multiple Sclerosis	PLOS ONE			English	Article							INDUCED DEMYELINATION; DYSFUNCTION; PATHOPHYSIOLOGY; THERAPY; DISEASE; REFLEX	Background: Patients with neurodegenerative diseases such as multiple sclerosis, Parkinson's, and Alzheimer's often present with lower urinary tract symptoms (LUTS, urinary frequency, urgency, nocturia and retention) resulting from damage to the peripheral and central nervous systems. These studies were designed to examine the changes in the function of the bladder that may underlie neurogenic bladder dysfunction using a mouse model of demyelination in the CNS. Methods: Bladders from 12 week old male C57BL/6J mice with coronavirus-induced encephalomyelitis (CIE, a chronic, progressive demyelinating disease model of human MS), and age-matched controls, were cut into 5-7 strips and suspended in physiological muscle baths for tension measurement in response to agonists and electric field stimulation (EFS). Experiments were performed on intact and denuded (with mucosa removed) bladder strips. Results: The maximum effect of EFS was not significantly different between CIE and control bladders. Nerve-evoked EFS contractions (tetrodotoxin-sensitive) were blocked by a combination of atropine (cholinergic antagonist) and alpha,beta-methylene ATP (an ATP analog that desensitizes purinergic receptors). In response to EFS, the a, b-methylene ATP-resistant (cholinergic) component of contraction was significantly reduced, while the atropine-resistant (purinergic) component was significantly increased in CIE bladders. Removal of the mucosa in CIE bladders restored the cholinergic component. Bethanechol (muscarinic receptor agonist) potency was significantly increased in CIE bladders. Conclusions: Our data demonstrate a deficit in the nerve-evoked cholinergic component of contraction that is not due to the ability of the smooth muscle to respond to acetylcholine. We conclude that neurodegenerative bladder dysfunction in this model of multiple sclerosis may be due, in part, to pathologic changes in the mucosa that causes suppression of muscarinic receptor-mediated contractile response and augmentation of purinergic response of the underlying muscle. Further studies utilizing CIE mice should help elucidate the pathological changes in the mucosa resulting from demyelination in the CNS.	[Lamarre, Neil S.; Braverman, Alan S.; Barbe, Mary F.; Ruggieri, Michael R., Sr.] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19122 USA; [Malykhina, Anna P.] Univ Penn, Perelman Sch Med, Dept Surg, Div Urol, Glenolden, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania	Ruggieri, MR (corresponding author), Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19122 USA.	rugg@temple.edu		Barbe, Mary/0000-0002-5235-9803	National Institute of Diabetes and Digestive and Kidney Diseases [DK-097819]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P20DK097819] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grant DK-097819 (to A. P. Malykhina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuntas CZ, 2008, J NEUROIMMUNOL, V203, P58, DOI 10.1016/j.jneuroim.2008.06.038; Altuntas CZ, 2012, AM J PHYSIOL-RENAL, V303, pF1363, DOI 10.1152/ajprenal.00273.2012; Apodaca G, 2003, AM J PHYSIOL-RENAL, V284, pF966, DOI 10.1152/ajprenal.00359.2002; Bender SJ, 2010, J NEUROIMMUNE PHARM, V5, P336, DOI 10.1007/s11481-010-9202-2; Birder L, 2013, PHYSIOL REV, V93, P653, DOI 10.1152/physrev.00030.2012; Brading AF, 1997, UROLOGY, V50, P57, DOI 10.1016/S0090-4295(97)00591-8; Braverman AS, 2007, NEUROUROL URODYNAM, V26, P63, DOI 10.1002/nau.20378; Burnstock G, 2001, PURINERGIC PYRIMIDIN, VI, P423; Chancellor MB, 2006, AM J PHYS MED REHAB, V85, P536, DOI 10.1097/01.phm.0000219229.92056.c2; de Seze M, 2007, MULT SCLER J, V13, P915, DOI 10.1177/1352458506075651; Fovaeus M, 1999, J UROLOGY, V161, P649, DOI 10.1016/S0022-5347(01)61988-8; Fowler CJ, 2011, CUAJ-CAN UROL ASSOC, V5, pS146, DOI 10.5489/cuaj.11187; Fry CH, 1999, EXP PHYSIOL, V84, P161, DOI 10.1111/j.1469-445X.1999.tb00081.x; Hawthorn MH, 2000, BRIT J PHARMACOL, V129, P416, DOI 10.1038/sj.bjp.0703068; Kalsi V, 2005, NAT CLIN PRACT UROL, V2, P492, DOI 10.1038/ncpuro0323; Kim YC, 2007, J KOREAN MED SCI, V22, P48, DOI 10.3346/jkms.2007.22.1.48; Kullmann FA, 2008, J NEUROSCI, V28, P1977, DOI 10.1523/JNEUROSCI.4694-07.2008; Lavi E, 1984, Adv Exp Med Biol, V173, P237; Li M, 2013, AM J PHYSIOL-RENAL, V305, P50; Mannie Mark, 2009, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1502s85; McMillan MT, 2014, AM J PHYSIOL-RENAL, V307, pF612, DOI 10.1152/ajprenal.00151.2014; MILLER H, 1965, BMJ-BRIT MED J, V1, P1265, DOI 10.1136/bmj.1.5445.1265; Mizusawa H, 2000, NEUROUROL URODYNAM, V19, P689, DOI 10.1002/1520-6777(2000)19:6<689::AID-NAU7>3.0.CO;2-6; Myung SC, 2007, EUR J PHARMACOL, V573, P196, DOI 10.1016/j.ejphar.2007.06.024; Negoro H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02152; Nicholas R, 2010, EXPERT OPIN DRUG SAF, V9, P905, DOI 10.1517/14740338.2010.501793; Pachner AR, 2011, CURR OPIN NEUROL, V24, P291, DOI 10.1097/WCO.0b013e328346c226; Ruggieri M. R. Sr., 2006, Autonomic & Autacoid Pharmacology, V26, P311, DOI 10.1111/j.1474-8673.2006.00377.x; Ruggieri M, 2014, J UROLOGY, V191, pE138, DOI 10.1016/j.juro.2014.02.529; Ruggieri MR, 2006, NAT CLIN PRACT UROL, V3, P206, DOI 10.1038/ncpuro0456; Sibley G, 1984, J PHYSL; van der Star BJ, 2012, CNS NEUROL DISORD-DR, V11, P570, DOI 10.2174/187152712801661284; Vignes JR, 2007, J PHYSIOL-LONDON, V578, P439, DOI 10.1113/jphysiol.2006.117366	33	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109314	10.1371/journal.pone.0109314	http://dx.doi.org/10.1371/journal.pone.0109314			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310403	gold, Green Published, Green Submitted			2022-12-27	WOS:000343210300045
J	Linseele, V; Van Neer, W; Thys, S; Phillipps, R; Cappers, R; Wendrich, W; Holdaway, S				Linseele, Veerle; Van Neer, Wim; Thys, Sofie; Phillipps, Rebecca; Cappers, Rene; Wendrich, Willeke; Holdaway, Simon			New Archaeozoological Data from the Fayum "Neolithic'' with a Critical Assessment of the Evidence for Early Stock Keeping in Egypt	PLOS ONE			English	Article							OREOCHROMIS-NILOTICUS; FOOD-PRODUCTION; AFRICA; OCCUPATION; TILAPIA; OASIS; DOMESTICATION; SUBSISTENCE; SETTLEMENT; DESERT	Faunal evidence from the Fayum Neolithic is often cited in the framework of early stock keeping in Egypt. However, the data suffer from a number of problems. In the present paper, large faunal datasets from new excavations at Kom K and Kom W (4850-4250 BC) are presented. They clearly show that, despite the presence of domesticates, fish predominate in the animal bone assemblages. In this sense, there is continuity with the earlier Holocene occupation from the Fayum, starting ca. 7350 BC. Domesticated plants and animals appear first from approximately 5400 BC. The earliest possible evidence for domesticates in Egypt are the very controversial domesticated cattle from the 9th/8th millennium BC in the Nabta Playa-Bir Kiseiba area. The earliest domesticates found elsewhere in Egypt date to the 6th millennium BC. The numbers of bones are generally extremely low at this point in time and only caprines are present. From the 5th millennium BC, the numbers of sites with domesticates dramatically increase, more species are also involved and they are usually represented by significant quantities of bones. The data from the Fayum reflect this two phase development, with very limited evidence for domesticates in the 6th millennium BC and more abundant and clearer indications in the 5th millennium BC. Any modelling of early food production in Egypt suffers from poor amounts of data, bias due to differential preservation and visibility of sites and archaeological remains, and a lack of direct dates for domesticates. In general, however, the evidence for early stock keeping and accompanying archaeological features shows large regional variation and seems to be mainly dependent on local environmental conditions. The large numbers of fish at Kom K and Kom W reflect the proximity of Lake Qarun.	[Linseele, Veerle; Van Neer, Wim] Katholieke Univ Leuven, Lab Biodivers & Evolutionary Genom, Leuven, Belgium; [Linseele, Veerle; Van Neer, Wim; Thys, Sofie] Royal Belgian Inst Nat Sci, Brussels, Belgium; [Phillipps, Rebecca; Holdaway, Simon] Univ Auckland, Dept Anthropol, Auckland 1, New Zealand; [Cappers, Rene] Univ Groningen, Groningen Inst Archaeol, Groningen, Netherlands; [Wendrich, Willeke] Univ Calif Los Angeles, Cotsen Inst Archaeol, Los Angeles, CA USA	KU Leuven; Royal Belgian Institute of Natural Sciences; University of Auckland; University of Groningen; University of California System; University of California Los Angeles	Linseele, V (corresponding author), Katholieke Univ Leuven, Lab Biodivers & Evolutionary Genom, Leuven, Belgium.	Veerle.Linseele@arts.kuleuven.be	Wendrich, Willeke/ABA-6744-2020; Holdaway, Simon J./AAE-5069-2020	Wendrich, Willeke/0000-0003-3984-2822; Holdaway, Simon J./0000-0002-9948-3182; Van Neer, Wim/0000-0003-1710-3623	FWO-Flanders	FWO-Flanders(FWO)	The excavations are funded through private sponsors. V. L. is a postdoctoral research fellow of the FWO-Flanders (www.fwo.be). The contribution of W.V.N. to this paper presents research results of the Interuniversity Attraction Poles Programme - Belgian Science Policy (www.belspo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 1. None of the research costs or authors' salaries were funded in whole or in part, by a tobacco company. 2. The private sponsors do not have any competing interests in relation to this work. 3. The identity of the donor is not relevant to editors or reviewers' assessment of the validity of the work. 4. The authors are not aware of any competing interests.	Admassu D, 1996, HYDROBIOLOGIA, V337, P77, DOI 10.1007/BF00028508; Albarella U., 2011, ETHNOZOOARCHAEOLOGY, P143, DOI DOI 10.2307/J.CTVH1DWVG.19; [Anonymous], 2010, EXPLOITATION DESERT; Barakat Hala N., 1995, Acta Palaeobotanica, V35, P163; Barakat HN., 2002, DROUGHTS FOOD CULTUR, P111, DOI [10.1007/0-306-47547-2_8, DOI 10.1007/0-306-47547-2_8]; Barich BE, 2014, QUATERN INT, V320, P15, DOI 10.1016/j.quaint.2013.09.007; Bertini L, 2014, SAIS 2 PREHISTORIC P, P135; Blench R, 2000, ORIGINS DEV AFRICAN; Blench R., 1993, ARCHAEOLOGY AFRICA F, P71; Blench R.M., 2000, ORIGINS DEV AFRICAN, P355; Boesneck J., 1990, OMARI NEOLITHIC SETT, P99; Brewer D.J., 1989, LATE PREHISTORY NILE, P127; Brewer DJ, 1989, ZOOARCHAEOLOGY FAYUM; BREWER DJ, 1989, FISH FISHING ANCIENT; Briois F, 2012, J FIELD ARCHAEOL, V37, P178, DOI 10.1179/0093469012Z.00000000018; BRUTON MN, 1979, ENVIRON BIOL FISH, V4, P273, DOI 10.1007/BF00005484; BRUTON MN, 1975, J FISH BIOL, V7, P423, DOI 10.1111/j.1095-8649.1975.tb04618.x; Cappers RTJ, 2013, NEOLITHISATION NE AF, P109; CATONTHOMPSON G, 1934, DESERT FAYUM; Churcher C. S., 2008, THE OASIS PAPERS 2, V2, P1; Conolly J, 2011, J ARCHAEOL SCI, V38, P538, DOI 10.1016/j.jas.2010.10.008; Dahl G, 1976, STUDIES SOCIAL ANTHR; Debono F, 1990, OMARI NEOLITHIC SETT; Decker JE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004254; Dunne J, 2012, NATURE, V486, P390, DOI 10.1038/nature11186; Duponchelle F, 1999, ENVIRON BIOL FISH, V56, P375, DOI 10.1023/A:1007588010824; Ehret C., 1993, ARCHAEOLOGY AFRICA F, P104; El-Shabrawy GM, 2009, MONOGR BIOL, V89, P95; Fader E, 2005, WADI BAKHT LANDSCHAF, P169; FERGUSON WW, 1981, MAMMALIA, V45, P459, DOI 10.1515/mamm.1981.45.4.459; Gallant J., 2002, STORY AFRICAN DOG; Garcea EAA, 2004, J WORLD PREHIST, V18, P107, DOI 10.1007/s10963-004-2878-6; Gautier, 2001, HOLOCENE SETTLEMENT; Gautier A., 2005, J AFR ARCHAEOL, V3, P195, DOI DOI 10.3213/1612-1651-10050; Gautier A, 1984, CATTLE KEEPERS E SAH, P49; Gautier A., 2002, DROUGHTS FOOD CULTUR, P195, DOI [10.1007/0-306-47547-2_12, DOI 10.1007/0-306-47547-2_12]; Gautier A., 1984, ANIMALS ARCHAEOLOGY, V227, P237; Gautier A, LAKE SAND ARCHAEOLOG; GAUTIER A, 1976, PREHISTORY NILE VALL, P369, DOI DOI 10.1016/B978-0-12-743950-1.50030-1; Gautier Achilles, 1994, Sahara, V6, P7; GOODMAN SM, 1989, BIRDS EGYPT; Grigson C., 2000, ORIGINS DEV AFRICAN, P38; Guenther MG, 1997, ENCY PRECOLONIAL AFR, P179; Haaland R, 2007, CAMB ARCHAEOL J, V17, P165, DOI 10.1017/S0959774307000236; HASSAN F.A., 1985, AFR ARCHAEOL REV, V3, P95; HASSAN FA, 1986, J ARCHAEOL SCI, V13, P483, DOI 10.1016/0305-4403(86)90018-X; Helbaek H, 1955, P PREHIST SOC, V21, P93; Hendrickx S, 2001, MAGHAR DENDERA; Holdaway S, 2010, ANTIQUITY, V84, P185, DOI 10.1017/S0003598X00099853; Horsburgh KA, 2008, J ARCHAEOL SCI, V35, P1474, DOI 10.1016/j.jas.2007.10.012; Jo rdeczka M, 2013, AFR ARCHAEOL REV, P1; Kindermann K, 2006, QUATERNARY SCI REV, V25, P1619, DOI 10.1016/j.quascirev.2005.12.005; Kuper R, 2006, SCIENCE, V313, P803, DOI 10.1126/science.1130989; Lesur J., 2011, PEOPLE ANIMALS HOLOC, P59; Linseele V, 2010, J ARID ENVIRON, V74, P818, DOI 10.1016/j.jaridenv.2009.04.014; Linseele V, 2009, J AM RES CTR EGYPT, V45, P105; Linseele V, 2012, KERMA, V4, P16; Linseele V, 2014, SAIS 2 PREHISTORIC P, P141; Linseele V, 2010, J WORLD PREHIST, V23, P43, DOI 10.1007/s10963-010-9033-3; Manlius N, 1999, CR ACAD SCI III-VIE, V322, P573, DOI 10.1016/S0764-4469(00)88527-3; Marinova E, 2008, QUATERNARY RES, V70, P392, DOI 10.1016/j.yqres.2008.08.002; Marshall F, 2002, J WORLD PREHIST, V16, P99, DOI 10.1023/A:1019954903395; Marshall F., 2007, RETHINKING AGR ARCHA, P371; McDonald MMA, 1998, J ANTHROPOL ARCHAEOL, V17, P124, DOI 10.1006/jaar.1998.0320; McDonald MMA, 2013, NEOLITHISATION NE AF, P175; MIDANTREYNES B, 2000, PREHISTORY EGYPT 1 E; Moeyersons J, 1999, GEOMORPHOLOGY, V26, P297, DOI 10.1016/S0169-555X(98)00067-1; Moeyersons J., 1996, ASPECTS AFRICAN ARCH, P53; Osborn D.J., 1980, CONT LAND MAMMALS EG; Payne S., 1988, ARCHAEOZOOLOGIA, V2, P27; Payne S., 1973, ANATOL STUD, V23, P281, DOI [10.2307/3642547, DOI 10.2307/3642547]; Phillipps R, 2012, QUATERN INT, V251, P64, DOI 10.1016/j.quaint.2011.04.004; Phillipps RS, 2012, DOCUMENTING SOCIOECO; Poellath Nadja, 2009, P79; Pollath N, 2010, DJARA MITTELHOLOZA 2, P836; Poppe G.T., 1991, EUROPEAN SEASHELLS; Reitz E.J., 2008, ZOOARCHAEOLOGY; Riemer H, 2007, ARIDITY CHANGE CONFL, P105; Rueness EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016385; Sharabati D, 1984, RED SEA SHELLS; Shirai N, 2010, NEW INSIGHTS FAYUM E; Silver I. A., 1963, P250; SIMOONS FJ, 1971, GEOGR REV, V61, P431, DOI 10.2307/213437; Smith A.B., 2013, NEOLITHISATION NE AF, P5; Smith AB, 2005, AFRICAN HERDERS EMER; Van Neer W, 2002, ADAIMA, P521; Van Neer W., 2004, J AFR ARCHAEOL, V2, P251, DOI [DOI 10.3213/1612-1651-10030, 10.3213/1612-1651-10030]; Van Neer W., 2002, DROUGHTS FOOD CULTUR, P251; Van zon HCJ, 1992, ENV PROFILE FAYOUM G, P20; Vermeersch P. M., 1992, FOLLOWERS HORUS STUD, P163; Vermeersch P.M., 2008, HOLOCENE PREHISTORIC; Vermeersch PM, 1994, SAHARA, V6, P32; Vermeersch PM, AFRICAN ARC IN PRESS; Vigne JD, 2013, PUBL INST ARCHAEOL, V59, P115; Von Den Driesch A., 1976, GUIDE MEASUREMENT AN; von den Driesch A, 1985, KNOCHENFUNDE NEOLITI; VONDENDRIESCH A, 1986, MITTEILUNGEN DTSCH A, V42, P1; Wendorf F, 2001, HOLOCENE SETTLEMENT, P648; Wendrich W, 2010, NUCL INSTRUM METH B, V268, P999, DOI 10.1016/j.nimb.2009.10.083; Wendrich WZ., 2005, EGYPTIAN ARCHAEOL, V27, P12; WENKE RJ, 1988, J FIELD ARCHAEOL, V15, P29, DOI 10.1179/009346988791974619; WETTERSTROM W, 1993, ARCHAEOLOGY AFRICA F, P165; Wilson P, 2003, ARCHEO NIL, V13, P65; Wilson P, 2006, J EGYPT ARCHAEOL, V92, P75; Zeder Meinda A., 1991, FEEDING CITIES SPECI; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105	106	41	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e108517	10.1371/journal.pone.0108517	http://dx.doi.org/10.1371/journal.pone.0108517			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AQ9WZ	25310283	Green Published, Green Accepted, gold			2022-12-27	WOS:000343210300020
J	Widmer, RJ; Chung, WY; Herrmann, J; Jordan, KL; Lerman, LO; Lerman, A				Widmer, R. Jay; Chung, Woo-Young; Herrmann, Joerg; Jordan, Kyra L.; Lerman, Lilach O.; Lerman, Amir			The Association between Circulating MicroRNA Levels and Coronary Endothelial Function	PLOS ONE			English	Article							ARTERY-DISEASE; HEART-DISEASE; IN-VITRO; DYSFUNCTION; EXPRESSION; CELL; ATHEROSCLEROSIS; EVENTS; HUMANS; RISK	Human microRNAs (miRs) have been implicated in human diseases presumably through the downregulation and silencing of targeted genes via post-translational modifications. However, their role in the early stage of coronary atherosclerosis is not known. The aim of this study was to test the hypothesis that patients with early atherosclerosis and coronary endothelial dysfunction (CED) have alterations in transcoronary miR gradients. Patients underwent coronary angiography and endothelial function testing in the cardiac catheterization laboratory. Patients were divided into abnormal (n = 26) and normal (n = 22) microvascular coronary endothelial function based on intracoronary response to infused acetylcholine measured as a percent change in coronary blood flow (CBF) and arterial diameter. Blood samples were obtained simultaneously from the aorta and coronary sinus at the time of catheterization for RNA isolation, and miR subsequently assessed. Baseline characteristics were similar in both groups. Patients with microvascular CED displayed transcoronary gradients significantly elevated in miR-92a and miR-133 normalized to C-elegans-39 miR. Percent change in CBF and the transcoronary gradient of miR-133 displayed a significant inverse correlation (r(2) = 0.11, p = 0.03). Thus, we present novel data whereupon selected miRs demonstrate elevated transcoronary gradients in patients with microvascular CED. The current findings support further studies on the mechanistic role of miRs in coronary atherosclerosis and in humans.	[Widmer, R. Jay; Chung, Woo-Young; Herrmann, Joerg; Lerman, Amir] Mayo Clin, Dept Internal Med, Div Cardiovasc Dis, Rochester, MN 55905 USA; [Widmer, R. Jay; Chung, Woo-Young; Herrmann, Joerg; Jordan, Kyra L.; Lerman, Lilach O.; Lerman, Amir] Coll Med, Rochester, MN USA; [Jordan, Kyra L.; Lerman, Lilach O.] Mayo Clin, Dept Internal Med, Div Nephrol & Hypertens, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Lerman, A (corresponding author), Mayo Clin, Dept Internal Med, Div Cardiovasc Dis, Rochester, MN 55905 USA.	lerman.amir@mayo.edu	Lerman, Lilach/M-4962-2017		National Institutes of Health [1R01AG034430, 1R01GM090311, 1R01ES020812]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health Grants 1R01AG034430, 1R01GM090311, 1R01ES020812. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Suwaidi J, 2000, CIRCULATION, V101, P948, DOI 10.1161/01.CIR.101.9.948; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Coleman CB, 2013, MOL CELL ENDOCRINOL, V374, P125, DOI 10.1016/j.mce.2013.04.019; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; De Rosa S, 2011, CIRCULATION, V124, P1936, DOI 10.1161/CIRCULATIONAHA.111.037572; Fang Y, 2012, ARTERIOSCL THROM VAS, V32, P979, DOI 10.1161/ATVBAHA.111.244053; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Gossl M, 2008, J AM COLL CARDIOL, V52, P1314, DOI 10.1016/j.jacc.2008.07.019; Han SH, 2008, EUR HEART J, V29, P1359, DOI 10.1093/eurheartj/ehn142; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Hasdai D, 1997, CIRCULATION, V96, P3390; He B, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-22; Iaconetti C, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0296-y; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Lavi S, 2008, HYPERTENSION, V51, P127, DOI 10.1161/HYPERTENSIONAHA.107.099986; Lavi S, 2007, CIRCULATION, V115, P2715, DOI 10.1161/CIRCULATIONAHA.106.671420; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14; Liu XJ, 2012, J MOL CELL CARDIOL, V52, P245, DOI 10.1016/j.yjmcc.2011.11.008; Lorenzen JM, 2011, CLIN J AM SOC NEPHRO, V6, P1540, DOI 10.2215/CJN.00430111; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mocharla P, 2013, BLOOD, V121, P226, DOI 10.1182/blood-2012-01-407106; Nazari-Jahantigh M, 2012, J CLIN INVEST, V122, P4190, DOI 10.1172/JCI61716; Reriani MK, 2012, CIRC J, V76, P778, DOI 10.1253/circj.CJ-12-0248; Rubinshtein R, 2010, EUR HEART J, V31, P1142, DOI 10.1093/eurheartj/ehq010; Targonski PV, 2003, CIRCULATION, V107, P2805, DOI 10.1161/01.CIR.0000072765.93106.EE; Taurino C, 2010, CLIN SCI, V119, P335, DOI 10.1042/CS20100043; Torella D, 2011, CIRC RES, V109, P880, DOI 10.1161/CIRCRESAHA.111.240150; Treguer K, 2012, J VASC RES, V49, P447, DOI 10.1159/000339429; Tu YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075872; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Widmer R, 2012, AM J PHYSL HEART CIR; Willeit P, 2013, CIRC RES, V112, P595, DOI 10.1161/CIRCRESAHA.111.300539; Wu CN, 2012, J LIPID RES, V53, P2355, DOI 10.1194/jlr.M028878; Xu QF, 2012, J AM COLL CARDIOL, V59, P2107, DOI 10.1016/j.jacc.2012.02.033; Yoon M, 2013, INT J CARDIOL, pS0167; Zeiger AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037904; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610	42	27	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109650	10.1371/journal.pone.0109650	http://dx.doi.org/10.1371/journal.pone.0109650			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310838	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210300064
J	Ishii, A; Tanaka, M; Watanabe, Y				Ishii, Akira; Tanaka, Masaaki; Watanabe, Yasuyoshi			The Neural Mechanisms Underlying the Decision to Rest in the Presence of Fatigue: A Magnetoencephalography Study	PLOS ONE			English	Article							EVENT-RELATED DESYNCHRONIZATION; PHYSICAL FATIGUE; POPULATION; INHIBITION; KAROSHI; EMOTION; JAPAN; TASK; FMRI; GO	Adequate rest is essential to avoid fatigue and disruption of homeostasis. However, the neural mechanisms underlying the decision to rest are not well understood. In the present study, we aimed to clarify the neural mechanisms of this decision-making process using magnetoencephalography. Fifteen healthy volunteers participated in decision and control experiments performed in a cross-over fashion. In the decision experiment, participants performed 1,200 reverse Stroop test trials and were intermittently asked to decide whether they wanted to take a rest or continue. In the control experiments, participants performed 1,200 reverse Stroop test trials and were instructed to press a response button intermittently without making any decision. Changes in oscillatory brain activity were assessed using a narrow-band adaptive spatial filtering method. The levels of decrease in theta (4-8 Hz) band power in left Brodmann's area (BA) 31, alpha (8-13 Hz) band power in left BA 10 and BA 9, and beta (13-25 Hz) band power in right BA 46 and left BA 10 were greater in trials when the participant opted to rest (rest trials) than those in control trials. The decrease in theta band power in BA 31 in the rest trials was positively correlated with the subjective level of fatigue after the decision experiment. These results demonstrated that the dorsolateral prefrontal cortex, frontal pole, and posterior cingulate cortex play a role in the decision to rest in the presence of fatigue. These findings may help clarify the neural mechanisms underlying fatigue and fatigue-related problems.	[Ishii, Akira; Tanaka, Masaaki; Watanabe, Yasuyoshi] Osaka City Univ, Grad Sch Med, Dept Physiol, Osaka 558, Japan; [Watanabe, Yasuyoshi] RIKEN, Ctr Life Sci Technol, Sayo, Hyogo, Japan	Osaka Metropolitan University; RIKEN	Ishii, A (corresponding author), Osaka City Univ, Grad Sch Med, Dept Physiol, Osaka 558, Japan.	a.ishii@med.osaka-cu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [KAKENHI: 25750351]; Ministry of Health, Labour and Welfare of Japan; Grants-in-Aid for Scientific Research [25750351] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Young Scientists (B) (KAKENHI: 25750351) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and by the grant from the Ministry of Health, Labour and Welfare of Japan (URL http://www.jsps.go.jp/j-grantsinaid/index.html http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hokabunya/kenkyujigyou/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balconi M, 2006, NEUROSCI LETT, V392, P118, DOI 10.1016/j.neulet.2005.09.004; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Caseras X, 2008, PSYCHOL MED, V38, P941, DOI 10.1017/S0033291708003450; Cella D, 2002, CANCER-AM CANCER SOC, V94, P528, DOI 10.1002/cncr.10245; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Cook DB, 2007, NEUROIMAGE, V36, P108, DOI 10.1016/j.neuroimage.2007.02.033; Dalal SS, 2008, NEUROIMAGE, V40, P1686, DOI 10.1016/j.neuroimage.2008.01.023; Damasio A.R., 2005, DESCARTES ERROR EMOT; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; DAVID A, 1990, BMJ-BRIT MED J, V301, P1199, DOI 10.1136/bmj.301.6762.1199; David O, 2006, NEUROIMAGE, V31, P1580, DOI 10.1016/j.neuroimage.2006.02.034; Ernst M, 2005, BIOL PSYCHIAT, V58, P597, DOI 10.1016/j.biopsych.2005.06.004; EVANS AC, 1994, NATO ADV SCI INST SE, V264, P263; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Hillebrand A, 2005, HUM BRAIN MAPP, V25, P199, DOI 10.1002/hbm.20102; Ishii A, 2014, NEUROSCIENCE, V261, P60, DOI 10.1016/j.neuroscience.2013.12.049; Ishii A, PLOS ONE IN PRESS; Ishii A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095763; Ishii A, 2012, BRAIN RES, V1455, P68, DOI 10.1016/j.brainres.2012.03.031; Iwasaki K, 2006, IND HEALTH, V44, P537, DOI 10.2486/indhealth.44.537; Kondo N, 2010, J EPIDEMIOL COMMUN H, V64, P649, DOI 10.1136/jech.2009.090787; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Li XR, 2010, HUM BRAIN MAPP, V31, P410, DOI 10.1002/hbm.20875; Liddle PF, 2001, HUM BRAIN MAPP, V12, P100, DOI 10.1002/1097-0193(200102)12:2<100::AID-HBM1007>3.0.CO;2-6; Loge JH, 1998, J PSYCHOSOM RES, V45, P53, DOI 10.1016/S0022-3999(97)00291-2; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; Nakata H, 2013, CLIN NEUROPHYSIOL, V124, P273, DOI 10.1016/j.clinph.2012.06.019; Noakes TD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00082; Okuda J, 2003, NEUROIMAGE, V19, P1369, DOI 10.1016/S1053-8119(03)00179-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pare D, 2003, PROG NEUROBIOL, V70, P409, DOI 10.1016/S0301-0082(03)00104-7; PAWLIKOWSKA T, 1994, BRIT MED J, V308, P763, DOI 10.1136/bmj.308.6931.763; PFURTSCHELLER G, 1992, J CLIN NEUROPHYSIOL, V9, P120, DOI 10.1097/00004691-199201000-00013; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Sekihara K, 2008, SER BIOMED ENG, P1; Tajima S, 2010, NEUROL RES INT, V2010, DOI 10.1155/2010/671421; Tanaka M, 2014, MED HYPOTHESES, V82, P567, DOI 10.1016/j.mehy.2014.02.013; Tanaka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080731; Tanaka M, 2013, BRAIN RES, V1537, P117, DOI 10.1016/j.brainres.2013.08.054; Tsujimoto S, 2010, NAT NEUROSCI, V13, P120, DOI 10.1038/nn.2453; van't Leven M, 2010, EUR J PUBLIC HEALTH, V20, P251, DOI 10.1093/eurpub/ckp113; Watanabe Y., 2007, FATIGUE SCI HUMAN HL, P5	44	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109740	10.1371/journal.pone.0109740	http://dx.doi.org/10.1371/journal.pone.0109740			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303465	gold, Green Submitted, Green Published			2022-12-27	WOS:000343730400076
J	Smid, A; Karas-Kuzelicki, N; Milek, M; Jazbec, J; Mlinaric-Rascan, I				Smid, Alenka; Karas-Kuzelicki, Natasa; Milek, Miha; Jazbec, Janez; Mlinaric-Rascan, Irena			Association of ITPA Genotype with Event-Free Survival and Relapse Rates in Children with Acute Lymphoblastic Leukemia Undergoing Maintenance Therapy	PLOS ONE			English	Article							INOSINE TRIPHOSPHATE PYROPHOSPHATASE; INFLAMMATORY-BOWEL-DISEASE; THIOPURINE S-METHYLTRANSFERASE; ADVERSE DRUG-REACTIONS; BFM STUDY-GROUP; AZATHIOPRINE THERAPY; KOREAN PATIENTS; CHILDHOOD; MERCAPTOPURINE; POLYMORPHISM	Although the treatment of acute lymphoblastic leukemia (ALL) has improved significantly over recent decades, failure due to treatment-related toxicities and relapse of the disease still occur in about 20% of patients. This retrospective study included 308 pediatric ALL patients undergoing maintenance therapy and investigated the effects of genetic variants of enzymes involved inthe 6-mercaptopurine (6-MP) metabolism and folate pathway on survival and relapse rates. The presence of at least on of the non-functional ITPA alleles (94C>A and/or IVS2+21A>C variant) was associated with longer event-free survival compared to patients with the wild-type ITPA genotype (p=0.033). Furthermore, patients carrying at least one non-functional ITPA allele were shown to be at a lower risk of suffering early (p=0.003) and/or bone marrow relapse (p=0.017). In conclusion, the ITPA genotype may serve as a genetic marker for the improvement of risk stratification and therapy individualization for patients with ALL.	[Smid, Alenka; Karas-Kuzelicki, Natasa; Milek, Miha; Mlinaric-Rascan, Irena] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia; [Jazbec, Janez] Univ Med Ctr Ljubljana, Univ Childrens Hosp, Ljubljana, Slovenia	University of Ljubljana; University Medical Centre Ljubljana	Mlinaric-Rascan, I (corresponding author), Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia.	irena.mlinaric@ffa.uni-lj.si		Milek, Miha/0000-0002-0803-8439; Mlinaric-Rascan, Irena/0000-0002-7459-3502	Slovenian Research Agency [J3-3615]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by Slovenian Research Agency grant No. J3-3615. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhojwani D, 2013, LANCET ONCOL, V14, pE205, DOI 10.1016/S1470-2045(12)70580-6; Breen DP, 2005, LIVER TRANSPLANT, V11, P826, DOI 10.1002/lt.20377; BUHRER C, 1993, MED PEDIATR ONCOL, V21, P470, DOI 10.1002/mpo.2950210703; de Beaumais TA, 2012, EUR J CLIN PHARMACOL, V68, P1233, DOI 10.1007/s00228-012-1251-4; de Beaumais TA, 2011, BRIT J CLIN PHARMACO, V71, P575, DOI 10.1111/j.1365-2125.2010.03867.x; Dorababu P, 2012, EUR J CLIN PHARMACOL, V68, P379, DOI 10.1007/s00228-011-1133-1; Freyer DR, 2011, BLOOD, V117, P3010, DOI 10.1182/blood-2010-07-294678; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hawwa AF, 2008, BRIT J CLIN PHARMACO, V66, P517, DOI 10.1111/j.1365-2125.2008.03248.x; Heller T, 2004, CLIN CHEM, V50, P2182, DOI 10.1373/clinchem.2004.039685; Henderson MJ, 2008, CELL CYCLE, V7, P1315, DOI 10.4161/cc.7.10.5885; Hogan LE, 2011, BLOOD, V118, P5218, DOI 10.1182/blood-2011-04-345595; Jung YS, 2010, J HUM GENET, V55, P121, DOI 10.1038/jhg.2009.125; Karas-Kuzelicki N, 2009, LEUKEMIA, V23, P971, DOI 10.1038/leu.2008.317; Karas-Kuzelicki N, 2009, PHARMACOGENOMICS, V10, P1309, DOI 10.2217/PGS.09.78; Kim H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045558; Kim JH, 2010, J CLIN GASTROENTEROL, V44, pE242, DOI 10.1097/MCG.0b013e3181d6baf5; Krynetski EY, 1998, AM J HUM GENET, V63, P11, DOI 10.1086/301941; Kuzelicki NK, 2009, LEUKEMIA RES, V33, P1344, DOI 10.1016/j.leukres.2008.12.011; Laks Dani, 2003, J. Pediatr. (Rio J.), V79, P149, DOI 10.1590/S0021-75572003000200010; Malempati S, 2007, J CLIN ONCOL, V25, P5800, DOI 10.1200/JCO.2007.10.7508; Marinaki AM, 2004, PHARMACOGENETICS, V14, P181, DOI 10.1097/00008571-200403000-00006; Menezes MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032313; Milek M, 2012, BIOCHEM PHARMACOL, V83, P969, DOI 10.1016/j.bcp.2012.01.010; Moricke A, 2010, LEUKEMIA, V24, P265, DOI 10.1038/leu.2009.257; Nguyen K, 2008, LEUKEMIA, V22, P2142, DOI 10.1038/leu.2008.251; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Raetz EA, 2012, HEMATOL-AM SOC HEMAT, P129, DOI 10.1182/asheducation-2012.1.129; Reismuller B, 2009, BRIT J HAEMATOL, V144, P559, DOI 10.1111/j.1365-2141.2008.07499.x; REITER A, 1994, BLOOD, V84, P3122, DOI 10.1182/blood.V84.9.3122.3122; RIEHM H, 1987, KLIN PADIATR, V199, P151, DOI 10.1055/s-2008-1026781; Rosalina WRW, 2012, J CLIN PHARM THER, V37, P237, DOI 10.1111/j.1365-2710.2011.01272.x; Schmiegelow K, 2009, LEUKEMIA, V23, P557, DOI 10.1038/leu.2008.316; Schrappe M, 2000, BLOOD, V95, P3310; Shipkova M, 2011, THER DRUG MONIT, V33, P321, DOI 10.1097/FTD.0b013e31821a7c34; Stocco G, 2009, CLIN PHARMACOL THER, V85, P164, DOI 10.1038/clpt.2008.154; Stocco G, 2012, HUM MOL GENET, V21, P4793, DOI 10.1093/hmg/dds302; Sumi S, 2002, HUM GENET, V111, P360, DOI 10.1007/s00439-002-0798-z; Tallen G, 2010, J CLIN ONCOL, V28, P2339, DOI 10.1200/JCO.2009.25.1983; Uchiyama K, 2009, J GASTROENTEROL, V44, P197, DOI 10.1007/s00535-008-2307-1; van der Veer A, 2013, BLOOD; Zabala-Fernandez W, 2011, J GASTROINTEST LIVER, V20, P247; Zaza G, 2004, BLOOD, V104, P1435, DOI 10.1182/blood-2003-12-4306	43	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109551	10.1371/journal.pone.0109551	http://dx.doi.org/10.1371/journal.pone.0109551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303517	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400065
J	Star, K; Edwards, IR; Choonara, I				Star, Kristina; Edwards, I. Ralph; Choonara, Imti			Valproic Acid and Fatalities in Children: A Review of Individual Case Safety Reports in VigiBase	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; TOXIC EPIDERMAL NECROLYSIS; STEVENS-JOHNSON-SYNDROME; ANTIEPILEPTIC DRUGS; HEPATIC FATALITIES; SODIUM VALPROATE; LIVER-FAILURE; CASE SERIES; PANCREATITIS; EPILEPSY	Introduction: Valproic acid is an effective first line drug for the treatment of epilepsy. Hepatotoxicity is a rare and potentially fatal adverse reaction for this medicine. Objective: Firstly to characterise valproic acid reports on children with fatal outcome and secondly to determine reporting over time of hepatotoxicity with fatal outcome. Methods: Individual case safety reports (ICSRs) for children <= 17 years with valproic acid and fatal outcome were retrieved from the WHO Global ICSR database, VigiBase, in June 2013. Reports were classified into hepatotoxic reactions or other reactions. Shrinkage observed-to-expected ratios were used to explore the relative reporting trend over time and for patient age. The frequency of polytherapy, i.e. reports with more than one antiepileptic medicine, was investigated. Results: There have been 268 ICSRs with valproic acid and fatal outcome in children, reported from 25 countries since 1977. A total of 156 fatalities were reported with hepatotoxicity, which has been continuously and disproportionally reported over time. There were 31 fatalities with pancreatitis. Other frequently reported events were coma/encephalopathy, seizures, respiratory disorders and coagulopathy. Hepatotoxicity was disproportionally and most commonly reported in children aged 6 years and under (104/156 reports) but affected children of all ages. Polytherapy was significantly more frequently reported for valproic acid with fatal outcome (58%) compared with non-fatal outcome (34%). Conclusion: Hepatotoxicity remains a considerable problem. The risk appears to be greatest in young children (6 years and below) but can occur at any age. Polytherapy is commonly reported and seems to be a risk factor for hepatotoxicity, pancreatitis and other serious adverse drug reactions with valproic acid.	[Star, Kristina; Edwards, I. Ralph] WHO Collaborating Ctr Int Drug Monitoring, Uppsala Monitoring Ctr, Uppsala, Sweden; [Choonara, Imti] Univ Nottingham, Derbyshire Childrens Hosp, Acad Div Child Hlth, Nottingham NG7 2RD, England	World Health Organization; University of Nottingham	Star, K (corresponding author), WHO Collaborating Ctr Int Drug Monitoring, Uppsala Monitoring Ctr, Uppsala, Sweden.	Kristina.Star@who-umc.org	Choonara, Imti/I-3559-2019	Choonara, Imti/0000-0002-3069-6323				Acharya S, 2000, J PEDIAT HEMATOL ONC, V22, P62, DOI 10.1097/00043426-200001000-00012; Anderson M, 2010, ARCH DIS CHILD, V95, P731, DOI 10.1136/adc.2009.165902; Arencibia Zeina Barzaga, 2012, Int J Pharm Pract, V20, P390, DOI 10.1111/j.2042-7174.2012.00215.x; Bate A, 1998, EUR J CLIN PHARMACOL, V54, P315, DOI 10.1007/s002280050466; Berg AT, 1999, ARCH PEDIAT ADOL MED, V153, P1267, DOI 10.1001/archpedi.153.12.1267; Chapman SA, 2001, PHARMACOTHERAPY, V21, P1549, DOI 10.1592/phco.21.20.1549.34480; Clarkson A, 2002, ARCH DIS CHILD, V87, P462, DOI 10.1136/adc.87.6.462; COLLETTI RB, 1986, J PEDIATR GASTR NUTR, V5, P990, DOI 10.1097/00005176-198611000-00032; Cvitanovic-Sojat L, 2010, EUR J PAEDIATR NEURO, V14, P73, DOI 10.1016/j.ejpn.2008.12.003; DONAT JF, 1979, NEUROLOGY, V29, P273; DREIFUSS FE, 1987, NEUROLOGY, V37, P379, DOI 10.1212/WNL.37.3.379; DREIFUSS FE, 1989, NEUROLOGY, V39, P201, DOI 10.1212/WNL.39.2.201; Electronic Medicines Compendium, 2014, SUMM PROD CHAR EP CH; FLETCHER AP, 1991, J ROY SOC MED, V84, P341, DOI 10.1177/014107689108400612; Gerstner T, 2006, EPILEPSIA, V47, P1136, DOI 10.1111/j.1528-1167.2006.00587.x; Gopaul S, 2003, EPILEPSIA, V44, P322, DOI 10.1046/j.1528-1157.2003.07202.x; Grauso-Eby NL, 2003, PEDIATR NEUROL, V28, P145, DOI 10.1016/S0887-8994(02)00517-9; Handoko KB, 2006, EPILEPSIA, V47, P1232, DOI 10.1111/j.1528-1167.2006.00596.x; Hazell L, 2006, DRUG SAFETY, V29, P385, DOI 10.2165/00002018-200629050-00003; Hsia Y, 2010, EPILEPSIA, V51, P789, DOI 10.1111/j.1528-1167.2009.02331.x; KISHI T, 1994, ARCH DIS CHILD, V71, P153, DOI 10.1136/adc.71.2.153; Koenig SA, 2006, EPILEPSIA, V47, P2027, DOI 10.1111/j.1528-1167.2006.00846.x; Kose G, 2009, J CHILD NEUROL, V24, P1493, DOI 10.1177/0883073808331084; Koh MJA, 2010, J AM ACAD DERMATOL, V62, P54, DOI 10.1016/j.jaad.2009.06.085; Lindquist M, 2008, DRUG INF J, V42, P409, DOI 10.1177/009286150804200501; Noren GN, 2007, DATA MIN KNOWL DISC, V14, P305, DOI 10.1007/s10618-006-0052-8; Noren GN, 2013, STAT METHODS MED RES, V22, P57, DOI 10.1177/0962280211403604; RAJANTIE J, 1992, EUR J PEDIATR, V151, P619, DOI 10.1007/BF01957735; Rzany B, 1999, LANCET, V353, P2190, DOI 10.1016/S0140-6736(98)05418-X; SCHEFFNER D, 1988, EPILEPSIA, V29, P530, DOI 10.1111/j.1528-1157.1988.tb03757.x; Schmid MM, 2013, PHARMACOPSYCHIATRY, V46, P63, DOI 10.1055/s-0032-1323671; SHORVON SD, 1978, BRIT MED J, V1, P474, DOI 10.1136/bmj.1.6111.474; Sinclair DB, 2004, J CHILD NEUROL, V19, P498, DOI 10.1177/08830738040190070401; Star K, 2011, DRUG SAFETY, V34, P415, DOI 10.2165/11587540-000000000-00000; SUCHY FJ, 1979, NEW ENGL J MED, V300, P962, DOI 10.1056/NEJM197904263001706; Talaat F, 2009, EGYPT J NEUROL PSYCH, V46, P19; Uppsala Monitoring Centre WHO Collaborating Centre for International Drug Monitoring, CAV DOC; Werlin SL, 2006, PEDIATRICS, V118, P1660, DOI 10.1542/peds.2006-1182	38	35	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108970	10.1371/journal.pone.0108970	http://dx.doi.org/10.1371/journal.pone.0108970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302991	Green Published, gold, Green Submitted			2022-12-27	WOS:000343730400038
J	Torres-Atencio, I; Ainsua-Enrich, E; de Mora, F; Picado, C; Martin, M				Torres-Atencio, Ivonne; Ainsua-Enrich, Erola; de Mora, Fernando; Picado, Cesar; Martin, Margarita			Prostaglandin E-2 Prevents Hyperosmolar-Induced Human Mast Cell Activation through Prostanoid Receptors EP2 and EP4	PLOS ONE			English	Article							EXERCISE-INDUCED BRONCHOCONSTRICTION; FC-EPSILON-RI; ASTHMATIC SUBJECTS; HISTAMINE-RELEASE; AIRWAY HYPERRESPONSIVENESS; IMMUNE-RESPONSES; PROTEIN-KINASES; INHALED PGE(2); DRY POWDER; LUNG	Background: Mast cells play a critical role in allergic and inflammatory diseases, including exercise-induced bronchoconstriction (EIB) in asthma. The mechanism underlying EIB is probably related to increased airway fluid osmolarity that activates mast cells to the release inflammatory mediators. These mediators then act on bronchial smooth muscle to cause bronchoconstriction. In parallel, protective substances such as prostaglandin E-2 (PGE(2)) are probably also released and could explain the refractory period observed in patients with EIB. Objective: This study aimed to evaluate the protective effect of PGE(2) on osmotically activated mast cells, as a model of exercise-induced bronchoconstriction. Methods: We used LAD2, HMC-1, CD34-positive, and human lung mast cell lines. Cells underwent a mannitol challenge, and the effects of PGE(2) and prostanoid receptor (EP) antagonists for EP1-4 were assayed on the activated mast cells. Beta-hexosaminidase release, protein phosphorylation, and calcium mobilization were assessed. Results: Mannitol both induced mast cell degranulation and activated phosphatidyl inositide 3-kinase and mitogen-activated protein kinase (MAPK) pathways, thereby causing de novo eicosanoid and cytokine synthesis. The addition of PGE(2) significantly reduced mannitol-induced degranulation through EP2 and EP4 receptors, as measured by beta-hexosaminidase release, and consequently calcium influx. Extracellular-signal-regulated kinase 1/2, c-Jun N-terminal kinase, and p38 phosphorylation were diminished when compared with mannitol activation alone. Conclusions: Our data show a protective role for the PGE(2) receptors EP2 and EP4 following osmotic changes, through the reduction of human mast cell activity caused by calcium influx impairment and MAP kinase inhibition.	[Torres-Atencio, Ivonne] Univ Panama, Fac Med, Unidad Farmacol, Panama City, Panama; [Torres-Atencio, Ivonne; Ainsua-Enrich, Erola; Picado, Cesar; Martin, Margarita] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Lab Immunoal Lergia Resp Clin & Expt, Barcelona, Spain; [Ainsua-Enrich, Erola; Martin, Margarita] Univ Barcelona, Fac Med, Dept Ciencies Fisol 1, Unitat Bioquim & Biol Mol, Barcelona 7, Spain; [de Mora, Fernando] Univ Autonoma Barcelona, Dept Farmacol Terapeut & Toxicol, E-08193 Barcelona, Spain; [Picado, Cesar] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedad Resp CIBERES, Madrid, Spain	Universidad de Panama; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Martin, M (corresponding author), Inst Invest Biomed August Pi & Sunyer IDIBAPS, Lab Immunoal Lergia Resp Clin & Expt, Barcelona, Spain.	martin_andorra@ub.edu	Ainsua Enrich, Erola/D-3582-2019; /AAL-7347-2021; Torres-Atencio, Ivonne/AAW-5905-2020; Andorra, Margarita Martin/H-2025-2015; de Mora, Fernando/O-4636-2014; /AFX-9519-2022	Ainsua Enrich, Erola/0000-0001-7901-5798; Torres-Atencio, Ivonne/0000-0001-5171-3439; Andorra, Margarita Martin/0000-0002-9245-4899; de Mora, Fernando/0000-0002-3002-6004; 	Plan Nacional Ministerio de Ciencia e Innovacion [SAF2009-07548]; Fondo de Investigaciones Sanitarias, Ministerio de Economia y Competitividad, Spain [PI1200332]; Secretaria Nacional de Ciencia, Tecnologia e Innovacion SENACYT, Gobierno de la Republica de Panama	Plan Nacional Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)); Fondo de Investigaciones Sanitarias, Ministerio de Economia y Competitividad, Spain; Secretaria Nacional de Ciencia, Tecnologia e Innovacion SENACYT, Gobierno de la Republica de Panama	This work was supported by grants from the Plan Nacional Ministerio de Ciencia e Innovacion (SAF2009-07548) and Fondo de Investigaciones Sanitarias, Ministerio de Economia y Competitividad, Spain (PI1200332). IT-A was the recipient of a doctoral studies scholarship from the Secretaria Nacional de Ciencia, Tecnologia e Innovacion SENACYT, Gobierno de la Republica de Panama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsua-Enrich E, 2012, J IMMUNOL, V189, P2727, DOI 10.4049/jimmunol.1200380; Alfonso A, 2000, BRIT J PHARMACOL, V130, P1809, DOI 10.1038/sj.bjp.0703490; Alvarez-Errico D, 2011, J IMMUNOL, V187, P5577, DOI 10.4049/jimmunol.1101626; Anderson SD, 2010, CHEST, V138, p25S, DOI 10.1378/chest.10-0116; ANDERSON SD, 1975, BRIT J DIS CHEST, V69, P1; Anderson SD, 1997, AM J RESP CRIT CARE, V156, P758, DOI 10.1164/ajrccm.156.3.9701113; ANDERSON SD, 1984, AUST NZ J MED, V14, P762, DOI 10.1111/j.1445-5994.1984.tb04932.x; Barnes PJ, 2003, ANN INTERN MED, V139, P359, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00012; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; Brannan JD, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-144; Brannan JD, 1998, AM J RESP CRIT CARE, V158, P1120, DOI 10.1164/ajrccm.158.4.9802087; Brannan JD, 2003, EUR RESPIR J, V22, P491, DOI 10.1183/09031936.03.00113403; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Buckley J, 2011, THORAX, V66, P1029, DOI 10.1136/thx.2010.158568; Chan CL, 2000, BRIT J PHARMACOL, V129, P589, DOI 10.1038/sj.bjp.0703072; Claudino RF, 2006, J PHARMACOL EXP THER, V318, P611, DOI 10.1124/jpet.106.102806; Davis TL, 2000, BRIT J PHARMACOL, V130, P1919, DOI 10.1038/sj.bjp.0703525; Diaz BL, 2002, J IMMUNOL, V168, P1397, DOI 10.4049/jimmunol.168.3.1397; EGGLESTON PA, 1984, AM REV RESPIR DIS, V130, P86; Feng CL, 2006, BLOOD, V107, P3243, DOI 10.1182/blood-2005-07-2772; Foudi N, 2012, EUR J PHARMACOL, V695, P1, DOI 10.1016/j.ejphar.2012.08.009; Gauvreau GM, 1999, AM J RESP CRIT CARE, V159, P31, DOI 10.1164/ajrccm.159.1.9804030; Gomi K, 2000, J IMMUNOL, V165, P6545, DOI 10.4049/jimmunol.165.11.6545; Hallstrand TS, 2005, AM J RESP CRIT CARE, V172, P679, DOI 10.1164/rccm.200412-1667OC; Hashimoto S, 2001, AM J RESP CRIT CARE, V163, P152, DOI 10.1164/ajrccm.163.1.2005069; Herrerias A, 2009, INT ARCH ALLERGY IMM, V149, P323, DOI 10.1159/000205578; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kay LJ, 2013, CLIN EXP ALLERGY, V43, P741, DOI 10.1111/cea.12142; Kay LJ, 2006, BRIT J PHARMACOL, V147, P707, DOI 10.1038/sj.bjp.0706664; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Kuehn HS, 2007, IMMUNOL LETT, V113, P59, DOI 10.1016/j.imlet.2007.08.007; Kunikata T, 2005, NAT IMMUNOL, V6, P524, DOI 10.1038/ni1188; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Maher SA, 2009, AM J RESP CRIT CARE, V180, P923, DOI 10.1164/rccm.200903-0388OC; Medeiros A, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/327568; Medeiros AI, 2009, J EXP MED, V206, P61, DOI 10.1084/jem.20082058; MELILLO E, 1994, AM J RESP CRIT CARE, V149, P1138, DOI 10.1164/ajrccm.149.5.8173753; NILSSON G, 1994, SCAND J IMMUNOL, V39, P489, DOI 10.1111/j.1365-3083.1994.tb03404.x; O'Sullivan S, 1998, EUR RESPIR J, V12, P345, DOI 10.1183/09031936.98.12020345; Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97; Pelaia G, 2005, J CELL PHYSIOL, V202, P642, DOI 10.1002/jcp.20169; Perez-Novo CA, 2005, J ALLERGY CLIN IMMUN, V115, P1189, DOI 10.1016/j.jaci.2005.02.029; Pierzchalska M, 2003, J ALLERGY CLIN IMMUN, V111, P1041, DOI 10.1067/mai.2003.1491; Pucsok JM, 2007, J SPORT MED PHYS FIT, V47, P223; Radinger M, 2010, CURR PROTOC IMMUNOL; Roca-Ferrer J, 2011, J ALLERGY CLIN IMMUN, V128, P66, DOI 10.1016/j.jaci.2011.01.065; Sanmugalingam D, 2000, J LEUKOCYTE BIOL, V68, P38; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serra-Pages M, 2012, J LEUKOCYTE BIOL, V92, P1155, DOI 10.1189/jlb.0212109; Sheibanie AF, 2007, J IMMUNOL, V178, P8138, DOI 10.4049/jimmunol.178.12.8138; Takayama K, 2006, CIRC RES, V98, P499, DOI 10.1161/01.RES.0000204451.88147.96; Taketomi Y, 2013, NAT IMMUNOL, V14, P554, DOI 10.1038/ni.2586; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; Torres R, 2013, PHARMACOL RES, V70, P50, DOI 10.1016/j.phrs.2012.12.008; Vancheri C, 2004, TRENDS IMMUNOL, V25, P40, DOI 10.1016/j.it.2003.11.001; Wang XS, 2006, ALLERGY, V61, P503, DOI 10.1111/j.1398-9995.2006.01043.x	57	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110870	10.1371/journal.pone.0110870	http://dx.doi.org/10.1371/journal.pone.0110870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329458	Green Submitted, gold, Green Published			2022-12-27	WOS:000343942100102
J	Ichii, O; Otsuka-Kanazawa, S; Horino, T; Kimura, J; Nakamura, T; Matsumoto, M; Toi, M; Kon, Y				Ichii, Osamu; Otsuka-Kanazawa, Saori; Horino, Taro; Kimura, Junpei; Nakamura, Teppei; Matsumoto, Manabu; Toi, Makoto; Kon, Yasuhiro			Decreased miR-26a Expression Correlates with the Progression of Podocyte Injury in Autoimmune Glomerulonephritis	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENE-EXPRESSION; KIDNEY-DISEASE; MICRORNA; NEPHRITIS; MIR-146A; OVEREXPRESSION; CHROMOSOME-1; NEPHROPATHY; MESSENGER	MicroRNAs contribute to the pathogenesis of certain diseases and may serve as biomarkers. We analyzed glomerular microRNA expression in B6. MRLc1, which serve as a mouse model of autoimmune glomerulonephritis. We found that miR-26a was the most abundantly expressed microRNA in the glomerulus of normal C57BL/6 and that its glomerular expression in B6. MRLc1 was significantly lower than that in C57BL/6. In mouse kidneys, podocytes mainly expressed miR-26a, and glomerular miR-26a expression in B6. MRLc1 mice correlated negatively with the urinary albumin levels and podocyte-specific gene expression. Puromycin-induced injury of immortalized mouse podocytes decreased miR-26a expression, perturbed the actin cytoskeleton, and increased the release of exosomes containing miR-26a. Although miR-26a expression increased with differentiation of immortalized mouse podocytes, silencing miR-26a decreased the expression of genes associated with the podocyte differentiation and formation of the cytoskeleton. In particular, the levels of vimentin and actin significantly decreased. In patients with lupus nephritis and IgA nephropathy, glomerular miR-26a levels were significantly lower than those of healthy controls. In B6. MRLc1 and patients with lupus nephritis, miR-26a levels in urinary exosomes were significantly higher compared with those for the respective healthy control. These data indicate that miR-26a regulates podocyte differentiation and cytoskeletal integrity, and its altered levels in glomerulus and urine may serve as a marker of injured podocytes in autoimmune glomerulonephritis.	[Ichii, Osamu; Otsuka-Kanazawa, Saori; Kimura, Junpei; Nakamura, Teppei; Kon, Yasuhiro] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Anat Lab, Sapporo, Hokkaido, Japan; [Horino, Taro] Kochi Univ, Kochi Med Sch, Dept Endocrinol Metab & Nephrol, Nankoku, Kochi, Japan; [Nakamura, Teppei] Japan Food Res Labs, Chitose Lab, Sect Biol Safety Res, Chitose, Hokkaido, Japan; [Matsumoto, Manabu; Toi, Makoto] Kochi Univ, Kochi Med Sch, Dept Diagnost Pathol, Nankoku, Kochi, Japan	Hokkaido University; Kochi University; Kochi University	Ichii, O (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Anat Lab, Sapporo, Hokkaido, Japan.	ichi-o@vetmed.hokudai.ac.jp	kimura, junpei/GXM-5106-2022	NAKAMURA, Teppei/0000-0003-3204-0245; Kon, Yasuhiro/0000-0002-8859-6122	Leave a Nest Inc. (Tokyo, Japan); Japan Society for the Promotion of Science [24688033, 90448382]	Leave a Nest Inc. (Tokyo, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from Leave a Nest Inc. (Tokyo, Japan) and the Japan Society for the Promotion of Science Grant-in-Aid for Young Scientists (A), No. 24688033 (O. I.) and Grant-in-Aid for Scientific Research (C), No. 90448382 (T.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez ML, 2012, KIDNEY INT, V82, P1024, DOI 10.1038/ki.2012.256; Argyropoulos C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054662; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Baudino L, 2010, J AUTOIMMUN, V35, P153, DOI 10.1016/j.jaut.2010.06.001; Borchers AT, 2012, AUTOIMMUN REV, V12, P174, DOI 10.1016/j.autrev.2012.08.018; Dey BK, 2012, GENE DEV, V26, P2180, DOI 10.1101/gad.198085.112; Fang DYP, 2013, NEPHROLOGY, V18, P1, DOI 10.1111/nep.12005; Gebeshuber CA, 2013, NAT MED, V19, P481, DOI 10.1038/nm.3142; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Hartner A, 2010, AM J PHYSIOL-RENAL, V299, pF1151, DOI 10.1152/ajprenal.00058.2010; He FF, 2013, CURR GENOMICS, V14, P477, DOI 10.2174/13892029113146660014; Ho J, 2008, J AM SOC NEPHROL, V19, P2069, DOI 10.1681/ASN.2008020162; Ichii O, 2010, LUPUS, V19, P897, DOI 10.1177/0961203310362534; Ichii O, 2008, KIDNEY INT, V74, P339, DOI 10.1038/ki.2008.182; Ichii O, 2008, HISTOL HISTOPATHOL, V23, P411, DOI 10.14670/HH-23.411; Ichii O, 2012, KIDNEY INT, V81, P280, DOI 10.1038/ki.2011.345; Ichii O, 2010, LAB INVEST, V90, P459, DOI 10.1038/labinvest.2009.148; Kajiyama H, 2009, AM J NEPHROL, V29, P153, DOI 10.1159/000151770; Kim JH, 2004, KIDNEY INT, V66, P1826, DOI 10.1111/j.1523-1755.2004.00956.x; Kimura J, 2013, AM J NEPHROL, V38, P27, DOI 10.1159/000353093; Kimura J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016472; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lu J, 2012, NEPHROLOGY, V17, P346, DOI 10.1111/j.1440-1797.2012.01573.x; Lv LL, 2013, AM J PHYSIOL-RENAL, V305, pF1220, DOI 10.1152/ajprenal.00148.2013; Menon MC, 2013, CONTRIB NEPHROL, V181, P41, DOI 10.1159/000348461; Mohamed JS, 2011, J BIOL CHEM, V286, P43394, DOI 10.1074/jbc.M111.235127; Prunotto M, 2013, J PROTEOMICS, V82, P193, DOI 10.1016/j.jprot.2013.01.012; Rezende GM, 2014, LUPUS, V23, P255, DOI 10.1177/0961203313517152; Salmanidis M, 2014, INT J BIOCHEM CELL B; Sanchez E, 2011, ANN RHEUM DIS, V70, P1752, DOI 10.1136/ard.2011.154104; Sepramaniam S, 2012, J BIOL CHEM, V287, P12006, DOI 10.1074/jbc.M111.280701; Srivastava T, 2013, J CELL COMMUN SIGNAL, V7, P49, DOI 10.1007/s12079-012-0184-0; Sun YQ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh186; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tian ZM, 2008, GENOME RES, V18, P404, DOI 10.1101/gr.6587008; Veeranki S, 2010, IMMUNOL LETT, V133, P1, DOI 10.1016/j.imlet.2010.06.008; Wang G, 2010, J RHEUMATOL, V37, P2516, DOI 10.3899/jrheum.100308; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405	38	86	96	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110383	10.1371/journal.pone.0110383	http://dx.doi.org/10.1371/journal.pone.0110383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329154	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204100069
J	Korkes, HA; Sass, N; Moron, AF; Camara, NOS; Bonetti, T; Cerdeira, AS; Da Silva, IDCG; De Oliveira, L				Korkes, Henri Augusto; Sass, Nelson; Moron, Antonio F.; Camara, Niels Olsen S.; Bonetti, Tatiana; Cerdeira, Ana Sofia; Cotrim Guerreiro Da Silva, Ismael Dale; De Oliveira, Leandro			Lipidomic Assessment of Plasma and Placenta of Women with Early-Onset Preeclampsia	PLOS ONE			English	Article							BODY-MASS INDEX; OXIDIZED PHOSPHOLIPIDS; SIGNALING PATHWAYS; MAMMALIAN TARGET; OXIDATIVE STRESS; KIDNEY MODEL; RAPAMYCIN; RISK; SPECTROMETRY; INFLAMMATION	Introduction: Adipose tissue is responsible for triggering chronic systemic inflammatory response and these changes may be involved in the pathophysiology of preeclampsia. Objective: To characterize the lipid profile in the placenta and plasma of patients with preeclampsia. Methodology: Samples were collected from placenta and plasma of 10 pregnant women with preeclampsia and 10 controls. Lipids were extracted using the Bligh-Dyer protocol and were analysed by MALDI TOF-TOF mass spectrometry. Results: Approximately 200 lipid signals were quantified. The most prevalent lipid present in plasma of patients with preeclampsia was the main class Glycerophosphoserines-GP03 (PS) representing 52.30% of the total lipid composition, followed by the main classes Glycerophosphoethanolamines-GP02 (PEt), Glycerophosphocholines-GP01 (PC) and Flavanoids-PK12 (FLV), with 24.03%, 9.47% and 8.39% respectively. When compared to the control group, plasma samples of patients with preeclampsia showed an increase of PS (p<0.0001), PC (p<0.0001) and FLV (p<0.0001). Placental analysis of patients with preeclampsia, revealed the PS as the most prevalent lipid representing 56.28%, followed by the main class Macrolides/polyketides-PK04 with 32.77%, both with increased levels when compared with patients control group, PS (p, 0.0001) and PK04 (p<0.0001). Conclusion: Lipids found in placenta and plasma from patients with preeclampsia differ from those of pregnant women in the control group. Further studies are needed to clarify if these changes are specific and a cause or consequence of preeclampsia.	[Korkes, Henri Augusto; Sass, Nelson; Moron, Antonio F.; De Oliveira, Leandro] Univ Fed Sao Paulo, Dept Obstet, Sao Paulo, Brazil; [Korkes, Henri Augusto; Sass, Nelson; De Oliveira, Leandro] Sch Matern Vila Nova Cachoeirinha, Lab Clin & Expt Invest, Sao Paulo, Brazil; [Camara, Niels Olsen S.; De Oliveira, Leandro] Univ Sao Paulo, Dept Immunol, Sao Paulo, Brazil; [Bonetti, Tatiana; Cotrim Guerreiro Da Silva, Ismael Dale] Univ Fed Sao Paulo, Dept Gynecol, Sao Paulo, Brazil; [Cerdeira, Ana Sofia] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Sch Med, Boston, MA 02215 USA	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Korkes, HA (corresponding author), Univ Fed Sao Paulo, Dept Obstet, Sao Paulo, Brazil.	korkes@me.com	De Oliveira, Leandro/G-3476-2012; Sass, Nelson/AAD-8259-2020; Korkes, Henri/AAG-3124-2020; Bonetti, Tatiana Carvalho de Souza/AAX-2706-2021; Camara, Niels OS/G-8336-2011; MORON, ANTONIO F./H-4987-2013; camara, niels olsen saraiva/AAX-3269-2020; Korkes, Henri/AAN-2954-2020; Sass, Nelson/E-3252-2013; Bonetti, Tatiana/HDM-9548-2022	De Oliveira, Leandro/0000-0002-8422-9907; Bonetti, Tatiana Carvalho de Souza/0000-0002-5193-700X; Camara, Niels OS/0000-0001-5436-1248; MORON, ANTONIO F./0000-0002-7963-1758; camara, niels olsen saraiva/0000-0001-5436-1248; Korkes, Henri/0000-0001-5345-3861; Cerdeira, A. Sofia/0000-0002-7643-3537	National Council for Scientific and Technological Development; CNPq [476486/2011-4]; Foundation for Research Support of the State of Sao Paulo [12/02270-2]	National Council for Scientific and Technological Development; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation for Research Support of the State of Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Funding provided by National Council for Scientific and Technological Development; CNPq Number: 476486/2011-4, http://www.cnpq.br/en and Foundation for Research Support of the State of Sao Paulo; FAPESP Number: 12/02270-2, http://www.fapesp.br/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2008, EXPERT OPIN THER TAR, V12, P209, DOI [10.1517/14728222.12.2.209, 10.1517/14728222.12.2.209 ]; Akhlaghi M, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/782321; Akhlaghi M, 2009, J MOL CELL CARDIOL, V46, P309, DOI 10.1016/j.yjmcc.2008.12.003; Andreyev AY, 2010, J LIPID RES, V51, P2785, DOI 10.1194/jlr.M008748; Baig S, 2013, PLACENTA, V34, P436, DOI 10.1016/j.placenta.2013.02.004; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Berry C, 2001, AM J PHYSIOL-HEART C, V281, pH2337, DOI 10.1152/ajpheart.2001.281.6.H2337; Biancone L, 2010, AM J TRANSPLANT, V10, P2270, DOI 10.1111/j.1600-6143.2010.03259.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bodnar LM, 2007, EPIDEMIOLOGY, V18, P234, DOI 10.1097/01.ede.0000254119.99660.e7; Boots AW, 2008, EUR J PHARMACOL, V585, P325, DOI 10.1016/j.ejphar.2008.03.008; Borzychowski AM, 2006, SEMIN FETAL NEONAT M, V11, P309, DOI 10.1016/j.siny.2006.04.001; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; CALNE RY, 1989, LANCET, V2, P227; Chapman JR, 2010, AM J KIDNEY DIS, V55, P213, DOI 10.1053/j.ajkd.2009.12.003; De Oliveira L, 2012, CLIN BIOCHEM, V45, P852, DOI 10.1016/j.clinbiochem.2012.04.012; de Oliveira LG, 2010, REV BRAS GINECOL OBS, V32, P609, DOI 10.1590/S0100-72032010001200008; Domingues MRM, 2008, CHEM PHYS LIPIDS, V156, P1, DOI 10.1016/j.chemphyslip.2008.07.003; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Fenger M, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-44; Franz S, 2010, AM J KIDNEY DIS, V55, P335, DOI 10.1053/j.ajkd.2009.09.004; Fruhwirth GO, 2007, BBA-MOL BASIS DIS, V1772, P718, DOI 10.1016/j.bbadis.2007.04.009; Ghulmiyyah L, 2012, SEMIN PERINATOL, V36, P56, DOI 10.1053/j.semperi.2011.09.011; Gross RW, 2011, CHEM BIOL, V18, P284, DOI 10.1016/j.chembiol.2011.01.014; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Harkewicz R, 2011, ANNU REV BIOCHEM, V80, P301, DOI 10.1146/annurev-biochem-060409-092612; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hernando E, 2009, ONCOGENE, V28, P2425, DOI 10.1038/onc.2009.91; Hogan JL, 2011, HYPERTENS PREGNANCY, V30, P396, DOI 10.3109/10641955.2010.506233; Hopkins PN, 2003, CIRCULATION, V108, P519, DOI 10.1161/01.CIR.0000081777.17879.85; Jagannathan NR, 2001, BRIT J CANCER, V84, P1016, DOI 10.1054/bjoc.2000.1711; Jarvie E, 2010, CLIN SCI, V119, P123, DOI 10.1042/CS20090640; Kagan VE, 2004, FREE RADICAL BIO MED, V37, P1963, DOI 10.1016/j.freeradbiomed.2004.08.016; Kahan BD, 2000, LANCET, V356, P194, DOI 10.1016/S0140-6736(00)02480-6; Khalil MB, 2010, MASS SPECTROM REV, V29, P877, DOI 10.1002/mas.20294; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Ko HT, 2013, NEPHROL DIAL TRANSPL, V28, P327, DOI 10.1093/ndt/gfs453; Kral JG, 2012, OBESITY FACTS, V5, P254, DOI 10.1159/000338566; Leitinger N, 2003, CURR OPIN LIPIDOL, V14, P421, DOI 10.1097/00041433-200310000-00002; Letavernier E, 2005, TRANSPLANTATION, V80, P1198, DOI 10.1097/01.tp.0000185200.17589.74; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Li M, 2009, THROMB RES, V124, P656, DOI 10.1016/j.thromres.2009.07.012; Mandel S, 2004, J NEUROCHEM, V88, P1555, DOI 10.1046/j.1471-4159.2003.02291.x; Meikle PJ, 2011, CURR OPIN LIPIDOL, V22, P210, DOI 10.1097/MOL.0b013e3283453dbe; Nakagami K, 1999, JPN J CANCER RES, V90, P419, DOI 10.1111/j.1349-7006.1999.tb00764.x; Park SR, 2010, J ANTIBIOT, V63, P434, DOI 10.1038/ja.2010.71; Pollheimer J, 2005, PLACENTA, V26, pS21, DOI 10.1016/j.placenta.2004.11.013; Postle AD, 2012, CURR OPIN CLIN NUTR, V15, P127, DOI 10.1097/MCO.0b013e32834fb003; Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509; Rajakumar A, 2012, HYPERTENSION, V59, P256, DOI 10.1161/HYPERTENSIONAHA.111.182170; Ramos S, 2007, J NUTR BIOCHEM, V18, P427, DOI 10.1016/j.jnutbio.2006.11.004; Rana S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048259; Redman CWG, 2008, PLACENTA, V29, pS73, DOI 10.1016/j.placenta.2007.11.016; Roos S, 2007, J PHYSIOL-LONDON, V582, P449, DOI 10.1113/jphysiol.2007.129676; Schmelzer K, 2007, METHOD ENZYMOL, V432, P171, DOI 10.1016/S0076-6879(07)32007-7; Sehgal SN, 2003, TRANSPLANT P, V35, p7S, DOI 10.1016/S0041-1345(03)00211-2; SEHGAL SN, 1975, J ANTIBIOT, V28, P727, DOI 10.7164/antibiotics.28.727; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Sohlberg S, 2012, AM J HYPERTENS, V25, P120, DOI 10.1038/ajh.2011.175; Spickett CM, 2005, BIOFACTORS, V24, P17, DOI 10.1002/biof.5520240103; Spijkers LJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021817; Steiner JP, 1997, NAT MED, V3, P421, DOI 10.1038/nm0497-421; Terao J, 2008, ASIA PAC J CLIN NUTR, V17, P291; Vogelbacher R, 2007, TRANSPLANTATION, V84, P1492, DOI 10.1097/01.tp.0000282866.92367.99; Vuiblet V, 2012, NEPHROL DIAL TRANSPL, V27, P411, DOI 10.1093/ndt/gfr261; Walsh SW, 2007, TRENDS ENDOCRIN MET, V18, P365, DOI 10.1016/j.tem.2007.09.003; Want EJ, 2005, CHEMBIOCHEM, V6, P1941, DOI 10.1002/cbic.200500151; Wen HY, 2005, PLACENTA, V26, pS63, DOI 10.1016/j.placenta.2005.02.004; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yetukuri L, 2008, MOL BIOSYST, V4, P121, DOI 10.1039/b715468b; Zhang WJ, 2005, MOL NUTR FOOD RES, V49, P1050, DOI 10.1002/mnfr.200500056	77	33	36	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110747	10.1371/journal.pone.0110747	http://dx.doi.org/10.1371/journal.pone.0110747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329382	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204100106
J	Tincati, C; Basilissi, M; Sinigaglia, E; Merlini, E; Carpani, G; Monforte, AD; Marchetti, G				Tincati, Camilla; Basilissi, Matteo; Sinigaglia, Elisabetta; Merlini, Esther; Carpani, Giovanni; Monforte, Antonella d'Arminio; Marchetti, Giulia			Invariant Natural Killer T (iNKT) Cells in HAART-Treated, HIV-Positive Patients with Bone and Cardiovascular Impairment	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; CD1D-RESTRICTED NKT CELLS; CAROTID-ARTERY-DISEASE; IMMUNE ACTIVATION; ANTIRETROVIRAL THERAPY; HUMAN ATHEROSCLEROSIS; TYPE-1 INFECTION; EXPRESSION; INFLAMMATION; MARKERS	Background: Invariant Natural Killer T (iNKT) cells represent a determinant in the course of infections and diseases, however, their role in the pathogenesis of non-infectious co-morbidities in HIV-positive patients is unknown. Methods: Flow cytometry was used to investigate iNKT cell frequency, phenotype and function in HIV-infected patients on HAART with bone and/or cardiovascular disorders and in HIV-positive controls free from co-morbidities. Results: iNKT cells from subjects with bone and cardiovascular impairment expressed high levels of CD161 and predominantly secreted TNF. iNKT cells from individuals with bone disease alone did not show any distinctive phenotypical or functional characteristics. The functional capacity of iNKT cells in patients with cardiovascular disorder was impaired with no cytokine release upon stimulation. Conclusion: iNKT cells may have a role in non-infectious co-morbidities in treated HIV disease, possibly through the exacerbation of inflammation. Further studies are needed to investigate iNKT cells in the pathogenesis of non-communicable disorders in HIV infection.	[Tincati, Camilla; Basilissi, Matteo; Merlini, Esther; Monforte, Antonella d'Arminio; Marchetti, Giulia] Univ Milan, Dept Hlth Sci, Clin Infect Dis & Trop Med, San Paolo Hosp, Milan, Italy; [Sinigaglia, Elisabetta; Carpani, Giovanni] San Paolo Hosp, Blood Transfus Unit, Milan, Italy	San Paolo-Polo Universitaria Hospital; University of Milan; San Paolo-Polo Universitaria Hospital	Marchetti, G (corresponding author), Univ Milan, Dept Hlth Sci, Clin Infect Dis & Trop Med, San Paolo Hosp, Milan, Italy.	giulia.marchetti@unimi.it	Marchetti, Giulia/GPX-7655-2022; Gori, Andrea/AAC-6078-2022; MARCHETTI, GIULIA CARLA/K-4384-2018; TINCATI, CAMILLA/K-4501-2018	MARCHETTI, GIULIA CARLA/0000-0002-4498-4828; TINCATI, CAMILLA/0000-0002-3083-2962	Italian Ministry of Health [GR-2009-1592029, 9Ab87b2822]	Italian Ministry of Health(Ministry of Health, Italy)	Grants from Italian Ministry of Health (GR-2009-1592029) and the Fellowship Program 2012 (9Ab87b2822). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoh Y, 2006, CORONARY ARTERY DIS, V17, P523, DOI 10.1097/00019501-200609000-00005; Aslanian AM, 2005, ARTERIOSCL THROM VAS, V25, P628, DOI 10.1161/01.ATV.0000153046.59370.13; Baker J, 2010, J INFECT DIS, V201, P285, DOI 10.1086/649560; BENDELAC A, 1995, SCIENCE, V269, P185, DOI 10.1126/science.7542402; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Berzins SP, 2005, EUR J IMMUNOL, V35, P1399, DOI 10.1002/eji.200425958; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Chan WL, 2005, CIRC RES, V96, P675, DOI 10.1161/01.RES.0000160543.84254.f1; de Lalla C, 2004, J IMMUNOL, V173, P1417, DOI 10.4049/jimmunol.173.2.1417; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Desai Seema, 2010, Curr HIV/AIDS Rep, V7, P4, DOI 10.1007/s11904-009-0038-4; Desquilbet L, 2009, JAIDS-J ACQ IMM DEF, V50, P299, DOI 10.1097/QAI.0b013e3181945eb0; Fernandez CS, 2014, IMMUNOL CELL BIOL, V92, P578, DOI 10.1038/icb.2014.25; Fleuridor R, 2003, IMMUNOLOGY, V108, P3, DOI 10.1046/j.1365-2567.2003.01560.x; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Funderburg NT, 2010, BLOOD, V115, P161, DOI 10.1182/blood-2009-03-210179; Gazzola L, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-51; GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Hu M, 2011, J IMMUNOL, V186, P2910, DOI 10.4049/jimmunol.1002353; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Ibarrondo FJ, 2013, MUCOSAL IMMUNOL, V6, P591, DOI 10.1038/mi.2012.101; Joyee AG, 2007, J IMMUNOL, V178, P1048, DOI 10.4049/jimmunol.178.2.1048; Juno JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002838; Kanis JA, 2002, LANCET, V359, P1929, DOI 10.1016/S0140-6736(02)08761-5; Kaplan RC, 2011, ATHEROSCLEROSIS, V217, P207, DOI 10.1016/j.atherosclerosis.2011.03.011; Kaplan RC, 2011, J INFECT DIS, V203, P452, DOI 10.1093/infdis/jiq071; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kyriakakis E, 2010, EUR J IMMUNOL, V40, P3268, DOI 10.1002/eji.201040619; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Longenecker CT, 2013, HIV MED, V14, P385, DOI 10.1111/hiv.12013; Major AS, 2004, ARTERIOSCL THROM VAS, V24, P2351, DOI 10.1161/01.ATV.0000147112.84168.87; Melian A, 1999, AM J PATHOL, V155, P775, DOI 10.1016/S0002-9440(10)65176-0; Merlini E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046073; Moll M, 2009, EUR J IMMUNOL, V39, P902, DOI 10.1002/eji.200838780; Motsinger A, 2002, J EXP MED, V195, P869, DOI 10.1084/jem.20011712; Nakai Y, 2004, BLOOD, V104, P2051, DOI 10.1182/blood-2003-10-3485; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Ostos MA, 2002, FEBS LETT, V519, P23, DOI 10.1016/S0014-5793(02)02692-3; Reilly EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037991; SALONEN JT, 1993, CIRCULATION, V87, P56; Sandberg JK, 2004, P NATL ACAD SCI USA, V101, P7058, DOI 10.1073/pnas.0305986101; Sandberg JK, 2002, J VIROL, V76, P7528, DOI 10.1128/JVI.76.15.7528-7534.2002; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Snyder-Cappione JE, 2007, J INFECT DIS, V195, P1361, DOI 10.1086/513567; Snyder-Cappione JE, 2013, EUR J IMMUNOL, V43, P2194, DOI 10.1002/eji.201243185; Snyder-Cappione JE, 2009, AIDS, V23, P1965, DOI 10.1097/QAD.0b013e32832b5134; Subleski JJ, 2011, IMMUNOTHERAPY-UK, V3, P1167, DOI [10.2217/IMT.11.117, 10.2217/imt.11.117]; Tarazona R, 2000, MECH AGEING DEV, V121, P77; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; Tincati C, 2009, JAIDS-J ACQ IMM DEF, V51, P642, DOI 10.1097/QAI.0b013e3181add695; To K, 2009, ARTERIOSCL THROM VAS, V29, P671, DOI 10.1161/ATVBAHA.108.182592; Tupin E, 2004, J EXP MED, V199, P417, DOI 10.1084/jem.20030997; van der Vliet HJJ, 2006, J IMMUNOL, V177, P5775, DOI 10.4049/jimmunol.177.9.5775; van der Vliet HJJ, 2002, J IMMUNOL, V168, P1490, DOI 10.4049/jimmunol.168.3.1490; VanderLaan PA, 2007, AM J PATHOL, V170, P1100, DOI 10.2353/ajpath.2007.060188; Vasan S, 2007, INT IMMUNOL, V19, P943, DOI 10.1093/intimm/dxm055; Yang OO, 2007, AIDS RES HUM RETROV, V23, P913, DOI 10.1089/aid.2006.0253	59	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110287	10.1371/journal.pone.0110287	http://dx.doi.org/10.1371/journal.pone.0110287			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329381	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204100056
J	Sanchez, D; Gomila, M; Bennasar, A; Lalucat, J; Garcia-Valdes, E				Sanchez, David; Gomila, Margarita; Bennasar, Antonio; Lalucat, Jorge; Garcia-Valdes, Elena			Genome Analysis of Environmental and Clinical P. aeruginosa Isolates from Sequence Type-1146	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; POPULATION-STRUCTURE; DIVERSITY; VIRULENCE; ADAPTATION; EVOLUTION; REVEALS; AIRWAYS; IMPACT; CLONE	The genomes of Pseudomonas aeruginosa isolates of the new sequence type ST-1146, three environmental (P37, P47 and P49) and one clinical (SD9) isolates, with differences in their antibiotic susceptibility profiles have been sequenced and analysed. The genomes were mapped against P. aeruginosa PAO1-UW and UCBPP-PA14. The allelic profiles showed that the highest number of differences were in "Related to phage, transposon or plasmid" and "Secreted factors" categories. The clinical isolate showed a number of exclusive alleles greater than that for the environmental isolates. The phage Pf1 region in isolate SD9 accumulated the highest number of nucleotide substitutions. The ORF analysis of the four genomes assembled de novo indicated that the number of isolate-specific genes was higher in isolate SD9 (132 genes) than in isolates P37 (24 genes), P47 (16 genes) and P49 (21 genes). CRISPR elements were found in all isolates and SD9 showed differences in the spacer region. Genes related to bacteriophages F116 and H66 were found only in isolate SD9. Genome comparisons indicated that the isolates of ST-1146 are close related, and most genes implicated in pathogenicity are highly conserved, suggesting a genetic potential for infectivity in the environmental isolates similar to the clinical one. Phage-related genes are responsible of the main differences among the genomes of ST-1146 isolates. The role of bacteriophages has to be considered in the adaptation processes of isolates to the host and in microevolution studies.	[Sanchez, David; Gomila, Margarita; Bennasar, Antonio; Lalucat, Jorge; Garcia-Valdes, Elena] Univ Illes Balears, Dept Biol, Palma De Mallorca, Spain; [Bennasar, Antonio] Univ Illes Balears, Inst Univ Invest Ciencias Salud IUNICS UIB, Palma De Mallorca, Spain; [Lalucat, Jorge; Garcia-Valdes, Elena] CSIC UIB, Inst Mediterrani Estudis Avancats IMEDEA, Palma De Mallorca, Spain	Universitat de les Illes Balears; Universitat de les Illes Balears; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona	Garcia-Valdes, E (corresponding author), Univ Illes Balears, Dept Biol, Campus UIB, Palma De Mallorca, Spain.	elena.garciavaldes@uib.es	Bennasar Figueras, Toni/I-4469-2015; Gomila, Margarita/H-3314-2015; Lalucat, Jorge/K-1127-2014; Garcia-Valdes, Elena/K-1143-2014	Bennasar Figueras, Toni/0000-0002-2221-3248; Gomila, Margarita/0000-0001-8725-190X; Lalucat, Jorge/0000-0002-8350-6087; Garcia-Valdes, Elena/0000-0001-5829-0002	Spanish MINECO [CGL2011-24318, CSD 2009-00006]; Government of the Balearic Islands; FEDER	Spanish MINECO(Spanish Government); Government of the Balearic Islands; FEDER(European Commission)	This work was supported by projects CGL2011-24318 and Consolider (CSD 2009-00006) from the Spanish MINECO in addition to funds for competitive Research Groups from the Government of the Balearic Islands (the latter two funds with FEDER co-funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezuidt OKI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-416; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Cramer N, 2011, ENVIRON MICROBIOL, V13, P1690, DOI 10.1111/j.1462-2920.2011.02483.x; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; de Jong A, 2010, NUCLEIC ACIDS RES, V38, pW647, DOI 10.1093/nar/gkq365; Ernst RK, 2003, ENVIRON MICROBIOL, V5, P1341, DOI 10.1111/j.1462-2920.2003.00518.x; Feinbaum RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002813; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Gomila M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-138; Grissa I, 2008, NUCLEIC ACIDS RES, V36, pW145, DOI 10.1093/nar/gkn228; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Grosso-Becerra MV, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-318; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Kashtan N, 2014, SCIENCE, V344, P416, DOI 10.1126/science.1248575; Khan NH, 2008, APPL ENVIRON MICROB, V74, P6194, DOI 10.1128/AEM.02322-07; Kidd TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044199; Klockgether J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00150; Klockgether J, 2010, J BACTERIOL, V192, P1113, DOI 10.1128/JB.01515-09; Kresse AU, 2003, MOL MICROBIOL, V47, P145, DOI 10.1046/j.1365-2958.2003.03261.x; Kung VL, 2010, MICROBIOL MOL BIOL R, V74, P621, DOI 10.1128/MMBR.00027-10; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Li LL, 2013, CURR MICROBIOL, V67, P423, DOI 10.1007/s00284-013-0382-x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maatallah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025617; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Martinez JL, 2013, ENVIRON MICROBIOL, V15, P325, DOI 10.1111/j.1462-2920.2012.02837.x; Mavrodi DV, 2006, ANNU REV PHYTOPATHOL, V44, P417, DOI 10.1146/annurev.phyto.44.013106.145710; Mikkelsen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029113; Mulet M, 2012, SYST APPL MICROBIOL, V35, P455, DOI 10.1016/j.syapm.2012.08.007; Ocampo-Sosa AA, 2012, ANTIMICROB AGENTS CH, V56, P1703, DOI 10.1128/AAC.05451-11; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Ozen AI, 2012, MICROB ECOL, V63, P239, DOI 10.1007/s00248-011-9914-8; Pirnay JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007740; Potvin E, 2003, ENVIRON MICROBIOL, V5, P1294, DOI 10.1046/j.1462-2920.2003.00542.x; Ramos JL., 2004, PSEUDOMONAS, V1; Romling U, 1997, J MOL BIOL, V271, P386, DOI 10.1006/jmbi.1997.1186; Sato H, 2004, MOL MICROBIOL, V53, P1279, DOI 10.1111/j.1365-2958.2004.04194.x; Schmidt KD, 1996, J BACTERIOL, V178, P85, DOI 10.1128/jb.178.1.85-93.1996; Selezska K, 2012, ENVIRON MICROBIOL, V14, P1952, DOI 10.1111/j.1462-2920.2012.02719.x; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Spencer DH, 2003, J BACTERIOL, V185, P1316, DOI 10.1128/JB.185.4.1316-1325.2003; Stewart L, 2014, PATHOG DIS, V71, P20, DOI 10.1111/2049-632X.12107; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Webb JS, 2004, J BACTERIOL, V186, P8066, DOI 10.1128/JB.186.23.8066-8073.2004; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Winstanley C, 2009, GENOME RES, V19, P12, DOI 10.1101/gr.086082.108; Wolfgang MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/pnas.0832438100; Zhu Wenhan, 2010, Nucleic Acids Res, V38, pe132, DOI 10.1093/nar/gkq275	53	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e107754	10.1371/journal.pone.0107754	http://dx.doi.org/10.1371/journal.pone.0107754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25329302	gold, Green Published, Green Submitted			2022-12-27	WOS:000346766200005
J	Xu, G; Sui, XM; Liu, SW; Liu, J; Liu, JX; Li, YC; Huang, SQ; Wang, ZZ; Blair, SN				Xu, Gang; Sui, Xuemei; Liu, Shiwei; Liu, Jie; Liu, Junxiu; Li, Yichong; Huang, Shouqing; Wang, Zhengzhen; Blair, Steven N.			Effects of Insufficient Physical Activity on Mortality and Life Expectancy in Jiangxi Province of China, 2007-2010	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; DOSE-RESPONSE; SELF-REPORTS; RISK; INACTIVITY; BURDEN; SURVEILLANCE; METAANALYSIS; PREVENTION	Background: Physical inactivity remains an under-researched field in terms of studying burden of disease at provincial level, and no studies have examined the effects of inactivity on life expectancy (LE) in China. The purpose of this study was to estimate mortality risk and LE effects associated with insufficient levels of physical activity in Jiangxi province. Methods/Findings: Prevalence of risk factors and mortality counts were extracted from Chronic Diseases and Risk Factors Surveillance Survey (CDRFSS) and Disease Surveillance Points system (DSP), respectively. Insufficient physical activity (IPA) was defined as less than 150 minutes of moderate-intensity physical activity or 60 minutes of vigorous-intensity physical activity per week, accumulated across work, home, transport and discretionary domains. Population-attributable fractions (PAF) were used to calculate the mortality attributable to risk factors, and life table methods were used to estimate the LE gains and LE shifts. Monte Carlo simulation techniques were used for uncertainty analysis. Overall, 5 885 (95% uncertainly interval (UI), 5 047-6 506) and 8 578 (95% UI, 8 227-9 789) deaths in Jiangxi province were attributable to IPA in 2007 and 2010, respectively. The LE gains for elimination of attributable deaths were 0.68 (95% UI, 0.61-076) in 2007, and increased to 0.91 (95% UI, 0.81-1.10) in 2010. If the prevalence of IPA in 2010 had been decreased by 50% or 30%, 3 678 (95% UI, 3 220-4 229) or 2 090 (95% UI, 1 771-2 533) deaths would be avoided, and 0.40 (95% UI, 0.34-0.53) or 0.23 (95% UI, 0.16-0.31) years of LE gained, respectively. Conclusions: Adults in Jiangxi province of China have a high and increasing prevalence of IPA. Due to the deaths and potential LE gains associated with IPA, there is an urgent need to promote physical activity, one of the most modifiable risk factors, within China's health care reform agenda.	[Xu, Gang] Jiangxi Univ Tradit Chinese Med, Sch Basic Med, Dept Prevent Med, Nanchang, Jiangxi, Peoples R China; [Sui, Xuemei; Blair, Steven N.] Univ S Carolina, Dept Exercise Sci, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Liu, Shiwei; Li, Yichong] Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China; [Liu, Jie] Jiangxi Prov Ctr Dis Control & Prevent, Div Chron Dis Control & Prevent, Nanchang, Jiangxi, Peoples R China; [Liu, Junxiu] Univ S Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA; [Huang, Shouqing] Fujian Univ Tradit Chinese Med, Peoples Hosp 2, Fuzhou, Fujian, Peoples R China; [Wang, Zhengzhen] Beijing Sport Univ, Sport Rehabil Coll, Div Exercise Rehabil, Beijing, Peoples R China	Jiangxi University of Traditional Chinese Medicine; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Fujian University of Traditional Chinese Medicine; Beijing Sport University	Liu, SW (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China.	liusw@chinacdc.cn	Li, Yichong/A-3559-2019	Li, Yichong/0000-0003-3842-475X	Humanities and Social Sciences Foundation for Young Scholar, Ministry of Education of China [13YJCZH212]; Humanities and Social Sciences Development Foundation for Higher Education of Jiangxi Province, China [JC1357]; Development Foundation for Jiangxi University of Traditional Chinese Medicine	Humanities and Social Sciences Foundation for Young Scholar, Ministry of Education of China; Humanities and Social Sciences Development Foundation for Higher Education of Jiangxi Province, China; Development Foundation for Jiangxi University of Traditional Chinese Medicine	This study was funded by the Humanities and Social Sciences Foundation for Young Scholar, Ministry of Education of China (13YJCZH212), Humanities and Social Sciences Development Foundation for Higher Education of Jiangxi Province, China (JC1357), and Development Foundation for Jiangxi University of Traditional Chinese Medicine. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SA, 2005, AM J EPIDEMIOL, V161, P389, DOI 10.1093/aje/kwi054; Armstrong T, 2006, J PUBLIC HEALTH-HEID, V14, P66, DOI 10.1007/s10389-006-0024-x; Bull F.C., 2004, PHYS INACTIVITY, V1, P729; Danaei G, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000248; Franco OH, 2005, ARCH INTERN MED, V165, P2355, DOI 10.1001/archinte.165.20.2355; Grundy SM, 1999, MED SCI SPORT EXER, V31, P1493, DOI 10.1097/00005768-199911000-00001; Guthold R, 2008, AM J PREV MED, V34, P486, DOI 10.1016/j.amepre.2008.02.013; Han D, 2008, J SPORT SCI, V29, P47; Hill JO, 1999, MED SCI SPORT EXER, V31, pS515, DOI 10.1097/00005768-199911001-00005; Jeon CY, 2007, DIABETES CARE, V30, P744, DOI 10.2337/dc06-1842; Joubert J, 2007, SAMJ S AFR MED J, V97, P725; Katzmarzyk PT, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000828; KIELY DK, 1994, AM J EPIDEMIOL, V140, P608, DOI 10.1093/oxfordjournals.aje.a117298; Kohl HW, 2001, MED SCI SPORT EXER, V33, pS472, DOI 10.1097/00005768-200106001-00017; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Li YC, 2013, B WORLD HEALTH ORGAN, V91, P650, DOI 10.2471/BLT.13.117549; Li YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033881; Li YC, 2011, ADDICTION, V106, P1946, DOI 10.1111/j.1360-0443.2011.03514.x; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Ministry of Health and Chinese Center for Disease Control and Prevention, 2011, CHIN NONC DIS REP; Monninkhof EM, 2007, EPIDEMIOLOGY, V18, P137, DOI 10.1097/01.ede.0000251167.75581.98; National Center for Chronic and Non-communicable Disease Control and Prevention of Chinese Center for Disease Control and Prevention, 2010, REP 2007 BEH RISK FA; National Center for Chronic and Non-communicable Disease Control and Prevention of Chinese Center for Disease Control and Prevention, 2011, REP 2010 BEH RISK FA; National Health and Family Planning Commission of the People's Republic of China, 2009, MON EV PLAN HLTH CAR; Ng SW, 2009, SOC SCI MED, V68, P1305, DOI 10.1016/j.socscimed.2009.01.035; Palisade Corporation, 2013, RISK SOFTW VERS 6 EX; PODSAKOFF PM, 1986, J MANAGE, V12, P531, DOI 10.1177/014920638601200408; Rastogi T, 2004, INT J EPIDEMIOL, V33, P759, DOI 10.1093/ije/dyh042; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; The Sate Council of the People's Republic of China, 2009, GUID OP DEEP REF MED; The Sate Council of the People's Republic of China, 2011, 12 5 YEAR PLAN OUTL; Veerman JL, 2012, BRIT J SPORT MED, V46, P927, DOI [10.1136/bjsports-2011-085662, 10.1136/bjsm.2011.085662]; Wan X, 2007, HLTH RES, V36, P285; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Wolin KY, 2009, BRIT J CANCER, V100, P611, DOI 10.1038/sj.bjc.6604917; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Zhang J, 2013, PREV MED, V56, P75, DOI 10.1016/j.ypmed.2012.11.010; Zhou MaiGeng, 2010, Disease Surveillance, V25, P239; 胡楠, 2012, [中国卫生统计, Chinese Journal of Health Statistics], V29, P424	39	7	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109826	10.1371/journal.pone.0109826	http://dx.doi.org/10.1371/journal.pone.0109826			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314595	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500080
J	Yang, H; Song, Z; Yang, GP; Zhang, BK; Chen, M; Wu, T; Guo, R				Yang, Heng; Song, Zhi; Yang, Guo-Ping; Zhang, Bi-Kui; Chen, Min; Wu, Tian; Guo, Ren			The ALDH2 rs671 Polymorphism Affects Post-Stroke Epilepsy Susceptibility and Plasma 4-HNE Levels	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE 2; ALCOHOL-CONSUMPTION; GLU504LYS POLYMORPHISM; GENETIC POLYMORPHISMS; JAPANESE MEN; RISK-FACTOR; STROKE; HEART; NITROGLYCERIN; ACTIVATION	Recent studies have demonstrated the protective effect of mitochondrial aldehyde dehydrogenase 2 (ALDH2) in cardiovascular diseases. Increased levels of the potential ALDH2 substrate 4-hydroxynonenal (4-HNE) are involved in myocardial/cerebral ischemia accompanied by a high level of oxidative stress. In this investigation, we first performed a case-control study to explore the potential association of ALDH2 rs671 polymorphism and post-stroke epilepsy (PSE). Then, we performed an in vitro study to determine whether the overexpression of ALDH2 could decrease the level of oxidative stress and the apoptosis ratio induced by 4-HNE. There was a significant difference in the distribution of the allele and genotype frequencies of the rs671 polymorphism between PSE patients and ischemic stroke (IS) patients. Individuals with the rs671 A allele showed significantly higher levels of plasma 4-HNE. The overexpression of ALDH2 partially blocked the increased levels of malondialdehyde (MDA), reactive oxygen species (ROS) and apoptosis ratio induced by 4-HNE and also partially restored the ALDH2 activity in PC12 cells; these effects were reversed in the presence of eV1-2. Our results suggest that the ALDH2 rs671 polymorphism is associated with PSE susceptibility and affects the 4-HNE levels. Targeting ALDH2 might be a useful strategy for the treatment or prevention of PSE.	[Zhang, Bi-Kui; Chen, Min; Wu, Tian; Guo, Ren] Cent S Univ, Xiangya Hosp 3, Dept Pharm, Changsha, Hunan, Peoples R China; [Yang, Heng; Song, Zhi] Cent S Univ, Xiangya Hosp 3, Dept Neurol, Changsha, Hunan, Peoples R China; [Yang, Guo-Ping] Cent S Univ, Xiangya Hosp 3, Dept Cent Lab, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University	Guo, R (corresponding author), Cent S Univ, Xiangya Hosp 3, Dept Pharm, Changsha, Hunan, Peoples R China.	grfw2012@aliyun.com		Yang, Heng/0000-0002-5635-8533	Chinese National Science Foundation [81000120]	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC))	This project was supported by Chinese National Science Foundation (No. 81000120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOSRON WF, 1988, MOL ASPECTS MED, V10, P147, DOI 10.1016/0098-2997(88)90019-2; Budas GR, 2010, J MOL CELL CARDIOL, V48, P757, DOI 10.1016/j.yjmcc.2009.10.030; Burneo JG, 2010, EUR J NEUROL, V17, P52, DOI 10.1111/j.1468-1331.2009.02739.x; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chen ZQ, 2005, P NATL ACAD SCI USA, V102, P12159, DOI 10.1073/pnas.0503723102; Cherubini A, 2000, STROKE, V31, P2295, DOI 10.1161/01.STR.31.10.2295; Churchill EN, 2009, J MOL CELL CARDIOL, V46, P278, DOI 10.1016/j.yjmcc.2008.09.713; CRABB DW, 1989, J CLIN INVEST, V83, P314, DOI 10.1172/JCI113875; Ferguson RA, 1997, CLIN CHIM ACTA, V257, P199, DOI 10.1016/S0009-8981(96)06444-3; Forsgren L, 1996, EPILEPSIA, V37, P224, DOI 10.1111/j.1528-1157.1996.tb00017.x; Guo JM, 2013, CELL RES, V23, P915, DOI 10.1038/cr.2013.69; Guo YJ, 2010, ATHEROSCLEROSIS, V211, P545, DOI 10.1016/j.atherosclerosis.2010.03.030; Hashimoto Y, 2002, CLIN CHEM, V48, P1043; He L, 2012, EUR J PHARMACOL, V678, P32, DOI 10.1016/j.ejphar.2011.12.042; Lagranha CJ, 2010, CIRC RES, V106, P1681, DOI 10.1161/CIRCRESAHA.109.213645; Lee WC, 2012, BIOCHEM BIOPH RES CO, V425, P842, DOI 10.1016/j.bbrc.2012.08.002; Li SY, 2006, J MOL CELL CARDIOL, V40, P283, DOI 10.1016/j.yjmcc.2005.11.006; Li XH, 1997, EPILEPSIA, V38, P1216, DOI 10.1111/j.1528-1157.1997.tb01219.x; Li YF, 2006, J CLIN INVEST, V116, P506, DOI 10.1172/JCI26564; Ma H, 2011, EUR HEART J, V32, P1025, DOI 10.1093/eurheartj/ehq253; Mackenzie IS, 2005, ARTERIOSCL THROM VAS, V25, P1891, DOI 10.1161/01.ATV.0000179599.71086.89; Nagasawa H, 2007, EUR J NEUROL, V14, P428, DOI 10.1111/j.1468-1331.2007.01700.x; Nakamura Y, 2002, ATHEROSCLEROSIS, V164, P171, DOI 10.1016/S0021-9150(02)00059-X; Patra J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-258; Renner A, 2005, J HEART LUNG TRANSPL, V24, P730, DOI 10.1016/j.healun.2004.02.021; Scharfman HE, 2007, CURR NEUROL NEUROSCI, V7, P348, DOI 10.1007/s11910-007-0053-z; Stewart MJ, 1996, J INVEST MED, V44, P42; Takagi S, 2002, HYPERTENS RES, V25, P677; Wang RS, 2002, DRUG METAB DISPOS, V30, P69, DOI 10.1124/dmd.30.1.69; Xu F, 2011, J CELL MOL MED, V15, P1955, DOI 10.1111/j.1582-4934.2010.01181.x; YOSHIDA A, 1984, P NATL ACAD SCI-BIOL, V81, P258, DOI 10.1073/pnas.81.1.258; Zhou SR, 2010, NEUROSCI LETT, V468, P312, DOI 10.1016/j.neulet.2009.11.022	32	39	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109634	10.1371/journal.pone.0109634	http://dx.doi.org/10.1371/journal.pone.0109634			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313998	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500061
J	DiFranco, M; Quinonez, M; Shieh, P; Fonarow, GC; Cruz, D; Deng, MC; Vergara, JL; Middlekauff, HR				DiFranco, Marino; Quinonez, Marbella; Shieh, Perry; Fonarow, Gregg C.; Cruz, Daniel; Deng, Mario C.; Vergara, Julio L.; Middlekauff, Holly R.			Action Potential-Evoked Calcium Release Is Impaired in Single Skeletal Muscle Fibers from Heart Failure Patients	PLOS ONE			English	Article							TRANSVERSE TUBULAR SYSTEM; GAP ISOLATION CHAMBER; EXERCISE CAPACITY; FAST-TWITCH; SLOW-TWITCH; CONTRACTION; DISEASE; RATS; MDX; ABNORMALITIES	Background: Exercise intolerance in chronic heart failure (HF) has been attributed to abnormalities of the skeletal muscles. Muscle function depends on intact excitation-contraction coupling (ECC), but ECC studies in HF models have been inconclusive, due to deficiencies in the animal models and tools used to measure calcium (Ca2+) release, mandating investigations in skeletal muscle from HF patients. The purpose of this study was to test the hypothesis that Ca2+ release is significantly impaired in the skeletal muscle of HF patients in whom exercise capacity is severely diminished compared to age-matched healthy volunteers. Methods and Findings: Using state-of-the-art electrophysiological and optical techniques in single muscle fibers from biopsies of the locomotive vastus lateralis muscle, we measured the action potential (AP)-evoked Ca2+ release in 4 HF patients and 4 age-matched healthy controls. The mean peak Ca2+ release flux in fibers obtained from HF patients (10 +/- 1.2 mu M/ms) was markedly (2.6-fold) and significantly (p<0.05) smaller than in fibers from healthy volunteers (28 +/- 3.3 mu M/ms). This impairment in AP-evoked Ca2+ release was ubiquitous and was not explained by differences in the excitability mechanisms since single APs were indistinguishable between HF patients and healthy volunteers. Conclusions: These findings prove the feasibility of performing electrophysiological experiments in single fibers from human skeletal muscle, and offer a new approach for investigations of myopathies due to HF and other diseases. Importantly, we have demonstrated that one step in the ECC process, AP-evoked Ca2+ release, is impaired in single muscle fibers in HF patients.	[DiFranco, Marino; Quinonez, Marbella; Vergara, Julio L.; Middlekauff, Holly R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Shieh, Perry] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Fonarow, Gregg C.; Cruz, Daniel; Deng, Mario C.; Middlekauff, Holly R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Middlekauff, HR (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.	hmiddlekauff@mednet.ucla.edu	Fonarow, Gregg C/D-5988-2014	Fonarow, Gregg C/0000-0002-3192-8093	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [AR047664, AR54816, AR041802]; Clinical and Translational Science Institute Grant [UL1TR000124]; UCLA Department of Medicine; UCLA Dean's Office; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR047664, R01AR041802, R01AR047664, R01AR054816] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Clinical and Translational Science Institute Grant; UCLA Department of Medicine; UCLA Dean's Office; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under award numbers AR047664, AR54816, and AR041802; the Clinical and Translational Science Institute Grant #UL1TR000124; and funds from the UCLA Department of Medicine and Dean's Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GR, 2006, AM J PHYSIOL-RENAL, V290, pF753, DOI 10.1152/ajprenal.00296.2005; Bacurau AVN, 2009, J APPL PHYSIOL, V106, P1631, DOI 10.1152/japplphysiol.91067.2008; Baylor SM, 2012, J GEN PHYSIOL, V139, P261, DOI 10.1085/jgp.201210773; Bueno CR, 2010, J APPL PHYSIOL, V109, P702, DOI 10.1152/japplphysiol.00281.2010; Capote J, 2010, AM J PHYSIOL-CELL PH, V298, pC1077, DOI 10.1152/ajpcell.00428.2009; Delbono O, 1995, J MEMBRANE BIOL, V148, P211; Desaphy JF, 2001, BRAIN, V124, P1100, DOI 10.1093/brain/124.6.1100; DiFranco M, 2005, J MEMBRANE BIOL, V208, P141, DOI 10.1007/s00232-005-0825-9; DiFranco M, 2002, PFLUG ARCH EUR J PHY, V443, P508, DOI 10.1007/s004240100719; DiFranco M, 1999, PFLUG ARCH EUR J PHY, V438, P412, DOI 10.1007/s004240050929; DiFranco M, 2008, P NATL ACAD SCI USA, V105, P14698, DOI 10.1073/pnas.0802217105; DRACUP K, 1992, J HEART LUNG TRANSPL, V11, P273; DREXLER H, 1992, CIRCULATION, V85, P1751, DOI 10.1161/01.CIR.85.5.1751; FERGUSON DG, 1988, MUSCLE NERVE, V11, P561, DOI 10.1002/mus.880110607; FRANCIOSA JA, 1981, AM J CARDIOL, V47, P33, DOI 10.1016/0002-9149(81)90286-1; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; HIGGINBOTHAM MB, 1983, AM J CARDIOL, V51, P52, DOI 10.1016/S0002-9149(83)80010-1; LAMB GD, 1987, J PHYSIOL-LONDON, V393, P595, DOI 10.1113/jphysiol.1987.sp016843; Lunde PK, 2006, CIRC RES, V98, P1514, DOI 10.1161/01.RES.0000226529.66545.e5; Lunde PK, 2001, CIRC RES, V88, P1299, DOI 10.1161/hh1201.092041; MANCINI DM, 1989, CIRCULATION, V80, P1338, DOI 10.1161/01.CIR.80.5.1338; MASKIN CS, 1983, AM J CARDIOL, V51, P177, DOI 10.1016/S0002-9149(83)80032-0; Mettaure B, 2001, J AM COLL CARDIOL, V38, P947, DOI 10.1016/S0735-1097(01)01460-7; Middlekauff HR, 2013, CLIN RES CARDIOL, V102, P547, DOI 10.1007/s00392-013-0564-3; Middlekauff HR, 2012, J CARD FAIL, V18, P724, DOI 10.1016/j.cardfail.2012.07.005; Middlekauff HR, 2010, CIRC-HEART FAIL, V3, P537, DOI 10.1161/CIRCHEARTFAILURE.109.903773; PERREAULT CL, 1993, CIRC RES, V73, P405, DOI 10.1161/01.RES.73.2.405; Quinonez M, 2000, JPN J PHYSIOL, V50, P457, DOI 10.2170/jjphysiol.50.457; Rehn TA, 2012, HEART FAIL REV, V17, P421, DOI 10.1007/s10741-011-9289-4; Rullman E, 2013, J HEART LUNG TRANSPL, V32, P925, DOI 10.1016/j.healun.2013.06.026; Schaufelberger M, 1997, EUR HEART J, V18, P971; Shah K, 2004, CAN J PHYSIOL PHARM, V82, P438, DOI 10.1139/Y04-051; Simonini A, 1996, CIRC RES, V79, P128, DOI 10.1161/01.RES.79.1.128; Song LS, 1998, J PHYSIOL-LONDON, V512, P677, DOI 10.1111/j.1469-7793.1998.677bd.x; Stevenson LW, 2008, J AM COLL CARDIOL, V52, P1702, DOI 10.1016/j.jacc.2008.08.028; Struk A, 1998, BIOPHYS J, V75, P2402, DOI 10.1016/S0006-3495(98)77684-2; SULLIVAN MJ, 1990, CIRCULATION, V81, P518, DOI 10.1161/01.CIR.81.2.518; Troosters Thierry, 2004, J Cardiopulm Rehabil, V24, P137, DOI 10.1097/00008483-200405000-00001; Ward CW, 2003, FASEB J, V17, P1517, DOI 10.1096/fj.02-1083fje; Whellan DJ, 2011, AM HEART J, V162, P1003, DOI 10.1016/j.ahj.2011.09.017; Williams AD, 2004, J CARD FAIL, V10, P141, DOI 10.1016/j.cardfail.2003.09.004; WILSON JR, 1995, J AM COLL CARDIOL, V26, P429, DOI 10.1016/0735-1097(95)80018-C; Woods CE, 2005, J PHYSIOL-LONDON, V568, P867, DOI 10.1113/jphysiol.2005.089318; Woods CE, 2004, J PHYSIOL-LONDON, V557, P59, DOI 10.1113/jphysiol.2004.061291; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807	45	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109309	10.1371/journal.pone.0109309	http://dx.doi.org/10.1371/journal.pone.0109309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310188	Green Published, gold			2022-12-27	WOS:000343210300043
J	Gworek, B; Klimczak, K; Kijenska, M				Gworek, Barbara; Klimczak, Katarzyna; Kijenska, Marta			The Relation between Polyaromatic Hydrocarbon Concentration in Sewage Sludge and Its Uptake by Plants: Phragmites communis, Polygonum persicaria and Bidens tripartita	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; PART II; ORGANIC CONTAMINANTS; CANCER-RISK; AIR-QUALITY; PAHS; PHENANTHRENE; LEAVES; L.	The aim of the study was to define the relationship between the concentration of PAHs in sewage sludge at a particular location and their amount in various plant materials growing on it. The credibility of the results is enhanced by the fact that sewage sludge from two separate sewage-treatment plants were selected for their influence on the content of PAHs in three plant species growing on them. The investigations were carried out for a period of three years. The results demonstrated unequivocally that the uptake of PAHs by a plant depended on polyaromatic hydrocarbon concentration in the sewage sludge. The correlation between accumulation coefficient of PAH in a plant and the content of the same PAH in the sewage sludge had for three-, four- and five-ring hydrocarbons an exponential character and for six-ring hydrocarbons was of a linear character. The accumulation coefficients calculated for three-ring aromatics were several times higher than for four-ring PAHs; further the coefficient values calculated for five-ring PAHs were several times lower than for four-ring hydrocarbons. Finally, the accumulation coefficient values of six-ring PAHs were the lowest in the series of studied polyaromatic hydrocarbons.	[Gworek, Barbara; Kijenska, Marta] Natl Res Inst, Inst Environm Protect, Warsaw, Poland; [Klimczak, Katarzyna] Warsaw Univ Life Sci SGGW, Dept Soil Environm Sci, Warsaw, Poland	Institute of Environmental Protection - National Research Institute; Warsaw University of Life Sciences	Kijenska, M (corresponding author), Natl Res Inst, Inst Environm Protect, Warsaw, Poland.	marta.kijenska@ios.edu.pl	Kijenska, Marta/Q-8637-2018	Kijenska, Marta/0000-0002-5191-4318; Gworek, Barbara/0000-0002-2368-5888	Ministry of Science and Higher Education	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	The work was supported by Ministry of Science and Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruti A, 2012, ENVIRON MONIT ASSESS, V184, P6513, DOI 10.1007/s10661-011-2437-4; Ashraf MW, 2013, J CHEM, P1; BENNER BA, 1989, ENVIRON SCI TECHNOL, V23, P1269, DOI 10.1021/es00068a014; De Nicola F, 2005, CHEMOSPHERE, V61, P432, DOI 10.1016/j.chemosphere.2005.01.082; De Nicola F, 2011, ATMOS ENVIRON, V45, P1428, DOI 10.1016/j.atmosenv.2010.12.022; Pereira MD, 2007, CHEMOSPHERE, V67, P1736, DOI 10.1016/j.chemosphere.2006.05.141; DuarteDavidson R, 1996, SCI TOTAL ENVIRON, V185, P59, DOI 10.1016/0048-9697(96)05042-5; Dutta K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009984; Gao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033503; Gao YZ, 2004, CHEMOSPHERE, V55, P1169, DOI 10.1016/j.chemosphere.2004.01.037; Garcia R, 2012, FUEL PROCESS TECHNOL, V104, P245, DOI 10.1016/j.fuproc.2012.05.018; Harvey PJ, 2002, ENVIRON SCI POLLUT R, V9, P29, DOI 10.1007/BF02987315; LAVOIE EJ, 1982, CARCINOGENESIS, V3, P49, DOI 10.1093/carcin/3.1.49; Lee BM, 2007, J TOXICOL ENV HEAL A, V70, P1391, DOI 10.1080/15287390701434182; Lehndorff E, 2004, ATMOS ENVIRON, V38, P3793, DOI 10.1016/j.atmosenv.2004.03.065; Lim LH, 1999, ENVIRON SCI TECHNOL, V33, P3538, DOI 10.1021/es990392d; Meudec A, 2006, CHEMOSPHERE, V65, P474, DOI 10.1016/j.chemosphere.2006.01.058; Nielsen T, 1996, ATMOS ENVIRON, V30, P3481, DOI 10.1016/1352-2310(96)00096-9; Orecchio S, 2007, ATMOS ENVIRON, V41, P8669, DOI 10.1016/j.atmosenv.2007.07.027; Ravindra K, 2008, ATMOS ENVIRON, V42, P2895, DOI 10.1016/j.atmosenv.2007.12.010; Van Metre PC, 2003, CHEMOSPHERE, V52, P1727, DOI 10.1016/S0045-6535(03)00454-5; Weisman D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-59; WILD SR, 1990, ENVIRON SCI TECHNOL, V24, P1706, DOI 10.1021/es00081a013; WILD SR, 1995, ENVIRON POLLUT, V88, P91, DOI 10.1016/0269-7491(95)91052-M; Yang YC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087749, 10.1371/journal.pone.0100677, 10.1371/journal.pone.0085863, 10.1371/journal.pone.0102942]; Yang ZY, 2007, CHEMOSPHERE, V67, P402, DOI 10.1016/j.chemosphere.2006.09.008; Yoon E, 2007, HUM ECOL RISK ASSESS, V13, P669, DOI 10.1080/10807030701226871; Zhou B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085676; Zhu LZ, 2004, ENVIRON POLLUT, V131, P505, DOI 10.1016/j.envpol.2004.02.003	29	4	4	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109548	10.1371/journal.pone.0109548	http://dx.doi.org/10.1371/journal.pone.0109548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310699	gold, Green Submitted, Green Published			2022-12-27	WOS:000343210300055
J	Bianco, L; Cestaro, A; Sargent, DJ; Banchi, E; Derdak, S; Di Guardo, M; Salvi, S; Jansen, J; Viola, R; Gut, I; Laurens, F; Chagne, D; Velasco, R; van de Weg, E; Troggio, M				Bianco, Luca; Cestaro, Alessandro; Sargent, Daniel James; Banchi, Elisa; Derdak, Sophia; Di Guardo, Mario; Salvi, Silvio; Jansen, Johannes; Viola, Roberto; Gut, Ivo; Laurens, Francois; Chagne, David; Velasco, Riccardo; van de Weg, Eric; Troggio, Michela			Development and Validation of a 20K Single Nucleotide Polymorphism (SNP) Whole Genome Genotyping Array for Apple (Malus x domestica Borkh)	PLOS ONE			English	Article							LINKAGE MAP; CONSTRUCTION; ALIGNMENT; ACCURATE	High-density SNP arrays for genome-wide assessment of allelic variation have made high resolution genetic characterization of crop germplasm feasible. A medium density array for apple, the IRSC 8 K SNP array, has been successfully developed and used for screens of bi-parental populations. However, the number of robust and well-distributed markers contained on this array was not sufficient to perform genome-wide association analyses in wider germplasm sets, or Pedigree-Based Analysis at high precision, because of rapid decay of linkage disequilibrium. We describe the development of an Illumina lnfinium array targeting 20 K SNPs. The SNPs were predicted from re-sequencing data derived from the genomes of 13 Malus x domestica apple cultivars and one accession belonging to a crab apple species (M. micromalus). A pipeline for SNP selection was devised that avoided the pitfalls associated with the inclusion of paralogous sequence variants, supported the construction of robust multi-allelic SNP haploblocics and selected up to 11 entries within narrow genomic regions of 5 kb, termed focal points (FPs). Broad genome coverage was attained by placing FPs at 1 cM intervals on a consensus genetic map, complementing them with FPs to enrich the ends of each of the chromosomes, and by bridging physical intervals greater than 400 Kbps. The selection also included similar to 3.7 K validated SNPs from the IRSC 8 K array. The array has already been used in other studies where similar to 15.8 K SNP markers were mapped with an average of similar to 6.8 K SNPs per full-sib family. The newly developed array with its high density of polymorphic validated SNPs is expected to be of great utility for Pedigree-Based Analysis and Genomic Selection. It will also be a valuable tool to help dissect the genetic mechanisms controlling important fruit quality traits, and to aid the identification of marker-trait associations suitable for the application of Marker Assisted Selection in apple breeding programs.	[Bianco, Luca; Cestaro, Alessandro; Sargent, Daniel James; Banchi, Elisa; Di Guardo, Mario; Viola, Roberto; Velasco, Riccardo; Troggio, Michela] Fdn Edmund Mach, Res & Innovat Ctr, Trento, Italy; [Derdak, Sophia; Gut, Ivo] Parc Cientific Barcelona, CNAG, Barcelona, Spain; [Di Guardo, Mario; van de Weg, Eric] Wageningen Univ, Res Ctr, Wageningen UR Plant Breeding, NL-6700 AP Wageningen, Netherlands; [Salvi, Silvio] Univ Bologna, DipSA, Bologna, Italy; [Jansen, Johannes] Wageningen Univ, Res Ctr, NL-6700 AP Wageningen, Netherlands; [Laurens, Francois] Inst Rech Hort & Semences, INRA, UMR1345, Beaucouze, France; [Chagne, David] Palmerston North Res Ctr, Palmerston North, New Zealand	Fondazione Edmund Mach; Wageningen University & Research; University of Bologna; Wageningen University & Research; INRAE	Troggio, M (corresponding author), Fdn Edmund Mach, Res & Innovat Ctr, Trento, Italy.	michela.troggio@fmach.it	Di Guardo, Mario/AAA-7498-2021; Sargent, Daniel James/A-2933-2014; Van de Weg, Eric W/G-3225-2011; Chagne, David/A-2596-2010; Gut, Ivo/ABF-3188-2020; Viola, Roberto/F-3657-2014	Sargent, Daniel James/0000-0002-6686-7147; Van de Weg, Eric W/0000-0002-9443-5974; Chagne, David/0000-0003-4018-0694; Gut, Ivo/0000-0001-7219-632X; Banchi, Elisa/0000-0002-6598-0447; Viola, Roberto/0000-0002-8202-8503; Di Guardo, Mario/0000-0003-3339-2007; Cestaro, Alessandro/0000-0003-1439-5165; Velasco, Riccardo/0000-0002-8760-5031; Bianco, Luca/0000-0002-0196-8422	EU seventh Framework Programme by the FruitBreedomics project [265582]	EU seventh Framework Programme by the FruitBreedomics project	This work has been funded under the EU seventh Framework Programme by the FruitBreedomics project No. 265582: Integrated Approach for increasing breeding efficiency in fruit tree crops. The views expressed in this work are the sole responsibility of the authors and do not necessary reflect the views of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antanaviciute L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-203; Arnold B, 2013, MOL ECOL, V22, P3179, DOI 10.1111/mec.12276; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bansal V, 2010, GENOME RES, V20, P537, DOI 10.1101/gr.100040.109; Bekele WA, 2013, PLANT BIOTECHNOL J, V11, P1112, DOI 10.1111/pbi.12106; Bink MCAM, 2014, THEOR APPL GENET, V127, P1073, DOI 10.1007/s00122-014-2281-3; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; Chen HD, 2014, MOL PLANT, V7, P541, DOI 10.1093/mp/sst135; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Clark MD, 2014, TREE GENET GENOMES, V10, P627, DOI 10.1007/s11295-014-0709-1; Derrien T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030377; Durel CE, 1998, THEOR APPL GENET, V96, P1077, DOI 10.1007/s001220050842; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evans KM, 2011, MOL BREEDING, V28, P535, DOI 10.1007/s11032-010-9502-5; Felcher KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036347; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Khan MA, 2012, J EXP BOT, V63, P4045, DOI 10.1093/jxb/ers105; Kumar S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-393; Kumar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036674; Lespinasse Y., 1999, Acta Horticulturae, P49; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084329; Liu H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-104; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Micheletti D, 2011, TREE GENET GENOMES, V7, P857, DOI 10.1007/s11295-011-0380-8; Montanari S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0077022, 10.1371/journal.pone.0066221]; Myles S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008219; Noiton DAM, 1996, J AM SOC HORTIC SCI, V121, P773, DOI 10.21273/JASHS.121.5.773; Pavy N, 2013, MOL ECOL RESOUR, V13, P324, DOI 10.1111/1755-0998.12062; Peace C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048305; Pfender WF, 2011, THEOR APPL GENET, V122, P1467, DOI 10.1007/s00122-011-1546-3; Pikunova A, 2014, TREE GENET GENOMES, V10, P261, DOI 10.1007/s11295-013-0679-8; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Salvi S, 2014, MOL BREEDING, V34, P511, DOI 10.1007/s11032-014-0054-y; Shulaev V, 2008, PLANT PHYSIOL, V147, P985, DOI 10.1104/pp.107.115618; Sim SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045520, 10.1371/journal.pone.0040563]; Song QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054985; Troggio M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067407; Van de Weg W, 2014, INT PLANT ANIMAL GEN; Van Ooijen JW, 2011, GENET RES, V93, P343, DOI 10.1017/S0016672311000279; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Wang ZhenYu, 2012, Acta Agronomica Sinica, V38, P971, DOI 10.3724/SP.J.1006.2012.00971; Ward JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-2; Yang HX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064799, 10.1371/journal.pone.0064058]	47	149	154	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110377	10.1371/journal.pone.0110377	http://dx.doi.org/10.1371/journal.pone.0110377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303088	Green Published, gold, Green Submitted			2022-12-27	WOS:000343730400127
J	Maier, L; Barthel, M; Stecher, B; Maier, RJ; Gunn, JS; Hardt, WD				Maier, Lisa; Barthel, Manja; Stecher, Baerbel; Maier, Robert J.; Gunn, John S.; Hardt, Wolf-Dietrich			Salmonella Typhimurium Strain ATCC14028 Requires H-2-Hydrogenases for Growth in the Gut, but Not at Systemic Sites	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; COLONIZATION RESISTANCE; ESCHERICHIA-COLI; HYDROGEN; SOPE; MICROBIOTA; MICE; INFECTION; PROVIDES; PROTEIN	Salmonella enterica is a common cause of diarrhea. For eliciting disease, the pathogen has to colonize the gut lumen, a site colonized by the microbiota. This process/initial stage is incompletely understood. Recent work established that one particular strain, Salmonella enterica subspecies 1 serovar Typhimurium strain SL1344, employs the hyb H-2-hydrogenase for consuming microbiota-derived H-2 to support gut luminal pathogen growth: Protons from the H-2-splitting reaction contribute to the proton gradient across the outer bacterial membrane which can be harvested for ATP production or for import of carbon sources. However, it remained unclear, if other Salmonella strains would use the same strategy. In particular, earlier work had left unanswered if strain ATCC14028 might use H-2 for growth at systemic sites. To clarify the role of the hydrogenases, it seems important to establish if H-2 is used at systemic sites or in the gut and if Salmonella strains may differ with respect to the host sites where they require H-2 in vivo. In order to resolve this, we constructed a strain lacking all three H-2-hydrogenases of ATCC14028 (14028(hyd3)) and performed competitive infection experiments. Upon intragastric inoculation, 14028(hyd3) was present at 100-fold lower numbers than 14028(WT) in the stool and at systemic sites. In contrast, i.v. inoculation led to equivalent systemic loads of 14028(hyd3) and the wild type strain. However, the pathogen population spreading to the gut lumen featured again up to 100-fold attenuation of 14028(hyd3). Therefore, ATCC14028 requires H-2-hydrogenases for growth in the gut lumen and not at systemic sites. This extends previous work on ATCC14028 and supports the notion that H-2-utilization might be a general feature of S. Typhimurium gut colonization.	[Maier, Lisa; Barthel, Manja; Hardt, Wolf-Dietrich] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland; [Stecher, Baerbel] Max Von Pettenkofer Inst, Munich, Germany; [Stecher, Baerbel] Partner Site LMU Munich, German Ctr Infect Res DZIF, Munich, Germany; [Maier, Robert J.] Univ Georgia, Dept Microbiol, Athens, GA USA; [Gunn, John S.] Ohio State Univ, Ctr Microbial Interface Biol, Dept Microbial Infect & Immun, Columbus, OH 43210 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Munich; German Center for Infection Research; University of Munich; University System of Georgia; University of Georgia; University System of Ohio; Ohio State University	Hardt, WD (corresponding author), ETH, Inst Microbiol, CH-8092 Zurich, Switzerland.	wolf-dietrich.hardt@micro.biol.ethz.ch	Stecher, Bärbel/A-2911-2015; Maier, Lisa/ABH-1893-2021; Stecher, Barbel/B-9940-2019	Stecher, Bärbel/0000-0002-7445-5193; Maier, Lisa/0000-0002-6473-4762; Hardt, Wolf-Dietrich/0000-0002-9892-6420	Swiss National Science Foundation [310030-132997/1]; Sinergia project [CRSII3_136286]; UBS Optimus Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Sinergia project; UBS Optimus Foundation	This work was supported in part by the Swiss National Science Foundation (310030-132997/1) and the Sinergia project CRSII3_136286 to WDH) and the UBS Optimus Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2013, INFECT GENET EVOL, V16, P314, DOI 10.1016/j.meegid.2013.03.003; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; BOHNHOFF M, 1964, J EXP MED, V120, P817, DOI 10.1084/jem.120.5.817; BOHNHOFF M, 1962, J INFECT DIS, V111, P117, DOI 10.1093/infdis/111.2.117; BROWN KJ, 1979, A VAN LEEUW J MICROB, V45, P531, DOI 10.1007/BF00403653; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Carbonero F, 2012, NAT REV GASTRO HEPAT, V9, P504, DOI 10.1038/nrgastro.2012.85; Crawford RW, 2010, P NATL ACAD SCI USA, V107, P4353, DOI 10.1073/pnas.1000862107; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Endt K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001097; Figueroa-Bossi N, 2001, MOL MICROBIOL, V39, P260, DOI 10.1046/j.1365-2958.2001.02234.x; Gordienko EN, 2013, J BACTERIOL, V195, P2786, DOI 10.1128/JB.02285-12; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; Hapfelmeier S, 2008, J EXP MED, V205, P437, DOI 10.1084/jem.20070633; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hardt WD, 1998, P NATL ACAD SCI USA, V95, P2574, DOI 10.1073/pnas.95.5.2574; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Jacobsen A, 2011, MICROB ECOL, V62, P487, DOI 10.1007/s00248-011-9880-1; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Kaiser P, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001793; Kaiser P, 2012, IMMUNOL REV, V245, P56, DOI 10.1111/j.1600-065X.2011.01070.x; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Knodler LA, 2010, P NATL ACAD SCI USA, V107, P17733, DOI 10.1073/pnas.1006098107; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; Lamichhane-Khadka R, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130146; Lamichhane-Khadka R, 2011, J BACTERIOL, V193, P5824, DOI 10.1128/JB.05456-11; Lamichhane-Khadka R, 2010, MBIO, V1, DOI 10.1128/mBio.00284-10; Lopez CA, 2012, MBIO, V3, DOI 10.1128/mBio.00143-12; Maier L, 2013, CELL HOST MICROBE, V14, P641, DOI 10.1016/j.chom.2013.11.002; Maier RJ, 2005, BIOCHEM SOC T, V33, P83, DOI 10.1042/BST0330083; Maier RJ, 2004, INFECT IMMUN, V72, P6294, DOI 10.1128/IAI.72.11.6294-6299.2004; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; MEYNELL GG, 1963, BRIT J EXP PATHOL, V44, P197; Meynell GG, 1955, P R SOC MED; Mirold S, 1999, P NATL ACAD SCI USA, V96, P9845, DOI 10.1073/pnas.96.17.9845; Mirold S, 2001, J MOL BIOL, V312, P7, DOI 10.1006/jmbi.2001.4950; Murray RA, 2000, INFECT IMMUN, V68, P5050, DOI 10.1128/IAI.68.9.5050-5055.2000; Nakamura N, 2010, ANNU REV FOOD SCI T, V1, P363, DOI 10.1146/annurev.food.102308.124101; Ng KM, 2013, NATURE; Nuccio SP, 2014, MBIO, V5, DOI 10.1128/mBio.00929-14; Pelludat C, 2003, J BACTERIOL, V185, P5182, DOI 10.1128/JB.185.17.5182-5191.2003; Pie S, 1996, INFECT IMMUN, V64, P849, DOI 10.1128/IAI.64.3.849-854.1996; QUE JU, 1985, INFECT IMMUN, V48, P169, DOI 10.1128/IAI.48.1.169-174.1985; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Stecher B, 2011, CURR OPIN MICROBIOL, V14, P82, DOI 10.1016/j.mib.2010.10.003; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Tsolis RM, 2011, INFECT IMMUN, V79, P1806, DOI 10.1128/IAI.01369-10; VANDERWAAIJ D, 1971, J HYG-CAMB, V69, P405, DOI 10.1017/S0022172400021653; Wallis TS, 2000, MOL MICROBIOL, V36, P997, DOI 10.1046/j.1365-2958.2000.01892.x; Wood MW, 1996, MOL MICROBIOL, V22, P327, DOI 10.1046/j.1365-2958.1996.00116.x; Zbell AL, 2008, INFECT IMMUN, V76, P4445, DOI 10.1128/IAI.00741-08; Zbell AL, 2007, MICROBIOL-SGM, V153, P3508, DOI 10.1099/mic.0.2007/009027-0; Zbell AL, 2009, APPL ENVIRON MICROB, V75, P1456, DOI 10.1128/AEM.02064-08; Zhang SP, 2002, FEMS MICROBIOL LETT, V217, P243, DOI 10.1111/j.1574-6968.2002.tb11482.x	57	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110187	10.1371/journal.pone.0110187	http://dx.doi.org/10.1371/journal.pone.0110187			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303479	Green Submitted, Green Published, gold			2022-12-27	WOS:000343730400120
J	Bizzarro, JJ; Broms, KM; Logsdon, MG; Ebert, DA; Yoklavich, MM; Kuhnz, LA; Summers, AP				Bizzarro, Joseph J.; Broms, Kristin M.; Logsdon, Miles G.; Ebert, David A.; Yoklavich, Mary M.; Kuhnz, Linda A.; Summers, Adam P.			Spatial Segregation in Eastern North Pacific Skate Assemblages	PLOS ONE			English	Article							NO-TAKE ZONE; CENTRAL CALIFORNIA; BATHYRAJA-INTERRUPTA; HABITAT ASSOCIATIONS; REPRODUCTIVE-BIOLOGY; SPECIES COMPOSITION; LEUCORAJA-OCELLATA; DEMERSAL FISH; SOUTHERN GULF; BERING SKATE	Skates (Rajiformes: Rajoidei) are common mesopredators in marine benthic communities. The spatial associations of individual species and the structure of assemblages are of considerable importance for effective monitoring and management of exploited skate populations. This study investigated the spatial associations of eastern North Pacific (ENP) skates in continental shelf and upper continental slope waters of two regions: central California and the western Gulf of Alaska. Long-term survey data were analyzed using GIS/spatial analysis techniques and regression models to determine distribution (by depth, temperature, and latitude/longitude) and relative abundance of the dominant species in each region. Submersible video data were incorporated for California to facilitate habitat association analysis. We addressed three main questions: 1) Are there regions of differential importance to skates?, 2) Are ENP skate assemblages spatially segregated?, and 3) When skates co-occur, do they differ in size? Skate populations were highly clustered in both regions, on scales of 10s of kilometers; however, high-density regions (i.e., hot spots) were segregated among species. Skate densities and frequencies of occurrence were substantially lower in Alaska as compared to California. Although skates are generally found on soft sediment habitats, Raja rhina exhibited the strongest association with mixed substrates, and R. stellulata catches were greatest on rocky reefs. Size segregation was evident in regions where species overlapped substantially in geographic and depth distribution (e. g., R. rhina and Bathyraja kincaidii off California; B. aleutica and B. interrupta in the Gulf of Alaska). Spatial niche differentiation in skates appears to be more pronounced than previously reported.	[Bizzarro, Joseph J.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Broms, Kristin M.] Colorado State Univ, Cooperat Fish & Wildlife Unit, Ft Collins, CO 80523 USA; [Logsdon, Miles G.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Ebert, David A.] Moss Landing Marine Labs, Pacific Shark Res Ctr, Moss Landing, CA 95039 USA; [Yoklavich, Mary M.] Natl Marine Fisheries Serv, SW Fisheries Sci Ctr, Fisheries Ecol Div, Santa Cruz, CA USA; [Kuhnz, Linda A.] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA; [Summers, Adam P.] Univ Washington, Friday Harbor Labs, Friday Harbor, WA 98250 USA	University of Washington; University of Washington Seattle; Colorado State University; University of Washington; University of Washington Seattle; Moss Landing Marine Laboratories; National Oceanic Atmospheric Admin (NOAA) - USA; Monterey Bay Aquarium Research Institute; University of Washington	Bizzarro, JJ (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	bizzarro@u.washington.edu		Summers, Adam/0000-0003-1930-9748	North Pacific Research Board [510, 621]; Williams-Mystic Seaport Program; School of Aquatic and Fishery Sciences, University of Washington; NOAA/NMFS; PSRC; NSF [IOS-1256602]; Direct For Biological Sciences [1256602] Funding Source: National Science Foundation	North Pacific Research Board; Williams-Mystic Seaport Program; School of Aquatic and Fishery Sciences, University of Washington(University of Washington); NOAA/NMFS(National Oceanic Atmospheric Admin (NOAA) - USA); PSRC; NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this research was provided by the North Pacific Research Board under Project 510, Project 621, and via a Graduate Student Research Award in the amount of $20,000 to the senior author (JJB); the Williams-Mystic Seaport Program; the School of Aquatic and Fishery Sciences, University of Washington; NOAA/NMFS to the National Shark Research Consortium and PSRC; and an NSF Grant (IOS-1256602) to APS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsley SM, 2014, FISH RES, V154, P17, DOI 10.1016/j.fishres.2014.02.002; Ainsley SM, 2011, MAR FRESHWATER RES, V62, P557, DOI 10.1071/MF10140; [Anonymous], 2005, PACIFIC COAST GROUND; Arkhipkin A, 2012, J FISH BIOL, V80, P1704, DOI 10.1111/j.1095-8649.2012.03260.x; Bizzarro JJ, 2009, NORTHWEST NATURALIST, V90, P247, DOI [10.1898/nwn08-44.1, DOI 10.1898/NWN08-44.1]; Bizzarro JJ, 2007, ENVIRON BIOL FISH, V80, P197, DOI 10.1007/s10641-007-9241-6; Bradburn M. J., 2011, 2003 2008 US W COAST; CAMHI M, 1999, SHARKS LINE 2 ANAL P; Casey JM, 1998, SCIENCE, V281, P690, DOI 10.1126/science.281.5377.690; Compagno LJV, 2007, ENVIRON BIOL FISH, V80, P125, DOI 10.1007/s10641-007-9243-4; COMPAGNO LJV, 1990, ENVIRON BIOL FISH, V28, P33, DOI 10.1007/BF00751027; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Dulvy NK, 2002, CONSERV BIOL, V16, P440, DOI 10.1046/j.1523-1739.2002.00416.x; Dulvy NK, 2000, CONSERV BIOL, V14, P283, DOI 10.1046/j.1523-1739.2000.98540.x; Ebert D. A., 2003, SHARKS RAYS CHIMAERA; Ebert DA, 2005, J FISH BIOL, V66, P618, DOI 10.1111/j.0022-1112.2005.00628.x; Ebert DA, 2008, FISH RES, V94, P48, DOI 10.1016/j.fishres.2008.06.016; Ebert DA, 2007, ENVIRON BIOL FISH, V80, P221, DOI 10.1007/s10641-007-9227-4; Ebert DA, 2007, ENVIRON BIOL FISH, V80, P111, DOI 10.1007/s10641-007-9247-0; Ebert DA, 2010, CRC MAR BIOL SER, P115; Edwards BD, 2002, MAR GEOL, V181, P83, DOI 10.1016/S0025-3227(01)00262-6; Ellis JR, 2011, J MAR BIOL ASSOC UK, V91, P1185, DOI 10.1017/S0025315410001906; Eschmeyer W. N., 2013, CATALOG FISHES ELECT; ESRI, 2012, SPAT STAT TOOLS ARCM; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; FITZ E. SAMUEL, 1963, BULL BINGHAM OCEANOG COLLECTION, V18, P69; Florin AB, 2013, J FISH BIOL, V83, P939, DOI 10.1111/jfb.12097; Fogarty MJ, 1998, ECOL APPL, V8, pS6, DOI 10.2307/2641359; Frisk MG, 2008, ECOL APPL, V18, P234, DOI 10.1890/06-1392.1; Frisk MG, 2002, ICES J MAR SCI, V59, P576, DOI 10.1006/jmsc.2002.1177; Frisk MG, 2010, CRC MAR BIOL SER, P283; Gaichas SK, 2010, CAN J FISH AQUAT SCI, V67, P1490, DOI 10.1139/F10-071; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gleason M, 2013, OCEAN COAST MANAGE, V74, P90, DOI 10.1016/j.ocecoaman.2012.08.013; Greene HG, 1999, OCEANOL ACTA, V22, P663, DOI 10.1016/S0399-1784(00)88957-4; Griffiths AM, 2010, P ROY SOC B-BIOL SCI, V277, P1497, DOI 10.1098/rspb.2009.2111; Haas DL, 2011, THESIS MOSS LANDING; Haas DL, 2009, CALCOFI REP, V50, P36; Haining R., 2003, SPATIAL DATA ANAL TH; Hoff GR, 2008, FISH B-NOAA, V106, P233; Hoff GR, 2010, MAR ECOL PROG SER, V403, P243, DOI 10.3354/meps08424; HOLDEN MJ, 1975, J CONSEIL, V36, P110; Ishihara Hajime, 2012, Bulletin of the Kanagawa Prefectural Museum Natural Science, V41, P9; Jacobson LD, 1996, CAN J FISH AQUAT SCI, V53, P600, DOI 10.1139/f95-207a; James KC, 2011, THESIS MOSS LANDING; Kelly JT, 2013, J FISH BIOL, V82, P877, DOI 10.1111/jfb.12028; Kulka DW, 2002, BARNDOOR SKATE NW AT; Laidig TE, 2009, ESTUAR COAST SHELF S, V83, P629, DOI 10.1016/j.ecss.2009.05.008; Levin PS, 2006, CONSERV BIOL, V20, P1181, DOI 10.1111/j.1523-1739.2006.00400.x; Love M., 2005, RESOURCE INVENTORY M; Love M. S., 2002, ROCKFISHES NE PACIFI; Mabragana E, 2002, J FISH BIOL, V60, P951, DOI 10.1006/jfbi.2002.1903; Maggs JQ, 2013, FISH RES, V144, P38, DOI 10.1016/j.fishres.2012.10.003; Mahe JC, 2005, 2005N04 ICES CM; Manly B., 1993, RESOURCE SELECTION A; Martin CS, 2005, ICES J MAR SCI CM, V2005, pN23; Matta ME, 2007, ENVIRON BIOL FISH, V80, P309, DOI 10.1007/s10641-007-9223-8; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; MCEACHRAN JD, 1975, FISH B-NOAA, V73, P110; McPhie RP, 2009, ICES J MAR SCI, V66, P546, DOI 10.1093/icesjms/fsp002; Methratta ET, 2006, N AM J FISH MANAGE, V26, P473, DOI 10.1577/M05-041.1; MORAN PAP, 1948, J ROY STAT SOC B, V10, P243; Mull CG, 2010, GEN COMP ENDOCR, V166, P379, DOI 10.1016/j.ygcen.2009.12.009; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Ormseth O., 2010, STOCK ASSESSMENT FIS, P1365; Perez CR, 2011, J MAR BIOL ASSOC UK, V91, P1149, DOI 10.1017/S0025315410002031; Perez-Brazen CR, 2014, ENV BIOL FISHES, DOI 10.1007/s10641-014-0220-4; Quero JC, 1998, ITAL J ZOOL, V65, P493, DOI 10.1080/11250009809386873; Reynolds JD, 2005, P ROY SOC B-BIOL SCI, V272, P2337, DOI 10.1098/rspb.2005.3281; RICHARDS SARAH W., 1963, BULL BINGHAM OCEANOG COLLECTION, V18, P5; Rinewalt CS, 2007, ENVIRON BIOL FISH, V80, P147, DOI 10.1007/s10641-007-9218-5; RIPLEY BD, 1976, J APPL PROBAB, V13, P255, DOI 10.2307/3212829; Rogers SI, 2000, ICES J MAR SCI, V57, P866, DOI 10.1006/jmsc.2000.0574; Simon JE, 2002, 0270 DFO; Sims David W., 2005, P127; Spalinger K, 2008, 0849 AL DEP FISH GAM; Stehmann M., 1990, CHECK LIST FISHES E, VVolume 1, P29; STEVENSON DE, 2004, NMFSAFSC142 NOAA; Stevenson DE, 2008, FISH B-NOAA, V106, P24; Stevenson Duane E., 2005, Northwestern Naturalist, V86, P71, DOI 10.1898/1051-1733(2005)086[0071:NROTDS]2.0.CO;2; Stevenson DE, 2010, FISH B-NOAA, V108, P208; Swain DP, 2006, FISH OCEANOGR, V15, P166, DOI 10.1111/j.1365-2419.2006.00357.x; Tolimieri N, 2006, T AM FISH SOC, V135, P317, DOI 10.1577/T05-092.1; von Szalay PG, 2010, NMFSAFSC208; Walker PA, 1998, ICES J MAR SCI, V55, P392, DOI 10.1006/jmsc.1997.0325; Wearmouth VJ, 2009, J EXP MAR BIOL ECOL, V380, P77, DOI 10.1016/j.jembe.2009.07.035; Wetherbee BM, 2012, CRC MAR BIOL SER, P239; Wooninck L, 2008, STATE US MARINE MANA; Yoklavich Mary M., 2008, Alaska Sea Grant Report, V08-03, P143	89	18	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e109907	10.1371/journal.pone.0109907	http://dx.doi.org/10.1371/journal.pone.0109907			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329312	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100035
J	Bourdages, KG; Lacroix, B; Dorn, JF; Descovich, CP; Maddox, AS				Bourdages, Karine G.; Lacroix, Benjamin; Dorn, Jonas F.; Descovich, Carlos P.; Maddox, Amy S.			Quantitative Analysis of Cytokinesis In Situ during C-elegans Postembryonic Development	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; FUNCTIONAL-ANALYSIS; ACTOMYOSIN RING; EMBRYONIC CYTOKINESIS; VULVAL INDUCTION; CELL-DIVISION; ACTIN; FURROW; JUNCTIONS; PROTEINS	The physical separation of a cell into two daughter cells during cytokinesis requires cell-intrinsic shape changes driven by a contractile ring. However, in vivo, cells interact with their environment, which includes other cells. How cytokinesis occurs in tissues is not well understood. Here, we studied cytokinesis in an intact animal during tissue biogenesis. We used high-resolution microscopy and quantitative analysis to study the three rounds of division of the C. elegans vulval precursor cells (VPCs). The VPCs are cut in half longitudinally with each division. Contractile ring breadth, but not the speed of ring closure, scales with cell length. Furrowing speed instead scales with division plane dimensions, and scaling is consistent between the VPCs and C. elegans blastomeres. We compared our VPC cytokinesis kinetics data with measurements from the C. elegans zygote and HeLa and Drosophila S2 cells. Both the speed dynamics and asymmetry of ring closure are qualitatively conserved among cell types. Unlike in the C. elegans zygote but similar to other epithelial cells, Anillin is required for proper ring closure speed but not asymmetry in the VPCs. We present evidence that tissue organization impacts the dynamics of cytokinesis by comparing our results on the VPCs with the cells of the somatic gonad. In sum, this work establishes somatic lineages in post-embryonic C. elegans development as cell biological models for the study of cytokinesis in situ.	[Bourdages, Karine G.; Lacroix, Benjamin; Dorn, Jonas F.] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Dorn, Jonas F.] Novartis Pharma AG, Adv Quantitat Sci, Basel, Switzerland; [Descovich, Carlos P.; Maddox, Amy S.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	Universite de Montreal; Novartis; University of North Carolina; University of North Carolina Chapel Hill	Maddox, AS (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	asm@unc.edu	Lacroix, Benjamin/AAL-8428-2020	Lacroix, Benjamin/0000-0003-2533-9150; Descovich, Carlos Patino/0000-0002-6366-5195; Dorn, Jonas/0000-0001-6696-0117	National Science and Engineering Research Council of Canada [355657]; National Institutes of Health (NIH) [GM102390]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102390] Funding Source: NIH RePORTER	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by operating funds from the National Science and Engineering Research Council of Canada (355657; http://www.nserc-crsng.gc.ca) and National Institutes of Health (NIH) (GM102390; http://www.nigms.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Audhya A, 2005, J CELL BIOL, V171, P267, DOI 10.1083/jcb.200506124; BEMENT WM, 1991, CELL MOTIL CYTOSKEL, V20, P145, DOI 10.1002/cm.970200207; Bement WM, 1999, CURR BIOL, V9, P579, DOI 10.1016/S0960-9822(99)80261-9; Brennan IM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000409; BRENNER S, 1974, GENETICS, V77, P71; Bringmann H, 2005, NATURE, V436, P731, DOI 10.1038/nature03823; Brown KS, 2007, J CELL BIOL, V176, P765, DOI 10.1083/jcb.200610043; Calvert MEK, 2011, J CELL BIOL, V195, P799, DOI 10.1083/jcb.201101055; Carvalho A, 2009, CELL, V137, P926, DOI 10.1016/j.cell.2009.03.021; Das T, 2003, NEURON, V37, P597, DOI 10.1016/S0896-6273(03)00066-7; Dorn JF, 2010, CURR BIOL, V20, P2046, DOI 10.1016/j.cub.2010.10.030; Dubreuil V, 2007, J CELL BIOL, V176, P483, DOI 10.1083/jcb.200608137; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; Field C.M., 2008, SEPTINS, P147; Fleming ES, 2007, J HISTOCHEM CYTOCHEM, V55, P1173, DOI 10.1369/jhc.7A7234.2007; Founounou N, 2013, DEV CELL, V24, P242, DOI 10.1016/j.devcel.2013.01.008; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Fung KYY, 2014, INT REV CEL MOL BIO, V310, P289, DOI 10.1016/B978-0-12-800180-6.00007-4; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gascoigne KE, 2009, J CELL SCI, V122, P2579, DOI 10.1242/jcs.039719; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Godinho SA, 2014, NATURE, V510, P167, DOI 10.1038/nature13277; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Guillot C, 2013, DEV CELL, V24, P227, DOI 10.1016/j.devcel.2013.01.010; Hara Y, 2009, CURR BIOL, V19, P1549, DOI 10.1016/j.cub.2009.07.050; HORVITZ HR, 1991, NATURE, V351, P535, DOI 10.1038/351535a0; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Lacroix B, 2012, J PATHOL, V226, P338, DOI 10.1002/path.3013; Lynch AM, 2009, FRONT BIOSCI-LANDMRK, V14, P1414, DOI 10.2741/3316; Ma XF, 2012, P NATL ACAD SCI USA, V109, P4509, DOI 10.1073/pnas.1116268109; MABUCHI I, 1990, ANN NY ACAD SCI, V582, P131; Maddox AS, 2007, DEV CELL, V12, P827, DOI 10.1016/j.devcel.2007.02.018; Mancuso VP, 2012, DEVELOPMENT, V139, P979, DOI 10.1242/dev.075135; Matus DQ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5184; Morais-de-Sa E, 2013, CELL CYCLE, V12, P3583, DOI 10.4161/cc.26910; Morais-de-Sa E, 2013, EMBO REP, V14, P696, DOI 10.1038/embor.2013.85; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Newman AP, 1996, DEVELOPMENT, V122, P3617; O'Connell CB, 1999, J CELL BIOL, V144, P305, DOI 10.1083/jcb.144.2.305; Oegema K, 2000, J CELL BIOL, V150, P539, DOI 10.1083/jcb.150.3.539; Piekny AJ, 2010, SEMIN CELL DEV BIOL, V21, P881, DOI 10.1016/j.semcdb.2010.08.002; Pinto IM, 2012, DEV CELL, V22, P1247, DOI 10.1016/j.devcel.2012.04.015; REINSCH S, 1994, J CELL BIOL, V126, P1509, DOI 10.1083/jcb.126.6.1509; Ririe TO, 2008, P NATL ACAD SCI USA, V105, P20095, DOI 10.1073/pnas.0806377105; Roh-Johnson M, 2009, J CELL SCI, V122, P3983, DOI 10.1242/jcs.057562; Segbert C, 2004, DEV BIOL, V266, P17, DOI 10.1016/j.ydbio.2003.10.019; Sharma-Kishore R, 1999, DEVELOPMENT, V126, P691; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Soto X, 2013, P NATL ACAD SCI USA, V110, P11029, DOI 10.1073/pnas.1217308110; Sternberg Paul W, 2005, WormBook, P1, DOI 10.1895/wormbook.1.6.1; STERNBERG PW, 1986, CELL, V44, P761, DOI 10.1016/0092-8674(86)90842-1; STERNBERG PW, 1989, CELL, V58, P679, DOI 10.1016/0092-8674(89)90103-7; STERNBERG PW, 1988, NATURE, V335, P551, DOI 10.1038/335551a0; Stiernagle Theresa, 2006, WormBook, P1; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Turlier H, 2014, BIOPHYS J, V106, P114, DOI 10.1016/j.bpj.2013.11.014; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Verbrugghe KJC, 2007, J CELL SCI, V120, P1772, DOI 10.1242/jcs.03447; Wuhr M, 2008, CURR BIOL, V18, P1256, DOI 10.1016/j.cub.2008.07.092; YONEDA M, 1972, J EXP BIOL, V57, P575	66	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110689	10.1371/journal.pone.0110689	http://dx.doi.org/10.1371/journal.pone.0110689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329167	Green Published, Green Submitted, gold			2022-12-27	WOS:000343942100083
J	Duan, YB; Ge, CY; Zhang, XK; Wang, JX; Zhou, MG				Duan, Ya-Bing; Ge, Chang-Yan; Zhang, Xiao-Ke; Wang, Jian-Xin; Zhou, Ming-Guo			Development and Evaluation of a Novel and Rapid Detection Assay for Botrytis cinerea Based on Loop-Mediated Isothermal Amplification	PLOS ONE			English	Article							SCLEROTINIA-SCLEROTIORUM; REVERSE-TRANSCRIPTION; PHYTOPHTHORA-RAMORUM; CANOLA PETALS; PCR ASSAY; STEM ROT; LAMP; DNA; QUANTIFICATION; STRAWBERRY	Botrytis cinerea is a devastating plant pathogen that causes grey mould disease. In this study, we developed a visual detection method of B. cinerea based on the Bcos5 sequence using loop-mediated isothermal amplification (LAMP) with hydroxynaphthol blue dye (HNB). The LAMP reaction was optimal at 63 degrees C for 45 min. When HNB was added prior to amplification, samples with B. cinerea DNA developed a characteristic sky blue color after the reaction but those without DNA or with DNA of other plant pathogenic fungi did not. Results of HNB staining method were reconfirmed when LAMP products were subjected to gel electrophoresis. The detection limit of this LAMP assay for B. cinerea was 10(-3) ng mu L-1 of genomic DNA per reaction, which was 10-fold more sensitive than conventional PCR (10(-2) ng mu L-1). Detection of the LAMP assay for inoculum of B. cinerea was possible in the inoculated tomato and strawberry petals. In the 191 diseased samples, 180 (94.2%) were confirmed as positive by LAMP, 172 (90.1%) positive by the tissue separation, while 147 (77.0%) positive by PCR. Because the LAMP assay performed well in aspects of sensitivity, specificity, repeatability, reliability, and visibility, it is suitable for rapid detection of B. cinerea in infected plant materials prior to storage and during transportation, such as cut flowers, fruits and vegetables.	[Duan, Ya-Bing; Ge, Chang-Yan; Zhang, Xiao-Ke; Wang, Jian-Xin; Zhou, Ming-Guo] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhou, MG (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.	mgzhou@njau.edu.cn			Special Fund for Agro-scientific Research in the Public Interest [201303023, 201303025]	Special Fund for Agro-scientific Research in the Public Interest	This research was supported by the Special Fund for Agro-scientific Research in the Public Interest (201303023 and 201303025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balali GR, 1995, PLANT PATHOL, V44, P1050, DOI 10.1111/j.1365-3059.1995.tb02664.x; Bekele B, 2011, PLANT PATHOL, V60, P345, DOI 10.1111/j.1365-3059.2010.02384.x; Bom M, 2000, CAN J MICROBIOL, V46, P723, DOI 10.1139/cjm-46-8-723; Cadle-Davidson L, 2008, AM J ENOL VITICULT, V59, P387; Celik M, 2009, POSTHARVEST BIOL TEC, V52, P235, DOI 10.1016/j.postharvbio.2008.10.007; Curtis KA, 2008, J VIROL METHODS, V151, P264, DOI 10.1016/j.jviromet.2008.04.011; Dai TT, 2012, FEMS MICROBIOL LETT, V334, P27, DOI 10.1111/j.1574-6968.2012.02619.x; Duan YB, 2014, AUSTRALAS PLANT PATH, V43, P61, DOI 10.1007/s13313-013-0239-6; Freeman J, 2002, EUR J PLANT PATHOL, V108, P877, DOI 10.1023/A:1021216720024; Gachon C, 2004, PLANT PHYSIOL BIOCH, V42, P367, DOI 10.1016/j.plaphy.2004.04.001; Goto M, 2009, BIOTECHNIQUES, V46, P167, DOI 10.2144/000113072; GRIFFITHS DA, 1971, CAN J MICROBIOL, V17, P441, DOI 10.1139/m71-074; Hill J, 2008, J CLIN MICROBIOL, V46, P2800, DOI 10.1128/JCM.00152-08; HWANG CS, 1995, MOL GEN GENET, V247, P282, DOI 10.1007/BF00293196; Lefol C, 1996, CAN J PLANT PATHOL, V18, P237, DOI 10.1080/07060669609500618; LEUNG H, 1988, PHYTOPATHOLOGY, V78, P1227, DOI 10.1094/Phyto-78-1227; Mehli L, 2005, NEW PHYTOL, V168, P465, DOI 10.1111/j.1469-8137.2005.01526.x; MERONUCK RA, 1972, APPL MICROBIOL, V23, P613, DOI 10.1108/03321640410540520; Mori Y, 2001, BIOCHEM BIOPH RES CO, V289, P150, DOI 10.1006/bbrc.2001.5921; Morrall RAA., 1991, PETAL TEST MANUAL SC; Nagamine K, 2002, BIOCHEM BIOPH RES CO, V290, P1195, DOI 10.1006/bbrc.2001.6334; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Nicholson P, 1996, PLANT PATHOL, V45, P872, DOI 10.1111/j.1365-3059.1996.tb02898.x; Niessen L, 2010, INT J FOOD MICROBIOL, V140, P183, DOI 10.1016/j.ijfoodmicro.2010.03.036; Niu JH, 2012, PLANT PATHOL, V61, P809, DOI 10.1111/j.1365-3059.2011.02562.x; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; NOWOTNY N, 1994, ACTA VET HUNG, V42, P377; Obanor FO, 2002, N Z PLANT PROTECT-SE, V55, P150, DOI 10.30843/nzpp.2002.55.3945; Parida M, 2005, J CLIN MICROBIOL, V43, P2895, DOI 10.1128/JCM.43.6.2895-2903.2005; PURDY LH, 1979, PHYTOPATHOLOGY, V69, P875, DOI 10.1094/Phyto-69-875; Rigotti S, 2002, FEMS MICROBIOL LETT, V209, P169, DOI 10.1016/S0378-1097(02)00491-3; Suarez MB, 2005, PLANT PHYSIOL BIOCH, V43, P890, DOI 10.1016/j.plaphy.2005.07.003; Sutton J. C., 1982, Canadian Journal of Plant Pathology, V4, P195; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Tomlinson JA, 2007, APPL ENVIRON MICROB, V73, P4040, DOI 10.1128/AEM.00161-07; Tomlinson JA, 2010, LETT APPL MICROBIOL, V51, P650, DOI 10.1111/j.1472-765X.2010.02949.x; Tomlinson JA, 2010, PHYTOPATHOLOGY, V100, P143, DOI 10.1094/PHYTO-100-2-0143; TURKINGTON TK, 1991, CAN J PLANT PATHOL, V13, P50, DOI 10.1080/07060669109500965; Wang L, 2007, J AGR FOOD CHEM, V55, P10509, DOI 10.1021/jf0721242; Wastling SL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000865; Williamson B, 2007, MOL PLANT PATHOL, V8, P561, DOI [10.1111/j.1364-3703.2007.00417.x, 10.1111/J.1364-3703.2007.00417.X]; Zoheir KMA, 2011, THERIOGENOLOGY, V76, P83, DOI 10.1016/j.theriogenology.2011.01.020	42	47	61	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e111094	10.1371/journal.pone.0111094	http://dx.doi.org/10.1371/journal.pone.0111094			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329402	gold, Green Submitted, Green Published			2022-12-27	WOS:000343942100111
J	Song, W; Yang, Z; He, B				Song, Wei; Yang, Zhen; He, Ben			Bestrophin 3 Ameliorates TNF alpha-Induced Inflammation by Inhibiting NF-kappa B Activation in Endothelial Cells	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; BEST-DISEASE; EXPRESSION; ATHEROSCLEROSIS; SITES; CONDUCTANCE; DYSFUNCTION; PATHWAY; PROTEIN; VCAM-1	Increasing evidences have suggested vascular endothelial inflammatory processes are the initiator of atherosclerosis. Bestrophin 3 (Best-3) is involved in the regulation of cell proliferation, apoptosis and differentiation of a variety of physiological functions, but its function in cardiovascular system remains unclear. In this study, we investigated the effect of Best-3 on endothelial inflammation. We first demonstrated that Best-3 is expressed in endothelial cells and decreased after tumor necrosis factor-alpha (TNF alpha) challenge. Overexpression of Best-3 significantly attenuated TNF alpha-induced expression of adhesion molecules and chemokines, and subsequently inhibited the adhesion of monocytes to human umbilical vein endothelial cells (HUVECs). Conversely, knockdown of Best-3 with siRNA resulted in an enhancement on TNF alpha-induced expression of adhesion molecules and chemokines and adhesion of monocytes to HUVECs. Furthermore, overexpression of Best-3 with adenovirus dramatically ameliorated inflammatory response in TNF alpha-injected mice. Mechanistically, we found up-regulation of Best-3 inhibited TNF alpha-induced IKK beta and I kappa B alpha phosphorylation, I kappa B alpha degradation and NF-kappa B translocation. Our results demonstrated that Best-3 is an endogenous inhibitor of NF-kappa B signaling pathway in endothelial cells, suggesting that forced Best-3 expression may be a novel approach for the treatment of vascular inflammatory diseases.	[Song, Wei; He, Ben] Shanghai Jiao Tong Univ, Dept Cardiol, Renji Hosp, Sch Med, Shanghai, Peoples R China; [Yang, Zhen] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hypertens & Vasc Dis, Guangzhou 510275, Guangdong, Peoples R China	Shanghai Jiao Tong University; Sun Yat Sen University	He, B (corresponding author), Shanghai Jiao Tong Univ, Dept Cardiol, Renji Hosp, Sch Med, Shanghai, Peoples R China.	rjheben@21cn.com			National Natural Scientific Foundation of China [31270992, 30800215]; project of Zhu Jiang Science and Technology new star of Guangzhou City [2013J2200019]; Fundamental Research Funds for the Central Universities in Sun Yat-Sen University [13ykpy24]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); project of Zhu Jiang Science and Technology new star of Guangzhou City; Fundamental Research Funds for the Central Universities in Sun Yat-Sen University	This study was financially supported by the grants from National Natural Scientific Foundation of China (31270992 and 30800215), the project of Zhu Jiang Science and Technology new star of Guangzhou City (2013J2200019), and the Fundamental Research Funds for the Central Universities in Sun Yat-Sen University (13ykpy24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allikmets R, 1999, HUM GENET, V104, P449, DOI 10.1007/s004390050986; Bakall B, 2008, INVEST OPHTH VIS SCI, V49, P1563, DOI 10.1167/iovs.07-1338; Barro-Soria R, 2008, BBA-MOL CELL RES, V1783, P1993, DOI 10.1016/j.bbamcr.2008.06.016; Broegger T, 2011, CARDIOVASC RES, V91, P685, DOI 10.1093/cvr/cvr111; Cunningham PN, 2002, J IMMUNOL, V168, P5817, DOI 10.4049/jimmunol.168.11.5817; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; de Martin R, 2000, ARTERIOSCL THROM VAS, V20, pE83; Foteinou PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004706; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Greenhill CJ, 2011, J IMMUNOL, V186, P1199, DOI 10.4049/jimmunol.1002971; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Henninger DD, 1997, J IMMUNOL, V158, P1825; Hua S, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00127; Iiyama K, 1999, CIRC RES, V85, P199, DOI 10.1161/01.RES.85.2.199; Jiang L, 2013, APOPTOSIS, V18, P556, DOI 10.1007/s10495-013-0828-4; Jung CH, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-41; Kempe S, 2005, NUCLEIC ACIDS RES, V33, P5308, DOI 10.1093/nar/gki836; Kunzelmann K, 2009, CELL CALCIUM, V46, P233, DOI 10.1016/j.ceca.2009.09.003; Lee WK, 2012, BBA-MOL CELL RES, V1823, P1864, DOI 10.1016/j.bbamcr.2012.06.003; Liu L, 2013, BIOCHEM J, V451, P55, DOI 10.1042/BJ20130019; Marmorstein AD, 2009, PROG RETIN EYE RES, V28, P206, DOI 10.1016/j.preteyeres.2009.04.004; Matchkov VV, 2008, CIRC RES, V103, P864, DOI 10.1161/CIRCRESAHA.108.178517; Monaco C, 2004, CARDIOVASC RES, V61, P671, DOI 10.1016/j.cardiores.2003.11.038; Nakashima Y, 1998, ARTERIOSCL THROM VAS, V18, P842, DOI 10.1161/01.ATV.18.5.842; Nie P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097009; O'Driscoll KE, 2008, AM J PHYSIOL-CELL PH, V295, pC1610, DOI 10.1152/ajpcell.00461.2008; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Schiffrin EL, 2002, AM J HYPERTENS, V15, p115S, DOI 10.1016/S0895-7061(02)03006-6; Spitzner M, 2008, J BIOL CHEM, V283, P7421, DOI 10.1074/jbc.M703758200; Steyers CM, 2014, INT J MOL SCI, V15, P11324, DOI 10.3390/ijms150711324; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; van den Oever IAM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/792393; Xia WH, 2012, HYPERTENSION, V59, P1225, DOI 10.1161/HYPERTENSIONAHA.111.179820; Yang H, 2012, HYPERTENSION, V60, P1287, DOI 10.1161/HYPERTENSIONAHA.112.198648; Yardley J, 2004, INVEST OPHTH VIS SCI, V45, P3683, DOI 10.1167/iovs.04-0550; Yu K, 2007, INVEST OPHTH VIS SCI, V48, P4694, DOI 10.1167/iovs.07-0301; Zhang S, 2013, MOL MED REP, V7, P93, DOI 10.3892/mmr.2012.1159	40	15	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e111093	10.1371/journal.pone.0111093	http://dx.doi.org/10.1371/journal.pone.0111093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329324	Green Published, Green Submitted, gold			2022-12-27	WOS:000343942100110
J	Magrini, N; Formoso, G; Capelli, O; Maestri, E; Nonino, F; Paltrinieri, B; Del Giovane, C; Voci, C; Magnano, L; Daya, L; Marata, AM				Magrini, Nicola; Formoso, Giulio; Capelli, Oreste; Maestri, Emilio; Nonino, Francesco; Paltrinieri, Barbara; Del Giovane, Cinzia; Voci, Claudio; Magnano, Lucia; Daya, Lisa; Marata, Anna Maria		INDRA-NET Study Grp	Long Term Effectiveness on Prescribing of Two Multifaceted Educational Interventions: Results of Two Large Scale Randomized Cluster Trials	PLOS ONE			English	Article							PHARMACEUTICAL-INDUSTRY; INFORMATION; OUTREACH; IMPROVE	Introduction: Information on benefits and risks of drugs is a key element affecting doctors' prescribing decisions. Outreach visits promoting independent information have proved moderately effective in changing prescribing behaviours. Objectives: Testing the short and long-term effectiveness on general practitioners' prescribing of small groups meetings led by pharmacists. Methods: Two cluster open randomised controlled trials (RCTs) were carried out in a large scale NHS setting. Ad hoc prepared evidence based material were used considering a therapeutic area approach - TEA, with information materials on osteoporosis or prostatic hyperplasia -and a single drug oriented approach - SIDRO, with information materials on me-too drugs of 2 different classes: barnidipine or prulifloxacin. In each study, all 115 Primary Care Groups in a Northern Italy area (2.2 million inhabitants, 1737 general practitioners) were randomised to educational small groups meetings, in which available evidence was provided together with drug utilization data and clinical scenarios. Main outcomes were changes in the six-months prescription of targeted drugs. Longer term results (24 and 48 months) were also evaluated. Results: In the TEA trial, one of the four primary outcomes showed a reduction (prescription of alfuzosin compared to tamsulosin and terazosin in benign prostatic hyperplasia: prescribing ratio -8.5%, p = 0.03). Another primary outcome (prescription of risedronate) showed a reduction at 24 and 48 months (-7.6%, p = 0.02; and -9,8%, p = 0.03), but not at six months (-5.1%, p = 0.36). In the SIDRO trial both primary outcomes showed a statistically significant reduction (prescription of barnidipine 29.8%, p = 0.02; prescription of prulifloxacin -11.1%, p = 0.04), which persisted or increased over time. Interpretation: These two cluster RCTs showed the large scale feasibility of a complex educational program in a NHS setting, and its potentially relevant long-term impact on prescribing habits, in particular when focusing on a single drug. National Health systems should invest in independent drug information programs.	[Magrini, Nicola; Formoso, Giulio; Maestri, Emilio; Nonino, Francesco; Paltrinieri, Barbara; Voci, Claudio; Magnano, Lucia; Marata, Anna Maria] Emilia Romagna Reg Agcy Hlth & Social Care, Drug Evaluat Area, Bologna, Italy; [Capelli, Oreste; Daya, Lisa] Local Hlth Author, Modena, Italy; [Del Giovane, Cinzia] Univ Modena & Reggio Emilia, Dept Clin & Diagnost Med & Publ Hlth, Modena, Italy	Universita di Modena e Reggio Emilia	Magrini, N (corresponding author), Emilia Romagna Reg Agcy Hlth & Social Care, Drug Evaluat Area, Bologna, Italy.	nmagrini@regione.emilia-romagna.it	Formoso, Giulio/H-9350-2018; voci, claudio/AAA-6516-2020; Nonino, Francesco/AAK-3260-2020	Formoso, Giulio/0000-0002-1819-6887; , claudio/0000-0002-0385-666X; Del Giovane, Cinzia/0000-0002-5028-932X; Nonino, Francesco/0000-0003-3601-6381	Agenzia Italiana del Farmaco; NHS	Agenzia Italiana del Farmaco; NHS	Funding was provided by Agenzia Italiana del Farmaco, 2005 NHS fund for independent research on drugs. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVORN J, 1983, NEW ENGL J MED, V308, P1457, DOI 10.1056/NEJM198306163082406; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Collier J, 2002, LANCET, V360, P1405, DOI 10.1016/S0140-6736(02)11394-8; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Dickersin K, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P11; Donner A, 1996, J CLIN EPIDEMIOL, V49, P435, DOI 10.1016/0895-4356(95)00511-0; Dukes MNG, 2002, LANCET, V360, P1682, DOI 10.1016/S0140-6736(02)11599-6; Formoso G, 2001, ARCH INTERN MED, V161, P2037, DOI 10.1001/archinte.161.16.2037; Formoso G, 2007, SOC SCI MED, V64, P949, DOI 10.1016/j.socscimed.2006.09.022; Garattini S, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1025; Godwin Marshall, 2003, BMC Med Res Methodol, V3, P28, DOI 10.1186/1471-2288-3-28; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3; Liberati A, 2010, EUR J CLIN INVEST, V40, P69, DOI 10.1111/j.1365-2362.2009.02226.x; Light DW, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4348; Magrini N, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-158; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Nkansah N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000336.pub2; Norman G, 2002, BMJ-BRIT MED J, V324, P1560, DOI 10.1136/bmj.324.7353.1560; O'Brien MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000409.pub2; Ridker PM, 2006, JAMA-J AM MED ASSOC, V295, P2270, DOI 10.1001/jama.295.19.2270; Schwartz LM, 2009, NEW ENGL J MED, V361, P1717, DOI 10.1056/NEJMp0907708; Simon SR, 2005, AM J MED, V118, P521, DOI 10.1016/j.amjmed.2004.12.023; SOUMERAI SB, 1990, JAMA-J AM MED ASSOC, V263, P549, DOI 10.1001/jama.263.4.549; The Congress of the United States - Congressional Budget Office, 2006, RES DEV PHARM IND; Woloshin S, 2008, KNOW YOUR CHANCES UN; Woloshin S, 2011, ANN INTERN MED, V155, P87, DOI 10.7326/0003-4819-155-2-201107190-00004	28	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109915	10.1371/journal.pone.0109915	http://dx.doi.org/10.1371/journal.pone.0109915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329386	Green Published, gold			2022-12-27	WOS:000345204100035
J	Betti, MI; Wahl, LM; Zamir, M				Betti, Matt I.; Wahl, Lindi M.; Zamir, Mair			Effects of Infection on Honey Bee Population Dynamics: A Model	PLOS ONE			English	Article							COLONY COLLAPSE DISORDER; NOSEMA-CERANAE; BEHAVIORAL MATURATION; APIS-MELLIFERA; SURVIVAL; GROWTH	We propose a model that combines the dynamics of the spread of disease within a bee colony with the underlying demographic dynamics of the colony to determine the ultimate fate of the colony under different scenarios. The model suggests that key factors in the survival or collapse of a honey bee colony in the face of an infection are the rate of transmission of the infection and the disease-induced death rate. An increase in the disease-induced death rate, which can be thought of as an increase in the severity of the disease, may actually help the colony overcome the disease and survive through winter. By contrast, an increase in the transmission rate, which means that bees are being infected at an earlier age, has a drastic deleterious effect. Another important finding relates to the timing of infection in relation to the onset of winter, indicating that in a time interval of approximately 20 days before the onset of winter the colony is most affected by the onset of infection. The results suggest further that the age of recruitment of hive bees to foraging duties is a good early marker for the survival or collapse of a honey bee colony in the face of infection, which is consistent with experimental evidence but the model provides insight into the underlying mechanisms. The most important result of the study is a clear distinction between an exposure of the honey bee colony to an environmental hazard such as pesticides or insecticides, or an exposure to an infectious disease. The results indicate unequivocally that in the scenarios that we have examined, and perhaps more generally, an infectious disease is far more hazardous to the survival of a bee colony than an environmental hazard that causes an equal death rate in foraging bees.	[Betti, Matt I.; Wahl, Lindi M.; Zamir, Mair] Univ Western Ontario, Dept Appl Math, London, ON N6A 5B9, Canada; [Zamir, Mair] Univ Western Ontario, Dept Med Biophys, London, ON N6A 5B9, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Zamir, M (corresponding author), Univ Western Ontario, Dept Appl Math, London, ON N6A 5B9, Canada.	zamir@uwo.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The work was funded by the Natural Sciences and Engineering Research Council of Canada. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, SCI SOC, V34, P35; Botias C, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-25; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Cramp D, 2008, PRACTICAL MANUAL BEE; Devillers J, 2002, HONEY BEES: ESTIMATING THE ENVIRONMENTAL IMPACT OF CHEMICALS, P1, DOI 10.1201/9780203218655.ch1; Dukas R, 2008, INSECT SOC, V55, P252, DOI 10.1007/s00040-008-0995-4; Fahrbach SE, 1996, DEV NEUROSCI-BASEL, V18, P102, DOI 10.1159/000111474; Favre D, 2011, APIDOLOGIE, V42, P270, DOI 10.1007/s13592-011-0016-x; Fries I, 2010, J INVERTEBR PATHOL, V103, pS73, DOI 10.1016/j.jip.2009.06.017; Goblirsch M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058165, 10.1371/journal.pone.0069831]; HARBO JR, 1993, J APICULT RES, V32, P11, DOI 10.1080/00218839.1993.11101282; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2009, ENV MICROBIOL REP, V1, P110, DOI 10.1111/j.1758-2229.2009.00014.x; Huang ZY, 1996, BEHAV ECOL SOCIOBIOL, V39, P147, DOI 10.1007/s002650050276; Jay S.C., 1974, Journal apic Res, V13, P149; Jones JC, 2005, J COMP PHYSIOL A, V191, P1121, DOI 10.1007/s00359-005-0035-z; Kauffeld NM, 1980, BEEKEEPING US AGR HD, V335; Khoury DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059084; Khoury DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018491; Leoncini I, 2004, P NATL ACAD SCI USA, V101, P17559, DOI 10.1073/pnas.0407652101; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Ratti V, CANADIAN AP IN PRESS; Russell S, 2013, ECOL MODEL, V265, P158, DOI 10.1016/j.ecolmodel.2013.06.005; SAKAGAMI S F, 1968, Researches on Population Ecology (Tokyo), V10, P127, DOI 10.1007/BF02510869; Schulz DJ, 1998, BEHAV ECOL SOCIOBIOL, V42, P295, DOI 10.1007/s002650050442; Seeley T.D., 2010, HONEYBEE DEMOCRACY; SEELEY TD, 1985, ECOL ENTOMOL, V10, P81, DOI 10.1111/j.1365-2311.1985.tb00537.x; Smith ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043319; SOUTHWICK EE, 1992, J ECON ENTOMOL, V85, P621, DOI 10.1093/jee/85.3.621; Stevanovic J, 2013, APIDOLOGIE, V44, P522, DOI 10.1007/s13592-013-0203-z; Sumpter DJT, 2004, J ANIM ECOL, V73, P51, DOI 10.1111/j.1365-2656.2004.00776.x; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Watanabe ME, 2008, BIOSCIENCE, V58, P384, DOI 10.1641/B580503; Winston M.L., 1991, BIOL HONEY BEE	36	44	44	2	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110237	10.1371/journal.pone.0110237	http://dx.doi.org/10.1371/journal.pone.0110237			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329468	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210800071
J	Cao, Q; Wang, J; Zhang, MC; Li, P; Qian, J; Zhang, SB; Zhang, L; Ju, XB; Wang, ML; Zhang, ZD; Li, J; Gu, M; Zhang, W; Qin, C; Shao, PF; Yin, CJ				Cao, Qiang; Wang, Jian; Zhang, Mingcong; Li, Pu; Qian, Jian; Zhang, Shaobo; Zhang, Lei; Ju, Xiaobing; Wang, Meilin; Zhang, Zhengdong; Li, Jie; Gu, Min; Zhang, Wei; Qin, Chao; Shao, Pengfei; Yin, Changjun			Genetic Variants in RKIP Are Associated with Clear Cell Renal Cell Carcinoma Risk in a Chinese Population	PLOS ONE			English	Article							KINASE INHIBITOR PROTEIN; COLORECTAL-CANCER; PROGNOSTIC MARKER; PROSTATE-CANCER; EXPRESSION; RAF-1; METASTASIS; PROLIFERATION; EPIDEMIOLOGY; REDUCTION	Background: Raf-1 kinase inhibitor protein (RKIP) plays a critical role in tumor development by regulating cell functions such as invasion, apoptosis and differentiation. Down-regulation of RKIP expression has been implicated in the development and progression of renal cell carcinoma (RCC). Herein, we hypothesized that genetic polymorphisms in RKIP might be associated with susceptibility and progression of RCC. Methods: A total of 5 tagging single-nucleotide polymorphisms (tSNPs) in RKIP were selected and genotyped by SNapShot method in a case-control study of 859 RCC patients and 1004 controls. The logistic regression was used to evaluate the genetic association with occurrence and progression of RCC. The functionality of the important SNP was preliminary examined by qRT-PCR. Result: We found that the rs17512051 in the promoter region of RKIP was significantly associated with decreased clear cell RCC (ccRCC) risk (TA/AA vs. TT: P = 0.039, OR = 0.78, 95%CI = 0.62-0.99). Another SNP (rs1051470) in the 3'UTR region of RKIP was marginally associated with increased ccRCC risk (TT vs. CC+CT: OR = 1.45, 95%CI = 1.01-2.09). In the stratified analysis, the protective effect of rs17512051 was more predominant in the subgroups of male, non-smokers, non-drinkers as well as subjects without history of diabetes. Furthermore, we observed higher RKIP mRNA levels in the presence of the rs17512051A allele in normal renal tissues. Conclusion: Our results suggest that the potentially functional RKIP rs17512051 polymorphism may affect ccRCC susceptibility through altering the endogenous RKIP expression level. Risk effects and the functional impact of this polymorphism need further validation.	[Cao, Qiang; Zhang, Mingcong; Li, Pu; Qian, Jian; Zhang, Shaobo; Zhang, Lei; Ju, Xiaobing; Li, Jie; Gu, Min; Zhang, Wei; Qin, Chao; Shao, Pengfei; Yin, Changjun] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Wang, Jian] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Wang, Meilin; Zhang, Zhengdong] Nanjing Med Univ, Dept Mol & Genet Toxicol, Ctr Canc, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Shao, PF (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	spf032@hotmail.com; drcjyin@gmail.com	zhang, zheng/HCH-9684-2022; Cao, Qiang/K-2349-2019		Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Provincial Special Program of Medical Science [BL2012027]; Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University; National Natural Science Foundation of China [81171963, 81201998, 81201571]	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Provincial Special Program of Medical Science; Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), by the Jiangsu Provincial Special Program of Medical Science (BL2012027), by the Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University, by the National Natural Science Foundation of China [grant number 81171963, 81201998, 81201571]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso J, 2013, VIRCHOWS ARCH, V462, P445, DOI 10.1007/s00428-013-1388-2; Akaishi J, 2006, ANTICANCER RES, V26, P4437; Al-Mulla F, 2006, J CLIN ONCOL, V24, P5672, DOI 10.1200/JCO.2006.07.5499; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Fu Z, 2006, PROSTATE, V66, P248, DOI 10.1002/pros.20319; Fu Z, 2002, PROSTATE, V51, P10, DOI 10.1002/pros.10056; Hagan S, 2005, CLIN CANCER RES, V11, P7392, DOI 10.1158/1078-0432.CCR-05-0283; Hellmann J, 2010, DEV NEUROSCI-BASEL, V32, P33, DOI 10.1159/000236595; Lee HC, 2006, GASTROENTEROLOGY, V131, P1208, DOI 10.1053/j.gastro.2006.07.012; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Minoo P, 2007, AM J CLIN PATHOL, V127, P820, DOI 10.1309/5D7MM22DAVGDT1R8; Moon A, 2012, PATHOLOGY, V44, P534, DOI 10.1097/PAT.0b013e32835817e8; Schuierer MM, 2006, ONCOL REP, V16, P451; Schuierer MM, 2004, CANCER RES, V64, P5186, DOI 10.1158/0008-5472.CAN-03-3861; SEDDIQI N, 1994, J MOL EVOL, V39, P655, DOI 10.1007/BF00160411; Semenza JC, 2001, AM J EPIDEMIOL, V153, P851, DOI 10.1093/aje/153.9.851; Trakul N, 2005, CELL RES, V15, P19, DOI 10.1038/sj.cr.7290258; Yang L, 2005, CANCER EPIDEM BIOMAR, V14, P243; Yeung KC, 2001, MOL CELL BIOL, V21, P7207, DOI 10.1128/MCB.21.21.7207-7217.2001; Zeng LC, 2008, EXPERT OPIN THER TAR, V12, P1275, DOI [10.1517/14728222.12.10.1275, 10.1517/14728222.12.10.1275 ]; Zhang LZ, 2004, SURGERY, V136, P708, DOI 10.1016/j.surg.2003.12.013; Zhu ST, 2005, CHEM BIOL, V12, P981, DOI 10.1016/j.chembiol.2005.07.007	23	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109285	10.1371/journal.pone.0109285	http://dx.doi.org/10.1371/journal.pone.0109285			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329396	gold, Green Submitted, Green Published			2022-12-27	WOS:000343210800017
J	Pitman, JL; Wheeler, MC; Lloyd, DJ; Walker, JR; Glynne, RJ; Gekakis, N				Pitman, Jeffrey L.; Wheeler, Matthew C.; Lloyd, David J.; Walker, John R.; Glynne, Richard J.; Gekakis, Nicholas			A Gain-of-Function Mutation in Adenylate Cyclase 3 Protects Mice from Diet-Induced Obesity	PLOS ONE			English	Article							RII-BETA-SUBUNIT; BODY-MASS INDEX; ADENYLYL-CYCLASE; GENETICS; INDIVIDUALS; ASSOCIATION; EXPRESSION	In a screen for genes that affect the metabolic response to high-fat diet (HFD), we selected one line of N-ethyl-N-nitrosourea (ENU)-mutagenized mice, Jll, with dominantly inherited resistance to diet-induced obesity (DIO). Mutant animals had dramatically reduced body weight and fat mass, and low basal insulin and glucose levels relative to unaffected controls. Both white adipose tissue (WAT) and brown adipose tissue (BAT) depots were smaller in mutant animals. Mutant animals fed a HFD gained only slightly more weight than animals fed regular chow, and were protected from hepatic lipid accumulation. The phenotype was genetically linked to a 5.7-Mb interval on chromosome 12, and sequencing of the entire interval identified a single coding mutation, predicted to cause a methionine-to-isoleucine substitution at position 279 of the Adcy3 protein (Adcy3(M279I), henceforth referred to as Adcy3(Jll)). The mutant protein is hyperactive, possibly constitutively so, producing elevated levels of cyclic AMP in a cell-based assay. These mice demonstrate that increased Adcy3 activity robustly protect animals from diet-induced metabolic derangements.	[Pitman, Jeffrey L.; Wheeler, Matthew C.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Lloyd, David J.; Walker, John R.; Glynne, Richard J.] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [Gekakis, Nicholas] San Diego State Univ, Donald P Shiley BioSci Ctr, San Diego, CA 92182 USA	Scripps Research Institute; Novartis; California State University System; San Diego State University	Gekakis, N (corresponding author), San Diego State Univ, Donald P Shiley BioSci Ctr, San Diego, CA 92182 USA.	ngekakis@mail.sdsu.edu		Lloyd, David/0000-0001-5924-0672	NIH [R01DK079925, R21HL113696, K01DK090185]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL113696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079925, K01DK090185] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by NIH grants R01DK079925 and R21HL113696 (NG) and K01DK090185 (M.C.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Chen M, 2005, P NATL ACAD SCI USA, V102, P7386, DOI 10.1073/pnas.0408268102; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Conley JM, 2013, J PHARMACOL EXP THER, V347, P276, DOI 10.1124/jpet.113.207449; Cousminer DL, 2013, HUM MOL GENET, V22, P2735, DOI 10.1093/hmg/ddt104; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Friedman JM, 2009, AM J CLIN NUTR, V89, p973S, DOI 10.3945/ajcn.2008.26788B; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Hurley JH, 1999, J BIOL CHEM, V274, P7599, DOI 10.1074/jbc.274.12.7599; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Leibel RL, 1997, J BIOL CHEM, V272, P31937, DOI 10.1074/jbc.272.51.31937; Lloyd DJ, 2006, HUM MOL GENET, V15, P1884, DOI 10.1093/hmg/ddl111; Lloyd DJ, 2010, DIABETES, V59, P460, DOI 10.2337/db08-1362; Lloyd DJ, 2005, PLOS GENET, V1, P171, DOI 10.1371/journal.pgen.0010020; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; Monda KL, 2013, NAT GENET, V45, P690, DOI 10.1038/ng.2608; Nagase I, 1996, J CLIN INVEST, V97, P2898, DOI 10.1172/JCI118748; Newhall KJ, 2005, MOL ENDOCRINOL, V19, P982, DOI 10.1210/me.2004-0343; Nguyen DM, 2010, GASTROENTEROL CLIN N, V39, P1, DOI 10.1016/j.gtc.2009.12.014; Nolan MA, 2004, MOL ENDOCRINOL, V18, P2302, DOI 10.1210/me.2004-0194; Nordman S, 2008, INT J OBESITY, V32, P407, DOI 10.1038/sj.ijo.0803742; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Seifert R, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003466; Song Y, 2010, NATURE, V468, P933, DOI 10.1038/nature09564; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Wang HR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013851; Wang ZS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006979; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; WHEELER MB, 1993, ENDOCRINOLOGY, V133, P57, DOI 10.1210/en.133.1.57; Xia QH, 2013, ANN NY ACAD SCI, V1281, P178, DOI 10.1111/nyas.12020; Xu TR, 2013, CELL SIGNAL; Zheng RM, 2013, P NATL ACAD SCI USA, V110, pE1631, DOI 10.1073/pnas.1219542110	37	32	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110226	10.1371/journal.pone.0110226	http://dx.doi.org/10.1371/journal.pone.0110226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329148	gold, Green Published, Green Submitted			2022-12-27	WOS:000343210800070
J	Gu, LJ; Kawana-Tachikawa, A; Shiino, T; Nakamura, H; Koga, M; Kikuchi, T; Adachi, E; Koibuchi, T; Ishida, T; Gao, GF; Matsushita, M; Sugiura, W; Iwamoto, A; Hosoya, N				Gu, Lijun; Kawana-Tachikawa, Ai; Shiino, Teiichiro; Nakamura, Hitomi; Koga, Michiko; Kikuchi, Tadashi; Adachi, Eisuke; Koibuchi, Tomohiko; Ishida, Takaomi; Gao, George F.; Matsushita, Masaki; Sugiura, Wataru; Iwamoto, Aikichi; Hosoya, Noriaki			Development and Customization of a Color-Coded Microbeads-Based Assay for Drug Resistance in HIV-1 Reverse Transcriptase	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIRETROVIRAL THERAPY; PRIMARY INFECTION; T-CELL; PCR; EPIDEMIOLOGY; SURVEILLANCE; VARIANTS; TRANSMISSION; POPULATION	Background: Drug resistance (DR) of HIV-1 can be examined genotypically or phenotypically. Although sequencing is the gold standard of the genotypic resistance testing (GRT), high-throughput GRT targeted to the codons responsible for DR may be more appropriate for epidemiological studies and public health research. Methods: We used a Japanese database to design and synthesize sequence-specific oligonucleotide probes (SSOP) for the detection of wild-type sequences and 6 DR mutations in the clade B HIV-1 reverse transcriptase region. We coupled SSOP to microbeads of the Luminex 100 xMAP system and developed a GRT based on the polymerase chain reaction (PCR)-SSOP-Luminex method. Results: Sixteen oligoprobes for discriminating DR mutations from wild-type sequences at 6 loci were designed and synthesized, and their sensitivity and specificity were confirmed using isogenic plasmids. The PCR-SSOP-Luminex DR assay was then compared to direct sequencing using 74 plasma specimens from treatment-naive patients or those on failing treatment. In the majority of specimens, the results of the PCR-SSOP-Luminex DR assay were concordant with sequencing results: 62/74 (83.8%) for M41, 43/74 (58.1%) for K65, 70/74 (94.6%) for K70, 55/73 (75.3%) for K103, 63/73 (86.3%) for M184 and 68/73 (93.2%) for T215. There were a number of specimens without any positive signals, especially for K65. The nucleotide position of A2723G, A2747G and C2750T were frequent polymorphisms for the wild-type amino acids K65, K66 and D67, respectively, and 14 specimens had the D67N mutation encoded by G2748A. We synthesized 14 additional oligoprobes for K65, and the sensitivity for K65 loci improved from 43/74 (58.1%) to 68/74 (91.9%). Conclusions: We developed a rapid high-throughput assay for clade B HIV-1 DR mutations, which could be customized by synthesizing oligoprobes suitable for the circulating viruses. The assay could be a useful tool especially for public health research in both resource-rich and resource-limited settings.	[Gu, Lijun; Ishida, Takaomi; Iwamoto, Aikichi] Univ Tokyo, Inst Med Sci, Res Ctr Asian Infect Dis, Tokyo, Japan; [Gu, Lijun; Ishida, Takaomi] Chinese Acad Sci, Inst Microbiol, Japan China Joint Lab Mol Immunol & Mol Microbiol, Beijing, Peoples R China; [Kawana-Tachikawa, Ai; Koga, Michiko; Kikuchi, Tadashi; Iwamoto, Aikichi; Hosoya, Noriaki] Univ Tokyo, Inst Med Sci, Div Infect Dis, Adv Clin Res Ctr, Tokyo, Japan; [Shiino, Teiichiro; Sugiura, Wataru] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Nakamura, Hitomi; Iwamoto, Aikichi; Hosoya, Noriaki] Univ Tokyo, Inst Med Sci, Dept Infect Dis Control, Int Res Ctr Infect Dis, Tokyo, Japan; [Nakamura, Hitomi; Koga, Michiko; Kikuchi, Tadashi; Adachi, Eisuke; Koibuchi, Tomohiko; Iwamoto, Aikichi] Univ Tokyo, Inst Med Sci, Res Hosp, Div Infect Dis & Appl Immunol, Tokyo, Japan; [Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Matsushita, Masaki] Wakunaga Pharmaceut Corp, Biotech Res & Dev, Hiroshima, Japan	University of Tokyo; Chinese Academy of Sciences; Institute of Microbiology, CAS; University of Tokyo; National Institute of Infectious Diseases (NIID); University of Tokyo; University of Tokyo; Chinese Academy of Sciences; Institute of Microbiology, CAS; Wakunaga Pharmaceutical Co., Ltd.	Hosoya, N (corresponding author), Univ Tokyo, Inst Med Sci, Div Infect Dis, Adv Clin Res Ctr, Tokyo, Japan.	hnori@ims.u-tokyo.ac.jp	Gao, George Fu/ABD-5229-2021		Ministry of Education, Culture, Sports, Science and Technology (MEXT) [10005010]; Global COE Program of MEXT [F06]; JSPS KAKENHI [25293226, 24790437, 26860300]; Ministry of Health, Labor, and Welfare of Japan [H24-AIDS-IPPAN-008, H25-AIDS-IPPAN-006, H25-KOKUISITEI-001]; Grants-in-Aid for Scientific Research [26293357] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program of MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a contract research fund from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) for Program of Japan Initiative for Global Research Network on Infectious Diseases (10005010)(AI); Global COE Program (Center of Education and Research for Advanced Genome-Based Medicine - For personalized medicine and the control of worldwide infectious diseases -) of MEXT (F06)(AI); JSPS KAKENHI (25293226)(AKT); JSPS KAKENHI (24790437, 26860300)(NH); Grants for AIDS research from the Ministry of Health, Labor, and Welfare of Japan (H24-AIDS-IPPAN-008)(AKT); Grants for AIDS research from the Ministry of Health, Labor, and Welfare of Japan (H25-AIDS-IPPAN-006)(NH); Research on international cooperation in medical science, Research on global health issues, Health and Labour Science Research Grants, the Ministry of Health, Labor, and Welfare of Japan (H25-KOKUISITEI-001)(AI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balajee SA, 2007, MED MYCOL, V45, P475, DOI 10.1080/13693780701449425; Boltz VF, 2012, J VIROL, V86, P12525, DOI 10.1128/JVI.01963-12; Cane P, 2005, BMJ-BRIT MED J, V331, P1368, DOI 10.1136/bmj.38665.534595.55; CHENGMAYER C, 1990, J VIROL, V64, P4390, DOI 10.1128/JVI.64.9.4390-4398.1990; Church JD, 2008, AIDS RES HUM RETROV, V24, P595, DOI 10.1089/aid.2007.0224; Claas EC, 2013, J MICROBIOL BIOTECHN, V23, P1041, DOI 10.4014/jmb.1212.12042; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; Deng HY, 2004, BIOSENS BIOELECTRON, V19, P1277, DOI 10.1016/j.bios.2003.11.022; Descamps D, 2005, JAIDS-J ACQ IMM DEF, V38, P545, DOI 10.1097/01.qai.0000155201.51232.2e; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; ERICE A, 1993, NEW ENGL J MED, V328, P1163, DOI 10.1056/NEJM199304223281605; Frentz D, 2012, AIDS REV, V14, P17; Gatanaga H, 2007, ANTIVIR RES, V75, P75, DOI 10.1016/j.antiviral.2006.11.012; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Hattori J, 2010, ANTIVIR RES, V88, P72, DOI 10.1016/j.antiviral.2010.07.008; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Itoh Y, 2005, IMMUNOGENETICS, V57, P717, DOI 10.1007/s00251-005-0048-3; Jiang HL, 2006, J MED MICROBIOL, V55, P715, DOI 10.1099/jmm.0.46493-0; Johnson Victoria A, 2013, Top Antivir Med, V21, P6; Koga I, 2006, MICROBES INFECT, V8, P2872, DOI 10.1016/j.micinf.2006.09.003; Mohamed S, 2014, J MED VIROL, V86, P394, DOI 10.1002/jmv.23853; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Rowley CF, 2008, J VIROL METHODS, V149, P69, DOI 10.1016/j.jviromet.2008.01.005; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Shafer RW, 2007, AIDS, V21, P215, DOI 10.1097/QAD.0b013e328011e691; Shi CJ, 2004, NAT METHODS, V1, P141, DOI 10.1038/NMETH713; SHIODA T, 1991, NATURE, V349, P167, DOI 10.1038/349167a0; Sungkanuparph S, 2010, ASIAN BIOMED, V4, P515, DOI 10.2478/abm-2010-0066; Vongphrachanh P, 2010, INFLUENZA OTHER RESP, V4, P47, DOI 10.1111/j.1750-2659.2009.00120.x; Wainberg MA, 1998, JAMA-J AM MED ASSOC, V279, P1977, DOI 10.1001/jama.279.24.1977; Walker BD, 2001, NAT IMMUNOL, V2, P473, DOI 10.1038/88656; Weinstock HS, 2004, J INFECT DIS, V189, P2174, DOI 10.1086/420789; Wensing AMJ, 2005, J INFECT DIS, V192, P958, DOI 10.1086/432916; Wensing Annemarie M, 2014, Top Antivir Med, V22, P642; WHO, 2012, WHO HIV DRUG RES REP; Yerly S, 2007, AIDS, V21, P2223, DOI 10.1097/QAD.0b013e3282f0b685; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655	38	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109823	10.1371/journal.pone.0109823	http://dx.doi.org/10.1371/journal.pone.0109823			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314293	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662500079
J	Wang, X; Tang, YQ; Zhang, XP; Yin, X; Du, X; Zhang, XP				Wang, Xuan; Tang, Yuqing; Zhang, Xiaopeng; Yin, Xi; Du, Xin; Zhang, Xinping			Effect of Publicly Reporting Performance Data of Medicine Use on Injection Use: A Quasi-Experimental Study	PLOS ONE			English	Article							HEALTH-CARE; INTERACTIONAL GROUP; QUALITY; INTERVENTION; POLICY; IMPACT; CHINA	Background: Inappropriate use of prescribing pharmaceuticals, particularly injections, not only affects the quality of medical care, but also leads to an increase in medical expenses. Publicly reporting performance data of medical care is becoming a common health policy tool adopted to supervise medical quality. To our knowledge, few studies about public reporting applied to medicine use have been reported. This study intended to introduce public reporting in the field of medicine use, and evaluate the effect of publicly reporting performance data of medicine use on the use of injections. Methods: The research sites were 20 primary healthcare institutions in Q City, Hubei. By matching, the institutions were divided into the intervention group and control group. A quasi-experimental design was applied in this study. In the intervention group, the performance data of medicine use were publicly reported. The injection prescribing rates of the two groups before and after intervention were measured and compared. Difference-in-difference method and logistic regression were employed to estimate the effect of public reporting on injection use. Results: Public reporting led to a reduction of approximately 4% in the injection prescribing rate four months after intervention (OR = 0.96; 95% CI: 0.94, 0.97). The intervention effect was inconsistent in each month after intervention, and it was most positive in the second month after intervention (OR = 0.90; 95% CI: 0.89, 0.92). Conclusions: In general, publicly reporting performance data of medicine use may have positive effects on injection use to some extent. Further research is needed to investigate the mechanism by which public reporting influences injection use. Comprehensive measures are also necessary to promote the rational use of injections.	[Wang, Xuan; Tang, Yuqing; Zhang, Xiaopeng; Yin, Xi; Du, Xin; Zhang, Xinping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Med & Hlth Management, Wuhan 430074, Hubei Province, Peoples R China	Huazhong University of Science & Technology	Zhang, XP (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Med & Hlth Management, Wuhan 430074, Hubei Province, Peoples R China.	xpzhang602@163.com		Zhang, Xinping/0000-0002-0688-2417; Zhang, Xinping/0000-0002-1579-1306	National Natural Science Foundation of China [71373092]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the National Natural Science Foundation of China (71373092, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berwick DM, 2003, MED CARE, V41, pI30; Bhunia R, 2010, INDIAN PEDIATR, V47, P409, DOI 10.1007/s13312-010-0076-4; Blumenthal D, 1996, NEW ENGL J MED, V335, P1328, DOI 10.1056/NEJM199610243351721; BROOMBERG J, 1990, S AFR MED J, V78, P130; Dong LF, 2011, J PUBLIC HEALTH-UK, V33, P565, DOI 10.1093/pubmed/fdr019; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Espeland WN, 2007, AM J SOCIOL, V113, P1, DOI 10.1086/517897; Faber M, 2009, MED CARE, V47, P1, DOI 10.1097/MLR.0b013e3181808bb5; Finkelstein JA, 2001, PEDIATRICS, V108, pU113; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; Gerber JS, 2013, JAMA-J AM MED ASSOC, V309, P2345, DOI 10.1001/jama.2013.6287; Hadiyono JEP, 1996, SOC SCI MED, V42, P1177, DOI 10.1016/0277-9536(95)00391-6; HANNAN EL, 1994, JAMA-J AM MED ASSOC, V271, P761, DOI 10.1001/jama.271.10.761; Hibbard JH, 2003, HEALTH AFFAIR, V22, P84, DOI 10.1377/hlthaff.22.2.84; Hu SL, 2001, HEALTH POLICY PLANN, V16, P4, DOI 10.1093/heapol/16.suppl_2.4; Ivers N, 2012, COCHRANE DB SYST REV, V6, pD259; Jin C, 2012, CHINESE HLTH EC, V31, P79; Lansky D, 2002, HEALTH AFFAIR, V21, P52, DOI 10.1377/hlthaff.21.4.52; Le Grand A, 1999, HEALTH POLICY PLANN, V14, P89, DOI 10.1093/heapol/14.2.89; Li LM, 2010, EPIDEMIOLOGY, V6th; Li YB, 2012, HEALTH AFFAIR, V31, P1075, DOI 10.1377/hlthaff.2010.0965; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Mainz J, 2004, INT J QUAL HEALTH C, V16, pI45, DOI 10.1093/intqhc/mzh031; Marshall MN, 2003, HEALTH AFFAIR, V22, P134, DOI 10.1377/hlthaff.22.3.134; Marshall MN, 2000, JAMA-J AM MED ASSOC, V283, P1866, DOI 10.1001/jama.283.14.1866; Meeker D, 2014, JAMA INTERN MED, V174, P425, DOI 10.1001/jamainternmed.2013.14191; Reynolds L, 2009, HEALTH POLICY, V90, P32, DOI 10.1016/j.healthpol.2008.09.002; Shen J, 2004, MED CARE, V42, P297, DOI 10.1097/01.mlr.0000114918.50088.1c; Snelling Iain, 2003, J Health Organ Manag, V17, P210, DOI 10.1108/14777260310480758; [孙奕 Sun Yi], 2005, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V5, P394; Tang YQ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-183; Tu JV, 2003, INT J QUAL HEALTH C, V15, P131, DOI 10.1093/intqhc/mzg015; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063225; WHO, INJECTION SAFETY; WHO, 1993, ACT PROGR ESS DRUGS, P1; WHO, 2009, MED US PRIM CAR DEV; WHO Website, MED RAT US MED; WHO. World Health Organization, 1993, INVESTIGATE DRUG USE; World Health Organization, 2002, ANTITB OTHER MED PRE; Xiang XX, 2012, J HUAZHONG U SCI-MED, V32, P626, DOI 10.1007/s11596-012-1008-4; Yang LP, 2013, HEALTH POLICY PLANN, V28, P750, DOI 10.1093/heapol/czs116	41	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109594	10.1371/journal.pone.0109594	http://dx.doi.org/10.1371/journal.pone.0109594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR5ZW	25313853	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500059
J	Zhang, WH; Zhi, JM; Cui, YY; Zhang, F; Habyarimana, A; Cambier, C; Gustin, P				Zhang, Wenhui; Zhi, Jianming; Cui, Yongyao; Zhang, Fan; Habyarimana, Adelite; Cambier, Carole; Gustin, Pascal			Potentiated Interaction between Ineffective Doses of Budesonide and Formoterol to Control the Inhaled Cadmium-Induced Up-Regulation of Metalloproteinases and Acute Pulmonary Inflammation in Rats	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; AIRWAY INFLAMMATION; NEUTROPHILIC INFLAMMATION; IPRATROPIUM BROMIDE; TISSUE INHIBITOR; MOUSE MODEL; MATRIX-METALLOPROTEINASE-9; CORTICOSTEROIDS; EXPRESSION; RECEPTOR	The anti-inflammatory properties of glucocorticoids are well known but their protective effects exerted with a low potency against heavy metals-induced pulmonary inflammation remain unclear. In this study, a model of acute pulmonary inflammation induced by a single inhalation of cadmium in male Sprague-Dawley rats was used to investigate whether formoterol can improve the anti-inflammatory effects of budesonide. The cadmium-related inflammatory responses, including matrix metalloproteinase-9 (MMP-9) activity, were evaluated. Compared to the values obtained in rats exposed to cadmium, pretreatment of inhaled budesonide (0.5 mg/15 ml) elicited a significant decrease in total cell and neutrophil counts in bronchoalveolar lavage fluid (BALF) associated with a significant reduction of MMP-9 activity which was highly correlated with the number of inflammatory cells in BALF. Additionally, cadmium-induced lung injuries characterized by inflammatory cell infiltration within alveoli and the interstitium were attenuated by the pre-treatment of budesonide. Though the low concentration of budesonide (0.25 mg/15 ml) exerted a very limited inhibitory effects in the present rat model, its combination with an inefficient concentration of formoterol (0.5 mg/30 ml) showed an enhanced inhibitory effect on neutrophil and total cell counts as well as on the histological lung injuries associated with a potentiation of inhibition on the MMP-9 activity. In conclusion, high concentration of budesonide alone could partially protect the lungs against cadmium exposure induced-acute neutrophilic pulmonary inflammation via the inhibition of MMP-9 activity. The combination with formoterol could enhance the protective effects of both drugs, suggesting a new therapeutic strategy for the treatment of heavy metals-induced lung diseases.	[Zhang, Wenhui; Zhi, Jianming] Shanghai Jiao Tong Univ, Sch Med, Dept Physiol, Shanghai 200030, Peoples R China; [Cui, Yongyao] Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol, Shanghai 200030, Peoples R China; [Zhang, Fan] Shanghai Jiao Tong Univ, Sch Med, Dept Pathol, Shanghai 200030, Peoples R China; [Habyarimana, Adelite; Cambier, Carole; Gustin, Pascal] Univ Liege, Fac Vet Med, Dept Funct Sci B41, Liege, Belgium	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Liege	Zhang, WH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Physiol, Shanghai 200030, Peoples R China.	i_zhangwenhui@163.com			Innovation Program of Shanghai Municipal Education Commission (China) [12YZ051]; National Natural Science Foundation of China [81373468]; Wallonie Bruxelles International grant (Belgium)	Innovation Program of Shanghai Municipal Education Commission (China)(Innovation Program of Shanghai Municipal Education Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wallonie Bruxelles International grant (Belgium)	This study was supported by Innovation Program of Shanghai Municipal Education Commission (No. 12YZ051, China); the National Natural Science Foundation of China (No. 81373468); and Wallonie Bruxelles International grant (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson JJ, 2011, AM J RESP CRIT CARE, V183, P876, DOI 10.1164/rccm.201005-0718OC; Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Bathoorn E, 2008, COPD, V5, P282, DOI 10.1080/15412550802363360; Birrell MA, 2005, FASEB J, V19, P840, DOI 10.1096/fj.04-2691fje; Bohlandt A, 2012, SCI TOTAL ENVIRON, V414, P738, DOI 10.1016/j.scitotenv.2011.11.017; Bolognin M, 2009, VET J, V179, P443, DOI 10.1016/j.tvjl.2007.10.004; Cazzola M, 2004, CHEST, V126, P220, DOI 10.1378/chest.126.1.220; Coccini T, 2013, HISTOL HISTOPATHOL, V28, P195, DOI 10.14670/HH-28.195; Dagouassat M, 2012, EUR RESPIR J, V39, P1021, DOI 10.1183/09031936.00195811; Fievez L, 2009, EUR J PHARMACOL, V606, P210, DOI 10.1016/j.ejphar.2009.01.020; Fligiel SEG, 2006, HUM PATHOL, V37, P422, DOI 10.1016/j.humpath.2005.11.023; Fuso L, 2013, CURR MED CHEM, V20, P1477, DOI 10.2174/0929867311320120003; Gueders MM, 2006, EUR J PHARMACOL, V533, P133, DOI 10.1016/j.ejphar.2005.12.082; Hanania Nicola A., 2004, Current Drug Targets - Inflammation and Allergy, V3, P271, DOI 10.2174/1568010043343598; Haque R, 2013, J ALLERGY CLIN IMMUN, V132, P1166, DOI 10.1016/j.jaci.2013.07.038; Ito K, 2008, AM J RESP CELL MOL, V39, P543, DOI 10.1165/rcmb.2008-0028OC; Kim JH, 2006, AM J PHYSIOL-LUNG C, V291, pL580, DOI 10.1152/ajplung.00270.2005; Kirschvink N, 2006, FREE RADICAL RES, V40, P241, DOI 10.1080/10715760500494657; Kirschvink N, 2005, TOXICOLOGY, V211, P36, DOI 10.1016/j.tox.2005.02.012; Kundu S, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-19; Lagente V, 2010, J MOL CELL CARDIOL, V48, P440, DOI 10.1016/j.yjmcc.2009.09.017; Lee J, 2011, J TRACE ELEM MED BIO, V25, P239, DOI 10.1016/j.jtemb.2011.08.142; Lee YC, 2001, CLIN EXP ALLERGY, V31, P1623, DOI 10.1046/j.1365-2222.2001.01211.x; Lin YS, 2009, ANN EPIDEMIOL, V19, P592, DOI 10.1016/j.annepidem.2009.02.005; Ma B, 2013, EUR REV MED PHARMACO, V17, P1051; Moitra S, 2013, THORAX, V68, P565, DOI 10.1136/thoraxjnl-2012-203029; Mortaz E, 2008, J MOL MED, V86, P1045, DOI 10.1007/s00109-008-0360-0; Newton R, 2010, PHARMACOL THERAPEUT, V125, P286, DOI 10.1016/j.pharmthera.2009.11.003; Oikonomidi S, 2009, CURR MED CHEM, V16, P1214, DOI 10.2174/092986709787846587; Perng DW, 2012, PULM PHARMACOL THER, V25, P312, DOI 10.1016/j.pupt.2012.04.001; Qiu YS, 2003, AM J RESP CRIT CARE, V168, P968, DOI 10.1164/rccm.200208-794OC; Riesenfeld EP, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-22; Rokadia HK, 2013, CHEST, V143, P388, DOI 10.1378/chest.12-0595; Russell REK, 2002, AM J RESP CELL MOL, V26, P602, DOI 10.1165/ajrcmb.26.5.4685; Russell REK, 2002, AM J PHYSIOL-LUNG C, V283, pL867, DOI 10.1152/ajplung.00020.2002; SHAPIRO SD, 1991, J IMMUNOL, V146, P2724; Silva PL, 2009, EUR RESPIR J, V33, P634, DOI 10.1183/09031936.00052408; Vlahos R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033277; Wirth D, 2004, AM J PHYSIOL-LUNG C, V287, pL953, DOI 10.1152/ajplung.00184.2003; Wollin L, 2010, PULM PHARMACOL THER, V23, P345, DOI 10.1016/j.pupt.2010.03.008; World Health Organization International Agency for Research on Cancer (IRAC), IRAC MON EV CARC RIS; Wang XQ, 2008, RESPIROLOGY, V13, P772, DOI 10.1111/j.1440-1843.2008.01344.x; Zhang WH, 2012, FUND CLIN PHARMACOL, V26, P118, DOI 10.1111/j.1472-8206.2011.01007.x; Zhang WH, 2010, EUR J PHARMACOL, V647, P178, DOI 10.1016/j.ejphar.2010.08.028; Zhang WH, 2010, EUR J PHARMACOL, V628, P171, DOI 10.1016/j.ejphar.2009.11.015	45	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109136	10.1371/journal.pone.0109136	http://dx.doi.org/10.1371/journal.pone.0109136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313925	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500024
J	Chaim, TM; Zhang, TH; Zanetti, MV; da Silva, MA; Louza, MR; Doshi, J; Serpa, MH; Duran, FLS; Caetano, SC; Davatzikos, C; Busatto, GF				Chaim, Tiffany M.; Zhang, Tianhao; Zanetti, Marcus V.; da Silva, Maria Aparecida; Louza, Mario R.; Doshi, Jimit; Serpa, Mauricio H.; Duran, Fabio L. S.; Caetano, Sheila C.; Davatzikos, Christos; Busatto, Geraldo F.			Multimodal Magnetic Resonance Imaging Study of Treatment-Naive Adults with Attention-Deficit/Hyperactivity Disorder	PLOS ONE			English	Article							DEFICIT-HYPERACTIVITY DISORDER; WHITE-MATTER ABNORMALITIES; 33-YEAR FOLLOW-UP; FRACTIONAL ANISOTROPY; ALZHEIMERS-DISEASE; COGNITIVE CONTROL; BRAIN-DEVELOPMENT; BIPOLAR DISORDER; DIFFUSION; MRI	Background: Attention-Deficit/Hiperactivity Disorder (ADHD) is a prevalent disorder, but its neuroanatomical circuitry is still relatively understudied, especially in the adult population. The few morphometric magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI) studies available to date have found heterogeneous results. This may be at least partly attributable to some well-known technical limitations of the conventional voxel-based methods usually employed to analyze such neuroimaging data. Moreover, there is a great paucity of imaging studies of adult ADHD to date that have excluded patients with history of use of stimulant medication. Methods: A newly validated method named optimally-discriminative voxel-based analysis (ODVBA) was applied to multimodal (structural and DTI) MRI data acquired from 22 treatment-naive ADHD adults and 19 age-and gender-matched healthy controls (HC). Results: Regarding DTI data, we found higher fractional anisotropy in ADHD relative to HC encompassing the white matter (WM) of the bilateral superior frontal gyrus, right middle frontal left gyrus, left postcentral gyrus, bilateral cingulate gyrus, bilateral middle temporal gyrus and right superior temporal gyrus; reductions in trace (a measure of diffusivity) in ADHD relative to HC were also found in fronto-striatal-parieto-occipital circuits, including the right superior frontal gyrus and bilateral middle frontal gyrus, right precentral gyrus, left middle occipital gyrus and bilateral cingulate gyrus, as well as the left body and right splenium of the corpus callosum, right superior corona radiata, and right superior longitudinal and fronto-occipital fasciculi. Volumetric abnormalities in ADHD subjects were found only at a trend level of significance, including reduced gray matter (GM) in the right angular gyrus, and increased GM in the right supplementary motor area and superior frontal gyrus. Conclusions: Our results suggest that adult ADHD is associated with neuroanatomical abnormalities mainly affecting the WM microstructure in fronto-parieto-temporal circuits that have been implicated in cognitive, emotional and visuomotor processes.	[Chaim, Tiffany M.; Zanetti, Marcus V.; Serpa, Mauricio H.; Duran, Fabio L. S.; Caetano, Sheila C.; Busatto, Geraldo F.] Univ Sao Paulo, Fac Med, Dept Psychiat, Lab Psychiat Neuroimaging, Sao Paulo, Brazil; [Chaim, Tiffany M.; Zanetti, Marcus V.; da Silva, Maria Aparecida; Louza, Mario R.; Serpa, Mauricio H.; Duran, Fabio L. S.; Caetano, Sheila C.; Busatto, Geraldo F.] Univ Sao Paulo, Fac Med, Inst Psychiat, Sao Paulo, Brazil; [Chaim, Tiffany M.; Zanetti, Marcus V.; Serpa, Mauricio H.; Duran, Fabio L. S.; Caetano, Sheila C.; Busatto, Geraldo F.] Univ Sao Paulo, Ctr Interdisciplinary Res Appl Neurosci, Sao Paulo, Brazil; [Chaim, Tiffany M.; da Silva, Maria Aparecida; Louza, Mario R.] Univ Sao Paulo, Fac Med, Dept Psychiat, Program Attent Deficit Hyperact Disorder, Sao Paulo, Brazil; [Zhang, Tianhao; Doshi, Jimit; Davatzikos, Christos] Univ Penn, Dept Radiol, Sect Biomed Image Anal, Philadelphia, PA 19104 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Pennsylvania	Chaim, TM (corresponding author), Univ Sao Paulo, Fac Med, Dept Psychiat, Lab Psychiat Neuroimaging, Sao Paulo, Brazil.	chaim.tiffany@gmail.com	Serpa, Mauricio H/E-9515-2014; Caetano, Sheila C./H-5010-2012; Busatto, Geraldo F/D-4431-2009; Serpa, Mauricio/O-6157-2019; Louza, Mario R/H-8540-2013; Louzã, Mario/L-4708-2019; Davatzikos, Christos/ABE-2057-2021; Caetano, Sheila C./AAS-9806-2021; Souza-Duran, Fabio Luis/L-1371-2013	Serpa, Mauricio H/0000-0001-9384-5587; Caetano, Sheila C./0000-0001-8403-7078; Busatto, Geraldo F/0000-0003-4749-4602; Serpa, Mauricio/0000-0001-9384-5587; Louza, Mario R/0000-0003-1359-4111; Louzã, Mario/0000-0003-1359-4111; Caetano, Sheila C./0000-0001-8403-7078; Souza-Duran, Fabio Luis/0000-0002-7603-6152; Davatzikos, Christos/0000-0002-1025-8561	NARSAD Independent Investigator Award (NARSAD: The Brain and Behavior Research Fund); CNPq-Brazil	NARSAD Independent Investigator Award (NARSAD: The Brain and Behavior Research Fund); CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The present investigation was supported by a 2010 NARSAD Independent Investigator Award (NARSAD: The Brain and Behavior Research Fund) awarded to Geraldo F. Busatto. Geraldo F. Busatto is also partially funded by CNPq-Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler Lenard A, 2006, Ann Clin Psychiatry, V18, P145, DOI 10.1080/10401230600801077; Ahrendts J, 2011, WORLD J BIOL PSYCHIA, V12, P260, DOI 10.3109/15622975.2010.518624; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Montes LGA, 2010, J PSYCHIATR NEUROSCI, V35, P238, DOI 10.1503/jpn.090099; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Amico F, 2011, PSYCHIAT RES-NEUROIM, V191, P31, DOI 10.1016/j.pscychresns.2010.08.011; Andersson J.L.R., 2007, TR07JA1 FMRIB; Arnsten AFT, 2012, J AM ACAD CHILD PSY, V51, P356, DOI 10.1016/j.jaac.2012.01.008; Ashburner J, 2009, MAGN RESON IMAGING, V27, P1163, DOI 10.1016/j.mri.2009.01.006; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Cao QJ, 2010, BRAIN RES, V1310, P172, DOI 10.1016/j.brainres.2009.10.031; Casey BJ, 2007, AM J PSYCHIAT, V164, P1729, DOI 10.1176/appi.ajp.2007.06101754; Caspers S, 2013, CEREB CORTEX, V23, P615, DOI 10.1093/cercor/bhs048; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; Chuang TC, 2013, PSYCHIAT RES-NEUROIM, V211, P186, DOI 10.1016/j.pscychresns.2012.11.008; Cortese S, 2013, BIOL PSYCHIAT, V74, P591, DOI 10.1016/j.biopsych.2013.02.025; Davatzikos C, 2004, NEUROIMAGE, V23, P17, DOI 10.1016/j.neuroimage.2004.05.010; Davatzikos C, 2001, NEUROIMAGE, V14, P1361, DOI 10.1006/nimg.2001.0937; Davenport ND, 2010, PSYCHIAT RES-NEUROIM, V181, P193, DOI 10.1016/j.pscychresns.2009.10.012; de Zwaan M, 2012, EUR ARCH PSY CLIN N, V262, P79, DOI 10.1007/s00406-011-0211-9; Depue BE, 2010, PSYCHIAT RES-NEUROIM, V182, P231, DOI 10.1016/j.pscychresns.2010.01.012; Di Trani M, 2014, PSYCHIAT INVEST, V11, P137, DOI 10.4306/pi.2014.11.2.137; Doshi J, 2013, ACAD RADIOL IN PRESS; Dramsdahl M, 2012, PSYCHIAT RES-NEUROIM, V201, P168, DOI 10.1016/j.pscychresns.2011.08.005; Duerden EG, 2012, BRAIN RES, V1445, P82, DOI 10.1016/j.brainres.2012.01.034; Elia Josephine, 2008, Child Adolesc Psychiatry Ment Health, V2, P15, DOI 10.1186/1753-2000-2-15; Filipek PA, 1997, NEUROLOGY, V48, P589, DOI 10.1212/WNL.48.3.589; First M.B., 2016, STRUCTURED CLIN INTE; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Frodl T, 2012, ACTA PSYCHIAT SCAND, V125, P114, DOI 10.1111/j.1600-0447.2011.01786.x; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Hamilton LS, 2008, NEUROREPORT, V19, P1705, DOI 10.1097/WNR.0b013e3283174415; Heng S, 2010, J NEURAL TRANSM, V117, P639, DOI 10.1007/s00702-010-0368-9; Hoeft F, 2007, J NEUROSCI, V27, P11960, DOI 10.1523/JNEUROSCI.3591-07.2007; Hoekzema E, 2014, BRAIN STRUCT FUNCT, V219, P23, DOI 10.1007/s00429-012-0481-7; Jones DK, 2008, CORTEX, V44, P936, DOI 10.1016/j.cortex.2008.05.002; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kates WR, 2002, PSYCHIAT RES-NEUROIM, V116, P63, DOI 10.1016/S0925-4927(02)00066-5; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kobel M, 2010, PSYCHIAT RES-NEUROIM, V183, P230, DOI 10.1016/j.pscychresns.2010.03.010; Konrad A, 2012, EUR ARCH PSY CLIN N, V262, P351, DOI 10.1007/s00406-011-0251-1; Konrad A, 2010, EUR J NEUROSCI, V31, P912, DOI 10.1111/j.1460-9568.2010.07110.x; Konrad K, 2010, HUM BRAIN MAPP, V31, P904, DOI 10.1002/hbm.21058; Krain AL, 2006, CLIN PSYCHOL REV, V26, P433, DOI 10.1016/j.cpr.2006.01.005; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Li CM, 2009, PROC CVPR IEEE, P218, DOI 10.1109/CVPRW.2009.5206553; Lim JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091400; Mahone EM, 2011, CLIN NEUROPSYCHOL, V25, P1009, DOI 10.1080/13854046.2011.580784; Makris N, 2013, J ATTEN DISORD; Makris N, 2008, CEREB CORTEX, V18, P1210, DOI 10.1093/cercor/bhm156; Makris N, 2007, CEREB CORTEX, V17, P1364, DOI 10.1093/cercor/bhl047; Makris N, 2010, J ATTEN DISORD, V13, P407, DOI 10.1177/1087054709351671; Marin A, 2013, PRIM CARE COMPANION, V15; McAlonan GM, 2007, PSYCHIAT RES-NEUROIM, V154, P171, DOI 10.1016/j.pscychresns.2006.09.006; Menezes PR, 1996, BRIT J PSYCHIAT, V168, P612, DOI 10.1192/bjp.168.5.612; Mostofsky SH, 2002, BIOL PSYCHIAT, V52, P785, DOI 10.1016/S0006-3223(02)01412-9; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nir TM, 2013, NEUROIMAGE-CLIN, V3, P180, DOI 10.1016/j.nicl.2013.07.006; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Onnink AMH, 2014, EUR NEUROPSYCHOPHARM, V24, P397, DOI 10.1016/j.euroneuro.2013.11.011; Ou YM, 2011, MED IMAGE ANAL, V15, P622, DOI 10.1016/j.media.2010.07.002; Pavuluri MN, 2009, BIOL PSYCHIAT, V65, P586, DOI 10.1016/j.biopsych.2008.10.015; Phillips MD, 2001, AM J NEURORADIOL, V22, P1583; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pliszka SR, 2006, NEUROLOGY, V67, P1023, DOI 10.1212/01.wnl.0000237385.84037.3c; Polanczyk G, 2007, CURR OPIN PSYCHIATR, V20, P386, DOI 10.1097/YCO.0b013e3281568d7a; Polanczyk G, 2010, INT J METH PSYCH RES, V19, P177, DOI 10.1002/mpr.319; Proal E, 2011, ARCH GEN PSYCHIAT, V68, P1122, DOI 10.1001/archgenpsychiatry.2011.117; Rodern C, 2013, ADV DTI PROCESSING; Rubia K, 2004, ACTA NEUROBIOL EXP, V64, P329; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Seidman LJ, 2006, BIOL PSYCHIAT, V60, P1071, DOI 10.1016/j.biopsych.2006.04.031; Seidman LJ, 2011, BIOL PSYCHIAT, V69, P857, DOI 10.1016/j.biopsych.2010.09.053; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2011, AM J PSYCHIAT, V168, P143, DOI 10.1176/appi.ajp.2010.10030385; Shaw P, 2009, AM J PSYCHIAT, V166, P58, DOI 10.1176/appi.ajp.2008.08050781; Siever LJ, 1999, NEUROPSYCHOPHARMACOL, V20, P413, DOI 10.1016/S0893-133X(98)00111-0; Silk TJ, 2009, HUM BRAIN MAPP, V30, P2757, DOI 10.1002/hbm.20703; Simon V, 2009, BRIT J PSYCHIAT, V194, P204, DOI 10.1192/bjp.bp.107.048827; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Suzuki Y, 2003, NMR BIOMED, V16, P257, DOI 10.1002/nbm.848; Tamm L, 2012, PSYCHIAT RES-NEUROIM, V202, P150, DOI 10.1016/j.pscychresns.2012.04.001; Teipel SJ, 2014, J ALZHEIMERS DIS, V41, P69, DOI 10.3233/JAD-131829; Tievsky AL, 1999, AM J NEURORADIOL, V20, P1491; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Ewijk H, 2014, J AM ACAD CHILD PSY, V53, P790, DOI 10.1016/j.jaac.2014.05.001; van Ewijk H, 2012, NEUROSCI BIOBEHAV R, V36, P1093, DOI 10.1016/j.neubiorev.2012.01.003; Versace A, 2008, ARCH GEN PSYCHIAT, V65, P1041, DOI 10.1001/archpsyc.65.9.1041; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Werring DJ, 2000, J NEUROL NEUROSUR PS, V69, P269, DOI 10.1136/jnnp.69.2.269; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; White DA, 2010, MOL GENET METAB, V99, pS41, DOI 10.1016/j.ymgme.2009.09.016; Yurgelun-Todd DA, 2007, BIPOLAR DISORD, V9, P504, DOI 10.1111/j.1399-5618.2007.00395.x; Zhang TH, 2013, NEUROIMAGE, V79, P94, DOI 10.1016/j.neuroimage.2013.04.063; Zhang TH, 2011, IEEE T MED IMAGING, V30, P1441, DOI 10.1109/TMI.2011.2114362	99	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110199	10.1371/journal.pone.0110199	http://dx.doi.org/10.1371/journal.pone.0110199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310815	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210300096
J	Chou, CT; Wu, WP; Chen, CB; Su, WW; Chen, RC; Chen, YL				Chou, Chen-Te; Wu, Wen-Pei; Chen, Chia-Bang; Su, Wei-Wen; Chen, Ran-Chou; Chen, Yao-Li			The Utility of Gadoxetic Acid-Enhanced MR Imaging to Characterize Atypical Cirrhotic Nodules Detected on Dynamic CT Images	PLOS ONE			English	Article							GD-EOB-DTPA; NONINVASIVE DIAGNOSTIC-CRITERIA; SMALL HEPATOCELLULAR-CARCINOMA; TUMOR SIZE; HISTOLOGIC GRADE; HEPATIC NODULES; LIVER; GADOLINIUM; DIFFERENTIATION; AGREEMENT	Purpose: To evaluate whether gadoxetic acid (Gd-EOB-DTPA)-enhanced MR images of tumors taken during the hepatocyte-specific phase can aid in the differentiation between hepatocellular carcinoma (HCC) and dysplastic nodules (DNs) in patients with atypical cirrhotic nodules detected on dynamic CT images. Materials and Methods: Seventy-one patients with 112 nodules showing atypical dynamic enhancement on CT images underwent gadoxetic acid-enhanced MR imaging (MRI) studies. Using a reference standard, we determined that 33 of the nodules were DNs and that 79 were true HCCs. Tumor size, signal intensity on precontrast T1-weighted images (T1WI) and T2WI, and the pattern of dynamic enhancement on MR images taken in the hepatocyte-phase were determined. Results: There were significant differences in tumor size, hyperintensity on T2WI, hypointensity on T1WI, typical HCC enhancement pattern on dynamic MR images, or hypointensity on hepatocyte-phase images between DNs and HCC. The sensitivity and specificity were 60.8% and 87.9% for T2WI, 38.0% and 87.9% for T1WI, 17.7% and 100% for dynamic MR imaging, 83.5% and 84.9% for hepatocyte-phase imaging, and 60.8% and 87.9% for tumor size (threshold of 1.7 cm). Conclusion: Gd-EOB-DTPA-enhanced hepatocyte-phase imaging is recommended for patients at high risk of HCC who present with atypical lesions on dynamic CT images.	[Chou, Chen-Te; Wu, Wen-Pei; Chen, Ran-Chou] Natl Yang Ming Med Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan; [Chou, Chen-Te; Chen, Chia-Bang] Chang Hua Christian Hosp, Dept Radiol, Changhua, Taiwan; [Chen, Yao-Li] Chang Hua Christian Hosp, Transplantat Med & Surg Res Ctr, Changhua, Taiwan; [Su, Wei-Wen] Chang Hua Christian Hosp, Dept Gastroenterol, Changhua, Taiwan; [Chen, Ran-Chou] Taipei City Hosp, Dept Radiol, Taipei, Taiwan; [Chen, Yao-Li] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Yao-Li] Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan	National Yang Ming Chiao Tung University; Changhua Christian Hospital; Changhua Christian Hospital; Changhua Christian Hospital; Taipei City Hospital; Chung Shan Medical University; Kaohsiung Medical University	Chen, RC (corresponding author), Natl Yang Ming Med Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan.	chenranchou@yahoo.com.tw; 31560@cch.org.tw			National Science Council, Taiwan [100-2314-B-010-012-MY2]; Chang-hua Christian Hospital, Taiwan [101-CCH-IRP-03]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang-hua Christian Hospital, Taiwan	The authors thank the National Science Council, Taiwan (100-2314-B-010-012-MY2) and the Chang-hua Christian Hospital, Taiwan (101-CCH-IRP-03) for financially supporting this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Choi JY, 2011, AM J ROENTGENOL, V197, P399, DOI 10.2214/AJR.10.5439; Donato F, 1997, HEPATOLOGY, V26, P579, DOI 10.1002/hep.510260308; EGUCHI A, 1992, HEPATOLOGY, V15, P843, DOI 10.1002/hep.1840150516; Forner A, 2008, HEPATOLOGY, V47, P97, DOI 10.1002/hep.21966; Frericks BB, 2009, AM J ROENTGENOL, V193, P1053, DOI 10.2214/AJR.08.1946; Furlan A, 2012, EUR J RADIOL, V81, P2099, DOI 10.1016/j.ejrad.2011.07.010; Huppertz A, 2004, RADIOLOGY, V230, P266, DOI 10.1148/radiol.2301020269; Hussain SM, 2002, RADIOGRAPHICS, V22, P1023, DOI 10.1148/radiographics.22.5.g02se061023; Hyodo T, 2013, RADIOLOGY, V266, P480, DOI 10.1148/radiol.12112677; Kawada N, 2010, HEPATOL RES, V40, P930, DOI 10.1111/j.1872-034X.2010.00697.x; KENMOCHI K, 1987, LIVER, V7, P18; Kim YK, 2009, J MAGN RESON IMAGING, V30, P437, DOI 10.1002/jmri.21839; Kudo M, 2011, ONCOLOGY-BASEL, V81, P73, DOI 10.1159/000333265; Kudo M, 2010, ONCOLOGY-BASEL, V78, P87, DOI 10.1159/000315235; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee JH, 2012, BRIT J RADIOL, V85, pE573, DOI 10.1259/bjr/86767895; Lim JH, 2004, BRIT J RADIOL, V77, P911, DOI 10.1259/bjr/56713551; Ouedraogo W, 2011, J RADIOL, V92, P688, DOI 10.1016/j.jradio.2011.03.020; Pauleit D, 2002, RADIOLOGY, V222, P73, DOI 10.1148/radiol.2221001599; Pawlik TM, 2005, LIVER TRANSPLANT, V11, P1086, DOI 10.1002/lt.20472; Rampone B, 2009, WORLD J GASTROENTERO, V15, P3210, DOI 10.3748/wjg.15.3210; SCHUHMANNGIAMPIERI G, 1992, RADIOLOGY, V183, P59, DOI 10.1148/radiology.183.1.1549695; Szklaruk J, 2003, AM J ROENTGENOL, V180, P441, DOI 10.2214/ajr.180.2.1800441; Vogl TJ, 1996, RADIOLOGY, V200, P59, DOI 10.1148/radiology.200.1.8657946; WEINMANN HJ, 1991, MAGNET RESON MED, V22, P233, DOI 10.1002/mrm.1910220214; Willatt JM, 2008, RADIOLOGY, V247, P311, DOI 10.1148/radiol.2472061331; Yoon SH, 2009, AM J ROENTGENOL, V193, pW482, DOI 10.2214/AJR.08.1818	28	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e107869	10.1371/journal.pone.0107869	http://dx.doi.org/10.1371/journal.pone.0107869			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310817	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210300008
J	Prakash, KNB; Gopalan, V; Lee, SS; Velan, SS				Prakash, Bhanu K. N.; Gopalan, Venkatesh; Lee, Swee Shean; Velan, S. Sendhil			Quantification of Abdominal Fat Depots in Rats and Mice during Obesity and Weight Loss Interventions	PLOS ONE			English	Article							SUBCUTANEOUS ADIPOSE-TISSUE; VISCERAL FAT; INSULIN SENSITIVITY; SEGMENTATION; RESISTANCE; SOFTWARE; WATER; MRI	Background & Aims: Obesity is a leading healthcare issue contributing to metabolic diseases. There is a great interest in non-invasive approaches for quantitating abdominal fat in obese animals and humans. In this work, we propose an automated method to distinguish and quantify subcutaneous and visceral adipose tissues (SAT and VAT) in rodents during obesity and weight loss interventions. We have also investigated the influence of different magnetic resonance sequences and sources of variability in quantification of fat depots. Materials and Methods: High-fat diet fed rodents were utilized for investigating the changes during obesity, exercise, and calorie restriction interventions (N = 7/cohort). Imaging was performed on a 7T Bruker ClinScan scanner using fast spin echo (FSE) and Dixon imaging methods to estimate the fat depots. Finally, we quantified the SAT and VAT volumes between the L1-L5 lumbar vertebrae using the proposed automatic hybrid geodesic region-based curve evolution algorithm. Results: Significant changes in SAT and VAT volumes (p<0.01) were observed between the pre-and post-intervention measurements. The SAT and VAT were 44.22 +/- 9%, 21.06 +/- 1.35% for control, -17.33 +/- 3.07%, -15.09 +/- 1.11% for exercise, and 18.56 +/- 2.05%, -3.9 +/- 0.96% for calorie restriction cohorts, respectively. The fat quantification correlation between FSE (with and without water suppression) sequences and Dixon for SAT and VAT were 0.9709, 0.9803 and 0.9955, 0.9840 respectively. The algorithm significantly reduced the computation time from 100 sec/slice to 25 sec/slice. The preprocessing, data-derived contour placement and avoidance of strong background-image boundary improved the convergence accuracy of the proposed algorithm. Conclusions: We developed a fully automatic segmentation algorithm to quantitate SAT and VAT from abdominal images of rodents, which can support large cohort studies. We additionally identified the influence of non-algorithmic variables including cradle disturbance, animal positioning, and MR sequence on the fat quantification. There were no large variations between FSE and Dixon-based estimation of SAT and VAT.	[Prakash, Bhanu K. N.; Gopalan, Venkatesh; Lee, Swee Shean; Velan, S. Sendhil] Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Lab Mol Imaging, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC)	Velan, SS (corresponding author), Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Lab Mol Imaging, Singapore, Singapore.	Sendhil_Velan@sbic.a-star.edu.sg	KN, Bhanu Prakash/AAI-7884-2020; Velan, S. Sendhil/B-6374-2017	KN, Bhanu Prakash/0000-0002-7555-7431; Velan, S. Sendhil/0000-0002-4096-0722	Singapore Bioimaging Consortium, A*STAR, Singapore	Singapore Bioimaging Consortium, A*STAR, Singapore	This research was supported by the intramural funding from Singapore Bioimaging Consortium, A*STAR, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 1997, MED SCI SPORT EXER, V29, P1549, DOI 10.1097/00005768-199712000-00001; Armao D, 2006, J MAGN RESON IMAGING, V23, P736, DOI 10.1002/jmri.20551; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; Bonekamp S, 2008, INT J OBESITY, V32, P100, DOI 10.1038/sj.ijo.0803696; Caselles V, 1997, INT J COMPUT VISION, V22, P61, DOI 10.1023/A:1007979827043; Chae Y, 2007, 9 INT C E HLTH NETW, P252; Despres JP, 2012, CIRCULATION, V126, P1301, DOI 10.1161/CIRCULATIONAHA.111.067264; Elliott JM, 2013, BMC MED IMAGING, V13, DOI 10.1186/1471-2342-13-30; Farvid MS, 2005, DIABETES OBES METAB, V7, P406, DOI 10.1111/j.1463-1326.2004.00410.x; Garg A, 2004, J CLIN ENDOCR METAB, V89, P4206, DOI 10.1210/jc.2004-0631; Goodpaster BH, 1997, DIABETES, V46, P1579, DOI 10.2337/diabetes.46.10.1579; Hickey MS, 1997, AM J PHYSIOL-ENDOC M, V272, pE562, DOI 10.1152/ajpendo.1997.272.4.E562; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Klein S, 2004, J CLIN INVEST, V113, P1530, DOI 10.1172/JCI200422028; Koch G.G., 1982, ENCY STAT SCI, V4, P212, DOI DOI 10.1002/0471667196.ESS1275.PUB2; Kullberg J, 2007, INT J OBESITY, V31, P1806, DOI 10.1038/sj.ijo.0803671; Kullberg J, 2010, J MAGN RESON IMAGING, V32, P204, DOI 10.1002/jmri.22193; Lankton S, 2008, IEEE T IMAGE PROCESS, V17, P2029, DOI 10.1109/TIP.2008.2004611; Lankton S, 2007, PROC SPIE, V6510, DOI 10.1117/12.709700; Li Y, 2003, EXP BIOL MED, V228, P1118, DOI 10.1177/153537020322801004; OSHER S, 1988, J COMPUT PHYS, V79, P12, DOI 10.1016/0021-9991(88)90002-2; PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205; Ranefall P, 2009, J MAGN RESON IMAGING, V30, P554, DOI 10.1002/jmri.21874; Reeder SB, 2011, J MAGN RESON IMAGING, V34, P729, DOI 10.1002/jmri.22580; Shen W, 2004, AM J CLIN NUTR, V80, P271, DOI 10.1093/ajcn/80.2.271; Siegel MJ, 2007, RADIOLOGY, V242, P846, DOI 10.1148/radiol.2423060111; Tang Y, 2011, J MAGN RESON IMAGING, V34, P866, DOI 10.1002/jmri.22690; Thormer G, 2013, J MAGN RESON IMAGING, V37, P1144, DOI 10.1002/jmri.23890; Udupa JK, 1996, GRAPH MODEL IM PROC, V58, P246, DOI 10.1006/gmip.1996.0021; Wagenknecht LE, 2003, DIABETES, V52, P2490, DOI 10.2337/diabetes.52.10.2490; Wu HH, 2009, MAGN RESON MED, V61, P639, DOI 10.1002/mrm.21865; Yaligar J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091436	33	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e108979	10.1371/journal.pone.0108979	http://dx.doi.org/10.1371/journal.pone.0108979			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310298	gold, Green Published, Green Submitted			2022-12-27	WOS:000343210300028
J	Puechal, X; Genin, E; Bienvenu, T; Le Jeunne, C; Dusser, DJ				Puechal, Xavier; Genin, Emmanuelle; Bienvenu, Thierry; Le Jeunne, Claire; Dusser, Daniel J.			Poor Survival in Rheumatoid Arthritis Associated with Bronchiectasis: A Family-Based Cohort Study	PLOS ONE			English	Article							RESOLUTION COMPUTED-TOMOGRAPHY; CYSTIC FIBROSIS BRONCHIECTASIS; EXTRAARTICULAR DISEASE MANIFESTATIONS; RANDOMIZED CONTROLLED-TRIAL; LOW-DOSE ERYTHROMYCIN; DOUBLE-BLIND; MORTALITY; EXACERBATIONS; AZITHROMYCIN; RISK	Background: Diffuse bronchiectasis (DB) may occur in rheumatoid arthritis (RA). CFTR (cystic fibrosis transmembrane conductance regulator) mutations predispose RA patients to DB, but the prognosis of RA-associated DB (RA-DB) is unclear. Methods: We report long-term mortality data from a nationwide family-based association study of patients with RA only, DB only or RA-DB. We assessed mortality as a function of clinical characteristics and CF/CFTR-RD (CFTR-related disorders) mutations in 137 subjects from 24 kindreds. Potential risk factors were investigated by Cox proportional-hazard analysis with shared Gaussian random effects to account for within-family correlations. Results: During a median follow-up of 11 years after inclusion, 18 patients died, mostly from cardiorespiratory causes. Survival was significantly lower for RA-DB patients than for unaffected relatives and for patients with RA or DB only. RA patients with DB had also a poorer prognosis in terms of survival after RA diagnosis (HR, 8.6; 95% CI, 1.5-48.2; P = 0.014) and from birth (HR, 9.6; 95% CI, 1.1-81.7; P = 0.039). Early onset of DB (HR, 15.4; 95% CI, 2.1-113.2; P = 0.007) and CF/CFTR-RD mutation (HR, 7.2; 95% CI, 1.4-37.1; P = 0.018) were associated with poorer survival in patients with RA-DB. Thus, CF/CFTR-RD mutations in RA patients with early-onset DB defined a subgroup of high-risk patients with higher mortality rates (log-rank test P = 1.28 x 10(-5)). Conclusion: DB is associated with poorer survival in patients with RA. Early-onset DB and CFTR mutations are two markers that identify RA patients at a high risk of death, for whom future therapeutic interventions should be designed and evaluated.	[Puechal, Xavier; Le Jeunne, Claire] Univ Paris 05, Hop Cochin, AP HP, Natl Referral Ctr Rare System Autoimmune Dis,Dept, Paris, France; [Puechal, Xavier] Inst Cochin, INSERM U1016, CNRS UMR 8104, Paris, France; [Genin, Emmanuelle] CHU Brest, INSERM, UMR 1078, F-29285 Brest, France; [Bienvenu, Thierry] Univ Paris 05, Hop Cochin, AP HP, Biochem & Mol Biol Lab, Paris, France; [Dusser, Daniel J.] Univ Paris 05, Hop Cochin, AP HP, Dept Resp Dis, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Puechal, X (corresponding author), Univ Paris 05, Hop Cochin, AP HP, Natl Referral Ctr Rare System Autoimmune Dis,Dept, Paris, France.	xavier.puechal@cch.aphp.fr	Puéchal, Xavier/P-1555-2017; Genin, Emmanuelle/C-4974-2013	Puéchal, Xavier/0000-0003-3573-9203; Genin, Emmanuelle/0000-0003-4117-2813	Assistance Publique-Hopitaux de Paris (Contrat de Recherche et d'Innovation Clinique) [CRC98046]; Societe Francaise de Rhumatologie	Assistance Publique-Hopitaux de Paris (Contrat de Recherche et d'Innovation Clinique); Societe Francaise de Rhumatologie	This work was supported by grants from the Assistance Publique-Hopitaux de Paris (Contrat de Recherche et d'Innovation Clinique CRC98046) (to XP) and the Societe Francaise de Rhumatologie (to XP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenburg J, 2013, JAMA-J AM MED ASSOC, V309, P1251, DOI 10.1001/jama.2013.1937; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Bombieri C, 2011, J CYST FIBROS, V10, pS86, DOI 10.1016/S1569-1993(11)60014-3; Demoruelle MK, 2012, ARTHRITIS RHEUM-US, V64, P1756, DOI 10.1002/art.34344; Elborn JS, 2013, JAMA-J AM MED ASSOC, V309, P1295, DOI 10.1001/jama.2013.2780; ERHARDT CC, 1989, ANN RHEUM DIS, V48, P7, DOI 10.1136/ard.48.1.7; FEWINS HE, 1991, BRIT J RHEUMATOL, V30, P214; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; FOSTER CS, 1984, OPHTHALMOLOGY, V91, P1253; Gabriel SE, 2003, ARTHRITIS RHEUM-US, V48, P54, DOI 10.1002/art.10705; HASSAN WU, 1995, ANN RHEUM DIS, V54, P308, DOI 10.1136/ard.54.4.308; Jacobsson LTH, 2007, ANN RHEUM DIS, V66, P670, DOI 10.1136/ard.2006.062497; Knowles MR, 2002, NEW ENGL J MED, V347, P439, DOI 10.1056/NEJMe020070; Koh YY, 1997, EUR RESPIR J, V10, P994, DOI 10.1183/09031936.97.10050994; MATHIEU JP, 1978, BRIT J DIS CHEST, V72, P57, DOI 10.1016/0007-0971(78)90007-4; MCDONAGH J, 1994, BRIT J RHEUMATOL, V33, P118; McKone EF, 2003, LANCET, V361, P1671, DOI 10.1016/S0140-6736(03)13368-5; MCMAHON MJ, 1993, ANN RHEUM DIS, V52, P776, DOI 10.1136/ard.52.11.776; Ogrendik M, 2007, CURR MED RES OPIN, V23, P515, DOI 10.1185/030079906X167642; Ogrendik M, 2011, POSTGRAD MED, V123, P220, DOI 10.3810/pgm.2011.09.2478; Pasteur MC, 2000, AM J RESP CRIT CARE, V162, P1277, DOI 10.1164/ajrccm.162.4.9906120; Perez T, 1998, AM J RESP CRIT CARE, V157, P1658, DOI 10.1164/ajrccm.157.5.9710018; Puechal X, 1998, Rev Rhum Engl Ed, V65, P447; Puechal X, 1999, EUR RESPIR J, V13, P1281, DOI 10.1183/09031936.99.13612889; Puechal X, 2011, ANN RHEUM DIS, V70, P653, DOI 10.1136/ard.2010.142760; R Core Team, 2012, R LANG ENV STAT COMP; Reynisdottir G, 2014, ARTHRITIS RHEUMATOL, V66, P31, DOI 10.1002/art.38201; Serisier DJ, 2013, JAMA-J AM MED ASSOC, V309, P1260, DOI 10.1001/jama.2013.2290; SHADICK NA, 1994, MEDICINE, V73, P161, DOI 10.1097/00005792-199405000-00005; SOLANKI T, 1992, BRIT J RHEUMATOL, V31, P691; Swinson DR, 1997, BRIT J RHEUMATOL, V36, P689; Therneau T, 2012, COXME MIXED EFFECTS; Therneau T. M, 2015, SURVIVAL SURVIVAL AN; Tsang KWT, 1999, EUR RESPIR J, V13, P361, DOI 10.1183/09031936.99.13236199; Turesson C, 1999, RHEUMATOLOGY, V38, P668, DOI 10.1093/rheumatology/38.7.668; Turesson C, 2002, J RHEUMATOL, V29, P62; Turesson C, 2007, ANN RHEUM DIS, V66, P70, DOI 10.1136/ard.2006.052506; Vergnenegre A, 1997, EUR RESPIR J, V10, P1072, DOI 10.1183/09031936.97.10051072; Wilson R, 2012, LANCET, V380, P627, DOI 10.1016/S0140-6736(12)61261-6; Wong C, 2012, LANCET, V380, P660, DOI 10.1016/S0140-6736(12)60953-2; Zrour SH, 2005, JOINT BONE SPINE, V72, P41, DOI 10.1016/j.jbspin.2004.02.001	41	21	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110066	10.1371/journal.pone.0110066	http://dx.doi.org/10.1371/journal.pone.0110066			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310716	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210300087
J	Williams, O; Del Genio, CI				Williams, Oliver; Del Genio, Charo I.			Degree Correlations in Directed Scale-Free Networks	PLOS ONE			English	Article							COMPLEX NETWORKS	Scale-free networks, in which the distribution of the degrees obeys a power-law, are ubiquitous in the study of complex systems. One basic network property that relates to the structure of the links found is the degree assortativity, which is a measure of the correlation between the degrees of the nodes at the end of the links. Degree correlations are known to affect both the structure of a network and the dynamics of the processes supported thereon, including the resilience to damage, the spread of information and epidemics, and the efficiency of defence mechanisms. Nonetheless, while many studies focus on undirected scale-free networks, the interactions in real-world systems often have a directionality. Here, we investigate the dependence of the degree correlations on the power-law exponents in directed scale-free networks. To perform our study, we consider the problem of building directed networks with a prescribed degree distribution, providing a method for proper generation of power-law-distributed directed degree sequences. Applying this new method, we perform extensive numerical simulations, generating ensembles of directed scale-free networks with exponents between 2 and 3, and measuring ensemble averages of the Pearson correlation coefficients. Our results show that scale-free networks are on average uncorrelated across directed links for three of the four possible degree-degree correlations, namely in-degree to in-degree, in-degree to out-degree, and out-degree to out-degree. However, they exhibit anticorrelation between the number of outgoing connections and the number of incoming ones. The findings are consistent with an entropic origin for the observed disassortativity in biological and technological networks.	[Williams, Oliver] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Del Genio, Charo I.] Univ Warwick, Warwick Math Inst, Coventry CV4 7AL, W Midlands, England; [Del Genio, Charo I.] Univ Warwick, Ctr Complex Sci, Coventry CV4 7AL, W Midlands, England; [Del Genio, Charo I.] Univ Warwick, Warwick Infect Dis Epidemiol Res WIDER Ctr, Coventry CV4 7AL, W Midlands, England	University of Warwick; University of Warwick; University of Warwick; University of Warwick	Del Genio, CI (corresponding author), Univ Warwick, Warwick Math Inst, Coventry CV4 7AL, W Midlands, England.	C.I.del-Genio@warwick.ac.uk	del Genio, Charo I/F-7249-2010	del Genio, Charo I/0000-0001-9958-017X	URSS (Undergraduate Research Support Scheme) of the University of Warwick; EINS, Network of Excellence in Internet Science, via European Commission's FP7 under Communications Networks, Content and Technologies [288021]	URSS (Undergraduate Research Support Scheme) of the University of Warwick; EINS, Network of Excellence in Internet Science, via European Commission's FP7 under Communications Networks, Content and Technologies	OW acknowledges support by the URSS (Undergraduate Research Support Scheme) of the University of Warwick. CIDG acknowledges support by EINS, Network of Excellence in Internet Science, via the European Commission's FP7 under Communications Networks, Content and Technologies, grant No. 288021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boccaletti S., 2014, PHYS REP IN PRESS; Boguna M, 2004, EUR PHYS J B, V38, P205, DOI 10.1140/epjb/e2004-00038-8; Caldarelli G., 2007, SCALE FREE NETWORKS; Catanzaro M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.027103; D'Agostino G, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/68006; Del Genio CI, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.040801; Del Genio CI, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.178701; Del Genio CI, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010012, 10.1371/journal.pone.0015369]; Drossel B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026102; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Foster JG, 2010, P NATL ACAD SCI USA, V107, P10815, DOI 10.1073/pnas.0912671107; Fulkerson Delbert R., 1960, PAC J MATH, V10, P831, DOI DOI 10.2140/PJM.1960.10.831; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Johnson S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.108702; Kim H, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/2/023012; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Litvak N, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.022801; Maslov S, 2004, PHYSICA A, V333, P529, DOI 10.1016/j.physa.2003.06.002; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Moller M, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.052106; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Park J, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026112; PRICE DJD, 1965, SCIENCE, V149, P510; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; Squartini T, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/8/083001; Teller S, 2014, PLOS COMP B IN PRESS; Toroczkai Z, 2004, NATURE, V428, P716, DOI 10.1038/428716a; Toroczkai Z, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/15/155103; van der Hoorn P, 2013, ARXIV13106528; Vazquez A, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066130; Youssef M, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.052810	39	35	35	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110121	10.1371/journal.pone.0110121	http://dx.doi.org/10.1371/journal.pone.0110121			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310101	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210300090
J	Besser, TE; Cassirer, EF; Potter, KA; Lahmers, K; Oaks, JL; Shanthalingam, S; Srikumaran, S; Foreyt, WJ				Besser, Thomas E.; Cassirer, E. Frances; Potter, Kathleen A.; Lahmers, Kevin; Oaks, J. Lindsay; Shanthalingam, Sudarvili; Srikumaran, Subramaniam; Foreyt, William J.			Epizootic Pneumonia of Bighorn Sheep following Experimental Exposure to Mycoplasma ovipneumoniae	PLOS ONE			English	Article							OVIS-CANADENSIS; PASTEURELLA-HAEMOLYTICA; MANNHEIMIA-HAEMOLYTICA; DOMESTIC SHEEP; RESPIRATORY-DISEASE; MICROORGANISMS; IDENTIFICATION; TRANSMISSION; ANTIBODIES; VACCINE	Background: Bronchopneumonia is a population limiting disease of bighorn sheep (Ovis canadensis). The cause of this disease has been a subject of debate. Leukotoxin expressing Mannheimia haemolytica and Bibersteinia trehalosi produce acute pneumonia after experimental challenge but are infrequently isolated from animals in natural outbreaks. Mycoplasma ovipneumoniae, epidemiologically implicated in naturally occurring outbreaks, has received little experimental evaluation as a primary agent of bighorn sheep pneumonia. Methodology/Principal Findings: In two experiments, bighorn sheep housed in multiple pens 7.6 to 12 m apart were exposed to M. ovipneumoniae by introduction of a single infected or challenged animal to a single pen. Respiratory disease was monitored by observation of clinical signs and confirmed by necropsy. Bacterial involvement in the pneumonic lungs was evaluated by conventional aerobic bacteriology and by culture-independent methods. In both experiments the challenge strain of M. ovipneumoniae was transmitted to all animals both within and between pens and all infected bighorn sheep developed bronchopneumonia. In six bighorn sheep in which the disease was allowed to run its course, three died with bronchopneumonia 34, 65, and 109 days after M. ovipneumoniae introduction. Diverse bacterial populations, predominantly including multiple obligate anaerobic species, were present in pneumonic lung tissues at necropsy. Conclusions/Significance:Exposure to a single M. ovipneumoniae infected animal resulted in transmission of infection to all bighorn sheep both within the pen and in adjacent pens, and all infected sheep developed bronchopneumonia. The epidemiologic, pathologic and microbiologic findings in these experimental animals resembled those seen in naturally occurring pneumonia outbreaks in free ranging bighorn sheep.	[Besser, Thomas E.; Potter, Kathleen A.; Lahmers, Kevin; Oaks, J. Lindsay; Shanthalingam, Sudarvili; Srikumaran, Subramaniam; Foreyt, William J.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Besser, Thomas E.; Potter, Kathleen A.; Oaks, J. Lindsay] Washington State Univ, Washington Anim Dis Diagnost Lab, Pullman, WA 99164 USA; [Cassirer, E. Frances] Idaho Dept Fish & Game, Lewiston, ID USA	Washington State University; Washington State University	Besser, TE (corresponding author), Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.	tbesser@vetmed.wsu.edu	Lahmers, Kevin/E-8272-2017	Lahmers, Kevin/0000-0002-5290-3426	Wyoming Wildlife/Livestock Disease Partnership; Washington Department of Fish and Wildlife; Idaho Domestic Wildlife Research Oversight Committee; Oregon chapter of the Foundation for North American Wild Sheep	Wyoming Wildlife/Livestock Disease Partnership; Washington Department of Fish and Wildlife; Idaho Domestic Wildlife Research Oversight Committee; Oregon chapter of the Foundation for North American Wild Sheep	These studies were funded by grants from the Wyoming Wildlife/Livestock Disease Partnership (T. E. Besser, S. Srikumaran), the Washington Department of Fish and Wildlife (T. E. Besser), the Idaho Domestic Wildlife Research Oversight Committee (E. F. Cassirer), and the Oregon chapter of the Foundation for North American Wild Sheep (T. E. Besser) or the grant support that made these studies possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley MR, 1999, NEW ZEAL VET J, V47, P155, DOI 10.1080/00480169.1999.36135; Besser TE, 2008, J CLIN MICROBIOL, V46, P423, DOI 10.1128/JCM.01931-07; Besser TE, 2013, PREV VET MED, V108, P85, DOI 10.1016/j.prevetmed.2012.11.018; Besser TE, 2012, EMERG INFECT DIS, V18, P406, DOI 10.3201/eid1803.111554; Besser TE, 2012, J WILDLIFE DIS, V48, P168, DOI 10.7589/0090-3558-48.1.168; Blodgett R, 2010, BACTERIOLOGIC ANAL M; Buechner H. K., 1960, Wildlife Monographs.; Cassirer EF, 2013, J ANIM ECOL, V82, P518, DOI 10.1111/1365-2656.12031; Dassanayake RP, 2010, VET MICROBIOL, V145, P354, DOI 10.1016/j.vetmic.2010.04.011; Dassanayake RP, 2010, APPL ENVIRON MICROB, V76, P1008, DOI 10.1128/AEM.02086-09; Dassanayake RP, 2009, VET MICROBIOL, V133, P366, DOI 10.1016/j.vetmic.2008.07.015; DEMARTINI JC, 1977, J WILDLIFE DIS, V13, P117, DOI 10.7589/0090-3558-13.2.117; Desrosiers Robert, 2011, Animal Health Research Reviews, V12, P1, DOI 10.1017/S1466252310000204; Festa-Bianchet M, 2008, OVIS CANADENSIS; Fisher MA, 1999, AM J VET RES, V60, P1402; Foreyt WJ, 2009, J WILDLIFE DIS, V45, P272, DOI 10.7589/0090-3558-45.2.272; Foreyt WJ, 1996, J WILDLIFE DIS, V32, P594, DOI 10.7589/0090-3558-32.4.594; FOREYT WJ, 1994, J WILDLIFE DIS, V30, P137, DOI 10.7589/0090-3558-30.2.137; Forrester D. J., 1971, pUnpaginated; GENTRY MJ, 1991, MICROB PATHOGENESIS, V10, P411, DOI 10.1016/0882-4010(91)90086-P; Herrmann LM, 2003, CLIN DIAGN LAB IMMUN, V10, P862, DOI 10.1128/CDLI.10.5.862-865.2003; Kraabel BJ, 1998, J WILDLIFE DIS, V34, P325, DOI 10.7589/0090-3558-34.2.325; Lawrence PK, 2010, J WILDLIFE DIS, V46, P706, DOI 10.7589/0090-3558-46.3.706; MARSH HADLEIGH, 1938, JOUR MAMMAL, V19, P214, DOI 10.2307/1374617; McAuliffe L, 2003, VET REC, V153, P687, DOI 10.1136/vr.153.22.687; Miller MW, 2001, INFECT DIS WILD MAMM, P558; ONDERKA DK, 1988, CAN J VET RES, V52, P439; Petti CA, 2007, CLIN INFECT DIS, V44, P1108, DOI 10.1086/512818; ROSSI CR, 1971, APPL MICROBIOL, V22, P32, DOI 10.1128/AEM.22.1.32-36.1971; Rudolph KM, 2007, J ZOO WILDLIFE MED, V38, P548, DOI 10.1638/2006-0027R.1; Rudolph KM, 2003, J WILDLIFE DIS, V39, P897, DOI 10.7589/0090-3558-39.4.897; Shanthalingam S, 2014, J WILDLIFE DIS, V50, P1, DOI 10.7589/2012-09-225; Subramaniam R, 2011, CLIN VACCINE IMMUNOL, V18, P1689, DOI 10.1128/CVI.05276-11; Townsend KM, 1998, J CLIN MICROBIOL, V36, P1096, DOI 10.1128/JCM.36.4.1096-1100.1998; Weiser GC, 2003, J WILDLIFE DIS, V39, P536, DOI 10.7589/0090-3558-39.3.536; Ziegler JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095698	36	30	33	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110039	10.1371/journal.pone.0110039	http://dx.doi.org/10.1371/journal.pone.0110039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302992	gold, Green Published			2022-12-27	WOS:000343730400104
J	Friedrich, DC; Genro, JP; Sortica, VA; Suarez-Kurtz, G; de Moraes, ME; Pena, SDJ; dos Santos, AKR; Romano-Silva, MA; Hutz, MH				Friedrich, Deise C.; Genro, Julia P.; Sortica, Vinicius A.; Suarez-Kurtz, Guilherme; de Moraes, Maria Elizabete; Pena, Sergio D. J.; Ribeiro dos Santos, Andrea K.; Romano-Silva, Marco A.; Hutz, Mara H.			Distribution of CYP2D6 Alleles and Phenotypes in the Brazilian Population	PLOS ONE			English	Article							XENOBIOTIC-METABOLIZING ENZYMES; HUMAN CYTOCHROME-P450 2D6; HAPLOTYPE RECONSTRUCTION; INTERETHNIC DIFFERENCES; GENETIC POLYMORPHISMS; CODEINE THERAPY; PHARMACOGENETICS; DIVERSITY; GENOTYPE; IMPACT	The CYP2D6 enzyme is one of the most important members of the cytochrome P450 superfamily. This enzyme metabolizes approximately 25% of currently prescribed medications. The CYP2D6 gene presents a high allele heterogeneity that determines great inter-individual variation. The aim of this study was to evaluate the variability of CYP2D6 alleles, genotypes and predicted phenotypes in Brazilians. Eleven single nucleotide polymorphisms and CYP2D6 duplications/multiplications were genotyped by TaqMan assays in 1020 individuals from North, Northeast, South, and Southeast Brazil. Eighteen CYP2D6 alleles were identified in the Brazilian population. The CYP2D6*1 and CYP2D6*2 alleles were the most frequent and widely distributed in different geographical regions of Brazil. The highest number of CYPD6 alleles observed was six and the frequency of individuals with more than two copies ranged from 6.3% (in Southern Brazil) to 10.2% (Northern Brazil). The analysis of molecular variance showed that CYP2D6 is homogeneously distributed across different Brazilian regions and most of the differences can be attributed to inter-individual differences. The most frequent predicted metabolic status was EM (83.5%). Overall 2.5% and 3.7% of Brazilians were PMs and UMs respectively. Genomic ancestry proportions differ only in the prevalence of intermediate metabolizers. The IM predicted phenotype is associated with a higher proportion of African ancestry and a lower proportion of European ancestry in Brazilians. PM and UM classes did not vary among regions and/or ancestry proportions therefore unique CYP2D6 testing guidelines for Brazilians are possible and could potentially avoid ineffective or adverse events outcomes due to drug prescriptions.	[Friedrich, Deise C.; Genro, Julia P.; Sortica, Vinicius A.; Hutz, Mara H.] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil; [Suarez-Kurtz, Guilherme] Inst Nacl Canc, Programa Farmacol, Rio De Janeiro, RJ, Brazil; [de Moraes, Maria Elizabete] Univ Fed Ceara, Dept Fisiol & Farmacol, Fortaleza, Ceara, Brazil; [Pena, Sergio D. J.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Ribeiro dos Santos, Andrea K.] Fed Univ Para, Lab Genet Humana & Med, BR-66059 Belem, Para, Brazil; [Romano-Silva, Marco A.] Univ Fed Minas Gerais, Inst Nacl Ciencia & Tecnol Med Mol, Belo Horizonte, MG, Brazil	Universidade Federal do Rio Grande do Sul; National Cancer Institute (Inca); Universidade Federal do Ceara; Universidade Federal de Minas Gerais; Universidade Federal do Para; Universidade Federal de Minas Gerais	Hutz, MH (corresponding author), Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil.	mara.hutz@ufrgs.br	Sortica, Vinicius A/G-5772-2017; Ribeiro dos Santos, Ândrea Kely Campos/W-6339-2019; Romano-Silva, Marco Aurelio/A-1790-2008; Santos, Ândrea Ribeiro dos/B-6061-2013; Hutz, Mara H/I-4070-2012; Romano-Silva, Marco Aurelio/T-8321-2019; Suarez-Kurtz, Guilherme/P-4620-2019; Genro, Julia/J-4795-2015; Suarez-Kurtz, Guilherme/J-6648-2012; Friedrich, Deise/F-5790-2017	Sortica, Vinicius A/0000-0001-6185-0832; Ribeiro dos Santos, Ândrea Kely Campos/0000-0001-7001-1483; Romano-Silva, Marco Aurelio/0000-0002-6558-4639; Santos, Ândrea Ribeiro dos/0000-0001-7001-1483; Suarez-Kurtz, Guilherme/0000-0002-1115-8319; Suarez-Kurtz, Guilherme/0000-0002-1115-8319; Friedrich, Deise/0000-0002-4613-5301; Hutz, Mara/0000-0002-9146-1229	Financiadora de Estudos e Projetos (Finep); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Financiadora de Estudos e Projetos (Finep)(Financiadora de Inovacao e Pesquisa (Finep)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by grants from Financiadora de Estudos e Projetos (Finep) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1; AGUNDEZ JAG, 1995, CLIN PHARMACOL THER, V57, P265, DOI 10.1016/0009-9236(95)90151-5; Aklillu E, 1996, J PHARMACOL EXP THER, V278, P441; [Anonymous], 2014, R LANG ENV STAT COMP; Antunes MV, 2012, THER DRUG MONIT, V34, P422, DOI 10.1097/FTD.0b013e318260b46e; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernal ML, 1999, PHARMACOGENETICS, V9, P657, DOI 10.1097/00008571-199910000-00013; Bernard S, 2006, ONCOLOGIST, V11, P126, DOI 10.1634/theoncologist.11-2-126; Bradford LD, 2002, PHARMACOGENOMICS, V3, P229, DOI 10.1517/14622416.3.2.229; Callegari-Jacques SM, 2003, AM J HUM BIOL, V15, P824, DOI 10.1002/ajhb.10217; Crews KR, 2014, CLIN PHARMACOL THER, V95, P376, DOI 10.1038/clpt.2013.254; Crews KR, 2012, CLIN PHARMACOL THER, V91, P321, DOI 10.1038/clpt.2011.287; de Leon J, 2008, CLIN LAB MED, V28, P599, DOI 10.1016/j.cll.2008.05.003; Eichelbaum M, 2006, ANNU REV MED, V57, P119, DOI 10.1146/annurev.med.56.082103.104724; Estrela RCE, 2008, PHARMACOGENOMICS, V9, P267, DOI 10.2217/14622416.9.3.267; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fang H, 2014, PHARMACOGENOMICS J; Gaedigk A, 2013, INT REV PSYCHIATR, V25, P534, DOI 10.3109/09540261.2013.825581; Gaedigk A, 2012, PHARMACOGENOMICS, V13, P91, DOI [10.2217/PGS.11.135, 10.2217/pgs.11.135]; Herbild L, 2013, BASIC CLIN PHARMACOL, V113, P266, DOI 10.1111/bcpt.12093; Hicks JK, CLIN PHARM THER, V93, P402; Ingelman-Sundberg M, 2005, PHARMACOGENOMICS J, V5, P6, DOI 10.1038/sj.tpj.6500285; Ingelman-Sundberg M, 2005, PHILOS T R SOC B, V360, P1563, DOI 10.1098/rstb.2005.1685; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; KIMURA S, 1989, AM J HUM GENET, V45, P889; Kirchheiner J, 2004, MOL PSYCHIATR, V9, P442, DOI 10.1038/sj.mp.4001494; Kohlrausch FB, 2008, PHARMACOGENET GENOM, V18, P599, DOI 10.1097/FPC.0b013e328301a763; Kohlrausch FB, 2009, PHARMACOGENOMICS, V10, P1457, DOI 10.2217/PGS.09.76; Kurose K, 2012, DRUG METAB PHARMACOK, V27, P9, DOI 10.2133/dmpk.DMPK-11-RV-111; Leite FPN, 2008, AM J HUM BIOL, V20, P359, DOI 10.1002/ajhb.20702; Leite FPN, 2009, AM J PHYS ANTHROPOL, V139, P404, DOI 10.1002/ajpa.20998; Lazalde-Ramos BP, 2014, PHARMACOGENOMICS, V15, P339, DOI 10.2217/pgs.13.203; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Ramamoorthy A, 2011, PHARMACOGENOMICS, V12, P299, DOI [10.2217/PGS.11.5, 10.2217/pgs.11.5]; Salzano FM, 2002, EVOLUTION GENETICS L; Schaeffeler E, 2003, HUM MUTAT, V22, P476, DOI 10.1002/humu.10280; Silveira VD, 2009, LEUKEMIA RES, V33, P898, DOI 10.1016/j.leukres.2008.12.006; Silveira VD, 2009, BIOMARKERS, V14, P111, DOI 10.1080/13547500902767294; Sistonen J, 2007, PHARMACOGENET GENOM, V17, P93; Sortica VD, 2012, BASIC CLIN PHARMACOL, V110, P460, DOI 10.1111/j.1742-7843.2011.00838.x; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Suarez-Kurtz G, 2007, PHARMACOGENOMICS, V8, P1299, DOI 10.2217/14622416.8.10.1299; Suarez-Kurtz G, 2014, PHARMACOGENOMICS, V15, P209, DOI 10.2217/pgs.13.238; Suarez-Kurtz G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083472; Suarez-Kurtz G, 2012, PHARMACOGENOMICS, V13, P771, DOI [10.2217/pgs.12.39, 10.2217/PGS.12.39]; Suarez-Kurtz G, 2010, PHARMACOGENOMICS, V11, P1257, DOI [10.2217/pgs.10.89, 10.2217/PGS.10.89]; Teh LK, 2012, DRUG METAB PHARMACOK, V27, P55, DOI 10.2133/dmpk.DMPK-11-RV-121; The Pharmacogenomics Knowledge Base (PharmGKB), CYP2D6 ALL FREQ; Vargens DD, 2008, EUR J CLIN PHARMACOL, V64, P253, DOI 10.1007/s00228-007-0413-2; Weir B, 1996, ETIC DATA ANAL; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zanger UM, 2004, N-S ARCH PHARMACOL, V369, P23, DOI 10.1007/s00210-003-0832-2; Zembrzuski VM, 2006, ANN HUM GENET, V70, P822, DOI 10.1111/j.1469-1809.2006.00270.x; Zhou SF, 2009, CLIN PHARMACOKINET, V48, P761, DOI 10.2165/11318070-000000000-00000; Zhou SF, 2009, CLIN PHARMACOKINET, V48, P689, DOI 10.2165/11318030-000000000-00000	57	37	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110691	10.1371/journal.pone.0110691	http://dx.doi.org/10.1371/journal.pone.0110691			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329392	Green Submitted, Green Published, gold			2022-12-27	WOS:000343942100085
J	Haastrup, E; Grau, K; Eugen-Olsen, J; Thorball, C; Kessing, LV; Ullum, H				Haastrup, Eva; Grau, Katrine; Eugen-Olsen, Jesper; Thorball, Christian; Kessing, Lars Vedel; Ullum, Henrik			Soluble Urokinase Plasminogen Activator Receptor as a Marker for Use of Antidepressants	PLOS ONE			English	Article							C-REACTIVE PROTEIN; DEPRESSIVE SYMPTOMS; REFERENCE INTERVALS; CANCER-PATIENTS; CYTOKINES; HEALTH; INFLAMMATION; ASSOCIATION; STRESS; ADULTS	Objectives: Inflammation is involved in the pathogenesis of depression. A few cross-sectional population-based studies have found that depression is associated with increased levels of inflammatory markers. Soluble urokinase plasminogen activation receptor (suPAR) is known to be a stable marker for inflammation. We investigated the bidirectional association between suPAR levels and use of antidepressants. Methods: suPAR level was measured in 9305 blood donors and analysed in relation to 5-years follow-up data on purchase of antidepressants and hospital diagnoses of depression from a nationwide Danish register. Results: For men and women without prior use of antidepressants we found a significantly higher risk for incident use of antidepressants with higher suPAR values. For men, the risk of first use of antidepressants increased by 72% from the 1st to the 4th quartile (HR = 1.72, 95% CI: 1.11-2.69). For women, it increased by 108% from the 1st to the 4th quartile (HR = 2.08, 95% CI: 1.45-2.98). Previous use of antidepressants was also significantly associated with higher suPAR levels (p = 0.002). Conclusions: High suPAR levels are associated with an increased risk for both previous and future use of antidepressants in healthy men and women. High suPAR are also associated with increased risk for a hospital diagnosis of depression.	[Haastrup, Eva; Ullum, Henrik] Univ Copenhagen Hosp, Rigshosp, Dept Clin Immunol, Blood Bank, DK-2100 Copenhagen, Denmark; [Grau, Katrine] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Eugen-Olsen, Jesper; Thorball, Christian] Univ Copenhagen Hosp, Hvidovre Hosp, Clin Res Ctr, DK-2100 Copenhagen, Denmark; [Kessing, Lars Vedel] Univ Copenhagen Hosp, Rigshosp, Ctr Psychiat, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Statens Serum Institut; University of Copenhagen; Rigshospitalet; University of Copenhagen	Haastrup, E (corresponding author), Univ Copenhagen Hosp, Rigshosp, Dept Clin Immunol, Blood Bank, DK-2100 Copenhagen, Denmark.	eva.haastrup@rh.regionh.dk	Stevens, David/F-4683-2015	Kessing, Lars/0000-0001-9377-9436; Ullum, Henrik/0000-0001-7306-9058; Eugen-Olsen, Jesper/0000-0002-4630-4275; Thorball, Christian Wandall/0000-0002-6869-6943				Andersen AB, 2006, NEUROIMMUNOMODULAT, V13, P69, DOI 10.1159/000095222; Andersen O, 2008, J MED VIROL, V80, P209, DOI 10.1002/jmv.21114; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Anisman H, 2002, BRAIN BEHAV IMMUN, V16, P513, DOI 10.1016/S0889-1591(02)00009-0; Anisman H, 1999, ADV EXP MED BIOL, V461, P199; Backes Y, 2012, INTENS CARE MED, V38, P1418, DOI 10.1007/s00134-012-2613-1; Cinque P, 2004, ANN NEUROL, V55, P687, DOI 10.1002/ana.20076; Cunningham O, 2009, GLIA, V57, P1802, DOI 10.1002/glia.20892; Danner M, 2003, PSYCHOSOM MED, V65, P347, DOI 10.1097/01.PSY.0000041542.29808.01; Dantzer R, 2004, EUR J PHARMACOL, V500, P399, DOI 10.1016/j.ejphar.2004.07.040; Dantzer R, 1998, ANN NY ACAD SCI, V840, P586, DOI 10.1111/j.1749-6632.1998.tb09597.x; Deininger MH, 2002, NEUROSCI LETT, V324, P80, DOI 10.1016/S0304-3940(02)00168-4; Deverts DJ, 2010, PSYCHOSOM MED, V72, P734, DOI 10.1097/PSY.0b013e3181ec4b98; Edgren G, 2007, TRANSFUSION, V47, P2017, DOI 10.1111/j.1537-2995.2007.01425.x; Elovainio M, 2009, PSYCHOSOM MED, V71, P423, DOI 10.1097/PSY.0b013e31819e333a; Eugen-Olsen J, 2010, J INTERN MED, V268, P296, DOI 10.1111/j.1365-2796.2010.02252.x; Fauser S, 2000, J NEUROIMMUNOL, V111, P234, DOI 10.1016/S0165-5728(00)00368-4; Florquin S, 2001, KIDNEY INT, V59, P2054, DOI 10.1046/j.1523-1755.2001.00719.x; Ford DE, 2004, ARCH INTERN MED, V164, P1010, DOI 10.1001/archinte.164.9.1010; Gariepy G, 2010, OBESITY, V18, P1033, DOI 10.1038/oby.2009.333; Gveric D, 2001, BRAIN, V124, P1978, DOI 10.1093/brain/124.10.1978; Kessing LV, 2008, INT CLIN PSYCHOPHARM, V23, P54, DOI 10.1097/YIC.0b013e3282f1c200; Kessing LV, 2007, INT PSYCHOGERIATR, V19, P902, DOI 10.1017/S1041610206004376; Langkilde AA, 2011, CANCER EPIDEM BIOMAR; Langkilde A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051698; Lyngbaek S, 2012, INT J CARDIOL; Macy EM, 1997, CLIN CHEM, V43, P52; MAES M, 1995, J AFFECT DISORDERS, V34, P301, DOI 10.1016/0165-0327(95)00028-L; Maes M, 2008, NEUROENDOCRINOL LETT, V29, P287; Manderbacka K, 2010, PHARMACOEPIDEMIOL DR; Matthews KA, 2007, PSYCHOSOM MED, V69, P124, DOI 10.1097/01.psy.0000256574.30389.1b; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Miller GE, 2003, BRAIN BEHAV IMMUN, V17, P276, DOI 10.1016/S0889-1591(03)00057-6; Musselman DL, 2001, AM J PSYCHIAT, V158, P1252, DOI 10.1176/appi.ajp.158.8.1252; Musselman DL, 2000, PROG BRAIN RES, V122, P43; Nielsen NO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080686; Ockene IS, 2001, CLIN CHEM, V47, P444; Ostrowski SR, 2005, JAIDS-J ACQ IMM DEF, V39, P23, DOI 10.1097/01.qai.0000157950.02076.a6; Pasco JA, 2010, BRIT J PSYCHIAT, V197, P372, DOI 10.1192/bjp.bp.109.076430; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Raison CL, 2003, BIOL PSYCHIAT, V54, P283, DOI 10.1016/S0006-3223(03)00413-X; Sennels HP, 2007, SCAND J CLIN LAB INV, V67, P821, DOI 10.1080/00365510701432509; Sier CFM, 1999, LAB INVEST, V79, P717; SMITH RS, 1991, MED HYPOTHESES, V35, P298, DOI 10.1016/0306-9877(91)90272-Z; The Danish State Serum Institute S, 2014, MED PROD STAT; Thielen K, 2009, ACTA PSYCHIAT SCAND, V119, P312, DOI 10.1111/j.1600-0447.2008.01282.x; Tuomainen TP, 1997, BRIT MED J, V314, P793, DOI 10.1136/bmj.314.7083.793; Walker DG, 2002, BRAIN RES, V926, P69, DOI 10.1016/S0006-8993(01)03298-X	48	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110555	10.1371/journal.pone.0110555	http://dx.doi.org/10.1371/journal.pone.0110555			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329298	Green Submitted, gold, Green Published			2022-12-27	WOS:000343942100072
J	Ramaioli, C; Colagiorgio, P; Saglam, M; Heuser, F; Schneider, E; Ramat, S; Lehnen, N				Ramaioli, Cecilia; Colagiorgio, Paolo; Saglam, Murat; Heuser, Fabian; Schneider, Erich; Ramat, Stefano; Lehnen, Nadine			The Effect of Vestibulo-Ocular Reflex Deficits and Covert Saccades on Dynamic Vision in Opioid-Induced Vestibular Dysfunction	PLOS ONE			English	Article							3-DIMENSIONAL VECTOR ANALYSIS; ACCELERATION HEAD ROTATIONS; VISUAL-ACUITY; IMPULSE TEST; RESPONSES; MOVEMENTS; SURGERY; WALKING; MOTION	Patients with bilateral vestibular dysfunction cannot fully compensate passive head rotations with eye movements, and experience disturbing oscillopsia. To compensate for the deficient vestibulo-ocular reflex (VOR), they have to rely on refixation saccades. Some can trigger "covert'' saccades while the head still moves; others only initiate saccades afterwards. Due to their shorter latency, it has been hypothesized that covert saccades are particularly beneficial to improve dynamic visual acuity, reducing oscillopsia. Here, we investigate the combined effect of covert saccades and the VOR on clear vision, using the Head Impulse Testing Device - Functional Test (HITD-FT), which quantifies reading ability during passive high-acceleration head movements. To reversibly decrease VOR function, fourteen healthy men (median age 26 years, range 2131) were continuously administrated the opioid remifentanil intravenously (0.15 mu g/kg/min). VOR gain was assessed with the video head-impulse test, functional performance (i.e. reading) with the HITD-FT. Before opioid application, VOR and dynamic reading were intact (head-impulse gain: 0.87 +/- 0.08, mean +/- SD; HITD-FT rate of correct answers: 90 +/- 9%). Remifentanil induced impairment in dynamic reading (HITD-FT 26 +/- 15%) in 12/14 subjects, with transient bilateral vestibular dysfunction (head-impulse gain 0.63 +/- 0.19). HITD-FT score correlated with head-impulse gain (R = 0.63, p = 0.03) and with gain difference (before/with remifentanil, R = -0.64, p = 0.02). One subject had a non-pathological head-impulse gain (0.82 +/- 0.03) and a high HITD-FT score (92%). One subject triggered covert saccades in 60% of the head movements and could read during passive head movements (HITD-FT 93%) despite a pathological head-impulse gain (0.59 +/- 0.03) whereas none of the 12 subjects without covert saccades reached such high performance. In summary, early catch-up saccades may improve dynamic visual function. HITD-FT is an appropriate method to assess the combined gaze stabilization effect of both VOR and covert saccades (overall dynamic vision), e.g., to document performance and progress during vestibular rehabilitation.	[Ramaioli, Cecilia; Saglam, Murat; Schneider, Erich; Lehnen, Nadine] Munich Univ Hosp, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Ramaioli, Cecilia; Colagiorgio, Paolo; Ramat, Stefano] Univ Pavia, Dept Elect Comp & Biomed Engn, I-27100 Pavia, Italy; [Heuser, Fabian] Tech Univ Munich, Klinikum Rechts Isar, Dept Anesthesiol, D-80290 Munich, Germany; [Schneider, Erich] Munich Univ Hosp, Munich, Germany; [Schneider, Erich] Brandenburg Tech Univ Cottbus, Cottbus, Germany; [Lehnen, Nadine] Munich Univ Hosp, Dept Neurol, Munich, Germany	University of Munich; University of Pavia; Technical University of Munich; University of Munich; Brandenburg University of Technology Cottbus; University of Munich	Ramaioli, C (corresponding author), Munich Univ Hosp, German Ctr Vertigo & Balance Disorders, Munich, Germany.	Cecilia.Ramaioli@lrz.uni-muenchen.de	Ramat, Stefano/E-6495-2011; Saglam, Murat/L-3123-2014	Ramat, Stefano/0000-0001-5932-186X; Saglam, Murat/0000-0001-8766-3883	German Federal Ministry of Education and Research (BMBF); Faculty of Medicine of the University of Munich; Friedrich-Baur Foundation; EyeSeeTec GmbH	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Faculty of Medicine of the University of Munich; Friedrich-Baur Foundation; EyeSeeTec GmbH	ES is the managing director and a shareholder of EyeSeeTec GmbH. NL received speaker honoraria and compensation for travel expenses from Interacoustics, Autronic Reglersysteme GmbH, and Meytec GmbH Medizinsysteme, and research support from the German Federal Ministry of Education and Research (BMBF), the Faculty of Medicine of the University of Munich, and the Friedrich-Baur Foundation. She is a shareholder and paid consultant of EyeSeeTec GmbH. SR has the European patent on head impulse testing device for assessing the functionality of the semicircular canals and for the rehabilitation of vestibular loss (ep 2398377, Stefano Ramat, Marco Mandala, 2011/12/28). CR, PC, MS, FH have no competing interests to report. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aw ST, 1996, J NEUROPHYSIOL, V76, P4021, DOI 10.1152/jn.1996.76.6.4021; Aw ST, 1996, J NEUROPHYSIOL, V76, P4009, DOI 10.1152/jn.1996.76.6.4009; Bartl K, 2009, ANN NY ACAD SCI, V1164, P331, DOI 10.1111/j.1749-6632.2009.03850.x; Carriot J, 2014, J NEUROSCI, V34, P8347, DOI 10.1523/JNEUROSCI.0692-14.2014; Colagiorgio P, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00165; Dandy W., 1941, SURG GYNAECOL OBSTET, V72, P421; DEMER JL, 1993, INVEST OPHTH VIS SCI, V34, P1894; Guinand N, 2012, ARCH OTOLARYNGOL, V138, P301, DOI 10.1001/archoto.2012.4; HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015; Hirasaki E, 1999, EXP BRAIN RES, V127, P117, DOI 10.1007/s002210050781; Lehnen N, 2013, NEUROLOGY; LEIGH RJ, 1994, ANN NEUROL, V36, P129, DOI 10.1002/ana.410360204; LONGRIDGE NS, 1987, ACTA OTO-LARYNGOL, V103, P273, DOI 10.3109/00016488709107794; MacDougall HG, 2009, NEUROLOGY, V73, P1134, DOI 10.1212/WNL.0b013e3181bacf85; Mantokoudis G, 2014, OTOL NEUROTOL, V35, P148, DOI 10.1097/MAO.0b013e3182956196; Ramat S, 2012, FRONT NEUROL, V3, P1; Scherer M, 2008, J VESTIBUL RES-EQUIL, V18, P147; Vital D, 2010, ARCH OTOLARYNGOL, V136, P686, DOI 10.1001/archoto.2010.99; Ward BK, 2013, JAMA OTOLARYNGOL, V139, P803, DOI 10.1001/jamaoto.2013.3913; Weber KP, 2008, NEUROLOGY, V70, P454, DOI 10.1212/01.wnl.0000299117.48935.2e; WESTMORELAND CL, 1993, ANESTHESIOLOGY, V79, P893, DOI 10.1097/00000542-199311000-00005	21	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110322	10.1371/journal.pone.0110322	http://dx.doi.org/10.1371/journal.pone.0110322			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329150	gold, Green Published, Green Submitted			2022-12-27	WOS:000343942100054
J	Orsatti, CL; Nahas, EAP; Nahas-Neto, J; Orsatti, FL; Giorgi, VI; Witkin, SS				Orsatti, Claudio Lera; Petri Nahas, Eliana Aguiar; Nahas-Neto, Jorge; Orsatti, Fabio Lera; Giorgi, Vanessa Innocenti; Witkin, Steven S.			Evaluation of Toll-Like Receptor 2 and 4 RNA Expression and the Cytokine Profile in Postmenopausal Women with Metabolic Syndrome	PLOS ONE			English	Article							ASP299GLY POLYMORPHISM; MYOCARDIAL-INFARCTION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; RISK-FACTORS; INFLAMMATION; INTERLEUKIN-10; ASSOCIATION; INNATE; CELLS	Objective: To evaluate the gene expression of Toll-Like (TLR-2 and TLR-4) receptors and cytokine profile in postmenopausal women with or without metabolic syndrome (MetS). Methods: In this cross-sectional study, 311 Brazilian women (age >= 45 years and amenorrhea >= 12 months) were included. Women showing three or more of the following diagnostic criteria were diagnosed as positive for MetS: waist circumference>88 cm, triglycerides >= 150 mg/dL, HDL cholesterol<50 mg/dL, blood pressure >= 130/85 mmHg, and fasting glucose >= 100 mg/dL. The expression of TLR-2 and TLR-4 in peripheral blood was evaluated by RNA extraction and subsequent real time PCR analysis. The cytokine profile, tumor necrosis factor alpha (TNF-alpha) and interleukins 1 beta, 6, and 10, were measured by ELISA. Results: The expression of TLR-2 RNA was demonstrated in 32.5% and TLR-4 in 20.6% of the subjects. There was no association between the expression of TLR-2 and TLR-4 and the presence or absence of MetS (P>0.05). A greater production of IL-6 was associated with TLR-2 and TLR-4 expressions and greater production of TNF-alpha was associated only with TLR-2 expression (P>0.05). Only the lower quartile of IL-10 was associated with the presence of the MetS (P>0.05). Conclusions: TLR-2 and TLR-4 expressions were associated with increased pro-inflammatory cytokines, IL-6 and TNF-alpha, with no association with biomarkers of MetS. The low concentrations of IL-10 may suggest an anti-inflammatory modulation in postmenopausal women with MetS.	[Orsatti, Claudio Lera; Petri Nahas, Eliana Aguiar; Nahas-Neto, Jorge] Sao Paulo State Univ UNESP, Botucatu Med Sch, Dept Gynecol & Obstet, Botucatu, SP, Brazil; [Orsatti, Fabio Lera] Inst Hlth Sci UFTM, Dept Sports Sci, Uberaba, MG, Brazil; [Giorgi, Vanessa Innocenti] Sao Paulo State Univ UNESP, Inst Biosci, Dept Microbiol & Immunol, Botucatu, SP, Brazil; [Witkin, Steven S.] Weill Cornell Med Coll, Div Immunol & Infect Dis, Dept Obstet & Gynecol, New York, NY USA	Universidade Estadual Paulista; Universidade Federal do Triangulo Mineiro; Universidade Estadual Paulista; Cornell University	Orsatti, CL (corresponding author), Sao Paulo State Univ UNESP, Botucatu Med Sch, Dept Gynecol & Obstet, Botucatu, SP, Brazil.	claudiorsatti@gmail.com	Orsatti, Fábio Lera/F-8441-2012; Witkin, Steven/AAF-3812-2019; Witkin, Steven/AAW-8602-2021; Nahas, Eliana Aguiar Petri/AAG-6249-2019; Orsatti, Claudio Lera/M-1227-2013	Orsatti, Fábio Lera/0000-0002-6258-2646; Witkin, Steven/0000-0002-3502-3929; Orsatti, Claudio Lera/0000-0001-9161-5737; Nahas, Eliana/0000-0002-0803-8535; Silvestre Innocenti Giorgi, Vanessa/0000-0001-6760-283X	Sao Paulo Research Foundation (FAPESP) [2009/14884-2, 2009/18256-6]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the Sao Paulo Research Foundation (FAPESP), process number 2009/14884-2 and 2009/18256-6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, SEMIN IMMUNOL, V16, P1, DOI 10.1016/j.smim.2003.10.001; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Allhorn S, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-40; Ameziane N, 2003, ARTERIOSCL THROM VAS, V23, pE61, DOI 10.1161/01.ATV.0000101191.92392.1D; Ashida K, 2005, J ATHEROSCLER THROMB, V12, P53, DOI 10.5551/jat.12.53; Caricilli AM, 2008, J ENDOCRINOL, V199, P399, DOI 10.1677/JOE-08-0354; Chedraui P, 2011, GYNECOL ENDOCRINOL, V27, P685, DOI 10.3109/09513590.2010.521270; Cioffi M, 2002, MATURITAS, V41, P187, DOI 10.1016/S0378-5122(01)00286-9; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cole JE, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/393946; Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Esposito K, 2003, J CLIN ENDOCR METAB, V88, P1055, DOI 10.1210/jc.2002-021437; Fernandez RP, 2002, REV ESP CARDIOL, V55, P738, DOI 10.1016/S0300-8932(02)76693-1; Ferrario CM, 2006, AM J CARDIOL, V98, P121, DOI 10.1016/j.amjcard.2006.01.059; Frantz S, 2007, NAT CLIN PRACT CARD, V4, P444, DOI 10.1038/ncpcardio0938; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Geloneze B, 2006, DIABETES RES CLIN PR, V72, P219, DOI 10.1016/j.diabres.2005.10.017; Ghanim H, 2004, CIRCULATION, V110, P1564, DOI 10.1161/01.CIR.0000142055.53122.FA; Grundy SM, 2004, ARTERIOSCL THROM VAS, V24, pE13, DOI 10.1161/01.ATV.0000111245.75752.C6; Hamann L, 2005, J MOL MED, V83, P478, DOI 10.1007/s00109-005-0643-7; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Huang CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021067; Janssen I, 2008, ARCH INTERN MED, V168, P1568, DOI 10.1001/archinte.168.14.1568; Jialal I, 2012, DIABETES CARE, V35, P900, DOI 10.2337/dc11-2375; Kim TH, 2013, ACTA DIABETOL, V50, P189, DOI 10.1007/s00592-011-0259-z; Koch W, 2006, EUR HEART J, V27, P2524, DOI 10.1093/eurheartj/ehl231; Krikun G, 2012, AM J REPROD IMMUNOL, V68, P233, DOI 10.1111/j.1600-0897.2012.01164.x; Lepper PM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/705612; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Methe H, 2005, CIRCULATION, V111, P2654, DOI 10.1161/CIRCULATIONAHA.104.498865; Muccioli Maria, 2012, ISRN Oncol, V2012, P642141, DOI 10.5402/2012/642141; Nahas EAP, 2009, CLIMACTERIC, V12, P431, DOI 10.1080/13697130902718168; Netea MG, 2004, EUR J CLIN INVEST, V34, P94, DOI 10.1111/j.1365-2362.2004.01303.x; Olivieri F, 2006, MECH AGEING DEV, V127, P552, DOI 10.1016/j.mad.2006.01.013; Poulain-Godefroy O, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/823486; Ridker Paul M., 2003, Cardiology Clinics, V21, P315, DOI 10.1016/S0733-8651(03)00079-1; Schneider J Gabriel, 2006, Cardiol Rev, V14, P286, DOI 10.1097/01.crd.0000233757.15181.67; Sell H, 2010, CURR OPIN CLIN NUTR, V13, P366, DOI 10.1097/MCO.0b013e32833aab7f; Shishido T, 2006, BIOCHEM BIOPH RES CO, V345, P1446, DOI 10.1016/j.bbrc.2006.05.056; Smith DA, 2001, CIRCULATION, V104, P746, DOI 10.1161/hc3201.094973; Spirig R, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/181394; Stoll G, 2006, STROKE, V37, P1923, DOI 10.1161/01.STR.0000226901.34927.10; Sutmuller RPM, 2006, TRENDS IMMUNOL, V27, P387, DOI 10.1016/j.it.2006.06.005; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tedgui A, 2001, CIRC RES, V88, P877, DOI 10.1161/hh0901.090440; Tobias PS, 2008, SEMIN IMMUNOPATHOL, V30, P23, DOI 10.1007/s00281-007-0102-3; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Vabulas RM, 2002, CURR TOP MICROBIOL, V270, P169; van Exel E, 2002, DIABETES, V51, P1088, DOI 10.2337/diabetes.51.4.1088; Wang HZ, 2013, J IMMUNOL, V191, P1164, DOI 10.4049/jimmunol.1203084; Wang L, 2011, CLIN CHEM, V57, P729, DOI 10.1373/clinchem.2010.156794; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Wilson AM, 2006, INT J CARDIOL, V106, P291, DOI 10.1016/j.ijcard.2005.01.068; Wong E, 2008, AM J EPIDEMIOL, V168, P443, DOI 10.1093/aje/kwn132; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Yang IA, 2003, ATHEROSCLEROSIS, V170, P187, DOI 10.1016/S0021-9150(03)00286-7; Yasui T, 2007, MATURITAS, V56, P396, DOI 10.1016/j.maturitas.2006.11.002; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	61	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109259	10.1371/journal.pone.0109259	http://dx.doi.org/10.1371/journal.pone.0109259			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329057	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204100013
J	Kasten, A; Naser, T; Brullhoff, K; Fiedler, J; Muller, P; Moller, M; Rychly, J; Groll, J; Brenner, RE				Kasten, Annika; Naser, Tamara; Bruellhoff, Kristina; Fiedler, Joerg; Mueller, Petra; Moeller, Martin; Rychly, Joachim; Groll, Juergen; Brenner, Rolf E.			Guidance of Mesenchymal Stem Cells on Fibronectin Structured Hydrogel Films	PLOS ONE			English	Article							TISSUE MORPHOGENESIS; ADHESION DYNAMICS; FOCAL ADHESIONS; MIGRATION; COATINGS; FORCE; NETWORKS; TRACTION; TENSION; STRESS	Designing of implant surfaces using a suitable ligand for cell adhesion to stimulate specific biological responses of stem cells will boost the application of regenerative implants. For example, materials that facilitate rapid and guided migration of stem cells would promote tissue regeneration. When seeded on fibronectin (FN) that was homogeneously immmobilized to NCO-sP(EO-stat-PO), which otherwise prevents protein binding and cell adhesion, human mesenchymal stem cells (MSC) revealed a faster migration, increased spreading and a more rapid organization of different cellular components for cell adhesion on fibronectin than on a glass surface. To further explore, how a structural organization of FN controls the behavior of MSC, adhesive lines of FN with varying width between 10 mu m and 80 mu m and spacings between 5 mu m and 20 mu m that did not allow cell adhesion were generated. In dependance on both line width and gaps, cells formed adjacent cell contacts, were individually organized in lines, or bridged the lines. With decreasing sizes of FN lines, speed and directionality of cell migration increased, which correlated with organization of the actin cytoskeleton, size and shape of the nuclei as well as of focal adhesions. Together, defined FN lines and gaps enabled a fine tuning of the structural organization of cellular components and migration. Microstructured adhesive substrates can mimic the extracellular matrix in vivo and stimulate cellular mechanisms which play a role in tissue regeneration.	[Kasten, Annika; Mueller, Petra; Rychly, Joachim] Univ Rostock, Med Ctr, Cell Biol Lab, D-18055 Rostock, Germany; [Naser, Tamara; Fiedler, Joerg; Brenner, Rolf E.] Univ Ulm, Div Biochem, Joint & Connect Tissue Dis Orthoped Dept, D-89069 Ulm, Germany; [Bruellhoff, Kristina; Moeller, Martin; Groll, Juergen] Rhein Westfal TH Aachen, DWI Leibniz Inst Interact Mat, Aachen, Germany; [Bruellhoff, Kristina; Moeller, Martin; Groll, Juergen] Rhein Westfal TH Aachen, Inst Tech & Macromol Chem, Aachen, Germany; [Groll, Juergen] Univ Wurzburg, Dept & Chair Funct Mat Med & Dent, D-97070 Wurzburg, Germany	University of Rostock; Ulm University; DWI Leibniz Institute for Interactive Materials; RWTH Aachen University; RWTH Aachen University; University of Wurzburg	Rychly, J (corresponding author), Univ Rostock, Med Ctr, Cell Biol Lab, D-18055 Rostock, Germany.	joachim.rychly@med.uni-rostock.de	Möller, Martin/F-7860-2015; Groll, Jürgen/F-4202-2012	Möller, Martin/0000-0002-5955-4185; Groll, Jürgen/0000-0003-3167-8466; Fiedler, Jorg/0000-0002-5834-3730	Deutsche Forschungsgemeinschaft [SFB Transregio 37]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft, SFB Transregio 37 (www.dfg.de) to AK, TN, and KB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed WW, 2010, BIOMATERIALS, V31, P250, DOI 10.1016/j.biomaterials.2009.09.047; Bulnheim U, 2012, J TISSUE ENG REGEN M, DOI 10.1002/term.1590; Chang SS, 2013, BIOPHYS J, V104, P313, DOI 10.1016/j.bpj.2012.12.001; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; Daley WP, 2013, CURR OPIN GENET DEV, V23, P408, DOI 10.1016/j.gde.2013.05.005; Downing TL, 2013, NAT MATER, V12, P1154, DOI [10.1038/NMAT3777, 10.1038/nmat3777]; Doyle AD, 2013, CURR OPIN CELL BIOL, V25, P642, DOI 10.1016/j.ceb.2013.06.004; Doyle AD, 2012, J CELL SCI, V125, P2244, DOI 10.1242/jcs.098806; Fiedler J, 2013, BIOMATERIALS, V34, P8851, DOI 10.1016/j.biomaterials.2013.08.010; Fiedler J, 2011, INT J MOL MED, V27, P139, DOI 10.3892/ijmm.2010.553; Gotz H, 2002, MACROMOL MATER ENG, V287, P223, DOI 10.1002/1439-2054(20020401)287:4<223::AID-MAME223>3.0.CO;2-Z; Groll J, 2005, J BIOMED MATER RES A, V74A, P607, DOI 10.1002/jbm.a.30335; Groll J, 2005, BIOMACROMOLECULES, V6, P956, DOI 10.1021/bm049350u; Groll J, 2009, INT J ARTIF ORGANS, V32, P655, DOI 10.1177/039139880903200915; Ilina O, 2009, J CELL SCI, V122, P3203, DOI 10.1242/jcs.036525; Kasten A, 2010, J CELL BIOCHEM, V111, P1586, DOI 10.1002/jcb.22890; Luo WW, 2013, J CELL BIOL, V202, P1057, DOI 10.1083/jcb.201210123; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Reska A, 2008, ADV MATER, V20, P2751, DOI 10.1002/adma.200800270; Rossier OM, 2010, EMBO J, V29, P1055, DOI 10.1038/emboj.2010.2; Saez A, 2007, P NATL ACAD SCI USA, V104, P8281, DOI 10.1073/pnas.0702259104; Senju Y, 2009, J BIOCHEM, V145, P137, DOI 10.1093/jb/mvn151; Sero JE, 2012, CELL ADHES MIGR, V6, P502, DOI 10.4161/cam.21672; STOPAK D, 1982, DEV BIOL, V90, P383, DOI 10.1016/0012-1606(82)90388-8; Sun YB, 2012, ANNU REV BIOPHYS, V41, P519, DOI 10.1146/annurev-biophys-042910-155306; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; Tambe DT, 2011, NAT MATER, V10, P469, DOI [10.1038/NMAT3025, 10.1038/nmat3025]; Thery M, 2006, CELL MOTIL CYTOSKEL, V63, P341, DOI 10.1002/cm.20126; Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799; Tsimbouri PM, 2013, BIOMATERIALS, V34, P2177, DOI 10.1016/j.biomaterials.2012.12.019; Vedula SRK, 2013, PHYSIOLOGY, V28, P370, DOI 10.1152/physiol.00033.2013; Vedula SRK, 2012, P NATL ACAD SCI USA, V109, P12974, DOI 10.1073/pnas.1119313109; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Vincent LG, 2013, BIOTECHNOL J, V8, P472, DOI 10.1002/biot.201200205; Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Wolfenson H, 2011, J CELL SCI, V124, P1425, DOI 10.1242/jcs.077388	39	7	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109411	10.1371/journal.pone.0109411	http://dx.doi.org/10.1371/journal.pone.0109411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25329487	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766200028
J	Cmoch, A; Podszywalow-Bartnicka, P; Palczewska, M; Piwocka, K; Groves, P; Pikula, S				Cmoch, Anna; Podszywalow-Bartnicka, Paulina; Palczewska, Malgorzata; Piwocka, Katarzyna; Groves, Patrick; Pikula, Slawomir			Stimulators of Mineralization Limit the Invasive Phenotype of Human Osteosarcoma Cells by a Mechanism Involving Impaired Invadopodia Formation	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX DEGRADATION; ALKALINE-PHOSPHATASE GENE; OSTEOBLASTIC DIFFERENTIATION; BETA-GLYCEROPHOSPHATE; INORGANIC-PHOSPHATE; MALIGNANT PHENOTYPE; CANCER METASTASIS; ASCORBIC-ACID; SAOS-2 CELLS; I COLLAGEN	Background: Osteosarcoma (OS) is a highly aggressive bone cancer affecting children and young adults. Growing evidence connects the invasive potential of OS cells with their ability to form invadopodia (structures specialized in extracellular matrix proteolysis). Results: In this study, we tested the hypothesis that commonly used in vitro stimulators of mineralization limit the invadopodia formation in OS cells. Here we examined the invasive potential of human osteoblast-like cells (Saos-2) and osteolytic-like (143B) OS cells treated with the stimulators of mineralization (ascorbic acid and B-glycerophosphate) and observed a significant difference in response of the tested cells to the treatment. In contrast to 143B cells, osteoblast-like cells developed a mineralization phenotype that was accompanied by a decreased proliferation rate, prolongation of the cell cycle progression and apoptosis. On the other hand, stimulators of mineralization limited osteolytic-like OS cell invasiveness into collagen matrix. We are the first to evidence the ability of 143B cells to degrade extracellular matrix to be driven by invadopodia. Herein, we show that this ability of osteolytic-like cells in vitro is limited by stimulators of mineralization. Conclusions: Our study demonstrates that mineralization competency determines the invasive potential of cancer cells. A better understanding of the molecular mechanisms by which stimulators of mineralization regulate and execute invadopodia formation would reveal novel clinical targets for treating osteosarcoma.	[Cmoch, Anna; Pikula, Slawomir] Polish Acad Sci, M Nencki Inst Expt Biol, Dept Biochem, Warsaw, Poland; [Podszywalow-Bartnicka, Paulina; Piwocka, Katarzyna] Polish Acad Sci, M Nencki Inst Expt Biol, Lab Cytometry, Warsaw, Poland; [Palczewska, Malgorzata; Groves, Patrick] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Dept Biol Chem, Oeiras, Portugal	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Universidade Nova de Lisboa	Pikula, S (corresponding author), Polish Acad Sci, M Nencki Inst Expt Biol, Dept Biochem, Warsaw, Poland.	s.pikula@nencki.gov.pl	Palczewska, Malgorzata/A-8172-2011; Groves, Patrick/B-1942-2008; Piwocka, Katarzyna/P-2451-2016	Groves, Patrick/0000-0003-2589-1455; Podszywalow-Bartnicka, Paulina/0000-0002-4965-828X; Piwocka, Katarzyna/0000-0001-6676-5282; Pikula, Slawomir/0000-0003-4640-3094	National Science Centre [2012/05/N/NZ3/00330, NN401140639]; EU [264173]; Nencki Institute of Experimental Biology; European Union funds by the European Social Fund [8.2.2]; Mazovia Scholarship	National Science Centre(National Science Centre, Poland); EU(European Commission); Nencki Institute of Experimental Biology; European Union funds by the European Social Fund; Mazovia Scholarship	This work was funded by grants 2012/05/N/NZ3/00330 and NN401140639 from the National Science Centre and supported by the EU FP7 Project BIO-IMAGINE: BIO-IMAGing in research INnovation and Education, GA No. 264173 and the Nencki Institute of Experimental Biology. AC is the recipient of Mazovia Scholarship co-financed with the European Union funds by the European Social Fund (8.2.2 Priority). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeen A, 2009, CANCER-AM CANCER SOC, V115, P5243, DOI 10.1002/cncr.24562; Albini A, 2007, NAT PROTOC, V2, P504, DOI 10.1038/nprot.2006.466; Ariganello MB, 2014, J CELL BIOCHEM, V115, P2089, DOI 10.1002/jcb.24886; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Baldassarre M, 2006, EUR J CELL BIOL, V85, P1217, DOI 10.1016/j.ejcb.2006.08.003; Beaty BT, 2013, MOL BIOL CELL, V24, P1661, DOI 10.1091/mbc.E12-12-0908; Bradbury P, 2012, CELL ADHES MIGR, V6, P424, DOI 10.4161/cam.21559; Neto AHC, 2011, DEV GROWTH DIFFER, V53, P88, DOI 10.1111/j.1440-169X.2010.01232.x; CHUNG CH, 1992, CALCIFIED TISSUE INT, V51, P305, DOI 10.1007/BF00334492; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; Cmoch A, 2011, BIOCHEM BIOPH RES CO, V412, P683, DOI 10.1016/j.bbrc.2011.08.025; Dvorak-Ewell MM, 2011, J BONE MINER RES, V26, P2935, DOI 10.1002/jbmr.520; Eckert MA, 2011, ONCOTARGET, V2, P562; Egas-Bejar Daniela, 2014, Oncoscience, V1, P167; Farley JR, 2001, CALCIFIED TISSUE INT, V68, P43, DOI 10.1007/BF02685002; Folio C, 2011, CANCER BIOMARK, V10, P35, DOI 10.3233/CBM-2012-0227; Geng S, 2014, MOL CANCER THER, V13, P1; Gregory KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013428; Haydon RC, 2007, CLIN ORTHOP RELAT R, P237, DOI 10.1097/BLO.0b013e31802b683c; He BC, 2010, CLIN CANCER RES, V16, P2235, DOI 10.1158/1078-0432.CCR-09-2499; Hoshino D, 2013, CELL REP, V5, P1159, DOI 10.1016/j.celrep.2013.10.050; Jilka RL, 1998, J BONE MINER RES, V13, P793, DOI 10.1359/jbmr.1998.13.5.793; Letourneau PA, 2011, J PEDIATR SURG, V46, P1333, DOI 10.1016/j.jpedsurg.2010.12.013; Lv ZL, 2013, MOL CELLS, V36, P119, DOI 10.1007/s10059-013-0043-8; Manara MC, 2000, BONE, V26, P215, DOI 10.1016/S8756-3282(99)00266-5; Millan JL, 2013, CALCIFIED TISSUE INT, V93, P299, DOI 10.1007/s00223-012-9672-8; Mogi M, 2003, J BIOL CHEM, V278, P47477, DOI 10.1074/jbc.M307055200; Mohseny AB, 2011, LAB INVEST, V91, P1195, DOI 10.1038/labinvest.2011.72; Nicolaije C, 2012, J CELL PHYSIOL, V227, P1309, DOI 10.1002/jcp.22841; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Papai Zsuzsa, 1997, Pathol Oncol Res, V3, P15; Postiglione L, 2003, EUR J HISTOCHEM, V47, P309; Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301; Robaszkiewicz A, 2012, FREE RADICAL BIO MED, V53, P1552, DOI 10.1016/j.freeradbiomed.2012.08.567; RUNGBY J, 1993, HISTOCHEM J, V25, P446, DOI 10.1007/BF00157809; Sathiyamoorthy S, 2012, ACTA CYTOL, V56, P481, DOI 10.1159/000339196; Sharma VP, 2013, METHODS MOL BIOL, V1046, P343, DOI 10.1007/978-1-62703-538-5_21; Shimizu T, 2012, MOL CANCER RES, V10, P454, DOI 10.1158/1541-7786.MCR-11-0347; Spina A, 2013, CURR PHARM DESIGN, V19, P5394, DOI 10.2174/1381612811319300008; Spina A, 2013, ONCOL REP, V29, P1689, DOI 10.3892/or.2013.2306; Takeshita H, 2000, BRIT J CANCER, V82, P1327, DOI 10.1054/bjoc.1999.1099; Thompson L, 2012, J ORTHOP RES, V30, P831, DOI 10.1002/jor.21585; Thouverey C, 2009, J CELL BIOCHEM, V106, P127, DOI 10.1002/jcb.21992; Valenti MT, 2014, ANTICANCER RES, V34, P1617; Vanoirbeek E, 2014, ONCOGENE, V33, P1904, DOI 10.1038/onc.2013.123; Vihinen P, 1996, CELL GROWTH DIFFER, V7, P439; Wallace JM, 2010, BONE, V46, P1349, DOI 10.1016/j.bone.2009.11.020; Wang L, 2013, INT J ONCOL, V43, P1095, DOI 10.3892/ijo.2013.2030; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Wu W, 2007, CANCER LETT, V254, P75, DOI 10.1016/j.canlet.2007.02.013; Yamakawa K, 2003, J RHEUMATOL, V30, P1032; Yuan J, 2009, CANCER INVEST, V27, P435, DOI 10.1080/07357900802491477; Zhao HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083571; Zucchini C, 2004, BONE, V34, P672, DOI 10.1016/j.bone.2003.12.008	54	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109938	10.1371/journal.pone.0109938	http://dx.doi.org/10.1371/journal.pone.0109938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314307	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500090
J	Liu, YN; Li, P; Liu, KY; He, QH; Han, S; Sun, XF; Li, T; Shen, L				Liu, Yinan; Li, Peng; Liu, Kaiyu; He, Qihua; Han, Shuo; Sun, Xiaofeng; Li, Tao; Shen, Li			Timely Inhibition of Notch Signaling by DAPT Promotes Cardiac Differentiation of Murine Pluripotent Stem Cells	PLOS ONE			English	Article							NEURONAL DIFFERENTIATION; WNT/BETA-CATENIN; SOMATIC-CELLS; CARDIOMYOGENESIS; PROTEIN; MOUSE; STAGE; CARDIOMYOCYTES; INDUCTION; FATE	The Notch signaling pathway plays versatile roles during heart development. However, there is contradictory evidence that Notch pathway either facilitates or impairs cardiomyogenesis in vitro. In this study, we developed iPSCs by reprogramming of murine fibroblasts with GFP expression governed by Oct4 promoter, and identified an effective strategy to enhance cardiac differentiation through timely modulation of Notch signaling. The Notch inhibitor DAPT (N-[N-(3,5-difluorophenacetyl)-l-alanyl]-S-phenylglycine t-butyl ester) alone drove the iPSCs to a neuronal fate. After mesoderm induction of embryoid bodies initiated by ascorbic acid (AA), the subsequent treatment of DAPT accelerated the generation of spontaneously beating cardiomyocytes. The timed synergy of AA and DAPT yielded an optimal efficiency of cardiac differentiation. Mechanistic studies showed that Notch pathway plays a biphasic role in cardiomyogenesis. It favors the early-stage cardiac differentiation, but exerts negative effects on the late-stage differentiation. Therefore, DAPT administration at the late stage enforced the inhibition of endogenous Notch activity, thereby enhancing cardiomyogenesis. In parallel, DAPT dramatically augmented the expression of Wnt3a, Wnt11, BMP2, and BMP4. In conclusion, our results highlight a practicable approach to generate cardiomyocytes from iPSCs based on the stage-specific biphasic roles of Notch signaling in cardiomyogenesis.	[Liu, Yinan; Li, Peng; Han, Shuo; Shen, Li] Peking Univ, Sch Basic Med Sci, Dept Cell Biol, Stem Cell Res Ctr, Beijing 100871, Peoples R China; [Liu, Kaiyu] Peking Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; [He, Qihua] Peking Univ, Sch Basic Med Sci, Ctr Med & Hlth Anal, Beijing 100871, Peoples R China; [Sun, Xiaofeng] Hunan Univ Chinese Med, Inst Chinese Med, Dept Histol & Embryol, Changsha, Hunan, Peoples R China; [Li, Tao] Zhejiang Normal Univ, Coll Chem & Life Sci, Dept Biol, Jinhua, Zhejiang, Peoples R China	Peking University; Peking University; Peking University; Hunan University of Chinese Medicine; Zhejiang Normal University	Li, T (corresponding author), Zhejiang Normal Univ, Coll Chem & Life Sci, Dept Biol, Jinhua, Zhejiang, Peoples R China.	litao@zjnu.cn; shenli@bjmu.edu.cn	Liu, You-Nian/G-2697-2013	Liu, You-Nian/0000-0002-7078-5937	National Basic Research Program of China (973 program) [2011CB510200]; National Natural Science Foundation of China [31101057, 81303004]; Zhejiang Provincial Natural Science Foundation [LY14C120001]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was supported by Grant 2011CB510200 from the National Basic Research Program of China (973 program), the National Natural Science Foundation of China (31101057, 81303004), and Zhejiang Provincial Natural Science Foundation (LY14C120001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2012, TRENDS CELL BIOL, V22, P257, DOI 10.1016/j.tcb.2012.02.003; Boni A, 2008, P NATL ACAD SCI USA, V105, P15529, DOI 10.1073/pnas.0808357105; Borghese L, 2010, STEM CELLS, V28, P955, DOI 10.1002/stem.408; Cao N, 2012, CELL RES, V22, P219, DOI 10.1038/cr.2011.195; Chan SSK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014414; Chan SSK, 2009, BIOCHEM BIOPH RES CO, V387, P723, DOI 10.1016/j.bbrc.2009.07.122; Chen VC, 2008, NAT BIOTECHNOL, V26, P1169, DOI 10.1038/nbt.1497; Crawford TQ, 2007, DEV DYNAM, V236, P886, DOI 10.1002/dvdy.21083; Gaur M, 2010, CYTOTHERAPY, V12, P807, DOI 10.3109/14653249.2010.491821; Gude N, 2012, J MOL CELL CARDIOL, V52, P1226, DOI 10.1016/j.yjmcc.2012.03.007; Hao JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002904; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Jang J, 2008, STEM CELLS, V26, P2782, DOI 10.1634/stemcells.2007-1053; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kawai T, 2004, CIRC J, V68, P691, DOI 10.1253/circj.68.691; Koyanagi M, 2007, CIRC RES, V101, P1139, DOI 10.1161/CIRCRESAHA.107.151381; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Kwon C, 2011, NAT CELL BIOL, V13, P1244, DOI 10.1038/ncb2313; Li BH, 2012, J CELL BIOCHEM, V113, P629, DOI 10.1002/jcb.23390; Li HW, 2006, BIOCHEM BIOPH RES CO, V341, P320, DOI 10.1016/j.bbrc.2005.12.182; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; de la Pompa JL, 2009, PEDIATR CARDIOL, V30, P643, DOI 10.1007/s00246-008-9368-z; MacGrogan D, 2010, CURR TOP DEV BIOL, V92, P333, DOI 10.1016/S0070-2153(10)92011-5; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Nemir M, 2008, J MOL CELL CARDIOL, V45, P495, DOI 10.1016/j.yjmcc.2008.02.273; Nemir M, 2006, CIRC RES, V98, P1471, DOI 10.1161/01.RES.0000226497.52052.2a; Rones MS, 2000, DEVELOPMENT, V127, P3865; Sato H, 2006, BIOCHEM BIOPH RES CO, V342, P107, DOI 10.1016/j.bbrc.2006.01.116; Schroeder T, 2003, P NATL ACAD SCI USA, V100, P4018, DOI 10.1073/pnas.0438008100; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; Takei S, 2009, AM J PHYSIOL-HEART C, V296, pH1793, DOI 10.1152/ajpheart.01288.2008; Tran TH, 2009, STEM CELLS, V27, P1869, DOI 10.1002/stem.95; Urbanek K, 2010, CIRC RES, V107, P429, DOI 10.1161/CIRCRESAHA.110.218487; Xu CH, 2011, REGEN MED, V6, P53, DOI 10.2217/RME.10.91; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	37	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109588	10.1371/journal.pone.0109588	http://dx.doi.org/10.1371/journal.pone.0109588			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313563	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662500056
J	Wallkamm, V; Dorlich, R; Rahm, K; Klessing, T; Nienhaus, GU; Wedlich, D; Gradl, D				Wallkamm, Veronika; Dorlich, Rene; Rahm, Karolin; Klessing, Tina; Nienhaus, Gerd Ulrich; Wedlich, Doris; Gradl, Dietmar			Live Imaging of Xwnt5A-ROR2 Complexes	PLOS ONE			English	Article							BETA-CATENIN; CORRELATION SPECTROSCOPY; CONVERGENT EXTENSION; SIGNALING PATHWAYS; WNT; LRP6; XENOPUS; INTERNALIZATION; SEQUESTRATION; ENDOCYTOSIS	Secreted molecules of the Wnt family regulate key decisions in embryogenesis and adult tissue homeostasis by activating a complex network of Wnt signaling pathways. Although the different branches of Wnt signaling have been studied for more than 25 years, fluorophore tagged constructs for live cell imaging of Wnt molecules activating the Wnt/beta-catenin pathway have become available only recently. We have generated a fluorophore tagged Wnt construct of the Xenopus Wnt5a protein (Xwnt5A) with the enhanced green fluorescent protein (EGFP), Xwnt5A-EGFP. This construct activates non-canonical Wnt pathways in an endocytosis dependent manner and is capable of compensating for the loss of endogenous Xwnt5A in Xenopus embryos. Strikingly, non-canonical Wnt pathway activation was restricted to short-range signaling while an inhibitory effect was observed in transwell cell cultures taken as long-range signaling model sytem. We used our Xwnt5A-EGFP construct to analyze in vivo binding of Wnt5A to its co-receptor ROR2 on the microscopic and on the molecular level. On the microscopic level, Xwnt5A-EGFP clusters in the membrane and recruits ROR2-mCherry to these clusters. Applying dual-colour dual-focus line-scanning fluorescence correlation spectroscopy on dorsal marginal zone explants, we identified membrane tethered Xwnt5A-EGFP molecules binding to ROR2-mCherry molecules. Our data favour a model, in which membrane-tethered Wnt-5A recruits ROR2 to form large ligand/receptor clusters and signals in an endocytosis-dependent manner.	[Wallkamm, Veronika; Rahm, Karolin; Klessing, Tina; Wedlich, Doris; Gradl, Dietmar] Karlsruhe Inst Technol, Inst Zool, Dept Cell & Dev Biol, D-76021 Karlsruhe, Germany; [Dorlich, Rene; Nienhaus, Gerd Ulrich] Karlsruhe Inst Technol, Inst Appl Phys, D-76021 Karlsruhe, Germany; [Dorlich, Rene; Nienhaus, Gerd Ulrich] Karlsruhe Inst Technol, Insitute Toxicol & Genet, D-76021 Karlsruhe, Germany; [Nienhaus, Gerd Ulrich] Univ Illinois, Dept Phys, Urbana, IL USA	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; University of Illinois System; University of Illinois Urbana-Champaign	Gradl, D (corresponding author), Karlsruhe Inst Technol, Inst Zool, Dept Cell & Dev Biol, D-76021 Karlsruhe, Germany.	dietmar.gradl@kit.edu	Nienhaus, Gerd Ulrich/G-8698-2012	Nienhaus, Gerd Ulrich/0000-0002-5027-3192	Karlsruhe Institute of Technology; Deutsche Forschungsgemeinschaft [FOR1036]; Open Access Publishing Fund of the Karlsruhe Institute of Technology	Karlsruhe Institute of Technology(Helmholtz Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of the Karlsruhe Institute of Technology	The authors are grateful to financial support provided by the Karlsruhe Institute of Technology (FYS to VW), to the Deutsche Forschungsgemeinschaft (FOR1036 to DW and DG and CFN to GUN), and Open Access Publishing Fund of the Karlsruhe Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Demir K, 2013, CELL REP, V4, P1224, DOI 10.1016/j.celrep.2013.08.008; Dertinger T, 2007, CHEMPHYSCHEM, V8, P433, DOI 10.1002/cphc.200600638; Feike AC, 2010, BIOCHEM BIOPH RES CO, V400, P500, DOI 10.1016/j.bbrc.2010.08.074; Gradl D, 1999, MOL CELL BIOL, V19, P5576; Hedde PN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3093; Holzer T, 2012, FEBS LETT, V586, P1638, DOI 10.1016/j.febslet.2012.04.035; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; KELLER R, 1992, DEV DYNAM, V193, P199, DOI 10.1002/aja.1001930302; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188; Kraft B, 2012, J CELL BIOL, V198, P695, DOI 10.1083/jcb.201110076; Luz M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084922; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305; Ohkawara B, 2011, DEV DYNAM, V240, P188, DOI 10.1002/dvdy.22500; Peradziryi H, 2012, ARCH BIOCHEM BIOPHYS, V524, P71, DOI 10.1016/j.abb.2011.12.019; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Rhinn M, 2005, DEVELOPMENT, V132, P1261, DOI 10.1242/dev.01685; Ries J, 2009, NAT METHODS, V6, P643, DOI [10.1038/NMETH.1355, 10.1038/nmeth.1355]; Rigo-Watermeier T, 2012, BIOL OPEN, V1, P43, DOI 10.1242/bio.2011021; Sakane H, 2012, J CELL SCI, V125, P449, DOI 10.1242/jcs.091876; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Thrasivoulou C, 2013, J BIOL CHEM, V288, P35651, DOI 10.1074/jbc.M112.437913; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003	28	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109428	10.1371/journal.pone.0109428	http://dx.doi.org/10.1371/journal.pone.0109428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313906	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662500042
J	Falk, M; Alcalde, M; Bartlett, PN; De Lacey, AL; Gorton, L; Gutierrez-Sanchez, C; Haddad, R; Kilburn, J; Leech, D; Ludwig, R; Magner, E; Mate, DM; Conghaile, PO; Ortiz, R; Pita, M; Poller, S; Ruzgas, T; Salaj-Kosla, U; Schuhmann, W; Sebelius, F; Shao, ML; Stoica, L; Sygmund, C; Tilly, J; Toscano, MD; Vivekananthan, J; Wright, E; Shleev, S				Falk, Magnus; Alcalde, Miguel; Bartlett, Philip N.; De Lacey, Antonio L.; Gorton, Lo; Gutierrez-Sanchez, Cristina; Haddad, Raoudha; Kilburn, Jeremy; Leech, Donal; Ludwig, Roland; Magner, Edmond; Mate, Diana M.; Conghaile, Peter O.; Ortiz, Roberto; Pita, Marcos; Poeller, Sascha; Ruzgas, Tautgirdas; Salaj-Kosla, Urszula; Schuhmann, Wolfgang; Sebelius, Fredrik; Shao, Minling; Stoica, Leonard; Sygmund, Cristoph; Tilly, Jonas; Toscano, Miguel D.; Vivekananthan, Jeevanthi; Wright, Emma; Shleev, Sergey			Self-Powered Wireless Carbohydrate/Oxygen Sensitive Biodevice Based on Radio Signal Transmission	PLOS ONE			English	Article							DIRECT ELECTRON-TRANSFER; IMPLANTABLE BIOFUEL CELL; CELLOBIOSE DEHYDROGENASE; FUEL-CELLS; GLUCOSE; LACCASE; NANOPARTICLES; ENHANCEMENT; COMPOSITE; WORKING	Here for the first time, we detail self-contained (wireless and self-powered) biodevices with wireless signal transmission. Specifically, we demonstrate the operation of self-sustained carbohydrate and oxygen sensitive biodevices, consisting of a wireless electronic unit, radio transmitter and separate sensing bioelectrodes, supplied with electrical energy from a combined multi-enzyme fuel cell generating sufficient current at required voltage to power the electronics. A carbohydrate/oxygen enzymatic fuel cell was assembled by comparing the performance of a range of different bioelectrodes followed by selection of the most suitable, stable combination. Carbohydrates (viz. lactose for the demonstration) and oxygen were also chosen as bioanalytes, being important biomarkers, to demonstrate the operation of the self-contained biosensing device, employing enzyme-modified bioelectrodes to enable the actual sensing. A wireless electronic unit, consisting of a micropotentiostat, an energy harvesting module (voltage amplifier together with a capacitor), and a radio microchip, were designed to enable the biofuel cell to be used as a power supply for managing the sensing devices and for wireless data transmission. The electronic system used required current and voltages greater than 44 mu A and 0.57 V, respectively to operate; which the biofuel cell was capable of providing, when placed in a carbohydrate and oxygen containing buffer. In addition, a USB based receiver and computer software were employed for proof-of concept tests of the developed biodevices. Operation of bench-top prototypes was demonstrated in buffers containing different concentrations of the analytes, showcasing that the variation in response of both carbohydrate and oxygen biosensors could be monitored wirelessly in real-time as analyte concentrations in buffers were changed, using only an enzymatic fuel cell as a power supply.	[Falk, Magnus; Ruzgas, Tautgirdas; Shleev, Sergey] Malmo Univ, Fac Hlth & Soc, Malmo, Sweden; [Alcalde, Miguel; De Lacey, Antonio L.; Gutierrez-Sanchez, Cristina; Mate, Diana M.; Pita, Marcos] Inst Catalysis & Petrochem, Madrid, Spain; [Bartlett, Philip N.; Wright, Emma] Univ Southampton, Fac Nat & Environm Sci, Southampton, Hants, England; [Gorton, Lo; Ortiz, Roberto] Lund Univ, Lund, Sweden; [Haddad, Raoudha; Poeller, Sascha; Schuhmann, Wolfgang; Shao, Minling; Stoica, Leonard; Vivekananthan, Jeevanthi] Ruhr Univ Bochum, Bochum, Germany; [Kilburn, Jeremy] Univ London, Sch Biol & Chem Sci, London, England; [Leech, Donal; Conghaile, Peter O.] Natl Univ Ireland Univ Coll Galway, Sch Chem, Galway, Ireland; [Ludwig, Roland; Sygmund, Cristoph] BOKU Univ Nat Resources & Life Sci, Vienna, Austria; [Magner, Edmond; Salaj-Kosla, Urszula] Univ Limerick, Limerick, Ireland; [Sebelius, Fredrik; Tilly, Jonas] Novosense AB, Lund, Sweden; [Toscano, Miguel D.] Novozymes AS, Bagsvaerd, Denmark	Malmo University; University of Southampton; Lund University; Ruhr University Bochum; University of London; Ollscoil na Gaillimhe-University of Galway; University of Natural Resources & Life Sciences, Vienna; University of Limerick; Novozymes	Shleev, S (corresponding author), Malmo Univ, Fac Hlth & Soc, Malmo, Sweden.	sergey.shleev@mah.se	Sebelius, Fredrik/AAG-4473-2020; Stoica, Leonard/C-1465-2008; Shleev, Sergey/AAY-6101-2021; Conghaile, Peter Ó/AGV-6773-2022; Pita, Marcos/F-3547-2015; Conghaile, Peter Ó/B-2240-2017; Schuhmann, Wolfgang/S-2626-2016; Ortiz, Roberto/J-7439-2012; De Lacey, Antonio L/H-3311-2015; Pita, Marcos/AAB-9772-2020; Ruzgas, Tautgirdas/C-4646-2008; Bartlett, Philip N/C-4606-2008; Magner, Edmond/AAM-7248-2020; Salaj-Kosla, Urszula/K-5975-2017	Conghaile, Peter Ó/0000-0002-3849-7409; Pita, Marcos/0000-0002-6714-3669; Conghaile, Peter Ó/0000-0002-3849-7409; Schuhmann, Wolfgang/0000-0003-2916-5223; Ortiz, Roberto/0000-0002-6578-1966; De Lacey, Antonio L/0000-0002-9347-0452; Pita, Marcos/0000-0002-6714-3669; Ruzgas, Tautgirdas/0000-0003-0304-7528; Bartlett, Philip N/0000-0002-7300-6900; Sebelius, Fredrik/0000-0002-8822-2550; Gutierrez-Sanchez, Cristina/0000-0001-8011-6211; Stoica, Leonard/0000-0003-0777-9582; Mate, Diana/0000-0002-8209-0542; Salaj-Kosla, Urszula/0000-0002-8761-6216; Shleev, Sergey/0000-0001-6421-2158; Ludwig, Roland/0000-0002-5058-5874; Leech, Donal/0000-0001-7844-1306; Magner, Edmond/0000-0003-2042-556X; Alcalde, Miguel/0000-0001-6780-7616; Andronescu, Sascha/0000-0002-6613-2247	EU; Novosense AB; Novozymes A/S	EU(European Commission); Novosense AB; Novozymes A/S	The research was undertaken as part of a "3D-nanobiodevice'' consortium (www.mah.se/3dnanobiodevice) organized and funded under the EU FP7 NMP program. Co-authors Fredrik Sebelius and Jonas Tilly are employed by Novosense AB. Novosense AB provided support in the form of salaries for authors Fredrik Sebelius and Jonas Tilly, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section. Co-author Miguel D. Toscano is employed by Novozymes A/S. Novozymes A/S provided support in the form of salary for author Miguel D. Toscano, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section.	Amir L, 2009, J AM CHEM SOC, V131, P826, DOI 10.1021/ja8076704; Amsel A.D., 2012, J AT MOL OPT PHYS; Barton SC, 2004, CHEM REV, V104, P4867, DOI 10.1021/cr020719k; Borton DA, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026010; Castorena-Gonzalez JA, 2013, ELECTROANAL, V25, P1579, DOI 10.1002/elan.201300136; Cheong JH, 2012, IEEE T BIO-MED ENG, V59, P2466, DOI 10.1109/TBME.2012.2203131; Cinquin P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010476; Conghaile PO, 2013, J ELECTROCHEM SOC, V160, pG3165, DOI 10.1149/2.026307jes; Cracknell JA, 2008, CHEM REV, V108, P2439, DOI 10.1021/cr0680639; Falk M, 2013, CHEMPHYSCHEM, V14, P2045, DOI 10.1002/cphc.201300044; Falk M, 2012, BIOSENS BIOELECTRON, V37, P38, DOI 10.1016/j.bios.2012.04.030; Gutierrez-Sanchez C, 2012, ELECTROCHIM ACTA, V82, P218, DOI 10.1016/j.electacta.2011.12.134; Gutierrez-Sanchez C, 2012, J AM CHEM SOC, V134, P17212, DOI 10.1021/ja307308j; Guyton A.C., 2006, TXB MED PHYSL; Halamkova L, 2012, J AM CHEM SOC, V134, P5040, DOI 10.1021/ja211714w; Hanashi Takuya, 2011, J Diabetes Sci Technol, V5, P1030; Hanashi T, 2009, BIOSENS BIOELECTRON, V24, P1837, DOI 10.1016/j.bios.2008.09.014; Heller A, 2004, PHYS CHEM CHEM PHYS, V6, P209, DOI 10.1039/b313149a; Kannan AM, 2009, J NANOSCI NANOTECHNO, V9, P1665, DOI 10.1166/jnn.2009.SI03; Kavanagh P, 2009, FUEL CELLS, V9, P79, DOI 10.1002/fuce.200800037; Leech D, 2012, ELECTROCHIM ACTA, V84, P223, DOI 10.1016/j.electacta.2012.02.087; Ludwig R, 2010, CHEMPHYSCHEM, V11, P2674, DOI 10.1002/cphc.201000216; MacAodha D, 2013, CHEMPHYSCHEM, V14, P2302, DOI 10.1002/cphc.201300239; MacVittie K, 2013, ENERG ENVIRON SCI, V6, P81, DOI 10.1039/c2ee23209j; Mano N, 2003, J AM CHEM SOC, V125, P6588, DOI 10.1021/ja0346328; Mate DM, 2013, CHEM BIOL, V20, P223, DOI 10.1016/j.chembiol.2013.01.001; Matsumura H, 2012, LANGMUIR, V28, P10925, DOI 10.1021/la3018858; Miyake T, 2011, ENERG ENVIRON SCI, V4, P5008, DOI 10.1039/c1ee02200h; Pita M, 2013, BIOELECTROCHEMISTRY, V94, P69, DOI 10.1016/j.bioelechem.2013.07.001; Poller S, 2013, ELECTROCHIM ACTA, V110, P152, DOI 10.1016/j.electacta.2013.02.083; Rasmussen M, 2012, J AM CHEM SOC, V134, P1458, DOI 10.1021/ja210794c; Salaj-Kosla U, 2012, ELECTROCHEM COMMUN, V16, P92, DOI 10.1016/j.elecom.2011.12.007; Sales FCPF, 2013, LAB CHIP, V13, P468, DOI [10.1039/c2lc41007a, 10.1039/c21c41007a]; Sapsford KE, 2013, CHEM REV, V113, P1904, DOI 10.1021/cr300143v; Schulz C, 2012, ELECTROCHEM COMMUN, V17, P71, DOI 10.1016/j.elecom.2012.01.031; Shao ML, 2013, ELECTROCHEM COMMUN, V29, P59, DOI 10.1016/j.elecom.2013.01.016; Shao ML, 2013, BIOSENS BIOELECTRON, V40, P308, DOI 10.1016/j.bios.2012.07.069; Sharpeshkar R., 2010, ULTRALOW POWER BIOEL; Shleev S, 2005, BIOSENS BIOELECTRON, V20, P2517, DOI 10.1016/j.bios.2004.10.003; Sokic-Lazic D, 2011, ELECTROCHIM ACTA, V56, P10772, DOI 10.1016/j.electacta.2011.01.050; Sosna M, 2012, PHYS CHEM CHEM PHYS, V14, P11882, DOI 10.1039/c2cp41588g; Southcott M, 2013, PHYS CHEM CHEM PHYS, V15, P6278, DOI 10.1039/c3cp50929j; Szczupak A, 2012, ENERG ENVIRON SCI, V5, P8891, DOI 10.1039/c2ee21626d; Tam TK, 2009, J AM CHEM SOC, V131, P11670, DOI 10.1021/ja9048459; Tarabella G, 2013, CHEM SCI, V4, P1395, DOI 10.1039/c2sc21740f; Tasca F, 2011, ANALYST, V136, P2033, DOI 10.1039/c0an00311e; Tasca F, 2011, ANAL CHEM, V83, P3042, DOI 10.1021/ac103250b; Texas Instrument, 2011, CC2530 DAT SWRS081B; TRUESDALE GA, 1954, NATURE, V173, P1236, DOI 10.1038/1731236a0; Turner APF, 2013, CHEM SOC REV, V42, P3184, DOI 10.1039/c3cs35528d; Wang J, 2008, CHEM REV, V108, P814, DOI 10.1021/cr068123a; Wang XJ, 2012, BIOSENS BIOELECTRON, V31, P219, DOI 10.1016/j.bios.2011.10.020; Willner I, 2005, BIOELECTRONICS: FROM THEORY TO APPLICATIONS, P1, DOI 10.1002/352760376X; Xu S, 2012, ACS CATAL, V2, P91, DOI 10.1021/cs200523s; Yoshino S, 2013, ADV ENERGY MATER, V3, P60, DOI 10.1002/aenm.201200422; Zafar MN, 2012, ANAL BIOCHEM, V425, P36, DOI 10.1016/j.ab.2012.02.026; Zebda A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01516; Zhang LL, 2012, ANAL CHEM, V84, P10345, DOI 10.1021/ac302414a; Zhou M, 2012, CHEM COMMUN, V48, P3815, DOI 10.1039/c2cc30464c; Zhou M, 2012, ANGEW CHEM INT EDIT, V51, P2686, DOI 10.1002/anie.201107068; Zhou M, 2012, ELECTROANAL, V24, P197, DOI 10.1002/elan.201100631	61	54	54	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109104	10.1371/journal.pone.0109104	http://dx.doi.org/10.1371/journal.pone.0109104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310190	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000343210300035
J	Murugeswari, P; Shukla, D; Kim, R; Namperumalsamy, P; Stitt, AW; Muthukkaruppan, V				Murugeswari, Ponnalagu; Shukla, Dhananjay; Kim, Ramasamy; Namperumalsamy, Perumalsamy; Stitt, Alan W.; Muthukkaruppan, Veerappan			Angiogenic Potential of Vitreous from Proliferative Diabetic Retinopathy and Eales' Disease Patients	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MONOCYTE CHEMOATTRACTANT PROTEIN-1; ANTI-VEGF ANTIBODY; KAPPA-B; BEVACIZUMAB; INTERLEUKIN-6; RANIBIZUMAB; CYTOKINES; PERMEABILITY; PATHOGENESIS	Purpose: Proliferative Diabetic Retinopathy (PDR) and Eales' Disease (ED) have different aetiologies although they share certain common clinical symptoms including pre-retinal neovascularization. Since there is a need to understand if the shared end-stage angiogenic pathology of PDR and ED is driven by common stimulating factors, we have studied the cytokines contained in vitreous from both patient groups and analyzed the angiogenic potential of these samples in vitro. Material and Methods: Vitreous samples from patients with PDR (n = 13) and ED (n = 5) were quantified for various cytokines using a cytokine biochip array and sandwich ELISA. An additional group of patients (n = 5) with macular hole (MH) was also studied for comparison. To determine the angiogenic potential of these vitreous samples, they were analyzed for their ability to induce tubulogenesis in human microvascular endothelial cells. Further, the effect of anti-VEGF (Ranibizumab) and anti-IL-6 antibodies were studied on vitreous-mediated vascular tube formation. Results: Elevated levels of IL-6, IL-8, MCP-1 and VEGF were observed in vitreous of both PDR and ED when compared to MH. PDR and ED vitreous induced greater levels of endothelial cell tube formation compared to controls without vitreous (P < 0.05). When VEGF in vitreous was neutralized by clinically-relevant concentrations of Ranibizumab, tube length was reduced significantly in 5 of 6 PDR and 3 of 5 ED samples. Moreover, when treated with IL-6 neutralizing antibody, apparent reduction (71.4%) was observed in PDR vitreous samples. Conclusions: We have demonstrated that vitreous specimens from PDR and ED patients share common elevations of pro-inflammatory and pro-angiogenic cytokines. This suggests that common cytokine profiles link these two conditions.	[Murugeswari, Ponnalagu; Muthukkaruppan, Veerappan] Dr G Venkataswamy Eye Res Inst, Aravind Med Res Fdn, Dept Immunol & Cell Biol, Madurai, Tamil Nadu, India; [Shukla, Dhananjay; Kim, Ramasamy; Namperumalsamy, Perumalsamy] Aravind Eye Care Syst, Vitreous & Retina Serv, Madurai, Tamil Nadu, India; [Stitt, Alan W.] Queens Univ Belfast, Ctr Med Expt, Belfast, Antrim, North Ireland	Queens University Belfast	Muthukkaruppan, V (corresponding author), Dr G Venkataswamy Eye Res Inst, Aravind Med Res Fdn, Dept Immunol & Cell Biol, Madurai, Tamil Nadu, India.	muthu@aravind.org	Veerappan, Muthukkaruppan/AAE-8516-2022; Stitt, Alan/A-9842-2009	Stitt, Alan/0000-0002-8647-9918	Department of Science and Technology, TIFAC-CORE in diabetic retinopathy, India [SR/SO/HS-04/2003]; Commonwealth Split-Site Scholarship programme; Diabetes UK [10/0004138] Funding Source: researchfish; Medical Research Council [G0801962] Funding Source: researchfish; Fight for Sight [1871/72] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [10JTA] Funding Source: researchfish; MRC [G0801962] Funding Source: UKRI	Department of Science and Technology, TIFAC-CORE in diabetic retinopathy, India; Commonwealth Split-Site Scholarship programme; Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Fight for Sight; The Sir Jules Thorn Charitable Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by grants from Department of Science and Technology (SR/SO/HS-04/2003), TIFAC-CORE in diabetic retinopathy, India, and Commonwealth Split-Site Scholarship programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abcouwer SF, 2013, J CLIN CELL IMMUN S1, V1; Abu El-Asrar AM, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/539658; Adamis AP, 2008, SEMIN IMMUNOPATHOL, V30, P65, DOI 10.1007/s00281-008-0111-x; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; [Anonymous], 1991, OPHTHALMOLOGY, V98, P823; Arevalo JF, 2009, EYE, V23, P117, DOI 10.1038/sj.eye.6702980; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Atmaca LS, 2002, OCUL IMMUNOL INFLAMM, V10, P213, DOI 10.1076/ocii.10.3.213.15598; Boyer DS, 2013, THER ADV ENDOCRINOL, V4, P151, DOI 10.1177/2042018813512360; Bromberg-White JL, 2013, INVEST OPHTH VIS SCI, V54, P6472, DOI 10.1167/iovs.13-12518; Chen Y, 1999, J MOL BIOL, V293, P865, DOI 10.1006/jmbi.1999.3192; Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736; Das Taraprasad, 1994, Indian Journal of Ophthalmology, V42, P3; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 2006, RETINA-J RET VIT DIS, V26, P859, DOI 10.1097/01.iae.0000242842.14624.e7; Funatsu H, 2005, GRAEF ARCH CLIN EXP, V243, P3, DOI 10.1007/s00417-004-0950-7; Funatsu H, 2001, RETINA-J RET VIT DIS, V21, P469, DOI 10.1097/00006982-200110000-00009; Goebeler M, 2001, BLOOD, V97, P46, DOI 10.1182/blood.V97.1.46; Grosjean J, 2006, BIOCHEM BIOPH RES CO, V340, P984, DOI 10.1016/j.bbrc.2005.12.095; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Koskela UE, 2013, OPHTHALMIC RES, V49, P108, DOI 10.1159/000342977; Koytak A, 2013, EYE, V27, P716, DOI 10.1038/eye.2013.17; Marumo T, 1999, DIABETES, V48, P1131, DOI 10.2337/diabetes.48.5.1131; MARUO N, 1992, ENDOCRINOLOGY, V131, P710, DOI 10.1210/en.131.2.710; Murthy K., 1977, PROC ALL IND OPHTHAL, V33, P323; Murugeswari P, 2008, RETINA-J RET VIT DIS, V28, P817, DOI 10.1097/IAE.0b013e31816576d5; Namperumalsamy P, 2013, TXB RETINA, P1479; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Osaadon P, 2014, EYE, V28, P510, DOI 10.1038/eye.2014.13; Petreaca ML, 2007, MOL BIOL CELL, V18, P5014, DOI 10.1091/mbc.E07-01-0004; REINHOLD HS, 1975, BRIT J RADIOL, V48, P727, DOI 10.1259/0007-1285-48-573-727; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Schnichels S, 2013, BRIT J OPHTHALMOL, V97, P917, DOI 10.1136/bjophthalmol-2013-303130; Stitt AW, 2005, DIABETES, V54, P785, DOI 10.2337/diabetes.54.3.785; Tolentino MJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P964, DOI 10.1001/archopht.1996.01100140172010; Wei LH, 2003, ONCOGENE, V22, P1517, DOI 10.1038/sj.onc.1206226; WILLIAMS MC, 1975, J CELL BIOL, V66, P531, DOI 10.1083/jcb.66.3.531; Yoshimura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008158	38	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e107551	10.1371/journal.pone.0107551	http://dx.doi.org/10.1371/journal.pone.0107551			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310689	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210300007
J	Secka, O; Moodley, Y; Antonio, M; Berg, DE; Tapgun, M; Walton, R; Worwui, A; Thomas, V; Corrah, T; Thomas, JE; Adegbola, RA				Secka, Ousman; Moodley, Yoshan; Antonio, Martin; Berg, Douglas E.; Tapgun, Mary; Walton, Robert; Worwui, Archibald; Thomas, Vivat; Corrah, Tumani; Thomas, Julian E.; Adegbola, Richard A.			Population Genetic Analyses of Helicobacter pylori Isolates from Gambian Adults and Children	PLOS ONE			English	Article							INFECTION; STRAINS; PREVALENCE; DIVERSITY; AFRICAN; RECOMBINATION; COLONIZATION; TRANSMISSION; ASSOCIATION	The gastric pathogen Helicobacter pylori is one of the most genetically diverse of bacterial species. Much of its diversity stems from frequent mutation and recombination, preferential transmission within families and local communities, and selection during persistent gastric mucosal infection. MLST of seven housekeeping genes had identified multiple distinct H. pylori populations, including three from Africa: hpNEAfrica, hpAfrica1 and hpAfrica2, which consists of three subpopulations (hspWAfrica, hspCAfrica and hspSAfrica). Most detailed H. pylori population analyses have used strains from non-African countries, despite Africa's high importance in the emergence and evolution of humans and their pathogens. Our concatenated sequences from seven H. pylori housekeeping genes from 44 Gambian patients (MLST) identified 42 distinct sequence types (or haplotypes), and no clustering with age or disease. STRUCTURE analysis of the sequence data indicated that Gambian H. pylori strains belong to the hspWAfrica subpopulation of hpAfrica1, in accord with Gambia's West African location. Despite Gambia's history of invasion and colonisation by Europeans and North Africans during the last millennium, no traces of Ancestral Europe1 (AE1) population carried by those people were found. Instead, admixture of 17% from Ancestral Europe2 (AE2) was detected in Gambian strains; this population predominates in Nilo-Saharan speakers of North-East Africa, and might have been derived from admixture of hpNEAfrica strains these people carried when they migrated across the Sahara during the Holocene humid period 6,000-9,000 years ago. Alternatively, shared AE2 ancestry might have resulted from shared ancestral polymorphisms already present in the common ancestor of sister populations hpAfrica1 and hpNEAfrica.	[Secka, Ousman; Antonio, Martin; Worwui, Archibald] MRC Unit, Fajara, Gambia; [Moodley, Yoshan] Univ Vet Med Vienna, Konrad Lorenz Inst Ethol, Dept Integrat Biol & Evolut, Vienna, Austria; [Berg, Douglas E.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Berg, Douglas E.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Tapgun, Mary; Walton, Robert; Thomas, Vivat; Corrah, Tumani] MRC Unit, Clin Serv Dept, Fajara, Gambia; [Thomas, Julian E.] Royal Victoria Infirm, Great North Childrens Hosp, Dept Paediat Gastroenterol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Adegbola, Richard A.] MRC Unit, Bacterial Dis Programme, Fajara, Gambia	University of London; London School of Hygiene & Tropical Medicine; University of Veterinary Medicine Vienna; Washington University (WUSTL); University of California System; University of California San Diego; University of London; London School of Hygiene & Tropical Medicine; Newcastle University - UK; University of London; London School of Hygiene & Tropical Medicine	Secka, O (corresponding author), MRC Unit, Fajara, Gambia.	osecka@mrc.gm		Moodley, Yoshan/0000-0003-4216-2924; Walton, Robert/0000-0001-7700-1907	MRC unit, The Gambia; US National Institutes of Health (NIH) [RO3-AI061308, R21-AI078237, R21-AI088337]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078237, R03AI061308, R21AI088337] Funding Source: NIH RePORTER; Medical Research Council [MC_U190081977, MC_U190074190, MC_U190081991] Funding Source: researchfish; MRC [MC_U190074190, MC_U190081991, MC_U190081977] Funding Source: UKRI	MRC unit, The Gambia(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by MRC unit, The Gambia and US National Institutes of Health (NIH) grants RO3-AI061308, R21-AI078237 and R21-AI088337. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, MOL MICROBIOL, V32, P459, DOI 10.1046/j.1365-2958.1999.01382.x; Akada JK, 2003, MICROBIOL-SGM, V149, P1901, DOI 10.1099/mic.0.26129-0; Alm RA, 1999, J MOL MED, V77, P834, DOI 10.1007/s001099900067; Bergman M, 2006, NAT REV MICROBIOL, V4, P151, DOI 10.1038/nrmicro1344; Blaser MJ, 1998, BRIT MED J, V316, P1507, DOI 10.1136/bmj.316.7143.1507; Breurec S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022058; Campbell DI, 2001, HELICOBACTER, V6, P263, DOI 10.1046/j.1083-4389.2001.00047.x; Chong VH, 2008, SINGAP MED J, V49, P42; Cover TL, 2009, GASTROENTEROLOGY, V136, P1863, DOI 10.1053/j.gastro.2009.01.073; Everhart JE, 2000, J INFECT DIS, V181, P1359, DOI 10.1086/315384; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Herrera PM, 2008, J CLIN MICROBIOL, V46, P3912, DOI 10.1128/JCM.01453-08; Isaacson PG, 2005, J PATHOL, V205, P255, DOI 10.1002/path.1703; Israel DA, 2001, P NATL ACAD SCI USA, V98, P14625, DOI 10.1073/pnas.251551698; Jemilohun AC, 2010, PAN AFR MED J, V6; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Kersulyte D, 1999, MOL MICROBIOL, V31, P31, DOI 10.1046/j.1365-2958.1999.01140.x; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Linz B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087355; McNulty SL, 2004, J CLIN MICROBIOL, V42, P5658, DOI 10.1128/JCM.42.12.5658-5663.2004; Moodley Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002693; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Nell S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003775; Passaro DJ, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e87; Perry S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008804; Raymond J, 2004, EMERG INFECT DIS, V10, P1816, DOI 10.3201/eid1010.040042; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schwarz S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000180; Secka O, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-5; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; Thomas JE, 2004, ARCH DIS CHILD, V89, P1149, DOI 10.1136/adc.2002.015313; Thomas JE, 1999, PEDIATR RES, V45, P218, DOI 10.1203/00006450-199902000-00010; Vakil N, 2008, ALIMENT PHARM THER, V28, P1304, DOI 10.1111/j.1365-2036.2008.03846.x; Weyermann M, 2009, AM J GASTROENTEROL, V104, P182, DOI 10.1038/ajg.2008.61	34	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109466	10.1371/journal.pone.0109466	http://dx.doi.org/10.1371/journal.pone.0109466			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310300	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000343210300052
J	Li, ZY; Pu-Liu; Chen, ZH; An, FH; Li, LH; Li-Li; Guo, CY; Gu, Y; Liu, Z; Zhu, TB; Wang, LS; Li, CJ; Kong, XQ; Ma, WZ; Yang, ZJ; Jia, EZ				Li, Zhao-Yang; Pu-Liu; Chen, Zhao-Hong; An, Feng-Hui; Li, Li-Hua; Li-Li; Guo, Chang-Yan; Gu, Yan; Liu, Zhe; Zhu, Tie-Bing; Wang, Lian-Sheng; Li, Chun-Jian; Kong, Xiang-Qing; Ma, Wen-Zhu; Yang, Zhi-Jian; Jia, En-Zhi			Combined Effects of Admission Serum Creatinine Concentration with Age and Gender on the Prognostic Significance of Subjects with Acute ST-Elevation Myocardial Infarction in China	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; IN-HOSPITAL MORTALITY; GLOMERULAR-FILTRATION-RATE; RENAL-INSUFFICIENCY; CARDIOVASCULAR-DISEASE; HEART-INSTITUTE; KIDNEY-DISEASE; RISK-FACTOR; ASSOCIATION; CARDIOLOGY	Objective: to explore the impact of admission serum creatinine concentration on the in-hospital mortality and its interaction with age and gender in patients with acute ST-segment elevation myocardial infarction (STEMI) in China. Methods: 1424 acute STEMI patients were enrolled in the study. Anthropometric and laboratory measurements were collected from every patient. A Cox proportional hazards regression model was used to determine the relationships between the admission serum creatinine level (Cr level), age, sex and the in-hospital mortality. A crossover analysis and a stratified analysis were used to determine the combined impact of Cr levels with age and gender. Results: Female (HR 1.687, 95%CI 1.051 similar to 2.708), elevated Cr level (HR 5.922, 95%CI 3.780 similar to 9,279) and old age (1.692, 95%CI 1.402 similar to 2.403) were associated with a high risk of death respectively. After adjusting for other confounders, the renal dysfunction was still independently associated with a higher risk of death (HR 2.48, 95% CI 1.32 similar to 4.63), while female gender (HR 1.19, 95%CI 0.62 similar to 2.29) and old age (HR 1.77, 95%CI 0.92 similar to 3.37) was not. In addition, crossover analysis revealed synergistic effects between elevated Cr level and female gender (SI = 3.01, SIM = 2.10, AP = 0.55). Stratified analysis showed that the impact of renal dysfunction on in-hospital mortality was more pronounced in patients <60 years old (odds ratios 11.10, 95% CI 3.72 to 33.14) compared with patients 60 to 74 years old (odds ratios 5.18, 95% CI 2.48 similar to 10.83) and patients >= 75years old (odds ratios 3.99, 95% CI 1.89 to 8.42). Conclusion: Serum Cr concentration on admission was a strong predictor for in-hospital mortality among Chinese acute STEMI patients especially in the young and the female.	[Li, Zhao-Yang; Li-Li; Guo, Chang-Yan; Gu, Yan; Liu, Zhe; Zhu, Tie-Bing; Wang, Lian-Sheng; Li, Chun-Jian; Kong, Xiang-Qing; Ma, Wen-Zhu; Yang, Zhi-Jian; Jia, En-Zhi] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Nanjing, Jiangsu, Peoples R China; [Pu-Liu; Chen, Zhao-Hong; An, Feng-Hui; Li, Li-Hua] Friendship Hosp Ili Kazakh Autonomous Prefecture, Dept Cardiovasc Med, Yining, Xinjiang, Peoples R China	Nanjing Medical University	Jia, EZ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Nanjing, Jiangsu, Peoples R China.	enzhijiacn@aliyun.com	Jia, Enzhi/AGX-9137-2022		National Natural Science Foundation of China [30400173, 30971257, 81170180]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	Support was provided by the National Natural Science Foundation of China, No. 30400173, 30971257, and 81170180. This work was a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai A, 2010, J CARD FAIL, V16, P381, DOI 10.1016/j.cardfail.2009.12.020; Assali AR, 2003, CATHETER CARDIO INTE, V59, P195, DOI 10.1002/ccd.10532; Bellomo R, 2007, NEW ENGL J MED, V357, P2205; Benamer H, 2011, EUROINTERVENTION, V6, P1073, DOI 10.4244/EIJV6I9A187; Cardarelli F, 2009, AM J CARDIOL, V103, P766, DOI 10.1016/j.amjcard.2008.11.033; Dharmarajan K, 2013, CIRC-CARDIOVASC QUAL, V6, P732, DOI 10.1161/CIRCOUTCOMES.113.000441; French WJ, 2003, J AM COLL CARDIOL, V42, P1544, DOI 10.1016/j.jacc.2003.08.001; GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Herzog CA, 1998, NEW ENGL J MED, V339, P799, DOI 10.1056/NEJM199809173391203; Hiew C, 2010, J INVASIVE CARDIOL, V22, P273; Hu SS, 2012, BIOMED ENVIRON SCI, V25, P251, DOI 10.3967/0895-3988.2012.03.001; Izadnegahdar M, 2013, J WOMENS HEALTH; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Marti TM, 2013, MED CLIN-BARCELONA, V140, P395, DOI 10.1016/j.medcli.2012.03.011; Naito K, 2008, J CARD FAIL, V14, P831, DOI 10.1016/j.cardfail.2008.07.233; O'Connor RE, 2010, CIRCULATION, V122, pS787, DOI 10.1161/CIRCULATIONAHA.110.971028; Peters SAE, 2014, DIABETOLOGIA, V57, P1542, DOI 10.1007/s00125-014-3260-6; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Shlipak MG, 2002, ANN INTERN MED, V137, P555, DOI 10.7326/0003-4819-137-7-200210010-00006; Yamaguchi J, 2004, AM J CARDIOL, V93, P1526, DOI 10.1016/j.amjcard.2004.02.065; Yamaguchi J, 2007, CIRC J, V71, P1354, DOI 10.1253/circj.71.1354; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Zhang B, 2013, CHINESE MED J-PEKING, V126, P3481, DOI 10.3760/cma.j.issn.0366-6999.20130381; Zhao L, 2009, J INVASIVE CARDIOL, V21, P493; Zhou CH, 2012, INT J CARDIOL, V162, P59, DOI 10.1016/j.ijcard.2012.09.174	27	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108986	10.1371/journal.pone.0108986	http://dx.doi.org/10.1371/journal.pone.0108986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303229	gold, Green Published, Green Submitted			2022-12-27	WOS:000343730400040
J	Sands, B; Jenkins, P; Peria, WJ; Naivar, M; Houston, JP; Brent, R				Sands, Bryan; Jenkins, Patrick; Peria, William J.; Naivar, Mark; Houston, Jessica P.; Brent, Roger			Measuring and Sorting Cell Populations Expressing Isospectral Fluorescent Proteins with Different Fluorescence Lifetimes	PLOS ONE			English	Article							SPATIOTEMPORAL REGULATION; NETWORKS; SYSTEM; PHOSPHORYLATION; ACTIVATION; REPORTERS; MECHANISM; SIGNALS; PROBES; REVEAL	Study of signal transduction in live cells benefits from the ability to visualize and quantify light emitted by fluorescent proteins (XFPs) fused to different signaling proteins. However, because cell signaling proteins are often present in small numbers, and because the XFPs themselves are poor fluorophores, the amount of emitted light, and the observable signal in these studies, is often small. An XFP's fluorescence lifetime contains additional information about the immediate environment of the fluorophore that can augment the information from its weak light signal. Here, we constructed and expressed in Saccharomyces cerevisiae variants of Teal Fluorescent Protein (TFP) and Citrine that were isospectral but had shorter fluorescence lifetimes, similar to 1.5 ns vs similar to 3 ns. We modified microscopic and flow cytometric instruments to measure fluorescence lifetimes in live cells. We developed digital hardware and a measure of lifetime called a pseudophasor that we could compute quickly enough to permit sorting by lifetime in flow. We used these abilities to sort mixtures of cells expressing TFP and the short-lifetime TFP variant into subpopulations that were respectively 97% and 94% pure. This work demonstrates the feasibility of using information about fluorescence lifetime to help quantify cell signaling in living cells at the high throughput provided by flow cytometry. Moreover, it demonstrates the feasibility of isolating and recovering subpopulations of cells with different XFP lifetimes for subsequent experimentation.	[Sands, Bryan; Peria, William J.; Brent, Roger] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Jenkins, Patrick; Houston, Jessica P.] New Mexico State Univ, Dept Chem Engn, Las Cruces, NM 88003 USA; [Naivar, Mark] Darkling X LLC, Los Alamos, NM USA	Fred Hutchinson Cancer Center; New Mexico State University	Brent, R (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA.	rbrent@fhcrc.org			National Cancer Institute [U54 CA132381-06A1]; National Institute of General Medical Sciences [RO1 GM097479]; National Institute of Health [RO1 GM086615]; NATIONAL CANCER INSTITUTE [U54CA132381, U54CA132383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086615, R01GM097479] Funding Source: NIH RePORTER; Direct For Biological Sciences [1150202] Funding Source: National Science Foundation	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Cancer Institute, grant number U54 CA132381-06A1 to JPH and RB. RB also had significant support from the National Institute of General Medical Sciences, grant number RO1 GM097479. Significant past support came from the National Institute of Health, grant number RO1 GM086615 to RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Akinfieva O, 2013, CRIT REV ONCOL HEMAT, V86, P1, DOI 10.1016/j.critrevonc.2012.09.004; Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; AMMERER G, 1983, METHOD ENZYMOL, V101, P192; Ausubel FM, 1987, CURRENT PROTOCOLS MO, V1-5; Beck R, 2001, IEEE T CIRCUITS-II, V48, P691, DOI 10.1109/82.958339; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Bodenmiller B, 2012, NAT BIOTECHNOL, V30, P858, DOI 10.1038/nbt.2317; Brent R, 2005, SCIENCE, V308, P504, DOI 10.1126/science.1110535; Brent R, 2009, FEBS LETT, V583, P4019, DOI 10.1016/j.febslet.2009.11.029; Bush A, 2013, BIOPHYS J, V104, P727, DOI 10.1016/j.bpj.2012.12.030; Cao RF, 2013, OPT EXPRESS, V21, P14816, DOI 10.1364/OE.21.014816; Chattopadhyay PK, 2010, WIRES NANOMED NANOBI, V2, P334, DOI 10.1002/wnan.75; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; COLICELLI J, 1989, P NATL ACAD SCI USA, V86, P3599, DOI 10.1073/pnas.86.10.3599; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Covey TM, 2013, CYTOM PART A, V83A, P386, DOI 10.1002/cyto.a.22244; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Du J, 2012, STEM CELLS, V30, P1447, DOI 10.1002/stem.1127; EKIMOV AI, 1981, JETP LETT+, V34, P345; Frigo M, 2005, P IEEE, V93, P216, DOI 10.1109/JPROC.2004.840301; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Gadella TWJ, 2009, LAB TECH BIOCHEM MOL, V33, P395, DOI 10.1016/S0075-7535(08)00009-0; Gohar AV, 2013, BIOMED OPT EXPRESS, V4, P1390, DOI 10.1364/BOE.4.001390; Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; Horgan AM, 2003, EXP CELL RES, V285, P208, DOI 10.1016/S0014-4827(03)00037-5; Houston J. P., 2009, Proceedings 25th Southern Biomedical Engineering Conference (IFMBE 2009), P261, DOI 10.1007/978-3-642-01697-4_91; Houston JP, 2010, CYTOM PART A, V77A, P861, DOI 10.1002/cyto.a.20930; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Irish JM, 2010, P NATL ACAD SCI USA, V107, P12747, DOI 10.1073/pnas.1002057107; Kasai RS, 2014, CURR OPIN CELL BIOL, V27, P78, DOI 10.1016/j.ceb.2013.11.008; Kiyokawa E, 2011, ANNU REV PHARMACOL, V51, P337, DOI 10.1146/annurev-pharmtox-010510-100234; Lackowicz JR, 2006, PRINCIPLES FLUORESCE; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Monici M, 2005, BIOTECHNOL ANN REV, V11, P227, DOI 10.1016/S1387-2656(05)11007-2; Murakoshi H, 2008, BRAIN CELL BIOL, V36, P31, DOI 10.1007/s11068-008-9024-9; Naivar MA, 2007, CYTOM PART A, V71A, P915, DOI 10.1002/cyto.a.20445; Naivar MA, 2009, CYTOM PART A, V75A, P979, DOI 10.1002/cyto.a.20814; Nakamura T, 2005, METHODS, V37, P146, DOI 10.1016/j.ymeth.2005.05.021; Palazzo AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024592; PINSKY BG, 1993, CYTOMETRY, V14, P123, DOI 10.1002/cyto.990140204; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Resch-Genger U, 2008, NAT METHODS, V5, P763, DOI [10.1038/nmeth.1248, 10.1038/NMETH.1248]; ROMAN H, 1956, CR TRAV LAB CARLS P, V26, P299; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Sachs K, 2009, IEEE ENG MED BIO, P6624, DOI 10.1109/IEMBS.2009.5332563; Sample V, 2014, J CELL SCI, V127, P1151, DOI 10.1242/jcs.099994; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/nmeth.1855, 10.1038/NMETH.1855]; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shapiro HM, 2003, PRACTICAL FLOW CYTOM; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; STEINKAMP JA, 1993, REV SCI INSTRUM, V64, P3440, DOI 10.1063/1.1144265; STEINKAMP JA, 1993, CYTOMETRY, V14, P210, DOI 10.1002/cyto.990140214; STEINKAMP JA, 2001, P SOC PHOTO-OPT INS, V2, P166; Thomson TM, 2011, P NATL ACAD SCI USA, V108, P20265, DOI 10.1073/pnas.1004042108; Ting AY, 2001, P NATL ACAD SCI USA, V98, P15003, DOI 10.1073/pnas.211564598; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; van der Pol B, 1946, J IEE, V93, P153, DOI DOI 10.1049/JI-3-2.1946.0024; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Yi TM, 2003, P NATL ACAD SCI USA, V100, P10764, DOI 10.1073/pnas.1834247100; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798; Zhou X, 2012, METHOD ENZYMOL, V504, P317, DOI 10.1016/B978-0-12-391857-4.00016-1	66	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109940	10.1371/journal.pone.0109940	http://dx.doi.org/10.1371/journal.pone.0109940			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25302964	Green Submitted, gold, Green Published			2022-12-27	WOS:000343730400093
J	Yao, B; Hametner, S; van Gelderen, P; Merkl, H; Chen, C; Lassmann, H; Duyn, JH; Bagnato, F				Yao, Bing; Hametner, Simon; van Gelderen, Peter; Merkl, Hellmuth; Chen, Christina; Lassmann, Hans; Duyn, Jeff H.; Bagnato, Francesca			7 Tesla Magnetic Resonance Imaging to Detect Cortical Pathology in Multiple Sclerosis	PLOS ONE			English	Article							HUMAN BRAIN; BIOPHYSICAL MECHANISMS; LESION DETECTION; CEREBRAL-CORTEX; MRI; CONTRAST; IRON; HETEROGENEITY; IDENTIFICATION; DEMYELINATION	Background: Neocortical lesions (NLs) are an important pathological component of multiple sclerosis (MS), but their visualization by magnetic resonance imaging (MRI) remains challenging. Objectives: We aimed at assessing the sensitivity of multi echo gradient echo (ME-GRE) T-2*-weighted MRI at 7.0 Tesla in depicting NLs compared to myelin and iron staining. Methods: Samples from two MS patients were imaged post mortem using a whole body 7T MRI scanner with a 24-channel receive-only array. Isotropic 200 micron resolution images with varying T-2* weighting were reconstructed from the ME-GRE data and converted into R-2* maps. Immunohistochemical staining for myelin (proteolipid protein, PLP) and diaminobenzidine-enhanced Turnbull blue staining for iron were performed. Results: Prospective and retrospective sensitivities of MRI for the detection of NLs were 48% and 67% respectively. We observed MRI maps detecting only a small portion of 20 subpial NLs extending over large cortical areas on PLP stainings. No MRI signal changes suggestive of iron accumulation in NLs were observed. Conversely, R-2* maps indicated iron loss in NLs, which was confirmed by histological quantification. Conclusions: High-resolution post mortem imaging using R-2* and magnitude maps permits detection of focal NLs. However, disclosing extensive subpial demyelination with MRI remains challenging.	[Yao, Bing; van Gelderen, Peter; Merkl, Hellmuth; Duyn, Jeff H.] NINDS, Adv Magnet Resonance Imaging Sect, Lab Funct & Mol Imaging, NIH, Bethesda, MD 20892 USA; [Yao, Bing] Kessler Fdn, Ctr Neuroimaging Res, W Orange, NJ USA; [Hametner, Simon; Lassmann, Hans] Med Univ, Ctr Brain Res, Vienna, Austria; [Chen, Christina; Bagnato, Francesca] NINDS, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA; [Bagnato, Francesca] Vanderbilt Univ, Inst Imaging Sci, Dept Radiol & Radiol Sci, Nashville, TN 37235 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Kessler Institute for Rehabilitation; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Vanderbilt University	Bagnato, F (corresponding author), NINDS, Neuroimmunol Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	fbagnato@umm.edu	Lassmann, Hans/Z-2269-2019; van Gelderen, Peter/U-4535-2019	Lassmann, Hans/0000-0001-8617-5052; 	Intramural Research Program of the NINDS, NIH; Austrian Science Fund [P19854-B02]	Intramural Research Program of the NINDS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Austrian Science Fund(Austrian Science Fund (FWF))	This research was supported by the Intramural Research Program of the NINDS, NIH and by the Austrian Science Fund (Project P19854-B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnato F, 2006, AM J NEURORADIOL, V27, P2161; Bagnato F, 2011, BRAIN, V134, P3599, DOI 10.1093/brain/awr278; Bagnato F, 2010, MULT SCLER J, V16, P1203, DOI 10.1177/1352458510377223; Bagnato F, 2009, J NEUROL SCI, V282, P80, DOI 10.1016/j.jns.2009.03.021; Bo L, 2003, J NEUROPATH EXP NEUR, V62, P723, DOI 10.1093/jnen/62.7.723; Bradl M, 2009, SEMIN IMMUNOPATHOL, V31, P455, DOI 10.1007/s00281-009-0182-3; Chen G, 2012, NEUROIMAGE, V59, P3441, DOI 10.1016/j.neuroimage.2011.10.079; Dawe RJ, 2009, MAGN RESON MED, V61, P810, DOI 10.1002/mrm.21909; de Zwart JA, 2004, MAGNET RESON MED, V51, P22, DOI 10.1002/mrm.10678; Dolezal O, 2007, INT REV NEUROBIOL, V79, P475, DOI 10.1016/S0074-7742(07)79021-9; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; Fishbein KW, 2007, MAGN RESON MED, V57, P1000, DOI 10.1002/mrm.21216; Forge JK, 1998, LIFE SCI, V63, P2271, DOI 10.1016/S0024-3205(98)00512-8; Fukunaga M, 2010, P NATL ACAD SCI USA, V107, P3834, DOI 10.1073/pnas.0911177107; Geurts JJG, 2008, J NEUROL, V255, P183, DOI 10.1007/s00415-008-0620-5; Haider L, 2014, J NEUROL NE IN PRESS; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Hametner S, 2013, ANN NEUROL, V74, P848, DOI 10.1002/ana.23974; Hammond KE, 2008, ANN NEUROL, V64, P707, DOI 10.1002/ana.21582; He X, 2009, P NATL ACAD SCI USA, V106, P13558, DOI 10.1073/pnas.0904899106; Kennan RP, 1996, J MAGN RESON SER B, V110, P267, DOI 10.1006/jmrb.1996.0042; Kooi EJ, 2012, NEUROLOGY, V79, P1369, DOI 10.1212/WNL.0b013e31826c1b1c; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Langkammer C, 2012, NEUROIMAGE, V59, P1413, DOI 10.1016/j.neuroimage.2011.08.045; Li TQ, 2006, NEUROIMAGE, V32, P1032, DOI 10.1016/j.neuroimage.2006.05.053; Li TQ, 2009, MAGN RESON MED, V62, P1652, DOI 10.1002/mrm.22156; Mainero C, 2009, NEUROLOGY, V73, P941, DOI 10.1212/WNL.0b013e3181b64bf7; Mike A, 2011, AM J NEURORADIOL, V32, P515, DOI 10.3174/ajnr.A2340; Moraal B, 2008, EUR RADIOL, V18, P2311, DOI 10.1007/s00330-008-1009-7; Nelson F, 2008, MULT SCLER J, V14, P1214, DOI 10.1177/1352458508094644; Nelson F, 2007, AM J NEURORADIOL, V28, P1645, DOI 10.3174/ajnr.A0645; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; Pitt D, 2010, ARCH NEUROL-CHICAGO, V67, P812, DOI 10.1001/archneurol.2010.148; Schmierer K, 2010, BRAIN, V133, P858, DOI 10.1093/brain/awp335; Seewann A, 2012, NEUROLOGY, V78, P302, DOI 10.1212/WNL.0b013e31824528a0; Seewann A, 2011, MULT SCLER J, V17, P1202, DOI 10.1177/1352458511406575; Spatz H, 1922, Z GESAMTE NEUROL PSY, V77, P261, DOI 10.1007/BF02865844; Wharton S, 2012, P NATL ACAD SCI USA, V109, P18559, DOI 10.1073/pnas.1211075109; Yablonskiy DA, 2012, P NATL ACAD SCI USA, V109, P14212, DOI 10.1073/pnas.1206037109; Yao B, 2012, RADIOLOGY, V262, P206, DOI 10.1148/radiol.11110601	40	60	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108863	10.1371/journal.pone.0108863	http://dx.doi.org/10.1371/journal.pone.0108863			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303286	Green Published, gold, Green Submitted			2022-12-27	WOS:000343730400031
J	Cheddad, A; Czene, K; Eriksson, M; Li, JM; Easton, D; Hall, P; Humphreys, K				Cheddad, Abbas; Czene, Kamila; Eriksson, Mikael; Li, Jingmei; Easton, Douglas; Hall, Per; Humphreys, Keith			Area and Volumetric Density Estimation in Processed Full-Field Digital Mammograms for Risk Assessment of Breast Cancer	PLOS ONE			English	Article							TOOL; FORM	Introduction: Mammographic density, the white radiolucent part of a mammogram, is a marker of breast cancer risk and mammographic sensitivity. There are several means of measuring mammographic density, among which are area-based and volumetric-based approaches. Current volumetric methods use only unprocessed, raw mammograms, which is a problematic restriction since such raw mammograms are normally not stored. We describe fully automated methods for measuring both area and volumetric mammographic density from processed images. Methods: The data set used in this study comprises raw and processed images of the same view from 1462 women. We developed two algorithms for processed images, an automated area-based approach (CASAM-Area) and a volumetric-based approach (CASAM-Vol). The latter method was based on training a random forest prediction model with image statistical features as predictors, against a volumetric measure, Volpara, for corresponding raw images. We contrast the three methods, CASAM-Area, CASAM-Vol and Volpara directly and in terms of association with breast cancer risk and a known genetic variant for mammographic density and breast cancer, rs10995190 in the gene ZNF365. Associations with breast cancer risk were evaluated using images from 47 breast cancer cases and 1011 control subjects. The genetic association analysis was based on 1011 control subjects. Results: All three measures of mammographic density were associated with breast cancer risk and rs10995190 (p<0.025 for breast cancer risk and p, 1610 26 for rs10995190). After adjusting for one of the measures there remained little or no evidence of residual association with the remaining density measures (p>0.10 for risk, p>0.03 for rs10995190). Conclusions: Our results show that it is possible to obtain reliable automated measures of volumetric and area mammographic density from processed digital images. Area and volumetric measures of density on processed digital images performed similar in terms of risk and genetic association.	[Cheddad, Abbas; Czene, Kamila; Eriksson, Mikael; Hall, Per; Humphreys, Keith] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Li, Jingmei] Genome Inst Singapore, Singapore, Singapore; [Easton, Douglas] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge, England	Karolinska Institutet; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Cambridge	Cheddad, A (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	Abbas.Cheddad@ki.se	Li, Jingmei/I-2904-2012; Cheddad, Abbas/R-7061-2018	Li, Jingmei/0000-0001-8587-7511; Czene, Kamila/0000-0002-3233-5695; Cheddad, Abbas/0000-0002-4390-411X; eriksson, mikael/0000-0001-8135-4270	Swedish Research Council [521-2011-3205]; Swedish Cancer Society [11 0600]; Swedish E-Science Research Centre; Marit and Hans Rausings Initiative against Breast Cancer; Cancer Risk Prediction Center; Linneus Centre [70867902]; Swedish Research Council; 2nd Joint Council Office (JCO) Career Development Grant [13302EG065]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish E-Science Research Centre; Marit and Hans Rausings Initiative against Breast Cancer; Cancer Risk Prediction Center; Linneus Centre; Swedish Research Council(Swedish Research CouncilEuropean Commission); 2nd Joint Council Office (JCO) Career Development Grant	This work was supported by the Swedish Research Council [grant number 521-2011-3205], the Swedish Cancer Society [contract number 11 0600] and the Swedish E-Science Research Centre. The KARMA study was supported by Marit and Hans Rausings Initiative against Breast Cancer and the Cancer Risk Prediction Center (CRisP:www.crispcenter.org), a Linneus Centre [contract number 70867902] financed by the Swedish Research Council. Jingmei Li is supported by the 2nd Joint Council Office (JCO) Career Development Grant (13302EG065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken Z, 2010, CANCER EPIDEM BIOMAR, V19, P418, DOI 10.1158/1055-9965.EPI-09-1059; Boyd N, 2009, CANCER EPIDEM BIOMAR, V18, P1754, DOI 10.1158/1055-9965.EPI-09-0107; Boyd NF, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2423; Brand JS, 2014, CANCER EPIDEM BIOMAR, V23, P1764, DOI 10.1158/1055-9965.EPI-13-1219; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BYNG JW, 1994, PHYS MED BIOL, V39, P1629, DOI 10.1088/0031-9155/39/10/008; Byrne C, 1997, J NATL CANCER I, V89, P531, DOI 10.1093/jnci/89.8.531; Cheddad A, 2014, CANCER EPIDEM BIOMAR, V23, P1314, DOI 10.1158/1055-9965.EPI-13-1240; Ciatto S, 2012, BREAST, V21, P503, DOI 10.1016/j.breast.2012.01.005; Ding J, 2008, CANCER EPIDEM BIOMAR, V17, P1074, DOI 10.1158/1055-9965.EPI-07-2634; Gjessing KH, 2013, HAPLIN SOFTWARE GENE; Gubern-Merida A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085952; Heine JJ, 2011, ACAD RADIOL, V18, P556, DOI 10.1016/j.acra.2010.12.015; Heine JJ, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-73; Highnam R, 2010, LECT NOTES COMPUT SC, V6136, P342, DOI 10.1007/978-3-642-13666-5_46; Hofvind S, 2008, ACTA RADIOL, V49, P975, DOI 10.1080/02841850802403730; Jaiantilal A, 2009, RANDOMFOREST MATLAB; Jeffreys M, 2010, LECT NOTES COMPUT SC, V6136, P408, DOI 10.1007/978-3-642-13666-5_55; Li D, 2011, SPIE P MED IMAGING C; Li JM, 2013, J CLIN ONCOL, V31, P2249, DOI 10.1200/JCO.2012.44.5015; Li JM, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3238; Lindstrom S, 2011, NAT GENET, V43, P185, DOI 10.1038/ng.760; McEntee MF, 2014, PROC SPIE, V9037, DOI 10.1117/12.2042966; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Nixon M., 2012, FEATURE EXTRACTION I; Sandberg MEC, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3451; Seo JM, 2013, CLIN RADIOL, V68, P690, DOI 10.1016/j.crad.2013.01.011; Sergeant Jamie C., 2012, Breast Imaging. Proceedings 11th International Workshop, IWDM 2012, P228, DOI 10.1007/978-3-642-31271-7_30; Shepherd JA, 2011, CANCER EPIDEM BIOMAR, V20, P1473, DOI 10.1158/1055-9965.EPI-10-1150; Vachon CM, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3372; Vachon CM, 2000, CANCER CAUSE CONTROL, V11, P653, DOI 10.1023/A:1008926607428; van Engeland S, 2006, IEEE T MED IMAGING, V25, P273, DOI 10.1109/TMI.2005.862741; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]	33	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110690	10.1371/journal.pone.0110690	http://dx.doi.org/10.1371/journal.pone.0110690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329322	Green Published, Green Submitted, gold			2022-12-27	WOS:000343942100084
J	Linsley, PS; Speake, C; Whalen, E; Chaussabel, D				Linsley, Peter S.; Speake, Cate; Whalen, Elizabeth; Chaussabel, Damien			Copy Number Loss of the Interferon Gene Cluster in Melanomas Is Linked to Reduced T Cell Infiltrate and Poor Patient Prognosis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; STAGE-III; CANCER; SIGNATURE; DELETIONS; 9P21	While immunotherapies are rapidly becoming mainstays of cancer treatment, significant gaps remain in our understanding of how to optimally target them, alone or in combination. Here we describe a novel method to monitor levels of immune cells and pathways in expression data from solid tumors using pre-defined groups or modules of co-regulated immune genes. We show that expression of an interconnected sub-network of type I interferon-stimulated genes (ISGs) in melanomas at the time of diagnosis significantly predicted patient survival, as did, to a lesser extent, sub-networks of T helper/T regulatory and NK/T Cytotoxic cell genes. As a group, poor prognosis tumors with reduced ISG and immune gene levels exhibited significant copy number loss of the interferon gene cluster located at chromosome 9p21.3. Our studies demonstrate a link between type I interferon action and immune cell levels in melanomas, and suggest that therapeutic approaches augmenting both activities may be most beneficial.	[Linsley, Peter S.; Speake, Cate; Whalen, Elizabeth; Chaussabel, Damien] Benaroya Res Inst, Dept Syst Immunol, Seattle, WA 98101 USA	Benaroya Research Institute	Linsley, PS (corresponding author), Benaroya Res Inst, Dept Syst Immunol, Seattle, WA 98101 USA.	plinsley@benaroyaresearch.org	Chaussabel, Damien/AAX-1909-2020	Chaussabel, Damien/0000-0002-6131-7242; Speake, Cate/0000-0003-1480-4272				Abhijit GT, 2011, ENHANCED KAPLAN MEIE; Acharya UH, 2013, CLIN PHARMACOL-ADV A, V5, P21, DOI 10.2147/CPAA.S45884; Ascierto ML, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-146; Banchereau R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034390; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Catchpoole DR, 2010, J CLIN ONCOL, V28, pE723, DOI 10.1200/JCO.2010.30.1986; Chatzinasiou F, 2011, JNCI-J NATL CANCER I, V103, P1227, DOI 10.1093/jnci/djr219; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Couzin-Frankel J, 2013, SCIENCE, V342, P1432, DOI 10.1126/science.342.6165.1432; Dunn GP, 2005, NAT IMMUNOL, V6, P722, DOI 10.1038/ni1213; Falchi M, 2009, NAT GENET, V41, P915, DOI 10.1038/ng.410; FOUNTAIN JW, 1992, P NATL ACAD SCI USA, V89, P10557, DOI 10.1073/pnas.89.21.10557; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fuertes MB, 2013, TRENDS IMMUNOL, V34, P67, DOI 10.1016/j.it.2012.10.004; Galon J, 2013, IMMUNITY, V39, P11, DOI 10.1016/j.immuni.2013.07.008; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Hamid O, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-204; HOTHORN T, PARTY LAB RECURSIVE; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Ji RR, 2012, CANCER IMMUNOL IMMUN, V61, P1019, DOI 10.1007/s00262-011-1172-6; Jonsson G, 2010, CLIN CANCER RES, V16, P3356, DOI 10.1158/1078-0432.CCR-09-2509; Lauwerys BR, 2013, ARTHRITIS RHEUM-US, V65, P447, DOI 10.1002/art.37785; Lenci RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050692; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Mann GJ, 2013, J INVEST DERMATOL, V133, P509, DOI 10.1038/jid.2012.283; Mitelman F, 1997, NAT GENET, V15, P417, DOI 10.1038/ng0497supp-417; Mlecnik B, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007240; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; OLOPADE OI, 1992, CANCER RES, V52, P2523; Quaglino P, 2010, ANN ONCOL, V21, P409, DOI 10.1093/annonc/mdp325; R Core Team, 2013, LANG ENV STAT COMP; Rakosy Z, 2008, CANCER GENET CYTOGEN, V182, P116, DOI 10.1016/j.cancergencyto.2008.01.008; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shay T, 2013, P NATL ACAD SCI USA, V110, P2946, DOI 10.1073/pnas.1222738110; Therneau T, PACKAGE SURVIVAL ANA; Therneau T.M., 2000, MODELING SURVIVAL DA; Ulloa-Montoya F, 2013, J CLIN ONCOL, V31, P2388, DOI 10.1200/JCO.2012.44.3762; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2007, J STAT SOFTW, V21, P1	40	105	106	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109760	10.1371/journal.pone.0109760	http://dx.doi.org/10.1371/journal.pone.0109760			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314013	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500070
J	Sun, LY; Liu, SK; Wang, RJ; Jiang, YL; Zhang, Y; Zhang, JR; Bao, LS; Kaltenboeck, L; Dunham, R; Waldbieser, G; Liu, ZJ				Sun, Luyang; Liu, Shikai; Wang, Ruijia; Jiang, Yanliang; Zhang, Yu; Zhang, Jiaren; Bao, Lisui; Kaltenboeck, Ludmilla; Dunham, Rex; Waldbieser, Geoff; Liu, Zhanjiang			Identification and Analysis of Genome-Wide SNPs Provide Insight into Signatures of Selection and Domestication in Channel Catfish (Ictalurus punctatus)	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; SOFT SWEEPS; POPULATIONS; GENE; ADAPTATION; REVEALS; HYPOXIA; WILD; DIFFERENTIATION; PARAMETERS	Domestication and selection for important performance traits can impact the genome, which is most often reflected by reduced heterozygosity in and surrounding genes related to traits affected by selection. In this study, analysis of the genomic impact caused by domestication and artificial selection was conducted by investigating the signatures of selection using single nucleotide polymorphisms (SNPs) in channel catfish (Ictalurus punctatus). A total of 8.4 million candidate SNPs were identified by using next generation sequencing. On average, the channel catfish genome harbors one SNP per 116 bp. Approximately 6.6 million, 5.3 million, 4.9 million, 7.1 million and 6.7 million SNPs were detected in the Marion, Thompson, USDA103, Hatchery strain, and wild population, respectively. The allele frequencies of 407,861 SNPs differed significantly between the domestic and wild populations. With these SNPs, 23 genomic regions with putative selective sweeps were identified that included 11 genes. Although the function for the majority of the genes remain unknown in catfish, several genes with known function related to aquaculture performance traits were included in the regions with selective sweeps. These included hypoxia-inducible factor 1 beta HIFi beta and the transporter gene ATP-binding cassette sub-family B member 5 (ABCB5). HIF1 beta is important for response to hypoxia and tolerance to low oxygen levels is a critical aquaculture trait. The large numbers of SNPs identified from this study are valuable for the development of high-density SNP arrays for genetic and genomic studies of performance traits in catfish.	[Sun, Luyang; Liu, Shikai; Wang, Ruijia; Jiang, Yanliang; Zhang, Yu; Zhang, Jiaren; Bao, Lisui; Kaltenboeck, Ludmilla; Dunham, Rex; Liu, Zhanjiang] Auburn Univ, Sch Fisheries Aquaculture & Aquat Sci, Aquat Genom Unit, Mol Genet & Biotechnol Lab 1, Auburn, AL 36849 USA; [Sun, Luyang; Liu, Shikai; Wang, Ruijia; Jiang, Yanliang; Zhang, Yu; Zhang, Jiaren; Bao, Lisui; Kaltenboeck, Ludmilla; Dunham, Rex; Liu, Zhanjiang] Auburn Univ, Program Cell & Mol Biosci, Auburn, AL USA; [Waldbieser, Geoff] USDA ARS, Warmwater Aquaculture Res Unit, Stoneville, MS 38776 USA	Auburn University System; Auburn University; Auburn University System; Auburn University; United States Department of Agriculture (USDA)	Liu, ZJ (corresponding author), Auburn Univ, Sch Fisheries Aquaculture & Aquat Sci, Aquat Genom Unit, Mol Genet & Biotechnol Lab 1, Auburn, AL 36849 USA.	liuzhan@auburn.edu	Liu, Zhanjiang/R-9633-2019; Liu, Shikai/AAO-2247-2021	Liu, Shikai/0000-0001-5777-489X; Wang, Ruijia/0000-0002-4211-5207	Agriculture and Food Research Initiative Competitive [2010-65205-20356, 2012-67015-19410]; USDA National Institute of Food and Agriculture (NIFA); China Scholarship Council (CSC)	Agriculture and Food Research Initiative Competitive; USDA National Institute of Food and Agriculture (NIFA); China Scholarship Council (CSC)(China Scholarship Council)	This project was supported by Agriculture and Food Research Initiative Competitive Grant no. 2010-65205-20356 and 2012-67015-19410 from the USDA National Institute of Food and Agriculture (NIFA). L. Sun was supported by a scholarship from the China Scholarship Council (CSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affonso EG, 2002, COMP BIOCHEM PHYS C, V133, P375, DOI 10.1016/S1532-0456(02)00127-8; Annilo T, 2006, GENOMICS, V88, P1, DOI 10.1016/j.ygeno.2006.03.001; Anttila K, 2013, J EXP BIOL, V216, P1183, DOI 10.1242/jeb.080556; Bansal V, 2010, GENOME RES, V20, P537, DOI 10.1101/gr.100040.109; Berejikian BA, 1996, CAN J FISH AQUAT SCI, V53, P2004, DOI 10.1139/cjfas-53-9-2004; Boitard S, 2013, ANIM GENET, V44, P579, DOI 10.1111/age.12042; Cano JM, 2006, MOL ECOL, V15, P4613, DOI 10.1111/j.1365-294X.2006.03099.x; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; Dunham R. A., 1984, ANCESTRY BREEDING CA; Dunham RA, 2011, AQUACULTURE AND FISHERIES BIOTECHNOLOGY: GENETIC APPROACHES, 2ND EDITION, P1; DUNHAM RA, 1983, GROWTH, V47, P97; Dunham Rex A., 1994, Journal of Applied Aquaculture, V3, P211; Faust HA, 2004, J EXP BIOL, V207, P1005, DOI 10.1242/jeb.00824; Fine ML, 2014, EVOLUTION, V68, P2102, DOI 10.1111/evo.12379; Geng X, 2014, COMP BIOCH PHYSL B, V228, P91; Glessner JT, 2010, AM J HUM GENET, V87, P661, DOI 10.1016/j.ajhg.2010.09.014; Grimm M, 2012, EUR J CANCER, V48, P3186, DOI 10.1016/j.ejca.2012.05.027; Guan B, 2011, MAR BIOTECHNOL, V13, P336, DOI 10.1007/s10126-010-9305-z; Guerriero G, 2002, COMP BIOCHEM PHYS A, V132, P205, DOI 10.1016/S1095-6433(01)00549-9; HALLERMAN EM, 1986, T AM FISH SOC, V115, P60, DOI 10.1577/1548-8659(1986)115<60:SODAFC>2.0.CO;2; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Jiang YL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-780; Johansson AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001188; Johnsson JI, 1996, CAN J FISH AQUAT SCI, V53, P1546, DOI 10.1139/cjfas-53-7-1546; Kim ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080813; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kofler R, 2011, BIOINFORMATICS, V27, P3435, DOI 10.1093/bioinformatics/btr589; Lamkom Thanathip, 2008, Kasetsart University Fisheries Research Bulletin, V32, P37; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lin JY, 2013, BIOCHEM BIOPH RES CO, V436, P536, DOI 10.1016/j.bbrc.2013.06.006; Liu Shikai, 2014, BMC Research Notes, V7, P135, DOI 10.1186/1756-0500-7-135; Liu SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063895; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Liu ZJ, 2003, COMP FUNCT GENOM, V4, P259, DOI 10.1002/cfg.265; Lucas MD, 2004, BEHAV GENET, V34, P355, DOI 10.1023/B:BEGE.0000017879.68818.21; MAGURRAN AE, 1995, ADV STUD BEHAV, V24, P155, DOI 10.1016/S0065-3454(08)60394-0; Makinen HS, 2008, GENETICS, V178, P453, DOI 10.1534/genetics.107.078782; Messer PW, 2013, TRENDS ECOL EVOL, V28, P659, DOI 10.1016/j.tree.2013.08.003; Mickett K, 2003, AQUACULTURE, V228, P91, DOI 10.1016/S0044-8486(03)00311-9; Ninwichian P, 2012, G3-GENES GENOM GENET, V2, P1233, DOI 10.1534/g3.112.003962; Pavlov D.S., 2000, J ICHTHYOL+, V40, pS163; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Ramey HR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-382; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Simmons M, 2006, AQUACULTURE, V252, P133, DOI 10.1016/j.aquaculture.2005.11.006; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Swanson HI, 2002, CHEM-BIOL INTERACT, V141, P63, DOI 10.1016/S0009-2797(02)00066-2; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Vasemagi A, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/628204; Waldbieser GC, 2007, ANIM GENET, V38, P180, DOI 10.1111/j.1365-2052.2007.01586.x; Wang SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-450; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wright D, 2006, BEHAV GENET, V36, P271, DOI 10.1007/s10519-005-9029-4	57	37	37	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109666	10.1371/journal.pone.0109666	http://dx.doi.org/10.1371/journal.pone.0109666			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313648	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662500066
J	Joseph, S; Kwan, AH; Stokes, PH; Mackay, JP; Cubeddu, L; Matthews, JM				Joseph, Soumya; Kwan, Ann H.; Stokes, Philippa H.; Mackay, Joel P.; Cubeddu, Liza; Matthews, Jacqueline M.			The Structure of an LIM-Only Protein 4 (LMO4) and Deformed Epidermal Autoregulatory Factor-1 (DEAF1) Complex Reveals a Common Mode of Binding to LMO4	PLOS ONE			English	Article							CELL-PROLIFERATION; DOMAIN; EXPRESSION; GENE; IDENTIFICATION; LDB1; DIFFERENTIATION; ASSIGNMENTS; PROGRESSION; RECRUITMENT	LIM-domain only protein 4 (LMO4) is a widely expressed protein with important roles in embryonic development and breast cancer. It has been reported to bind many partners, including the transcription factor Deformed epidermal autoregulatory factor-1 (DEAF1), with which LMO4 shares many biological parallels. We used yeast two-hybrid assays to show that DEAF1 binds both LIM domains of LMO4 and that DEAF1 binds the same face on LMO4 as two other LMO4-binding partners, namely LIM domain binding protein 1 (LDB1) and C-terminal binding protein interacting protein (CtIP/RBBP8). Mutagenic screening analysed by the same method, indicates that the key residues in the interaction lie in LMO4(LIM2) and the N-terminal half of the LMO4-binding domain in DEAF1. We generated a stable LMO4(LIM2)-DEAF1 complex and determined the solution structure of that complex. Although the LMO4-binding domain from DEAF1 is intrinsically disordered, it becomes structured on binding. The structure confirms that LDB1, CtIP and DEAF1 all bind to the same face on LMO4. LMO4 appears to form a hub in protein-protein interaction networks, linking numerous pathways within cells. Competitive binding for LMO4 therefore most likely provides a level of regulation between those different pathways.	[Joseph, Soumya; Kwan, Ann H.; Stokes, Philippa H.; Mackay, Joel P.; Cubeddu, Liza; Matthews, Jacqueline M.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Cubeddu, Liza] Univ Western Sydney, Sch Sci & Hlth, Campbelltown, NSW, Australia	University of Sydney; Western Sydney University	Matthews, JM (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.	jacqui.matthews@sydney.edu.au	; Mackay, Joel/D-6834-2011	Joseph, Soumya/0000-0002-0487-1378; Mackay, Joel/0000-0001-7508-8033; Kwan, Ann/0000-0002-1506-2226; Matthews, Jacqueline/0000-0001-8518-3472	Australian Postgraduate Award; Australian National and Medical Research Council; Australian Research Council [DP110104332]	Australian Postgraduate Award(Australian Government); Australian National and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	SJ was funded by an Australian Postgraduate Award (education.gov.au/australian-postgraduate-awards). JPM and JMM were awarded Senior Research Fellowships from the Australian National and Medical Research Council (www.nhmrc.gov.au). This project was funded by an Australian Research Council (www.arc.gov.au) Discovery Project Grant (DP110104332) to JMM and LC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Asprer JST, 2011, DEVELOPMENT, V138, P2823, DOI 10.1242/dev.061879; Barker HE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-94; Bhati M, 2008, EMBO J, V27, P2018, DOI 10.1038/emboj.2008.123; Bhati M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040719; Bieri M, 2011, J BIOMOL NMR, V50, P147, DOI 10.1007/s10858-011-9509-1; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cross AJ, 2010, J MOL BIOL, V399, P133, DOI 10.1016/j.jmb.2010.04.006; Cubeddu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039218; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P121, DOI 10.1007/s10858-007-9213-3; Dastmalchi S, 2012, PROTEIN SCI, V21, P1768, DOI 10.1002/pro.2153; Deane JE, 2004, EMBO J, V23, P3589, DOI 10.1038/sj.emboj.7600376; Deane JE, 2003, EMBO J, V22, P2224, DOI 10.1093/emboj/cdg196; Deng M, 2010, DEV BIOL, V338, P38, DOI 10.1016/j.ydbio.2009.11.003; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; El Omari K, 2013, CELL REP, V4, P135, DOI 10.1016/j.celrep.2013.06.008; El Omari K, 2011, BLOOD, V117, P2146, DOI 10.1182/blood-2010-07-293357; Faqeih EA, 2014, AM J MED GENET A; Gadd MS, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.478586; Gadd MS, 2011, J BIOL CHEM, V286, P42971, DOI 10.1074/jbc.M111.248559; Grutz G, 1998, ONCOGENE, V17, P2799, DOI 10.1038/sj.onc.1202502; Hahm KM, 2004, MOL CELL BIOL, V24, P2074, DOI 10.1128/MCB.24.5.2074-2082.2004; Huggenvik JI, 1998, MOL ENDOCRINOL, V12, P1619, DOI 10.1210/me.12.10.1619; Jeffries CM, 2006, PROTEIN SCI, V15, P2612, DOI 10.1110/ps.062377006; Jensik PJ, 2004, J BIOL CHEM, V279, P32692, DOI 10.1074/jbc.M400946200; Joseph S, 2014, BIOMOL NMR ASSIGN, V8, P141, DOI 10.1007/s12104-013-9470-x; Jurata LW, 1997, MOL CELL BIOL, V17, P5688, DOI 10.1128/MCB.17.10.5688; Kenny DA, 1998, P NATL ACAD SCI USA, V95, P11257, DOI 10.1073/pnas.95.19.11257; Konrat R, 1997, J BIOL CHEM, V272, P12001, DOI 10.1074/jbc.272.18.12001; Krane SM, 2008, AMINO ACIDS, V35, P703, DOI 10.1007/s00726-008-0073-2; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krivega I, 2014, GENE DEV, V28, P1278, DOI 10.1101/gad.239749.114; Kwan AH, 2011, FEBS J, V278, P687, DOI 10.1111/j.1742-4658.2011.08004.x; Lee S, 2008, DEV CELL, V14, P877, DOI 10.1016/j.devcel.2008.03.021; Lee SK, 2005, MOL CELL NEUROSCI, V28, P205, DOI 10.1016/j.mcn.2004.04.010; Lee W, 2009, BIOINFORMATICS, V25, P2085, DOI 10.1093/bioinformatics/btp345; Leuba G, 2004, NEUROPATH APPL NEURO, V30, P57, DOI 10.1046/j.0305-1846.2003.00511.x; Leuba G, 2008, NEUROBIOL DIS, V30, P408, DOI 10.1016/j.nbd.2008.02.012; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Manetopoulos C, 2003, BIOCHEM BIOPH RES CO, V307, P891, DOI 10.1016/S0006-291X(03)01298-1; Matthews JM, 2013, FEBS LETT, V587, P1164, DOI 10.1016/j.febslet.2013.01.002; Matthews JM, 2013, NAT REV CANCER, V13, P111, DOI 10.1038/nrc3418; Matthews JM, 2008, BIOCHEM SOC T, V36, P1393, DOI 10.1042/BST0361393; Montanez-Wiscovich ME, 2009, ONCOGENE, V28, P3608, DOI 10.1038/onc.2009.221; Montanez-Wiscovich ME, 2010, J PATHOL, V222, P271, DOI 10.1002/path.2762; Mousses S, 2002, CANCER RES, V62, P1256; Munger SC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003630; Murphy NC, 2008, BRIT J CANCER, V98, P537, DOI 10.1038/sj.bjc.6604177; Pandey NR, 2013, J NEUROSCI, V33, P12647, DOI 10.1523/JNEUROSCI.0746-13.2013; Perez-Magan E, 2012, J NEUROPATH EXP NEUR, V71, P882, DOI 10.1097/NEN.0b013e31826bf704; PEREZALVARADO GC, 1994, NAT STRUCT BIOL, V1, P388, DOI 10.1038/nsb0694-388; Pilot-Storck F, 2010, MOL CELL PROTEOMICS, V9, P1578, DOI 10.1074/mcp.M900568-MCP200; Qin ZH, 2012, J NEUROSCI, V32, P4271, DOI 10.1523/JNEUROSCI.6271-11.2012; Savitz J, 2009, PROG NEUROBIOL, V88, P17, DOI 10.1016/j.pneurobio.2009.01.009; Schaffar G, 2008, J NEUROCHEM, V107, P418, DOI 10.1111/j.1471-4159.2008.05621.x; Setogawa T, 2006, BIOCHEM BIOPH RES CO, V343, P1186, DOI 10.1016/j.bbrc.2006.03.077; Sewell H, 2014, SCI REP-UK, V4, DOI 10.1038/srep03643; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Singh RR, 2005, CANCER RES, V65, P10594, DOI 10.1158/0008-5472.CAN-05-2268; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Song MR, 2009, DEVELOPMENT, V136, P2923, DOI 10.1242/dev.037986; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Stokes PH, 2013, J MOL BIOL, V425, P1101, DOI 10.1016/j.jmb.2013.01.017; Sugihara TM, 1998, P NATL ACAD SCI USA, V95, P15418, DOI 10.1073/pnas.95.26.15418; Sum EYM, 2005, P NATL ACAD SCI USA, V102, P7659, DOI 10.1073/pnas.0502990102; Sum EYM, 2002, J BIOL CHEM, V277, P7849, DOI 10.1074/jbc.M110603200; Sutherland KD, 2003, INT J CANCER, V107, P155, DOI 10.1002/ijc.11343; Taniwaki M, 2006, INT J ONCOL, V29, P567; Tse E, 2004, MOL CELL BIOL, V24, P2063, DOI 10.1128/MCB.24.5.2063-2073.2004; Veraksa A, 2002, GENESIS, V33, P67, DOI 10.1002/gene.10090; Visvader JE, 2001, P NATL ACAD SCI USA, V98, P14452, DOI 10.1073/pnas.251547698; Vulto-van Silfhout AT, 2014, AM J HUM GENET; Wang N, 2007, ONCOGENE, V26, P6431, DOI 10.1038/sj.onc.1210465; Wang N, 2013, FEBS LETT, V587, P3032, DOI 10.1016/j.febslet.2013.07.033; Wilkinson-White L, 2011, P NATL ACAD SCI USA, V108, P14443, DOI 10.1073/pnas.1105898108; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yip LD, 2009, NAT IMMUNOL, V10, P1026, DOI 10.1038/ni.1773; Zhou X, 2012, CELL MOL LIFE SCI, V69, P819, DOI 10.1007/s00018-011-0794-3	79	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109108	10.1371/journal.pone.0109108	http://dx.doi.org/10.1371/journal.pone.0109108			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310299	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210300036
J	Lundqvist, A; Carlsson, KS; Johansen, P; Andersson, E; Willis, M				Lundqvist, Adam; Carlsson, Katarina Steen; Johansen, Pierre; Andersson, Emelie; Willis, Michael			Validation of the IHE Cohort Model of Type 2 Diabetes and the Impact of Choice of Macrovascular Risk Equations	PLOS ONE			English	Article							LIFETIME HEALTH OUTCOMES; FOLLOW-UP; CARDIOVASCULAR-DISEASE; MELLITUS; FRAMINGHAM; COMPLICATIONS; ATORVASTATIN; PREVENTION; ENGINE; NIDDM	Background: Health-economic models of diabetes are complex since the disease is chronic, progressive and there are many diabetic complications. External validation of these models helps building trust and satisfies demands from decision makers. We evaluated the external validity of the IHE Cohort Model of Type 2 Diabetes; the impact of using alternative macrovascular risk equations; and compared the results to those from microsimulation models. Methods: The external validity of the model was analysed from 12 clinical trials and observational studies by comparing 167 predicted microvascular, macrovascular and mortality outcomes to the observed study outcomes. Concordance was examined using visual inspection of scatterplots and regression-based analysis, where an intercept of 0 and a slope of 1 indicate perfect concordance. Additional subgroup analyses were conducted on 'dependent' vs. 'independent' endpoints and microvascular vs. macrovascular vs. mortality endpoints. Results: Visual inspection indicates that the model predicts outcomes well. The UKPDS-OM1 equations showed almost perfect concordance with observed values (slope 0.996), whereas Swedish NDR (0.952) and UKPDS-OM2 (0.899) had a slight tendency to underestimate. The R 2 values were uniformly high (>0.96). There were no major differences between 'dependent' and 'independent' outcomes, nor for microvascular and mortality outcomes. Macrovascular outcomes tended to be underestimated, most so for UKPDS-OM2 and least so for NDR risk equations. Conclusions: External validation indicates that the IHE Cohort Model of Type 2 Diabetes has predictive accuracy in line with microsimulation models, indicating that the trade-off in accuracy using cohort simulation might not be that large. While the choice of risk equations was seen to matter, each were associated with generally reasonable results, indicating that the choice must reflect the specifics of the application. The largest variation was observed for macrovascular outcomes. There, NDR performed best for relatively recent and well-treated patients, while UKPDS-OM1 performed best for the older UKPDS cohort.	[Lundqvist, Adam; Carlsson, Katarina Steen; Johansen, Pierre; Andersson, Emelie; Willis, Michael] IHE, Swedish Inst Hlth Econ, Lund, Sweden; [Carlsson, Katarina Steen] Lund Univ, Dept Clin Sci, Malmo, Sweden	Lund University	Lundqvist, A (corresponding author), IHE, Swedish Inst Hlth Econ, Lund, Sweden.	al@ihe.se		Willis, Michael/0000-0002-6565-7025; Fridhammar, Adam/0000-0003-3715-003X; Steen Carlsson, Katarina/0000-0002-2325-5634	The Swedish Institute for Health Economics, IHE; Novo Nordisk Ltd	The Swedish Institute for Health Economics, IHE; Novo Nordisk Ltd(Novo Nordisk)	The Swedish Institute for Health Economics, IHE, provided core funding. An unrestricted research grant from Novo Nordisk Ltd is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagust A, 2001, DIABETOLOGIA, V44, P2140, DOI 10.1007/s001250100023; Caro JJ, 2012, VALUE HEALTH, V15, P796, DOI 10.1016/j.jval.2012.06.012; Clarke PM, 2004, DIABETOLOGIA, V47, P1747, DOI 10.1007/s00125-004-1527-z; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Davis WA, 2010, INTERN MED J, V40, P286, DOI 10.1111/j.1445-5994.2009.01958.x; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Eastman RC, 1997, DIABETES CARE, V20, P725, DOI 10.2337/diacare.20.5.725; Eddy DM, 2012, VALUE HEALTH, V15, P843, DOI 10.1016/j.jval.2012.04.012; Eddy DM, 2003, DIABETES CARE, V26, P3102, DOI 10.2337/diacare.26.11.3102; Eeg-Olofsson K, 2010, J INTERN MED, V268, P471, DOI 10.1111/j.1365-2796.2010.02265.x; Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; Grant D, 2012, 72 SCI SESS AM DIAB; Hayes AJ, 2013, DIABETOLOGIA, V56, P1925, DOI 10.1007/s00125-013-2940-y; Hoerger TJ, 2009, RTI PRESS PUBLICATIO, VMR-0013-0909; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Kahn R, 2004, DIABETES CARE, V27, P2262; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kengne AP, 2010, DIABETOLOGIA, V53, P821, DOI 10.1007/s00125-010-1681-4; Kiadaliri AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062650; KLEIN R, 1984, OPHTHALMOLOGY, V91, P1464; Knopp RH, 2006, DIABETES CARE, V29, P1478, DOI 10.2337/dc05-2415; Palmer AJ, 2004, CURR MED RES OPIN, V20, pS27, DOI 10.1185/030079904X2006; Palmer AJ, 2007, DIABETES CARE, V30, P1638, DOI 10.2337/dc07-9919; Palmer AJ, 2013, VALUE HEALTH, V16, P670, DOI 10.1016/j.jval.2013.01.002; PALUMBO PJ, 1976, DIABETES, V25, P566, DOI 10.2337/diabetes.25.7.566; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Sasaki A, 1997, DIABETES RES CLIN PR, V36, P41, DOI 10.1016/S0168-8227(97)00026-0; Siebert U, 2012, VALUE HEALTH, V15, P812, DOI 10.1016/j.jval.2012.06.014; Simmons RK, 2009, DIABETES CARE, V32, P708, DOI 10.2337/dc08-1918; Stahl JE, 2008, PHARMACOECONOMICS, V26, P131, DOI 10.2165/00019053-200826020-00004; Tarride JE, 2010, PHARMACOECONOMICS, V28, P255, DOI 10.2165/11531590-000000000-00000; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; van der Heijden AAWA, 2009, DIABETES CARE, V32, P2094, DOI 10.2337/dc09-0745; van Dieren S, 2011, DIABETOLOGIA, V54, P264, DOI 10.1007/s00125-010-1960-0; Willis Michael, 2013, J Med Econ, V16, P1007, DOI 10.3111/13696998.2013.809352	35	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110235	10.1371/journal.pone.0110235	http://dx.doi.org/10.1371/journal.pone.0110235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310196	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210300099
J	Miletta, MC; Petkovic, V; Eble, A; Ammann, RA; Fluck, CE; Mullis, PE				Miletta, Maria Consolata; Petkovic, Vibor; Eble, Andree; Ammann, Roland A.; Flueck, Christa E.; Mullis, Primus-E.			Butyrate Increases Intracellular Calcium Levels and Enhances Growth Hormone Release from Rat Anterior Pituitary Cells via the G-Protein-Coupled Receptors GPR41 and 43	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; SERUM BETA-HYDROXYBUTYRATE; CA2+ CONCENTRATION; FUNCTIONAL-CHARACTERIZATION; SODIUM-BUTYRATE; AMINO-ACID; SECRETION; SOMATOTROPHS; METABOLISM; LEPTIN	Butyrate is a short-chain fatty acid (SCFA) closely related to the ketone body beta-hydroxybutyrate (BHB), which is considered to be the major energy substrate during prolonged exercise or starvation. During fasting, serum growth hormone (GH) rises concomitantly with the accumulation of BHB and butyrate. Interactions between GH, ketone bodies and SCFA during the metabolic adaptation to fasting have been poorly investigated to date. In this study, we examined the effect of butyrate, an endogenous agonist for the two G-protein-coupled receptors (GPCR), GPR41 and 43, on non-stimulated and GH-releasing hormone (GHRH)-stimulated hGH secretion. Furthermore, we investigated the potential role of GPR41 and 43 on the generation of butyrate-induced intracellular Ca2+ signal and its ultimate impact on hGH secretion. To study this, wt-hGH was transfected into a rat pituitary tumour cell line stably expressing the human GHRH receptor. Treatment with butyrate promoted hGH synthesis and improved basal and GHRH-induced hGH-secretion. By acting through GPR41 and 43, butyrate enhanced intracellular free cytosolic Ca2+. Gene-specific silencing of these receptors led to a partial inhibition of the butyrate-induced intracellular Ca2+ rise resulting in a decrease of hGH secretion. This study suggests that butyrate is a metabolic intermediary, which contributes to the secretion and, therefore, to the metabolic actions of GH during fasting.	[Miletta, Maria Consolata; Petkovic, Vibor; Eble, Andree; Flueck, Christa E.; Mullis, Primus-E.] Univ Childrens Hosp, Div Paediat Endocrinol Diabetol & Metab, Bern, Switzerland; [Miletta, Maria Consolata; Petkovic, Vibor; Eble, Andree; Flueck, Christa E.; Mullis, Primus-E.] Univ Childrens Hosp, Dept Clin Res, Bern, Switzerland; [Ammann, Roland A.] Univ Bern, Dept Paediat, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern	Mullis, PE (corresponding author), Univ Childrens Hosp, Div Paediat Endocrinol Diabetol & Metab, Bern, Switzerland.	primus.mullis@insel.ch	Ammann, Roland A/I-4716-2019	Ammann, Roland A/0000-0002-1902-2352; Flueck, Christa/0000-0002-4568-5504	Swiss National Science Foundation [320000-121998]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by a grant of the Swiss National Science Foundation 320000-121998 to PEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANCROFT FC, 1973, EXP CELL RES, V79, P275, DOI 10.1016/0014-4827(73)90445-X; Besson A, 2005, J CLIN ENDOCR METAB, V90, P2493, DOI 10.1210/jc.2004-1838; BRATUSCHMARRAIN PR, 1982, J CLIN ENDOCR METAB, V55, P973, DOI 10.1210/jcem-55-5-973; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Carro E, 1997, ENDOCRINOLOGY, V138, P2203, DOI 10.1210/en.138.5.2203; Chang JP, 2012, CELL CALCIUM, V51, P240, DOI 10.1016/j.ceca.2011.11.001; Chen C, 2000, IMMUNOL CELL BIOL, V78, P356, DOI 10.1046/j.1440-1711.2000.00917.x; CHEN ZX, 1994, CANCER RES, V54, P3494; COPELAND KC, 1994, J CLIN ENDOCR METAB, V78, P1040, DOI 10.1210/jc.78.5.1040; Cummings BP, 2011, P NATL ACAD SCI USA, V108, P14670, DOI 10.1073/pnas.1107163108; DANNIES PS, 1976, ENDOCRINOLOGY, V98, P1147, DOI 10.1210/endo-98-5-1147; Everitt BS, 2001, ANAL MED DATA USING; Fluck CE, 2002, J CLIN ENDOCR METAB, V87, P4318, DOI 10.1210/jc.2002-020501; Fulop M, 1999, ARCH INTERN MED, V159, P381, DOI 10.1001/archinte.159.4.381; Gilbert DL, 2000, J CHILD NEUROL, V15, P787, DOI 10.1177/088307380001501203; HARTMAN ML, 1992, J CLIN ENDOCR METAB, V74, P757, DOI 10.1210/jc.74.4.757; HO KY, 1988, J CLIN INVEST, V81, P968, DOI 10.1172/JCI113450; Ishiwata H, 2005, GEN COMP ENDOCR, V143, P222, DOI 10.1016/j.ygcen.2005.03.015; Juul A., 2000, GROWTH HORMONE ADULT; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; LUSSIER BT, 1991, ENDOCRINOLOGY, V128, P570, DOI 10.1210/endo-128-1-570; LUSSIER BT, 1991, ENDOCRINOLOGY, V128, P583, DOI 10.1210/endo-128-1-583; LUSSIER BT, 1991, ENDOCRINOLOGY, V128, P592, DOI 10.1210/endo-128-1-592; MILLER AA, 1987, EUR J CANCER CLIN ON, V23, P1283, DOI 10.1016/0277-5379(87)90109-X; Nakamura K, 2012, ARTERIOSCL THROM VAS, V32, P2670, DOI 10.1161/ATVBAHA.112.254946; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Nohr MK, 2013, ENDOCRINOLOGY, V154, P3552, DOI 10.1210/en.2013-1142; Norrelund H, 2005, GROWTH HORM IGF RES, V15, P95, DOI 10.1016/j.ghir.2005.02.005; Petkovic V, 2010, ENDOCRINOLOGY, V151, P2650, DOI 10.1210/en.2009-1280; QUABBE HJ, 1983, J CLIN ENDOCR METAB, V57, P613, DOI 10.1210/jcem-57-3-613; RIZZA RA, 1982, DIABETES, V31, P663, DOI 10.2337/diabetes.31.8.663; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; STANLEY F, 1984, J BIOL CHEM, V259, P9768; Sun SX, 2012, BIOSCIENCE REP, V32, P83, DOI 10.1042/BSR20110062; Tannenbaum GS, 1998, ENDOCRINOLOGY, V139, P3871, DOI 10.1210/en.139.9.3871; Vescovi PP, 2001, DRUG ALCOHOL DEPEN, V61, P217, DOI 10.1016/S0376-8716(00)00149-6; Volpi R, 2000, PSYCHONEUROENDOCRINO, V25, P179, DOI 10.1016/S0306-4530(99)00048-7; Wang A, 2009, J DAIRY SCI, V92, P2696, DOI 10.3168/jds.2009-2037; Xiong YM, 2004, P NATL ACAD SCI USA, V101, P1045, DOI 10.1073/pnas.2637002100; Yang SK, 2008, ENDOCRINOLOGY, V149, P4726, DOI 10.1210/en.2008-0405; Yang SK, 2012, CELL CALCIUM, V51, P231, DOI 10.1016/j.ceca.2011.12.005; YEN PM, 1981, ENDOCRINOLOGY, V109, P17, DOI 10.1210/endo-109-1-17; Yudkoff M, 2005, NEUROCHEM INT, V47, P119, DOI 10.1016/j.neuint.2005.04.014	45	31	32	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e107388	10.1371/journal.pone.0107388	http://dx.doi.org/10.1371/journal.pone.0107388			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310566	gold, Green Submitted, Green Published			2022-12-27	WOS:000343210300006
J	Pey, B; Laporte, MA; Nahmani, J; Auclerc, A; Capowiez, Y; Caro, G; Cluzeau, D; Cortet, J; Decaens, T; Dubs, F; Joimel, S; Guernion, M; Briard, C; Grumiaux, F; Laporte, B; Pasquet, A; Pelosi, C; Pernin, C; Ponge, JF; Salmon, S; Santorufo, L; Hedde, M				Pey, Benjamin; Laporte, Marie-Angelique; Nahmani, Johanne; Auclerc, Apolline; Capowiez, Yvan; Caro, Gael; Cluzeau, Daniel; Cortet, Jerome; Decaens, Thibaud; Dubs, Florence; Joimel, Sophie; Guernion, Muriel; Briard, Charlene; Grumiaux, Fabien; Laporte, Baptiste; Pasquet, Alain; Pelosi, Celine; Pernin, Celine; Ponge, Jean-Francois; Salmon, Sandrine; Santorufo, Lucia; Hedde, Mickael			A Thesaurus for Soil Invertebrate Trait-Based Approaches	PLOS ONE			English	Article							GROUND BEETLES COLEOPTERA; SPECIES TRAITS; CARABID BEETLE; DISTURBANCE; COMMUNITIES; HISTORY; FOREST	Soil invertebrates are known to be much involved in soil behaviour and therefore in the provision of ecosystem services. Functional trait-based approaches are methodologies which can be used to understand soil invertebrates' responses to their environment. They (i) improve the predictions and (ii) are less dependent on space and time. The way traits have been used recently has led to misunderstandings in the integration and interpretation of data. Trait semantics are especially concerned. The aim of this paper is to propose a thesaurus for soil invertebrate trait-based approaches. T-SITA, an Internet platform, is the first initiative to deal with the semantics of traits and ecological preferences for soil invertebrates. It reflects the agreement of a scientific expert community to fix semantic properties (e. g. definition) of approximately 100 traits and ecological preferences. In addition, T-SITA has been successfully linked with a fully operational database of soil invertebrate traits. Such a link enhances data integration and improves the scientific integrity of data.	[Pey, Benjamin; Caro, Gael; Pelosi, Celine; Hedde, Mickael] INRA, PESSAC UR251, F-78026 Versailles, France; [Pey, Benjamin; Laporte, Baptiste] CESAB FRB, Aix En Provence, France; [Laporte, Marie-Angelique] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Laporte, Marie-Angelique] Biovers Int, Montpellier, France; [Nahmani, Johanne] Univ Montpellier 2, CNRS, CEFE, Montpellier, France; [Auclerc, Apolline; Joimel, Sophie; Santorufo, Lucia] INRA, UMR 1120, Lab Sols & Environm, Vandoeuvre Les Nancy, France; [Capowiez, Yvan] INRA, Plantes & Syst Hort UR1115, Avignon, France; [Cluzeau, Daniel; Guernion, Muriel; Briard, Charlene] Univ Rennes 1, UMR CNRS EcoBio 6553, Paimpont, France; [Cortet, Jerome] Univ Montpellier 2, UMR CEFE 5175, Lab Zoogeog, Ctr Ecol Fonct & Evolut, Montpellier, France; [Decaens, Thibaud] Univ Rouen, EA ECODIV 1293, UFR Sci & Tech, Mont St Aignan, France; [Dubs, Florence] IRD, UMR IEES P, Bondy, France; [Grumiaux, Fabien; Pernin, Celine] Univ Lille 1, EA 4515, Lab Genie Civil & Geo Environm, F-59655 Villeneuve Dascq, France; [Grumiaux, Fabien] Univ Lille Nord France, ESPE, Arras, France; [Pasquet, Alain] Univ Lorraine, Fac Sci & Technol, UR AFPA, Vandoeuvre Les Nancy, France; [Ponge, Jean-Francois; Salmon, Sandrine] Museum Natl Hist Nat, CNRS, UMR 7179, Brunoy, France; [Santorufo, Lucia] Univ Naples Federico II, Dept Struct & Funct Biol, Naples, Italy	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Alliance; Bioversity International; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; INRAE; Universite de Lorraine; INRAE; Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Universite de Rouen Normandie; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); University of Naples Federico II	Laporte, MA (corresponding author), German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany.	marieangelique.laporte@gmail.com; mickael.hedde@versailles.inra.fr	Ponge, Jean-Francois/D-5089-2009; Pelosi, Céline/AAB-3280-2019; PEY, Benjamin/ABB-7414-2021; Hedde, Mickael/K-5195-2016; Decaens, Thibaud/AAA-5287-2020; Pelosi, Céline/J-8323-2016; Benjamin, Pey/A-3323-2016; AUCLERC, Apolline/ABF-7844-2020	Ponge, Jean-Francois/0000-0001-6504-5267; Pelosi, Céline/0000-0002-7100-5760; Hedde, Mickael/0000-0002-6733-3622; Pelosi, Céline/0000-0002-7100-5760; Benjamin, Pey/0000-0003-4138-8542; AUCLERC, Apolline/0000-0003-2172-2750; Laporte, Marie-Angelique/0000-0002-8461-9745; Cortet, Jerome/0000-0002-7410-8626; Joimel, Sophie/0000-0002-1974-171X; Pernin, Celine/0000-0003-4035-9504; Dubs, Florence/0000-0002-6657-9911; Santorufo, Lucia/0000-0002-3409-0273	Centre de synthese et d'analyse sur la biodiversite/ Fondation pour la Recherche sur la Biodiversite	Centre de synthese et d'analyse sur la biodiversite/ Fondation pour la Recherche sur la Biodiversite	Support was provided by the Centre de synthese et d'analyse sur la biodiversite/ Fondation pour la Recherche sur la Biodiversite (http://cesab.org/index.php?lang=fr;http://www.fondationbiodiversite.fr/). All authors benefit from the funding. One of them, BL is employed by the CESAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbaro L, 2009, ECOGRAPHY, V32, P321, DOI 10.1111/j.1600-0587.2008.05546.x; Barrios E, 2007, ECOL ECON, V64, P269, DOI 10.1016/j.ecolecon.2007.03.004; CHEVENET F, 1994, FRESHWATER BIOL, V31, P295, DOI 10.1111/j.1365-2427.1994.tb01742.x; Cole LJ, 2002, AGR ECOSYST ENVIRON, V93, P323, DOI 10.1016/S0167-8809(01)00333-4; Decaens T, 2006, EUR J SOIL BIOL, V42, pS23, DOI 10.1016/j.ejsobi.2006.07.001; Decaens T, 2011, ACTA OECOL, V37, P212, DOI 10.1016/j.actao.2011.02.004; Decaens T, 2008, APPL SOIL ECOL, V39, P321, DOI 10.1016/j.apsoil.2008.01.007; Gerisch M, 2012, OIKOS, V121, P508, DOI 10.1111/j.1600-0706.2011.19749.x; Gerisch M, 2011, ZOOKEYS, P353, DOI 10.3897/zookeys.100.1427; Gobbi M, 2008, AGR ECOSYST ENVIRON, V127, P273, DOI 10.1016/j.agee.2008.04.011; Grimbacher PS, 2009, BIOTROPICA, V41, P328, DOI 10.1111/j.1744-7429.2008.00477.x; Jones MB, 2006, ANNU REV ECOL EVOL S, V37, P519, DOI 10.1146/annurev.ecolsys.37.091305.110031; Karen M, 2008, FOREST ECOL MANAG, V256, P624, DOI 10.1016/j.foreco.2008.05.005; Kibblewhite MG, 2008, PHILOS T R SOC B, V363, P685, DOI 10.1098/rstb.2007.2178; Laporte M. A., 2012, Ecological Informatics, V11, P34, DOI 10.1016/j.ecoinf.2012.04.004; Laporte MA, 2013, SEMANTICS BIODIVERSI, V25; Lavelle P, 2006, EUR J SOIL BIOL, V42, pS3, DOI 10.1016/j.ejsobi.2006.10.002; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Madin J, 2007, ECOL INFORM, V2, P279, DOI 10.1016/j.ecoinf.2007.05.004; Makkonen M, 2011, SOIL BIOL BIOCHEM, V43, P377, DOI 10.1016/j.soilbio.2010.11.004; Manola F., 2004, W3C RECOMMENDATION; Peres G, 2011, PEDOBIOLOGIA, V54, pS77, DOI 10.1016/j.pedobi.2011.09.015; Pey B, 2014, BASIC APPL ECOL, V15, P194, DOI 10.1016/j.baae.2014.03.007; Ribera I, 2001, ECOLOGY, V82, P1112, DOI 10.1890/0012-9658(2001)082[1112:EOLDAS]2.0.CO;2; Statzner B, 2001, ANNU REV ENTOMOL, V46, P291, DOI 10.1146/annurev.ento.46.1.291; Vandewalle M, 2010, BIODIVERS CONSERV, V19, P2921, DOI 10.1007/s10531-010-9798-9; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x	27	38	38	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e108985	10.1371/journal.pone.0108985	http://dx.doi.org/10.1371/journal.pone.0108985			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310431	Green Submitted, gold, Green Published			2022-12-27	WOS:000343210300029
J	Shi, XL; Wang, ZY; Deng, CY; Song, T; Pan, LQ; Chen, ZH				Shi, Xiaolong; Wang, Zhiyu; Deng, Chenyan; Song, Tao; Pan, Linqiang; Chen, Zhihua			A Novel Bio-Sensor Based on DNA Strand Displacement	PLOS ONE			English	Article							AMPLIFICATION; COMPUTATION	DNA strand displacement technology performs well in sensing and programming DNA segments. In this work, we construct DNA molecular systems based on DNA strand displacement performing computation of logic gates. Specifically, a class of so-called "DNA neurons'' are achieved, in which a "smart'' way inspired by biological neurons encoding information is developed to encode and deliver information using DNA molecules. The "DNA neuron'' is bistable, that is, it can sense DNA molecules as input signals, and release "negative'' or "positive'' signals DNA molecules. We design intelligent DNA molecular systems that are constructed by cascading some particularly organized "DNA neurons'', which could perform logic computation, including AND, OR, XOR logic gates, automatically. Both simulation results using visual DSD (DNA strand displacement) software and experimental results are obtained, which shows that the proposed systems can detect DNA signals with high sensitivity and accretion; moreover, the systems can process input signals automatically with complex nonlinear logic. The method proposed in this work may provide a new way to construct a sensitive molecular signal detection system with neurons spiking behavior in vitro, and can be used to develop intelligent molecular processing systems in vivo.	[Shi, Xiaolong; Wang, Zhiyu; Deng, Chenyan; Song, Tao; Pan, Linqiang; Chen, Zhihua] Huazhong Univ Sci & Technol, Sch Automat, Key Lab Image Informat Proc & Intelligent Control, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Song, T (corresponding author), Huazhong Univ Sci & Technol, Sch Automat, Key Lab Image Informat Proc & Intelligent Control, Wuhan 430074, Hubei, Peoples R China.	taosong@hust.edu.cn; lqpan@hust.edu.cn	Song, Tao/T-7360-2018; Pan, Linqiang/E-4714-2011	Song, Tao/0000-0002-0130-3340; Pan, Linqiang/0000-0002-4554-455X	National Science Foundations of China [61272071, 61033003, 61370105, 61402187]	National Science Foundations of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Science Foundations of China (Grant Nos. 61272071, 61033003, 61370105, and 61402187). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Benenson Y, 2001, NATURE, V414, P430, DOI 10.1038/35106533; Brett BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024668; de Vries SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049733; Farsad N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082935; Hampp N, 2000, CHEM REV, V100, P1755, DOI 10.1021/cr980072x; LaBean TH, 2007, NANO TODAY, V2, P26, DOI 10.1016/S1748-0132(07)70056-7; Little MC, 1999, CLIN CHEM, V45, P777; Lubrich D, 2009, J AM CHEM SOC, V131, P2422, DOI 10.1021/ja807765v; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; Paun Gh., 2002, MEMBRANE COMPUTING I; Phillips A, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2009.0072.focus; Pilo-Pais M, 2011, NANO LETT, V11, P3489, DOI 10.1021/nl202066c; Poli R., 2004, Genetic Programming and Evolvable Machines, V5, P31, DOI 10.1023/B:GENP.0000017010.41337.a7; Pun G., 2010, OXFORD HDB MEMBRANE; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Rothemund PWK, 2004, PLOS BIOL, V2, P2041, DOI 10.1371/journal.pbio.0020424; Rowan AE, 1998, ANGEW CHEM INT EDIT, V37, P63, DOI 10.1002/(SICI)1521-3773(19980202)37:1/2<63::AID-ANIE63>3.0.CO;2-4; Samano EC, 2011, SOFT MATTER, V7, P3240, DOI 10.1039/c0sm01318h; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Shi XL, 2006, LECT NOTES COMPUT SC, V4115, P258; Shi XL, 2005, LECT NOTES COMPUT SC, V3645, P71; Stuart JA, 2002, SYNTHETIC MET, V127, P3, DOI 10.1016/S0379-6779(01)00586-0; WALKER GT, 1992, NUCLEIC ACIDS RES, V20, P1691, DOI 10.1093/nar/20.7.1691; Wang YF, 2012, J COMPUT THEOR NANOS, V9, P2086, DOI 10.1166/jctn.2012.2620; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Zhang DY, 2011, NAT CHEM, V3, P103, DOI [10.1038/nchem.957, 10.1038/NCHEM.957]	27	42	43	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108856	10.1371/journal.pone.0108856	http://dx.doi.org/10.1371/journal.pone.0108856			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303242	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400030
J	Zhao, J; Jian, JB; Liu, GN; Wang, JR; Lin, MJ; Ming, Y; Liu, ZG; Chen, YY; Liu, XY; Liu, MJ				Zhao, Jin; Jian, Jianbo; Liu, Guannan; Wang, Jiurui; Lin, Minjuan; Ming, Yao; Liu, Zhiguo; Chen, Yingying; Liu, Xiuyun; Liu, Mengjun			Rapid SNP Discovery and a RAD-Based High-Density Linkage Map in Jujube (Ziziphus Mill.)	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; GENETIC-MAP; DE-NOVO; CONSTRUCTION; MARKERS; IDENTIFICATION; STACKS; TOOL; SEQ; L.	Background: Ziziphus Mill. (jujube), the most valued genus of Rhamnaceae, comprises of a number of economically and ecologically important species such as Z. jujuba Mill., Z. acidojujuba Cheng et Liu and Z. mauritiana Lam. Single nucleotide polymorphism (SNP) markers and a high-density genetic map are of great benefit to the improvement of the crop, mapping quantitative trait loci (QTL) and analyzing genome structure. However, such a high-density map is still absent in the genus Ziziphus and even the family Rhamnaceae. The recently developed restriction-site associated DNA (RAD) marker has been proven to be most powerful in genetic map construction. The objective of this study was to construct a high-density linkage map using the RAD tags generated by next generation sequencing. Results: An interspecific F1 population and their parents (Z. jujuba Mill. 'JMS2' x Z. acidojujuba Cheng et Liu 'Xing 16') were genotyped using a mapping-by-sequencing approach, to generate RAD-based SNP markers. A total of 42,784 putative high quality SNPs were identified between the parents and 2,872 high-quality RAD markers were grouped in genetic maps. Of the 2,872 RAD markers, 1,307 were linked to the female genetic map, 1,336 to the male map, and 2,748 to the integrated map spanning 913.87 centi-morgans (cM) with an average marker interval of 0.34 cM. The integrated map contained 12 linkage groups (LGs), consistent with the haploid chromosome number of the two parents. Conclusion: We first generated a high-density genetic linkage map with 2,748 RAD markers for jujube and a large number of SNPs were also developed. It provides a useful tool for both marker-assisted breeding and a variety of genome investigations in jujube, such as sequence assembly, gene localization, QTL detection and genome structure comparison.	[Zhao, Jin] Agr Univ Hebei, Coll Life Sci, Baoding, Peoples R China; [Jian, Jianbo; Ming, Yao] BGI Shenzhen, Shenzhen, Peoples R China; [Liu, Guannan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Wang, Jiurui] Agr Univ Hebei, Coll Forestry, Baoding, Peoples R China; [Liu, Zhiguo; Chen, Yingying; Liu, Xiuyun; Liu, Mengjun] Agr Univ Hebei, Res Ctr Chinese Jujube, Baoding, Peoples R China; [Liu, Mengjun] Minist Sci & Technol, Natl Agr Engn Ctr North Mt Reg, Baoding, Peoples R China	Hebei Agricultural University; Beijing Genomics Institute (BGI); Nankai University; Hebei Agricultural University; Hebei Agricultural University	Liu, MJ (corresponding author), Agr Univ Hebei, Res Ctr Chinese Jujube, Baoding, Peoples R China.	lmj1234567@aliyun.com		Jian, Jianbo/0000-0003-2187-5490	National Science and Technology Support Plan of China [2013BAD14B03]; Provincial Key Technology R&D Program of Hebei of China [11230606D-6]	National Science and Technology Support Plan of China; Provincial Key Technology R&D Program of Hebei of China	This study was supported by grants from National Science and Technology Support Plan of China (No. 2013BAD14B03), Provincial Key Technology R&D Program of Hebei of China (No. 11230606D-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barchi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043740; Barchi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-304; Bus A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-281; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; China Agricultural Yearbook Editing Committee, 2012, CHIN AGR YB; Chong ZC, 2012, BIOINFORMATICS, V28, P2732, DOI 10.1093/bioinformatics/bts482; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Delourme R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-120; Etter PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018561; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Leonforte A, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-161; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lijavetzky D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-424; Liu MJ, 2013, ACTA HORTIC, V993, P15, DOI 10.17660/ActaHortic.2013.993.1; Liu M.J., 2009, GERMPLASM RESOURCES; Liu MengJun, 2006, Horticultural Reviews, V32, P229; Pujolar JM, 2013, MOL ECOL RESOUR, V13, P706, DOI 10.1111/1755-0998.12117; Qi Jing, 2009, Scientia Silvae Sinicae, V45, P44; Qu ZZ, 1993, CHINESE FRUIT TREES, p33p; Shen LY, 2005, THESIS AGR U HEBEI; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Wang N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-148; Willing EM, 2011, BIOINFORMATICS, V27, P2187, DOI 10.1093/bioinformatics/btr346; Yang HX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064799, 10.1371/journal.pone.0064058]; Zhu YL, 2003, GENETICS, V163, P1123; Zou J, 2011, PLANT J, V68, P212, DOI 10.1111/j.1365-313X.2011.04679.x	29	20	25	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109850	10.1371/journal.pone.0109850	http://dx.doi.org/10.1371/journal.pone.0109850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303289	gold, Green Published, Green Submitted			2022-12-27	WOS:000343730400086
J	Williams, GM; Faraji, A; Unlu, I; Healy, SP; Farooq, M; Gaugler, R; Hamilton, G; Fonseca, DM				Williams, Gregory M.; Faraji, Ary; Unlu, Isik; Healy, Sean P.; Farooq, Muhammad; Gaugler, Randy; Hamilton, George; Fonseca, Dina M.			Area-Wide Ground Applications of Bacillus thuringiensis var. israelensis for the Control of Aedes albopictus in Residential Neighborhoods: From Optimization to Operation	PLOS ONE			English	Article							LARVAL COMPETITION; DIPTERA-CULICIDAE; SOURCE REDUCTION; NEW-JERSEY; MOSQUITO; TIGER; FORMULATIONS; AEGYPTI; JAPONICUS	The increasing range of Aedes albopictus, the Asian tiger mosquito, in the USA and the threat of chikungunya and dengue outbreaks vectored by this species have necessitated novel approaches to control this peridomestic mosquito. Conventional methods such as adulticiding provide temporary relief, but fail to manage this pest on a sustained basis. We explored the use of cold aerosol foggers and misting machines for area-wide applications of Bacillus thuringiensis var. israelensis (VectoBac WDG) as a larvicide targeting Aedes albopictus. During 2010-2013 we performed initially open field trials and then 19 operational area-wide applications in urban and suburban residential areas in northeastern USA to test three truck-mounted sprayers at two application rates. Area-wide applications of WDG in open field conditions at 400 and 800 g/ha killed on average 87% of tested larvae. Once techniques were optimized in residential areas, applications with a Buffalo Turbine Mist Sprayer at a rate of 800 g/ha, the best combination, consistently provided over 90% mortality. Importantly, there was no significant decrease in efficacy with distance from the spray line even in blocks of row homes with trees and bushes in the backyards. Under laboratory conditions Bti deposition in bioassay cups during the operational trials resulted in over 6 weeks of residual control. Our results demonstrate that area-wide truck mounted applications of WDG can effectively suppress Ae. albopictus larvae and should be used in integrated mosquito management approaches to control this nuisance pest and disease vector.	[Williams, Gregory M.] Hudson Reg Hlth Commiss, Secaucus, NJ USA; [Williams, Gregory M.; Faraji, Ary; Unlu, Isik; Healy, Sean P.; Gaugler, Randy; Hamilton, George; Fonseca, Dina M.] Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ 08903 USA; [Faraji, Ary] Salt Lake City Mosquito Abatement Dist, Salt Lake City, UT USA; [Unlu, Isik] Mercer Cty Mosquito Control, West Trenton, NJ USA; [Healy, Sean P.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA; [Farooq, Muhammad] Navy Entomol Ctr Excellence, Jacksonville, FL USA	Rutgers State University New Brunswick; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Williams, GM (corresponding author), Hudson Reg Hlth Commiss, Secaucus, NJ USA.	gwilliams@hudsonregionalhealth.org	Fonseca, Dina/HHS-1320-2022; Fonseca, Dina Madeira/B-9951-2011; Williams, Gregory/ABD-8038-2020	Fonseca, Dina Madeira/0000-0003-4726-7100; Williams, Gregory/0000-0001-9760-6831	US Department of Agriculture, Agricultural Research Service (USDA-ARS) [USDA-ARS-58-6615-8-105]; USDA-ARS [2008-34103-18978]; Rutgers University [USDA-ARS-58-6615-8-105, 2008-34103-18978]	US Department of Agriculture, Agricultural Research Service (USDA-ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Rutgers University	This work was funded by Cooperative Agreement USDA-ARS-58-6615-8-105 between the US Department of Agriculture, Agricultural Research Service (USDA-ARS) and Rutgers University (PI at Rutgers: DMF) and Regional IPM Grant 2008-34103-18978 between USDA-ARS and Rutgers University (PI at Rutgers: GH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew P, 2000, J MED ENTOMOL, V37, P732, DOI 10.1603/0022-2585-37.5.732; Armstrong PM, 2013, J MED ENTOMOL, V50, P1310, DOI 10.1603/ME13099; Bartlett-Healy K, 2012, J MED ENTOMOL, V49, P813, DOI 10.1603/ME11031; Bartlett-Healy K, 2011, INT J ENV RES PUB HE, V8, P1358, DOI 10.3390/ijerph8051358; Batra CP, 2000, J AM MOSQUITO CONTR, V16, P321; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Dow GW, 2014, J AM MOSQ C IN PRESS; Farajollahi A, 2013, J AM MOSQUITO CONTR, V29, P385, DOI 10.2987/13-6332.1; Farajollahi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049181; Farajollahi A, 2009, J MED ENTOMOL, V46, P1220, DOI 10.1603/033.046.0533; Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Halasa YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089221; Jacups SP, 2013, AM J TROP MED HYG, V88, P490, DOI 10.4269/ajtmh.12-0385; Lacey LA, 2003, PROG BIOL CONTROL, V1, P151; Lacey LA, 2007, J AM MOSQUITO CONTR, V23, P133, DOI 10.2987/8756-971X(2007)23[133:BTSIAB]2.0.CO;2; Lam PHY, 2010, SE ASIAN J TROP MED, V41, P1071; Lee H. L., 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P601; Lee HL, 1996, J AM MOSQUITO CONTR, V12, P651; Mulla MS, 2004, J AM MOSQUITO CONTR, V20, P64; Punter W, 1981, MANUAL FIELD TRIALS; Regis L, 2000, ENTOMOPATHOGENIC BAC, P419, DOI [10.1007/978-94-017-1429-7_23, DOI 10.1007/978-94-017-1429-7_23]; Reiskind MH, 2009, MED VET ENTOMOL, V23, P62, DOI 10.1111/j.1365-2915.2008.00782.x; Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874; Seleena P., 1998, Israel Journal of Entomology, V32, P25; Sokal R.R., 2012, BIOMETRY; Sun DB, 2014, J AM MOSQUITO CONTR, V30, P99, DOI 10.2987/13-6394.1; Unlu I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077999; Unlu I, 2012, J AM MOSQUITO CONTR, V28, P334, DOI 10.2987/12-6262R.1; Unlu Isik, 2012, HACETTEPE JOURNAL OF BIOLOGY AND CHEMISTRY, V40, P23; Unlu I, 2011, PEST MANAG SCI, V67, P965, DOI 10.1002/ps.2140; Valent BioSciences Corporation, 2012, VECTOBAC 12AS SPEC L; Valent BioSciences Corporation, 2003, TECHN US B VECTOBAC; Vilarinhos PTR, 2004, J AM MOSQUITO CONTR, V20, P311; *WHO, 2004, 7 WHOPES WORK GROUP; Yap HH, 1997, J AM MOSQUITO CONTR, V13, P384; Zhou YiBin, 2009, Zhongguo Meijie Shengwuxue ji Kongzhi Zazhi = Chinese Journal of Vector Biology and Control, V20, P3	37	35	36	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110035	10.1371/journal.pone.0110035	http://dx.doi.org/10.1371/journal.pone.0110035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329314	Green Published, gold, Green Submitted			2022-12-27	WOS:000343942100036
J	Gomariz, M; Blaya, S; Acebal, P; Carretero, L				Gomariz, Maria; Blaya, Salvador; Acebal, Pablo; Carretero, Luis			Real-Time UV-Visible Spectroscopy Analysis of Purple Membrane-Polyacrylamide Film Formation Taking into Account Fano Line Shapes and Scattering	PLOS ONE			English	Article							BACTERIORHODOPSIN WILDTYPE; QUANTUM DOTS; PROTEIN; ABSORPTION; EFFICIENCY; RHODOPSIN; MECHANISM; DYNAMICS; NANOGELS; SPECTRA	We theoretically and experimentally analyze the formation of thick Purple Membrane (PM) polyacrylamide (PA) films by means of optical spectroscopy by considering the absorption of bacteriorhodopsin and scattering. We have applied semiclassical quantum mechanical techniques for the calculation of absorption spectra by taking into account the Fano effects on the ground state of bacteriorhodopsin. A model of the formation of PM-polyacrylamide films has been proposed based on the growth of polymeric chains around purple membrane. Experimentally, the temporal evolution of the polymerization process of acrylamide has been studied as function of the pH solution, obtaining a good correspondence to the proposed model. Thus, due to the formation of intermediate bacteriorhodopsin-doped nanogel, by controlling the polymerization process, an alternative methodology for the synthesis of bacteriorhodopsin-doped nanogels can be provided.	[Gomariz, Maria; Blaya, Salvador; Acebal, Pablo; Carretero, Luis] Univ Miguel Hernandez, Dept Ciencia Mat Opt & Tecnol Elect, Elx, Alicante, Spain	Universidad Miguel Hernandez de Elche	Blaya, S (corresponding author), Univ Miguel Hernandez, Dept Ciencia Mat Opt & Tecnol Elect, Elx, Alicante, Spain.	salva@dite.umh.es	Blaya, Salvador/K-7730-2014; Acebal, Pablo/ABG-9250-2020; Gomariz Clemente, María/ABF-5222-2021; Carretero, Luis/K-8578-2014; Carretero, Luis/AAA-8565-2020	Blaya, Salvador/0000-0002-9219-3545; Carretero, Luis/0000-0003-4738-8834; ACEBAL, PABLO/0000-0001-7437-7247				Acebal P, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.016608; Adamov GE, 2008, J PHOTOCH PHOTOBIO A, V196, P254, DOI 10.1016/j.jphotochem.2007.07.027; Adamov GE, 2013, RUSS J GEN CHEM+, V83, P2195, DOI 10.1134/S107036321311039X; BALASHOV SP, 1991, BIOPHYS J, V60, P475, DOI 10.1016/S0006-3495(91)82074-4; BECHER B, 1978, BIOCHEMISTRY-US, V17, P2293, DOI 10.1021/bi00605a006; BIRGE RR, 1989, J AM CHEM SOC, V111, P4063, DOI 10.1021/ja00193a044; BIRGE RR, 1988, BIOPHYS J, V53, P367, DOI 10.1016/S0006-3495(88)83114-X; Birge RR, 1999, J PHYS CHEM B, V103, P10746, DOI 10.1021/jp991883n; Bohren C.F., 2008, ABSORPTION SCATTERIN; BRAUCHLE C, 1991, ADV MATER, V3, P420, DOI 10.1002/adma.19910030903; Byron ML, 2013, EXP FLUIDS, V54, DOI 10.1007/s00348-013-1456-z; Chae DH, 2011, NANO LETT, V11, P1379, DOI 10.1021/nl200040q; Chuong AS, 2014, NAT NEUROSCI, V17, P1123, DOI 10.1038/nn.3752; DECKER C, 1992, J POLYM SCI POL CHEM, V30, P913, DOI 10.1002/pola.1992.080300523; DOWNIE JD, 1994, APPL OPTICS, V33, P4353, DOI 10.1364/AO.33.004353; Druzhko AB, 2009, PHOTOCHEM PHOTOBIOL, V85, P614, DOI 10.1111/j.1751-1097.2008.00527.x; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; FANO U, 1968, REV MOD PHYS, V40, P441, DOI 10.1103/RevModPhys.40.441; FRASER RDB, 1969, ANAL CHEM, V41, P37, DOI 10.1021/ac60270a007; Fujimoto K, 2007, J CHEM THEORY COMPUT, V3, P605, DOI 10.1021/ct6002687; Gupta R, 2003, NANO LETT, V3, P627, DOI 10.1021/nl0341133; Hampp N, 2000, CHEM REV, V100, P1755, DOI 10.1021/cr980072x; HAMPP N, 1990, BIOPHYS J, V58, P83, DOI 10.1016/S0006-3495(90)82355-9; HAMPP N, 1992, J PHYS CHEM-US, V96, P4679, DOI 10.1021/j100190a098; Haupts U, 1999, ANNU REV BIOPH BIOM, V28, P367, DOI 10.1146/annurev.biophys.28.1.367; Hegemann P, 2013, EMBO MOL MED, V5, P173, DOI 10.1002/emmm.201202387; Hopkins B, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.053819; HUANG JY, 1989, J PHYS CHEM-US, V93, P3314, DOI 10.1021/j100345a086; Karjalainen EL, 2012, J PHYS CHEM B, V116, P4448, DOI 10.1021/jp300329k; KATES M, 1982, METHOD ENZYMOL, V88, P98; Kos A, 2013, MOL NEUROBIOL, V47, P172, DOI 10.1007/s12035-012-8361-y; Kumar R, 2013, INDIAN J PHYS, V87, P49, DOI 10.1007/s12648-012-0183-2; Lanyi JK, 2000, J PHYS CHEM B, V104, P11441, DOI 10.1021/jp0023718; Liu GY, 2014, POLYM CHEM-UK, V5, P1559, DOI 10.1039/c3py01502e; May V., 2011, CHARGE ENERGY TRANSF; Maya S, 2013, CURR PHARM DESIGN, V19, P7203, DOI 10.2174/138161281941131219124142; Mennucci B, 2011, PHYS CHEM CHEM PHYS, V13, P11538, DOI 10.1039/c1cp20601j; Mercer IP, 1999, J PHYS CHEM B, V103, P7720, DOI 10.1021/jp990284d; Miroshnichenko AE, 2010, REV MOD PHYS, V82, P2257, DOI 10.1103/RevModPhys.82.2257; MIYASAKA T, 1993, APPL OPTICS, V32, P6371, DOI 10.1364/AO.32.006371; Neugebauer J, 2009, CHEMPHYSCHEM, V10, P3148, DOI 10.1002/cphc.200900538; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; Olbrich C, 2011, J PHYS CHEM LETT, V2, P1771, DOI 10.1021/jz2007676; Patil AV, 2012, CHEM-EUR J, V18, P5632, DOI 10.1002/chem.201103597; Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612; Pescitelli G, 2012, J PHYS CHEM B, V116, P6751, DOI 10.1021/jp212166k; Renugopalakrishnan V, 2014, J PHYS CHEM C, V118, P16710, DOI 10.1021/jp502885s; Riffe DM, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.064308; Singh CP, 2003, OPT COMMUN, V218, P55, DOI 10.1016/S0030-4018(03)01169-6; SORBELLO RS, 1985, PHYS REV B, V32, P6294, DOI 10.1103/PhysRevB.32.6294; STAVENGA DG, 1993, VISION RES, V33, P1011, DOI 10.1016/0042-6989(93)90237-Q; STOECKENIUS W, 1979, BIOCHIM BIOPHYS ACTA, V505, P215, DOI 10.1016/0304-4173(79)90006-5; Stuart JA, 2002, SYNTHETIC MET, V127, P3, DOI 10.1016/S0379-6779(01)00586-0; TORQUATO S, 1995, PHYS REV E, V51, P3170, DOI 10.1103/PhysRevE.51.3170; V Centeno M, 1941, J OPT SOC AM, V31, P244; van Stokkum IHM, 2004, BBA-BIOENERGETICS, V1657, P82, DOI 10.1016/j.bbabio.2004.04.011; Wise KJ, 2002, TRENDS BIOTECHNOL, V20, P387, DOI 10.1016/S0167-7799(02)02023-1; WU JW, 1991, J OPT SOC AM B, V8, P142, DOI 10.1364/JOSAB.8.000142; Wu PF, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.253601; Yao BL, 2005, OPT EXPRESS, V13, P20, DOI 10.1364/OPEX.13.000020; Zaitsev SY, 2014, COLLOID SURFACE B, V117, P248, DOI 10.1016/j.colsurfb.2014.02.033; Zhivkov AM, 2002, COLLOID SURFACE A, V209, P319, DOI 10.1016/S0927-7757(02)00195-4	62	0	0	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110518	10.1371/journal.pone.0110518	http://dx.doi.org/10.1371/journal.pone.0110518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329473	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100087
J	Prokopec, SD; Watson, JD; Pohjanvirta, R; Boutros, PC				Prokopec, Stephenie D.; Watson, John D.; Pohjanvirta, Raimo; Boutros, Paul C.			Identification of Reference Proteins for Western Blot Analyses in Mouse Model Systems of 2,3,7,8-Tetrachlorodibenzo-P-Dioxin (TCDD) Toxicity	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; POLYMERASE-CHAIN-REACTION; MESSENGER-RNA EXPRESSION; GENE-EXPRESSION; HOUSEKEEPING GENES; TRANSCRIPTOMIC RESPONSES; DIFFERENTIAL EXPRESSION; REVERSE TRANSCRIPTION; RAT STRAIN; PCR DATA	Western blotting is a well-established, inexpensive and accurate way of measuring protein content. Because of technical variation between wells, normalization is required for valid interpretation of results across multiple samples. Typically this involves the use of one or more endogenous controls to adjust the measured levels of experimental molecules. Although some endogenous controls are widely used, validation is required for each experimental system. This is critical when studying transcriptional-modulators, such as toxicants like 2,3,7,8-tetrachlorodibenzo-p-dioxin ( TCDD). To address this issue, we examined hepatic tissue from 192 mice representing 47 unique combinations of strain, sex, Ahr-genotype, TCDD dose and treatment time. We examined 7 candidate reference proteins in each animal and assessed consistency of protein abundance through: 1) TCDD-induced fold-difference in protein content from basal levels, 2) inter-and intra-animal stability, and 3) the ability of each candidate to reduce instability of the other candidates. Univariate analyses identified HPRT as the most stable protein. Multivariate analysis indicated that stability generally increased with the number of proteins used, but gains from using >3 proteins were small. Lastly, by comparing these new data to our previous studies of mRNA controls on the same animals, we were able to show that the ideal mRNA and protein control-genes are distinct, and use of only 2-3 proteins provides strong stability, unlike in mRNA studies in the same cohort, where larger control-gene batteries were needed.	[Prokopec, Stephenie D.; Watson, John D.; Boutros, Paul C.] Ontario Inst Canc Res, Informat & Biocomp Program, Toronto, ON, Canada; [Pohjanvirta, Raimo] Natl Inst Hlth & Welf, Toxicol Lab, Kuopio, Finland; [Pohjanvirta, Raimo] Univ Helsinki, Dept Food Hyg & Environm Hlth, Helsinki, Finland; [Boutros, Paul C.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Boutros, Paul C.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada	Ontario Institute for Cancer Research; Finland National Institute for Health & Welfare; University of Helsinki; University of Toronto; University of Toronto	Boutros, PC (corresponding author), Ontario Inst Canc Res, Informat & Biocomp Program, Toronto, ON, Canada.	Paul.Boutros@oicr.on.ca	Pohjanvirta, Raimo/I-4509-2019	Pohjanvirta, Raimo/0000-0003-0952-5746; Boutros, Paul/0000-0003-0553-7520	Academy of Finland [123345, 261232]; Canadian Institutes of Health [MOP-57903]; Ontario Institute for Cancer Research; Government of Ontario	Academy of Finland(Academy of Finland); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Ontario Institute for Cancer Research; Government of Ontario	This study was conducted with the support of the Academy of Finland (grant nos. 123345 and 261232 to RP), the Canadian Institutes of Health Research (grant no. MOP-57903 to ABO and PCB), and the Ontario Institute for Cancer Research to PCB through funding provided by the Government of Ontario. Dr. Boutros was supported by a Terry Fox Research Institute New Investigator Award and a CIHR New Investigator Salary Award. The above funding sources had no involvement in the study design, in the collection, analysis and interpretation of data, in the writing of the document, or in the decision to submit the work for publication.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anderson LVB, 1999, AM J PATHOL, V154, P1017, DOI 10.1016/S0002-9440(10)65354-0; Baumgartner R, 2013, J PROTEOMICS, V94, P540, DOI 10.1016/j.jprot.2013.10.015; Bertazzi PA, 1997, EPIDEMIOLOGY, V8, P646, DOI 10.1097/00001648-199710000-00006; Boutros PC, 2011, TOXICOL APPL PHARM, V251, P119, DOI 10.1016/j.taap.2010.12.010; Boutros PC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-419; Boverhof DR, 2006, TOXICOL SCI, V94, P398, DOI 10.1093/toxsci/kfl100; Boverhof DR, 2005, TOXICOL SCI, V85, P1048, DOI 10.1093/toxsci/kfi162; CHAPMAN DE, 1985, TOXICOL APPL PHARM, V78, P147, DOI 10.1016/0041-008X(85)90314-X; Deindl E, 2002, MOL CELL BIOCHEM, V236, P139, DOI 10.1023/A:1016166127465; Eaton SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072457; Ferguson RE, 2005, PROTEOMICS, V5, P566, DOI 10.1002/pmic.200400941; Franc MA, 2008, ARCH TOXICOL, V82, P809, DOI 10.1007/s00204-008-0303-0; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gerk PM, 2011, J PHARMACOL TOX MET, V63, P279, DOI 10.1016/j.vascn.2011.01.003; Greer S, 2010, J IMMUNOL METHODS, V355, P76, DOI 10.1016/j.jim.2010.02.006; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hanlon PR, 2005, TOXICOL APPL PHARM, V202, P215, DOI 10.1016/j.taap.2004.06.018; Hinson JA, 2000, TOXICOL SCI, V53, P467, DOI 10.1093/toxsci/53.2.467; Hoene V, 2009, BRIT J CANCER, V101, P1481, DOI 10.1038/sj.bjc.6605276; Karge W H 3rd, 1998, Methods Mol Biol, V110, P43; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim S, 2009, TOXICOL SCI, V112, P229, DOI 10.1093/toxsci/kfp189; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Kislinger T, 2005, J AM SOC MASS SPECTR, V16, P1207, DOI 10.1016/j.jasms.2005.02.015; Li XM, 2011, J EXP BOT, V62, P4763, DOI 10.1093/jxb/err084; Linden J, 2012, ANAL BIOCHEM, V428, P81, DOI 10.1016/j.ab.2012.06.010; Longnecker MP, 2000, EPIDEMIOLOGY, V11, P44, DOI 10.1097/00001648-200001000-00010; Marinkovic N, 2010, ARH HIG RADA TOKSIKO, V61, P445, DOI 10.2478/10004-1254-61-2010-2024; OKEY AB, 1994, TOXICOL LETT, V70, P1, DOI 10.1016/0378-4274(94)90139-2; Okey AB, 2007, TOXICOL SCI, V98, P5, DOI 10.1093/toxsci/kfm096; Pastorelli R, 2006, MOL CELL PROTEOMICS, V5, P882, DOI 10.1074/mcp.M500415-MCP200; Pohjanvirta R, 1998, MOL PHARMACOL, V54, P86, DOI 10.1124/mol.54.1.86; Pohjanvirta R, 2006, CHEM-BIOL INTERACT, V160, P134, DOI 10.1016/j.cbi.2006.01.001; POHJANVIRTA R, 1993, PHARMACOL TOXICOL, V73, P52, DOI 10.1111/j.1600-0773.1993.tb01958.x; Pohjanvirta R., 2011, AH RECEPTOR BIOL TOX; Pohjanvirta R, 2012, TOXICOL APPL PHARM, V262, P167, DOI 10.1016/j.taap.2012.04.032; Pohjanvirta R, 2009, TOXICOL APPL PHARM, V236, P166, DOI 10.1016/j.taap.2009.01.005; POLAND A, 1994, MOL PHARMACOL, V46, P915; Prokopec SD, 2013, CHEM-BIOL INTERACT, V205, P63, DOI 10.1016/j.cbi.2013.06.008; Puga Alvaro, 2004, Cardiovasc Toxicol, V4, P385, DOI 10.1385/CT:4:4:385; Schecter A, 2006, ENVIRON RES, V101, P419, DOI 10.1016/j.envres.2005.12.003; Schutz-Geschwender A, 2004, QUANTITATIVE 2 COLOR; SEEFELD MD, 1984, TOXICOL APPL PHARM, V73, P311, DOI 10.1016/0041-008X(84)90337-5; Shen CF, 2009, ENVIRON INT, V35, P50, DOI 10.1016/j.envint.2008.07.005; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Tramm T, 2013, DIAGN MOL PATHOL, V22, P181, DOI 10.1097/PDM.0b013e318285651e; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walter RF, 2013, PATHOL RES PRACT; Watson JD, 2013, TOXICOL APPL PHARM; Weisglas-Kuperus N, 2000, ENVIRON HEALTH PERSP, V108, P1203, DOI 10.2307/3434834; Weldon S, 2008, ANAL BIOCHEM, V375, P156, DOI 10.1016/j.ab.2007.11.035; Yao CDQ, 2012, TOXICOL APPL PHARM, V260, P135, DOI 10.1016/j.taap.2012.02.001; Zeng L, 2013, ELECTROPHORESIS, V34, P2234, DOI 10.1002/elps.201300140; Zhu MM, 2012, MOL VIS, V18, P1156	57	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110730	10.1371/journal.pone.0110730	http://dx.doi.org/10.1371/journal.pone.0110730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329058	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100104
J	Chu, LH; Lee, E; Bader, JS; Popel, AS				Chu, Liang-Hui; Lee, Esak; Bader, Joel S.; Popel, Aleksander S.			Angiogenesis Interactome and Time Course Microarray Data Reveal the Distinct Activation Patterns in Endothelial Cells	PLOS ONE			English	Article							GENE-EXPRESSION DATA; GROWTH-FACTOR; BIOLOGICAL NETWORKS; VEGF; CYTOSCAPE; THROMBOSPONDIN; MORPHOGENESIS; INTEGRATION; MOLECULES; ONTOLOGY	Angiogenesis involves stimulation of endothelial cells (EC) by various cytokines and growth factors, but the signaling mechanisms are not completely understood. Combining dynamic gene expression time-course data for stimulated EC with protein-protein interactions associated with angiogenesis (the "angiome'') could reveal how different stimuli result in different patterns of network activation and could implicate signaling intermediates as points for control or intervention. We constructed the protein-protein interaction networks of positive and negative regulation of angiogenesis comprising 367 and 245 proteins, respectively. We used five published gene expression datasets derived from in vitro assays using different types of blood endothelial cells stimulated by VEGFA (vascular endothelial growth factor A). We used the Short Time-series Expression Miner (STEM) to identify significant temporal gene expression profiles. The statistically significant patterns between 2D fibronectin and 3D type I collagen substrates for telomerase-immortalized EC (TIME) show that different substrates could influence the temporal gene activation patterns in the same cell line. We investigated the different activation patterns among 18 transmembrane tyrosine kinase receptors, and experimentally measured the protein level of the tyrosine-kinase receptors VEGFR1, VEGFR2 and VEGFR3 in human umbilical vein EC (HUVEC) and human microvascular EC (MEC). The results show that VEGFR1-VEGFR2 levels are more closely coupled than VEGFR1-VEGFR3 or VEGFR2-VEGFR3 in HUVEC and MEC. This computational methodology can be extended to investigate other molecules or biological processes such as cell cycle.	[Chu, Liang-Hui; Lee, Esak; Bader, Joel S.; Popel, Aleksander S.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Bader, Joel S.] Johns Hopkins Univ, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Popel, Aleksander S.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Popel, Aleksander S.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Chu, LH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	lchu5@jhmi.edu	Popel, Aleksander S/A-6724-2009; Lee, Esak/AAC-6403-2020	Lee, Esak/0000-0002-5328-6677; Popel, Aleksander/0000-0002-6706-9235	National Institutes of Health (NIH) [R01 CA138264, R01 HL101200, R21 HL122721, U54 RR020839]; Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation; NATIONAL CANCER INSTITUTE [R01CA138264] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101200, R21HL122721] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (NIH) grants R01 CA138264, R01 HL101200, and R21 HL122721 (ASP), and U54 RR020839 and the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation (JSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bando H, 2004, INT J CANCER, V111, P184, DOI 10.1002/ijc.20211; Bein K, 2000, J BIOL CHEM, V275, P32167, DOI 10.1074/jbc.M003834200; Cebe-Suarez S, 2006, CELL MOL LIFE SCI, V63, P601, DOI 10.1007/s00018-005-5426-3; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chu LH, 2012, PHYSIOL GENOMICS, V44, P915, DOI 10.1152/physiolgenomics.00181.2011; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; Filleur S, 2005, CANCER RES, V65, P5144, DOI 10.1158/0008-5472.CAN-04-3744; Gabhann FM, 2008, MICROCIRCULATION, V15, P715, DOI 10.1080/10739680802095964; GALVIN NJ, 1987, J CELL BIOL, V104, P1413, DOI 10.1083/jcb.104.5.1413; Gao J, 2009, BIOINFORMATICS, V25, P137, DOI 10.1093/bioinformatics/btn501; Glesne DA, 2006, CANCER RES, V66, P4030, DOI 10.1158/0008-5472.CAN-05-3294; Hagedorn M, 2000, CRIT REV ONCOL HEMAT, V34, P89, DOI 10.1016/S1040-8428(00)00056-1; Jesmin S, 2012, INFLAMMATION, V35, P484, DOI 10.1007/s10753-011-9337-1; Kajdaniuk D, 2011, ENDOKRYNOL POL, V62, P444; Karagiannis ED, 2008, P NATL ACAD SCI USA, V105, P13775, DOI 10.1073/pnas.0803241105; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mellberg S, 2009, FASEB J, V23, P1490, DOI 10.1096/fj.08-123810; Minami T, 2005, TRENDS CARDIOVAS MED, V15, P174, DOI 10.1016/j.tcm.2005.06.002; Nolan DJ, 2013, DEV CELL, V26, P204, DOI 10.1016/j.devcel.2013.06.017; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rivera CG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024887; Ryu J, 2008, CARDIOVASC RES, V78, P333, DOI 10.1093/cvr/cvm067; Schweighofer B, 2009, THROMB HAEMOSTASIS, V102, P544, DOI 10.1160/TH08-12-0830; Sillen A, 2010, J HUM GENET, V55, P649, DOI 10.1038/jhg.2010.79; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stelzer Gil, 2011, Human Genomics, V5, P709; Tarcea VG, 2009, NUCLEIC ACIDS RES, V37, pD642, DOI 10.1093/nar/gkn722; TOLSMA SS, 1993, J CELL BIOL, V122, P497, DOI 10.1083/jcb.122.2.497; van Beijnum JR, 2008, EXP CELL RES, V314, P264, DOI 10.1016/j.yexcr.2007.08.013; Vempati P, 2013, CYTOKINE GROWTH FACT; Zaedi S, 2006, EXP BIOL MED, V231, P1182	34	14	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110871	10.1371/journal.pone.0110871	http://dx.doi.org/10.1371/journal.pone.0110871			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329517	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210800112
J	Hamilton, JL; Hatef, A; Ul-Haq, MI; Nair, N; Unniappan, S; Kizhakkedathu, JN				Hamilton, Jasmine L.; Hatef, Azadeh; Ul-Haq, Muhammad Imran; Nair, Neelima; Unniappan, Suraj; Kizhakkedathu, Jayachandran N.			Clinically Approved Iron Chelators Influence Zebrafish Mortality, Hatching Morphology and Cardiac Function	PLOS ONE			English	Article							DEVELOPMENTAL TOXICITY; BETA-THALASSEMIA; GENE-EXPRESSION; THERAPY; DEFEROXAMINE; DEFERASIROX; DEFERIPRONE; DRUGS; PERMEABILITY	Iron chelation therapy using iron (III) specific chelators such as desferrioxamine (DFO, Desferal), deferasirox (Exjade or ICL-670), and deferiprone (Ferriprox or L1) are the current standard of care for the treatment of iron overload. Although each chelator is capable of promoting some degree of iron excretion, these chelators are also associated with a wide range of well documented toxicities. However, there is currently very limited data available on their effects in developing embryos. In this study, we took advantage of the rapid development and transparency of the zebrafish embryo, Danio rerio to assess and compare the toxicity of iron chelators. All three iron chelators described above were delivered to zebrafish embryos by direct soaking and their effects on mortality, hatching and developmental morphology were monitored for 96 hpf. To determine whether toxicity was specific to embryos, we examined the effects of chelator exposure via intra peritoneal injection on the cardiac function and gene expression in adult zebrafish. Chelators varied significantly in their effects on embryo mortality, hatching and morphology. While none of the embryos or adults exposed to DFO were negatively affected, ICL-treated embryos and adults differed significantly from controls, and L1 exerted toxic effects in embryos alone. ICL-670 significantly increased the mortality of embryos treated with doses of 0.25 mM or higher and also affected embryo morphology, causing curvature of larvae treated with concentrations above 0.5 mM. ICL-670 exposure (10 mu L of 0.1 mM injection) also significantly increased the heart rate and cardiac output of adult zebrafish. While L1 exposure did not cause toxicity in adults, it did cause morphological defects in embryos at 0.5 mM. This study provides first evidence on iron chelator toxicity in early development and will help to guide our approach on better understanding the mechanism of iron chelator toxicity.	[Hamilton, Jasmine L.; Ul-Haq, Muhammad Imran; Kizhakkedathu, Jayachandran N.] Univ British Columbia, Ctr Blood Res, Dept Pathol & Lab Med, Inst Life Sci, Vancouver, BC V5Z 1M9, Canada; [Hatef, Azadeh; Nair, Neelima; Unniappan, Suraj] Univ Saskatchewan, Western Coll Vet Med, Lab Integrat Neuroendocrinol, Saskatoon, SK S7N 0W0, Canada; [Kizhakkedathu, Jayachandran N.] Univ British Columbia, Dept Chem, Vancouver, BC, Canada	University of British Columbia; University of Saskatchewan; University of British Columbia	Unniappan, S (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Lab Integrat Neuroendocrinol, Saskatoon, SK S7N 0W0, Canada.	suraj.unniappan@usask.ca; jay@pathology.ubc.ca		Hatef, Azadeh/0000-0002-7366-3273	Canadian Institutes of Health Research [MOP-130408, MOP-97833]; Natural Sciences and Engineering Research Council (NSERC) of Canada; Saskatchewan Health Research Foundation (SHRF)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Saskatchewan Health Research Foundation (SHRF)	This research was funded by grants from Canadian Institutes of Health Research (MOP-130408 & MOP-97833) to JNK. The research using zebrafish was partly supported by a Discovery grant and Discovery Accelerator award from the Natural Sciences and Engineering Research Council (NSERC) of Canada, and an Establishment Grant from the Saskatchewan Health Research Foundation (SHRF) to SU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2005, NEW ENGL J MED, V353, P2769; Andersen O, 1997, FISH PHYSIOL BIOCHEM, V16, P223, DOI 10.1023/A:1007729900376; BERDOUKAS V, 1993, LANCET, V341, P1088, DOI 10.1016/0140-6736(93)92443-W; BOSQUE MA, 1995, ARCH TOXICOL, V69, P467, DOI 10.1007/s002040050200; Bury N, 2003, COMP BIOCHEM PHYS C, V135, P97, DOI 10.1016/S1532-0456(03)00021-8; Camenisch G, 1998, EUR J PHARM SCI, V6, P313, DOI 10.1016/S0928-0987(97)10019-7; Cappellini MD, 2005, BEST PRACT RES CL HA, V18, P289, DOI 10.1016/j.beha.2004.09.002; Cohen AR, 2003, BLOOD, V102, P1583, DOI 10.1182/blood-2002-10-3280; Cooper CE, 1996, J BIOL CHEM, V271, P20291, DOI 10.1074/jbc.271.34.20291; Craig PM, 2009, AM J PHYSIOL-REG I, V296, pR362, DOI 10.1152/ajpregu.90581.2008; Crisponi G, 2008, COORDIN CHEM REV, V252, P1225, DOI 10.1016/j.ccr.2007.12.014; Domingo JL, 1998, REPROD TOXICOL, V12, P499, DOI 10.1016/S0890-6238(98)00036-7; Donovan A, 2002, BLOOD, V100, P4655, DOI 10.1182/blood-2002-04-1169; Fraenkel PG, 2005, J CLIN INVEST, V115, P1532, DOI 10.1172/JCI23780; Galanello R, 2012, EXPERT OPIN DRUG MET, V8, P123, DOI 10.1517/17425255.2012.640674; Gattermann N, 2010, LEUKEMIA RES, V34, P1143, DOI 10.1016/j.leukres.2010.03.009; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Haldi M, 2012, ZEBRAFISH: METHODS FOR ASSESSING DRUG SAFETY AND TOXICITY, P15; Hershko C, 2005, ANN NY ACAD SCI, V1054, P124, DOI 10.1196/annals.1345.015; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Hoffbrand AV, 2003, BLOOD, V102, P17, DOI 10.1182/blood-2002-06-1867; Kansy M, 1998, J MED CHEM, V41, P1007, DOI 10.1021/jm970530e; Kontoghiorghes GJ, 2010, EXPERT OPIN DRUG SAF, V9, P201, DOI 10.1517/14740330903535845; KONTOGHIORGHES GJ, 1987, BRIT MED J, V295, P1509, DOI 10.1136/bmj.295.6612.1509; Kontoghiorghes GJ, 2000, TRANSFUS SCI, V23, P211, DOI 10.1016/S0955-3886(00)00089-8; Koren G, 1998, NEW ENGL J MED, V338, P1128, DOI 10.1056/NEJM199804163381607; Levine JE, 1997, J PEDIAT HEMATOL ONC, V19, P139, DOI 10.1097/00043426-199703000-00008; Link G, 2001, J LAB CLIN MED, V138, P130, DOI 10.1067/mlc.2001.116487; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MODELL CB, 1974, ANN NY ACAD SCI, V232, P201, DOI 10.1111/j.1749-6632.1974.tb20586.x; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Olivieri NF, 1997, BLOOD, V89, P739, DOI 10.1182/blood.V89.3.739; OLIVIERI NF, 1994, NEW ENGL J MED, V331, P574, DOI 10.1056/NEJM199409013310903; Peterson RT, 2012, ANNU REV PHARMACOL, V52, P433, DOI 10.1146/annurev-pharmtox-010611-134751; ROBOTHAM JL, 1980, AM J DIS CHILD, V134, P875, DOI 10.1001/archpedi.1980.02130210059016; ROEDER M, 1966, J NUTR, V90, P86, DOI 10.1093/jn/90.1.86; Sanchez-Gonzalez PD, 2011, TOXICOL LETT, V203, P154, DOI 10.1016/j.toxlet.2011.03.018; Shike H, 2004, DEV COMP IMMUNOL, V28, P747, DOI 10.1016/j.dci.2003.11.009; Steinhauser S, 2004, EUR J INORG CHEM, P4177, DOI 10.1002/ejic.200400363; Tan JL, 2011, METHOD CELL BIOL, V105, P493, DOI 10.1016/B978-0-12-381320-6.00021-7; WALTER A, 1986, J MEMBRANE BIOL, V90, P207, DOI 10.1007/BF01870127; Wei HY, 2011, TRANSFUSION, V51, P949, DOI 10.1111/j.1537-2995.2010.02939.x; Zhou T, 2012, DALTON T, V41, P6371, DOI 10.1039/c2dt12159j; Zhu JJ, 2014, J APPL TOXICOL, V34, P139, DOI 10.1002/jat.2843; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	45	17	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109880	10.1371/journal.pone.0109880	http://dx.doi.org/10.1371/journal.pone.0109880			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329065	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210800045
J	Rao, YS; Wang, ZF; Chai, XW; Nie, QH; Zhang, XQ				Rao, Yousheng; Wang, Zhangfeng; Chai, Xuewen; Nie, Qinghua; Zhang, Xiquan			Hydrophobicity and Aromaticity Are Primary Factors Shaping Variation in Amino Acid Usage of Chicken Proteome	PLOS ONE			English	Article							HIGHLY EXPRESSED GENES; TRANSFER-RNA GENES; CODON USAGE; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; GALLUS-GALLUS; HUMAN GENOME; PROTEINS; BIAS; TRENDS	Amino acids are utilized with different frequencies both among species and among genes within the same genome. Up to date, no study on the amino acid usage pattern of chicken has been performed. In the present study, we carried out a systematic examination of the amino acid usage in the chicken proteome. Our data indicated that the relative amino acid usage is positively correlated with the tRNA gene copy number. GC contents, including GC1, GC2, GC3, GC content of CDS and GC content of the introns, were correlated with the most of the amino acid usage, especially for GC rich and GC poor amino acids, however, multiple linear regression analyses indicated that only approximately 10-40% variation of amino acid usage can be explained by GC content for GC rich and GC poor amino acids. For other intermediate GC content amino acids, only approximately 10% variation can be explained. Correspondence analyses demonstrated that the main factors responsible for the variation of amino acid usage in chicken are hydrophobicity, aromaticity and genomic GC content. Gene expression level also influenced the amino acid usage significantly. We argued that the amino acid usage of chicken proteome likely reflects a balance or near balance between the action of selection, mutation, and genetic drift.	[Rao, Yousheng; Wang, Zhangfeng; Chai, Xuewen] Nanchang Normal Univ, Dept Biol Technol, Nanchang, Jiangxi, Peoples R China; [Rao, Yousheng; Nie, Qinghua; Zhang, Xiquan] South China Agr Univ, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Guangzhou, Guangdong, Peoples R China	Nanchang Normal University; South China Agricultural University	Zhang, XQ (corresponding author), South China Agr Univ, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Guangzhou, Guangdong, Peoples R China.	xqzhang@scau.edu.cn			Science and Technology Program of Jiangxi Education Department, China [GJJ12658, GJJ13781]; Jiangxi provincial natural science fund project, China [2010GZN0021]	Science and Technology Program of Jiangxi Education Department, China; Jiangxi provincial natural science fund project, China	This work was supported by the Science and Technology Program of Jiangxi Education Department, China, Project No. GJJ12658 and No. GJJ13781, and Jiangxi provincial natural science fund project, China, Project No. 2010GZN0021. The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi H, 2003, GENETICS, V164, P1291; Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; Behura SK, 2011, INSECT MOL BIOL, V20, P177, DOI 10.1111/j.1365-2583.2010.01055.x; Bernardi G, 2000, GENE, V241, P3, DOI 10.1016/S0378-1119(99)00485-0; D'Onofrio G, 2002, GENE, V300, P179, DOI 10.1016/S0378-1119(02)01045-4; DONOFRIO G, 1991, J MOL EVOL, V32, P504, DOI 10.1007/BF02102652; Duret L, 2000, TRENDS GENET, V16, P287, DOI 10.1016/S0168-9525(00)02041-2; Foster PG, 1997, J MOL EVOL, V44, P282, DOI 10.1007/PL00006145; Fryxell KJ, 2008, NOVA HEDWIGIA BIEHEF, V133, P285; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; HOLM S, 1979, SCAND J STAT, V6, P65; Kanaya S, 1999, GENE, V238, P143, DOI 10.1016/S0378-1119(99)00225-5; Knight R. D., 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-4-RESEARCH0010; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lightfield J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017677; LOBRY JR, 1994, NUCLEIC ACIDS RES, V22, P3174, DOI 10.1093/nar/22.15.3174; Novoa EM, 2012, TRENDS GENET, V28, P574, DOI 10.1016/j.tig.2012.07.006; Palacios C, 2002, MOL BIOL EVOL, V19, P1575, DOI 10.1093/oxfordjournals.molbev.a004219; Qian WF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002603; Rao YS, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-35; Rao YS, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-9; Rao YS, 2011, DNA RES, V18, P499, DOI 10.1093/dnares/dsr035; Rispe C, 2004, GENOME RES, V14, P44, DOI 10.1101/gr.1358104; Sabbia V, 2007, J BIOMOL STRUCT DYN, V25, P55, DOI 10.1080/07391102.2007.10507155; Seligmann H, 2003, J MOL EVOL, V56, P151, DOI 10.1007/s00239-002-2388-z; Singer GAC, 2000, MOL BIOL EVOL, V17, P1581, DOI 10.1093/oxfordjournals.molbev.a026257; Webster MT, 2006, MOL BIOL EVOL, V23, P1203, DOI 10.1093/molbev/msk008; Zavala A, 2002, J MOL EVOL, V54, P563, DOI 10.1007/s00239-001-0040-y	28	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110381	10.1371/journal.pone.0110381	http://dx.doi.org/10.1371/journal.pone.0110381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329059	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210800080
J	Bashir, SMA; Ghouri, FAK				Bashir, Syed Muhammad Arsalan; Ghouri, Farhan Ali Khan			Perspective Texture Synthesis Based on Improved Energy Optimization	PLOS ONE			English	Article							IMAGE	Perspective texture synthesis has great significance in many fields like video editing, scene capturing etc., due to its ability to read and control global feature information. In this paper, we present a novel example-based, specifically energy optimization-based algorithm, to synthesize perspective textures. Energy optimization technique is a pixel-based approach, so it's time-consuming. We improve it from two aspects with the purpose of achieving faster synthesis and high quality. Firstly, we change this pixel-based technique by replacing the pixel computation with a little patch. Secondly, we present a novel technique to accelerate searching nearest neighborhoods in energy optimization. Using k- means clustering technique to build a search tree to accelerate the search. Hence, we make use of principal component analysis (PCA) technique to reduce dimensions of input vectors. The high quality results prove that our approach is feasible. Besides, our proposed algorithm needs shorter time relative to other similar methods.	[Bashir, Syed Muhammad Arsalan] Inst Space Technol, Dept Elect Engn, Islamabad, Pakistan; [Bashir, Syed Muhammad Arsalan] Pakistan Space & Upper Atmosphere Res Commiss SUP, Qual Management Directorate Gen, Karachi, Pakistan; [Ghouri, Farhan Ali Khan] Univ Karachi, Dept Comp Sci, Karachi, Pakistan	University of Karachi	Bashir, SMA (corresponding author), Inst Space Technol, Dept Elect Engn, Islamabad, Pakistan.	smab1176@yahoo.com	Bashir, Syed Muhammad Arsalan/E-6848-2013	Bashir, Syed Muhammad Arsalan/0000-0002-9899-6293				Ashikhmin M., 2001, P ACM S INT 3D GRAPH, P217; Dellaert F, 2005, PROC CVPR IEEE, P619; Dong WM, 2008, VISUAL COMPUT, V24, P515, DOI 10.1007/s00371-008-0232-1; Efros A. A., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1033, DOI 10.1109/ICCV.1999.790383; Elkan C., 2003, P 20 INT C MACHINE L, P147, DOI DOI 10.1016/0026-2714(92)90278-S; Ji RR, 2013, IEEE T MULTIMEDIA, V15, P153, DOI 10.1109/TMM.2012.2225035; Ji RR, 2010, PROC CVPR IEEE, P918, DOI 10.1109/CVPR.2010.5540118; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Kopf J, 2007, ACM T GRAPHIC, V26, DOI 10.1145/1239451.1239453; Kwatra V, 2005, ACM T GRAPHIC, V24, P795, DOI 10.1145/1073204.1073263; Kwatra V, 2003, ACM T GRAPHIC, V22, P277, DOI 10.1145/882262.882264; Liang L, 2001, ACM T GRAPHIC, V20, P127, DOI 10.1145/501786.501787; McLachlan G., 2007, EM ALGORITHM EXTENSI, V382; Norman JF, 2006, VISION RES, V46, P1057, DOI 10.1016/j.visres.2005.09.034; Plantier J, 2001, 2001 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL II, PROCEEDINGS, P261, DOI 10.1109/ICIP.2001.958474; Wei LY, 2000, COMP GRAPH, P479, DOI 10.1145/344779.345009; Wu Q, 2004, ACM T GRAPHIC, V23, P364, DOI 10.1145/1015706.1015730; Zhang JD, 2003, ACM T GRAPHIC, V22, P295, DOI 10.1145/882262.882266	19	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110622	10.1371/journal.pone.0110622	http://dx.doi.org/10.1371/journal.pone.0110622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313637	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500120
J	Giorgi, FM; Lopez, G; Woo, JH; Bisikirska, B; Califano, A; Bansal, M				Giorgi, Federico M.; Lopez, Gonzalo; Woo, Jung H.; Bisikirska, Brygida; Califano, Andrea; Bansal, Mukesh			Inferring Protein Modulation from Gene Expression Data Using Conditional Mutual Information	PLOS ONE			English	Article							B-CELL LYMPHOMAS; TRANSCRIPTIONAL REGULATION; REGULATORY NETWORKS; PHOSPHORYLATION; INHIBITION; BCL-2; CDK2; IDENTIFICATION; TRANSFAC(R); RECRUITMENT	Systematic, high-throughput dissection of causal post-translational regulatory dependencies, on a genome wide basis, is still one of the great challenges of biology. Due to its complexity, however, only a handful of computational algorithms have been developed for this task. Here we present CINDy (Conditional Inference of Network Dynamics), a novel algorithm for the genome-wide, context specific inference of regulatory dependencies between signaling protein and transcription factor activity, from gene expression data. The algorithm uses a novel adaptive partitioning methodology to accurately estimate the full Condition Mutual Information (CMI) between a transcription factor and its targets, given the expression of a signaling protein. We show that CMI analysis is optimally suited to dissecting post-translational dependencies. Indeed, when tested against a gold standard dataset of experimentally validated protein-protein interactions in signal transduction networks, CINDy significantly outperforms previous methods, both in terms of sensitivity and precision.	[Giorgi, Federico M.; Lopez, Gonzalo; Woo, Jung H.; Bisikirska, Brygida; Califano, Andrea; Bansal, Mukesh] Columbia Univ, Dept Syst Biol, New York, NY 10027 USA; [Giorgi, Federico M.; Lopez, Gonzalo; Woo, Jung H.; Bisikirska, Brygida; Califano, Andrea; Bansal, Mukesh] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY USA; [Califano, Andrea] Columbia Univ, High Throughput Screening Facil, Columbia Genome Ctr, New York, NY USA; [Califano, Andrea] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Califano, Andrea] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY USA; [Califano, Andrea] Columbia Univ, Inst Canc Genet, New York, NY USA; [Califano, Andrea] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Califano, A (corresponding author), Columbia Univ, Dept Syst Biol, New York, NY 10027 USA.	califano@c2b2.columbia.edu; mb3113@c2b2.columbia.edu	Giorgi, Federico M./AAD-5797-2020; Lopez, Gonzalo/AAG-1169-2019	Giorgi, Federico M./0000-0002-7325-9908; Lopez, Gonzalo/0000-0002-5092-1284; Califano, Andrea/0000-0003-4742-3679	MaGNeT (Multiscale Analysis of Genomic and Cellular Networks) [5U54CA121852]; CTD2 (Cancer Target Discovery and Development) [U01CA168426]; NATIONAL CANCER INSTITUTE [U01CA168426] Funding Source: NIH RePORTER	MaGNeT (Multiscale Analysis of Genomic and Cellular Networks); CTD2 (Cancer Target Discovery and Development); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by MaGNeT (Multiscale Analysis of Genomic and Cellular Networks - http://magnet.c2b2.columbia.edu/) grant (5U54CA121852) and CTD2 (Cancer Target Discovery and Development - http://ocg.cancer.gov/programs/ctd2) grant (U01CA168426). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Assar O, 2006, BRIT J HAEMATOL, V133, P612, DOI 10.1111/j.1365-2141.2006.06093.x; Aytes A, 2014, CANC CELL IN PRESS; BANSAL M, 2012, GENOME WIDE DISSECTI, V786, P131; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Basso K, 2010, BLOOD, V115, P975, DOI 10.1182/blood-2009-06-227017; Bisikirska BC, 2012, ONCOGENE; Califano A, 2012, NAT GENET, V44, P841, DOI 10.1038/ng.2355; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Cleynen I, 2008, INT J ONCOL, V32, P289; Crescenzi E, 2002, ANN NY ACAD SCI, V973, P268, DOI 10.1111/j.1749-6632.2002.tb04647.x; DALLAFAVERA R, 1983, SCIENCE, V219, P963, DOI 10.1126/science.6401867; De Keersmaecker K, 2010, NAT MED, V16, P1321, DOI 10.1038/nm.2246; Della Gatta G, 2012, NAT MED, V18, P436, DOI 10.1038/nm.2610; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Esposito F, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.126; Esposito F, 2010, CANCER RES, V70, P5379, DOI 10.1158/0008-5472.CAN-09-4199; Evens AM, 2010, J CLIN ONCOL, V28, P1017, DOI 10.1200/JCO.2009.24.1893; Faber AC, 2007, CELL CYCLE, V6, P2982, DOI 10.4161/cc.6.23.4994; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Fang NY, 2003, P NATL ACAD SCI USA, V100, P5372, DOI 10.1073/pnas.0831102100; Fisher Robert P, 2012, Genes Cancer, V3, P731, DOI 10.1177/1947601912473308; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Frasca F, 2006, CANCER RES, V66, P2980, DOI 10.1158/0008-5472.CAN-05-2637; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Gilmore T, 1991, CANC SURVEYS, V15, P69; Giono LE, 2007, MOL CELL BIOL, V27, P4166, DOI 10.1128/MCB.01967-06; Giorgi FM, 2013, BIOINFORMATICS, V29, P717, DOI 10.1093/bioinformatics/btt053; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Jang IS, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2013.0011; Junk DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053776; Klapproth K, 2009, BLOOD, V114, P2448, DOI 10.1182/blood-2008-09-181008; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Lefebvre C, 2012, WIRES SYST BIOL MED, V4, P311, DOI 10.1002/wsbm.1159; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Liang KC, 2008, EURASIP J BIOINFORM, DOI 10.1155/2008/253894; Luo WJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-467; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Mani KM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.2; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Obaya AJ, 2002, CELL MOL LIFE SCI, V59, P126, DOI 10.1007/s00018-002-8410-1; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Ott G, 2013, BLOOD, V122, P3884, DOI 10.1182/blood-2013-05-498329; Piovan E, 2013, CANCER CELL, V24, P766, DOI 10.1016/j.ccr.2013.10.022; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Qiao QA, 2010, EXP HEMATOL, V38, P1199, DOI 10.1016/j.exphem.2010.08.007; QUELLE FW, 1995, J BIOL CHEM, V270, P20775, DOI 10.1074/jbc.270.35.20775; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; SETH A, 1992, J BIOL CHEM, V267, P24796; Shao H, 2003, CANCER RES, V63, P3923; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Villaverde AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096732; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]; Yu YL, 2005, J BIOL CHEM, V280, P29533, DOI 10.1074/jbc.M506514200; Zampieri M, 2008, BIOINFORMATICS, V24, P1510, DOI 10.1093/bioinformatics/btn220; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009	65	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109569	10.1371/journal.pone.0109569	http://dx.doi.org/10.1371/journal.pone.0109569			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314274	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500053
J	Idol, RA; Wozniak, DF; Fujiwara, H; Yuede, CM; Ory, DS; Kornfeld, S; Vogel, P				Idol, Rachel A.; Wozniak, David F.; Fujiwara, Hideji; Yuede, Carla M.; Ory, Daniel S.; Kornfeld, Stuart; Vogel, Peter			Neurologic Abnormalities in Mouse Models of the Lysosomal Storage Disorders Mucolipidosis II and Mucolipidosis III gamma	PLOS ONE			English	Article							ENZYME N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE; ACID-HYDROLASES; GNPTG GENE; MICE; ALPHA/BETA; MUTATIONS; SUBUNIT; LACKING; IDENTIFICATION; DEGENERATION	UDP-GlcNAc: lysosomal enzyme N-acetylglucosamine-1-phosphotransferase is an alpha(2)beta(2)gamma(2) hexameric enzyme that catalyzes the synthesis of the mannose 6-phosphate targeting signal on lysosomal hydrolases. Mutations in the alpha/beta subunit precursor gene cause the severe lysosomal storage disorder mucolipidosis II (ML II) or the more moderate mucolipidosis III alpha/beta (ML III a/b), while mutations in the c subunit gene cause the mildest disorder, mucolipidosis III gamma (ML III gamma). Here we report neurologic consequences of mouse models of ML II and ML III c. The ML II mice have a total loss of acid hydrolase phosphorylation, which results in depletion of acid hydrolases in mesenchymal-derived cells. The ML III c mice retain partial phosphorylation. However, in both cases, total brain extracts have normal or near normal activity of many acid hydrolases reflecting mannose 6-phosphate-independent lysosomal targeting pathways. While behavioral deficits occur in both models, the onset of these changes occurs sooner and the severity is greater in the ML II mice. The ML II mice undergo progressive neurodegeneration with neuronal loss, astrocytosis, microgliosis and Purkinje cell depletion which was evident at 4 months whereas ML III gamma mice have only mild to moderate astrocytosis and microgliosis at 12 months. Both models accumulate the ganglioside GM2, but only ML II mice accumulate fucosylated glycans. We conclude that in spite of active mannose 6-phosphate-independent targeting pathways in the brain, there are cell types that require at least partial phosphorylation function to avoid lysosomal dysfunction and the associated neurodegeneration and behavioral impairments.	[Idol, Rachel A.; Kornfeld, Stuart] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Wozniak, David F.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Fujiwara, Hideji; Ory, Daniel S.] Washington Univ, Sch Med, Diabet Cardiovasc Dis Ctr, St Louis, MO 63110 USA; [Yuede, Carla M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); St Jude Children's Research Hospital	Kornfeld, S (corresponding author), Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.	skornfel@dom.wustl.edu	Vogel, Peter/N-2490-2018	Vogel, Peter/0000-0002-7535-0545	National Institutes of Health [CA08759]; Developmental Disabilities Research Center [P30 HD062171]; Washington University Metabolomics Facility [P30 DK020579]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD062171] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA008759, R01CA008759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Developmental Disabilities Research Center; Washington University Metabolomics Facility; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant CA08759 to SK, Washington University Intellectual and Developmental Disabilities Research Center P30 HD062171 to DFW, Washington University Metabolomics Facility P30 DK020579 to DSO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apps R, 2009, NAT REV NEUROSCI, V10, P670, DOI 10.1038/nrn2698; Boonen M, 2011, MOL BIOL CELL, V22, P1135, DOI 10.1091/mbc.E10-07-0584; Braulke T., 2014, ONLINE METABOLIC MOL; Cathey SS, 2010, J MED GENET, V47, P38, DOI 10.1136/jmg.2009.067736; Cathey SS, 2008, AM J MED GENET A, V146A, P512, DOI 10.1002/ajmg.a.32193; DISCHE Z, 1948, J BIOL CHEM, V175, P595; Dittmer F, 1999, J CELL SCI, V112, P1591; Fan M, 2013, J LIPID RES, V54, P2800, DOI 10.1194/jlr.M040618; Gelfman CM, 2007, INVEST OPHTH VIS SCI, V48, P5221, DOI 10.1167/iovs.07-0452; Grady RM, 2006, J NEUROSCI, V26, P2841, DOI 10.1523/JNEUROSCI.4823-05.2006; Griffey MA, 2006, MOL THER, V13, P538, DOI 10.1016/j.ymthe.2005.11.008; Hawkes R, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00041; Kollmann K, 2012, BRAIN, V135, P2661, DOI 10.1093/brain/aws209; Lalonde R, 2011, BRAIN RES REV, V67, P252, DOI 10.1016/j.brainresrev.2011.02.005; Lee WS, 2007, J BIOL CHEM, V282, P27198, DOI 10.1074/jbc.M704067200; Liu S, 2014, GENE, V535, P294, DOI 10.1016/j.gene.2013.11.010; OWADA M, 1982, BIOCHEM BIOPH RES CO, V105, P814, DOI 10.1016/0006-291X(82)91042-7; Persichetti E, 2009, HUM MUTAT, V30, P978, DOI 10.1002/humu.20959; Pohl S, 2010, AM J MED GENET A, V152A, P124, DOI 10.1002/ajmg.a.33170; Qian Y, 2010, J BIOL CHEM, V285, P3360, DOI 10.1074/jbc.M109.068650; REISSIG JL, 1955, J BIOL CHEM, V217, P959; Ruigrok TJH, 2011, CEREBELLUM, V10, P464, DOI 10.1007/s12311-010-0164-y; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; Vogel P, 2009, VET PATHOL, V46, P313, DOI 10.1354/vp.46-2-313; WAHEED A, 1982, BIOCHEM BIOPH RES CO, V105, P1052, DOI 10.1016/0006-291X(82)91076-2; Weimer JM, 2009, BRAIN RES, V1266, P93, DOI 10.1016/j.brainres.2009.02.009; Wozniak DF, 2004, NEUROBIOL DIS, V17, P403, DOI 10.1016/j.nbd.2004.08.006; Xu YH, 2010, J LIPID RES, V51, P1643, DOI 10.1194/jlr.R003996; Zhou HB, 2014, ELIFE, V3, DOI 10.7554/eLife.02536	29	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109768	10.1371/journal.pone.0109768	http://dx.doi.org/10.1371/journal.pone.0109768			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314316	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500072
J	Liu, F; Xiong, XJ; Wu, L; Fu, DH; Hayward, A; Zeng, XH; Cao, YL; Wu, YH; Li, YJ; Wu, G				Liu, Fang; Xiong, Xiaojuan; Wu, Lei; Fu, Donghui; Hayward, Alice; Zeng, Xinhua; Cao, Yinglong; Wu, Yuhua; Li, Yunjing; Wu, Gang			BraLTP1, a Lipid Transfer Protein Gene Involved in Epicuticular Wax Deposition, Cell Proliferation and Flower Development in Brassica napus	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; EXPRESSION; IDENTIFICATION; BIOSYNTHESIS; REVEALS; SURFACE; GENOME; ACID; TRANSLOCATION; ACCUMULATION	Plant non-specific lipid transfer proteins (nsLTPs) constitute large multigene families that possess complex physiological functions, many of which remain unclear. This study isolated and characterized the function of a lipid transfer protein gene, BraLTP1 from Brassica rapa, in the important oilseed crops Brassica napus. BraLTP1 encodes a predicted secretory protein, in the little known VI Class of nsLTP families. Overexpression of BnaLTP1 in B. napus caused abnormal green coloration and reduced wax deposition on leaves and detailed wax analysis revealed 17-80% reduction in various major wax components, which resulted in significant water-loss relative to wild type. BnaLTP1 overexpressing leaves exhibited morphological disfiguration and abaxially curled leaf edges, and leaf cross-sections revealed cell overproliferation that was correlated to increased cytokinin levels (tZ, tZR, iP, and iPR) in leaves and high expression of the cytokinin biosynthsis gene IPT3. BnaLTP1-overexpressing plants also displayed morphological disfiguration of flowers, with early-onset and elongated carpel development and outwardly curled stamen. This was consistent with altered expression of a a number of ABC model genes related to flower development. Together, these results suggest that BraLTP1 is a new nsLTP gene involved in wax production or deposition, with additional direct or indirect effects on cell division and flower development.	[Liu, Fang; Xiong, Xiaojuan; Wu, Lei; Zeng, Xinhua; Cao, Yinglong; Wu, Yuhua; Li, Yunjing; Wu, Gang] Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Oil Crop Biol, Wuhan, Peoples R China; [Fu, Donghui] Jiangxi Agr Univ, Agron Coll, Key Lab Crop Physiol Ecol & Genet Breeding, Nanchang, Peoples R China; [Hayward, Alice] Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld 4072, Australia	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Jiangxi Agricultural University; University of Queensland	Wu, G (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Oil Crop Biol, Wuhan, Peoples R China.	wugang@caas.cn	Hayward, Alice/A-5528-2011; Hayward, Alice/D-5986-2014	Hayward, Alice/0000-0001-5868-559X; Hayward, Alice/0000-0001-5868-559X	Major Research Project of CAAS Science and Technology Innovation Program, the National Natural Science Foundation of China [31400243, 31201152]; Natural Science Foundation of Hubei Province [2013CFB423]	Major Research Project of CAAS Science and Technology Innovation Program, the National Natural Science Foundation of China; Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This work was supported by Major Research Project of CAAS Science and Technology Innovation Program, the National Natural Science Foundation of China (grant numbers 31400243 and 31201152) and the Natural Science Foundation of Hubei Province (grant number 2013CFB423). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariizumi T, 2002, PLANT CELL REP, V21, P90, DOI 10.1007/s00299-002-0487-3; Bey M, 2004, PLANT CELL, V16, P3197, DOI 10.1105/tpc.104.026724; Bird D, 2007, PLANT J, V52, P485, DOI 10.1111/j.1365-313X.2007.03252.x; Black PN, 2000, J NUTR, V130, p305S, DOI 10.1093/jn/130.2.305S; Blein JP, 2002, TRENDS PLANT SCI, V7, P293, DOI 10.1016/S1360-1385(02)02284-7; Boutrot F, 2005, BBA-GENE STRUCT EXPR, V1730, P114, DOI 10.1016/j.bbaexp.2005.06.010; Boutrot F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-86; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Carvalho AD, 2007, PEPTIDES, V28, P1144, DOI 10.1016/j.peptides.2007.03.004; Chae K, 2010, J EXP BOT, V61, P4277, DOI 10.1093/jxb/erq228; Chae K, 2009, PLANT CELL, V21, P3902, DOI 10.1105/tpc.109.070854; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; DeBono A, 2009, PLANT CELL, V21, P1230, DOI 10.1105/tpc.108.064451; Dong JZ, 2004, PLANTA, V218, P483, DOI 10.1007/s00425-003-1124-2; Edstam MM, 2011, MOL PLANT, V4, P947, DOI 10.1093/mp/ssr019; Eklund DM, 2003, PLANT PHYSIOL, V132, P1249, DOI 10.1104/pp.103.020875; FOSTER GD, 1992, PLANT SCI, V84, P187, DOI 10.1016/0168-9452(92)90133-7; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Guo L, 2013, J EXP BOT, V64, P1755, DOI 10.1093/jxb/ert040; Harada T, 2010, J EXP BOT, V61, P2345, DOI 10.1093/jxb/erq064; Hincha DK, 2002, PHILOS T R SOC B, V357, P909, DOI 10.1098/rstb.2002.1079; Hu ZY, 2009, PLANT CELL REP, V28, P541, DOI 10.1007/s00299-008-0654-2; Hua DP, 2012, PLANT CELL, V24, P2546, DOI 10.1105/tpc.112.100107; Imin N, 2006, MOL CELL PROTEOMICS, V5, P274, DOI 10.1074/mcp.M500242-MCP200; Jung B, 2009, PLANT CELL, V21, P876, DOI 10.1105/tpc.108.062612; Jung HW, 2009, SCIENCE, V324, P89, DOI 10.1126/science.1170025; Kader JC, 1996, ANNU REV PLANT PHYS, V47, P627, DOI 10.1146/annurev.arplant.47.1.627; Kakimoto T, 2001, PLANT CELL PHYSIOL, V42, P677, DOI 10.1093/pcp/pce112; Kim H, 2012, PLANT CELL PHYSIOL, V53, P1391, DOI 10.1093/pcp/pcs083; KOTILAINEN M, 1994, PLANT MOL BIOL, V26, P971, DOI 10.1007/BF00028863; Kudo T, 2010, J INTEGR PLANT BIOL, V52, P53, DOI 10.1111/j.1744-7909.2010.00898.x; Kurdyukov S, 2006, PLANTA, V224, P315, DOI 10.1007/s00425-005-0215-7; Lauga B, 2000, PLANT SCI, V157, P65, DOI 10.1016/S0168-9452(00)00267-3; Lee SB, 2009, PLANT PHYSIOL, V150, P42, DOI 10.1104/pp.109.137745; Li C, 2013, THEOR APPL GENET, V126, P637, DOI 10.1007/s00122-012-2007-3; Liu KH, 2003, DNA SEQUENCE, V14, P420, DOI 10.1080/1042517032000160198; Liu SY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4930; Liu ZC, 2000, PLANT CELL, V12, P1879, DOI 10.1105/tpc.12.10.1879; Lu SY, 2011, PLANT PHYSIOL, V157, P1079, DOI 10.1104/pp.111.185132; Maldonado AM, 2002, NATURE, V419, P399, DOI 10.1038/nature00962; Maniatis T., 1992, MOL CLONING LAB MANU; NACKEN WKF, 1991, MOL GEN GENET, V229, P129, DOI 10.1007/BF00264221; Nieuwland J, 2005, PLANT CELL, V17, P2009, DOI 10.1105/tpc.105.032094; Nobusawa T, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001531; Park SY, 2000, PLANT CELL, V12, P151, DOI 10.1105/tpc.12.1.151; PYEE J, 1994, ARCH BIOCHEM BIOPHYS, V311, P460, DOI 10.1006/abbi.1994.1263; Riederer M, 2006, BIOL PLANT CUTICLE, P11; Sambrook J., 2002, MOL CLONING LAB MANU; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; Savchenko T, 2010, PLANT CELL, V22, P3193, DOI 10.1105/tpc.110.073858; SHIN DH, 1995, STRUCTURE, V3, P189, DOI 10.1016/S0969-2126(01)00149-6; STERK P, 1991, PLANT CELL, V3, P907, DOI 10.1105/tpc.3.9.907; Takei K, 2001, PLANT CELL PHYSIOL, V42, P85, DOI 10.1093/pcp/pce009; Tanaka T, 2004, PLANT J, V37, P139, DOI 10.1046/j.1365-313X.2003.01946.x; THOMA S, 1993, PLANT J, V3, P427, DOI 10.1046/j.1365-313X.1993.t01-21-00999.x; Todd J, 1999, PLANT J, V17, P119, DOI 10.1046/j.1365-313X.1999.00352.x; VERGNOLLE C, 1992, METHOD ENZYMOL, V209, P522; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Worrall D, 2003, TRENDS PLANT SCI, V8, P317, DOI 10.1016/S1360-1385(03)00128-6; Yeats TH, 2008, PROTEIN SCI, V17, P191, DOI 10.1110/ps.073300108	60	22	23	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110272	10.1371/journal.pone.0110272	http://dx.doi.org/10.1371/journal.pone.0110272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314222	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500106
J	Zhao, W; Han, C; Shi, XG; Xiong, CH; Sun, J; Shan, ZY; Teng, WP				Zhao, Wei; Han, Cheng; Shi, Xiaoguang; Xiong, Chuhui; Sun, Jie; Shan, Zhongyan; Teng, Weiping			Prevalence of Goiter and Thyroid Nodules before and after Implementation of the Universal Salt Iodization Program in Mainland China from 1985 to 2014: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							IODINE-DEFICIENCY DISORDERS; ENDEMIC GOITER; MANAGEMENT; GUIDELINES; DIAGNOSIS; REGIONS; EXCESS	Objectives: We comprehensively estimated the prevalence of goiter and thyroid nodules (TNs) before and after the implementation of the Universal Salt Iodization (USI) program in mainland China and provided information for creating effective health policies. Methods: PubMed, Google Scholar, CNKI, Chinese Wanfang and Chongqing VIP databases were searched for relevant studies from Jan 1985 to Feb 2014. Data from eligible citations were extracted by two independent reviewers. All analyses were performed with Stata 11.0 and SPSS 17.0. Results: Eligible articles (N = 31; 4 in English and 27 in Chinese) included 52 studies (15 about goiter rates made before 1996 and 14 afterwards, and 23 about TNs). Our meta-analysis suggests a pooled prevalence for goiter before and after 1996 and for TNs of 22.8% (95% CI: 15.3%, 30.3%), 12.6% (95% CI: 9.4%, 15.8%) and 22.7% (95% CI: 18.3%, 27.0%), respectively. Egger's test of three independent categories revealed no evidence of publication bias (p = 0.101, 0.148 and 0.113, respectively). Conclusions: The prevalence of goiter was reduced by almost half after 1996 in mainland China, so the USI program was considered beneficial. However, subgroup analysis suggests that both insufficient and excess iodine may be associated with goiter. The prevalence of goiter and TNs increased significantly after 2002, suggesting a risk of excessive iodine intake. Thus, salt iodization standardizations should be set according to local conditions.	[Zhao, Wei; Han, Cheng; Shi, Xiaoguang; Xiong, Chuhui; Sun, Jie; Shan, Zhongyan; Teng, Weiping] China Med Univ, Affiliated Hosp 1, Liaoning Prov Key Lab Endocrine Dis, Dept Endocrinol & Metab,Inst Endocrinol, Shenyang, Liaoning Provin, Peoples R China	China Medical University	Teng, WP (corresponding author), China Med Univ, Affiliated Hosp 1, Liaoning Prov Key Lab Endocrine Dis, Dept Endocrinol & Metab,Inst Endocrinol, Shenyang, Liaoning Provin, Peoples R China.	twp@vip.163.com		Han, Cheng/0000-0001-8553-4420	National Natural Science Foundation [81370893]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation (81370893, URL: http://npd.nsfc.gov.cn/fundingProjectSearchAction.action). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Eshy SA, 2001, SAUDI MED J, V22, P146; Abuye Cherinet, 2008, East Afr J Public Health, V5, P163; [Anonymous], 2007, ASS IOD DEF DIS MON; Bao Y, 1994, ENDEMIC DISEASES B, V9, P58; Chen HM, 2000, CHIN J ENDEMIOL, V19, P275; Chen LD, 2011, CHIN RURAL HLTH SERV, V31, P981; Chen ZX, 2013, AM J CLIN NUTR, V98, P684, DOI 10.3945/ajcn.112.054353; Chi HY, 2013, CHIN J PRAC MED, V40, P24; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Delange F, 2002, THYROID, V12, P915, DOI 10.1089/105072502761016557; Dou DX, 1992, MIL MED SCI, V16, P256; Endemic Disease Control Department, 1989, CHIN J ENDEMIOL, V8, P252; FAO/WHO, 2005, VIT MIN REQ HUM NUTR, V2nd ed.; [冯尚勇 FENG Shangyong], 2006, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V26, P717; Gharib H, 2010, J ENDOCRINOL INVEST, V33, P51; Gharib H, 1997, ENDOCRIN METAB CLIN, V26, P777, DOI 10.1016/S0889-8529(05)70282-6; Guo HW, 2014, ENDOCRINE, V45, P230, DOI 10.1007/s12020-013-9968-0; Harris NS, 2001, NEW ENGL J MED, V344, P341, DOI 10.1056/NEJM200102013440504; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; [侯祥 Hou Xiang], 2003, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V19, P104; HULL OH, 1955, ARCH PATHOL, V59, P291; Hurtado-Lopez Luis Mauricio, 2011, Cir Cir, V79, P114; Jin Y, 2001, CHIN J ENDOCRINOL ME, V17, P79; Knudsen N, 2000, CLIN ENDOCRINOL, V53, P479, DOI 10.1046/j.1365-2265.2000.01121.x; LEMAR HJ, 1995, J CLIN ENDOCR METAB, V80, P220, DOI 10.1210/jc.80.1.220; Leng S, 2011, MED PHILOS, V32, P22; Li SJ, 2012, ZHEJIANG PREV MED, V24, P4; Liberati A, 2009, PLOS MED, V6, DOI DOI 10.1186/s13643-016-0384-4; Liu F, 2012, CHIN J PRIM MED PHAR, V19, P3400; Liu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089608; Liu Y, 2012, P 11 ANN M CHIN SOC, P114; Liu ZY, 2012, CHIN J CTRL ENDEM DI, V27, P57; [楼晓明 Lou Xiaoming], 2011, [中国公共卫生, China Public Health], V27, P1564; Luton D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014707; MAZZAFERRI EL, 1992, AM J MED, V93, P359, DOI 10.1016/0002-9343(92)90163-6; Ministry of Health of the People's Republic of China, 2011, NAT GUID FOOD SAF IO; Ministry of Health of the People's Republic of China Ministry of Light Industry of the People's Republic of China, 1994, OUTL EL IOD DEF DIS; MORTENSEN JD, 1955, J CLIN ENDOCR METAB, V15, P1270, DOI 10.1210/jcem-15-10-1270; NAMBA H, 1993, J CLIN ENDOCR METAB, V76, P605, DOI 10.1210/jc.76.3.605; OERTEL J E, 1965, Med Ann Dist Columbia, V34, P75; Ozpinar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088206; Pandav C S, 1982, Indian J Pediatr, V49, P259, DOI 10.1007/BF02830764; Pearce EN, 2002, J CLIN ENDOCR METAB, V87, P5499, DOI 10.1210/jc.2002-020692; Polyzos Stergios A, 2007, Hormones (Athens), V6, P101; ROJESKI MT, 1985, NEW ENGL J MED, V313, P428, DOI 10.1056/NEJM198508153130707; Shen Yao, 2013, China Tropical Medicine, V13, P307; Singer PA, 1996, ARCH INTERN MED, V156, P2165, DOI 10.1001/archinte.156.19.2165; Su MY, 1989, CHIN J ENDEMIOL, V8, P375; Takahashi T, 1999, INT J EPIDEMIOL, V28, P742, DOI 10.1093/ije/28.4.742; Tan GH, 1997, ANN INTERN MED, V126, P226, DOI 10.7326/0003-4819-126-3-199702010-00009; Tan J, 2001, CHIN J ENDOCRINOL ME, V17, P75; Volzke H, 2003, THYROID, V13, P803, DOI 10.1089/105072503768499680; Wang CY, 2012, HEBEI MED J, V34, P1402; Wang L. F., 1992, Endemic Diseases Bulletin, V7, P56; Wang XiaoDong, 2008, Zhongguo Shiyong Neike Zazhi / Chinese Journal of Practical Internal Medicine, V28, P860; [吴民义 Wu Minyi], 2004, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V20, P104; Wu WY, 2002, OCCUPATION HLTH, V18, P94; Yadav S, 2010, PUBLIC HEALTH NUTR, V13, P424, DOI 10.1017/S1368980009990280; Yang F, 2001, CHINESE J ENDOCRINOL, V17, P197; Yang NianZhong, 2012, Journal of Environmental & Occupational Medicine, V29, P148; Yang Y, 2011, P 10 ANN M CHIN SOC, P162; Yu J, 2004, CHIN J CTRL ENDEM DI, V19, P114; Yu JS, 2011, J ENDOCRINOL, V209, P299, DOI 10.1530/JOE-11-0030; Yu X, 2008, J ENDOCRINOL INVEST, V31, P243, DOI 10.1007/BF03345597; Zhang JL, 2013, CHIN J CLIN MED, V20, P548; Zhang JL, 1992, J LINYI MED SCHOOL, V14, P327; Zhang SG, 2010, ACTA ACAD MEX XUZHOU, V30, P65; Zhang Z, 2002, CHIN J ENDOCRINOL ME, V18, P342; Zhao JK, 2000, AM J PUBLIC HEALTH, V90, P1633, DOI 10.2105/AJPH.90.10.1633; Zhao SH., 2004, MED J QILU, V19, P221; Zheng HB, 1988, ENDEMIC DIS B, V3, P61; Zhou RH, 2000, CHIN J ENDEMIOL, V19, P191; Zhu WangYu, 2010, Chinese Preventive Medicine, V11, P113; Zhu WY, 2009, ZHEJIANG PREV MED, V21, P1; Zimmermann MB, 2012, CURR OPIN ENDOCRINOL, V19, P382, DOI 10.1097/MED.0b013e328357271a; Zimmermann MB, 2009, ENDOCR REV, V30, P376, DOI 10.1210/er.2009-0011; Zou SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040718	77	49	57	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109549	10.1371/journal.pone.0109549	http://dx.doi.org/10.1371/journal.pone.0109549			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313993	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662500051
J	Bellini, N; Cox, MJ; Harper, DJ; Stott, SR; Ashok, PC; Dholakia, K; Kawaguchi, S; King, R; Horton, T; Brown, CTA				Bellini, Nicola; Cox, Martin J.; Harper, Danielle J.; Stott, Sebastian R.; Ashok, Praveen C.; Dholakia, Kishan; Kawaguchi, So; King, Robert; Horton, Tammy; Brown, Christian T. A.			The Application of Optical Coherence Tomography to Image Subsurface Tissue Structure of Antarctic Krill Euphausia superba	PLOS ONE			English	Article							TARGET-STRENGTH MODEL; VARIABILITY	Many small open ocean animals, such as Antarctic krill, are an important part of marine ecosystems. To discover what will happen to animals such as krill in a changing ocean, experiments are run in aquaria where conditions can be controlled to simulate water characteristics predicted to occur in the future. The response of individual animals to changing water conditions can be hard to observe, and with current observation techniques it is very difficult to follow the progress of an individual animal through its life. Optical coherence tomography (OCT) is an optical imaging technique that allows images at high resolution to be obtained from depths up to a few millimeters inside biological specimens. It is compatible with in vivo imaging and can be used repeatedly on the same specimens. In this work, we show how OCT may be applied to post mortem krill samples and how important physiological data such as shell thickness and estimates of organ volume can be obtained. Using OCT we find an average value for the thickness of krill exoskeleton to be (30 +/- 4) mu m along a 1 cm length of the animal body. We also show that the technique may be used to provide detailed imagery of the internal structure of a pleopod joint and provide an estimate for the heart volume of (0.73 +/- 0.03) mm(3).	[Bellini, Nicola; Harper, Danielle J.; Stott, Sebastian R.; Ashok, Praveen C.; Dholakia, Kishan; Brown, Christian T. A.] Univ St Andrews, Sch Phys & Astron, SUPA, St Andrews, Fife, Scotland; [Cox, Martin J.; Kawaguchi, So; King, Robert] Australian Antarctic Div, Kingston, Tas, Australia; [Horton, Tammy] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England	University of St Andrews; Australian Antarctic Division; NERC National Oceanography Centre; University of Southampton	Brown, CTA (corresponding author), Univ St Andrews, Sch Phys & Astron, SUPA, St Andrews, Fife, Scotland.	ctab@st-andrews.ac.uk	Horton, Tammy/G-3590-2010	Horton, Tammy/0000-0003-4250-1068; Kawaguchi, So/0000-0002-2042-5095; King, Robert/0000-0002-4650-2335; Brown, Christian Thomas Alcuin/0000-0002-4405-6677; Dholakia, Kishan/0000-0001-6534-9009; Harper, Danielle J./0000-0003-2768-3684	Australian Antarctic Division science programme [4037, 4050]; Australian Research Council [FS110200057]; U.K. Engineering and Physical Sciences Research Council [EP/G061688/1]; European Union [317744]; CR-UK/EPSRC/MRC/DoH (England) imaging programme; School of Physics and Astronomy Student Staff Council Vacation Award research studentship; Engineering and Physical Sciences Research Council [EP/G061688/1] Funding Source: researchfish; Natural Environment Research Council [noc010009] Funding Source: researchfish; EPSRC [EP/G061688/1] Funding Source: UKRI; NERC [noc010009] Funding Source: UKRI	Australian Antarctic Division science programme; Australian Research Council(Australian Research Council); U.K. Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Union(European Commission); CR-UK/EPSRC/MRC/DoH (England) imaging programme(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); School of Physics and Astronomy Student Staff Council Vacation Award research studentship; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The collection and rearing of krill specimens was funded by Australian Antarctic Division science programme Project 4037 (Experimental Krill Biology: Response of krill to environmental change), and Project 4050 (Assessing change in krill distribution and abundance in Eastern Antarctica). MJC is funded by Australian Research Council grant FS110200057. The OCT imaging was funded in part by the U.K. Engineering and Physical Sciences Research Council grant EP/G061688/1, the European Union European Union project FAMOS (FP7 ICT, contract no. 317744) and the CR-UK/EPSRC/MRC/DoH (England) imaging programme. DH was funded by a School of Physics and Astronomy Student Staff Council Vacation Award research studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An L, 2011, BIOMED OPT EXPRESS, V2, P2770, DOI 10.1364/BOE.2.002770; Brierley AS, 1997, MAR ECOL PROG SER, V150, P87, DOI 10.3354/meps150087; Brown H., 1999, APPL MIXED MODELS ME; BUCHHOLZ C, 1989, MAR BIOL, V101, P355, DOI 10.1007/BF00428132; BUCHHOLZ F, 1982, MAR BIOL, V66, P301, DOI 10.1007/BF00397036; Butterworth DS, 1991, SIMPLE APPROACH CALC; Calise L, 2011, CCAMLR SCI, V18, P97; Croxall JP, 1988, REPROD PERFORMANCE S; Dana J. D., 1850, AM J SCI ARTS, V9, P129; Demer DA, 2005, ICES J MAR SCI, V62, P25, DOI 10.1016/j.icesjms.2004.07.027; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Drexler W, 2008, BIOL MED PHYS BIOMED, P1, DOI 10.1007/978-3-540-77550-8; Flores H, 2012, MAR ECOL PROG SER, V458, P1, DOI 10.3354/meps09831; Fujimoto JG, 2003, NAT BIOTECHNOL, V21, P1361, DOI 10.1038/nbt892; HEWITT RP, 1991, NATURE, V353, P310, DOI 10.1038/353310b0; Hill SL, 2006, BIOL REV, V81, P581, DOI 10.1017/S1464793106007123; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Kawaguchi S, 2013, NAT CLIM CHANGE, V3, DOI 10.1038/NCLIMATE1937; Kawaguchi S, 2010, DEEP-SEA RES PT II, V57, P934, DOI 10.1016/j.dsr2.2008.06.014; Krstajic N, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.071305; McGehee DE, 1998, DEEP-SEA RES PT II, V45, P1273, DOI 10.1016/S0967-0645(98)00036-8; McLaughlin PA, 1980, COMP MORPHOLOGY RECE; Miller DG, 1989, BIOMASS SCI SER, V9, P1; Murphy DW, 2011, MAR BIOL, V158, P2541, DOI 10.1007/s00227-011-1755-y; Nicol S, 2004, DEEP-SEA RES PT II, V51, P2215, DOI 10.1016/j.dsr2.2004.07.002; Nicol S, 2012, FISH FISH, V13, P30, DOI 10.1111/j.1467-2979.2011.00406.x; Reid K, 2005, ICES J MAR SCI, V62, P366, DOI 10.1016/j.icesjms.2004.11.003; Ritz DA, 2003, J MAR BIOL ASSOC UK, V83, P329, DOI 10.1017/S002531540300715Xh; Ryu SY, 2008, APPL OPTICS, V47, P1510, DOI 10.1364/AO.47.001510; Saba GK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052224; Tan KM, 2009, OPT EXPRESS, V17, P2375, DOI 10.1364/OE.17.002375	31	3	3	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110367	10.1371/journal.pone.0110367	http://dx.doi.org/10.1371/journal.pone.0110367			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310589	Green Published, gold, Green Accepted			2022-12-27	WOS:000343210300110
J	Chiang, C; Hsiao, CF; Liu, JP				Chiang, Chieh; Hsiao, Chin-Fu; Liu, Jen-Pei			Sample Size Determination for Individual Bioequivalence Inference	PLOS ONE			English	Article								Statistical criterion for evaluation of individual bioequivalence (IBE) between generic and innovative products often involves a function of the second moments of normal distributions. Under replicated crossover designs, the aggregate criterion for IBE proposed by the guidance of the U. S. Food and Drug Administration (FDA) contains the squared mean difference, variance of subject-by-formulation interaction, and the difference in within-subject variances between the generic and innovative products. The upper confidence bound for the linearized form of the criterion derived by the modified large sample (MLS) method is proposed in the 2001 U. S. FDA guidance as a testing procedure for evaluation of IBE. Due to the complexity of the power function for the criterion based on the second moments, literature on sample size determination for the inference of IBE is scarce. Under the two-sequence and four-period crossover design, we derive the asymptotic distribution of the upper confidence bound of the linearized criterion. Hence the asymptotic power can be derived for sample size determination for evaluation of IBE. Results of numerical studies are reported. Discussion of sample size determination for evaluation of IBE based on the aggregate criterion of the second moments in practical applications is provided.	[Chiang, Chieh; Hsiao, Chin-Fu; Liu, Jen-Pei] Natl Taiwan Univ, Dept Agron, Div Biometry, Taipei, Taiwan; [Liu, Jen-Pei] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Chiang, Chieh; Hsiao, Chin-Fu; Liu, Jen-Pei] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Zhunan, Taiwan	National Taiwan University; National Taiwan University; National Health Research Institutes - Taiwan	Liu, JP (corresponding author), Natl Taiwan Univ, Dept Agron, Div Biometry, Taipei, Taiwan.	jpliu@ntu.edu.tw	Hsiao, Chin-Fu/E-3993-2010; Chiang, Chieh/C-3815-2015	Chiang, Chieh/0000-0003-4319-4565; Liu, Jen-pei/0000-0002-9565-1812; Hsiao, Chin-Fu/0000-0003-1284-7260	Taiwan's National Science Council [NSC 101-2118-M-002-002-MY2]	Taiwan's National Science Council	This research was supported by a grant from Taiwan's National Science Council (NSC 101-2118-M-002-002-MY2) to JPL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barndorff-Nielsen OE, 1989, ASYMPTOTIC TECHNIQUE, P118; Chow SC, 2002, STAT MED, V21, P629, DOI 10.1002/sim.1056; Chow SC, 2010, DESIGN ANAL BIOAVAIL, P335; Chow SC, 2013, STAT MED, V32, P370, DOI 10.1002/sim.5571; Hyslop T, 2000, STAT MED, V19, P2885, DOI 10.1002/1097-0258(20001030)19:20<2885::AID-SIM553>3.3.CO;2-8; Serfling RJ, 1980, APPROXIMATION THEORE, p[120, 190]; The European Agency for the Evaluation of medicinal Products (EMEA), 2001, NOT GUID INV BIOAV B, P2; U.S. Food and Drug Administration (FDA), 2001, GUID IND STAT APPR E, P7; US Food and Drug Administration (FDA), 2012, GUID SCI CO IN PRESS, P12; World Health Organization (WHO), 2005, MOV TSUN WHO ST, P4	10	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109746	10.1371/journal.pone.0109746	http://dx.doi.org/10.1371/journal.pone.0109746			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310592	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210300070
J	Da, M; Feng, Y; Xu, J; Hu, YL; Lin, Y; Ni, BX; Qian, B; Hu, ZB; Mo, XM				Da, Min; Feng, Yu; Xu, Jing; Hu, Yuanli; Lin, Yuan; Ni, Bixian; Qian, Bo; Hu, Zhibin; Mo, Xuming			Association of Aminoacyl-tRNA Synthetases Gene Polymorphisms with the Risk of Congenital Heart Disease in the Chinese Han Population	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; SCIENTIFIC STATEMENT; CURRENT KNOWLEDGE; DEFECTS; PATHWAY; HYPERTROPHY; TRANSLATION; EXPRESSION; COUNCIL; GROWTH	Aminoacyl-tRNA synthetases (ARSs) are in charge of cellular protein synthesis and have additional domains that function in a versatile manner beyond translation. Eight core ARSs (EPRS, MRS, QRS, RRS, IRS, LRS, KRS, DRS) combined with three nonenzymatic components form a complex known as multisynthetase complex (MSC). We hypothesize that the single-nucleotide polymorphisms (SNPs) of the eight core ARS coding genes might influence the susceptibility of sporadic congenital heart disease (CHD). Thus, we conducted a case-control study of 984 CHD cases and 2953 non-CHD controls in the Chinese Han population to evaluate the associations of 16 potentially functional SNPs within the eight ARS coding genes with the risk of CHD. We observed significant associations with the risk of CHD for rs1061248 [G/A; odds ratio (OR) = 0.90, 95% confidence interval (CI) = 0.81-0.99; P = 3.81 x 10(-2)], rs2230301 [A/C; OR = 0.73, 95%CI = 0.60-0.90, P = 3.81 x 10(-2)], rs1061160 [G/A; OR = 1.18, 95%CI = 1.06-1.31; P = 3.53 x 10(-3)] and rs5030754 [G/A; OR = 1.39, 95%CI = 1.11-1.75; P = 4.47 x 10(-3)] of EPRS gene. After multiple comparisons, rs1061248 conferred no predisposition to CHD. Additionally, a combined analysis showed a significant dosage-response effect of CHD risk among individuals carrying the different number of risk alleles (P-trend = 5.00 x 10(-4)). Compared with individuals with "0-2" risk allele, those carrying "3", "4" or "5 or more" risk alleles had a 0.97-, 1.25- or 1.38-fold increased risk of CHD, respectively. These findings indicate that genetic variants of the EPRS gene may influence the individual susceptibility to CHD in the Chinese Han population.	[Da, Min; Feng, Yu; Hu, Yuanli; Qian, Bo; Mo, Xuming] Nanjing Med Univ, Affiliated Nanjing Childrens Hosp, Dept Cardiothorac Surg, Nanjing, Jiangsu, Peoples R China; [Xu, Jing] Nanjing Med Univ, Affiliated Hosp 1, Dept Thorac & Cardiovasc Surg, Nanjing, Jiangsu, Peoples R China; [Lin, Yuan; Ni, Bixian; Hu, Zhibin] Nanjing Med Univ, Dept Epidemiol & Biostat, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Mo, XM (corresponding author), Nanjing Med Univ, Affiliated Nanjing Childrens Hosp, Dept Cardiothorac Surg, Nanjing, Jiangsu, Peoples R China.	mohsuming15@sina.com			National Natural Science Foundation of China [81370277, 81300128]; Jiangsu Provincial Special Program of Medical Science [BL2013013]; Ph.D. Programs Foundation of Ministry of Education of China [20123234120015]; Jiangsu Natural Science Foundation [BK20131025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Special Program of Medical Science; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province)	This work was supported in part by National Natural Science Foundation of China (grant numbers 81370277 and 81300128); Jiangsu Provincial Special Program of Medical Science (grant number BL2013013); Ph.D. Programs Foundation of Ministry of Education of China (grant number 20123234120015); and Jiangsu Natural Science Foundation (grant number BK20131025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman C, 2012, AM J HUM GENET, V91, P646, DOI 10.1016/j.ajhg.2012.08.017; Aizenshtat L I, 1975, Biomed Eng (NY), V8, P177; Arif A, 2011, P NATL ACAD SCI USA, V108, P1415, DOI 10.1073/pnas.1011275108; Botto LD, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e32; Choi TG, 2011, BBA-MOL CELL RES, V1813, P1412, DOI 10.1016/j.bbamcr.2011.04.001; Garg V, 2006, CELL MOL LIFE SCI, V63, P1141, DOI 10.1007/s00018-005-5532-2; Gatzoulis MA, 2004, INT J CARDIOL, V97, P1, DOI 10.1016/j.ijcard.2004.08.001; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hopper AK, 2003, GENE DEV, V17, P162, DOI 10.1101/gad.1049103; Huhta J, 2013, SEMIN FETAL NEONAT M, V18, P245, DOI 10.1016/j.siny.2013.05.003; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Lee YN, 2004, IMMUNITY, V20, P145, DOI 10.1016/S1074-7613(04)00020-2; Malhowski AJ, 2011, HUM MOL GENET, V20, P1290, DOI 10.1093/hmg/ddq570; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Nathanson L, 2000, J BIOL CHEM, V275, P31559, DOI 10.1074/jbc.C000385200; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Ray PS, 2007, EMBO J, V26, P3360, DOI 10.1038/sj.emboj.7601774; Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; Rho SB, 1998, J BIOL CHEM, V273, P11267, DOI 10.1074/jbc.273.18.11267; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.bi.56.070187.001013; Simos George, 2002, Results Probl Cell Differ, V35, P115; Tshori S, 2006, J CLIN INVEST, V116, P2673, DOI 10.1172/JCI27643; van der Bom T, 2011, NAT REV CARDIOL, V8, P50, DOI 10.1038/nrcardio.2010.166; Vannay A, 2006, AM HEART J, V151, P878, DOI 10.1016/j.ahj.2005.10.012; Wessels MW, 2010, CLIN GENET, V78, P103, DOI 10.1111/j.1399-0004.2010.01435.x; Wolf M, 2010, CURR OPIN CARDIOL, V25, P192, DOI 10.1097/HCO.0b013e328337b4ce; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Zhao W, 2010, BIOCHEM BIOPH RES CO, V396, P483, DOI 10.1016/j.bbrc.2010.04.124	38	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110072	10.1371/journal.pone.0110072	http://dx.doi.org/10.1371/journal.pone.0110072			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310850	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210300088
J	Smith, KR; Barthman-Thompson, L; Gould, WR; Mabry, KE				Smith, Katherine R.; Barthman-Thompson, Laureen; Gould, William R.; Mabry, Karen E.			Effects of Natural and Anthropogenic Change on Habitat Use and Movement of Endangered Salt Marsh Harvest Mice	PLOS ONE			English	Article							SAN-FRANCISCO BAY; CONSERVATION BIOLOGY; BEHAVIOR; RESPONSES; ECOLOGY	The northern salt marsh harvest mouse (Reithrodontomys raviventris halicoetes) is an endangered species endemic to the San Francisco Bay Estuary. Using a conservation behavior perspective, we examined how salt marsh harvest mice cope with both natural (daily tidal fluctuations) and anthropogenic (modification of tidal regime) changes in natural tidal wetlands and human-created diked wetlands, and investigated the role of behavioral flexibility in utilizing a human-created environment in the Suisun Marsh. We used radio telemetry to determine refuge use at high tide, space use, and movement rates to investigate possible differences in movement behavior in tidal versus diked wetlands. We found that the vast majority of the time salt marsh harvest mice remain in vegetation above the water during high tides. We also found no difference in space used by mice during high tide as compared to before or after high tide in either tidal or diked wetlands. We found no detectable difference in diurnal or nocturnal movement rates in tidal wetlands. However, we did find that diurnal movement rates for mice in diked wetlands were lower than nocturnal movement rates, especially during the new moon. This change in movement behavior in a relatively novel human-created habitat indicates that behavioral flexibility may facilitate the use of human-created environments by salt marsh harvest mice.	[Smith, Katherine R.; Mabry, Karen E.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Smith, Katherine R.; Barthman-Thompson, Laureen] Calif Dept Fish & Wildlife, Stockton, CA USA; [Gould, William R.] New Mexico State Univ, Dept Econ Appl Stat & Int Business, Las Cruces, NM 88003 USA	New Mexico State University; New Mexico State University	Smith, KR (corresponding author), Univ Calif Davis, Wildlife Fish & Conservat Biol Dept, Davis, CA 95616 USA.	ratsmith@ucdavis.edu			California Department of Water Resources; New Mexico State University	California Department of Water Resources; New Mexico State University	This work was supported financially by the California Department of Water Resources and New Mexico State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeloni L, 2008, ANIM BEHAV, V75, P731, DOI 10.1016/j.anbehav.2007.08.007; BDCP Steering Committee, 2013, BAY DELT CONS PLAN H; Berger-Tal O, 2011, BEHAV ECOL, V22, P236, DOI 10.1093/beheco/arq224; Blumstein DT, 2004, CONSERV BIOL, V18, P1175, DOI 10.1111/j.1523-1739.2004.00587.x; Buchholz R, 2007, TRENDS ECOL EVOL, V22, P401, DOI 10.1016/j.tree.2007.06.002; California Department of Water Resources and California Department of Fish and Game, 2010, DWR DFG FISH REST PR; California Department of Water Resources U.S. Department of the Interior National Oceanic and Atmospheric Administration U.S. Fish and Wildlife Service, 2012, BAY DELT CONS PLAN; Candolin U, 2012, BEHAVIOURAL RESPONSES TO A CHANGING WORLD: MECHANISMS AND CONSEQUENCES, P1, DOI 10.1093/acprof:osobl/9780199602568.001.0001; Caro T, 2013, ANIM BEHAV, V85, P305, DOI 10.1016/j.anbehav.2012.11.007; Caro T, 2011, TRENDS ECOL EVOL, V26, P111, DOI 10.1016/j.tree.2010.12.008; COULOMBE HN, 1970, OECOLOGIA, V4, P223, DOI 10.1007/BF00377248; FAHRIG L, 1994, CONSERV BIOL, V8, P50, DOI 10.1046/j.1523-1739.1994.08010050.x; Fisler GF, 1965, THESIS U CALIFORNIA; Fraterrigo JM, 2009, LANDSCAPE ECOL, V24, P863, DOI 10.1007/s10980-009-9364-6; GEISSEL W, 1988, J MAMMAL, V69, P696, DOI 10.2307/1381624; Ghalambor Cameron K., 2010, P90; Goals Project, 1999, BAYL EC HAB GOALS RE; Greenberg R, 2006, STUD AV BIO, V32, P675; HADAWAY HC, 1971, J MAMMAL, V52, P818, DOI 10.2307/1378931; Hulst MD, T W SECT WILDLIFE SO, V37, P88; Johnston R. F., 1957, Journal of Mammalogy, V38, P529, DOI 10.2307/1376420; JOHNSTON RICHARD F., 1956, WILSON BULL, V68, P91; Kuroe M, 2011, OIKOS, V120, P271, DOI 10.1111/j.1600-0706.2010.18697.x; Moore JA, 2008, BIOSCIENCE, V58, P454, DOI 10.1641/B580513; Moyle Peter B., 2010, San Francisco Estuary & Watershed Science, V8, P1; Nams VO, 2005, OECOLOGIA, V143, P179, DOI 10.1007/s00442-004-1804-z; Oliver T, 2010, ECOL LETT, V13, P473, DOI 10.1111/j.1461-0248.2010.01441.x; PEARSON OLIVER P., 1960, PHYSIOL ZOOL, V33, P152; SHELLHAMMER H S, 1988, Wasmann Journal of Biology, V46, P89; SHELLHAMMER H S, 1982, Wasmann Journal of Biology, V40, P102; Shellhammer H, 2010, CALIF FISH GAME, V96, P256; SHELLHAMMER HS, 1989, CONSERV BIOL, V3, P59, DOI 10.1111/j.1523-1739.1989.tb00225.x; Shumway CA, 1999, ENVIRON BIOL FISH, V55, P183, DOI 10.1023/A:1007562023150; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; Sih A, 2010, INTEGR COMP BIOL, V50, P934, DOI 10.1093/icb/icq148; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Smith KR, 2012, THESIS NEW MEXICO ST; Strier KB, 1997, ADV STUD BEHAV, V26, P101, DOI 10.1016/S0065-3454(08)60378-2; Sustaita D, 2011, J WILDLIFE MANAGE, V75, P1498, DOI 10.1002/jwmg.187; Takekawa John Y., 2006, Studies in Avian Biology, P176; U.S. Fish and Wildlife Service, 2010, REC PLAN TI IN PRESS; United States Department of the Interior Bureau of Reclamation U.S. Fish and Wildlife Service California Department of Fish and Game and IFC International, 2011, SUIS MARSH HAB MAN P; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; White G.C., 1990, ANAL WILDLIFE RADIO; Wildermuth RP, 2013, CONSERV LETT, V6, P86, DOI 10.1111/j.1755-263X.2012.00298.x; Williams P., 2004, DESIGN GUIDELINES TI; Wong MYL, 2012, BIOL CONSERV, V155, P77, DOI 10.1016/j.biocon.2012.05.018; Wright GD., 2012, THESIS NEW MEXICO ST; Wright TF, 2010, ETHOL ECOL EVOL, V22, P393, DOI 10.1080/03949370.2010.505580	49	13	13	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e108739	10.1371/journal.pone.0108739	http://dx.doi.org/10.1371/journal.pone.0108739			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310800	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210300024
J	Vanhauwaert, S; Van Peer, G; Rihani, A; Janssens, E; Rondou, P; Lefever, S; De Paepe, A; Coucke, PJ; Speleman, F; Vandesompele, J; Willaert, A				Vanhauwaert, Suzanne; Van Peer, Gert; Rihani, Ali; Janssens, Els; Rondou, Pieter; Lefever, Steve; De Paepe, Anne; Coucke, Paul J.; Speleman, Frank; Vandesompele, Jo; Willaert, Andy			Expressed Repeat Elements Improve RT-qPCR Normalization across a Wide Range of Zebrafish Gene Expression Studies	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; HOUSEKEEPING GENES; RIBOSOMAL-RNA; MESSENGER; QUANTIFICATION; VALIDATION; INAPPROPRIATE; EMBRYOS; GLUT10	The selection and validation of stably expressed reference genes is a critical issue for proper RT-qPCR data normalization. In zebrafish expression studies, many commonly used reference genes are not generally applicable given their variability in expression levels under a variety of experimental conditions. Inappropriate use of these reference genes may lead to false interpretation of expression data and unreliable conclusions. In this study, we evaluated a novel normalization method in zebrafish using expressed repetitive elements (ERE) as reference targets, instead of specific protein coding mRNA targets. We assessed and compared the expression stability of a number of EREs to that of commonly used zebrafish reference genes in a diverse set of experimental conditions including a developmental time series, a set of different organs from adult fish and different treatments of zebrafish embryos including morpholino injections and administration of chemicals. Using geNorm and rank aggregation analysis we demonstrated that EREs have a higher overall expression stability compared to the commonly used reference genes. Moreover, we propose a limited set of ERE reference targets (hatn10, dna15ta1 and loopern4), that show stable expression throughout the wide range of experiments in this study, as strong candidates for inclusion as reference targets for qPCR normalization in future zebrafish expression studies. Our applied strategy to find and evaluate candidate expressed repeat elements for RT-qPCR data normalization has high potential to be used also for other species.	[Vanhauwaert, Suzanne; Van Peer, Gert; Rihani, Ali; Janssens, Els; Rondou, Pieter; Lefever, Steve; De Paepe, Anne; Coucke, Paul J.; Speleman, Frank; Vandesompele, Jo; Willaert, Andy] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium	Ghent University	Willaert, A (corresponding author), Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium.	andy.willaert@ugent.be	speleman, frank/AAR-5184-2020; Coucke, Paul J/AAO-2954-2020; Willaert, Andy/AAZ-9111-2020; Vandesompele, Jo/W-3411-2018; Van Peer, Gert/AAV-6861-2020; Rihani, Ali/R-6608-2019	speleman, frank/0000-0002-6628-8559; Coucke, Paul J/0000-0001-7119-586X; Vandesompele, Jo/0000-0001-6274-0184; Rihani, Ali/0000-0002-6176-0519; Van Peer, Gert/0000-0001-7597-5521; Vanhauwaert, Suzanne/0000-0002-7768-4549; Willaert, Andy/0000-0002-9543-1932	Ghent University [BOF08/01M01108]; GOA-UGent grant [12051203]; Fund for Scientific Research - Flanders (FWO) [G.0574.13]; Belgian Program of Interuniversity Poles of Attraction IUAP; Stichting tegen kanker [365O9110]; Fund for Scientific Research - Flanders (FWO); Ghent University research fund (BOF); Fund for Scientific Research Flanders (FWO); Special Research Fund (BOF) of Ghent University	Ghent University(Ghent University); GOA-UGent grant; Fund for Scientific Research - Flanders (FWO)(FWO); Belgian Program of Interuniversity Poles of Attraction IUAP; Stichting tegen kanker; Fund for Scientific Research - Flanders (FWO)(FWO); Ghent University research fund (BOF)(Ghent University); Fund for Scientific Research Flanders (FWO)(FWO); Special Research Fund (BOF) of Ghent University(Ghent University)	This work was supported by Ghent University (Methusalem grant BOF08/01M01108 to A. D. P., GOA-UGent grant no. 12051203 to F. S.), by the Fund for Scientific Research - Flanders (FWO) (grant no. G.0574.13 to P. C.), by the Belgian Program of Interuniversity Poles of Attraction IUAP (to F. S.) and by the "Stichting tegen kanker'' (grant no. 365O9110 to F. S.). S. V. is supported by a PhD fellowship from the Fund for Scientific Research - Flanders (FWO). G. V. P. and A. R. are supported by a PhD fellowship from the Ghent University research fund (BOF). P. R. has a postdoctoral research grant from the Fund for Scientific Research Flanders (FWO). A. W. and S. L. are postdoctoral fellows supported by the Special Research Fund (BOF) of Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsson A, 2010, ZEBRAFISH, V7, P161, DOI 10.1089/zeb.2009.0644; Bally-Cuif L, 1998, MECH DEVELOP, V77, P31, DOI 10.1016/S0925-4773(98)00109-9; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2013, NAT METHODS, V10, P1063, DOI 10.1038/nmeth.2697; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Casadei R, 2011, GENE EXPR PATTERNS, V11, P271, DOI 10.1016/j.gep.2011.01.003; Coucke PJ, 2006, NAT GENET, V38, P452, DOI 10.1038/ng1764; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Dhorne-Pollet S, 2013, DEV DYNAM, V242, P709, DOI 10.1002/dvdy.23972; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; Gupta T., 2010, J VIS EXP; Hansen MC, 2001, J BACTERIOL, V183, P4747, DOI 10.1128/JB.183.16.4747-4751.2001; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hendriks-Balk MC, 2007, BASIC RES CARDIOL, V102, P195, DOI 10.1007/s00395-007-0649-0; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kim BS, 2004, GENOMICS, V84, P441, DOI 10.1016/j.ygeno.2004.02.015; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lakowski J, 2007, DEV BIOL, V307, P498, DOI 10.1016/j.ydbio.2007.04.015; Ledderose Carola, 2011, BMC Res Notes, V4, P427, DOI 10.1186/1756-0500-4-427; Lin JT, 2012, DEV GENES EVOL, V222, P369, DOI 10.1007/s00427-012-0420-x; Marullo M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r9; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; Murphey RD, 2006, METHODS, V39, P255, DOI 10.1016/j.ymeth.2005.09.019; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Pihur V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-62; Rihani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071776; Rojas JC, 2005, BLOOD COAGUL FIBRIN, V16, P389, DOI 10.1097/01.mbc.0000174079.47248.0c; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Solanas M, 2001, ANAL BIOCHEM, V288, P99, DOI 10.1006/abio.2000.4889; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vermeulen Joelle, 2009, BMC Res Notes, V2, P235, DOI 10.1186/1756-0500-2-235; Vossaert L, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-21; Weigt S, 2012, REPROD TOXICOL, V33, P133, DOI 10.1016/j.reprotox.2011.07.001; Willaert A, 2012, HUM MOL GENET, V21, P1248, DOI 10.1093/hmg/ddr555; Yang HX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064799, 10.1371/journal.pone.0064058]	44	28	28	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109091	10.1371/journal.pone.0109091	http://dx.doi.org/10.1371/journal.pone.0109091			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310091	gold, Green Published			2022-12-27	WOS:000343210300034
J	Deng, QW; Sun, HL; He, BS; Pan, YQ; Gao, TY; Chen, J; Ying, HQ; Liu, X; Wang, F; Xu, Y; Wang, SK				Deng, Qiwen; Sun, Huiling; He, Bangshun; Pan, Yuqin; Gao, Tianyi; Chen, Jie; Ying, Houqun; Liu, Xian; Wang, Feng; Xu, Yong; Wang, Shukui			Prognostic Value of Long Non-Coding RNA HOTAIR in Various Cancers	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; POOR-PROGNOSIS; METASTASIS; EXPRESSION; SURVIVAL; TRANSCRIPTION; PREDICTOR; INSIGHTS; MARKER; GENOME	Long non-coding RNA has been involved in cancer progression, and high FIOX transcript antisense intergenic RNA (HOTAIR) hought to be a poor prognostic indicator in turnorigenesis of multiple types of cancer. Hence, the present study furthe als its prognostic value in tumor malignancy. A systematic review of PubMed and Web of Science was carried out to eratures relevant to he correlation between HOTAIR expression levels and clinical outcome of various tumors. urvival (OS), metastasis -free survival (MFS), recurrence-free survival RFS and disease-free survival DFS) were subsequently analyzed. Data from studies directly reporting a hazard rat! (HR) and the carrespanding 95% confidence e a C a P value as well as survival curves were pooled in the current meta-analysis. A total of 2255 patients from 19 literatures almost published in 2011 or later were included. h analysis. The results suggest that highly associated with HR for OS of 2.33 (95%Cl = 1.77-3.09, P-heterogeneity= 0.016). Stratified analyses indicate that elevated levels of 1-10TAIR appears to be a powerful prognostic biornarker for patients with colorectal cancer (HR =3.02, 950% = 84-4.95, P-herterogeneity=0.699) and esophageal squamous cell carcinomas (HR= 2.24, 95CI%= 1.67-3.01, P-heterogenfity =0.711, a effect was also observed in analysis method and specimen, except for ethnicity. In addition, Hazard ratios for up-regulation of HOTAIR for MFS, RFS, and INS were 2.32 (P<0.001), 1.98 (P=0.369), and 3.29 (P= 0.001), respectively. In summary, the high level of HOTAIR is intimately associated with an adverse OS in numerous cancers, suggesting that HOTAIR may act as potential biomarker for he development of malignancies	[Deng, Qiwen; He, Bangshun; Pan, Yuqin; Liu, Xian; Wang, Feng; Xu, Yong; Wang, Shukui] Nanjing Med Univ, Nanjing Hosp 1, Cent Lab, Nanjing, Jiangsu, Peoples R China; [Sun, Huiling; Chen, Jie] Nanjing Normal Univ, Dept Life Sci, Nanjing, Jiangsu, Peoples R China; [Gao, Tianyi] Nanjing Med Univ, Nanjing Hosp 1, Dept Clin Lab, Nanjing, Jiangsu, Peoples R China; [Ying, Houqun] Southeast Univ, Coll Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Normal University; Nanjing Medical University; Southeast University - China	Wang, SK (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Cent Lab, Nanjing, Jiangsu, Peoples R China.	shukwang@163.com	Deng, Qi-Wen/E-9434-2016; Deng, Qi-Wen/AAL-3005-2021	Deng, Qi-Wen/0000-0003-4324-8009; Deng, Qi-Wen/0000-0003-4324-8009; Ying, Hou-Qun/0000-0003-3858-4761	National Nature Science Foundation of China [81172141, 81200401]; Nanjing Science and Technology Committee [201108025]; Nanjing Medical Technology Development Project [ZKX11025]; Nanjing Health Young Talent Project; Jiangsu Provincial Key Medical Talents; Nanjing Medical Science and Technique Development Foundation [QRX11255, QRX11254]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Science and Technology Committee; Nanjing Medical Technology Development Project; Nanjing Health Young Talent Project; Jiangsu Provincial Key Medical Talents; Nanjing Medical Science and Technique Development Foundation	This project was supported by grants from The National Nature Science Foundation of China (no. 81172141, 81200401), Nanjing Science and Technology Committee Project (no. 201108025), Nanjing Medical Technology Development Project (no. ZKX11025), Nanjing Health Young Talent Project, Jiangsu Provincial Key Medical Talents to S.K.W., and Nanjing Medical Science and Technique Development Foundation to Y.Q.P. (no. QRX11255) and B.S.H. (no. QRX11254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chen FJ, 2013, MOL CARCINOGEN, V52, P908, DOI 10.1002/mc.21944; Costa FF, 2010, BIOESSAYS, V32, P599, DOI 10.1002/bies.200900112; Deng QW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103022; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ebisuya M, 2008, NAT CELL BIOL, V10, P1106, DOI 10.1038/ncb1771; Frith MC, 2005, EUR J HUM GENET, V13, P894, DOI 10.1038/sj.ejhg.5201459; Ge XS, 2013, CANCER SCI, V104, P1675, DOI 10.1111/cas.12296; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Huang L, 2014, ARCH GYNECOL OBSTET; Huang L, 2014, ARCH GYNECOLOGY OBST; Izzo JG, 2006, J CLIN ONCOL, V24, P748, DOI 10.1200/JCO.2005.03.8810; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kim K, 2013, ONCOGENE, V32, P1616, DOI 10.1038/onc.2012.193; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Li DD, 2013, AM J PATHOL, V182, P64, DOI 10.1016/j.ajpath.2012.08.042; Li X, 2013, BRIT J CANCER, V109, P2266, DOI 10.1038/bjc.2013.548; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liu XH, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-92; Liu XH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-464; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Lu LG, 2012, BREAST CANCER RES TR, V136, P875, DOI 10.1007/s10549-012-2314-z; Lv XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063516; MANTEL N, 1959, J NATL CANCER I, V22, P719; Maruyama R, 2012, P NATL ACAD SCI USA, V109, P2820, DOI 10.1073/pnas.1010559107; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Milhem M. M., 2011, J CANC SCI THER S, V5; Nakagawa T, 2013, BIOCHEM BIOPH RES CO, V436, P319, DOI 10.1016/j.bbrc.2013.05.101; Necsulea A, 2014, NATURE, V505, P635, DOI 10.1038/nature12943; Nie Y, 2013, CANCER SCI, V104, P458, DOI 10.1111/cas.12092; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Perez DS, 2008, HUM MOL GENET, V17, P642, DOI 10.1093/hmg/ddm336; Qiu JJ, 2014, GYNECOL ONCOL, V134, P121, DOI 10.1016/j.ygyno.2014.03.556; Richly H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.84; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sorensen KP, 2013, BREAST CANCER RES TR, V142, P529, DOI 10.1007/s10549-013-2776-7; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Sun M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-319; Svoboda M, 2014, CARCINOGENESIS, V35, P1510, DOI 10.1093/carcin/bgu055; Wang W, 2014, TUMOUR BIOL; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Woo CJ, 2007, CELL, V129, P1257, DOI 10.1016/j.cell.2007.06.014; Wu Z-H, 2014, ONCOLOGY REPORTS; Wu ZH, 2014, ONCOL REP, V32, P395, DOI 10.3892/or.2014.3186; Yan T-H, 2014, TUMOR BIOL; Yan TH, 2014, TUMOUR BIOL; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y; Zhang JX, 2013, NEURO-ONCOLOGY, V15, P1595, DOI 10.1093/neuonc/not131; Zhang JX, 2012, FUTURE ONCOL, V8, P723, DOI [10.2217/fon.12.52, 10.2217/FON.12.52]	52	35	37	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110059	10.1371/journal.pone.0110059	http://dx.doi.org/10.1371/journal.pone.0110059			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303230	gold, Green Published, Green Submitted			2022-12-27	WOS:000343730400106
J	Gabl, M; Winther, M; Skovbakke, SL; Bylund, J; Dahlgren, C; Forsman, H				Gabl, Michael; Winther, Malene; Skovbakke, Sarah Line; Bylund, Johan; Dahlgren, Claes; Forsman, Huamei			A Pepducin Derived from the Third Intracellular Loop of FPR2 Is a Partial Agonist for Direct Activation of This Receptor in Neutrophils But a Full Agonist for Cross-Talk Triggered Reactivation of FPR2	PLOS ONE			English	Article							FORMYL PEPTIDE RECEPTORS; RESPIRATORY BURST PRODUCTS; PROTEIN-COUPLED RECEPTORS; NADPH-OXIDASE; FUNCTIONAL SELECTIVITY; GRANULE MOBILIZATION; INSIGHTS; DESENSITIZATION; PHARMACOLOGY; INHIBITION	We recently described a novel receptor cross-talk mechanism in neutrophils, unique in that the signals generated by the PAF receptor (PAFR) and the ATP receptor (P2Y(2)R) transfer formyl peptide receptor 1 (FPR1) from a desensitized (non-signaling) state back to an actively signaling state (Forsman H et al., PLoS One, 8:e60169, 2013; Onnheim K, et al., Exp Cell Res, 323:209, 2014). In addition to the G-protein coupled FPR1, neutrophils also express the closely related receptor FPR2. In this study we used an FPR2 specific pepducin, proposed to work as an allosteric modulator at the cytosolic signaling interface, to determine whether the cross-talk pathway is utilized also by FPR2. The pepducin used contains a fatty acid linked to a peptide sequence derived from the third intracellular loop of FPR2, and it activates as well as desensensitizes this receptor. We now show that neutrophils desensitized with the FPR2-specific pepducin display increased cellular responses to stimulation with PAF or ATP. The secondary PAF/ATP induced response was sensitive to FPR2-specific inhibitors, disclosing a receptor cross-talk mechanism underlying FPR2 reactivation. The pepducin induced an activity in naive cells similar to that of a conventional FPR2 agonist, but with lower potency (partial efficacy), meaning that the pepducin is a partial agonist. The PAF- or ATP-induced reactivation was, however, much more pronounced when neutrophils had been desensitized to the pepducin as compared to cells desensitized to conventional agonists. The pepducin should thus in this respect be classified as a full agonist. In summary, we demonstrate that desensitized FPR2 can be transferred back to an actively signaling state by receptor cross-talk signals generated through PAFR and P2Y(2)R, and the difference in agonist potency with respect to pepducin-induced direct receptor activation and cross-talk reactivation of FPR2 puts the concept of functional selectivity in focus.	[Gabl, Michael; Winther, Malene; Skovbakke, Sarah Line; Bylund, Johan; Dahlgren, Claes; Forsman, Huamei] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Skovbakke, Sarah Line] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark	University of Gothenburg; University of Copenhagen	Forsman, H (corresponding author), Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.	Huamei.Forsman@Rheuma.gu.se		Skovbakke, Sarah Line/0000-0002-4673-4419	Swedish Medical Research Council; King Gustaf the V 80-Year foundation; Swedish Society of Medicine; Ingabritt and Arne Lundberg foundation; Swedish Government under the ALF-agreement	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); King Gustaf the V 80-Year foundation; Swedish Society of Medicine; Ingabritt and Arne Lundberg foundation; Swedish Government under the ALF-agreement	The work was supported by the Swedish Medical Research Council, the King Gustaf the V 80-Year foundation, the Swedish Society of Medicine, the Ingabritt and Arne Lundberg foundation, and the Swedish Government under the ALF-agreement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almkvist J, 2001, INFECT IMMUN, V69, P832, DOI 10.1128/IAI.69.2.832-837.2001; Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; BOYUM A, 1991, SCAND J IMMUNOL, V34, P697, DOI 10.1111/j.1365-3083.1991.tb01594.x; Bylund J, 2002, INFECT IMMUN, V70, P2908, DOI 10.1128/IAI.70.6.2908-2914.2002; Bylund J, 2003, J BIOL CHEM, V278, P30578, DOI 10.1074/jbc.M209202200; Bylund J, 2014, INFLAMM CELL SIGNAL, V1, P24; Bylund J, 2014, METHODS MOL BIOL, V1124, P321, DOI 10.1007/978-1-62703-845-4_21; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; Dahlgren C, 2000, BLOOD, V95, P1810, DOI 10.1182/blood.V95.5.1810.005k06_1810_1818; Dahlgren Claes, 2007, V412, P349, DOI 10.1007/978-1-59745-467-4_23; Eglen RM, 2011, PHARMACEUTICALS, V4, P244, DOI 10.3390/ph4020244; Forsman H, 2013, BBA-MOL CELL RES, V1833, P1914, DOI 10.1016/j.bbamcr.2013.03.026; Forsman H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060169; Forsman H, 2012, J IMMUNOL, V189, P629, DOI 10.4049/jimmunol.1101616; Fu HM, 2006, J LEUKOCYTE BIOL, V79, P247, DOI 10.1189/jlb.0905498; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Hendriks-Balk MC, 2008, EUR J PHARMACOL, V585, P278, DOI 10.1016/j.ejphar.2008.02.088; Jamieson T, 2012, J CLIN INVEST, V122, P3127, DOI 10.1172/JCI61067; JESAITIS AJ, 1993, EUR J HAEMATOL, V51, P288; JESAITIS AJ, 1985, J CELL BIOCHEM, V27, P241, DOI 10.1002/jcb.240270306; Karlsson A, 1998, BLOOD, V91, P3430, DOI 10.1182/blood.V91.9.3430.3430_3430_3438; Karlsson J, 2010, J IMMUNOL METHODS, V352, P45, DOI 10.1016/j.jim.2009.10.011; Karlsson J, 2009, CELL CALCIUM, V45, P431, DOI 10.1016/j.ceca.2009.02.002; Kemp PA, 2004, AM J RESP CELL MOL, V31, P446, DOI 10.1165/rcmb.2003-0211OC; Kindon N, 1998, Patent No. [WO1998054180, 1998054180]; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Lee HY, 2010, FEBS LETT, V584, P4102, DOI 10.1016/j.febslet.2010.08.036; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Manglik A, 2014, CURR OPIN CELL BIOL, V27, P136, DOI 10.1016/j.ceb.2014.01.008; Meghani P, 2002, AM CHEM SOC; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; O'Callaghan K, 2012, J BIOL CHEM, V287, P12787, DOI 10.1074/jbc.R112.355461; Onnheim K, 2014, EXP CELL RES, V323, P209, DOI 10.1016/j.yexcr.2014.01.023; Quoyer J, 2013, P NATL ACAD SCI USA, V110, pE5088, DOI 10.1073/pnas.1312515110; Sadik CD, 2011, TRENDS IMMUNOL, V32, P452, DOI 10.1016/j.it.2011.06.008; Seifert R, 2013, BIOCHEM PHARMACOL, V86, P853, DOI 10.1016/j.bcp.2013.07.029; Shukla AK, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005021; Stallaert W, 2011, EXPERT OPIN DRUG DIS, V6, P811, DOI 10.1517/17460441.2011.586691; Tressel SL, 2011, METHODS MOL BIOL, V683, P259, DOI 10.1007/978-1-60761-919-2_19; Ye R D, 1997, Adv Pharmacol, V39, P221, DOI 10.1016/S1054-3589(08)60073-3; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	42	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109516	10.1371/journal.pone.0109516	http://dx.doi.org/10.1371/journal.pone.0109516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303226	Green Published, gold, Green Submitted			2022-12-27	WOS:000343730400062
J	Haring, B; Gronroos, N; Nettleton, JA; von Ballmoos, MCW; Selvin, E; Alonso, A				Haring, Bernhard; Gronroos, Noelle; Nettleton, Jennifer A.; von Ballmoos, Moritz C. Wyler; Selvin, Elizabeth; Alonso, Alvaro			Dietary Protein Intake and Coronary Heart Disease in a Large Community Based Cohort: Results from the Atherosclerosis Risk in Communities (ARIC) Study	PLOS ONE			English	Article							MIDDLE-AGED MEN; BLOOD-PRESSURE; MEAT CONSUMPTION; FAT INTAKE; WOMEN; METAANALYSIS; MORTALITY; TRIAL; QUESTIONNAIRE; ASSOCIATION	Background: Prospective data examining the relationship between dietary protein intake and incident coronary heart disease (CHD) are inconclusive. Most evidence is derived from homogenous populations such as health professionals. Large community-based analyses in more diverse samples are lacking. Methods: We studied the association of protein type and major dietary protein sources and risk for incident CHD in 12,066 middle-aged adults (aged 45-64 at baseline, 1987-1989) from four U.S. communities enrolled in the Atherosclerosis Risk in Communities (ARK) Study who were free of diabetes mellitus and cardiovascular disease at baseline. Dietary protein intake was assessed at baseline and after 6 years of follow-up by food frequency questionnaire. Our primary outcome was adjudicated coronary heart disease events or deaths with following up through December 31, 2010. Cox proportional hazard models with multivariable adjustment were used for statistical analyses. Results: During a median follow-up of 22 years, there were 1,147 CHD events. In multivariable analyses total, animal and vegetable protein were not associated with an increased risk for CHD before or after adjustment. In food group analyses of major dietary protein sources, protein intake from red and processed meat, dairy products, fish, nuts, eggs, and legumes were not significantly associated with CHD risk. The hazard ratios [with 95% confidence intervals] for risk of CHD across quintiles of protein from poultry were 1.00 [ref], 0.83 [0.70-0.99], 0.93 [0.75-1.15], 0.88 [0.73-1.06], 0.79 [0.64-0.98], P for trend = 0.16). Replacement analyses evaluating the association of substituting one source of dietary protein for another or of decreasing protein intake at the expense of carbohydrates or total fats did not show any statistically significant association with CHD risk. Conclusion: Based on a large community cohort we found no overall relationship between protein type and major dietary protein sources and risk for CHD.	[Haring, Bernhard] Univ Wurzburg, Dept Internal Med 1, Comprehens Heart Failure Ctr, D-97070 Wurzburg, Bavaria, Germany; [Gronroos, Noelle; Alonso, Alvaro] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Nettleton, Jennifer A.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Epidemiol, Houston, TX 77030 USA; [von Ballmoos, Moritz C. Wyler] Froedtert Mem Hosp, Dept Surg, Milwaukee, WI USA; [von Ballmoos, Moritz C. Wyler] Froedtert Mem Hosp, Div Cardiothorac Surg, Milwaukee, WI USA; [von Ballmoos, Moritz C. Wyler] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Selvin, Elizabeth] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Selvin, Elizabeth] Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA	University of Wurzburg; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Medical College of Wisconsin; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Haring, B (corresponding author), Univ Wurzburg, Dept Internal Med 1, Comprehens Heart Failure Ctr, D-97070 Wurzburg, Bavaria, Germany.	Haring_B@ukw.de	Reardon, Michael/ABF-8880-2021; Alonso, Alvaro/A-4917-2010	Alonso, Alvaro/0000-0002-2225-8323	National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; German Research Foundation (DFG); University of Wurzburg	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wurzburg	The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). There are no relationships with industry to declare. Open Access publication was funded by the German Research Foundation (DFG) and the University of Wurzburg in the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, AM J EPIDEMIOL, V129, P687; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; Bernstein AM, 2010, CIRCULATION, V122, P876, DOI 10.1161/CIRCULATIONAHA.109.915165; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; Elliott P, 2006, ARCH INTERN MED, V166, P79, DOI 10.1001/archinte.166.1.79; Halton TL, 2006, NEW ENGL J MED, V355, P1991, DOI 10.1056/NEJMoa055317; Hu FB, 1999, AM J CLIN NUTR, V70, P1001; Hu FB, 2002, JAMA-J AM MED ASSOC, V287, P1815, DOI 10.1001/jama.287.14.1815; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Hu FB, 1999, AM J CLIN NUTR, V70, P221; Iseki K, 2003, HYPERTENS RES, V26, P289, DOI 10.1291/hypres.26.289; Kelemen LE, 2005, AM J EPIDEMIOL, V161, P239, DOI 10.1093/aje/kwi038; Kumanyika SK, 2000, HEALTH PSYCHOL, V19, P42, DOI 10.1037/0278-6133.19.Suppl1.42; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; LUEPKER RV, 1994, AM J PUBLIC HEALTH, V84, P1383, DOI 10.2105/AJPH.84.9.1383; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Oh K, 2005, AM J EPIDEMIOL, V161, P672, DOI 10.1093/aje/kwi085; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Preis SR, 2010, AM J CLIN NUTR, V92, P1265, DOI 10.3945/ajcn.2010.29626; Ramsden CE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8707; RICHARDSON MT, 1995, INT J EPIDEMIOL, V24, P685, DOI 10.1093/ije/24.4.685; Roussell MA, 2014, J HUM HYPERTENS; Roussell MA, 2012, AM J CLIN NUTR, V95, P9, DOI 10.3945/ajcn.111.016261; Sacks FM, 2010, NEW ENGL J MED, V362, P2102, DOI 10.1056/NEJMct0911013; Sinha R, 2009, ARCH INTERN MED, V169, P562, DOI 10.1001/archinternmed.2009.6; SNOWDON DA, 1984, PREV MED, V13, P490, DOI 10.1016/0091-7435(84)90017-3; Stamler J, 1996, CIRCULATION, V94, P1629, DOI 10.1161/01.CIR.94.7.1629; Stamler J, 2002, HYPERTENSION, V39, P1000, DOI 10.1161/01.HYP.0000016178.80811.D9; Stamler J, 1996, CIRCULATION, V94, P2417, DOI 10.1161/01.CIR.94.10.2417; Vega-Lopez Sonia, 2005, Prev Cardiol, V8, P31, DOI 10.1111/j.1520-037X.2005.3923.x; Wang YF, 2008, J HUM HYPERTENS, V22, P745, DOI 10.1038/jhh.2008.64; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; Whiteman D, 1999, PUBLIC HEALTH NUTR, V2, P477, DOI 10.1017/S136898009900066X; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086	36	56	57	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109552	10.1371/journal.pone.0109552	http://dx.doi.org/10.1371/journal.pone.0109552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303709	Green Published, gold, Green Submitted			2022-12-27	WOS:000343730400066
J	Rico, S; Yepes, A; Rodriguez, H; Santamaria, J; Antoraz, S; Krause, EM; Diaz, M; Santamaria, RI				Rico, Sergio; Yepes, Ana; Rodriguez, Hector; Santamaria, Jorge; Antoraz, Sergio; Krause, Eva M.; Diaz, Margarita; Santamaria, Ramon I.			Regulation of the AbrA1/A2 Two-Component System in Streptomyces coelicolor and the Potential of Its Deletion Strain as a Heterologous Host for Antibiotic Production	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION SYSTEMS; BIOSYNTHETIC GENE-CLUSTER; RESPONSE REGULATOR; ESCHERICHIA-COLI; OVIEDOMYCIN; EXPRESSION; ORGANIZATION; INTEGRATION; BACTERIA; SEQUENCE	The Two-Component System (TCS) AbrA1/A2 from Streptomyces coelicolor M145 is a negative regulator of antibiotic production and morphological differentiation. In this work we show that it is able to auto-regulate its expression, exerting a positive induction of its own operon promoter, and that its activation is dependent on the presence of iron. The overexpression of the abrA2 response regulator (RR) gene in the mutant DabrA1/A2 results in a toxic phenotype. The reason is an excess of phosphorylated AbrA2, as shown by phosphoablative and phosphomimetic AbrA2 mutants. Therefore, non-cognate histidine kinases (HKs) or small phospho-donors may be responsible for AbrA2 phosphorylation in vivo. The results suggest that in the parent strain S. coelicolor M145 the correct amount of phosphorylated AbrA2 is adjusted through the phosphorylation-dephosphorylation activity rate of the HK AbrA1. Furthermore, the ABC transporter system, which is part of the four-gene operon comprising AbrA1/A2, is necessary to de-repress antibiotic production in the TCS null mutant. Finally, in order to test the possible biotechnological applications of the DabrA1/A2 strain, we demonstrate that the production of the antitumoral antibiotic oviedomycin is duplicated in this strain as compared with the production obtained in the wild type, showing that this strain is a good host for heterologous antibiotic production. Thus, this genetically modified strain could be interesting for the biotechnology industry.	[Rico, Sergio; Rodriguez, Hector; Santamaria, Jorge; Antoraz, Sergio; Diaz, Margarita; Santamaria, Ramon I.] Univ Salamanca, CSIC, Inst Biol Func & Genom, Dept Microbiol & Genet, E-37008 Salamanca, Spain; [Yepes, Ana] Univ Wurzburg, Inst Mol Infect Biol, D-97070 Wurzburg, Germany; [Krause, Eva M.] Univ Bibliothek Marburg, Marburg, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; University of Wurzburg	Diaz, M (corresponding author), Univ Salamanca, CSIC, Inst Biol Func & Genom, Dept Microbiol & Genet, E-37008 Salamanca, Spain.	mardi@usal.es; santa@usal.es	Martínez, Margarita Díaz/L-3069-2014; Krause, Evamaria/AHB-0043-2022; Santamaria, Ramon I/M-9069-2019; Santamaria, Ramon I/K-2870-2014; Rodríguez, Héctor/E-6887-2013	Martínez, Margarita Díaz/0000-0003-4286-1506; Krause, Evamaria/0000-0002-4946-6544; Santamaria, Ramon I/0000-0002-2181-6776; Santamaria, Ramon I/0000-0002-2181-6776; Rodríguez, Héctor/0000-0002-9948-2497; Santamaria, Jorge/0000-0003-4425-6297; Antoraz, Sergio/0000-0001-8429-5245	Spanish Comision Interministerial de Ciencia y Tecnologia (CICYT) [GEN2003-20245-C09-02]; Junta de Castilla y Leon (JCyL) [SA072A07, CSI099A12-1]; Spanish Ministerio de Ciencia e Innovacion (MICINN) [BFU2010-17551]; CSIC; Botin Foundation	Spanish Comision Interministerial de Ciencia y Tecnologia (CICYT)(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Junta de Castilla y Leon (JCyL)(Junta de Castilla y Leon); Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CSIC; Botin Foundation	This work was supported by Spanish Comision Interministerial de Ciencia y Tecnologia (CICYT) [GEN2003-20245-C09-02]; Junta de Castilla y Leon (JCyL) [SA072A07, CSI099A12-1]; Spanish Ministerio de Ciencia e Innovacion (MICINN) [BFU2010-17551]. SR had a JAE-predoctoral grant from the CSIC. AY was a holder of a predoctoral grant from the Junta de Castilla y Leon. HR had a postdoctoral fellowship from Botin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham SAI, 2001, ARCH MICROBIOL, V177, P91, DOI 10.1007/s00203-001-0365-3; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; CABALLERO JL, 1991, MOL GEN GENET, V230, P401, DOI 10.1007/BF00280297; Chen YH, 2010, APPL MICROBIOL BIOT, V86, P19, DOI 10.1007/s00253-009-2428-3; Cho HS, 2001, CURR OPIN STRUC BIOL, V11, P679, DOI 10.1016/S0959-440X(01)00271-8; Coisne S, 1999, LETT APPL MICROBIOL, V28, P199, DOI 10.1046/j.1365-2672.1999.00509.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; FERNANDEZMORENO MA, 1991, CELL, V66, P769, DOI 10.1016/0092-8674(91)90120-N; Gebhard S, 2012, MOL MICROBIOL, V86, P1295, DOI 10.1111/mmi.12078; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hesketh A, 2009, MOL MICROBIOL, V74, P1427, DOI 10.1111/j.1365-2958.2009.06941.x; Hopwood D. A., 1985, GENETIC MANIPULATION; Hoskisson PA, 2006, TRENDS MICROBIOL, V14, P444, DOI 10.1016/j.tim.2006.08.005; KATZ E, 1983, J GEN MICROBIOL, V129, P2703; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Lee LF, 2007, MICROBIOL-SGM, V153, P924, DOI 10.1099/mic.0.2006/000018-0; Liu R, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-207; Lombo F, 2004, CHEMBIOCHEM, V5, P1181, DOI 10.1002/cbic.200400073; Lombo F, 2009, CHEMBIOCHEM, V10, P296, DOI 10.1002/cbic.200800425; Lucana DOD, 2009, AMINO ACIDS, V37, P479, DOI 10.1007/s00726-009-0260-9; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; MACNEIL DJ, 1992, GENE, V111, P61, DOI 10.1016/0378-1119(92)90603-M; Martin J., 2012, 2 COMPONENT SYSTEMS, P315; Medema MH, 2011, NAT REV MICROBIOL, V9, P131, DOI 10.1038/nrmicro2478; Mendez C, 2002, J NAT PROD, V65, P779, DOI 10.1021/np010555n; Mitrophanov AY, 2008, GENE DEV, V22, P2601, DOI 10.1101/gad.1700308; Mitrophanov AY, 2010, J MOL BIOL, V401, P671, DOI 10.1016/j.jmb.2010.06.051; Neumuller AM, 2001, EUR J BIOCHEM, V268, P3180, DOI 10.1046/j.1432-1327.2001.02203.x; Pawelczyk S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037737; Rico S, 2014, APPL ENVIRON MICROB, V80, P2417, DOI 10.1128/AEM.03378-13; Robinson VL, 2003, J BACTERIOL, V185, P4186, DOI 10.1128/JB.185.14.4186-4194.2003; Rodriguez H, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-127; Rodriguez S, 2005, GENE, V351, P1, DOI 10.1016/j.gene.2005.03.007; Sambrook J., 2002, MOL CLONING LAB MANU; Sheridan R. C., 2007, INORG SYN, P23; Sprusansky O, 2005, J BACTERIOL, V187, P664, DOI 10.1128/JB.187.2.664-671.2005; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Yepes A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019980; Zerikly M, 2009, CHEMBIOCHEM, V10, P625, DOI 10.1002/cbic.200800389	42	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109844	10.1371/journal.pone.0109844	http://dx.doi.org/10.1371/journal.pone.0109844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303210	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400084
J	Bashar, K; Healy, D; Clarke-Moloney, M; Burke, P; Kavanagh, E; Walsh, SR				Bashar, Khalid; Healy, Donagh; Clarke-Moloney, Mary; Burke, Paul; Kavanagh, Eamon; Walsh, Stewart-Redmond			Effects of Neck Radiation Therapy on Extra-Cranial Carotid Arteries Atherosclerosis Disease Prevalence: Systematic Review and a Meta-Analysis	PLOS ONE			English	Review							INTIMA-MEDIA THICKNESS; STENOSIS; RADIOTHERAPY; HEAD; IRRADIATION; STROKE	Introduction: Radiation arteritis following neck irradiation as a treatment for head and neck malignancy has been well documented. The long-term sequelae of radiation exposure of the carotid arteries may take years to manifest clinically, and extra-cranial carotid artery (ECCA) stenosis is a well-recognised vascular complication. These carotid lesions should not be regarded as benign and should be treated in the same manner as standard carotid stenosis. Previous studies have noted increased cerebrovascular events such as stroke in this cohort of patients because of high-grade symptomatic carotid stenosis resulting in emboli. Aim: To evaluate the effect of radiation therapy on ECCA atherosclerosis progression. Methods: Online search for case-control studies and randomised clinical trials that reported on stenosis in extra-cranial carotid arteries in patients with neck malignancies who received radiation therapy (RT) comparing them to patients with neck malignancies who did not receive RT. Results: Eight studies were included in the final analysis with total of 1070 patients - 596 received RT compared to 474 in the control group. There was statistically significant difference in overall stenosis rate (Pooled risk ratio = 4.38 [2.98, 6.45], P = 0.00001) and severe stenosis (Pooled risk ratio = 7.51 [2.78, 20.32], P < 0.0001), both being higher in the RT group. Pooled analysis of the five studies that reported on mild stenosis also showed significant difference (Pooled risk ratio = 2.74 [1.75, 4.30], 95% CI, P = 0.0001). Conclusion: The incidence of severe ECCA stenosis is higher among patients who received RT for neck malignancies. Those patients should be closely monitored and screening programs should be considered in all patients who receive neck RT.	[Bashar, Khalid; Healy, Donagh; Clarke-Moloney, Mary; Burke, Paul; Kavanagh, Eamon] Univ Hosp Limerick, Dept Vasc Surg, Limerick, Ireland; [Walsh, Stewart-Redmond] Natl Univ Ireland Galway, Dept Surg, Galway, Ireland	University of Limerick; Ollscoil na Gaillimhe-University of Galway	Bashar, K (corresponding author), Univ Hosp Limerick, Dept Vasc Surg, Limerick, Ireland.	khalid@live.ie	Walsh, Stewart R/AAC-1229-2021	Walsh, Stewart/0000-0002-1006-9541				BROSIUS FC, 1981, AM J MED, V70, P519, DOI 10.1016/0002-9343(81)90574-X; Carmody BJ, 1999, J VASC SURG, V30, P1045, DOI 10.1016/S0741-5214(99)70042-X; Chang YJ, 2009, J VASC SURG, V50, P280, DOI 10.1016/j.jvs.2009.01.033; Cheng SWK, 1999, AM J SURG, V178, P323, DOI 10.1016/S0002-9610(99)00184-1; Cheng SWK, 2000, ARCH OTOLARYNGOL, V126, P517, DOI 10.1001/archotol.126.4.517; CHUNG TS, 1994, J COMPUT ASSIST TOMO, V18, P533, DOI 10.1097/00004728-199407000-00003; DERSIMONIAN R, 1983, HARVARD EDUC REV, V53, P1; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Dyson P, 1993, Clin Oncol (R Coll Radiol), V5, P260, DOI 10.1016/S0936-6555(05)80243-2; Fokkema M, 2012, STROKE, V43, P793, DOI 10.1161/STROKEAHA.111.633743; FONKALSRUD EW, 1977, SURG GYNECOL OBSTET, V145, P395; GARCIAALBEA E, 1982, REV CLIN ESP, V166, P89; Greco A, 2012, CLIN OTOLARYNGOL, V37, P376, DOI 10.1111/coa.12007; Gujral DM, 2014, CLIN ONCOL-UK, V26, P94, DOI 10.1016/j.clon.2013.10.002; Gujral DM, 2013, CLIN ONCOL; Hoving S, 2008, INT J RADIAT ONCOL, V71, P848, DOI 10.1016/j.ijrobp.2008.02.031; Huang YS, 2011, ORAL ONCOL, V47, P1092, DOI 10.1016/j.oraloncology.2011.07.024; King LJ, 1999, RADIOLOGY, V213, P167, DOI 10.1148/radiology.213.1.r99oc07167; Lam WMM, 2001, CANCER, V92, P2357, DOI 10.1002/1097-0142(20011101)92:9<2357::AID-CNCR1583>3.0.CO;2-K; Lam WWM, 2002, CEREBROVASC DIS, V13, P168, DOI 10.1159/000047771; Lam WWM, 2001, HEAD NECK-J SCI SPEC, V23, P780, DOI 10.1002/hed.1111.abs; Li CS, 2010, CLIN NEUROL NEUROSUR, V112, P682, DOI 10.1016/j.clineuro.2010.05.007; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; MCGUIRT WF, 1992, ANN OTO RHINOL LARYN, V101, P222, DOI 10.1177/000348949210100305; MELLIERE D, 1983, J MAL VASCUL, V8, P321; MORITZ MW, 1990, ARCH SURG-CHICAGO, V125, P1181; Muzaffar K, 2000, LARYNGOSCOPE, V110, P1811, DOI 10.1097/00005537-200011000-00007; Protack CD, 2007, J VASC SURG, V45, P110, DOI 10.1016/j.jvs.2006.08.083; REILLY LM, 1983, AM J SURG, V146, P188, DOI 10.1016/0002-9610(83)90370-7; Rockman CB, 1996, AM J SURG, V172, P191, DOI 10.1016/S0002-9610(96)00150-X; Santoro F, 2013, INT J CARDIOL, V165, P373, DOI 10.1016/j.ijcard.2012.08.027; Shariat M, 2008, POSTGRAD MED J, V84, P609, DOI 10.1136/pgmj.2008.068569; Sterne JAC, 2011, COCHRANE HDB SYSTEMA; Thapa GB, 2013, J NEPAL MED ASSOC, V52, P251, DOI 10.31729/jnma.568; The Nordic Cochrane Centre TCc, 2012, REV MAN REVMAN COMP; Toprak U, 2012, J CLIN ULTRASOUND, V40, P566, DOI 10.1002/jcu.21971	36	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110389	10.1371/journal.pone.0110389	http://dx.doi.org/10.1371/journal.pone.0110389			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329500	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210800082
J	Lee, EK; Kim, YJ; Kim, JY; Song, HB; Yu, HG				Lee, Eun Kyoung; Kim, Young Joo; Kim, Jin Young; Song, Hyun Beom; Yu, Hyeong Gon			Melissa officinalis Extract Inhibits Laser-Induced Choroidal Neovascularization in a Rat Model	PLOS ONE			English	Article							NONLETHAL OXIDANT INJURY; RETINAL-DETACHMENT; ALZHEIMERS-DISEASE; IN-VITRO; OB-X; INTRAVITREAL; GROWTH; EXPRESSION; MMP-2; ACID	Purpose: This study investigated the effect of Melissa officinalis extract on laser-induced choroidal neovascularization (CNV) in a rat model. The mechanism by which M. officinalis extract acted was also investigated. Methods: Experimental CNV was induced by laser photocoagulation in Brown Norway rats. An active fraction of the Melissa leaf extract was orally administered (50 or 100 mg/kg/day) beginning 3 days before laser photocoagulation and ending 14 days after laser photocoagulation. Optical coherence tomography and fluorescein angiography were performed in vivo to evaluate the thickness and leakage of CNV. Choroidal flat mount and histological analysis were conducted to observe the CNV in vitro. Vascular endothelial growth factor (VEGF), matrix metalloproteinase (MMP)-2, and MMP-9 expression were measured in retinal and choroidal-scleral lysates 7 days after laser injury. Moreover, the effect of M. officinalis extract on tertiary-butylhydroperoxide (t-BH)-induced VEGF secretion and mRNA levels of VEGF, MMP-2, and MMP-9 were evaluated in human retinal epithelial cells (ARPE-19) as well as in human umbilical vein endothelial cells (HUVECs). Results: The CNV thickness in M. officinalis-treated rats was significantly lower than in vehicle-treated rats by histological analysis. The CNV thickness was 33.93 +/- 7.64 mu m in the high-dose group (P<0.001), 44.09 +/- 12.01 mu m in the low-dose group (P = 0.016), and 51.00 +/- 12.37 mu m in the control group. The proportion of CNV lesions with clinically significant fluorescein leakage was 9.2% in rats treated with high-dose M. officinalis, which was significantly lower than in control rats (53.4%, P<0.001). The levels of VEGF, MMP-2, and MMP-9 were significantly lower in the high-dose group than in the control group. Meanwhile, M. officinalis extract suppressed t-BH-induced transcription of VEGF and MMP-9 in ARPE-19 cells and HUVECs. Conclusions: Systemic administration of M. officinalis extract suppressed laser-induced CNV formation in rats. Inhibition of VEGF and MMP-9 via anti-oxidative activity may underlie this effect.	[Lee, Eun Kyoung; Kim, Jin Young; Yu, Hyeong Gon] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Kim, Young Joo] Seoul Natl Univ Hosp, Biomed Res Inst, Dept Ophthalmol, Seoul 110744, South Korea; [Song, Hyun Beom] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Yu, HG (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Ophthalmol, Seoul, South Korea.	hgonyu@snu.ac.kr		Song, Hyun Beom/0000-0002-3500-2984; Yu, Hyeong Gon/0000-0002-1795-202X; Kim, Jin Young/0000-0001-6204-9537	Korea Health technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [A121835-1201-0000103]	Korea Health technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (Grant Number: A121835-1201-0000103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhondzadeh S, 2003, J NEUROL NEUROSUR PS, V74, P863, DOI 10.1136/jnnp.74.7.863; Allahverdiyev A, 2004, PHYTOMEDICINE, V11, P657, DOI 10.1016/j.phymed.2003.07.014; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Blasiak J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/768026; Bolkent S, 2005, J ETHNOPHARMACOL, V99, P391, DOI 10.1016/j.jep.2005.02.038; Campochiaro P A, 1999, Mol Vis, V5, P34; de Sousa AC, 2004, J PHARM PHARMACOL, V56, P677, DOI 10.1211/0022357023321; Dimitrova Z., 1993, Acta Microbiologica Bulgarica, V29, P65; dos Santos-Neto LL, 2006, EVID-BASED COMPL ALT, V3, P441, DOI 10.1093/ecam/nel071; Ferreira A, 2006, J ETHNOPHARMACOL, V108, P31, DOI 10.1016/j.jep.2006.04.010; Fintak DR, 2008, RETINA-J RET VIT DIS, V28, P1395, DOI 10.1097/IAE.0b013e3181884fd2; Hara R, 2010, CURR EYE RES, V35, P1012, DOI 10.3109/02713683.2010.500112; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Hong Y, 2011, PHARM BIOL, V49, P775, DOI 10.3109/13880209.2010.547208; Huang SS, 2006, CANCER LETT, V239, P271, DOI 10.1016/j.canlet.2005.08.025; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jung JE, 2007, CARCINOGENESIS, V28, P1780, DOI 10.1093/carcin/bgm130; Kennedy DO, 2003, NEUROPSYCHOPHARMACOL, V28, P1871, DOI 10.1038/sj.npp.1300230; Kennedy DO, 2002, PHARMACOL BIOCHEM BE, V72, P953, DOI 10.1016/S0091-3057(02)00777-3; Kim JH, 2009, VASC PHARMACOL, V51, P262, DOI 10.1016/j.vph.2009.06.010; Kim JH, 2009, EUR J PHARMACOL, V615, P150, DOI 10.1016/j.ejphar.2009.05.015; Kim MY, 2010, INT J OBESITY, V34, P820, DOI 10.1038/ijo.2010.13; Krzystolik MG, 2002, ARCH OPHTHALMOL-CHIC, V120, P338; Kugu S, 2012, CLIN OPHTHALMOL, V6, P1399, DOI 10.2147/OPTH.S31721; Kumar A, 2012, GRAEF ARCH CLIN EXP, V250, P685, DOI 10.1007/s00417-011-1890-7; Kvanta A, 2000, CURR EYE RES, V21, P684, DOI 10.1076/0271-3683(200009)21:3;1-R;FT684; Kvanta A, 2000, EXP EYE RES, V70, P419, DOI 10.1006/exer.1999.0790; Lambert V, 2003, FASEB J, V17, P2290, DOI 10.1096/fj.03-0113fje; Lambert V, 2002, AM J PATHOL, V161, P1247, DOI 10.1016/S0002-9440(10)64401-X; Lee SH, 2010, EYE, V24, P226, DOI 10.1038/eye.2009.86; Marin-Castano ME, 2006, INVEST OPHTH VIS SCI, V47, P4098, DOI 10.1167/iovs.05-1230; Marin-Castano ME, 2005, INVEST OPHTH VIS SCI, V46, P3331, DOI 10.1167/iovs.04-1224; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Otsuka K, 2012, CASE REP OPHTHALM, V3, P424, DOI 10.1159/000346041; Pascolini D, 2004, OPHTHAL EPIDEMIOL, V11, P67, DOI 10.1076/opep.11.2.67.28158; Pennesi ME, 2012, MOL ASPECTS MED, V33, P487, DOI 10.1016/j.mam.2012.06.003; Roggia MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098864; Steen B, 1998, INVEST OPHTH VIS SCI, V39, P2194; Van der Reis MI, 2011, RETINA-J RET VIT DIS, V31, P1449, DOI 10.1097/IAE.0b013e3182278ab4; Yamasaki K, 1998, BIOL PHARM BULL, V21, P829, DOI 10.1248/bpb.21.829; Ziakova A, 2003, J CHROMATOGR A, V983, P271, DOI 10.1016/S0021-9673(02)01712-0	41	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110109	10.1371/journal.pone.0110109	http://dx.doi.org/10.1371/journal.pone.0110109			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314292	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500097
J	Terasawa, T; Nishida, H; Kato, K; Miyashiro, I; Yoshikawa, T; Takaku, R; Hamashima, C				Terasawa, Teruhiko; Nishida, Hiroshi; Kato, Katsuaki; Miyashiro, Isao; Yoshikawa, Takaki; Takaku, Reo; Hamashima, Chisato			Prediction of Gastric Cancer Development by Serum Pepsinogen Test and Helicobacter pylori Seropositivity in Eastern Asians: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							EXTERNAL VALIDATION; INFECTION; RISK; CARCINOMA; ASSOCIATION; HISAYAMA; MODELS; TRIALS; RATIO	Background: To identify high-risk groups for gastric cancer in presumptively healthy populations, several studies have investigated the predictive ability of the pepsinogen test, H. Pylori antibodies, and a risk-prediction model based on these two tests. To investigate whether these tests accurately predict gastric cancer development, we conducted a systematic review and meta-analysis. Methods: PubMed and other electronic databases were searched for cohort studies published in English or Japanese from January 1985 through December 2013. Six reviewers identified eligible studies, and at least two investigators extracted data on population and study-design characteristics, quality items, and outcomes of interest. Meta-analyses were performed on non-overlapping studies. Results: Nine prospective cohorts from Eastern Asia reported in 12 publications, including 33,741 asymptomatic middle-aged participants of gastric cancer screening, were eligible. For discriminating between asymptomatic adults at high and low risk of gastric cancer, the pepsinogen test (summary hazard ratio [HR], 3.5; 95% confidence interval [CI], 2.7-4.7; I-2 = 0%) and H. pylori antibodies (summary HR, 3.2; 95% CI, 2.0-5.2; I-2 = 0%) were statistically significant predictors as standalone tests. Although the risk-prediction model was in general moderately accurate in separating asymptomatic adults into four risk groups (summary c-statistic, 0.71; 95% CI: 0.68-0.73; I-2 = 7%), calibration seemed to be poor. The study validity was generally limited. Conclusions: The serum pepsinogen test, H. pylori antibodies, and the four-risk-group model for predicting gastric cancer development seem to have the potential to stratify middle-aged presumptively healthy adults. Future research needs to focus on comparative studies to evaluate the impact of screening programs adopting these tests. Also, validation, preferably with model updating, is necessary to see whether the current model performance is transferable to different populations.	[Terasawa, Teruhiko] Fujita Hlth Univ, Sch Med, Gen Internal Med Sect, Dept Emergency & Gen Internal Med, Toyoake, Aichi 47011, Japan; [Terasawa, Teruhiko] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Ctr Clin Evidence Synth, Boston, MA USA; [Nishida, Hiroshi] Panason Hlth Care Ctr, Dept Hlth Informat & Stat, Osaka, Japan; [Kato, Katsuaki] Miyagi Canc Soc, Canc Detect Ctr, Sendai, Miyagi, Japan; [Miyashiro, Isao] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka, Japan; [Yoshikawa, Takaki] Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa, Japan; [Takaku, Reo] Inst Hlth Econ & Policy, Tokyo, Japan; [Hamashima, Chisato] Natl Canc Ctr, Canc Screening Assessment & Management Div, Res Ctr Canc Prevent & Screening, Tokyo 104, Japan	Fujita Health University; Tufts Medical Center; Miyagi Cancer Center; Osaka Medical Center for Cancer & Cardiovascular Diseases; Kanagawa Prefectural Cancer Center; National Cancer Center - Japan	Terasawa, T (corresponding author), Fujita Hlth Univ, Sch Med, Gen Internal Med Sect, Dept Emergency & Gen Internal Med, Toyoake, Aichi 47011, Japan.	terasawa@fujita-hu.ac.jp	Hamashima, Chisato/AAI-3061-2021	Takaku, Reo/0000-0001-6091-9199	Japanese Ministry of Health, Labour and Welfare	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was supported solely by the Grant-in-Aid for H22-Third Term, Comprehensive Control Research for Cancer 022 from the Japanese Ministry of Health, Labour and Welfare. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamu MA, 2010, EUR J EPIDEMIOL, V25, P439, DOI 10.1007/s10654-010-9482-0; Agency for Healthcare Research and Quality Publication, 2013, METH GUID EFF COMP E; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Bretthauer M, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2864; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Brown LM, 2000, EPIDEMIOL REV, V22, P283, DOI 10.1093/oxfordjournals.epirev.a018040; Correa P, 2012, J DIGEST DIS, V13, P2, DOI 10.1111/j.1751-2980.2011.00550.x; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dinis-Ribeiro M, 2004, J MED SCREEN, V11, P141, DOI 10.1258/0969141041732184; Eslick GD, 1999, AM J GASTROENTEROL, V94, P2373, DOI 10.1111/j.1572-0241.1999.01360.x; Ferlay J, 2013, CANC INCIDENCE MORTA; Foundation for Promotion of Cancer Research, CANC STAT JAP 2013; Hamashima C, 2008, JPN J CLIN ONCOL, V38, P288, DOI 10.1093/jjco/hyn016; Harbord RM, 2007, BIOSTATISTICS, V8, P239, DOI 10.1093/biostatistics/kxl004; Hayden JA, 2013, ANN INTERN MED, V158, P280, DOI 10.7326/0003-4819-158-4-201302190-00009; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang JQ, 1998, GASTROENTEROLOGY, V114, P1169, DOI 10.1016/S0016-5085(98)70422-6; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC Monogr Eval Carcinog Risks Hum, V100, P1; Islami F, 2011, ANN ONCOL, V22, P754, DOI 10.1093/annonc/mdq411; Ito F, 2007, NIHON GAN KENSHIN SH, V14, P156; Kim N, 2008, J CLIN GASTROENTEROL, V42, P448, DOI 10.1097/MCG.0b013e318046eac3; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Meads C, 2012, BREAST CANCER RES TR, V132, P365, DOI 10.1007/s10549-011-1818-2; Miki Kazumasa, 2006, Gastric Cancer, V9, P245, DOI 10.1007/s10120-006-0397-0; Mizuno S, 2010, DIGEST DIS SCI, V55, P3132, DOI 10.1007/s10620-010-1154-0; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Ohata H, 2004, INT J CANCER, V109, P138, DOI 10.1002/ijc.11680; Oishi Y, 2006, AM J EPIDEMIOL, V163, P629, DOI 10.1093/aje/kwj088; Okuno T, 2012, J TSURUMA HLTH SCI S, V36, P15; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Rector TS, 2012, J GEN INTERN MED, V27, pS94, DOI 10.1007/s11606-011-1899-y; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-33; Shikata K, 2006, INT J CANCER, V119, P196, DOI 10.1002/ijc.21822; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Sugishita Y., 2003, NIHON GAN KENSHIN SH, V10, P161; The Steering Committee for the Development of Gastric Cancer Screening Guidelines, 2013, JAP GUID GASTR CANC; Watabe H, 2005, GUT, V54, P764, DOI 10.1136/gut.2004.055400; Watase H, 2004, NIHONGANKENSHIN SHIN, V11, P77; Webb PM, 2001, GUT, V49, P347, DOI 10.1136/gut.49.3.347; Week MN, 2008, INT J CANCER, V123, P874, DOI 10.1002/ijc.23539; Woods BS, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-54; Xue FB, 2001, WORLD J GASTROENTERO, V7, P801, DOI 10.3748/wjg.v7.i6.801; Yoshida T, 2014, INT J CANCER, V134, P1445, DOI 10.1002/ijc.28470; Zhang XH, 2012, INT J CANCER, V130, P1614, DOI 10.1002/ijc.26172	47	66	77	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109783	10.1371/journal.pone.0109783	http://dx.doi.org/10.1371/journal.pone.0109783			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314140	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500078
J	Yang, CF; Yu, LF; Kong, LB; Ma, R; Zhang, JL; Zhu, QS; Zhu, JY; Hao, DJ				Yang, Chongfei; Yu, Lifeng; Kong, Lingbo; Ma, Rui; Zhang, Juliang; Zhu, Qingsheng; Zhu, Jinyu; Hao, Dingjun			Pyrroloquinoline Quinone (PQQ) Inhibits Lipopolysaccharide Induced Inflammation in Part via Downregulated NF-kappa B and p38/JNK Activation in Microglial and Attenuates Microglia Activation in Lipopolysaccharide Treatment Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; UP-REGULATION; EXPRESSION; BRAIN; NEUROPROTECTION; ALZHEIMER; CYTOKINES; TRIGGERS; DISEASES; SYSTEM	Therapeutic strategies designed to inhibit the activation of microglia may lead to significant advancement in the treatment of most neurodegenerative diseases. Pyrroloquinoline quinone (PQQ) is a naturally occurring redox cofactor that acts as an essential nutrient, antioxidant, and has been reported to exert potent immunosuppressive effects. In the present study, the anti-inflammatory effects of PQQ was investigated in LPS treated primary microglia cells. Our observations showed that pretreatment with PQQ significantly inhibited the production of NO and PGE2 and suppressed the expression of pro-inflammatory mediators such as iNOS, COX-2, TNF-a, IL-1b, IL-6, MCP-1 and MIP-1a in LPS treated primary microglia cells. The nuclear translocation of NF-kappa B and the phosphorylation level of p65, p38 and JNK MAP kinase pathways were also inhibited by PQQ in LPS stimulated primary microglia cells. Further a systemic LPS treatment acute inflammation murine brain model was used to study the suppressive effects of PQQ against neuroinflammation in vivo. Mice treated with PQQ demonstrated marked attenuation of neuroinflammation based on Western blotting and immunohistochemistry analysis of Iba1-against antibody in the brain tissue. Indicated that PQQ protected primary cortical neurons against microglia-mediated neurotoxicity. These results collectively suggested that PQQ might be a promising therapeutic agent for alleviating the progress of neurodegenerative diseases associated with microglia activation.	[Yang, Chongfei; Yu, Lifeng; Zhang, Juliang; Zhu, Qingsheng; Zhu, Jinyu] Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed Surg, Xian 710032, Peoples R China; [Kong, Lingbo; Hao, Dingjun] Xi An Jiao Tong Univ, Coll Med, Hong Hui Hosp, Xian 710049, Peoples R China; [Ma, Rui] Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Peoples R China	Air Force Military Medical University; Xi'an Jiaotong University; Air Force Military Medical University	Zhu, JY (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed Surg, Xian 710032, Peoples R China.	jinyuzhu@outlook.com; dhao.honghui@outlook.com	kong, lingbo/O-7491-2017		National Natural Science Foundation of China [81301541]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (Grant No. 81301541). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrova ML, 2005, FREE RADICAL BIO MED, V39, P297, DOI 10.1016/j.freeradbiomed.2005.04.017; Beumer W, 2012, J LEUKOCYTE BIOL, V92, P959, DOI 10.1189/jlb.0212100; Bhat NR, 1998, J NEUROSCI, V18, P1633; BLINZING.K, 1968, Z ZELLFORSCH MIK ANA, V85, P145, DOI 10.1007/BF00325030; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; Cagnin A, 2001, LANCET, V358, P461, DOI 10.1016/S0140-6736(01)05625-2; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Chen ZB, 2010, J CEREBR BLOOD F MET, V30, P1356, DOI 10.1038/jcbfm.2010.19; Chowanadisai W, 2010, J BIOL CHEM, V285, P142, DOI 10.1074/jbc.M109.030130; GALLOP PM, 1993, CONNECT TISSUE RES, V29, P153, DOI 10.3109/03008209309014242; GALLOP PM, 1989, BIOCHEM BIOPH RES CO, V163, P755, DOI 10.1016/0006-291X(89)92287-0; HAGA S, 1989, ACTA NEUROPATHOL, V77, P569, DOI 10.1007/BF00687883; Han LJ, 2013, NEUROCHEM INT, V62, P913, DOI 10.1016/j.neuint.2013.03.003; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; JENSEN FE, 1994, NEUROSCIENCE, V62, P399, DOI 10.1016/0306-4522(94)90375-1; Jha Mithilesh Kumar, 2012, Immune Netw, V12, P41, DOI 10.4110/in.2012.12.2.41; Kanazawa H, 2002, J BIOL CHEM, V277, P20026, DOI 10.1074/jbc.M109218200; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kitayama M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025234; Kong LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061013; Kumazawa T, 2007, INT J MOL MED, V19, P765; Li P, 2009, NEUROSCIENCE, V164, P948, DOI 10.1016/j.neuroscience.2009.08.044; Magrone T, 2012, CURR PHARM DESIGN, V18, P34, DOI 10.2174/138161212798919057; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; Park SM, 2012, BIOL PHARM BULL, V35, P1546, DOI 10.1248/bpb.b12-00393; Pascual O, 2012, P NATL ACAD SCI USA, V109, pE197, DOI 10.1073/pnas.1111098109; Peca J, 2012, CURR OPIN NEUROBIOL, V22, P866, DOI 10.1016/j.conb.2012.02.015; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Possel H, 2000, GLIA, V32, P51, DOI 10.1002/1098-1136(200010)32:1<51::AID-GLIA50>3.0.CO;2-4; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Sheng WW, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-121; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Waetzig V, 2005, GLIA, V50, P235, DOI 10.1002/glia.20173; Zhang YH, 2006, BRAIN RES, V1094, P200, DOI 10.1016/j.brainres.2006.03.111	36	33	39	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109502	10.1371/journal.pone.0109502	http://dx.doi.org/10.1371/journal.pone.0109502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314304	Green Submitted, gold, Green Published			2022-12-27	WOS:000343662500045
J	Charlson, FJ; Diminic, S; Lund, C; Degenhardt, L; Whiteford, HA				Charlson, Fiona J.; Diminic, Sandra; Lund, Crick; Degenhardt, Louisa; Whiteford, Harvey A.			Mental and Substance Use Disorders in Sub-Saharan Africa: Predictions of Epidemiological Changes and Mental Health Workforce Requirements for the Next 40 Years	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; GLOBAL BURDEN; SYSTEMATIC ANALYSIS; SOUTH-AFRICA; DISEASE; SERVICES; CARE; PREVALENCE; RESOURCES; MORTALITY	The world is undergoing a rapid health transition, with an ageing population and disease burden increasingly defined by disability. In Sub-Saharan Africa the next 40 years are predicted to see reduced mortality, signalling a surge in the impact of chronic diseases. We modelled these epidemiological changes and associated mental health workforce requirements. Years lived with a disability (YLD) predictions for mental and substance use disorders for each decade from 2010 to 2050 for four Sub-Saharan African regions were calculated using Global Burden of Disease 2010 study (GBD 2010) data and UN population forecasts. Predicted mental health workforce requirements for 2010 and 2050, by region and for selected countries, were modelled using GBD 2010 prevalence estimates and recommended packages of care and staffing ratios for low-and middle-income countries, and compared to current staffing from the WHO Mental Health Atlas. Significant population growth and ageing will result in an estimated 130% increase in the burden of mental and substance use disorders in Sub-Saharan Africa by 2050, to 45 million YLDs. As a result, the required mental health workforce will increase by 216,600 full time equivalent staff from 2010 to 2050, and far more compared to the existing workforce. The growth in mental and substance use disorders by 2050 is likely to significantly affect health and productivity in Sub-Saharan Africa. To reduce this burden, packages of care for key mental disorders should be provided through increasing the mental health workforce towards targets outlined in this paper. This requires a shift from current practice in most African countries, involving substantial investment in the training of primary care practitioners, supported by district based mental health specialist teams using a task sharing model that mobilises local community resources, with the expansion of inpatient psychiatric units based in district and regional general hospitals.	[Charlson, Fiona J.; Diminic, Sandra; Whiteford, Harvey A.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Charlson, Fiona J.; Diminic, Sandra; Whiteford, Harvey A.] Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia; [Charlson, Fiona J.; Whiteford, Harvey A.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Lund, Crick] Univ Cape Town, Dept Psychiat & Mental Hlth, Alan J Flisher Ctr Publ Mental Hlth, ZA-7925 Cape Town, South Africa; [Degenhardt, Louisa] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Degenhardt, Louisa] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia	University of Queensland; Queensland Centre for Mental Health Research; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Cape Town; University of New South Wales Sydney; University of Melbourne	Charlson, FJ (corresponding author), Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia.	fiona_charlson@qcmhr.uq.edu.au	Diminic, Sandra/O-7572-2016; Diminic, Sandra/ABC-2127-2020; Charlson, Fiona/R-8963-2019; Degenhardt, Louisa J/D-4515-2012; Charlson, Fiona J/F-5290-2011; Whiteford, Harvey A/A-4840-2009	Diminic, Sandra/0000-0001-8742-8816; Diminic, Sandra/0000-0001-8742-8816; Charlson, Fiona/0000-0003-2876-5040; Degenhardt, Louisa J/0000-0002-8513-2218; Charlson, Fiona J/0000-0003-2876-5040; Whiteford, Harvey A/0000-0003-4667-6623; Lund, Crick/0000-0002-5159-8220	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) receives funding from the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, LANCET, V380, P2053; [Anonymous], 2013, GBD COMP; [Anonymous], 2013, GLOB BURD DIS GEN EV; APA, 1994, DIAGN STAT MAN MENT; Bloom D.E., 2012, PGDA WORKING PAPERS, V8712; Bruckner TA, 2011, B WORLD HEALTH ORGAN, V89, P184, DOI 10.2471/BLT.10.082784; Charlson FJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-250; Chisholm D, 2014, DEFAULT DISTRIBUTION; Chisholm D, 2007, BRIT J PSYCHIAT, V191, P528, DOI 10.1192/bjp.bp.107.038463; Cockayne James, 2009, INVISIBLE TIDE INT S; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Dewing S, 2006, DRUG-EDUC PREV POLIC, V13, P121, DOI 10.1080/09687630500480228; Eaton J, 2011, LANCET, V378, P1592, DOI 10.1016/S0140-6736(11)60891-X; Kakuma R, 2011, LANCET, V378, P1654, DOI 10.1016/S0140-6736(11)61093-3; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Lund C, 2009, TROP MED INT HEALTH, V14, P1040, DOI 10.1111/j.1365-3156.2009.02332.x; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Ortblad KF, 2013, AIDS, V27, P2003, DOI 10.1097/QAD.0b013e328362ba67; Patel V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000160; Patel V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000159; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; United Nations, 2011, WORLD POP PROSP 2010; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; WHO, 2012, ICD 10 CLASS MENT BE; WHO, 2001, WORLD HLTH REPORT 20; WHO, 2008, MHGAP MENTAL HLTH GA; Williams DR, 2008, PSYCHOL MED, V38, P211, DOI 10.1017/S0033291707001420; World Health Organization, 2011, MENT HLTH ATL; World Health Organization, 2009, GUID PSYCH ASS PHARM	35	66	66	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110208	10.1371/journal.pone.0110208	http://dx.doi.org/10.1371/journal.pone.0110208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ9WZ	25310010	Green Published, gold			2022-12-27	WOS:000343210300097
J	Evans, TJ; Milne, E; Anderson, D; de Klerk, NH; Jamieson, SE; Talseth-Palmer, BA; Bowden, NA; Holliday, EG; Rudant, J; Orsi, L; Richardson, E; Lavis, L; Catchpoole, D; Attia, JR; Armstrong, BK; Clavel, J; Scott, RJ				Evans, Tiffany-Jane; Milne, Elizabeth; Anderson, Denise; de Klerk, Nicholas H.; Jamieson, Sarra E.; Talseth-Palmer, Bente A.; Bowden, Nikola A.; Holliday, Elizabeth G.; Rudant, Jeremie; Orsi, Laurent; Richardson, Ebony; Lavis, Laura; Catchpoole, Daniel; Attia, John R.; Armstrong, Bruce K.; Clavel, Jacqueline; Scott, Rodney J.			Confirmation of Childhood Acute Lymphoblastic Leukemia Variants, ARID5B and IKZF1, and Interaction with Parental Environmental Exposures	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; RISK; ASSOCIATION; POPULATION; 14Q11.2; 10Q21.2; FOLATE; 7P12.2; GENE	Genome wide association studies (GWAS) have established association of ARID5B and IKZF1 variants with childhood acute lymphoblastic leukemia (ALL). Epidemiological studies suggest that environmental factors alone appear to make a relatively minor contribution to disease risk. The polygenic nature of childhood ALL predisposition together with the timing of environmental triggers may hold vital clues for disease etiology. This study presents results from an Australian GWAS of childhood ALL cases (n = 358) and population controls (n = 1192). Furthermore, we utilised family trio (n = 204) genotypes to extend our investigation to gene-environment interaction of significant loci with parental exposures before conception, and child's sex and age. Thirteen SNPs achieved genome wide significance in the population based case/control analysis; ten annotated to ARID5B and three to IKZF1. The most significant SNPs in these regions were ARID5B rs4245595 (OR 1.63, CI 1.38-1.93, P = 2.13x10(-9)), and IKZF1 rs1110701 (OR 1.69, CI 1.42-2.02, p = 7.26x10(-9)). There was evidence of gene-environment interaction for risk genotype at IKZF1, whereby an apparently stronger genetic effect was observed if the mother took folic acid or if the father did not smoke prior to pregnancy (respective interaction P-values: 0.04, 0.05). There were no interactions of risk genotypes with age or sex (P-values >0.2). Our results evidence that interaction of genetic variants and environmental exposures may further alter risk of childhood ALL however, investigation in a larger population is required. If interaction of folic acid supplementation and IKZF1 variants holds, it may be useful to quantify folate levels prior to initiating use of folic acid supplements.	[Evans, Tiffany-Jane; Talseth-Palmer, Bente A.; Bowden, Nikola A.; Holliday, Elizabeth G.; Attia, John R.; Scott, Rodney J.] Hunter Med Res Inst, Ctr Bioinformat Biomarker Discovery & Informat Ba, Newcastle, NSW, Australia; [Evans, Tiffany-Jane; Talseth-Palmer, Bente A.; Bowden, Nikola A.; Richardson, Ebony; Lavis, Laura; Scott, Rodney J.] Univ Newcastle, Sch Biomed Sci & Pharm, Newcastle, NSW 2300, Australia; [Milne, Elizabeth; Anderson, Denise; de Klerk, Nicholas H.; Jamieson, Sarra E.] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia; [Holliday, Elizabeth G.; Attia, John R.] Univ Newcastle, Sch Med & Publ Hlth, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2300, Australia; [Rudant, Jeremie; Orsi, Laurent; Clavel, Jacqueline] INSERM, U1018, Dept Environm Epidemiol Canc, Villejuif, France; [Rudant, Jeremie; Orsi, Laurent; Clavel, Jacqueline] Univ Paris 11, UMR S1018, Dept Environm Epidemiol Canc, Res Ctr Epidemiol & Populat Hlth, Villejuif, France; [Orsi, Laurent; Clavel, Jacqueline] French Natl Registry Childhood Blood Malignancies, Villejuif, France; [Catchpoole, Daniel] Childrens Hosp Westmead, Childrens Canc Res Unit, Tumour Bank, Westmead, NSW, Australia; [Attia, John R.] John Hunter Hosp, Dept Med, New Lambton, NSW, Australia; [Attia, John R.] Hunter Med Res Inst, New Lambton, NSW, Australia; [Armstrong, Bruce K.] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Armstrong, Bruce K.] Sax Inst, Sydney, NSW, Australia; [Scott, Rodney J.] Hunter Area Pathol Serv, Newcastle, NSW, Australia	Hunter Medical Research Institute; University of Newcastle; University of Newcastle; Telethon Kids Institute; University of Western Australia; University of Newcastle; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of Sydney; John Hunter Hospital; Hunter Medical Research Institute; University of Newcastle; University of Sydney; University of Sydney	Scott, RJ (corresponding author), Hunter Med Res Inst, Ctr Bioinformat Biomarker Discovery & Informat Ba, Newcastle, NSW, Australia.	rodney.scott@newcastle.edu.au	Talseth-Palmer, Bente/AAT-8751-2021; Talseth-Palmer, Bente A/D-7106-2012; Orsi, Laurent/H-7863-2018; Armstrong, Bruce K/K-9464-2015; de Klerk, Nicholas H/D-8388-2016; Attia, John R/F-5376-2013; Bowden, Nikola A/E-6527-2013; Milne, Elizabeth/E-5349-2012; Clavel, Jacqueline/Q-2750-2016; Scott, Rodney/B-2827-2013	Talseth-Palmer, Bente/0000-0003-0286-7161; Orsi, Laurent/0000-0002-9332-3620; Armstrong, Bruce K/0000-0001-8940-7525; de Klerk, Nicholas H/0000-0001-9223-0767; Attia, John R/0000-0001-9800-1308; Bowden, Nikola A/0000-0002-6047-1694; Milne, Elizabeth/0000-0002-9319-9148; Clavel, Jacqueline/0000-0002-3616-7676; Scott, Rodney/0000-0001-7724-3404; Richardson, Ebony/0000-0003-4260-7356; Anderson, Denise/0000-0003-0643-4136	National Health and Medical Research Council of Australia [APP254534]; Hunter Medical Research Institute - the Lawrie Bequest Paediatric Oncology Grant; Hunter Children's Research Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Hunter Medical Research Institute - the Lawrie Bequest Paediatric Oncology Grant; Hunter Children's Research Foundation	The collection of samples and data from the patients with childhood ALL was funded by the National Health and Medical Research Council of Australia (https://www.rgms.nhmrc.gov.au) Grant number APP254534. Genotyping was funded by the Hunter Medical Research Institute - the Lawrie Bequest Paediatric Oncology Grant, and the Hunter Children's Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belson M, 2007, ENVIRON HEALTH PERSP, V115, P138, DOI 10.1289/ehp.9023; Chokkalingam AP, 2013, CANCER CAUSE CONTROL, V24, P1789, DOI 10.1007/s10552-013-0256-3; Clayton DG, GENASSOC STATA MODUL; Cordell HJ, 2004, GENET EPIDEMIOL, V26, P167, DOI 10.1002/gepi.10307; Healy J, 2010, HAEMATOL-HEMATOL J, V95, P1608, DOI 10.3324/haematol.2010.022459; Imai K, 2000, LANCET, V356, P1795, DOI 10.1016/S0140-6736(00)03231-1; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lahoud MH, 2001, GENOME RES, V11, P1327, DOI 10.1101/gr.168801; Linabery AM, 2013, LEUKEMIA RES, V37, P936, DOI 10.1016/j.leukres.2013.04.022; Liu MJ, 2004, BIOCHEM J, V383, P249, DOI 10.1042/BJ20040414; McEvoy M, 2010, INT J EPIDEMIOL, V39, P1452, DOI 10.1093/ije/dyp343; Meyer C, 2013, AM J BLOOD RES, V3, P165; Migliorini G, 2013, BLOOD, V122, P3298, DOI 10.1182/blood-2013-03-491316; Milne E, 2013, CANCER CAUSE CONTROL, V24, P391, DOI 10.1007/s10552-012-0125-5; Milne E, 2012, AM J EPIDEMIOL, V175, P43, DOI 10.1093/aje/kwr275; Milne E, 2010, INT J CANCER, V126, P2690, DOI 10.1002/ijc.24969; Orsi L, 2012, LEUKEMIA, V26, P2561, DOI 10.1038/leu.2012.148; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Prasad RB, 2010, BLOOD, V115, P1765, DOI 10.1182/blood-2009-09-241513; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Sherborne AL, 2010, NAT GENET, V42, P492, DOI 10.1038/ng.585; Trevino LR, 2009, NAT GENET, V41, P1001, DOI 10.1038/ng.432; Troen AM, 2006, J NUTR, V136, P189, DOI 10.1093/jn/136.1.189; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Xu H, 2013, JNCI-J NATL CANCER I, V105, P733, DOI 10.1093/jnci/djt042	28	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110255	10.1371/journal.pone.0110255	http://dx.doi.org/10.1371/journal.pone.0110255			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310577	Green Published, gold			2022-12-27	WOS:000343210300102
J	Maldonado, E; Sunagar, K; Almeida, D; Vasconcelos, V; Antunes, A				Maldonado, Emanuel; Sunagar, Kartik; Almeida, Daniela; Vasconcelos, Vitor; Antunes, Agostinho			IMPACT_S: Integrated Multiprogram Platform to Analyze and Combine Tests of Selection	PLOS ONE			English	Article							AMINO-ACID SITES; DETECTING POSITIVE SELECTION; PHYLOGENETIC ANALYSIS; ADAPTIVE EVOLUTION; SWISS-MODEL; VENOM; DATAMONKEY; PRESSURE	Among the major goals of research in evolutionary biology are the identification of genes targeted by natural selection and understanding how various regimes of evolution affect the fitness of an organism. In particular, adaptive evolution enables organisms to adapt to changing ecological factors such as diet, temperature, habitat, predatory pressures and prey abundance. An integrative approach is crucial for the identification of non-synonymous mutations that introduce radical changes in protein biochemistry and thus in turn influence the structure and function of proteins. Performing such analyses manually is often a time-consuming process, due to the large number of statistical files generated from multiple approaches, especially when assessing numerous taxa and/or large datasets. We present IMPACT_S, an easy-to-use Graphical User Interface (GUI) software, which rapidly and effectively integrates, filters and combines results from three widely used programs for assessing the influence of selection: Codeml (PAML package), Datamonkey and TreeSAAP. It enables the identification and tabulation of sites detected by these programs as evolving under the influence of positive, neutral and/or negative selection in protein-coding genes. IMPACT_S further facilitates the automatic mapping of these sites onto the three-dimensional structures of proteins. Other useful tools incorporated in IMPACT_S include Jmol, Archaeopteryx, Gnuplot, PhyML, a built-in Swiss-Model interface and a PDB downloader. The relevance and functionality of IMPACT_S is shown through a case study on the toxicoferan-reptilian Cysteine-rich Secretory Proteins (CRiSPs). IMPACT_S is a platform-independent software released under GPLv3 license, freely available online from http://impact-s.sourceforge.net.	[Maldonado, Emanuel; Sunagar, Kartik; Almeida, Daniela; Vasconcelos, Vitor; Antunes, Agostinho] Univ Porto, CIIMAR CIMAR, Interdisciplinary Ctr Marine & Environm Res, P-4100 Oporto, Portugal; [Sunagar, Kartik; Almeida, Daniela; Vasconcelos, Vitor; Antunes, Agostinho] Univ Porto, Fac Sci, Dept Biol, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Antunes, A (corresponding author), Univ Porto, CIIMAR CIMAR, Interdisciplinary Ctr Marine & Environm Res, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	aantunes@ciimar.up.pt	Almeida, Daniela/D-1956-2019; Sunagar, Kartik/F-9241-2013; Maldonado, Emanuel/X-1620-2019; Vasconcelos, Vitor/A-8933-2008	Almeida, Daniela/0000-0002-9874-933X; Maldonado, Emanuel/0000-0002-0084-6116; Vasconcelos, Vitor/0000-0003-3585-2417; Sunagar, Kartik/0000-0003-0998-1581; Antunes, Agostinho/0000-0002-1328-1732	European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Program; national funds through FCT [PEst-C/MAR/LA0015/2013]; FCT projects [PTDC/AAC-AMB/104983/2008 (FCOMP-01-0124-FEDER-008610), PTDC/AAC-CLI/116122/2009 (FCOMP-01-0124-FEDER-014029) PTDC/AAC-AMB/121301/2010 (FCOMP-01-0124-FEDER-019490)]; University of Porto; Santander Totta project [PP-IJUP2011-315]	European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Program; national funds through FCT(Portuguese Foundation for Science and Technology); FCT projects(Portuguese Foundation for Science and Technology); University of Porto; Santander Totta project	This research was supported in part by the European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Program and national funds through FCT under the project PEst-C/MAR/LA0015/2013, by the FCT projects PTDC/AAC-AMB/104983/2008 (FCOMP-01-0124-FEDER-008610), PTDC/AAC-CLI/116122/2009 (FCOMP-01-0124-FEDER-014029) and PTDC/AAC-AMB/121301/2010 (FCOMP-01-0124-FEDER-019490), and by the University of Porto and Santander Totta project PP-IJUP2011-315 to AA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antunes A, 2007, EVOL BIOINFORM, V3, P207; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Brust A, 2013, MOL CELL PROTEOMICS, V12, P1488, DOI [10.1074/mcp.A112.023135, 10.1074/mcp.M112.023135]; da Fonseca RR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-119; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Ghosh S, 2011, NAT REV GENET, V12, P821, DOI 10.1038/nrg3096; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Herraez A, 2006, BIOCHEM MOL BIOL EDU, V34, P255, DOI 10.1002/bmb.2006.494034042644; Kini RM, 1999, J MOL EVOL, V48, P125, DOI 10.1007/PL00006450; Kozminsky-Atias A, 2012, FASEB J, V26, P576, DOI 10.1096/fj.11-187179; Low DHW, 2013, J PROTEOMICS, V89, P95, DOI 10.1016/j.jprot.2013.05.034; Maldonado E, 2011, J HERED, V102, P366, DOI 10.1093/jhered/esr003; McClellan DA, 2005, MOL BIOL EVOL, V22, P437, DOI 10.1093/molbev/msi028; McClellan DA, 2001, MOL BIOL EVOL, V18, P917, DOI 10.1093/oxfordjournals.molbev.a003892; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nabholz B, 2013, MOL BIOL EVOL, V30, P272, DOI 10.1093/molbev/mss238; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; Rose PW, 2011, NCI NAT PATH INTERAC, DOI [10.1038/pid.2011.1, DOI 10.1038/PID.2011.1]; Ruder T, 2013, J MOL EVOL, V76, P192, DOI 10.1007/s00239-013-9552-5; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sunagar K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081827; Sunagar K, 2013, TOXINS, V5, P2172, DOI 10.3390/toxins5112172; Sunagar K, 2012, MOL BIOL EVOL, V29, P1807, DOI 10.1093/molbev/mss058; Tian CH, 2008, TOXICON, V51, P555, DOI 10.1016/j.toxicon.2007.11.010; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Woolley S, 2003, BIOINFORMATICS, V19, P671, DOI 10.1093/bioinformatics/btg043; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhu SY, 2004, J MOL EVOL, V58, P145, DOI 10.1007/s00239-003-2534-2; Zmasek CM, 2001, BIOINFORMATICS, V17, P383, DOI 10.1093/bioinformatics/17.4.383	41	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e96243	10.1371/journal.pone.0096243	http://dx.doi.org/10.1371/journal.pone.0096243			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329307	gold, Green Published, Green Submitted			2022-12-27	WOS:000343942100001
J	Dong, KZ; Yao, N; Pu, YB; He, XH; Zhao, QJ; Luan, YZ; Guan, WJ; Rao, SQ; Ma, YH				Dong, Kunzhe; Yao, Na; Pu, Yabin; He, Xiaohong; Zhao, Qianjun; Luan, Yizhao; Guan, Weijun; Rao, Shaoqi; Ma, Yuehui			Genomic Scan Reveals Loci under Altitude Adaptation in Tibetan and Dahe Pigs	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OXIDATIVE STRESS; DNA-REPAIR; OCHOTONA-CURZONIAE; HYPOXIA; ROLES; HEMATOPOIESIS; ASSOCIATION; EXPRESSION; SELECTION	High altitude environments are of particular interest in the studies of local adaptation as well as their implications in physiology and clinical medicine in human. Some Chinese pig breeds, such as Tibetan pig (TBP) that is well adapted to the high altitude and Dahe pig (DHP) that dwells at the moderate altitude, provide ideal materials to study local adaptation to altitudes. Yet, it is still short of in-depth analysis and understanding of the genetic adaptation to high altitude in the two pig populations. In this study we conducted a genomic scan for selective sweeps using F-ST to identify genes showing evidence of local adaptations in TBP and DHP, with Wuzhishan pig (WZSP) as the low-altitude reference. Totally, we identified 12 specific selective genes (CCBE1, F2RL1, AGGF1, ZFPM2, IL2, FGF5, PLA2G4A, ADAMTS9, NRBF2, JMJD1C, VEGFC and ADAM19) for TBP and six (OGG1, FOXM, FLT3, RTEL1, CRELD1 and RHOG) for DHP. In addition, six selective genes (VPS13A, GNA14, GDAP1, PARP8, FGF10 and ADAMTS16) were shared by the two pig breeds. Among these selective genes, three (VEGFC, FGF10 and ADAMTS9) were previously reported to be linked to the local adaptation to high altitudes in pigs, while many others were newly identified by this study. Further bioinformatics analysis demonstrated that majority of these selective signatures have some biological functions relevant to the altitude adaptation, for examples, response to hypoxia, development of blood vessels, DNA repair and several hematological involvements. These results suggest that the local adaptation to high altitude environments is sophisticated, involving numerous genes and multiple biological processes, and the shared selective signatures by the two pig breeds may provide an effective avenue to identify the common adaptive mechanisms to different altitudes.	[Dong, Kunzhe; Yao, Na; Pu, Yabin; He, Xiaohong; Zhao, Qianjun; Guan, Weijun; Ma, Yuehui] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China; [Luan, Yizhao; Rao, Shaoqi] Guangdong Med Coll, Inst Med Syst Biol, Dongguan, Peoples R China; [Luan, Yizhao; Rao, Shaoqi] Guangdong Med Coll, Dept Med Stat & Epidemiol, Dongguan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Guangdong Medical University; Guangdong Medical University	Rao, SQ (corresponding author), Guangdong Med Coll, Inst Med Syst Biol, Dongguan, Peoples R China.	raoshaoq@gdmc.edu.cn; mayuehui@caas.cn	yao, na/HDL-8772-2022; ma, yue/GXE-9897-2022	Dong, Kunzhe/0000-0003-0039-9835; Rao, Shaoqi/0000-0001-7809-3700	National Natural Science Foundation of China [31272403, 81373085]; Agricultural Science and Technology Innovation Program of China [ASTIP-IAS01]; Livestock and Poultry Sharing Platform in China, Determination of Molecular Characterization for Genetically Modified Organisms [2013ZX08012-002]; Science and Technology Planning Project of Guangdong Province [2009A030301004]; Dongguan City Science and Technology Project [2011108101015]; Guangdong Medical College [XG1001, XZ1105, STIF201122, JB1214]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Science and Technology Innovation Program of China; Livestock and Poultry Sharing Platform in China, Determination of Molecular Characterization for Genetically Modified Organisms; Science and Technology Planning Project of Guangdong Province; Dongguan City Science and Technology Project; Guangdong Medical College	This work was supported in part by the National Natural Science Foundation of China (grant nos. 31272403 and 81373085), the Agricultural Science and Technology Innovation Program of China (grant no. ASTIP-IAS01), the Livestock and Poultry Sharing Platform in China, Determination of Molecular Characterization for Genetically Modified Organisms (2013ZX08012-002), Science and Technology Planning Project of Guangdong Province (grant no. 2009A030301004), Dongguan City Science and Technology Project (grant no. 2011108101015) and the grants from Guangdong Medical College (grant nos. XG1001, XZ1105, STIF201122, JB1214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056001, 10.1371/journal.pone.0069836, 10.1371/journal.pone.0063641]; Alexandre BM, 2012, J PROTEOMICS, V76, P259, DOI 10.1016/j.jprot.2012.04.008; Askew EW, 2002, TOXICOLOGY, V180, P107, DOI 10.1016/S0300-483X(02)00385-2; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Bos FL, 2011, CIRC RES, V109, P486, DOI 10.1161/CIRCRESAHA.111.250738; Chevillard S, 1998, ONCOGENE, V16, P3083, DOI 10.1038/sj.onc.1202096; Ge RL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2860; Ge RL, 1998, AM J PHYSIOL-HEART C, V274, pH1792, DOI 10.1152/ajpheart.1998.274.5.H1792; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Giordano FJ, 1996, NAT MED, V2, P534, DOI 10.1038/nm0596-534; Gopalakrishnan K, 2012, P NATL ACAD SCI USA, V109, P20555, DOI 10.1073/pnas.1211290109; Huber N, 2013, EMBO REP, V14, P545, DOI 10.1038/embor.2013.56; Ichinose F, 2002, J CLIN INVEST, V109, P1493, DOI 10.1172/JCI200214294; Javle M, 2011, BRIT J CANCER, V105, P1114, DOI 10.1038/bjc.2011.382; Ji LD, 2012, MOL BIOL EVOL, V29, P3359, DOI 10.1093/molbev/mss144; Joukov V, 1996, EMBO J, V15, P290; Kern CB, 2010, MATRIX BIOL, V29, P304, DOI 10.1016/j.matbio.2010.01.005; Kurohara K, 2004, DEV BIOL, V267, P14, DOI 10.1016/j.ydbio.2003.10.021; Letourneau S, 2009, J ALLERGY CLIN IMMUN, V123, P758, DOI 10.1016/j.jaci.2009.02.011; Li MZ, 2013, NAT GENET, V45, P1431, DOI 10.1038/ng.2811; Lu QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046998; Luo YJ, 2008, MITOCHONDRION, V8, P352, DOI 10.1016/j.mito.2008.07.005; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mortola JP, 2000, J PEDIATR-US, V136, P324, DOI 10.1067/mpd.2000.103507; Mulloy JC, 2010, BLOOD, V115, P936, DOI 10.1182/blood-2009-09-198127; Nakanishi I, 1995, J PHYSIOL-LONDON, V489, P869, DOI 10.1113/jphysiol.1995.sp021099; Oshima H, 2013, ONCOGENE; Pagani L, 2012, HUM GENET, V131, P423, DOI 10.1007/s00439-011-1084-8; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiu Q, 2012, NAT GENET, V44, P946, DOI 10.1038/ng.2343; RADAK Z, 1994, EUR J APPL PHYSIOL, V69, P392, DOI 10.1007/BF00865401; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ren J, 2011, HEREDITY, V106, P862, DOI 10.1038/hdy.2010.129; Robinson SW, 2003, AM J HUM GENET, V72, P1047, DOI 10.1086/374319; Sakai A, 2003, JPN J PHYSIOL, V53, P377, DOI 10.2170/jjphysiol.53.377; Sallmyr A, 2008, BLOOD, V111, P3173, DOI 10.1182/blood-2007-05-092510; Sarada SKS, 2002, J ETHNOPHARMACOL, V79, P149, DOI 10.1016/S0378-8741(01)00360-9; Shetty PB, 2012, J HYPERTENS, V30, P1970, DOI 10.1097/HJH.0b013e3283578c80; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Sun J, 2013, GENE, V529, P131, DOI 10.1016/j.gene.2013.06.075; Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06; Tan ZP, 2012, CLIN GENET, V82, P466, DOI 10.1111/j.1399-0004.2011.01787.x; Wagh K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044751; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wright S, 1978, VARIABILITY NATURAL, V4; Xing GQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002342; Yang SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028215; Yang SB, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-7; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; ZHANG Z, 1986, PIG BREEDS CHINA; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606; Zhou HM, 2004, MOL CELL BIOL, V24, P96, DOI 10.1128/MCB.24.1.96-104.2004	57	29	30	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110520	10.1371/journal.pone.0110520	http://dx.doi.org/10.1371/journal.pone.0110520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329542	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204100088
J	Moon, TD; Ossemane, EB; Green, AF; Ndatimana, E; Jose, E; Buehler, CP; Wester, CW; Vermund, SH; Olupona, O				Moon, Troy D.; Ossemane, Ezequiel B.; Green, Ann F.; Ndatimana, Elisee; Jose, Eurico; Buehler, Charlotte P.; Wester, C. William; Vermund, Sten H.; Olupona, Omo			Antiretroviral Therapy Program Expansion in Zambezia Province, Mozambique: Geospatial Mapping of Community-Based and Health Facility Data for Integrated Health Planning	PLOS ONE			English	Article							HIV TREATMENT WORK; SCALE-UP; RURAL MOZAMBIQUE; AFRICA; INITIATION; PEPFAR; CARE	Objective: To generate maps reflecting the intersection of community-based Voluntary Counseling and Testing (VCT) delivery points with facility-based HIV program demographic information collected at the district level in three districts (Ile, Maganja da Costa and Chinde) of Zambe ' zia Province, Mozambique; in order to guide planning decisions about antiretroviral therapy (ART) program expansion. Methods: Program information was harvested from two separate open source databases maintained for community-based VCT and facility-based HIV care and treatment monitoring from October 2011 to September 2012. Maps were created using ArcGIS 10.1. Travel distance by foot within a 10 km radius is generally considered a tolerable distance in Mozambique for purposes of adherence and retention planning. Results: Community-based VCT activities in each of three districts were clustered within geographic proximity to clinics providing ART, within communities with easier transportation access, and/or near the homes of VCT volunteers. Community HIV testing results yielded HIV seropositivity rates in some regions that were incongruent with the Ministry of Health's estimates for the entire district (2-13% vs. 2% in Ile, 2-54% vs. 11.5% in Maganja da Costa, and 23-43% vs. 14.4% in Chinde). All 3 districts revealed gaps in regional disbursement of community-based VCT activities as well as access to clinics offering ART. Conclusions: Use of geospatial mapping in the context of program planning and monitoring allowed for characterizing the location and size of each district's HIV population. In extremely resource limited and logistically challenging settings, maps are valuable tools for informing evidence-based decisions in planning program expansion, including ART.	[Moon, Troy D.; Green, Ann F.; Buehler, Charlotte P.; Wester, C. William; Vermund, Sten H.] Vanderbilt Inst Global Hlth, Nashville, TN 37203 USA; [Moon, Troy D.; Ossemane, Ezequiel B.; Green, Ann F.; Ndatimana, Elisee; Jose, Eurico; Wester, C. William; Vermund, Sten H.] Friends Global Hlth LLC, Maputo, Mozambique; [Olupona, Omo] World Vis, Maputo, Mozambique	Vanderbilt University	Moon, TD (corresponding author), Vanderbilt Inst Global Hlth, Nashville, TN 37203 USA.	troy.moon@vanderbilt.edu	Vermund, Sten/AAD-3592-2020	Vermund, Sten/0000-0001-7289-8698; Moon, Troy/0000-0002-1637-829X; Green, Ann/0000-0002-9248-2216	United States Agency for International Development, Strengthening Communities [656A000900014100]; Centers for Disease Control and Prevention [U2GPS000631, 1U2GGH000812]; National Institutes of Health, AIDS International Training and Research Program [D43TW001035]	United States Agency for International Development, Strengthening Communities(United States Agency for International Development (USAID)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health, AIDS International Training and Research Program	This research has been supported by the United States Agency for International Development, Strengthening Communities through Integrated Programs under the terms of Cooperative Agreement #656A000900014100 to World Vision and by the President's Emergency Plan for AIDS Relief, through the Centers for Disease Control and Prevention under the terms of Cooperative Agreements U2GPS000631 and 1U2GGH000812 to Vanderbilt University. Research training was supported by the National Institutes of Health, AIDS International Training and Research Program grant D43TW001035. The findings and conclusions in this report are those of the authors and do not necessarily represent the official positions of USAID, CDC or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, MOC INQ DEM SAUD 201; [Anonymous], 2009, NCMS SUMM ENGL; [Anonymous], 2008, MICS SUMM ENGL; Audet CM, 2012, SAHARA J-J SOC ASP H, V9, P41, DOI 10.1080/17290376.2012.665257; Audet CM, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-15; Boyer S, 2011, CURR OPIN HIV AIDS, V6, P239, DOI 10.1097/COH.0b013e3283478757; Ciampa PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048676; Ciampa PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039391; Ciampa PJ, 2012, JAIDS-J ACQ IMM DEF, V60, pE46, DOI 10.1097/QAI.0b013e31824c0267; Cook RE, 2011, JAIDS-J ACQ IMM DEF, V56, pE104, DOI 10.1097/QAI.0b013e318207a535; De Cock KM, 2011, JAIDS-J ACQ IMM DEF, V57, pS61, DOI 10.1097/QAI.0b013e3182217f00; El-Sadr WM, 2012, JAIDS-J ACQ IMM DEF, V60, pS96, DOI 10.1097/QAI.0b013e31825eb27b; Focus Countries, PRES EM PLAN AIDS RE; Groh K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-650; Harries AD, 2011, JAIDS-J ACQ IMM DEF, V57, pS64, DOI 10.1097/QAI.0b013e31821f6bab; HIV/SIDA, MIN SAUD MOC; INSIDA, 2009, INQ NAC PREV RISC CO; Lahuerta M, 2013, J HEALTH CARE POOR U, V24, P359, DOI 10.1353/hpu.2013.0014; Larson E, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-173; Manders EJ, 2010, STUD HEALTH TECHNOL, V160, P411, DOI 10.3233/978-1-60750-588-4-411; Moon TD, 2011, INT J STD AIDS, V22, P621, DOI 10.1258/ijsa.2011.010442; Moon Troy D, 2010, Retrovirology (Auckl), V3, P1; Vermund SH, 2012, AIDS, V26, P1303, DOI 10.1097/QAD.0b013e3283552185; Young PW, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-96	24	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109653	10.1371/journal.pone.0109653	http://dx.doi.org/10.1371/journal.pone.0109653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329169	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204100018
J	van der Meijden, K; Lips, P; van Driel, M; Heijboer, AC; Schulten, EAJM; den Heijer, M; Bravenboer, N				van der Meijden, Karen; Lips, Paul; van Driel, Marjolein; Heijboer, Annemieke C.; Schulten, Engelbert A. J. M.; den Heijer, Martin; Bravenboer, Nathalie			Primary Human Osteoblasts in Response to 25-Hydroxyvitamin D-3, 1,25-Dihydroxyvitamin D-3 and 24R, 25-Dihydroxyvitamin D-3	PLOS ONE			English	Article							HUMAN-BONE-CELLS; VITAMIN-D; 24R,25-DIHYDROXYVITAMIN D-3; IN-VITRO; DIFFERENTIATION; METABOLISM; CYP27B1; OSTEOCALCIN; EXPRESSION; CULTURE	The most biologically active metabolite 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3) has well known direct effects on osteoblast growth and differentiation in vitro. The precursor 25-hydroxyvitamin D-3 (25(OH) D-3) can affect osteoblast function via conversion to 1,25(OH)(2)D-3, however, it is largely unknown whether 25(OH) D-3 can affect primary osteoblast function on its own. Furthermore, 25(OH) D-3 is not only converted to 1,25(OH)(2)D-3, but also to 24R, 25-dihydroxyvitamin D-3 (24R, 25(OH)(2)D-3) which may have bioactivity as well. Therefore we used a primary human osteoblast model to examine whether 25(OH) D-3 itself can affect osteoblast function using CYP27B1 silencing and to investigate whether 24R, 25(OH)(2)D-3 can affect osteoblast function. We showed that primary human osteoblasts responded to both 25(OH) D-3 and 1,25(OH)(2)D-3 by reducing their proliferation and enhancing their differentiation by the increase of alkaline phosphatase, osteocalcin and osteopontin expression. Osteoblasts expressed CYP27B1 and CYP24 and synthesized 1,25(OH)(2)D-3 and 24R, 25(OH)(2)D-3 dose-dependently. Silencing of CYP27B1 resulted in a decline of 1,25(OH)(2)D-3 synthesis, but we observed no significant differences in mRNA levels of differentiation markers in CYP27B1-silenced cells compared to control cells after treatment with 25(OH) D-3. We demonstrated that 24R, 25(OH)(2)D-3 increased mRNA levels of alkaline phosphatase, osteocalcin and osteopontin. In addition, 24R, 25(OH)(2)D-3 strongly increased CYP24 mRNA. In conclusion, the vitamin D metabolites 25(OH) D-3, 1,25(OH)(2)D-3 and 24R, 25(OH)(2)D-3 can affect osteoblast differentiation directly or indirectly. We showed that primary human osteoblasts not only respond to 1,25(OH)(2)D-3, but also to 24R, 25(OH)(2)D-3 by enhancing osteoblast differentiation. This suggests that 25(OH) D-3 can affect osteoblast differentiation via conversion to the active metabolite 1,25(OH)(2)D-3, but also via conversion to 24R, 25(OH)(2)D-3. Whether 25(OH) D-3 has direct actions on osteoblast function needs further investigation.	[van der Meijden, Karen; Lips, Paul; den Heijer, Martin] Vrije Univ Amsterdam, Med Ctr, Dept Internal Med Endocrinol, Res Inst MOVE, Amsterdam, Netherlands; [van Driel, Marjolein] Erasmus MC, Dept Internal Med Endocrinol, Rotterdam, Netherlands; [Heijboer, Annemieke C.; Bravenboer, Nathalie] Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, Res Inst MOVE, Amsterdam, Netherlands; [Schulten, Engelbert A. J. M.] Vrije Univ Amsterdam, Med Ctr, Dept Oral & Maxillofacial Surg Oral Pathol, Acad Ctr Dent Amsterdam, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam	Bravenboer, N (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, Res Inst MOVE, Amsterdam, Netherlands.	n.bravenboer@vumc.nl	den Heijer, Martin/J-8036-2015; van Driel, Marjolein/K-6745-2019	den Heijer, Martin/0000-0003-3620-5617; Schulten, Engelbert A.J.M./0000-0001-8245-6367; Heijboer, Annemieke/0000-0002-6712-9955				Anderson PH, 2007, J STEROID BIOCHEM, V103, P601, DOI 10.1016/j.jsbmb.2006.12.084; Anderson PH, 2008, MOL ASPECTS MED, V29, P397, DOI 10.1016/j.mam.2008.05.003; Atkins GJ, 2007, BONE, V40, P1517, DOI 10.1016/j.bone.2007.02.024; BERESFORD JN, 1986, ENDOCRINOLOGY, V119, P1776, DOI 10.1210/endo-119-4-1776; Beresford JN, 1983, CLIN SCI, V64, P33; BOUILLON R, 1995, ENDOCR REV, V16, P200, DOI 10.1210/er.16.2.200; Chen FP, 2002, FERTIL STERIL, V77, P1038, DOI 10.1016/S0015-0282(02)03065-0; Curtis KM, 2014, MOL ENDOCRINOL, V28, P644, DOI 10.1210/me.2013-1241; Geng S, 2011, J BONE MINER RES, V26, P1145, DOI 10.1002/jbmr.298; HOWARD GA, 1981, J BIOL CHEM, V256, P7738; Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016/j.pbiomolbio.2006.02.016; Lips P, 2011, BEST PRACT RES CL EN, V25, P585, DOI 10.1016/j.beem.2011.05.002; Lou YR, 2010, J STEROID BIOCHEM, V118, P162, DOI 10.1016/j.jsbmb.2009.11.011; MARIE PJ, 1989, IN VITRO CELL DEV B, V25, P373; Morris HA, 2014, ANN LAB MED, V34, P181, DOI 10.3343/alm.2014.34.3.181; Peterlik M, 2005, EUR J CLIN INVEST, V35, P290, DOI 10.1111/j.1365-2362.2005.01487.x; Rowling MJ, 2007, J NUTR, V137, P2608, DOI 10.1093/jn/137.12.2608; Seo EG, 1997, ENDOCRINOLOGY, V138, P3864, DOI 10.1210/en.138.9.3864; Slominski AT, 2014, J STEROID BIOCHEM, V144, P28, DOI 10.1016/j.jsbmb.2013.10.012; Slominski AT, 2014, FASEB J, V28, P2775, DOI 10.1096/fj.13-242040; Slominski AT, 2014, MOL CELL ENDOCRINOL, V383, P181, DOI 10.1016/j.mce.2013.12.012; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; St-Arnaud R., 2011, VITAMIN D, P43; St-Arnaud R, 2010, J STEROID BIOCHEM, V121, P254, DOI 10.1016/j.jsbmb.2010.02.002; van Driel M, 2006, FASEB J, V20, P2417, DOI 10.1096/fj.06-6374fje; van Driel M, 2006, J CELL BIOCHEM, V99, P922, DOI 10.1002/jcb.20875; van Driel M, 2004, CURR PHARM DESIGN, V10, P2535; Yamamoto T, 1998, EXP CELL RES, V244, P71, DOI 10.1006/excr.1998.4189; Zerwekh JE, 2008, AM J CLIN NUTR, V87, p1087S, DOI 10.1093/ajcn/87.4.1087S	29	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110283	10.1371/journal.pone.0110283	http://dx.doi.org/10.1371/journal.pone.0110283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329305	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100055
J	Cazet, A; Charest, J; Bennett, DC; Sambrooks, CL; Contessa, JN				Cazet, Aurelie; Charest, Jonathan; Bennett, Daniel C.; Sambrooks, Cecilia Lopez; Contessa, Joseph N.			Mannose Phosphate Isomerase Regulates Fibroblast Growth Factor Receptor Family Signaling and Glioma Radiosensitivity	PLOS ONE			English	Article							HAMSTER OVARY CELLS; HUMAN GLIOBLASTOMA; TYROSINE KINASES; N-GLYCOSYLATION; CANCER-THERAPY; BREAST-CANCER; IN-VITRO; ACTIVATION; SULFATE; INHIBITION	Asparagine-linked glycosylation is an endoplasmic reticulum co- and post-translational modification that enables the transit and function of receptor tyrosine kinase (RTK) glycoproteins. To gain insight into the regulatory role of glycosylation enzymes on RTK function, we investigated shRNA and siRNA knockdown of mannose phosphate isomerase (MPI), an enzyme required for mature glycan precursor biosynthesis. Loss of MPI activity reduced phosphorylation of FGFR family receptors in U-251 and SKMG-3 malignant glioma cell lines and also resulted in significant decreases in FRS2, Akt, and MAPK signaling. However, MPI knockdown did not affect ligand-induced activation or signaling of EGFR or MET RTKs, suggesting that FGFRs are more susceptible to MPI inhibition. The reductions in FGFR signaling were not caused by loss of FGF ligands or receptors, but instead were caused by interference with receptor dimerization. Investigations into the cellular consequences of MPI knockdown showed that cellular programs driven by FGFR signaling, and integral to the clinical progression of malignant glioma, were impaired. In addition to a blockade of cellular migration, MPI knockdown also significantly reduced glioma cell clonogenic survival following ionizing radiation. Therefore our results suggest that targeted inhibition of enzymes required for cell surface receptor glycosylation can be manipulated to produce discrete and limited consequences for critical client glycoproteins expressed by tumor cells. Furthermore, this work identifies MPI as a potential enzymatic target for disrupting cell surface receptor-dependent survival signaling and as a novel approach for therapeutic radiosensitization.	[Cazet, Aurelie; Charest, Jonathan; Bennett, Daniel C.; Sambrooks, Cecilia Lopez; Contessa, Joseph N.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA	Yale University	Contessa, JN (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA.	joseph.contessa@yale.edu		Cazet, Aurelie/0000-0001-7075-8448	National Institutes of Health [1R01CA172391]; National Research Service Award postdoctoral training grant [T32CA009259]; NATIONAL CANCER INSTITUTE [R01CA172391, T32CA009259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award postdoctoral training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health 1R01CA172391 and the National Research Service Award postdoctoral training grant T32CA009259 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allerstorfer S, 2008, ONCOGENE, V27, P4180, DOI 10.1038/onc.2008.61; Auguste P, 2001, CANCER RES, V61, P1717; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; Brooks AN, 2012, CLIN CANCER RES, V18, P1855, DOI 10.1158/1078-0432.CCR-11-0699; Browne BC, 2009, CURR CANCER DRUG TAR, V9, P419, DOI 10.2174/156800909788166484; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Casaletto JB, 2012, NAT REV CANCER, V12, P386, DOI 10.1038/nrc3277; Chavan M, 2006, TRENDS BIOCHEM SCI, V31, P17, DOI 10.1016/j.tibs.2005.11.010; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Contessa JN, 2008, CANCER RES, V68, P3803, DOI 10.1158/0008-5472.CAN-07-6389; Contessa JN, 2010, CLIN CANCER RES, V16, P3205, DOI 10.1158/1078-0432.CCR-09-3331; Dahl R, 2011, J MED CHEM, V54, P3661, DOI 10.1021/jm101401a; Delehedde M, 2000, J BIOL CHEM, V275, P33905, DOI 10.1074/jbc.M005949200; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; DeRossi C, 2006, J BIOL CHEM, V281, P5916, DOI 10.1074/jbc.M511982200; Duchesne L, 2006, J BIOL CHEM, V281, P27178, DOI 10.1074/jbc.M601248200; Dupre T, 2000, GLYCOBIOLOGY, V10, P1277, DOI 10.1093/glycob/10.12.1277; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Freeze HH, 2013, J BIOL CHEM, V288, P6936, DOI 10.1074/jbc.R112.429274; Fukai J, 2008, MOL CANCER THER, V7, P2768, DOI 10.1158/1535-7163.MCT-07-2263; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; Hatch NE, 2006, J BIOL CHEM, V281, P27292, DOI 10.1074/jbc.M600448200; Higashidani A, 2009, MOL GENET METAB, V96, P268, DOI 10.1016/j.ymgme.2008.12.005; Ichisaka S, 1998, BRAIN DEV-JPN, V20, P302, DOI 10.1016/S0387-7604(98)00035-7; Irie F, 2008, P NATL ACAD SCI USA, V105, P12307, DOI 10.1073/pnas.0801302105; Kunii K, 2008, CANCER RES, V68, P2340, DOI 10.1158/0008-5472.CAN-07-5229; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Loilome W, 2009, J NEURO-ONCOL, V94, P359, DOI 10.1007/s11060-009-9885-5; Lopez CA, 2007, INT J RADIAT ONCOL, V69, P214, DOI 10.1016/j.ijrobp.2007.04.069; Luo YD, 2006, J BIOL CHEM, V281, P21052, DOI 10.1074/jbc.M601559200; MARQUARDT T, 1995, EUR J CELL BIOL, V66, P268; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Pardo OE, 2009, CANCER RES, V69, P8645, DOI 10.1158/0008-5472.CAN-09-1576; Phillips JJ, 2012, J CLIN INVEST, V122, P911, DOI 10.1172/JCI58215; Powell AK, 2002, J BIOL CHEM, V277, P28554, DOI 10.1074/jbc.M111754200; Quellhorst GJ, 1999, GLYCOBIOLOGY, V9, P65, DOI 10.1093/glycob/9.1.65; Schneider A, 2012, NAT MED, V18, P71, DOI 10.1038/nm.2548; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Tsuda T, 2000, J BIOL CHEM, V275, P21988, DOI 10.1074/jbc.M003400200; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Verstraete K, 2012, NAT REV CANCER, V12, P753, DOI 10.1038/nrc3371; Ware FE, 1996, J BIOL CHEM, V271, P13935, DOI 10.1074/jbc.271.24.13935; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Winterpacht A, 2000, PHYSIOL GENOMICS, V2, P9, DOI 10.1152/physiolgenomics.2000.2.1.9; Xu AM, 2010, CANCER RES, V70, P3857, DOI 10.1158/0008-5472.CAN-10-0163; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	55	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110345	10.1371/journal.pone.0110345	http://dx.doi.org/10.1371/journal.pone.0110345			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314669	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500108
J	Fareed, M; Afzal, M				Fareed, Mohd; Afzal, Mohammad			Estimating the Inbreeding Depression on Cognitive Behavior: A Population Based Study of Child Cohort	PLOS ONE			English	Article							LINKED MENTAL-RETARDATION; SOCIOECONOMIC-STATUS; ENVIRONMENTAL-INFLUENCES; SEQUENCING REVEALS; GENETIC INFLUENCES; GENERALIST GENES; CONSANGUINITY; INTELLIGENCE; RISK; IQ	Background: Cognitive ability tests are widely assumed to measure maximal intellectual performance and predictive associations between intelligence quotient (IQ) scores and later mental health problems. Very few epidemiologic studies have been done to demonstrate the relationship between familial inbreeding and modest cognitive impairments in children. Objective: We aimed to estimate the effect of inbreeding on children's cognitive behavior in comparison with non-inbred children. Methodology: A cohort of 408 children (6 to 15 years of age) was selected from inbred and non-inbred families of five Muslim populations of Jammu region. The Wechsler Intelligence Scales for Children (WISC) was used to measure the verbal IQ (VIQ), performance IQ (PIQ) and full scale IQ (FSIQ). Family pedigrees were drawn to access the family history and children's inbred status in terms of coefficient of inbreeding (F). Results: We found significant decline in child cognitive abilities due to inbreeding and high frequency of mental retardation among offspring from inbred families. The mean differences (95% C.I.) were reported for the VIQ, being -22.00 (-24.82, -19.17), PIQ -26.92 (-29.96, -23.87) and FSIQ -24.47 (-27.35, -21.59) for inbred as compared to non-inbred children (p>0.001). The higher risk of being mentally retarded was found to be more obvious among inbred categories corresponding to the degree of inbreeding and the same accounts least for non-inbred children (p>0.0001). We observed an increase in the difference in mean values for VIQ, PIQ and FSIQ with the increase of inbreeding coefficient and these were found to be statistically significant (p<0.05). The regression analysis showed a fitness decline (depression) for VIQ (R-2 = 0.436), PIQ (R-2 = 0.468) and FSIQ (R-2 = 0.464) with increasing inbreeding coefficients (p<0.01). Conclusions: Our comprehensive assessment provides the evidence for inbreeding depression on cognitive abilities among children.	[Fareed, Mohd; Afzal, Mohammad] Aligarh Muslim Univ, Fac Life Sci, Dept Zool, Human Genet & Toxicol Lab,Sect Genet, Aligarh 202001, Uttar Pradesh, India	Aligarh Muslim University	Fareed, M (corresponding author), Aligarh Muslim Univ, Fac Life Sci, Dept Zool, Human Genet & Toxicol Lab,Sect Genet, Aligarh 202001, Uttar Pradesh, India.	mohdfareedk@gmail.com; afzal1235@rediffmail.com		Afzal, Mohammad/0000-0001-8189-8753	Council of Scientific and Industrial Research (CSIR), New Delhi, India	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	We thank the Council of Scientific and Industrial Research (CSIR), New Delhi, India, for the award of Senior Research Fellowship (to MF). We are thankful to the Chairman, Department of Zoology, AMU, Aligarh for providing necessary laboratory facilities for this work. We are also thankful to Dr. Mir Kaisar Ahmad, Senior Resident, Department of Clinical Biochemistry, Sher-I-Kashmir Institute of Medical Sciences, Srinagar for his help and suggestions during this study. Thanks are due to the parents of the children without whose cooperation this work could not have been completed.	Abu Saad H, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00003; AFZAL M, 1988, BEHAV GENET, V18, P583, DOI 10.1007/BF01082310; AGRAWAL N, 1984, BEHAV GENET, V14, P579, DOI 10.1007/BF01068128; American Psychiatric Association, 2013, THE DIAGNOSTIC AND S; Apolinario D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060084; Badaruddoza, 1998, Indian Pediatr, V35, P1110; BADARUDDOZA, 1994, CLIN GENET, V45, P288; Badaruddoza, 2004, Asia Pac J Public Health, V16, P99, DOI 10.1177/101053950401600204; BADARUDDOZA, 1993, BEHAV GENET, V23, P343, DOI 10.1007/BF01067435; Bartels M, 2002, BEHAV GENET, V32, P237, DOI 10.1023/A:1019772628912; BASHI J, 1977, NATURE, V266, P440, DOI 10.1038/266440a0; Bener A, 2013, J PAK MED ASSOC, V63, P598; Bittles AH, 2010, P NATL ACAD SCI USA, V107, P1779, DOI 10.1073/pnas.0906079106; Bittles AH, 2001, CLIN GENET, V60, P89, DOI 10.1034/j.1399-0004.2001.600201.x; Blankevoort CG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070799; Bouchard TJ, 2003, J NEUROBIOL, V54, P4, DOI 10.1002/neu.10160; Brucki Sonia Maria Dozzi, 2011, Dement. neuropsychol., V5, P26, DOI 10.1590/S1980-57642011DN05010005; Butcher LM, 2006, CURR OPIN NEUROBIOL, V16, P145, DOI 10.1016/j.conb.2006.03.004; Caliskan M, 2011, HUM MOL GENET, V20, P1285, DOI 10.1093/hmg/ddq569; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Darwin CR, 1876, THE EFFECTS OF CROSS; Deary IJ, 2006, EUR J HUM GENET, V14, P690, DOI 10.1038/sj.ejhg.5201588; Fareed M, 2012, EGYPTIAN J MED HUMAN, V13, P161; Fareed M., 2013, EGYPT J MED HUM GENE, V14, P123, DOI DOI 10.1016/J.EJMHG.2012.08.001; Fareed M, 2014, AM J HUM BIOL, V26, P784, DOI 10.1002/ajhb.22599; Fareed M, 2014, TRANSFUS APHER SCI, V50, P247, DOI 10.1016/j.transci.2014.01.014; Goldberg TE, 2004, TRENDS COGN SCI, V8, P325, DOI 10.1016/j.tics.2004.05.011; Gustavson KH, 2005, ACTA PAEDIATR, V94, P769, DOI 10.1080/08035250410025636; Hanscombe KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030320; HERBST DS, 1980, AM J MED GENET, V7, P461, DOI 10.1002/ajmg.1320070407; Jaber L, 1998, Community Genet, V1, P12, DOI 10.1159/000016130; JENSEN AR, 1983, PERS INDIV DIFFER, V4, P71, DOI 10.1016/0191-8869(83)90054-5; Jones DF, 1924, GENETICS, V9, P405; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kendler KS, 2007, PSYCHOL MED, V37, P615, DOI 10.1017/S0033291706009524; Kovas Y, 2006, TRENDS COGN SCI, V10, P198, DOI 10.1016/j.tics.2006.03.001; Kumar Neeta, 2012, Indian J Public Health, V56, P103, DOI 10.4103/0019-557X.96988; LYNCH M, 1991, EVOLUTION, V45, P622, DOI [10.1111/j.1558-5646.1991.tb04333.x, 10.2307/2409915]; LYNCH M, 1988, GENETICS, V120, P791; Lynn R, 2012, INTELLIGENCE, V40, P226, DOI 10.1016/j.intell.2011.11.004; Maika A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078809; MITSUI T, 1994, J NEUROL SCI, V125, P153, DOI 10.1016/0022-510X(94)90028-0; MORTON NE, 1978, P NATL ACAD SCI USA, V75, P3906, DOI 10.1073/pnas.75.8.3906; Musante L, 2014, TRENDS GENET, V30, P32, DOI 10.1016/j.tig.2013.09.008; Najmabadi H, 2007, HUM GENET, V121, P43, DOI 10.1007/s00439-006-0292-0; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Petrill SA, 2004, INTELLIGENCE, V32, P445, DOI 10.1016/j.intell.2004.06.010; Plomin R, 1998, SCI AM, V278, P62, DOI 10.1038/scientificamerican0598-62; PLOMIN R, 1991, BEHAV BRAIN SCI, V14, P414, DOI 10.1017/S0140525X00070588; Power RA, 2014, EUR J HUM GENET, V22, P386, DOI 10.1038/ejhg.2013.155; Reed WE, 1965, MENTAL RETARDATION A; Reilly D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039904; Richards CM, 2000, AM NAT, V155, P383, DOI 10.1086/303324; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; SCHULL WJ, 1972, AM J HUM GENET, V24, P425; Schull WJ, 1965, THE EFFECTS OF INBRE; Shieh JTC, 2012, AM J MED GENET A, V158A, P1236, DOI 10.1002/ajmg.a.35272; Stoltenberg C, 1999, AM J PUBLIC HEALTH, V89, P517, DOI 10.2105/AJPH.89.4.517; Tadmouri Ghazi O, 2009, Reprod Health, V6, P17, DOI 10.1186/1742-4755-6-17; Trzaskowski M, 2014, INTELLIGENCE, V42, P83, DOI 10.1016/j.intell.2013.11.002; Turkheimer E, 2003, PSYCHOL SCI, V14, P623, DOI 10.1046/j.0956-7976.2003.psci_1475.x; van der Sluis S, 2008, BEHAV GENET, V38, P348, DOI 10.1007/s10519-008-9212-5; VANDENBERG SG, 1972, BEHAV GENET, V2, P127, DOI 10.1007/BF01065686; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Verweij KJH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103102; Vinkhuyzen AAE, 2010, GENES BRAIN BEHAV, V9, P276, DOI 10.1111/j.1601-183X.2009.00554.x; Woodley MA, 2009, INTELLIGENCE, V37, P268, DOI 10.1016/j.intell.2008.10.007; Wright S, 1934, GENETICS, V19, P0506	69	35	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109585	10.1371/journal.pone.0109585	http://dx.doi.org/10.1371/journal.pone.0109585			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR5ZW	25313490	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662500055
J	Wang, B; Wen, FX; Wu, JT; Wang, XJ; Hu, YN				Wang, Bing; Wen, Fenxiang; Wu, Jiangtao; Wang, Xiaojun; Hu, Yani			Vertical Profiles of Soil Water Content as Influenced by Environmental Factors in a Small Catchment on the Hilly-Gully Loess Plateau	PLOS ONE			English	Article							SPATIAL VARIABILITY; DISTRIBUTION PATTERNS; MOISTURE; SURFACE; DEPLETION; RECHARGE; DROUGHT; CLIMATE; BALANCE	Characterization of soil water content (SWC) profiles at catchment scale has profound implications for understanding hydrological processes of the terrestrial water cycle, thereby contributing to sustainable water management and ecological restoration in arid and semi-arid regions. This study described the vertical profiles of SWC at the small catchment scale on the hilly and gully Loess Plateau in Northeast China, and evaluated the influences of selected environmental factors (land-use type, topography and landform) on average SWC within 300 cm depth. Soils were sampled from 101 points across a small catchment before and after the rainy season. Cluster analysis showed that soil profiles with high-level SWC in a stable trend (from top to bottom) were most commonly present in the catchment, especially in the gully related to terrace. Woodland soil profiles had low-level SWC with vertical variations in a descending or stable trend. Most abandoned farmland and grassland soil profiles had medium-level SWC with vertical variations in varying trends. No soil profiles had low-level SWC with vertical variations in an ascending trend. Multi-regression analysis showed that average SWC was significantly affected by land-use type in different soil layers (0-20, 20-160, and 160-300 cm), generally in descending order of terrace, abandoned farmland, grassland, and woodland. There was a significant negative correlation between average SWC and gradient along the whole profile (P<0.05). Landform significantly affected SWC in the surface soil layer (0-20 cm) before the rainy season but throughout the whole profile after the rainy season, with lower levels on the ridge than in the gully. Altitude only strongly affected SWC after the rainy season. The results indicated that land-use type, gradient, landform, and altitude should be considered in spatial SWC estimation and sustainable water management in these small catchments on the Loess Plateau as well as in other complex terrains with similar settings.	[Wang, Bing; Wen, Fenxiang; Wu, Jiangtao; Wang, Xiaojun] Shanxi Univ, Coll Environm Sci & Resources, Taiyuan, Peoples R China; [Hu, Yani] Hebei Univ Sci & Technol, Shijiazhuang, Peoples R China	Shanxi University; Hebei University of Science & Technology	Wang, XJ (corresponding author), Shanxi Univ, Coll Environm Sci & Resources, Taiyuan, Peoples R China.	xjwang@sxu.edu.cn			Natural Science Foundation of China [41201277, 41101025]; Natural Science Foundation of Shanxi Province of China [2014011034-2]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanxi Province of China(Natural Science Foundation of Shanxi Province)	This work was supported by the Natural Science Foundation of China (No. 41201277 and 41101025) and the Natural Science Foundation of Shanxi Province of China (No. 2014011034-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Tian-lu, 2009, Shengtaixue Zazhi, V28, P2508; Beldring S, 1999, AGR FOREST METEOROL, V98-9, P305, DOI 10.1016/S0168-1923(99)00103-3; BURT TP, 1985, J SOIL SCI, V36, P469, DOI 10.1111/j.1365-2389.1985.tb00351.x; Canton Y, 2004, J HYDROL, V285, P199, DOI 10.1016/j.jhydrol.2003.08.018; Chen LD, 2007, CATENA, V70, P200, DOI 10.1016/j.catena.2006.08.007; Cheng LP, 2014, J INTEGR AGR, V13, P1382, DOI 10.1016/S2095-3119(13)60292-0; Dripps WR, 2007, HYDROGEOL J, V15, P433, DOI 10.1007/s10040-007-0160-6; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Fu XL, 2013, J HYDROL ENG, V18, P413, DOI 10.1061/(ASCE)HE.1943-5584.0000628; Gomez-Plaza A, 2001, J HYDROL, V253, P211, DOI 10.1016/S0022-1694(01)00483-8; Grassini P, 2010, AGR WATER MANAGE, V97, P1063, DOI 10.1016/j.agwat.2010.02.019; HAWLEY ME, 1983, J HYDROL, V62, P179, DOI 10.1016/0022-1694(83)90102-6; HENNINGER DL, 1976, SOIL SCI SOC AM J, V40, P773, DOI 10.2136/sssaj1976.03615995004000050041x; Huang J, 2013, CATENA, V104, P93, DOI 10.1016/j.catena.2012.10.013; Huang MB, 2003, AGR WATER MANAGE, V58, P267, DOI 10.1016/S0378-3774(02)00086-0; [黄奕龙 Huang Yilong], 2005, [自然资源学报, Journal of Natural Resources], V20, P483; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Jipp PH, 1998, CLIMATIC CHANGE, V39, P395, DOI 10.1023/A:1005308930871; Kizito F, 2006, J ARID ENVIRON, V67, P436, DOI 10.1016/j.jaridenv.2006.02.021; Li B, 2013, HYDROL EARTH SYST SC, V17, P1177, DOI 10.5194/hess-17-1177-2013; Li JiWei, 2011, Acta Agrestia Sinica, V19, P43; [李军 LI Jun], 2008, [生态学报, Acta Ecologica Sinica], V28, P1429; Li Y.S., 2001, ACTA PEDOLOGICA SINI, V38, P353; [连纲 LIAN Gang], 2006, [生态学报, Acta Ecologica Sinica], V26, P647; Liu W, 2010, AGR WATER MANAGE, V97, P1133, DOI 10.1016/j.agwat.2010.01.001; Markewitz D, 2010, NEW PHYTOL, V187, P592, DOI 10.1111/j.1469-8137.2010.03391.x; OLOUGHLIN EM, 1981, J HYDROL, V53, P229, DOI 10.1016/0022-1694(81)90003-2; OWE M, 1982, WATER RESOUR BULL, V18, P949; Qiu Y, 2003, CATENA, V54, P173, DOI 10.1016/S0341-8162(03)00064-X; Qiu Y, 2010, J ARID ENVIRON, V74, P208, DOI 10.1016/j.jaridenv.2009.08.003; Qiu Y., 2000, ACTA ECOLOGICA SINIC, V20, P741; ROBINSON M, 1993, HYDROL PROCESS, V7, P77, DOI 10.1002/hyp.3360070108; Shi Zhi-hua, 2012, Yingyong Shengtai Xuebao, V23, P889; Wang MB, 1995, ACTA ECOLOGICA SINIC, V15, P172; Wang XinZeng, 2011, Journal of Northwest A & F University - Natural Science Edition, V39, P191; Wang Yun-qiang, 2008, Huanjing Kexue, V29, P1020; Wang YQ, 2013, J HYDROL, V487, P13, DOI 10.1016/j.jhydrol.2013.02.006; [邢贵 Xing Gui], 2012, [干旱地区农业研究, Agricultural Research in the Arid Areas], V30, P225; [杨磊 YANG Lei], 2011, [生态学报, Acta Ecologica Sinica], V31, P3060; Yao XL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056537, 10.1371/journal.pone.0054660]; Zeng C, 2011, ACTA AGR SCAND B-S P, V61, P1, DOI 10.1080/09064710903352589; [张瑞 Zhang Rui], 2012, [水土保持研究, Research of Soil and Water Conservation], V19, P52; [邹俊亮 Zou Junliang], 2011, [水土保持研究, Research of Soil and Water Conservation], V18, P12	43	11	12	6	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109546	10.1371/journal.pone.0109546	http://dx.doi.org/10.1371/journal.pone.0109546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313829	Green Submitted, gold, Green Published			2022-12-27	WOS:000343662500049
J	Daniel, JW; Veiga, JCE				Daniel, Jefferson W.; Veiga, Jose C. E.			Prognostic Parameters and Spinal Metastases: A Research Study	PLOS ONE			English	Article							SURGICAL-MANAGEMENT; CORD COMPRESSION; PREOPERATIVE EVALUATION; SCORING SYSTEM; SURVIVAL; DISEASE; CANCER; TUMORS; PREDICTORS; DIAGNOSIS	Object: To identify pre-operative prognostic parameters for survival in patients with spinal epidural neoplastic metastasis when the primary tumour is unknown. Methods: This study was a retrospective chart review of patients who underwent surgery for spinal epidural neoplastic metastases between February 1997 and January 2011. The inclusion criteria were as follows: known post-operative survival period, a Karnofsky Performance Score equal to or greater than 30 points and a post-operative neoplastic metastasis histological type. The Kaplan-Meier method was used to estimate post-operative survival, and the Log-Rank test was used for statistical inference. Results: A total of 52 patients who underwent 52 surgical procedures were identified. The mean age at the time of spinal surgery was 53.92 years (std. deviation, 19.09). The median survival after surgery was 70 days (95% CI 49.97-90.02), and post-operative mortality occurred within 6 months in 38 (73.07%) patients. Lung cancer, prostate cancer, myeloma and lymphoma, the 4 most common primary tumour types, affected 32 (61.53%) patients. The three identified prognostic parameters were the following: pre-operative walking incapacity (American Spinal Injury Association, A and B), present in 86.53% of the patients (p-value = 0.107); special care dependency (Karnofsky Performance Score, 10-40 points), present in 90.38% of the patients (p-value = 0.322); and vertebral epidural neoplastic metastases that were in contact with the thecal sac (Weinstein-Boriani-Biagini, sector D), present in 94.23% of the patients (p-value = 0.643). When the three secondary prognostic parameters were combined, the mean post-operative survival was 45 days; when at least one was present, the survival was 82 days (p-value = 0.175). Conclusions: Walking incapacity, special care dependency and contact between the neoplastic metastases and the thecal sac can help determine the ultimate survival of this patient population and, potentially, which patients would benefit from surgery versus palliation alone. A 2- to 3-month post-operative survival period justified surgical treatment.	[Daniel, Jefferson W.; Veiga, Jose C. E.] Santa Casa Sao Paulo Fac Med Sci, Div Neurosurg, Sao Paulo, Brazil		Daniel, JW (corresponding author), Santa Casa Sao Paulo Fac Med Sci, Div Neurosurg, Sao Paulo, Brazil.	jefferson.w.daniel@gmail.com	Veiga, José/AAV-1687-2020	daniel, jefferson/0000-0001-6222-6708				Aizenberg MR, 2012, J NEUROSURG-SPINE, V16, P86, DOI 10.3171/2011.9.SPINE11422; Araujo João Luiz Vitorino, 2013, Rev. Col. Bras. Cir., V40, P508; Arrigo RT, 2011, NEUROSURGERY, V68, P674, DOI 10.1227/NEU.0b013e318207780c; Bartels RHMA, 2007, CANCER-AM CANCER SOC, V110, P2042, DOI 10.1002/cncr.23002; Boriani S, 1996, SPINE, V21, P1927, DOI 10.1097/00007632-199608150-00020; BYRNE TN, 1992, NEW ENGL J MED, V327, P614; Chaichana KL, 2009, NEUROSURGERY, V65, P267, DOI 10.1227/01.NEU.0000349919.31636.05; Choi D, 2010, EUR SPINE J, V19, P215, DOI 10.1007/s00586-009-1252-x; Daniel JW, 2007, BRAZ NEUROSURG, V26, P93; de Oliveira MF, 2013, ARQ NEURO-PSIQUIAT, V71, P798, DOI 10.1590/0004-282X20130125; Douglas S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-261; Fisher CG, 2010, SPINE, V35, pE1221, DOI 10.1097/BRS.0b013e3181e16ae2; Fourney DR, 2006, J NEUROSURG-SPINE, V2, P40; Frankel H L, 1969, Paraplegia, V7, P179; Gasbarrini A, 2010, SPINE, V35, P1466, DOI 10.1097/BRS.0b013e3181c680b9; Hirabayashi H, 2003, CANCER-AM CANCER SOC, V97, P476, DOI 10.1002/cncr.11039; Holman PJ, 2005, J NEUROSURG-SPINE, V2, P550, DOI 10.3171/spi.2005.2.5.0550; Iizuka Y, 2009, EUR SPINE J, V18, P1431, DOI 10.1007/s00586-009-1061-2; Instituto Nacional de Cancer Coordenacao Geral de Acoes Estrategicas, 2011, EST 2012 CANC INC BR; Karnofsky D, 1949, EVALUATION CHEMOTHER, P196; Kataoka M, 2012, ACTA MED OKAYAMA, V66, P213; L'Esperance S, 2012, CURR ONCOL, V19, pE478, DOI 10.3747/co.19.1128; Lau D, 2012, J NEUROSURG-SPINE, V17, P565, DOI 10.3171/2012.8.SPINE12449; Leithner A, 2008, EUR SPINE J, V17, P1488, DOI 10.1007/s00586-008-0763-1; Loblaw DA, 2005, J CLIN ONCOL, V23, P2028, DOI 10.1200/JCO.2005.00.067; Mannion RJ, 2007, BRIT J NEUROSURG, V21, P593, DOI 10.1080/02688690701593579; Marino RJ., 2003, J SPINAL CORD MED S1, V26, pS50, DOI [10.1080/10790268.2003.11754575, DOI 10.1080/10790268.2003.11754575]; Meyer SA, 2010, MT SINAI J MED, V77, P124, DOI 10.1002/msj.20162; Mut M, 2005, J NEURO-ONCOL, V75, P43, DOI 10.1007/s11060-004-8097-2; National Cancer Institute, 2012, GEN INF CARC UNKN PR; National Cancer Institute, 2012, CANC STAG; North RB, 2005, J NEUROSURG-SPINE, V2, P564, DOI 10.3171/spi.2005.2.5.0564; Paholpak Permsak, 2012, Open Orthop J, V6, P440, DOI 10.2174/1874325001206010440; Pavlidis N, 2003, EUR J CANCER, V39, P1990, DOI 10.1016/S0959-8049(03)00547-1; Peus D, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-72; Putz C, 2008, SPINE, V33, P2669, DOI 10.1097/BRS.0b013e318188b98f; Quraishi NA, 2010, J BONE JOINT SURG BR, V92B, P1054, DOI 10.1302/0301-620X.92B8.22296; Sciubba DM, 2010, J NEUROSURG-SPINE, V13, P94, DOI 10.3171/2010.3.SPINE09202; SIOUTOS PJ, 1995, CANCER, V76, P1453, DOI 10.1002/1097-0142(19951015)76:8<1453::AID-CNCR2820760824>3.0.CO;2-T; Tokuhashi Y, 2005, SPINE, V30, P2186, DOI 10.1097/01.brs.0000180401.06919.a5; Tokuhashi Y, 2009, SPINE, V34, P69, DOI 10.1097/BRS.0b013e3181913f19; Tomita K, 2001, SPINE, V26, P298, DOI 10.1097/00007632-200102010-00016; Varadhachary Gauri R, 2007, Gastrointest Cancer Res, V1, P229; Wibmer C, 2011, SPINE, V36, P1977, DOI 10.1097/BRS.0b013e3182011f84; Yamashita T, 2011, SPINE, V36, P910, DOI 10.1097/BRS.0b013e3181e56ec1; Yang SB, 2012, J KOREAN NEUROSURG S, V51, P127, DOI 10.3340/jkns.2012.51.3.127	46	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109579	10.1371/journal.pone.0109579	http://dx.doi.org/10.1371/journal.pone.0109579			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310095	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210300058
J	Gui, D; Yu, RQ; Sun, Y; Chen, LG; Tu, Q; Mo, H; Wu, YP				Gui, Duan; Yu, Ri-Qing; Sun, Yong; Chen, Laiguo; Tu, Qin; Mo, Hui; Wu, Yuping			Mercury and Selenium in Stranded Indo-Pacific Humpback Dolphins and Implications for Their Trophic Transfer in Food Chains	PLOS ONE			English	Article							PEARL RIVER ESTUARY; TRACE-ELEMENTS; STENELLA-COERULEOALBA; CONTAMINATION LEVELS; REDUCING BACTERIA; STRIPED DOLPHIN; SOUSA-CHINENSIS; HEAVY-METALS; HONG-KONG; LIVER	As top predators in the Pearl River Estuary (PRE) of China, Indo-Pacific humpback dolphins (Sousa chinensis) are bioindicators for examining regional trends of environmental contaminants in the PRE. We examined samples from stranded S. chinensis in the PRE, collected since 2004, to study the distribution and fate of total mercury (THg), methylmercury (MeHg) and selenium (Se) in the major tissues, in individuals at different ages and their prey fishes from the PRE. This study also investigated the potential protective effects of Se against the toxicities of accumulated THg. Dolphin livers contained the highest concentrations of THg (32.34 +/- 58.98 mu g g(-1) dw) and Se (15.16 +/- 3.66 mu g g(-1) dw), which were significantly different from those found in kidneys and muscles, whereas the highest residue of MeHg (1.02 +/- 1.11 mg g(-1) dw) was found in dolphin muscles. Concentrations of both THg and MeHg in the liver, kidney and muscle of dolphins showed a significantly positive correlation with age. The biomagnification factors (BMFs) of inorganic mercury (Hg-inorg) in dolphin livers (350x) and MeHg in muscles (18.7x) through the prey fishes were the highest among all three dolphin tissues, whereas the BMFs of Se were much lower in all dolphin tissues. The lower proportion of MeHg in THg and higher Se/THg ratios in tissues were demonstrated. Our studies suggested that S. chinensis might have the potential to detoxify Hg via the demethylation of MeHg and the formation of tiemannite (HgSe) in the liver and kidney. The lower threshold of hepatic THg concentrations for the equimolar accumulation of Se and Hg in S. chinensis suggests that this species has a greater sensitivity to THg concentrations than is found in striped dolphins and Dall's porpoises.	[Gui, Duan; Sun, Yong; Tu, Qin; Wu, Yuping] Sun Yat Sen Univ, Sch Marine Sci, Guangdong Prov Key Lab Marine Resources & Coastal, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Ri-Qing] Univ Texas Tyler, Dept Biol, Tyler, TX 75799 USA; [Chen, Laiguo] Minist Environm Protect, South China Inst Environm Sci, Urban Environm & Ecol Res Ctr, Guangzhou, Guangdong, Peoples R China; [Mo, Hui] Chinese Acad Sci, South China Bot Garden, Guangzhou, Guangdong, Peoples R China	Guangdong Provincial Key Laboratory of Marine Resources & Coastal Engineering; Sun Yat Sen University; University of Texas System; University of Texas at Tyler; Chinese Academy of Sciences; South China Botanical Garden, CAS	Wu, YP (corresponding author), Sun Yat Sen Univ, Sch Marine Sci, Guangdong Prov Key Lab Marine Resources & Coastal, Guangzhou 510275, Guangdong, Peoples R China.	exwyp@mail.sysu.edu.cn	Yu, Riqing/ABA-6643-2020	Gui, Duan/0000-0002-0236-6837	National Natural Science Foundation of China [41276147]; Marine Non-profit Industry [201105011-5]; Ocean Park Conservation Foundation, Hong Kong; National Key Technology R D Program [2011BAG07B05-3]; Sousa chinensis Conservation Action Project from the Administrator of Ocean and Fisheries of Guangdong Province, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Marine Non-profit Industry; Ocean Park Conservation Foundation, Hong Kong; National Key Technology R D Program(National Key Technology R&D Program); Sousa chinensis Conservation Action Project from the Administrator of Ocean and Fisheries of Guangdong Province, China	This research was supported by the National Natural Science Foundation of China (Grant no. 41276147); a Science and Research Project of the Marine Non-profit Industry (Grant no. 201105011-5); the Ocean Park Conservation Foundation, Hong Kong; the National Key Technology R & D Program (Grant no. 2011BAG07B05-3); and the Sousa chinensis Conservation Action Project from the Administrator of Ocean and Fisheries of Guangdong Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRE JM, 1990, MAR ENVIRON RES, V30, P43, DOI 10.1016/0141-1136(90)90010-L; [Anonymous], 1630 US EPA OFF WAT, V4303, P20460; Barros Nelio B., 2004, Aquatic Mammals, V30, P179, DOI 10.1578/AM.30.1.2004.179; Caceres-Saez I, 2013, BIOL TRACE ELEM RES, V151, P195, DOI 10.1007/s12011-012-9555-x; Caurant F, 1996, SCI TOTAL ENVIRON, V186, P95, DOI 10.1016/0048-9697(96)05087-5; COMPEAU GC, 1985, APPL ENVIRON MICROB, V50, P498, DOI 10.1128/AEM.50.2.498-502.1985; Das K, 2000, CELL MOL BIOL, V46, P283; Dietz R, 2000, SCI TOTAL ENVIRON, V245, P15, DOI 10.1016/S0048-9697(99)00430-1; Endo T, 2008, SCI TOTAL ENVIRON, V401, P73, DOI 10.1016/j.scitotenv.2008.04.006; Fleming EJ, 2006, APPL ENVIRON MICROB, V72, P457, DOI 10.1128/AEM.72.1.457-464.2006; Gilmour CC, 2013, ENVIRON SCI TECHNOL, V47, P11810, DOI 10.1021/es403075t; Holsbeek L, 1998, SCI TOTAL ENVIRON, V217, P241, DOI 10.1016/S0048-9697(98)00177-6; HONDA K, 1983, AGR BIOL CHEM TOKYO, V47, P1219, DOI 10.1080/00021369.1983.10863383; Hong YS, 2012, SCI TOTAL ENVIRON, V414, P220, DOI 10.1016/j.scitotenv.2011.11.021; Hung CLH, 2004, CHEMOSPHERE, V56, P643, DOI 10.1016/j.chemosphere.2004.04.016; Jefferson TA, 2000, WILDLIFE MONOGR, P1; Jefferson TA, 2012, MAR MAMMAL SCI, V28, P84, DOI 10.1111/j.1748-7692.2010.00462.x; Khan MAK, 2009, ENVIRON TOXICOL CHEM, V28, P1567, DOI 10.1897/08-375.1; Kunito T, 2004, MAR POLLUT BULL, V49, P574, DOI 10.1016/j.marpolbul.2004.03.009; Lailson-Brito J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042162; LEONZIO C, 1992, SCI TOTAL ENVIRON, V119, P77, DOI 10.1016/0048-9697(92)90257-S; Martoja R, 1981, IDENTIFICATION TIEMA; Meador JP, 1999, ARCH ENVIRON CON TOX, V36, P87, DOI 10.1007/s002449900446; Moreira I, 2009, J COASTAL RES, P866; Myrck jr AC, 1983, ESTIMATING AGE SPOTT; Nakazawa E, 2011, METALLOMICS, V3, P719, DOI 10.1039/c0mt00106f; NIGRO M, 1994, J MAR BIOL ASSOC UK, V74, P975, DOI 10.1017/S0025315400090226; PALMISANO F, 1995, MAR ENVIRON RES, V40, P109, DOI 10.1016/0141-1136(94)00142-C; Parks JM, 2013, SCIENCE, V339, P1332, DOI 10.1126/science.1230667; Parsons ECM, 1998, SCI TOTAL ENVIRON, V214, P175, DOI 10.1016/S0048-9697(98)00063-1; Peterson SA, 2009, ENVIRON SCI TECHNOL, V43, P3919, DOI 10.1021/es803203g; Ruelas-Inzunza JR, 2003, CIENC MAR, V29, P1; Seixas TG, 2007, SCI TOTAL ENVIRON, V385, P208, DOI 10.1016/j.scitotenv.2007.06.045; Shi JB, 2010, ENVIRON POLLUT, V158, P1974, DOI 10.1016/j.envpol.2010.01.033; Sormo EG, 2011, ENVIRON SCI TECHNOL, V45, P6561, DOI 10.1021/es200478b; Storelli MM, 1998, B ENVIRON CONTAM TOX, V61, P541, DOI 10.1007/s001289900796; Thompson D.R., 1990, P143; Wagemann R., 1984, CONCENTRATIONS HEAVY; WREN CD, 1986, ENVIRON RES, V40, P210, DOI 10.1016/S0013-9351(86)80098-6; Wu YL, 2013, SCI TOTAL ENVIRON, V444, P423, DOI 10.1016/j.scitotenv.2012.11.110; Yang J, 2007, ENVIRON POLLUT, V148, P669, DOI 10.1016/j.envpol.2006.11.008; Yu RQ, 2013, APPL ENVIRON MICROB, V79, P6325, DOI 10.1128/AEM.01556-13; Yu RQ, 2012, ENVIRON SCI TECHNOL, V46, P2684, DOI 10.1021/es2033718; Yu XJ, 2012, MAR POLLUT BULL, V64, P1699, DOI 10.1016/j.marpolbul.2012.03.018	44	16	16	5	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110336	10.1371/journal.pone.0110336	http://dx.doi.org/10.1371/journal.pone.0110336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310100	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210300106
J	Kumar, P; Smith, T; Rahman, K; Thorn, NE; Anania, FA				Kumar, Pradeep; Smith, Tekla; Rahman, Khalidur; Thorn, Natalie E.; Anania, Frank A.			Adiponectin Agonist ADP355 Attenuates CCl4-Induced Liver Fibrosis in Mice	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; TISSUE GROWTH-FACTOR; HEPATOCELLULAR-CARCINOMA; GOLD NANOPARTICLES; NITRIC-OXIDE; LEPTIN; RATS; FIBROGENESIS; ACTIVATION; MECHANISMS	Liver fibrosis is a growing global health problem characterized by excess deposition of fibrillar collagen, and activation of hepatic stellate cells (HSCs). Adiponectin is known to possess anti-fibrotic properties; however a high physiological concentration and multiple forms circulating in blood prohibit clinical use. Recently, an adiponectin-like small synthetic peptide agonist (ADP355: H-DAsn-Ile-Pro-Nva-Leu-Tyr-DSer-Phe-Ala-DSer-NH2) was synthesized for the treatment of murine breast cancer. The present study was designed to evaluate the efficacy of ADP355 as an anti-fibrotic agent in the in vivo carbon tetrachloride (CCl4)-induced liver fibrosis model. Liver fibrosis was induced in eight-week old male C57BL/6J mice by CCl4-gavage every other day for four weeks before injection of a nanoparticle-conjugated with ADP355 (nano-ADP355). Control gold nanoparticles and nano-ADP355 were administered by intraperitoneal injection for two weeks along with CCl4-gavage. All mice were sacrificed after 6 weeks, and serum and liver tissue were collected for biochemical, histopathologic and molecular analyses. Biochemical studies suggested ADP355 treatment attenuates liver fibrosis, determined by reduction of serum aspartate aminotransferase (AST), alanine aminotransferase ALT) and hydroxyproline. Histopathology revealed chronic CCl4-treatment results in significant fibrosis, while ADP355 treatment induced significantly reversed fibrosis. Key markers for fibrogenesis-alpha-smooth muscle actin (alpha-SMA), transforming growth factor-beta1 (TGF-beta 1), connective tissue growth factor (CTGF), and the tissue inhibitor of metalloproteinase I (TIMP1) were also markedly attenuated. Conversely, liver lysates from ADP355 treated mice increased phosphorylation of both endothelial nitric oxide synthase (eNOS) and AMPK while AKT phosphorylation was diminished. These findings suggest ADP355 is a potent anti-fibrotic agent that can be an effective intervention against liver fibrosis.	[Kumar, Pradeep; Smith, Tekla; Rahman, Khalidur; Thorn, Natalie E.; Anania, Frank A.] Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA	Emory University	Anania, FA (corresponding author), Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA.	fanania@emory.edu	Raeman, Reben/AAF-7282-2021	Raeman, Reben/0000-0002-3914-1797	US PHS National Institutes of Health [DK R01062092, PHS VA I01BX001746]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062092] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001746] Funding Source: NIH RePORTER	US PHS National Institutes of Health(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	The study was supported by funding from US PHS National Institutes of Health grants DK R01062092 and PHS VA I01BX001746. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian JE, 2007, J PHARMACOL EXP THER, V321, P536, DOI 10.1124/jpet.106.117945; Aranda C, 2013, EUR J PHARM BIOPHARM, V85, P390, DOI 10.1016/j.ejpb.2013.06.011; Balasubramanian SK, 2010, BIOMATERIALS, V31, P2034, DOI 10.1016/j.biomaterials.2009.11.079; Bartneck M, 2012, ACS NANO, V6, P8767, DOI 10.1021/nn302502u; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Boll M, 2001, Z NATURFORSCH C, V56, P649; Buechler C, 2011, WORLD J GASTROENTERO, V17, P2801, DOI 10.3748/wjg.v17.i23.2801; Cao Y, 2009, J MOL CELL CARDIOL, V46, P413, DOI 10.1016/j.yjmcc.2008.10.014; Chandrasekar B, 2008, J BIOL CHEM, V283, P24889, DOI 10.1074/jbc.M804236200; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; Chen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058208; Chen TH, 2006, BBA-MOL BASIS DIS, V1762, P711, DOI 10.1016/j.bbadis.2006.06.008; Chen YS, 2009, NANOSCALE RES LETT, V4, P858, DOI 10.1007/s11671-009-9334-6; Combs TP, 2014, REV ENDOCR METAB DIS, V15, P137, DOI 10.1007/s11154-013-9280-6; Coulouarn C, 2014, J HEPATOL; Ding XK, 2005, AM J PATHOL, V166, P1655, DOI 10.1016/S0002-9440(10)62476-5; Endo H, 2011, PATHOBIOLOGY, V78, P239, DOI 10.1159/000328841; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Frederiks WM, 2004, J HISTOCHEM CYTOCHEM, V52, P711, DOI 10.1369/jhc.4R6251.2004; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Gressner OA, 2008, LIVER INT, V28, P1065, DOI 10.1111/j.1478-3231.2008.01826.x; Guo JS, 2007, SEMIN LIVER DIS, V27, P413, DOI 10.1055/s-2007-991517; Handy JA, 2011, BIOCHEM J, V440, P385, DOI 10.1042/BJ20102148; Handy JA, 2010, J CELL BIOCHEM, V110, P1195, DOI 10.1002/jcb.22634; Huang PH, 2011, J MOL CELL CARDIOL, V51, P109, DOI 10.1016/j.yjmcc.2011.03.008; Ikejima K, 2007, J GASTROEN HEPATOL, V22, pS87, DOI 10.1111/j.1440-1746.2007.04961.x; JUNQUEIRA LCU, 1985, HISTOCHEM J, V17, P1197, DOI 10.1007/BF01002502; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kang EH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3218; Kim EJ, 2011, MOL THER, V19, P355, DOI 10.1038/mt.2010.262; Kisseleva T, 2007, J GASTROEN HEPATOL, V22, pS73, DOI 10.1111/j.1440-1746.2006.04658.x; Kisseleva T, 2006, J GASTROEN HEPATOL, V21, pS84, DOI 10.1111/j.1440-1746.2006.04584.x; Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109; Li GM, 2006, J GENE MED, V8, P889, DOI 10.1002/jgm.894; Lim S, 2014, ATHEROSCLEROSIS, V233, P721, DOI 10.1016/j.atherosclerosis.2014.01.051; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; Liu Xiao, 2013, Curr Pathobiol Rep, V1, P209; Liu Y, 2013, J BIOL CHEM, V288, P30708, DOI 10.1074/jbc.M113.478685; Magnussen A, 2013, WORLD J GASTROENTERO, V19, P1508, DOI 10.3748/wjg.v19.i10.1508; Onat A, 2008, INT J BIOL SCI, V4, P208; Otvos L, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-90; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Pan Y, 2007, SMALL, V3, P1941, DOI 10.1002/smll.200700378; Peng Z, 2009, J CLIN INVEST, V119, P582, DOI 10.1172/JCI37409; Saxena NK, 2010, GASTROENTEROLOGY, V139, P1762, DOI 10.1053/j.gastro.2010.07.001; Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028; Sharma D, 2010, HEPATOLOGY, V52, P1713, DOI 10.1002/hep.23892; Silva TE, 2014, DIABETES METAB, V40, P95, DOI 10.1016/j.diabet.2013.11.004; TAMAYO RP, 1983, HEPATOLOGY, V3, P112; Tian Q, 2010, BIOMATERIALS, V31, P4748, DOI 10.1016/j.biomaterials.2010.02.042; Zhang H, 2007, ENDOCRINOLOGY, V148, P5667, DOI 10.1210/en.2007-0647	52	48	51	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110405	10.1371/journal.pone.0110405	http://dx.doi.org/10.1371/journal.pone.0110405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310107	gold, Green Published, Green Submitted			2022-12-27	WOS:000343210300114
J	Lim, S; Marcus, SM; Singh, TP; Harris, TG; Seligson, AL				Lim, Sungwoo; Marcus, Sue M.; Singh, Tejinder P.; Harris, Tiffany G.; Seligson, Amber Levanon			Bias Due to Sample Selection in Propensity Score Matching for a Supportive Housing Program Evaluation in New York City	PLOS ONE			English	Article								Objectives: Little is known about influences of sample selection on estimation in propensity score matching. The purpose of the study was to assess potential selection bias using one-to-one greedy matching versus optimal full matching as part of an evaluation of supportive housing in New York City (NYC). Study Design and Settings: Data came from administrative data for 2 groups of applicants who were eligible for an NYC supportive housing program in 2007-09, including chronically homeless adults with a substance use disorder and young adults aging out of foster care. We evaluated the 2 matching methods in their ability to balance covariates and represent the original population, and in how those methods affected outcomes related to Medicaid expenditures. Results: In the population with a substance use disorder, only optimal full matching performed well in balancing covariates, whereas both methods created representative populations. In the young adult population, both methods balanced covariates effectively, but only optimal full matching created representative populations. In the young adult population, the impact of the program on Medicaid expenditures was attenuated when one-to-one greedy matching was used, compared with optimal full matching. Conclusion: Given covariate balancing with both methods, attenuated program impacts in the young adult population indicated that one-to-one greedy matching introduced selection bias.	[Lim, Sungwoo; Singh, Tejinder P.; Harris, Tiffany G.; Seligson, Amber Levanon] New York City Dept Hlth & Mental Hyg, Bur Epidemiol Serv, Div Epidemiol, New York, NY 10013 USA; [Marcus, Sue M.] Columbia Univ, Dept Psychiat & Biostat, New York, NY USA	New York City Department of Health & Mental Hygiene; Columbia University	Lim, S (corresponding author), New York City Dept Hlth & Mental Hyg, Bur Epidemiol Serv, Div Epidemiol, New York, NY 10013 USA.	slim1@health.nyc.gov		Lim, Sungwoo/0000-0002-4890-0396; Harris, Tiffany/0000-0003-2212-0874				Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Gu Xing S., 1993, J COMPUTATIONAL GRAP, V2, P405, DOI [DOI 10.1080/10618600.1993.10474623, DOI 10.7326/0003-4819-152-6-201003160-00008]; Hansen BB, 2006, J COMPUT GRAPH STAT, V15, P609, DOI 10.1198/106186006X137047; Haviland A, 2007, PSYCHOL METHODS, V12, P247, DOI 10.1037/1082-989X.12.3.247; HODGES JL, 1963, ANN MATH STAT, V34, P598, DOI 10.1214/aoms/1177704172; Little RJ, 2000, ANNU REV PUBL HEALTH, V21, P121, DOI 10.1146/annurev.publhealth.21.1.121; Marcus SM, 1997, J CLIN EPIDEMIOL, V50, P823, DOI 10.1016/S0895-4356(97)00068-1; Marcus SM, 2012, PHARMACOEPIDEM DR S, V21, P710, DOI 10.1002/pds.3202; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Pearl J, 2011, AM J EPIDEMIOL, V174, P1223, DOI 10.1093/aje/kwr352; Rosenbaum PR, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-1213-8; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Singh T`, 2013, NEW YORK NEW YORK 3; Stuart E., 2007, BEST PRACTICES QUANT; Sturmer T, 2006, PHARMACOEPIDEM DR S, V15, P698, DOI 10.1002/pds.1231	15	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109112	10.1371/journal.pone.0109112	http://dx.doi.org/10.1371/journal.pone.0109112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ9WZ	25310449	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210300037
J	Maurya, R; Ghosh, T; Paliwal, C; Shrivastav, A; Chokshi, K; Pancha, I; Ghosh, A; Mishra, S				Maurya, Rahulkumar; Ghosh, Tonmoy; Paliwal, Chetan; Shrivastav, Anupama; Chokshi, Kaumeel; Pancha, Imran; Ghosh, Arup; Mishra, Sandhya			Biosorption of Methylene Blue by De-Oiled Algal Biomass: Equilibrium, Kinetics and Artificial Neural Network Modelling	PLOS ONE			English	Article							AQUEOUS-SOLUTIONS; CATIONIC DYE; WASTE-WATER; BASIC-DYES; AZO-DYE; ADSORPTION; REMOVAL; DECOLORIZATION; MECHANISM; ACID	The main objective of the present study is to effectively utilize the de-oiled algal biomass (DAB) to minimize the waste streams from algal biofuel by using it as an adsorbent. Methylene blue (MB) was used as a sorbate for evaluating the potential of DAB as a biosorbent. The DAB was characterized by SEM, FTIR, pH(PZC), particle size, pore volume and pore diameter to understand the biosorption mechanism. The equilibrium studies were carried out by variation in different parameters, i.e., pH (2-9), temperature (293.16-323.16 K), biosorbent dosage (1-10 g L-1), contact time (0-1,440 min), agitation speed (0-150 rpm) and dye concentration (25-2,500 mg L-1). MB removal was greater than 90% in both acidic and basic pH. The optimum result of MB removal was found at 5-7 g L-1 DAB concentration. DAB removes 86% dye in 5 minutes under static conditions and nearly 100% in 24 hours when agitated at 150 rpm. The highest adsorption capacity was found 139.11 mg g(-1) at 2,000 mg L-1 initial MB concentration. The process attained equilibrium in 24 hours. It is an endothermic process whose spontaneity increases with temperature. MB biosorption by DAB follows pseudo-second order kinetics. Artificial neural network (ANN) model also validates the experimental dye removal efficiency (R-2 = 0.97) corresponding with theoretically predicted values. Sensitivity analysis suggests that temperature and agitation speed affect the process most with 23.62% and 21.08% influence on MB biosorption, respectively. Dye adsorption capacity of DAB in fixed bed column was 107.57 mg g(-1) in preliminary study while it went up to 139.11 mg g(-1) in batch studies. The probable mechanism for biosorption in this study is chemisorptions via surface active charges in the initial phase followed by physical sorption by occupying pores of DAB.	[Maurya, Rahulkumar; Ghosh, Tonmoy; Paliwal, Chetan; Shrivastav, Anupama; Chokshi, Kaumeel; Pancha, Imran; Mishra, Sandhya] CSIR, Cent Salt & Marine Chem Res Inst, Discipline Salt & Marine Chem, Bhavnagar, Gujarat, India; [Maurya, Rahulkumar; Ghosh, Tonmoy; Paliwal, Chetan; Chokshi, Kaumeel; Pancha, Imran; Ghosh, Arup; Mishra, Sandhya] CSIR, Cent Salt & Marine Chem Res Inst, Acad Sci & Innovat Res AcSIR, Bhavnagar, Gujarat, India; [Ghosh, Arup] CSIR, Cent Salt & Marine Chem Res Inst, Discipline Wasteland Res, Bhavnagar, Gujarat, India; [Shrivastav, Anupama] Korea Adv Inst Sci & Technol, Chem & Biomol Engn Dept, Bioenergy Engn Res Lab, Taejon 305701, South Korea	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Salt & Marine Chemical Research Institute (CSMCRI); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Salt & Marine Chemical Research Institute (CSMCRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Salt & Marine Chemical Research Institute (CSMCRI); Korea Advanced Institute of Science & Technology (KAIST)	Mishra, S (corresponding author), CSIR, Cent Salt & Marine Chem Res Inst, Discipline Salt & Marine Chem, GB Marg, Bhavnagar, Gujarat, India.	smishra@csmcri.org	Maurya, Rahulkumar/A-1835-2014; Pancha, Imran/AAT-6443-2021; Chokshi, Kaumeel/I-7341-2016; Paliwal, Chetan/B-1882-2015; Ghosh, Tonmoy/H-4996-2012; Mishra, Sandhya/D-1963-2010	Maurya, Rahulkumar/0000-0001-6767-303X; Chokshi, Kaumeel/0000-0003-4847-3707; Paliwal, Chetan/0000-0002-9818-8448; Ghosh, Tonmoy/0000-0001-9805-6229; Mishra, Sandhya/0000-0002-2412-4927; Ghosh, Arup/0000-0003-0656-6569	CSIR; Ministry of Earth Sciences [TLP 0096, CSC 0203, MLP 0016];  [CSC-0203]	CSIR(Council of Scientific & Industrial Research (CSIR) - India); Ministry of Earth Sciences; 	The authors (RM TG CP AS KC IP AG SM) would like to acknowledge CSIR & Ministry of Earth Sciences for providing the financial support through NMITLI project no. TLP 0096, SIP project no. CSC 0203 and network project no. MLP 0016. RM, CP, TG, and IP also acknowledge CSIR for their Senior Research Fellowship. KC acknowledges CSC-0203 for his fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber S, 2009, J HAZARD MATER, V171, P484, DOI 10.1016/j.jhazmat.2009.06.025; Al-Degs YS, 2008, DYES PIGMENTS, V77, P16, DOI 10.1016/j.dyepig.2007.03.001; Al-Ghouti MA, 2009, J HAZARD MATER, V165, P589, DOI 10.1016/j.jhazmat.2008.10.018; Aleboyeh A, 2008, DYES PIGMENTS, V77, P288, DOI 10.1016/j.dyepig.2007.05.014; [Anonymous], 2010, J CHEM PHARM RES; Ashkenazy R, 1997, BIOTECHNOL BIOENG, V55, P1, DOI 10.1002/(SICI)1097-0290(19970705)55:1<1::AID-BIT1>3.0.CO;2-H; Banat F, 2003, PROCESS BIOCHEM, V39, P193, DOI 10.1016/S0032-9592(03)00065-7; Celekli A, 2012, BIORESOURCE TECHNOL, V103, P64, DOI 10.1016/j.biortech.2011.09.106; Chen KC, 2003, J BIOTECHNOL, V101, P57, DOI 10.1016/S0168-1656(02)00303-6; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Darzins A., 2010, CURRENT STATUS POTEN; Demir GK, 2012, NEURAL NETW WORLD, V22, P479, DOI 10.14311/NNW.2012.22.029; Dheetcha A, 2008, CURR MICROBIOL, V57, P508, DOI 10.1007/s00284-008-9277-7; Fernandez ME, 2012, BIORESOURCE TECHNOL, V106, P55, DOI 10.1016/j.biortech.2011.12.003; Fu YZ, 2001, BIORESOURCE TECHNOL, V79, P251, DOI 10.1016/S0960-8524(01)00028-1; Garg VK, 2004, DYES PIGMENTS, V63, P243, DOI 10.1016/j.dyepig.2004.03.005; Garson G.D., 1991, AI EXPERT, V6, P46; Gong RM, 2005, DYES PIGMENTS, V64, P187, DOI 10.1016/j.dyepig.2004.05.005; Gunasekar V, 2012, J CHEM, V2013; Guo YP, 2005, DYES PIGMENTS, V66, P123, DOI 10.1016/j.dyepig.2004.09.014; Gupta VK, 2004, SEP PURIF TECHNOL, V40, P87, DOI 10.1016/j.seppur.2004.01.008; Hao OJ, 2000, CRIT REV ENV SCI TEC, V30, P449, DOI 10.1080/10643380091184237; Hisarli G, 2005, J COLLOID INTERF SCI, V281, P18, DOI 10.1016/j.jcis.2004.08.089; Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5; Ibrahim OM., 2013, J APPL SCI RES, V9, P5692, DOI DOI 10.1067/MMT.2002.123333; Kannan N, 2001, DYES PIGMENTS, V51, P25, DOI 10.1016/S0143-7208(01)00056-0; Karaca S, 2008, MICROPOR MESOPOR MAT, V115, P376, DOI 10.1016/j.micromeso.2008.02.008; Khataee AR, 2010, BIORESOURCE TECHNOL, V101, P2252, DOI 10.1016/j.biortech.2009.11.079; Khodaie M, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/383985; Kumar KV, 2007, J HAZARD MATER, V146, P214, DOI 10.1016/j.jhazmat.2006.12.010; Kumar PS, 2014, DESALIN WATER TREAT, P1; Lagergren S.K., 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332; Lee CK, 1997, J CHEM TECHNOL BIOT, V69, P93; LOW KS, 1995, BIORESOURCE TECHNOL, V52, P79, DOI 10.1016/0960-8524(95)00007-2; Mishra S, 2014, Patent Application, Patent No. [US20140099684 A1, 20140099684]; Mohan SV, 2008, BIOCHEM ENG J, V38, P61, DOI 10.1016/j.bej.2007.06.014; Otero M, 2005, SEP PURIF TECHNOL, V45, P86, DOI 10.1016/j.seppur.2005.02.011; Ponnusami V, 2008, J HAZARD MATER, V152, P276, DOI 10.1016/j.jhazmat.2007.06.107; Pota AA, 2000, CHEM ENG SCI, V55, P1399, DOI 10.1016/S0009-2509(99)00032-9; Rajeshwarisivaraj, 2002, BIORESOURCE TECHNOL, V85, P205, DOI 10.1016/S0960-8524(02)00089-5; Rashid N, 2013, BIOCHEM ENG J, V75, P101, DOI 10.1016/j.bej.2013.04.001; Rubin E, 2005, J CHEM TECHNOL BIOT, V80, P291, DOI 10.1002/jctb.1192; Saad B, 2003, MALAYS J CHEM, V5, P008; Sadaf S, 2014, J TAIWAN INST CHEM E, V45, P541, DOI 10.1016/j.jtice.2013.05.004; Sadaf S, 2014, DESALIN WATER TREAT, V52, P184, DOI 10.1080/19443994.2013.780985; Sarma GK, 2011, SEP SCI TECHNOL, V46, P1602, DOI 10.1080/01496395.2011.565012; Sharma YC, 2009, ENERG FUEL, V23, P2983, DOI 10.1021/ef9001132; Sundaraganesan N, 2004, INDIAN J PURE AP PHY, V42, P585; TANADA S, 1980, CHEM PHARM BULL, V28, P2503; Vadivelan V, 2005, J COLLOID INTERF SCI, V286, P90, DOI 10.1016/j.jcis.2005.01.007; Vilar VJP, 2007, J HAZARD MATER, V147, P120, DOI 10.1016/j.jhazmat.2006.12.055; Weber W.J., 1963, J SANIT ENG DIV, V89, P31, DOI [10.1061/JSEDAI.0000430, DOI 10.1061/JSEDAI.0000430]; Yang Y, 2014, INT J ENVIRON SCI TE, V11, P1093, DOI 10.1007/s13762-013-0306-0; Yang YY, 2011, BIORESOURCE TECHNOL, V102, P828, DOI 10.1016/j.biortech.2010.08.125	54	46	46	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109545	10.1371/journal.pone.0109545	http://dx.doi.org/10.1371/journal.pone.0109545			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310576	gold, Green Published, Green Submitted			2022-12-27	WOS:000343210300054
J	Peacock, O; Lee, AC; Cameron, F; Tarbox, R; Vafadar-Isfahani, N; Tufarelli, C; Lund, JN				Peacock, Oliver; Lee, Andrew C.; Cameron, Fraser; Tarbox, Rebecca; Vafadar-Isfahani, Natasha; Tufarelli, Cristina; Lund, Jonathan N.			Inflammation and MiR-21 Pathways Functionally Interact to Downregulate PDCD4 in Colorectal Cancer	PLOS ONE			English	Article							CYCLOOXYGENASE-2 INHIBITOR; SELECTIVE-INHIBITION; LIVER METASTASIS; ASPIRIN USE; EXPRESSION; CELLS; MICRORNA; MODEL; RISK; PROLIFERATION	Inflammation plays a direct role in colorectal cancer (CRC) progression; however the molecular mechanisms responsible for this effect are unclear. The inflammation induced cyclooxygenase 2 (COX-2) enzyme required for the production of Prostaglandin E2 (PGE(2)), can promote colorectal cancer by decreasing expression of the tumour suppressor gene Programmed Cell Death 4 (PDCD4). As PDCD4 is also a direct target of the oncogene microRNA-21 (miR-21) we investigated the relationship between the COX-2 and miR-21 pathways in colorectal cancer progression. Gene expression profile in tumour and paired normal mucosa from 45 CRC patients demonstrated that up-regulation of COX-2 and miR-21 in tumour tissue correlates with worse Dukes' stage. In vitro studies in colonic adenocarcinoma cells revealed that treatment with the selective COX-2 inhibitor NS398 significantly decreased miR-21 levels (p = 0.0067) and increased PDCD4 protein levels (p < 0.001), whilst treatment with PGE(2) up-regulated miR-21 expression (p = 0.019) and down-regulated PDCD4 protein (p < 0.05). These findings indicate that miR-21 is a component of the COX-2 inflammation pathway and that this pathway promotes worsening of disease stage in colorectal cancer by inducing accumulation of PGE(2) and increasing expression of miR-21 with consequent downregulation of the tumour suppressor gene PDCD4.	[Peacock, Oliver; Lee, Andrew C.; Cameron, Fraser; Tarbox, Rebecca; Vafadar-Isfahani, Natasha; Tufarelli, Cristina; Lund, Jonathan N.] Univ Nottingham, Royal Derby Hosp, Sch Med, Surg Grp,Div Med Sci & Grad Entry Med, Derby, England	University of Nottingham	Tufarelli, C (corresponding author), Univ Nottingham, Royal Derby Hosp, Sch Med, Surg Grp,Div Med Sci & Grad Entry Med, Derby, England.	cristina.tufarelli@nottingham.ac.uk	Tufarelli, Cristina/AAD-3265-2019; Lund, Jonathan/K-6631-2019	Tufarelli, Cristina/0000-0002-1053-4618; Lund, Jonathan/0000-0001-5195-2181	Derby Colorectal Cancer Fund	Derby Colorectal Cancer Fund	The work was supported by a donation from the Derby Colorectal Cancer Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2005, MOL PHARMACOL, V68, P317, DOI 10.1124/mol.105.011825; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bhatti I, 2011, J GASTROINTEST SURG, V15, P199, DOI 10.1007/s11605-010-1381-x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Chan AT, 2009, JAMA-J AM MED ASSOC, V302, P649, DOI 10.1001/jama.2009.1112; Chang KH, 2011, EUR J SURG ONCOL; Cmarik JL, 1999, P NATL ACAD SCI USA, V96, P14037, DOI 10.1073/pnas.96.24.14037; Elwood PC, 2009, LANCET, V373, P1301, DOI 10.1016/S0140-6736(09)60243-9; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Figueredo A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005390.pub2; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Foreman JE, 2009, MOL CARCINOGEN, V48, P942, DOI 10.1002/mc.20546; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Holmes MD, 2010, J CLIN ONCOL, V28, P1467, DOI 10.1200/JCO.2009.22.7918; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KIRKLAND SC, 1985, CANCER RES, V45, P3790; Kutchera W, 1996, P NATL ACAD SCI USA, V93, P4816, DOI 10.1073/pnas.93.10.4816; Leahy KM, 2002, CANCER RES, V62, P625; Leitzmann MF, 2002, CANCER EPIDEM BIOMAR, V11, P1108; Li M, 2001, CLIN CANCER RES, V7, P1010; Lin CJF, 2008, BIOCHEM BIOPH RES CO, V375, P315, DOI 10.1016/j.bbrc.2008.07.154; Lu L, 2014, MOL CANC RES; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; Ludwig K, 2013, VIRCHOWS ARCH, V462, P57, DOI 10.1007/s00428-012-1345-5; Masferrer JL, 2000, CANCER RES, V60, P1306; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Nagatsuka I, 2002, INT J CANCER, V100, P515, DOI 10.1002/ijc.10508; O'Callaghan G, 2008, BRIT J CANCER, V99, P502, DOI 10.1038/sj.bjc.6604490; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pisani P, 1997, CANCER EPIDEM BIOMAR, V6, P387; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Rothwell PM, 2011, OBSTET GYNECOL SURV, V66, P222, DOI 10.1097/OGX.0b013e318225cec2; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schetter AJ, 2010, CARCINOGENESIS, V31, P37, DOI 10.1093/carcin/bgp272; Schmid T, 2011, CARCINOGENESIS, V32, P1427, DOI 10.1093/carcin/bgr131; Sheng HM, 1997, J CLIN INVEST, V99, P2254, DOI 10.1172/JCI119400; Shin VY, 2011, CARCINOGENESIS, V32, P240, DOI 10.1093/carcin/bgq240; Singer II, 1998, GASTROENTEROLOGY, V115, P297, DOI 10.1016/S0016-5085(98)70196-9; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Smith G, 2002, P NATL ACAD SCI USA, V99, P9433, DOI 10.1073/pnas.122612899; Sonkoly E, 2008, CLIN EXP DERMATOL, V33, P312, DOI 10.1111/j.1365-2230.2008.02804.x; The Royal College of Pathologists U, 2007, DAT COL CANC; UK CR, 2011, BOW CANC SURV STAT; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Walsh JME, 2003, JAMA-J AM MED ASSOC, V289, P1288, DOI 10.1001/jama.289.10.1288; Wang P, 2009, CANCER RES, V69, P8157, DOI 10.1158/0008-5472.CAN-09-1996; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Yao M, 2004, BRIT J CANCER, V90, P712, DOI 10.1038/sj.bjc.6601489; Zhang ZH, 2001, ONCOGENE, V20, P4450, DOI 10.1038/sj.onc.1204588; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94	52	48	54	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110267	10.1371/journal.pone.0110267	http://dx.doi.org/10.1371/journal.pone.0110267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310697	gold, Green Submitted, Green Published			2022-12-27	WOS:000343210300103
J	Saisawang, C; Ketterman, AJ				Saisawang, Chonticha; Ketterman, Albert J.			Micro-Plasticity of Genomes As Illustrated by the Evolution of Glutathione Transferases in 12 Drosophila Species	PLOS ONE			English	Article							S-TRANSFERASES; SUPERGENE FAMILY; GENE FAMILY; FRUIT-FLY; MELANOGASTER; PHYLOGENY; INTERACTS; SIGNALS; STRESS; ROLES	Glutathione transferases (GST) are an ancient superfamily comprising a large number of paralogous proteins in a single organism. This multiplicity of GSTs has allowed the copies to diverge for neofunctionalization with proposed roles ranging from detoxication and oxidative stress response to involvement in signal transduction cascades. We performed a comparative genomic analysis using FlyBase annotations and Drosophila melanogaster GST sequences as templates to further annotate the GST orthologs in the 12 Drosophila sequenced genomes. We found that GST genes in the Drosophila subgenera have undergone repeated local duplications followed by transposition, inversion, and micro-rearrangements of these copies. The colinearity and orientations of the orthologous GST genes appear to be unique in many of the species which suggests that genomic rearrangement events have occurred multiple times during speciation. The high microplasticity of the genomes appears to have a functional contribution utilized for evolution of this gene family.	[Saisawang, Chonticha; Ketterman, Albert J.] Mahidol Univ, Inst Mol Biosci, Nakhon Pathom, Thailand	Mahidol University	Ketterman, AJ (corresponding author), Mahidol Univ, Inst Mol Biosci, Salaya Campus, Nakhon Pathom, Thailand.	albertketterman@yahoo.com			Mahidol University	Mahidol University	This work was supported by funding from Mahidol University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Aniya Y, 2011, DRUG METAB REV, V43, P292, DOI 10.3109/03602532.2011.552913; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Cho SG, 2001, J BIOL CHEM, V276, P12749, DOI 10.1074/jbc.M005561200; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cummins I, 2011, DRUG METAB REV, V43, P266, DOI 10.3109/03602532.2011.552910; Hahn MW, 2007, PLOS GENET, V3, P2135, DOI 10.1371/journal.pgen.0030197; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Jakobsson PJ, 1999, PROTEIN SCI, V8, P689, DOI 10.1110/ps.8.3.689; Kim J, 2006, BIOCHEM J, V398, P451, DOI 10.1042/BJ20060424; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Lan T, 2009, PLANT CELL, V21, P3749, DOI 10.1105/tpc.109.070219; Le Goff G, 2001, COMP BIOCHEM PHYS B, V129, P837, DOI 10.1016/S1096-4959(01)00392-X; Letsou A, 2005, DEV DYNAM, V232, P526, DOI 10.1002/dvdy.20307; Lin MF, 2007, GENOME RES, V17, P1823, DOI 10.1101/gr.6679507; Low WY, 2007, GENETICS, V177, P1363, DOI 10.1534/genetics.107.075838; Markow TA, 2007, GENETICS, V177, P1269, DOI 10.1534/genetics.107.074112; Morgenstern R, 2011, DRUG METAB REV, V43, P300, DOI 10.3109/03602532.2011.558511; Piano F, 1997, MOL PHYLOGENET EVOL, V7, P173, DOI 10.1006/mpev.1996.0387; Raza H, 2002, BIOCHEM J, V366, P45, DOI 10.1042/BJ20020533; Rife CL, 2001, CHEM-BIOL INTERACT, V133, P40; Ryoo K, 2004, J BIOL CHEM, V279, P43589, DOI 10.1074/jbc.M404359200; Saisawang C, 2012, BIOCHEM J, V442, P181, DOI 10.1042/BJ20111747; Schaeffer SW, 2008, GENETICS, V179, P1601, DOI 10.1534/genetics.107.086074; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Udomsinprasert R, 2004, BIOCHEM J, V383, P483, DOI 10.1042/BJ20040519; Vararattanavech A, 2007, BIOCHEM J, V406, P247, DOI 10.1042/BJ20070422; Walters KB, 2009, J HERED, V100, P742, DOI 10.1093/jhered/esp043; Wang T, 2001, J BIOL CHEM, V276, P20999, DOI 10.1074/jbc.M101355200; Wongtrakul J, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.10701; Wu Y, 2006, ONCOGENE, V25, P5787, DOI 10.1038/sj.onc.1209576	34	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109518	10.1371/journal.pone.0109518	http://dx.doi.org/10.1371/journal.pone.0109518			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310450	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210300053
J	Zhu, WL; Kan, X				Zhu, Wenliang; Kan, Xuan			Neural Network Cascade Optimizes MicroRNA Biomarker Selection for Nasopharyngeal Cancer Prognosis	PLOS ONE			English	Article							CIRCULATING MICRORNAS; DIAGNOSTICS	MicroRNAs (miRNAs) have been shown to be promising biomarkers in predicting cancer prognosis. However, inappropriate or poorly optimized processing and modeling of miRNA expression data can negatively affect prediction performance. Here, we propose a holistic solution for miRNA biomarker selection and prediction model building. This work introduces the use of a neural network cascade, a cascaded constitution of small artificial neural network units, for evaluating miRNA expression and patient outcome. A miRNA microarray dataset of nasopharyngeal carcinoma was retrieved from Gene Expression Omnibus to illustrate the methodology. Results indicated a nonlinear relationship between miRNA expression and patient death risk, implying that direct comparison of expression values is inappropriate. However, this method performs transformation of miRNA expression values into a miRNA score, which linearly measures death risk. Spearman correlation was calculated between miRNA scores and survival status for each miRNA. Finally, a nine-miRNA signature was optimized to predict death risk after nasopharyngeal carcinoma by establishing a neural network cascade consisting of 13 artificial neural network units. Area under the ROC was 0.951 for the internal validation set and had a prediction accuracy of 83% for the external validation set. In particular, the established neural network cascade was found to have strong immunity against noise interference that disturbs miRNA expression values. This study provides an efficient and easy-to-use method that aims to maximize clinical application of miRNAs in prognostic risk assessment of patients with cancer.	[Zhu, Wenliang] Harbin Med Univ, Affiliated Hosp 2, Inst Clin Pharmacol, Harbin, Peoples R China; [Kan, Xuan] Harbin Med Univ, Affiliated Hosp 2, Dept Otolaryngol, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Zhu, WL (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Inst Clin Pharmacol, Harbin, Peoples R China.	wenzwl@yeah.net			National Natural Science Foundation of China [31301136]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 31301136). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbod MF, 2007, J UROLOGY, V178, P1150, DOI 10.1016/j.juro.2007.05.122; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Boettger T, 2012, CIRC RES, V110, P1000, DOI 10.1161/CIRCRESAHA.111.247742; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cho WCS, 2010, INT J BIOCHEM CELL B, V42, P1273, DOI 10.1016/j.biocel.2009.12.014; De Cecco Loris, 2013, Critical Reviews in Oncogenesis, V18, P273; de Planell-Saguer M, 2011, ANAL CHIM ACTA, V699, P134, DOI 10.1016/j.aca.2011.05.025; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Hastie T., 2009, UNSUPERVISED LEARNIN; Hu XH, 2013, NAT REV UROL, V10, P174, DOI 10.1038/nrurol.2013.9; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Lisboa PJ, 2006, NEURAL NETWORKS, V19, P408, DOI 10.1016/j.neunet.2005.10.007; Liu N, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70102-X; Luque A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04882; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Okugawa Y, 2014, EXPERT REV MOL DIAGN, V28, P1; Pereira DM, 2013, DRUG DISCOV TODAY, V18, P282, DOI 10.1016/j.drudis.2012.10.002; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shen J, 2013, CANCER LETT, V329, P125, DOI 10.1016/j.canlet.2012.11.001; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; van Rooij E, 2014, EMBO MOL MED, V6, P851, DOI 10.15252/emmm.201100899; Wang JL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078393, 10.1371/journal.pone.0073683, 10.1371/journal.pone.0063924, 10.1371/journal.pone.0066563, 10.1371/journal.pone.0070587]; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Zhou X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102413	27	18	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110537	10.1371/journal.pone.0110537	http://dx.doi.org/10.1371/journal.pone.0110537			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310846	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210300120
J	Haesebaert, J; Lutringer-Magnin, D; Kalecinski, J; Barone, G; Jacquard, AC; Leocmach, Y; Regnier, V; Vanhems, P; Chauvin, F; Lasset, C				Haesebaert, Julie; Lutringer-Magnin, Delphine; Kalecinski, Julie; Barone, Giovanna; Jacquard, Anne-Carole; Leocmach, Yann; Regnier, Veronique; Vanhems, Philippe; Chauvin, Franck; Lasset, Christine			Disparities of Perceptions and Practices Related to Cervical Cancer Prevention and the Acceptability of HPV Vaccination According to Educational Level in a French Cross-Sectional Survey of 18-65 Years Old Women	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; PARENTAL ACCEPTANCE; PREDICTORS; KNOWLEDGE; ATTITUDES; DAUGHTERS; MORTALITY; CHILDREN; MOTHERS	Introduction: We aimed to study the relationships between educational level, women's knowledge about cervical cancer (CC), and acceptance of HPV vaccination for their daughters. Methods: We analysed data from a quantitative (self-administrated questionnaire) and qualitative (semi-structured interviews) cross-sectional study performed in 2008 among 1,229 French 18-65-year-old women recruited by general practitioners. Women were categorized into three educational level groups: low (LEL: 43.9%), medium (MEL: 33.4%) and high (HEL: 22.6%). Results: Knowledge about CC and its prevention was lower among LEL women. In the 180 mothers of 14-18-year-old daughters (99 LEL, 54 MEL, 45 HEL), acceptance of HPV vaccine was higher in LEL (60.4%) and MEL (68.6%) than in HEL mothers (46.8%). Among LEL mothers, those who were favourable to HPV vaccination were more likely to be young (OR = 8.44 [2.10-34.00]), to be vaccinated against hepatitis B (OR = 4.59 [1.14-18.52]), to have vaccinated their children against pneumococcus (OR = 3.52 [0.99-12.48]) and to present a history of abnormal Pap smear (OR = 6.71 [0.70-64.01]). Conclusion: Although LEL women had poorer knowledge about CC and its prevention, they were more likely to accept HPV vaccination than HEL mothers.	[Haesebaert, Julie; Lutringer-Magnin, Delphine; Barone, Giovanna; Vanhems, Philippe; Lasset, Christine] Univ Lyon 1, CNRS, UMR 5558, F-69365 Lyon, France; [Haesebaert, Julie; Lutringer-Magnin, Delphine; Barone, Giovanna; Lasset, Christine] Ctr Leon Berard, F-69373 Lyon, France; [Kalecinski, Julie; Regnier, Veronique; Chauvin, Franck] Inst Cancerol Loire, St Etienne, France; [Kalecinski, Julie; Regnier, Veronique; Chauvin, Franck] Univ St Etienne, IFR 143, St Etienne, France; [Jacquard, Anne-Carole; Leocmach, Yann] Sanofi Pasteur MSD, Lyon, France; [Vanhems, Philippe] Hosp Civils Lyon, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; UNICANCER; Centre Leon Berard; Institut de Cancerologie de la Loire; Universite Jean Monnet; Sanofi-Aventis; Sanofi France; CHU Lyon	Lasset, C (corresponding author), Univ Lyon 1, CNRS, UMR 5558, F-69365 Lyon, France.	christine.lasset@lyon.unicancer.fr	HAESEBAERT, JULIE/E-7141-2017; Haesebaert, Julie/AAN-1702-2020	HAESEBAERT, JULIE/0000-0001-9109-5604; Haesebaert, Julie/0000-0001-9109-5604; Regnier, veronique/0000-0002-0293-5606	La Ligue contre le cancer	La Ligue contre le cancer(Ligue nationale contre le cancer)	The work was supported by a grant by La Ligue contre le cancer http://www.ligue-cancer.net/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnack JL, 2010, WOMEN HEALTH ISS, V20, P28, DOI 10.1016/j.whi.2009.08.007; Bingham A, 2009, ARCH PEDIAT ADOL MED, V163, P455, DOI 10.1001/archpediatrics.2009.50; Chao C, 2009, AM J PUBLIC HEALTH, V99, P1137, DOI 10.2105/AJPH.2008.147876; Constantine NA, 2007, J ADOLESCENT HEALTH, V40, P108, DOI 10.1016/j.jadohealth.2006.10.007; Dahlstrom LA, 2010, INT J CANCER, V126, P500, DOI 10.1002/ijc.24712; Das A, 2010, VACCINE, V28, P1440, DOI 10.1016/j.vaccine.2009.11.041; Dempsey AF, 2006, PEDIATRICS, V117, P1486, DOI 10.1542/peds.2005-1381; Dempsey A, 2011, VACCINE, V29, P528, DOI 10.1016/j.vaccine.2010.10.051; Downs LS, 2010, GYNECOL ONCOL, V117, P486, DOI 10.1016/j.ygyno.2010.02.011; Duport N, 2005, DEPISTAGE CANC COL U; Gerend MA, 2007, SEX TRANSM DIS, V34, P468, DOI 10.1097/01.olq.0000245915.38315.bd; Haesebaert J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1034; HAS, 2008, REC COLL HAS VACC AN; HAS, 2010, ET LIEUX REC DEP CAN; INCA. Institut National du Cancer, 2009, FRANC FAC DEP CANC; INVS. Institut National de Veille Sanitaire, 2012, PROJ INC MORT CANC F; Lutringer-Magnin D, 2011, VACCINE, V29, P5322, DOI 10.1016/j.vaccine.2011.05.006; Marlow LAV, 2007, BRIT J CANCER, V97, P691, DOI 10.1038/sj.bjc.6603927; Marlow LAV, 2007, HUM VACCINES, V3, P171, DOI 10.4161/hv.3.5.4310; Marlow LAV, 2009, J ADOLESCENT HEALTH, V44, P446, DOI 10.1016/j.jadohealth.2008.09.011; Menvielle G, 2008, BRIT J CANCER, V98, P1012, DOI 10.1038/sj.bjc.6604274; Menvielle G, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-260; Ogilvie G, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000270; Olshen E, 2005, J ADOLESCENT HEALTH, V37, P248, DOI 10.1016/j.jadohealth.2005.05.016; Perkins RB, 2011, J WOMENS HEALTH, V20, P85, DOI 10.1089/jwh.2009.1919; Roberts SA, 2011, EPIDEMIOL INFECT, V139, P400, DOI 10.1017/S095026881000066X; Rosenthal SL, 2008, J ADOLESCENT HEALTH, V43, P239, DOI 10.1016/j.jadohealth.2008.06.009; Rousseau A, 2002, BEH, V19, P81; Shelton RC, 2013, J RELIG HEALTH, V52, P1120, DOI 10.1007/s10943-011-9553-x; Trim K, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/921236; UNESCO, 2006, IND STAND CLASS ED I; Waller J, 2006, CANCER EPIDEM BIOMAR, V15, P1257, DOI 10.1158/1055-9965.EPI-06-0041; Wu JP, 2010, J LOW GENIT TRACT DI, V14, P155, DOI 10.1097/LGT.0b013e3181d4e747	33	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109320	10.1371/journal.pone.0109320	http://dx.doi.org/10.1371/journal.pone.0109320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6ZS	25303180	gold, Green Published, Green Submitted			2022-12-27	WOS:000343730400051
J	Li, L; Yan, J; Xu, J; Liu, CQ; Zhen, ZJ; Chen, HW; Ji, Y; Wu, ZP; Hu, JY; Zheng, LM; Lau, WY				Li, Li; Yan, Jing; Xu, Jing; Liu, Chao-Qun; Zhen, Zuo-Jun; Chen, Huan-Wei; Ji, Yong; Wu, Zhi-Peng; Hu, Jian-Yuan; Zheng, Limin; Lau, Wan Yee			CXCL17 Expression Predicts Poor Prognosis and Correlates with Adverse Immune Infiltration in Hepatocellular Carcinoma	PLOS ONE			English	Article							CHEMOKINE; CANCER; TISSUE; CELLS; VCC-1; OVEREXPRESSION; VALIDATION; SURVIVAL	CXC ligand 17 (CXCL17) is a novel CXC chemokine whose clinical significance remains largely unknown. In the present study, we characterized the prognostic value of CXCL17 in patients with hepatocellular carcinoma (HCC) and evaluated the association of CXCL17 with immune infiltration. We examined CXCL17 expression in 227 HCC tissue specimens by immunohistochemical staining, and correlated CXCL17 expression patterns with clinicopathological features, prognosis, and immune infiltrate density (CD4 T cells, CD8 T cells, B cells, natural killer cells, neutrophils, macrophages). Kaplan-Meier survival analysis showed that both increased intratumoral CXCL17 (P-0.015 for overall survival [OS], P=0.003 for recurrence-free survival [RFS]) and peritumoral CXCL17 (P=0.002 for OS, P<0.001 for RFS) were associated with shorter OS and RFS. Patients in the CXCL171 W group had significantly lower 5-year recurrence rate compared with patients in the CXCL17hi9h group (peritumoral: 53.1% vs. 77.7%, P<0.001, intratumoral: 58.6% vs. 73.0%, P= 0.001, respectively). Multivariate Cox proportional hazards analysis identified peritumoral CXCL17 as an independent prognostic factor for both OS (hazard ratio [HR] = 2.066, 95% confidence interval [CI] = 1.296-3.292, P=0.002) and RFS (HR = 1.844, 95% CI = 1.218 2.793, P= 0.004). Moreover, CXCL17 expression was associated with more CD68 and less CD4 cell infiltration (both P<0.05). The combination of CXCL17 density and immune infiltration could be used to further classify patients into subsets with different prognosis for RFS. Our results provide the first evidence that tumor-infiltrating CXCL17 cell density is an independent prognostic factor that predicts both OS and RFS in HCC. CXCL17 production correlated with adverse immune infiltration and might be an important target for anti-HCC therapies.	[Li, Li; Zhen, Zuo-Jun; Chen, Huan-Wei; Ji, Yong; Wu, Zhi-Peng; Hu, Jian-Yuan; Lau, Wan Yee] First Peoples Hosp Foshan, Dept Hepat & Pancreat Surg, Foshan, Guangdong, Peoples R China; [Li, Li; Yan, Jing; Xu, Jing; Liu, Chao-Qun; Zheng, Limin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Lau, Wan Yee] Chinese Univ Hong Kong, Fac Med, Shatin, Hong Kong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Chinese University of Hong Kong	Zhen, ZJ (corresponding author), First Peoples Hosp Foshan, Dept Hepat & Pancreat Surg, Foshan, Guangdong, Peoples R China.	zzjun@fsyyy.com; josephlau@cuhk.edu.hk	zheng, limin/HGB-2510-2022	Zheng, Limin/0000-0002-8281-1450	Ministry of Health of China [2012ZX10002-011]; China Postdoctoral Science Foundation [2013M540676]; FoShan Postdoctoral Scientific Research project	Ministry of Health of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); FoShan Postdoctoral Scientific Research project	This work was supported by project grants from the Ministry of Health of China (LZ; 2012ZX10002-011; http://www.moh.gov.cn/publicfiles//business/htmlfiles/wsb/index.htm); China Postdoctoral Science Foundation (JY; 2013M540676; http://res.chinapostdoctor.org.cn/BshWeb/InnerPages_c5a0971c-60a5-4c35-917c-4b5526056791.shtml); and FoShan Postdoctoral Scientific Research project; (LL; 2013; http://www.fshrss.gov.cn/zwgk/tzgg/201312/t20131223_4501821.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abastado JP, 2012, CANCER RES, V72, P2159, DOI 10.1158/0008-5472.CAN-11-3538; Abel EJ, 2014, HUM PATHOL, V45, P1092, DOI 10.1016/j.humpath.2014.01.008; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bjorkstrom NK, 2010, TRENDS IMMUNOL, V31, P401, DOI 10.1016/j.it.2010.08.003; Bruix J, 2002, HEPATOLOGY, V35, P519, DOI 10.1053/jhep.2002.32089; Ding T, 2011, CANCER-AM CANCER SOC, V117, P4878, DOI 10.1002/cncr.26137; Ding T, 2009, HUM PATHOL, V40, P381, DOI 10.1016/j.humpath.2008.08.011; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Galon J, 2013, IMMUNITY, V39, P11, DOI 10.1016/j.immuni.2013.07.008; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Gao Q, 2012, CANCER RES, V72, P3546, DOI 10.1158/0008-5472.CAN-11-4032; Hiraoka N, 2011, GASTROENTEROLOGY, V140, P310, DOI 10.1053/j.gastro.2010.10.009; Huang F, 2010, WORLD J GASTROENTERO, V16, P1832, DOI 10.3748/wjg.v16.i15.1832; Huang W, 2013, HUM PATHOL, V44, P29, DOI 10.1016/j.humpath.2012.05.009; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kuang DM, 2007, BLOOD, V110, P587, DOI 10.1182/blood-2007-01-068031; Kuang DM, 2011, J HEPATOL, V54, P948, DOI 10.1016/j.jhep.2010.08.041; Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Lee WY, 2013, AM J PHYSIOL-ENDOC M, V304, pE32, DOI 10.1152/ajpendo.00083.2012; Li YW, 2011, J HEPATOL, V54, P497, DOI 10.1016/j.jhep.2010.07.044; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2009, CANCER CELL, V16, P173, DOI 10.1016/j.ccr.2009.08.014; Matsui A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044080; Mishra P, 2011, J LEUKOCYTE BIOL, V89, P31, DOI 10.1189/jlb.0310182; Mu X, 2009, ACTA BIOCH BIOPH SIN, V41, P631, DOI 10.1093/abbs/gmp051; Nicholson TM, 2013, DIFFERENTIATION, V85, P140, DOI 10.1016/j.diff.2013.02.006; Pisabarro MT, 2006, J IMMUNOL, V176, P2069, DOI 10.4049/jimmunol.176.4.2069; Poon D, 2009, LANCET ONCOL, V10, P1111, DOI 10.1016/S1470-2045(09)70241-4; Rotondi M, 2007, ENDOCR REV, V28, P492, DOI 10.1210/er.2006-0044; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Takeishi K, 2011, SURG TODAY, V41, P1016, DOI [10.1007/s00595-011-0058-8, 10.1007/s00595-010-4392-z]; Villanueva A, 2010, CLIN CANCER RES, V16, P4688, DOI 10.1158/1078-0432.CCR-09-1811; Weinstein EJ, 2006, BIOCHEM BIOPH RES CO, V350, P74, DOI 10.1016/j.bbrc.2006.08.194; Xu J, 2012, J HEPATOL, V57, P313, DOI 10.1016/j.jhep.2012.03.027; Yan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058006; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zhou SL, 2012, HEPATOLOGY, V56, P2242, DOI 10.1002/hep.25907; Zhou ZT, 2012, BIOCHEM BIOPH RES CO, V420, P336, DOI 10.1016/j.bbrc.2012.02.160; Zhu XD, 2008, J CLIN ONCOL, V26, P2707, DOI 10.1200/JCO.2007.15.6521	42	41	43	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110064	10.1371/journal.pone.0110064	http://dx.doi.org/10.1371/journal.pone.0110064			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303284	gold, Green Submitted, Green Published			2022-12-27	WOS:000343730400107
J	Yang, XB; Duan, QH; Wang, JJ; Zhang, ZB; Jiang, GF				Yang, Xiaobing; Duan, Qionghong; Wang, Jianjie; Zhang, Zhengbin; Jiang, Gaofeng			Seasonal Variation of Newly Notified Pulmonary Tuberculosis Cases from 2004 to 2013 in Wuhan, China	PLOS ONE			English	Article							VITAMIN-D; CHEMICAL CHARACTERISTICS; DIESEL EXHAUST; DISEASES; HEALTH; PM2.5	Background: Although there was a report about the seasonal variation in Wuhan city, it only analyzed the prevalence data of pulmonary tuberculosis (TB) cases, and just studied the seasonality by subgroup of smear positive and negative from 2006 to 2010 by spectral analysis. In this study, we investigated the seasonality of the total newly notified pulmonary TB cases by subgroups such as time period, sex, age, occupation, district, and sputum smear result from 2004 to 2013 in Wuhan by a popular seasonal adjustment model (TRAMO-SEATS). Methods: Monthly pulmonary TB cases from 2004 to 2013 in Wuhan were analyzed by the TRAMO-SEATS seasonal adjustment program. Seasonal amplitude was calculated and compared within the subgroups. Results: From 2004 to 2013, there were 77.76 thousand newly notified pulmonary TB cases in Wuhan, China. There was a dominant peak spring peak (March) with seasonal amplitude of 56.81% and a second summer peak (September) of 43.40%, compared with the trough month (December). The spring seasonal amplitude in 2004-2008 was higher than that of 2009-2013(P<0.05). There were no statistical differences for spring seasonal amplitude within subgroups of gender, age, district, and sputum smear result (P>0.05). However, there were significant differences in spring seasonal amplitude by occupation, with amplitude ranging from 59.37% to 113.22% (P<0.05). The summer seasonal amplitude in 2004-2008 was higher than that of 2009-2013(P<0.05). There were no statistical differences in summer seasonal amplitude within subgroups of gender, district, sputum smear result(P<0.05). There were significant differences in summer seasonal amplitude by age, with amplitude ranging from 36.05% to 100.09% (P<0.05). Also, there were significant differences in summer seasonal amplitude by occupation, with amplitude ranging from 43.40% to 109.88% (P<0.05). Conclusions: There was an apparent seasonal variation in pulmonary TB cases in Wuhan. We speculated that spring peak in our study was most likely caused by the increased reactivation of the latent TB due to vitamin D deficiency and high PM2.5 concentration, while the summer peak was mainly resulted from the enhanced winter transmission due to indoor crowding in winter, overcrowding of public transportation over the period of the Spring Festival and health care seeking delay in winter.	[Duan, Qionghong; Wang, Jianjie; Zhang, Zhengbin] Wuhan TB Inst, Dept TB Control, Wuhan, Hubei, Peoples R China; [Yang, Xiaobing] Wuhan Ctr Dis Prevent & Control, Dept Infect Dis Prevent & Control, Wuhan, Hubei, Peoples R China; [Jiang, Gaofeng] Wuhan Univ Sci & Technol, Coll Med, Sch Publ Hlth, Wuhan, Hubei, Peoples R China	Wuhan University of Science & Technology	Duan, QH (corresponding author), Wuhan TB Inst, Dept TB Control, Wuhan, Hubei, Peoples R China.	lsdqh@mails.tjmu.edu.cn						Akhtar S, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-3; Ane-Anyangwe I N, 2006, East Afr Med J, V83, P588; Atun RA, 2005, EUR J PUBLIC HEALTH, V15, P350, DOI 10.1093/eurpub/cki018; Borgdorff MW, 2011, INT J EPIDEMIOL, V40, P964, DOI 10.1093/ije/dyr058; Chen Z, 2009, DI LI KE XUE, V29, P911; Choi CJ, 2013, J CLIN ENDOCR METAB, V98, P1703, DOI 10.1210/jc.2012-3901; DAVIES PDO, 1985, TUBERCLE, V66, P301, DOI 10.1016/0041-3879(85)90068-6; Douglas AS, 1996, THORAX, V51, P944, DOI 10.1136/thx.51.9.944; Duan QiongHong, 2011, Acta Medicinae Universitatis Scientiae et Technologiae Huazhong, V40, P231; Edelson PJ, 2011, TRAVEL MED INFECT DI, V9, P27, DOI 10.1016/j.tmaid.2010.11.001; Eurostat, 2002, SEAS ADJ INT TRAM SE; Hiramatsu K, 2005, EXP LUNG RES, V31, P405, DOI 10.1080/01902140590918786; Hungarian Central Statistical Office, 2007, SEAS ADJ METH PRACT; Kelsey MC, 1999, THORAX, V54, P862; Leung CC, 2005, INT J EPIDEMIOL, V34, P924, DOI 10.1093/ije/dyi080; Li XZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068102, 10.1371/journal.pone.0067744]; Luo TY, 2013, EPIDEMIOL INFECT, P1; Luquero FJ, 2008, INT J TUBERC LUNG D, V12, P221; Lv XP, 2013, HUNAN KE JI DA XUE X, V28, P104; Martinez L, 2010, TRAVEL MED INFECT DI, V8, P84, DOI 10.1016/j.tmaid.2009.02.005; Mehra M, 2013, INT J TUBERC LUNG D, V17, P1186, DOI 10.5588/ijtld.12.0959; Mohan AK, 2004, CLIN INFECT DIS, V39, P295, DOI 10.1086/421494; Mohr O, 2012, EUROSURVEILLANCE, V17, P12; Nagayama N, 2006, INT J TUBERC LUNG D, V10, P1117; Naranbat N, 2009, EUR RESPIR J, V34, P921, DOI 10.1183/09031936.00035309; Pasco JA, 2004, J BONE MINER RES, V19, P752, DOI 10.1359/JBMR.040125; Rios M, 2000, EUR J EPIDEMIOL, V16, P483, DOI 10.1023/A:1007653329972; Saito Y, 2002, EXP LUNG RES, V28, P201, DOI 10.1080/019021402753570509; Smith GS, 2014, INT J ENVIRON HEAL R, V24, P103, DOI 10.1080/09603123.2013.800959; Song YC, 1998, HUA ZHONG SHI FAN DA, V32, P105; STRACHAN DP, 1995, THORAX, V50, P175, DOI 10.1136/thx.50.2.175; Sun YL, 2006, ENVIRON SCI TECHNOL, V40, P3148, DOI 10.1021/es051533g; Sun YL, 2004, ATMOS ENVIRON, V38, P5991, DOI 10.1016/j.atmosenv.2004.07.009; Tan JH, 2009, J ENVIRON SCI-CHINA, V21, P774, DOI 10.1016/S1001-0742(08)62340-2; Thorpe LE, 2004, LANCET, V364, P1613, DOI 10.1016/S0140-6736(04)17316-9; Wacker M, 2013, DERM-ENDOCRINOL, V5, DOI [10.4161/derm.24476, 10.4161/derm.24494]; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Willis MD, 2012, CLIN INFECT DIS, V54, P1553, DOI 10.1093/cid/cis235; Wingfield T, 2014, J INFECT DIS, V210, P774, DOI 10.1093/infdis/jiu121; World Health Organization, 2013, WHOHTMTB201311; Zhang A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080969, 10.1371/journal.pone.0063486, 10.1371/journal.pone.0059428, 10.1371/journal.pone.0059254, 10.1371/journal.pone.0064689]	41	17	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108369	10.1371/journal.pone.0108369	http://dx.doi.org/10.1371/journal.pone.0108369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303675	gold, Green Published, Green Submitted			2022-12-27	WOS:000343730400011
J	Zhao, N; Zhu, DH				Zhao, Nan; Zhu, Donghui			Collagen Self-Assembly on Orthopedic Magnesium Biomaterials Surface and Subsequent Bone Cell Attachment	PLOS ONE			English	Article							IN-VIVO CORROSION; ALLOYS; TITANIUM; ROUGHNESS; BEHAVIOR; VITRO; DIFFERENTIATION; FABRICATION; SCAFFOLDS; SUBSTRATE		[Zhao, Nan; Zhu, Donghui] North Carolina Agr & Tech State Univ, Dept Chem Biol & Bio Engn, Greensboro, NC 27411 USA; [Zhao, Nan; Zhu, Donghui] North Carolina Agr & Tech State Univ, NSF Engn Res Ctr Revolutionizing Metall Biomat, Greensboro, NC USA	University of North Carolina; North Carolina A&T State University; National Science Foundation (NSF); University of North Carolina; North Carolina A&T State University	Zhu, DH (corresponding author), North Carolina Agr & Tech State Univ, Dept Chem Biol & Bio Engn, Greensboro, NC 27411 USA.	dzhu@ncat.edu	Zhao, Nan/GMX-1019-2022; Zhu, Donghui/H-9058-2017	Zhu, Donghui/0000-0002-3057-1889	National Institute of Health [SC2NS082475]; NSF Engineering Research Center-Revolutionizing Metallic Biomaterials (ERC-RMB) at North Carolina A&T State University [NSF-0812348]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [SC2NS082475] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Engineering Research Center-Revolutionizing Metallic Biomaterials (ERC-RMB) at North Carolina A&T State University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge funding from the National Institute of Health (SC2NS082475) and support from NSF Engineering Research Center-Revolutionizing Metallic Biomaterials (ERC-RMB) (NSF-0812348) at North Carolina A&T State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2; Ao HY, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0070; Bornapour M, 2013, ACTA BIOMATER, V9, P5319, DOI 10.1016/j.actbio.2012.07.045; Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9; Castellani C, 2011, ACTA BIOMATER, V7, P432, DOI 10.1016/j.actbio.2010.08.020; Chen XN, 2013, BIOMATERIALS, V34, P8203, DOI 10.1016/j.biomaterials.2013.07.035; Choudhary L, 2012, ACTA BIOMATER, V8, P916, DOI 10.1016/j.actbio.2011.10.031; Cisneros DA, 2006, J STRUCT BIOL, V154, P232, DOI 10.1016/j.jsb.2006.02.006; Fang M, 2013, LANGMUIR, V29, P2330, DOI 10.1021/la3048104; Ferreira AM, 2009, ACTA MICROSC, V18, P278; Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014; Franz CM, 2011, METHODS MOL BIOL, V736, P97, DOI 10.1007/978-1-61779-105-5_7; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Gu XN, 2012, ACTA BIOMATER, V8, P2360, DOI 10.1016/j.actbio.2012.02.018; Hanada K, 2013, MAT SCI ENG C-MATER, V33, P4746, DOI 10.1016/j.msec.2013.07.033; He LR, 2012, J INORG BIOCHEM, V117, P124, DOI 10.1016/j.jinorgbio.2012.08.017; Huang HH, 2004, BIOMOL ENG, V21, P93, DOI 10.1016/j.bioeng.2004.05.001; Ji DW, 2013, MATER SCI TECH-LOND, V29, P480, DOI 10.1179/1743284712Y.0000000165; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; Kadler KE, 1996, BIOCHEM J, V316, P1; Kim HW, 2005, J BIOMED MATER RES A, V75A, P629, DOI 10.1002/jbm.a.30463; Kim WY, 2014, MAT SCI ENG A-STRUCT, V594, P189, DOI 10.1016/j.msea.2013.11.066; Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Leow WW, 2011, LANGMUIR, V27, P10907, DOI 10.1021/la2018055; Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021; Loo RW, 2008, LANGMUIR, V24, P13276, DOI 10.1021/la803041v; Mao L, 2012, MATER LETT, V88, P1, DOI 10.1016/j.matlet.2012.08.012; MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314; Matschegewski C, 2010, BIOMATERIALS, V31, P5729, DOI 10.1016/j.biomaterials.2010.03.073; Mendonca DBS, 2011, BONE, V49, P463, DOI 10.1016/j.bone.2011.04.019; Narayanan B, 2014, LANGMUIR, V30, P1343, DOI 10.1021/la4043364; Nassif N, 2010, CHEM MATER, V22, P3307, DOI 10.1021/cm903594n; NEBE JB, 2007, METALLIC BIOMATERIAL, P215; Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875; O'Leary LER, 2011, NAT CHEM, V3, P821, DOI [10.1038/NCHEM.1123, 10.1038/nchem.1123]; Perez P, 2013, CORROS SCI, V69, P226, DOI 10.1016/j.corsci.2012.12.007; Reznikov N, 2013, BONE, V52, P676, DOI 10.1016/j.bone.2012.10.034; Sader MS, 2013, MAT SCI ENG C-MATER, V33, P4188, DOI 10.1016/j.msec.2013.06.006; Seitz JM, 2012, ACTA BIOMATER, V8, P3852, DOI 10.1016/j.actbio.2012.05.024; Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003; Stephanopoulos N, 2013, ACTA MATER, V61, P912, DOI 10.1016/j.actamat.2012.10.046; Walter R, 2013, APPL SURF SCI, V279, P343, DOI 10.1016/j.apsusc.2013.04.096; Walter R, 2011, MATER DESIGN, V32, P2350, DOI 10.1016/j.matdes.2010.12.016; Wang L, 2014, J PHYS CHEM B, V118, P511, DOI 10.1021/jp405035x; Wang ZL, 2013, P I MECH ENG H, V227, P1094, DOI 10.1177/0954411913493845; Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049; Wu LL, 2014, ACTA BIOMATER, V10, P2843, DOI 10.1016/j.actbio.2014.02.010; Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273; Xu SW, 2011, SCRIPTA MATER, V65, P269, DOI 10.1016/j.scriptamat.2011.04.026; Zhao N, 2013, INT J BIOMED ENG TEC, V12, P382, DOI 10.1504/IJBET.2013.057677; Zhao N, 2014, INT J MOL SCI, V15, P5263, DOI 10.3390/ijms15045263; Zheng YF, 2014, MAT SCI ENG R, V77, P1, DOI 10.1016/j.mser.2014.01.001	54	26	28	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110420	10.1371/journal.pone.0110420	http://dx.doi.org/10.1371/journal.pone.0110420			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303459	Green Submitted, gold, Green Published			2022-12-27	WOS:000343730400130
J	de Sousa, F; Bertrand, YJK; Nylinder, S; Oxelman, B; Eriksson, JS; Pfeil, BE				de Sousa, Filipe; Bertrand, Yann J. K.; Nylinder, Stephan; Oxelman, Bengt; Eriksson, Jonna S.; Pfeil, Bernard E.			Phylogenetic Properties of 50 Nuclear Loci in Medicago (Leguminosae) Generated Using Multiplexed Sequence Capture and Next-Generation Sequencing	PLOS ONE			English	Article							NUCLEOTIDE SUBSTITUTION; ENRICHMENT STRATEGIES; ARABIDOPSIS-THALIANA; INFERRING PHYLOGENY; FLOWERING PLANTS; MODEL SELECTION; EVOLUTION; BIOLOGY; RATES; DNA	Next-generation sequencing technology has increased the capacity to generate molecular data for plant biological research, including phylogenetics, and can potentially contribute to resolving complex phylogenetic problems. The evolutionary history of Medicago L. (Leguminosae: Trifoliae) remains unresolved due to incongruence between published phylogenies. Identification of the processes causing this genealogical incongruence is essential for the inference of a correct species phylogeny of the genus and requires that more molecular data, preferably from low-copy nuclear genes, are obtained across different species. Here we report the development of 50 novel LCN markers in Medicago and assess the phylogenetic properties of each marker. We used the genomic resources available for Medicago truncatula Gaertn., hybridisation-based gene enrichment (sequence capture) techniques and Next-Generation Sequencing to generate sequences. This alternative proves to be a cost-effective approach to amplicon sequencing in phylogenetic studies at the genus or tribe level and allows for an increase in number and size of targeted loci. Substitution rate estimates for each of the 50 loci are provided, and an overview of the variation in substitution rates among a large number of low-copy nuclear genes in plants is presented for the first time. Aligned sequences of major species lineages of Medicago and its sister genus are made available and can be used in further probe development for sequence-capture of the same markers.	[de Sousa, Filipe; Bertrand, Yann J. K.; Oxelman, Bengt; Eriksson, Jonna S.; Pfeil, Bernard E.] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Nylinder, Stephan] Swedish Museum Nat Hist, Dept Bot, S-10405 Stockholm, Sweden	University of Gothenburg; Swedish Museum of Natural History	de Sousa, F (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	filipedeportugal@gmail.com	Bertrand, Yann/R-5850-2018; Pfeil, Bernard E/C-1108-2008	Bertrand, Yann/0000-0001-6593-6959; Pfeil, Bernard E/0000-0001-8179-2270; Nylinder, Stephan/0000-0001-5199-7128; Sousa, Filipe/0000-0003-4681-8951	Swedish Research Council; Royal Swedish Academy of Sciences [2009-5206]; Lars Hiertas Minne fund; Royal Physiographic Society in Lund; Helge Ax:son Johnsons fund; Lundgrenska fund; P. A. Larssons fund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Swedish Academy of Sciences; Lars Hiertas Minne fund; Royal Physiographic Society in Lund; Helge Ax:son Johnsons fund; Lundgrenska fund; P. A. Larssons fund	This work was supported by grants from the Swedish Research Council, the Royal Swedish Academy of Sciences (grant 2009-5206), Lars Hiertas Minne fund, The Royal Physiographic Society in Lund, Helge Ax:son Johnsons fund, and the Lundgrenska fund to B. E. P; from the P. A. Larssons fund and Lars Hiertas Minne fund to F. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Bacon CD, 2008, MOL ECOL RESOUR, V8, P211, DOI 10.1111/j.1471-8286.2007.01928.x; Bena G, 1998, J MOL EVOL, V46, P299, DOI 10.1007/PL00006306; Bena G, 2001, PLANT SYST EVOL, V229, P217, DOI 10.1007/s006060170012; Carstens BC, 2013, MOL ECOL, V22, P4014, DOI 10.1111/mec.12347; Chung Y, 2012, U C BERKELEY DIVISIO; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Cronn R, 2002, THEOR APPL GENET, V104, P482, DOI 10.1007/s001220100741; Cronn R, 2012, AM J BOT, V99, P291, DOI 10.3732/ajb.1100356; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dos Reis M, 2014, SYST BIOL, V63, P555, DOI 10.1093/sysbio/syu020; Downie SR, 1998, CAN J BOT, V76, P791, DOI 10.1139/cjb-76-5-791; Doyle JJ, 2013, S AFR J BOT, V89, P10, DOI 10.1016/j.sajb.2013.06.012; Eaton DAR, 2013, SYST BIOL, V62, P689, DOI 10.1093/sysbio/syt032; Egan AN, 2012, AM J BOT, V99, P175, DOI 10.3732/ajb.1200020; Enk JM, 2014, MOL BIOL EVOL, V31, P1292, DOI 10.1093/molbev/msu074; Fourment M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-1; Grover CE, 2015, GENET RESOUR CROP EV, V62, P103, DOI 10.1007/s10722-014-0138-x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guschanski K, 2013, SYST BIOL, V62, P539, DOI 10.1093/sysbio/syt018; Hughes CE, 2006, PHILOS T R SOC B, V361, P211, DOI 10.1098/rstb.2005.1735; Kallersjo M, 1999, CLADISTICS, V15, P91; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; Kepler RM, 2013, MOL ECOL RESOUR, V13, P210, DOI 10.1111/1755-0998.12058; Knight R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r171; Kolaczkowski B, 2004, NATURE, V431, P980, DOI 10.1038/nature02917; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lancaster LT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-162; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Lemmon AR, 2012, SYST BIOL, V61, P727, DOI 10.1093/sysbio/sys049; Lemmon AR, 2012, SYST BIOL, V61, P745, DOI 10.1093/sysbio/sys051; Li CH, 2013, BIOTECHNIQUES, V54, P321, DOI 10.2144/000114039; Lopez P, 2002, MOL BIOL EVOL, V19, P1; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Mandel JR, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1300085; Maureira-Butler IJ, 2008, SYST BIOL, V57, P466, DOI 10.1080/10635150802172168; McCormack JE, 2013, MOL PHYLOGENET EVOL, V66, P526, DOI 10.1016/j.ympev.2011.12.007; McMahon MM, 2006, SYST BIOL, V55, P818, DOI 10.1080/10635150600999150; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Salichos L, 2013, NATURE, V497, P327, DOI 10.1038/nature12130; Sang T, 2002, CRIT REV BIOCHEM MOL, V37, P121, DOI 10.1080/10409230290771474; Schneeberger K, 2011, P NATL ACAD SCI USA, V108, P10249, DOI 10.1073/pnas.1107739108; Small E., 2011, ALFALFA RELATIVES EV; Small RL, 1998, AM J BOT, V85, P1301, DOI 10.2307/2446640; Small RL, 2004, AUST SYST BOT, V17, P145, DOI 10.1071/SB03015; Smith BT, 2014, SYST BIOL, V63, P83, DOI 10.1093/sysbio/syt061; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Staats M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069189; Steele KP, 2010, AM J BOT, V97, P1142, DOI 10.3732/ajb.1000009; Steele KP, 2003, ADV LEGUME SYSTEMATI, V10, P355; Stefanovic S, 2009, SYST BOT, V34, P115, DOI 10.1600/036364409787602221; Straub SCK, 2012, AM J BOT, V99, P349, DOI 10.3732/ajb.1100335; Stull GW, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200497; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Team RC, 2012, R LANG ENV STAT COMP; Thomson RC, 2009, SYST BIOL, V59, P42, DOI DOI 10.1093/SYSBI0/; Wang XQ, 2013, MOL ECOL RESOUR, V13, P938, DOI 10.1111/1755-0998.12136; Weitemier K, 2014, SCIENCES, V2; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085; Yoder JB, 2013, SYST BIOL, V62, P424, DOI 10.1093/sysbio/syt009; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zhang LQ, 2002, MOL BIOL EVOL, V19, P1464, DOI 10.1093/oxfordjournals.molbev.a004209	64	37	37	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109704	10.1371/journal.pone.0109704	http://dx.doi.org/10.1371/journal.pone.0109704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329401	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204100019
J	Hsu, WL				Hsu, Wei-Li			Adaptive Postural Control for Joint Immobilization during Multitask Performance	PLOS ONE			English	Article							AGE-RELATED-CHANGES; MOTOR ABUNDANCE; QUIET STANCE; COORDINATION; BALANCE; SYNERGIES; INSTABILITY; CONTACT; SYSTEMS; SUPPORT	Motor abundance is an essential feature of adaptive control. The range of joint combinations enabled by motor abundance provides the body with the necessary freedom to adopt different positions, configurations, and movements that allow for exploratory postural behavior. This study investigated the adaptation of postural control to joint immobilization during multi-task performance. Twelve healthy volunteers (6 males and 6 females; 21-29 yr) without any known neurological deficits, musculoskeletal conditions, or balance disorders participated in this study. The participants executed a targeting task, alone or combined with a ball-balancing task, while standing with free or restricted joint motions. The effects of joint configuration variability on center of mass (COM) stability were examined using uncontrolled manifold (UCM) analysis. The UCM method separates joint variability into two components: the first is consistent with the use of motor abundance, which does not affect COM position (VUCM); the second leads to COM position variability (VORT). The analysis showed that joints were coordinated such that their variability had a minimal effect on COM position. However, the component of joint variability that reflects the use of motor abundance to stabilize COM (VUCM) was significant decreased when the participants performed the combined task with immobilized joints. The component of joint variability that leads to COM variability (VORT) tended to increase with a reduction in joint degrees of freedom. The results suggested that joint immobilization increases the difficulty of stabilizing COM when multiple tasks are performed simultaneously. These findings are important for developing rehabilitation approaches for patients with limited joint movements.	[Hsu, Wei-Li] Natl Taiwan Univ, Coll Med, Sch & Grad Inst Phys Therapy, Taipei 10764, Taiwan; [Hsu, Wei-Li] Natl Taiwan Univ, Phys Therapy Ctr, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Hsu, WL (corresponding author), Natl Taiwan Univ, Coll Med, Sch & Grad Inst Phys Therapy, Taipei 10764, Taiwan.	wlhsu@ntu.edu.tw		Hsu, Wei-Li/0000-0003-4577-140X	National Science Council in Taiwan [NSC101-2320-B002-004-MY3]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council in Taiwan (NSC101-2320-B002-004-MY3). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baroni G, 2001, J APPL PHYSIOL, V90, P205, DOI 10.1152/jappl.2001.90.1.205; Bernstein N, 1967, COORDINATION REGULAT; Buchanan JJ, 1999, J MOTOR BEHAV, V31, P126, DOI 10.1080/00222899909600984; Buchanan JJ, 2004, EXP BRAIN RES, V156, P39, DOI 10.1007/s00221-003-1763-3; Clapp S, 1999, EXP BRAIN RES, V125, P521, DOI 10.1007/s002210050711; de Freitas PB, 2009, HUM MOVEMENT SCI, V28, P515, DOI 10.1016/j.humov.2009.02.001; Decker LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041306; Domkin D, 2005, EXP BRAIN RES, V163, P44, DOI 10.1007/s00221-004-2137-1; Hsu WL, 2007, J NEUROPHYSIOL, V97, P3024, DOI 10.1152/jn.01142.2006; Hsu WL, 2014, EUR J APPL PHYSIOL, V114, P261, DOI 10.1007/s00421-013-2768-7; Hsu WL, 2013, AGE, V35, P1299, DOI 10.1007/s11357-012-9422-x; Hsu WL, 2012, HUM MOVEMENT SCI, V31, P844, DOI 10.1016/j.humov.2011.07.017; Hsu WL, 2012, HUM MOV SCI; Hsu WL, 2012, AGE; Hu XG, 2011, J APPL PHYSIOL, V111, P1671, DOI 10.1152/japplphysiol.00760.2011; JEKA JJ, 1994, EXP BRAIN RES, V100, P495, DOI 10.1007/BF02738408; Jeka JJ, 1997, PHYS THER, V77, P476, DOI 10.1093/ptj/77.5.476; Kapur S, 2010, J APPL PHYSIOL, V109, P1827, DOI 10.1152/japplphysiol.00430.2010; Krishnamoorthy V, 2005, EXP BRAIN RES, V164, P1, DOI 10.1007/s00221-004-2205-6; Latash ML, 2007, MOTOR CONTROL, V11, P276, DOI 10.1123/mcj.11.3.276; Latash ML, 2012, EXP BRAIN RES, V217, P1, DOI 10.1007/s00221-012-3000-4; Latash ML, 2005, BIOL CYBERN, V92, P186, DOI 10.1007/s00422-005-0548-0; Martin V, 2005, THEORETICAL ACCOUNT; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; Milner AD, 2006, VISUAL BRAIN ACTION, DOI 10.1093/acprof:oso/9780198524724.001.0001; Olafsdottir H, 2007, J APPL PHYSIOL, V102, P1490, DOI 10.1152/japplphysiol.00966.2006; Park E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041583; Reisman DS, 2003, BRAIN, V126, P2510, DOI 10.1093/brain/awg246; Santos MJ, 2004, CLIN BIOMECH, V19, P964, DOI 10.1016/j.clinbiomech.2004.07.002; Scholz JP, 2007, EXP BRAIN RES, V180, P163, DOI 10.1007/s00221-006-0848-1; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Scholz JP, 2001, EXP BRAIN RES, V141, P485, DOI 10.1007/s002210100878; Slijper H, 2000, EXP BRAIN RES, V135, P81, DOI 10.1007/s002210000492; Slobounov S, 2006, MOTOR CONTROL, V10, P69, DOI 10.1123/mcj.10.1.69; Slobounov S, 2005, CLIN NEUROPHYSIOL, V116, P315, DOI 10.1016/j.clinph.2004.09.007; Ting LH, 2007, PROG BRAIN RES, V165, P299, DOI 10.1016/S0079-6123(06)65019-X; Ting LH, 2005, J NEUROPHYSIOL, V93, P609, DOI 10.1152/jn.00681.2004; TURVEY MT, 1990, AM PSYCHOL, V45, P938, DOI 10.1037/0003-066X.45.8.938; Verrel J, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.006; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Wu JH, 2009, EXP BRAIN RES, V196, P329, DOI 10.1007/s00221-009-1852-z	42	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e108667	10.1371/journal.pone.0108667	http://dx.doi.org/10.1371/journal.pone.0108667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329477	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204100004
J	Thome, R; Bombeiro, AL; Issayama, LK; Raposo, C; Lopes, SCP; da Costa, TA; Di Gangi, R; Ferreira, IT; Longhini, ALF; Oliveira, ALR; Hofling, MAD; Costa, FTM; Verinaud, L				Thome, Rodolfo; Bombeiro, Andre Luis; Issayama, Luidy Kazuo; Raposo, Catarina; Pinto Lopes, Stefanie Costa; da Costa, Thiago Alves; Di Gangi, Rosaria; Ferreira, Isadora Tassinari; Figueiredo Longhini, Ana Leda; Rodrigues Oliveira, Alexandre Leite; da Cruz Hoefling, Maria Alice; Maranhao Costa, Fabio Trindade; Verinaud, Liana			Exacerbation of Autoimmune Neuro-Inflammation in Mice Cured from Blood-Stage Plasmodium berghei Infection	PLOS ONE			English	Article							MYELIN BASIC-PROTEIN; DENDRITIC CELLS; T-CELLS; MULTIPLE-SCLEROSIS; STREPTOCOCCAL INFECTIONS; RHEUMATIC-FEVER; IFN-GAMMA; MALARIA; ENCEPHALOMYELITIS; IMMUNE	The thymus plays an important role shaping the T cell repertoire in the periphery, partly, through the elimination of inflammatory auto-reactive cells. It has been shown that, during Plasmodium berghei infection, the thymus is rendered atrophic by the premature egress of CD4(+)CD8(+) double-positive (DP) T cells to the periphery. To investigate whether autoimmune diseases are affected after Plasmodium berghei NK65 infection, we immunized C57BL/6 mice, which was previously infected with P. berghei NK65 and treated with chloroquine (CQ), with MOG(35-55) peptide and the clinical course of Experimental Autoimmune Encephalomyelitis (EAE) was evaluated. Our results showed that NK65+CQ+EAE mice developed a more severe disease than control EAE mice. The same pattern of disease severity was observed in MOG(35-55)-immunized mice after adoptive transfer of P. berghei-elicited splenic DP-T cells. The higher frequency of IL-17(+)- and IFN-gamma+-producing DP lymphocytes in the Central Nervous System of these mice suggests that immature lymphocytes contribute to disease worsening. To our knowledge, this is the first study to integrate the possible relationship between malaria and multiple sclerosis through the contribution of the thymus. Notwithstanding, further studies must be conducted to assert the relevance of malaria-induced thymic atrophy in the susceptibility and clinical course of other inflammatory autoimmune diseases.	[Thome, Rodolfo; Bombeiro, Andre Luis; Issayama, Luidy Kazuo; da Costa, Thiago Alves; Di Gangi, Rosaria; Ferreira, Isadora Tassinari; Rodrigues Oliveira, Alexandre Leite; Verinaud, Liana] Univ Estadual Campinas, Dept Struct & Funct Biol, Inst Biol, Campinas, SP, Brazil; [Raposo, Catarina; da Cruz Hoefling, Maria Alice] Univ Estadual Campinas, Dept Histol & Embryol, Inst Biol, Campinas, SP, Brazil; [Pinto Lopes, Stefanie Costa; Maranhao Costa, Fabio Trindade] Univ Estadual Campinas, Dept Genet Evolut & Bioagents, Inst Biol, Campinas, SP, Brazil; [Figueiredo Longhini, Ana Leda] Univ Estadual Campinas, Dept Hematol, Fac Ciencias Med, Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Verinaud, L (corresponding author), Univ Estadual Campinas, Dept Struct & Funct Biol, Inst Biol, Campinas, SP, Brazil.	verinaud@unicamp.br	Lopes, Stefanie/A-8314-2012; da Costa, Thiago Alves/F-8187-2016; Oliveira, Alexandre L. R./C-4436-2012; Costa, Fabio/E-1181-2012; Oliveira, Alexandre/AAI-6815-2020; Thome, Rodolfo/C-1564-2012	Oliveira, Alexandre L. R./0000-0003-4224-4575; Costa, Fabio/0000-0001-9969-7300; Oliveira, Alexandre/0000-0003-4224-4575; Thome, Rodolfo/0000-0001-7627-4137; Lopes, Stefanie/0000-0002-6981-2192; Alves da Costa, Thiago/0000-0001-9591-331X; Raposo, Catarina/0000-0001-8804-497X; Issayama, Luidy/0000-0003-1701-0101	Sao Paulo Research Foundation (FAPESP) [2011/17965-3]; FAPESP [2011/13191-3]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Sao Paulo Research Foundation (FAPESP, grant number #2011/17965-3). RT received a FAPESP scholarship (# 2011/13191-3). MACH, FTMC and LV are fellows of the National Council of Technological and Scientific Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADU D, 1982, CLIN EXP IMMUNOL, V49, P310; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Andrade CF, 2008, CELL IMMUNOL, V253, P1, DOI 10.1016/j.cellimm.2008.06.001; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Ataide MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003885; Bang K, 2001, BRIT J DERMATOL, V144, P1140, DOI 10.1046/j.1365-2133.2001.04223.x; Bettiol E, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-64; Bhaumik S, 2013, NATL MED J INDIA, V26, P62; Butcher GA, 1996, MED HYPOTHESES, V47, P97, DOI 10.1016/S0306-9877(96)90446-6; Butcher G, 2008, TRENDS PARASITOL, V24, P291, DOI 10.1016/j.pt.2008.03.010; Capalbo D, 2012, INT REV IMMUNOL, V31, P344, DOI 10.3109/08830185.2012.697230; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Clemente AM, 2013, INFECT IMMUN, V81, P1842, DOI 10.1128/IAI.01226-12; Cockburn IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000877; COX HW, 1964, AM J TROP MED HYG, V13, P225, DOI 10.4269/ajtmh.1964.13.225; Daniel-Ribeiro CT, 2000, MEM I OSWALDO CRUZ, V95, P199, DOI 10.1590/S0074-02762000000200011; Daniel-Ribeiro CT, 2000, ACTA TROP, V76, P205, DOI 10.1016/S0001-706X(00)00099-1; Das G, 2003, P NATL ACAD SCI USA, V100, P5324, DOI 10.1073/pnas.0831037100; Dittel BN, 1999, J IMMUNOL, V163, P32; Domingues HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015531; FALANGA PB, 1987, EUR J IMMUNOL, V17, P599, DOI 10.1002/eji.1830170504; Farias AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017849; FAWCETT PT, 1989, CELL IMMUNOL, V118, P192, DOI 10.1016/0008-8749(89)90368-7; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Francelin C, 2011, IMMUNOBIOLOGY, V216, P1148, DOI 10.1016/j.imbio.2011.03.009; Franklin BS, 2009, P NATL ACAD SCI USA, V106, P5789, DOI 10.1073/pnas.0809742106; Gameiro J, 2010, CELL ADHES MIGR, V4, P382, DOI 10.4161/cam.4.3.11789; Gameiro J, 2010, IMMUNOLOGY, V129, P248, DOI 10.1111/j.1365-2567.2009.03177.x; Gilden DH, 2005, LANCET NEUROL, V4, P195, DOI 10.1016/S1474-4422(05)01017-3; Giusti P, 2011, INFECT IMMUN, V79, P2727, DOI 10.1128/IAI.00649-10; Goncalves RM, 2010, INFECT IMMUN, V78, P4763, DOI 10.1128/IAI.00578-10; Hartgers FC, 2008, INFECT IMMUN, V76, P5149, DOI 10.1128/IAI.01579-07; Hermann I, 2006, INFECT IMMUN, V74, P4841, DOI 10.1128/IAI.00026-06; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Itoh M, 1999, J IMMUNOL, V162, P5317; JARRA W, 1983, CIBA F SYMP, V94, P137; KAWAKITA S, 1976, JPN HEART J, V17, P592; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; LLOYD CM, 1994, INFECT IMMUN, V62, P1982, DOI 10.1128/IAI.62.5.1982-1988.1994; LOOSE LD, 1973, MICROBIOS, V8, P111; Mauduit M, 2012, IMMUNOLOGIC RES; McCall MBB, 2007, J IMMUNOL, V179, P162, DOI 10.4049/jimmunol.179.1.162; Mendes-da-Cruz DA, 2003, MICROBES INFECT, V5, P825, DOI 10.1016/S1286-4579(03)00156-4; Mix E, 2010, PROG NEUROBIOL, V92, P386, DOI 10.1016/j.pneurobio.2010.06.005; Muxel SM, 2010, J INTERF CYTOK RES, V30, P417, DOI 10.1089/jir.2009.0095; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Peron JPS, 2010, J NEUROIMMUNOL, V227, P10, DOI 10.1016/j.jneuroim.2010.06.002; PHANUPHAK P, 1983, CLIN EXP IMMUNOL, V53, P627; POELS LG, 1980, EXP PARASITOL, V49, P97, DOI 10.1016/0014-4894(80)90061-2; READ SE, 1974, J CLIN INVEST, V54, P439, DOI 10.1172/JCI107780; Sardinha LR, 2002, SCAND J IMMUNOL, V56, P408, DOI 10.1046/j.1365-3083.2002.01146.x; Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X; Savino W, 2007, BRIT J NUTR, V98, pS11, DOI 10.1017/S0007114507832880; Skorokhod OA, 2004, J IMMUNOL, V173, P4066, DOI 10.4049/jimmunol.173.6.4066; Sotgiu S, 2008, MED HYPOTHESES, V70, P819, DOI 10.1016/j.mehy.2006.10.069; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Thome R, 2014, IMMUNOLOGY IN PRESS; Thome R, 2014, IMMUNOL CELL BIOL, V92, P124, DOI 10.1038/icb.2013.73; Thome R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065913; Tutaj M, 2007, J AUTOIMMUN, V28, P208, DOI 10.1016/j.jaut.2007.02.017; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900; Urban Britta C, 2006, J Biol, V5, P4, DOI 10.1186/jbiol37; Willenborg DO, 1999, J IMMUNOL, V163, P5278; Wykes MN, 2011, P NATL ACAD SCI USA, V108, P11205, DOI 10.1073/pnas.1108579108	64	7	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110739	10.1371/journal.pone.0110739	http://dx.doi.org/10.1371/journal.pone.0110739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329161	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204100105
J	Nagel, A; Mobs, C; Raifer, H; Wiendl, H; Hertl, M; Eming, R				Nagel, Angela; Moebs, Christian; Raifer, Hartmann; Wiendl, Heinz; Hertl, Michael; Eming, Ruediger			CD3-Positive B Cells: A Storage-Dependent Phenomenon	PLOS ONE			English	Article							T-CELLS; PERIPHERAL-BLOOD; DENDRITIC CELLS; FLOW-CYTOMETRY; INTERCELLULAR EXCHANGES; MEMBRANE-COMPONENTS; DEPLETION THERAPY; TARGET-CELLS; TROGOCYTOSIS; RITUXIMAB	The majority of clinical studies requires extensive management of human specimen including e. g. overnight shipping of blood samples in order to convey the samples in a central laboratory or to simultaneously analyze large numbers of patients. Storage of blood samples for periods of time before in vitro/ex vivo testing is known to influence the antigen expression on the surface of lymphocytes. In this context, the present results show for the first time that the T cell antigen CD3 can be substantially detected on the surface of human B cells after ex vivo storage and that the degree of this phenomenon critically depends on temperature and duration after blood withdrawal. The appearance of CD3 on the B cell surface seems to be a result of contact-dependent antigen exchange between T and B lymphocytes and is not attributed to endogenous production by B cells. Since cellular subsets are often classified by phenotypic analyses, our results indicate that ex vivo cellular classification in peripheral blood might result in misleading interpretations. Therefore, in order to obtain results reflecting the in vivo situation, it is suggested to minimize times of ex vivo blood storage after isolation of PBMC. Moreover, to enable reproducibility of results between different research groups and multicenter studies, we would emphasize the necessity to specify and standardize the storage conditions, which might be the basis of particular findings.	[Nagel, Angela; Moebs, Christian; Hertl, Michael; Eming, Ruediger] Univ Marburg, Dept Dermatol & Allergol, Marburg, Germany; [Nagel, Angela] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-91054 Erlangen, Germany; [Raifer, Hartmann] Univ Marburg, Inst Med Microbiol & Hyg, Marburg, Germany; [Wiendl, Heinz] Univ Munster, Dept Neurol, D-48149 Munster, Germany	Philipps University Marburg; University of Erlangen Nuremberg; Philipps University Marburg; University of Munster	Eming, R (corresponding author), Univ Marburg, Dept Dermatol & Allergol, Marburg, Germany.	eming@med.uni-marburg.de	Wiendl, Heinz/AAX-6041-2021	Wiendl, Heinz/0000-0003-4310-3432; Mobs, Christian/0000-0002-5197-7669	German Research Foundation [1602/8-1, 1602/8-2]; University Hospital Giessen; Marburg GmbH, Marburg, Germany (UKGM); European Community [HEALTH-F2-2008-200515]	German Research Foundation(German Research Foundation (DFG)); University Hospital Giessen; Marburg GmbH, Marburg, Germany (UKGM); European Community(European Commission)	Financial support for the study was provided by the German Research Foundation (He 1602/8-1 and 1602/8-2 to MH) and a grant from the University Hospital Giessen and Marburg GmbH, Marburg, Germany (UKGM, to MH). Furthermore, this project was supported by Coordination Theme 1 (Health) of the European Community's FP7, Grant agreement number HEALTH-F2-2008-200515 (to MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admyre C, 2007, J ALLERGY CLIN IMMUN, V120, P1418, DOI 10.1016/j.jaci.2007.06.040; Admyre C, 2006, EUR J IMMUNOL, V36, P1772, DOI 10.1002/eji.200535615; Ahmed KA, 2008, CELL MOL IMMUNOL, V5, P261, DOI 10.1038/cmi.2008.32; Ahmed KA, 2011, J CELL MOL MED, V15, P1458, DOI 10.1111/j.1582-4934.2010.01008.x; Aucher A, 2008, BLOOD, V111, P5621, DOI 10.1182/blood-2008-01-134155; Beum PV, 2006, J IMMUNOL, V176, P2600, DOI 10.4049/jimmunol.176.4.2600; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Cambridge G, 2003, ARTHRITIS RHEUM-US, V48, P2146, DOI 10.1002/art.11181; Cambridge G, 2006, ARTHRITIS RHEUM-US, V54, P3612, DOI 10.1002/art.22211; Caumartin J, 2006, TRANSPL IMMUNOL, V17, P20, DOI 10.1016/j.trim.2006.09.032; Caumartin J, 2007, EMBO J, V26, P1423, DOI 10.1038/sj.emboj.7601570; Daubeuf S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008716; Davis C, 2011, J IMMUNOL METHODS, V363, P158, DOI 10.1016/j.jim.2010.09.029; EKONG T, 1993, J IMMUNOL METHODS, V164, P263, DOI 10.1016/0022-1759(93)90319-3; EKONG T, 1993, CYTOMETRY, V14, P679, DOI 10.1002/cyto.990140613; EKONG T, 1992, J IMMUNOL METHODS, V151, P217, DOI 10.1016/0022-1759(92)90120-I; Eming R, 2008, J INVEST DERMATOL, V128, P2850, DOI 10.1038/jid.2008.172; Fayette J, 1997, J EXP MED, V185, P1909, DOI 10.1084/jem.185.11.1909; Gagro A, 2000, IMMUNOLOGY, V101, P201, DOI 10.1046/j.1365-2567.2000.00098.x; Harshyne LA, 2001, J IMMUNOL, V166, P3717, DOI 10.4049/jimmunol.166.6.3717; Henry C, 2010, ARTHRITIS RHEUM-US, V62, P2561, DOI 10.1002/art.27527; Hodge G, 2005, CYTOKINE, V32, P7, DOI 10.1016/j.cyto.2005.06.010; Huang YP, 2004, J BIOL CHEM, V279, P28827, DOI 10.1074/jbc.R400012200; Hudrisier D, 2002, FASEB J, V16, P477, DOI 10.1096/fj.01-0933rev; Hudrisier D, 2007, J IMMUNOL, V178, P3637, DOI 10.4049/jimmunol.178.6.3637; HULTIN LE, 1993, CYTOMETRY, V14, P196, DOI 10.1002/cyto.990140212; Iwasaki S, 2011, CYTOM PART A, V79A, P46, DOI 10.1002/cyto.a.20984; Jamsa J, 2011, J CLIN LAB ANAL, V25, P118, DOI 10.1002/jcla.20444; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Kim DW, 2013, ANN CLIN LAB SCI, V43, P267; Kuhns MS, 2006, IMMUNITY, V24, P133, DOI 10.1016/j.immuni.2006.01.006; Leandro MJ, 2006, ARTHRITIS RHEUM-US, V54, P613, DOI 10.1002/art.21617; Leandro MJ, 2002, ANN RHEUM DIS, V61, P883, DOI 10.1136/ard.61.10.883; LeMaoult J, 2007, HUM IMMUNOL, V68, P240, DOI 10.1016/j.humimm.2006.11.001; LeMaoult J, 2007, BLOOD, V109, P2040, DOI 10.1182/blood-2006-05-024547; Masuda S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052918; Nagel A, 2009, J INVEST DERMATOL, V129, P2202, DOI 10.1038/jid.2009.27; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; Puaux AL, 2006, EUR J IMMUNOL, V36, P779, DOI 10.1002/eji.200535407; Rechavi O, 2009, FEBS LETT, V583, P1792, DOI 10.1016/j.febslet.2009.03.014; Rialland P, 2006, BIOL CELL, V98, P491, DOI 10.1042/BC20060027; Riond J, 2007, SCAND J IMMUNOL, V66, P441, DOI 10.1111/j.1365-3083.2007.01996.x; Rizzo K, 2009, CYTOM PART B-CLIN CY, V76B, P142, DOI 10.1002/cyto.b.20442; Roda-Navarro P, 2007, FASEB J, V21, P1636, DOI 10.1096/fj.06-7488rev; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Sabzevari H, 2001, J IMMUNOL, V166, P2505, DOI 10.4049/jimmunol.166.4.2505; Schmidt E, 2008, CLIN REV ALLERG IMMU, V34, P56, DOI 10.1007/s12016-007-8021-6; Seror R, 2007, ANN RHEUM DIS, V66, P351, DOI 10.1136/ard.2006.057919; Stasi R, 2007, BLOOD, V110, P2924, DOI 10.1182/blood-2007-02-068999; Streitz M, 2013, TRANSPLANT RES, V2, DOI 10.1186/2047-1440-2-17; Vallerskog T, 2007, CLIN IMMUNOL, V122, P62, DOI 10.1016/j.clim.2006.08.016; VERNINO LA, 1992, CELL IMMUNOL, V139, P185, DOI 10.1016/0008-8749(92)90111-2; Wang J, 2009, AM J SURG PATHOL, V33, P505, DOI 10.1097/PAS.0b013e318185d231; Waschbisch A, 2009, J NEUROIMMUNOL, V209, P131, DOI 10.1016/j.jneuroim.2009.02.005; Wiendl H, 2007, BLOOD, V109, P1796, DOI 10.1182/blood-2006-12-062059; Wilk E, 2009, ARTHRITIS RHEUM; Xu H, 2006, J IMMUNOL, V176, P750, DOI 10.4049/jimmunol.176.2.750; Youinou P, 1999, IMMUNOL TODAY, V20, P312, DOI 10.1016/S0167-5699(99)01476-0	59	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110138	10.1371/journal.pone.0110138	http://dx.doi.org/10.1371/journal.pone.0110138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329048	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210800060
J	Saldanha, IJ; Dickersin, K; Wang, X; Li, TJ				Saldanha, Ian J.; Dickersin, Kay; Wang, Xue; Li, Tianjing			Outcomes in Cochrane Systematic Reviews Addressing Four Common Eye Conditions: An Evaluation of Completeness and Comparability	PLOS ONE			English	Article							RANDOMIZED-TRIALS; CLINICAL-TRIALS; REPORTING BIAS; QUALITY; IMPACT	Introduction: Choice of outcomes is critical for clinical trialists and systematic reviewers. It is currently unclear how systematic reviewers choose and pre-specify outcomes for systematic reviews. Our objective was to assess the completeness of pre-specification and comparability of outcomes in all Cochrane reviews addressing four common eye conditions. Methods: We examined protocols for all Cochrane reviews as of June 2013 that addressed glaucoma, cataract, age-related macular degeneration (AMD), and diabetic retinopathy (DR). We assessed completeness and comparability for each outcome that was named in >= 25% of protocols on those topics. We defined a completely-specified outcome as including information about five elements: domain, specific measurement, specific metric, method of aggregation, and time-points. For each domain, we assessed comparability in how individual elements were specified across protocols. Results: We identified 57 protocols addressing glaucoma (22), cataract (16), AMD (15), and DR (4). We assessed completeness and comparability for five outcome domains: quality-of-life, visual acuity, intraocular pressure, disease progression, and contrast sensitivity. Overall, these five outcome domains appeared 145 times (instances). Only 15/145 instances (10.3%) were completely specified (all five elements) (median = three elements per outcome). Primary outcomes were more completely specified than non-primary (median = four versus two elements). Quality-of-life was least completely specified (median = one element). Due to largely incomplete outcome pre-specification, conclusive assessment of comparability in outcome usage across the various protocols per condition was not possible. Discussion: Outcome pre-specification was largely incomplete; we encourage systematic reviewers to consider all five elements. This will indicate the importance of complete specification to clinical trialists, on whose work systematic reviewers depend, and will indirectly encourage comparable outcome choice to reviewers undertaking related research questions. Complete pre-specification could improve efficiency and reduce bias in data abstraction and analysis during a systematic review. Ultimately, more completely specified and comparable outcomes could make systematic reviews more useful to decision-makers.	[Saldanha, Ian J.; Dickersin, Kay; Wang, Xue; Li, Tianjing] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Saldanha, IJ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	isaldan1@jhmi.edu		Li, Tianjing/0000-0001-5371-4558; Wang, Xue/0000-0002-7436-8233	National Eye Institute [1U01EY020522]; NATIONAL EYE INSTITUTE [U01EY020522] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This project was funded by the National Eye Institute, grant number 1U01EY020522 (http://www.nei.nih.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender R, 2008, J CLIN EPIDEMIOL, V61, P857, DOI 10.1016/j.jclinepi.2008.03.004; Booth A, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-4; Booth A, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-2; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; CAMPBELL MJ, 1995, BRIT MED J, V311, P1145, DOI 10.1136/bmj.311.7013.1145; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; Chandler J, 2012, METHODOLOGICAL STAND; Clarke M, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-39; COMET Initiative, 2014, OV; Dwan K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000031.pub2; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; EQUATOR Network, 2014, REP GUID DEV; GOODMAN SN, 1989, CONTROL CLIN TRIALS, V10, P188, DOI 10.1016/0197-2456(89)90030-5; Institute of Medicine, 2011, FIND WHAT WORKS HLTH; Jadad AR, 1998, JAMA-J AM MED ASSOC, V280, P278, DOI 10.1001/jama.280.3.278; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub3, 10.1002/14651858.CD008965.pub4]; Kirkham JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009810; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Li TJ, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-79; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Meinert CL, 2012, CLIN TRIALS DICT TER, V2nd, DOI 10.1002/9781118315293; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; National Eye Institute, 2010, STAT DAT; Page Matthew J, 2013, J Clin Epidemiol, V66, P524, DOI 10.1016/j.jclinepi.2012.10.010; Robinson KA, 2011, J CLIN EPIDEMIOL, V64, P1325, DOI 10.1016/j.jclinepi.2011.06.009; Salek S, 1999, COMPENDIUM QUALITY L; Singh S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3215; Stewart L, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-7; Thornley B, 1998, BRIT MED J, V317, P1181, DOI 10.1136/bmj.317.7167.1181; Tugwell P, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-38; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Wieseler B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001526; Wieseler B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8141; Williamson PR, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-132; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	38	69	70	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109400	10.1371/journal.pone.0109400	http://dx.doi.org/10.1371/journal.pone.0109400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329377	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210800023
J	Chen, PC; Yang, CC; Wu, CJ; Liu, WS; Huang, WL; Lee, CC				Chen, Po-Chun; Yang, Ching-Chieh; Wu, Cheng-Jung; Liu, Wen-Shan; Huang, Wei-Lun; Lee, Ching-Chih			Factors Predict Prolonged Wait Time and Longer Duration of Radiotherapy in Patients with Nasopharyngeal Carcinoma: A Multilevel Analysis	PLOS ONE			English	Article							PHASE-III; CONCURRENT CHEMORADIOTHERAPY; SOCIOECONOMIC-STATUS; COMORBIDITY; HEAD; INSURANCE; COHORT; DELAY	Purpose: Radiotherapy with or without chemotherapy is the primary treatment for patients with nasopharyngeal carcinoma (NPC). It wastes time from diagnosis to treatment. Treatment time of radiotherapy generally takes at least seven weeks. The current study aimed to evaluate factors associated with prolonged wait time and longer duration of radiotherapy in NPC patients. Methods and Materials: From Taiwan's National Health Insurance research database, we identified 3,605 NPC patients treated with radiotherapy between 2008 and 2011. Wait time was calculated from the date of diagnosis to the start of radiotherapy. The impact of each variable on wait time and duration of radiotherapy was examined by multilevel analysis using a random-intercept model. Results: The mean wait time and duration of radiotherapy were 1.78 +/- 3.33 and 9.72 +/- 7.27 weeks, respectively. Multilevel analysis revealed prolonged wait time in patients aged 45-65 years, those receiving radiotherapy alone, those with more comorbidities, those with low SES, and those living in eastern Taiwan. A prolonged duration of radiotherapy was associated with receipt of concurrent chemoradiotherapy, more comorbidities, and moderate SES. Conclusions: Understanding the factors associated with longer wait times and duration of radiotherapy in patients with NPC may help healthcare providers better assist both these patients and potentially those with other head-and-neck cancers.	[Chen, Po-Chun] Pingtung Christian Hosp, Dept Radiat Oncol, Pingtung, Taiwan; [Yang, Ching-Chieh] Chi Mei Med Ctr, Dept Radiat Oncol, Tainan, Taiwan; [Wu, Cheng-Jung] Kaohsiung Vet Gen Hosp, Dept Otolaryngol, Kaohsiung, Taiwan; [Liu, Wen-Shan; Huang, Wei-Lun] Kaohsiung Vet Gen Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan; [Lee, Ching-Chih] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Otolarygol, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Ctr Canc, Chiayi, Taiwan; [Lee, Ching-Chih] Tzu Chi Univ, Sch Med, Hualin, Taiwan	Chi Mei Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University	Lee, CC (corresponding author), Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Otolarygol, Chiayi, Taiwan.	hematcd2@hotmail.com						Abdel-Wahab M, 2013, LANCET ONCOL, V14, pE168, DOI 10.1016/S1470-2045(12)70532-6; [Anonymous], 2001, TAIW CANC REG ANN RE; Baijal G, 2012, HEAD NECK-J SCI SPEC, V34, P1251, DOI 10.1002/hed.21897; Boje CR, 2014, RADIOTHER ONCOL, V110, P91, DOI 10.1016/j.radonc.2013.11.009; Cannon DM, 2013, HEAD NECK-J SCI SPEC, V36, P1120; Chan ATC, 2002, J CLIN ONCOL, V20, P2038, DOI 10.1200/JCO.2002.08.149; Chang JT, 1998, JPN J CLIN ONCOL, V28, P207, DOI 10.1093/jjco/28.3.207; Chang TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073889; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fortin A, 2002, INT J RADIAT ONCOL, V52, P929, DOI 10.1016/S0360-3016(01)02606-2; Huang J, 2003, J CLIN ONCOL, V21, P555, DOI 10.1200/JCO.2003.04.171; Kim Tae Hee, 2008, Cancer Res Treat, V40, P62, DOI 10.4143/crt.2008.40.2.62; Kwong DLW, 1997, INT J RADIAT ONCOL, V39, P703, DOI 10.1016/S0360-3016(97)00339-8; Lin JC, 2003, J CLIN ONCOL, V21, P631, DOI 10.1200/JCO.2003.06.158; Paleri V, 2010, ORAL ONCOL, V46, P712, DOI 10.1016/j.oraloncology.2010.07.008; Round CE, 2013, CLIN ONCOL-UK, V25, P522, DOI 10.1016/j.clon.2013.05.005; Sher DJ, 2011, INT J RADIAT ONCOL, V81, pE813, DOI 10.1016/j.ijrobp.2010.12.005; Takahashi PY, 2009, OSTOMY WOUND MANAG, V55, P32; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Willems S, 2005, PATIENT EDUC COUNS, V56, P139, DOI 10.1016/j.pec.2004.02.011; Wu XC, 2012, J CLIN ONCOL, V30, P142, DOI 10.1200/JCO.2011.36.8399; Zhang L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-558	23	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109930	10.1371/journal.pone.0109930	http://dx.doi.org/10.1371/journal.pone.0109930			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314009	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662500088
J	Lemieux, J; Cusson, M				Lemieux, Julie; Cusson, Mathieu			Effects of Habitat-Forming Species Richness, Evenness, Identity, and Abundance on Benthic Intertidal Community Establishment and Productivity	PLOS ONE			English	Article							ECOSYSTEM FUNCTION; DIVERSITY; BIODIVERSITY; STABILITY; DOMINANCE; CONSEQUENCES; RECRUITMENT; COMPETITION; CONSUMER; CLIMATE	In a context of reduced global biodiversity, the potential impacts from the loss of habitat-forming species (HFS) on ecosystem structure and functioning must be established. These species are often the main community primary producers and have a major role in the establishment of organisms through facilitation processes. This study focuses on macroalgae and mussels as HFS within an intertidal zone along the St. Lawrence estuary (Quebec, Canada). Over a 16-week period, we manipulated the in situ diversity profile (richness, evenness, identity, and abundance) of the dominant HFS (Fucus distichus edentatus, F. vesiculosus, and Mytilus spp.) in order to define their role in both the establishment of associated species and community primary production. Contrary to expectation, no general change in HFS richness, evenness, abundance, or identity on associated species community establishment was observed. However, over the study period, the HFS diversity profile modified the structure within the trophic guilds, which may potentially affect further community functions. Also, our results showed that the low abundance of HFS had a negative impact on the primary productivity of the community. Our results suggest that HFS diversity profiles have a limited short-term role in our study habitat and may indicate that biological forcing in these intertidal communities is less important than environmental conditions. As such, there was an opportunistic establishment of species that ensured rapid colonization regardless of the absence, or the diversity profile, of facilitators such as HFS.	[Lemieux, Julie; Cusson, Mathieu] Univ Quebec Chicoutimi, Dept Sci Fondamentales, Chicoutimi, PQ, Canada	University of Quebec; University of Quebec Chicoutimi	Lemieux, J (corresponding author), Univ Quebec Chicoutimi, Dept Sci Fondamentales, Chicoutimi, PQ, Canada.	julie.lemieux3@uqac.ca; mathieu.cusson@uqac.ca		Cusson, Mathieu/0000-0002-2111-4803	Natural Sciences and Engineering Research Council of Canada (NSERC) [371464-2009]; Funds for Research in Nature and Technology, New University Researchers Start-up Program [2010-NC-131180]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Funds for Research in Nature and Technology, New University Researchers Start-up Program	This research was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC, Discovery Grants) #371464-2009 and by the Funds for Research in Nature and Technology, New University Researchers Start-up Program #2010-NC-131180 to MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACIA, 2004, IMPACTS WARMING ARCT; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2005, PERMANOVA FORTRAN CO; ARCHAMBAULT D, 1983, CAN J FISH AQUAT SCI, V40, P1278, DOI 10.1139/f83-146; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bates CR, 2007, J EXP MAR BIOL ECOL, V344, P206, DOI 10.1016/j.jembe.2007.01.002; Begin C, 2004, MAR ECOL PROG SER, V271, P121, DOI 10.3354/meps271121; BELL SS, 1991, ECOLOGY, V72, P350, DOI 10.2307/1938929; Benedetti-Cecchi L, 2001, MAR ECOL PROG SER, V214, P137, DOI 10.3354/meps214137; Benedetti-Cecchi L, 2009, HARD BOTTOM COMMUNIT; BERGERON P, 1986, MAR ECOL PROG SER, V28, P129, DOI 10.3354/meps028129; Bertness MD, 1999, ECOLOGY, V80, P2711, DOI 10.1890/0012-9658(1999)080[2711:TTRCOP]2.0.CO;2; Boer GJ, 2000, CLIM DYNAM, V16, P427, DOI 10.1007/s003820050338; Bolam SG, 2002, ECOL MONOGR, V72, P599, DOI 10.1890/0012-9615(2002)072[0599:DBAEPI]2.0.CO;2; Brey T, 2004, VIRTUAL HDB A WEGENE; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Bruno JF, 2001, MARINE COMMUNITY ECOLOGY, P201; Bulleri F, 2012, OIKOS; Campbell V, 2011, OIKOS, V120, P399, DOI 10.1111/j.1600-0706.2010.18768.x; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Cerabolini B, 2010, PLANT ECOL, V207, P333, DOI 10.1007/s11258-009-9677-1; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Christie H, 2009, MAR ECOL PROG SER, V396, P221, DOI 10.3354/meps08351; Commito JA, 2000, J EXP MAR BIOL ECOL, V255, P133, DOI 10.1016/S0022-0981(00)00285-9; Commito JA, 2008, J EXP MAR BIOL ECOL, V366, P70, DOI 10.1016/j.jembe.2008.07.010; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; Crowe TP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066238; Danovaro R, 2012, MARINE BIODIVERSITY AND ECOSYSTEM FUNCTIONING: FRAMEWORKS, METHODOLOGIES, AND INTEGRATION, P115; DAYTON PK, 1975, ECOL MONOGR, V45, P137, DOI 10.2307/1942404; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; Enderlein P, 2004, J SEA RES, V51, P145, DOI 10.1016/j.seares.2003.05.006; Eriksson BK, 2006, LIMNOL OCEANOGR, V51, P1813, DOI 10.4319/lo.2006.51.4.1813; FRADETTE P, 1980, CAN J FISH AQUAT SCI, V37, P979, DOI 10.1139/f80-127; GEE JM, 1994, MAR ECOL PROG SER, V103, P141, DOI 10.3354/meps103141; Grabowski JH, 2005, ECOLOGY, V86, P1312, DOI 10.1890/04-1216; GREZE II, 1968, MAR BIOL, V1, P316, DOI 10.1007/BF00360783; Griffin JN, 2009, OIKOS, V118, P37, DOI 10.1111/j.1600-0706.2008.16960.x; Grman E, 2010, ECOL LETT, V13, P1400, DOI 10.1111/j.1461-0248.2010.01533.x; Guay M, 2004, J EXP MAR BIOL ECOL, V312, P299, DOI 10.1016/j.jembe.2004.07.008; Gutierrez JL, 2003, OIKOS, V101, P79, DOI 10.1034/j.1600-0706.2003.12322.x; Haddad NM, 2001, AM NAT, V158, P17, DOI 10.1086/320866; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; Hillebrand H, 2007, P NATL ACAD SCI USA, V104, P10904, DOI 10.1073/pnas.0701918104; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Isbell FI, 2009, ECOL LETT, V12, P443, DOI 10.1111/j.1461-0248.2009.01299.x; Jenkins SR, 1999, J EXP MAR BIOL ECOL, V233, P41, DOI 10.1016/S0022-0981(98)00128-2; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Largaespada C, 2012, ECOLOGY, V93, P324, DOI 10.1890/10-2359.1; Lilley SA, 2006, OECOLOGIA, V148, P672, DOI 10.1007/s00442-006-0411-6; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Maggi E, 2009, MAR ECOL PROG SER, V381, P39, DOI 10.3354/meps07949; Magurran EA, 2011, BIOL DIVERSITY FRONT; MCCOOK LJ, 1993, MAR BIOL, V115, P565, DOI 10.1007/BF00349363; McKindsey CW, 2001, ECOLOGY, V82, P3462, DOI 10.2307/2680165; MENGE BA, 1981, ECOL MONOGR, V51, P429, DOI 10.2307/2937323; Migne A, 2002, MAR BIOL, V140, P865, DOI 10.1007/s00227-001-0741-1; Montgomery D.C., 2005, DESIGN ANAL EXPT; Mulder CPH, 2004, OIKOS, V107, P50, DOI 10.1111/j.0030-1299.2004.13110.x; Naeem S, 1996, OIKOS, V76, P259, DOI 10.2307/3546198; Naeem S, 1999, ISSUES ECOLOGY ECOLO; Naeem S, 2009, INTRO ECOLOGICAL SOC; Nijs I, 2000, OIKOS, V88, P57, DOI 10.1034/j.1600-0706.2000.880107.x; Norling P, 2007, MAR ECOL PROG SER, V351, P163, DOI 10.3354/meps07033; O'Connor NE, 2005, ECOLOGY, V86, P1783, DOI 10.1890/04-1172; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Polley HW, 2003, ECOL LETT, V6, P248, DOI 10.1046/j.1461-0248.2003.00422.x; Proulx R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013382; Prowse TD, 2006, AMBIO, V35, P347, DOI 10.1579/0044-7447(2006)35[347:CCEOHO]2.0.CO;2; ROMAN CT, 1990, ESTUAR COAST SHELF S, V30, P35, DOI 10.1016/0272-7714(90)90075-3; Scrosati RA, 2011, ECOGRAPHY, V34, P151, DOI 10.1111/j.1600-0587.2010.06119.x; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Stachowicz JJ, 2007, ANNU REV ECOL EVOL S, V38, P739, DOI 10.1146/annurev.ecolsys.38.091206.095659; Stachowicz JJ, 2008, ECOLOGY, V89, P3008, DOI 10.1890/07-1873.1; Stirling G, 2001, AM NAT, V158, P286, DOI 10.1086/321317; Tilman D, 1997, OIKOS, V80, P185, DOI 10.2307/3546532; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; Valdivia N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036541; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WARWICK RM, 1991, J MAR BIOL ASSOC UK, V71, P225, DOI 10.1017/S0025315400037528; Watt CA, 2013, ESTUAR COAST SHELF S, V123, P10, DOI 10.1016/j.ecss.2013.02.006; Weiher E, 1999, OIKOS, V87, P355, DOI 10.2307/3546751; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; Wilsey BJ, 2005, ECOLOGY, V86, P1178, DOI 10.1890/04-0394; Wilsey BJ, 2000, ECOLOGY, V81, P887, DOI 10.1890/0012-9658(2000)081[0887:BAEFIO]2.0.CO;2; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840	93	16	16	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109261	10.1371/journal.pone.0109261	http://dx.doi.org/10.1371/journal.pone.0109261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313459	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000343662500028
J	Li, QW; Dahl, DB; Vannucci, M; Joo, H; Tsai, JW				Li, Qiwei; Dahl, David B.; Vannucci, Marina; Joo, Hyun; Tsai, Jerry W.			Bayesian Model of Protein Primary Sequence for Secondary Structure Prediction	PLOS ONE			English	Article							NEURAL-NETWORKS; SCOP DATABASE; ALPHA-HELICES; PACKING; SERVER; ALIGNMENT; DESIGN; PHD	Determining the primary structure (i.e., amino acid sequence) of a protein has become cheaper, faster, and more accurate. Higher order protein structure provides insight into a protein's function in the cell. Understanding a protein's secondary structure is a first step towards this goal. Therefore, a number of computational prediction methods have been developed to predict secondary structure from just the primary amino acid sequence. The most successful methods use machine learning approaches that are quite accurate, but do not directly incorporate structural information. As a step towards improving secondary structure reduction given the primary structure, we propose a Bayesian model based on the knob-socket model of protein packing in secondary structure. The method considers the packing influence of residues on the secondary structure determination, including those packed close in space but distant in sequence. By performing an assessment of our method on 2 test sets we show how incorporation of multiple sequence alignment data, similarly to PSIPRED, provides balance and improves the accuracy of the predictions. Software implementing the methods is provided as a web application and a stand-alone implementation.	[Li, Qiwei; Vannucci, Marina] Rice Univ, Dept Stat, Houston, TX 77251 USA; [Dahl, David B.] Brigham Young Univ, Dept Stat, Provo, UT 84602 USA; [Joo, Hyun; Tsai, Jerry W.] Univ Pacific, Dept Chem, Stockton, CA 95211 USA	Rice University; Brigham Young University; University of the Pacific	Dahl, DB (corresponding author), Brigham Young Univ, Dept Stat, Provo, UT 84602 USA.	dahl@stat.byu.edu	Vannucci, Marina/I-8439-2014; Joo, Hyun/M-7622-2015	Vannucci, Marina/0000-0002-7360-5321; Joo, Hyun/0000-0002-2298-5475; Li, Qiwei/0000-0002-1020-3050	National Institutes of Health National Institute of General Medical Sciences [R01 GM104972]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104972] Funding Source: NIH RePORTER	National Institutes of Health National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health National Institute of General Medical Sciences R01 GM104972. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscipt.	Adams PD, 2013, BIOPHYSICS, V42; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Aydin Z, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-178; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bettella F, 2012, J CHEM INF MODEL, V52, P545, DOI 10.1021/ci200321u; Birzele F, 2006, BIOINFORMATICS, V22, P2628, DOI 10.1093/bioinformatics/btl453; Bondugula R, 2011, PROTEIN ENG DES SEL, V24, P455, DOI 10.1093/protein/gzr003; Boomsma W, 2008, P NATL ACAD SCI USA, V105, P8932, DOI 10.1073/pnas.0801715105; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Chandonia JM, 2004, NUCLEIC ACIDS RES, V32, pD189, DOI 10.1093/nar/gkh034; CHOTHIA C, 1977, P NATL ACAD SCI USA, V74, P4130, DOI 10.1073/pnas.74.10.4130; COHEN FE, 1983, BIOCHEMISTRY-US, V22, P4894, DOI 10.1021/bi00290a005; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Feng YE, 2008, AMINO ACIDS, V35, P607, DOI 10.1007/s00726-008-0089-7; Figureau A, 2003, PROTEIN ENG, V16, P103, DOI 10.1093/proeng/gzg019; Fox NK, 2013, NUCL ACIDS RES; Guo J, 2004, PROTEINS, V54, P738, DOI 10.1002/prot.10634; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Joo H, 2014, PROTEINS STRUCTURE F; Joo H, 2012, J MOL BIOL, V419, P234, DOI 10.1016/j.jmb.2012.03.004; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kerry PS, 2011, ACTA CRYSTALLOGR F, V67, P858, DOI 10.1107/S1744309111019312; Kiss G, 2013, ANGEW CHEM INT EDIT, V52, P5700, DOI 10.1002/anie.201204077; LIM VI, 1974, J MOL BIOL, V88, P873, DOI 10.1016/0022-2836(74)90405-7; Madera M, 2010, BIOINFORMATICS, V26, P596, DOI 10.1093/bioinformatics/btq020; Malekpour SA, 2009, MATH BIOSCI, V221, P130, DOI 10.1016/j.mbs.2009.07.004; Montgomerie S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-301; Mooney C, 2009, PROTEINS, V77, P181, DOI 10.1002/prot.22429; Moult J, 2011, PROTEINS, V79, P1, DOI 10.1002/prot.23200; Nguyen M.N., 2004, PAC S BIOC PAC S BIO, P346; Pirovano W, 2010, METHODS MOL BIOL, V609, P327, DOI 10.1007/978-1-60327-241-4_19; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rost B, 1996, METHOD ENZYMOL, V266, P525; Rost B, 2001, J STRUCT BIOL, V134, P204, DOI 10.1006/jsbi.2001.4336; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; Schmidler SC, 2000, J COMPUT BIOL, V7, P233, DOI 10.1089/10665270050081496; Schmidler SC, 2002, CASE STUDIES BAYESIA, P363; Sleator RD, 2012, METHODS MOL BIOL, V815, P15, DOI [10.1007/978-1-61779-424-72, 10.1007/978-1-61779-424-7_2]; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Winter C, 2012, J STRUCT BIOL, V179, P347, DOI 10.1016/j.jsb.2012.04.009; Yao XQ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-49; Yasee A, 2014, J CHEM INFORM MODELI; Zhang H, 2011, BRIEF BIOINFORM, V12, P672, DOI 10.1093/bib/bbq088; Zhang JH, 1997, GENOME RES, V7, P649, DOI 10.1101/gr.7.6.649	48	8	8	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109832	10.1371/journal.pone.0109832	http://dx.doi.org/10.1371/journal.pone.0109832			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314659	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500081
J	Chen, LH; Klaric, G; Wadsworth, S; Jayasinghe, S; Kuo, TY; Evensen, O; Mutoloki, S				Chen, Lihan; Klaric, Goran; Wadsworth, Simon; Jayasinghe, Suwan; Kuo, Tsun-Yung; Evensen, Oystein; Mutoloki, Stephen			Augmentation of the Antibody Response of Atlantic Salmon by Oral Administration of Alginate-Encapsulated IPNV Antigens	PLOS ONE			English	Article							INFECTIOUS PANCREATIC NECROSIS; MUCOSAL IMMUNE-RESPONSES; VIRUS-VACCINES; IMMUNIZATION; SALAR; VACCINATION; CHALLENGE; INDUCTION; FISH; CARP	The objective of the present study was to assess the effect of alginate-encapsulated infectious pancreatic necrosis virus antigens in inducing the immune response of Atlantic salmon as booster vaccines. One year after intraperitoneal injection with an oil-adjuvanted vaccine, post-smolts were orally boosted either by 1) alginate-encapsulated IPNV antigens (ENCAP); 2) soluble antigens (UNENCAP) or 3) untreated feed (control). This was done twice, seven weeks apart. Sampling was done twice, firstly at 7 weeks post 1st oral boost and the 2nd, at 4 weeks after the 2nd oral boost. Samples included serum, head kidney, spleen and hindgut. Serum antibodies were analyzed by ELISA while tissues were used to assess the expression of IgM, IgT, CD4, GATA3, FOXP3, TGF-beta and IL-10 genes by quantitative PCR. Compared to controls, fish fed with ENCAP had a significant increase (p<0.04) in serum antibodies following the 1st boost but not after the 2nd boost. This coincided with significant up-regulation of CD4 and GATA3 genes. In contrast, serum antibodies in the UNENCAP group decreased both after the 1st and 2nd oral boosts. This was associated with significant up-regulation of FOXP3, TGF-beta and IL-10 genes. The expression of IgT was not induced in the hindgut after the 1st oral boost but was significantly up-regulated following the 2nd one. CD4 and GATA3 mRNA expressions exhibited a similar pattern to IgT in the hindgut. IgM mRNA expression on the other hand was not differentially regulated at any of the times examined. Our findings suggest that 1) Parenteral prime with oil-adjuvanted vaccines followed by oral boost with ENCAP results in augmentation of the systemic immune response; 2) Symmetrical prime and boost (mucosal) with ENCAP results in augmentation of mucosal immune response and 3) Symmetrical priming and boosting (mucosal) with soluble antigens results in the induction of systemic immune tolerance.	[Chen, Lihan; Evensen, Oystein; Mutoloki, Stephen] Norwegian Univ Life Sci, Dept Basic Sci & Aquat Med, Oslo, Norway; [Klaric, Goran; Wadsworth, Simon] EWOS Innovat AS, Sandnes, Norway; [Klaric, Goran; Jayasinghe, Suwan] UCL, Dept Mech Engn, London, England; [Kuo, Tsun-Yung] Natl Ilan Univ, Inst Biotechnol, Dept Anim Sci, Taipei, Taiwan	Norwegian University of Life Sciences; University of London; University College London; National Ilan University	Mutoloki, S (corresponding author), Norwegian Univ Life Sci, Dept Basic Sci & Aquat Med, Oslo, Norway.	stephen.mutoloki@nmbu.no	Evensen, Øystein/O-3011-2015; Chen, Li-Han/ABA-6377-2021	Evensen, Øystein/0000-0002-4856-3043; Chen, Li-Han/0000-0002-4789-3155; Jayasinghe, Suwan/0000-0002-7125-2219	Research Council of Norway [187848]; EWOS Innovation AS	Research Council of Norway(Research Council of Norway); EWOS Innovation AS	This work was funded by the Research Council of Norway (FUGE project no. 187848). OE and SW were the grant recipients. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Goran Klaric and Simon Wadsworth are employed by EWOS Innovation AS. EWOS Innovation AS provided support in the form of salaries for authors GK and SW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adelmann M, 2008, VACCINE, V26, P837, DOI 10.1016/j.vaccine.2007.11.065; Berzofsky JA, 1999, IMMUNOL REV, V170, P151, DOI 10.1111/j.1600-065X.1999.tb01336.x; Biering E, 2014, FISH VACCINATION, P47; de las Heras AI, 2010, FISH SHELLFISH IMMUN, V28, P562, DOI 10.1016/j.fsi.2009.12.006; Espenes A, 1996, FISH SHELLFISH IMMUN, V6, P413, DOI 10.1006/fsim.1996.0040; Evensen O, 1990, J Vet Diagn Invest, V2, P288; Evensen O, 2004, DEV BIOL STAND, V121, P117; Gonnella PA, 1998, J IMMUNOL, V160, P4708; Holm A, 2014, FISH VACCINATION, P128; Joosten PHM, 1997, FISH SHELLFISH IMMUN, V7, P471, DOI 10.1006/fsim.1997.0100; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuo A, 2008, J IMMUNOL, V181, P3474, DOI 10.4049/jimmunol.181.5.3474; Maurice S, 2004, VACCINE, V23, P450, DOI 10.1016/j.vaccine.2004.06.022; MCKNIGHT IJ, 1976, BRIT VET J, V132, P76, DOI 10.1016/S0007-1935(17)34791-7; Munang'andu HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054263; Munang'andu HM, 2012, VACCINE, V30, P4007, DOI 10.1016/j.vaccine.2012.04.039; Munang'andu HM, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-7; Mutwiri G, 2002, VET IMMUNOL IMMUNOP, V87, P269, DOI 10.1016/S0165-2427(02)00052-1; Romalde JL, 2004, AQUACULTURE, V236, P119, DOI 10.1016/j.aquaculture.2004.02.028; ROMBOUT JHWM, 1989, J FISH BIOL, V35, P179, DOI 10.1111/j.1095-8649.1989.tb02967.x; ROMBOUT JHWM, 1985, CELL TISSUE RES, V239, P519, DOI 10.1007/BF00219230; Salvador A, 2012, VACCINE, V30, P589, DOI 10.1016/j.vaccine.2011.11.057; Sarei F, 2013, INDIAN J PHARM SCI, V75, P442, DOI 10.4103/0250-474X.119829; Taksdal T, 1997, DIS AQUAT ORGAN, V28, P39, DOI 10.3354/dao028039; Thinh NH, 2009, FISH SHELLFISH IMMUN, V27, P773, DOI 10.1016/j.fsi.2009.08.012; THUVANDER A, 1990, DEV COMP IMMUNOL, V14, P415, DOI 10.1016/0145-305X(90)90034-C; Tobar JA, 2011, VACCINE, V29, P2336, DOI 10.1016/j.vaccine.2010.12.107; Weiner HL, 2001, MICROBES INFECT, V3, P947, DOI 10.1016/S1286-4579(01)01456-3; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x	29	27	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109337	10.1371/journal.pone.0109337	http://dx.doi.org/10.1371/journal.pone.0109337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310804	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210300048
J	Mentewab, A; Matheson, K; Adebiyi, M; Robinson, S; Elston, B				Mentewab, Ayalew; Matheson, Kinnari; Adebiyi, Morayo; Robinson, Shanice; Elston, Brianna			RNA-Seq Analysis of the Effect of Kanamycin and the ABC Transporter AtWBC19 on Arabidopsis thaliana Seedlings Reveals Changes in Metal Content	PLOS ONE			English	Article							CHLOROPLASTIC NAD(P)H DEHYDROGENASE; IRON-DEFICIENCY; PHOTOSYSTEM-II; MULTICOPPER OXIDASE; ZINC TRANSPORTER; CYTOCHROME B561; OXIDIZING SIDE; FE-DEFICIENCY; PSBP PROTEIN; GENE FAMILY	Plants are exposed to antibiotics produced by soil microorganisms, but little is known about their responses at the transcriptional level. Likewise, few endogenous mechanisms of antibiotic resistance have been reported. The Arabidopsis thaliana ATP Binding Cassette (ABC) transporter AtWBC19 (ABCG19) is known to confer kanamycin resistance, but the exact mechanism of resistance is not well understood. Here we examined the transcriptomes of control seedlings and wbc19 mutant seedlings using RNA-seq analysis. Exposure to kanamycin indicated changes in the organization of the photosynthetic apparatus, metabolic fluxes and metal uptake. Elemental analysis showed a 60% and 80% reduction of iron uptake in control and wbc19 mutant seedlings respectively, upon exposure to kanamycin. The drop in iron content was accompanied by the upregulation of the gene encoding for FERRIC REDUCTION OXIDASE 6 (FRO6) in mutant seedlings but not by the differential expression of other transport genes known to be induced by iron deficiency. In addition, wbc19 mutants displayed a distinct expression profile in the absence of kanamycin. Most notably the expression of several zinc ion binding proteins, including ZINC TRANSPORTER 1 PRECURSOR (ZIP1) was increased, suggesting abnormal zinc uptake. Elemental analysis confirmed a 50% decrease of zinc content in wbc19 mutants. Thus, the antibiotic resistance gene WBC19 appears to also have a role in zinc uptake.	[Mentewab, Ayalew; Matheson, Kinnari; Adebiyi, Morayo; Robinson, Shanice; Elston, Brianna] Spelman Coll, Dept Biol, Atlanta, GA 30314 USA; [Matheson, Kinnari] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Adebiyi, Morayo] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Elston, Brianna] Nova SE Univ, Coll Hlth Care Sci, Davie, FL USA	Spelman College; Princeton University; University of Texas System; University of Texas Health Science Center Houston; Nova Southeastern University	Mentewab, A (corresponding author), Spelman Coll, Dept Biol, Atlanta, GA 30314 USA.	mayalew@spelman.edu			National Science Foundation [1052172]; Quality Education for Minorities Network; Howard Hughes Medical Institute [52006930]	National Science Foundation(National Science Foundation (NSF)); Quality Education for Minorities Network; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This study was supported by grants from the National Science Foundation (www.nsf.gov; Molecular and Cellular Biology grant #1052172) and Quality Education for Minorities Network (qemnetwork.qem.org; Professional Development and Mentoring program) to AM and the Howard Hughes Medical Institute (www.hhmi.org; Educational grant #52006930) to the Biology Department at the Massachusetts Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Arrivault S, 2006, PLANT J, V46, P861, DOI 10.1111/j.1365-313X.2006.02746.x; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; Aufsatz Werner, 2009, Biotechnology Journal, V4, P224, DOI 10.1002/biot.200800156; Bauer P, 2004, PLANT PHYSIOL, V136, P4169, DOI 10.1104/pp.104.047233; Berczi A, 2007, FEBS LETT, V581, P1505, DOI 10.1016/j.febslet.2007.03.006; Bernal M, 2012, PLANT CELL, V24, P738, DOI 10.1105/tpc.111.090431; Burris K, 2008, MICROB BIOTECHNOL, V1, P191, DOI 10.1111/j.1751-7915.2007.00010.x; Carrie C, 2008, FEBS LETT, V582, P3073, DOI 10.1016/j.febslet.2008.07.061; Cenacchi L, 2012, BBA-BIOMEMBRANES, V1818, P679, DOI 10.1016/j.bbamem.2011.10.030; Chu HH, 2010, PLANT PHYSIOL, V154, P197, DOI 10.1104/pp.110.159103; Clemens S, 2013, BIOMETALS, V26, P623, DOI 10.1007/s10534-013-9643-1; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colangelo EP, 2004, PLANT CELL, V16, P3400, DOI 10.1105/tpc.104.024315; Conte S, 2009, PLANT PHYSIOL, V151, P559, DOI 10.1104/pp.109.143487; Conte SS, 2010, PLANT SIGNAL BEHAV, V5, P49, DOI 10.4161/psb.5.1.10142; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Desbrosses-Fonrouge AG, 2005, FEBS LETT, V579, P4165, DOI 10.1016/j.febslet.2005.06.046; DHARIWAL KR, 1991, J BIOL CHEM, V266, P5384; DiDonato RJ, 2004, PLANT J, V39, P403, DOI 10.1111/j.1365-313X.2004.02128.x; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; Durrett TP, 2007, PLANT PHYSIOL, V144, P197, DOI 10.1104/pp.107.097162; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Elhafez D, 2006, PLANT CELL PHYSIOL, V47, P43, DOI 10.1093/pcp/pci221; Endo T, 1999, FEBS LETT, V457, P5, DOI 10.1016/S0014-5793(99)00989-8; Eren E, 2004, PLANT PHYSIOL, V136, P3712, DOI 10.1104/pp.104.046292; Feng HZ, 2006, PLANT PHYSIOL, V140, P1345, DOI 10.1104/pp.105.074138; Fourmy D, 1996, SCIENCE, V274, P1367, DOI 10.1126/science.274.5291.1367; Gebert M, 2009, PLANT CELL, V21, P4018, DOI 10.1105/tpc.109.070557; GHANOTAKIS DF, 1984, BIOCHIM BIOPHYS ACTA, V767, P524, DOI 10.1016/0005-2728(84)90051-3; GHANOTAKIS DF, 1984, FEBS LETT, V170, P169, DOI 10.1016/0014-5793(84)81393-9; Glaesener AG, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00337; Green LS, 2004, PLANT PHYSIOL, V136, P2523, DOI 10.1104/pp.104.045633; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hanke GT, 2004, PLANT PHYSIOL, V134, P255, DOI 10.1104/pp.103.032755; Hanke G, 2013, PLANT CELL ENVIRON, V36, P1071, DOI 10.1111/pce.12046; Hashimoto M, 2003, PLANT J, V36, P541, DOI 10.1046/j.1365-313X.2003.01900.x; Haydon MJ, 2007, NEW PHYTOL, V174, P499, DOI 10.1111/j.1469-8137.2007.02051.x; Haydon MJ, 2012, PLANT CELL, V24, P724, DOI 10.1105/tpc.111.095042; Henriques R, 2002, PLANT MOL BIOL, V50, P587, DOI 10.1023/A:1019942200164; Hoopes JT, 2004, PLANT PHYSIOL BIOCH, V42, P27, DOI 10.1016/j.plaphy.2003.10.011; Horvath EM, 2000, PLANT PHYSIOL, V123, P1337, DOI 10.1104/pp.123.4.1337; Hussain D, 2004, PLANT CELL, V16, P1327, DOI 10.1105/tpc.020487; Ifuku K, 2005, PLANT PHYSIOL, V139, P1175, DOI 10.1104/pp.105.068643; Ifuku K, 2011, PLANT CELL PHYSIOL, V52, P1560, DOI 10.1093/pcp/pcr098; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kang BG, 2010, PLANT CELL REP, V29, P643, DOI 10.1007/s00299-010-0850-8; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klatte M, 2009, PLANT PHYSIOL, V150, P257, DOI 10.1104/pp.109.136374; Kobae Y, 2004, PLANT CELL PHYSIOL, V45, P1749, DOI 10.1093/pcp/pci015; Kwok EY, 2006, BIOCHEMISTRY-US, V45, P6317, DOI 10.1021/bi052173c; La Fontaine S, 2002, EUKARYOT CELL, V1, P736, DOI 10.1128/EC.1.5.736-757.2002; Li LY, 2011, MOL BIOL REP, V38, P3605, DOI 10.1007/s11033-010-0472-9; Li XG, 2004, PLANT CELL PHYSIOL, V45, P103, DOI 10.1093/pcp/pch011; MACHOLD O, 1971, BIOCHIM BIOPHYS ACTA, V238, P324, DOI 10.1016/0005-2787(71)90099-2; McCaig BC, 2005, PLANTA, V221, P619, DOI 10.1007/s00425-004-1472-6; Melis A, 1999, TRENDS PLANT SCI, V4, P130, DOI 10.1016/S1360-1385(99)01387-4; Mentewab A, 2005, NAT BIOTECHNOL, V23, P1177, DOI 10.1038/nbt1134; Michalecka AM, 2003, PLANT PHYSIOL, V133, P642, DOI 10.1104/pp.103.024208; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P727, DOI 10.1128/AAC.43.4.727; Morrissey J, 2009, PLANT CELL, V21, P3326, DOI 10.1105/tpc.109.069401; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; MUNEKAGE Y, 2005, PLANT BIOTECHNOL, V22, P361; Naumann B, 2005, J BIOL CHEM, V280, P20431, DOI 10.1074/jbc.M414486200; Naumann B, 2007, PROTEOMICS, V7, P3964, DOI 10.1002/pmic.200700407; Ossenbuhl F, 2004, PLANT CELL, V16, P1790, DOI 10.1105/tpc.023226; Palmer CM, 2009, NAT CHEM BIOL, V5, P333, DOI 10.1038/nchembio.166; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Picciocchi A, 2003, J BIOL CHEM, V278, P24966, DOI 10.1074/jbc.M302154200; Piller LE, 2011, P NATL ACAD SCI USA, V108, P14354, DOI 10.1073/pnas.1104790108; Provart NJ., 2003, CURRENT COMPUTER MOL, V2003, P271; Ravet K, 2013, ANTIOXID REDOX SIGN, V19, P919, DOI 10.1089/ars.2012.5084; Recht MI, 1999, EMBO J, V18, P3133, DOI 10.1093/emboj/18.11.3133; Recht MI, 1996, J MOL BIOL, V262, P421, DOI 10.1006/jmbi.1996.0526; Rellan-Alvarez R, 2008, RAPID COMMUN MASS SP, V22, P1553, DOI 10.1002/rcm.3523; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Rogers EE, 2002, PLANT CELL, V14, P1787, DOI 10.1105/tpc.001495; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Rumeau D, 2005, PLANT CELL, V17, P219, DOI 10.1105/tpc.104.028282; Saito A, 2010, PLANT CELL PHYSIOL, V51, P2013, DOI 10.1093/pcp/pcq160; Schuler M, 2012, PLANT CELL, V24, P2380, DOI 10.1105/tpc.112.099077; SHOJIMA S, 1989, PLANT CELL PHYSIOL, V30, P673; Sinclair SA, 2012, BBA-MOL CELL RES, V1823, P1553, DOI 10.1016/j.bbamcr.2012.05.016; Song WY, 2010, PLANT CELL, V22, P2237, DOI 10.1105/tpc.109.070185; Sun XW, 2010, PLANT PHYSIOL, V152, P1263, DOI 10.1104/pp.109.150722; Takubo K, 2003, PLANT MOL BIOL, V52, P817, DOI 10.1023/A:1025015811141; Taylor AB, 2005, P NATL ACAD SCI USA, V102, P15459, DOI 10.1073/pnas.0506227102; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsubaki M, 2005, BBA-PROTEINS PROTEOM, V1753, P174, DOI 10.1016/j.bbapap.2005.08.015; Vashchenko G, 2013, NUTRIENTS, V5, P2289, DOI 10.3390/nu5072289; Verret F, 2004, FEBS LETT, V576, P306, DOI 10.1016/j.febslet.2004.09.023; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; von Wiren N, 1999, PLANT PHYSIOL, V119, P1107, DOI 10.1104/pp.119.3.1107; Wang P, 2006, PLANT PHYSIOL, V141, P465, DOI 10.1104/pp.105.070490; Waters BM, 2008, NEW PHYTOL, V179, P1033, DOI 10.1111/j.1469-8137.2008.02544.x; Waters BM, 2006, PLANT PHYSIOL, V141, P1446, DOI 10.1104/pp.106.082586; Waters BM, 2012, J EXP BOT, V63, P5903, DOI 10.1093/jxb/ers239; Wintz H, 2003, J BIOL CHEM, V278, P47644, DOI 10.1074/jbc.M309338200; Wyman S, 2008, FEBS LETT, V582, P1901, DOI 10.1016/j.febslet.2008.05.010; Yi XP, 2007, J BIOL CHEM, V282, P24833, DOI 10.1074/jbc.M705011200; Yruela I, 2013, METALLOMICS, V5, P1090, DOI 10.1039/c3mt00086a	104	7	7	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109310	10.1371/journal.pone.0109310	http://dx.doi.org/10.1371/journal.pone.0109310			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310285	gold, Green Published, Green Submitted			2022-12-27	WOS:000343210300044
J	Pothasin, P; Compton, SG; Wangpakapattanawong, P				Pothasin, Pornwiwan; Compton, Stephen G.; Wangpakapattanawong, Prasit			Riparian Ficus Tree Communities: The Distribution and Abundance of Riparian Fig Trees in Northern Thailand	PLOS ONE			English	Article							SPECIES RICHNESS; VEGETATION; ECOLOGY; MORACEAE; POLLINATION; RESOURCES; DIVERSITY; FOREST; FLOOD; ZONES	Fig trees (Ficus) are often ecologically significant keystone species because they sustain populations of the many seed-dispersing animals that feed on their fruits. They are prominent components of riparian zones where they may also contribute to bank stability as well as supporting associated animals. The diversity and distributions of riparian fig trees in deciduous and evergreen forests in Chiang Mai Province, Northern Thailand were investigated in 2010-2012. To record the diversity and abundance of riparian fig trees, we (1) calculated stem density, species richness, and diversity indices in 20650 m randomly selected quadrats along four streams and (2) measured the distances of individual trees from four streams to determine if species exhibit distinct distribution patterns within riparian zones. A total of 1169 individuals (from c. 4 ha) were recorded in the quadrats, representing 33 Ficus species (13 monoecious and 20 dioecious) from six sub-genera and about 70% of all the species recorded from northern Thailand. All 33 species had at least some stems in close proximity to the streams, but they varied in their typical proximity, with F. squamosa Roxb. and F. ischnopoda Miq the most strictly stream-side species. The riparian forests in Northern Thailand support a rich diversity and high density of Ficus species and our results emphasise the importance of fig tree within the broader priorities of riparian area conservation. Plans to maintain or restore properly functioning riparian forests need to take into account their significance.	[Pothasin, Pornwiwan; Wangpakapattanawong, Prasit] Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai 50000, Thailand; [Compton, Stephen G.] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England; [Compton, Stephen G.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa; [Wangpakapattanawong, Prasit] Chiang Mai Univ, Fac Social Sci, World Agroforestry Ctr, Knowledge Support Ctr Greater Mekong Subreg, Chiang Mai 50000, Thailand	Chiang Mai University; University of Leeds; Rhodes University; Chiang Mai University	Wangpakapattanawong, P (corresponding author), Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai 50000, Thailand.	prasitwang@yahoo.com		Compton, Stephen/0000-0002-1247-8058	Office of the Higher Education Commission; PERDO-Climate change; Department of Biology, Faculty of Science, Chiang Mai University, Thailand	Office of the Higher Education Commission; PERDO-Climate change; Department of Biology, Faculty of Science, Chiang Mai University, Thailand	This study was supported by the Office of the Higher Education Commission, PERDO-Climate change and Department of Biology, Faculty of Science, Chiang Mai University, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstett MC, 1997, TRENDS ECOL EVOL, V12, P94, DOI 10.1016/S0169-5347(96)10064-1; Austin MP, 1996, AUST J ECOL, V21, P154, DOI 10.1111/j.1442-9993.1996.tb00596.x; Balasubramanian P, 2004, BIRD CONSERV INT, V14, pS69, DOI 10.1017/S0959270905000249; Banack SA, 2002, BIOTROPICA, V34, P232, DOI 10.1111/j.1744-7429.2002.tb00534.x; Berg C.C., 2005, FLORA MALESIANA SERI, V17; BERG CC, 1989, EXPERIENTIA, V45, P605, DOI 10.1007/BF01975677; Berg CC, 2003, BLUMEA, V48, P289; Berg CC, 2011, FLORA THAILAND 4, V10; Buckland S. T., 2005, ENCY BIOSTATISTICS; center C, 2012, MET DAT CHIANG UNPUB; Chantarasuwan B, 2007, THAILAND NATURAL HIS, V2, P12; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Cook JM, 2003, TRENDS ECOL EVOL, V18, P241, DOI 10.1016/S0169-5347(03)00062-4; Corner E., 1965, CHECK LIST FICUS ASI; Corner E.J.H., 1969, BIOL SCI, V256, P281, DOI [10.1098/rstb.1969.0043, DOI 10.1098/RSTB.1969.0043]; Corner EJH, 1963, PACIFIC BASIN BIOGEO, P233; Corner EJH, 1960, TAXONOMIC NOTES FICU; Database CH, 2000, TREES DOI SUTH UNPUB; DEFERRARI CM, 1994, J VEG SCI, V5, P247, DOI 10.2307/3236157; Elliott S, 2003, EDEN PROJECT FRIENDS, V10, P33; ELLIOTT S, 1998, FORESTS FUTURE GROWI; Gaines W.L., 1999, MONITORING BIODIVERS; GALIL J, 1968, ECOLOGY, V49, P259, DOI 10.2307/1934454; Gardner S., 2000, FIELD GUIDE FOREST T; GAUTIERHION A, 1989, ECOLOGY, V70, P1826, DOI 10.2307/1938115; Gorley C.K., 2006, GETTING STARTED PRIM; GREGORY SV, 1991, BIOSCIENCE, V41, P540, DOI 10.2307/1311607; Harrison RD, 2003, OIKOS, V100, P628, DOI 10.1034/j.1600-0706.2003.11829.x; Harrison RD, 2003, BIOL J LINN SOC, V78, P439, DOI 10.1046/j.0024-4066.2002.00205.x; Harrison RD, 2005, ECOL STU AN, V174, P111; Heartsill-Scalley T, 2009, CARIBB J SCI, V45, P52; Herre EA, 1996, J BIOGEOGR, V23, P593, DOI 10.1111/j.1365-2699.1996.tb00020.x; Hood WG, 2000, PLANT ECOL, V148, P105, DOI 10.1023/A:1009800327334; Hossaert-McKey M, 2001, AM J BOT, V88, P685, DOI 10.2307/2657069; JANZEN DH, 1979, ANNU REV ECOL SYST, V10, P13, DOI 10.1146/annurev.es.10.110179.000305; Kerdelhue C, 2000, ECOLOGY, V81, P2832, DOI 10.1890/0012-9658(2000)081[2832:CCESOO]2.0.CO;2; Kong-ied K, 2011, FLORISTIC COMPOSITIO; Laman T.G., 1998, TROP BIODIVERS, V5, P245; LAMBERT FR, 1991, J ECOL, V79, P793, DOI 10.2307/2260668; Mark AF, 2000, ARCT ANTARCT ALP RES, V32, P240, DOI 10.2307/1552522; Maxwell JF, 2001, VEGETAION VASCULAR F, V5; MAXWELL JF, 1988, TIGER PAPER, V15, P6; Metcalfe DJ, 1998, J TROP ECOL, V14, P103, DOI 10.1017/S0266467498000091; Mongkolsawat C, 2008, ESTIMATING RIPARIAN; Munishi LK, 2007, DISCOV INNOVAT, V19, P36; Naiman R.J., 2010, RIPARIA ECOLOGY CONS; Naiman RJ, 1997, ANNU REV ECOL SYST, V28, P621, DOI 10.1146/annurev.ecolsys.28.1.621; NAIMAN RJ, 1993, ECOL APPL, V3, P209, DOI 10.2307/1941822; Naiman RJ, 2000, BIOSCIENCE, V50, P996, DOI 10.1641/0006-3568(2000)050[0996:REAMIT]2.0.CO;2; Nason JD, 1998, NATURE, V391, P685, DOI 10.1038/35607; Nilsson C, 2002, ENVIRON MANAGE, V30, P468, DOI 10.1007/s00267-002-2735-2; Norton David A., 2000, Ecological Management & Restoration, V1, P26; PETTS G, 1990, WATER, ENGINEERING AND LANDSCAPE, P12; Pollock MM, 1998, ECOLOGY, V79, P94; Prach K, 2001, APPL VEG SCI, V4, P111, DOI 10.1111/j.1654-109X.2001.tb00241.x; RAMIREZ W, 1969, SCIENCE, V163, P580, DOI 10.1126/science.163.3867.580; ROBERTS DW, 1986, VEGETATIO, V66, P123, DOI 10.1007/BF00039905; Sabo JL, 2005, ECOLOGY, V86, P56, DOI 10.1890/04-0668; Santisuk T., 1988, ACCOUNT VEGETATION N; Shanahan M, 2001, BIOL REV, V76, P529, DOI 10.1017/S1464793101005760; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smitinand T., 1989, FLORISTIC INVENTORY, P63; Tabacchi E, 2000, HYDROL PROCESS, V14, P2959, DOI 10.1002/1099-1085(200011/12)14:16/17&lt;2959::AID-HYP129&gt;3.0.CO;2-B; Taesombat W., 2010, Kasetsart Journal, Natural Sciences, V44, P152; TANG SM, 1995, ENVIRON MANAGE, V19, P741, DOI 10.1007/BF02471956; Team R. D. C, 2011, R LANG ENV STAT COMP; vanNoort S, 1996, J BIOGEOGR, V23, P415, DOI 10.1111/j.1365-2699.1996.tb00003.x; VERKERKE W, 1989, EXPERIENTIA, V45, P612, DOI 10.1007/BF01975678; Weiblen GD, 2002, ANNU REV ENTOMOL, V47, P299, DOI 10.1146/annurev.ento.47.091201.145213; Whitmore T.C., 1984, TROPICAL RAM FORESTS; WHITTAKER RJ, 1995, BIOTROPICA, V27, P346, DOI 10.2307/2388920; WIEBES JT, 1979, ANNU REV ECOL SYST, V10, P1, DOI 10.1146/annurev.es.10.110179.000245; Wintle BC, 2007, AUSTRAL ECOL, V32, P592, DOI 10.1111/j.1442-9993.2007.01753.x; Wood SH, 2008, HYDROL EARTH SYST SC, V12, P959, DOI 10.5194/hess-12-959-2008	75	6	7	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e108945	10.1371/journal.pone.0108945	http://dx.doi.org/10.1371/journal.pone.0108945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310189	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210300027
J	White, MK; Kaminski, R; Khalili, K; Wollebo, HS				White, Martyn K.; Kaminski, Rafal; Khalili, Kamel; Wollebo, Hassen S.			Rad51 Activates Polyomavirus JC Early Transcription	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; NF-KAPPA-B; HOMOLOGOUS RECOMBINATION; MULTIPLE-SCLEROSIS; PROMOTER ACTIVITY; GLIAL-CELLS; VIRUS; NATALIZUMAB; ELEMENT; MEDULLOBLASTOMA	The human neurotropic polyomavirus JC (JCV) causes the fatal CNS demyelinating disease progressive multifocal leukoencephalopathy (PML). JCV infection is very common and after primary infection, the virus is able to persist in an asymptomatic state. Rarely, and usually only under conditions of immune impairment, JCV re-emerges to actively replicate in the astrocytes and oligodendrocytes of the brain causing PML. The regulatory events involved in the reactivation of active viral replication in PML are not well understood but previous studies have implicated the transcription factor NF-kappa B acting at a well-characterized site in the JCV noncoding control region (NCCR). NF-kappa B in turn is regulated in a number of ways including activation by cytokines such as TNF-alpha, interactions with other transcription factors and epigenetic events involving protein acetylation - all of which can regulate the transcriptional activity of JCV. Active JCV infection is marked by the occurrence of rapid and extensive DNA damage in the host cell and the induction of the expression of cellular proteins involved in DNA repair including Rad51, a major component of the homologous recombination-directed double-strand break DNA repair machinery. Here we show that increased Rad51 expression activates the JCV early promoter. This activation is co-operative with the stimulation caused by NF-kappa B p65, abrogated by mutation of the NF-kappa B binding site or siRNA to NF kappa B p65 and enhanced by the histone deacetylase inhibitor sodium butyrate. These data indicate that the induction of Rad51 resulting from infection with JCV acts through NF-kappa B via its binding site to stimulate JCV early transcription. We suggest that this provides a novel positive feedback mechanism to enhance viral gene expression during the early stage of JCV infection.	[White, Martyn K.; Kaminski, Rafal; Khalili, Kamel; Wollebo, Hassen S.] Temple Univ, Sch Med, Dept Neurosci, Ctr Neurovirol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	White, MK (corresponding author), Temple Univ, Sch Med, Dept Neurosci, Ctr Neurovirol, Philadelphia, PA 19122 USA.	martyn.white@temple.edu; kamel.khalili@temple.edu	Kaminski, Rafal/V-3516-2018	Kaminski, Rafal/0000-0001-8827-6658; Wollebo, Hassen/0000-0003-2285-3496	NIH/National Institute of Allergies and Infectious Diseases [R01, AI077460]; NIH/National Institute of Mental Health [P30 MH092177, R01 MH093271]; NIH/National Heart, Lung, and Blood Institute [R01 HL123093]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093271, P30MH092177] Funding Source: NIH RePORTER	NIH/National Institute of Allergies and Infectious Diseases; NIH/National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by MW NIH/National Institute of Allergies and Infectious Diseases R01, AI077460, KK NIH/National Institute of Mental Health P30 MH092177, KK NIH/National Institute of Mental Health R01 MH093271, KK NIH/National Heart, Lung, and Blood Institute R01 HL123093. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Berger JR, 2007, CURR NEUROL NEUROSCI, V7, P461, DOI 10.1007/s11910-007-0072-9; Berger JR, 2011, CURR OPIN NEUROL, V24, P262, DOI 10.1097/WCO.0b013e328346d2a3; BERGER JR, 1995, J NEUROVIROL, V1, P5, DOI 10.3109/13550289509111006; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Budke B, 2012, NUCLEIC ACIDS RES, V40, P7347, DOI 10.1093/nar/gks353; Clifford DB, 2011, ARCH NEUROL-CHICAGO, V68, P1156, DOI 10.1001/archneurol.2011.103; D'Souza A, 2010, CL LYMPH MYELOM LEUK, V10, DOI 10.3816/CLML.2010.n.009; Darbinyan A, 2007, VIROLOGY, V364, P73, DOI 10.1016/j.virol.2007.02.015; DeCaprio JA, 2013, FIELDS VIROLOGY, P6133; Del Valle L, 2002, JNCI-J NATL CANCER I, V94, P267, DOI 10.1093/jnci/94.4.267; FRISQUE RJ, 1984, J VIROL, V51, P458, DOI 10.1128/JVI.51.2.458-469.1984; Habraken Y, 2006, BIOCHEM PHARMACOL, V72, P1132, DOI 10.1016/j.bcp.2006.07.015; Kaminski R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098304; Khalili K, 2007, NEUROLOGY, V68, P985, DOI 10.1212/01.wnl.0000257832.38943.2b; Khalili K, 2008, NEUROTROPIC VIRAL INFECTIONS, P190, DOI 10.1017/CBO9780511541728.014; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Kothary N, 2011, J AM ACAD DERMATOL, V65, P546, DOI 10.1016/j.jaad.2010.05.033; Kumar D, 2010, CURR OPIN INFECT DIS, V23, P374, DOI 10.1097/QCO.0b013e32833bc19d; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; Mateen FJ, 2011, ANN NEUROL, V70, P305, DOI 10.1002/ana.22408; Mayreddy RPR, 1996, J VIROL, V70, P2387, DOI 10.1128/JVI.70.4.2387-2393.1996; McCool KW, 2012, IMMUNOL REV, V246, P311, DOI 10.1111/j.1600-065X.2012.01101.x; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; PADGETT BL, 1971, LANCET, V1, P1257; RANGANATHAN PN, 1993, NUCLEIC ACIDS RES, V21, P1959, DOI 10.1093/nar/21.8.1959; Rom I, 2010, CELL CYCLE, V9, P3715, DOI 10.4161/cc.9.18.12930; Romagnoli L, 2009, VIRUS RES, V146, P97, DOI 10.1016/j.virusres.2009.09.005; Safak M, 1999, VIROLOGY, V262, P178, DOI 10.1006/viro.1999.9886; Shinohara H, 2014, SCIENCE, V344, P760, DOI 10.1126/science.1250020; Van Assche G, 2005, NEW ENGL J MED, V353, P362, DOI 10.1056/NEJMoa051586; White MK, 2006, ANTICANCER RES, V26, P4079; White MK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003206; White MK, 2011, J INFECT DIS, V203, P578, DOI 10.1093/infdis/jiq097; White MK, 2009, J VIROL, V83, P10846, DOI 10.1128/JVI.00542-09; Wollebo HS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-264; Wollebo HS, 2012, VIROLOGY, V432, P146, DOI 10.1016/j.virol.2012.06.010; Wollebo HS, 2011, J NEUROIMMUNOL, V233, P46, DOI 10.1016/j.jneuroim.2010.11.013	39	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110122	10.1371/journal.pone.0110122	http://dx.doi.org/10.1371/journal.pone.0110122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310191	Green Submitted, gold, Green Published			2022-12-27	WOS:000343210300091
J	Ye, X; Zhao, Y; Zhao, LL; Sun, YX; Yang, JS; Yang, WJ				Ye, Xiang; Zhao, Yang; Zhao, Ling-Ling; Sun, Yu-Xia; Yang, Jin-Shu; Yang, Wei-Jun			Characterization of PHB1 and Its Role in Mitochondrial Maturation and Yolk Platelet Degradation during Development of Artemia Embryos	PLOS ONE			English	Article							FRANCISCANA EMBRYOS; BRINE SHRIMP; PROHIBITIN; PROTEINS; TRANSCRIPTION; METABOLISM; RECRUITS; ANOXIA; RB; PHOSPHORYLATION	Background: To cope with harsh environments, crustaceans such as Artemia produce diapause gastrula embryos (cysts) with suppressed metabolism. Metabolism and development resume during post-diapause development, but the mechanism behind these cellular events remains largely unknown. Principal Finding: Our study investigated the role of prohibitin 1 (PHB1) in metabolic reinitiation during post-diapause development. We found that PHB1 was developmentally regulated via changes in phosphorylation status and localization. Results from RNA interference experiments demonstrated PHB1 to be critical for mitochondrial maturation and yolk degradation during development. In addition, PHB1 was present in yolk platelets, and it underwent ubiquitin-mediated degradation during the proteolysis of yolk protein. Conclusions/Significance: PHB1 has an indispensable role in coordinating mitochondrial maturation and yolk platelet degradation during development in Artemia. This novel function of PHB1 provides new clues to comprehend the roles of PHB1 in metabolism and development.	[Ye, Xiang; Zhao, Ling-Ling; Sun, Yu-Xia; Yang, Jin-Shu; Yang, Wei-Jun] Zhejiang Univ, Minist Educ, Key Lab Conservat Biol Endangered Wildlife, Hangzhou 310003, Zhejiang, Peoples R China; [Ye, Xiang; Zhao, Ling-Ling; Sun, Yu-Xia; Yang, Jin-Shu; Yang, Wei-Jun] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Yang] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Zhejiang University; Zhejiang University; University of California System; University of California Berkeley	Yang, WJ (corresponding author), Zhejiang Univ, Minist Educ, Key Lab Conservat Biol Endangered Wildlife, Hangzhou 310003, Zhejiang, Peoples R China.	w_jyang@cls.zju.edu.cn		Yang, Jin-Shu/0000-0001-6680-7737; Yang, Wei-Jun/0000-0002-4591-8830	National Natural Science Foundation of China [31270424]; National Basic Research Program of China (973 Program) [2012CB944903]; 863 programs of China [2012AA10A401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); 863 programs of China(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China (31270424), the National Basic Research Program of China (973 Program, 2012CB944903), and 863 programs of China (2012AA10A401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATZOPOULOS TJ, 2002, ARTEMIA BASIC APPL B; ANCHORDOGUY TJ, 1995, J EXP BIOL, V198, P1299; Ande SR, 2012, INT J OBESITY, V36, P1236, DOI 10.1038/ijo.2011.227; Ande SR, 2009, BBA-MOL CELL RES, V1793, P1372, DOI 10.1016/j.bbamcr.2009.05.008; Ande SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004586; Artal-Sanz M, 2009, NATURE, V461, P793, DOI 10.1038/nature08466; Back JW, 2002, PROTEIN SCI, V11, P2471, DOI 10.1110/ps.0212602; Chen S, 2011, BIOL REPROD, V85, P31, DOI 10.1095/biolreprod.110.090340; Chiu CF, 2013, ONCOGENE, V32, P777, DOI 10.1038/onc.2012.86; Coates PJ, 2001, EXP CELL RES, V265, P262, DOI 10.1006/excr.2001.5166; Coates PJ, 1997, CURR BIOL, V7, P607, DOI 10.1016/S0960-9822(06)00261-2; Dai JQ, 2008, J BIOL CHEM, V283, P1705, DOI 10.1074/jbc.M707853200; Eads BD, 2003, J EXP BIOL, V206, P577, DOI 10.1242/jeb.00110; Eads BD, 1999, AM J PHYSIOL-REG I, V277, pR1588, DOI 10.1152/ajpregu.1999.277.6.R1588; Faller DV, 2002, BLOOD, V100, p738A; Fusaro G, 2002, ONCOGENE, V21, P4539, DOI 10.1038/sj.onc.1205551; Hand SC, 1998, J EXP BIOL, V201, P1233; Joshi B, 2003, BIOCHEM BIOPH RES CO, V312, P459, DOI 10.1016/j.bbrc.2003.10.148; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kwast KE, 1996, BIOCHEM J, V313, P207, DOI 10.1042/bj3130207; Liu D, 2012, PLOS ONE, V7; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Merkwirth C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003021; Mishra S, 2005, TRENDS MOL MED, V11, P192, DOI 10.1016/j.molmed.2005.02.004; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Polier G, 2012, CHEM BIOL, V19, P1093, DOI 10.1016/j.chembiol.2012.07.012; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Rizwani W, 2009, CELL CYCLE, V8, P1621, DOI 10.4161/cc.8.10.8578; Robert AB, 1991, ARTEMIA BIOL; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sripathi SR, 2011, BIOCHEMISTRY-US, V50, P8342, DOI 10.1021/bi2008933; Supale S, 2013, DIABETES, V62, P3488, DOI 10.2337/db13-0152; Vallejo CG, 1996, BIOCHEM J, V314, P505, DOI 10.1042/bj3140505; Van Breukelen F, 2000, J EXP BIOL, V203, P1123; Vessal M, 2006, FEBS J, V273, P568, DOI 10.1111/j.1742-4658.2005.05090.x; Wang S, 1999, MOL CELL BIOL, V19, P7447; Wang S, 2002, ONCOGENE, V21, P8388, DOI 10.1038/sj.onc.1205944; Xie M, 2012, CELL METAB, V16, P322, DOI 10.1016/j.cmet.2012.07.016; Yurugi H, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004646	40	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109152	10.1371/journal.pone.0109152	http://dx.doi.org/10.1371/journal.pone.0109152			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310573	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210300038
J	Yeon, SI; Kim, JY; Yeon, DS; Abramowitz, J; Birnbaumer, L; Muallem, S; Lee, YH				Yeon, Soo-In; Kim, Joo Young; Yeon, Dong-Soo; Abramowitz, Joel; Birnbaumer, Lutz; Muallem, Shmuel; Lee, Young-Ho			Transient Receptor Potential Canonical Type 3 Channels Control the Vascular Contractility of Mouse Mesenteric Arteries	PLOS ONE			English	Article							TRPC3 CHANNELS; ION CHANNELS; ACTIVATION; EXPRESSION; TONE	Transient receptor potential canonical type 3 (TRPC3) channels are non-selective cation channels and regulate intracellular Ca2+ concentration. We examined the role of TRPC3 channels in agonist-, membrane depolarization (high K+)-, and mechanical (pressure)-induced vasoconstriction and vasorelaxation in mouse mesenteric arteries. Vasoconstriction and vasorelaxation of endothelial cells intact mesenteric arteries were measured in TRPC3 wild-type (WT) and knockout (KO) mice. Calcium concentration ([Ca2+]) was measured in isolated arteries from TRPC3 WT and KO mice as well as in the mouse endothelial cell line bEnd.3. Nitric oxide (NO) production and nitrate/nitrite concentrations were also measured in TRPC3 WT and KO mice. Phenylephrine-induced vasoconstriction was reduced in TRPC3 KO mice when compared to that of WT mice, but neither high K+- nor pressure-induced vasoconstriction was altered in TRPC3 KO mice. Acetylcholine-induced vasorelaxation was inhibited in TRPC3 KO mice and by the selective TRPC3 blocker pyrazole-3. Acetylcholine blocked the phenylephrine-induced increase in Ca2+ ratio and then relaxation in TRPC3 WT mice but had little effect on those outcomes in KO mice. Acetylcholine evoked a Ca2+ increase in endothelial cells, which was inhibited by pyrazole-3. Acetylcholine induced increased NO release in TRPC3 WT mice, but not in KO mice. Acetylcholine also increased the nitrate/nitrite concentration in TRPC3 WT mice, but not in KO mice. The present study directly demonstrated that the TRPC3 channel is involved in agonist-induced vasoconstriction and plays important role in NO-mediated vasorelaxation of intact mesenteric arteries.	[Yeon, Soo-In; Lee, Young-Ho] Yonsei Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Yeon, Soo-In; Kim, Joo Young; Lee, Young-Ho] Yonsei Univ, Coll Med, PLUS Project Med Sci BK21, Seoul, South Korea; [Kim, Joo Young] Yonsei Univ, Coll Med, Dept Pharmacol, Seoul, South Korea; [Yeon, Dong-Soo] Kwandong Univ, Coll Med, Dept Physiol, Kangnung, South Korea; [Abramowitz, Joel; Birnbaumer, Lutz] NIEHS, Neurobiol Lab, Res Triangle Pk, NC 27709 USA; [Muallem, Shmuel] Natl Inst Dent & Craniofacial Res, Epithelial Signaling & Transport Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Catholic Kwandong University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Lee, YH (corresponding author), Yonsei Univ, Coll Med, Dept Physiol, Seoul, South Korea.	yhlee@yuhs.ac	Abramowitz, Joel/A-2620-2015; Kim, Joo Young/X-7562-2019	Kim, Joo Young/0000-0003-2623-1491; Lee, Young-Ho/0000-0002-5749-1045	National Research Foundation of Korea (NRF) - Korean government (MEST) [NRF-2011-0029459]; Intramural Research Program of the National Institutes of Health (NIH) [Z0-ES101864]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000735] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); Intramural Research Program of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. NRF-2011-0029459) and by the Intramural Research Program of the National Institutes of Health (NIH) (project Z0-ES101864 to LB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beech DJ, 2013, CIRC J, V77, P570, DOI 10.1253/circj.CJ-13-0154; Birnbaumer L, 2009, ANNU REV PHARMACOL, V49, P395, DOI 10.1146/annurev.pharmtox.48.113006.094928; Brayden JE, 2008, CLIN EXP PHARMACOL P, V35, P1116, DOI 10.1111/j.1440-1681.2007.04855.x; Cartwright EJ, 2011, SCI CHINA LIFE SCI, V54, P691, DOI 10.1007/s11427-011-4199-1; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Dietrich A, 2011, ADV EXP MED BIOL, V704, P781, DOI 10.1007/978-94-007-0265-3_41; Earley S, 2004, CIRC RES, V95, P922, DOI 10.1161/01.RES.0000147311.54833.03; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Gao G, 2012, ARCH MED RES, V43, P431, DOI 10.1016/j.arcmed.2012.08.010; Gaudet R, 2008, J PHYSIOL-LONDON, V586, P3565, DOI 10.1113/jphysiol.2008.155812; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Hartmann J, 2008, NEURON, V59, P392, DOI 10.1016/j.neuron.2008.06.009; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huang JH, 2011, CARDIOVASC RES, V91, P472, DOI 10.1093/cvr/cvr102; Kim EC, 2012, EXP PHYSIOL, V97, P544, DOI 10.1113/expphysiol.2011.062232; Kochukov MY, 2013, J VASC RES, V50, P11, DOI 10.1159/000342461; Lim M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035177; Liu CL, 2006, ACTA PHARMACOL SIN, V27, P981, DOI 10.1111/j.1745-7254.2006.00354.x; Liu DY, 2007, AM J HYPERTENS, V20, P1111, DOI 10.1016/j.amjhyper.2007.04.004; Liu Y, 2010, AM J NEPHROL, V31, P36, DOI 10.1159/000254060; Matchkov VV, 2012, BASIC CLIN PHARMACOL, V110, P42, DOI 10.1111/j.1742-7843.2011.00818.x; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Nishida Motohiro, 2013, Clin Calcium, V23, P561, DOI CliCa1304561568; Peppiatt-Wildman CM, 2007, J PHYSIOL-LONDON, V580, P755, DOI 10.1113/jphysiol.2006.126656; Reading SA, 2005, AM J PHYSIOL-HEART C, V288, pH2055, DOI 10.1152/ajpheart.00861.2004; Schiffrin EL, 2004, AM J HYPERTENS, V17, p39S, DOI 10.1016/j.amjhyper.2004.08.019; Schleifer H, 2012, BRIT J PHARMACOL, V167, P1712, DOI 10.1111/j.1476-5381.2012.02126.x; Schneider JC, 2003, AM J PHYSIOL-HEART C, V284, pH2311, DOI 10.1152/ajpheart.00932.2001; Senadheera S, 2012, CARDIOVASC RES, V95, P439, DOI 10.1093/cvr/cvs208; Thilo F, 2009, J HYPERTENS, V27, P1217, DOI 10.1097/HJH.0b013e32832a5a9f; Tiruppathi C, 2002, VASC PHARMACOL, V39, P173, DOI 10.1016/S1537-1891(03)00007-7; Trebak M, 2002, J BIOL CHEM, V277, P21617, DOI 10.1074/jbc.M202549200; Watanabe H, 2008, PHARMACOL THERAPEUT, V118, P337, DOI 10.1016/j.pharmthera.2008.03.008; Weissmann N, 2006, P NATL ACAD SCI USA, V103, P19093, DOI 10.1073/pnas.0606728103; Welsh DG, 2002, CIRC RES, V90, P248, DOI 10.1161/hh0302.105662; Wong CO, 2011, ADV EXP MED BIOL, V704, P759, DOI 10.1007/978-94-007-0265-3_40; Yao XQ, 2005, CIRC RES, V97, P853, DOI 10.1161/01.RES.0000187473.85419.3e; Yeon DS, 2002, CARDIOVASC RES, V53, P431, DOI 10.1016/S0008-6363(01)00496-5; Yip H, 2004, HISTOCHEM CELL BIOL, V122, P553, DOI 10.1007/s00418-004-0720-y; Zhang DX, 2011, J CARDIOVASC PHARM, V57, P133, DOI 10.1097/FJC.0b013e3181fd35d1; Zhao ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032628	43	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110413	10.1371/journal.pone.0110413	http://dx.doi.org/10.1371/journal.pone.0110413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310225	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210300115
J	Curtis, AD; Taslim, N; Reece, SP; Grebenciucova, E; Ray, RH; Rosenbaum, MD; Wardle, RL; Van Scott, MR; Mannie, MD				Curtis, Alan D., II; Taslim, Najla; Reece, Shaun P.; Grebenciucova, Elena; Ray, Richard H.; Rosenbaum, Matthew D.; Wardle, Robert L.; Van Scott, Michael R.; Mannie, Mark D.			The Extracellular Domain of Myelin Oligodendrocyte Glycoprotein Elicits Atypical Experimental Autoimmune Encephalomyelitis in Rat and Macaque Species	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; NONHUMAN PRIMATE MODELS; MULTIPLE-SCLEROSIS; T-CELL; DEMYELINATED LESIONS; RHESUS-MONKEYS; BRAIN-STEM; LEWIS RAT; DISEASE	Atypical models of experimental autoimmune encephalomyelitis (EAE) are advantageous in that the heterogeneity of clinical signs appears more reflective of those in multiple sclerosis (MS). Conversely, models of classical EAE feature stereotypic progression of an ascending flaccid paralysis that is not a characteristic of MS. The study of atypical EAE however has been limited due to the relative lack of suitable models that feature reliable disease incidence and severity, excepting mice deficient in gamma-interferon signaling pathways. In this study, atypical EAE was induced in Lewis rats, and a related approach was effective for induction of an unusual neurologic syndrome in a cynomolgus macaque. Lewis rats were immunized with the rat immunoglobulin variable (IgV)-related extracellular domain of myelin oligodendrocyte glycoprotein (IgV-MOG) in complete Freund's adjuvant (CFA) followed by one or more injections of rat IgV-MOG in incomplete Freund's adjuvant (IFA). The resulting disease was marked by torticollis, unilateral rigid paralysis, forelimb weakness, and high titers of anti-MOG antibody against conformational epitopes of MOG, as well as other signs of atypical EAE. A similar strategy elicited a distinct atypical form of EAE in a cynomolgus macaque. By day 36 in the monkey, titers of IgG against conformational epitopes of extracellular MOG were evident, and on day 201, the macaque had an abrupt onset of an unusual form of EAE that included a pronounced arousal-dependent, transient myotonia. The disease persisted for 6-7 weeks and was marked by a gradual, consistent improvement and an eventual full recovery without recurrence. These data indicate that one or more boosters of IgV-MOG in IFA represent a key variable for induction of atypical or unusual forms of EAE in rat and Macaca species. These studies also reveal a close correlation between humoral immunity against conformational epitopes of MOG, extended confluent demyelinating plaques in spinal cord and brainstem, and atypical disease induction.	[Curtis, Alan D., II; Taslim, Najla; Grebenciucova, Elena; Mannie, Mark D.] E Carolina Univ, Sch Med, Dept Microbiol & Immunol, Greenville, NC 27858 USA; [Reece, Shaun P.; Ray, Richard H.; Wardle, Robert L.; Van Scott, Michael R.] E Carolina Univ, Sch Med, Dept Physiol, Greenville, NC 27858 USA; [Rosenbaum, Matthew D.] E Carolina Univ, Sch Med, Dept Comparat Med, Greenville, NC 27858 USA; [Curtis, Alan D., II; Taslim, Najla; Mannie, Mark D.] E Carolina Univ, Sch Med, Harriet & John Wooten Lab Alzheimers & Neurodegen, Greenville, NC 27858 USA; [Grebenciucova, Elena] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of Chicago	Mannie, MD (corresponding author), E Carolina Univ, Sch Med, Dept Microbiol & Immunol, Greenville, NC 27858 USA.	manniem@ecu.edu		Rosenbaum, Matthew/0000-0003-0777-0510; Mannie, Mark/0000-0003-0475-8516	National Multiple Sclerosis Society [RG3524B7/2]; National Institute of Neurological Disorders and Stroke [R15NS075830, R01-NS072150]; The Harriet and John Wooten Laboratory for Alzheimer's and Neurodegenerative Disease Research [MT7881]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072150, R15NS075830] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); The Harriet and John Wooten Laboratory for Alzheimer's and Neurodegenerative Disease Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Multiple Sclerosis Society (RG3524B7/2), the National Institute of Neurological Disorders and Stroke (R15NS075830 and R01-NS072150), and The Harriet and John Wooten Laboratory for Alzheimer's and Neurodegenerative Disease Research (MT7881). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abromson-Leeman S, 2004, AM J PATHOL, V165, P1519, DOI 10.1016/S0002-9440(10)63410-4; Adelmann M, 1995, J NEUROIMMUNOL, V63, P17, DOI 10.1016/0165-5728(95)00124-7; Batoulis H, 2011, APMIS, V119, P819, DOI 10.1111/j.1600-0463.2011.02794.x; Bettelli E, 2007, ANN NY ACAD SCI, V1103, P11, DOI 10.1196/annals.1394.021; BONTROP RE, 1990, J EXP MED, V172, P53, DOI 10.1084/jem.172.1.53; Brok HPM, 2001, IMMUNOL REV, V183, P173, DOI 10.1034/j.1600-065x.2001.1830114.x; de Rosbo NK, 2000, J NEUROIMMUNOL, V110, P83, DOI 10.1016/S0165-5728(00)00306-4; DEROSBO NK, 1995, EUR J IMMUNOL, V25, P985, DOI 10.1002/eji.1830250419; ELFERINK BG, 1993, HUM IMMUNOL, V38, P201, DOI 10.1016/0198-8859(93)90541-8; Fierz W, 1988, Ann N Y Acad Sci, V540, P360, DOI 10.1111/j.1749-6632.1988.tb27099.x; Frohman TC, 2013, NAT REV NEUROL, V9, P535, DOI 10.1038/nrneurol.2013.98; GELUK A, 1993, J EXP MED, V177, P979, DOI 10.1084/jem.177.4.979; Geurts JJG, 2008, LANCET NEUROL, V7, P841, DOI 10.1016/S1474-4422(08)70191-1; Haanstra KG, 2013, J NEUROIMMUNE PHARM; Hundgeburth LC, 2013, CLIN IMMUNOL, V146, P155, DOI 10.1016/j.clim.2012.12.007; Iglesias A, 2001, GLIA, V36, P220, DOI 10.1002/glia.1111; Jagessar SA, 2010, J NEUROPATH EXP NEUR, V69, P372, DOI 10.1097/NEN.0b013e3181d5d053; Kroenke MA, 2010, EUR J IMMUNOL, V40, P2340, DOI 10.1002/eji.201040489; LASSMANN H, 1988, ACTA NEUROPATHOL, V75, P566, DOI 10.1007/BF00686201; Lassmann H, 2013, J NEUROL SCI, V333, P1, DOI 10.1016/j.jns.2013.05.010; Lee E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-7; Lees JR, 2008, J EXP MED, V205, P2633, DOI 10.1084/jem.20080155; LININGTON C, 1992, J NEUROIMMUNOL, V40, P219, DOI 10.1016/0165-5728(92)90136-9; LININGTON C, 1988, AM J PATHOL, V130, P443; Mannie Mark, 2009, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1502s85; MANNIE MD, 1990, J NEUROIMMUNOL, V26, P201, DOI 10.1016/0165-5728(90)90002-5; Marta CB, 2005, P NATL ACAD SCI USA, V102, P13992, DOI 10.1073/pnas.0504979102; MASSACESI L, 1992, J CLIN INVEST, V90, P399, DOI 10.1172/JCI115874; Mathey E, 2004, EUR J IMMUNOL, V34, P2065, DOI 10.1002/eji.200425291; Mayer MC, 2012, THER ADV NEUROL DISO, V5, P147, DOI 10.1177/1756285611433772; MEESON AP, 1994, EXP NEUROL, V129, P299, DOI 10.1006/exnr.1994.1172; MEINL E, 1995, INT IMMUNOL, V7, P1489, DOI 10.1093/intimm/7.9.1489; Menge T, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-161; Muhallab S, 2005, J NEUROIMMUNOL, V161, P155, DOI 10.1016/j.jneuroim.2005.01.002; Muller DM, 2000, ACTA NEUROPATHOL, V100, P174, DOI 10.1007/s004019900163; Muller DM, 2005, J NEUROIMMUNOL, V160, P162, DOI 10.1016/j.jneuroim.2004.11.011; Nataf S, 2000, J IMMUNOL, V165, P5867, DOI 10.4049/jimmunol.165.10.5867; Oliver AR, 2003, J IMMUNOL, V171, P462, DOI 10.4049/jimmunol.171.1.462; Sakuma H, 2004, BRAIN, V127, P2201, DOI 10.1093/brain/awh260; SCHLUESENER HJ, 1987, J IMMUNOL, V139, P4016; Simmons SB, 2013, TRENDS IMMUNOL, V34, P410, DOI 10.1016/j.it.2013.04.006; Storch MK, 1998, BRAIN PATHOL, V8, P681, DOI 10.1111/j.1750-3639.1998.tb00194.x; Szalai AJ, 2007, MOL IMMUNOL, V44, P3132, DOI 10.1016/j.molimm.2007.02.002; 't Hart BA, 2005, J NEUROIMMUNOL, V168, P1, DOI 10.1016/j.jneuroim.2005.05.017; t'Hart BA, 2004, LANCET NEUROL, V3, P588, DOI 10.1016/S1474-4422(04)00879-8; tHart BA, 1997, FEBS LETT, V409, P91, DOI 10.1016/S0014-5793(97)00493-6; Tran GT, 2002, J IMMUNOL, V168, P4293, DOI 10.4049/jimmunol.168.9.4293; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; von Budingen HC, 2004, EUR J IMMUNOL, V34, P2072, DOI 10.1002/eji.200425050; Wekerle H, 2008, ANN RHEUM DIS, V67, P56, DOI 10.1136/ard.2008.098020; Wensky AK, 2005, J IMMUNOL, V174, P1416, DOI 10.4049/jimmunol.174.3.1416	51	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110048	10.1371/journal.pone.0110048	http://dx.doi.org/10.1371/journal.pone.0110048			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303101	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400105
J	Rabizadeh, E; Cherny, I; Wolach, O; Sherman, S; Binkovski, N; Peretz, A; Lederfein, D; Inbal, A				Rabizadeh, Esther; Cherny, Izhack; Wolach, Ofir; Sherman, Shany; Binkovski, Natalia; Peretz, Alon; Lederfein, Doron; Inbal, Aida			Increased Activity of Cell Membrane-Associated Prothrombinase, Fibrinogen-Like Protein 2, in Peripheral Blood Mononuclear Cells of B-Cell Lymphoma Patients	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; VENOUS THROMBOSIS; LACTATE-DEHYDROGENASE; T-LYMPHOCYTES; IFN-GAMMA; IMMUNOCHEMOTHERAPY; MALIGNANCIES; CONTRIBUTES; INDUCTION; REJECTION	Fibrinogen like protein 2, FGL-2, was reported to be overexpressed in various cancer tissues, where it acts as a transmembrane prothrombinase. This study aims to determine the prothrombinase activity of FGL-2 in peripheral blood mononuclear cells (PBMC) of patients with B-cell lymphoma. FGL-2 activity was determined in patients with B-cell lymphoma (n=53), and healthy controls (n=145). FGL-2 activity in patients at diagnosis increased 3 +/- 0.3 fold (p<0.001). Sensitivity and specificity of the test was established at 73.6% and 80.7%, respectively, using a cutoff of 150% activity over control. Moreover, FGL-2 activity in 10 of 11 patients in remission decreased by 76%. In contrast, no significant difference was observed in expression levels of fgl-2 gene in patients and controls. Taken together, our study indicates that FGL-2 prothrombinase activity in PBMC of lymphoma patients is increased in active disease and normalizes during remission, thus being a potential marker for follow up of lymphoma patients.	[Rabizadeh, Esther; Cherny, Izhack; Sherman, Shany; Binkovski, Natalia; Lederfein, Doron] Rabin Med Ctr, Felsenstein Med Res Ctr, Hematooncol Lab, Petah Tiqwa, Israel; [Rabizadeh, Esther; Cherny, Izhack; Wolach, Ofir; Sherman, Shany; Binkovski, Natalia; Lederfein, Doron; Inbal, Aida] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Rabizadeh, Esther] Rabin Med Ctr, Hematol Lab, Petah Tiqwa, Israel; [Wolach, Ofir; Sherman, Shany; Inbal, Aida] Rabin Med Ctr, Inst Hematol, Thrombosis & Hemostasis Unit, Petah Tiqwa, Israel; [Peretz, Alon] Rabin Med Ctr, Occupat Hlth Clin, Petah Tiqwa, Israel	Rabin Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Rabin Medical Center; Rabin Medical Center	Inbal, A (corresponding author), Rabin Med Ctr, Inst Hematol, Thrombosis & Hemostasis Unit, Petah Tiqwa, Israel.	aidainbal@hotmail.com		Wolach, Ofir/0000-0002-8662-0707	Nufar grant, Ministry of Health, Israel [44776]	Nufar grant, Ministry of Health, Israel	Funding provided by Nufar grant number 44776, Chief Scientist, Ministry of Health, Israel, http://www.magnet.org.il/article.aspx?id = 687. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, N ENGL J MED, V329, P987; Blom JW, 2006, EUR J CANCER, V42, P410, DOI 10.1016/j.ejca.2005.09.013; Blom JW, 2006, J THROMB HAEMOST, V4, P529, DOI 10.1111/j.1538-7836.2006.01804.x; Blom JW, 2005, JAMA-J AM MED ASSOC, V293, P715, DOI 10.1001/jama.293.6.715; Caruso V, 2007, J THROMB HAEMOST, V5, P621, DOI 10.1111/j.1538-7836.2007.02383.x; Chan CWY, 2003, J IMMUNOL, V170, P4036, DOI 10.4049/jimmunol.170.8.4036; Chan CWY, 2002, J IMMUNOL, V168, P5170, DOI 10.4049/jimmunol.168.10.5170; Cheson BD, 2005, J CLIN ONCOL, V23, P6283, DOI 10.1200/JCO.2005.08.005; El-Sharkawi D, 2012, LEUKEMIA LYMPHOMA, V53, P1949, DOI 10.3109/10428194.2012.679360; Fisher SG, 2004, ONCOGENE, V23, P6524, DOI 10.1038/sj.onc.1207843; Geisler CH, 2010, BLOOD, V115, P1530, DOI 10.1182/blood-2009-08-236570; Ghanekar A, 2004, J IMMUNOL, V172, P5693, DOI 10.4049/jimmunol.172.9.5693; Gry M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-365; Hancock WW, 2004, P NATL ACAD SCI USA, V101, P3005, DOI 10.1073/pnas.0308369101; Huijgen HJ, 1997, EUR J CLIN CHEM CLIN, V35, P569; Liu YL, 2012, LIVER INT, V32, P1585, DOI 10.1111/j.1478-3231.2012.02865.x; Marazzi S, 1998, J IMMUNOL, V161, P138; Martelli M, 2013, CRIT REV ONCOL HEMAT, V87, P146, DOI 10.1016/j.critrevonc.2012.12.009; Ning Q, 2005, J IMMUNOL, V174, P7403, DOI 10.4049/jimmunol.174.11.7403; RUEGG C, 1995, GENE, V160, P257, DOI 10.1016/0378-1119(95)00240-7; Shankland KR, 2012, LANCET, V380, P848, DOI 10.1016/S0140-6736(12)60605-9; Smith A, 2011, BRIT J CANCER, V105, P1684, DOI 10.1038/bjc.2011.450; Solal-Celigny Philippe, 2006, Curr Treat Options Oncol, V7, P270, DOI 10.1007/s11864-006-0036-3; Sorensen HT, 2000, NEW ENGL J MED, V343, P1846, DOI 10.1056/NEJM200012213432504; Su K, 2008, WORLD J GASTROENTERO, V14, P5980, DOI 10.3748/wjg.14.5980; Trousseau A., 1865, CLINIQUE M DICALE LH, VVolume 3, P654	26	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109648	10.1371/journal.pone.0109648	http://dx.doi.org/10.1371/journal.pone.0109648			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303152	gold, Green Submitted, Green Published			2022-12-27	WOS:000343730400073
J	Tahara, T; Shibata, T; Okubo, M; Ishizuka, T; Nakamura, M; Nagasaka, M; Nakagawa, Y; Ohmiya, N; Arisawa, T; Hirata, I				Tahara, Tomomitsu; Shibata, Tomoyuki; Okubo, Masaaki; Ishizuka, Takamitsu; Nakamura, Masakatsu; Nagasaka, Mitsuo; Nakagawa, Yoshihito; Ohmiya, Naoki; Arisawa, Tomiyasu; Hirata, Ichiro			DNA Methylation Status of Epithelial-Mesenchymal Transition (EMT) - Related Genes Is Associated with Severe Clinical Phenotypes in Ulcerative Colitis (UC)	PLOS ONE			English	Article							E-CADHERIN; COLORECTAL-CANCER; EXPRESSION; NEOPLASIA	Background: Epithelial-to-mesenchymal transition (EMT) is a phenomenon that allows the conversion of adherent epithelial cells to a mesenchymal cell phenotype, which enhances migratory capacity and invasiveness. Recent studies have suggested that EMT contributes to the pathogenesis of ulcerative colitis (UC). We investigated the promoter DNA methylation status of EMT-related genes in the colonic mucosa in UC. Methods: Colonic biopsies were obtained from the rectal inflammatory mucosa of 86 UC patients and the noninflammatory proximal colonic mucosa of 10 paired patients. Bisulfite pyrosequencing was used to quantify the methylation of 5 candidate CpG island promoters (NEUROG1, CDX1, miR-1247, CDH1, and CDH13) and LINE1. Results: Using an unsupervised hierarchical clustering analysis, inflamed rectal mucosa was well separated from mucosa that appeared normal. The CDH1 and CDH13 promoters were significantly associated with patient age (p = 0.04, 0.03, respectively). A similar trend was found between those genes and the duration of disease (CDH1: p = 0.07, CDH13: p = 0.0002, mean of both: p<0.00001). Several positive associations were found between hypermethylation and severe clinical phenotypes (CDX1 and miR-1247 and a refractory phenotype: p = 0.04 and 0.006, respectively. miR-1247 and CDH1 hyper methylation and a more severe Mayo endoscopic subscore: miR-1247: p = 0.0008, CDH1: p = 0.03, mean of both: p = 0.003). When the severe clinical phenotype was defined as having any of five phenotypes (hospitalized more than twice, highest Mayo endoscopic subscore, steroid dependence, refractory, or a history of surgery) miR-1247 hypermethylation was associated with the same phenotype (p = 0.008). Conclusions: Our data suggest that variability in the methylation status of EMT-related genes is associated with more severe clinical phenotypes in UC.	[Tahara, Tomomitsu; Shibata, Tomoyuki; Okubo, Masaaki; Ishizuka, Takamitsu; Nagasaka, Mitsuo; Nakagawa, Yoshihito; Ohmiya, Naoki; Hirata, Ichiro] Fujita Hlth Univ, Sch Med, Dept Gastroenterol, Toyoake, Aichi 47011, Japan; [Nakamura, Masakatsu; Arisawa, Tomiyasu] Kanazawa Med Univ, Dept Gastroenterol, Uchinada, Ishikawa, Japan	Fujita Health University; Kanazawa Medical University	Tahara, T (corresponding author), Fujita Hlth Univ, Sch Med, Dept Gastroenterol, Toyoake, Aichi 47011, Japan.	tomomiccyu@yahoo.co.jp						Auersperg N, 1999, P NATL ACAD SCI USA, V96, P6249, DOI 10.1073/pnas.96.11.6249; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Estecio MRH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000399; Flier SN, 2010, J BIOL CHEM, V285, P20202, DOI 10.1074/jbc.M110.102012; Head Kathleen A, 2003, Altern Med Rev, V8, P247; Issa JP, 1999, CRIT REV ONCOL HEMAT, V32, P31, DOI 10.1016/S1040-8428(99)00019-0; Issa JPJ, 2001, CANCER RES, V61, P3573; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Karayiannakis AJ, 1998, J PATHOL, V185, P413; Kim JG, 2014, EPIGENETICS; Konishi K, 2007, GASTROENTEROLOGY, V132, P1254, DOI 10.1053/j.gastro.2007.01.035; Lakatos Laszlo, 2003, Orv Hetil, V144, P1853; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Malouf GG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r144; Saito S, 2011, INFLAMM BOWEL DIS, V17, P1955, DOI 10.1002/ibd.21573; Scharl M, 2011, INFLAMM BOWEL DIS, V17, P1907, DOI [10.1002/ibd.21555, 10.1002/ibd.21913]; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Shiovitz S, 2014, GASTROENTEROLOGY; Suh ER, 2002, J BIOL CHEM, V277, P35795, DOI 10.1074/jbc.M205567200; Tahara T, 2014, CLIN EXP MED; Tahara T, 2011, VIRCHOWS ARCH, V458, P205, DOI 10.1007/s00428-010-1038-x; Tahara T, 2009, CLIN EXP MED, V9, P125, DOI 10.1007/s10238-008-0025-x; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Tominaga K, 2005, CLIN CANCER RES, V11, P8880, DOI 10.1158/1078-0432.CCR-05-1309; Wang Z, 2012, PATHOL ONCOL RES, V18, P263, DOI 10.1007/s12253-011-9437-0	28	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e107947	10.1371/journal.pone.0107947	http://dx.doi.org/10.1371/journal.pone.0107947			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303049	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400006
J	Jiang, YH; Kuo, HC				Jiang, Yuan-Hong; Kuo, Hann-Chorng			Urothelial Dysfunction and Increased Suburothelial Inflammation of Urinary Bladder Are Involved in Patients with Upper Urinary Tract Urolithiasis - Clinical and Immunohistochemistry Study	PLOS ONE			English	Article							INTERSTITIAL CYSTITIS; MECHANISMS; WOMEN	Objectives: To investigate the urothelial dysfunction and inflammation of urinary bladder in patients with upper urinary tract (UUT) urolithiasis through the results of cystoscopic hydrodistension and immunohistochemistry study. Methods: Ninety-one patients with UUT urolithiasis underwent cystoscopic hydrodistension before the stone surgery. Immunofluorescence staining of E-cadherin, zonula occludens-1 (ZO-1), tryptase (mast cell activation), and TUNEL (urothelial apoptosis) were performed in 42 patients with glomerulations after hydrodistension, 10 without glomerulations, and 10 controls. Results: Of the 91 patients, 62 (68.2%) developed glomerulations after hydrodistension. Lower urinary tract symptoms (LUTS) were present in 53.8% patients, in whom significantly smaller maximal anesthetic bladder capacity (MBC) was noted. Patients with middle or lower 1/3 ureteral stones had a significantly higher glomerulation rate (88.6% vs. 55.4%, p<0.01) and lower MBC (618.4 +/- 167.6 vs. 701.2 +/- 158.4 ml, p = 0.027) than those with upper 1/3 ureteral or renal stones. Patients with UUT urolithiasis had significantly lower expression of E-cadherin (26.2 +/- 14.8 vs. 42.4 +/- 16.7) and ZO-1 (5.16 +/- 4.02 vs. 11.02 +/- 5.66); and higher suburothelial mast cell (13.3 +/- 66.8 vs. 1.3 +/- 61.2) and apoptotic cell (2.6 +/- 2.5 vs. 0.1 +/- 0.3) numbers than in controls (all p<0.01). Conclusions: Urothelial dysfunction and increased suburothelial inflammation and apoptosis are highly prevalent in the bladders of UUT urolithiasis patients, indicating inflammation cross-talk between UUT and urinary bladder. Patients with UUT urolithiaisis concomitant with LUTS had a smaller MBC, which may explain the presence of irritative bladder symptoms.	[Kuo, Hann-Chorng] Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan; Tzu Chi Univ, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University	Kuo, HC (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan.	hck@tzuchi.com.tw						Acharya P, 2004, AM J PHYSIOL-RENAL, V287, pF305, DOI 10.1152/ajprenal.00341.2003; Bjorling DE, 2011, NEUROUROL URODYNAM, V30, P673, DOI 10.1002/nau.21078; Bouchelouche K, 2003, CURR OPIN UROL, V13, P309, DOI 10.1097/00042307-200307000-00007; Brumovsky PR, 2010, AUTON NEUROSCI-BASIC, V153, P106, DOI 10.1016/j.autneu.2009.07.006; Chiu IM, 2012, NAT NEUROSCI, V15, P1063, DOI 10.1038/nn.3144; Chuang FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063760; Chung Maurice K, 2005, JSLS, V9, P25; ERICKSON DR, 1995, J UROLOGY, V153, P728, DOI 10.1016/S0022-5347(01)67700-0; GILLENWATER JY, 1988, J UROLOGY, V140, P203, DOI 10.1016/S0022-5347(17)41529-1; Homma Y, 2009, INT J UROL, V16, P597, DOI 10.1111/j.1442-2042.2009.02326.x; Janssen DAW, 2011, J UROLOGY, V186, P1121, DOI 10.1016/j.juro.2011.04.107; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kaczmarek E, 2004, Rocz Akad Med Bialymst, V49 Suppl 1, P155; Kuo HC, 2010, LUTS, V2, P88, DOI 10.1111/j.1757-5672.2010.00065.x; Kuo HannChorng, 2012, Clinical Investigation, V2, P1085; Lee CL, 2013, BJU INT, V112, P1156, DOI 10.1111/bju.12256; Liu HT, 2012, UROLOGY, V80, DOI 10.1016/j.urology.2012.01.047; Malykhina AP, 2007, NEUROSCIENCE, V149, P660, DOI 10.1016/j.neuroscience.2007.07.053; Moore KL, 2013, CLIN ORIENTED ANATOM, P297; Nazif O, 2007, UROLOGY, V69, P24, DOI 10.1016/j.urology.2006.08.1108; Paulson John D, 2005, JSLS, V9, P426; Shie JH, 2011, BJU INT, V108, pE136, DOI 10.1111/j.1464-410X.2010.09911.x; van de Merwe JP, 2008, EUR UROL, V53, P60, DOI 10.1016/j.eururo.2007.09.019; Waxman JA, 1998, J UROLOGY, V160, P1663, DOI 10.1016/S0022-5347(01)62376-0; WEIN A, 1990, INTERSTITIAL CYSTITI	25	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110754	10.1371/journal.pone.0110754	http://dx.doi.org/10.1371/journal.pone.0110754			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329457	Green Submitted, gold, Green Published			2022-12-27	WOS:000343942100092
J	Cohen, Y; Rubin, AE; Galperin, M; Ploch, S; Runge, F; Thines, M				Cohen, Yigal; Rubin, Avia E.; Galperin, Mariana; Ploch, Sebastian; Runge, Fabian; Thines, Marco			Seed Transmission of Pseudoperonospora cubensis	PLOS ONE			English	Article							DOWNY MILDEW PATHOGEN; A2 MATING-TYPE; AGENT; PHYLOGENY; CUCURBITS	Pseudoperonospora cubensis, an obligate biotrophic oomycete causing devastating foliar disease in species of the Cucurbitaceae family, was never reported in seeds or transmitted by seeds. We now show that P. cubensis occurs in fruits and seeds of downy mildew-infected plants but not in fruits or seeds of healthy plants. About 6.7% of the fruits collected during 2012-2014 have developed downy mildew when homogenized and inoculated onto detached leaves and 0.9% of the seeds collected developed downy mildew when grown to the seedling stage. This is the first report showing that P. cubensis has become seed-transmitted in cucurbits. Species-specific PCR assays showed that P. cubensis occurs in ovaries, fruit seed cavity and seed embryos of cucurbits. We propose that international trade of fruits or seeds of cucurbits might be associated with the recent global change in the population structure of P. cubensis.	[Cohen, Yigal; Rubin, Avia E.; Galperin, Mariana] Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel; [Runge, Fabian; Thines, Marco] Univ Hohenheim, Inst Bot 210, Stuttgart, Germany; [Ploch, Sebastian] Biodivers & Climate Res Ctr, Frankfurt, Germany	Bar Ilan University; University Hohenheim	Cohen, Y (corresponding author), Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel.	yigal.cohen1@gmail.com		Ploch, Sebastian/0000-0002-7129-4523				Babiker EM, 2012, PLANT DIS, V96, P1670, DOI 10.1094/PDIS-02-12-0212-RE; BALASS M, 1993, PHYSIOL MOL PLANT P, V43, P11, DOI 10.1006/pmpp.1993.1036; Cappelli C., 2003, Plant Disease, V87, P449, DOI 10.1094/PDIS.2003.87.4.449A; Cohen Y, 2013, PLANT DIS, V97, P559, DOI 10.1094/PDIS-09-12-0899-PDN; Cohen Y, 2013, PLANT DIS, V97, P292, DOI 10.1094/PDIS-10-12-0911-PDN; Cohen Y, 2003, PHYTOPARASITICA, V31, P458, DOI 10.1007/BF02979739; COHEN Y, 1974, CAN J BOT, V52, P231, DOI 10.1139/b74-027; Cohen Y, 2013, SEED TRANSMISSION PS; Cohen Y, 2012, EUR J PLANT PATHOL, V132, P577, DOI 10.1007/s10658-011-9902-3; D'Ercole N., 1975, Informatore Fitopatologico, V25, P11; Farahani-Kofoet RD, 2012, MYCOL PROG, V11, P961, DOI 10.1007/s11557-012-0816-z; Garibaldi A, 2004, Z PFLANZENK PFLANZEN, V111, P465; Holmes GJ, 2006, OLD ENEMY EMERGES DO; Hudspeth DSS, 2000, MYCOLOGIA, V92, P674, DOI 10.2307/3761425; Landa BB, 2007, PHYTOPATHOLOGY, V97, P1380, DOI 10.1094/PHYTO-97-11-1380; Lebeda A, 2011, FUNGICIDE RESISTANCE IN CROP PROTECTION: RISK AND MANAGEMENT, P44, DOI 10.1079/9781845939052.0044; Lebeda A, 2011, EUR J PLANT PATHOL, V129, P157, DOI 10.1007/s10658-010-9658-1; PALTI J, 1980, PHYTOPARASITICA, V8, P109, DOI 10.1007/BF02994506; Ploch S, 2011, MOL ECOL, V20, P3692, DOI 10.1111/j.1365-294X.2011.05188.x; Rubin E, 2001, PHYTOPATHOLOGY, V91, P1074, DOI 10.1094/PHYTO.2001.91.11.1074; Runge F, 2011, EUR J PLANT PATHOL, V129, P135, DOI 10.1007/s10658-010-9714-x; Savory EA, 2011, MOL PLANT PATHOL, V12, P217, DOI 10.1111/j.1364-3703.2010.00670.x; Testen AL, 2014, PHYTOPATHOLOGY, V104, P379, DOI 10.1094/PHYTO-07-13-0198-R; Thomas A, 2013, PHYTOPATHOLOGY, V103, P145; THOMAS CE, 1987, PHYTOPATHOLOGY, V77, P1621, DOI 10.1094/Phyto-77-1621; TINKER NA, 1993, THEOR APPL GENET, V85, P976, DOI 10.1007/BF00215037; Van Haltern F, 1933, B GEORGIA EXPT STATI, V175; White TJ., 1990, PCR PROTOCOLS GUIDE, P315	28	29	30	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109766	10.1371/journal.pone.0109766	http://dx.doi.org/10.1371/journal.pone.0109766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329308	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204100025
J	Ghosh, A; Davey, M; Chute, IC; Griffiths, SG; Lewis, S; Chacko, S; Barnett, D; Crapoulet, N; Fournier, S; Joy, A; Caissie, MC; Ferguson, AD; Daigle, M; Meli, MV; Lewis, SM; Ouellette, RJ				Ghosh, Anirban; Davey, Michelle; Chute, Ian C.; Griffiths, Steven G.; Lewis, Scott; Chacko, Simi; Barnett, David; Crapoulet, Nicolas; Fournier, Sebastien; Joy, Andrew; Caissie, Michelle C.; Ferguson, Amanda D.; Daigle, Melissa; Meli, M. Vicki; Lewis, Stephen M.; Ouellette, Rodney J.			Rapid Isolation of Extracellular Vesicles from Cell Culture and Biological Fluids Using a Synthetic Peptide with Specific Affinity for Heat Shock Proteins	PLOS ONE			English	Article							J-DOMAIN; PROTEOMIC ANALYSIS; NMR STRUCTURE; HUMAN SALIVA; EXOSOMES; BINDING; HSP70; HEAT-SHOCK-PROTEIN-70; MACROPHAGES; RELEASE	Recent studies indicate that extracellular vesicles are an important source material for many clinical applications, including minimally-invasive disease diagnosis. However, challenges for rapid and simple extracellular vesicle collection have hindered their application. We have developed and validated a novel class of peptides (which we named venceremin, or Vn) that exhibit nucleotide-independent specific affinity for canonical heat shock proteins. The Vn peptides were validated to specifically and efficiently capture HSP-containing extracellular vesicles from cell culture growth media, plasma, and urine by electron microscopy, atomic force microscopy, sequencing of nucleic acid cargo, proteomic profiling, immunoblotting, and nanoparticle tracking analysis. All of these analyses confirmed the material captured by the Vn peptides was comparable to those purified by the standard ultracentrifugation method. We show that the Vn peptides are a useful tool for the rapid isolation of extracellular vesicles using standard laboratory equipment. Moreover, the Vn peptides are adaptable to diverse platforms and therefore represent an excellent solution to the challenge of extracellular vesicle isolation for research and clinical applications.	[Ghosh, Anirban; Davey, Michelle; Chute, Ian C.; Griffiths, Steven G.; Chacko, Simi; Barnett, David; Crapoulet, Nicolas; Fournier, Sebastien; Joy, Andrew; Caissie, Michelle C.; Ferguson, Amanda D.; Daigle, Melissa; Lewis, Stephen M.; Ouellette, Rodney J.] Atlantic Canc Res Inst, Moncton, NB, Canada; [Ghosh, Anirban; Barnett, David; Lewis, Stephen M.; Ouellette, Rodney J.] Univ Moncton, Dept Chem & Biochem, Moncton, NB E1A 3E9, Canada; [Lewis, Scott] New England Peptide Inc, Gardner, MA USA; [Barnett, David; Meli, M. Vicki] Mt Allison Univ, Dept Chem & Biochem, Sackville, NB E0A 3C0, Canada; [Lewis, Stephen M.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Lewis, Stephen M.] Univ New Brunswick, Dept Biol, St John, NB ST JO, Canada	University of Moncton; Mount Allison University; Dalhousie University; University of New Brunswick	Ghosh, A (corresponding author), Atlantic Canc Res Inst, Moncton, NB, Canada.	anirbang@canceratl.ca; rodneyo@canceratl.ca	Lewis, Stephen/E-5533-2010	Lewis, Stephen/0000-0001-9537-5822; Joy, Andrew/0000-0002-5477-1615; Barnett, David/0000-0001-9205-058X	Atlantic Canada Opportunities Agency; New Brunswick Innovation Foundation; Ride for Dad; New Investigator Salary Award from the Canadian Institutes of Health Research - Regional Partnerships Program	Atlantic Canada Opportunities Agency; New Brunswick Innovation Foundation; Ride for Dad; New Investigator Salary Award from the Canadian Institutes of Health Research - Regional Partnerships Program(Canadian Institutes of Health Research (CIHR))	The authors thank the Atlantic Innovation Fund from the Atlantic Canada Opportunities Agency, the New Brunswick Innovation Foundation, and Ride for Dad for funding this research. Stephen M. Lewis is supported by a New Investigator Salary Award from the Canadian Institutes of Health Research - Regional Partnerships Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atay Safinur, 2014, Commun Integr Biol, V7, pe28231, DOI 10.4161/cib.28231; Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; Bard MP, 2004, AM J RESP CELL MOL, V31, P114, DOI 10.1165/rcmb.2003-0238OC; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Bhatnagar S, 2007, J BIOL CHEM, V282, P25779, DOI 10.1074/jbc.M702277200; De Maio A, 2011, CELL STRESS CHAPERON, V16, P235, DOI 10.1007/s12192-010-0236-4; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Gao XC, 2012, J BIOL CHEM, V287, P6044, DOI 10.1074/jbc.M111.294728; Gassler CS, 1998, P NATL ACAD SCI USA, V95, P15229, DOI 10.1073/pnas.95.26.15229; Giri PK, 2010, PROTEOMICS, V10, P3190, DOI 10.1002/pmic.200900840; Graner MW, 2007, J NEUROSCI, V27, P11214, DOI 10.1523/JNEUROSCI.3588-07.2007; Graner MW, 2009, CANCER SCI, V100, P1870, DOI 10.1111/j.1349-7006.2009.01269.x; Graner MW, 2009, FASEB J, V23, P1541, DOI 10.1096/fj.08-122184; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; Hong M, 2011, PROTEIN SCI, V20, P641, DOI 10.1002/pro.600; Hu JB, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-3; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Jia SD, 2014, EXPERT REV MOL DIAGN, V14, P307, DOI 10.1586/14737159.2014.893828; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Joly AL, 2010, J INNATE IMMUN, V2, P238, DOI 10.1159/000296508; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Kettern N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016398; Khan S, 2011, APOPTOSIS, V16, P1, DOI 10.1007/s10495-010-0534-4; Kotsiopriftis M, 2005, J VIROL, V79, P7255, DOI 10.1128/JVI.79.11.7255-7261.2005; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Liu YL, 2010, AM J PATHOL, V176, P2490, DOI 10.2353/ajpath.2010.090777; Lv LH, 2012, J BIOL CHEM, V287, P15874, DOI 10.1074/jbc.M112.340588; Maeda H, 2007, J BIOL CHEM, V282, P26956, DOI 10.1074/jbc.M703436200; Michael A, 2010, ORAL DIS, V16, P34, DOI 10.1111/j.1601-0825.2009.01604.x; Mihajlovic M, 2010, BBA-BIOMEMBRANES, V1798, P1494, DOI 10.1016/j.bbamem.2010.02.023; Multhoff G, 2007, METHODS, V43, P229, DOI 10.1016/j.ymeth.2007.06.006; Multhoff G, 2011, CELL STRESS CHAPERON, V16, P251, DOI 10.1007/s12192-010-0247-1; Nicolai A, 2010, J CHEM THEORY COMPUT, V6, P2501, DOI 10.1021/ct1002169; Palanisamy V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008577; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Pellecchia M, 1996, J MOL BIOL, V260, P236, DOI 10.1006/jmbi.1996.0395; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Qian YQ, 1996, J MOL BIOL, V260, P224, DOI 10.1006/jmbi.1996.0394; Rerole AL, 2011, CANCER RES, V71, P484, DOI 10.1158/0008-5472.CAN-10-1443; Runz S, 2007, GYNECOL ONCOL, V107, P563, DOI 10.1016/j.ygyno.2007.08.064; Sakashita N, 2000, AM J PATHOL, V156, P227, DOI 10.1016/S0002-9440(10)64723-2; Salomon C, 2013, ROLE PLACENTAL EXOSO, DOI [10.5772/55298, DOI 10.5772/55298.]; Simon JP, 1998, P NATL ACAD SCI USA, V95, P11181, DOI 10.1073/pnas.95.19.11181; Simpson RJ, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18374; Street JM, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-5; Su YC, 2013, AMINO ACIDS, V44, P821, DOI 10.1007/s00726-012-1421-9; SZYPERSKI T, 1994, P NATL ACAD SCI USA, V91, P11343, DOI 10.1073/pnas.91.24.11343; Tamura Y, 2012, IMMUNOTHERAPY-UK, V4, P841, DOI [10.2217/imt.12.75, 10.2217/IMT.12.75]; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thevenet P, 2012, NUCLEIC ACIDS RES, V40, pW288, DOI 10.1093/nar/gks419; Triantafilou M, 2004, BIOCHEM SOC T, V32, P636, DOI 10.1042/BST0320636; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Udono H, 2012, ACTA MED OKAYAMA, V66, P1; Vagt T, 2006, CHEMPHYSCHEM, V7, P1361, DOI 10.1002/cphc.200600010	55	115	119	6	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110443	10.1371/journal.pone.0110443	http://dx.doi.org/10.1371/journal.pone.0110443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329303	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100076
J	Park, H; Shimamura, T; Miyano, S; Imoto, S				Park, Heewon; Shimamura, Teppei; Miyano, Satoru; Imoto, Seiya			Robust Prediction of Anti-Cancer Drug Sensitivity and Sensitivity-Specific Biomarker	PLOS ONE			English	Article							FEATURE-SELECTION; EXPRESSION; CANCER; GENE; IDENTIFICATION; REGRESSION; REGULARIZATION; LASSO	The personal genomics era has attracted a large amount of attention for anti-cancer therapy by patient-specific analysis. Patient-specific analysis enables discovery of individual genomic characteristics for each patient, and thus we can effectively predict individual genetic risk of disease and perform personalized anti-cancer therapy. Although the existing methods for patient-specific analysis have successfully uncovered crucial biomarkers, their performance takes a sudden turn for the worst in the presence of outliers, since the methods are based on non-robust manners. In practice, clinical and genomic alterations datasets usually contain outliers from various sources (e.g., experiment error, coding error, etc.) and the outliers may significantly affect the result of patient-specific analysis. We propose a robust methodology for patient-specific analysis in line with the NetwrokProfiler. In the proposed method, outliers in high dimensional gene expression levels and drug response datasets are simultaneously controlled by robust Mahalanobis distance in robust principal component space. Thus, we can effectively perform for predicting anti-cancer drug sensitivity and identifying sensitivity-specific biomarkers for individual patients. We observe through Monte Carlo simulations that the proposed robust method produces outstanding performances for predicting response variable in the presence of outliers. We also apply the proposed methodology to the Sanger dataset in order to uncover cancer biomarkers and predict anti-cancer drug sensitivity, and show the effectiveness of our method.	[Park, Heewon; Shimamura, Teppei; Miyano, Satoru; Imoto, Seiya] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan	University of Tokyo	Park, H (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan.	hwpark@ims.u-tokyo.ac.jp		Miyano, Satoru/0000-0002-1753-6616; Shimamura, Teppei/0000-0003-2994-872X	RIKEN Advanced Institute for Computational Science through the HPCI System Research project [hp140230]	RIKEN Advanced Institute for Computational Science through the HPCI System Research project	This research used computational resources of the K computer provided by the RIKEN Advanced Institute for Computational Science through the HPCI System Research project (Project ID:hp140230) and the Super Computer System, Human Genome Center, Institute of Medical Science, University of Tokyo. The authors would like to thank the associate editor and anonymous reviewers for the constructive and valuable comments that improved the quality of the paper.	Alfons A, 2013, ANN APPL STAT, V7, P226, DOI 10.1214/12-AOAS575; Chin L, 2011, NAT MED, V17, P297, DOI 10.1038/nm.2323; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Fan JW, 2008, CANCER-AM CANCER SOC, V113, P266, DOI 10.1002/cncr.23551; Filzmoser P, 2008, COMPUT STAT DATA AN, V52, P1694, DOI 10.1016/j.csda.2007.05.018; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fujimoto K, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-159; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gu X, 2013, CONTEMP CLIN TRIALS, V36, P642, DOI 10.1016/j.cct.2013.09.009; Helleman J, 2008, CLIN CANC RES, V19; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Hubert M, 2005, TECHNOMETRICS, V47, P64, DOI 10.1198/004017004000000563; Jacob L., 2009, P 26 ANN INT C MACH, P433; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Khan JA, 2007, J AM STAT ASSOC, V102, P1289, DOI 10.1198/016214507000000950; Korkola JE, 2009, J CLIN ONCOL, V27, P5240, DOI 10.1200/JCO.2008.20.0386; Kristiansen G, 2003, CLIN CANCER RES, V9, P4906; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Li XX, 2014, COMPUT STAT DATA AN, V79, P203, DOI 10.1016/j.csda.2014.05.017; Liang Y, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-198; Loss LA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-305; Ma SG, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-60; McCleland ML, 2012, CANCER RES, V72, P5812, DOI 10.1158/0008-5472.CAN-12-1098; Meeh PF, 2009, NEOPLASIA, V11, P1074, DOI 10.1593/neo.09808; Park H, 2014, COMMUN STAT IN PRESS; Peralta B, 2014, INFORM SCIENCES, V269, P176, DOI 10.1016/j.ins.2014.01.008; Shimamura T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020804; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wang Lily, 2012, J Biom Biostat, VSuppl 8, P7313; Wu M, 2011, BMC GENOMICS, V12; Xue L, 2012, J MACH LEARN RES, V13, P1973; Yamada M, 2014, NEURAL COMPUT, V26, P185, DOI 10.1162/NECO_a_00537; Yin H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024080; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zou H, 2009, ANN STAT, V37, P1733, DOI 10.1214/08-AOS625	35	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e108990	10.1371/journal.pone.0108990	http://dx.doi.org/10.1371/journal.pone.0108990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329067	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204100007
J	Rakhila, H; Girard, K; Leboeuf, M; Lemyre, M; Akoum, A				Rakhila, Halima; Girard, Karine; Leboeuf, Mathieu; Lemyre, Madeleine; Akoum, Ali			Macrophage Migration Inhibitory Factor Is Involved in Ectopic Endometrial Tissue Growth and Peritoneal-Endometrial Tissue Interaction In Vivo: A Plausible Link to Endometriosis Development	PLOS ONE			English	Article							FACTOR MIF; SIGNALING PATHWAYS; INTEGRIN ALPHA(V)BETA(3); PROSTAGLANDIN E-2; CELL-GROWTH; EXPRESSION; WOMEN; ANGIOGENESIS; MODEL; STAGE	Pelvic inflammation is a hallmark of endometriosis pathogenesis and a major cause of the disease's symptoms. Abnormal immune and inflammatory changes may not only contribute to endometriosis-major symptoms, but also contribute to ectopic endometrial tissue growth and endometriosis development. A major pro-inflammatory factors found elevated in peritoneal fluid of women with endometriosis and to be overexpressed in peritoneal fluid macrophages and active, highly vascularized and early stage endometriotic lesions, macrophage migration inhibitory factor (MIF) appeared to induce angiogenic and inflammatory and estrogen producing phenotypes in endometriotic cells in vitro and to be a possible therapeutic target in vivo. Using a mouse model where MIF-knock out (KO) mice received intra-peritoneal injection of endometrial tissue from MIF-KO or syngeneic wild type (WT) mice and vice versa, our current study revealed that MIF genetic depletion resulted in a marked reduction ectopic endometrial tissue growth, a disrupted tissue structure and a significant down regulation of the expression of major inflammatory (cyclooxygenease-2), cell adhesion (alpha v and beta 3 integrins), survival (B-cell lymphoma-2) and angiogenic (vascular endothelial cell growth) factorsrelevant to endometriosis pathogenesis, whereas MIF add-back to MIF-KO mice significantly restored endometriosis-like lesions number and size. Interestingly, cross-experiments revealed that MIF presence in both endometrial and peritoneal host tissues is required for ectopic endometrial tissue growth and pointed to its involvement in endometrial-peritoneal interactions. This study provides compelling evidence for the role of MIF in endometriosis development and its possible interest for a targeted treatment of endometriosis.	[Rakhila, Halima; Akoum, Ali] Univ Quebec, Ctr Hosp, Quebec City, PQ, Canada; [Girard, Karine; Leboeuf, Mathieu; Lemyre, Madeleine; Akoum, Ali] Univ Laval, Fac Med, Dept Obstet & Gynecol, Quebec City, PQ G1K 7P4, Canada	Laval University; University of Quebec; Laval University	Rakhila, H (corresponding author), Univ Quebec, Ctr Hosp, Quebec City, PQ, Canada.	halima.rakhila.1@ulaval.ca		Leboeuf, Mathieu/0000-0001-7173-1335	Canadian Institutes for Health Research [MOP-120769, MOP-123259]; "Reseau Quebecois en Reproduction (RQR)''	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); "Reseau Quebecois en Reproduction (RQR)''	Supported by grants MOP-120769 and MOP-123259 to AA from the Canadian Institutes for Health Research. AA is "Chercheur National'' of the FRQ-S; HR is supported by a scholarship from the "Reseau Quebecois en Reproduction (RQR)''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla-Ribeiro HS, 2013, HISTOL HISTOPATHOL; Adachi M, 2011, EUR J OBSTET GYN R B, V155, P85, DOI 10.1016/j.ejogrb.2010.10.026; Akoum A, 2002, FERTIL STERIL, V77, P989, DOI 10.1016/S0015-0282(02)03082-0; Akoum A, 2006, FERTIL STERIL, V85, P1379, DOI 10.1016/j.fertnstert.2005.10.073; Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Amin MA, 2003, CIRC RES, V93, P321, DOI 10.1161/01.RES.0000087641.56024.DA; Asare Y, 2013, THROMB HAEMOSTASIS, V109, P391, DOI 10.1160/TH12-11-0831; Assoian RK, 1997, J CELL BIOL, V136, P1, DOI 10.1083/jcb.136.1.1; Bach JP, 2008, ONCOLOGY-BASEL, V75, P127, DOI 10.1159/000155223; Banu SK, 2008, ENDOCRINOLOGY, V149, P1180, DOI 10.1210/en.2007-1168; Berbic M, 2013, WOMENS HEALTH, V9, P387, DOI [10.2217/whe.13.32, 10.2217/WHE.13.32]; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bevilacqua E, 2014, PLACENTA, V35, pS51, DOI 10.1016/j.placenta.2013.10.015; Bondza PK, 2008, FERTIL STERIL, V90, P1433, DOI 10.1016/j.fertnstert.2007.08.046; Patrick KBA, 2008, J REPROD IMMUNOL, V77, P142, DOI 10.1016/j.jri.2007.07.004; Bondza PK, 2007, FERTIL STERIL; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Bruner-Tran K L, 2013, Minerva Ginecol, V65, P199; Carli C, 2009, ENDOCRINOLOGY, V150, P3128, DOI 10.1210/en.2008-1088; Chen PF, 2010, MOL MED, V16, P400, DOI 10.2119/molmed.2009.00128; Chesney J, 1999, MOL MED, V5, P181, DOI 10.1007/BF03402061; Das R, 2013, P NATL ACAD SCI USA, V110, pE2997, DOI 10.1073/pnas.1301128110; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Donnez J, 1998, HUM REPROD, V13, P1686, DOI 10.1093/humrep/13.6.1686; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Groothuis PG, 1999, FERTIL STERIL, V71, P1119, DOI 10.1016/S0015-0282(99)00122-3; Harada T, 2007, FRONT BIOSCI-LANDMRK, V12, P3140, DOI 10.2741/2302; Heinrichs D, 2011, P NATL ACAD SCI USA, V108, P17444, DOI 10.1073/pnas.1107023108; Hermanowski-Vosatka A, 1999, BIOCHEMISTRY-US, V38, P12841, DOI 10.1021/bi991352p; Hii LPP, 1998, HUM REPROD, V13, P1030, DOI 10.1093/humrep/13.4.1030; Jabbour HN, 2006, MOL CELL ENDOCRINOL, V252, P191, DOI 10.1016/j.mce.2006.03.025; Jensen JR, 2010, FERTIL STERIL, V93, P251, DOI 10.1016/j.fertnstert.2008.09.050; Kats R, 2002, FERTIL STERIL, V78, P69, DOI 10.1016/S0015-0282(02)03189-8; Kats R, 2002, J CLIN ENDOCR METAB, V87, P883, DOI 10.1210/jc.87.2.883; Khoufache K, 2012, MINERVA ENDOCRINOL, V37, P75; Khoufache K, PLOS ONE, V7; Khoufache K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037264; KOZAK CA, 1995, GENOMICS, V27, P405, DOI 10.1006/geno.1995.1070; Kyama CM, 2008, FERTIL STERIL, V89, P301, DOI 10.1016/j.fertnstert.2007.02.057; Kyama Cleophas M, 2009, Front Biosci (Elite Ed), V1, P444; Lee J, 2011, MOL CELL ENDOCRINOL, V332, P306, DOI 10.1016/j.mce.2010.11.022; Leech M, 2003, ARTHRITIS RHEUM, V48, P1881, DOI 10.1002/art.11165; Leng L, 2006, CELL RES, V16, P162, DOI 10.1038/sj.cr.7310022; Leng L, 2011, J IMMUNOL, V186, P527, DOI 10.4049/jimmunol.1001767; Lin W, 2010, J OBSTET GYNAECOL RE, V36, P344, DOI 10.1111/j.1447-0756.2009.01123.x; Lucidi RS, 2005, FERTIL STERIL, V84, P16, DOI 10.1016/j.fertnstert.2004.10.058; Mahutte NG, 2004, FERTIL STERIL, V82, P97, DOI 10.1016/j.fertnstert.2003.11.044; Meyer-Siegler K, 2000, CYTOKINE, V12, P914, DOI 10.1006/cyto.2000.0682; Meyer-Siegler KL, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-34; Morin M, 2005, FERTIL STERIL, V83, P865, DOI 10.1016/j.fertnstert.2004.10.039; Nishihira J, 2003, ANN NY ACAD SCI, V995, P171, DOI 10.1111/j.1749-6632.2003.tb03220.x; Onodera S, 2002, J BIOL CHEM, V277, P7865, DOI 10.1074/jbc.M106020200; Ota H, 2001, HUM REPROD, V16, P561, DOI 10.1093/humrep/16.3.561; Petrenko O, 2003, J BIOL CHEM, V278, P11078, DOI 10.1074/jbc.M211985200; Rakhila H, 2013, FERTIL STERIL, V100, P1650, DOI 10.1016/j.fertnstert.2013.08.016; Reis FM, 2013, HUM REPROD UPDATE, V19, P406, DOI 10.1093/humupd/dmt010; Sacco K, 2012, GYNECOL ENDOCRINOL, V28, P134, DOI 10.3109/09513590.2011.588753; Sampson JA, 1927, AM J OBSTET GYNECOL, V14, P422, DOI 10.1016/S0002-9378(15)30003-X; Seeber B, 2008, FERTIL STERIL, V89, P1073, DOI 10.1016/j.fertnstert.2007.05.014; Taylor RN, 2004, GYNECOL OBSTET INVES, V57, P54; Van Calsteren K, 2009, REPROD SCI, V16, P280, DOI 10.1177/1933719108324890; Veillat V, 2012, AM J PATHOL, V181, P917, DOI 10.1016/j.ajpath.2012.05.018; Veillat V, 2010, J CLIN ENDOCR METAB, V95, pE403, DOI 10.1210/jc.2010-0417; Wu Meng-Hsing, 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S146239940700021X; Yang YB, 2000, J CLIN ENDOCR METAB, V85, P4721, DOI 10.1210/jc.85.12.4721; Young VJ, 2013, HUM REPROD UPDATE, V19, P558, DOI 10.1093/humupd/dmt024	67	17	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110434	10.1371/journal.pone.0110434	http://dx.doi.org/10.1371/journal.pone.0110434			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329068	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100075
J	Yoon, BR; Yoo, SJ; Choi, YH; Chung, YH; Kim, J; Yoo, IS; Kang, SW; Lee, WW				Yoon, Bo Ruem; Yoo, Su-Jin; Choi, Yeon Ho; Chung, Yeon-Ho; Kim, Jinhyun; Yoo, In Seol; Kang, Seong Wook; Lee, Won-Woo			Functional Phenotype of Synovial Monocytes Modulating Inflammatory T-Cell Responses in Rheumatoid Arthritis (RA)	PLOS ONE			English	Article							DENDRITIC CELLS; BLOOD MONOCYTES; ACTIVATED MONOCYTES; TGF-BETA; IN-VIVO; EXPRESSION; SUBSETS; DISEASE; MONOCYTES/MACROPHAGES; PATHOGENESIS	Monocytes function as crucial innate effectors in the pathogenesis of chronic inflammatory diseases, including autoimmunity, as well as in the inflammatory response against infectious pathogens. Human monocytes are heterogeneous and can be classified into three distinct subsets based on CD14 and CD16 expression. Although accumulating evidence suggests distinct functions of monocyte subsets in inflammatory conditions, their pathogenic roles in autoimmune diseases remain unclear. Thus, we investigated the phenotypic and functional characteristics of monocytes derived from synovial fluid and peripheral blood in RA patients in order to explore the pathogenic roles of these cells. In RA patients, CD14(+)CD16(+), but not CD14(dim) CD16(+), monocytes are predominantly expanded in synovial fluid and, to a lesser degree, in peripheral blood. Expression of co-signaling molecules of the B7 family, specifically CD80 and CD276, was markedly elevated on synovial monocytes, while peripheral monocytes of RA and healthy controls did not express these molecules without stimulation. To explore how synovial monocytes might gain these unique properties in the inflammatory milieu of the synovial fluid, peripheral monocytes were exposed to various stimuli. CD16 expression on CD14(+) monocytes was clearly induced by TGF-beta, although co-treatment with IL-1 beta, TNF-alpha, or IL-6 did not result in any additive effects. In contrast, TLR stimulation with LPS or zymosan significantly downregulated CD16 expression such that the CD14(+)CD16(+) monocyte subset could not be identified. Furthermore, treatment of monocytes with IFN-gamma resulted in the induction of CD80 and HLA-DR expression even in the presence of TGF-beta. An in vitro assay clearly showed that synovial monocytes possess the unique capability to promote Th1 as well as Th17 responses of autologous peripheral CD4 memory T cells. Our findings suggest that the cytokine milieu of the synovial fluid shapes the unique features of synovial monocytes as well as their cardinal role in shaping inflammatory T-cell responses in RA.	[Yoon, Bo Ruem; Choi, Yeon Ho; Chung, Yeon-Ho; Lee, Won-Woo] Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Seoul, South Korea; [Yoo, Su-Jin; Kim, Jinhyun; Yoo, In Seol; Kang, Seong Wook] Chungnam Natl Univ, Sch Med, Dept Internal Med, Taejon, South Korea; [Lee, Won-Woo] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Choi, Yeon Ho; Lee, Won-Woo] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Lee, Won-Woo] Seoul Natl Univ, Coll Med, Ischemic Hypox Dis Inst, Seoul, South Korea; [Lee, Won-Woo] Seoul Natl Univ, Coll Med, Inst Infect Dis, Seoul, South Korea	Seoul National University (SNU); Chungnam National University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kang, SW (corresponding author), Chungnam Natl Univ, Sch Med, Dept Internal Med, Taejon, South Korea.	kangsw@cnuh.co.kr; wonwoolee@snu.ac.kr		Kang, Seong Wook/0000-0002-0076-0822; Kim, Jinhyun/0000-0001-5235-2612; Lee, Won-Woo/0000-0002-5347-9591	Korea Healthcare Technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea [HI11C1705(A111752)]	Korea Healthcare Technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea	This work was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea [Grant No. HI11C1705(A111752)]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Blumenstein M, 1997, SHOCK, V8, P73, DOI 10.1097/00024382-199707000-00012; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Davignon JL, 2013, RHEUMATOLOGY, V52, P590, DOI 10.1093/rheumatology/kes304; Evans HG, 2007, P NATL ACAD SCI USA, V104, P17034, DOI 10.1073/pnas.0708426104; Evans HG, 2009, P NATL ACAD SCI USA, V106, P6232, DOI 10.1073/pnas.0808144106; GAY D, 1987, NATURE, V328, P626, DOI 10.1038/328626a0; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; HATHCOCK KS, 1994, J EXP MED, V180, P631, DOI 10.1084/jem.180.2.631; Hofmeyer KA, 2008, P NATL ACAD SCI USA, V105, P10277, DOI 10.1073/pnas.0805458105; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; Iwahashi M, 2004, ARTHRITIS RHEUM-US, V50, P1457, DOI 10.1002/art.20219; Katschke KJ, 2001, ARTHRITIS RHEUM, V44, P1022, DOI 10.1002/1529-0131(200105)44:5<1022::AID-ANR181>3.3.CO;2-E; Kawanaka N, 2002, ARTHRITIS RHEUM, V46, P2578, DOI 10.1002/art.10545; Koch S, 2010, CLIN EXP IMMUNOL, V161, P332, DOI 10.1111/j.1365-2249.2010.04177.x; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; Mackensen A, 1992, Eur Cytokine Netw, V3, P571; Mazzieri R, 2000, METH MOL B, V142, P13; McCartney-Francis N, 1990, GROWTH FACTORS, V4, DOI 10.3109/08977199009011007; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; McInnes IB, 2010, ANN RHEUM DIS, V69, P1898, DOI 10.1136/ard.2010.134684; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Rossol M, 2012, ARTHRITIS RHEUM-US, V64, P671, DOI 10.1002/art.33418; Sanchez-Torres C, 2001, INT IMMUNOL, V13, P1571, DOI 10.1093/intimm/13.12.1571; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; WAHL SM, 1990, ANN NY ACAD SCI, V593, P188, DOI 10.1111/j.1749-6632.1990.tb16111.x; WELCH GR, 1990, J IMMUNOL, V144, P3444; Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3; Woollard KJ, 2010, CURR PHARM DESIGN, V16, P4113; Yamada H, 2008, ANN RHEUM DIS, V67, P1299, DOI 10.1136/ard.2007.080341; Yi KH, 2009, IMMUNOL REV, V229, P145, DOI 10.1111/j.1600-065X.2009.00768.x; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510	36	64	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109775	10.1371/journal.pone.0109775	http://dx.doi.org/10.1371/journal.pone.0109775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329467	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204100027
J	Huang, NY; Chen, JH; Fan, L; Zhou, Q; Xu, QD; Xu, RC; Xiong, LP; Yu, XQ; Mao, HP				Huang, Naya; Chen, Jiehui; Fan, Li; Zhou, Qian; Xu, Qingdong; Xu, Ricong; Xiong, Liping; Yu, Xueqing; Mao, Haiping			High Peritoneal Transport Status Was Not Associated with Mortality in Peritoneal Dialysis Patients with Diabetes	PLOS ONE			English	Article							INDEPENDENT RISK-FACTOR; MEMBRANE-TRANSPORT; TECHNIQUE FAILURE; NUTRITIONAL-STATUS; PREDICTS SURVIVAL; DISEASE; PERMEABILITY; REMOVAL; IMPACT; COHORT	Background: Continuous ambulatory peritoneal dialysis (CAPD) patients with diabetes are at increased risk of mortality and high peritoneal transporters appear to contribute to poor survival. However, little is known about the combined impacts of high peritoneal transporters and diabetes on mortality. Methods: This was a prospective observational cohort study. 776 incident CAPD patients were enrolled. Unadjusted and adjusted Cox proportional regression models were used to evaluate the association and interaction of peritoneal transport and diabetic status with mortality. Results: In the entire cohort, high peritoneal transport status was associated with an increased risk of all-cause mortality in unadjusted model [hazard ratio (HR) 2.35, 95% confidence interval (CI) 1.30 to 4.25, P = 0.01], but this association was not significant in multivariable model. There was an interaction between peritoneal membrane transport status and diabetes (P = 0.028). Subgroup analyses showed that compared to low and low average transporters, high transporters was associated with a higher risk of all-cause mortality (adjusted HR 1.78, 95% CI 1.07 to 4.70, P = 0.04) in CAPD patients without diabetes, but not in those with diabetes (adjusted HR 0.79, 95% CI 0.33 to 1.89, P = 0.59). Results were similar when transport status was assessed as a continuous variable. Conclusions: The association between high peritoneal transport and all-cause mortality was likely to vary with diabetes status. High peritoneal transport was associated with an elevated risk of death among CAPD patients without diabetes, but not in those with diabetes.	[Huang, Naya; Chen, Jiehui; Fan, Li; Xu, Qingdong; Xu, Ricong; Xiong, Liping; Yu, Xueqing; Mao, Haiping] Sun Yat Sen Univ, Dept Nephrol, Affiliated Hosp 1, Key Lab Nephrol,Minist Hlth China,Guangdong Prov, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Jiehui] Sixth Peoples Hosp Shenzhen, Dept Nephrol, Shenzhen, Guangdong, Peoples R China; [Zhou, Qian] Sun Yat Sen Univ, Affiliated Hosp 1, Translat Med Res Ctr, Epidemiol Res Unit, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Mao, HP (corresponding author), Sun Yat Sen Univ, Dept Nephrol, Affiliated Hosp 1, Key Lab Nephrol,Minist Hlth China,Guangdong Prov, Guangzhou 510275, Guangdong, Peoples R China.	haipingmao@126.com		Qian, Zhou/0000-0003-3954-5449; Mao, Haiping/0000-0002-3608-3851	National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2011BAI10B05]; National Basic Research Program of China [2012CB517700-2012CB517706]; Guangzhou Committee of Science and Technology, China [2010U1-E00831]; Sun Yat-sen University [2007007]	National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); National Basic Research Program of China(National Basic Research Program of China); Guangzhou Committee of Science and Technology, China; Sun Yat-sen University	This work was supported by the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2011BAI10B05), the National Basic Research Program of China (2012CB517700-2012CB517706), the Guangzhou Committee of Science and Technology, China (2010U1-E00831), and 5010 Clinical Program of Sun Yat-sen University (2007007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brimble KS, 2006, J AM SOC NEPHROL, V17, P2591, DOI 10.1681/ASN.2006030194; Brown EA, 2003, J AM SOC NEPHROL, V14, P2948, DOI 10.1097/01.ASN.0000092146.67909.E2; Chang TI, 2010, J KOREAN MED SCI, V25, P1313, DOI 10.3346/jkms.2010.25.9.1313; Chung SH, 2003, PERITON DIALYSIS INT, V23, P174; Churchill DN, 1998, J AM SOC NEPHROL, V9, P1285; Cueto-Manzano AM, 2000, KIDNEY INT, V57, P314, DOI 10.1046/j.1523-1755.2000.00817.x; Davies SJ, 1998, NEPHROL DIAL TRANSPL, V13, P962, DOI 10.1093/ndt/13.4.962; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Honda K, 2008, CLIN J AM SOC NEPHRO, V3, P720, DOI 10.2215/CJN.03630807; Johnson DW, 2010, NEPHROL DIAL TRANSPL, V25, P1973, DOI 10.1093/ndt/gfp780; Ma Seung Hyun, 2012, J Prev Med Public Health, V45, P394, DOI 10.3961/jpmph.2012.45.6.394; Magliano DJ, 2010, DIABETES CARE, V33, P1983, DOI 10.2337/dc10-0312; Margetts PJ, 2000, PERITON DIALYSIS INT, V20, P14; Morgan CL, 2000, DIABETES CARE, V23, P1103, DOI 10.2337/diacare.23.8.1103; Paniagua R, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1351307; Parfrey PS, 1999, J AM SOC NEPHROL, V10, P1606; Park HC, 2001, PERITON DIALYSIS INT, V21, pS80; Perl J, 2009, CLIN J AM SOC NEPHRO, V4, P1201, DOI 10.2215/CJN.01910309; Rumpsfeld M, 2006, J AM SOC NEPHROL, V17, P271, DOI 10.1681/ASN.2005050566; Szeto CC, 2001, AM J KIDNEY DIS, V37, P329, DOI 10.1053/ajkd.2001.21298; Tobias D, 2014, NEW ENGL J MED, V370, P1363, DOI 10.1056/NEJMc1401876; TURNER RC, 1991, DIABETOLOGIA, V34, P877; TWARDOWSKI ZJ, 1987, PERITON DIALYSIS INT, V7, P138; Wang T, 1998, NEPHROL DIAL TRANSPL, V13, P1242, DOI 10.1093/ndt/13.5.1242; Xu R, 2013, PLOS ONE IN PRESS, V8; Yang X, 2008, PERITON DIALYSIS INT, V28, P82; Yang X, 2013, DIABETES RES CLIN PR, V100, P354, DOI 10.1016/j.diabres.2013.03.030; Zitt E, 2011, CLIN J AM SOC NEPHRO, V6, P2650, DOI 10.2215/CJN.03780411	28	4	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110445	10.1371/journal.pone.0110445	http://dx.doi.org/10.1371/journal.pone.0110445			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329459	gold, Green Published, Green Submitted			2022-12-27	WOS:000343210800088
J	Sun, BR; Peng, Y; Yang, HY; Li, ZJ; Gao, YZ; Wang, C; Yan, YL; Liu, YM				Sun, Baoru; Peng, Yi; Yang, Hongyu; Li, Zhijian; Gao, Yingzhi; Wang, Chao; Yan, Yuli; Liu, Yanmei			Alfalfa (Medicago sativa L.)/Maize (Zea mays L.) Intercropping Provides a Feasible Way to Improve Yield and Economic Incomes in Farming and Pastoral Areas of Northeast China	PLOS ONE			English	Article							RADIATION INTERCEPTION; NITROGEN-FIXATION; CROPPING SYSTEMS; MAIZE; MANAGEMENT; COWPEA; RICE; SOIL; TEMPERATURE; WHEAT/MAIZE	Given the growing challenges to food and eco-environmental security as well as sustainable development of animal husbandry in the farming and pastoral areas of northeast China, it is crucial to identify advantageous intercropping modes and some constraints limiting its popularization. In order to assess the performance of various intercropping modes of maize and alfalfa, a field experiment was conducted in a completely randomized block design with five treatments: maize monoculture in even rows, maize monoculture in alternating wide and narrow rows, alfalfa monoculture, maize intercropped with one row of alfalfa in wide rows and maize intercropped with two rows of alfalfa in wide rows. Results demonstrate that maize monoculture in alternating wide and narrow rows performed best for light transmission, grain yield and output value, compared to in even rows. When intercropped, maize intercropped with one row of alfalfa in wide rows was identified as the optimal strategy and the largely complementary ecological niches of alfalfa and maize were shown to account for the intercropping advantages, optimizing resource utilization and improving yield and economic incomes. These findings suggest that alfalfa/maize intercropping has obvious advantages over monoculture and is applicable to the farming and pastoral areas of northeast China.	[Sun, Baoru; Peng, Yi; Yang, Hongyu; Li, Zhijian; Gao, Yingzhi; Wang, Chao; Yan, Yuli; Liu, Yanmei] NE Normal Univ, Key Lab Vegetat Ecol, Changchun, Peoples R China	Northeast Normal University - China	Li, ZJ (corresponding author), NE Normal Univ, Key Lab Vegetat Ecol, Changchun, Peoples R China.	lizj004@nenu.edu.cn; gaoyz108@nenu.edu.cn			National Natural Science Foundation of China (NSFC) [31072080, 31270444]; program for New Century Excellent Talents in University [NCET-13-0717]; Key Science and Technology Program of Jilin Province [20100212, 2012ZDGG008]; National Key Technology RD Program [2011BAD17B04-3-2]; National Program on Key Basic Research Project [2012CB722202]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Key Science and Technology Program of Jilin Province; National Key Technology RD Program(National Key Technology R&D Program); National Program on Key Basic Research Project(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (NSFC, 31072080 and 31270444), the program for New Century Excellent Talents in University (NCET-13-0717), Key Science and Technology Program of Jilin Province (20100212, 2012ZDGG008), National Key Technology R&D Program (2011BAD17B04-3-2), and the National Program on Key Basic Research Project (2012CB722202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anil L, 1998, GRASS FORAGE SCI, V53, P301, DOI 10.1046/j.1365-2494.1998.00144.x; [Anonymous], 1976, MULTIPLE CROPPING; Awal MA, 2006, AGR FOREST METEOROL, V139, P74, DOI 10.1016/j.agrformet.2006.06.001; Bedoussac L, 2010, PLANT SOIL, V330, P37, DOI 10.1007/s11104-010-0303-8; [陈玉祥 CHEN Yu-xiang], 2009, [西南石油大学学报．自然科学版, Journal of Southwest Petroleum University], V31, P113; Chu GX, 2004, PLANT SOIL, V263, P17, DOI 10.1023/B:PLSO.0000047722.49160.9e; Ghanbari A, 2010, J FOOD AGRIC ENVIRON, V8, P102; Ghosh PK, 2006, AGRON J, V98, P1097, DOI 10.2134/agronj2005.0328; Gilbert RA, 2003, J AGRON CROP SCI, V189, P21, DOI 10.1046/j.1439-037X.2003.00005.x; GOODMAN PJ, 1988, PLANT SOIL, V112, P247, DOI 10.1007/BF02140002; Guldan SJ, 1998, J SUSTAIN AGR, V12, P85, DOI 10.1300/J064v12n02_07; Hauggaard-Nielsen H, 2001, FIELD CROP RES, V70, P101, DOI 10.1016/S0378-4290(01)00126-5; He LiNa, 2008, Journal of Northwest A & F University - Natural Science Edition, V36, P155; Inal A, 2007, PLANT PHYSIOL BIOCH, V45, P350, DOI 10.1016/j.plaphy.2007.03.016; Jensen JR, 2003, AGR WATER MANAGE, V59, P217, DOI 10.1016/S0378-3774(02)00151-8; Lesoing GW, 1999, AGRON J, V91, P807, DOI 10.2134/agronj1999.915807x; Li L, 2001, FIELD CROP RES, V71, P123, DOI 10.1016/S0378-4290(01)00156-3; Li YF, 2009, PLANT SOIL, V315, P285, DOI 10.1007/s11104-008-9751-9; [李志坚 Li Zhijian], 2003, [吉林农业科学, Journal of Jilin Agricultural Sciences], V28, P40; Liebman M, 2012, RENEW AGR FOOD SYST, V27, P180, DOI 10.1017/S1742170511000299; Lin J, 2011, GRASS FORAGE SCI, V66, P578, DOI 10.1111/j.1365-2494.2011.00818.x; Lithourgidis AS, 2011, EUR J AGRON, V34, P287, DOI 10.1016/j.eja.2011.02.007; Liu A N, 2005, J MT AGR BIOL, V24, P471; [刘武仁 Liu Wuren], 2003, [玉米科学, Maize Science], V11, P63; Lu XS, 2012, 2 CHIN GRASSL AGR C, P7; Luo CP, 1995, J ARID LAND RESOURCE, V9, P1, DOI DOI 10.13448/J.CNKI.JALRE.1995.01.001; Mandal BK, 1996, INDIAN J AGRON, V41, P17; Miriti JM, 2012, AGR WATER MANAGE, V115, P148, DOI 10.1016/j.agwat.2012.09.002; Mucheru-Muna M, 2010, FIELD CROP RES, V115, P132, DOI 10.1016/j.fcr.2009.10.013; Prasad RB, 2005, EXP AGR, V41, P365, DOI 10.1017/S0014479705002693; Ren JiZhou, 2002, Acta Prataculturae Sinica, V11, P1; Rusinamhodzi L, 2012, FIELD CROP RES, V136, P12, DOI 10.1016/j.fcr.2012.07.014; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Shen QR, 2004, BIOL FERT SOILS, V40, P81, DOI 10.1007/s00374-004-0737-3; Smith MA, 1998, J PROD AGRIC, V11, P345, DOI 10.2134/jpa1998.0345; [孙洪仁 Sun Hongren], 2003, [草地学报, Acta agrestia sinica], V11, P346; Sun QiZhong, 2004, Pratacultural Science, V21, P21; TA TC, 1987, PLANT SOIL, V98, P265, DOI 10.1007/BF02374830; Tian Xun, 2009, Shengtaixue Zazhi, V28, P152; TRENBATH BR, 1993, FIELD CROP RES, V34, P381, DOI 10.1016/0378-4290(93)90123-5; Tsubo M, 2002, AGR FOREST METEOROL, V110, P203, DOI 10.1016/S0168-1923(01)00287-8; Wahla IH, 2009, INT J AGRIC BIOL, V11, P69; Wang T, 2012, J MT SCI-ENGL, V9, P105, DOI 10.1007/s11629-012-2197-9; Wang X, 2003, PRATACULTURAL SCI, V10, P39; WILLEY RW, 1990, AGR WATER MANAGE, V17, P215, DOI 10.1016/0378-3774(90)90069-B; Yang SX, 1992, SCI AGR SIN, V25, P63; Yin XJ, 2006, FEED REV, V4, P31; Yu Y, 2009, SHANXI J AGR SCI, V5, P90; Zhang GuiGuo, 2013, Journal of Agricultural Science (Toronto), V5, P128; Zhang GG, 2011, FIELD CROP RES, V124, P66, DOI 10.1016/j.fcr.2011.06.006; [张汉雄 Zhang Hanxiong], 2004, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V18, P129; Zhao LanPo, 2006, Acta Pedologica Sinica, V43, P79; [甄珍 Zhen Zhen], 2012, [工程研究, Journal of Engineering Studies], V4, P19; Zhou DW, 1999, RESOURCES SCI, V21, P57; Zhu TC, 2002, ACTA PRATACULTURAE S, V12, P34	55	30	34	5	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110556	10.1371/journal.pone.0110556	http://dx.doi.org/10.1371/journal.pone.0110556			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329376	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210800095
J	Das, R; Sebo, Z; Pence, L; Dobens, LL				Das, Rahul; Sebo, Zachary; Pence, Laramie; Dobens, Leonard L.			Drosophila Tribbles Antagonizes Insulin Signaling-Mediated Growth and Metabolism via Interactions with Akt Kinase	PLOS ONE			English	Article							SUPPRESSES ADIPOCYTE DIFFERENTIATION; GLUCOSE-HOMEOSTASIS; S6 KINASE; LIPID-METABOLISM; GENE-EXPRESSION; RESPONSIVE GENE; CELL-MIGRATION; FAMILY-MEMBERS; B ACTIVATION; C/EBP-ALPHA	Drosophila Tribbles (Trbl) is the founding member of the Trib family of kinase-like docking proteins that modulate cell signaling during proliferation, migration and growth. In a wing misexpression screen for Trbl interacting proteins, we identified the Ser/Thr protein kinase Akt1. Given the central role of Akt1 in insulin signaling, we tested the function of Trbl in larval fat body, a tissue where rapid increases in size are exquisitely sensitive to insulin/insulin-like growth factor levels. Consistent with a role in antagonizing insulin-mediated growth, trbl RNAi knockdown in the fat body increased cell size, advanced the timing of pupation and increased levels of circulating triglyceride. Complementarily, overexpression of Trbl reduced fat body cell size, decreased overall larval size, delayed maturation and lowered levels of triglycerides, while circulating glucose levels increased. The conserved Trbl kinase domain is required for function in vivo and for interaction with Akt in a yeast two-hybrid assay. Consistent with direct regulation of Akt, overexpression of Trbl in the fat body decreased levels of activated Akt (pSer505-Akt) while misexpression of trbl RNAi increased phospho-Akt levels, and neither treatment affected total Akt levels. Trbl misexpression effectively suppressed Akt-mediated wing and muscle cell size increases and reduced phosphorylation of the Akt target FoxO (pSer256-FoxO). Taken together, these data show that Drosophila Trbl has a conserved role to bind Akt and block Akt-mediated insulin signaling, and implicate Trib proteins as novel sites of signaling pathway integration that link nutrient availability with cell growth and proliferation.	[Das, Rahul; Sebo, Zachary; Pence, Laramie; Dobens, Leonard L.] Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City	Dobens, LL (corresponding author), Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, Kansas City, MO 64110 USA.	dobensl@umkc.edu	Das, Rahul/AAS-7819-2021	Das, Rahul/0000-0001-9445-8562	National Science Foundation [RPG-00251-01-DDC]; University of Missouri Research Board	National Science Foundation(National Science Foundation (NSF)); University of Missouri Research Board	This work was supported by a research grant from the National Science Foundation (RPG-00251-01-DDC) and support from the University of Missouri Research Board to LLD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreozzi F, 2008, ARTERIOSCL THROM VAS, V28, P1355, DOI 10.1161/ATVBAHA.108.162883; Angyal A, 2012, CURR OPIN LIPIDOL, V23, P122, DOI 10.1097/MOL.0b013e3283508c3b; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; Barcelo H, 2002, GENESIS, V34, P83, DOI 10.1002/gene.10132; Bi XP, 2008, ENDOCR J, V55, P747, DOI 10.1507/endocrj.K08E-049; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Burkhardt R, 2010, J CLIN INVEST, V120, P4410, DOI 10.1172/JCI44213; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; Coffer PJ, 1998, BIOCHEM J, V335, P1; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Dedhia PH, 2010, BLOOD, V116, P1321, DOI 10.1182/blood-2009-07-229450; DiAngelo JR, 2009, MOL CELL BIOL, V29, P6341, DOI 10.1128/MCB.00675-09; Ding JX, 2008, EXP CELL RES, V314, P1566, DOI 10.1016/j.yexcr.2008.01.026; Dobens AC, 2013, G3-GENES GENOM GENET, V3, P1443, DOI 10.1534/g3.113.006676; Dobens LL, 2012, DEV DYNAM, V241, P1239, DOI 10.1002/dvdy.23822; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Du KY, 2009, MOL ENDOCRINOL, V23, P475, DOI 10.1210/me.2008-0284; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Dugast E, 2013, CURR MOL MED, V13, P80, DOI 10.2174/156652413804486197; Duggan SP, 2010, CARCINOGENESIS, V31, P936, DOI 10.1093/carcin/bgq036; Eder K, 2008, IMMUNOL LETT, V116, P178, DOI 10.1016/j.imlet.2007.12.011; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Farrell JA, 2013, CURR BIOL, V23, P118, DOI 10.1016/j.cub.2012.11.036; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gilby DC, 2010, IMMUNOL LETT, V130, P115, DOI 10.1016/j.imlet.2009.12.007; Grandinetti KB, 2011, ONCOGENE, V30, P3328, DOI 10.1038/onc.2011.57; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; He L, 2006, J BIOL CHEM, V281, P11126, DOI 10.1074/jbc.M510724200; Hegedus Z, 2007, CELL SIGNAL, V19, P238, DOI 10.1016/j.cellsig.2006.06.010; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Ishizuka Y, 2014, J MOL ENDOCRINOL; Iynedjian PB, 2005, BIOCHEM J, V386, P113, DOI 10.1042/BJ20041425; Johansson P, 2010, LEUKEMIA RES, V34, P892, DOI 10.1016/j.leukres.2010.02.038; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kiss-Toth E, 2011, BIOCHEM SOC T, V39, P684, DOI 10.1042/BST0390684; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Koyama T, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00263; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Liew CW, 2010, J CLIN INVEST, V120, P2876, DOI 10.1172/JCI36849; Liu JR, 2010, AM J PHYSIOL-ENDOC M, V298, pE565, DOI 10.1152/ajpendo.00467.2009; Masoner V, 2013, DEV BIOL, V375, P33, DOI 10.1016/j.ydbio.2012.12.016; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Matsushima R, 2006, J BIOL CHEM, V281, P29719, DOI 10.1074/jbc.M511636200; Miron M, 2003, MOL CELL BIOL, V23, P9117, DOI 10.1128/MCB.23.24.9117-9126.2003; Miyoshi N, 2009, BRIT J CANCER, V101, P1664, DOI 10.1038/sj.bjc.6605361; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Musselman LP, 2011, DIS MODEL MECH, V4, P842, DOI 10.1242/dmm.007948; Na JB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003175; Naiki T, 2007, J BIOL CHEM, V282, P24075, DOI 10.1074/jbc.M701409200; Oberkofler H, 2010, DIABETOLOGIA, V53, P1971, DOI 10.1007/s00125-010-1772-2; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Okamoto H, 2007, DIABETES, V56, P1350, DOI 10.2337/db06-1448; Oldham S, 2000, PHILOS T R SOC B, V355, P945, DOI 10.1098/rstb.2000.0630; Oldham S, 2011, TRENDS ENDOCRIN MET, V22, P45, DOI 10.1016/j.tem.2010.11.002; Parisi F, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-65; Pasco MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036583; Prudente S, 2005, DIABETES, V54, P2807, DOI 10.2337/diabetes.54.9.2807; Prudente S., 2012, ENDOCR REV; Prudente S, 2009, J CLIN ENDOCR METAB, V94, P190, DOI 10.1210/jc.2008-1365; Prudente S, 2013, J CLIN ENDOCR METAB, V98, pE1143, DOI 10.1210/jc.2012-4282; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Rorth P, 2000, MOL CELL, V6, P23; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Seher TC, 2000, CURR BIOL, V10, P623, DOI 10.1016/S0960-9822(00)00502-9; Shang YY, 2009, FEBS J, V276, P2752, DOI 10.1111/j.1742-4658.2009.06998.x; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Takahashi Y, 2008, J LIPID RES, V49, P880, DOI 10.1194/jlr.M700545-JLR200; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Varbo A, 2011, ANN NEUROL, V69, P628, DOI 10.1002/ana.22384; Weismann D, 2011, DIABETOLOGIA, V54, P935, DOI 10.1007/s00125-010-1984-5; Wennemers M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2934; Wasef SZY, 2006, AM J PHYSIOL-ENDOC M, V291, pE1274, DOI 10.1052/ajpendo.00117.2006; Yamamoto M, 2007, J EXP MED, V204, P2233, DOI 10.1084/jem.20070183; Yokoyama T, 2011, CANCER SCI, V102, P1115, DOI 10.1111/j.1349-7006.2011.01914.x; Zanella F, 2010, ONCOGENE, V29, P2973, DOI 10.1038/onc.2010.58	86	29	31	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109530	10.1371/journal.pone.0109530	http://dx.doi.org/10.1371/journal.pone.0109530			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25329475	gold, Green Published, Green Submitted			2022-12-27	WOS:000346766200034
J	Waewthongrak, W; Leelasuphakul, W; McCollum, G				Waewthongrak, Waewruedee; Leelasuphakul, Wichitra; McCollum, Greg			Cyclic Lipopeptides from Bacillus subtilis ABS-S14 Elicit Defense-Related Gene Expression in Citrus Fruit	PLOS ONE			English	Article							SYSTEMIC RESISTANCE; PENICILLIUM-DIGITATUM; MASS-SPECTROMETRY; PLANT-DISEASE; BIOCONTROL; STRAINS; LIPOXYGENASE; SURFACTIN; RESPONSES; PATHOGEN	Effects of cyclic lipopeptides (CLPs) obtained from Bacillus subtilis ABS-S14 on eliciting defense-related gene transcription and activity of defense-related enzymes; glucanase (GLU), chitinase (CHI), peroxidase (POX) and lipoxygenase (LOX) in Citrus sinensis cv. Valencia fruit were determined. The maximum level of GLU transcripts induced in fruit treated with fengycin was significantly greatest among treatments at 48 h. Surfactin enhanced the LOX and POX transcripts. In parallel, corresponding enzyme activities were correlated with changes in gene expression observed in fruit inoculated with Penicillium digitatum following treatment with individual CLPs. Synergistic effects of fengycin and iturin A, fengycin and surfactin were shown in gene transcript of GLU and CHI, respectively, and surfactin induced POX and LOX gene expression of citrus flavedo without pathogen infection. These results suggest that fengycin and surfactin act as elicitors of defense-related gene expression in "Valencia" fruit following infection.	[Waewthongrak, Waewruedee; Leelasuphakul, Wichitra] Prince Songkla Univ, Dept Biochem, Fac Sci, Hat Yai, Songkhla, Thailand; [McCollum, Greg] USDA ARS, US Hort Res Lab, Ft Pierce, FL USA	Prince of Songkla University; United States Department of Agriculture (USDA)	Leelasuphakul, W (corresponding author), Prince Songkla Univ, Dept Biochem, Fac Sci, Hat Yai, Songkhla, Thailand.	wichitra.l@psu.ac.th		Leelasuphakul, Wichitra/0000-0002-9974-8777	Thailand Research Fund [DBG5380015]; National Research University Project of Thailand's Office of Higher Education Commission [SCI540530S]; TRF Royal Golden Jubilee Ph.D. student scholarship; University Academic Excellence Strengthening Program in Biochemistry of Prince of Songkla University (PSU), the PSU Graduate Fund	Thailand Research Fund(Thailand Research Fund (TRF)); National Research University Project of Thailand's Office of Higher Education Commission; TRF Royal Golden Jubilee Ph.D. student scholarship; University Academic Excellence Strengthening Program in Biochemistry of Prince of Songkla University (PSU), the PSU Graduate Fund	WL has received funds from the Thailand Research Fund, grants no. DBG5380015, the National Research University Project of Thailand's Office of Higher Education Commission (Grant no. SCI540530S), www.psu.ac.th. WW has received TRF Royal Golden Jubilee Ph.D. student scholarship; www.trf.or.th, and the University Academic Excellence Strengthening Program in Biochemistry of Prince of Songkla University (PSU), the PSU Graduate Fund, www.psu.ac.th. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballester AR, 2010, POSTHARVEST BIOL TEC, V56, P31, DOI 10.1016/j.postharvbio.2009.10.002; Baysal T, 2007, ENZYME MICROB TECH, V40, P491, DOI 10.1016/j.enzmictec.2006.11.025; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brotman Y, 2009, APPL ENVIRON MICROB, V75, P5373, DOI 10.1128/AEM.00724-09; Cai KZ, 2008, PHYSIOL PLANTARUM, V134, P324, DOI 10.1111/j.1399-3054.2008.01140.x; Cazorla FM, 2007, J APPL MICROBIOL, V103, P1950, DOI 10.1111/j.1365-2672.2007.03433.x; CHEN AO, 1986, J AGR FOOD CHEM, V34, P203, DOI 10.1021/jf00068a013; Choudhary DK, 2009, MICROBIOL RES, V164, P493, DOI 10.1016/j.micres.2008.08.007; Desoignies N, 2013, MOL PLANT PATHOL, V14, P416, DOI 10.1111/mpp.12008; Distefano G, 2008, TRANSGENIC RES, V17, P873, DOI 10.1007/s11248-008-9172-9; Droby S, 2002, PHYTOPATHOLOGY, V92, P393, DOI 10.1094/PHYTO.2002.92.4.393; Droby S, 2009, POSTHARVEST BIOL TEC, V52, P137, DOI 10.1016/j.postharvbio.2008.11.009; Dunlap CA, 2011, J MICROBIOL, V49, P603, DOI 10.1007/s12275-011-1044-y; Emmert EAB, 1999, FEMS MICROBIOL LETT, V171, P1, DOI 10.1111/j.1574-6968.1999.tb13405.x; Garcia-Gutierrez L, 2013, MICROB BIOTECHNOL, V6, P264, DOI 10.1111/1751-7915.12028; Grebner W, 2013, PLANT PHYSIOL, V161, P2159, DOI 10.1104/pp.113.214544; Henry G, 2011, CELL MICROBIOL, V13, P1824, DOI 10.1111/j.1462-5822.2011.01664.x; Hiraga S, 2001, PLANT CELL PHYSIOL, V42, P462, DOI 10.1093/pcp/pce061; Jourdan E, 2009, MOL PLANT MICROBE IN, V22, P456, DOI 10.1094/MPMI-22-4-0456; Leelasuphakul W, 2008, POSTHARVEST BIOL TEC, V48, P113, DOI 10.1016/j.postharvbio.2007.09.024; Leenders F, 1999, RAPID COMMUN MASS SP, V13, P943; Oide S, 2013, NEW PHYTOL, V200, P1187, DOI 10.1111/nph.12436; Ongena M, 2005, APPL MICROBIOL BIOT, V69, P29, DOI 10.1007/s00253-005-1940-3; Ongena M, 2004, MOL PLANT MICROBE IN, V17, P1009, DOI 10.1094/MPMI.2004.17.9.1009; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Ongena M, 2007, ENVIRON MICROBIOL, V9, P1084, DOI 10.1111/j.1462-2920.2006.01202.x; Overgard AC, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-36; Porat R, 2002, J PHYTOPATHOL, V150, P70, DOI 10.1046/j.1439-0434.2002.00719.x; Price NPJ, 2007, FEMS MICROBIOL LETT, V271, P83, DOI 10.1111/j.1574-6968.2007.00702.x; Pueyo M, 2009, MICROB ECOL, V57, P367, DOI 10.1007/s00248-008-9464-x; Raaijmakers JM, 2010, FEMS MICROBIOL REV, V34, P1037, DOI 10.1111/j.1574-6976.2010.00221.x; Rao R, 2005, PARASITOL RES, V97, P219, DOI 10.1007/s00436-005-1421-8; Sangwanich S., 2013, International Food Research Journal, V20, P3381; Scuderi G, 2011, J PHYTOPATHOL, V159, P555, DOI 10.1111/j.1439-0434.2011.01804.x; Selim S, 2010, APPL ENVIRON MICROB, V76, P7420, DOI 10.1128/AEM.00171-10; Silva HSA, 2004, BIOL CONTROL, V29, P288, DOI 10.1016/S1049-9644(03)00163-4; Stein T, 2005, MOL MICROBIOL, V56, P845, DOI 10.1111/j.1365-2958.2005.04587.x; Strommer Judith, 1993, P49; Van der Ent S, 2009, PHYTOCHEMISTRY, V70, P1581, DOI 10.1016/j.phytochem.2009.06.009; van Loon LC, 1998, ANNU REV PHYTOPATHOL, V36, P453, DOI 10.1146/annurev.phyto.36.1.453; Vater J, 2002, APPL ENVIRON MICROB, V68, P6210, DOI 10.1128/AEM.68.12.6210-6219.2002; Vilanova L, 2013, POSTHARVEST BIOL TEC, V78, P113, DOI 10.1016/j.postharvbio.2012.12.013; Waewthongrak W, 2015, POSTHARVEST BIOL TEC, V99, P44, DOI 10.1016/j.postharvbio.2014.07.016; Witmer X, 2003, SEED SCI RES, V13, P167, DOI 10.1079/SSR2003134; Yanez-Mendizabal V, 2012, EUR J PLANT PATHOL, V132, P609, DOI 10.1007/s10658-011-9905-0	45	46	49	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e109386	10.1371/journal.pone.0109386	http://dx.doi.org/10.1371/journal.pone.0109386			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25329301	gold, Green Published, Green Submitted			2022-12-27	WOS:000346766200027
J	Fowler, VL; Bankowski, BM; Armson, B; Di Nardo, A; Valdazo-Gonzalez, B; Reid, SM; Barnett, PV; Wadsworth, J; Ferris, NP; Mioulet, V; King, DP				Fowler, Veronica L.; Bankowski, Bartlomiej M.; Armson, Bryony; Di Nardo, Antonello; Valdazo-Gonzalez, Begona; Reid, Scott M.; Barnett, Paul V.; Wadsworth, Jemma; Ferris, Nigel P.; Mioulet, Valerie; King, Donald P.			Recovery of Viral RNA and Infectious Foot-and-Mouth Disease Virus from Positive Lateral-Flow Devices	PLOS ONE			English	Article							LINKED IMMUNOSORBENT-ASSAY; CLASSICAL SWINE-FEVER; RT-PCR; DIAGNOSIS; RESCUE; STRAIN	Foot-and-mouth disease Virus (FMDV) is an economically important, highly contagious picornavirus that affects both wild and domesticated cloven hooved animals. In developing countries, the effective laboratory diagnosis of foot-and-mouth disease (FMD) is often hindered by inadequate sample preservation due to difficulties in the transportation and storage of clinical material. These factors can compromise the ability to detect and characterise FMD virus in countries where the disease is endemic. Furthermore, the high cost of sending infectious virus material and the biosecurity risk it presents emphasises the need for a thermo-stable, non-infectious mode of transporting diagnostic samples. This paper investigates the potential of using FMDV lateral-flow devices (LFDs) for dry transportation of clinical samples for subsequent nucleic acid amplification, sequencing and recovery of infectious virus by electroporation. FMDV positive samples (epithelial suspensions and cell culture isolates) representing four FMDV serotypes were applied to antigen LFDs: after which it was possible to recover viral RNA that could be detected using real-time RT-PCR. Using this nucleic acid, it was also possible to recover VP1 sequences and also successfully utilise protocols for amplification of complete FMD virus genomes. It was not possible to recover infectious FMDV directly from the LFDs, however following electroporation into BHK-21 cells and subsequent cell passage, infectious virus could be recovered. Therefore, these results support the use of the antigen LFD for the dry, nonhazardous transportation of samples from FMD endemic countries to international reference laboratories.	[Fowler, Veronica L.; Bankowski, Bartlomiej M.; Armson, Bryony; Di Nardo, Antonello; Valdazo-Gonzalez, Begona; Reid, Scott M.; Barnett, Paul V.; Wadsworth, Jemma; Ferris, Nigel P.; Mioulet, Valerie; King, Donald P.] Pirbright Inst, Vesicular Dis Reference Lab, Pirbright, Surrey, England; [Reid, Scott M.] Anim Hlth & Vet Labs Agcy, New Haw, Surrey, England; [Barnett, Paul V.] Vet Med Directorate, New Haw, Surrey, England; [Di Nardo, Antonello] Univ Glasgow, Coll Med Vet & Life Sci, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Glasgow	Fowler, VL (corresponding author), Pirbright Inst, Vesicular Dis Reference Lab, Pirbright, Surrey, England.	veronica.fowler@pirbright.ac.uk	Armson, Bryony/L-7226-2019	Armson, Bryony/0000-0002-2703-1574; King, Donald/0000-0002-6959-2708	Department for the Environment, Food and Rural Affairs [DEFRA SE1127]; European Union [289364]; U.S. Department of Homeland Security through Texas A&M AgriLife Research [HSHQDC-12-J-00415]; Institute for Infectious Diseases (IIAD)	Department for the Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); European Union(European Commission); U.S. Department of Homeland Security through Texas A&M AgriLife Research(United States Department of Homeland Security (DHS)); Institute for Infectious Diseases (IIAD)	The work was supported financially by Department for the Environment, Food and Rural Affairs (DEFRA SE1127) and funding from the European Union FP7-KBBE-2011-5 under grant agreement no. 289364 (RAPIDIA-Field). In addition this material is based upon work supported by the U.S. Department of Homeland Security under Award Number HSHQDC-12-J-00415 through Texas A&M AgriLife Research and the Institute for Infectious Diseases (IIAD). The views and conclusions contained in this document are those of the authors and should not be interpreted as necessarily representing the official policies, either expressed or implied, of the U.S. Department of Homeland Security. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Belsham GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014621; Bisht P, 2014, J VIROL METHODS, V196, P65, DOI 10.1016/j.jviromet.2013.10.041; Bruckner G., 2010, Compendium of technical items presented to the OIE World Assembly of Delegates and to OIE Regional Commissions, P187; Callahan JD, 2002, J AM VET MED ASSOC, V220, P1636, DOI 10.2460/javma.2002.220.1636; Cottam EM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000050; Ellard FM, 1999, J GEN VIROL, V80, P1911, DOI 10.1099/0022-1317-80-8-1911; Ferris NP, 2009, J VIROL METHODS, V155, P10, DOI 10.1016/j.jviromet.2008.09.009; FERRIS NP, 1988, VET MICROBIOL, V16, P201, DOI 10.1016/0378-1135(88)90024-7; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HAMBLIN C, 1984, VET MICROBIOL, V9, P435, DOI 10.1016/0378-1135(84)90064-6; Hofmann MA, 2000, J VIROL METHODS, V87, P29, DOI 10.1016/S0166-0934(00)00154-3; Knowles NJ, 2005, EMERG INFECT DIS, V11, P1887; Knowles NJ, 2001, VET REC, V148, P258; Knowles NJ, 2012, VIRUS TAXONOMY CLASS, P855, DOI DOI 10.1016/B978-0-12-384684-6.00074-4; Metwally S, 2010, OP SESS EUR COMM CON; Reid SM, 2003, J VIROL METHODS, V107, P129, DOI 10.1016/S0166-0934(02)00210-0; Ruggli N, 1996, J VIROL, V70, P3478, DOI 10.1128/JVI.70.6.3478-3487.1996; Rweyemamu M, 2008, TRANSBOUND EMERG DIS, V55, P57, DOI 10.1111/j.1865-1682.2007.01013.x; Shaw AE, 2007, J VIROL METHODS, V143, P81, DOI 10.1016/j.jviromet.2007.02.009	20	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109322	10.1371/journal.pone.0109322	http://dx.doi.org/10.1371/journal.pone.0109322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313787	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000343662500031
J	Ci, HP; Wu, N; Su, YJ				Ci, Haipeng; Wu, Nan; Su, Yanjie			Clock Gene Modulates Roles of OXTR and AVPR1b Genes in Prosociality	PLOS ONE			English	Article							CIRCADIAN-CLOCK; EVENING PREFERENCE; BIPOLAR DISORDER; DICTATOR GAME; POLYMORPHISM; OXYTOCIN; BEHAVIOR; ASSOCIATION; ADOLESCENTS; VASOPRESSIN	Background: The arginine vasopressin receptor (AVPR) and oxytocin receptor (OXTR) genes have been demonstrated to contribute to prosocial behavior. Recent research has focused on the manner by which these simple receptor genes influence prosociality, particularly with regard to the AVP system, which is modulated by the clock gene. The clock gene is responsible for regulating the human biological clock, affecting sleep, emotion and behavior. The current study examined in detail whether the influences of the OXTR and AVPR1b genes on prosociality are dependent on the clock gene. Methodology/Principal Findings: This study assessed interactions between the clock gene (rs1801260, rs6832769) and the OXTR (rs1042778, rs237887) and AVPR1b (rs28373064) genes in association with individual differences in prosociality in healthy male Chinese subjects (n = 436). The Prosocial Tendencies Measure (PTM-R) was used to assess prosociality. Participants carrying both the GG/GA variant of AVPR1b rs28373064 and the AA variant of clock rs6832769 showed the highest scores on the Emotional PTM. Carriers of both the T allele of OXTR rs1042778 and the C allele of clock rs1801260 showed the lowest total PTM scores compared with the other groups. Conclusions: The observed interaction effects provide converging evidence that the clock gene and OXT/AVP systems are intertwined and contribute to human prosociality.	[Ci, Haipeng; Wu, Nan; Su, Yanjie] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Wu, Nan] Beijing Union Univ, Teachers Coll, Beijing, Peoples R China	Peking University; Beijing Union University	Su, YJ (corresponding author), Peking Univ, Dept Psychol, Beijing 100871, Peoples R China.	yjsu@pku.edu.cn	Su, Yanjie/E-7003-2019	Su, Yanjie/0000-0003-3508-8674	National Natural Science Foundation of China [31170995, 31371040]; National Basic Research Program (973 Program) [2010CB833904]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (Project 31170995, 31371040) and National Basic Research Program (973 Program: 2010CB833904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera G, 2000, REGUL PEPTIDES, V96, P23, DOI 10.1016/S0167-0115(00)00196-8; Benca R, 2009, BRAIN RES REV, V62, P57, DOI 10.1016/j.brainresrev.2009.09.005; Benedetti F, 2007, AM J MED GENET B, V144B, P631, DOI 10.1002/ajmg.b.30475; Brown SL, 2008, PERS SOC PSYCHOL B, V34, P849, DOI 10.1177/0146167208314972; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Carlo G, 2002, J YOUTH ADOLESCENCE, V31, P31, DOI 10.1023/A:1014033032440; Ciarleglio CM, 2008, J BIOL RHYTHM, V23, P330, DOI 10.1177/0748730408320284; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Eagly AH, 2009, AM PSYCHOL, V64, P644, DOI 10.1037/0003-066X.64.8.644; Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020; Feldman R, 2012, BIOL PSYCHIAT, V72, P175, DOI 10.1016/j.biopsych.2011.12.025; Garaulet M, 2012, INT J OBESITY, V36, P1436, DOI 10.1038/ijo.2011.270; Garaulet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017435; Hampp G, 2008, CURR BIOL, V18, P678, DOI 10.1016/j.cub.2008.04.012; Hasler BP, 2010, PSYCHIAT RES, V176, P166, DOI 10.1016/j.psychres.2009.06.006; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Israel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005535; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Knafo A, 2008, GENES BRAIN BEHAV, V7, P266, DOI 10.1111/j.1601-183X.2007.00341.x; Kou Y, 2008, INT J PSYCHOL, V43, P250; Lahiri K, 2005, PLOS BIOL, V3, P2005, DOI 10.1371/journal.pbio.0030351; Lange L, 2011, SLEEP BIOL RHYTHMS, V9, P12, DOI 10.1111/j.1479-8425.2010.00478.x; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee KY, 2010, PROG NEURO-PSYCHOPH, V34, P1196, DOI 10.1016/j.pnpbp.2010.06.010; Leszczynska-Rodziewicz A, 2012, J AFFECT DISORDERS, V138, P490, DOI 10.1016/j.jad.2012.01.025; Maywood ES, 2003, J NEUROENDOCRINOL, V15, P329, DOI 10.1046/j.1365-2826.2003.00971.x; Mishima K, 2005, AM J MED GENET B, V133B, P101, DOI 10.1002/ajmg.b.30110; Montag C, 2011, BIOL PSYCHIAT, V69, P601, DOI 10.1016/j.biopsych.2010.10.026; Partonen T, 2012, J NEURAL TRANSM, V119, P1133, DOI 10.1007/s00702-012-0810-2; Ring RH, 2005, CURR PHARM DESIGN, V11, P205, DOI 10.2174/1381612053382241; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Schreiter S, 2013, J AFFECT DISORDERS, V150, P1, DOI 10.1016/j.jad.2013.03.009; Serretti A, 2003, AM J MED GENET B, V121B, P35, DOI 10.1002/ajmg.b.20053; Takao T, 2007, EUR NEUROPSYCHOPHARM, V17, P273, DOI 10.1016/j.euroneuro.2006.09.002; Terracciano A, 2010, MOL PSYCHIATR, V15, P647, DOI 10.1038/mp.2008.113; Vaccari C, 1998, ENDOCRINOLOGY, V139, P5015, DOI 10.1210/en.139.12.5015; Vatine G, 2011, FEBS LETT, V585, P1485, DOI 10.1016/j.febslet.2011.04.007; Wu N, 2012, J AFFECT DISORDERS, V138, P468, DOI 10.1016/j.jad.2012.01.009; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327	40	7	9	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109086	10.1371/journal.pone.0109086	http://dx.doi.org/10.1371/journal.pone.0109086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25309987	gold, Green Submitted, Green Published			2022-12-27	WOS:000343210300033
J	Uematsu, A; Tsuchiya, K; Kadono, N; Kobayashi, H; Kaetsu, T; Hortobagyi, T; Suzuki, S				Uematsu, Azusa; Tsuchiya, Kazushi; Kadono, Norio; Kobayashi, Hirofumi; Kaetsu, Takamasa; Hortobagyi, Tibor; Suzuki, Shuji			A Behavioral Mechanism of How Increases in Leg Strength Improve Old Adults' Gait Speed	PLOS ONE			English	Article							WALKING-SPEED; FUNCTIONAL PERFORMANCE; PHYSICAL PERFORMANCE; COGNITIVE FUNCTION; EXECUTIVE FUNCTION; MUSCLE FUNCTION; POWER; AGE; BALANCE; HEALTH	We examined a behavioral mechanism of how increases in leg strength improve healthy old adults' gait speed. Leg press strength training improved maximal leg press load 40% (p = 0.001) and isometric strength in 5 group of leg muscles 32% (p = 0.001) in a randomly allocated intervention group of healthy old adults (age 74, n = 15) but not in no-exercise control group (age 74, n = 8). Gait speed increased similarly in the training (9.9%) and control (8.6%) groups (time main effect, p = 0.001). However, in the training group only, in line with the concept of biomechanical plasticity of aging gait, hip extensors and ankle plantarflexors became the only significant predictors of self-selected and maximal gait speed. The study provides the first behavioral evidence regarding a mechanism of how increases in leg strength improve healthy old adults' gait speed.	[Uematsu, Azusa; Suzuki, Shuji] Waseda Univ, Fac Human Sci, Tokorozawa, Saitama, Japan; [Tsuchiya, Kazushi] Waseda Univ, Grad Sch Human Sci, Tokorozawa, Saitama, Japan; [Kadono, Norio] Waseda Univ, Adv Res Ctr Human Sci, Tokorozawa, Saitama, Japan; [Kobayashi, Hirofumi] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1138654, Japan; [Kaetsu, Takamasa] Waseda Univ, Sch Human Sci, Tokorozawa, Saitama, Japan; [Hortobagyi, Tibor] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Hortobagyi, Tibor] Northumbria Univ, Dept Sport Exercise & Rehabil, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England	Waseda University; Waseda University; Waseda University; University of Tokyo; Waseda University; University of Groningen; Northumbria University	Uematsu, A (corresponding author), Waseda Univ, Fac Human Sci, Tokorozawa, Saitama, Japan.	uematsu@aoni.waseda.jp			Waseda University [2013A-943, 2013B-224]	Waseda University	This study was supported in part by Waseda University Grant for Special Research Projects (2013A-943 and 2013B-224) (http://www.waseda.jp/rps/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson HH, 2007, J GERONTOL A-BIOL, V62, P844, DOI 10.1093/gerona/62.8.844; BASSEY EJ, 1992, CLIN SCI, V82, P321, DOI 10.1042/cs0820321; Beijersbergen CMI, 2013, AGEING RES REV, V12, P618, DOI 10.1016/j.arr.2013.03.001; BENDALL MJ, 1989, AGE AGEING, V18, P327, DOI 10.1093/ageing/18.5.327; Bollard E, 2013, PHYSIOTHER THEOR PR, V29, P142, DOI 10.3109/09593985.2012.703760; Bottaro M, 2007, EUR J APPL PHYSIOL, V99, P257, DOI 10.1007/s00421-006-0343-1; BROWN M, 1995, J GERONTOL A-BIOL, V50, P55; Buchner D M, 1992, Clin Geriatr Med, V8, P1; Buchner DM, 1997, J GERONTOL A-BIOL, V52, pM218, DOI 10.1093/gerona/52A.4.M218; Cao Zhen-Bo, 2007, Journal of Physiological Anthropology, V26, P325, DOI 10.2114/jpa2.26.325; Capodaglio P, 2007, EUR J APPL PHYSIOL, V100, P535, DOI 10.1007/s00421-006-0195-8; Caserotti P, 2008, SCAND J MED SCI SPOR, V18, P773, DOI 10.1111/j.1600-0838.2007.00732.x; Cofre Lizama LE, 2011, GAIT POSTURE, V33, P484, DOI 10.1016/j.gaitpost.2010.12.030; DargentMolina P, 1996, LANCET, V348, P145, DOI 10.1016/S0140-6736(96)01440-7; DeVita P, 2000, J APPL PHYSIOL, V88, P1804, DOI 10.1152/jappl.2000.88.5.1804; FIATARONE MA, 1990, JAMA-J AM MED ASSOC, V263, P3029, DOI 10.1001/jama.263.22.3029; Fielding RA, 2002, J AM GERIATR SOC, V50, P655, DOI 10.1046/j.1532-5415.2002.50159.x; Fielding RA, 2011, J GERONTOL A-BIOL, V66, P1226, DOI 10.1093/gerona/glr123; Fitzsimons CF, 2005, J AGING PHYS ACTIV, V13, P172, DOI 10.1123/japa.13.2.172; Granacher U, 2011, SPORTS MED, V41, P377, DOI 10.2165/11539920-000000000-00000; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; Guralnik JM, 2013, ASSESSING PHYS PERFO; Henwood TR, 2008, J GERONTOL A-BIOL, V63, P83, DOI 10.1093/gerona/63.1.83; HIMANN JE, 1988, MED SCI SPORT EXER, V20, P161, DOI 10.1249/00005768-198820020-00010; Hirano Y, 2013, RIGAKURYOHO KAGAKU, V28, P115; Hunter SK, 2000, J GERONTOL A-BIOL, V55, pB264, DOI 10.1093/gerona/55.6.B264; Ijmker T, 2012, GAIT POSTURE, V35, P126, DOI 10.1016/j.gaitpost.2011.08.022; JUDGE JO, 1994, J AM GERIATR SOC, V42, P937, DOI 10.1111/j.1532-5415.1994.tb06584.x; Judge JO, 1996, J GERONTOL A-BIOL, V51, pM303, DOI 10.1093/gerona/51A.6.M303; JUDGE JO, 1993, ARCH PHYS MED REHAB, V74, P400; Kalapotharakos VI, 2005, J STRENGTH COND RES, V19, P652; Kamiya A, 2010, RIGAKURYOHO KAGAKU, V25, P919; Kerrigan DC, 1998, ARCH PHYS MED REHAB, V79, P317, DOI 10.1016/S0003-9993(98)90013-2; Liu-Ambrose T, 2010, ARCH INTERN MED, V170, P170, DOI 10.1001/archinternmed.2009.494; Lord SR, 1996, J GERONTOL A-BIOL, V51, pM64, DOI 10.1093/gerona/51A.2.M64; Marsh AP, 2009, J AGING PHYS ACTIV, V17, P416, DOI 10.1123/japa.17.4.416; Masakado Y, 1995, ELECTROMYOGR MOTOR C, V97, P290, DOI 10.1016/0924-980X(95)00188-Q; McGibbon CA, 2004, J APPL PHYSIOL, V96, P149, DOI 10.1152/japplphysiol.00422.2003; Miszko TA, 2003, J GERONTOL A-BIOL, V58, P171; Miyazaki J, 2013, ARCH GERONTOL GERIAT, V56, P141, DOI 10.1016/j.archger.2012.09.004; Monaco V, 2009, CLIN BIOMECH, V24, P493, DOI 10.1016/j.clinbiomech.2009.04.004; POTTER JM, 1995, ARCH PHYS MED REHAB, V76, P997, DOI 10.1016/S0003-9993(95)81036-6; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; Reid KF, 2012, EUR J APPL PHYSIOL, V112, P2289, DOI 10.1007/s00421-011-2200-0; Savelberg HHCM, 2007, GAIT POSTURE, V25, P259, DOI 10.1016/j.gaitpost.2006.04.006; Schlicht J, 2001, J GERONTOL A-BIOL, V56, pM281, DOI 10.1093/gerona/56.5.M281; Schrack JA, 2012, J AM GERIATR SOC, V60, P1811, DOI 10.1111/j.1532-5415.2012.04153.x; Silder A, 2008, J BIOMECH, V41, P1520, DOI 10.1016/j.jbiomech.2008.02.016; SKELTON DA, 1994, AGE AGEING, V23, P371, DOI 10.1093/ageing/23.5.371; SKELTON DA, 1995, J AM GERIATR SOC, V43, P1081, DOI 10.1111/j.1532-5415.1995.tb07004.x; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Symons TB, 2005, J GERONTOL A-BIOL, V60, P777, DOI 10.1093/gerona/60.6.777; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; van Kan GA, 2012, CURR OPIN CLIN NUTR, V15, P436, DOI 10.1097/MCO.0b013e328356bbf4; Viccaro LJ, 2011, J AM GERIATR SOC, V59, P887, DOI 10.1111/j.1532-5415.2011.03336.x; Wallerstein LF, 2012, J AGING PHYS ACTIV, V20, P171, DOI 10.1123/japa.20.2.171; Watson NL, 2010, J GERONTOL A-BIOL, V65, P1093, DOI 10.1093/gerona/glq111; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454	58	22	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110350	10.1371/journal.pone.0110350	http://dx.doi.org/10.1371/journal.pone.0110350			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ9WZ	25310220	Green Accepted, Green Published, gold			2022-12-27	WOS:000343210300107
J	Meza, JS; Diaz-Fleischer, F; Sanchez-Velasquez, LR; Zepeda-Cisneros, CS; Handler, AM; Schetelig, MF				Meza, Jose S.; Diaz-Fleischer, Francisco; Sanchez-Velasquez, Lazaro R.; Silvia Zepeda-Cisneros, Cristina; Handler, Alfred M.; Schetelig, Marc F.			Fitness Cost Implications of PhiC31-Mediated Site-Specific Integrations in Target-Site Strains of the Mexican Fruit Fly, Anastrepha ludens (Diptera: Tephritidae)	PLOS ONE			English	Article							CERATITIS-CAPITATA DIPTERA; STERILE INSECT TECHNIQUE; MUTANT LOX SITES; MAMMALIAN-CELLS; GERM-LINE; DROSOPHILA-MELANOGASTER; SEXUAL COMPATIBILITY; TRANSPOSABLE ELEMENT; TRANSGENIC STRAINS; GENE-EXPRESSION	Site-specific recombination technologies are powerful new tools for the manipulation of genomic DNA in insects that can improve transgenesis strategies such as targeting transgene insertions, allowing transgene cassette exchange and DNA mobilization for transgene stabilization. However, understanding the fitness cost implications of these manipulations for transgenic strain applications is critical. In this study independent piggyBac-mediated attP target-sites marked with DsRed were created in several genornic positions in the Mexican fruit fly, Anastrepha lud ens Two of these strains, one having an autosonlal (attP_F7) and the other a Y-linked (attP_2-1V16y) integration, exhibited fitness parameters (dynamic demography and sexual competitiveness) similar to wild type flies. These strains were thus selected for targeted insertion using, for the first time in mexfly, the iahiC *ntegrase recombination system to insert an additional EGFP-marked transgene to determine its effect on host strain fitness. Fitness tests showed that the integration event in the int 2-M6y recombinant strain had no significant effect, while the int_F7 recombinant strain exhibited significantly lower fitness relative to the original attP_F7 target site host strain. These results indicate that while targeted transgene integrations can be achieved withoLit an additional fitness cost, at some genomic positions insertion of additional DNA into a previously integrated transgene can have a significant negative effect. Thus, for targeted transgene insertions fitness costs mList be evaluated both previous to and subsequent to new site-specific insertions in the target-site strain	[Meza, Jose S.; Silvia Zepeda-Cisneros, Cristina] SAGARPA IICA, Programa Moscafrut, Metapa De Dominguez, Chiapas, Mexico; [Meza, Jose S.; Diaz-Fleischer, Francisco; Sanchez-Velasquez, Lazaro R.] Univ Veracruzana, Inst Biotecnol & Ecol Aplicada INBIOTECA, Xalapa 91000, Veracruz, Mexico; [Handler, Alfred M.; Schetelig, Marc F.] USDA, Ctr Med Agr & Vet Entomol, Agr Res Serv, Gainesville, FL 32614 USA; [Schetelig, Marc F.] Univ Giessen, Inst Phytopathol & Appl Zool, D-35390 Giessen, Germany	Universidad Veracruzana; United States Department of Agriculture (USDA); Justus Liebig University Giessen	Schetelig, MF (corresponding author), USDA, Ctr Med Agr & Vet Entomol, Agr Res Serv, Gainesville, FL 32614 USA.	marc.schetelig@agrar.uni-giessen.de	Fleischer, Francisco Díaz/J-9437-2019; Sánchez-Velásquez, Lázaro Rafael/O-9911-2018; Hernández, José Salvador Meza/AAS-2085-2021; Schetelig, Marc F./AAD-2332-2019; Díaz-Fleischer, Francisco/N-1275-2016; Meza Hernández, José Salvador/B-6203-2015	Fleischer, Francisco Díaz/0000-0003-2137-6587; Sánchez-Velásquez, Lázaro Rafael/0000-0002-6014-8731; Hernández, José Salvador Meza/0000-0001-5178-419X; Schetelig, Marc F./0000-0002-9217-394X; Díaz-Fleischer, Francisco/0000-0003-2137-6587; Meza Hernández, José Salvador/0000-0001-5178-419X	Programa Moscafrut/SAGARPA-IICA; "Consejo Nacional de Ciencia y Tecnologia (CONACyT)" [229669]; USDA-NIFA-Biotechnology Risk Assessment Grant Program [2011-39211-30769]; Emmy Noether program of the German Research Foundation [SCHE 1833/1-1]; LOEWE Center for Insect Biotechnology & Bioresources (Hessen State Ministry of Higher Education, Research and the Arts)	Programa Moscafrut/SAGARPA-IICA; "Consejo Nacional de Ciencia y Tecnologia (CONACyT)"(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); USDA-NIFA-Biotechnology Risk Assessment Grant Program; Emmy Noether program of the German Research Foundation(German Research Foundation (DFG)); LOEWE Center for Insect Biotechnology & Bioresources (Hessen State Ministry of Higher Education, Research and the Arts)	The authors thank the staff of "sexado genetico" sub-direction and "validacion tecnologica" of the Programa Moscafrut, SAGARPA-IICA for their invaluable technical support. This research was funded and supported by the Programa Moscafrut/SAGARPA-IICA, the "Consejo Nacional de Ciencia y Tecnologia (CONACyT)" (no. 229669; to JSM), the USDA-NIFA-Biotechnology Risk Assessment Grant Program (no. 2011-39211-30769; to AMH), the Emmy Noether program of the German Research Foundation (SCHE 1833/1-1; to MFS) and the LOEWE Center for Insect Biotechnology & Bioresources (Hessen State Ministry of Higher Education, Research and the Arts; to MFS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT H, 1995, PLANT J, V7, P649, DOI 10.1046/j.1365-313X.1995.7040649.x; Araki K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf102; Bhadra U, 1998, GENETICS, V150, P251; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Caswell, 2000, MATRIX POPULATION MO; Caswell H, 2004, THEOR POPUL BIOL, V65, P401, DOI 10.1016/j.tpb.2003.09.007; Catteruccia F, 2005, NAT BIOTECHNOL, V23, P1414, DOI 10.1038/nbt1152; Cayol JP, 1999, J ECON ENTOMOL, V92, P140, DOI 10.1093/jee/92.1.140; Condon KC, 2007, INSECT MOL BIOL, V16, P573, DOI 10.1111/j.1365-2583.2007.00752.x; Day CD, 2000, GENE DEV, V14, P2869, DOI 10.1101/gad.849600; FRANZ G, 1991, NUCLEIC ACIDS RES, V19, P6646, DOI 10.1093/nar/19.23.6646; FRASER MJ, 1983, J VIROL, V47, P287, DOI 10.1128/JVI.47.2.287-300.1983; Fu GL, 2007, NAT BIOTECHNOL, V25, P353, DOI 10.1038/nbt1283; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x; Handler AM, 2004, NAT BIOTECHNOL, V22, P1150, DOI 10.1038/nbt1002; Handler AM, 2001, INSECT BIOCHEM MOLEC, V31, P199, DOI 10.1016/S0965-1748(00)00119-3; HAYMER DS, 1986, DEV GENET, V6, P281; Horn C, 2005, P NATL ACAD SCI USA, V102, P12483, DOI 10.1073/pnas.0504305102; *IAEA, 1997, 3 RES COORD M TEL AV; Irvin N, 2004, P NATL ACAD SCI USA, V101, P891, DOI 10.1073/pnas.0305511101; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marrelli MT, 2006, TRENDS PARASITOL, V22, P197, DOI 10.1016/j.pt.2006.03.004; McGraw JB, 1996, AM NAT, V147, P47, DOI 10.1086/285839; McInnis DO, 1996, ANN ENTOMOL SOC AM, V89, P739, DOI 10.1093/aesa/89.5.739; Meredith JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059264; Meza-Hernandez JS, 2006, J ECON ENTOMOL, V99, P1979, DOI 10.1603/0022-0493-99.6.1979; Moreira LA, 2004, GENETICS, V166, P1337, DOI 10.1534/genetics.166.3.1337; Nimmo DD, 2006, INSECT MOL BIOL, V15, P129, DOI 10.1111/j.1365-2583.2006.00615.x; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; Paton D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067364; Meza JS, 2011, GENETICA, V139, P53, DOI 10.1007/s10709-010-9484-6; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Schetelig MF, 2012, INSECT BIOCHEM MOLEC, V42, P790, DOI 10.1016/j.ibmb.2012.07.007; Schetelig MF, 2009, P NATL ACAD SCI USA, V106, P18171, DOI 10.1073/pnas.0907264106; Schetelig MF, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-4; Schetelig MF, 2013, G3, pG3; Scolari F, 2011, GENETICA, V139, P41, DOI 10.1007/s10709-010-9483-7; Scolari F, 2008, NEW BIOTECHNOL, V25, P76, DOI 10.1016/j.nbt.2008.02.001; Smith RC, 2007, INSECT MOL BIOL, V16, P61, DOI 10.1111/j.1365-2583.2006.00701.x; Stevens L, 1991, MANUAL STANDORT OPER; Stone CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076228; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Thyagarajan B, 2001, MOL CELL BIOL, V21, P3926, DOI 10.1128/MCB.21.12.3926-3934.2001; Vandermeer J.H., 2003, POPULATION ECOLOGY 1; WARREN WD, 1994, GENET RES, V64, P87, DOI 10.1017/S0016672300032699; White SM, 2010, J APPL ECOL, V47, P1329, DOI 10.1111/j.1365-2664.2010.01880.x; Zhou Q, 2000, GENOME, V43, P434, DOI 10.1139/gen-43-3-434; Zimowska GJ, 2009, INSECT BIOCHEM MOLEC, V39, P508, DOI 10.1016/j.ibmb.2009.05.004	54	3	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109690	10.1371/journal.pone.0109690	http://dx.doi.org/10.1371/journal.pone.0109690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303238	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400074
J	Zhong, YH; Song, B; Mo, GX; Yuan, MW; Li, HL; Wang, P; Yuan, ML; Lu, QM				Zhong, Yunhua; Song, Bo; Mo, Guoxiang; Yuan, Mingwei; Li, Hongli; Wang, Ping; Yuan, Minglong; Lu, Qiumin			A Novel Neurotoxin from Venom of the Spider, Brachypelma albopilosum	PLOS ONE			English	Article							CUPIENNIUS-SALEI; PEPTIDE; CTENIDAE; CELLS	Spiders have evolved highly selective toxins for insects. There are many insecticidal neurotoxins in spider venoms. Although a large amount of work has been done to focus on neurotoxicity of spider components, little information, which is related with effects of spider toxins on tumor cell proliferation and cytotoxicity, is available for Brachypelma albopilosum venom. In this work, a novel spider neurotoxin (brachyin) was identified and characterized from venoms of the spider, Brachypelma albopilosum. Brachyin is composed of 41 amino acid residues with the sequence of CLGENVPCDKDRPNCCSRYECLEPT-GYGWWYASYYCYKKRS. There are six cysteines in this sequence, which form three disulfided bridges. The serine residue at the C-terminus is amidated. Brachyin showed strong lethal effects on American cockroaches (Periplaneta americana) and Tenebrio molitor (common mealbeetle). This neurotoxin also showed significant analgesic effects in mice models including abdominal writhing induced by acetic acid and formalin-induced paw licking tests. It was interesting that brachyin exerted marked inhibition on tumor cell proliferation.	[Zhong, Yunhua; Wang, Ping] Kunming Univ Sci & Technol, Fac Environm Sci & Engn, Kunming, Yunnan, Peoples R China; [Zhong, Yunhua; Wang, Ping] First Peoples Hosp Yunnan Prov, Cadres Treatment Sect, Kunming, Yunnan, Peoples R China; [Zhong, Yunhua; Wang, Ping] First Peoples Hosp Yunnan Prov, Dept Thorac Surg, Kunming, Yunnan, Peoples R China; [Song, Bo] Yunnan Univ Tradit Chinese Med, Sch Basic Med Sci, Kunming, Yunnan, Peoples R China; [Mo, Guoxiang] Nanjing Agr Univ, Coll Humanities & Social Sci, Nanjing, Jiangsu, Peoples R China; [Yuan, Mingwei; Li, Hongli; Yuan, Minglong] Yunnan Univ Nationalities, Engn Res Ctr Biopolymer Funct Mat Yunnan, Kunming, Yunnan, Peoples R China; [Lu, Qiumin] Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech Chinese Acad, Kunming, Yunnan, Peoples R China	Kunming University of Science & Technology; Yunnan University of Chinese Medicine; Nanjing Agricultural University; Yunnan Minzu University; Chinese Academy of Sciences; Kunming Institute of Zoology	Wang, P (corresponding author), Kunming Univ Sci & Technol, Fac Environm Sci & Engn, Kunming, Yunnan, Peoples R China.	710205373@qq.com; yml@188.com; lvqm@mail.kiz.ac.cn	Lu, Qiumin/AAB-4791-2022		National Natural Science Foundation of China [31160198, 31360417]; Applied Basic Research Key Project of Yunnan [2013FA039]; Applied Basic Research Project of Yunnan [2011FB084]; High-End Technology Professionals Introduction Plan in Yunnan province [2010CI119]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Applied Basic Research Key Project of Yunnan; Applied Basic Research Project of Yunnan; High-End Technology Professionals Introduction Plan in Yunnan province	This work was supported by the National Natural Science Foundation of China (31160198, 31360417), the Applied Basic Research Key Project of Yunnan (2013FA039), the Applied Basic Research Project of Yunnan (2011FB084), the High-End Technology Professionals Introduction Plan in Yunnan province (2010CI119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter R. N., 1993, KEEPING BREEDING TAR; Bettini S, 1978, ARTH RO POD VENOMS; Corzo G, 2003, FEBS LETT, V547, P43, DOI 10.1016/S0014-5793(03)00666-5; Corzo G, 2008, PEPTIDES, V29, P1901, DOI 10.1016/j.peptides.2008.07.003; Escoubas P, 2008, J MASS SPECTROM, V43, P279, DOI 10.1002/jms.1389; FRIEDEL T, 1989, TOXICON, V27, P305, DOI 10.1016/0041-0101(89)90178-5; FRIEDMAN M, 1970, J BIOL CHEM, V245, P3868; Gao L, 2005, ACTA PHARMACOL SIN, V26, P369, DOI 10.1111/j.1745-7254.2005.00052.x; Herzig V, 2008, TOXICON, V51, P1167, DOI 10.1016/j.toxicon.2008.02.001; Kuhn-Nentwig L, 2004, TOXICON, V43, P543, DOI 10.1016/j.toxicon.2004.02.009; Lai R, 2002, PEPTIDES, V23, P427, DOI 10.1016/S0196-9781(01)00641-6; Liang S, 2008, EXPERT REV PROTEOMIC, V5, P731, DOI 10.1586/14789450.5.5.731; Liu Z, 2012, CURR MOL MED, V12, P1350, DOI 10.2174/156652412803833643; Liu Z, 2003, CELL MOL LIFE SCI, V60, P972, DOI 10.1007/s00018-003-2354-x; McLachlan A, 2005, APOPTOSIS, V10, P619, DOI 10.1007/s10495-005-1896-x; Mebs D, 2002, VENOMOUS POISO NOUS; Owoyele Victor B., 2005, Inflammopharmacology, V13, P479, DOI 10.1163/156856005774649386; Santos JA, 2012, J ETHNOPHARMACOL, V144, P802, DOI 10.1016/j.jep.2012.10.024; Tang X, 2010, J PROTEOME RES, V9, P2550, DOI 10.1021/pr1000016; Tedford HW, 2001, J BIOL CHEM, V276, P26568, DOI 10.1074/jbc.M102199200; Vapenik Z, 2000, TOXICON, V38, P293, DOI 10.1016/S0041-0101(99)00146-4; Vassilevski AA, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1505, DOI 10.1134/S0006297909130069; Wullschleger B, 2005, J EXP BIOL, V208, P2115, DOI 10.1242/jeb.01594; Yang SL, 2013, P NATL ACAD SCI USA, V110, P17534, DOI 10.1073/pnas.1306285110; Yang S, 2012, MOL CELL PROTEOMICS, V11, P640, DOI 10.1074/mcp.M112.018853	25	5	6	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110221	10.1371/journal.pone.0110221	http://dx.doi.org/10.1371/journal.pone.0110221			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329070	Green Published, Green Submitted, gold			2022-12-27	WOS:000343942100043
J	Fedele, A; Tedeschi, P				Fedele, Alessandro; Tedeschi, Piero			Reputation and Competition in a Hidden Action Model	PLOS ONE			English	Article							EARNINGS ANNOUNCEMENTS; MARKET-STRUCTURE; PRODUCT QUALITY; INFORMATION; PERFORMANCE	The economics models of reputation and quality in markets can be classified in three categories. (i) Pure hidden action, where only one type of seller is present who can provide goods of different quality. (ii) Pure hidden information, where sellers of different types have no control over product quality. (iii) Mixed frameworks, which include both hidden action and hidden information. In this paper we develop a pure hidden action model of reputation and Bertrand competition, where consumers and firms interact repeatedly in a market with free entry. The price of the good produced by the firms is contractible, whilst the quality is noncontractible, hence it is promised by the firms when a contract is signed. Consumers infer future quality from all available information, i. e., both from what they know about past quality and from current prices. According to early contributions, competition should make reputation unable to induce the production of high-quality goods. We provide a simple solution to this problem by showing that high quality levels are sustained as an outcome of a stationary symmetric equilibrium.	[Fedele, Alessandro] Free Univ Bozen Bolzano, Sch Econ & Management, Bolzano, Bolzano, Italy; [Tedeschi, Piero] Univ Cattol Sacro Cuore, Dept Econ & Finance, Milan, Italy	Free University of Bozen-Bolzano; Catholic University of the Sacred Heart	Fedele, A (corresponding author), Free Univ Bozen Bolzano, Sch Econ & Management, Bolzano, Bolzano, Italy.	alessandro.fedele@unibz.it			Progetti di ricerca di interesse nazionale (PRIN) [2007R5PN7Y]; School of Economics and Management, Free University of Bozen/Bolzano, [2005137858_001]	Progetti di ricerca di interesse nazionale (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); School of Economics and Management, Free University of Bozen/Bolzano,	AF and PT: Progetti di ricerca di interesse nazionale (PRIN) 2007, (Protocollo 2007R5PN7Y). AF: School of Economics and Management, Free University of Bozen/Bolzano, research project "Competition, credit, taxation, and motivation (WW501R)". PT: PRIN 2005 (Protocollo 2005137858_001) URL: http://prin.miur.it/index.php?pag = 2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN F, 1984, RAND J ECON, V15, P311, DOI 10.2307/2555440; ATIASE RK, 1985, J ACCOUNTING RES, V23, P21, DOI 10.2307/2490905; BAMBER LS, 1987, ACCOUNT REV, V62, P510; Bar-Isaac H, 2005, ECON LETT, V89, P167, DOI 10.1016/j.econlet.2005.05.022; Bar-Isaac Heski, 2008, Foundations and Trends in Microeconomics, V4, P273, DOI 10.1561/0700000027; Brand R, 2000, BUSINESS INSIGHTS; Bushan R, 1989, J ACCOUNT ECON, V11, P255; Dana JD, 2011, INT ECON REV, V52, P1059, DOI 10.1111/j.1468-2354.2011.00659.x; Economist Intelligence Unit, 2005, EC INT UN GLOB RISK; Horner J, 2002, AM ECON REV, V92, P644; KLEIN B, 1981, J POLIT ECON, V89, P615, DOI 10.1086/260996; Kranton RE, 2003, ECONOMICA, V70, P385, DOI 10.1111/1468-0335.t01-1-00289; KREPS DM, 1982, J ECON THEORY, V27, P253, DOI 10.1016/0022-0531(82)90030-8; Raju JS, 2000, MANAGE SCI, V46, P1075, DOI 10.1287/mnsc.46.8.1075.12024; Rob R, 2005, J POLIT ECON, V113, P1146, DOI 10.1086/444552; SHAPIRO C, 1983, Q J ECON, V98, P659, DOI 10.2307/1881782; Stiglitz JE, 1989, HDB IND ORG, V1, P771; Tadelis S, 2002, J POLIT ECON, V110, P854, DOI 10.1086/340781; Toth A, 2012, RAND J ECON, V43, P348, DOI 10.1111/j.1756-2171.2012.00169.x; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218	20	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110233	10.1371/journal.pone.0110233	http://dx.doi.org/10.1371/journal.pone.0110233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TF	25329387	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204100049
J	Abdelsaid, MA; Matragoon, S; Ergul, A; El-Remessy, AB				Abdelsaid, Mohammed A.; Matragoon, Suraporn; Ergul, Adviye; El-Remessy, Azza B.			Deletion of Thioredoxin Interacting Protein (TXNIP) Augments Hyperoxia-Induced Vaso-Obliteration in a Mouse Model of Oxygen Induced-Retinopathy	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OXIDATIVE STRESS; NITRIC-OXIDE; LUNG INJURY; CELL-DEATH; APOPTOSIS; SYSTEM; MICE; INFLAMMATION; SURVIVAL	We have recently shown that thioredoxin interacting protein (TXNIP) is required for VEGF-mediated VEGFR2 receptor activation and angiogenic signal. Retinas from TXNIP knockout mice (TKO) exhibited higher cellular antioxidant defense compared to wild type (WT). This study aimed to examine the impact of TXNIP deletion on hyperoxia-induced vaso-obliteration in ischemic retinopathy. TKO and WT pups were subjected to oxygen-induced retinopathy model. Retinal central capillary dropout was measured at p12. Retinal redox and nitrative state were assessed by reduced-glutathione (GSH), thioredoxin reductase activity and nitrotyrosine formation. Western blot and QT-PCR were used to assess VEGF, VEGFR-2, Akt, iNOS and eNOS, thioredoxin expression, ASK-1 activation and downstream cleaved caspase-3 and PARP in retinal lysates. Retinas from TKO mice exposed to hyperoxia showed significant increases (1.5-fold) in vaso-obliteration as indicated by central capillary drop out area compared to WT. Retinas from TKO showed minimal nitrotyrosine levels (10% of WT) with no change in eNOS or iNOS mRNA expression. There was no change in levels of VEGF or activation of VEGFR2 and its downstream Akt in retinas from TKO and WT. In comparison to WT, retinas from TKO showed significantly higher level of GSH and thioredoxin reductase activity in normoxia but comparable levels under hyperoxia. Exposure of TKO to hyperoxia significantly decreased the anti-apoptotic thioredoxin protein (similar to 50%) level compared with WT. This effect was associated with a significant increase in activation of the apoptotic ASK-1, PARP and caspase-3 pathway. Our results showed that despite comparable VEGF level and signal in TKO, exposure to hyperoxia significantly decreased Trx expression compared to WT. This effect resulted in liberation and activation of the apoptotic ASK-1 signal. These findings suggest that TXNIP is required for endothelial cell survival and homeostasis especially under stress conditions including hyperoxia.	[Abdelsaid, Mohammed A.; Matragoon, Suraporn; Ergul, Adviye; El-Remessy, Azza B.] Univ Georgia, Augusta, GA 30912 USA; [Matragoon, Suraporn; El-Remessy, Azza B.] Culver Vis Discovery Inst, Augusta, GA USA; [Abdelsaid, Mohammed A.; Ergul, Adviye] Georgia Regents Univ, Dept Physiol, Augusta, GA USA; [Abdelsaid, Mohammed A.; Matragoon, Suraporn; Ergul, Adviye; El-Remessy, Azza B.] Charlie Norwood VA Med Ctr, Augusta, GA USA	University System of Georgia; University of Georgia; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	El-Remessy, AB (corresponding author), Univ Georgia, Augusta, GA 30912 USA.	aelremessy@gru.edu	El-Remessy, Azza B./AAA-3771-2020	El-Remessy, Azza B./0000-0003-4386-1989; Abdelsaid, Mohammed/0000-0001-9846-6623	VDI pilot grant; Juvenile Diabetes Research Foundation [2-2008-149]; VA Merit Award [BX000347]; VA Research Career Scientist Award; NIH [R01NS083559]; American Heart Association [10PRE3660004];  [R01-EY022408]; NATIONAL EYE INSTITUTE [R01EY022408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083559] Funding Source: NIH RePORTER	VDI pilot grant; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); VA Merit Award(US Department of Veterans Affairs); VA Research Career Scientist Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Source of research support: American Heart Association predoctoral fellowship award #10PRE3660004 to M. A. A., VDI pilot grant to A. B. E., Career Development Award from Juvenile Diabetes Research Foundation (2-2008-149) to A. B. E. and R01-EY022408 to A. B. E. A. E. is a Research Career Scientist at the Charlie Norwood Veterans Affairs Medical Center in Augusta, Georgia. This work was supported in part by VA Merit Award (BX000347), VA Research Career Scientist Award, and NIH (R01NS083559) to A. E. The contents do not represent the views of any of the funding agencies, the Department of Veterans Affairs or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsaid MA, 2013, ANTIOXID REDOX SIGN, V19, P2199, DOI 10.1089/ars.2012.4761; Abdelsaid MA, 2010, J PHARMACOL EXP THER, V332, P125, DOI 10.1124/jpet.109.157941; Adluri RS, 2011, J MOL CELL CARDIOL, V50, P239, DOI 10.1016/j.yjmcc.2010.11.002; Al-Gayyar MMH, 2011, BRIT J PHARMACOL, V164, P170, DOI 10.1111/j.1476-5381.2011.01336.x; Al-Gayyar MMH, 2010, AM J PATHOL, V177, P1187, DOI 10.2353/ajpath.2010.091289; ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Beauchamp MH, 2004, FREE RADICAL BIO MED, V37, P1885, DOI 10.1016/j.freeradbiomed.2004.09.008; Bendix I, 2012, BRAIN RES, V1484, P68, DOI 10.1016/j.brainres.2012.09.024; Britt RD, 2014, ANTIOXID REDOX SIGN, V20, P2681, DOI 10.1089/ars.2013.5332; Brooks SE, 2001, INVEST OPHTH VIS SCI, V42, P222; Chen J, 2014, MOL ENDOCRINOL; Chen Jing, 2007, Angiogenesis, V10, P133, DOI 10.1007/s10456-007-9066-0; Chen JQ, 2009, AM J PHYSIOL-ENDOC M, V296, pE1133, DOI 10.1152/ajpendo.90944.2008; de Bem AF, 2013, NITRIC OXIDE-BIOL CH, V31, P20, DOI 10.1016/j.niox.2013.03.003; Devi TS, 2013, EXP CELL RES, V319, P1001, DOI 10.1016/j.yexcr.2013.01.012; Du YT, 2013, J BIOL CHEM, V288, P32241, DOI 10.1074/jbc.M113.495150; Dunn LL, 2014, DIABETES, V63, P675, DOI 10.2337/db13-0417; Ebrahimian T, 2008, AM J PHYSIOL-HEART C, V295, pH1481, DOI 10.1152/ajpheart.00163.2008; El-Azab MF, 2014, BRIT J PHARMACOL, V171, P1299, DOI 10.1111/bph.12535; El-Remessy AB, 2005, J CELL SCI, V118, P243, DOI 10.1242/jcs.01612; Ferrara N, 1996, EUR J CANCER, V32A, P2413, DOI 10.1016/S0959-8049(96)00387-5; Fujino G, 2007, MOL CELL BIOL, V27, P8152, DOI 10.1128/MCB.00227-07; Gu XL, 2003, AM J PHYSIOL-CELL PH, V285, pC546, DOI 10.1152/ajpcell.00424.2002; HOLMGREN A, 1995, STRUCTURE, V3, P239, DOI 10.1016/S0969-2126(01)00153-8; Hsieh CC, 2006, FASEB J, V20, P259, DOI 10.1096/fj.05-4376com; Huang CL, 2014, LAB INVEST, V94, P309, DOI 10.1038/labinvest.2014.2; Hui STY, 2008, P NATL ACAD SCI USA, V105, P3921, DOI 10.1073/pnas.0800293105; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Jung H, 2014, CURR OPIN HEMATOL; Kolliputi N, 2009, AM J RESP CELL MOL, V40, P314, DOI 10.1165/rcmb.2007-0287OC; Lu J, 2012, ANTIOXID REDOX SIGN, V17, P1738, DOI 10.1089/ars.2012.4650; Mahmood DFD, 2013, ANTIOXID REDOX SIGN, V19, P1266, DOI 10.1089/ars.2012.4757; Makena PS, 2012, AM J RESP CELL MOL, V46, P461, DOI 10.1165/rcmb.2011-0234OC; Manoharan R, 2013, FREE RADICAL BIO MED, V63, P313, DOI 10.1016/j.freeradbiomed.2013.05.020; Nivet-Antoine V, 2010, BIOCHIMIE, V92, P1766, DOI 10.1016/j.biochi.2010.07.018; Ogata FT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084588; Park SY, 2013, ARTERIOSCL THROM VAS, V33, P737, DOI 10.1161/ATVBAHA.112.300386; Perrone L, 2009, J CELL PHYSIOL, V221, P262, DOI 10.1002/jcp.21852; Sennlaub F, 2002, J NEUROSCI, V22, P3987, DOI 10.1523/JNEUROSCI.22-10-03987.2002; Shan RY, 2011, J HUAZHONG U SCI-MED, V31, P258, DOI 10.1007/s11596-011-0263-0; Singh LP, 2013, J CLIN EXP OPHTHALMO, V4; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Tian L, 2014, NEUROPHARMACOLOGY, V77, P453, DOI 10.1016/j.neuropharm.2013.10.027; Tipple TE, 2009, AM J RESP CELL MOL, V41, P612, DOI 10.1165/rcmb.2008-0224OC; Yamawaki H, 2005, CURR OPIN NEPHROL HY, V14, P149, DOI 10.1097/00041552-200503000-00010; Yoshihara E, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00514; Yoshioka J, 2006, ANTIOXID REDOX SIGN, V8, P2143, DOI 10.1089/ars.2006.8.2143; Zhang QY, 2014, J NUTR BIOCHEM, V25, P420, DOI 10.1016/j.jnutbio.2013.11.014	48	11	11	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110388	10.1371/journal.pone.0110388	http://dx.doi.org/10.1371/journal.pone.0110388			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329456	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210800081
J	Borges, LMS; Merckelbach, LM; Cragg, SM				Borges, Luisa M. S.; Merckelbach, Lucas M.; Cragg, Simon M.			Biogeography of Wood-Boring Crustaceans (Isopoda: Limnoriidae) Established in European Coastal Waters	PLOS ONE			English	Article							CLIMATE-CHANGE; VERTICAL DISTRIBUTION; MARINE ORGANISMS; BORER LIMNORIA; SEA; TEREDINIDAE; DIVERSITY; BIOLOGY; COMMUNITIES; POPULATIONS	Marine wood-borers of the Limnoriidae cause great destruction to wooden structures exposed in the marine environment. In this study we collated occurrence data obtained from field surveys, spanning over a period of 10 years, and from an extensive literature review. We aimed to determine which wood-boring limnoriid species are established in European coastal waters; to map their past and recent distribution in Europe in order to infer species range extension or contraction; to determine species environmental requirements using climatic envelopes. Of the six species of wood-boring Limnoria previously reported occurring in Europe, only Limnoria lignorum, L. quadripunctata and L. tripunctata are established in European coastal waters. L. carinata and L. tuberculata have uncertain established status, whereas L. borealis is not established in European waters. The species with the widest distribution in Europe is Limnoria lignorum, which is also the most tolerant species to a range of salinities. L. quadripunctata and L. tripunctata appear to be stenohaline. However, the present study shows that both L. quadripunctata and L. tripunctata are more widespread in Europe than previous reports suggested. Both species have been found occurring in Europe since they were described, and their increased distribution is probably the results of a range expansion. On the other hand L. lignorum appears to be retreating poleward with ocean warming. In certain areas (e.g. southern England, and southern Portugal), limnoriids appear to be very abundant and their activity is rivalling that of teredinids. Therefore, it is important to monitor the distribution and destructive activity of these organisms in Europe.	[Borges, Luisa M. S.; Cragg, Simon M.] Univ Portsmouth, Inst Marine Sci, Sch Biol Sci, Portsmouth, Hants, England; [Borges, Luisa M. S.; Merckelbach, Lucas M.] Helmholtz Zentrum Geesthacht, Ctr Mat & Coastal Res, Geesthacht, Germany	University of Portsmouth; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung	Borges, LMS (corresponding author), Univ Portsmouth, Inst Marine Sci, Sch Biol Sci, Portsmouth, Hants, England.	luisaborges2000@yahoo.co.uk	Borges, Luisa/M-7361-2019; Cragg, Simon/C-8463-2011	Borges, Luisa/0000-0001-8582-0013; Cragg, Simon/0000-0003-1082-7653	Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/17915/2004]; BBSRC [BB/G016208/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G016208/1] Funding Source: researchfish	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by Fundacao para a Ciencia e a Tecnologia, Portugal through a personal grant to LMSB (SFRH/BD/17915/2004), www.fct.pt, except the publication fees that will be payed by The Helmholtz-Zentrum Geesthacht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abushaala Najla M., 2014, Journal of the Black Sea Mediterranean Environment, V20, P33; [Anonymous], 2002, CEISM ATLAS EXOTIC S; Beare D, 2004, GLOBAL CHANGE BIOL, V10, P1209, DOI 10.1111/j.1529-8817.2003.00790.x; Beaugrand G, 2001, MAR ECOL PROG SER, V219, P189, DOI 10.3354/meps219189; BECKER G, 1971, MARINE BORERS FUNGI, P303; Borges LMS, 2012, INVERTEBR SYST, V26, P572, DOI 10.1071/IS12028; Borges LMS, 2009, INT BIODETER BIODEGR, V63, P289, DOI 10.1016/j.ibiod.2008.10.007; Borges L.M.S., 2007, THESIS PORTSMOUTH U; Borges LMS, 2010, MAR BIODIVERS REC, V3, P1, DOI DOI 10.1017/S1755267209991059; Borges LMS, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-13; Carlton James T., 2009, V204, P13; Carlton JT, 1999, MALACOLOGIA, V41, P439; CARLTON JT, 1995, MAR BIOL, V121, P721, DOI 10.1007/BF00349308; CARLTON JT, 1985, OCEANOGR MAR BIOL, V23, P313; Carlton JT, 2009, HONOLULU BISHO MUSEU, V4; Carlton JT, 2001, INTRO SPSECIES US CO; Carlton JT, 1995, CGD1195; Castello J, 2011, ZOOTAXA, P1; Clapp W. F., 1963, MARINE BORERS ANNOTA; Cookson LJ, 2012, ZOOTAXA, P25; COOKSON L J, 1991, Memoirs of the Museum of Victoria, V52, P137; COOKSON L J, 1991, Raffles Bulletin of Zoology, V39, P87; Coutts ADM, 2003, MAR POLLUT BULL, V46, P1510, DOI 10.1016/S0025-326X(03)00292-3; Coutts ADM, 2007, MAR POLLUT BULL, V54, P875, DOI 10.1016/j.marpolbul.2007.03.011; Cragg SM, 2003, ACS SYM SER, V845, P272; Cragg SM, 1999, INT BIODETER BIODEGR, V43, P197, DOI 10.1016/S0964-8305(99)00054-2; Drake P., 1997, Publicaciones Especiales Instituto Espanol de Oceanografia, V23, P133; Eaton R.A., 1993, WOOD DECAY PESTS PRO; ELTRINGHAM S, 1961, J MAR BIOL ASSOC UK, V41, P785; ELTRINGHAM SK, 1971, INT BIODETERIOR, V7, P61; ELTRINGHAM SK, 1958, NATURE, V181, P1659, DOI 10.1038/1811659b0; ESAKOVA S. E., 1965, ZOOL ZH, V44, P456; Fraser CI, 2011, P ROY SOC B-BIOL SCI, V278, P649, DOI 10.1098/rspb.2010.1117; GELDIAY R, 1972, Crustaceana Supplement (Leiden), V3, P19; Gollasch S, 2002, BIOFOULING, V18, P105, DOI 10.1080/08927010290011361; Hall GS, 1967, INCIDENCE MARINE BOR; Hawkins SJ, 2009, MAR ECOL PROG SER, V396, P245, DOI 10.3354/meps08378; Haye PA, 2012, MAR ECOL PROG SER, V455, P111, DOI 10.3354/meps09673; Helmuth B, 2006, ANNU REV ECOL EVOL S, V37, P373, DOI 10.1146/annurev.ecolsys.37.091305.110149; Holthuis L. B., 1949, Zoologische Mededeelingen Leiden, V30, P163; Ishii M, 2005, FRONTIER RES SYSTEM; Johnson MW, 1935, BIOL BULL-US, V69, P427, DOI 10.2307/1537402; Jones E.B.G., 1972, Material Organismen, V7, P93; Jones EBG, 2001, INT BIODETER BIODEGR, V48, P112; JONES LT, 1963, J MAR BIOL ASSOC UK, V43, P589, DOI 10.1017/S0025315400025546; Kern M, 2013, P NATL ACAD SCI USA, V110, P10189, DOI 10.1073/pnas.1301502110; King AJ, 2010, P NATL ACAD SCI USA, V107, P5345, DOI 10.1073/pnas.0914228107; Kirkim Fevzi, 2006, Turkish Journal of Zoology, V30, P361; Kuhne H., 1976, Material und Organismen, P543; Kuhne H, 1971, MARINE BORERS FUNGI, P66; Le Roux Aguste, 2009, Bulletin de la Societe des Sciences Naturelles de l'Ouest de la France, V31, P75; Lopes DB, 2014, MADERAS-CIENC TECNOL, V16, P109, DOI 10.4067/S0718-221X2014005000010; Menzies R. J., 1957, Zeitschrift fuer Angewandte Zoologie, V44, P85; MENZIES RJ, 1972, MAR BIOL, V17, P149; Menzies RJ, 1957, B MAR SCI GULF CARIB, V7, P100; MENZIES ROBERT J., 1951, BULL SOUTHERN CALIFORNIA AKAD SCI, V50, P86; Miranda L, 2008, J SEA RES, V60, P176, DOI 10.1016/j.seares.2008.06.002; NAIR NB, 1958, NATURE, V182, P814, DOI 10.1038/182814a0; Neves CMB, 1962, SOBRE EXISTENCIA POR; Nobre A, 1938, FAUNA MALACOLOGICA; Oevering P, 2001, INT BIODETER BIODEGR, V47, P175, DOI 10.1016/S0964-8305(01)00046-4; Paalvast P, 2011, MAR POLLUT BULL, V62, P1822, DOI 10.1016/j.marpolbul.2011.05.009; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Poloczanska ES, 2008, ECOLOGY, V89, P3138, DOI 10.1890/07-1169.1; Quayle D.B., 1992, CAN SPEC PUBL FISH A, V115, P1; RATHKE J, 1799, SKRIVTER NATURHISTOR, V5, P61; Rodriguez-Sanchez L., 2001, Boletin Instituto Espanol de Oceanografia, V17, P149; Ruiz GM, 2000, ANNU REV ECOL SYST, V31, P481, DOI 10.1146/annurev.ecolsys.31.1.481; Sanchez-Mata A, 1992, P 1 EUR CRUST C CRUS, V64, P337; Sellius G, 1733, HIST NATURALIS TERDI; Shipway JR, 2014, BIOL INVASIONS, V16, P2037, DOI 10.1007/s10530-014-0646-9; SOMME OLAUG MATHISEN, 1940, NYTT MAG NATURVIDENSK, V81, P145; SVAVARSSON J, 1982, SARSIA, V67, P223, DOI 10.1080/00364827.1982.10421337; Sylvester F, 2010, DIVERS DISTRIB, V16, P132, DOI 10.1111/j.1472-4642.2009.00622.x; Thiel M, 2005, OCEANOGR MAR BIOL, V43, P279; Thiel M, 2003, J NAT HIST, V37, P1713, DOI 10.1080/00222930210125416; Turner R.D., 1966, PROVIDES GORGEOUSLY; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; Vind HP, 1961, EFFECT TEMPERATURE W; Zenetos A, 2005, MEDITERR MAR SCI, V6, P63, DOI 10.12681/mms.186	81	21	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109593	10.1371/journal.pone.0109593	http://dx.doi.org/10.1371/journal.pone.0109593			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313796	Green Published, gold			2022-12-27	WOS:000343662500058
J	Dai, GH; Ma, PZ; Song, XB; Liu, N; Zhang, T; Wu, B				Dai, Guo-Hua; Ma, Pei-Ze; Song, Xian-Bo; Liu, Ning; Zhang, Tong; Wu, Bo			MicroRNA-223-3p Inhibits the Angiogenesis of Ischemic Cardiac Microvascular Endothelial Cells via Affecting RPS6KB1/hif-1a Signal Pathway	PLOS ONE			English	Article							VASCULAR INTEGRITY; GROWTH; EXPRESSION; MEMBERS; GENES	Background: MicroRNAs (miRNAs) are a recently discovered class of posttranscriptional regulators of gene expression with critical functions in the angiogenesis and cardiovascular diseases; however, the details of miRNAs regulating mechanism of angiogenesis of ischemic cardiac microvascular endothelial cells (CMECs) are not yet reported. Methods and Results: This study analyzes the changes of the dynamic expression of miRNAs during the process of angiogenesis of ischemic CMECs by applying miRNA chip and real-time PCR for the first time. Compared with normal CMECs, ischemic CMECs have a specific miRNAs expression profile, in which mir-223-3p has the most significant up-regulation, especially during the process of migration and proliferation, while the up-regulation is the most significant during migration, reaching 11.02 times. Rps6kb1 is identified as a potential direct and functional target of mir-223-3p by applying bioinformatic prediction, real-time PCR and Western blot. Pathway analysis report indicates Rps6kb1 regulates the angiogenesis by participating into hif-1a signal pathway. Further analysis reveals that both the gene and protein expression of the downstream molecules VEGF, MAPK, PI3K and Akt of Rps6kb1/hif-1a signal pathway decrease significantly during the process of migration and proliferation in the ischemic CMECs. Therefore, it is confirmed that mir-223-3p inhibits the angiogenesis of CMECs, at least partly, via intervening RPS6KB1/hif-1a signal pathway and affecting the process of migration and proliferation. Conclusion: This study elucidates the miRNA regulating law in the angiogenesis of CMECs; mir-223-3p inhibits the process of migration and proliferation of ischemic CMECs probably via affecting RPS6KB1/hif-1a signal pathway, which in turn suppresses the angiogenesis. It is highly possible that mir-223-3p becomes a novel intervention core target in the treatment of angiogenesis of ischemic heart diseases.	[Dai, Guo-Hua; Zhang, Tong; Wu, Bo] Shandong Univ Tradit Chinese Med, Affiliated Hosp, Jinan, Peoples R China; [Ma, Pei-Ze; Song, Xian-Bo; Liu, Ning] Shandong Univ Tradit Chinese Med, Jinan, Peoples R China	Shandong University of Traditional Chinese Medicine; Shandong University of Traditional Chinese Medicine	Dai, GH (corresponding author), Shandong Univ Tradit Chinese Med, Affiliated Hosp, Jinan, Peoples R China.	Daigh2004@163.com			Chinese National Natural Science Foundation [81173441]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was funded by Chinese National Natural Science Foundation # 81173441. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardos JI, 2004, MOL CELL BIOL, V24, P2905, DOI 10.1128/MCB.24.7.2905-2914.2004; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; CHOI DW, 1987, J NEUROSCI, V7, P357; Cory G, 2011, METHODS MOL BIOL, V769, P25, DOI 10.1007/978-1-61779-207-6_2; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Drexler H, 1985, CIRCULATION, V71, P1260; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Han YC, 2010, J EXP MED, V207, P475, DOI 10.1084/jem.20090831; Hwang YJ, 2013, KOREAN J PHYSIOL PHA, V17, P237, DOI 10.4196/kjpp.2013.17.3.237; KASS RW, 1992, AM HEART J, V123, P486, DOI 10.1016/0002-8703(92)90665-I; Kim JH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.117; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim JC, 2012, KOREAN J PHYSIOL PHA, V16, P313, DOI 10.4196/kjpp.2012.16.5.313; Manthey JA, 2002, J AGR FOOD CHEM, V50, P5837, DOI 10.1021/jf020121d; Mujahid S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055911; Park SY, 2011, N-S ARCH PHARMACOL, V383, P191, DOI 10.1007/s00210-010-0594-6; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; PU LQ, 1993, CIRCULATION, V88, P208, DOI 10.1161/01.CIR.88.1.208; Qin WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009429; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; Sellke FW, 1999, DRUGS, V58, P391, DOI 10.2165/00003495-199958030-00001; Shi L, 2013, CIRC RES, V113, P1320, DOI 10.1161/CIRCRESAHA.113.301824; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Yuan ZK, 2009, PROGR MODERN BIOMEDI, V9, P1405; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108	33	44	49	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e108468	10.1371/journal.pone.0108468	http://dx.doi.org/10.1371/journal.pone.0108468			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313822	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662500013
J	Dixit, S; Huang, BE; Cruz, MTS; Maturan, PT; Ontoy, JCE; Kumar, A				Dixit, Shalabh; Huang, B. Emma; Cruz, Ma. Teresa Sta; Maturan, Paul T.; Ontoy, Jhon Christian E.; Kumar, Arvind			QTLs for Tolerance of Drought and Breeding for Tolerance of Abiotic and Biotic Stress: An Integrated Approach	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GRAIN-YIELD; DIRECT SELECTION; LOWLAND DROUGHT; MAJOR QTL; IDENTIFICATION; METAANALYSIS; COMPONENTS; GENOTYPES; REVEALS	Background: The coupling of biotic and abiotic stresses leads to high yield losses in rainfed rice (Oryza sativa L.) growing areas. While several studies target these stresses independently, breeding strategies to combat multiple stresses seldom exist. This study reports an integrated strategy that combines QTL mapping and phenotypic selection to develop rice lines with high grain yield (GY) under drought stress and non-stress conditions, and tolerance of rice blast. Methodology: A blast-tolerant BC2F3-derived population was developed from the cross of tropical japonica cultivar Moroberekan (blast-and drought-tolerant) and high-yielding indica variety Swarna (blast-and drought-susceptible) through phenotypic selection for blast tolerance at the BC2F2 generation. The population was studied for segregation distortion patterns and QTLs for GY under drought were identified along with study of epistatic interactions for the trait. Results: Segregation distortion, in favour of Moroberekan, was observed at 50 of the 59 loci. Majority of these marker loci co-localized with known QTLs for blast tolerance or NBS-LRR disease resistance genes. Despite the presence of segregation distortion, high variation for DTF, PH and GY was observed and several QTLs were identified under drought stress and non-stress conditions for the three traits. Epistatic interactions were also detected for GY which explained a large proportion of phenotypic variance observed in the population. Conclusions: This strategy allowed us to identify QTLs for GY along with rapid development of high-yielding purelines tolerant to blast and drought with considerably reduced efforts. Apart from this, it also allowed us to study the effects of the selection cycle for blast tolerance. The developed lines were screened at IRRI and in the target environment, and drought and blast tolerant lines with high yield were identified. With tolerance to two major stresses and high yield potential, these lines may provide yield stability in rainfed rice areas.	[Dixit, Shalabh; Cruz, Ma. Teresa Sta; Maturan, Paul T.; Ontoy, Jhon Christian E.; Kumar, Arvind] Int Rice Res Inst, Los Banos, Philippines; [Huang, B. Emma] CSIRO, Dutton Park, Qld, Australia	CGIAR; International Rice Research Institute (IRRI); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Kumar, A (corresponding author), Int Rice Res Inst, Los Banos, Philippines.	a.kumar@irri.org	Kumar, Arvind/N-3181-2017; Huang, Bevan/A-5949-2009	Kumar, Arvind/0000-0002-5488-9410; Huang, Bevan/0000-0002-1981-5838	Global Rice Science Partnership (GRiSP); Generation Challenge Program (GCP); Federal ministry for economic cooperation and development (BMZ) Germany; Bill and Melinda Gates Foundation (BMGF)	Global Rice Science Partnership (GRiSP); Generation Challenge Program (GCP); Federal ministry for economic cooperation and development (BMZ) Germany; Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation)	The work was funded by Global Rice Science Partnership (GRiSP), Generation Challenge Program (GCP), Federal ministry for economic cooperation and development (BMZ), Germany, and the Bill and Melinda Gates Foundation (BMGF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, 1203 ESA; Ballini E, 2008, MOL PLANT MICROBE IN, V21, P859, DOI 10.1094/MPMI-21-7-0859; Bernier J, 2007, CROP SCI, V47, P507, DOI 10.2135/cropsci2006.07.0495; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Cooper M., 1996, P193; Ding XP, 2011, THEOR APPL GENET, V123, P815, DOI 10.1007/s00122-011-1629-1; Dixit S, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-16; Dixit S, 2012, MOL BREEDING, V30, P1767, DOI 10.1007/s11032-012-9760-5; Fujino K, 2004, THEOR APPL GENET, V108, P794, DOI 10.1007/s00122-003-1509-4; Ghimire KH, 2012, FIELD CROP RES, V131, P88, DOI 10.1016/j.fcr.2012.02.028; Huke R.E., 1997, RICE AREA TYPE CULTU; Ishimaru K, 2001, THEOR APPL GENET, V102, P793, DOI 10.1007/s001220000467; Kumar A, 2012, FIELD CROP RES, V133, P37, DOI 10.1016/j.fcr.2012.03.007; Kumar A, 2008, FIELD CROP RES, V107, P221, DOI 10.1016/j.fcr.2008.02.007; Li ZK, 1997, GENETICS, V145, P453; Swamy BPM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-319; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Mishra KK, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-12; Neeraja CN, 2007, THEOR APPL GENET, V115, P767, DOI 10.1007/s00122-007-0607-0; Ouk M, 2006, FIELD CROP RES, V99, P48, DOI 10.1016/j.fcr.2006.03.003; SAS Institute Inc, 2004, SAS ONL DOC 9 1 3; Serraj R., 2008, DROUGHT FRONTIERS RI; Thomson MJ, 2003, THEOR APPL GENET, V107, P479, DOI 10.1007/s00122-003-1270-8; van Berloo R, 2008, J HERED, V99, P232, DOI 10.1093/jhered/esm109; Venuprasad R, 2008, FIELD CROP RES, V107, P232, DOI 10.1016/j.fcr.2008.02.004; Venuprasad R, 2007, CROP SCI, V47, P285, DOI 10.2135/cropsci2006.03.0181; Venuprasad R, 2009, THEOR APPL GENET, V120, P177, DOI 10.1007/s00122-009-1168-1; Verulkar SB, 2010, FIELD CROP RES, V117, P197, DOI 10.1016/j.fcr.2010.03.005; Vikram P, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-89; Xing YZ, 2002, THEOR APPL GENET, V105, P248, DOI 10.1007/s00122-002-0952-y; Yadaw RB, 2013, FIELD CROP RES, V144, P281, DOI 10.1016/j.fcr.2013.01.019; Yamagishi J, 2004, THEOR APPL GENET, V109, P1555, DOI 10.1007/s00122-004-1795-5; You AQ, 2006, GENETICS, V172, P1287, DOI 10.1534/genetics.105.047209; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780	35	32	32	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109574	10.1371/journal.pone.0109574	http://dx.doi.org/10.1371/journal.pone.0109574			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314587	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500054
J	Schneider, J; Hapfelmeier, A; Fremd, J; Schenk, P; Obermeier, A; Burgkart, R; Forkl, S; Feihl, S; Wantia, N; Neu, B; Bajbouj, M; von Delius, S; Schmid, RM; Algul, H; Weber, A				Schneider, Jochen; Hapfelmeier, Alexander; Fremd, Julia; Schenk, Philipp; Obermeier, Andreas; Burgkart, Rainer; Forkl, Stefanie; Feihl, Susanne; Wantia, Nina; Neu, Bruno; Bajbouj, Monther; von Delius, Stefan; Schmid, Roland M.; Alguel, Hana; Weber, Andreas			Biliary Endoprosthesis: A Prospective Analysis of Bacterial Colonization and Risk Factors for Sludge Formation	PLOS ONE			English	Article							PRIMARY SCLEROSING CHOLANGITIS; PROSPECTIVE RANDOMIZED-TRIAL; BILE-DUCT STRICTURES; POLYETHYLENE STENTS; CARBON COATINGS; INFECTION; OBSTRUCTION; SONICATION; DIAGNOSIS; BIOFILMS	Bacterial colonization of biliary stents is one of the driving forces behind sludge formation which may result in stent occlusion. Major focus of the study was to analyze the spectrum and number of microorganisms in relation to the indwelling time of stents and the risk factors for sludge formation. 343 stents were sonicated to optimize the bacterial release from the biofilm and identified by matrix-associated laser desorption/ionization-time of flight mass spectrometer (MALDI-TOF). 2283 bacteria were analyzed in total. The most prevalent microorganisms were Enterococcus species (spp.) (504;22%), followed by Klebsiella spp. (218;10%) and Candida spp. (188;8%). Colonization of the stents mainly began with aerobic gram-positive bacteria (43/49;88%) and Candida spp. (25/49;51%), whereas stents with an indwelling time. 60 days(d) showed an almost equal colonization rate by aerobic gram-negative (176/184;96%) and aerobic gram-positive bacteria (183/184;99%) and a high proportion of anaerobes (127/184;69%). Compared to stents without sludge, more Clostridium spp. [(P = 0.02; Odds Ratio (OR): 2.4;95% confidence interval (95% CI): (1.1-4.9)]) and Staphylococcus spp. [(P=0.03; OR (95% CI): 4.3 (1.1-16.5)] were cultured from stents with sludge. Multivariate analysis revealed a significant relationship between the number of microorganisms [P<0.01; OR (95% CI): 1.3(1.1-1.5)], the indwelling time [P<0.01; 1-15 d vs. 20-59 d: OR (95% CI): 5.6(1.4-22), 1-15 d vs. 60-3087 d: OR (95% CI): 9.5(2.5-35.7)], the presence of sideholes [P<0.01; OR (95% CI): 3.5(1.6-7.9)] and the occurrence of sludge. Stent occlusion was found in 70/343(20%) stents. In 35% of cases, stent occlusion resulted in a cholangitis or cholestasis. In conclusion, microbial colonization of the stents changed with the indwelling time. Sludge was associated with an altered spectrum and an increasing number of microorganisms, a long indwelling time and the presence of sideholes. Interestingly, stent occlusion did not necessarily lead to a symptomatic biliary obstruction.	[Schneider, Jochen; Fremd, Julia; Schenk, Philipp; Neu, Bruno; Bajbouj, Monther; von Delius, Stefan; Schmid, Roland M.; Alguel, Hana; Weber, Andreas] Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 2, D-80290 Munich, Germany; [Schneider, Jochen; Forkl, Stefanie; Feihl, Susanne; Wantia, Nina] Tech Univ Munich, Inst Med Mikrobiol & Hyg, D-80290 Munich, Germany; [Hapfelmeier, Alexander] Tech Univ Munich, Inst Med Stat & Epidemiol, D-80290 Munich, Germany; [Obermeier, Andreas; Burgkart, Rainer] Tech Univ Munich, Klin Orthopadie & Sportorthopadie, D-80290 Munich, Germany	Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Technical University of Munich; Technical University of Munich; Technical University of Munich	Weber, A (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 2, D-80290 Munich, Germany.	andreas.weber@lrz.tum.de	Obermeier, Andreas/B-3020-2016; Hapfelmeier, Alexander/I-9966-2019	Obermeier, Andreas/0000-0002-1774-5194; Hapfelmeier, Alexander/0000-0001-6765-6352; Schneider, Jochen/0000-0002-0300-0159; Algul, Hana/0000-0002-5067-7031				Agostinho A, 2009, CTS-CLIN TRANSL SCI, V2, P193, DOI 10.1111/j.1752-8062.2009.00123.x; Aljiffry M, 2011, HPB, V13, P79, DOI 10.1111/j.1477-2574.2010.00268.x; Baron Todd H Sr, 2013, Gastrointest Endosc Clin N Am, V23, P295, DOI 10.1016/j.giec.2013.01.001; Boulay BR, 2010, J CLIN GASTROENTEROL, V44, P452, DOI 10.1097/MCG.0b013e3181d2ef06; BROOK I, 1989, J CLIN MICROBIOL, V27, P2373, DOI 10.1128/JCM.27.10.2373-2375.1989; Castellino M, 2013, ANAL BIOANAL CHEM, V405, P321, DOI 10.1007/s00216-012-6449-x; COENE PPLO, 1990, GUT, V31, P913, DOI 10.1136/gut.31.8.913; DAVIDS PHP, 1992, LANCET, V340, P1488, DOI 10.1016/0140-6736(92)92752-2; deWit AWMV, 1996, GASTROINTEST ENDOSC, V44, P293, DOI 10.1016/S0016-5107(96)70167-0; Di Rosa Roberta, 1999, Microbial Ecology in Health and Disease, V11, P84, DOI 10.1080/089106099435817; Donelli G, 2007, CLIN MED RES, V5, P53, DOI 10.3121/cmr.2007.683; DOWIDAR N, 1992, SCAND J GASTROENTERO, V27, P77, DOI 10.3109/00365529209011171; ENGLAND DM, 1977, J CLIN MICROBIOL, V6, P494; FINEGOLD SM, 1979, ARCH INTERN MED, V139, P1338, DOI 10.1001/archinte.139.12.1338; Fu H Q, 1989, Zhonghua Wai Ke Za Zhi, V27, P454; GROEN AK, 1987, ENDOSCOPY, V19, P57, DOI 10.1055/s-2007-1018235; Guaglianone Emilio, 2008, Microbial Ecology in Health and Disease, V20, P207, DOI 10.1080/08910600802408145; Lappalainen R, 1998, CLIN ORTHOP RELAT R, P118; Laube N, 2007, J UROLOGY, V177, P1923, DOI 10.1016/j.juro.2007.01.016; Lawrence C, 2010, GASTROINTEST ENDOSC, V72, P558, DOI 10.1016/j.gie.2010.05.029; Meyenberger Ch, 2003, Ther Umsch, V60, P225, DOI 10.1024/0040-5930.60.4.225; Naber KG, 2008, EUR UROL, V54, P1164, DOI 10.1016/j.eururo.2008.05.010; Obermeier A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101426; Park JW, 2014, CLIN RES HEPATOL GAS, V38, P300, DOI 10.1016/j.clinre.2014.02.005; Piper KE, 2009, J CLIN MICROBIOL, V47, P1878, DOI 10.1128/JCM.01686-08; Rerknimitr R, 2002, GASTROINTEST ENDOSC, V56, P885, DOI 10.1067/mge.2002.129604; REY JF, 1985, ENDOSCOPY, V17, P145, DOI 10.1055/s-2007-1018485; Rieger UM, 2009, AESTHET PLAST SURG, V33, P404, DOI 10.1007/s00266-009-9333-0; Roy RK, 2007, J BIOMED MATER RES B, V83B, P72, DOI 10.1002/jbm.b.30768; SHAH HN, 1990, INT J SYST BACTERIOL, V40, P205, DOI 10.1099/00207713-40-2-205; Sheen-Chen SR, 2000, AM J INFECT CONTROL, V28, P298, DOI 10.1067/mic.2000.107071; Speer HF, 1986, GASTROINTEST ENDOSC, V32, P156; SUNG JJY, 1994, GASTROINTEST ENDOSC, V40, P321, DOI 10.1016/S0016-5107(94)70064-8; Tabata M, 1984, PROGR CLIN BIOL RES, V152, P163; Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588; van Berkel AM, 2005, ENDOSCOPY, V37, P729, DOI 10.1055/s-2005-870131; van Berkel AM, 1998, ENDOSCOPY, V30, P681, DOI 10.1055/s-2007-1001388; van Bunderen CC, 2010, NETH J MED, V68, P343; Weber A, 2013, J INFECTION, V67, P111, DOI 10.1016/j.jinf.2013.04.008; Zhang HJ, 2003, J LAB CLIN MED, V142, P58, DOI 10.1016/S0022-2143(03)00087-8	40	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110112	10.1371/journal.pone.0110112	http://dx.doi.org/10.1371/journal.pone.0110112			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314593	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662500098
J	Hallmark, CJ; Skillicorn, J; Giordano, TP; Davila, JA; McNeese, M; Rocha, N; Smith, A; Cooper, S; Castel, AD				Hallmark, Camden J.; Skillicorn, Jennifer; Giordano, Thomas P.; Davila, Jessica A.; McNeese, Marlene; Rocha, Nestor; Smith, Avemaria; Cooper, Stacey; Castel, Amanda D.			HIV Testing Implementation in Two Urban Cities: Practice, Policy, and Perceived Barriers	PLOS ONE			English	Article							HEALTH CENTER PERSONNEL; LOW-INCOME COUNTRIES; FOR-DISEASE-CONTROL; EMERGENCY-DEPARTMENT; OPERATIONAL-RESEARCH; UNITED-STATES; SAN-FRANCISCO; PRIMARY-CARE; HIGH-RISK; ROUTINE	Background: Although funding has supported the scale up of routine, opt-out HIV testing in the US, variance in implementation mechanisms and barriers in high-burden jurisdictions remains unknown. Methods: We conducted a survey of health care organizations in Washington, DC and Houston/Harris County to determine number of HIV tests completed in 2011, policy and practices associated with HIV testing, funding mechanisms, and reported barriers to testing in each jurisdiction and to compare results between jurisdictions. Results: In 2012, 43 Houston and 35 DC HIV-testing organizations participated in the survey. Participants represented 85% of Department of Health-supported testers in DC and 90% of Department of Health-supported testers in Houston. The median number of tests per organization was 568 in DC and 1045 in Houston. Approximately 50% of organizations in both DC and Houston exclusively used opt-in consent and most conducted both pre- and post-test counseling with HIV testing (80% of organizations in DC, 70% in Houston). While the most frequent source of funding in DC was the Department of Health, Houston organizations primarily billed the patient or third-party payers. Barriers to testing most often reported were lack of funding, followed by patient discomfort/refusal with more barriers reported in DC. Conclusions: Given unique policies, resources and programmatic contexts, DC and Houston have taken different approaches to support routine testing. Many organizations in both cities reported opt-in consent approaches and pre-test counseling, suggesting 2006 national HIV testing recommendations are not being followed consistently. Addressing the barriers to testing identified in each jurisdiction may improve expansion of testing.	[Hallmark, Camden J.; McNeese, Marlene] Houston Dept Hlth & Human Serv, Houston, TX 77024 USA; [Skillicorn, Jennifer; Castel, Amanda D.] George Washington Univ, Dept Epidemiol & Biostat, Sch Publ Hlth & Hlth Serv, Washington, DC USA; [Giordano, Thomas P.; Davila, Jessica A.] Michael E DeBakey VA Med Ctr, Ctr Innovat Qual Effectiveness & Safety, Houston, TX USA; [Giordano, Thomas P.; Davila, Jessica A.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Rocha, Nestor; Smith, Avemaria; Cooper, Stacey] Dist Columbia Dept Hlth, HIV AIDS Hepatitis STD & TB Adm, Washington, DC USA	George Washington University; Baylor College of Medicine; Baylor College of Medicine	Hallmark, CJ (corresponding author), Houston Dept Hlth & Human Serv, Houston, TX 77024 USA.	camden.hallmark@houstontx.gov		Giordano, Thomas/0000-0002-9346-5530	National Institutes of Health [P30AI036211]; District of Columbia Developmental Center for AIDS Research [P30AI087714]; Centers for Disease Control and Prevention [5U62PS000775-03]; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [U62PS000775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211, P30AI087714] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); District of Columbia Developmental Center for AIDS Research; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a supplement to the National Institutes of Health-funded Baylor College of Medicine-University of Texas Houston Center for AIDS Research (Grant Number P30AI036211, www.nih.gov, TPG, JAD), the District of Columbia Developmental Center for AIDS Research (Grant Number P30AI087714, www.nih.gov, JS, ADC), the Centers for Disease Control and Prevention (Grant Number 5U62PS000775-03, www.cdc.gov, CJH, MM), and the facilities and resources of the Department of Veterans Affairs (www.va.gov, TPG, JAD). The opinions expressed are those of the authors and not the National Institutes of Health, the Department of Veterans Affairs or the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GUID DC MED PROV ROU; [Anonymous], NATL SURVEY HLTH CTR; Arya Monisha, 2013, Mil Med, V178, pe483, DOI 10.7205/MILMED-D-12-00222; Awad GH, 2004, AIDS EDUC PREV, V16, P115, DOI 10.1521/aeap.16.2.115.29397; Branson BM, 2006, MMWR RECOMM REP MORB; Brown J, 2008, PUBLIC HEALTH REP, V123, P21, DOI 10.1177/00333549081230S304; Castel AD, 2012, PUBLIC HEALTH REP, V127, P422, DOI 10.1177/003335491212700410; Centers for Disease Control and Prevention, ENH COMPR HIV PREV P; Chadborn TR, 2006, AIDS, V20, P2371, DOI 10.1097/QAD.0b013e32801138f7; Chen JC, 2011, AM J EMERG MED, V29, P418, DOI 10.1016/j.ajem.2009.11.016; District of Columbia Department of Health HIV/AIDS Hepatitis STD and TB Administration (HAHSTA), HAHSTA ANN REP 2011; District of Columbia Department of Health HIV/AIDS Hepatitis STD and TB Administration (HAHSTA), 2011, ENH COMPR HIV AIDS P; Egan DJ, 2014, AIDS PATIENT CARE ST, V28, P91, DOI 10.1089/apc.2013.0124; Giordano TP, 2013, JAIDS-J ACQ IMM DEF, V64, pS7, DOI 10.1097/QAI.0b013e3182a90183; Herbst JH, 2012, JAIDS-J ACQ IMM DEF, V59, P530, DOI 10.1097/QAI.0b013e3182479077; HIV Prevention Trials Network [HPTN] 065, 2010, TLC PLUS STUD EV FEA; Houston Area Ryan White Planning Council and Houston Area HIV Prevention Community Planning Group, 2013, HIV AIDS HOUST AR 20; Hoxhaj S, 2011, ANN EMERG MED, V58, pS79, DOI 10.1016/j.annemergmed.2011.03.030; Johnson AS., 2019, ARXIV PREPRINT ARXIV; Johnson CV, 2011, AIDS PATIENT CARE ST, V25, P647, DOI 10.1089/apc.2011.0180; Korthuis PT, 2011, AIDS EDUC PREV, V23, P70, DOI 10.1521/aeap.2011.23.3_supp.70; Mahajan AP, 2009, ANN INTERN MED, V150, P263, DOI 10.7326/0003-4819-150-4-200902170-00007; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Merchant RC, 2012, PUBLIC HEALTH REP, V127, P318, DOI 10.1177/003335491212700312; Mimiaga MJ, 2011, PUBLIC HEALTH REP, V126, P643, DOI 10.1177/003335491112600506; Mohajer MA, 2012, J INT ASS PHYS AIDS, V11, P101, DOI [DOI 10.1177/1545109711430165, 10.1177/1545109711430165]; Mumma BE, 2011, ANN EMERG MED, V58, pS44, DOI 10.1016/j.annemergmed.2011.03.022; Myers JJ, 2011, AIDS EDUC PREV, V23, P84, DOI 10.1521/aeap.2011.23.3_supp.84; Myers JE, 2012, JAIDS-J ACQ IMM DEF, V61, P23, DOI 10.1097/QAI.0b013e3182632960; Nayak SU, 2012, JAIDS-J ACQ IMM DEF, V60, P165, DOI 10.1097/QAI.0b013e318251aefe; Nunn A, 2014, AM J PUBLIC HEALTH, V104, P775, DOI 10.2105/AJPH.2013.301864; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Schnall R, 2013, ACAD EMERG MED, V20, P279, DOI 10.1111/acem.12084; U.S. Department of Health and Human Services, NHAS HHS 12 PDF 12 C; Ubhayakar ND, 2011, AM J EMERG MED, V29, P367, DOI 10.1016/j.ajem.2009.10.005; US Census Bureau, AM FACTFINDER; Viall Abigail H., 2011, Morbidity and Mortality Weekly Report, V60, P805; Wing C, 2009, AM J PUBLIC HEALTH, V99, P1087, DOI 10.2105/AJPH.2008.141069; Zachariah R, 2012, LANCET INFECT DIS, V12, P415, DOI 10.1016/S1473-3099(11)70309-7; Zachariah R, 2009, LANCET INFECT DIS, V9, P711, DOI 10.1016/S1473-3099(09)70229-4; Zetola NM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002591	41	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110010	10.1371/journal.pone.0110010	http://dx.doi.org/10.1371/journal.pone.0110010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ9WZ	25310462	Green Published, gold			2022-12-27	WOS:000343210300085
J	Leng, PF; Zhang, ZM; Li, Q; Zhao, MJ; Pan, GT				Leng, Pengfei; Zhang, Zhiming; Li, Qian; Zhao, Maojun; Pan, Guangtang			Microemulsion Formulation of Carbendazim and Its In Vitro Antifungal Activities Evaluation	PLOS ONE			English	Article							RHIZOCTONIA-SOLANI AG1-IA; FOOD-GRADE MICROEMULSIONS; TRICHODERMA-HARZIANUM; SCLEROTIUM-ROLFSII; BLOCK-COPOLYMERS; DEGRADATION; BIOCONTROL; SYSTEMS; OIL; SOLUBILIZATION	The fungus Rhizoctonia solani Kuhn is a widespread and destructive plant pathogen with a very broad host range. Although various pathogens, including R. solani, have been traditionally controlled using chemical pesticides, their use faces drawbacks such as environmental pollution, development of pesticide resistance, and other negative effects. Carbendazim is a well-known antifungal agent capable of controlling a broad range of plant diseases, but its use is hampered by its poor aqueous solubility. In this study, we describe an environmentally friendly pharmaceutical microemulsion system using carbendazim as the active ingredient, chloroform and acetic acid as solvents, and the surfactants HSH and 0204 as emulsifiers. This system increased the solubility of carbendazim to 30 g/L. The optimal microemulsion formulation was determined based on a pseudo-ternary phase diagram; its physicochemical characteristics were also tested. The cloud point was greater than 90 degrees C and it was resistant to freezing down to -18 degrees C, both of which are improvements over the temperature range in which pure carbendazim can be used. This microemulsion meets the standard for pesticide microemulsions and demonstrated better activity against R. solani AG1-IA, relative to an aqueous solution of pure carbendazim (0.2 g/L). The mechanism of activity was reflected in the inhibition of against R. solani AG1-IA including mycelium growth, and sclerotia formation and germination were significantly better than that of 0.2 g/L carbendazim water solution according to the results of t-test done by SPSS 19.	[Leng, Pengfei; Zhang, Zhiming; Pan, Guangtang] Sichuan Agr Univ, Maize Res Inst, Yaan, Sichuan, Peoples R China; [Li, Qian] Chongqing Coll Humanities Sci & Technol, Sch Foreign Languages, Chongqing, Peoples R China; [Zhao, Maojun] Sichuan Agr Univ, Coll Life & Basic Sci, Yaan, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Zhao, MJ (corresponding author), Sichuan Agr Univ, Coll Life & Basic Sci, Yaan, Sichuan, Peoples R China.	wlisa0920@163.com; pfleng@163.com			Application Foundation of Science and Technology Bureau of Sichuan Province [2006J13-039]; Priority Projects of Sichuan Education Office [07ZA063]	Application Foundation of Science and Technology Bureau of Sichuan Province; Priority Projects of Sichuan Education Office	This work was funded by the Application Foundation of Science and Technology Bureau of Sichuan Province (Grant No. 2006J13-039) and Priority Projects of Sichuan Education Office (Grant No. 07ZA063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOOFAZELI R, 1995, INT J PHARM, V125, P107, DOI 10.1016/0378-5173(95)00125-3; ANDERSON NA, 1982, ANNU REV PHYTOPATHOL, V20, P329, DOI 10.1146/annurev.py.20.090182.001553; BOYD J, 1972, J COLLOID INTERF SCI, V41, P359, DOI 10.1016/0021-9797(72)90122-1; Changez M, 2000, DRUG DEV IND PHARM, V26, P507, DOI 10.1081/DDC-100101261; Chin CP, 2012, IND ENG CHEM RES, V51, P4710, DOI 10.1021/ie201151p; Cooke LR, 2006, PLANT PATHOL, V55, P320, DOI 10.1111/j.1365-3059.2006.01335.x; ELAD Y, 1980, PHYTOPATHOLOGY, V70, P119, DOI 10.1094/Phyto-70-119; Ellegaard MD, 2010, IND ENG CHEM RES, V49, P11620, DOI 10.1021/ie101059y; Galloway J, 2008, CROP PROT, V27, P566, DOI 10.1016/j.cropro.2007.08.014; Garti N, 2001, J AGR FOOD CHEM, V49, P2552, DOI 10.1021/jf001390b; Gea FJ, 2010, CROP PROT, V29, P1021, DOI 10.1016/j.cropro.2010.06.006; Gonzalez-Vera AD, 2010, PHYTOPATHOLOGY, V100, P172, DOI 10.1094/PHYTO-100-2-0172; Gradzielski M, 1998, LANGMUIR, V14, P6037, DOI 10.1021/la980074c; HELWEG A, 1977, PESTIC SCI, V8, P71, DOI 10.1002/ps.2780080111; KABALNOV A, 1995, J PHYS CHEM-US, V99, P6220, DOI 10.1021/j100016a068; Leng PF, 2013, CURR PHARM ANAL, V9, P396, DOI 10.2174/15734129113099990001; Leng PF, 2012, PHARMAZIE, V67, P534, DOI 10.1691/ph.2012.1144; Lin X, 2011, ADV BIOM ENG, P384; MARQUES C, 1988, MACROMOLECULES, V21, P1051, DOI 10.1021/ma00182a035; Mazellier P, 2003, ENVIRON CHEM LETT, V1, P68, DOI 10.1007/s10311-002-0010-7; Meyer MC, 2006, CROP PROT, V25, P848, DOI 10.1016/j.cropro.2005.11.008; Mohan M, 2011, RES J PHARM BIO CHEM, V2, P102; Ni N, 2002, INT J PHARM, V244, P99, DOI 10.1016/S0378-5173(02)00318-6; NOOLANDI J, 1982, MACROMOLECULES, V15, P482, DOI 10.1021/ma00230a054; OGOSHI A, 1987, ANNU REV PHYTOPATHOL, V25, P125, DOI 10.1146/annurev.py.25.090187.001013; PAPAVIZAS GC, 1985, ANNU REV PHYTOPATHOL, V23, P23, DOI 10.1146/annurev.py.23.090185.000323; Pascual Cecilia B., 2000, Journal of General Plant Pathology, V66, P206, DOI 10.1007/PL00012946; SHAH DO, 1971, J COLLOID INTERF SCI, V37, P744, DOI 10.1016/0021-9797(71)90353-5; Sinclair JB, 1982, COMPENDIUM SOYBEAN D; Sneh B., 1996, RHIZOCTONIA SPECIES; Song F, 2005, CHINESE J PESTIC SCI, V44, P460; Tenjarla S, 1999, CRIT REV THER DRUG, V16, P461; VELEV OD, 1994, COLLOID SURFACE A, V83, P43, DOI 10.1016/0927-7757(93)02639-V; Wang Han-cheng, 2007, Nongyaoxue Xuebao, V9, P357; Weller D. M., 1986, IRON SIDEROPHORES PL, V117, P99, DOI DOI 10.1007/978-1-4615-9480-2_12; WELLS HD, 1972, PHYTOPATHOLOGY, V62, P442, DOI 10.1094/Phyto-62-442; Yalkowsky SH., 1999, SOLUBILITY SOLUBILIZ; Zhang H, 2008, EUR FOOD RES TECHNOL, V226, P613, DOI 10.1007/s00217-007-0606-z; Zhang LZ, 2007, PESTIC BIOCHEM PHYS, V89, P54, DOI 10.1016/j.pestbp.2007.02.007; Zhang S, 1999, PLANT PROT, V3, P35; Zhong F, 2009, FOOD CHEM, V115, P539, DOI 10.1016/j.foodchem.2008.12.048; Zhu F, 1999, CHEM IND STAND QUAL, V8, P29	42	9	9	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109580	10.1371/journal.pone.0109580	http://dx.doi.org/10.1371/journal.pone.0109580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310219	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210300059
J	Moller, SE; Ajslev, TA; Andersen, CS; Dalgard, C; Sorensen, TIA				Moller, Susanne Eifer; Ajslev, Teresa Adeltoft; Andersen, Camilla Schou; Dalgard, Christine; Sorensen, Thorkild I. A.			Risk of Childhood Overweight after Exposure to Tobacco Smoking in Prenatal and Early Postnatal Life	PLOS ONE			English	Article							SELF-REPORTED SMOKING; NATIONAL BIRTH COHORT; BODY-MASS INDEX; MATERNAL SMOKING; FOLLOW-UP; PARENTAL SMOKING; OBESITY; PREGNANCY; GROWTH; ASSOCIATION	Objective: To investigate the association between exposure to mothers smoking during prenatal and early postnatal life and risk of overweight at age 7 years, while taking birth weight into account. Methods: From the Danish National Birth Cohort a total of 32,747 families were identified with available information on maternal smoking status in child's pre-and postnatal life and child's birth weight, and weight and height at age 7 years. Outcome was overweight according to the International Obesity Task Force gender and age specific body mass index. Smoking exposure was categorized into four groups: no exposure (n = 25,076); exposure only during pregnancy (n = 3,343); exposure only postnatally (n = 140); and exposure during pregnancy and postnatally (n = 4,188). Risk of overweight according to smoking status as well as dose-response relationships were estimated by crude and adjusted odds ratios using logistic regression models. Results: Exposure to smoking only during pregnancy, or both during pregnancy and postnatally were both significantly associated with overweight at 7 years of age (OR: 1.31, 95% CI: 1.15-1.48, and OR: 1.76, 95% CI: 1.58-1.97, respectively). Analyses excluding children with low birth weight (<2,500 gram) revealed similar results. A significant prenatal dose-response relationship was found. Per one additional cigarette smoked per day an increase in risk of overweight was observed (OR: 1.02, 95% CI: 1.01-1.03). When adjusting for quantity of smoking during pregnancy, prolonged exposure after birth further increased the risk of later overweight in the children (OR 1.28, 95% CI: 1.09-1.50) compared with exposure only in the prenatal period. Conclusions: Mother's perinatal smoking increased child's OR of overweight at age 7 years irrespective of birth weight, and with higher OR if exposed both during pregnancy and in early postnatal life. Clear dose-response relationships were observed, which emphasizes the need for prevention of any tobacco exposure of infants.	[Moller, Susanne Eifer] Univ Southern Denmark, Inst Publ Hlth Epidemiol Biostat & Biodemog, Odense, Denmark; [Ajslev, Teresa Adeltoft; Andersen, Camilla Schou; Sorensen, Thorkild I. A.] Bispebjerg Hosp, Inst Prevent Med, The Capital Region, Denmark; [Ajslev, Teresa Adeltoft; Andersen, Camilla Schou; Sorensen, Thorkild I. A.] Frederiksberg Univ Hosp, The Capital Region, Denmark; [Dalgard, Christine] Univ Southern Denmark, Inst Publ Hlth, Odense, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark	University of Southern Denmark; University of Copenhagen; Bispebjerg Hospital; University of Southern Denmark; Novo Nordisk Foundation; University of Copenhagen	Ajslev, TA (corresponding author), Bispebjerg Hosp, Inst Prevent Med, The Capital Region, Denmark.	teresa.ajslev@regionh.dk		Dalgard, Christine/0000-0001-8184-3429	Danish National Research Foundation; Pharmacy Foundation; March of Dimes Birth Defects Foundation; Augustinus Foundation; Health Foundation; UNIK Food, Fitness and Pharma program - Danish Ministry of Science, Technology and Innovation [28a]	Danish National Research Foundation(Danmarks Grundforskningsfond); Pharmacy Foundation; March of Dimes Birth Defects Foundation(March of Dimes); Augustinus Foundation; Health Foundation; UNIK Food, Fitness and Pharma program - Danish Ministry of Science, Technology and Innovation	The DNBC has been funded by the Danish National Research Foundation, Pharmacy Foundation, the March of Dimes Birth Defects Foundation, the Augustinus Foundation, and the Health Foundation. TAA received grants from the UNIK Food, Fitness and Pharma program, grant 28a, supported by the Danish Ministry of Science, Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AMN, 2011, SCAND J PUBLIC HEALT, V39, P115, DOI 10.1177/1403494811407674; Andersen CS, 2012, VALIDATION ANTHROPOM; Andersen MR, 2009, CIRCULATION, V119, P857, DOI 10.1161/CIRCULATIONAHA.107.755769; Been JV, 2014, LANCET, V383, P1549, DOI 10.1016/S0140-6736(14)60082-9; Beyerlein A, 2011, EUR J EPIDEMIOL, V26, P413, DOI 10.1007/s10654-011-9560-y; Chen AM, 2006, INT J EPIDEMIOL, V35, P121, DOI 10.1093/ije/dyi218; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Desai M, 2013, CURR DIABETES REP, V13, P27, DOI 10.1007/s11892-012-0344-x; Due P, 2007, OBES REV, V8, P187, DOI 10.1111/j.1467-789X.2006.00291.x; England LJ, 2007, NICOTINE TOB RES, V9, P1005, DOI 10.1080/14622200701491255; Florath I, 2014, PEDIATR OBES, V9, P121, DOI 10.1111/j.2047-6310.2012.00146.x; Greene N, 2011, EPIDEMIOLOGY, V22, P815, DOI 10.1097/EDE.0b013e31822939fd; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; Harris HR, 2013, INT J OBESITY, V37, P1356, DOI 10.1038/ijo.2013.101; Horta BL, 1997, PAEDIATR PERINAT EP, V11, P140, DOI 10.1046/j.1365-3016.1997.d01-17.x; Ino T, 2012, INT J OBESITY, V36, P554, DOI 10.1038/ijo.2011.255; Ino T, 2010, PEDIATR INT, V52, P94, DOI 10.1111/j.1442-200X.2009.02883.x; Leary SD, 2006, OBESITY, V14, P2284, DOI 10.1038/oby.2006.268; Mamun AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041106; Mizutani T, 2007, OBESITY, V15, P3133, DOI 10.1038/oby.2007.373; Monasta L, 2010, OBES REV, V11, P695, DOI 10.1111/j.1467-789X.2010.00735.x; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Morgen CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069860; Nohr EA, 2006, EPIDEMIOLOGY, V17, P413, DOI 10.1097/01.ede.0000220549.14177.60; Oken E, 2008, INT J OBESITY, V32, P201, DOI 10.1038/sj.ijo.0803760; Oken E, 2005, OBES RES, V13, P2021, DOI 10.1038/oby.2005.248; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Ong KK, 2006, HORM RES, V65, P65, DOI 10.1159/000091508; Ong KK, 2002, BEST PRACT RES CL EN, V16, P191, DOI 10.1053/beem.2002.0195; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/00006450-200212000-00009; PATRICK DL, 1994, AM J PUBLIC HEALTH, V84, P1086, DOI 10.2105/AJPH.84.7.1086; Power C, 2002, INT J EPIDEMIOL, V31, P413, DOI 10.1093/ije/31.2.413; Raum E, 2011, OBESITY, V19, P2411, DOI 10.1038/oby.2011.129; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; Russell TV, 2004, NICOTINE TOB RES, V6, pS141, DOI 10.1080/14622200410001669141; Toschke AM, 2002, EUR J PEDIATR, V161, P445, DOI 10.1007/s00431-002-0983-z; von Kries R, 2002, AM J EPIDEMIOL, V156, P954, DOI 10.1093/aje/kwf128; von Kries R, 2008, INT J EPIDEMIOL, V37, P210, DOI 10.1093/ije/dym239; Wideroe M, 2003, PAEDIATR PERINAT EP, V17, P171, DOI 10.1046/j.1365-3016.2003.00481.x; Wong SL, 2012, HEALTH REP, V23, P47; World Health Organization, 2000, WHO TECHN REP SER, P894; Yang SM, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-104	44	38	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109184	10.1371/journal.pone.0109184	http://dx.doi.org/10.1371/journal.pone.0109184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ9WZ	25310824	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210300040
J	Pavelitz, T; Renfro, L; Foster, NR; Caracol, A; Welsch, P; Lao, VV; Grady, WB; Niedzwiecki, D; Saltz, LB; Bertagnolli, MM; Goldberg, RM; Rabinovitch, PS; Emond, M; Monnat, RJ; Maizels, N				Pavelitz, Thomas; Renfro, Lindsay; Foster, Nathan R.; Caracol, Amber; Welsch, Piri; Lao, Victoria Valinluck; Grady, William B.; Niedzwiecki, Donna; Saltz, Leonard B.; Bertagnolli, Monica M.; Goldberg, Richard M.; Rabinovitch, Peter S.; Emond, Mary; Monnat, Raymond J., Jr.; Maizels, Nancy			MRE11-Deficiency Associated with Improved Long-Term Disease Free Survival and Overall Survival in a Subset of Stage III Colon Cancer Patients in Randomized CALGB 89803 Trial	PLOS ONE			English	Article							DNA MISMATCH REPAIR; MICROSATELLITE INSTABILITY; COLORECTAL-CANCER; MRE11 EXPRESSION; IRINOTECAN; FLUOROURACIL; LEUCOVORIN; MUTATIONS; THERAPY; CELLS	Purpose: Colon cancers deficient in mismatch repair (MMR) may exhibit diminished expression of the DNA repair gene, MRE11, as a consequence of contraction of a T-11 mononucleotide tract. This study investigated MRE11 status and its association with prognosis, survival and drug response in patients with stage III colon cancer. Patients and Methods: Cancer and Leukemia Group B 89803 (Alliance) randomly assigned 1,264 patients with stage III colon cancer to postoperative weekly adjuvant bolus 5-fluorouracil/leucovorin (FU/LV) or irinotecan+FU/LV (IFL), with 8 year follow-up. Tumors from these patients were analyzed to determine stability of a T-11 tract in the MRE11 gene. The primary endpoint was overall survival (OS), and a secondary endpoint was disease-free survival (DFS). Non-proportional hazards were addressed using time-dependent covariates in Cox analyses. Results: Of 625 tumor cases examined, 70 (11.2%) exhibited contraction at the T-11 tract in one or both MRE11 alleles and were thus predicted to be deficient in MRE11 (dMRE11). In pooled treatment analyses, dMRE11 patients showed initially reduced DFS and OS but improved long-term DFS and OS compared with patients with an intact MRE11 T-11 tract. In the subgroup of dMRE11 patients treated with IFL, an unexplained early increase in mortality but better long-term DFS than IFL-treated pMRE11 patients was observed. Conclusions: Analysis of this relatively small number of patients and events showed that the dMRE11 marker predicts better prognosis independent of treatment in the long-term. In subgroup analyses, dMRE11 patients treated with irinotecan exhibited unexplained short-term mortality. MRE11 status is readily assayed and may therefore prove to be a useful prognostic marker, provided that the results reported here for a relatively small number of patients can be generalized in independent analyses of larger numbers of samples.	[Pavelitz, Thomas; Caracol, Amber; Maizels, Nancy] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Renfro, Lindsay; Foster, Nathan R.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Caracol, Amber; Maizels, Nancy] Univ Washington, Mol & Cellular Biol Grad Program, Seattle, WA 98195 USA; [Welsch, Piri; Monnat, Raymond J., Jr.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Lao, Victoria Valinluck; Grady, William B.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Lao, Victoria Valinluck] Univ Washington, Sch Med, Dept Surg, Seattle, WA 98195 USA; [Grady, William B.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Niedzwiecki, Donna] Duke Univ, Med Ctr, Canc & Leukemia Grp B, Ctr Stat, Durham, NC USA; [Saltz, Leonard B.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Bertagnolli, Monica M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Bertagnolli, Monica M.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Goldberg, Richard M.] Ohio State Univ, Columbus, OH 43210 USA; [Rabinovitch, Peter S.; Monnat, Raymond J., Jr.; Maizels, Nancy] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Emond, Mary] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Maizels, Nancy] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Pavelitz, Thomas; Renfro, Lindsay] Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Mayo Clinic; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Duke University; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; University System of Ohio; Ohio State University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Maizels, N (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	maizels@u.washington.edu	Goldberg, Richard/O-1871-2017	Goldberg, Richard/0000-0003-3713-6895; Saltz, Leonard/0000-0001-8353-4670; Niedzwiecki, Donna/0000-0002-3566-0450	National Institutes of Health National Cancer Institute [P01 CA077852]; NIH [F31 GM073318]; HHMI MedIntoGrad Scholar Awards; NATIONAL CANCER INSTITUTE [U24CA196171, U10CA180850, P01CA077852, U10CA180821, U10CA180882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM073318] Funding Source: NIH RePORTER	National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI MedIntoGrad Scholar Awards; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported here was supported by National Institutes of Health National Cancer Institute P01 CA077852 (WBG, PSR, RJM, NM); and NIH F31 GM073318 and HHMI MedIntoGrad Scholar Awards (AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman CA, 2009, CELL CYCLE, V8, P1510, DOI 10.4161/cc.8.10.8380; Attwooll CL, 2009, MOL CELL BIOL; Bertagnolli MM, 2011, J CLIN ONCOL, V29, P3153, DOI 10.1200/JCO.2010.33.0092; Bertagnolli MM, 2009, J CLIN ONCOL, V27, P1814, DOI 10.1200/JCO.2008.18.2071; Boland CR, 1998, CANCER RES, V58, P5248; Giannini G, 2004, ONCOGENE, V23, P2640, DOI 10.1038/sj.onc.1207409; Giannini G, 2002, EMBO REP, V3, P248, DOI 10.1093/embo-reports/kvf044; Gomez-Herreros F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003226; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hamilton NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015387; Hewish M, 2010, NAT REV CLIN ONCOL, V7, P197, DOI 10.1038/nrclinonc.2010.18; Kakar S, 2004, MODERN PATHOL, V17, P696, DOI 10.1038/modpathol.3800093; Kim NG, 2001, CANCER RES, V61, P36; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; Miquel C, 2007, ONCOGENE, V26, P5919, DOI 10.1038/sj.onc.1210419; Ottini L, 2004, CARCINOGENESIS, V25, P2337, DOI 10.1093/carcin/bgh257; Peltomaki P, 2001, HUM MOL GENET, V10, P735, DOI 10.1093/hmg/10.7.735; Peltomaki P, 2001, MUTAT RES-REV MUTAT, V488, P77, DOI 10.1016/S1383-5742(00)00058-2; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Rustgi AK, 2007, GENE DEV, V21, P2525, DOI 10.1101/gad.1593107; Sacho EJ, 2011, J BIOL CHEM, V286, P44945, DOI 10.1074/jbc.M111.299347; Saltz LB, 2007, J CLIN ONCOL, V25, P3456, DOI 10.1200/JCO.2007.11.2144; Sinicrope FA, 2011, JNCI-J NATL CANCER I, V103, P863, DOI 10.1093/jnci/djr153; Stracker Travis H., 2013, Frontiers in Genetics, V4, P37, DOI 10.3389/fgene.2013.00037; Truong LN, 2013, P NATL ACAD SCI USA, V110, P7720, DOI 10.1073/pnas.1213431110; Vilar E, 2008, BRIT J CANCER, V99, P1607, DOI 10.1038/sj.bjc.6604691; Wen Q, 2008, MOL BIOL CELL, V19, P1693, DOI 10.1091/mbc.E07-09-0975; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Zeng ZH, 2011, J BIOL CHEM, V286, P403, DOI 10.1074/jbc.M110.181016	31	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e108483	10.1371/journal.pone.0108483	http://dx.doi.org/10.1371/journal.pone.0108483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310185	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210300019
J	Scharrer, S; Presi, P; Hattendorf, J; Chitnis, N; Reist, M; Zinsstag, J				Schaerrer, Sara; Presi, Patrick; Hattendorf, Jan; Chitnis, Nakul; Reist, Martin; Zinsstag, Jakob			Demographic Model of the Swiss Cattle Population for the Years 2009-2011 Stratified by Gender, Age and Production Type	PLOS ONE			English	Article							RISK-BASED SURVEILLANCE; MORTALITY	Demographic composition and dynamics of animal and human populations are important determinants for the transmission dynamics of infectious disease and for the effect of infectious disease or environmental disasters on productivity. In many circumstances, demographic data are not available or of poor quality. Since 1999 Switzerland has been recording cattle movements, births, deaths and slaughter in an animal movement database (AMD). The data present in the AMD offers the opportunity for analysing and understanding the dynamic of the Swiss cattle population. A dynamic population model can serve as a building block for future disease transmission models and help policy makers in developing strategies regarding animal health, animal welfare, livestock management and productivity. The Swiss cattle population was therefore modelled using a system of ordinary differential equations. The model was stratified by production type (dairy or beef), age and gender (male and female calves: 0-1 year, heifers and young bulls: 1-2 years, cows and bulls: older than 2 years). The simulation of the Swiss cattle population reflects the observed pattern accurately. Parameters were optimized on the basis of the goodness-of-fit (using the Powell algorithm). The fitted rates were compared with calculated rates from the AMD and differed only marginally. This gives confidence in the fitted rates of parameters that are not directly deductible from the AMD (e. g. the proportion of calves that are moved from the dairy system to fattening plants).	[Schaerrer, Sara; Presi, Patrick] Univ Bern, Vet Publ Hlth Inst, Bern, Switzerland; [Hattendorf, Jan; Chitnis, Nakul; Zinsstag, Jakob] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Chitnis, Nakul] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Reist, Martin] Fed Food Safety & Vet Off, Bern, Switzerland	University of Bern; University of Basel; Swiss Tropical & Public Health Institute; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Scharrer, S (corresponding author), Univ Bern, Vet Publ Hlth Inst, Bern, Switzerland.	sara.schaerrer@vetsuisse.unibe.ch	Zinsstag, Jakob/A-8317-2008; Hattendorf, Jan/F-5371-2010; Chitnis, Nakul/B-3105-2013	Zinsstag, Jakob/0000-0002-8899-6097; Hattendorf, Jan/0000-0002-1176-401X; Chitnis, Nakul/0000-0002-1103-9141	Swiss Federal Veterinary Office	Swiss Federal Veterinary Office	The study was funded as part of a PhD project by the Swiss Federal Veterinary Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, AGREEMENT EUROPEAN C; [Anonymous], 1995, TIERSEUCHENVERORDNUN; Bleul U, 2011, LIVEST SCI, V135, P257, DOI 10.1016/j.livsci.2010.07.022; Golan E, 2004, AGR EC REP, V830; Hadorn DC, 2009, VET RES, V40, DOI 10.1051/vetres/2009040; Ludi F, 2004, DEMOGRAPHIE RAUMLICH; O'Connor J, 2009, PREV VET MED, V89, P249, DOI 10.1016/j.prevetmed.2009.02.011; Perrin JB, 2011, INRA PROD ANIM, V24, P235; Press W, 1991, NUMERICAL RECIPIES C; R Core Team, 2018, R LANG ENV STAT COMP; Reber A, 2012, SCHWEIZ ARCH TIERH, V154, P189, DOI 10.1024/0036-7281/a000329; Reist M, 2012, PREV VET MED, V105, P176, DOI 10.1016/j.prevetmed.2011.12.014; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Rosen S, 2012, J POLIT ECON, V102, P468; Stark KDC, 2006, BMC HEALTH SERV RES, V6, P1, DOI 10.1186/1472-6963-6-20; Ventana Systems I, 2008, VENS SIM BUS; WTO, WTO AGR APPL SAN PHY	17	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109329	10.1371/journal.pone.0109329	http://dx.doi.org/10.1371/journal.pone.0109329			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310680	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000343210300047
J	Seyed, N; Taheri, T; Vauchy, C; Dosset, M; Godet, Y; Eslamifar, A; Sharifi, I; Adotevi, O; Borg, C; Rohrlich, PS; Rafati, S				Seyed, Negar; Taheri, Tahereh; Vauchy, Charline; Dosset, Magalie; Godet, Yann; Eslamifar, Ali; Sharifi, Iraj; Adotevi, Olivier; Borg, Christophe; Rohrlich, Pierre Simon; Rafati, Sima			Immunogenicity Evaluation of a Rationally Designed Polytope Construct Encoding HLA-A*0201 Restricted Epitopes Derived from Leishmania major Related Proteins in HLA-A2/DR1 Transgenic Mice: Steps toward Polytope Vaccine	PLOS ONE			English	Article							CD8(+) T-CELLS; TELOMERASE REVERSE-TRANSCRIPTASE; HUMAN CUTANEOUS LEISHMANIASIS; IFN-GAMMA PRODUCTION; IMMUNITY IN-VIVO; DNA VACCINE; BETA-2-MICROGLOBULIN-DEFICIENT MICE; INTRADERMAL CHALLENGE; MUCOSAL LEISHMANIASIS; PROTECTIVE IMMUNITY	Background: There are several reports demonstrating the role of CD8 T cells against Leishmania species. Therefore peptide vaccine might represent an effective approach to control the infection. We developed a rational polytope-DNA construct encoding immunogenic HLA-A2 restricted peptides and validated the processing and presentation of encoded epitopes in a preclinical mouse model humanized for the MHC-class-I and II. Methods and Findings: HLA-A*0201 restricted epitopes from LPG-3, LmSTI-1, CPB and CPC along with H-2Kd restricted peptides, were lined-up together as a polytope string in a DNA construct. Polytope string was rationally designed by harnessing advantages of ubiquitin, spacers and HLA-DR restricted Th1 epitope. Endotoxin free pcDNA plasmid expressing the polytope was inoculated into humanized HLA-DRB1*0101/HLA-A*0201 transgenic mice intramuscularly 4 days after Cardiotoxin priming followed by 2 boosters at one week interval. Mice were sacrificed 10 days after the last booster, and splenocytes were subjected to ex-vivo and in-vitro evaluation of specific IFN-gamma production and in-vitro cytotoxicity against individual peptides by ELISpot and standard chromium-51(Cr-51) release assay respectively. 4 H-2Kd and 5 HLA-A*0201 restricted peptides were able to induce specific CD8 T cell responses in BALB/C and HLA-A2/DR1 mice respectively. IFN-gamma and cytolytic activity together discriminated LPG-3-P1 as dominant, LmSTI-1-P3 and LmSTI-1-P6 as subdominant with both cytolytic activity and IFN-gamma production, LmSTI-1-P4 and LPG-3-P5 as subdominant with only IFN-gamma production potential. Conclusions: Here we described a new DNA-polytope construct for Leishmania vaccination encompassing immunogenic HLA-A2 restricted peptides. Immunogenicity evaluation in HLA-transgenic model confirmed CD8 T cell induction with expected affinities and avidities showing almost efficient processing and presentation of the peptides in relevant preclinical model. Further evaluation will determine the efficacy of this polytope construct protecting against infectious challenge of Leishmania. Fortunately HLA transgenic mice are promising preclinical models helping to speed up immunogenicity analysis in a human related mouse model.	[Seyed, Negar; Taheri, Tahereh; Rafati, Sima] Pasteur Inst Iran, Mol Immunol & Vaccine Res Lab, Tehran, Iran; [Vauchy, Charline; Dosset, Magalie; Godet, Yann; Adotevi, Olivier; Borg, Christophe; Rohrlich, Pierre Simon] INSERM, U1098, Unite Mixte Rech, Besancon, France; [Vauchy, Charline; Dosset, Magalie; Godet, Yann; Adotevi, Olivier; Borg, Christophe; Rohrlich, Pierre Simon] Etab Francais du Sang Bourgogne Franche Comte, Besancon, France; [Vauchy, Charline; Dosset, Magalie; Godet, Yann; Adotevi, Olivier; Borg, Christophe; Rohrlich, Pierre Simon] Univ Franche Comte, F-25030 Besancon, France; [Eslamifar, Ali] Pasteur Inst Iran, Dept Electron Microscopy & Clin Res, Tehran, Iran; [Sharifi, Iraj] Kerman Univ Med Sci, Leishmaniasis Res Ctr, Sch Med, Kerman, Iran; [Adotevi, Olivier; Borg, Christophe] CHRU Besancon, Serv Oncol, Besancon, France; [Rohrlich, Pierre Simon] CHRU Besancon, Serv Pediat, Besancon, France	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Kerman University of Medical Sciences; Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Besancon	Rafati, S (corresponding author), Pasteur Inst Iran, Mol Immunol & Vaccine Res Lab, Tehran, Iran.	sima-rafatisy@pasteur.ac.ir	DOSSET, Magalie/AAX-2144-2020; Rafati, Sima/L-2202-2017; Adotevi, Olivier/AAX-8290-2021; Dosset, Magalie/AAP-9086-2020; Sharifi, Iraj/AAY-8267-2020	DOSSET, Magalie/0000-0002-3531-4371; Rafati, Sima/0000-0002-7221-1320; adotevi, olivier/0000-0002-7742-136X; Sharifi, Iraj/0000-0002-6894-6834; Godet, Yann/0000-0003-4017-6070; Rohrlich, Pierre S/0000-0001-8801-4164; Taheri, Tahereh/0000-0002-2619-6879	Pasteur Institute of Iran; National Science Foundation of Iran [87020176]; INSERM UMR 1098, Besancon, France	Pasteur Institute of Iran; National Science Foundation of Iran(Iran National Science Foundation (INSF)); INSERM UMR 1098, Besancon, France	This work was financially supported by a grant from Pasteur Institute of Iran (PhD scholarship), National Science Foundation of Iran (grant no. 87020176) and INSERM UMR 1098, Besancon, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdian N, 2011, EXP PARASITOL, V127, P627, DOI 10.1016/j.exppara.2010.12.007; Adotevi O, 2006, CLIN CANCER RES, V12, P3158, DOI 10.1158/1078-0432.CCR-05-2647; Adotevi O, 2010, BLOOD, V115, P3025, DOI 10.1182/blood-2009-11-253641; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Babe LM, 2009, OPTIMIZED MULTIEPITO, V77, P5226; BARRALNETTO M, 1995, PARASITE IMMUNOL, V17, P21, DOI 10.1111/j.1365-3024.1995.tb00962.x; Basu R, 2007, J INFECT DIS, V195, P1373, DOI 10.1086/513439; Bazhan SI, 2010, MOL IMMUNOL, V47, P1507, DOI 10.1016/j.molimm.2010.01.020; Beaumier CM, 2013, TRANSL RES, V162, P144, DOI 10.1016/j.trsl.2013.03.006; Belkaid Y, 2002, J IMMUNOL, V168, P3992, DOI 10.4049/jimmunol.168.8.3992; Bhasin M, 2007, J BIOSCIENCES, V32, P31, DOI 10.1007/s12038-007-0004-5; Bolhassani A, 2011, EXP PARASITOL, V127, P637, DOI 10.1016/j.exppara.2010.12.006; Brinkman JA, 2004, EXPERT OPIN BIOL TH, V4, P181, DOI 10.1517/eobt.4.2.181.26328; Burgevin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002402; Chen JH, 2012, WORLD J GASTROENTERO, V18, P1319, DOI 10.3748/wjg.v18.i12.1319; Cho HI, 2012, CANCER IMMUNOL IMMUN, V61, P343, DOI 10.1007/s00262-011-1110-7; Chou B, 2012, J IMMUNOL, V189, P1618, DOI 10.4049/jimmunol.1101971; Colmenares M, 2003, INFECT IMMUN, V71, P3172, DOI 10.1128/IAI.71.6.3172-3182.2003; Cong Hua, 2010, Immunome Res, V6, P12, DOI 10.1186/1745-7580-6-12; Croft SL, 2011, CLIN MICROBIOL INFEC, V17, P1478, DOI 10.1111/j.1469-0691.2011.03630.x; Dani A, 2004, J CELL SCI, V117, P4219, DOI 10.1242/jcs.01288; DELVAL M, 1991, CELL, V66, P1145, DOI 10.1016/0092-8674(91)90037-Y; Descoteaux A, 2002, EMBO J, V21, P4458, DOI 10.1093/emboj/cdf447; Dominguez MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022011; Doroud D, 2011, J CONTROL RELEASE, V153, P154, DOI 10.1016/j.jconrel.2011.04.011; EGGERS M, 1995, J EXP MED, V182, P1865, DOI 10.1084/jem.182.6.1865; Elkington R, 2003, J VIROL, V77, P5226, DOI 10.1128/JVI.77.9.5226-5240.2003; Faria DR, 2009, PARASITE IMMUNOL, V31, P432, DOI 10.1111/j.1365-3024.2009.01125.x; Faria DR, 2005, INFECT IMMUN, V73, P7853, DOI 10.1128/IAI.73.12.7853-7859.2005; Firat H, 1999, EUR J IMMUNOL, V29, P3112, DOI 10.1002/(SICI)1521-4141(199910)29:10<3112::AID-IMMU3112>3.0.CO;2-Q; Fu F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-264; Gaze ST, 2006, SCAND J IMMUNOL, V63, P70, DOI 10.1111/j.1365-3083.2005.01707.x; Geluk A, 2011, J IMMUNOL, V187, P1393, DOI 10.4049/jimmunol.1100980; Gomez-Nunez M, 2006, LEUKEMIA RES, V30, P1293, DOI 10.1016/j.leukres.2006.02.010; Gurunathan S, 2000, J IMMUNOL, V165, P915, DOI 10.4049/jimmunol.165.2.915; Herath S, 2003, PARASITE IMMUNOL, V25, P559, DOI 10.1111/j.0141-9838.2004.00668.x; Hernandez-Ruiz J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000871; Herrera-Najera C, 2009, PROTEOMICS, V9, P1293, DOI 10.1002/pmic.200800533; Huber M, 1998, INFECT IMMUN, V66, P3968, DOI 10.1128/IAI.66.8.3968-3970.1998; Huebener N, 2008, MOL CANCER THER, V7, P2241, DOI 10.1158/1535-7163.MCT-08-0109; Im EJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002041; Imai T, 2008, BIOCHEM BIOPH RES CO, V365, P758, DOI 10.1016/j.bbrc.2007.11.034; Iurescia S, 2012, BIOTECHNOL ADV, V30, P372, DOI 10.1016/j.biotechadv.2011.06.020; John L, 2012, APPL BIOCHEM BIOTECH, V167, P1340, DOI 10.1007/s12010-012-9649-0; Joshi T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000431; Kedzierski L, 2010, J GLOB INFECT DIS, V2, P177, DOI 10.4103/0974-777X.62881; Kishore K, 2006, INDIAN J MED RES, V123, P467; Larsen MV, 2005, EUR J IMMUNOL, V35, P2295, DOI 10.1002/eji.200425811; Li XM, 2005, INT IMMUNOL, V17, P1293, DOI 10.1093/intimm/dxh305; Lich JD, 2000, J EXP MED, V191, P1513, DOI 10.1084/jem.191.9.1513; Livingston BD, 2001, VACCINE, V19, P4652, DOI 10.1016/S0264-410X(01)00233-X; Machado P, 2002, EUR J DERMATOL, V12, P449; Mendez A, 2002, VACCINE, V20, P3702, DOI 10.1016/S0264-410X(02)00376-6; Mendez S, 2001, J IMMUNOL, V166, P5122, DOI 10.4049/jimmunol.166.8.5122; Modabber F, 2010, INT J ANTIMICROB AG, V36, pS58, DOI 10.1016/j.ijantimicag.2010.06.024; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Mougneau E, 2011, IMMUNOL REV, V240, P286, DOI 10.1111/j.1600-065X.2010.00983.x; Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443; MULLER I, 1993, INFECT IMMUN, V61, P3730; MULLER I, 1992, EUR J IMMUNOL, V22, P3063, DOI 10.1002/eji.1830221206; MULLER I, 1994, INFECT IMMUN, V62, P2575; Nascimento E, 2010, VACCINE, V28, P6581, DOI 10.1016/j.vaccine.2010.07.063; NEISIG A, 1995, J IMMUNOL, V154, P1273; Nylen S, 2010, J GLOB INFECT DIS, V2, P135, DOI 10.4103/0974-777X.62876; Okwor I, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00128; Organization WH, 2010, WHO TECHNICAL REPORT, pxii; Oseroff C, 1998, VACCINE, V16, P823, DOI 10.1016/S0264-410X(97)00264-8; OVERATH P, 1993, IMMUNOL LETT, V37, P13, DOI 10.1016/0165-2478(93)90126-M; Pajot A, 2004, EUR J IMMUNOL, V34, P3060, DOI 10.1002/eji.200425463; Pajot A, 2007, EUR J IMMUNOL, V37, P2635, DOI 10.1002/eji.200636819; Pascolo S, 2005, EXPERT OPIN BIOL TH, V5, P919, DOI 10.1517/14712598.5.7.919; Perez SA, 2010, CANCER-AM CANCER SOC, V116, P2071, DOI 10.1002/cncr.24988; Pinchuk I, 2005, J IMMUNOL, V174, P5729, DOI 10.4049/jimmunol.174.9.5729; Pirdel Leila, 2012, Avicenna Journal of Medical Biotechnology, V4, P186; Rezvan H, 2012, IRAN J PARASITOL, V7, P27; Rodriguez F, 2000, VIROLOGY, V268, P233, DOI 10.1006/viro.2000.0209; Rodriguez F, 1997, J VIROL, V71, P8497, DOI 10.1128/JVI.71.11.8497-8503.1997; Rogers KA, 2004, AM J TROP MED HYG, V71, P568, DOI 10.4269/ajtmh.2004.71.568; Rohrlich PS, 2003, INT IMMUNOL, V15, P765, DOI 10.1093/intimm/dxg073; Rostami MN, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000845; Ruiz JH, 2007, PARASITE IMMUNOL, V29, P671, DOI 10.1111/j.1365-3024.2007.00991.x; Russo DM, 1999, EXP PARASITOL, V93, P161, DOI 10.1006/expr.1999.4452; Santarem N, 2007, BIOMED RES INT, V2007; Schroeder J, 2011, HUM VACCINES, V7, P10, DOI 10.4161/hv.7.0.14556; SETTE A, 1994, J IMMUNOL, V153, P5586; Sewell DA, 2004, CANCER RES, V64, P8821, DOI 10.1158/0008-5472.CAN-04-1958; Seyed N, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001295; Silverman JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r35; Silverman JM, 2011, FRONTIERS CELLULAR I, V1; Stager S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00005; Tewari MK, 2005, NAT IMMUNOL, V6, P287, DOI 10.1038/ni1171; Toes REM, 1997, P NATL ACAD SCI USA, V94, P14660, DOI 10.1073/pnas.94.26.14660; Uzonna JE, 2004, J EXP MED, V199, P1559, DOI 10.1084/jem.20040172; Velders MP, 2001, J IMMUNOL, V166, P5366, DOI 10.4049/jimmunol.166.9.5366; WANG ZE, 1993, J IMMUNOL, V151, P2077	96	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e108848	10.1371/journal.pone.0108848	http://dx.doi.org/10.1371/journal.pone.0108848			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310094	Green Published, gold			2022-12-27	WOS:000343210300026
J	Spanu, S; van Roeyen, CRC; Denecke, B; Floege, J; Muhlfeld, AS				Spanu, Silvia; van Roeyen, Claudia R. C.; Denecke, Bernd; Floege, Juergen; Muehlfeld, Anja S.			Urinary Exosomes: A Novel Means to Non-Invasively Assess Changes in Renal Gene and Protein Expression	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; CYSTATIN-C; BIOMARKER; NORMALIZATION; PROTEOMICS; MARKER	Background: In clinical practice, there is a lack of markers for the non-invasive diagnosis and follow-up of kidney disease. Exosomes are membrane vesicles, which are secreted from their cells of origin into surrounding body fluids and contain proteins and mRNA which are protected from digestive enzymes by a cell membrane. Methods: Toxic podocyte damage was induced by puromycin aminonucleoside in rats (PAN). Urinary exosomes were isolated by ultracentrifugation at different time points during the disease. Exosomal mRNA was isolated, amplified, and the mRNA species were globally assessed by gene array analysis. Tissue-specific gene and protein expression was assessed by RT-qPCR analysis and immunohistochemistry. Results: Gene array analysis of mRNA isolated from urinary exosomes revealed cystatin C mRNA as one of the most highly regulated genes. Its gene expression increased 7.5-fold by day 5 and remained high with a 1.9-fold increase until day 10. This was paralleled by a 2-fold increase in cystatin C mRNA expression in the renal cortex. Protein expression in the kidneys also dramatically increased with de novo expression of cystatin C in glomerular podocytes in parts of the proximal tubule and the renal medulla. Urinary excretion of cystatin C increased approximately 2-fold. Conclusion: In this proof-of-concept study, we could demonstrate that changes in urinary exosomal cystatin C mRNA expression are representative of changes in renal mRNA and protein expression. Because cells lining the urinary tract produce urinary exosomal cystatin C mRNA, it might be a more specific marker of renal damage than glomerular-filtered free cystatin C.	[Spanu, Silvia] Univ Med & Pharm I Hatieganu, Dept Nephrol, Cluj Napoca, Romania; [van Roeyen, Claudia R. C.; Floege, Juergen; Muehlfeld, Anja S.] Uniklin RWTH Aachen, Div Nephrol & Immunol, Aachen, Germany; [Denecke, Bernd] Uniklin RWTH Aachen, IZKF, Aachen, Germany	Iuliu Hatieganu University of Medicine & Pharmacy; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Muhlfeld, AS (corresponding author), Uniklin RWTH Aachen, Div Nephrol & Immunol, Aachen, Germany.	amuehlfeld@ukaachen.de			KfH-Stiftung Praventivmedizin; "Habilitationsstipendium" of the medical faculty of the RWTH Aachen University; Deutsche Forschungsgemeinschaft [RO4036/1]	KfH-Stiftung Praventivmedizin; "Habilitationsstipendium" of the medical faculty of the RWTH Aachen University; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	"Fritz Scheler-Stipendium" from the KfH-Stiftung Praventivmedizin to Anja S. Muhlfeld. Anja S. Muhlfeld was also supported by a "Habilitationsstipendium" of the medical faculty of the RWTH Aachen University. In addition, this work was supported by the Deutsche Forschungsgemeinschaft RO4036/1 to Claudia R. C. van Roeyen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barutta F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073798; Cheruvanky A, 2007, AM J PHYSIOL-RENAL, V292, pF1657, DOI 10.1152/ajprenal.00434.2006; Conde-Vancells J, 2010, PROTEOM CLIN APPL, V4, P416, DOI 10.1002/prca.200900103; Conti M, 2006, CLIN CHEM LAB MED, V44, P288, DOI 10.1515/CCLM.2006.050; Conti M, 2009, CLIN CHEM LAB MED, V47, P1553, DOI 10.1515/CCLM.2009.341; Dieterle F, 2010, NAT BIOTECHNOL, V28, P463, DOI 10.1038/nbt.1622; Eldh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015353; Emig D, 2010, NUCLEIC ACIDS RES, V38, pW755, DOI 10.1093/nar/gkq405; Esteva-Font C, 2010, NEPHRON PHYSIOL, V114, pP25, DOI 10.1159/000274468; Fernandez-Llama P, 2010, KIDNEY INT, V77, P736, DOI 10.1038/ki.2009.550; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Gildea JJ, 2013, CLIN BIOCHEM, V46, P1131, DOI 10.1016/j.clinbiochem.2013.05.052; Goligorsky MS, 2007, J AM SOC NEPHROL, V18, P2233, DOI 10.1681/ASN.2006121399; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kalani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060177; Kim JS, 2012, RENAL FAILURE, V34, P676, DOI 10.3109/0886022X.2012.672154; Kim SS, 2013, DIABETES CARE, V36, P656, DOI 10.2337/dc12-0849; Koyner JL, 2013, AM J KIDNEY DIS, V61, P730, DOI 10.1053/j.ajkd.2012.12.006; Lee H, 2012, PEDIATR NEPHROL, V27, P317, DOI 10.1007/s00467-011-2035-2; Lv LL, 2014, CLIN CHIM ACTA, V428, P26, DOI 10.1016/j.cca.2013.10.003; Lv LL, 2013, AM J PHYSIOL-RENAL, V305, pF1220, DOI 10.1152/ajprenal.00148.2013; Miranda KC, 2010, KIDNEY INT, V78, P191, DOI 10.1038/ki.2010.106; Muhlfeld AS, 2004, KIDNEY INT; Nejat M, 2012, NEPHROL DIAL TRANSPL, V27, P96, DOI 10.1093/ndt/gfr222; Nejat M, 2010, CRIT CARE, V14, DOI 10.1186/cc9014; Ostendorf T, 2003, J AM SOC NEPHROL, V14, P2237, DOI 10.1097/01.ASN.0000083393.00959.02; Peake PW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098644; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Sonoda H, 2009, AM J PHYSIOL-RENAL, V297, pF1006, DOI 10.1152/ajprenal.00200.2009; Thakkar H, 1998, KIDNEY INT, V54, P1197, DOI 10.1046/j.1523-1755.1998.00098.x; Togashi Y, 2013, EXP TOXICOL PATHOL, V65, P615, DOI 10.1016/j.etp.2012.06.005; Togashi Y, 2012, EXP TOXICOL PATHOL, V64, P797, DOI 10.1016/j.etp.2011.01.018; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang G, 2007, NEPHROLOGY, V12, P494, DOI 10.1111/j.1440-1797.2007.00836.x; Yu DH, 2005, J AM SOC NEPHROL, V16, P1733, DOI 10.1681/ASN.2005020159; Zhou H, 2006, KIDNEY INT, V70, P1847, DOI 10.1038/sj.ki.5001874; Zhou H, 2006, KIDNEY INT, V69, P1471, DOI 10.1038/sj.ki.5000273; Zhou H, 2013, AM J PHYSIOL-RENAL, V305, pF553, DOI 10.1152/ajprenal.00056.2013	40	33	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109631	10.1371/journal.pone.0109631	http://dx.doi.org/10.1371/journal.pone.0109631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310591	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210300062
J	Pour, MB; Bergstrom, A; Bottai, M; Magnusson, J; Kull, I; Wickman, M; Moradi, T				Pour, Mohsen Besharat; Bergstrom, Anna; Bottai, Matteo; Magnusson, Jessica; Kull, Inger; Wickman, Magnus; Moradi, Tahereh			Body Mass Index Development from Birth to Early Adolescence; Effect of Perinatal Characteristics and Maternal Migration Background in a Swedish Cohort	PLOS ONE			English	Article							CHILDHOOD OVERWEIGHT; SOCIOECONOMIC-STATUS; CHILDREN; OBESITY; IMMIGRANT; WEIGHT; GROWTH; PREDICTORS; INFANTS; TRAJECTORIES	Background: Well documented diversity in risk of developing overweight and obesity between children of immigrant and of native mothers, might be explained by different body mass index (BMI) development trajectories in relation to maternal and perinatal characteristics of offspring. Objectives: To assess BMI development trajectories among children born to immigrant and to Swedish mothers from birth to adolescence in relation to perinatal characteristics. Methods: A cohort of 2517 children born in Stockholm during 1994 to 1996 was followed with repeated measurement of height and weight at eleven time points until age 12 years. We estimated changes over time for BMI in relation to maternal and perinatal characteristics of offspring using mixed linear model analysis for repeated measure data. Results: We observed a significant BMI change over time in children and time interaction with maternal migration status (P<0.0001). Estimated BMI over time adjusted for maternal and perinatal characteristics of offspring, showed slower BMI growth before age of 5, followed by an earlier plateau and steeper BMI growth after 5 years among children of immigrant mothers compared with children of Swedish mothers. These differences in BMI growth were more prominent among children with mothers from outside Europe. Conclusion: Beside reinforcing early childhood as a crucial period in development of overweight, the observed slower BMI development at early childhood among children of immigrants followed by a steeper increase in BMI compared with children of Swedish mothers is important for further studies and for planning of preventive public health programs.	[Pour, Mohsen Besharat; Bergstrom, Anna; Magnusson, Jessica; Kull, Inger; Wickman, Magnus; Moradi, Tahereh] Karolinska Inst, Inst Environm Med, Div Epidemiol, Stockholm, Sweden; [Bottai, Matteo] Karolinska Inst, Inst Environm Med, Biostat Unit, Stockholm, Sweden; [Kull, Inger] Stockholm South Gen Hosp, Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Kull, Inger; Wickman, Magnus] Stockholm South Gen Hosp, Sachs Children & Youth Hosp, Stockholm, Sweden; [Moradi, Tahereh] Stockholm Cty Council, Ctr Epidemiol & Community Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Stockholm County Council	Pour, MB (corresponding author), Karolinska Inst, Inst Environm Med, Div Epidemiol, Stockholm, Sweden.	Mohsen.besharat.pour@ki.se	; Besharat Pour, Mohsen/G-2172-2010	Wickman, Magnus/0000-0003-2710-8620; Kull, Inger/0000-0001-6096-3771; Besharat Pour, Mohsen/0000-0002-3180-1922				Alder J, 2008, EUR J CONTRACEP REPR, V13, P103, DOI 10.1080/13625180701780254; Apfelbacher CJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-171; Balakrishnan R, 2008, J PUBLIC HEALTH-UK, V30, P139, DOI 10.1093/pubmed/fdn013; Balistreri KS, 2009, AM J PUBLIC HEALTH, V99, P2238, DOI 10.2105/AJPH.2007.116103; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; BarnHalsovard, 2012, MAT MATT; BATTAGLI.FC, 1967, J PEDIATR-US, V71, P159, DOI 10.1016/S0022-3476(67)80066-0; Buekens P, 1998, AM J PUBLIC HEALTH, V88, P808, DOI 10.2105/AJPH.88.5.808; Chivers P, 2009, OBESITY FACTS, V2, P302, DOI 10.1159/000235561; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cole TJ, 2005, EUR J CLIN NUTR, V59, P419, DOI 10.1038/sj.ejcn.1602090; Dietz WH, 1998, PEDIATRICS, V101, P518; Ekblom OB, 2004, SCAND J PUBLIC HEALT, V32, P257, DOI 10.1080/1403494031009498; El-Sayed AM, 2011, ETHNIC DIS, V21, P47; Eriksson M, 2008, PAEDIATR PERINAT EP, V22, P379, DOI 10.1111/j.1365-3016.2008.00944.x; Forna F, 2003, INT J GYNECOL OBSTET, V83, P257, DOI 10.1016/S0020-7292(03)00307-2; Fredriks AM, 2005, ACTA PAEDIATR, V94, P496, DOI [10.1080/08035250410024240, 10.1111/j.1651-2227.2005.tb01923.x]; Hendrix N, 2008, SEMIN PERINATOL, V32, P161, DOI 10.1053/j.semperi.2008.02.004; Hjern A, 2004, ACTA PAEDIATR, V93, P1535, DOI 10.1080/08035250410022161; Hjern A, 2012, SCAND J PUBLIC HEALT, V40, P255, DOI 10.1177/1403494812459610; Hof MHP, 2011, ANN HUM BIOL, V38, P544, DOI 10.3109/03014460.2011.576701; Huang JS, 2007, MATERN CHILD HLTH J, V11, P461, DOI 10.1007/s10995-006-0141-8; Kallen B., 2003, SWEDISH MED BIRTH RE; Kiess W, 2001, Obes Rev, V2, P29, DOI 10.1046/j.1467-789x.2001.00017.x; Kipping RR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1824; Kirchengast S, 2006, J BIOSOC SCI, V38, P695, DOI 10.1017/S0021932005027094; Kosti Rena I., 2006, Central European Journal of Public Health, V14, P151; Li CY, 2007, OBESITY, V15, P760, DOI 10.1038/oby.2007.585; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Oken E, 2003, OBES RES, V11, P496, DOI 10.1038/oby.2003.69; Rogers I, 2003, INT J OBESITY, V27, P755, DOI 10.1038/sj.ijo.0802316; Sankaran S, 2009, BEST PRACT RES CL OB, V23, P765, DOI 10.1016/j.bpobgyn.2009.05.003; Socialstyrelsen, 2004, SOC RIKTL SKOLH; Stillman S, 2012, ECON INQ, V50, P62, DOI 10.1111/j.1465-7295.2009.00284.x; Stockholms Lans Landsting (SLL), 2013, MET BARNH BED TILLV; Stockholms Lans Landsting (SLL), 2013, BARNH BARNH STOCKH L; Sundblom E, 2008, INT J OBESITY, V32, P1525, DOI 10.1038/ijo.2008.104; Van Hook J, 2007, SOC SCI MED, V65, P976, DOI 10.1016/j.socscimed.2007.04.032; Wen XZ, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-38; Wickman M, 2002, PEDIATR ALLERGY IMMU, V13, P11, DOI 10.1034/j.1399-3038.13.s.15.10.x; Will B, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-45; World Health Organization, 2013, GLOB STRAT DIET PHYS	42	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109519	10.1371/journal.pone.0109519	http://dx.doi.org/10.1371/journal.pone.0109519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6ZS	25303283	Green Published, gold			2022-12-27	WOS:000343730400063
J	Yadav, AK; Chaudhari, H; Warke, H; Shah, PK; Dodagatta-Marri, E; Kishore, U; Madan, T				Yadav, Ajit Kumar; Chaudhari, Hemangi; Warke, Himangi; Shah, Premanand Keshavlal; Dodagatta-Marri, Eswari; Kishore, Uday; Madan, Taruna			Differential Expression of Collectins in Human Placenta and Role in Inflammation during Spontaneous Labor	PLOS ONE			English	Article							SURFACTANT PROTEIN-D; MANNOSE-BINDING LECTIN; HUMAN FETAL MEMBRANES; SP-A; D GENE; PRETERM; INNATE; FLUID; LAVAGE; TRANSCRIPTION	Collectins, collagen-containing Ca2+ dependent C-type lectins and a class of secretory proteins including SP-A, SP-D and MBL, are integral to immunomodulation and innate immune defense. In the present study, we aimed to investigate their placental transcript synthesis, labor associated differential expression and localization at feto-maternal interface, and their functional implication in spontaneous labor. The study involved using feto-maternal interface (placental/decidual tissues) from two groups of healthy pregnant women at term (>= 37 weeks of gestation), undergoing either elective C-section with no labor ('NLc' group, n = 5), or normal vaginal delivery with spontaneous labor ('SLv' group, n = 5). The immune function of SP-D, on term placental explants, was analyzed for cytokine profile using multiplexed cytokine array. SP-A, SP-D and MBL transcripts were observed in the term placenta. The 'SLv' group showed significant up-regulation of SP-D (p = 0.001), and down-regulation of SP-A (p = 0.005), transcripts and protein compared to the 'NLc' group. Significant increase in 43 kDa and 50 kDa SP-D forms in placental and decidual tissues was associated with the spontaneous labor (p<0.05). In addition, the MMP-9-cleaved form of SP-D (25 kDa) was significantly higher in the placentae of 'SLv' group compared to the 'NLc' group (p = 0.002). Labor associated cytokines IL-1 alpha, IL-1 beta, IL-6, IL-8, IL-10, TNF-alpha and MCP-1 showed significant increase (p<0.05) in a dose dependent manner in the placental explants treated with nSP-D and rhSP-D. In conclusion, the study emphasizes that SP-A and SP-D proteins associate with the spontaneous labor and SP-D plausibly contributes to the pro-inflammatory immune milieu of feto-maternal tissues.	[Yadav, Ajit Kumar; Madan, Taruna] Indian Council Med Res, Natl Inst Res Reprod Hlth, Dept Innate Immun, Bombay, Maharashtra, India; [Chaudhari, Hemangi; Warke, Himangi; Shah, Premanand Keshavlal] Seth Gordhandas Sunderdas Med Coll, Dept Obstet & Gynecol, Mumbai, Maharashtra, India; [Chaudhari, Hemangi; Warke, Himangi; Shah, Premanand Keshavlal] King Edward Med KEM Hosp, Mumbai, Maharashtra, India; [Dodagatta-Marri, Eswari; Kishore, Uday] Brunel Univ London, Coll Hlth & Life Sci, Ctr Infect Immun & Dis Mech, Uxbridge, Middx, England	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Brunel University	Madan, T (corresponding author), Indian Council Med Res, Natl Inst Res Reprod Hlth, Dept Innate Immun, Bombay, Maharashtra, India.	taruna_m@hotmail.com	Kishore, Uday/Y-7976-2018	Kishore, Uday/0000-0002-6033-6759	Department of Biotechnology (DBT), Government of India [BT/PR15227/BRB/10/906/2011]; Indian Council of Medical Research (ICMR), Government of India	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Indian Council of Medical Research (ICMR), Government of India(Indian Council of Medical Research (ICMR))	Funding provided by BT/PR15227/BRB/10/906/2011) Department of Biotechnology (DBT), Government of India http://dbtindia.nic.in/index.asp (TM) and Indian Council of Medical Research (ICMR) Junior Research Fellowship (JRF)/Senior Research Fellowship (SRF), Government of India, www.icmr.nic.in (AKY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinis C, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/484321; Agrawal V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063990; Boggaram V, 2009, CLIN SCI, V116, P27, DOI 10.1042/CS20080068; Bratcher PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041881; Breuiller-Fouche M, 2010, AM J PHYSIOL-ENDOC M, V298, pE1188, DOI 10.1152/ajpendo.00746.2009; Bridges JP, 2000, J BIOL CHEM, V275, P38848, DOI 10.1074/jbc.M005322200; Bulla R, 2010, MOL IMMUNOL, V48, P281, DOI 10.1016/j.molimm.2010.07.016; Chaiworapongsa T, 2008, J MATERN-FETAL NEO M, V21, P652, DOI 10.1080/14767050802215193; Chaiworapongsa T, 2008, J MATERN-FETAL NEO M, V21, P663, DOI 10.1080/14767050802215664; Christiaens I, 2008, J REPROD IMMUNOL, V79, P50, DOI 10.1016/j.jri.2008.04.002; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; Dulkerian SJ, 1996, AM J RESP CELL MOL, V15, P781, DOI 10.1165/ajrcmb.15.6.8969273; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Gomez-Lopez N, 2010, J LEUKOCYTE BIOL, V88, P625, DOI 10.1189/jlb.1209796; Guo CJ, 2008, PLOS BIOL, V6, P2414, DOI 10.1371/journal.pbio.0060266; Han PX, 2013, KIDNEY BLOOD PRESS R, V37, P295, DOI 10.1159/000350157; Han YM, 2007, J PATHOL, V211, P489, DOI 10.1002/path.2131; He C, 2003, PROTEOMICS, V3, P87, DOI 10.1002/pmic.200390013; He YC, 2000, J BIOL CHEM, V275, P31051, DOI 10.1074/jbc.M003499200; IANNUZZI DM, 1993, AM J PHYSIOL, V264, pL236, DOI 10.1152/ajplung.1993.264.3.L236; Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x; Karjalainen MK, 2012, PEDIATR RES, V71, P93, DOI 10.1038/pr.2011.2; Lee CL, 2011, J REPROD IMMUNOL, V90, P29, DOI 10.1016/j.jri.2011.04.007; Lee DC, 2010, J IMMUNOL, V184, P6479, DOI 10.4049/jimmunol.0903867; Leth-Larsen R, 2005, J IMMUNOL, V174, P1532, DOI 10.4049/jimmunol.174.3.1532; Leth-Larsen R, 2004, MOL HUM REPROD, V10, P149, DOI 10.1093/molehr/gah022; LeVine AM, 2002, AM J PHYSIOL-LUNG C, V282, pL563, DOI 10.1152/ajplung.00280.2001; Lindstrom TM, 2005, REPRODUCTION, V130, P569, DOI 10.1530/rep.1.00197; MacNeill C, 2004, IMMUNOLOGY, V111, P91, DOI 10.1111/j.1365-2567.2004.01782.x; Mahajan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085046; Mason RJ, 1998, EUR RESPIR J, V12, P1147, DOI 10.1183/09031936.98.12051147; Montalbano AP, 2013, ENDOCRINOLOGY, V154, P483, DOI 10.1210/en.2012-1797; Myatt L, 2010, PLACENTA, V31, pS66, DOI 10.1016/j.placenta.2009.12.021; Naito H, 1999, J BIOCHEM-TOKYO, V126, P1004, DOI 10.1093/oxfordjournals.jbchem.a022543; Nayak A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00131; Oberley RE, 2004, MOL HUM REPROD, V10, P861, DOI 10.1093/molehr/gah117; Osman I, 2003, MOL HUM REPROD, V9, P41, DOI 10.1093/molehr/gag001; Park SK, 2012, CELL PHYSIOL BIOCHEM, V30, P334, DOI 10.1159/000339068; Rabinovich GA, 2012, ANN NY ACAD SCI, V1253, P1, DOI 10.1111/j.1749-6632.2012.06492.x; Riley JK, 2008, IMMUNOL INVEST, V37, P395, DOI 10.1080/08820130802206066; Salminen A, 2012, CYTOKINE, V60, P423, DOI 10.1016/j.cyto.2012.07.021; Sati L, 2010, HISTOCHEM CELL BIOL, V133, P85, DOI 10.1007/s00418-009-0642-9; Seyfarth J, 2006, MOL IMMUNOL, V43, P962, DOI 10.1016/j.molimm.2005.06.033; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; Snegovskikh VV, 2011, J CLIN ENDOCR METAB, V96, pE624, DOI 10.1210/jc.2010-1496; Strong P, 1998, J IMMUNOL METHODS, V220, P139, DOI 10.1016/S0022-1759(98)00160-4; Sun K, 2006, J CLIN ENDOCR METAB, V91, P4988, DOI 10.1210/jc.2006-1472; Than NG, 2012, TRENDS ENDOCRIN MET, V23, P23, DOI 10.1016/j.tem.2011.09.003; van de Geijn FE, 2007, HUM REPROD, V22, P362, DOI 10.1093/humrep/del392; Warning JC, 2011, REPRODUCTION, V141, P715, DOI 10.1530/REP-10-0360; Xu P, 2002, J CLIN ENDOCR METAB, V87, P1353, DOI 10.1210/jc.87.3.1353; Yadav Ajit Kumar, 2011, Front Biosci (Elite Ed), V3, P291, DOI 10.2741/e244	52	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108815	10.1371/journal.pone.0108815	http://dx.doi.org/10.1371/journal.pone.0108815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303045	Green Submitted, Green Published, gold			2022-12-27	WOS:000343730400028
J	Yim, SS; Bang, HB; Kim, YH; Lee, YJ; Jeong, GM; Jeong, KJ				Yim, Sung Sun; Bang, Hyun Bae; Kim, Young Hwan; Lee, Yong Jae; Jeong, Gu Min; Jeong, Ki Jun			Rapid Isolation of Antibody from a Synthetic Human Antibody Library by Repeated Fluorescence-Activated Cell Sorting (FACS)	PLOS ONE			English	Article							PERIPLASMIC EXPRESSION; PROTEIN; CONSTRUCTION; TECHNOLOGY; EXTENSION; DISPLAY; EPITOPE; VIRUS; CDRS	Antibodies and their derivatives are the most important agents in therapeutics and diagnostics. Even after the significant progress in the technology for antibody screening from huge libraries, it takes a long time to isolate an antibody, which prevents a prompt action against the spread of a disease. Here, we report a new strategy for isolating desired antibodies from a combinatorial library in one day by repeated fluorescence-activated cell sorting (FACS). First, we constructed a library of synthetic human antibody in which single-chain variable fragment (scFv) was expressed in the periplasm of Escherichia coli. After labeling the cells with fluorescent antigen probes, the highly fluorescent cells were sorted by using a high-speed cell sorter, and these cells were reused without regeneration in the next round of sorting. After repeating this sorting, the positive clones were completely enriched in several hours. Thus, we screened the library against three viral antigens, including the H1N1 influenza virus, Hepatitis B virus, and Foot-and-mouth disease virus. Finally, the potential antibody candidates, which show K-D values between 10 and 100 nM against the target antigens, could be successfully isolated even though the library was relatively small (similar to 10(6)). These results show that repeated FACS screening without regeneration of the sorted cells can be a powerful method when a rapid response to a spreading disease is required.	[Yim, Sung Sun; Bang, Hyun Bae; Kim, Young Hwan; Lee, Yong Jae; Jeong, Gu Min; Jeong, Ki Jun] Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, Plus Program BK21, Taejon 305701, South Korea; [Jeong, Ki Jun] Korea Adv Inst Sci & Technol, Inst BioCentury, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Jeong, KJ (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, Plus Program BK21, Taejon 305701, South Korea.	kjjeong@kaist.ac.kr	JEONG, KI JUN/C-1704-2011	Lee, Yong Jae/0000-0001-9917-8199	National Research Foundation of Korea (NRF) [20110016235]; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Science, ICT and Future Planning (MSIP) [2011-0031955]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Science, ICT and Future Planning (MSIP)	This research was supported by the National Research Foundation of Korea (NRF) grant (No. 20110016235) and by the Intelligent Synthetic Biology Center of Global Frontier Project (Grant no. 2011-0031955) funded by the Ministry of Science, ICT and Future Planning (MSIP)(http://www.msip.go.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Chen G, 2001, NAT BIOTECHNOL, V19, P537, DOI 10.1038/89281; Daugherty PS, 1999, PROTEIN ENG, V12, P613, DOI 10.1093/protein/12.7.613; Daugherty PS, 2000, J IMMUNOL METHODS, V243, P211, DOI 10.1016/S0022-1759(00)00236-2; Ewert S, 2003, J MOL BIOL, V325, P531, DOI 10.1016/S0022-2836(02)01237-8; FUCHS P, 1991, BIO-TECHNOL, V9, P1369, DOI 10.1038/nbt1291-1369; Fuchs P, 1996, IMMUNOTECHNOLOGY, V2, P97, DOI 10.1016/1380-2933(96)85197-9; Ge X, 2010, BIOTECHNOL BIOENG, V106, P347, DOI 10.1002/bit.22712; Gu B, 2009, SMALL, V5, P2407, DOI 10.1002/smll.200900450; Haitjema CH, 2014, ACS SYNTH BIOL, V3, P74, DOI 10.1021/sb400142b; Harding FA, 2010, MABS-AUSTIN, V2, P256, DOI 10.4161/mabs.2.3.11641; Harvey BR, 2004, P NATL ACAD SCI USA, V101, P9193, DOI 10.1073/pnas.0400187101; HAYASHI N, 1994, BIOTECHNIQUES, V17, P310; Hayhurst A, 2003, J IMMUNOL METHODS, V276, P185, DOI 10.1016/S0022-1759(03)00100-5; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Jang SH, 2011, APPL MICROBIOL BIOT, V92, P327, DOI 10.1007/s00253-011-3423-z; Jeong KJ, 2007, P NATL ACAD SCI USA, V104, P8247, DOI 10.1073/pnas.0702650104; Johnson G, 2000, NUCLEIC ACIDS RES, V28, P214, DOI 10.1093/nar/28.1.214; Jung JG, 2013, J IND MICROBIOL BIOT, V40, P705, DOI 10.1007/s10295-013-1273-7; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; Li M, 2000, NAT BIOTECHNOL, V18, P1251, DOI 10.1038/82355; Park SJ, 1999, BIOTECHNOL PROGR, V15, P164, DOI 10.1021/bp9900108; Quan JY, 2011, NAT PROTOC, V6, P242, DOI 10.1038/nprot.2010.181; Sarkar CA, 2008, P NATL ACAD SCI USA, V105, P14808, DOI 10.1073/pnas.0803103105; SEEHAUS T, 1992, GENE, V114, P235, DOI 10.1016/0378-1119(92)90580-I; Sidhu SS, 2006, NAT CHEM BIOL, V2, P682, DOI 10.1038/nchembio843; Soderlind E, 2000, NAT BIOTECHNOL, V18, P852, DOI 10.1038/78458; TJANDRA JJ, 1990, IMMUNOL CELL BIOL, V68, P367, DOI 10.1038/icb.1990.50; Villa A, 2011, MABS-AUSTIN, V3, P264, DOI 10.4161/mabs.3.3.15616; Wang S, 2011, ANTIBODY TECHNOL J, V1, P1; Yang HY, 2009, MOL CELLS, V27, P225, DOI 10.1007/s10059-009-0028-9; Zheng S, 2010, TALANTA, V82, P803, DOI 10.1016/j.talanta.2010.05.059	33	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108225	10.1371/journal.pone.0108225	http://dx.doi.org/10.1371/journal.pone.0108225			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303314	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400009
J	Laridjani, M; Leboucher, P				Laridjani, Morteza; Leboucher, Pierre			An Epistemology on the Nature of Polymers	PLOS ONE			English	Article							X-RAY-DIFFRACTION; ANOMALOUS DIFFRACTION; LIQUIDS; ORDER	Liquids have neither a periodic structure nor the completely random character of gases therefore the detailed study of their x-ray scattering diagram encounters many difficulties. The idea of periodic regularity in molecules of liquid polymers has been an attractive proposition for the simple interpretation of liquid polymer x-ray diagrams. The categorisation of polymer substances as being between a crystal phase with a perfect order and an amorphous disordered state is an over simplification of the complex reality. For obtaining structural information, during the early stages of the application of x-ray diffraction, a near crystalline model of the molecular arrangements in liquids was utilised. However, the results from these investigations led to just an approximation of the crystalline state. Our studies have analysed the real image of Fourier space of liquid polymers, for the first time, using anomalous diffractometry. The findings show the precise atomic structure of liquid polymers when transformed, by cooling, to solid polymers. We demonstrate that there is an intermediate ordered structure, characterised by the real full image of Fourier space. This prominent state of matter, an intermediate ordered structure, is defined by a regular unit cell with a five-fold symmetry. These structural atomic studies contribute to a more detailed understanding of the properties of polymers than the traditional studies of the degree of crystallinity.	[Laridjani, Morteza] Univ Paris 11, Phys Solides Lab, Orsay, France; [Leboucher, Pierre] CNRS, UMR7225, Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Laridjani, M (corresponding author), Univ Paris 11, Phys Solides Lab, Orsay, France.	M.larij@gmail.com						BERNAL JD, 1960, NATURE, V188, P910, DOI 10.1038/188910a0; Bernal JD, 1964, P R SOC A, P284; DAVIES RO, 1953, ADV PHYS, V2, P370, DOI 10.1080/00018735300101252; Eisenstein A, 1943, PHYS REV, V63, P0304, DOI 10.1103/PhysRev.63.304; FINNEY JL, 1970, PROC R SOC LON SER-A, V319, P479, DOI [10.1098/rspa.1970.0189, 10.1098/rspa.1970.0190]; FRANK FC, 1952, PROC R SOC LON SER-A, V215, P43, DOI 10.1098/rspa.1952.0194; Gingrich NS, 1943, REV MOD PHYS, V15, P0090, DOI 10.1103/RevModPhys.15.90; Guinier A, 1952, XRAY CRYSTALLOGRAPHI, P271; Guinier A., 1994, XRAY DIFFRACTION CRY; HUMEROTHERY W, 1960, PHILOS MAG, V5, P383, DOI 10.1080/14786436008235856; Kaplow R, 1965, PHYSREV, V138; Klug BP, 1974, XRAY DIFFRACTION PRO, P144; Laridjani M, 1999, J MATER SCI, V34, P5945, DOI 10.1023/A:1004711709642; LARIDJANI M, 1989, J PHYS-PARIS, V50, P1953, DOI 10.1051/jphys:0198900500140195300; LARIDJANI M, 1987, J NON-CRYST SOLIDS, V91, P217, DOI 10.1016/S0022-3093(87)80305-8; Laridjani M, 2004, J APPL CRYSTALLOGR, V37, P716, DOI 10.1107/S0021889804014657; LARIDJANI M, 1988, J NON-CRYST SOLIDS, V106, P42, DOI 10.1016/0022-3093(88)90224-4; Laridjani M, 2002, STRUCT CHEM, V13, P385, DOI 10.1023/A:1015832511433; Laridjani M, 1996, J PHYS I, V6, P1347, DOI 10.1051/jp1:1996140; LARIDJANI M, 1992, J PHYS I, V2, P1003, DOI 10.1051/jp1:1992193; Laridjani M, 1999, EUR PHYS J B, V7, P585, DOI 10.1007/s100510050651; LARIDJANI M, 1984, APPL PHYS A-MATER, V34, P111, DOI 10.1007/BF00614762; LARIDJANI M, 1982, J PHYS-PARIS, V43, P83, DOI 10.1051/jphyscol:1982915; LARIDJANI M, 1992, MACROMOLECULES, V25, P4106, DOI 10.1021/ma00042a010; LARIDJANI M, 1987, J PHYS-PARIS, V48, P1141, DOI 10.1051/jphyscol:19879209; LARIDJANI M, 1984, J NON-CRYST SOLIDS, V61-2, P367, DOI 10.1016/0022-3093(84)90576-3; Laridjani M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006228; Pauling, 1940, NATURE CHEM BOND; TAKAHASHI Y, 1973, J POLYM SCI POL PHYS, V11, P2113, DOI 10.1002/pol.1973.180111103; Warren BE, 1937, J APPL PHYS, V8, P645, DOI 10.1063/1.1710241; Zernike F., 1927, Z PHYS, V41, P184, DOI DOI 10.1007/BF01391926	31	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e109403	10.1371/journal.pone.0109403	http://dx.doi.org/10.1371/journal.pone.0109403			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329440	Green Published, Green Submitted, gold			2022-12-27	WOS:000343942100024
J	Tefera, T; Mebrie, G				Tefera, Tamirat; Mebrie, Getye			Prevalence and Predictors of Intestinal Parasites among Food Handlers in Yebu Town, Southwest Ethiopia	PLOS ONE			English	Article							INFECTIONS; BURDEN; AREA	Background: As a result of urbanization, eating and drinking from food service establishments is becoming a common practice in developing countries like Ethiopia, which increases the chances of food borne diseases. The health status and hygiene practices of food handlers are the major determinants of food contamination. In developing countries where there are poor regulatory systems for food hygiene, food handlers are often appointed without screening for possible infections associated with poor hygiene like intestinal parasites. Objective: This study aimed at determining the prevalence and predictors of intestinal parasites and assessing the hygiene practices among food handlers in Yebu Town, southwest Ethiopia. Methods: A cross-sectional study was conducted among a total of 118 food handlers in Yebu Town in January 2011. Fresh stool specimens were collected and processed using both direct wet mount and Formol ether concentration techniques. Results: The overall prevalence of intestinal parasites among the study subjects was 44.1% (52/118). Ascaris lumbricoides and hookworm spp were the predominant parasites identified from the stool of study participants. Age above 35 years (AOR: 4.8, 95% CI: 1.1, 21.8), no regular practice of washing hands before a meal (AOR: 7.8, 95% CI: 2.8, 24.8), and untrimmed finger nail (AOR: 14.7, 95% CI: 2.8, 75.4) were independent predictors of intestinal parasitic infection among the food handlers. Conclusion: The present study showed high prevalence of intestinal parasites among the study subjects. The study also revealed poor personal hygiene like poor practice of hand washing and poor finger nail hygiene. Therefore, much has to be done to improve the personal hygiene of the food handlers. Pre-placement and periodic screening of food handlers for parasites and prompt treatment, and health education on regular trimming or cleaning of fingernails would be the way forward for prevention of food borne diseases.	[Tefera, Tamirat] Jimma Univ, Dept Med Lab Sci & Pathol, Coll Publ Hlth & Med Sci, Jimma, Ethiopia; [Mebrie, Getye] Yebu Hlth Ctr, Jimma Zone, Ethiopia	Jimma University	Tefera, T (corresponding author), Jimma Univ, Dept Med Lab Sci & Pathol, Coll Publ Hlth & Med Sci, Jimma, Ethiopia.	tamirat.tefera@ju.edu.et		Temesgen, Tamirat Tefera/0000-0002-6946-5055				Abera B, 2010, ETHIOP J HEALTH DEV, V24, P46; AI-Hindi A, 2012, ANN ALQUDS MED, V8, P2; Andargie G, 2008, J HEALTH POPUL NUTR, V26, P451; Chan MS, 1997, PARASITOL TODAY, V13, P438, DOI 10.1016/S0169-4758(97)01144-7; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Deribe K, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-240; Egbuobi RC, 2014, OPEN J MED MICROBIOL, V4, P23; Idowu O A, 2006, Afr Health Sci, V6, P160; Kaferstein F, 1999, B WORLD HEALTH ORGAN, V77, P347; Kalantan K A, 2001, J Family Community Med, V8, P67; Kretchy JP, 2009, J TROPICAL MED PARAS, V32, P1; Mariam S. T., 2000, Ethiopian Journal of Health Development, V14, P91; Mohan U., 2006, Indian Journal of Community Medicine, V31, P60; Mudey A.B., 2010, GLOBAL J HLTH SCI, V2, P198, DOI [10.5539/gjhs.v2n2p198, DOI 10.5539/GJHS.V2N2P198]; Nigusse D, 2012, GLOB ADV RES J SOC S, V1, P065; Nyarango RM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-237; Okyay P, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-64; Omalu I. C. J., 2013, Annual Review and Research in Biology, V3, P705; Duc PP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-102; Saeed HA, 2010, J MICROBIOL IMMUNOL, V43, P70, DOI 10.1016/S1684-1182(10)60010-2; Sahlemariam Z, 2001, ETHIOP J HLTH SCI, V11, P131; Schlundt J, 2004, REV SCI TECH OIE, V23, P513, DOI 10.20506/rst.23.2.1506; Suriptiastuti, 2011, UNIVERSA MED, V30, P120; Wegayehu T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-151; WHO, 1989, HLTH ELD, P7; Who, 2007, FOOD SAF FOOD BORN I; World Health Organization, 1991, BAS LAB METH MED PAR	27	39	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110621	10.1371/journal.pone.0110621	http://dx.doi.org/10.1371/journal.pone.0110621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329050	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204100097
J	Wen, ML; Gao, Y; Wang, LJ; Ran, LY; Li, JH; Luo, KM				Wen, Mengling; Gao, Yuan; Wang, Lijun; Ran, Lingyu; Li, Jiahui; Luo, Keming			Split-Cre Complementation Restores Combination Activity on Transgene Excision in Hair Roots of Transgenic Tobacco	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; DNA RECOMBINATION; SELECTABLE MARKER; GENE; EXPRESSION; SYSTEM; SEQUENCES; TRANSFORMATION; SPECIFICITY; DELETION	The Cre/loxP system is increasingly exploited for genetic manipulation of DNA in vitro and in vivo. It was previously reported that inactive "split-Cre'' fragments could restore Cre activity in transgenic mice when overlapping co-expression was controlled by two different promoters. In this study, we analyzed recombination activities of split-Cre proteins, and found that no recombinase activity was detected in the in vitro recombination reaction in which only the N-terminal domain (NCre) of split-Cre protein was expressed, whereas recombination activity was obtained when the C-terminal (CCre) or both NCre and CCre fragments were supplied. We have also determined the recombination efficiency of split-Cre proteins which were co-expressed in hair roots of transgenic tobacco. No Cre recombination event was observed in hair roots of transgenic tobacco when the NCre or CCre genes were expressed alone. In contrast, an efficient recombination event was found in transgenic hairy roots co-expressing both inactive split-Cre genes. Moreover, the restored recombination efficiency of split-Cre proteins fused with the nuclear localization sequence (NLS) was higher than that of intact Cre in transgenic lines. Thus, DNA recombination mediated by split-Cre proteins provides an alternative method for spatial and temporal regulation of gene expression in transgenic plants.	[Wen, Mengling; Gao, Yuan; Wang, Lijun; Ran, Lingyu; Li, Jiahui; Luo, Keming] Southwest Univ, Key Lab Ecoenvironm Gorges Reservoir Reservoir Re, Sch Life Sci, Minist Educ,Inst Resources Bot, Chongqing, Peoples R China; [Wen, Mengling; Gao, Yuan; Wang, Lijun; Ran, Lingyu; Li, Jiahui; Luo, Keming] Southwest Univ, Chongqing Key Lab Transgen Plant & Safety Control, Chongqing, Peoples R China; [Luo, Keming] Chinese Acad Sci, Northwest Inst Plateau Biol, Key Lab Adaptat & Evolut Plateau Biota, Xining, Peoples R China	Southwest University - China; Southwest University - China; Chinese Academy of Sciences	Luo, KM (corresponding author), Southwest Univ, Key Lab Ecoenvironm Gorges Reservoir Reservoir Re, Sch Life Sci, Minist Educ,Inst Resources Bot, Chongqing, Peoples R China.	kemingl@swu.edu.cn	wang, lijun/GWZ-6960-2022	wang, lijun/0000-0002-8511-7181	National Natural Science Foundation of China [31370672, 31171620]; National Key Project for Research on Transgenic Plant [2011ZX08010-003]; 100 Talents Programme of The Chinese Academy of Sciences; Natural Science Foundation Project of CQ CSTC [CSTC2013JJB8007]; program for New Century Excellent Talents in University [NCET-11-0700]; Fundamental Research Funds for the Central Universities [XDJK2014a005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Project for Research on Transgenic Plant; 100 Talents Programme of The Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC); program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (31370672, 31171620), the National Key Project for Research on Transgenic Plant (2011ZX08010-003), 100 Talents Programme of The Chinese Academy of Sciences, the Natural Science Foundation Project of CQ CSTC (CSTC2013JJB8007), the program for New Century Excellent Talents in University (NCET-11-0700), the Fundamental Research Funds for the Central Universities (XDJK2014a005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABREMSKI K, 1983, CELL, V32, P1301, DOI 10.1016/0092-8674(83)90311-2; Bai XQ, 2008, TRANSGENIC RES, V17, P1035, DOI 10.1007/s11248-008-9182-7; Casanova E, 2003, GENESIS, V37, P25, DOI 10.1002/gene.10227; CHEN C, 1990, BIOTECHNOL BIOENG, V36, P993, DOI 10.1002/bit.260361004; CHEN H, 1994, BIOTECHNIQUES, V16, P664; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Delneri D, 2000, GENE, V252, P127, DOI 10.1016/S0378-1119(00)00217-1; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; FRALEY RT, 1986, CRC CR REV PLANT SCI, V4, P1, DOI 10.1080/07352688609382217; Gu H, 2013, J IMMUNOL, V191, P7; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; Han XZ, 2013, PLANT CELL TISS ORG, V113, P529, DOI 10.1007/s11240-013-0294-2; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hirrlinger, 2009, PLOS ONE, V4, P4286; Hirrlinger J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008354; HOESS R, 1990, J MOL BIOL, V216, P873, DOI 10.1016/S0022-2836(99)80007-2; JEFFERSON RA, 1987, J CELL BIOCHEM, P57; Jullien N, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng131; Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E; Kellendonk C, 1996, NUCLEIC ACIDS RES, V24, P1404, DOI 10.1093/nar/24.8.1404; KENTON A, 1995, CHROMOSOME RES, V3, P346, DOI 10.1007/BF00710015; Luo KM, 2007, PLANT BIOTECHNOL J, V5, P263, DOI 10.1111/j.1467-7652.2006.00237.x; Luo KM, 2006, PLANT CELL REP, V25, P403, DOI 10.1007/s00299-005-0051-z; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Maruo T, 2008, NEUROSCI RES, V61, pS279; Miller AJ, 2008, NAT METHODS, V5, P227, DOI 10.1038/NMETH.1183; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Pan XF, 2005, TRANSGENIC RES, V14, P217, DOI 10.1007/s11248-004-5790-z; PETERS R, 1983, J BIOL CHEM, V258, P1427; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Roodveldt C, 2005, PROTEIN ENG DES SEL, V18, P51, DOI 10.1093/protein/gzi005; SAUER B, 1987, MOL CELL BIOL, V7, P2087, DOI 10.1128/MCB.7.6.2087; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Seidi A, 2007, BIOTECHNOL LETT, V29, P1315, DOI 10.1007/s10529-007-9406-6; Shaikh AC, 2000, J MOL BIOL, V302, P27, DOI 10.1006/jmbi.2000.3967; Sreekala C, 2005, PLANT CELL REP, V24, P86, DOI 10.1007/s00299-004-0909-5; Srivastava V, 2003, PLANT MOL BIOL, V52, P661, DOI 10.1023/A:1024839617490; STERNBERG N, 1981, J MOL BIOL, V150, P603, DOI 10.1016/0022-2836(81)90384-3; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Van Duyne GD, 2001, ANNU REV BIOPH BIOM, V30, P87, DOI 10.1146/annurev.biophys.30.1.87; Wu Y, 2008, BIOCHEM MOL BIOL EDU, V36, P43, DOI 10.1002/bmb.117; Xu YW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm559; Yang SM, 2010, P NATL ACAD SCI USA, V107, P18735, DOI 10.1073/pnas.1011957107	46	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110290	10.1371/journal.pone.0110290	http://dx.doi.org/10.1371/journal.pone.0110290			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329460	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204100057
J	de Araujo, J; de Azevedo, SM; Gaidet, N; Hurtado, RF; Walker, D; Thomazelli, LM; Ometto, T; Seixas, MMM; Rodrigues, R; Galindo, DB; da Silva, ACS; Rodrigues, AMM; Bomfim, LL; Mota, MA; Larrazabal, ME; Branco, JO; Serafini, P; Neto, IS; Franks, J; Webby, RJ; Webster, RG; Durigon, EL				de Araujo, Jansen; de Azevedo Junior, Severino M.; Gaidet, Nicolas; Hurtado, Renata F.; Walker, David; Thomazelli, Luciano M.; Ometto, Tatiana; Seixas, Marina M. M.; Rodrigues, Roberta; Galindo, Daniele B.; da Silva, Adriana C. S.; Rodrigues, Arlinea M. M.; Bomfim, Leonardo L.; Mota, Marcelo A.; Larrazabal, Maria E.; Branco, Joaquim O.; Serafini, Patricia; Neto, Isaac S.; Franks, John; Webby, Richard J.; Webster, Robert G.; Durigon, Edison L.			Avian Influenza Virus (H11N9) in Migratory Shorebirds Wintering in the Amazon Region, Brazil	PLOS ONE			English	Article							WILD BIRDS; A VIRUSES; SOUTH-AMERICA; SURVEILLANCE; NORTH; RECOMBINATION; PREVALENCE; ARGENTINA; WATERFOWL; GENES	Aquatic birds are the natural reservoir for avian influenza viruses (AIV). Habitats in Brazil provide stopover and wintering sites for water birds that migrate between North and South America. The current study was conducted to elucidate the possibility of the transport of influenza A viruses by birds that migrate annually between the Northern and Southern Hemispheres. In total, 556 orotracheal/cloacal swab samples were collected for influenza A virus screening using real-time RT-PCR (rRT-PCR). The influenza A virus-positive samples were subjected to viral isolation. Four samples were positive for the influenza A matrix gene by rRT-PCR. From these samples, three viruses were isolated, sequenced and characterized. All positive samples originated from a single bird species, the ruddy turnstone (Arenaria interpres), that was caught in the Amazon region at Caete Bay, Northeast Para, at Ilha de Canelas. To our knowledge, this is the first isolation of H11N9 in the ruddy turnstone in South America.	[de Araujo, Jansen; Hurtado, Renata F.; Thomazelli, Luciano M.; Ometto, Tatiana; Seixas, Marina M. M.; Durigon, Edison L.] Univ Sao Paulo, Inst Ciencias Biomed ICB II, Lab Virol Clin Mol BSL3, Sao Paulo, Brazil; [de Azevedo Junior, Severino M.; Rodrigues, Roberta] Univ Fed Rural Pernambuco, Dept Biol, Pernambuco, Brazil; [Gaidet, Nicolas] UR AGIRS, CIRAD ES, Montpellier, France; [Walker, David; Webby, Richard J.; Webster, Robert G.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Galindo, Daniele B.; Rodrigues, Arlinea M. M.; Bomfim, Leonardo L.] Agencia Defesa Agr Estado Para ADEPARA, Belem, Para, Brazil; [da Silva, Adriana C. S.; Mota, Marcelo A.] Minist Agr Pecuaria & Abastecimento, SFA PA Superintendencia Fed Agr Estado Para, Brasilia, DF, Brazil; [Larrazabal, Maria E.] Univ Fed Pernambuco, Recife, Brazil; [Branco, Joaquim O.] Univ Vale Itajai UNIVALI, Ctr Ciencias Tecnol Terra & Mar, Santa Catarina, Brazil; [Serafini, Patricia; Neto, Isaac S.] Ctr Nacl Pesquisa & Conservacao Aves Silvestres C, Cabedelo, Paraiba, Brazil	Universidade de Sao Paulo; Universidade Federal Rural de Pernambuco (UFRPE); CIRAD; St Jude Children's Research Hospital; Universidade Federal de Pernambuco; Universidade do Vale do Itajai	de Araujo, J (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed ICB II, Lab Virol Clin Mol BSL3, Sao Paulo, Brazil.	jansentequila@usp.br	Webby, Richard J/N-5657-2018; Thomazelli, Luciano/Q-6119-2017; Gaidet, Niccolas/H-8122-2013; Rodrigues, Roberta/AGG-3342-2022	Thomazelli, Luciano/0000-0002-9157-6122; Araujo, Jansen/0000-0002-7250-3024; Branco, Joaquim/0000-0002-3521-1671; Durigon, Edison/0000-0003-4898-6553; de Andrade Mota, Marcelo/0000-0002-8420-4726	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento a Pesquisa (CNPq); Ministerio da Agricultura, Pecuaria e Abastecimento (MAPA); Wildlife Conservation Society (WCS); National Institute of Allergy and Infectious Diseases of the National Institutes of Health [HHSN266200700005C]; ALSAC	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento a Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministerio da Agricultura, Pecuaria e Abastecimento (MAPA); Wildlife Conservation Society (WCS); National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ALSAC(American Lebanese Syrian Associated Charities (ALSAC))	This work has been funded in part by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Desenvolvimento a Pesquisa (CNPq), Ministerio da Agricultura, Pecuaria e Abastecimento (MAPA), the Wildlife Conservation Society (WCS) and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, under contract number HHSN266200700005C and ALSAC. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alvarez P, 2010, VIROLOGY, V396, P76, DOI 10.1016/j.virol.2009.10.009; Antas PTZ, 1983, WADER STUDY GROUP B, V39, P51; AYMARDHENRY M, 1973, B WORLD HEALTH ORGAN, V48, P199; AZEVEDO JUNIOR S. M., 2001, ARARAJUBA, V9, P33; BEARE AS, 1991, ARCH VIROL, V119, P37, DOI 10.1007/BF01314321; Blanco DE, 2007, MAPPING WATERBIRD DI, P1; Brown JD, 2010, J WILDLIFE DIS, V46, P896, DOI 10.7589/0090-3558-46.3.896; Chen E, 2013, EURO SURVEILL, V18; Curd E, 2011, J VIROL METHODS, V176, P125, DOI 10.1016/j.jviromet.2011.05.033; D'Amico VL, 2007, J WILDLIFE DIS, V43, P794, DOI 10.7589/0090-3558-43.4.794; Das A, 2008, AVIAN DIS, V52, P40, DOI 10.1637/8093-082107-Reg; Gaidet N, 2012, P ROY SOC B-BIOL SCI, V279, P1131, DOI 10.1098/rspb.2011.1417; Gaidet N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046049; Ghersi BM, 2011, J WILDLIFE DIS, V47, P792, DOI 10.7589/0090-3558-47.3.792; Ghersi BM, 2009, EMERG INFECT DIS, V15, P935, DOI 10.3201/eid1506.080981; Gonzalez-Reiche AS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032873, 10.1371/journal.pone.0046852]; Hanson BA, 2008, J WILDLIFE DIS, V44, P351, DOI 10.7589/0090-3558-44.2.351; Hoye BJ, 2010, EMERG INFECT DIS, V16, P1827, DOI 10.3201/eid1612.100589; Karamendin K, 2011, VIRUS GENES, V43, P46, DOI 10.1007/s11262-011-0603-y; Karlsson EA, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.20; Kawamoto AHN, 2005, BRAZ J MICROBIOL, V36, P88, DOI 10.1590/S1517-83822005000100017; KAWAOKA Y, 1988, VIROLOGY, V163, P247, DOI 10.1016/0042-6822(88)90260-7; Kober K, 2004, FORAGING ECOLOGY HAB; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Krauss S, 2010, P ROY SOC B-BIOL SCI, V277, P3373, DOI 10.1098/rspb.2010.1090; Lara-Resende S de M, 1982, REV BRAS ZOOL, V1, P231; Larrazábal Maria Eduarda de, 2002, Rev. Bras. Zool., V19, P1081, DOI 10.1590/S0101-81752002000400013; Lyra-Neves Rachel M. de, 2004, Rev. Bras. Zool., V21, P319, DOI 10.1590/S0101-81752004000200027; Ministerio da Saude (BR), 2004, B ELETRON EPIDEMIOL, V4, P1; Morrison RIG, 1989, CAN WILDL SERV, V2, P128; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Okamatsu M, 2013, VIRUS GENES, V47, P317, DOI 10.1007/s11262-013-0954-7; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Palmer DF, 1975, IMMUNOLOGY SERIES US; Pasick J, 2005, J GEN VIROL, V86, P727, DOI 10.1099/vir.0.80478-0; Pearce JM, 2010, VIRUS RES, V148, P44, DOI 10.1016/j.virusres.2009.12.002; Pereda AJ, 2008, VIROLOGY, V378, P363, DOI 10.1016/j.virol.2008.06.010; Rimondi A, 2011, J VIROL, V85, P13354, DOI 10.1128/JVI.05946-11; Rodrigues RC, 2009, ZOOLOGIA-CURITIBA, V26, P386, DOI 10.1590/S1984-46702009000300002; Secretaria de Vigilancia em Saude, 2005, PLAN PREP BRAS ENFR, P223; Senne DA, 2007, AVIAN DIS, V51, P167, DOI 10.1637/7621-042606R1.1; SHORTRIDGE KF, 1977, B WORLD HEALTH ORGAN, V55, P15; Sick H, 1997, ORNITOLOGIA BRASILEI, P129; Slavec B, 2012, AVIAN DIS, V56, P999, DOI 10.1637/10175-041012-ResNote.1; Spackman E, 2007, AVIAN DIS, V51, P273, DOI 10.1637/7529-032106R.1; Stallknecht DE, 2007, CURR TOP MICROBIOL, V315, P445; Stallknecht DE, 2012, J WILDLIFE DIS, V48, P382, DOI 10.7589/0090-3558-48.2.382; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Telino-Junior WR, 2003, REV BRAS ZOOL, V21, P451; Thomazelli LM, 2012, BRAZ J POULTRY SCI, V14, P1, DOI 10.1590/S1516-635X2012000100001; WEBSTER RG, 1974, B WORLD HEALTH ORGAN, V51, P325; Williams RAJ, 2012, J WILDLIFE DIS, V48, P910, DOI 10.7589/2011-02-052; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	53	28	28	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110141	10.1371/journal.pone.0110141	http://dx.doi.org/10.1371/journal.pone.0110141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329399	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210800063
J	Tang, ML; Chen, K; Yang, FX; Liu, WP				Tang, Mengling; Chen, Kun; Yang, Fangxing; Liu, Weiping			Exposure to Organochlorine Pollutants and Type 2 Diabetes: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							PERSISTENT ORGANIC POLLUTANTS; POLYCHLORINATED-BIPHENYLS; SERUM CONCENTRATIONS; INSULIN-RESISTANCE; NATIONAL-HEALTH; RISK; ASSOCIATION; PESTICIDES; PREVALENCE; OBESITY	Objective: Though exposure to organochlorine pollutants (OCPs) is considered a risk factor for type 2 diabetes (T2DM), epidemiological evidence for the association remains controversial. A systematic review and meta-analysis was applied to quantitatively evaluate the association between exposure to OCPs and incidence of T2DM and pool the inconsistent evidence. Design and Methods: Publications in English were searched in MEDLINE and WEB OF SCIENCE databases and related reference lists up to August 2013. Quantitative estimates and information regarding study characteristics were extracted from 23 original studies. Quality assessments of external validity, bias, exposure measurement and confounding were performed, and subgroup analyses were conducted to examine the heterogeneity sources. Results: We retrieved 23 eligible articles to conduct this meta-analysis. OR (odds ratio) or RR (risk ratio) estimates in each subgroup were discussed, and the strong associations were observed in PCB-153 (OR, 1.52; 95% CI, 1.19-1.94), PCBs (OR, 2.14; 95% CI, 1.53-2.99), and p,p'-DDE (OR, 1.33; 95% CI, 1.15-1.54) based on a random-effects model. Conclusions: This meta-analysis provides quantitative evidence supporting the conclusion that exposure to organochlorine pollutants is associated with an increased risk of incidence of T2DM.	[Tang, Mengling; Yang, Fangxing; Liu, Weiping] Zhejiang Univ, Coll Environm & Resource Sci, MOE Key Lab Environm Remediat & Ecosyst Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Kun] Zhejiang Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Liu, WP (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, MOE Key Lab Environm Remediat & Ecosyst Hlth, Hangzhou 310003, Zhejiang, Peoples R China.	wliu@zju.edu.cn	Yang, Fangxing/G-8677-2011; Liu, Weiping/E-9208-2010; Tang, Mengling/N-1066-2014	Yang, Fangxing/0000-0002-3558-1410; Liu, Weiping/0000-0002-1173-892X; Tang, Mengling/0000-0003-2876-9199	National Natural Science Foundations of China [21177112, 21320102007]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundations of China (21177112, 21320102007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen R, 2011, DIABETES CARE, V34, P1972, DOI 10.2337/dc10-2303; Arrebola JP, 2013, ENVIRON RES, V122, P31, DOI 10.1016/j.envres.2012.12.001; Bernert JT, 2007, CHEMOSPHERE, V68, P824, DOI 10.1016/j.chemosphere.2007.02.043; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Codru N, 2007, ENVIRON HEALTH PERSP, V115, P1442, DOI 10.1289/ehp.10315; Cox S, 2007, ENVIRON HEALTH PERSP, V115, P1747, DOI 10.1289/ehp.10258; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Everett CJ, 2007, ENVIRON RES, V103, P413, DOI 10.1016/j.envres.2006.11.002; Everett CJ, 2010, ENVIRON INT, V36, P398, DOI 10.1016/j.envint.2010.02.010; Everett CJ, 2011, J ENVIRON MONITOR, V13, P241, DOI 10.1039/c0em00400f; Fierens S, 2003, BIOMARKERS, V8, P529, DOI 10.1080/1354750032000158420; Gasull M, 2012, ENVIRON SCI TECHNOL, V46, P7799, DOI 10.1021/es300712g; Glynn AW, 2003, ENVIRON HEALTH PERSP, V111, P349, DOI 10.1289/ehp.5456; Govarts E, 2012, ENVIRON HEALTH PERSP, V120, P162, DOI 10.1289/ehp.1103767; Grandjean P, 2011, EPIDEMIOLOGY, V22, P410, DOI 10.1097/EDE.0b013e318212fab9; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; Gress TW, 2000, NEW ENGL J MED, V342, P905, DOI 10.1056/NEJM200003303421301; Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D; Henley P, 2012, TOXICOL ENVIRON CHEM, V94, P814, DOI 10.1080/02772248.2012.680276; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jorgensen ME, 2008, DIABETOLOGIA, V51, P1416, DOI 10.1007/s00125-008-1066-0; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Langer P, 2010, FRONT NEUROENDOCRIN, V31, P497, DOI 10.1016/j.yfrne.2010.08.001; Lee DH, 2008, DIABETES, V57, P3108, DOI 10.2337/db08-0668; Lee DH, 2007, DIABETES CARE, V30, P622, DOI 10.2337/dc06-2190; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Lee DH, 2011, DIABETES CARE, V34, P1778, DOI 10.2337/dc10-2116; Lee DH, 2010, ENVIRON HEALTH PERSP, V118, P1235, DOI 10.1289/ehp.0901480; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Longnecker MP, 2001, DIABETES CARE, V24, P1099, DOI 10.2337/diacare.24.6.1099; Lopez-Cervantes M, 2004, ENVIRON HEALTH PERSP, V112, P207, DOI [10.1289/ehp.6492, 10.1289/ehp.112-1241830]; MANTEL N, 1959, J NATL CANCER I, V22, P719; Montgomery MP, 2008, AM J EPIDEMIOL, V167, P1235, DOI 10.1093/aje/kwn028; Navas-Acien A, 2006, ENVIRON HEALTH PERSP, V114, P641, DOI 10.1289/ehp.8551; Ntow WJ, 2008, ENVIRON RES, V106, P17, DOI 10.1016/j.envres.2007.05.020; Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746; Persky V, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-57; Philibert A, 2009, INT J ENV RES PUB HE, V6, P3179, DOI 10.3390/ijerph6123179; Remillard RBJ, 2002, ENVIRON HEALTH PERSP, V110, P853, DOI 10.1289/ehp.02110853; Ren AG, 2011, P NATL ACAD SCI USA, V108, P12770, DOI 10.1073/pnas.1105209108; Rignell-Hydbom A, 2007, HUM EXP TOXICOL, V26, P447, DOI 10.1177/0960327107076886; Rignell-Hydbom A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007503; Rylander L, 2005, ENV HLTH, V4, P28; Silverstone AE, 2012, ENVIRON HEALTH PERSP, V120, P727, DOI 10.1289/ehp.1104247; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Son HK, 2010, ENVIRON INT, V36, P410, DOI 10.1016/j.envint.2010.02.012; Tanaka T, 2011, ENDOCR J, V58, P589, DOI 10.1507/endocrj.K10E-361; Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597; Turner Michelle C, 2010, Environ Health Perspect, V118, P33, DOI 10.1289/ehp.0900966; Turyk M, 2009, ENVIRON HEALTH PERSP, V117, P1076, DOI 10.1289/ehp.0800281; Turyk M, 2009, CHEMOSPHERE, V75, P674, DOI 10.1016/j.chemosphere.2008.12.035; Ukropec J, 2010, DIABETOLOGIA, V53, P899, DOI 10.1007/s00125-010-1683-2; Vasiliu O, 2006, EPIDEMIOLOGY, V17, P352, DOI 10.1097/01.ede.0000220553.84350.c5; Vrijheid M, 2011, ENVIRON HEALTH PERSP, V119, P598, DOI 10.1289/ehp.1002946; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang SL, 2008, DIABETES CARE, V31, P1574, DOI 10.2337/dc07-2449; Wigle DT, 2009, ENVIRON HEALTH PERSP, V117, P1505, DOI 10.1289/ehp.0900582; Wu HY, 2013, ENVIRON HEALTH PERSP, V121, P153, DOI 10.1289/ehp.1205248	59	39	41	5	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2014	9	10							e85556	10.1371/journal.pone.0085556	http://dx.doi.org/10.1371/journal.pone.0085556			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IH	25329153	gold, Green Published, Green Submitted			2022-12-27	WOS:000346766200001
J	Inoue, AH; Serpeloni, M; Hiraiwa, PM; Yamada-Ogatta, SF; Muniz, JRC; Motta, MCM; Vidal, NM; Goldenberg, S; Avila, AR				Inoue, Alexandre Haruo; Serpeloni, Mariana; Hiraiwa, Priscila Mazzocchi; Yamada-Ogatta, Sueli Fumie; Carvalho Muniz, Joao Renato; Machado Motta, Maria Cristina; Vidal, Newton Medeiros; Goldenberg, Samuel; Avila, Andrea Rodrigues			Identification of a Novel Nucleocytoplasmic Shuttling RNA Helicase of Trypanosomes	PLOS ONE			English	Article							INDUCIBLE EXPRESSION SYSTEM; NUCLEAR-PORE COMPLEX; MESSENGER-RNA; EXPORT RECEPTOR; BINDING PROTEINS; GENE; TRANSPORT; CRM1; FAMILY; CRUZI	Gene expression in trypanosomes is controlled mostly by post-transcriptional pathways. Little is known about the components of mRNA nucleocytoplasmic export routes in these parasites. Comparative genomics has shown that the mRNA transport pathway is the least conserved pathway among eukaryotes. Nonetheless, we identified a RNA helicase (Hel45) that is conserved across eukaryotes and similar to shuttling proteins involved in mRNA export. We used in silico analysis to predict the structure of Trypanosoma cruzi Hel45, including the N-terminal domain and the C-terminal domain, and our findings suggest that this RNA helicase can form complexes with mRNA. Hel45 was present in both nucleus and cytoplasm. Electron microscopy showed that Hel45 is clustered close to the cytoplasmic side of nuclear pore complexes, and is also present in the nucleus where it is associated with peripheral compact chromatin. Deletion of a predicted Nuclear Export Signal motif led to the accumulation of Hel45 Delta NES in the nucleus, indicating that Hel45 shuttles between the nucleus and the cytoplasm. This transport was dependent on active transcription but did not depend on the exportin Crm1. Knockdown of Mex67 in T. brucei caused the nuclear accumulation of the T. brucei ortholog of Hel45. Indeed, Hel45 is present in mRNA ribonucleoprotein complexes that are not associated with polysomes. It is still necessary to confirm the precise function of Hel45. However, this RNA helicase is associated with mRNA metabolism and its nucleocytoplasmic shuttling is dependent on an mRNA export route involving Mex67 receptor.	[Inoue, Alexandre Haruo; Serpeloni, Mariana; Hiraiwa, Priscila Mazzocchi; Vidal, Newton Medeiros; Goldenberg, Samuel; Avila, Andrea Rodrigues] Fiocruz MS, Inst Carlos Chagas, Curitiba, Parana, Brazil; [Serpeloni, Mariana] Univ Fed Parana, Dept Biol Celular & Mol, BR-80060000 Curitiba, Parana, Brazil; [Yamada-Ogatta, Sueli Fumie] Univ Estadual Londrina, Dept Microbiol, Londrina, Brazil; [Carvalho Muniz, Joao Renato] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil; [Machado Motta, Maria Cristina] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Dept Biol Celular & Parasitol, BR-21941 Rio De Janeiro, Brazil; [Vidal, Newton Medeiros] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	Fundacao Oswaldo Cruz; Universidade Federal do Parana; Universidade Estadual de Londrina; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Avila, AR (corresponding author), Fiocruz MS, Inst Carlos Chagas, Curitiba, Parana, Brazil.	aravila@fiocruz.br	GOLDENBERG, SAMUEL/B-4116-2009; Yamada-Ogatta, Sueli Fumie/C-7020-2019; Muniz, Joao R/B-7782-2016; Motta, Maria Cristina M/I-3140-2014; Goldenberg, Samuel/ABD-8908-2022	GOLDENBERG, SAMUEL/0000-0002-4892-163X; Yamada-Ogatta, Sueli Fumie/0000-0003-1183-146X; Muniz, Joao R/0000-0003-2731-3966; Motta, Maria Cristina/0000-0002-0947-4830	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Oswaldo Cruz (PAPES- FIOCRUZ Program); Fundacao Araucaria-PR	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Oswaldo Cruz (PAPES- FIOCRUZ Program); Fundacao Araucaria-PR(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA)	Funding was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao Oswaldo Cruz (PAPES- FIOCRUZ Program) and Fundacao Araucaria-PR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alves LR, 2010, GENE, V452, P72, DOI 10.1016/j.gene.2009.12.009; Batista M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-259; Bercovich N, 2009, MOL BIOCHEM PARASIT, V166, P190, DOI 10.1016/j.molbiopara.2009.03.008; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Cassola A, 2009, J BIOL CHEM, V284, P35015, DOI 10.1074/jbc.M109.031633; Chan CC, 2004, RNA, V10, P200, DOI 10.1261/rna.5230104; CONTRERAS V T, 1988, Memorias do Instituto Oswaldo Cruz, V83, P123, DOI 10.1590/S0074-02761988000100016; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Cuevas IC, 2005, MOL BIOCHEM PARASIT, V139, P15, DOI 10.1016/j.molbiopara.2004.11.002; D'Orso I, 2003, TRENDS PARASITOL, V19, P151, DOI 10.1016/S1471-4922(03)00035-7; D'Orso I, 2001, J BIOL CHEM, V276, P34801, DOI 10.1074/jbc.M102120200; Dallagiovanna B, 2001, EXP PARASITOL, V99, P7, DOI 10.1006/expr.2001.4628; Dallagiovanna B, 2008, J BIOL CHEM, V283, P8266, DOI 10.1074/jbc.M703097200; DaRocha WD, 2004, MOL BIOCHEM PARASIT, V133, P175, DOI 10.1016/j.molbiopara.2003.10.005; Delhi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025112; Dong X, 2012, NATURE, V458, P1136; Dostalova A, 2013, MOL MICROBIOL, V88, P728, DOI 10.1111/mmi.12217; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferraiuolo MA, 2004, P NATL ACAD SCI USA, V101, P4118, DOI 10.1073/pnas.0400933101; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fu S, 2011, NUCLEIC ACIDS RES, V39, P1; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Hellman K, 2007, EUKARYOT CELL, V6, P2206, DOI 10.1128/EC.00176-07; Herold A, 2003, EMBO J, V22, P2472, DOI 10.1093/emboj/cdg233; Hodge CA, 1999, EMBO J, V18, P5778, DOI 10.1093/emboj/18.20.5778; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kolev NG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001090; LEBOWITZ JH, 1993, GENE DEV, V7, P996, DOI 10.1101/gad.7.6.996; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; LU HY, 1991, MOL BIOCHEM PARASIT, V44, P109, DOI 10.1016/0166-6851(91)90226-V; Lu WT, 2014, BIOCHEM SOC T, V42, P166, DOI 10.1042/BST20130161; Lund MK, 2005, MOL CELL, V20, P645, DOI 10.1016/j.molcel.2005.10.005; Maquat LE, 2005, J CELL SCI, V118, P1773, DOI 10.1242/jcs.01701; MATTHEWS KR, 1994, GENE DEV, V8, P491, DOI 10.1101/gad.8.4.491; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; Mor A, 2010, NAT CELL BIOL, V12, P543, DOI 10.1038/ncb2056; Motta MCM, 2003, FEMS MICROBIOL LETT, V221, P17, DOI 10.1016/S0378-1097(03)00087-9; Nazer E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019920; Neville M, 1999, EMBO J, V18, P3746, DOI 10.1093/emboj/18.13.3746; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; de Souza FSP, 2010, MOL BIOCHEM PARASIT, V172, P90, DOI 10.1016/j.molbiopara.2010.03.014; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roberts TG, 1998, MOL CELL BIOL, V18, P4409, DOI 10.1128/MCB.18.8.4409; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Schwede A, 2009, NUCLEIC ACIDS RES, V37, P5511, DOI 10.1093/nar/gkp571; Serpeloni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020730; Serpeloni M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-7; Siebrasse JP, 2012, P NATL ACAD SCI USA, V2012, P1; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Strom AC, 2001, GENOME BIOL, V2; Tatusova T, 2014, NUCLEIC ACIDS RES, V42, pD553, DOI 10.1093/nar/gkt1274; VANHAMME L, 1995, MICROBIOL REV, V59, P223, DOI 10.1128/MMBR.59.2.223-240.1995; Watanabe M, 1999, GENES CELLS, V4, P291, DOI 10.1046/j.1365-2443.1999.00259.x; Westbrook J, 2002, NUCLEIC ACIDS RES, V30, P245, DOI 10.1093/nar/30.1.245; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	63	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109521	10.1371/journal.pone.0109521	http://dx.doi.org/10.1371/journal.pone.0109521			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313564	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662500047
J	Lee, SML; Schelcher, C; Laubender, RP; Frose, N; Thasler, RMK; Schiergens, TS; Mansmann, U; Thasler, WE				Lee, Serene M. L.; Schelcher, Celine; Laubender, Ruediger P.; Froese, Natalja; Thasler, Reinhard M. K.; Schiergens, Tobias S.; Mansmann, Ulrich; Thasler, Wolfgang E.			An Algorithm that Predicts the Viability and the Yield of Human Hepatocytes Isolated from Remnant Liver Pieces Obtained from Liver Resections	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; FIBROSIS; CAPILLARIZATION; SORAFENIB; SINUSOIDS; MECHANISM; TOXICITY; CULTURES; OXIDASE	Isolated human primary hepatocytes are an essential in vitro model for basic and clinical research. For successful application as a model, isolated hepatocytes need to have a good viability and be available in sufficient yield. Therefore, this study aims to identify donor characteristics, intra-operative factors, tissue processing and cell isolation parameters that affect the viability and yield of human hepatocytes. Remnant liver pieces from tissue designated as surgical waste were collected from 1034 donors with informed consent. Human hepatocytes were isolated by a two-step collagenase perfusion technique with modifications and hepatocyte yield and viability were subsequently determined. The accompanying patient data was collected and entered into a database. Univariate analyses found that the viability and the yield of hepatocytes were affected by many of the variables examined. Multivariate analyses were then carried out to confirm the factors that have a significant relationship with the viability and the yield. It was found that the viability of hepatocytes was significantly decreased by the presence of fibrosis, liver fat and with increasing gamma-glutamyltranspeptidase activity and bilirubin content. Yield was significantly decreased by the presence of liver fat, septal fibrosis, with increasing aspartate aminotransferase activity, cold ischemia times and weight of perfused liver. However, yield was significantly increased by chemotherapy treatment. In conclusion, this study determined the variables that have a significant effect on the viability and the yield of isolated human hepatocytes. These variables have been used to generate an algorithm that can calculate projected viability and yield of isolated human hepatocytes. In this way, projected viability can be determined even before isolation of hepatocytes, so that donors that result in high viability and yield can be identified. Further, if the viability and yield of the isolated hepatocytes is lower than expected, this will highlight a methodological problem that can be addressed.	[Lee, Serene M. L.; Froese, Natalja; Schiergens, Tobias S.; Thasler, Wolfgang E.] Univ Munich, Grosshadern Hosp, Dept Gen Visceral Transplantat Vasc & Thorac Surg, Munich, Germany; [Schelcher, Celine; Thasler, Reinhard M. K.] Univ Munich, Tissue Bank, Dept Gen Visceral Transplantat Vasc & Thorac Surg, Munich, Germany; [Laubender, Ruediger P.; Mansmann, Ulrich] Univ Munich, Grosshadern Hosp, Inst Med Informat Proc Biometry & Epidemiol, Munich, Germany	University of Munich; University of Munich; University of Munich	Thasler, WE (corresponding author), Univ Munich, Grosshadern Hosp, Dept Gen Visceral Transplantat Vasc & Thorac Surg, Munich, Germany.	Wolfgang.Thasler@med.uni-muenchen.de		Lee, Serene/0000-0001-5231-0607	Federal Ministry of Education and Research (grant name: Virtual Liver Network) [0315759]; Hepacult GmbH	Federal Ministry of Education and Research (grant name: Virtual Liver Network); Hepacult GmbH	WET received a grant from the Federal Ministry of Education and Research (grant name: Virtual Liver Network, grant number: 0315759) and a grant from Hepacult GmbH. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alexandre E., 2002, Cell and Tissue Banking, V3, P223; Alexandrova K, 2005, CELL TRANSPLANT, V14, P845, DOI 10.3727/000000005783982530; Anavi S, 2012, FREE RADICAL BIO MED, V52, P1531, DOI 10.1016/j.freeradbiomed.2012.02.014; Bartlett DC, 2014, CYTOTHERAPY, V16, P800, DOI 10.1016/j.jcyt.2014.01.006; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; BHUNCHET E, 1993, HEPATOLOGY, V18, P1450; BRAMBILLA G, 1993, CYTOTECHNOLOGY, V11, P6; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Canbay A, 2003, LAB INVEST, V83, P655, DOI 10.1097/01.LAB.0000069036.63405.5C; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; De Souza MM, 2006, PATHOL RES PRACT, V202, P883, DOI 10.1016/j.prp.2006.07.004; Deng YR, 2013, J AUTOIMMUN; DROZDZ M, 1977, ARCH IMMUNOL THER EX, V25, P773; Ennulat D, 2010, TOXICOL SCI, V116, P397, DOI 10.1093/toxsci/kfq144; Farrell GC, 2008, ANAT REC, V291, P684, DOI 10.1002/ar.20715; Fotiadu A, 2010, PATHOL INT, V60, P87, DOI 10.1111/j.1440-1827.2009.02489.x; Gramignoli R, 2013, STEM CELL RES, V11, P563, DOI 10.1016/j.scr.2013.03.002; Gramignoli R, 2012, CELL TRANSPLANT, V21, P1245, DOI 10.3727/096368911X600939; Greupink R, 2006, J PHARMACOL EXP THER, V317, P514, DOI 10.1124/jpet.105.099499; Hewes JC, 2006, J HEPATOL, V45, P263, DOI 10.1016/j.jhep.2006.02.015; Hong F, 2013, DIGEST DIS SCI, V58, P257, DOI 10.1007/s10620-012-2325-y; IQBAL S, 1991, J HEPATOL, V12, P336, DOI 10.1016/0168-8278(91)90837-2; Johnston DE, 1999, AM FAM PHYSICIAN, V59, P2223; Kawahara T, 2010, LIVER TRANSPLANT, V16, P974, DOI 10.1002/lt.22099; Lee SML, 2013, JOVE-J VIS EXP, DOI 10.3791/50615; Lloyd T. D. R., 2004, Cell and Tissue Banking, V5, P81, DOI 10.1023/B:CATB.0000034079.10985.bd; Mitry RR, 2003, CELL TRANSPLANT, V12, P69, DOI 10.3727/000000003783985197; Nyblom H, 2004, ALCOHOL ALCOHOLISM, V39, P336, DOI 10.1093/alcalc/agh074; Olson H, 2000, REGUL TOXICOL PHARM, V32, P56, DOI 10.1006/rtph.2000.1399; Richert L, 2004, LIVER INT, V24, P371, DOI 10.1111/j.1478-3231.2004.0930.x; Russell WMS., 1959, MED J AUSTRALIA; Sauerbrei W, 1999, J R STAT SOC A STAT, V162, P71, DOI 10.1111/1467-985X.00122; SEGLEN PO, 1973, EXP CELL RES, V82, P391, DOI 10.1016/0014-4827(73)90357-1; Serralta A, 2003, TOXICOL IN VITRO, V17, P769, DOI 10.1016/S0887-2333(03)00122-X; Shin WG, 2007, GUT LIVER, V1, P145, DOI 10.5009/gnl.2007.1.2.145; Shionoya T, 1927, J EXP MED, V46, P957, DOI 10.1084/jem.46.6.957; Thasler Wolfgang E., 2003, Cell and Tissue Banking, V4, P49, DOI 10.1023/A:1026392429112; Van Beers BE, 2003, MAGN RESON MED, V49, P692, DOI 10.1002/mrm.10420; Vondran FWR, 2008, ARTIF ORGANS, V32, P205, DOI 10.1111/j.1525-1594.2007.00524.x; Wang Y, 2010, J HEPATOL, V53, P132, DOI 10.1016/j.jhep.2010.02.027; Yoon JH, 2002, J HEPATOL, V37, P400, DOI 10.1016/S0168-8278(02)00209-X; Zhan SS, 2006, HEPATOLOGY, V43, P435, DOI 10.1002/hep.21093	42	232	234	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e107567	10.1371/journal.pone.0107567	http://dx.doi.org/10.1371/journal.pone.0107567			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313881	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500004
J	Scott, A; Hardefeldt, JM; Hall, KC				Scott, Anna; Hardefeldt, Jannah M.; Hall, Karina C.			Asexual Propagation of Sea Anemones That Host Anemonefishes: Implications for the Marine Ornamental Aquarium Trade and Restocking Programs	PLOS ONE			English	Article							ENTACMAEA-QUADRICOLOR; HETERACTIS-CRISPA; GROWTH; REGENERATION; FISH	Anemonefishes and their host sea anemones form an iconic symbiotic association in reef environments, and are highly sought after in the marine aquarium trade. This study examines asexual propagation as a method for culturing a geographically widespread and commonly traded species of host sea anemone, Entacmaea quadricolor. Two experiments were done: the first to establish whether size or colour morph influenced survival after cutting into halves or quarters; and the second to see whether feeding was needed to maximise survival and growth after cutting. Survival rates were high in both experiments, with 89.3 and 93.8% of the anemones cut in half, and 62.5 and 80.4% cut in quarters surviving in experiments 1 and 2, respectively. Anemones that were cut in half were larger in size, and healed and grew quicker than those cut in quarters. However, even though survival was lower when the individuals were cut in quarters, this treatment produced the greatest number of anemones. Feeding increased oral disc diameter growth and reduced wet weight loss, but did not significantly influence pedal disc diameter. Given that the anemones took up to 56 d to form an off-centre mouth, it is highly likely that feeding may have produced greater effect if the experiment was run for longer. This low technology method of propagation could be used to produce individuals throughout the year and the anemones could then be used to supply the aquarium trade or restock depleted habitats, thus supporting biodiversity conservation in coral reef areas.	[Scott, Anna] Southern Cross Univ, Sch Environm Sci & Engn, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia; Southern Cross Univ, Sch Environm Sci & Engn, Marine Ecol Res Ctr, Coffs Harbour, NSW, Australia	Southern Cross University; Southern Cross University	Scott, A (corresponding author), Southern Cross Univ, Sch Environm Sci & Engn, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia.	anna.scott@scu.edu.au	Scott, Anna/S-6141-2017	Scott, Anna/0000-0001-6894-8808; Hall, Karina/0000-0002-0519-4030	Associate Deans Research Support Scheme; Marine Ecology Research Centre, Southern Cross University	Associate Deans Research Support Scheme; Marine Ecology Research Centre, Southern Cross University	Funding for this research was provided by the Associate Deans Research Support Scheme and the Marine Ecology Research Centre, Southern Cross University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baums IB, 2008, MOL ECOL, V17, P2796, DOI 10.1111/j.1365-294X.2008.03787.x; Bell JD, 2006, FISH RES, V80, P1, DOI 10.1016/j.fishres.2006.03.008; Borneman EH, 2001, B MAR SCI, V69, P897; Chomsky O, 2004, J EXP MAR BIOL ECOL, V299, P217, DOI 10.1016/j.jembe.2003.09.009; Dunn D.F., 1981, Transactions of the American Philosophical Society, V71, P1; EDWARDS AJ, 1992, ENVIRON CONSERV, V19, P61, DOI 10.1017/S0376892900030265; Fautin DG, 1997, ANEMONEFISHES THEIR; FITT WK, 1981, MAR BIOL, V61, P199, DOI 10.1007/BF00386660; Gasparini JL, 2005, BIODIVERS CONSERV, V14, P2883, DOI 10.1007/s10531-004-0222-1; HIROSE Y, 1985, Galaxea, V4, P113; Leal MC, 2012, AQUACULTURE, V354, P91, DOI 10.1016/j.aquaculture.2012.03.035; Mire P, 1998, J EXP ZOOL, V282, P344; Moorhead JA, 2010, REV FISH SCI, V18, P315, DOI 10.1080/10641262.2010.516035; Muller-Parker G, 2001, INVERTEBR BIOL, V120, P104, DOI 10.1111/j.1744-7410.2001.tb00115.x; Olivotto I, 2011, J WORLD AQUACULT SOC, V42, P135, DOI 10.1111/j.1749-7345.2011.00453.x; Passamaneck YJ, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-34; Porat D, 2004, HYDROBIOLOGIA, V530, P513, DOI 10.1007/s10750-004-2688-y; Porat D, 2005, MAR FRESHW BEHAV PHY, V38, P43, DOI 10.1080/10236240500057929; Purcell S.W., 2012, ASIA PACIFIC TROPICA, P92; Roopin M, 2009, J EXP MAR BIOL ECOL, V370, P27, DOI 10.1016/j.jembe.2008.11.006; Scott A, 2005, CORAL REEFS, V24, P208, DOI 10.1007/s00338-005-0488-0; Scott A, 2008, MAR BIOL, V154, P833, DOI 10.1007/s00227-008-0976-1; Scott A, 2007, INVERTEBR REPROD DEV, V50, P163, DOI 10.1080/07924259.2007.9652241; Scott A, 2007, BIOL BULL-US, V213, P110, DOI 10.2307/25066627; Scott A, 2012, B MAR SCI, V88, P81, DOI 10.5343/bms.2011.1042; Scott A, 2009, MAR BIOL, V156, P1659, DOI 10.1007/s00227-009-1201-6; Shuman CS, 2005, CORAL REEFS, V24, P564, DOI 10.1007/s00338-005-0027-z; Shuman CS, 2004, ENVIRON CONSERV, V31, P339, DOI 10.1017/S0376892904001663; Smith ESJ, 2009, J COMP PHYSIOL A, V195, P1089, DOI 10.1007/s00359-009-0482-z; STEPHENSON T. A., 1929, JOUR MARINE BIOL ASSOC UNITED KINGDOM, V16, P131; Tlusty M, 2002, AQUACULTURE, V205, P203, DOI 10.1016/S0044-8486(01)00683-4; Tsuchida Craig B., 1994, Journal of Experimental Marine Biology and Ecology, V183, P227, DOI 10.1016/0022-0981(94)90089-2; Wabnitz C., 2003, OCEAN AQUARIUM GLOBA; Whitehead MJ, 1986, AQUARIUM FISHES COLL, P1; Wood E., 2001, COLLECTION CORAL REE; Wood E.M., 2001, AQUARIUM SCI CONSERV, V3, P65, DOI DOI 10.1023/A:1011391700880	36	12	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109566	10.1371/journal.pone.0109566	http://dx.doi.org/10.1371/journal.pone.0109566			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314131	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500052
J	Bychkov, ML; Gasparian, ME; Dolgikh, DA; Kirpichnikov, MP				Bychkov, Maxim L.; Gasparian, Marine E.; Dolgikh, Dmitry A.; Kirpichnikov, Mikhail P.			Combination of TRAIL with Bortezomib Shifted Apoptotic Signaling from DR4 to DR5 Death Receptor by Selective Internalization and Degradation of DR4	PLOS ONE			English	Article							CANCER-CELLS; MEDIATED APOPTOSIS; P53; SENSITIZES; INHIBITION; EXPRESSION; ANTIBODIES; INDUCTION; MUTANTS	TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) mediates apoptosis in cancer cells through death receptors DR4 and DR5 preferring often one receptor over another in the cells expressing both receptors. Receptor selective mutant variants of TRAIL and agonistic antibodies against DR4 and DR5 are highly promising anticancer agents. Here using DR5 specific mutant variant of TRAIL - DR5-B we have demonstrated for the first time that the sensitivity of cancer cells can be shifted from one TRAIL death receptor to another during co-treatment with anticancer drugs. First we have studied the contribution of DR4 and DR5 in HCT116 p53+/+ and HCT116 p53-/- cells and demonstrated that in HCT116 p53+/+ cells the both death receptors are involved in TRAIL-induced cell death while in HCT116 p53-/- cells prevailed DR4 signaling. The expression of death (DR4 and DR5) as well as decoy (DcR1 and DcR2) receptors was upregulated in the both cell lines either by TRAIL or by bortezomib. However, combined treatment of cells with two drugs induced strong time-dependent and p53-independent internalization and further lysosomal degradation of DR4 receptor. Interestingly DR5-B variant of TRAIL which do not bind with DR4 receptor also induced elimination of DR4 from cell surface in combination with bortezomib indicating the ligand-independent mechanism of the receptor internalization. Eliminatory internalization of DR4 resulted in activation of DR5 receptor thus DR4-dependent HCT116 p53-/- cells became highly sensitive to DR5-B in time-dependent manner. Internalization and degradation of DR4 receptor depended on activation of caspases as well as of lysosomal activity as it was completely inhibited by Z-VAD-FMK, E-64 and Baf-A1. In light of our findings, it is important to explore carefully which of the death receptors is active, when sensitizing drugs are combined with agonistic antibodies to the death receptors or receptor selective variants of TRAIL to enhance cancer treatment efficiency.	[Bychkov, Maxim L.; Gasparian, Marine E.; Dolgikh, Dmitry A.; Kirpichnikov, Mikhail P.] Shemyakin & Ovchinnikov Inst Bioorgan Chem, Dept Bioengn, Moscow, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Gasparian, ME (corresponding author), Shemyakin & Ovchinnikov Inst Bioorgan Chem, Dept Bioengn, Moscow, Russia.	marine_gasparian@yahoo.com	Chernyak, Boris V/D-9917-2012; Dolgikh, Dmitry A/F-2369-2014; Gasparian, Marine/J-6725-2018	Chernyak, Boris V/0000-0003-1523-0864; Kirpichnikov, Mikhail/0000-0001-8170-1607; Dolgikh, Dmitry/0000-0002-9880-7202; Gasparian, Marine/0000-0003-2308-2574	Program of Molecular and Cellular Biology, Russian Academy of Sciences	Program of Molecular and Cellular Biology, Russian Academy of Sciences(Russian Academy of Sciences)	This work was supported by the Program of Molecular and Cellular Biology, Russian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; An WG, 2000, LEUKEMIA, V14, P1276, DOI 10.1038/sj.leu.2401812; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Bin L, 2007, J BIOL CHEM, V282, P28189, DOI 10.1074/jbc.M704210200; Brooks AD, 2005, ANN NY ACAD SCI, V1059, P160, DOI 10.1196/annals.1339.042; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Chen KF, 2009, J BIOL CHEM, V284, P11121, DOI 10.1074/jbc.M806268200; Clancy L, 2005, P NATL ACAD SCI USA, V102, P18099, DOI 10.1073/pnas.0507329102; Conus S, 2008, BIOCHEM PHARMACOL, V76, P1374, DOI 10.1016/j.bcp.2008.07.041; de Wilt LHAM, 2013, CRIT REV ONCOL HEMAT, V85, P363, DOI 10.1016/j.critrevonc.2012.08.001; Elrod HA, 2008, CANCER BIOL THER, V7, P163, DOI 10.4161/cbt.7.2.5335; Gasparian ME, 2011, PROTEIN EXPRES PURIF, V79, P191, DOI 10.1016/j.pep.2011.04.005; Gasparian ME, 2009, APOPTOSIS, V14, P778, DOI 10.1007/s10495-009-0349-3; Georgakis GV, 2005, BRIT J HAEMATOL, V130, P501, DOI 10.1111/j.1365-2141.2005.05656.x; Griffith TS, 1999, J IMMUNOL, V162, P2597; Hymowitz SG, 2000, BIOCHEMISTRY-US, V39, P633, DOI 10.1021/bi992242l; Kelley RF, 2005, J BIOL CHEM, V280, P2205, DOI 10.1074/jbc.M410660200; Koschny R, 2007, CLIN CANCER RES, V13, P3403, DOI 10.1158/1078-0432.CCR-07-0251; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Ling X, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-8; Luster TA, 2009, MOL CANCER THER, V8, P292, DOI 10.1158/1535-7163.MCT-08-0918; MacFarlane M, 2005, CELL DEATH DIFFER, V12, P773, DOI 10.1038/sj.cdd.4401649; Mahalingam D, 2009, CANCER TREAT REV, V35, P280, DOI 10.1016/j.ctrv.2008.11.006; Marini P, 2006, ONCOGENE, V25, P5145, DOI 10.1038/sj.onc.1209516; Menke C, 2011, CANCER RES, V71, P1883, DOI 10.1158/0008-5472.CAN-10-2252; Merino D, 2006, MOL CELL BIOL, V26, P7046, DOI 10.1128/MCB.00520-06; Nagaraj NS, 2006, J CANCER RES CLIN, V132, P171, DOI 10.1007/s00432-005-0053-9; Saulle E, 2007, APOPTOSIS, V12, P635, DOI 10.1007/s10495-006-0025-9; Seki N, 2010, MOL CANCER THER, V9, P1842, DOI 10.1158/1535-7163.MCT-09-0918; Strauss SJ, 2007, CANCER RES, V67, P2783, DOI 10.1158/0008-5472.CAN-06-3254; van de Kooij B, 2013, J BIOL CHEM, V288, P6617, DOI 10.1074/jbc.M112.448209; Voortman J, 2007, MOL CANCER THER, V6, P2103, DOI 10.1158/1535-7163.MCT-07-0167; Werneburg NW, 2007, J BIOL CHEM, V282, P28960, DOI 10.1074/jbc.M705671200; Yang A, 2010, CURR OPIN CELL BIOL, V22, P837, DOI 10.1016/j.ceb.2010.08.001; Yeung BHY, 2006, J BIOL CHEM, V281, P11923, DOI 10.1074/jbc.M508533200; Yu R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.19	36	13	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109756	10.1371/journal.pone.0109756	http://dx.doi.org/10.1371/journal.pone.0109756			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310712	Green Submitted, gold, Green Published			2022-12-27	WOS:000343210300071
J	Lerchbaum, E; Schwetz, V; Rabe, T; Giuliani, A; Obermayer-Pietsch, B				Lerchbaum, Elisabeth; Schwetz, Verena; Rabe, Thomas; Giuliani, Albrecht; Obermayer-Pietsch, Barbara			Hyperandrogenemia in Polycystic Ovary Syndrome: Exploration of the Role of Free Testosterone and Androstenedione in Metabolic Phenotype	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; ADRENAL ANDROGEN EXCESS; INSULIN SENSITIVITY; DEHYDROEPIANDROSTERONE-SULFATE; ADIPOSE-TISSUE; WOMEN; OBESITY; RESISTANCE; PREVALENCE; HORMONE	Objective: To evaluate the association between androstenedione, testosterone, and free testosterone and metabolic disturbances in polycystic ovary syndrome. Methods: We analyzed the association between androstenedione, testosterone, and free testosterone and metabolic parameters in a cross-sectional study including 706 polycystic ovary syndrome and 140 BMI-matched healthy women. Polycystic ovary syndrome women were categorized into 4 groups: normal androstenedione and normal free testosterone (NA/NFT), elevated androstenedione and normal free testosterone (HA/NFT), normal androstenedione and elevated free testosterone (NA/HFT), elevated androstenedione and free testosterone (HA/HFT). Results: Polycystic ovary syndrome women with elevated free testosterone levels (HA/HFT and NA/HFT) have an adverse metabolic profile including 2 h glucose, HbA1c, fasting and 2 h insulin, area under the insulin response curve, insulin resistance, insulin sensitivity index (Matsuda), triglycerides, total and high density lipoprotein cholesterol levels compared to NA/NFT (p < 0.05 for all age- and BMI-adjusted analyses). In binary logistic regression analysis adjusted for age and BMI, odds ratio for insulin resistance was 2.78 (1.34-5.75, p = 0.006) for polycystic ovary syndrome women with HA/HFT compared to NA/NFT. We found no significantly increased risk of metabolic disorders in polycystic ovary syndrome women with HA/NFT. In multiple linear regression analyses (age- and BMI-adjusted), we found a significant negative association between androstenedione/free testosterone-ratio and area under the insulin response curve, insulin resistance, and total cholesterol/high density lipoprotein cholesterol-ratio and a positive association with Matsuda-index, and high density lipoprotein cholesterol (p < 0.05 for all). Conclusions: Polycystic ovary syndrome women with elevated free testosterone levels but not with isolated androstenedione elevation have an adverse metabolic phenotype. Further, a higher androstenedione/free testosterone-ratio was independently associated with a beneficial metabolic profile.	[Lerchbaum, Elisabeth; Schwetz, Verena; Obermayer-Pietsch, Barbara] Med Univ Graz, Dept Internal Med, Div Endocrinol & Metab, Graz, Austria; [Lerchbaum, Elisabeth; Rabe, Thomas] Univ Womens Hosp, Heidelberg, Germany; [Giuliani, Albrecht] Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria	Medical University of Graz; Medical University of Graz	Lerchbaum, E (corresponding author), Med Univ Graz, Dept Internal Med, Div Endocrinol & Metab, Graz, Austria.	elisabeth.lerchbaum@medunigraz.at						Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Asagami T, 2008, METABOLISM, V57, P1355, DOI 10.1016/j.metabol.2008.05.002; Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; Bernasconi D, 1996, METABOLISM, V45, P72, DOI 10.1016/S0026-0495(96)90202-4; Brennan K, 2009, FERTIL STERIL, V91, P1848, DOI 10.1016/j.fertnstert.2008.02.101; BUFFINGTON CK, 1991, DIABETES, V40, P693, DOI 10.2337/diabetes.40.6.693; Carmina E, 2007, J ENDOCRINOL INVEST, V30, P111, DOI 10.1007/BF03347408; Chen MJ, 2008, HUM REPROD, V23, P952, DOI 10.1093/humrep/den015; De Frene V, 2014, HUM REPROD; Dewailly D, 2006, J CLIN ENDOCR METAB, V91, P3922, DOI 10.1210/jc.2006-1054; Doi SAR, 2006, STEROIDS, V71, P751, DOI 10.1016/j.steroids.2006.05.005; Essah PA, 2008, J ENDOCRINOL INVEST, V31, P35, DOI 10.1007/BF03345564; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Fulghesu A, 2010, J ADOLESCENT HEALTH, V46, P474, DOI 10.1016/j.jadohealth.2009.10.008; Guido M, 2004, HUM REPROD, V19, P534, DOI 10.1093/humrep/deh145; Ivandic A, 1998, METABOLISM, V47, P13, DOI 10.1016/S0026-0495(98)90186-X; Jonard S, 2004, HUM REPROD UPDATE, V10, P107, DOI 10.1093/humupd/dmh010; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kosus N, 2012, GYNECOL ENDOCRINOL, V28, P611, DOI 10.3109/09513590.2011.650770; Legro RS, 2014, NEW ENGL J MED, V371, P119, DOI 10.1056/NEJMoa1313517; Legro RS, 2013, J CLIN ENDOCR METAB, V98, P4565, DOI 10.1210/jc.2013-2350; Lerchbaum E, 2013, HUM REPROD, V28, P2537, DOI 10.1093/humrep/det255; Lerchbaum E, 2013, NUTR METAB CARDIOVAS, V23, pE15, DOI 10.1016/j.numecd.2012.11.004; Lerchbaum E, 2012, FERTIL STERIL, V98, P1318, DOI 10.1016/j.fertnstert.2012.07.1057; Lerchbaum E, 2012, CLIN ENDOCRINOL, V77, P834, DOI 10.1111/j.1365-2265.2012.04334.x; Lerchbaum E, 2011, EUR J ENDOCRINOL, V165, P935, DOI 10.1530/EJE-11-0614; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Misichronis G, 2012, GYNECOL ENDOCRINOL, V28, P249, DOI 10.3109/09513590.2011.613965; O'Reilly MW, 2014, J CLIN ENDOCR METAB, V99, P1027, DOI 10.1210/jc.2013-3399; Patel K, 2003, J CLIN ENDOCR METAB, V88, P5456, DOI 10.1210/jc.2003-030816; Quinkler M, 2004, J ENDOCRINOL, V183, P331, DOI 10.1677/joe.1.05762; RITTMASTER RS, 1993, J CLIN ENDOCR METAB, V76, P1295, DOI 10.1210/jc.76.5.1295; Rosner W, 2010, J CLIN ENDOCR METAB, V95, P4542, DOI 10.1210/jc.2010-1314; Valkenburg O, 2008, J CLIN ENDOCR METAB, V93, P470, DOI 10.1210/jc.2007-1756; Wehr E, 2011, J CLIN ENDOCR METAB, V96, pE986, DOI 10.1210/jc.2011-0031; Wehr E, 2009, WIEN KLIN WOCHENSCHR, V121, P262, DOI 10.1007/s00508-009-1162-2; Wild RA, 2010, J CLIN ENDOCR METAB, V95, P2038, DOI 10.1210/jc.2009-2724; Yildiz BO, 2012, HUM REPROD, V27, P3067, DOI 10.1093/humrep/des232	39	58	63	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e108263	10.1371/journal.pone.0108263	http://dx.doi.org/10.1371/journal.pone.0108263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310562	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210300014
J	Long, JD; Porturas, LD				Long, Jeremy D.; Porturas, Laura D.			Herbivore Impacts on Marsh Production Depend upon a Compensatory Continuum Mediated by Salinity Stress	PLOS ONE			English	Article							SALT-MARSHES; WATER-STRESS; BOTTOM-UP; SPARTINA-ALTERNIFLORA; ENVIRONMENTAL-STRESS; RELATIVE IMPORTANCE; PLANT TOLERANCE; SCALE INSECTS; TOP-DOWN; NITROGEN	Plant communities are disturbed by several stressors and they are expected to be further impacted by increasing anthropogenic stress. The consequences of these stressors will depend, in part, upon the ability of plants to compensate for herbivory. Previous studies found that herbivore impacts on plants can vary from negative to positive because of environmental control of plant compensatory responses, a.k.a. the Compensatory Continuum Hypothesis. While these influential studies enhanced our appreciation of the dynamic nature of plant-herbivore interactions, they largely focused on the impact of resource limitation. This bias limits our ability to predict how other environmental factors will shape the impact of herbivory. We examined the role of salinity stress on herbivory of salt marsh cordgrass, Spartina foliosa, by an herbivore previously hypothesized to influence the success of restoration projects (the scale insect, Haliaspis spartinae). Using a combination of field and mesocosm manipulations of scales and salinity, we measured how these factors affected Spartina growth and timing of senescence. In mesocosm studies, Spartina overcompensated for herbivory by growing taller shoots at low salinities but the impact of scales on plants switched from positive to neutral with increasing salinity stress. In field studies of intermediate salinities, scales reduced Spartina growth and increased the rate of senescence. Experimental salinity additions at this field site returned the impact of scales to neutral. Because salinity decreased scale densities, the switch in impact of scales on Spartina with increasing salinity was not simply a linear function of scale abundance. Thus, the impact of scales on primary production depended strongly upon environmental context because intermediate salinity stress prevented plant compensatory responses to herbivory. Understanding this context-dependency will be required if we are going to successfully predict the success of restoration efforts and the ecological consequences of anthropogenic disturbances.	[Long, Jeremy D.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; San Diego State Univ, Coastal & Marine Inst Lab, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University	Long, JD (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	jlong@mail.sdsu.edu		Porturas, Laura/0000-0001-5665-8934	United States National Science Foundation Biological Oceanography program [OCE-0825846]; California Sea Grant [NA10OAR4170060]; CSU COAST	United States National Science Foundation Biological Oceanography program; California Sea Grant; CSU COAST	This research was supported by grants from the United States National Science Foundation Biological Oceanography program (OCE-0825846 awarded to JL and Geoff Trussell), California Sea Grant (NA10OAR4170060), and CSU COAST (awarded to LP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam P, 2002, ENVIRON CONSERV, V29, P39, DOI 10.1017/S0376892902000048; Arthur AL, 2013, ENVIRON ENTOMOL, V42, P998, DOI 10.1603/EN13008; BANDYOPADHYAY BK, 1993, WETLANDS, V13, P10, DOI 10.1007/BF03160860; Bowdish TI, 1998, OECOLOGIA, V113, P400, DOI 10.1007/s004420050392; Boyer KE, 1996, ESTUARIES, V19, P1, DOI 10.2307/1352646; Boyer KE, 1994, SCALE INSECT DAMAGE; BRADLEY PM, 1991, J EXP BOT, V42, P1525, DOI 10.1093/jxb/42.12.1525; Brown CE, 2006, ENVIRON EXP BOT, V58, P140, DOI 10.1016/j.envexpbot.2005.07.006; Canepuccia AD, 2010, MAR ECOL PROG SER, V404, P151, DOI 10.3354/meps08507; Chase JM, 2000, ECOLOGY, V81, P2485, DOI 10.1890/0012-9658(2000)081[2485:TEOPHA]2.0.CO;2; COCKFIELD SD, 1986, OECOLOGIA, V71, P41, DOI 10.1007/BF00377318; COVIN JD, 1988, WETLANDS, V8, P51, DOI 10.1007/BF03160808; Crain CM, 2004, ECOLOGY, V85, P2539, DOI 10.1890/03-0745; Denno RF, 2002, ECOLOGY, V83, P1443, DOI 10.1890/0012-9658(2002)083[1443:BUFMNE]2.0.CO;2; Gonzales WL, 2008, ACTA OECOL, V34, P104, DOI 10.1016/j.actao.2008.04.004; Goranson CE, 2004, OECOLOGIA, V140, P591, DOI 10.1007/s00442-004-1615-2; Grinnan R, 2013, ECOL ENTOMOL, V38, P290, DOI 10.1111/een.12017; Hawkes CV, 2001, ECOLOGY, V82, P2045, DOI 10.1890/0012-9658(2001)082[2045:TIOHOP]2.0.CO;2; HJALTEN J, 1993, ECOLOGY, V74, P1136, DOI 10.2307/1940483; Hopkinson CS, 2008, FRONT ECOL ENVIRON, V6, P255, DOI 10.1890/070153; Howard FW, 1999, FLA ENTOMOL, V82, P14, DOI 10.2307/3495833; Huberty AF, 2004, ECOLOGY, V85, P1383, DOI 10.1890/03-0352; Japoshvili G, 2012, ANN ENTOMOL SOC AM, V105, P493, DOI 10.1603/AN11110; Jimenez JM, 2012, ESTUAR COAST, V35, P475, DOI 10.1007/s12237-011-9458-7; Joern A, 2005, J CHEM ECOL, V31, P2069, DOI 10.1007/s10886-005-6078-3; Johnson KM, 1991, EFFECTS HOST QUALITY; LANGIS R, 1991, ECOL APPL, V1, P40, DOI 10.2307/1941846; LARSSON S, 1989, OIKOS, V56, P277, DOI 10.2307/3565348; Long JD, 2011, ECOLOGY, V92, P180, DOI 10.1890/10-0179.1; LOUDA SM, 1992, ECOLOGY, V73, P153, DOI 10.2307/1938728; Louthan AM, 2013, J ECOL, V101, P1074, DOI 10.1111/1365-2745.12090; Macdonald K, 1990, S SAN DIEGO BAY ENHA; MASCHINSKI J, 1989, AM NAT, V134, P1, DOI 10.1086/284962; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Moon DC, 2002, OIKOS, V98, P480, DOI 10.1034/j.1600-0706.2002.980312.x; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Pennings SC, 2005, J ECOL, V93, P159, DOI 10.1111/j.1365-2745.2004.00959.x; PENNINGS SC, 1992, ECOLOGY, V73, P681, DOI 10.2307/1940774; Pennings SC, 2001, OECOLOGIA, V126, P587, DOI 10.1007/s004420000548; PRICE PW, 1991, OIKOS, V62, P244, DOI 10.2307/3545270; ROSENTHAL JP, 1994, TRENDS ECOL EVOL, V9, P145, DOI 10.1016/0169-5347(94)90180-5; Silliman BR, 2005, SCIENCE, V310, P1803, DOI 10.1126/science.1118229; Spitzer BW, 2004, EVOLUTION, V58, P2452; Stewart G. R., 1980, The biochemistry of plants. A comprehensive treatise. Volume 5. Amino acids and derivatives., P609; Stiling P, 2005, ECOLOGY, V86, P1730, DOI 10.1890/04-1384; Trnka S, 2000, ESTUARIES, V23, P572, DOI 10.2307/1353147; Vranjic JA, 1997, J ECOL, V85, P143, DOI 10.2307/2960646; WHITE T C R, 1969, Ecology (Washington D C), V50, P905, DOI 10.2307/1933707; Williams K, 1990, CONTROL SCALE INSECT; WILLIS AJ, 1993, OECOLOGIA, V96, P517, DOI 10.1007/BF00320509; Wise MJ, 2007, AM NAT, V169, P443, DOI 10.1086/512044; Wise MJ, 2005, OIKOS, V109, P417, DOI 10.1111/j.0030-1299.2005.13878.x; Zedler J., 1992, ECOLOGY TIJUANA ESTU; ZEDLER JB, 1993, ECOL APPL, V3, P123, DOI 10.2307/1941796; Zedler JB, 1999, RESTOR ECOL, V7, P69, DOI 10.1046/j.1526-100X.1999.07108.x	55	11	11	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110419	10.1371/journal.pone.0110419	http://dx.doi.org/10.1371/journal.pone.0110419			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310475	gold, Green Published, Green Submitted			2022-12-27	WOS:000343210300117
J	Moncao-Ribeiro, LC; Faffe, DS; Santana, PT; Vieira, FS; da Graca, CLAL; Marques-da-Silva, C; Machado, MN; Caruso-Neves, C; Zin, WA; Borojevic, R; Takiya, CM; Coutinho-Silva, R				Moncao-Ribeiro, Leonardo C.; Faffe, Debora S.; Santana, Patricia T.; Vieira, Flavia S.; da Graca, Carolyne Lalucha A. L.; Marques-da-Silva, Camila; Machado, Mariana N.; Caruso-Neves, Celso; Zin, Walter A.; Borojevic, Radovan; Takiya, Christina M.; Coutinho-Silva, Robson			P2X7 Receptor Modulates Inflammatory and Functional Pulmonary Changes Induced by Silica	PLOS ONE			English	Article							KAPPA-B ACTIVATION; P2X(7) RECEPTOR; NALP3 INFLAMMASOME; EXTRACELLULAR ATP; LUNG INFLAMMATION; TNF-ALPHA; TGF-BETA; MODEL; TRANSCRIPTION; MECHANISMS	Silicosis is an occupational lung disease, characterized by irreversible and progressive fibrosis. Silica exposure leads to intense lung inflammation, reactive oxygen production, and extracellular ATP (eATP) release by macrophages. The P2X7 purinergic receptor is thought to be an important immunomodulator that responds to eATP in sites of inflammation and tissue damage. The present study investigates the role of P2X7 receptor in a murine model of silicosis. To that end wild-type (C57BL/6) and P2X7 receptor knockout mice received intratracheal injection of saline or silica particles. After 14 days, changes in lung mechanics were determined by the end-inflation occlusion method. Bronchoalveolar lavage and flow cytometry analyzes were performed. Lungs were harvested for histological and immunochemistry analysis of fibers content, inflammatory infiltration, apoptosis, as well as cytokine and oxidative stress expression. Silica particle effects on lung alveolar macrophages and fibroblasts were also evaluated in cell line cultures. Phagocytosis assay was performed in peritoneal macrophages. Silica exposure increased lung mechanical parameters in wild-type but not in P2X7 knockout mice. Inflammatory cell infiltration and collagen deposition in lung parenchyma, apoptosis, TGF-beta and NF-kappa B activation, as well as nitric oxide, reactive oxygen species (ROS) and IL-1 beta secretion were higher in wild-type than knockout silica-exposed mice. In vitro studies suggested that P2X7 receptor participates in silica particle phagocytosis, IL-1 beta secretion, as well as reactive oxygen species and nitric oxide production. In conclusion, our data showed a significant role for P2X7 receptor in silica-induced lung changes, modulating lung inflammatory, fibrotic, and functional changes.	[Moncao-Ribeiro, Leonardo C.; Faffe, Debora S.; Santana, Patricia T.; Vieira, Flavia S.; da Graca, Carolyne Lalucha A. L.; Marques-da-Silva, Camila; Machado, Mariana N.; Caruso-Neves, Celso; Zin, Walter A.; Takiya, Christina M.; Coutinho-Silva, Robson] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Moncao-Ribeiro, Leonardo C.; Borojevic, Radovan; Takiya, Christina M.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Coutinho-Silva, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.	rcsilva@biof.ufrj.br	Coutinho-Silva, Robson/M-4690-2013; Caruso-Neves, Celso/C-4014-2013; Marques-da-Silva, Camila/B-9284-2014; Borojevic, Radovan/V-8500-2019; Zin, Walter A/H-8220-2013	Coutinho-Silva, Robson/0000-0002-7318-0204; Caruso-Neves, Celso/0000-0002-2415-7753; Borojevic, Radovan/0000-0002-2393-7280; Zin, Walter A/0000-0001-8226-9123	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (CNPq); Instituto Nacional para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica (INCT-INPeTAm/CNPq/MCT); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Programa de Apoio a Nucleos de Excelencia (PRONEX), Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica (INCT-INPeTAm/CNPq/MCT)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Programa de Apoio a Nucleos de Excelencia (PRONEX), Brazil	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (CNPq), Instituto Nacional para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica (INCT-INPeTAm/CNPq/MCT), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Programa de Apoio a Nucleos de Excelencia (PRONEX), Brazil, to RCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aga M, 2002, J LEUKOCYTE BIOL, V72, P222; [Anonymous], 1996, PHYSIOLOGIST; BATES JHT, 1985, J APPL PHYSIOL, V58, P1840, DOI 10.1152/jappl.1985.58.6.1840; Bayne K, 1996, Physiologist, V39, P208; Bayne K, 1996, PHYSIOLOGIST, V39, P211; Belete HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027469; Borges VM, 2002, AM J RESP CELL MOL, V27, P78, DOI 10.1165/ajrcmb.27.1.4717; Bours Martijn Jan Leo, 2011, Front Biosci (Schol Ed), V3, P1443; Burnstock G, 2011, ADV PHARMACOL, V61, P333, DOI 10.1016/B978-0-12-385526-8.00011-4; Carroll WA, 2009, PURINERG SIGNAL, V5, P63, DOI 10.1007/s11302-008-9110-6; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Cho HY, 2003, TOXICOL LETT, V143, P323, DOI 10.1016/S0378-4274(03)00193-0; da Silva CM, 2008, IMMUNOBIOLOGY, V213, P481, DOI 10.1016/j.imbio.2007.11.006; da Silva GL, 2013, EXP DERMATOL, V22, P184, DOI 10.1111/exd.12094; Davis CW, 2008, RESP PHYSIOL NEUROBI, V163, P208, DOI 10.1016/j.resp.2008.05.015; de Campos NE, 2012, J INNATE IMMUN, V4, P529, DOI 10.1159/000336628; Denlinger LC, 2009, AM J RESP CRIT CARE, V179, P265, DOI 10.1164/rccm.200802-293OC; Di Giuseppe M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005689; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; ELIAS JA, 1990, ANN NY ACAD SCI, V580, P233, DOI 10.1111/j.1749-6632.1990.tb17932.x; Eltom S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024097; Faffe DS, 2001, J APPL PHYSIOL, V90, P1400, DOI 10.1152/jappl.2001.90.4.1400; Ferrari D, 1997, J CELL BIOL, V139, P1635, DOI 10.1083/jcb.139.7.1635; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Fubini B, 2003, FREE RADICAL BIO MED, V34, P1507, DOI 10.1016/S0891-5849(03)00149-7; Gao HS, 2011, TOXICOL IND HEALTH, V27, P607, DOI 10.1177/0748233710393778; Goncalves RG, 2006, KIDNEY INT, V70, P1599, DOI 10.1038/sj.ki.5001804; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Jagirdar J, 1996, AM J RESP CRIT CARE, V154, P1076, DOI 10.1164/ajrccm.154.4.8887610; Joshi GN, 2013, APOPTOSIS, V18, P271, DOI 10.1007/s10495-012-0798-y; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Lenertz LY, 2009, PURINERG SIGNAL, V5, P175, DOI 10.1007/s11302-009-9133-7; Leung CC, 2012, LANCET, V379, P2008, DOI 10.1016/S0140-6736(12)60235-9; Lucattelli M, 2011, AM J RESP CELL MOL, V44, P423, DOI 10.1165/rcmb.2010-0038OC; Moncao-Ribeiro LC, 2011, RESP PHYSIOL NEUROBI, V179, P314, DOI 10.1016/j.resp.2011.09.015; Pisetsky DS, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13256; Rajagopal M, 2011, AM J PHYSIOL-RENAL, V301, pF544, DOI 10.1152/ajprenal.00709.2010; Rastrick J, 2014, MINERVA MED, V105, P9; Riteau N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.144; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; Rubartelli A, 2007, TRENDS IMMUNOL, V28, P429, DOI 10.1016/j.it.2007.08.004; Santibanez JF, 2011, CLIN SCI, V121, P233, DOI 10.1042/CS20110086; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; TONETTI M, 1995, BIOCHEM BIOPH RES CO, V214, P125, DOI 10.1006/bbrc.1995.2265; Wiley JS, 2012, PURINERG SIGNAL, V8, P579, DOI 10.1007/s11302-012-9308-5; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Woods LT, 2012, AM J PHYSIOL-CELL PH, V303, pC790, DOI 10.1152/ajpcell.00072.2012	48	46	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110185	10.1371/journal.pone.0110185	http://dx.doi.org/10.1371/journal.pone.0110185			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310682	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210300095
J	Qu, B; Xin, GR; Zhao, LX; Xing, H; Lian, LY; Jiang, HY; Tong, JZ; Wang, BB; Jin, SZ				Qu, Bo; Xin, Guo-Rong; Zhao, Li-Xia; Xing, Hui; Lian, Li-Ying; Jiang, Hai-Yan; Tong, Jia-Zhao; Wang, Bei-Bei; Jin, Shi-Zhu			Testing Stem Cell Therapy in a Rat Model of Inflammatory Bowel Disease: Role of Bone Marrow Stem Cells and Stem Cell Factor in Mucosal Regeneration	PLOS ONE			English	Article							TRANSPLANTATION; PROLIFERATION; APOPTOSIS; TISSUE; LABEL; IBD	Background: The gastrointestinal (GI) mucosal cells turnover regularly under physiological conditions, which may be stimulated in various pathological situations including inflammation. Local epithelial stem cells appear to play a major role in such mucosal renewal or pathological regeneration. Less is clear about the involvement of multipotent stem cells from blood in GI repair. We attempted to explore a role of bone marrow mesenchymal stromal cells (BMMSCs) and soluble stem cell factor (SCF) in GI mucosa regeneration in a rat model of inflammatory bowel diseases (IBD). Methods: BMMSCs labelled with the fluorescent dye PKH26 from donor rats were transfused into rats suffering indomethacin-induced GI injury. Experimental effects by BMMSCs transplant and SCF were determined by morphometry of intestinal mucosa, double labeling of PKH26 positive BMMSCs with endogenous proliferative and intestinal cell markers, and western blot and PCR analyses of the above molecular markers in the recipient rats relative to controls. Results: PKH26 positive BMMSCs were found in the recipient mucosa, partially colocalizing with the proliferating cell nuclear antigen (PCNA), Lgr5, Musashi-1 and ephrin-B3. mRNA and protein levels of PCNA, Lgr5, Musashi-1 and ephrin-B3 were elevated in the intestine in BMMSCs-treated rats, most prominent in the BMMSCs-SCF co-treatment group. The mucosal layer and the crypt layer of the small intestine were thicker in BMMSCs-treated rats, more evident in the BMMSCs-SCF co-treatment group. Conclusion: BMMSCs and SCF participate in but may play a synergistic role in mucosal cell regeneration following experimentally induced intestinal injury. Bone marrow stem cell therapy and SCF administration may be of therapeutic value in IBD.	[Qu, Bo; Zhao, Li-Xia; Xing, Hui; Lian, Li-Ying; Tong, Jia-Zhao; Wang, Bei-Bei; Jin, Shi-Zhu] Harbin Med Univ, Affiliated Hosp 2, Dept Gastroenterol & Hepatol, Harbin, Peoples R China; [Xin, Guo-Rong] JiaMuSi Med Univ, Affiliated Hosp 1, Anorectal Dept, Jiamusi, Peoples R China; [Jiang, Hai-Yan] JiaMuSi Cent Hosp, Infect Dept, Jiamusi, Peoples R China	Harbin Medical University; Jiamusi University	Jin, SZ (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Gastroenterol & Hepatol, Harbin, Peoples R China.	shizhujinsci@hotmail.com		Jin, Shizhu/0000-0002-1058-2054	Harbin Municipality Science and Technology Youth Innovation Funding [2018RFQYS103]	Harbin Municipality Science and Technology Youth Innovation Funding	This work was supported by Harbin Municipality Science and Technology Youth Innovation Funding (2018RFQYS103 to Bo Qu). The funders had a role in the preparation of the manuscript, but had no other role in the study design, data collection and analysis, or decision to publish.	Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Benchimol EI, 2009, GUT, V58, P1490, DOI 10.1136/gut.2009.188383; Bernstein CN, 2000, INFLAMM BOWEL DIS, V6, P34, DOI 10.1097/00054725-200002000-00005; Brittan M, 2007, GASTROENTEROLOGY, V132, P1171, DOI 10.1053/j.gastro.2007.01.064; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Cook D, 2013, ADV EXP MED BIOL, V786, P213, DOI 10.1007/978-94-007-6621-1_12; Danese S, 2004, AUTOIMMUN REV, V3, P394, DOI 10.1016/j.autrev.2004.03.002; Ditschkowski M, 2003, TRANSPLANTATION, V75, P1745, DOI 10.1097/01.TP.0000062540.29757.E9; Duijvestein M, 2010, GUT, V59, P1662, DOI 10.1136/gut.2010.215152; Giannakis M, 2006, J BIOL CHEM, V281, P11292, DOI 10.1074/jbc.M512118200; Heyman MB, 2005, J PEDIATR-US, V146, P35, DOI 10.1016/j.jpeds.2004.08.043; Hoggatt J, 2014, EXPERT OPIN INV DRUG, V23, P21, DOI 10.1517/13543784.2013.838558; Kim BC, 2013, J CRANIOFAC SURG, V24, pE409, DOI 10.1097/SCS.0b013e318292c91d; Leedham SJ, 2005, J CELL MOL MED, V9, P11, DOI 10.1111/j.1582-4934.2005.tb00333.x; Lin YT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022924; Markel TA, 2008, J PEDIATR SURG, V43, P1953, DOI 10.1016/j.jpedsurg.2008.06.019; Mimeault M, 2012, ADV EXP MED BIOL, V741, P171, DOI 10.1007/978-1-4614-2098-9_12; Ohishi M, 2010, J CELL BIOCHEM, V109, P277, DOI 10.1002/jcb.22399; Qi SH, 2013, INT J MOL MED, V32, P1262, DOI 10.3892/ijmm.2013.1517; Sauerzweig S, 2009, J NEUROSCI METH, V177, P149, DOI 10.1016/j.jneumeth.2008.10.009; Saurer L, 2009, ALLERGY, V64, P505, DOI 10.1111/j.1398-9995.2009.01965.x; Shaker A, 2010, TRANSL RES, V156, P180, DOI 10.1016/j.trsl.2010.06.003; Suh KT, 2005, CLIN ORTHOP RELAT R, P220, DOI 10.1097/01.blo.0000150568.16133.3c; Tayman C, 2011, PEDIATR RES, V70, P489, DOI 10.1203/PDR.0b013e31822d7ef2; Telukuntla KS, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000338; Thoree VC, 2002, GUT, V51, P44, DOI 10.1136/gut.51.1.44; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Wang L, 2003, WORLD J GASTROENTERO, V9, P2060, DOI 10.3748/wjg.v9.i9.2060; Woltman AM, 2007, KIDNEY INT, V71, P1001, DOI 10.1038/sj.ki.5002187	29	11	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e107891	10.1371/journal.pone.0107891	http://dx.doi.org/10.1371/journal.pone.0107891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25309991	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210300009
J	Wu, JY; Huang, YJ; Lin, YQ; Fu, C; Liu, SM; Deng, ZH; Li, QW; Huang, ZX; Chen, RK; Zhang, MQ				Wu, Jiayun; Huang, Yongji; Lin, Yanquan; Fu, Cheng; Liu, Shaomou; Deng, Zuhu; Li, Qiwei; Huang, Zhongxing; Chen, Rukai; Zhang, Muqing			Unexpected Inheritance Pattern of Erianthus arundinaceus Chromosomes in the Intergeneric Progeny between Saccharum spp. and Erianthus arundinaceus	PLOS ONE			English	Article							SEXUAL POLYPLOIDIZATION; DIVISION RESTITUTION; MOLECULAR MARKERS; GAMETE FORMATION; LILY HYBRIDS; 2N EGG; SUGARCANE; IDENTIFICATION; SEGREGATION; MECHANISMS	Erianthus arundinaceus is a valuable source of agronomic traits for sugarcane improvement such as ratoonability, biomass, vigor, tolerance to drought and water logging, as well as resistance to pests and disease. To investigate the introgression of the E. arundinaceus genome into sugarcane, five intergeneric F-1 hybrids between S. officinarum and E. arundinaceus and 13 of their BC1 progeny were studied using the genomic in situ hybridization (GISH) technique. In doing so, we assessed the chromosome composition and chromosome transmission in these plants. All F-1 hybrids were aneuploidy, containing either 28 or 29 E. arundinaceus chromosomes. The number of E. arundinaceus chromosomes in nine of the BC1 progeny was less than or equal to 29. Unexpectedly, the number of E. arundinaceus chromosomes in the other four BC1 progeny was above 29, which was more than in their F-1 female parents. This is the first cytogenetic evidence for an unexpected inheritance pattern of E. arundinaceus chromosomes in sugarcane. We pointed to several mechanisms that may be involved in generating more than 2n gametes in the BC1 progeny. Furthermore, the implication of these results for sugarcane breeding programs was discussed.	[Wu, Jiayun; Huang, Yongji; Lin, Yanquan; Deng, Zuhu; Chen, Rukai; Zhang, Muqing] Fujian Agr & Forestry Univ, Minist Agr, Key Lab Sugarcane Biol & Genet Breeding, Fuzhou, Peoples R China; [Wu, Jiayun; Fu, Cheng; Liu, Shaomou; Li, Qiwei; Huang, Zhongxing] Guangzhou Res Inst Sugarcane Ind, Guangzhou, Guangdong, Peoples R China; [Zhang, Muqing] Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Peoples R China	Fujian Agriculture & Forestry University; Ministry of Agriculture & Rural Affairs; Guangxi University	Deng, ZH (corresponding author), Fujian Agr & Forestry Univ, Minist Agr, Key Lab Sugarcane Biol & Genet Breeding, Fuzhou, Peoples R China.	dengzuhu@163.com		zhang, muqing/0000-0003-3138-3422	National Natural Science Foundation of China [30671329]; Modern Agriculture Technology of China [CARS-20-1-5]; Guangxi Natural Science Foundation [2014GXNSFFA118002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Modern Agriculture Technology of China; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	This work was funded by National Natural Science Foundation of China (30671329), the earmarked fund for the Modern Agriculture Technology of China (CARS-20-1-5). This project is also supported by Guangxi Natural Science Foundation (2014GXNSFFA118002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwala S, 2009, EUPHYTICA, V167, P127, DOI 10.1007/s10681-008-9869-0; Amalraj VA, 2006, GENET RESOUR CROP EV, V53, P35, DOI 10.1007/s10722-004-0581-1; Barba-Gonzalez R, 2005, GENOME, V48, P884, DOI 10.1139/g05-057; Bielig LM, 2003, EUPHYTICA, V133, P117, DOI 10.1023/A:1025628103101; Birchler JA, 2001, DEV BIOL, V234, P275, DOI 10.1006/dbio.2001.0262; Birchler JA, 2007, BBA-GENE STRUCT EXPR, V1769, P422, DOI 10.1016/j.bbaexp.2006.12.002; BREMER G, 1961, EUPHYTICA, V10, P121, DOI 10.1007/BF00037206; Bremer G, 1959, BIBL GENET, V18, P1; BRETAGNOLLE F, 1995, NEW PHYTOL, V129, P1, DOI 10.1111/j.1469-8137.1995.tb03005.x; Cai Q, 2005, PLANT SCI, V169, P976, DOI 10.1016/j.plantsci.2005.07.002; Cai XW, 2007, CURR GENOMICS, V8, P151, DOI 10.2174/138920207780833847; de Souza AM, 1999, BRAZ ARCH BIOL TECHN, V42, P47; De Storme N, 2012, PLANT PHYSIOL, V160, P1808, DOI 10.1104/pp.112.208611; De Storme N, 2011, PLANT PHYSIOL, V155, P1403, DOI 10.1104/pp.110.170415; DHONT A, 1995, THEOR APPL GENET, V91, P320, DOI 10.1007/BF00220894; Edme SJ, 2006, HEREDITY, V97, P366, DOI 10.1038/sj.hdy.6800888; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Fukuhara S, 2013, EUPHYTICA, V189, P321, DOI 10.1007/s10681-012-0748-3; Goff SA, 2011, NEW PHYTOL, V189, P923, DOI 10.1111/j.1469-8137.2010.03574.x; Govindaraj P, 2012, INT SUGAR J, V114, P350; Hermann SR, 2012, EUPHYTICA, V187, P359, DOI 10.1007/s10681-012-0698-9; Irvine JE, 1999, THEOR APPL GENET, V98, P186, DOI 10.1007/s001220051057; Jannoo N, 2007, PLANT J, V50, P574, DOI 10.1111/j.1365-313X.2007.03082.x; Khan N, 2010, EUPHYTICA, V171, P157, DOI 10.1007/s10681-009-9998-0; Lim KB, 2001, THEOR APPL GENET, V103, P219, DOI 10.1007/s001220100638; LU YH, 1994, EUPHYTICA, V78, P7; Narayanaswami S, 1940, INDIAN J AGR SCI, V10, P534; Pecrix Y, 2011, J EXP BOT, V62, P3587, DOI 10.1093/jxb/err052; PFEIFFER TW, 1983, CAN J GENET CYTOL, V25, P107, DOI 10.1139/g83-021; PHILLIPS LL, 1962, AM J BOT, V49, P51, DOI 10.2307/2439388; PHILLIPS LL, 1964, AM J BOT, V51, P324, DOI 10.2307/2440304; Piperidis G, 2000, GENOME, V43, P1033, DOI 10.1139/gen-43-6-1033; Piperidis N, 2010, GENOME, V53, P331, DOI [10.1139/G10-010, 10.1139/g10-010]; Ram B, 2001, EUPHYTICA, V122, P145, DOI 10.1023/A:1012626805467; Ramanna MS, 2003, EUPHYTICA, V133, P3, DOI 10.1023/A:1025600824483; Roach BT, 1972, P INT SOC SUGAR CANE, V14, P206; Rott P, 1997, PHYTOPATHOLOGY, V87, P1202, DOI 10.1094/PHYTO.1997.87.12.1202; Singh RK, 2011, EUPHYTICA, V182, P335, DOI 10.1007/s10681-011-0484-0; Waclawovsky AJ, 2010, PLANT BIOTECHNOL J, V8, P263, DOI 10.1111/j.1467-7652.2009.00491.x; WERNER JE, 1987, AM POTATO J, V64, P641, DOI 10.1007/BF02853909; Zhou S, 2008, EUPHYTICA, V160, P207, DOI 10.1007/s10681-007-9538-8	41	23	26	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110390	10.1371/journal.pone.0110390	http://dx.doi.org/10.1371/journal.pone.0110390			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310831	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210300112
J	Attia, SM; Ahmad, SF; Okash, RM; Bakheet, SA				Attia, Sabry Mohamed; Ahmad, Sheikh Fayaz; Okash, Radwa Mohamed; Bakheet, Saleh Abdulrahman			Aneugenic Effects of Epirubicin in Somatic and Germinal Cells of Male Mice	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; TELOMERIC DNA PROBES; TOPOISOMERASE-II; MICRONUCLEUS INDUCTION; BREAST-CANCER; CHROMOSOMAL-ABERRATIONS; MALE MEIOSIS; MOUSE SPERM; DOXORUBICIN; ANEUPLOIDY	The ability of the antineoplastic agent epiruibicin to induce aneuploidy and meiotic delay in the somatic and germinal cells of male mice was investigated by fluorescence in situ hybridization assay using labeled DNA probes and BrdU-incorporation assay. Mitomycin C and colchicine were used as positive controls for clastogen and aneugen, respectively, and these compounds produced the expected responses. The fluorescence in situ hybridization assay with a centromeric DNA probe for erythrocyte micronuclei showed that epirubicin is not only clastogenic but also aneugenic in somatic cells in vivo by using the 48 h. Incorporation assay, it could be shown that the meiotic delay caused by epiru ion in germ cells was approximately 48 h. Disornic and diploid sperm were shown in epididyrnal sperm hybridized with DNA probes specific for chromosomes 8, X and Y after epirubicin treatment. The observation that XX- and YY-sperm significantly prevailed over XYperm sperm indicates missegregation during the second meiotic division. The results also suggest that earlier prophase stages contribute less to epirubicin-induced aneuploidy. Both the clastogenic and aneugenic potential of epirubicin can give rise he development of secondary tumors and abnormal reproductive outcomes in cured cancer patients and medical onnel exposed to epirubicin	[Attia, Sabry Mohamed; Ahmad, Sheikh Fayaz; Bakheet, Saleh Abdulrahman] King Saud Univ, Coll Pharm, Dept Pharmacol & Toxicol, Riyadh, Saudi Arabia; [Attia, Sabry Mohamed] Minist Hlth Cairo, Lab Chem & Clin Pathol, Cairo, Egypt; [Okash, Radwa Mohamed] Al Azhar Univ, Coll Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt	King Saud University; Egyptian Knowledge Bank (EKB); Ministry of Health & Population - Egypt; Egyptian Knowledge Bank (EKB); Al Azhar University	Attia, SM (corresponding author), King Saud Univ, Coll Pharm, Dept Pharmacol & Toxicol, Riyadh, Saudi Arabia.	attiasm@yahoo.com	Ahmad, Sheikh Fayaz/R-5853-2017; attia, Sabry M./GRO-6742-2022; Bakheet, Saleh A/AEC-8869-2022; Ahmad, Sheikh F./AAC-8750-2021	Ahmad, Sheikh Fayaz/0000-0002-8282-3726; Bakheet, Saleh A/0000-0003-2008-6377; 	National Plan for Science and Technology (NPST) in the Kingdom of Saudi Arabia [12-MED2648-02]	National Plan for Science and Technology (NPST) in the Kingdom of Saudi Arabia	This work was supported by National Plan for Science and Technology (NPST), grant number 12-MED2648-02 in the Kingdom of Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler I.-D., 1984, MUTAGENICITY TESTING, P275; ADLER ID, 1993, MUTAT RES, V287, P131, DOI 10.1016/0027-5107(93)90152-6; Adler ID, 2002, MUTAT RES-FUND MOL M, V504, P173, DOI 10.1016/S0027-5107(02)00090-8; Aly MS, 1999, ENVIRON MOL MUTAGEN, V33, P161, DOI 10.1002/(SICI)1098-2280(1999)33:2<161::AID-EM8>3.0.CO;2-M; AMES MM, 1992, LEUKEMIA, V6, P70; Attia S.M., 2008, SAUDI PHARM J, V16, P1; Attia SM, 2008, MUTAT RES-GEN TOX EN, V651, P105, DOI 10.1016/j.mrgentox.2007.10.011; Attia SM, 2007, TOXICOLOGY, V235, P112, DOI 10.1016/j.tox.2007.03.011; Attia SM, 2011, MUTAT RES-FUND MOL M, V715, P79, DOI 10.1016/j.mrfmmm.2011.07.012; Attia SM, 2010, OXID MED CELL LONGEV, V3, P238, DOI 10.4161/oxim.3.4.13246; Attia SM, 2009, ENVIRON MOL MUTAGEN, V50, P394, DOI 10.1002/em.20451; Attia SM, 2005, MUTAT RES-GEN TOX EN, V583, P158, DOI 10.1016/j.mrgentox.2005.03.010; Attia SM, 2003, ENVIRON MOL MUTAGEN, V41, P99, DOI 10.1002/em.10135; Attia SM, 2002, MUTAT RES-GEN TOX EN, V520, P1, DOI 10.1016/S1383-5718(02)00079-7; Bonassi S, 2007, CARCINOGENESIS, V28, P625, DOI 10.1093/carcin/bgl177; Brumfield JM, 2002, TEX J SCI, V54, P249; Burrello N, 2011, J ENDOCRINOL INVEST, V34, pE121, DOI [10.1007/BF03346719, 10.3275/7224]; CANTONI O, 1989, J CANCER RES CLIN, V115, P373, DOI 10.1007/BF00400965; Chabner BA, 1993, CANC PRINCIPLES PRAC, P374; Coukell AJ, 1997, DRUGS, V53, P453, DOI 10.2165/00003495-199753030-00008; Fritz B, 2001, EUR J HUM GENET, V9, P910, DOI 10.1038/sj.ejhg.5200741; Gamen S, 2000, EXP CELL RES, V258, P223, DOI 10.1006/excr.2000.4924; Ganapathi R, 1996, CANCER GENET CYTOGEN, V86, P116, DOI 10.1016/0165-4608(95)00207-3; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; HACKERKLOM UB, 1986, MUTAT RES, V160, P39, DOI 10.1016/S0027-5107(96)90007-X; Haddy N, 2014, CARCINOGENESIS, V35, P1745, DOI 10.1093/carcin/bgu077; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hastwell PW, 2009, MUTAGENESIS, V24, P455, DOI 10.1093/mutage/gep029; HOLM C, 1989, MOL CELL BIOL, V9, P159, DOI 10.1128/MCB.9.1.159; Hortobagyi GN, 1997, DRUGS S4, V54, P1; ISLAM MQ, 1993, CANCER GENET CYTOGEN, V65, P35; Jeremic B, 1996, CHEMOTHERAPY, V42, P266, DOI 10.1159/000239454; Kallio M, 1996, MUTAGENESIS, V11, P435, DOI 10.1093/mutage/11.5.435; Marchetti F, 2001, P NATL ACAD SCI USA, V98, P3952, DOI 10.1073/pnas.061404598; Murray WA, 1992, NATURE, V359, P599; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; Olinski R, 1997, MOL PHARMACOL, V52, P882, DOI 10.1124/mol.52.5.882; Olsen Ann-Karin, 2005, Toxicol Appl Pharmacol, V207, P521, DOI 10.1016/j.taap.2005.01.060; OTHMAN OES, 2000, MUTAT RES, V468, P109; Pacchierotti F, 2008, MUTAT RES-GEN TOX EN, V651, P64, DOI 10.1016/j.mrgentox.2007.10.009; PEDERSENBJERGAARD J, 1992, J CLIN ONCOL, V10, P1444, DOI 10.1200/JCO.1992.10.9.1444; PEDERSENBJERGAARD J, 1987, BRIT J HAEMATOL, V66, P199, DOI 10.1111/j.1365-2141.1987.tb01299.x; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; Russell LB, 2004, MUTAT RES-GEN TOX EN, V565, P61, DOI 10.1016/j.mrgentox.2004.09.005; Schmid TE, 2001, MUTAGENESIS, V16, P339, DOI 10.1093/mutage/16.4.339; SCHRIEVERSCHWEMMER G, 1994, MUTAGENESIS, V9, P333, DOI 10.1093/mutage/9.4.333; Sen AK, 2010, Z NATURFORSCH C, V65, P211; SEN P, 1990, CANCER RES, V50, P558; Silva LM, 2002, TERATOGEN CARCIN MUT, V22, P257, DOI 10.1002/tcm.10019; Sloter E, 2004, FERTIL STERIL, V81, P925, DOI 10.1016/j.fertnstert.2003.07.043; Tempest HG, 2004, CYTOGENET GENOME RES, V107, P83, DOI 10.1159/000079575; Venizelos ID, 2007, ACTA DERMATOVEN ALP, V16, P77; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wolf T, 2008, MUTAT RES-GEN TOX EN, V650, P150, DOI 10.1016/j.mrgentox.2007.11.009	54	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109942	10.1371/journal.pone.0109942	http://dx.doi.org/10.1371/journal.pone.0109942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303090	gold, Green Published, Green Submitted			2022-12-27	WOS:000343730400094
J	Takumi, Y; Nishio, S; Mugridge, K; Oguchi, T; Hashimoto, S; Suzuki, N; Iwasaki, S; Jolly, C; Usami, S				Takumi, Yutaka; Nishio, Shin-ya; Mugridge, Kenneth; Oguchi, Tomohiro; Hashimoto, Shigenari; Suzuki, Nobuyoshi; Iwasaki, Satoshi; Jolly, Claude; Usami, Shin-ichi			Gene Expression Pattern after Insertion of Dexamethasone-Eluting Electrode into the Guinea Pig Cochlea	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; LIPOPROTEIN-LIPASE; CELLS; NEUTROPHIL; EXPLANTS; BINDING; SYSTEM; INTERLEUKIN-1-BETA; LEUKOTRIENE-B4; RECRUITMENT	A cochlear implant is an indispensable apparatus for a profound hearing loss patient. But insertion of the electrode entails a great deal of stress to the cochlea, and may cause irreversible damage to hair cells and related nerve structure. Although damage prevention effects of dexamethasone have been reported, long-term administration is difficult. In this study, we used a dexamethasone-eluting electrode in the guinea pig cochlea, and compared the gene expression after 7 days insertion with that of a normal electrode and non-surgically treated control by microarray. 40 genes were up-regulated 2-fold or more in the normal electrode group compared to the non-surgically treated group. Most of the up-regulated genes were associated with immune response and inflammation. In the dexamethasone-eluting group, compared to the normal electrode group, 7 of the 40 genes were further up-regulated, while 12 of them were down-regulated and there was a tendency to return to the non-surgical condition. 9 genes were down-regulated 2-fold or less with normal electrode insertion, and 4 of the 9 tended to return to the non-surgical condition in the dexamethasone-eluting group. These genes are certainly involved in the maintenance of the physiological functions of the cochlea. Our results indicate that the dexamethasone-eluting electrode will have an effect on the normalization of homeostasis in the cochlea.	[Takumi, Yutaka; Nishio, Shin-ya; Oguchi, Tomohiro; Hashimoto, Shigenari; Suzuki, Nobuyoshi; Usami, Shin-ichi] Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan; [Takumi, Yutaka; Nishio, Shin-ya; Iwasaki, Satoshi] Shinshu Univ, Sch Med, Dept Hearing Implant Sci, Matsumoto, Nagano 390, Japan; [Mugridge, Kenneth; Jolly, Claude] MED EL Headquarters, Innsbruck, Austria	Shinshu University; Shinshu University	Usami, S (corresponding author), Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan.	usami@shinshu-u.ac.jp		Nishio, Shin-ya/0000-0001-6640-2297	Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare of Japan; Acute Profound Deafness Research Committee of the Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Science and Culture of Japan	Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare of Japan; Acute Profound Deafness Research Committee of the Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare of Japan (S. U.), by the Acute Profound Deafness Research Committee of the Ministry of Health, Labour and Welfare of Japan (S. U.), and by a Grant-in-Aid for Scientific Research from the (then) Ministry of Education, Science and Culture of Japan (http://www.mext.go.jp/english/) (Y.T. and S. U.). MED-EL GmbH provided support in the form of salaries for authors K. M. & C.J., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	AMANO Y, 1993, MOL PHARMACOL, V43, P176; BESSESEN DH, 1993, J LIPID RES, V34, P229; CHANEY MO, 1992, RECEPTOR, V2, P169; CLAESSON HE, 1992, INT J IMMUNOPHARMACO, V14, P441, DOI 10.1016/0192-0561(92)90174-J; Dinh CT, 2011, NEUROSCIENCE, V188, P157, DOI 10.1016/j.neuroscience.2011.04.061; Fain JN, 2005, INT J OBESITY, V29, P1299, DOI 10.1038/sj.ijo.0803032; Farhadi Mohammad, 2013, Cochlear Implants Int, V14, P45; FRIDMAN WH, 1991, FASEB J, V5, P2684, DOI 10.1096/fasebj.5.12.1916092; Getting SJ, 1997, BRIT J PHARMACOL, V120, P1075, DOI 10.1038/sj.bjp.0701029; Ghavi FF, 2010, J BIOMED MATER RES B, V94B, P388, DOI 10.1002/jbm.b.31666; Hochmair Ingeborg, 2006, Trends Amplif, V10, P201, DOI 10.1177/1084713806296720; Huey PU, 2002, J LIPID RES, V43, P19; Hwang JH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-30; Jeon YJ, 2000, IMMUNOPHARMACOLOGY, V48, P173, DOI 10.1016/S0162-3109(00)00199-5; Kask L, 2004, J BIOL CHEM, V279, P23869, DOI 10.1074/jbc.C400159200; Kim HH, 2007, LARYNGOSCOPE, V117, P1209, DOI 10.1097/MLG.0b013e318058195f; Kim HJ, 2011, CELL RES, V21, P944, DOI 10.1038/cr.2011.27; Maeda K, 2005, HEARING RES, V202, P154, DOI 10.1016/j.heares.2004.08.022; Maeda Y, 2012, ACTA OTO-LARYNGOL, V132, P4, DOI 10.3109/00016489.2011.619571; Maeda Y, 2010, ACTA OTO-LARYNGOL, V130, P1329, DOI 10.3109/00016489.2010.498836; Nakamoto T, 2012, AURIS NASUS LARYNX, V39, P270, DOI 10.1016/j.anl.2011.06.001; NISHIDA T, 1988, BIOCHEM BIOPH RES CO, V156, P269, DOI 10.1016/S0006-291X(88)80835-0; PALMBLAD J, 1981, BLOOD, V58, P658; Poetker DM, 2010, OTOLARYNG CLIN N AM, V43, P753, DOI 10.1016/j.otc.2010.04.003; Quick K, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120068; Ransohoff RM, 2002, J INFECT DIS, V186, pS152, DOI 10.1086/344266; Sautter NB, 2006, JARO-J ASSOC RES OTO, V7, P361, DOI 10.1007/s10162-006-0051-x; Schramm R, 2003, INFECT IMMUN, V71, P2542, DOI 10.1128/IAI.71.5.2542-2547.2003; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Tornabene SV, 2006, HEARING RES, V222, P115, DOI 10.1016/j.heares.2006.09.004; Trouw LA, 2008, MOL IMMUNOL, V45, P3649, DOI 10.1016/j.molimm.2008.04.025; Wang HR, 1999, J CELL PHYSIOL, V181, P361, DOI 10.1002/(SICI)1097-4652(199911)181:2<361::AID-JCP18>3.0.CO;2-9; WEBB AC, 1986, LYMPHOKINE RES, V5, P77; Xia MD, 2009, EXPERT OPIN THER PAT, V19, P295, DOI 10.1517/13543770902755129; Yang J, 2008, ACTA OTO-LARYNGOL, V128, P496, DOI 10.1080/00016480701558906; Yu SY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/652059	36	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110238	10.1371/journal.pone.0110238	http://dx.doi.org/10.1371/journal.pone.0110238			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329543	Green Published, Green Submitted, gold			2022-12-27	WOS:000343942100045
J	Jin, Y; Wan, Y; Chen, G; Chen, L; Zhang, MQ; Deng, L; Zhang, JC; Xiong, XZ; Xin, JB				Jin, Yang; Wan, Yong; Chen, Gang; Chen, Long; Zhang, Ming-Qiang; Deng, Li; Zhang, Jian-Chu; Xiong, Xian-Zhi; Xin, Jian-Bao			Treg/IL-17 Ratio and Treg Differentiation in Patients with COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; REGULATORY T-CELLS; GROWTH-FACTOR-BETA; TGF-BETA; PSEUDORECEPTOR BAMBI; TH17 CELLS; INFLAMMATION; EXPRESSION; CYTOKINES; INTERLEUKIN-17	Background: Chronic obstructive pulmonary disease (COPD) is characterized by chronic pulmonary and systematic inflammation. An abnormal adaptive immune response leads to an imbalance between pro- and anti-inflammatory processes. T-helper (Th), T-cytotoxic (Tc) and T-regulatory (Treg) cells may play important roles in immune and inflammatory responses. This study was conducted to clarify the changes and imbalance of cytokines and T lymphocyte subsets in patients with COPD, especially during acute exacerbations (AECOPD). Methods: Twenty-three patients with stable COPD (SCOPD) and 21 patients with AECOPD were enrolled in the present study. In addition, 20 age-, sex- and weight-matched non-smoking healthy volunteers were included as controls. The serum levels of selected cytokines (TGF-beta, IL-10, TNF-alpha, IL-17 and IL-9) were measured by enzyme-linked immunosorbent assay (ELISA) kits. Furthermore, the T lymphocyte subsets collected from peripheral blood samples were evaluated by flow cytometry after staining with anti-CD3-APC, anti-CD4-PerCP, anti-CD8-PerCP, anti-CD25-FITC and anti-FoxP3-PE monoclonal antibodies. Importantly, to remove the confounding effects of inflammatory factors, the authors introduced a concept of "inflammation adjustment'' and corrected each measured value using representative inflammatory markers, such as TNF-alpha and IL-17. Results: Unlike the other cytokines, serum TGF-beta levels were considerably higher in patients with AECOPD relative to the control group regardless of adjustment. There were no significant differences in the percentages of either CD4(+) or CD8(+) T cells among the three groups. Although Tregs were relatively upregulated during acute exacerbations, their capacities of generation and differentiation were far from sufficient. Finally, the authors noted that the ratios of Treg/IL-17 were similar among groups. Conclusions: These observations suggest that in patients with COPD, especially during acute exacerbations, both proinflammatory and anti-inflammatory reactions are strengthened, with the pro-inflammatory reactions dominating. Although the Treg/IL-17 ratios were normal, the regulatory T cells were still insufficient to suppress the accompanying increases in inflammation. All of these changes suggest a complicated mechanism of pro- and anti-inflammatory imbalance which needs to be further investigated.	[Jin, Yang; Chen, Gang; Chen, Long; Zhang, Ming-Qiang; Deng, Li; Zhang, Jian-Chu; Xiong, Xian-Zhi; Xin, Jian-Bao] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Key Lab Pulm Dis Hlth Minist,Dept Resp & Crit Car, Wuhan 430074, Peoples R China; [Wan, Yong] Wuhan 1 Hosp, Dept Resp & Crit Care Med, Wuhan, Peoples R China	Huazhong University of Science & Technology	Xiong, XZ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Key Lab Pulm Dis Hlth Minist,Dept Resp & Crit Car, Wuhan 430074, Peoples R China.	xxz0508@hust.edu.cn	Jin, Yang/AAX-2586-2021; Reid, David W/B-3263-2011		Science and Technology Program of Wuhan, China [201052399660]; Natural Science Fund of Hubei Province, China [2010CDB07805]; National Natural Science Foundation of China [81370146]	Science and Technology Program of Wuhan, China; Natural Science Fund of Hubei Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by a grant from the Science and Technology Program of Wuhan, China (No. 201052399660), and in part by a grant from the Natural Science Fund of Hubei Province, China (No. 2010CDB07805); and in part by a grant from the National Natural Science Foundation of China (No. 81370146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang SH, 2011, CELL SIGNAL, V23, P1069, DOI 10.1016/j.cellsig.2010.11.022; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Di Stefano A, 2009, CLIN EXP IMMUNOL, V157, P316, DOI 10.1111/j.1365-2249.2009.03965.x; Doe C, 2010, CHEST, V138, P1140, DOI 10.1378/chest.09-3058; Dromann D, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-67; Grubek-Jaworska H, 2012, RESPIRATION, V84, P101, DOI 10.1159/000334900; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; Hodge SJ, 2003, AM J PHYSIOL-LUNG C, V285, pL492, DOI 10.1152/ajplung.00428.2002; Isajevs S, 2009, EUR RESPIR J, V33, P61, DOI 10.1183/09031936.00145307; Konigshoff M, 2009, SWISS MED WKLY, V139, P554, DOI smw-12528; Kuchroo VK, 2012, EUR J IMMUNOL, V42, P2211, DOI 10.1002/eji.201242872; Lane N, 2010, CLIN SCI, V119, P75, DOI 10.1042/CS20100033; Letourneau S, 2009, J ALLERGY CLIN IMMUN, V123, P758, DOI 10.1016/j.jaci.2009.02.011; MacNee William, 2005, Proc Am Thorac Soc, V2, P50, DOI 10.1513/pats.200411-056SF; Maeno T, 2007, J IMMUNOL, V178, P8090, DOI 10.4049/jimmunol.178.12.8090; Mai JT, 2010, FRONT BIOSCI-LANDMRK, V15, P986, DOI 10.2741/3657; Mak JCW, 2009, RESP MED, V103, P1083, DOI 10.1016/j.rmed.2009.01.005; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; O'Shaughnessy TC, 1997, AM J RESP CRIT CARE, V155, P852; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Plumb J, 2009, EUR RESPIR J, V34, P89, DOI 10.1183/09031936.00100708; Pridgeon C, 2011, CLIN SCI, V120, P515, DOI 10.1042/CS20100417; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Saetta M, 1998, AM J RESP CRIT CARE, V157, P822, DOI 10.1164/ajrccm.157.3.9709027; Smolonska J, 2009, AM J RESP CRIT CARE, V180, P618, DOI 10.1164/rccm.200905-0722OC; Smyth LJC, 2007, CHEST, V132, P156, DOI 10.1378/chest.07-0083; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tran DQ, 2012, J MOL CELL BIOL, V4, P29, DOI 10.1093/jmcb/mjr033; Tuder Rubin M, 2010, Proc Am Thorac Soc, V7, P381, DOI 10.1513/pats.201002-020AW; van Durme YMTA, 2011, RESPIRATION, V82, P530, DOI 10.1159/000332336; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wouters Emiel F M, 2005, Proc Am Thorac Soc, V2, P26, DOI 10.1513/pats.200408-039MS; Xiong Xian-Zhi, 2008, Zhonghua Yi Xue Za Zhi, V88, P471; Zhang JC, 2011, J HUAZHONG U SCI-MED, V31, P463, DOI 10.1007/s11596-011-0474-4	35	36	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e111044	10.1371/journal.pone.0111044	http://dx.doi.org/10.1371/journal.pone.0111044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329073	gold, Green Published, Green Submitted			2022-12-27	WOS:000343210800113
J	Matsuo, R; Kamouchi, M; Fukuda, H; Hata, J; Wakisaka, Y; Kuroda, J; Ago, T; Kitazono, T				Matsuo, Ryu; Kamouchi, Masahiro; Fukuda, Haruhisa; Hata, Jun; Wakisaka, Yoshinobu; Kuroda, Junya; Ago, Tetsuro; Kitazono, Takanari		FSR Investigators	Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator for Ischemic Stroke Patients over 80 Years Old: The Fukuoka Stroke Registry	PLOS ONE			English	Article							RT-PA; TRIAL IST-3; MANAGEMENT; GREATER-THAN-OR-EQUAL-TO-80; ALTEPLASE; TPA	Objectives: The benefit of intravenous recombinant tissue plasminogen activator (rt-PA) therapy for very old patients with acute ischemic stroke remains unclear. The aim of this study was to elucidate the efficacy and safety of intravenous rt-PA therapy for patients over 80 years old. Methods: Of 13,521 stroke patients registered in the Fukuoka Stroke Registry in Japan from June 1999 to February 2013, 953 ischemic stroke patients who were over 80 years old, hospitalized within 3 h of onset, and not treated with endovascular therapy were included in this study. Among them, 153 patients were treated with intravenous rt-PA (0.6 mg/kg). For propensity score (PS)-matched case-control analysis, 148 patients treated with rt-PA and 148 PS-matched patients without rt-PA therapy were selected by 1:1 matching with propensity for using rt-PA. Clinical outcomes were neurological improvement, good functional outcome at discharge, in-hospital mortality, and hemorrhagic complications (any intracranial hemorrhage [ICH], symptomatic ICH, and gastrointestinal bleeding). Results: In the full cohort of 953 patients, rt-PA use was associated positively with neurological improvement and good functional outcome, and negatively with in-hospital mortality after adjustment for multiple confounding factors. In PS-matched case-control analysis, patients treated with rt-PA were still at lower risk for unfavorable clinical outcomes than non-treated patients (neurological improvement, odds ratio 2.67, 95% confidence interval 1.61-4.40; good functional outcome, odds ratio 2.23, 95% confidence interval 1.16-4.29; in-hospital mortality, odds ratio 0.30, 95% confidence interval 0.13-0.65). There was no significant association between rt-PA use and risk of hemorrhagic complications in the full and PS-matched cohorts. Conclusions: Intravenous rt-PA therapy was associated with improved clinical outcomes without significant increase in risk of hemorrhagic complications in very old patients (aged. 80 years) with acute ischemic stroke.	[Matsuo, Ryu; Hata, Jun; Wakisaka, Yoshinobu; Kuroda, Junya; Ago, Tetsuro; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; [Matsuo, Ryu; Kamouchi, Masahiro; Fukuda, Haruhisa] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Care Adm & Management, Fukuoka 812, Japan; [Kamouchi, Masahiro; Fukuda, Haruhisa; Hata, Jun; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Ctr Cohort Studies, Fukuoka 812, Japan	Kyushu University; Kyushu University; Kyushu University	Kamouchi, M (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Hlth Care Adm & Management, Fukuoka 812, Japan.	kamouchi@hcam.med.kyushu-u.ac.jp		Ago, Tetsuro/0000-0003-4560-6594	JSPS KAKENHI [22249069, 24310024, 26293158]; Japanese Ministry of Education, Culture, Sports, Science and Technology	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by JSPS KAKENHI Grant Numbers 22249069 for MK, 24310024 for MK and TK, and 26293158 for MK, and Coordination, Support and Training Program for Translational Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology for TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshekhlee A, 2010, STROKE, V41, P2259, DOI 10.1161/STROKEAHA.110.588632; Berrouschot J, 2005, STROKE, V36, P2421, DOI 10.1161/01.STR.0000185696.73938.e0; Bhatnagar P, 2011, J NEUROL NEUROSUR PS, V82, P712, DOI 10.1136/jnnp.2010.223149; Chen CI, 2005, EUR NEUROL, V54, P140, DOI 10.1159/000089086; Engelter ST, 2005, NEUROLOGY, V65, P1795, DOI 10.1212/01.wnl.0000183702.04080.27; Engelter ST, 2006, AGE AGEING, V35, P572, DOI 10.1093/ageing/afl104; Ford GA, 2010, STROKE, V41, P2568, DOI 10.1161/STROKEAHA.110.581884; Gomez-Choco M, 2008, EUR J NEUROL, V15, P253, DOI 10.1111/j.1468-1331.2007.02042.x; Kamouchi M, 2011, STROKE, V42, P2788, DOI 10.1161/STROKEAHA.111.617415; Koga M, 2012, STROKE, V43, P253, DOI 10.1161/STROKEAHA.111.631176; Kumai Y, 2012, NEUROLOGY, V78, P1909, DOI 10.1212/WNL.0b013e318259e110; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Matsuo R, 2014, GERIATR GERONTOL INT, V14, P954, DOI 10.1111/ggi.12205; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mishra NK, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6046; Mouradian MS, 2005, J NEUROL NEUROSUR PS, V76, P1234, DOI 10.1136/jnnp.2004.047803; Ringleb A, 2007, J NEUROL NEUROSUR PS, V78, P690, DOI 10.1136/jnnp.2006.105890; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; Sandercock P, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-37; Shinohara Y, 2008, INT J STROKE, V3, P55, DOI 10.1111/j.1747-4949.2008.00178.x; Sung PS, 2011, EUR NEUROL, V66, P110, DOI 10.1159/000328429; Sylaja PN, 2006, J NEUROL NEUROSUR PS, V77, P826, DOI 10.1136/jnnp.2005.086595; Tanne D, 2000, STROKE, V31, P370, DOI 10.1161/01.STR.31.2.370; Toni D, 2008, CEREBROVASC DIS, V25, P129, DOI 10.1159/000112323; Toyoda K, 2009, DRUGS, V69, P633, DOI 10.2165/00003495-200969060-00001; van Oostenbrugge RJ, 2006, J NEUROL NEUROSUR PS, V77, P375, DOI 10.1136/jnnp.2005.070292; Yamaguchi T, 2006, STROKE, V37, P1810, DOI 10.1161/01.STR.0000227191.01792.e3; Yong M, 2008, STROKE, V39, P2749, DOI 10.1161/STROKEAHA.108.514307; Zeevi N, 2007, CEREBROVASC DIS, V23, P304, DOI 10.1159/000098332	29	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110444	10.1371/journal.pone.0110444	http://dx.doi.org/10.1371/journal.pone.0110444			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329379	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210800087
J	Yang, RL; Liu, XM; Chen, ZY; Yang, CY; Lin, YS; Wang, SY				Yang, Rongling; Liu, Xueming; Chen, Zhiyi; Yang, Chunying; Lin, Yaosheng; Wang, Siyuan			Highly Efficient and Enzymatic Regioselective Undecylenoylation of Gastrodin in 2-Methyltetrahydrofuran-Containing Systems	PLOS ONE			English	Article							FRIENDLY SOLVENT 2-METHYLTETRAHYDROFURAN; CANDIDA-ANTARCTICA; UNDECYLENIC ACID; IN-VITRO; ACYLATION; LIPASE; DERIVATIVES; NUCLEOSIDES; FLAVONOIDS; GLYCOSIDES	Highly efficient and regioselective acylation of pharmacologically interesting gastrodin with vinyl undecylenic acid has been firstly performed through an enzymatic approach. The highest catalytic activity and regioselectivity towards the acylation of 7'-hydroxyl of gastrodin was obtained with Pseudomonas cepacia lipase. In addition, it was observed the lipase displayed higher activity in the eco-friendly solvent 2-methyltetrahydrofuran-containing systems than in other organic solvents. In the co-solvent mixture of tetrahydrofuran and 2-methyltetrahydrofuran ( 3/1, v/v), the reaction rate was 60.6 mM/h, substrate conversion exceeded 99%, and 7'-regioselectivity was 93%. It was also interesting that the lipase-catalyzed acylation couldn't be influenced by the benzylic alcohol in gastrodin. However, pseudomonas cepacia lipase displayed different regioselectivity towards gastrodin and arbutin.	[Yang, Rongling; Liu, Xueming; Chen, Zhiyi; Yang, Chunying; Lin, Yaosheng; Wang, Siyuan] Guangdong Acad Agr Sci, Sericulture & Agrifood Res Inst, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Agricultural Sciences	Yang, RL (corresponding author), Guangdong Acad Agr Sci, Sericulture & Agrifood Res Inst, Guangzhou, Guangdong, Peoples R China.	ronglingyang@qq.com; xuemingliu37@126.com	Liu, Xueming/AAR-2243-2020; Liu, Xueming/GSD-3517-2022		Guangdong National Natural Science Foundation [S2012040008048]; Guangzhou Science and Technology Plan Projects of China [11D84070010, 2014J2200068]	Guangdong National Natural Science Foundation; Guangzhou Science and Technology Plan Projects of China	This research was financially supported by the Guangdong National Natural Science Foundation (Grant No. S2012040008048), Guangzhou Science and Technology Plan Projects of China (grant number 11D84070010) and the Guangzhou Science and Technology Plan Projects of China (grant number 2014J2200068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardhaoui M, 2004, J MOL CATAL B-ENZYM, V29, P63, DOI 10.1016/j.molcatb.2004.02.013; Ardhaoui M, 2004, J BIOTECHNOL, V110, P265, DOI 10.1016/j.jbiotec.2004.03.003; Aycock DF, 2007, ORG PROCESS RES DEV, V11, P156, DOI 10.1021/op060155c; Bizerra AMC, 2011, TETRAHEDRON, V67, P2858, DOI 10.1016/j.tet.2011.02.070; Caufin S, 2014, J MOL CATAL B-ENZYM, V104, P42, DOI 10.1016/j.molcatb.2014.02.019; Chen ZG, 2013, BIORESOURCE TECHNOL, V133, P82, DOI 10.1016/j.biortech.2013.01.117; Ferrer M, 2005, ENZYME MICROB TECH, V36, P391, DOI 10.1016/j.enzmictec.2004.02.009; Gao WL, 2012, BIORESOURCE TECHNOL, V118, P82, DOI 10.1016/j.biortech.2012.04.104; Gao WL, 2011, BIOTECHNOL LETT, V33, P2233, DOI 10.1007/s10529-011-0685-6; Klibanov AM, 2001, NATURE, V409, P241, DOI 10.1038/35051719; Koeller KM, 2001, NATURE, V409, P232, DOI 10.1038/35051706; Kren V, 2001, CURR MED CHEM, V8, P1303, DOI 10.2174/0929867013372193; Lee E, 2012, EUR J PHARM SCI, V46, P17, DOI 10.1016/j.ejps.2012.01.015; Lee MY, 2002, CURR OPIN BIOTECH, V13, P376, DOI 10.1016/S0958-1669(02)00337-3; Li N, 2007, J MOL CATAL B-ENZYM, V47, P6, DOI 10.1016/j.molcatb.2007.02.006; Li X, 2008, J APPL POLYM SCI, V108, P431, DOI 10.1002/app.27680; Mellou F, 2005, J BIOTECHNOL, V116, P295, DOI 10.1016/j.jbiotec.2004.12.002; Ojemann LM, 2006, EPILEPSY BEHAV, V8, P376, DOI 10.1016/j.yebeh.2005.12.009; Pace V, 2012, CHEMSUSCHEM, V5, P1369, DOI 10.1002/cssc.201100780; Pace V, 2011, GREEN CHEM, V13, P1986, DOI 10.1039/c1gc15574a; Plou FJ, 2002, J BIOTECHNOL, V96, P55, DOI 10.1016/S0168-1656(02)00037-8; Van der Steen M, 2009, CHEMSUSCHEM, V2, P692, DOI 10.1002/cssc.200900075; Wang ZY, 2013, PROCESS BIOCHEM, V48, P1208, DOI 10.1016/j.procbio.2013.06.022; Xue ST, 2013, MOLECULES, V18, P3789, DOI 10.3390/molecules18043789; Yang RL, 2010, BIORESOURCE TECHNOL, V101, P1, DOI 10.1016/j.biortech.2009.07.067; Yang RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080715; Ye XL, 2006, COLLOID SURFACE A, V279, P218, DOI 10.1016/j.colsurfa.2006.01.007; Zeng XH, 2006, PLANTA MED, V72, P1359, DOI 10.1055/s-2006-951709; Ziaullah, 2013, TETRAHEDRON LETT, V54, P1933, DOI 10.1016/j.tetlet.2013.01.103	29	4	4	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e110342	10.1371/journal.pone.0110342	http://dx.doi.org/10.1371/journal.pone.0110342			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329539	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210800077
J	Bao, XY; Wen, XF; Sun, XM; Zhao, FH; Wang, YY				Bao, Xueyan; Wen, Xuefa; Sun, Xiaomin; Zhao, Fenghua; Wang, Yuying			Interannual Variation in Carbon Sequestration Depends Mainly on the Carbon Uptake Period in Two Croplands on the North China Plain	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; NET ECOSYSTEM EXCHANGE; WATER-USE EFFICIENCY; DIOXIDE EXCHANGE; DECIDUOUS FOREST; EDDY COVARIANCE; WINTER-WHEAT; SUGAR-BEET; VARIABILITY; BALANCE	Interannual variation in plant phenology can lead to major modifications in the interannual variation of net ecosystem production (NEP) and net biome production (NBP) as a result of recent climate change in croplands. Continuous measurements of carbon flux using the eddy covariance technique were conducted in two winter wheat and summer maize double-cropped croplands during 2003-2012 in Yucheng and during 2007-2012 in Luancheng on the North China Plain. Our results showed that the difference between the NEP and the NBP, i.e., the crop economic yield, was conservative even though the NEP and the NBP for both sites exhibited marked fluctuations during the years of observation. A significant and positive relationship was found between the annual carbon uptake period (CUP) and the NEP as well as the NBP. The NEP and the NBP would increase by 14.8 +/- 5.2 and 14.7 +/- 6.6 g C m(-2) 22 yr(-1), respectively, if one CUP-day was extended. A positive relationship also existed between the CUP and the NEP as well as the NBP for winter wheat and summer maize, respectively. The annual air temperature, through its negative effect on the start date of the CUP, determined the length of the CUP. The spring temperature was the main indirect factor controlling the annual carbon sequestration when a one-season crop (winter wheat) was considered. Thus, global warming can be expected to extend the length of the CUP and thus increase carbon sequestration in croplands.	[Bao, Xueyan; Wen, Xuefa; Sun, Xiaomin; Zhao, Fenghua] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China; [Bao, Xueyan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Yuying] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources Res, Shijiazhuang, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Wen, XF (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China.	wenxf@igsnrr.ac.cn; sunxm@igsnrr.ac.cn	zhao, fenghua/B-5235-2013	zhao, fenghua/0000-0003-1447-0460	Strategic Priority Research Program-Climate Change: C Budget and Relevant Issues of the Chinese Academy of Sciences [XDA05050601]; Strategic Program of Knowledge Innovation of the Chinese Academy of Sciences [KZCX2-EW-QN305]	Strategic Priority Research Program-Climate Change: C Budget and Relevant Issues of the Chinese Academy of Sciences; Strategic Program of Knowledge Innovation of the Chinese Academy of Sciences	This study was supported by the Strategic Priority Research Program-Climate Change: C Budget and Relevant Issues of the Chinese Academy of Sciences (Grant No. XDA05050601) and the Strategic Program of Knowledge Innovation of the Chinese Academy of Sciences (Grant No. KZCX2-EW-QN305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthoni PM, 2004, AGR FOREST METEOROL, V121, P55, DOI 10.1016/S0168-1923(03)00162-X; Baker JM, 2005, AGR FOREST METEOROL, V128, P163, DOI 10.1016/j.agrformet.2004.11.005; Baldocchi DD, 2001, ECOL MODEL, V142, P155, DOI 10.1016/S0304-3800(01)00287-3; Barr AG, 2004, AGR FOREST METEOROL, V126, P237, DOI 10.1016/j.agrformet.2004.06.011; Barr AG, 2002, CAN J FOREST RES, V32, P813, DOI [10.1139/x01-131, 10.1139/X01-131]; Barr AG, 2007, GLOBAL CHANGE BIOL, V13, P561, DOI 10.1111/j.1365-2486.2006.01220.x; Bernacchi CJ, 2005, GLOBAL CHANGE BIOL, V11, P1867, DOI 10.1111/j.1365-2486.01050.x; Beziat P, 2009, AGR FOREST METEOROL, V149, P1628, DOI 10.1016/j.agrformet.2009.05.004; Black TA, 2000, GEOPHYS RES LETT, V27, P1271, DOI 10.1029/1999GL011234; Chen J, 2000, GLOBAL BIOGEOCHEM CY, V14, P839, DOI 10.1029/1999GB001207; Chen Z, 2013, AGR FOREST METEOROLO; Churkina G, 2005, GLOBAL CHANGE BIOL, V11, P1777, DOI 10.1111/j.1365-2486.2005.001012.x; Du Q, 2013, AGR ECOSYST ENVIRON, V173, P1, DOI 10.1016/j.agee.2013.04.009; EUGSTER W, 1995, BOUND-LAY METEOROL, V74, P321, DOI 10.1007/BF00712375; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; Fang QX, 2006, PLANT SOIL, V284, P335, DOI 10.1007/s11104-006-0055-7; Gilmanov TG, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB002023; Goulden ML, 1996, SCIENCE, V271, P1576, DOI 10.1126/science.271.5255.1576; Grant RF, 2007, AGRON J, V99, P1404, DOI 10.2134/agronj2006.0308; Hollinger SE, 2005, AGR FOREST METEOROL, V130, P59, DOI 10.1016/j.agrformet.2005.01.005; Jans WWP, 2010, AGR ECOSYST ENVIRON, V139, P316, DOI 10.1016/j.agee.2010.06.008; Lei HM, 2010, GLOBAL CHANGE BIOL, V16, P2944, DOI 10.1111/j.1365-2486.2009.02136.x; Li J, 2006, SCI CHINA SER D, V49, P226, DOI 10.1007/s11430-006-8226-1; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Ma SY, 2007, AGR FOREST METEOROL, V147, P157, DOI 10.1016/j.agrformet.2007.07.008; Maraseni TN, 2010, J AGR SCI-CAMBRIDGE, V148, P501, DOI 10.1017/S002185960999058X; Maraseni TN, 2007, J ENVIRON SCI HEAL A, V42, P11, DOI 10.1080/10934520601015354; Maraseni TN, 2010, J ENVIRON SCI HEAL B, V45, P578, DOI 10.1080/03601234.2010.493497; Moffat AM, 2007, AGR FOREST METEOROL, V147, P209, DOI 10.1016/j.agrformet.2007.08.011; Moors EJ, 2010, AGR ECOSYST ENVIRON, V139, P325, DOI 10.1016/j.agee.2010.04.013; Moureaux C, 2008, BIOTECHNOL AGRON SOC, V12, P303; Moureaux C, 2006, AGR FOREST METEOROL, V139, P25, DOI 10.1016/j.agrformet.2006.05.009; Osborne B, 2010, AGR ECOSYST ENVIRON, V139, P293, DOI 10.1016/j.agee.2010.05.009; Penuelas J, 2001, SCIENCE, V294, P793, DOI 10.1126/science.1066860; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Richardson AD, 2010, PHILOS T R SOC B, V365, P3227, DOI 10.1098/rstb.2010.0102; Roosta HR, 2014, J PLANT NUTR, V37, P1782, DOI 10.1080/01904167.2014.890220; Saigusa N, 2005, AGR FOREST METEOROL, V134, P4, DOI 10.1016/j.agrformet.2005.08.016; Saigusa N, 2002, AGR FOREST METEOROL, V112, P203, DOI 10.1016/S0168-1923(02)00082-5; Sainju UM, 2014, J ENVIRON QUAL, V43, P777, DOI 10.2134/jeq2013.10.0405; Schmidt M, 2012, AGR FOREST METEOROL, V165, P114, DOI 10.1016/j.agrformet.2012.05.012; SCOTT RK, 1973, J AGR SCI, V81, P339, DOI 10.1017/S0021859600059001; Shen YJ, 2013, AGR FOREST METEOROL, V181, P133, DOI 10.1016/j.agrformet.2013.07.013; Smith P, 2000, SOIL USE MANAGE, V16, P1, DOI 10.1111/j.1475-2743.2000.tb00162.x; Suyker AE, 2004, AGR FOREST METEOROL, V124, P1, DOI 10.1016/j.agrformet.2004.01.011; Tanner C. B., 1969, ANEMOCLINOMETER MEAS; Tong XJ, 2007, NEW ZEAL J AGR RES, V50, P1347; Tong XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089469; Verma SB, 2005, AGR FOREST METEOROL, V131, P77, DOI 10.1016/j.agrformet.2005.05.003; Wang EL, 2008, INT J CLIMATOL, V28, P1959, DOI 10.1002/joc.1677; Wang HX, 2001, AGR WATER MANAGE, V48, P151, DOI 10.1016/S0378-3774(00)00118-9; Wang XH, 2011, P NATL ACAD SCI USA, V108, P1240, DOI 10.1073/pnas.1014425108; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Welp LR, 2007, AGR FOREST METEOROL, V147, P172, DOI 10.1016/j.agrformet.2007.07.010; West TO, 2002, ENVIRON POLLUT, V116, P439, DOI 10.1016/S0269-7491(01)00221-4; White MA, 1997, GLOBAL BIOGEOCHEM CY, V11, P217, DOI 10.1029/97GB00330; White MA, 2003, GLOBAL CHANGE BIOL, V9, P967, DOI 10.1046/j.1365-2486.2003.00585.x; Wu CY, 2012, AGR FOREST METEOROL, V164, P29, DOI 10.1016/j.agrformet.2012.05.002; Yu GR, 2013, GLOBAL CHANGE BIOL, V19, P798, DOI 10.1111/gcb.12079; Zhao FH, 2007, AGR WATER MANAGE, V93, P99, DOI 10.1016/j.agwat.2007.06.012	61	8	9	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110021	10.1371/journal.pone.0110021	http://dx.doi.org/10.1371/journal.pone.0110021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313713	Green Submitted, gold, Green Published			2022-12-27	WOS:000343662500093
J	Chacon, M; Jara, JL; Panerai, RB				Chacon, Max; Luis Jara, Jose; Panerai, Ronney B.			A New Model-Free Index of Dynamic Cerebral Blood Flow Autoregulation	PLOS ONE			English	Article							SPONTANEOUS FLUCTUATIONS; TRANSCRANIAL DOPPLER; ARTERIAL; PRESSURE; VELOCITY; VARIABILITY; RESPONSES	The classic dynamic autoregulatory index (ARI), proposed by Aaslid and Tiecks, is one of the most widely used methods to assess the efficiency of dynamic cerebral autoregulation. Although this index is often used in clinical research and is also included in some commercial equipment, it exhibits considerable intra-subject variability, and has the tendency to produce false positive results in clinical applications. An alternative index of dynamic cerebral autoregulation is proposed, which overcomes most of the limitations of the classic method and also has the advantage of being model-free. This new index uses two parameters that are obtained directly from the response signal of the cerebral blood flow velocity to a transient decrease in arterial blood pressure provoked by the sudden release of bilateral thigh cuffs, and a third parameter measuring the difference in slope of this response and the change in arterial blood pressure achieved. With the values of these parameters, a corresponding classic autoregulatory index value could be calculated by using a linear regression model built from theoretical curves generated with the Aaslid-Tiecks model. In 16 healthy subjects who underwent repeated thigh-cuff manoeuvres, the model-free approach exhibited significantly lower intra-subject variability, as measured by the unbiased coefficient of variation, than the classic autoregulatory index (p = 0.032) and the Rate of Return (p, 0.001), another measure of cerebral autoregulation used for this type of systemic pressure stimulus, from 39.23%+/- 41.91% and 55.31%+/- 31.27%, respectively, to 15.98%+/- 7.75%.	[Chacon, Max; Luis Jara, Jose] Univ Santiago Chile, Dept Ingn Informat, Santiago, Chile; [Panerai, Ronney B.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England	Universidad de Santiago de Chile; University of Leicester	Chacon, M (corresponding author), Univ Santiago Chile, Dept Ingn Informat, Santiago, Chile.	max.chacon@usach.cl	Jara, José Luis/J-7254-2015; Jara, Jose/GQB-5331-2022	Jara, José Luis/0000-0002-3348-7017; 	DICYT grant from Universidad de Santiago de Chile [061419CHP]; MESESUP grant USA Proyecto de Aportes Basales por Desempeno	DICYT grant from Universidad de Santiago de Chile; MESESUP grant USA Proyecto de Aportes Basales por Desempeno(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL)	This work has been partially funded by DICYT grant no. 061419CHP from Universidad de Santiago de Chile and MESESUP grant USA 1298 Proyecto de Aportes Basales por Desempeno. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLID R, 1991, STROKE, V22, P1148, DOI 10.1161/01.STR.22.9.1148; AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chacon M, 2008, PHYSIOL MEAS, V29, P1179, DOI 10.1088/0967-3334/29/10/003; Chacon M, 2011, MED ENG PHYS, V33, P180, DOI 10.1016/j.medengphy.2010.09.023; Claassen JAHR, 2007, J APPL PHYSIOL, V102, P870, DOI 10.1152/japplphysiol.00906.2006; Czosnyka M, 2008, ANESTH ANALG, V106, P234, DOI 10.1213/01.ane.0000295802.89962.13; Dineen NE, 2010, J APPL PHYSIOL, V108, P604, DOI 10.1152/japplphysiol.01157.2009; Duda R.O., 2000, PATTERN CLASSIFICATI; Elting JW, 2013, MED ENG PHY IN PRESS; GILLER CA, 1993, NEUROSURGERY, V32, P737, DOI 10.1227/00006123-199305000-00006; Hlatky R, 2006, NEUROCRIT CARE, V4, P127, DOI 10.1385/NCC:4:2:127; Hopkins WG, 2009, CALCULATING RELIABIL; Horsfield MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062588; Hu K, 2008, CARDIOVASC ENG, V8, P60, DOI 10.1007/s10558-007-9045-5; LARSEN FS, 1994, STROKE, V25, P1985, DOI 10.1161/01.STR.25.10.1985; Liu Y, 2003, MED ENG PHYS, V25, P647, DOI 10.1016/S1350-4533(03)00015-8; Mahony PJ, 2000, STROKE, V31, P476, DOI 10.1161/01.STR.31.2.476; Nogueira RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070821; Novak V, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-39; Panerai RB, 2003, PHYSIOL MEAS, V24, P367, DOI 10.1088/0967-3334/24/2/312; Panerai RB, 1998, MED BIOL ENG COMPUT, V36, P315, DOI 10.1007/BF02522477; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; Panerai RB, 2003, ULTRASOUND MED BIOL, V29, P31, DOI 10.1016/S0301-5629(02)00698-1; Panerai RB, 1998, STROKE, V29, P2341, DOI 10.1161/01.STR.29.11.2341; Panerai RB, 2001, AM J PHYSIOL-HEART C, V280, pH2162, DOI 10.1152/ajpheart.2001.280.5.H2162; Panerai RB, 2008, CARDIOVASC ENG, V8, P42, DOI 10.1007/s10558-007-9044-6; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Pettitt A.N, 1977, J R STAT SOC, V26, P156, DOI DOI 10.2307/2347023; Saeed NP, 2013, CEREBROVASC DIS, V35, P257, DOI 10.1159/000347075; Simpson DM, 2000, MED BIOL ENG COMPUT, V38, P535, DOI 10.1007/BF02345749; Sokal RR, 1995, BIOMETRY; Sorond FA, 2009, ULTRASOUND MED BIOL, V35, P21, DOI 10.1016/j.ultrasmedbio.2008.08.001; Tiecks FP, 1996, STROKE, V27, P1177, DOI 10.1161/01.STR.27.7.1177; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; van Beek AHEA, 2010, ULTRASOUND MED BIOL, V36, P192, DOI 10.1016/j.ultrasmedbio.2009.10.011; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Ziegler J. G., 1993, Transactions of the ASME. Journal of Dynamic Systems, Measurement and Control, V115, P220, DOI 10.1115/1.2899060	38	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e108281	10.1371/journal.pone.0108281	http://dx.doi.org/10.1371/journal.pone.0108281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313519	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500010
J	Consolati, G; Quasso, F; Trezzi, D				Consolati, Giovanni; Quasso, Fiorenza; Trezzi, Davide			Swelling of Positronium Confined in a Small Cavity	PLOS ONE			English	Article							CONTACT DENSITY; MOLECULAR-SOLIDS; ANNIHILATION; DEFECTS; SPECTROSCOPY; DEPENDENCE; LIFETIMES	The electron density at the positron (contact density) in the ground state positronium (Ps) formed in condensed matter is generally found to be lower than in vacuum. This is usually attributed to microscopic electric fields which polarize Ps, by acting on the two particles of the atom. In this paper we quantitatively investigate an opposite effect. It is due to the confinement of Ps in small cavities existing in the host solid (e. g. free volume in polymers), which increases the contact density. Although this phenomenon is greater, the smaller is the size of the cavity, Ps polarization seems to play anyway a predominant role.	[Consolati, Giovanni; Quasso, Fiorenza] Politecn Milan, Dept Aerosp Sci & Technol, I-20133 Milan, Italy; [Trezzi, Davide] Univ Milan, Dept Phys, Milan, Italy	Polytechnic University of Milan; University of Milan	Consolati, G (corresponding author), Politecn Milan, Dept Aerosp Sci & Technol, I-20133 Milan, Italy.	giovanni.consolati@polimi.it	Quasso, Fiorenza/C-5671-2013; Consolati, Giovanni/C-5680-2013	Quasso, Fiorenza/0000-0002-2867-5830; Consolati, Giovanni/0000-0003-3614-245X				BERKO S, 1980, ANNU REV NUCL PART S, V30, P543, DOI 10.1146/annurev.ns.30.120180.002551; BISI A, 1988, NUOVO CIMENTO D, V10, P1069, DOI 10.1007/BF02450205; BRANDT W, 1960, PHYS REV, V120, P1289, DOI 10.1103/PhysRev.120.1289; CONSOLATI G, 1988, SOLID STATE COMMUN, V67, P1113, DOI 10.1016/0038-1098(88)91066-6; CONSOLATI G, 1988, J PHYS C SOLID STATE, V21, P4143, DOI 10.1088/0022-3719/21/22/026; CONSOLATI G, 1990, APPL PHYS A-MATER, V50, P43, DOI 10.1007/BF00323953; Consolati G, 2002, J CHEM PHYS, V117, P7279, DOI 10.1063/1.1507578; Consolati G, 2005, J POLYM SCI POL PHYS, V43, P2225, DOI 10.1002/polb.20516; Consolati G, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4832321; CONSOLATI G, 1990, J PHYS-CONDENS MAT, V2, P3941, DOI 10.1088/0953-8984/2/17/004; CONSOLATI G, 1994, PHYS REV B, V50, P5848, DOI 10.1103/PhysRevB.50.5848; Consolati G, 1996, J RADIOAN NUCL CH AR, V210, P273, DOI 10.1007/BF02056373; CONSOLATI G, 1991, APPL PHYS A-MATER, V52, P295, DOI 10.1007/BF00324767; CONSOLATI G, 1991, Z PHYS D ATOM MOL CL, V21, P259, DOI 10.1007/BF01426383; DEGROOT SR, 1946, PHYSICA, V12, P669, DOI 10.1016/S0031-8914(46)80096-X; Dupasquier A., 1983, POSITRON SOLID STATE, P510; ELDRUP M, 1981, CHEM PHYS, V63, P51, DOI 10.1016/0301-0104(81)80307-2; ELDRUP M, 1979, PHYS REV LETT, V43, P1407, DOI 10.1103/PhysRevLett.43.1407; GOLDANSK.VI, 1968, ATOM ENERGY REV, V6, P3; GOLDMAN S, 1992, J PHYS CHEM-US, V96, P6021, DOI 10.1021/j100193a069; GORNIAK W, 1991, CHEM PHYS LETT, V177, P23, DOI 10.1016/0009-2614(91)90169-A; GOWOREK T, 1994, J CHEM SOC FARADAY T, V90, P1501, DOI 10.1039/ft9949001501; GOWOREK T, 1987, PHYS STATUS SOLIDI A, V102, P511, DOI 10.1002/pssa.2211020206; GOWOREK T, 1978, PHYS STATUS SOLIDI B, V89, P253, DOI 10.1002/pssb.2220890132; GOWOREK T, 1982, PHYS STATUS SOLIDI B, V113, pK9, DOI 10.1002/pssb.2221130145; Griffiths D.J., 2018, INTRO QUANTUM MECH, V3rd ed.; HALPERN O, 1954, PHYS REV, V94, P904, DOI 10.1103/PhysRev.94.904; Hofmann D, 2003, MACROMOLECULES, V36, P8528, DOI 10.1021/ma034971l; Jasinska B, 1996, J RADIOAN NUCL CH AR, V210, P617, DOI 10.1007/BF02056403; Jean YC, 2003, PRINCIPLES APPL POSI, P3; MCMULLEN T, 1983, CAN J PHYS, V61, P504, DOI 10.1139/p83-063; Michels A, 1937, PHYSICA, V4, P0995, DOI 10.1016/S0031-8914(37)80197-4; Nagashima Y, 2001, MATER SCI FORUM, V363-3, P567, DOI 10.4028/www.scientific.net/MSF.363-365.567; Nakanishi H., 1988, POSITRON ANNIHILATIO, P292; ROCHANAKIJ S, 1988, RADIAT PHYS CHEM, V32, P557; Slater L. J., 1960, CONFLUENT HYPERGEOME; Sommerfeld A, 1938, ANN PHYS-BERLIN, V32, P56; TAO SJ, 1972, J CHEM PHYS, V56, P5499, DOI 10.1063/1.1677067; Wawryszczuk J, 1996, J RADIOAN NUCL CH AR, V211, P161, DOI 10.1007/BF02036268	39	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109937	10.1371/journal.pone.0109937	http://dx.doi.org/10.1371/journal.pone.0109937			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314151	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662500089
J	Goetz, JJ; Martin, GM; Chowdhury, R; Trimarchi, JM				Goetz, Jillian J.; Martin, Gregory M.; Chowdhury, Rebecca; Trimarchi, Jeffrey M.			Onecut1 and Onecut2 Play Critical Roles in the Development of the Mouse Retina	PLOS ONE			English	Article							TRANSCRIPTION FACTOR HNF-6; CELL-FATE DETERMINATION; GANGLION-CELL; GENE-EXPRESSION; HORIZONTAL CELLS; COMPETENCE STATE; MATH5; SPECIFICATION; PROGENITOR; PHOTORECEPTORS	The entire repertoire of intrinsic factors that control the cell fate determination process of specific retinal neurons has yet to be fully identified. Single cell transcriptome profiling experiments of retinal progenitor cells revealed considerable gene expression heterogeneity between individual cells, especially among different classes of transcription factors. In this study, we show that two of those factors, Onecut1 and Onecut2, are expressed during mouse retinal development. Using mice that are deficient for each of these transcription factors, we further demonstrate a significant loss (similar to 70-80%) of horizontal cells in the absence of either of these proteins, while the other retinal cells appear at normal numbers. Microarray profiling experiments performed on knockout retinas revealed defects in horizontal cell genes as early as E14.5. Additional profiling assays showed an upregulation of several stress response genes in the adult Onecut2 knockout, suggesting that the integrity of the retina is compromised in the absence of normal numbers of horizontal cells. Interestingly, melanopsin, the gene coding for the photopigment found in photosensitive ganglion cells, was observed to be upregulated in Onecut1 deficient retinas, pointing to a possible regulatory role for Onecut1. Taken together, our data show that similar to Onecut1, Onecut2 is also necessary for the formation of normal numbers of horizontal cells in the developing retina.	[Goetz, Jillian J.; Martin, Gregory M.; Chowdhury, Rebecca; Trimarchi, Jeffrey M.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA	Iowa State University	Trimarchi, JM (corresponding author), Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.	jtrimarc@iastate.edu	Chowdhury, Rebecca/ABE-1513-2021	Trimarchi, Jeffrey/0000-0001-7923-1538	Iowa State University	Iowa State University	This work was funded by start-up funds from Iowa State University provided to JMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Brown NL, 2001, DEVELOPMENT, V128, P2497; Brzezinski JA, 2012, DEV BIOL, V365, P395, DOI 10.1016/j.ydbio.2012.03.006; Cepko CL, 1996, CURR OPIN NEUROBIOL, V6, P542, DOI 10.1016/S0959-4388(96)80062-6; Chaitin MH, 1996, DEV BRAIN RES, V94, P92, DOI 10.1016/0165-3806(96)00046-6; Chen ZQ, 2012, NEURON, V75, P739, DOI 10.1016/j.neuron.2012.08.008; Cherry TJ, 2009, P NATL ACAD SCI USA, V106, P9495, DOI 10.1073/pnas.0903264106; Clotman F, 2002, DEVELOPMENT, V129, P1819; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Emanuela P, 2009, J COMP NEUROL, V517, P737, DOI 10.1002/cne.22200; Emerson MM, 2013, DEV CELL, V26, P59, DOI 10.1016/j.devcel.2013.06.005; Feng L, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-36; Furuno K, 2008, GENES IMMUN, V9, P302, DOI 10.1038/gene.2008.18; Goetz JJ, 2014, INT REV CEL MOL BIO, V308, P273, DOI 10.1016/B978-0-12-800097-7.00007-5; GRUNERT U, 1993, J COMP NEUROL, V335, P523, DOI 10.1002/cne.903350405; He J, 2012, NEURON, V75, P786, DOI 10.1016/j.neuron.2012.06.033; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Iyaguchi D, 2007, STRUCTURE, V15, P75, DOI 10.1016/j.str.2006.11.004; Jacquemin P, 2003, DEV BIOL, V258, P105, DOI 10.1016/S0012-1606(03)00115-5; Jiang Y, 2013, J BIOL CHEM, V288, P18429, DOI 10.1074/jbc.M113.478503; Jin Z, 2003, DEVELOPMENT, V130, P1037, DOI 10.1242/dev.00326; Kay JN, 2001, NEURON, V30, P725, DOI 10.1016/S0896-6273(01)00312-9; Kim DS, 2008, J COMP NEUROL, V507, P1795, DOI 10.1002/cne.21639; Lemaigre FP, 1996, P NATL ACAD SCI USA, V93, P9460, DOI 10.1073/pnas.93.18.9460; Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Morrow EM, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-2; Poche RA, 2007, J NEUROSCI, V27, P14099, DOI 10.1523/JNEUROSCI.4046-07.2007; Rattner A, 2005, J NEUROSCI, V25, P4540, DOI 10.1523/JNEUROSCI.0492-05.2005; Samardzija M, 2012, EXP EYE RES, V99, P17, DOI 10.1016/j.exer.2012.04.004; Schmidt TM, 2011, J NEUROSCI, V31, P16094, DOI 10.1523/JNEUROSCI.4132-11.2011; Sidman RL, 1961, STRUCTURE EYE, P487; Skowronska-Krawczyk D, 2009, DEVELOPMENT, V136, P3767, DOI 10.1242/dev.033449; Swiderski RE, 2007, INVEST OPHTH VIS SCI, V48, P3329, DOI 10.1167/iovs.06-1477; Templeton JP, 2013, INVEST OPHTH VIS SCI, V54, P2599, DOI 10.1167/iovs.12-11175; Trimarchi JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001588; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wu FG, 2013, J NEUROSCI, V33, P13053, DOI 10.1523/JNEUROSCI.0116-13.2013; Wu FG, 2012, J COMP NEUROL, V520, P952, DOI 10.1002/cne.22741; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; YOUNG RW, 1985, DEV BRAIN RES, V21, P229, DOI 10.1016/0165-3806(85)90211-1	47	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110194	10.1371/journal.pone.0110194	http://dx.doi.org/10.1371/journal.pone.0110194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313862	gold, Green Submitted, Green Published			2022-12-27	WOS:000343662500103
J	Han, SY; Hong, JW; Noh, JH; Kim, DJ				Han, Sang Youb; Hong, Jae Won; Noh, Jung Hyun; Kim, Dong-Jun			Association of the Estimated 24-H Urinary Sodium Excretion with Albuminuria in Adult Koreans: The 2011 Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; TYPE-2 DIABETIC-PATIENTS; DIETARY SALT INTAKE; BLOOD-PRESSURE; GENERAL-POPULATION; RENAL-DISEASE; RISK; MICROALBUMINURIA; PROGRESSION; FAILURE	Background: Sodium intake and albuminuria have important roles in blood pressure and renal progression. Although their relationship has been reported, the results have not been consistent and all studies have examined small populations. Objective: This study investigated the role of the estimated 24-h urinary sodium excretion as a marker of sodium intake and albuminuria. Design: This investigation included 5,187 individuals age 19 years and older from a cross-sectional, nationally representative, stratified survey: The Korea National Health and Nutrition Examination Survey (KNHANES V-2), in 2011. Albuminuria was defined as a urinary albumin/creatinine ratio >= 30 mg/g. The 24-h urinary sodium excretion was estimated from a spot urine. Results: On classifying our participants into quartiles based on the estimated 24-h urinary sodium excretion, the prevalence of albuminuria increased with the 24-h urinary sodium excretion (5.3, 5.7, 7.5, and 11.8% in the first through fourth quartiles, respectively, p for trend <0.001). Even after adjusting for age, sex, diabetes, obesity, and hypertension, the significance persisted. In a multiple logistic regression analysis, the second and third quartiles of the estimated 24-h urinary sodium excretion were not associated with the presence of albuminuria with the first quartile as a control. However, the fourth quartile was significantly associated with the presence of albuminuria (odds ratio 1.61 [95% confidence interval 1.71-2.21], p = 0.003) after adjusting for age, sex, diabetes, obesity, and hypertension. Conclusions: These findings suggest that salt intake is associated with the presence of albuminuria in the general Korean adult population.	[Han, Sang Youb; Hong, Jae Won; Noh, Jung Hyun; Kim, Dong-Jun] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med, Goyang, South Korea	Inje University	Kim, DJ (corresponding author), Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med, Goyang, South Korea.	djkim@paik.ac.kr	Noh, Junghyun/AAU-8113-2020; Noh, Junghyun/ABD-9067-2021	Noh, Junghyun/0000-0002-7964-0515	Inje University research grant	Inje University research grant	This work was supported by the 2013 Inje University research grant (SYH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron KJ, 2011, AM J CLIN NUTR, V94, P1071, DOI 10.3945/ajcn.111.013094; Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Bingham SA, 1987, NUTR ABSTR REV, V57, P705; Chang A, 2013, AM J KIDNEY DIS, V62, P267, DOI 10.1053/j.ajkd.2013.02.363; de Zeeuw D, 2004, CIRCULATION, V110, P921, DOI 10.1161/01.CIR.0000139860.33974.28; du Cailar G, 2002, AM J HYPERTENS, V15, P222, DOI 10.1016/S0895-7061(01)02287-7; Fox CS, 2006, KIDNEY INT, V69, P2064, DOI 10.1038/sj.ki.5000378; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hillege HL, 2001, J INTERN MED, V249, P519, DOI 10.1046/j.1365-2796.2001.00833.x; Imai E, 2011, CLIN EXP NEPHROL, V15, P861, DOI 10.1007/s10157-011-0523-0; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; JOHNSON RK, 1994, AM J CLIN NUTR, V59, P1286, DOI 10.1093/ajcn/59.6.1286; Jones CA, 2002, AM J KIDNEY DIS, V39, P445, DOI 10.1053/ajkd.2002.31388; Jones-Burton C, 2006, AM J NEPHROL, V26, P268, DOI 10.1159/000093833; Konta T, 2006, KIDNEY INT, V70, P751, DOI 10.1038/sj.ki.5001504; KOOMANS HA, 1985, HYPERTENSION, V7, P714, DOI 10.1161/01.HYP.7.5.714; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Lin JL, 2010, CLIN J AM SOC NEPHRO, V5, P836, DOI 10.2215/CJN.08001109; LIVINGSTONE MBE, 1990, BRIT MED J, V300, P708, DOI 10.1136/bmj.300.6726.708; Ogura M, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-36; Sanders MW, 2005, HYPERTENSION, V46, P71, DOI 10.1161/01.HYP.0000171475.40259.d1; Swift PA, 2005, HYPERTENSION, V46, P308, DOI 10.1161/01.HYP.0000172662.12480.7f; Tamaki J, 2004, HYPERTENS RES, V27, P157, DOI 10.1291/hypres.27.157; Tanaka T, 2002, J HUM HYPERTENS, V16, P97, DOI 10.1038/sj.jhh.1001307; The Japanese Society of Hypertension, 2009, HYPERTENS RES, V32, P29; Vedovato M, 2004, DIABETOLOGIA, V47, P300, DOI 10.1007/s00125-003-1303-5; Verhave JC, 2004, J INTERN MED, V256, P324, DOI 10.1111/j.1365-2796.2004.01390.x; Won JC, 2012, PLOS ONE, V8; Yilmaz R, 2012, EUR J CLIN NUTR, V66, P1214, DOI 10.1038/ejcn.2012.110; Yu HCM, 1998, CIRCULATION, V98, P2621, DOI 10.1161/01.CIR.98.23.2621	32	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109073	10.1371/journal.pone.0109073	http://dx.doi.org/10.1371/journal.pone.0109073			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313865	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500023
J	Herce, ME; Elmore, SN; Kalanga, N; Keck, JW; Wroe, EB; Phiri, A; Mayfield, A; Chingoli, F; Beste, JA; Tengatenga, L; Bazile, J; Krakauer, EL; Rigodon, J				Herce, Michael E.; Elmore, Shekinah N.; Kalanga, Noel; Keck, James W.; Wroe, Emily B.; Phiri, Atupere; Mayfield, Alishya; Chingoli, Felix; Beste, Jason A.; Tengatenga, Listern; Bazile, Junior; Krakauer, Eric L.; Rigodon, Jonas			Assessing and Responding to Palliative Care Needs in Rural Sub-Saharan Africa: Results from a Model Intervention and Situation Analysis in Malawi	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; SYMPTOM EXPERIENCE; EASTERN CAPE; SOUTH-AFRICA; OF-LIFE; HIV; BURDEN; CANCER; HEALTH; UGANDA	Introduction: Palliative care is rarely accessible in rural sub-Saharan Africa. Partners In Health and the Malawi government established the Neno Palliative Care Program (NPCP) to provide palliative care in rural Neno district. We conducted a situation analysis to evaluate early NPCP outcomes and better understand palliative care needs, knowledge, and preferences. Methods: Employing rapid evaluation methodology, we collected data from 3 sources: 1) chart review of all adult patients from the NPCP's first 9 months; 2) structured interviews with patients and caregivers; 3) semi-structured interviews with key stakeholders. Results: The NPCP enrolled 63 patients in its first 9 months. Frequent diagnoses were cancer (n = 50, 79%) and HIV/AIDS (n = 37 of 61, 61%). Nearly all (n = 31, 84%) patients with HIV/AIDS were on antiretroviral therapy. Providers registered 112 patient encounters, including 22 (20%) home visits. Most (n = 43, 68%) patients had documented pain at baseline, of whom 23 (53%) were treated with morphine. A majority (n = 35, 56%) had >= 1 follow-up encounter. Mean African Palliative Outcome Scale pain score decreased non-significantly between baseline and follow-up (3.0 vs. 2.7, p = 0.5) for patients with baseline pain and complete pain assessment documentation. Providers referred 48 (76%) patients for psychosocial services, including community health worker support, socioeconomic assistance, or both. We interviewed 36 patients referred to the NPCP after the chart review period. Most had cancer (n = 19, 53%) or HIV/AIDS (n = 10, 28%). Patients frequently reported needing income (n = 24, 67%) or food (n = 22, 61%). Stakeholders cited a need to make integrated palliative care widely available. Conclusions: We identified a high prevalence of pain and psychosocial needs among patients with serious chronic illnesses in rural Malawi. Early NPCP results suggest that comprehensive palliative care can be provided in rural Africa by integrating disease-modifying treatment and palliative care, linking hospital, clinic, and home-based services, and providing psychosocial support that includes socioeconomic assistance.	[Herce, Michael E.] Univ N Carolina, Sch Med, Dept Med, Div Infect Dis, Chapel Hill, NC 27514 USA; [Herce, Michael E.; Kalanga, Noel; Keck, James W.; Wroe, Emily B.; Phiri, Atupere; Beste, Jason A.; Bazile, Junior; Rigodon, Jonas] Abwenzi Pa Za Umoyo, Neno, Malawi; [Herce, Michael E.; Kalanga, Noel; Keck, James W.; Wroe, Emily B.; Phiri, Atupere; Beste, Jason A.; Bazile, Junior; Krakauer, Eric L.; Rigodon, Jonas] Partners Hlth, Boston, MA USA; [Elmore, Shekinah N.; Krakauer, Eric L.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Wroe, Emily B.; Mayfield, Alishya] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Chingoli, Felix; Tengatenga, Listern] Govt Republ Malawi, Minist Hlth, Neno Dist Hosp, Neno Dist Hlth Off, Neno, Malawi; [Krakauer, Eric L.] Massachusetts Gen Hosp, Dept Med, Div Palliat Care, Boston, MA 02114 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Partners Healthcare System; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Herce, ME (corresponding author), Univ N Carolina, Sch Med, Dept Med, Div Infect Dis, Chapel Hill, NC 27514 USA.	michael_herce@med.unc.edu		Elmore, Shekinah/0000-0002-7136-1597; Keck, James/0000-0001-7193-065X	True Colours Trust/Waterloo Coalition [TCT 833]; Diana Princess of Wales Memorial Fund [URN6650/3423]; US National Institutes of Health [T32 AI007001-36, CTSA UL1TR000083]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, T32AI007001] Funding Source: NIH RePORTER	True Colours Trust/Waterloo Coalition; Diana Princess of Wales Memorial Fund; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The True Colours Trust/Waterloo Coalition and the Diana Princess of Wales Memorial Fund provided generous financial support for key components of the Neno Palliative Care Program. Grant funding from these organizations was provided under awards TCT 833 and URN6650/3423, respectively. Additional information about these organizations may be found at the following URLs: http://www.truecolourstrust.org.uk; http://www.dianaprincessofwalesmemorialfund.org. This work was supported in part by the US National Institutes of Health, grants T32 AI007001-36 (MH) and CTSA UL1TR000083 (MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	African Palliative Care Association, 2010, BEAT PAIN POCK GUID; Aikins AD, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-5; Anker M, 1991, World Health Stat Q, V44, P94; ANKER M, 1993, B WORLD HEALTH ORGAN, V71, P15; Annett H., 1995, GUIDELINES RAPID PAR; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Arnold BL, 2011, BMC PALLIAT CARE, V10, DOI 10.1186/1472-684X-10-1; Dekker Annette M, 2012, J Pain Palliat Care Pharmacother, V26, P334, DOI 10.3109/15360288.2012.734897; Di Sorbo PG, 2010, J PAIN SYMPTOM MANAG, V40, P19, DOI 10.1016/j.jpainsymman.2010.04.005; Eramova I, 2007, HIV AIDS TREATMENT C; Finch T, 2008, MALAWI MED J, V20, P118; Fleming DA, 2006, J PAIN SYMPTOM MANAG, V31, P407, DOI 10.1016/j.jpainsymman.2005.09.002; Government of Kenya, 2010, THE CHILDR ACT; Government of Malawi Ministry of Health, 2011, MAL GUID CLIN MAN HI; Government of Malawi Ministry of Health, 2011, INTR PALL CAR HLTH C; Government of Malawi Ministry of Health, 2009, PALL CAR TRAIN MAN H; Government of Malawi Ministry of Health, 2011, NAT PALL CAR GUID; Grant E, 2003, J PALLIATIVE CARE, V19, P159, DOI 10.1177/082585970301900303; Grant Liz, 2011, BMJ Support Palliat Care, V1, P118, DOI 10.1136/bmjspcare-2011-000057; Grant L, 2011, BMC PALLIAT CARE, V10, DOI 10.1186/1472-684X-10-8; Harding R, 2005, LANCET, V365, P1971, DOI 10.1016/S0140-6736(05)66666-4; Harding R, 2008, J PAIN SYMPTOM MANAG, V36, P304, DOI 10.1016/j.jpainsymman.2008.04.008; Harding R, 2013, J PAIN SYMPTOM MANAG, V45, P746, DOI 10.1016/j.jpainsymman.2012.04.007; Harding R, 2012, J PAIN SYMPTOM MANAG, V44, P1, DOI 10.1016/j.jpainsymman.2011.08.008; Harding R, 2011, CLIN INFECT DIS, V52, P553, DOI 10.1093/cid/ciq180; Harding R, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-10; Jagwe J, 2007, J PAIN SYMPTOM MANAG, V33, P547, DOI 10.1016/j.jpainsymman.2007.02.014; Kanavos P, 2006, ANN ONCOL, V17, P15, DOI 10.1093/annonc.mdl983; Krakauer EL, 2008, J PAIN SYMPTOM MANAG, V36, P505, DOI 10.1016/j.jpainsymman.2007.11.015; Krakauer EL, 2007, J PAIN SYMPTOM MANAG, V33, P578, DOI 10.1016/j.jpainsymman.2007.02.004; Krakauer EL, 2010, J PAIN SYMPTOM MANAG, V40, P27, DOI 10.1016/j.jpainsymman.2010.04.009; Lamas D, 2012, NEW ENGL J MED, V366, P199, DOI 10.1056/NEJMp1113622; Makoae LN, 2005, J ASSOC NURSE AIDS C, V16, P22, DOI 10.1016/j.jana.2005.03.005; Ministry of Health Department of Planning, 2004, JOINT PROGR WORK HLT; Mlombe Y, 2008, MALAWI MED J, V20, P129; Murray SA, 2003, BRIT MED J, V326, P368, DOI 10.1136/bmj.326.7385.368; MURRAY SA, 1994, BRIT MED J, V308, P698, DOI 10.1136/bmj.308.6930.698; Nanney E, 2010, J PAIN SYMPTOM MANAG, V40, P15, DOI 10.1016/j.jpainsymman.2010.04.002; Neno District Executive Committee, 2013, NEN DISTR SOC PROF 2; Olenja JM, 1999, J COMMUN HEALTH, V24, P187, DOI 10.1023/A:1018709314503; Organization WH, 2016, GLOBAL STATUS REPORT; Peltzer K, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-271; Powell RA, 2007, J PAIN SYMPTOM MANAG, V33, P229, DOI 10.1016/j.jpainsymman.2006.10.008; Powell RA, 2014, J PAIN SYMPTOM MANAG, V47, P315, DOI 10.1016/j.jpainsymman.2013.03.022; Robinson CA, 2009, J PALLIAT MED, V12, P253, DOI 10.1089/jpm.2008.0228; Selman L, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-35; Simms V, 2012, LANCET INFECT DIS, V12, P571, DOI 10.1016/S1473-3099(12)70085-3; Stjernsward J, 2007, J PAIN SYMPTOM MANAG, V33, P486, DOI 10.1016/j.jpainsymman.2007.02.016; Tapsfield JB, 2011, BMC PALLIAT CARE, V10, DOI 10.1186/1472-684X-10-12; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Wakeham K, 2010, J PALLIAT MED, V13, P375, DOI 10.1089/jpm.2009.0259; Wolfe BA, 2006, AMIA ANN S P, P1146; World Bank, 2013, RUR POP DAT; World Bank, 2007, MAL POV VULN ASS INV; Wright M, 2006, HOSPICE PALLIATIVE C	57	39	39	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110457	10.1371/journal.pone.0110457	http://dx.doi.org/10.1371/journal.pone.0110457			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR5ZW	25313997	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662500115
J	Salem, TZ; Allam, WR; Thiem, SM				Salem, Tamer Z.; Allam, Walaa R.; Thiem, Suzanne M.			Verifying the Stability of Selected Genes for Normalization in Q PCR Experiments of Spodoptera frugiperda Cells during AcMNPV Infection	PLOS ONE			English	Article							REAL-TIME PCR; NUCLEAR POLYHEDROSIS-VIRUS; 28S RIBOSOMAL-RNA; BACULOVIRUS INFECTION; BETA-ACTIN; RT-PCR; NUCLEOPOLYHEDROVIRUS INFECTION; HOUSEKEEPING GENES; INTERNAL STANDARDS; MESSENGER-RNA	It is challenging to find genes with stable transcripts for use as reference genes for quantitative realtime polymerase chain reaction (qRT-PCR) during viral infection. Autographa californica nucleopolyhedrovirus (AcMNPV) is known to globally shut off host gene transcription in Sf21 cells and to modify their cytoskeletons. In this study, seven host genes were selected for validation as references for gene expression experiments using qRT-PCR. Two of them, ecdysoneless (ECD) and myosin showed stable RNA levels in our previous microarray study at 6, 12, and 24 hpi for both genes and 48 hpi for ECD. The others, actin, tubulin, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and 28S ribosome (28S), are commonly employed as reference genes for qRT-PCR. Ribosomal protein L35 (L35) gene was selected to test if ribosomal protein genes show stable RNA transcript levels similar to 28S and 18S rRNA and to validate the microarray data. In addition to 28S, previously known to have stable transcript levels, qRT-PCR showed that ECD transcript levels remained constant throughout the time course of AcMNPV infection. Transcripts of cytoskeleton genes such as actin, tubulin, and myosin declined dramatically as the infection progressed. GAPDH and L35 transcripts also declined over time. These results indicate that ECD is a reliable reference gene for qRT-PCR experiments during AcMNPV infection of Spodoptera frugiperda cells. Although 28S could be used as a reference gene for these experiments, it is less useful than ECD because of its abundance, which might make it difficult to establish an accurate baseline value for data analysis.	[Salem, Tamer Z.; Allam, Walaa R.] Univ Sci & Technol, Dept Biomed Sci, Zewail City Sci & Technol, Giza, Egypt; [Salem, Tamer Z.] Agr Res Ctr, AGERI, Dept Microbial Mol Biol, Giza, Egypt; [Thiem, Suzanne M.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Thiem, Suzanne M.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Egyptian Knowledge Bank (EKB); Misr University for Science & Technology; Zewail City of Science & Technology; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; Michigan State University; Michigan State University	Salem, TZ (corresponding author), Univ Sci & Technol, Dept Biomed Sci, Zewail City Sci & Technol, Giza, Egypt.	tsalem@zewailcity.edu.eg; smthiem@msu.edu	Salem, Tamer/I-5778-2019	Salem, Tamer/0000-0002-6264-5037	University of Science and Technology at Zewail City, Egypt; National Institutes of Health [5R01GM086719]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086719] Funding Source: NIH RePORTER	University of Science and Technology at Zewail City, Egypt(Zewail City of Science & Technology); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of Science and Technology at Zewail City, Egypt to TZS and National Institutes of Health Grant 5R01GM086719 to SMT. http://taggs.hhs.gov/readinesstool/AwardDetail.cfm?s_AwardDetail = 5R01GM086719-02&STATE_CODE = 26&s_RecipID = 0AAEA318EF070A0FAAD29E87. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burleigh SH, 2001, PLANT SCI, V160, P899, DOI 10.1016/S0168-9452(00)00460-X; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; GUZO D, 1992, J VIROL, V66, P2966, DOI 10.1128/JVI.66.5.2966-2972.1992; Hardwick JM, 2000, METHOD ENZYMOL, V322, P492; Katsuma S, 2007, J VIROL, V81, P13700, DOI 10.1128/JVI.01683-07; Klok EJ, 2002, PLANT CELL, V14, P2481, DOI 10.1105/tpc.004747; LEE HH, 1978, J VIROL, V27, P754, DOI 10.1128/JVI.27.3.754-767.1978; Luu-The V, 2005, BIOTECHNIQUES, V38, P287, DOI 10.2144/05382RR05; Nobiron I, 2003, J GEN VIROL, V84, P3029, DOI 10.1099/vir.0.19270-0; Ojala PM, 2000, NAT CELL BIOL, V2, P819, DOI 10.1038/35041064; OOI BG, 1988, VIROLOGY, V166, P515, DOI 10.1016/0042-6822(88)90522-3; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Radonic A, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-7; Salem TZ, 2011, VIROLOGY, V412, P167, DOI 10.1016/j.virol.2011.01.006; Scharlaken B, 2008, DEV COMP IMMUNOL, V32, P883, DOI 10.1016/j.dci.2008.01.010; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Selvey S, 2001, MOL CELL PROBE, V15, P307, DOI 10.1006/mcpr.2001.0376; Sturzenbaum SR, 2001, COMP BIOCHEM PHYS B, V130, P281, DOI 10.1016/S1096-4959(01)00440-7; Sun W, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.20801; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; van Oers MM, 2003, INSECT MOL BIOL, V12, P75, DOI 10.1046/j.1365-2583.2003.00389.x; van Oers MM, 2001, INSECT MOL BIOL, V10, P255, DOI 10.1046/j.1365-2583.2001.00263.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Wang DZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024900; Xue JL, 2010, J VIROL METHODS, V163, P210, DOI 10.1016/j.jviromet.2009.09.019; Zhong H, 1999, BIOCHEM BIOPH RES CO, V259, P523, DOI 10.1006/bbrc.1999.0815	29	10	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e108516	10.1371/journal.pone.0108516	http://dx.doi.org/10.1371/journal.pone.0108516			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313905	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500015
J	Tian, ZL; Cabrol, L; Ruiz-Filippi, G; Pullammanappallil, P				Tian, Zhuoli; Cabrol, Lea; Ruiz-Filippi, Gonzalo; Pullammanappallil, Pratap			Microbial Ecology in Anaerobic Digestion at Agitated and Non-Agitated Conditions	PLOS ONE			English	Article							METHANOBREVIBACTER-SMITHII; BIOHYDROGEN PRODUCTION; HYDROGEN-PRODUCTION; EMENDED DESCRIPTION; SP-NOV.; PROPIONATE; DIVERSITY; WASTE; METHANOGEN; BACTERIUM	To investigate the distribution and dynamics of microbial community in anaerobic digestion at agitated and non-agitated condition, 454 pyrosequencing of 16s rRNA was conducted. It revealed the distinct community compositions between the two digesters and their progressive shifting over time. Methanogens and syntrophic bacteria were found much less abundant in the agitated digester, which was mainly attributed to the presence of bacterial genera Acetanaerobacterium and Ruminococcus with relatively high abundance. The characterization of the microbial community corroborated the digestion performance affected at the agitated condition, where lower methane yield and delayed methane production rate were observed. This was further verified by the accumulation of propionic acid in the agitated digester.	[Tian, Zhuoli; Pullammanappallil, Pratap] Univ Florida, Dept Agr & Biol Engn, Gainesville, FL 32611 USA; [Cabrol, Lea; Ruiz-Filippi, Gonzalo] Pontificia Univ Catolica Valparaiso, Escuela Ingn Bioquim, Valparaiso, Chile	State University System of Florida; University of Florida; Pontificia Universidad Catolica de Valparaiso	Tian, ZL (corresponding author), Univ Florida, Dept Agr & Biol Engn, Gainesville, FL 32611 USA.	troytian@ufl.edu	Cabrol, Lea/L-2438-2016; Pullammanappallil, Pratap/AAN-8891-2021; Ruiz-Filippi, Gonzalo/B-5167-2010	Cabrol, Lea/0000-0003-0417-2021; Ruiz-Filippi, Gonzalo/0000-0003-1870-8667	Florida Energy System Consortium (FESC)	Florida Energy System Consortium (FESC)	The study was funded by the Florida Energy System Consortium ( FESC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angenent LT, 2004, TRENDS BIOTECHNOL, V22, P477, DOI 10.1016/j.tibtech.2004.07.001; BARREDO MS, 1991, APPL ENVIRON MICROB, V57, P1764, DOI 10.1128/AEM.57.6.1764-1769.1991; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Chen CC, 2002, APPL MICROBIOL BIOT, V58, P224, DOI 10.1007/s002530100814; Cho SK, 2013, BIORESOURCE TECHNOL, V131, P210, DOI 10.1016/j.biortech.2012.12.100; Dar SA, 2008, APPL MICROBIOL BIOT, V78, P1045, DOI 10.1007/s00253-008-1391-8; de Bok FAM, 2005, INT J SYST EVOL MICR, V55, P1697, DOI 10.1099/ijs.0.02880-0; Ivanova G, 2009, INT J HYDROGEN ENERG, V34, P3659, DOI 10.1016/j.ijhydene.2009.02.082; Jindou S, 2008, FEMS MICROBIOL LETT, V285, P188, DOI 10.1111/j.1574-6968.2008.01234.x; Kotsyurbenko OR, 2004, ENVIRON MICROBIOL, V6, P1159, DOI 10.1111/j.1462-2920.2004.00634.x; Li A, 2013, BIOTECHNOL BIOFUELS, V6; Liang BH, 2011, PLOS ONE, P6; Manes RJ, 2001, ANAEROBE, V7, P17; McMahon KD, 2001, WATER RES, V35, P1817, DOI 10.1016/S0043-1354(00)00438-3; Menes RJ, 2002, INT J SYST EVOL MICR, V52, P157, DOI 10.1099/00207713-52-1-157; Mosoni P, 2011, J ANIM SCI, V89, P783, DOI 10.2527/jas.2010-2947; Muller N, 2010, ENV MICROBIOL REP, V2, P489, DOI 10.1111/j.1758-2229.2010.00147.x; Nielsen HB, 2007, BIOMASS BIOENERG, V31, P820, DOI 10.1016/j.biombioe.2007.04.004; Ntaikou I, 2010, INT J HYDROGEN ENERG, V35, P3423, DOI 10.1016/j.ijhydene.2010.01.118; Rademacher A, 2012, FEMS MICROBIOL ECOL, V79, P785, DOI 10.1111/j.1574-6941.2011.01265.x; Ren NQ, 2005, FUTURE OF URBAN WASTEWATER SYSTEMS - DECENTRALISATION AND REUSE, P161; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; Rychlik JL, 2000, CURR MICROBIOL, V40, P176, DOI 10.1007/s002849910035; Saraphirom P, 2010, INT J HYDROGEN ENERG, V35, P13435, DOI 10.1016/j.ijhydene.2009.11.122; Schloss P.D., 2011, PLOS ONE, P6; Shcherbakova V, 2011, INT J SYST EVOL MICR, V61, P144, DOI 10.1099/ijs.0.021311-0; Shin SG, 2010, BIORESOURCE TECHNOL, V101, P9461, DOI 10.1016/j.biortech.2010.07.081; Sugihara T, 2007, J GEN APPL MICROBIOL, V53, P363, DOI 10.2323/jgam.53.363; Tian ZL, 2013, BIORESOURCE TECHNOL, V129, P411, DOI 10.1016/j.biortech.2012.11.056; Valdez-Vazquez I, 2005, INT J HYDROGEN ENERG, V30, P1383, DOI 10.1016/j.ijhydene.2004.09.016; Vavilin VA, 2005, BIOTECHNOL BIOENG, V89, P113, DOI 10.1002/bit.20323; Vedrenne F, 2008, BIORESOURCE TECHNOL, V99, P146, DOI 10.1016/j.biortech.2006.11.043; Weiss A, 2008, APPL MICROBIOL BIOT, V81, P163, DOI 10.1007/s00253-008-1717-6; Zhou ZM, 2011, APPL ENVIRON MICROB, V77, P2634, DOI 10.1128/AEM.02779-10; Zhu HG, 2009, BIORESOURCE TECHNOL, V100, P5097, DOI 10.1016/j.biortech.2009.02.066	35	19	19	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109769	10.1371/journal.pone.0109769	http://dx.doi.org/10.1371/journal.pone.0109769			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313520	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500073
J	Yoda, E; Rai, K; Ogawa, M; Takakura, Y; Kuwata, H; Suzuki, H; Nakatani, Y; Murakami, M; Hara, S				Yoda, Emiko; Rai, Kohmi; Ogawa, Mai; Takakura, Yuki; Kuwata, Hiroshi; Suzuki, Hidenori; Nakatani, Yoshihito; Murakami, Makoto; Hara, Shuntaro			Group VIB Calcium-Independent Phospholipase A(2) (iPLA(2)gamma) Regulates Platelet Activation, Hemostasis and Thrombosis in Mice	PLOS ONE			English	Article							INHIBITION; ARACHIDONATE; HYDROLYSIS; A(2)GAMMA; RECEPTORS; RELEASE	In platelets, group IVA cytosolic phospholipase A(2) (cPLA(2)alpha) has been implicated as a key regulator in the hydrolysis of platelet membrane phospholipids, leading to pro-thrombotic thromboxane A(2) and anti-thrombotic 12-(S)-hydroxyeicosa-tetranoic acid production. However, studies using cPLA(2)alpha-deficient mice have indicated that other PLA(2)(s) may also be involved in the hydrolysis of platelet glycerophospholipids. In this study, we found that group VIB Ca2+-independent PLA(2) (iPLA(2)gamma)-deficient platelets showed decreases in adenosine diphosphate (ADP)-dependent aggregation and ADP- or collagen-dependent thromboxane A(2) production. Electrospray ionization mass spectrometry analysis of platelet phospholipids revealed that fatty acyl compositions of ethanolamine plasmalogen and phosphatidylglycerol were altered in platelets from iPLA(2)gamma null mice. Furthermore, mice lacking iPLA(2)gamma displayed prolonged bleeding times and were protected against pulmonary thromboembolism. These results suggest that iPLA(2)gamma is an additional, long-sought-after PLA(2) that hydrolyzes platelet membranes and facilitates platelet aggregation in response to ADP.	[Yoda, Emiko; Rai, Kohmi; Ogawa, Mai; Takakura, Yuki; Kuwata, Hiroshi; Nakatani, Yoshihito; Hara, Shuntaro] Showa Univ, Sch Pharm, Dept Healthcare & Regulatory Sci, Div Hlth Chem,Shinagawa Ku, Tokyo, Japan; [Suzuki, Hidenori] Nippon Med Sch, Grad Sch Med, Div Morphol & Biomol Res, Bunkyo Ku, Tokyo 113, Japan; [Murakami, Makoto] Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Setagaya Ku, Tokyo 113, Japan	Showa University; Nippon Medical School; Tokyo Metropolitan Institute of Medical Science	Hara, S (corresponding author), Showa Univ, Sch Pharm, Dept Healthcare & Regulatory Sci, Div Hlth Chem,Shinagawa Ku, Tokyo, Japan.	haras@pharm.showa-u.ac.jp			Japan Society for the Promotion of Science [21390036, 25293033, 21890254]; Private University High Technology Research Center Project from the Ministry of Education, Sports, Science, Culture and Technology of Japan [25116720]; Terumo Life Science Foundation; Grants-in-Aid for Scientific Research [25116720, 22116005] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Private University High Technology Research Center Project from the Ministry of Education, Sports, Science, Culture and Technology of Japan; Terumo Life Science Foundation(Terumo Life Science Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was in part by a Grant-in-Aid for Scientific Research (B) (21390036 and 25293033) and a Grant-in-Aid for Research Activity start-up (21890254) from the Japan Society for the Promotion of Science; by a Grant-in-Aid for Scientific Research on Innovative Areas (25116720) and a grant for Private University High Technology Research Center Project from the Ministry of Education, Sports, Science, Culture and Technology of Japan; and by a grant from the Terumo Life Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMANN EJ, 1995, J BIOL CHEM, V270, P445, DOI 10.1074/jbc.270.1.445; Akiba S, 2004, BIOL PHARM BULL, V27, P1174, DOI 10.1248/bpb.27.1174; Balsinde J, 1997, J BIOL CHEM, V272, P16069, DOI 10.1074/jbc.272.26.16069; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; BARTOLI F, 1994, J BIOL CHEM, V269, P15625; Baulande S, 2010, M S-MED SCI, V26, P177, DOI 10.1051/medsci/2010262177; Beckett CS, 2007, THROMB RES, V120, P259, DOI 10.1016/j.thromres.2006.09.005; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Broos K, 2011, BLOOD REV, V25, P155, DOI 10.1016/j.blre.2011.03.002; Cimmino G, 2013, J CARDIOVASC TRANSL, V6, P299, DOI 10.1007/s12265-012-9445-9; Franchi L, 2009, J INNATE IMMUN, V1, P607, DOI 10.1159/000227263; Gachet C, 2008, THROMB HAEMOSTASIS, V99, P466, DOI 10.1160/TH07-11-0673; Johnson EN, 1998, P NATL ACAD SCI USA, V95, P3100, DOI 10.1073/pnas.95.6.3100; Kahner BN, 2006, J THROMB HAEMOST, V4, P2317, DOI 10.1111/j.1538-7836.2006.02192.x; Kudo I, 2002, PROSTAG OTH LIPID M, V68-69, P53; Kuwata H, 2013, BIOCHIM BIOPHYS ACTA, V1841, P44; Kuwata H, 2007, J BIOL CHEM, V282, P20124, DOI 10.1074/jbc.M611883200; Lehr M, 2000, MEDIAT INFLAMM, V9, P31, DOI 10.1080/09629350050024357; Lenain N, 2003, J THROMB HAEMOST, V1, P1144, DOI 10.1046/j.1538-7836.2003.00144.x; Leon C, 1999, J CLIN INVEST, V104, P1731, DOI 10.1172/JCI8399; Mancuso DJ, 2007, J BIOL CHEM, V282, P34611, DOI 10.1074/jbc.M707795200; Mancuso DJ, 2009, J BIOL CHEM, V284, P35632, DOI 10.1074/jbc.M109.055194; Moon SH, 2012, J BIOL CHEM, V287, P14880, DOI 10.1074/jbc.M111.336776; Murakami M, 2005, J BIOL CHEM, V280, P14028, DOI 10.1074/jbc.M413766200; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Nakahata N, 2008, PHARMACOL THERAPEUT, V118, P18, DOI 10.1016/j.pharmthera.2008.01.001; PACKHAM MA, 1994, CAN J PHYSIOL PHARM, V72, P278, DOI 10.1139/y94-043; Shen RF, 1998, J BIOMED SCI, V5, P153, DOI 10.1007/BF02253465; Stalker Timothy J, 2012, Handb Exp Pharmacol, P59, DOI 10.1007/978-3-642-29423-5_3; Thomas DW, 1998, J CLIN INVEST, V102, P1994, DOI 10.1172/JCI5116; Wong DA, 2002, J EXP MED, V196, P349, DOI 10.1084/jem.20011443; Yan W, 2005, J BIOL CHEM, V280, P26669, DOI 10.1074/jbc.M502358200; Yeung Jennifer, 2011, Cardiovascular & Hematological Agents in Medicinal Chemistry, V9, P154; Yoda E, 2010, J LIPID RES, V51, P3003, DOI 10.1194/jlr.M008060	34	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109409	10.1371/journal.pone.0109409	http://dx.doi.org/10.1371/journal.pone.0109409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313821	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500040
J	Golan, I; Dominguez, PG; Konrad, Z; Shkolnik-Inbar, D; Carrari, F; Bar-Zvi, D				Golan, Ido; Guadalupe Dominguez, Pia; Konrad, Zvia; Shkolnik-Inbar, Doron; Carrari, Fernando; Bar-Zvi, Dudy			Tomato ABSCISIC ACID STRESS RIPENING (ASR) Gene Family Revisited	PLOS ONE			English	Article							WATER-DEFICIT; SALT-STRESS; DNA-BINDING; GRAPE ASR; TRANSCRIPTION FACTOR; PROMOTER ACTIVITY; RESPONSIVE GENE; CONFERS DROUGHT; REGULATED GENE; OSMOTIC-STRESS	Tomato ABSCISIC ACID RIPENING 1 (ASR1) was the first cloned plant ASR gene. ASR orthologs were then cloned from a large number of monocot, dicot and gymnosperm plants, where they are mostly involved in response to abiotic (drought and salinity) stress and fruit ripening. The tomato genome encodes five ASR genes: ASR1, 2, 3 and 5 encode low-molecular-weight proteins (ca. 110 amino acid residues each), whereas ASR4 encodes a 297-residue polypeptide. Information on the expression of the tomato ASR gene family is scarce. We used quantitative RT-PCR to assay the expression of this gene family in plant development and in response to salt and osmotic stresses. ASR1 and ASR4 were the main expressed genes in all tested organs and conditions, whereas ASR2 and ASR3/5 expression was two to three orders of magnitude lower (with the exception of cotyledons). ASR1 is expressed in all plant tissues tested whereas ASR4 expression is limited to photosynthetic organs and stamens. Essentially, ASR1 accounted for most of ASR gene expression in roots, stems and fruits at all developmental stages, whereas ASR4 was the major gene expressed in cotyledons and young and fully developed leaves. Both ASR1 and ASR4 were expressed in flower organs, with ASR1 expression dominating in stamens and pistils, ASR4 in sepals and petals. Steady-state levels of ASR1 and ASR4 were upregulated in plant vegetative organs following exposure to salt stress, osmotic stress or the plant abiotic stress hormone abscisic acid (ABA). Tomato plants overexpressing ASR1 displayed enhanced survival rates under conditions of water stress, whereas ASR1-antisense plants displayed marginal hypersensitivity to water withholding.	Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Golan, Ido; Konrad, Zvia; Shkolnik-Inbar, Doron; Bar-Zvi, Dudy] Ben Gurion Univ Negev, Doris & Bertie Black Ctr Bioenerget Life Sci, IL-84105 Beer Sheva, Israel; [Guadalupe Dominguez, Pia; Carrari, Fernando] Inst Nacl Tecnol Agr, Inst Biotecnol, Buenos Aires, DF, Argentina	Ben Gurion University; Ben Gurion University; Instituto Nacional de Tecnologia Agropecuaria (INTA)	Bar-Zvi, D (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	barzvi@bgu.ac.il		Dominguez, Pia Guadalupe/0000-0003-0413-2273; Bar-Zvi, Dudy/0000-0003-1546-1726	I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [757]	I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation)	This study was supported in part by the I-CORE Program of the Planning and Budgeting Committee and the Israel Science Foundation (Center No. 757). DBZ is the incumbent of The Israel and Bernard Nichunsky Chair in Desert Agriculture, Ben-Gurion University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler G, 2010, PLANTA, V232, P187, DOI 10.1007/s00425-010-1160-7; AMITAIZEIGERSON H, 1995, PLANT SCI, V110, P205, DOI 10.1016/0168-9452(95)94515-K; AMITAIZEIGERSON H, 1994, PLANT PHYSIOL, V106, P1699, DOI 10.1104/pp.106.4.1699; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Cakir B, 2003, PLANT CELL, V15, P2165, DOI 10.1105/tpc.013854; Carrari F, 2004, TRENDS PLANT SCI, V9, P57, DOI 10.1016/j.tplants.2003.12.004; Chang SJ, 1996, PHYSIOL PLANTARUM, V97, P139, DOI 10.1111/j.1399-3054.1996.tb00490.x; Chen JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024649; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Dai JR, 2011, PLANT CELL REP, V30, P1219, DOI 10.1007/s00299-011-1030-1; de Vienne D, 1999, J EXP BOT, V50, P303, DOI 10.1093/jexbot/50.332.303; Doczi R, 2005, PLANT PHYSIOL BIOCH, V43, P269, DOI 10.1016/j.plaphy.2005.02.002; Doczi R, 2002, PLANT CELL ENVIRON, V25, P1197, DOI 10.1046/j.1365-3040.2002.00904.x; Fischer I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078182; Fischer I, 2011, NEW PHYTOL, V190, P1032, DOI 10.1111/j.1469-8137.2011.03648.x; Frankel N, 2003, MOL BIOL EVOL, V20, P1955, DOI 10.1093/molbev/msg214; Frankel N, 2007, PLANT MOL BIOL, V63, P719, DOI 10.1007/s11103-006-9120-0; Frankel N, 2006, GENE, V378, P74, DOI 10.1016/j.gene.2006.05.010; Gilad A, 1997, ACTA HORTIC, P447, DOI 10.17660/ActaHortic.1997.447.89; GILLASPY G, 1993, PLANT CELL, V5, P1439, DOI 10.1105/tpc.5.10.1439; Goldgur Y, 2007, PLANT PHYSIOL, V143, P617, DOI 10.1104/pp.106.092965; Dominguez PG, 2013, PLANT PHYSIOL, V161, P1486, DOI 10.1104/pp.112.208199; Hara M, 2002, PLANT BIOTECHNOL, V19, P277; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hong SH, 2002, J EXP BOT, V53, P2271, DOI 10.1093/jxb/erf075; Hsu YF, 2011, PLANT PHYSIOL BIOCH, V49, P937, DOI 10.1016/j.plaphy.2011.07.002; Hu W, 2013, PLANT CELL ENVIRON, V36, P1449, DOI 10.1111/pce.12074; IUSEM ND, 1993, PLANT PHYSIOL, V102, P1353, DOI 10.1104/pp.102.4.1353; Jeanneau M, 2002, BIOCHIMIE, V84, P1127, DOI 10.1016/S0300-9084(02)00024-X; Jha B, 2012, MAR BIOTECHNOL, V14, P782, DOI 10.1007/s10126-012-9442-7; Joo J, 2013, MOL CELLS, V35, P421, DOI 10.1007/s10059-013-0036-7; Kalifa Y, 2004, PLANT CELL ENVIRON, V27, P1459, DOI 10.1111/j.1365-3040.2004.01251.x; Kalifa Y, 2004, BIOCHEM J, V381, P373, DOI 10.1042/BJ20031800; Kim IS, 2012, MOL CELLS, V33, P285, DOI 10.1007/s10059-012-2253-x; Kim SJ, 2009, MOL CELLS, V27, P449, DOI 10.1007/s10059-009-0055-6; Konrad Z, 2008, PLANTA, V227, P1213, DOI 10.1007/s00425-008-0693-5; Li RH, 2013, BIOSCI BIOTECH BIOCH, V77, P475, DOI 10.1271/bbb.120666; Liu HY, 2010, J INTEGR PLANT BIOL, V52, P315, DOI 10.1111/j.1744-7909.2010.00912.x; Liu JH, 2013, PLANTA, V237, P1025, DOI 10.1007/s00425-012-1820-x; LIU XJ, 1990, MOL GEN GENET, V223, P401, DOI 10.1007/BF00264446; Luo C, 2014, J HORTIC SCI BIOTECH, V89, P352, DOI 10.1080/14620316.2014.11513090; Maskin L, 2001, PLANT SCI, V161, P739, DOI 10.1016/S0168-9452(01)00464-2; Maskin L, 2008, MOL BIOL REP, V35, P501, DOI 10.1007/s11033-007-9114-2; Maskin L, 2007, BIOCHEM BIOPH RES CO, V352, P831, DOI 10.1016/j.bbrc.2006.11.115; Obiadalla-Ali H, 2004, PLANTA, V219, P533, DOI 10.1007/s00425-004-1257-y; Padmanabhan V, 1997, PLANT MOL BIOL, V35, P801, DOI 10.1023/A:1005897921567; Philippe R, 2010, THEOR APPL GENET, V121, P769, DOI 10.1007/s00122-010-1348-z; Ricardi MM, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-29; Ricardi MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041008; Riccardi F, 1998, PLANT PHYSIOL, V117, P1253, DOI 10.1104/pp.117.4.1253; Rocco M, 2006, PROTEOMICS, V6, P3781, DOI 10.1002/pmic.200600128; Rom S, 2006, BIOCHIMIE, V88, P621, DOI 10.1016/j.biochi.2005.11.008; Rossi M, 1998, MOL GEN GENET, V258, P1, DOI 10.1007/s004380050700; ROSSI M, 1995, DNA SEQUENCE, V5, P225, DOI 10.3109/10425179509030970; Rossi M, 1996, MOL GEN GENET, V252, P489, DOI 10.1007/s004380050254; Salekdeh GH, 2002, FIELD CROP RES, V76, P199, DOI 10.1016/S0378-4290(02)00040-0; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Saumonneau A, 2008, FEBS LETT, V582, P3281, DOI 10.1016/j.febslet.2008.09.015; Saumonneau A, 2012, J EXP BOT, V63, P1495, DOI 10.1093/jxb/err391; Schneider A, 1997, PLANT PHYSIOL, V113, P335, DOI 10.1104/pp.113.2.335; Shkolnik D, 2008, PLANT BIOTECHNOL J, V6, P368, DOI 10.1111/j.1467-7652.2008.00328.x; Shkolnik-Inbar D, 2013, PLANT J, V73, P993, DOI 10.1111/tpj.12091; Shkolnik-Inbar D, 2010, PLANT CELL, V22, P3560, DOI 10.1105/tpc.110.074641; SILHAVY D, 1995, PLANT MOL BIOL, V27, P587, DOI 10.1007/BF00019324; Srivastava A, 2005, J PLANT GROWTH REGUL, V24, P67, DOI 10.1007/s00344-005-0015-0; Sugiharto B, 2002, PLANT CELL PHYSIOL, V43, P350, DOI 10.1093/pcp/pcf039; Vaidyanathan R, 1999, PLANT SCI, V140, P21, DOI 10.1016/S0168-9452(98)00194-0; Virlouvet L, 2011, PLANT PHYSIOL, V157, P917, DOI 10.1104/pp.111.176818; Wang CS, 1998, PLANT CELL PHYSIOL, V39, P1307, DOI 10.1093/oxfordjournals.pcp.a029335; Wang HJ, 2005, PHYSIOL PLANTARUM, V123, P314, DOI 10.1111/j.1399-3054.2005.00454.x; Wang JT, 2002, J PLANT GROWTH REGUL, V21, P469, DOI 10.1007/s00344-002-0128-7; Xu BY, 2007, PLANTA, V226, P529, DOI 10.1007/s00425-007-0502-6; Yamada T, 2007, PLANT CELL REP, V26, P823, DOI 10.1007/s00299-006-0285-4; Yang CY, 2005, PLANT PHYSIOL, V139, P836, DOI 10.1104/pp.105.065458	74	32	38	4	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e107117	10.1371/journal.pone.0107117	http://dx.doi.org/10.1371/journal.pone.0107117			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310287	gold, Green Published, Green Submitted			2022-12-27	WOS:000343210300004
J	Pebworth, MP; Cismas, SA; Asuri, P				Pebworth, Mark-Phillip; Cismas, Sabrina A.; Asuri, Prashanth			A Novel 2.5D Culture Platform to Investigate the Role of Stiffness Gradients on Adhesion-Independent Cell Migration	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; FORCE TRANSMISSION; DUROTAXIS DEPENDS; INVASION; 3D; DIFFERENTIATION; ACTIVATION; INHIBITOR; KINASE; RHOA	Current studies investigating the role of biophysical cues on cell migration focus on the use of culture platforms with static material parameters. However, migrating cells in vivo often encounter spatial variations in extracellular matrix stiffness. To better understand the effects of stiffness gradients on cell migration, we developed a 2.5D cell culture platform where cells are sandwiched between stiff tissue culture plastic and soft alginate hydrogel. Under these conditions, we observed migration of cells from the underlying stiff substrate into the alginate matrix. Observation of migration into alginate in the presence of integrin inhibition as well as qualitative microscopic analyses suggested an adhesion-independent cell migration mode. Observed migration was dependent on alginate matrix stiffness and the RhoA-ROCK-myosin-II pathway; inhibitors specifically targeting ROCK and myosin-II arrested cell migration. Collectively, these results demonstrate the utility of the 2.5D culture platform to advance our understanding of the effects of stiffness gradients and mechanotransductive signaling on adhesion-independent cell migration.	[Pebworth, Mark-Phillip; Cismas, Sabrina A.; Asuri, Prashanth] Santa Clara Univ, Dept Bioengn, Santa Clara, CA 95053 USA	Santa Clara University	Asuri, P (corresponding author), Santa Clara Univ, Dept Bioengn, Santa Clara, CA 95053 USA.	asurip@scu.edu			School of Engineering, Santa Clara University; W.F. Keck Foundation through the Advanced Biosciences Institute at Santa Clara University; Arthur H. Hayes Jr. Scholarship	School of Engineering, Santa Clara University; W.F. Keck Foundation through the Advanced Biosciences Institute at Santa Clara University; Arthur H. Hayes Jr. Scholarship	The research was funded by School of Engineering, Santa Clara University, the W.F. Keck Foundation through the Advanced Biosciences Institute at Santa Clara University, and Arthur H. Hayes Jr. Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann K, 2012, NEPHROL DIAL TRANSPL, V27, P1755, DOI 10.1093/ndt/gfr603; Amerongen GPV, 2000, ARTERIOSCL THROM VAS, V20, pE127, DOI 10.1161/01.ATV.20.12.e127; Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050; Cheng NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090374; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Fournier MF, 2010, J CELL BIOL, V188, P287, DOI 10.1083/jcb.200906139; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Friedl P, 2001, J LEUKOCYTE BIOL, V70, P491; Guck J, 2010, INTEGR BIOL-UK, V2, P575, DOI 10.1039/c0ib00050g; Hadjipanayi E, 2009, CELL MOTIL CYTOSKEL, V66, P121, DOI 10.1002/cm.20331; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Isenberg BC, 2009, BIOPHYS J, V97, P1313, DOI 10.1016/j.bpj.2009.06.021; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lessey EC, 2012, BIOCHEMISTRY-US, V51, P7420, DOI 10.1021/bi300758e; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Liu HW, 2003, AM J RESP CELL MOL, V29, P39, DOI 10.1165/rcmb.2002-0206OC; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Nunamaker EA, 2011, J MECH BEHAV BIOMED, V4, P16, DOI 10.1016/j.jmbbm.2010.08.006; Oliveira-Ferrer L, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-86; Petrie RJ, 2012, J CELL SCI, V125, P5917, DOI 10.1242/jcs.093732; Phillips-Mason PJ, 2011, CELL ADHES MIGR, V5, P298, DOI 10.4161/cam.5.4.16970; Renkawitz J, 2010, EMBO REP, V11, P744, DOI 10.1038/embor.2010.147; Renkawitz J, 2009, NAT CELL BIOL, V11, P1438, DOI 10.1038/ncb1992; Ridley AJ, 2001, J CELL SCI, V114, P2713; Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0; Rubtsova SN, 1998, FEBS LETT, V430, P353, DOI 10.1016/S0014-5793(98)00692-9; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Schmidt S, 2010, CELL TISSUE RES, V339, P83, DOI 10.1007/s00441-009-0892-9; SHANKAR G, 1993, J CELL SCI, V105, P61; Sivasubramaiyan K, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-88; Tozluoglu M, 2013, NAT CELL BIOL, V15, P751, DOI 10.1038/ncb2775; Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978; Tsygankova OM, 2013, J BIOL CHEM, V288, P24636, DOI 10.1074/jbc.M113.464594; Ulrich TA, 2010, BIOMATERIALS, V31, P1875, DOI 10.1016/j.biomaterials.2009.10.047; van Zijl F, 2011, MUTAT RES-REV MUTAT, V728, P23, DOI 10.1016/j.mrrev.2011.05.002; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Vincent LG, 2013, BIOTECHNOL J, V8, P472, DOI 10.1002/biot.201200205; Wilisch-Neumann A, 2013, CLIN CANCER RES, V19, P5402, DOI 10.1158/1078-0432.CCR-12-0299; Wu JD, 2012, INTERFACE FOCUS, V2, P337, DOI 10.1098/rsfs.2011.0124; Wu MH, 2001, J PHYSIOL-LONDON, V532, P785, DOI 10.1111/j.1469-7793.2001.0785e.x; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	44	17	18	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110453	10.1371/journal.pone.0110453	http://dx.doi.org/10.1371/journal.pone.0110453			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310593	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210300118
J	Remaud, A; Bilodeau, M; Tremblay, F				Remaud, Anthony; Bilodeau, Martin; Tremblay, Francois			Age and Muscle-Dependent Variations in Corticospinal Excitability during Standing Tasks	PLOS ONE			English	Article							ANTICIPATORY POSTURAL ADJUSTMENTS; CORTICOMOTOR EXCITABILITY; MOTOR THRESHOLD; TRANSCRANIAL STIMULATION; RESPONSES; FACILITATION; BALANCE; YOUNG; INHIBITION; MECHANISMS	In this study, we investigated how modulation in corticospinal excitability elicited in the context of standing tasks varies as a function of age and between muscles. Changes in motor evoked potentials (MEPs) recorded in tibialis anterior (TA) and gastrocnemius lateralis (GL) were monitored while participants (young, n = 10; seniors, n = 11) either quietly stood (QS) or performed a heel raise (HR) task. In the later condition, transcranial magnetic stimulation (TMS) pulses were delivered at three specific time points during the task: 1) 250 ms before the "go" cue (preparatory (PREP) phase), 2) 100 ms before the heel rise (anticipatory postural adjustment (APA) phase), and 3) 200 ms after heel rise (execution (EXEC) phase). In each task and each phase, variations in MEP characteristics were analysed for age and muscle-dependent effects. Variations in silent period (SP) duration were also examined for certain phases (APA and EXEC). Our analysis revealed no major difference during QS, as participants exhibited very similar patterns of modulation in both TA and GL, irrespective of their age group. During the HR task, young adults exhibited a differential modulation in the PREP phase with enhanced responses in TA relative to GL, which was not seen in seniors. Finally, besides differences in MEP latency, age had little influence on MEP modulation during the APA and EXEC phases, where amplitude was largely a function of background muscle activity associated with each phase (i.e., APA: TA; EXEC: GL). No age or muscle effects were detected for SP measurements. Overall, our results revealed no major differences between young adults and healthy seniors in the ability to modulate corticospinal facilitation destined to ankle muscles during standing tasks, with maybe the exception of the ability to prime muscle synergies in the preparatory phase of action.	[Remaud, Anthony; Bilodeau, Martin; Tremblay, Francois] Bruyere Res Inst, Ottawa, ON, Canada; [Bilodeau, Martin; Tremblay, Francois] Univ Ottawa, Sch Rehabil Sci, Ottawa, ON, Canada	University of Ottawa; University of Ottawa	Tremblay, F (corresponding author), Bruyere Res Inst, Ottawa, ON, Canada.	francois.tremblay@uottawa.ca	Remaud, Anthony/H-3120-2019; Tremblay, François/D-4378-2009	Remaud, Anthony/0000-0001-6946-3407; Tremblay, François/0000-0001-5450-8035	Faculty of Health Sciences (Research Development Funds), University of Ottawa; Bruyere Research Institute	Faculty of Health Sciences (Research Development Funds), University of Ottawa; Bruyere Research Institute	This study was funded in part by the Faculty of Health Sciences (Research Development Funds), University of Ottawa; AR received support from a Bruyere Research Institute research internship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudry S, 2014, ACTA PHYSIOL, V210, P667, DOI 10.1111/apha.12233; Bawa P, 2002, J NEUROPHYSIOL, V88, P124, DOI 10.1152/jn.2002.88.1.124; Billot M, 2010, EUR J APPL PHYSIOL, V109, P669, DOI 10.1007/s00421-010-1397-7; Borckardt JJ, 2006, J ECT, V22, P169, DOI 10.1097/01.yct.0000235923.52741.72; BRASILNETO JP, 1995, ACTA NEUROL SCAND, V92, P383; BROUWER B, 1995, ELECTROMYOGR MOTOR C, V97, P49, DOI 10.1016/0924-980X(94)00265-9; Di Lazzaro V, 1998, J PHYSIOL-LONDON, V508, P625; Drew T, 2002, BRAIN RES REV, V40, P178, DOI 10.1016/S0165-0173(02)00200-X; Flavel SC, 2012, J APPL PHYSL; Fujiyama H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.019; Fujiyama H, 2012, J COGNITIVE NEUROSCI, V24, P1253, DOI 10.1162/jocn_a_00201; Fujiyama H, 2011, PSYCHOPHYSIOLOGY, V48, P1448, DOI 10.1111/j.1469-8986.2011.01201.x; Fujiyama H, 2009, BRAIN RES, V1262, P38, DOI 10.1016/j.brainres.2009.01.023; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Heuninckx S, 2005, J NEUROSCI, V25, P6787, DOI 10.1523/JNEUROSCI.1263-05.2005; INGLIN B, 1988, J GERONTOL, V43, pM105, DOI 10.1093/geronj/43.4.M105; Jacobs JV, 2007, J NEURAL TRANSM, V114, P1339, DOI 10.1007/s00702-007-0657-0; JUDGE JO, 1995, J GERONTOL A-BIOL, V50, pM263, DOI 10.1093/gerona/50A.5.M263; Kloppel S, 2008, NEUROIMAGE, V40, P1782, DOI 10.1016/j.neuroimage.2008.01.019; Lacour M, 2008, NEUROPHYSIOL CLIN, V38, P411, DOI 10.1016/j.neucli.2008.09.005; Laughton CA, 2003, GAIT POSTURE, V18, P101, DOI 10.1016/S0966-6362(02)00200-X; Leonard G, 2007, EXP BRAIN RES, V177, P167, DOI 10.1007/s00221-006-0657-6; Levin O, 2014, NEUROSCI BIOBEHAV R, V43, P100, DOI 10.1016/j.neubiorev.2014.04.001; Levin O, 2011, NEUROSCI LETT, V487, P53, DOI 10.1016/j.neulet.2010.09.072; MacKinnon CD, 2007, J NEUROPHYSIOL; Master S, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-27; Master S, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-16; Mishory A, 2004, J ECT, V20, P160, DOI 10.1097/00124509-200409000-00007; Nielsen JF, 1996, J CLIN NEUROPHYSIOL, V13, P423, DOI 10.1097/00004691-199609000-00005; Obata H, 2009, EXP BRAIN RES, V197, P207, DOI 10.1007/s00221-009-1874-6; Oliviero A, 2006, NEUROSCI RES, V55, P74, DOI 10.1016/j.neures.2006.02.002; Petersen TH, 2009, EXP BRAIN RES, V193, P161, DOI 10.1007/s00221-008-1603-6; ROGERS MW, 1992, J GERONTOL, V47, pM159, DOI 10.1093/geronj/47.5.M159; Rossini PM, 2007, PROG NEUROBIOL, V83, P375, DOI 10.1016/j.pneurobio.2007.07.010; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Sinclair C, 2008, EXP BRAIN RES, V186, P385, DOI 10.1007/s00221-007-1241-4; Sinclair C, 2009, EXP BRAIN RES, V194, P103, DOI 10.1007/s00221-008-1684-2; Sterr A, 2009, NEUROSCI LETT, V457, P61, DOI 10.1016/j.neulet.2009.04.013; Stokes MG, 2007, CLIN NEUROPHYSIOL, V118, P1617, DOI 10.1016/j.clinph.2007.04.004; THOMPSON PD, 1991, ELECTROEN CLIN NEURO, V81, P397, DOI 10.1016/0168-5597(91)90029-W; Tremblay F, 2002, CLIN NEUROPHYSIOL, V113, P2006, DOI 10.1016/S1388-2457(02)00301-2; Tremblay F, 2001, J REHABIL MED, V33, P230; Ward NS, 2006, AGEING RES REV, V5, P239, DOI 10.1016/j.arr.2006.04.003; WOLFSON L, 1992, NEUROLOGY, V42, P2069, DOI 10.1212/WNL.42.11.2069; WOOLLACOTT MH, 1993, J GERONTOL, V48, pM64, DOI 10.1093/geronj/48.2.M64; WOOLLACOTT MH, 1986, INT J AGING HUM DEV, V23, P97, DOI 10.2190/VXN3-N3RT-54JB-X16X	46	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110004	10.1371/journal.pone.0110004	http://dx.doi.org/10.1371/journal.pone.0110004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310218	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210300083
J	Carstens, M; McCrindle, TK; Adams, N; Diener, A; Guzha, DT; Murray, SL; Parker, JE; Denby, KJ; Ingle, RA				Carstens, Maryke; McCrindle, Tyronne K.; Adams, Nicolette; Diener, Anastashia; Guzha, Delroy T.; Murray, Shane L.; Parker, Jane E.; Denby, Katherine J.; Ingle, Robert A.			Increased Resistance to Biotrophic Pathogens in the Arabidopsis Constitutive Induced Resistance 1 Mutant Is EDS1 and PAD4-Dependent and Modulated by Environmental Temperature	PLOS ONE			English	Article							DISEASE-RESISTANCE; PLANT-DISEASE; TRIGGERED IMMUNITY; DEFENSE; EXPRESSION; PROTEINS; MUTATION; LEADS; ACTIVATION; SALICYLATE	The Arabidopsis constitutive induced resistance 1 (clr1) mutant displays salicylic acid (SA)-dependent constitutive expression of defence genes and enhanced resistance to biotrophic pathogens. To fLirther characterise the role of CIR1 in plant immunity we conducted epistasis analyses with two key components of the SA-signalling branch of the defence network, ENHANCED DISEASE SUSCEPTIBILITY1 (EDS1) and PHYTOALEXIN DEFICIENT4 (PAD4). We demonstrate that the constitutive defence phenotypes of cirl require both EDS1 and PAD4, indicating that CIR1 lies upstream of the EDS1-PAD4 regulatory node in the immune signalling network. In light of this finding we examined EDS1 expression in cirl and observed increased protein, but not mRNA levels in this mutant, suggesting that CIR1 might act as a negative regulator of EDS1 via a posttranscriptional mechanism. Finally, as environmental temperature is known to influence the outcome of plant-pathogen interactions, we analysed cirl plants grown at 18, 22 or 25 degrees C We found that susceptibility to Pseudomonas syringae pv. tomato (Pst) DC3000 is modulated by temperature in ciri. Greatest resistance to this pa hogen (relative to PR-1:LUC control plants) was observed at 18 degrees C, while at 25 degrees C no difference in susceptibility between cirl and control plants was apparent. The increase in resistance to Pst DC3000 at 18 C correlated with a stunted growth phenotype, suggesting that activation of defence responses may be enhanced at lower temperatures in the cir1 mutant.	[Carstens, Maryke; McCrindle, Tyronne K.; Adams, Nicolette; Diener, Anastashia; Guzha, Delroy T.; Murray, Shane L.; Ingle, Robert A.] Univ Cape Town, Dept Mol & Cell Biol, ZA-7700 Rondebosch, South Africa; [Parker, Jane E.] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Cologne, Germany; [Denby, Katherine J.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Denby, Katherine J.] Univ Warwick, Warwick Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England	University of Cape Town; Max Planck Society; University of Warwick; University of Warwick	Ingle, RA (corresponding author), Univ Cape Town, Dept Mol & Cell Biol, ZA-7700 Rondebosch, South Africa.	Robert.ingle@uct.ac.za	Ingle, Robert A/C-5599-2008; Denby, Katherine/P-3464-2014	Ingle, Robert A/0000-0002-8362-3777; Denby, Katherine/0000-0002-7857-6814	National Research Foundation, South Africa [IFR2011032900062]; University of Cape Town; Max-Planck Society; Alexander von Humboldt Foundation	National Research Foundation, South Africa(National Research Foundation - South Africa); University of Cape Town; Max-Planck Society(Max Planck SocietyFoundation CELLEX); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This research was funded by a grant (IFR2011032900062) from the National Research Foundation, South Africa (www.nrEac.za) and by the University of Cape Town (www.uct.ac.za). Experiments carried out in Jane Parker's lab were funded by the Max-Planck Society (www.mpg.de) and an Alexander von Humboldt Foundation (www.humboldt-foundation.de/web/home.html) 'Sofja Kovaleskaja' award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Alcazar R, 2011, TRENDS PLANT SCI, V16, P666, DOI 10.1016/j.tplants.2011.09.001; Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Bhardwaj V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026968; Bhattacharjee S, 2011, SCIENCE, V334, P1405, DOI 10.1126/science.1211592; BOWLING SA, 1994, PLANT CELL, V6, P1845, DOI 10.1105/tpc.6.12.1845; Cheng YT, 2011, P NATL ACAD SCI USA, V108, P14694, DOI 10.1073/pnas.1105685108; Clarke JD, 2001, PLANT J, V26, P409, DOI 10.1046/j.1365-313X.2001.2641041.x; Feys BJ, 2005, PLANT CELL, V17, P2601, DOI 10.1105/tpc.105.033910; Feys BJ, 2001, EMBO J, V20, P5400, DOI 10.1093/emboj/20.19.5400; Fu ZQ, 2013, ANNU REV PLANT BIOL, V64, P839, DOI 10.1146/annurev-arplant-042811-105606; Garcia AV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000970; Glazebrook J, 2003, PLANT J, V34, P217, DOI 10.1046/j.1365-313X.2003.01717.x; Glazebrook J, 1996, GENETICS, V143, P973; Gou MY, 2009, PLANT J, V60, P757, DOI 10.1111/j.1365-313X.2009.03995.x; Ingle RA, 2005, BIOMETALS, V18, P627, DOI 10.1007/s10534-005-2999-0; Jirage D, 2001, PLANT J, V26, P395, DOI 10.1046/j.1365-313X.2001.2641040.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kim SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001172; Kwon SI, 2009, PLANT J, V57, P109, DOI 10.1111/j.1365-313X.2008.03669.x; Li X, 2001, MOL PLANT MICROBE IN, V14, P1131, DOI 10.1094/MPMI.2001.14.10.1131; Murray SL, 2007, MOL PLANT MICROBE IN, V20, P1431, DOI 10.1094/MPMI-20-11-1431; Murray SL, 2005, MOL PLANT PATHOL, V6, P31, DOI 10.1111/j.1364-3703.2004.00261.x; Murray SL, 2002, MOL PLANT MICROBE IN, V15, P557, DOI 10.1094/MPMI.2002.15.6.557; PARKER JE, 1993, PLANT J, V4, P821, DOI 10.1046/j.1365-313X.1993.04050821.x; Parker JE, 1996, PLANT CELL, V8, P2033, DOI 10.1105/tpc.8.11.2033; Rietz S, 2011, NEW PHYTOL, V191, P107, DOI 10.1111/j.1469-8137.2011.03675.x; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Schwessinger B, 2008, CURR OPIN PLANT BIOL, V11, P389, DOI 10.1016/j.pbi.2008.06.001; Schwessinger B, 2012, ANNU REV PLANT BIOL, V63, P451, DOI 10.1146/annurev-arplant-042811-105518; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Venugopal SC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000545; Wang Y, 2009, MOL PLANT MICROBE IN, V22, P498, DOI 10.1094/MPMI-22-5-0498; Wiermer M, 2005, CURR OPIN PLANT BIOL, V8, P383, DOI 10.1016/j.pbi.2005.05.010; Windram O, 2012, PLANT CELL, V24, P3530, DOI 10.1105/tpc.112.102046; Yang SH, 2004, PLANT CELL, V16, P1060, DOI 10.1105/tpc.020479; Zhang YL, 2003, PLANT CELL, V15, P2636, DOI 10.1105/tpc.015842; Zhu SF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002318; Zhu Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000844	40	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109853	10.1371/journal.pone.0109853	http://dx.doi.org/10.1371/journal.pone.0109853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303634	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400088
J	Pellicano, E; Dinsmore, A; Charman, T				Pellicano, Elizabeth; Dinsmore, Adam; Charman, Tony			Views on Researcher-Community Engagement in Autism Research in the United Kingdom: A Mixed-Methods Study	PLOS ONE			English	Article							PARTICIPATORY RESEARCH; CLINICAL-RESEARCH; HEALTH RESEARCH; INVOLVEMENT; DISORDERS; SPECTRUM; EPIDEMIOLOGY; PARTNERSHIP; PREVALENCE; STRATEGIES	There has been a substantial increase in research activity on autism during the past decade. Research into effective ways of responding to the immediate needs of autistic people is, however, less advanced, as are efforts at translating basic science research into service provision. Involving community members in research is one potential way of reducing this gap. This study therefore investigated the views of community involvement in autism research both from the perspectives of autism researchers and of community members, including autistic adults, family members and practitioners. Results from a large-scale questionnaire study (n = 1,516) showed that researchers perceive themselves to be engaged with the autism community but that community members, most notably autistic people and their families, did not share this view. Focus groups/interviews with 72 participants further identified the potential benefits and remaining challenges to involvement in research, especially regarding the distinct perspectives of different stakeholders. Researchers were skeptical about the possibilities of dramatically increasing community engagement, while community members themselves spoke about the challenges to fully understanding and influencing the research process. We suggest that the lack of a shared approach to community engagement in UK autism research represents a key roadblock to translational endeavors.	[Pellicano, Elizabeth; Dinsmore, Adam] Univ London, Inst Educ, Dept Psychol & Human Dev, CRAE, London WC1N 1AZ, England; [Dinsmore, Adam] Wellcome Trust Res Labs, Strateg Planning & Policy Unit, London, England; [Charman, Tony] Kings Coll London, Inst Psychiat, Dept Psychol, London, England	University of London; University College London; UCL Institute of Education; University of London; King's College London	Pellicano, E (corresponding author), Univ London, Inst Educ, Dept Psychol & Human Dev, CRAE, London WC1N 1AZ, England.	l.pellicano@ioe.ac.uk	Pellicano, Liz/I-5749-2019; Charman, Tony/A-2085-2014	Pellicano, Liz/0000-0002-7246-8003; Charman, Tony/0000-0003-1993-6549; Dinsmore, Adam/0000-0002-3314-7944	Inge Wakehurst Foundation; Charles Wolfson Foundation; Waterloo Foundation	Inge Wakehurst Foundation; Charles Wolfson Foundation; Waterloo Foundation	This work was funded by the Inge Wakehurst Foundation, the Charles Wolfson Foundation, and The Waterloo Foundation. The funders had no role in the design of the study, collection and analysis of the data, or preparation and review of the manuscript.	Ahmed SM, 2010, AM J PUBLIC HEALTH, V100, P1380, DOI 10.2105/AJPH.2009.178137; ARNSTEIN SR, 1969, J AM I PLANNERS, V35, P216, DOI 10.1080/01944366908977225; Bagatell N, 2010, ETHOS, V38, P33, DOI 10.1111/j.1548-1352.2009.01080.x; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Bettelheim B., 1967, EMPTY FORTRESS INFAN; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brugha TS, 2011, ARCH GEN PSYCHIAT, V68, P459, DOI 10.1001/archgenpsychiatry.2011.38; Callard F, 2012, HEALTH EXPECT, V15, P389, DOI 10.1111/j.1369-7625.2011.00681.x; Chalmers L, 2004, BMJ-BRIT MED J, V328, P475; Cooksey D., 2006, REV UK HLTH RES FUND; Dawson G, 2013, JAMA PSYCHIAT, V70, P9, DOI 10.1001/jamapsychiatry.2013.488; Dawson M., 2004, MISBEHAVIOUR BEHAV; Elsabbagh M, 2012, AUTISM RES, V5, P160, DOI 10.1002/aur.239; Faridi Z., 2007, PREVENTING CHRONIC D, V43, P1; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Gernsbacher MA, 2005, CURR DIR PSYCHOL SCI, V14, P55, DOI 10.1111/j.0963-7214.2005.00334.x; Goodare H, 1999, BRIT MED J, V319, P724, DOI 10.1136/bmj.319.7212.724; Gross L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000114; Ham M., 2004, J LEARNING DISABILIT, V8, P397, DOI DOI 10.1177/1469004704047507; Hanley B, 2001, BRIT MED J, V322, P519, DOI 10.1136/bmj.322.7285.519; Insel TR, 2009, ARCH GEN PSYCHIAT, V66, P128, DOI 10.1001/archgenpsychiatry.2008.540; Ioannidis JP, 2004, J TRANSL MED, V2, P5, DOI DOI 10.1186/1479-5876-2-5; Israel BA, 2005, ENVIRON HEALTH PERSP, V113, P1463, DOI 10.1289/ehp.7675; Jones L, 2007, JAMA-J AM MED ASSOC, V297, P407, DOI 10.1001/jama.297.4.407; Lambert R., 2003, LAMBERT REV BUSINESS; Lloyd K, 2011, NATURE, V474, P277, DOI 10.1038/474277a; Medical Research Council, 2008, RES CHANG LIV STRAT; Moore Kelly, 2008, DISRUPTING SCI SOCIA; National Institute for Health Research, 2012, INVOLVE STRAT 2012 2; Nicolaidis C, 2013, J GEN INTERN MED, V28, P761, DOI 10.1007/s11606-012-2262-7; Nicolaidis C, 2011, PROG COMM HLTH PARTN, V5, P143, DOI 10.1353/cpr.2011.0022; Office of Autism Research Coordination National Institute of Mental Health on behalf of the Interagency Autism Coordinating Committee (IACC), 2010, IACC AUT SPECTR DIS; Oliver S, 2004, HEALTH TECHNOL ASSES, V8, P1; Partridge N, 2004, LANCET, V364, P1923, DOI 10.1016/S0140-6736(04)17494-1; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P528, DOI 10.1177/1745691612465253; Pellicano E, 2014, AUTISM, V18, P756, DOI 10.1177/1362361314529627; Pellicano E, 2011, NAT REV NEUROSCI, V12, P769, DOI 10.1038/nrn3113-c1; Pellicano E, 2011, AUTISM RES, V4, P271, DOI 10.1002/aur.201; Pellicano L., 2013, FUTURE MADE TOGETHER; Powers LE, 2007, EXCEPTIONALITY, V15, P45, DOI DOI 10.1080/09362830709336925; Sinclair J., 1993, AUTISM NETWORK INT N, V1; Sinclair J., 1999, WHY I DISLIKE PERSON; Thompson J, 2009, HEALTH EXPECT, V12, P209, DOI 10.1111/j.1369-7625.2009.00532.x; Tinetti ME, 2013, JAMA-J AM MED ASSOC, V309, P2331, DOI 10.1001/jama.2013.5592; Tritter JQ, 2006, HEALTH POLICY, V76, P156, DOI 10.1016/j.healthpol.2005.05.008; van der Laan AL, 2012, HEALTH CARE ANAL, V20, P84; Ward K, 2001, MENT RETARD, V39, P57, DOI 10.1352/0047-6765(2001)039<0057:ROPARW>2.0.CO;2; Ward PR, 2010, J SOCIOL, V46, P63, DOI 10.1177/1440783309351771; Yudell M, 2013, AUTISM, V17, P701, DOI 10.1177/1362361312453511; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867	50	54	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109946	10.1371/journal.pone.0109946	http://dx.doi.org/10.1371/journal.pone.0109946			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6ZS	25303222	Green Published, gold, Green Submitted			2022-12-27	WOS:000343730400095
J	Wang, HC; Chen, Y; Chen, JB; Zhang, ZT; Lao, WS; Li, XZ; Huang, JS; Wang, T				Wang, Hongcai; Chen, Yan; Chen, Jinbo; Zhang, Zhentao; Lao, Wansheng; Li, Xizhi; Huang, Jinsha; Wang, Tao			Cell Cycle Regulation of DNA Polymerase Beta in Rotenone-Based Parkinson's Disease Models	PLOS ONE			English	Article							ENDOREPLICATION; NEURONS; POLYPLOIDY; INSIGHTS; BRAIN; DEATH	In Parkinson's disease (PD), neuronal cells undergo mitotic catastrophe and endoreduplication prior to cell death; however the regulatory mechanisms remain to be defined. In this study, we investigated cell cycle regulation of DNA polymerase (poly beta) in rotenone-based doparninergic cellular and animal models. Incubation with a low concentration (0.25.t,th4) of rotenone for 1.5 to 7 days resulted in a flattened cell body and decreased DNA replication during S phase, whereas a high concentration (2 mu M) of rotenone exposure resulted in enlarged, multi-nucleated cells and converted the mitotic cycle in to endorediaplication. Consistently, DNA poly 13, which is mainly involved in DNA repair synthesis, was upregulated to a high level following exposure to 2 RIVI rotenone. The abrogation of DNA poly ji by siRNiN transfection or dideo)(ycytidine (DDC) treatment attenuated the rotenone-induced endoreduplication. The cell cycle was reactivated in cyclin D-expressing dopaminergic neurons from the substantia nigra (SN) of rats following stereotactic (ST) infusion of rotenone. Increased DNA poly beta expression was observed in the substantia nigra pars compacta (SNc) and the substantia nigra pars reticulate (SNr) of rotenone-treated rats. Collectively, in the in vitro model of rotenone-induced mitotic catastrophe, the overexpression of DNA poly ji promotes endoreduplication; in the in vivo model, the upregulation of DNA poly beta and cell cycle reentry were also observed in the adult rat substantia nigra. Therefore, the cell cycle regulation of DNA poly beta may be involved in the pathological processes of PD, which resLilts in the induction of endoreduplication	[Wang, Hongcai; Chen, Jinbo; Li, Xizhi] Binzhou Med Univ, Affiliated Hosp, Dept Neurol, Binzhou City, Shandong Provin, Peoples R China; [Chen, Yan] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gastroenterol, Wuhan 430074, Peoples R China; [Huang, Jinsha; Wang, Tao] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Neurol, Wuhan 430074, Peoples R China; [Zhang, Zhentao] Wuhan Univ, Renmin Hosp, Dept Neurol, Wuhan 430072, Peoples R China; [Lao, Wansheng] Yangxin Tradit Chinese Med Hosp, Dept Surg, Binzhou City, Shandong Provin, Peoples R China	Binzhou Medical University; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Wuhan University	Wang, HC (corresponding author), Binzhou Med Univ, Affiliated Hosp, Dept Neurol, Binzhou City, Shandong Provin, Peoples R China.	whc2891@126.com; wangtaowh@hust.edu.cn		Zhang, Zhentao/0000-0001-6708-1472	National Natural Science Foundation of China [81071021, 31171211, 81100958, 81200983]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants (No. 81071021, No. 31171211, No. 81100958 and No. 81200983) from the National Natural Science Foundation of China (to Tao Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canitrot Y, 1999, FASEB J, V13, P1107, DOI 10.1096/fasebj.13.9.1107; Copani A, 2006, J NEUROSCI, V26, P10949, DOI 10.1523/JNEUROSCI.2793-06.2006; De Veylder L, 2011, TRENDS PLANT SCI, V16, P624, DOI 10.1016/j.tplants.2011.07.001; Fox DT, 2013, DEVELOPMENT, V140, P3, DOI 10.1242/dev.080531; Frade JM, 2010, CELL CYCLE, V9, P1934, DOI 10.4161/cc.9.10.11582; Hoglinger GU, 2007, P NATL ACAD SCI USA, V104, P3585, DOI 10.1073/pnas.0611671104; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; MATSUMOTO K, 1993, JPN J GENET, V68, P185, DOI 10.1266/jjg.68.185; Modi PK, 2012, MOL BIOL CELL, V23, P3722, DOI 10.1091/mbc.E12-02-0125; Moon Y, 2005, J NEUROCHEM, V93, P1199, DOI 10.1111/j.1471-4159.2005.03112.x; Roy S, 2007, FEBS J, V274, P2005, DOI 10.1111/j.1742-4658.2007.05744.x; Sherer TB, 2003, EXP NEUROL, V179, P9, DOI 10.1006/exnr.2002.8072; Sykora P, 2013, MECH AGEING DEV, V134, P440, DOI 10.1016/j.mad.2013.04.005; Trembleau A, 1998, BIOL CELL, V90, P39, DOI 10.1016/S0248-4900(98)80231-1; Xiong NA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007878; Zhu X, 2008, NEUROPATH APPL NEURO, V34, P457, DOI 10.1111/j.1365-2990.2007.00908.x	16	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109697	10.1371/journal.pone.0109697	http://dx.doi.org/10.1371/journal.pone.0109697			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303312	Green Submitted, gold, Green Published			2022-12-27	WOS:000343730400075
J	Cavallo, S; April, KT; Grandpierre, V; Majnemer, A; Feldman, DE				Cavallo, Sabrina; April, Karine Toupin; Grandpierre, Viviane; Majnemer, Annette; Feldman, Debbie Ehrmann			Leisure in Children and Adolescents with Juvenile Idiopathic Arthritis: A Systematic Review	PLOS ONE			English	Review							OPTIMAL SEARCH STRATEGIES; PHYSICAL-ACTIVITY LEVEL; RHEUMATOID-ARTHRITIS; EXERCISE; PARTICIPATION; FITNESS; PREDICTORS; CHILDHOOD; SYMPTOMS; PROGRAM	The aim of this systematic review is to describe participation in social and physical leisure activities among children and adolescents with JIA, as well as identify potential determinants of leisure participation. Methods: Electronic databases were systematically searched for articles published up until June 2013 pertaining to participation in leisure activities among youth with JIA and other rheumatic diseases. Studies were included if they measured involvement in either social or physical leisure activities. Selection and quality appraisal of articles were completed independently by two authors. Results: Eight hundred and ninety-three articles were found through electronic and reference search. One hundred and nine full articles were reviewed to assess for eligibility. Twelve articles met inclusion criteria and findings were reviewed. Most focused on describing participation in physical rather than social activities. Results suggest that youth with JIA participated less in both social and physical leisure activities as compared to healthy peers, and those with JIA did not meet national recommendations for physical activity. Potential determinants of leisure participation were socio-demographic (age, sex), anthropometric (height, weight) and disease-related (JIA subtype, disease duration, pain, number of swollen or painful joints, stiffness, fatigue, well-being) factors. Conclusion: Characterization of leisure activity remains limited and mostly focused on physical activity in JIA. Assessment of more comprehensive outcome measures is warranted to obtain a better description of leisure in this population. Evidence of the influence of contextual factors as potential determinants of involvement in leisure among children with pediatric rheumatologic diseases is needed.	[Cavallo, Sabrina; Feldman, Debbie Ehrmann] Univ Montreal, Ecole Sante Publ, Dept Social & Prevent Med, Montreal, PQ, Canada; [Cavallo, Sabrina; Majnemer, Annette] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Montreal, PQ H3H 1P3, Canada; [Cavallo, Sabrina; Feldman, Debbie Ehrmann] Univ Montreal, Inst Rech Sante Publ, Montreal, PQ, Canada; [Cavallo, Sabrina; Feldman, Debbie Ehrmann] Inst Readaptat Montreal, Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [April, Karine Toupin; Grandpierre, Viviane] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [April, Karine Toupin] Univ Ottawa, Fac Med, Dept Pediat, Ottawa, ON, Canada; [Grandpierre, Viviane] Univ Ottawa, Fac Hlth Sci, Sch Rehabil Sci, Ottawa, ON, Canada; [Majnemer, Annette] McGill Univ, Fac Med, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Feldman, Debbie Ehrmann] Univ Montreal, Fac Med, Ecole Readaptat, Montreal, PQ, Canada; [Feldman, Debbie Ehrmann] Direct Sante Publ Montreal, Montreal, PQ, Canada	Universite de Montreal; McGill University; Universite de Montreal; Universite de Montreal; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa; McGill University; Universite de Montreal	Cavallo, S (corresponding author), Univ Montreal, Ecole Sante Publ, Dept Social & Prevent Med, Montreal, PQ, Canada.	sabrina.cavallo@yahoo.ca	Cavallo, Sabrina/AAX-8970-2020; Cavallo, Sabrina/AAN-9872-2021		Fonds de Recherche Sante Quebec; MENTOR program of the Canadian Institutes of Health Research; Children's Hospital of Eastern Ontario Research Institute	Fonds de Recherche Sante Quebec; MENTOR program of the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Children's Hospital of Eastern Ontario Research Institute	The first author benefited from doctoral student bursaries awarded by the Fonds de Recherche Sante Quebec and the MENTOR program of the Canadian Institutes of Health Research. Dr. Karine Toupin April would like to acknowledge funding from the Children's Hospital of Eastern Ontario Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BILEZIKIAN JP, 1994, JAMA-J AM MED ASSOC, V272, P1942, DOI 10.1001/jama.1994.03520240070044; BILLINGS AG, 1987, HEALTH PSYCHOL, V6, P343, DOI 10.1037/0278-6133.6.4.343; Booth FW, 2002, J APPL PHYSIOL, V93, P3, DOI 10.1152/japplphysiol.00073.2002; Bruunsgaard H, 2005, J LEUKOCYTE BIOL, V78, P819, DOI 10.1189/jlb.0505247; Cassidy JT, 2005, TXB PEDIAT RHEUMATOL, P206; Connelly M, 2010, J PAIN SYMPTOM MANAG, V39, P579, DOI 10.1016/j.jpainsymman.2009.07.013; Deeks J J, 2003, Health Technol Assess, V7, piii; Effective Public Health Practice Project, 1998, QUAL ASS TOOL QUANT; Felin EMO, 2007, ARTHRITIS RHEUM, V56, P984, DOI 10.1002/art.22420; Furlan AD, 2006, J CLIN EPIDEMIOL, V59, P1303, DOI 10.1016/j.jclinepi.2006.03.004; GARTON AF, 1991, J ADOLESCENCE, V14, P305, DOI 10.1016/0140-1971(91)90023-K; Guell C, 2007, QUAL HEALTH RES, V17, P884, DOI 10.1177/1049732307305883; Henderson C J, 1995, Arthritis Care Res, V8, P114, DOI 10.1002/art.1790080210; Henderson CJ, 1997, ARTHRITIS RHEUM, V40, P1967, DOI 10.1002/art.1780401108; Henderson CJ, 2000, ARTHRITIS RHEUM-US, V43, P531, DOI 10.1002/1529-0131(200003)43:3<531::AID-ANR8>3.0.CO;2-X; Higgins JPT, 2022, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; Huygen ACJ, 2000, ANN RHEUM DIS, V59, P276, DOI 10.1136/ard.59.4.276; Kasapis C, 2005, J AM COLL CARDIOL, V45, P1563, DOI 10.1016/j.jacc.2004.12.077; King G., 2004, CHILDRENS ASSESSMENT; King GA, 2007, CHILD CARE HLTH DEV, V33, P28, DOI 10.1111/j.1365-2214.2006.00613.x; King Gillian, 2003, Physical & Occupational Therapy in Pediatrics, V23, P63, DOI 10.1300/J006v23n01_05; Klepper S E, 1992, Arthritis Care Res, V5, P93, DOI 10.1002/art.1790050208; Klepper SE, 1999, ARTHRIT CARE RES, V12, P52, DOI 10.1002/1529-0131(199902)12:1<52::AID-ART9>3.0.CO;2-X; Kohut ML, 2004, EXERC IMMUNOL REV, V10, P6; Larson RW, 1999, PSYCHOL BULL, V125, P701, DOI 10.1037/0033-2909.125.6.701; Larson RW, 2000, AM PSYCHOL, V55, P170, DOI 10.1037/0003-066X.55.1.170; Law M, 2006, DEV MED CHILD NEUROL, V48, P337, DOI 10.1017/S0012162206000740; Lelieveld OTHM, 2008, ARTHRIT RHEUM-ARTHR, V59, P1379, DOI 10.1002/art.24102; Lien G, 2005, ARTHRITIS RHEUM-US, V52, P833, DOI 10.1002/art.20963; Maggio ABR, 2010, EUR J PEDIATR, V169, P1187, DOI 10.1007/s00431-010-1199-2; Manners PJ, 2002, J RHEUMATOL, V29, P1520; Masten AS, 1998, AM PSYCHOL, V53, P205, DOI 10.1037/0003-066X.53.2.205; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; NEVITT MC, 1994, RHEUM DIS CLIN N AM, V20, P535; Orlin MN, 2010, DEV MED CHILD NEUROL, V52, P160, DOI 10.1111/j.1469-8749.2009.03363.x; Reid GJ, 2005, PAIN, V113, P201, DOI 10.1016/j.pain.2004.10.018; Reiter-Purtill J, 2003, J PEDIATR PSYCHOL, V28, P17, DOI 10.1093/jpepsy/28.1.17; Rowlands AV, 2000, ANN HUM BIOL, V27, P479, DOI 10.1080/030144600419314; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sandstedt E, 2012, PEDIATR PHYS THER, V24, P155, DOI 10.1097/PEP.0b013e31824cce6e; Schanberg LE, 2003, ARTHRITIS RHEUM-US, V48, P1390, DOI 10.1002/art.10986; Shikako-Thomas K, 2013, RES DEV DISABIL, V34, P1001, DOI 10.1016/j.ridd.2012.11.026; Singh-Grewal D, 2006, ARTHRIT RHEUM-ARTHR, V55, P364, DOI 10.1002/art.21996; Singh-Grewal D, 2007, ARTHRIT RHEUM-ARTHR, V57, P1202, DOI 10.1002/art.23008; Streiner DL, 2008, VALIDITY, P247; Takken T, 2008, EUR J PHYS REHAB MED, V44, P287; Takken T, 2003, RHEUMATOLOGY, V42, P1408, DOI 10.1093/rheumatology/keg386; Takken T, 2003, ANN RHEUM DIS, V62, P885, DOI 10.1136/ard.62.9.885; Takken T, 2001, ARTHRIT RHEUM-ARTHR, V45, P81, DOI 10.1002/1529-0131(200102)45:1<81::AID-ANR88>3.0.CO;2-I; Tarakci E, 2011, CLIN RHEUMATOL, V30, P1415, DOI 10.1007/s10067-011-1832-0; Thomas B H, 2004, Worldviews Evid Based Nurs, V1, P176, DOI 10.1111/j.1524-475X.2004.04006.x; Wilczynski NL, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-23; Wilczynski NL, 2005, J AM MED INFORM ASSN, V12, P481, DOI 10.1197/jamia.M1752; Woods JA, 2006, NEUROL CLIN, V24, P585, DOI 10.1016/j.ncl.2006.03.008; World Health Organization, 2001, ICF INT CLASFUNCT	55	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e104642	10.1371/journal.pone.0104642	http://dx.doi.org/10.1371/journal.pone.0104642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0AY	25329390	Green Published, Green Submitted, gold			2022-12-27	WOS:000343942100002
J	Chesne, J; Danger, R; Botturi, K; Reynaud-Gaubert, M; Mussot, S; Stern, M; Danner-Boucher, I; Mornex, JF; Pison, C; Dromer, C; Kessler, R; Dahan, M; Brugiere, O; Le Pavec, J; Perros, F; Humbert, M; Gomez, C; Brouard, S; Magnan, A				Chesne, Julie; Danger, Richard; Botturi, Karine; Reynaud-Gaubert, Martine; Mussot, Sacha; Stern, Marc; Danner-Boucher, Isabelle; Mornex, Jean-Francois; Pison, Christophe; Dromer, Claire; Kessler, Romain; Dahan, Marcel; Brugiere, Olivier; Le Pavec, Jerome; Perros, Frederic; Humbert, Marc; Gomez, Carine; Brouard, Sophie; Magnan, Antoine		COLT Consortium	Systematic Analysis of Blood Cell Transcriptome in End-Stage Chronic Respiratory Diseases	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; GENE-EXPRESSION; CYSTIC-FIBROSIS; SURVIVAL; PROTEIN; BETA; INFLAMMATION; IMMUNITY; THERAPY; DISPLAY	Background: End-stage chronic respiratory diseases (CRD) have systemic consequences, such as weight loss and susceptibility to infection. However the mechanisms of such dysfunctions are as yet poorly explained. We hypothesized that the genes putatively involved in these mechanisms would emerge from a systematic analysis of blood mRNA profiles from pre-transplant patients with cystic fibrosis (CF), pulmonary hypertension (PAH), and chronic obstructive pulmonary disease (COPD). Methods: Whole blood was first collected from 13 patients with PAH, 23 patients with CF, and 28 Healthy Controls (HC). Microarray results were validated by quantitative PCR on a second and independent group (7PAH, 9CF, and 11HC). Twelve pre-transplant COPD patients were added to validate the common signature shared by patients with CRD for all causes. To further clarify a role for hypoxia in the candidate gene dysregulation, peripheral blood mononuclear cells from HC were analysed for their mRNA profile under hypoxia. Results: Unsupervised hierarchical clustering allowed the identification of 3 gene signatures related to CRD. One was common to CF and PAH, another specific to CF, and the final one was specific to PAH. With the common signature, we validated T-Cell Factor 7 (TCF-7) and Interleukin 7 Receptor (IL-7R), two genes related to T lymphocyte activation, as being under-expressed. We showed a strong impact of the hypoxia on modulation of TCF-7 and IL-7R expression in PBMCs from HC under hypoxia or PBMCs from CRD. In addition, we identified and validated genes upregulated in PAH or CF, including Lectin Galactoside-binding Soluble 3 and Toll Like Receptor 4, respectively. Conclusions: Systematic analysis of blood cell transcriptome in CRD patients identified common and specific signatures relevant to the systemic pathologies. TCF-7 and IL-7R were downregulated whatever the cause of CRD and this could play a role in the higher susceptibility to infection of these patients.	[Chesne, Julie; Botturi, Karine; Danner-Boucher, Isabelle; Magnan, Antoine] Univ Nantes, CHU Nantes, Ctr Natl Reference Mucoviscidose Nantes Roscoff, Inst Thorax,UMR S 1087 CNRS UMR 6291, Nantes, France; [Chesne, Julie; Danger, Richard; Botturi, Karine; Brouard, Sophie; Magnan, Antoine] Univ Nantes, Nantes, France; [Danger, Richard; Brouard, Sophie] Ctr Hosp Univ Hotel Dieu, INSERM U1064, Nantes, France; [Danger, Richard; Brouard, Sophie] Ctr Hosp Univ Hotel Dieu, Inst Transplantat Urol Nephrol, Nantes, France; [Reynaud-Gaubert, Martine; Gomez, Carine] Aix Marseille Univ, CHU Marseille, Marseille, France; [Mussot, Sacha; Le Pavec, Jerome] Ctr Chirurg Marie Lannelongue, Serv Chirurg Thorac Vasc & Transplantat Cardiopul, Le Plessis Robinson, France; [Stern, Marc] Hop Foch, Suresnes, France; [Mornex, Jean-Francois] Univ Lyon, Lyon, France; [Mornex, Jean-Francois] Univ Lyon 1, F-69365 Lyon, France; [Mornex, Jean-Francois] INRA, UMR S 754, Lyon, France; [Mornex, Jean-Francois] Hospices Civils Lyon, Lyon, France; [Pison, Christophe] CHU Grenoble, Clin Univ Pneumol, F-38043 Grenoble, France; [Pison, Christophe] Univ Joseph Fourier, Grenoble, France; [Pison, Christophe] Inserm U1055, Grenoble, France; [Pison, Christophe] European Inst Syst Biol & Med, Lyon, France; [Dromer, Claire] CHU Bordeaux, Bordeaux, France; [Kessler, Romain] CHU Strasbourg, F-67000 Strasbourg, France; [Dahan, Marcel] CHU Toulouse, Toulouse, France; [Brugiere, Olivier] Hop Bichat Claude Bernard, Serv Pneumol B & Transplantat Pulm, F-75877 Paris, France; [Perros, Frederic; Humbert, Marc] Univ Paris Sud, F-94275 Le Kremlin Bicetre, France; [Perros, Frederic; Humbert, Marc] Hop Bicetre, AP HP, DHU Thorax Innovat, Serv Pneumol, Le Kremlin Bicetre, France; [Perros, Frederic; Humbert, Marc] Ctr Chirurg Marie Lannelongue, LabEx LERMIT, INSERM U999, Le Plessis Robinson, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Nantes Universite; CHU de Nantes; Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Hopital Marie Lannelongue; Hospital Foch; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE; CHU Lyon; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Bordeaux; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Hopital Marie Lannelongue; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Magnan, A (corresponding author), Univ Nantes, CHU Nantes, Ctr Natl Reference Mucoviscidose Nantes Roscoff, Inst Thorax,UMR S 1087 CNRS UMR 6291, Nantes, France.	antoine.magnan@univ-nantes.fr	Reynaud-Gaubert, Martine LM/P-6958-2016; Chavanon, Olivier/AAC-8171-2019; MAGNAN, ANTOINE/GVT-4308-2022; Rolain, Jean-Marc/Y-3788-2019; Botturi, Karine/D-5255-2015; Tuna, Turgay/AAR-7130-2021; maury, jean-michel/D-7872-2018; brouard, sophie c/Q-1285-2016; Humbert, Marc/AAC-8459-2019; Perros, Frédéric/N-6921-2017; Leone, Marc/P-4835-2016; Humbert, Marc/ABD-5112-2021; Mussot, S/AAL-7512-2020; Royer, Pierre-Joseph/D-4768-2015; Mordant, Pierre/J-3603-2017; vasse, marc/B-9595-2018	Chavanon, Olivier/0000-0001-8625-691X; Rolain, Jean-Marc/0000-0002-2402-4467; Tuna, Turgay/0000-0003-1032-794X; Humbert, Marc/0000-0003-0703-2892; Perros, Frédéric/0000-0001-7730-2427; Leone, Marc/0000-0002-3097-758X; Mussot, S/0000-0002-4669-7216; Royer, Pierre-Joseph/0000-0001-5534-7982; Chesne, Julie/0000-0001-8831-4386; Danger, Richard/0000-0002-5058-795X; vasse, marc/0000-0002-8784-7209; maury, jean-michel/0000-0002-3494-3678; Mercier, Olaf/0000-0002-4760-6267; Le Pavec, Jerome/0000-0003-4426-9645	Vaincre La Mucoviscidose; Programme National Hospitalier de Recherche Clinique; CENTAURE foundation grant; Agence de la Biomedecine Francaise (ABM) grant; ESOT grant; French government [ANR-10-IBHU-005]; Nantes Metropole; Pays de la Loire Region	Vaincre La Mucoviscidose; Programme National Hospitalier de Recherche Clinique; CENTAURE foundation grant; Agence de la Biomedecine Francaise (ABM) grant; ESOT grant; French government; Nantes Metropole(Region Pays de la Loire); Pays de la Loire Region(Region Pays de la Loire)	This study was funded mainly by a grant from Vaincre La Mucoviscidose, the Programme National Hospitalier de Recherche Clinique, a CENTAURE foundation grant, an Agence de la Biomedecine Francaise (ABM) grant, and an ESOT grant. This work was realized in the context of the IHU-Cesti project thanks to French government financial support managed by the National Research Agency via the "Investment Into The Future'' program ANR-10-IBHU-005. The IHU-Cesti project is also supported by Nantes Metropole and the Pays de la Loire Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2008, MOL MED, V14, P36, DOI 10.2119/2007-00081.Adib-Conquy; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; *APPL BIOS, 1997, ABI PRISM 7700 SEQ D, V2, P11; Bahr TM, 2013, AM J RESP CELL MOL, V49, P316, DOI 10.1165/rcmb.2012-0230OC; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Bull TM, 2004, AM J RESP CRIT CARE, V170, P911, DOI 10.1164/rccm.200312-1686OC; Cai SS, 2012, J IMMUNOL, V188, P5623, DOI 10.4049/jimmunol.1200195; Cano NJM, 2004, CHEST, V126, P540, DOI 10.1378/chest.126.2.540; Chailleux E, 1996, CHEST, V109, P741, DOI 10.1378/chest.109.3.741; Chen H, 2012, J PROTEOMICS, V75, P2835, DOI 10.1016/j.jprot.2012.01.027; Chopard A, 2009, PHYSIOL GENOMICS, V38, P291, DOI 10.1152/physiolgenomics.00036.2009; Chowdhury P, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0372-4; Cohen TS, 2012, NAT MED, V18, P509, DOI 10.1038/nm.2715; de Boer Rudolf A, 2010, Curr Heart Fail Rep, V7, P1, DOI 10.1007/s11897-010-0004-x; de Theije C, 2011, CURR OPIN CLIN NUTR, V14, P548, DOI 10.1097/MCO.0b013e32834b6e79; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gaggin HK, 2013, BBA-MOL BASIS DIS, V1832, P2442, DOI 10.1016/j.bbadis.2012.12.014; Hobo A, 2009, J CLIN INVEST, V119, P1616, DOI 10.1172/JCI37249; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Iyer SS, 2012, J IMMUNOL, V188, P77, DOI 10.4049/jimmunol.1004027; Krieg AM, 2007, IMMUNOL REV, V220, P251, DOI 10.1111/j.1600-065X.2007.00572.x; Kuimelis R G, 1997, Nucleic Acids Symp Ser, P255; Le Meur N, 2004, NUCLEIC ACIDS RES, V32, P5349, DOI 10.1093/nar/gkh870; Ma J, 2012, J NEUROIMMUNE PHARM, V7, P750, DOI 10.1007/s11481-012-9367-y; Mai HL, 2014, J CLIN INVEST, V124, P1723, DOI 10.1172/JCI66287; Orfanos SE, 2000, CIRCULATION, V102, P2011; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Price LC, 2012, CHEST, V141, P210, DOI 10.1378/chest.11-0793; Qiu WL, 2006, BIOINFORMATION, V1, P251, DOI 10.6026/97320630001251; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Schermuly RT, 2011, NAT REV CARDIOL, V8, P443, DOI 10.1038/nrcardio.2011.87; Sturges NC, 2010, PEDIATR PULM, V45, P883, DOI 10.1002/ppul.21230; Taniguchi T, 2012, J RHEUMATOL, V39, P539, DOI 10.3899/jrheum.110755; Tribulatti MV, 2012, J IMMUNOL, V188, P2991, DOI 10.4049/jimmunol.1102182; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Weckbach LT, 2011, THESCIENTIFICWORLDJO, V11, P2491, DOI 10.1100/2011/517152; Xie LK, 2011, AM J PHYSIOL-CELL PH, V301, pC1161, DOI 10.1152/ajpcell.00486.2010; Yu Q, 2007, J IMMUNOL, V179, P126, DOI 10.4049/jimmunol.179.1.126	40	21	22	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e109291	10.1371/journal.pone.0109291	http://dx.doi.org/10.1371/journal.pone.0109291			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329529	Green Published, Green Submitted, gold			2022-12-27	WOS:000343942100020
J	Liu, JK; Chen, WH; Ren, SX; Zhao, GP; Wang, J				Liu, Jia-Kun; Chen, Wei-Hua; Ren, Shuang-Xi; Zhao, Guo-Ping; Wang, Jin			iBrick: A New Standard for Iterative Assembly of Biological Parts with Homing Endonucleases	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; GROUP-I INTRON; ONE-STEP; ESCHERICHIA-COLI; CLONING VECTORS; ONE-POT; DNA; GENE; STREPTOMYCES; EXPRESSION	The BioBricks standard has made the construction of DNA modules easier, quicker and cheaper. So far, over 100 BioBricks assembly schemes have been developed and many of them, including the original standard of BBF RFC 10, are now widely used. However, because the restriction endonucleases employed by these standards usually recognize short DNA sequences that are widely spread among natural DNA sequences, and these recognition sites must be removed before the parts construction, there is much inconvenience in dealing with large-size DNA parts (e.g., more than couple kilobases in length) with the present standards. Here, we introduce a new standard, namely iBrick, which uses two homing endonucleases of I-SceI and PI-PspI. Because both enzymes recognize long DNA sequences (>18 bps), their sites are extremely rare in natural DNA sources, thus providing additional convenience, especially in handling large pieces of DNA fragments. Using the iBrick standard, the carotenoid biosynthetic cluster (>4 kb) was successfully assembled and the actinorhodin biosynthetic cluster (>20 kb) was easily cloned and heterologously expressed. In addition, a corresponding nomenclature system has been established for the iBrick standard.	[Liu, Jia-Kun; Chen, Wei-Hua; Ren, Shuang-Xi; Zhao, Guo-Ping; Wang, Jin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai, Peoples R China; [Zhao, Guo-Ping] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhao, Guo-Ping] Fudan Univ, Sch Life Sci, Ctr Synthet Biol, Dept Microbiol & Microbial Engn, Shanghai 200433, Peoples R China; [Zhao, Guo-Ping] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Dis & Hlth Gen, Shanghai, Peoples R China; [Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Fudan University; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Zhao, GP (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai, Peoples R China.	gpzhao@sibs.ac.cn; cmg.wangjin@gmail.com	Wang, Jin/P-5458-2019; WANG, Jin/K-2085-2016	Wang, Jin/0000-0003-4008-9284; WANG, Jin/0000-0003-4008-9284; Zhao, Guo-Ping/0000-0002-7621-6620	National Basic Research Program of China [2012CB721102]; Natural Science Foundation for the Youth [31300095]; National Natural Science Foundation of China [31121001]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation for the Youth(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China [2012CB721102], Natural Science Foundation for the Youth [31300095] and National Natural Science Foundation of China [31121001]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon J, 2008, J BACTERIOL, V190, P7108, DOI 10.1128/JB.00855-08; [Anonymous], 2000, PRACTICAL STREPTOMYC; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Blake WJ, 2010, NUCLEIC ACIDS RES, V38, P2594, DOI 10.1093/nar/gkq123; BOOTH PM, 1994, GENE, V146, P303, DOI 10.1016/0378-1119(94)90310-7; Chen WH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt122; Chen WH, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-243; COLLEAUX L, 1988, P NATL ACAD SCI USA, V85, P6022, DOI 10.1073/pnas.85.16.6022; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2011, METHODS MOL BIOL, V729, P167, DOI 10.1007/978-1-61779-065-2_11; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Fu J, 2012, NAT BIOTECHNOL, V30, P440, DOI 10.1038/nbt.2183; Gibson DG, 2010, NAT METHODS, V7, P901, DOI 10.1038/nmeth.1515; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gust B, 2004, ADV APPL MICROBIOL, V54, P107, DOI 10.1016/S0065-2164(04)54004-2; Hunt R, 2009, METHODS MOL BIOL, V578, P23, DOI 10.1007/978-1-60327-411-1_2; Jamsai D, 2003, GENOMICS, V82, P68, DOI 10.1016/S0888-7543(03)00100-9; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Komar AA, 2007, PHARMACOGENOMICS, V8, P1075, DOI 10.2217/14622416.8.8.1075; Komar AA, 2007, SCIENCE, V315, P466, DOI 10.1126/science.1138239; Kuijpers NGA, 2013, FEMS YEAST RES, V13, P769, DOI 10.1111/1567-1364.12087; Lee TS, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-12; Lippow SM, 2009, NUCLEIC ACIDS RES, V37, P3061, DOI 10.1093/nar/gkp182; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; Mamedov TG, 2007, J BIOTECHNOL, V131, P379, DOI 10.1016/j.jbiotec.2007.08.010; Marchand Julie A, 2012, Methods Mol Biol, V852, P3, DOI 10.1007/978-1-61779-564-0_1; Marsischky G, 2004, GENOME RES, V14, P2020, DOI 10.1101/gr.2528804; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; MONTEILHET C, 1990, NUCLEIC ACIDS RES, V18, P1407, DOI 10.1093/nar/18.6.1407; Naatsaari L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039720; PLESSIS A, 1992, GENETICS, V130, P451; Rokke G, 2014, METHODS MOL BIOL, V1116, P1, DOI 10.1007/978-1-62703-764-8_1; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; TerMaat JR, 2009, J MICROBIOL METH, V79, P295, DOI 10.1016/j.mimet.2009.09.015; VIRET JF, 1993, BIOTECHNIQUES, V14, P325; Wild J, 2002, GENOME RES, V12, P1434, DOI 10.1101/gr.130502; XU MQ, 1993, CELL, V75, P1371, DOI 10.1016/0092-8674(93)90623-X; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhang L, 2011, SCI REP-UK, V1, DOI 10.1038/srep00141; Zhang L, 2010, J MOL CELL BIOL, V2, P264, DOI 10.1093/jmcb/mjq025	44	16	20	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110852	10.1371/journal.pone.0110852	http://dx.doi.org/10.1371/journal.pone.0110852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329380	Green Submitted, Green Published, gold			2022-12-27	WOS:000343942100101
J	Do, JS; Baldwin, WM; Min, B				Do, Jeong-su; Baldwin, William M., III; Min, Booki			Spontaneous Proliferation of H2M-/-CD4 T Cells Results in Unusual Acute Hepatocellular Necrosis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SINGLE MHC/PEPTIDE LIGAND; ANTIGEN PRESENTATION; THYMIC SELECTION; SCID MICE; REPERTOIRE; MHC; LYMPHOCYTES; RESPONSES; PATHWAY	Naive CD4 T cells are triggered to undergo spontaneous proliferation, a proliferative response induced in response to homeostatic stimulation, when exposed to severe lymphopenic environments. They spontaneously acquire proinflammatory effector phenotypes, playing a major role in inducing chronic inflammation in the intestine that is believed to be induced by T cell recognition of commensal antigens. While the antigens inducing the T cell responses and inflammation are being extensively investigated, the role of clonality of T cells involved in this process remains poorly understood. In this study, we utilized naive CD4 T cells isolated from B6 H2M-/- mice, in which MHCII molecules are complexed with a single CLIP molecule, and examined spontaneous proliferation and intestinal inflammation of CD4 T cells expressing limited T cell receptor repertoire diversity. We found that H2M-/- CD4 T cells undergo robust spontaneous proliferation, differentiate into IFN gamma-producing Th1 type effector cells, and, most unexpectedly, induce severe acute hepatocellular necrosis. T cell interaction with MHCII molecule on cells of hematopoietic origin was essential to induce the pathology. Interestingly, B cells are fully capable of preventing necrotic inflammation via IL-10-independent and B7-H1-dependent mechanism. This could be a useful animal model to examine T cell-mediated liver inflammation and B cell-mediated immune regulation.	[Do, Jeong-su; Baldwin, William M., III; Min, Booki] Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Min, B (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	minb@ccf.org		Do, Jeong-su/0000-0002-2375-2585	NIH [R01-AI074932]; Crohn's & Colitis Foundation of America Senior Investigator Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074932] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's & Colitis Foundation of America Senior Investigator Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by NIH grant R01-AI074932 and in part by Crohn's & Colitis Foundation of America Senior Investigator Award (B.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brimnes J, 2001, EUR J IMMUNOL, V31, P23, DOI 10.1002/1521-4141(200101)31:1<23::AID-IMMU23>3.0.CO;2-2; Cebula M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068720; Do JS, 2011, J IMMUNOL, V186, P4546, DOI 10.4049/jimmunol.1004021; Do JS, 2014, J IMMUNOL, V192, P2537, DOI 10.4049/jimmunol.1303101; Do JS, 2012, CELL IMMUNOL, V272, P117, DOI 10.1016/j.cellimm.2011.11.002; Do JS, 2009, P NATL ACAD SCI USA, V106, P20394, DOI 10.1073/pnas.0909954106; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Herkel J, 2003, HEPATOLOGY, V37, P1079, DOI 10.1053/jhep.2003.50191; HOSHINO Y, 1995, HEPATOLOGY, V22, P142, DOI 10.1002/hep.1840220123; Kusters S, 1996, GASTROENTEROLOGY, V111, P462, DOI 10.1053/gast.1996.v111.pm8690213; Lee DS, 1999, IMMUNITY, V10, P83, DOI 10.1016/S1074-7613(00)80009-6; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Ren XF, 2011, STROKE, V42, P2578, DOI 10.1161/STROKEAHA.111.613182; Surh CD, 1997, IMMUNITY, V7, P209, DOI 10.1016/S1074-7613(00)80524-5; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017	21	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110516	10.1371/journal.pone.0110516	http://dx.doi.org/10.1371/journal.pone.0110516			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313460	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500118
J	Miyamoto, Y; Mauer, AS; Kumar, S; Mott, JL; Malhi, H				Miyamoto, Yasuhiro; Mauer, Amy S.; Kumar, Swarup; Mott, Justin L.; Malhi, Harmeet			Mmu-miR-615-3p Regulates Lipoapoptosis by Inhibiting C/EBP Homologous Protein	PLOS ONE			English	Article							FATTY LIVER-DISEASE; GENE-EXPRESSION DATA; ER-STRESS; ENDOPLASMIC-RETICULUM; CELL-DEATH; NONALCOHOLIC STEATOHEPATITIS; APOPTOSIS; MICRORNA; CHOP; HEPATOCYTES	Lipoapoptosis occurring due to an excess of saturated free fatty acids such as palmitate is a key pathogenic event in the initiation of nonalcoholic fatty liver disease. Palmitate loading of cells activates the endoplasmic reticulum stress response, including induction of the proapoptotic transcription factor C/EBP homologous protein (CHOP). Furthermore, the loss of microRNAs is implicated in regulating apoptosis under conditions of endoplasmic reticulum (ER) stress. The aim of this study was to identify specific microRNAs regulating CHOP expression during palmitate-induced ER stress. Five microRNAs were repressed under palmitate-induced endoplasmic reticulum stress conditions in hepatocyte cell lines (miR-92b-3p, miR-328-3p, miR-484, miR-574-5p, and miR-615-3p). We identified miR-615-3p as a candidate microRNA which was repressed by palmitate treatment and regulated CHOP protein expression, by RNA sequencing and in silico analyses, respectively. There is a single miR-615-3p binding site in the 3' untranslated region (UTR) of the Chop transcript. We characterized this as a functional binding site using a reporter gene-based assay. Augmentation of miR-615-3p levels, using a precursor molecule, repressed CHOP expression; and under these conditions palmitate-or tunicamycin-induced cell death were significantly reduced. Our results suggest that palmitate-induced apoptosis requires maximal expression of CHOP which is achieved via the downregulation of its repressive microRNA, miR-615-3p. We speculate that enhancement of miR-615-3p levels may be of therapeutic benefit by inhibiting palmitate-induced hepatocyte lipoapoptosis.	[Miyamoto, Yasuhiro; Mauer, Amy S.; Kumar, Swarup; Malhi, Harmeet] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Mott, Justin L.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA	Mayo Clinic; University of Nebraska System; University of Nebraska Medical Center	Malhi, H (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA.	malhi.harmeet@mayo.edu		Mott, Justin/0000-0002-2927-6962; Kumar, Swarup/0000-0003-4292-3148	Nebraska Center for the Prevention of Obesity Diseases [P20GM104320, DK97178]; Mayo Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK097178, P30DK084567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104320] Funding Source: NIH RePORTER	Nebraska Center for the Prevention of Obesity Diseases; Mayo Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by the Nebraska Center for the Prevention of Obesity Diseases, grant number P20GM104320 (JLM), DK97178 (www.NIH.gov), and Mayo Foundation (www.mayo.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Alisi A, 2011, LAB INVEST, V91, P283, DOI 10.1038/labinvest.2010.166; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Behrman S, 2011, J CELL BIOL, V192, P919, DOI 10.1083/jcb.201010055; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Cazanave SC, 2011, J LIPID RES, V52, P1517, DOI 10.1194/jlr.M014654; Cazanave SC, 2010, AM J PHYSIOL-GASTR L, V299, pG236, DOI 10.1152/ajpgi.00091.2010; Charlton M, 2011, AM J PHYSIOL-GASTR L, V301, pG825, DOI 10.1152/ajpgi.00145.2011; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Chitnis NS, 2012, MOL CELL, V48, P353, DOI 10.1016/j.molcel.2012.08.025; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gaudette BT, 2014, J BIOL CHEM, V289, P23629, DOI 10.1074/jbc.M114.569376; Gupta S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.74; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu M, 2014, SCIENCE, V345, P98, DOI 10.1126/science.1254312; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Malhi H, 2007, GUT, V56, P1124, DOI 10.1136/gut.2006.118059; Malhi H, 2013, J BIOL CHEM, V288, P18624, DOI 10.1074/jbc.M112.442954; Martin M, 2011, EMBNETJOURNAL, V17; Nehra V, 2001, DIGEST DIS SCI, V46, P2347, DOI 10.1023/A:1012338828418; Pfaffenbach KT, 2010, AM J PHYSIOL-ENDOC M, V298, pE1027, DOI 10.1152/ajpendo.00642.2009; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SPIVEY JR, 1993, J CLIN INVEST, V92, P17, DOI 10.1172/JCI116546; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	37	25	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109637	10.1371/journal.pone.0109637	http://dx.doi.org/10.1371/journal.pone.0109637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314137	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500062
J	Pontes, HM; Kiraly, O; Demetrovics, Z; Griffiths, MD				Pontes, Halley M.; Kiraly, Orsolya; Demetrovics, Zsolt; Griffiths, Mark D.			The Conceptualisation and Measurement of DSM-5 Internet Gaming Disorder: The Development of the IGD-20 Test	PLOS ONE			English	Article							COMPUTER GAME; ADDICTION; SCALE; SENSITIVITY; PREVALENCE	Background: Over the last decade, there has been growing concern about 'gaming addiction' and its widely documented detrimental impacts on a minority of individuals that play excessively. The latest (fifth) edition of the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders (DSM-5) included nine criteria for the potential diagnosis of Internet Gaming Disorder (IGD) and noted that it was a condition that warranted further empirical study. Aim: The main aim of this study was to develop a valid and reliable standardised psychometrically robust tool in addition to providing empirically supported cut-off points. Methods: A sample of 1003 gamers (85.2% males; mean age 26 years) from 57 different countries were recruited via online gaming forums. Validity was assessed by confirmatory factor analysis (CFA), criterion-related validity, and concurrent validity. Latent profile analysis was also carried to distinguish disordered gamers from non-disordered gamers. Sensitivity and specificity analyses were performed to determine an empirical cut-off for the test. Results: The CFA confirmed the viability of IGD-20 Test with a six-factor structure (salience, mood modification, tolerance, withdrawal, conflict and relapse) for the assessment of IGD according to the nine criteria from DSM-5. The IGD-20 Test proved to be valid and reliable. According to the latent profile analysis, 5.3% of the total participants were classed as disordered gamers. Additionally, an optimal empirical cut-off of 71 points (out of 100) seemed to be adequate according to the sensitivity and specificity analyses carried. Conclusions: The present findings support the viability of the IGD-20 Test as an adequate standardised psychometrically robust tool for assessing internet gaming disorder. Consequently, the new instrument represents the first step towards unification and consensus in the field of gaming studies.	[Pontes, Halley M.; Griffiths, Mark D.] Nottingham Trent Univ, Psychol Div, Nottingham, England; [Pontes, Halley M.; Griffiths, Mark D.] Nottingham Trent Univ, Int Gaming Res Unit, Nottingham, England; [Kiraly, Orsolya; Demetrovics, Zsolt] Eotvos Lorand Univ, Inst Psychol, Dept Clin Psychol & Addict, Budapest, Hungary	Nottingham Trent University; Nottingham Trent University; Eotvos Lorand University	Pontes, HM (corresponding author), Nottingham Trent Univ, Psychol Div, Nottingham, England.	halley.pontes2013@ntu.ac.uk	Demetrovics, Zsolt/F-8613-2010; Griffiths, Mark D./AAY-3546-2021; Pontes, Halley M./N-6706-2019	Demetrovics, Zsolt/0000-0001-5604-7551; Griffiths, Mark D./0000-0001-8880-6524; Pontes, Halley M./0000-0001-8020-7623				ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; [Anonymous], PSYCHOL B BRIT PSYCH; Byrne B.M., 2010, STRUCTURAL EQUATION, DOI DOI 10.4324/9781410600219; Charlton JP, 2007, COMPUT HUM BEHAV, V23, P1531, DOI 10.1016/j.chb.2005.07.002; Charlton JP, 2002, BRIT J PSYCHOL, V93, P329, DOI 10.1348/000712602760146242; Cole H, 2007, CYBERPSYCHOL BEHAV, V10, P575, DOI 10.1089/cpb.2007.9988; Collins L.M., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; COMREY AL, 1988, J CONSULT CLIN PSYCH, V56, P754, DOI 10.1037/0022-006X.56.5.754; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; Demetrovics Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036417; Gentile D, 2009, PSYCHOL SCI, V20, P594, DOI 10.1111/j.1467-9280.2009.02340.x; GLAROS AG, 1988, J CLIN PSYCHOL, V44, P1013, DOI 10.1002/1097-4679(198811)44:6<1013::AID-JCLP2270440627>3.0.CO;2-Z; Griffiths M.D., 2005, J SUBST USE, V10, P191, DOI [DOI 10.1080/14659890500114359, 10.1080/14659890500114359]; Griffiths MD, 2014, NEUROPSYCHIATRY-LOND, V4, P1, DOI 10.2217/NPY.13.82; Griffiths MD, 2012, CURR PSYCHIATRY REV, V8, P308, DOI 10.2174/157340012803520414; Griffiths MD, 2012, J BEHAV ADDICT, V1, P143, DOI 10.1556/JBA.1.2012.4.1; Griffiths MD, 2004, CYBERPSYCHOL BEHAV, V7, P479, DOI 10.1089/cpb.2004.7.479; Griffiths MD, 1998, PSYCHOL REP, V82, P475, DOI 10.2466/PR0.82.2.475-480; Grusser SM, 2007, CYBERPSYCHOL BEHAV, V10, P290, DOI 10.1089/cpb.2006.9956; Haladyna TM, 1992, APPL MEAS EDUC, V5, P73, DOI DOI 10.1207/S15324818AME0501_; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hussain Z., 2009, INT J MENTAL HLTH AD, V7, P563, DOI DOI 10.1007/S11469-009-9202-8; Joinson AN, 2001, CYBERPSYCHOL BEHAV, V4, P587, DOI 10.1089/109493101753235179; King DL, 2013, CLIN PSYCHOL REV, V33, P331, DOI 10.1016/j.cpr.2013.01.002; Ko C-H, 2014, J PSYCHIAT RES; Kuss DJ, 2012, INT J MENT HEALTH AD, V10, P278, DOI 10.1007/s11469-011-9318-5; Lemmens JS, 2009, MEDIA PSYCHOL, V12, P77, DOI 10.1080/15213260802669458; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Muthen LK., 2017, MPLUS, VEight; Papay O, 2013, PSYCHOMETRIC PROPERT; Petry NM, 2014, ADDICTION, V109, P1399, DOI 10.1111/add.12457; Petry NM, 2013, ADDICTION, V108, P1186, DOI 10.1111/add.12162; Rehbein F, 2010, CYBERPSYCH BEH SOC N, V13, P269, DOI 10.1089/cyber.2009.0227; Salguero RAT, 2002, ADDICTION, V97, P1601; Suler J, 2004, CYBERPSYCHOL BEHAV, V7, P321, DOI 10.1089/1094931041291295; Thomas NJ, 2010, AUST J PSYCHOL, V62, P59, DOI 10.1080/00049530902748283; Wood R. T. A., 2007, INT J MENT HEALTH AD, V5, P151, DOI DOI 10.1007/S11469-007-9055-Y; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]	41	198	202	7	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110137	10.1371/journal.pone.0110137	http://dx.doi.org/10.1371/journal.pone.0110137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR5ZW	25313515	Green Published, Green Accepted, gold			2022-12-27	WOS:000343662500100
J	Pulmanns, N; Diele, K; Mehlig, U; Nordhaus, I				Puelmanns, Nathalie; Diele, Karen; Mehlig, Ulf; Nordhaus, Inga			Burrows of the Semi-Terrestrial Crab Ucides cordatus Enhance CO2 Release in a North Brazilian Mangrove Forest	PLOS ONE			English	Article							FIDDLER-CRAB; BENTHIC DECOMPOSITION; MARINE-SEDIMENTS; ORGANIC-MATTER; UCA SPP.; CARBON; DYNAMICS; POPULATION; ECOSYSTEMS; MINERALIZATION	Ucides cordatus is an abundant mangrove crab in Brazil constructing burrows of up to 2 m depth. Sediment around burrows may oxidize during low tides. This increase in sediment-air contact area may enhance carbon degradation processes. We hypothesized that 1) the sediment CO2 efflux rate is greater with burrows than without and 2) the reduction potential in radial profiles in the sediment surrounding the burrows decreases gradually, until approximating non-bioturbated conditions. Sampling was conducted during the North Brazilian wet season at neap tides. CO2 efflux rates of inhabited burrows and plain sediment were measured with a CO2/H2O gas analyzer connected to a respiration chamber. Sediment redox potential, pH and temperature were measured in the sediment surrounding the burrows at horizontal distances of 2, 5, 8 and 15 cm at four sediment depths (1, 10, 30 and 50 cm) and rH values were calculated. Sediment cores (50 cm length) were taken to measure the same parameters for plain sediment. CO2 efflux rates of plain sediment and individual crab burrows with entrance diameters of 7 cm were 0.7-1.3 mu mol m(-2) s(-1) and 0.2-0.4 mu mol burrows(-1) s(-1), respectively. CO2 released from a Rhizophora mangle dominated forest with an average of 1.7 U. cordatus burrows(-1) m(-2) yielded 1.0-1.7 mu mol m(-2) s(-1), depending on the month and burrow entrance diameter. Laboratory experiments revealed that 20-60% of the CO2 released by burrows originated from crab respiration. Temporal changes in the reduction potential in the sediment surrounding the burrows did not influence the CO2 release from burrows. More oxidized conditions of plain sediment over time may explain the increase in CO2 release until the end of the wet season. CO2 released by U. cordatus and their burrows may be a significant pathway of CO2 export from mangrove sediments and should be considered in mangrove carbon budget estimates.	[Puelmanns, Nathalie; Nordhaus, Inga] Leibniz Ctr Trop Marine Ecol ZMT, Dept Ecol, Bremen, Germany; [Diele, Karen] Edinburgh Napier Univ, Sch Life Sport & Social Sci, Edinburgh, Midlothian, Scotland; [Mehlig, Ulf] Fed Univ Para, Inst Estudos Costeiros, Braganca, PA, Brazil	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Edinburgh Napier University; Universidade Federal do Para	Pulmanns, N (corresponding author), Leibniz Ctr Trop Marine Ecol ZMT, Dept Ecol, Bremen, Germany.	nathalie.puelmanns@gmail.com	Mehlig, Ulf/A-2280-2013	Mehlig, Ulf/0000-0002-0142-4505; Nordhaus, Inga/0000-0003-4669-3677	Leibniz Center for Tropical Marine Ecology [6201]; MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council [HR09011]; European Commission	Leibniz Center for Tropical Marine Ecology; MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council; European Commission(European CommissionEuropean Commission Joint Research Centre)	N.P. and I.N. were funded by the Leibniz Center for Tropical Marine Ecology (project 6201, http://www.zmt-bremen.de). K.D. received funding from the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland, http://www.masts.ac.uk/) and its support is gratefully acknowledged. MASTS is funded by the Scottish Funding Council (grant reference HR09011) and contributing institutions. The European Commission funded the contributions by U.M. within this study via the international cooperation through the ''Coastal Research Network on Environmental Changes'' (CREC, http://www.forst.tudresden.de/CREC/) as part of its 7th 825 Framework Programme. The CREC project is classified as a Marie Curie Action (FP7-PEOPLE-2009-IRSES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2012, BIOGEOCHEMISTRY, V109, P151, DOI 10.1007/s10533-011-9616-9; Alongi DM, 1998, J EXP MAR BIOL ECOL, V225, P197, DOI 10.1016/S0022-0981(97)00223-2; Alongi DM, 2000, MAR ECOL PROG SER, V194, P87, DOI 10.3354/meps194087; Andreetta A, 2014, J SEA RES, V85, P524, DOI 10.1016/j.seares.2013.08.010; Araujo JMC, 2012, GEO-MAR LETT, V32, P289, DOI 10.1007/s00367-011-0268-5; Bouillon S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003052; CANFIELD DE, 1994, CHEM GEOL, V114, P315, DOI 10.1016/0009-2541(94)90061-2; Curran HA, 2003, PALAEOGEOGR PALAEOCL, V192, P229, DOI 10.1016/S0031-0182(02)00687-9; de Araujo MSLC, 2011, TROP OCEANOGR, V39, P155; Diele K, 2005, AQUAT LIVING RESOUR, V18, P169, DOI 10.1051/alr:2005018; Diele K, 2010, ECOL STUD-ANAL SYNTH, V211, P275, DOI 10.1007/978-3-642-13457-9_18; Diele K, 2000, N ZMT CONTRIBUTION; Diele K, 2010, J EXP MAR BIOL ECOL, V395, P171, DOI 10.1016/j.jembe.2010.08.029; EMMERSON WD, 1992, J EXP MAR BIOL ECOL, V157, P41, DOI 10.1016/0022-0981(92)90073-J; Ferreira TO, 2010, J SOIL SEDIMENT, V10, P995, DOI 10.1007/s11368-010-0224-4; Gribsholt B, 2003, MAR ECOL PROG SER, V259, P237, DOI 10.3354/meps259237; Heron SF, 2008, ESTUAR COAST SHELF S, V78, P135, DOI 10.1016/j.ecss.2007.11.018; KATZ LC, 1980, ESTUAR COAST MAR SCI, V11, P233, DOI 10.1016/S0302-3524(80)80043-0; Krause G, 2010, ECOL STUD-ANAL SYNTH, V211, P19, DOI 10.1007/978-3-642-13457-9_3; Krause G, 2001, ECOTROPICA, V7, P93; Kristensen E, 2005, COAST ESTUAR STUD, V60, P125; Kristensen E, 2000, HYDROBIOLOGIA, V426, P1, DOI 10.1023/A:1003980226194; Kristensen E, 2000, AQUAT MICROB ECOL, V22, P199, DOI 10.3354/ame022199; Kristensen E, 2008, MAR ECOL PROG SER, V370, P53, DOI 10.3354/meps07642; Kristensen E, 2008, J SEA RES, V59, P30, DOI 10.1016/j.seares.2007.05.004; Kristensen E, 2008, AQUAT BOT, V89, P201, DOI 10.1016/j.aquabot.2007.12.005; Kristensen E, 2012, MAR ECOL PROG SER, V446, P285, DOI 10.3354/meps09506; Lee SY, 2008, J SEA RES, V59, P16, DOI 10.1016/j.seares.2007.05.002; Lee SY, 1998, MAR FRESHWATER RES, V49, P335, DOI 10.1071/MF97179; Leopold A, 2013, GEODERMA, V202, P62, DOI 10.1016/j.geoderma.2013.03.008; LI-COR Biosciences, 2010, LI 8100 INSTR MAN RE; Lovelock CE, 2008, ECOSYSTEMS, V11, P342, DOI 10.1007/s10021-008-9125-4; Maier M, 2011, AGR FOREST METEOROL, V151, P1723, DOI 10.1016/j.agrformet.2011.07.006; Maier M, 2010, EUR J SOIL SCI, V61, P877, DOI 10.1111/j.1365-2389.2010.01287.x; Marchand C, 2004, MAR GEOL, V208, P361, DOI 10.1016/j.margeo.2004.04.015; Michaels RE, 2013, J EXP MAR BIOL ECOL, V448, P104, DOI 10.1016/j.jembe.2013.06.020; Nielsen OI, 2003, J EXP MAR BIOL ECOL, V289, P59, DOI 10.1016/S0022-0981(03)00041-8; Nordhaus I, 2006, ESTUAR COAST SHELF S, V67, P239, DOI 10.1016/j.ecss.2005.11.022; Nordhaus I, 2007, MAR BIOL, V151, P1665, DOI 10.1007/s00227-006-0597-5; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; Piou C, 2009, WETL ECOL MANAG, V17, P93, DOI 10.1007/s11273-008-9089-3; Popel F, 2000, LEHRBUCH ABWASSERTEC; R Core Team, 2012, R LANG ENV STAT COMP; REVSBECH NP, 1980, LIMNOL OCEANOGR, V25, P403, DOI 10.4319/lo.1980.25.3.0403; ROBERTSON AI, 1986, J EXP MAR BIOL ECOL, V102, P237, DOI 10.1016/0022-0981(86)90179-6; ROBERTSON AI, 1989, OECOLOGIA, V78, P191, DOI 10.1007/BF00377155; Schories D, 2003, WETL ECOL MANAG, V11, P243, DOI 10.1023/A:1025011431984; Smith NF, 2009, MAR BIOL, V156, P2255, DOI 10.1007/s00227-009-1253-7; SMITH TJ, 1991, ESTUAR COAST SHELF S, V33, P419, DOI 10.1016/0272-7714(91)90081-L; Susilo Adi, 2005, Wetlands Ecology and Management, V13, P377, DOI 10.1007/s11273-004-0164-0; Thongtham N, 2005, ESTUAR COAST SHELF S, V65, P213, DOI 10.1016/j.ecss.2005.05.014; Twilley RR, 1997, OECOLOGIA, V111, P109, DOI 10.1007/s004420050214; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xin P, 2009, ADV WATER RESOUR, V32, P439, DOI 10.1016/j.advwatres.2008.12.008; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	58	27	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109532	10.1371/journal.pone.0109532	http://dx.doi.org/10.1371/journal.pone.0109532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313661	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662500048
J	Ren, JG; Xu, YH				Ren, Jianguo; Xu, Yonghong			Modelling the Effects of Selection Temperature and Mutation on the Prisoner's Dilemma Game on a Complete Oriented Star	PLOS ONE			English	Article							SCALE-FREE NETWORKS; EVOLUTIONARY GAME; COOPERATION; DYNAMICS; STRATEGY	This paper models the prisoner's dilemma game based on pairwise comparison in finite populations on a complete oriented star (COS). First, we derive a linear system on a COS for calculating the corresponding fixation probabilities that imply dependence of the selection temperature and mutation. Then we observe and analyze the effects of two parameters on fixation probability under different population sizes. In particular, it is found through the experimental results that (1) high mutation is more sensitive to the fixation probability than the low one when population size is increasing, while the opposite is the case when the number of cooperators is increasing, and (2) selection temperature demotes the fixation probability.	[Ren, Jianguo] Jiangsu Normal Univ, Dept Comp Sci, Xuzhou, Peoples R China; [Xu, Yonghong] Jiangsu Normal Univ, Dept Live Sci, Xuzhou, Peoples R China	Jiangsu Normal University; Jiangsu Normal University	Ren, JG (corresponding author), Jiangsu Normal Univ, Dept Comp Sci, Xuzhou, Peoples R China.	rjgrjgrjgrjg@126.com			National Natural Science Foundation of China [61304117]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [13KJB520008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC))	The work is supported by the National Natural Science Foundation of China under grant no. 61304117 and the Natural Science Foundation of the Jiangsu Higher Education Institutions of China under grant no. 13KJB520008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal T, 2009, J THEOR BIOL, V257, P340, DOI 10.1016/j.jtbi.2008.11.023; BLUME LE, 1993, GAME ECON BEHAV, V5, P387, DOI 10.1006/game.1993.1023; Brewster RC, 2008, J COMB THEORY B, V98, P558, DOI 10.1016/j.jctb.2007.09.004; Chiong R, 2012, PHYSICA A, V391, P3915, DOI 10.1016/j.physa.2012.03.010; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Du WB, 2009, PHYSICA A, V388, P4509, DOI 10.1016/j.physa.2009.07.012; Fort H, 2008, PHYSICA A, V387, P1613, DOI 10.1016/j.physa.2007.11.001; Fudenberg D, 2006, J ECON THEORY, V131, P251, DOI 10.1016/j.jet.2005.04.006; Gao X, 2013, COMPUT ECON, V41, P233, DOI 10.1007/s10614-012-9320-4; Grujic J, 2010, PLOS ONE, P11; Hauert C, 2005, AM J PHYS, V73, P405, DOI 10.1119/1.1848514; Jin Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep04095; KANDORI M, 1993, ECONOMETRICA, V61, P29, DOI 10.2307/2951777; Li G, 2012, PHYSICA A, V391, P6664, DOI 10.1016/j.physa.2012.07.057; Li P, 2014, EPL-EUROPHYS LETT, V105, DOI 10.1209/0295-5075/105/48003; Lieberman E, 2005, NATURE, V433, P312, DOI 10.1038/nature03204; Miyaji K, 2013, CHAOS SOLITON FRACT, V56, P13, DOI 10.1016/j.chaos.2013.05.007; Miyaji K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071961; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Paley CJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.098103; Poncela J, 2007, NEW J PHYS, V184, P1; Shigaki K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076942; Shigaki K, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.031141; Szabo G, 1998, PHYS REV E, P58; Tanimoto J, 2007, BIOSYSTEMS, V90, P105, DOI 10.1016/j.biosystems.2006.07.005; Tanimoto J, 2010, PHYSICA A, V389, P3325, DOI 10.1016/j.physa.2010.03.020; Tarnita CE, 2009, J THEOR BIOL, V259, P570, DOI 10.1016/j.jtbi.2009.03.035; Taylor C, 2004, B MATH BIOL, V66, P1621, DOI 10.1016/j.bulm.2004.03.004; Traulsen A, 2007, J THEOR BIOL, V246, P522, DOI 10.1016/j.jtbi.2007.01.002; Wang Z, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/3/033041; Wang Z, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042145; West D.B., 1996, INTRO GRAPH THEORY	34	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e107417	10.1371/journal.pone.0107417	http://dx.doi.org/10.1371/journal.pone.0107417			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313825	Green Published, Green Submitted, gold			2022-12-27	WOS:000343662500003
J	Vu, DM; Tai, A; Tatro, JB; Karas, RH; Huber, BT; Beasley, D				Vu, Duc M.; Tai, Albert; Tatro, Jeffrey B.; Karas, Richard H.; Huber, Brigitte T.; Beasley, Debbie			gamma delta T Cells Are Prevalent in the Proximal Aorta and Drive Nascent Atherosclerotic Lesion Progression and Neutrophilia in Hypercholesterolemic Mice	PLOS ONE			English	Article							E-DEFICIENT MICE; SMOOTH-MUSCLE-CELLS; APOLIPOPROTEIN-E; INTERFERON-GAMMA; IN-VIVO; REDUCES ATHEROSCLEROSIS; ADAPTIVE IMMUNITY; GENERATION; PLAQUE; LYMPHOCYTES	Unique innate immunity-linked gamma delta T cells have been seen in early human artery lesions, but their role in lesion development has received little attention. Here we investigated whether gamma delta T cells modulate atherogenesis in apolipoprotein E-deficient (ApoE KO) mice. We found that gamma delta T cell numbers were markedly increased in the proximal aorta of ApoE-deficient vs. wildtype mice during early atherogenesis, particularly in the aortic root and arch, where they comprised most of the T cells and lesion progression is most rapid. gamma delta T cells infiltrated intimal lesions in ApoE KO mice, but only the adventitia in wild-type mice, and were more prevalent than CD4(+) T cells in early nascent lesions, as evaluated by en face confocal microscopy. These aortic gamma delta T cells produced IL-17, but not IFN-gamma, analyzed by ex vivo FACS. Furthermore, aortic arch lipid accumulation correlated strongly with abundance of IL-17-expressing splenic gamma delta T cells in individual ApoE KO mice. To investigate the role of these gamma delta T cells in early atherogenesis, we analyzed ApoE/gamma delta T double knockout (DKO) compared to ApoE KO mice. We observed reduced early intimal lipid accumulation at sites of nascent lesion formation, both in chow-fed (by 40%) and Western diet-fed (by 44%) ApoE/gamma delta T DKO mice. In addition, circulating neutrophils were drastically reduced in these DKO mice on Western diet, while expansion of inflammatory monocytes and splenic Th1 or Th17 lymphocytes was not affected. These data reveal, for the first time, a pathogenic role of gamma delta T cells in early atherogenesis in ApoE KO mice, by mechanisms likely to involve their IL-17 production and induction of neutrophilia. Targeting gamma delta T cells thus might offer therapeutic benefit in atherosclerosis or other inflammatory vascular diseases.	[Vu, Duc M.; Karas, Richard H.; Beasley, Debbie] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA; [Tai, Albert; Huber, Brigitte T.] Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, Boston, MA 02111 USA; [Tatro, Jeffrey B.] Tufts Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA USA	Tufts Medical Center; Tufts University; Tufts Medical Center	Beasley, D (corresponding author), Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA.	dbeasley@tuftsmedicalcenter.org			National Heart, Lung and Blood Institute [R01 HL47569, R01 HL113732]; National Center for Advancing Translational Sciences [CTSI UL1TR001064]; National Institute of Neurological Disorders and Stroke [P30]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001064] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047569, R21HL113732] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by R01 HL47569 (DB) and R01 HL113732 (DB) from the National Heart, Lung and Blood Institute, CTSI UL1TR001064 (BTH) from the National Center for Advancing Translational Sciences, and P30 (FRJ) from the National Institute of Neurological Disorders and Stroke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorkegren JLM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004201; Buono C, 2005, P NATL ACAD SCI USA, V102, P1596, DOI 10.1073/pnas.0409015102; Buono C, 2003, ARTERIOSCL THROM VAS, V23, P454, DOI 10.1161/01.ATV.0000059419.11002.6E; Butcher MJ, 2012, CIRC RES, V110, P675, DOI 10.1161/CIRCRESAHA.111.261784; Campbell KA, 2012, CIRC RES, V110, P889, DOI 10.1161/CIRCRESAHA.111.263186; Casetti R, 2009, J IMMUNOL, V183, P3574, DOI 10.4049/jimmunol.0901334; Chen SA, 2010, J IMMUNOL, V185, P5619, DOI 10.4049/jimmunol.1001879; Cheng HY, 2014, ATHEROSCLEROSIS, V234, P265, DOI 10.1016/j.atherosclerosis.2014.03.007; Cheng HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063746; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Danzaki K, 2012, ARTERIOSCL THROM VAS, V32, P273, DOI 10.1161/ATVBAHA.111.229997; Do JS, 2011, J IMMUNOL, V186, P4546, DOI 10.4049/jimmunol.1004021; Doring Y, 2012, CIRC RES, V110, P1052, DOI 10.1161/CIRCRESAHA.112.265868; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; Eid RE, 2009, CIRCULATION, V119, P1424, DOI 10.1161/CIRCULATIONAHA.108.827618; Elhage R, 2005, AM J PATHOL, V167, P267, DOI 10.1016/S0002-9440(10)62971-9; Elhage R, 2004, AM J PATHOL, V165, P2013, DOI 10.1016/S0002-9440(10)63252-X; Erbel C, 2009, J IMMUNOL, V183, P8167, DOI 10.4049/jimmunol.0901126; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Galkina E, 2006, J EXP MED, V203, P1273, DOI 10.1084/jem.20052205; Gao Q, 2010, J IMMUNOL, V185, P5820, DOI 10.4049/jimmunol.1000116; Gistera A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006133; Gray EE, 2013, NAT IMMUNOL, V14, P584, DOI 10.1038/ni.2585; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; Hansson GK, 2009, ARTERIOSCL THROM VAS, V29, P1714, DOI 10.1161/ATVBAHA.108.179713; Higashimori M, 2011, ARTERIOSCL THROM VAS, V31, P50, DOI 10.1161/ATVBAHA.110.210971; Houtkamp MA, 2001, J PATHOL, V193, P263, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH774>3.0.CO;2-N; Huber S, 2002, J VIROL, V76, P6487, DOI 10.1128/JVI.76.13.6487-6494.2002; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; JONASSON L, 1986, ARTERIOSCLEROSIS, V6, P131, DOI 10.1161/01.ATV.6.2.131; KLEINDIENST R, 1993, AM J PATHOL, V142, P1927; Li XY, 2011, J IMMUNOL, V186, P6693, DOI 10.4049/jimmunol.1002776; Libby P, 2013, IMMUNITY, V38, P1092, DOI 10.1016/j.immuni.2013.06.009; Lim H, 2014, IMMUNITY, V40, P153, DOI 10.1016/j.immuni.2013.11.021; Lohmann C, 2009, ATHEROSCLEROSIS, V207, P360, DOI 10.1016/j.atherosclerosis.2009.05.004; Madhur MS, 2011, ARTERIOSCL THROM VAS, V31, P1565, DOI 10.1161/ATVBAHA.111.227629; Maiellaro K, 2007, CARDIOVASC RES, V75, P640, DOI 10.1016/j.cardiores.2007.06.023; Martel C, 2013, J CLIN INVEST, V123, P1571, DOI 10.1172/JCI63685; McGillicuddy CJ, 2001, ARTERIOSCL THROM VAS, V21, P1220, DOI 10.1161/hq0701.091996; Moos MPW, 2005, ARTERIOSCL THROM VAS, V25, P2386, DOI 10.1161/01.ATV.0000187470.31662.fe; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Rosas M, 2010, J LEUKOCYTE BIOL, V88, P169, DOI 10.1189/jlb.0809548; Roselaar SE, 1996, ARTERIOSCL THROM VAS, V16, P1013, DOI 10.1161/01.ATV.16.8.1013; Schwarzenberger P, 1998, J IMMUNOL, V161, P6383; Schwarzenberger P, 2000, J IMMUNOL, V164, P4783, DOI 10.4049/jimmunol.164.9.4783; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Smith E, 2010, CIRCULATION, V121, P1746, DOI 10.1161/CIRCULATIONAHA.109.924886; Soehnlein O, 2008, BLOOD, V112, P1461, DOI 10.1182/blood-2008-02-139634; Soehnlein O, 2012, CIRC RES, V110, P875, DOI 10.1161/CIRCRESAHA.111.257535; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Taleb S, 2010, CURR OPIN LIPIDOL, V21, P404, DOI 10.1097/MOL.0b013e32833dc7f9; Taleb S, 2010, CURR OPIN PHARMACOL, V10, P197, DOI 10.1016/j.coph.2010.02.003; VanderLaan PA, 2005, J LIPID RES, V46, P829, DOI 10.1194/jlr.R500003-JLR200; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Whitman SC, 2000, AM J PATHOL, V157, P1819, DOI 10.1016/S0002-9440(10)64820-1; Whitman SC, 2002, J INTERF CYTOK RES, V22, P661, DOI 10.1089/10799900260100141; WICK G, 1995, IMMUNOL TODAY, V16, P27, DOI 10.1016/0167-5699(95)80067-0; Wick G, 1997, FASEB J, V11, P1199, DOI 10.1096/fasebj.11.13.9367355; Ye J, 2013, J IMMUNOL, V190, P2403, DOI 10.4049/jimmunol.1202369; Zernecke A, 2008, CIRC RES, V102, P209, DOI 10.1161/CIRCRESAHA.107.160697	64	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109416	10.1371/journal.pone.0109416	http://dx.doi.org/10.1371/journal.pone.0109416			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313857	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662500041
J	Wen, P; Song, D; Ye, H; Wu, XC; Jiang, L; Tang, B; Zhou, Y; Fang, L; Cao, HD; He, WC; Yang, YF; Dai, CS; Yang, JW				Wen, Ping; Song, Dan; Ye, Hong; Wu, Xiaochun; Jiang, Lei; Tang, Bing; Zhou, Yang; Fang, Li; Cao, Hongdi; He, Weichun; Yang, Yafang; Dai, Chunsun; Yang, Junwei			Circulating MiR-133a as a Biomarker Predicts Cardiac Hypertrophy in Chronic Hemodialysis Patients	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; STAGE RENAL-DISEASE; ELEVATION MYOCARDIAL-INFARCTION; MICRORNAS; ECHOCARDIOGRAPHY; MAINTENANCE; DIAGNOSIS; CANCER; DAMAGE; TRIAL	Background: MicroRNAs (miRNAs) are small ribonucleotides regulating gene expression. MicroRNAs are present in the blood in a remarkably stable form and have emerged as potential diagnostic markers in patients with cardiovascular disease. Our study aimed to assess circulating miR-133a levels in MHD patients and the relation of miR-133a to cardiac hypertrophy. Methods: We profiled miRNAs using RNA isolated from the plasma of participants. The results were validated in 64 MHD patients and 18 healthy controls. Results: Levels of plasma miR-133a decreased in MHD patients with LVH compared with those in healthy controls. Plasma miR-133a concentrations were negatively correlated with LVMI and IVS. After single hemodialytic treatment, plasma miR-133a levels remained unchanged. Cardiac Troponin I and T were not associated with LVMI and IVS. Conclusions: Our observations supplied the possibility that circulating miR-133a could be a surrogate biomarker of cardiac hypertrophy in MHD patients.	[Wen, Ping; Ye, Hong; Wu, Xiaochun; Jiang, Lei; Tang, Bing; Zhou, Yang; Fang, Li; Cao, Hongdi; He, Weichun; Dai, Chunsun; Yang, Junwei] Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, Nanjing, Jiangsu, Peoples R China; [Yang, Yafang] Nanjing Med Univ, Affiliated Hosp 2, Dept Radiol, Nanjing, Jiangsu, Peoples R China; [Song, Dan] Nanjing Med Univ, Affiliated Wuxi Hosp, Dept Nephrol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Yang, JW (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, Nanjing, Jiangsu, Peoples R China.	jwyang@njmu.edu.cn			National Science Foundation of China [31171093, 81170659]; "973" Science Program of the Ministry of Science and Technology, China [2011CB504005]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); "973" Science Program of the Ministry of Science and Technology, China	This work was supported by National Science Foundation of China Grants 31171093, "973" Science Program of the Ministry of Science and Technology, China (2011CB504005) to Junwei Yang. The author Weichun He was supported by National Science Foundation of China Grants 81170659. Junwei Yang took responsibility of the design of the study and Weichun He was in charge of the preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng YH, 2010, CLIN SCI, V119, P87, DOI 10.1042/CS20090645; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613; Eitel I, 2012, AM HEART J, V164, P706, DOI 10.1016/j.ahj.2012.08.004; Emilian C, 2012, CLIN J AM SOC NEPHRO, V7, P619, DOI 10.2215/CJN.10471011; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Gidlof O, 2011, CARDIOLOGY, V118, P217, DOI 10.1159/000328869; Jakubovic BD, 2013, CAN J CARDIOL, V29, P384, DOI 10.1016/j.cjca.2012.07.013; Levin A, 2005, AM J KIDNEY DIS, V46, P799, DOI 10.1053/j.ajkd.2005.08.007; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lorenzen JM, 2012, CLIN J AM SOC NEPHRO, V7, P1528, DOI 10.2215/CJN.01170212; Martino F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038269; Middleton RJ, 2001, J AM SOC NEPHROL, V12, P1079, DOI 10.1681/ASN.V1251079; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Petrovic D, 2008, CLIN LAB, V54, P145; SILBERBERG JS, 1989, KIDNEY INT, V36, P286, DOI 10.1038/ki.1989.192; Stewart GA, 1999, KIDNEY INT, V56, P2248, DOI 10.1046/j.1523-1755.1999.00786.x; Strand Arne H, 2007, J Clin Hypertens (Greenwich), V9, P365, DOI 10.1111/j.1524-6175.2007.06479.x; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Truong QA, 2010, J HYPERTENS, V28, P1959, DOI 10.1097/HJH.0b013e32833b49cb; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang HL, 2012, RENAL FAILURE, V34, P685, DOI 10.3109/0886022X.2012.676491; Zoccali C, 2004, KIDNEY INT, V65, P1492, DOI 10.1111/j.1523-1755.2004.00530.x	28	20	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e103079	10.1371/journal.pone.0103079	http://dx.doi.org/10.1371/journal.pone.0103079			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313674	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662500002
J	Zhang, MM; Niu, XL; Hu, JQ; Yuan, Y; Sun, SH; Wang, JX; Yu, WJ; Wang, C; Sun, DD; Wang, HC				Zhang, Mingming; Niu, Xiaolin; Hu, Jianqiang; Yuan, Yuan; Sun, Shuhong; Wang, Jiaxing; Yu, Wenjun; Wang, Chen; Sun, Dongdong; Wang, Haichang			Lin28a Protects against Hypoxia/Reoxygenation Induced Cardiomyocytes Apoptosis by Alleviating Mitochondrial Dysfunction under High Glucose/High Fat Conditions	PLOS ONE			English	Article							GAMMA COACTIVATOR 1-ALPHA; NITRIC-OXIDE SYNTHASE; MYOCARDIAL ISCHEMIA/REPERFUSION; SKELETAL-MUSCLE; HEART-DISEASE; INFLAMMATION; PREVALENCE; RECEPTOR; ADULTS; PALMITATE	Aim: The aim of the present study was to investigate the role of Lin28a in protecting against hypoxia/reoxygenation (H/R)-induced cardiomyocytes apoptosis under high glucose/high fat (HG/HF) conditions. Methods: Primary cardiomyocytes which were isolated from neonatal mouse were randomized to be treated with lentivirus carrying Lin28a siRNA, Lin28acDNA 72 h before H/R (9 h/2 h). Cardiomyocytes biomarkers release (LDH and CK), cardiomyocytes apoptosis, mitochondria biogenesis and morphology, intracellular reactive oxygen species (ROS) production, ATP content and inflammatory cytokines levels after H/R injury in high glucose/high fat conditions were compared between groups. The target proteins of Lin28a were examined by western blot analysis. Results: Our results revealed that Lin28a cDNA transfection (overexpression) significantly inhibited cardiomyocyte apoptotic index, improved mitochondria biogenesis, increased ATP production and reduced ROS production as compared with the H/R group in HG/HF conditions. Lin28a siRNA transfection (knockdown) rendered the cardiomyocytes more susceptible to H/R injury as evidenced by increased apoptotic index, impaired mitochondrial biogenesis, decreased ATP production and increased ROS level. Interestingly, these effects of Lin28a were blocked by pretreatment with the PI3K inhibitor wortmannin. Lin28a overexpression increased, while Lin28a knockdown inhibited IGF1R, Nrf-1, Tfam, p-IRS-1, p-Akt, p-mTOR, p-p70s6k, p-AMPK expression levels after H/R injury in HG/HF conditions. Moreover, pretreatment with wortmannin abolished the effects of Lin28a on the expression levels of p-AKT, p-mTOR, p-p70s6k, p-AMPK. Conclusions: The present results suggest that Lin28a inhibits cardiomyocytes apoptosis by enhancing mitochondrial biogenesis and function under high glucose/high fat conditions. The mechanism responsible for the effects of Lin28a is associated with the PI3K/Akt dependent pathway.	[Zhang, Mingming; Hu, Jianqiang; Yuan, Yuan; Wang, Jiaxing; Yu, Wenjun; Wang, Chen; Sun, Dongdong; Wang, Haichang] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Peoples R China; [Niu, Xiaolin] Fourth Mil Med Univ, Tangdu Hosp, Dept Cardiol, Xian 710032, Peoples R China; [Sun, Shuhong] Chinese Peoples Armed Police Forces, Corps Hosp, Dept Cardiol, Xian, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Sun, DD (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Peoples R China.	wintersun3@gmail.com; wanghc@fmmu.edu.cn	Zhang, Mingming/C-6005-2017	niu, xiaolin/0000-0002-8320-5516	National Nature Science Foundation of China [81270263, 81100579]; Haichang Wang [81270263]; Dongdong Sun [81100579]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Haichang Wang; Dongdong Sun	This work was supported by National Nature Science Foundation of China (No. 81270263, No. 81100579). Haichang Wang (No. 81270263) participated in study design, data collection and analysis (http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list#). Dongdong Sun (No. 81100579) participated in study design, data collection and analysis (http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list#). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Gao HK, 2008, J CARDIOVASC PHARM, V52, P286, DOI 10.1097/FJC.0b013e318186a84d; Gomes MB, 2012, DIABETES RES CLIN PR, V97, P63, DOI 10.1016/j.diabres.2012.02.008; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hu HX, 2012, CRIT CARE MED, V40, P740, DOI 10.1097/CCM.0b013e3182376e84; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kemp TM, 2005, DIABETES CARE, V28, P1490, DOI 10.2337/diacare.28.6.1490; Laing SP, 2003, DIABETOLOGIA, V46, P760, DOI 10.1007/s00125-003-1116-6; Li J, 2008, CRIT CARE MED, V36, P1551, DOI 10.1097/CCM.0b013e3181782335; Lopez N, 2007, CARDIOVASC RES, V75, P536, DOI 10.1016/j.cardiores.2007.04.025; Luo JD, 2004, CIRCULATION, V110, P2484, DOI 10.1161/01.CIR.0000137969.87365.05; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Orasanu G, 2009, J AM COLL CARDIOL, V53, pS35, DOI 10.1016/j.jacc.2008.09.055; Pan Q, 2014, THERANOSTICS, V4, P475, DOI 10.7150/thno.7729; Paradies G, 2004, CIRC RES, V94, P53, DOI 10.1161/01.RES.0000109416.56608.64; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rondelet B, 2012, EUR HEART J, V33, P1017, DOI 10.1093/eurheartj/ehr111; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Sangetha S, 2009, MICRON, V40, P439, DOI 10.1016/j.micron.2009.01.003; Sarkey JP, 2011, J MOL CELL CARDIOL, V50, P1044, DOI 10.1016/j.yjmcc.2011.03.004; Shinoda G, 2013, STEM CELLS, V31, P1563, DOI 10.1002/stem.1423; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Shyh-Chang N, 2013, CELL, V155, P778, DOI 10.1016/j.cell.2013.09.059; Si R, 2011, J MOL CELL CARDIOL, V50, P16, DOI 10.1016/j.yjmcc.2010.08.017; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Sun LJ, 2006, MITOCHONDRION, V6, P136, DOI 10.1016/j.mito.2006.04.003; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wei LP, 2010, APOPTOSIS, V15, P488, DOI 10.1007/s10495-009-0439-2; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang Y, 2010, DIABETES OBES METAB, V12, P316, DOI 10.1111/j.1463-1326.2009.01166.x; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	40	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110580	10.1371/journal.pone.0110580	http://dx.doi.org/10.1371/journal.pone.0110580			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313561	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662500119
J	Maldonado, AA; Cristobal, L; Martin-Lopez, J; Mallen, M; Garcia-Honduvilla, N; Bujan, J				Maldonado, Andres A.; Cristobal, Lara; Martin-Lopez, Javier; Mallen, Mar; Garcia-Honduvilla, Natalio; Bujan, Julia			A Novel Model of Human Skin Pressure Ulcers in Mice	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; HYPERTROPHIC SCAR; MOUSE MODEL; NUDE-MOUSE; PREVENTION; CELL; NUTRITION	Introduction: Pressure ulcers are a prevalent health problem in today's society. The shortage of suitable animal models limits our understanding and our ability to develop new therapies. This study aims to report on the development of a novel and reproducible human skin pressure ulcer model in mice. Material and Methods: Male non-obese, diabetic, severe combined immunodeficiency mice (n = 22) were engrafted with human skin. A full-thickness skin graft was placed onto 463 cm wounds created on the dorsal skin of the mice. Two groups with permanent grafts were studied after 60 days. The control group (n = 6) was focused on the process of engraftment. Evaluations were conducted with photographic assessment, histological analysis and fluorescence in situ hybridization (FISH) techniques. The pressure ulcer group (n = 12) was created using a compression device. A pressure of 150 mmHg for 8 h, with a total of three cycles of compression-release was exerted. Evaluations were conducted with photographic assessment and histological analysis. Results: Skin grafts in the control group took successfully, as shown by visual assessment, FISH techniques and histological analysis. Pressure ulcers in the second group showed full-thickness skin loss with damage and necrosis of all the epidermal and dermal layers (ulcer stage III) in all cases. Complete repair occurred after 40 days. Conclusions: An inexpensive, reproducible human skin pressure ulcer model has been developed. This novel model will facilitate the development of new clinically relevant therapeutic strategies that can be tested directly on human skin.	[Maldonado, Andres A.; Cristobal, Lara] Univ Hosp Getafe, Dept Plast & Reconstruct Surg, Madrid, Spain; [Maldonado, Andres A.; Cristobal, Lara] Univ Hosp Getafe, Burn Unit, Madrid, Spain; [Martin-Lopez, Javier] Univ Hosp Puerta de Hierro, Dept Pathol, Madrid, Spain; [Mallen, Mar] Univ Hosp Cent Def, Dept Genet, Madrid, Spain; [Garcia-Honduvilla, Natalio; Bujan, Julia] Univ Alcala, Fac Med, Dept Med Specialties, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid, Spain	Hospital Universitario de Getafe; Hospital Universitario de Getafe; Hospital Puerta de Hierro-Majadahonda; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universidad de Alcala	Maldonado, AA (corresponding author), Univ Hosp Getafe, Dept Plast & Reconstruct Surg, Madrid, Spain.	mail@andresmaldonado.es	Garcia-Honduvilla, Natalio/GLQ-5957-2022; Maldonado, Andres A./Q-8326-2019	Maldonado, Andres A./0000-0002-3703-5667; Garcia Honduvilla, Natalio/0000-0003-0904-6198; Cristobal, Lara/0000-0001-7328-4890; bujan, Julia/0000-0003-2419-2476	Fundacion MAPFRE [SA/11/AYU/444]	Fundacion MAPFRE	This study was supported by a Grant from the Fundacion MAPFRE (SA/11/AYU/444). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita S, 2012, CLIN PLAST SURG, V39, P281, DOI 10.1016/j.cps.2012.04.005; Carretero Marta, 2011, Bioeng Bugs, V2, P203, DOI 10.4161/bbug.2.4.16112; De la Garza-Rodea de AS, 2011, DERMATOLOGY, V223; Dealey C, 2009, EUROPEAN PRESSURE UL; Del Rio M, 2002, HUM GENE THER, V13, P959, DOI 10.1089/10430340252939069; Dorner B, 2009, ADV SKIN WOUND CARE, V22, P212, DOI 10.1097/01.ASW.0000350838.11854.0a; Gantwerker EA, 2012, CLIN PLAST SURG, V39, P85, DOI 10.1016/j.cps.2011.09.005; Garcia M, 2007, MOL CARCINOGEN, V46, P741, DOI 10.1002/mc.20327; Groeber F, 2012, CLIN PLAST SURG, V39, P33, DOI 10.1016/j.cps.2011.09.007; Karr Jeff, 2008, Adv Skin Wound Care, V21, P270, DOI 10.1097/01.ASW.0000323504.68401.d6; Keys KA, 2010, PLAST RECONSTR SURG, V125, P1725, DOI 10.1097/PRS.0b013e3181d51227; Kierney PC, 1998, PLAST RECONSTR SURG, V102, P765, DOI 10.1097/00006534-199809030-00022; KISCHER CW, 1989, ANAT REC, V225, P189; KISCHER CW, 1989, CONNECT TISSUE RES, V23, P279, DOI 10.3109/03008208909005627; Larson DL, 2012, PLAST RECONSTR SURG, V129, P897, DOI 10.1097/PRS.0b013e3182442197; Levine SM, 2013, ANN SURG, V257, P603, DOI 10.1097/SLA.0b013e318285516a; Lin Y, 1997, J IMMUNOL, V158, P5658; Lyder CH, 2003, JAMA-J AM MED ASSOC, V289, P223, DOI 10.1001/jama.289.2.223; Moore Z, 2008, J CLIN NURS, V17, P1963, DOI 10.1111/j.1365-2702.2008.02381.x; MURRAY AG, 1994, P NATL ACAD SCI USA, V91, P9146, DOI 10.1073/pnas.91.19.9146; Murray AG, 1998, AM J PATHOL, V153, P627, DOI 10.1016/S0002-9440(10)65604-0; Peirce SM, 2000, WOUND REPAIR REGEN, V8, P68, DOI 10.1046/j.1524-475x.2000.00068.x; Racki WJ, 2010, TRANSPLANTATION, V89, P527, DOI 10.1097/TP.0b013e3181c90242; Reid RR, 2004, J SURG RES, V116, P172, DOI 10.1016/S0022-4804(03)00227-0; Salcido R, 2007, J SPINAL CORD MED, V30, P107, DOI 10.1080/10790268.2007.11753921; SHETLAR MR, 1991, CONNECT TISSUE RES, V26, P23, DOI 10.3109/03008209109152161; Stadler I, 2004, J INVEST SURG, V17, P221, DOI 10.1080/08941930490472046; Thomas DR, 2014, NUTR CLIN PRACT, V29, P466, DOI 10.1177/0884533614539016; Thomas DR, 2010, J AM MED DIR ASSOC, V11, P397, DOI 10.1016/j.jamda.2010.03.007; Thorne C.H., 2007, GRABB SMITHS PLASTIC, P7; Tsuji S, 2005, WOUND REPAIR REGEN, V13, P209, DOI 10.1111/j.1067-1927.2005.130213.x; Waldron-Lynch F, 2012, AM J TRANSPLANT, V12, P2652, DOI 10.1111/j.1600-6143.2012.04178.x; Wang JF, 2011, WOUND REPAIR REGEN, V19, P274, DOI 10.1111/j.1524-475X.2011.00672.x; Wassermann E, 2009, WOUND REPAIR REGEN, V17, P480, DOI 10.1111/j.1524-475X.2009.00502.x; Yang DY, 2007, PLAST RECONSTR SURG, V119, P104, DOI 10.1097/01.prs.0000244828.80490.62; Yang JJ, 2013, ANAT REC, V296, P1161, DOI 10.1002/ar.22676	36	11	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109003	10.1371/journal.pone.0109003	http://dx.doi.org/10.1371/journal.pone.0109003			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310568	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210300030
J	Silva, UD; Mendes, GD; Silva, NMRM; Duarte, JL; Silva, IR; Totola, MR; Costa, MD				Silva, Ubiana de Cassia; Mendes, Gilberto de Oliveira; Silva, Nina Morena R. M.; Duarte, Josiane Leal; Silva, Ivo Ribeiro; Totola, Marcos Rogerio; Costa, Mauricio Dutra			Fluoride-Tolerant Mutants of Aspergillus niger Show Enhanced Phosphate Solubilization Capacity	PLOS ONE			English	Article							CITRIC-ACID PRODUCTION; UV-INDUCED MUTANTS; WILD-TYPE STRAIN; ROCK PHOSPHATE; MICROBIAL SOLUBILIZATION; ORGANIC-ACIDS; PLANT-GROWTH; SOIL; DISSOLUTION; MUTAGENESIS	P-solubilizing microorganisms are a promising alternative for a sustainable use of P against a backdrop of depletion of high-grade rock phosphates (RPs). Nevertheless, toxic elements present in RPs, such as fluorine, can negatively affect microbial solubilization. Thus, this study aimed at selecting Aspergillus niger mutants efficient at P solubilization in the presence of fluoride (F-). The mutants were obtained by exposition of conidia to UV light followed by screening in a medium supplemented with Ca-3(PO4)(2) and F-. The mutant FS1-555 showed the highest solubilization in the presence of F-, releasing approximately 70% of the P contained in Ca-3(PO4)(2), a value 1.7 times higher than that obtained for the wild type (WT). The mutant FS1-331 showed improved ability of solubilizing fluorapatites, increasing the solubilization of Araxa, Catalao, and Patos RPs by 1.7, 1.6, and 2.5 times that of the WT, respectively. These mutants also grew better in the presence of F-, indicating that mutagenesis allowed the acquisition of F- tolerance. Higher production of oxalic acid by FS1-331 correlated with its improved capacity for RP solubilization. This mutant represents a significant improvement and possess a high potential for application in solubilization systems with fluoride-rich phosphate sources.	[Silva, Ubiana de Cassia; Silva, Nina Morena R. M.; Duarte, Josiane Leal; Totola, Marcos Rogerio; Costa, Mauricio Dutra] Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil; [Mendes, Gilberto de Oliveira; Silva, Ivo Ribeiro] Univ Fed Vicosa, Dept Solos, Vicosa, MG, Brazil; [Mendes, Gilberto de Oliveira] Univ Fed Uberlandia, Inst Ciencias Agr, Monte Carmelo, MG, Brazil; [Silva, Ivo Ribeiro; Totola, Marcos Rogerio; Costa, Mauricio Dutra] CNPq, Conselho Nacl Desenvolvimento Cient & Tecnol, Brasilia, DF, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Uberlandia	Costa, MD (corresponding author), Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil.	mdcosta@ufv.br	de Oliveira Mendes, Gilberto/K-4781-2012; Costa, Maurício/AAV-1267-2020	de Oliveira Mendes, Gilberto/0000-0003-3900-719X; Costa, Mauricio/0000-0002-0828-4437	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [GAG-APQ-00712-12]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	Funding provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (www.cnpq.br), scholarships to UCS, NMRMS, IRS, MRT, and MDC. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) (www.capes.gov.br), scholarship to GOM. Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) (www.fapemig.br), grant GAG-APQ-00712-12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achal V, 2007, SOIL BIOL BIOCHEM, V39, P695, DOI 10.1016/j.soilbio.2006.09.003; AGRAWAL PK, 1983, ENZYME MICROB TECH, V5, P373, DOI 10.1016/0141-0229(83)90011-X; BANIK S, 1982, PLANT SOIL, V69, P353, DOI 10.1007/BF02372456; Barbier O, 2010, CHEM-BIOL INTERACT, V188, P319, DOI 10.1016/j.cbi.2010.07.011; Ben Farhat M, 2009, ARCH MICROBIOL, V191, P815, DOI 10.1007/s00203-009-0513-8; BOLAN NS, 1994, BIOL FERT SOILS, V18, P311, DOI 10.1007/BF00570634; Braga J.M., 1974, REV CERES, V21, P73; Chuang CC, 2007, BIOL FERT SOILS, V43, P575, DOI 10.1007/s00374-006-0140-3; Cue, 2000, ULLMANNS ENCY IND CH, P397; GADD GM, 1993, NEW PHYTOL, V124, P25, DOI 10.1111/j.1469-8137.1993.tb03796.x; GOLDSTEIN AH, 1993, BIO-TECHNOL, V11, P1250; Maresma BG, 2010, BRAZ J MICROBIOL, V41, P186, DOI [10.1590/S1517-83822010000100027, 10.1590/S1517-838220100001000027]; Hao XC, 2006, FOOD TECHNOL BIOTECH, V44, P89; ILLMER P, 1995, SOIL BIOL BIOCHEM, V27, P257, DOI 10.1016/0038-0717(94)00190-C; Jones DL, 1998, PLANT SOIL, V205, P25, DOI 10.1023/A:1004356007312; KPOMBLEKOUA K, 1994, SOIL SCI, V158, P442, DOI 10.1097/00010694-199415860-00006; KUBICEK CP, 1988, APPL ENVIRON MICROB, V54, P633, DOI 10.1128/AEM.54.3.633-637.1988; Lin TF, 2006, BIORESOURCE TECHNOL, V97, P957, DOI 10.1016/j.biortech.2005.02.017; Lotfy WA, 2007, BIORESOURCE TECHNOL, V98, P3464, DOI 10.1016/j.biortech.2006.11.007; Magnuson J.K., 2004, ADV FUNGAL BIOTECHNO, P307, DOI DOI 10.1007/978-1-4419-8859-1_12; Marquis RE, 2003, FEMS MICROBIOL REV, V26, P493, DOI 10.1111/j.1574-6976.2003.tb00627.x; Mendes GD, 2014, APPL ENVIRON MICROB, V80, P3081, DOI 10.1128/AEM.00241-14; Mendes GD, 2014, ANN MICROBIOL, V64, P239, DOI 10.1007/s13213-013-0656-3; Mendes GD, 2013, APPL ENVIRON MICROB, V79, P4906, DOI 10.1128/AEM.01487-13; Nautiyal CS, 1999, FEMS MICROBIOL LETT, V170, P265, DOI 10.1111/j.1574-6968.1999.tb13383.x; Nevalainen K, 2001, APPL MYCOL BIOTECHNO, V1, P289; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Razzaghe-Karim M, 1975, CR ACSC PARIS T, V280, P2645; Reyes I, 1999, FEMS MICROBIOL ECOL, V28, P291, DOI 10.1016/S0168-6496(98)00118-4; Reyes I, 2001, SOIL BIOL BIOCHEM, V33, P1741, DOI 10.1016/S0038-0717(01)00099-2; Richardson AE, 2011, PLANT PHYSIOL, V156, P989, DOI 10.1104/pp.111.175448; Schneider KD, 2010, J APPL MICROBIOL, V108, P366, DOI 10.1111/j.1365-2672.2009.04489.x; Vassilev N, 2006, PLANT SOIL, V287, P77, DOI 10.1007/s11104-006-9054-y; Vassilev N, 1995, APPL MICROBIOL BIOT, V44, P546, DOI 10.1007/BF00169958; Vassilev N, 2014, GEOMICROBIOL J, V31, P751, DOI 10.1080/01490451.2013.822615; Xiao CQ, 2013, APPL BIOCHEM BIOTECH, V169, P123, DOI 10.1007/s12010-012-9967-2	36	8	11	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e110246	10.1371/journal.pone.0110246	http://dx.doi.org/10.1371/journal.pone.0110246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310310	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210300100
J	Zhang, Y; Chen, TW; Zhang, XM; Wang, YX; Chi, XX; Li, XH; Gao, XF; Ji, YF				Zhang, Yang; Chen, Tian Wu; Zhang, Xiao Ming; Wang, Yi-Xiang; Chi, Xiao Xiao; Li, Xing Hui; Gao, Xiao Feng; Ji, Yi Fan			Abdominal Regional Fat Distribution on MRI Correlates with Cholecystolithiasis	PLOS ONE			English	Article							VISCERAL ADIPOSE-TISSUE; GALLBLADDER-DISEASE; GALLSTONE DISEASE; RISK-FACTORS; WEIGHT-LOSS; BODY-FAT; OBESITY; MEN; CANCER; CHOLELITHIASIS	Aims: To determine whether abdominal regional fat distribution pattern on MRI is correlated with cholecystolithiasis. Methods: Magnetic resonance imaging (MRI) of 163 patients with cholecystolithiasis and 163 non-cholecystolithiasis control subjects admitted to our institution between March 2011 and September 2013 were included in this cross-sectional evaluation. There were 98 women and 65 men in cholecystolithiasis group with an average age of 57616 years (range 2586 years). There were 87 women and 76 men in the control group with an average age of 41616 years (range 14-77 years). Visceral adipose tissue (VAT), abdominal subcutaneous adipose tissue (SAT) and total abdominal adipose tissue (TAT) of all the subjects at navel level were measured on abdominal MRI. According to the visceral adipose area (cut-off point VAT = 100 cm 2), study subjects were divided into 1) increased accumulation of intra-abdominal fat and 2) normal distribution of intra-abdominal fat. Logistic regression was used to assess the association of fat with the presence of cholecystolithiasis, adjusted for age and sex. Results: The incidence of increased intra-abdominal fat accumulation in the cholecystolithiasis group was significantly higher than that of the control group (P = 0.000). After adjusting for age and sex, cholecystolithiasis was associated with a one standard deviation increment in the waist circumference (WC) (OR = 1.44; 95% CI: 1.01,1.93; p = 0.00), VAT (OR = 4.26; 95% CI: 1.85,5.29; p = 0.00), VAT/SAT (OR = 8.66; 95% CI: 1.60,12.63; p = 0.00), and VAT/TAT (OR = 6.73; 95% CI: 4.24,12.18; p = 0.00), but not with fat content in the abdominal subcutaneous fat (p = 0.19). Conclusions: The visceral adipose tissue and distribution proportion of abdominal adipose tissue are correlates of cholecystolithiasis.	[Zhang, Yang; Chen, Tian Wu; Zhang, Xiao Ming; Chi, Xiao Xiao; Li, Xing Hui; Ji, Yi Fan] North Sichuan Med Coll, Affiliated Hosp, Dept Radiol, Sichuan Key Lab Med Imaging, Nanchong, Sichuan Provinc, Peoples R China; [Wang, Yi-Xiang] Chinese Univ Hong Kong, Prince Wales Hosp, Fac Med, Dept Imaging & Intervent Radiol, Hong Kong, Hong Kong, Peoples R China; [Gao, Xiao Feng] North Sichuan Med Coll, Dept Prevent Med, Nanchong, Sichuan Provinc, Peoples R China	North Sichuan Medical University; Chinese University of Hong Kong; Prince of Wales Hospital; North Sichuan Medical University	Zhang, XM (corresponding author), North Sichuan Med Coll, Affiliated Hosp, Dept Radiol, Sichuan Key Lab Med Imaging, Nanchong, Sichuan Provinc, Peoples R China.	cjr.zhxm@vip.163.com	Zhang, Xiao Ming/H-7104-2019; Wang, Yi Xiang/I-5952-2016	Zhang, Xiao Ming/0000-0001-5327-8506; Wang, Yi Xiang/0000-0001-5697-0717				Abate N, 1997, AM J CLIN NUTR, V65, P403, DOI 10.1093/ajcn/65.2.403; AMARAL JF, 1985, AM J SURG, V149, P551, DOI 10.1016/S0002-9610(85)80055-6; BORKAN GA, 1982, AM J CLIN NUTR, V36, P172, DOI 10.1093/ajcn/36.1.172; BOWEN JC, 1992, MED CLIN N AM, V76, P1143, DOI 10.1016/S0025-7125(16)30313-3; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; Cirillo DJ, 2005, JAMA-J AM MED ASSOC, V293, P330, DOI 10.1001/jama.293.3.330; Despres JP, 2001, ANN MED, V33, P534, DOI 10.3109/07853890108995963; EINARSSON K, 1985, NEW ENGL J MED, V313, P277, DOI 10.1056/NEJM198508013130501; Erlinger S, 2000, EUR J GASTROEN HEPAT, V12, P1347, DOI 10.1097/00042737-200012120-00015; Grundy SM, 2000, ENDOCRINE, V13, P155, DOI 10.1385/ENDO:13:2:155; HAFFNER SM, 1989, AM J EPIDEMIOL, V129, P587, DOI 10.1093/oxfordjournals.aje.a115171; Hou L, 2004, AM J EPIDEMIOL, V160, P860, DOI 10.1093/aje/kwh301; Jang YS, 2003, J LIPID RES, V44, P2356, DOI 10.1194/jlr.M300233-JLR200; Johansen C, 1996, GUT, V39, P439, DOI 10.1136/gut.39.3.439; Johnson LW, 2001, AM SURGEON, V67, P11; Jorgensen Torben, 2005, Ugeskr Laeger, V167, P2610; Lambou-Gianoukos S, 2008, SURG CLIN N AM, V88, P1175, DOI 10.1016/j.suc.2008.07.009; Lee JH, 2004, SURG ENDOSC, V18, DOI 10.1007/s00464-003-4514-4; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Menakuru SR, 2004, ANZ J SURG, V74, P843, DOI 10.1111/j.1445-1433.2004.03186.x; Naeem Muhammad, 2012, BMC Res Notes, V5, P334, DOI 10.1186/1756-0500-5-334; Njeze Gabriel E, 2013, Niger J Surg, V19, P49, DOI 10.4103/1117-6806.119236; Panpimanmas S, 2009, J EPIDEMIOL, V19, P116, DOI 10.2188/jea.JE20080019; PEER A, 1995, ABDOM IMAGING, V20, P452, DOI 10.1007/BF01213270; Rankinen T, 1999, INT J OBESITY, V23, P801, DOI 10.1038/sj.ijo.0800929; Ross R, 1996, J APPL PHYSIOL, V81, P2445, DOI 10.1152/jappl.1996.81.6.2445; ROSS R, 1994, AM J CLIN NUTR, V60, P695, DOI 10.1093/ajcn/60.5.695; Ross R, 1996, INT J OBESITY, V20, P533; Ruhl CE, 2001, HEPATOLOGY, V34, P877, DOI 10.1053/jhep.2001.29005; SHAFFER EA, 1977, J CLIN INVEST, V59, P828, DOI 10.1172/JCI108705; Shaffer EA, 2006, BEST PRACT RES CL GA, V20, P981, DOI 10.1016/j.bpg.2006.05.004; Shaffer Eldon A, 2005, Curr Gastroenterol Rep, V7, P132; Sjostrom L, 1988, Acta Med Scand Suppl, V723, P169; Thomas EL, 2003, INT J OBESITY, V27, P211, DOI 10.1038/sj.ijo.802229; Thomas EL, 1998, J APPL PHYSIOL, V85, P1778, DOI 10.1152/jappl.1998.85.5.1778; Tsai CJ, 2004, AM J CLIN NUTR, V80, P38; Volzke H, 2005, DIGESTION, V71, P97, DOI 10.1159/000084525; Wang Wei, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P272; Wernberg JA, 2014, SURG CLIN N AM, V94, P343, DOI 10.1016/j.suc.2014.01.009; ZAHOR Z, 1974, SCAND J GASTROENTERO, V9, P3	40	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109776	10.1371/journal.pone.0109776	http://dx.doi.org/10.1371/journal.pone.0109776			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310024	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210300073
J	Chen, W; Lin, HT; Zhong, XJ; Liu, ZC; Geng, Y; Xie, CF; Chen, WR				Chen, Wan; Lin, Haotian; Zhong, Xiaojian; Liu, Zhaochuan; Geng, Yu; Xie, Chufang; Chen, Weirong			Discrepant Expression of Cytokines in Inflammation- and Age-Related Cataract Patients	PLOS ONE			English	Article							BEHCETS-DISEASE; PRODUCTION PROFILE; UVEITIS PATIENTS; UP-REGULATION; TNF-ALPHA; CELLS; AUTOIMMUNITY; IL-6	Purpose: Inflammatory cataracts secondary to Behcet's disease (BD) or Vogt-Koyanagi-Harada disease (VKH) are thought to result from a pathological dysregulation of cytokines that is different from that of age-related (AR) cataracts. However, little is known about the function of cytokines in the development of inflammatory cataracts. The purpose of this study was to identify possible differences in cytokine expression in inflammation- and age-related cataract patients. Methods: Analysis techniques involving the concomitant use of a cocktail of antibody-coated non-magnetic beads were used to determine the cytokine expression profiles of BD, VKH and AR cataract patients. Furthermore, anterior chamber aqueous flares and inflammatory cells were quantitatively measured with a laser flare cell meter (LFCM). Results: The expressions of interleukin-2 (IL-2), IL-4, IL-6, IL-10, IL-17A, and interferon-7 (IFN-7) were analyzed in aqueous humor (AqH), phytohemagglutinin (PHA)-stimulated and non-PHA-stimulated cultures of peripheral blood mononuclear cells (PBMCs) from the three types of cataract patients. IL-6 and IFN-7 were identified above the detection limits, but, among the BD and VKH cataract patients, only the levels of IL-6 were significantly higher in both the AqH and PBMC non-PHA cultures compared with the levels observed in the AR cataract patients. In contrast, IFN-7 was significantly elevated in the AqH of the BD cataract patients compared with the VKH and AR cataract patients. In the PHA-stimulated PBMC cultures, IL-2, IFN-7, IL-6, and IL-17A were significantly increased, and the IL-6 level was significantly higher in the VKH patients than in the BD and AR cataract patients. The correlation analyses of the cytokines and inflammation indexes of the AqH obtained with the LFCM revealed that only IL-6 was significantly correlated with the inflammation index. Conclusion: Distinct expression profiles of cytokines and the correlations of these profiles with in vivo inflammatory indexes for inflammatory and AR cataract patients were identified.	[Chen, Wan; Lin, Haotian; Zhong, Xiaojian; Liu, Zhaochuan; Geng, Yu; Xie, Chufang; Chen, Weirong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Chen, WR (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	chenwr_q@aliyun.com	Chen, Wei/GZK-7348-2022; Zhong, Xiaojian/J-9727-2016	Zhong, Xiaojian/0000-0002-4201-0747	National Natural Science Foundation of China [81270980]; Guangdong Technology Programs [2009B080701017]; Pearl River Science and Technology New Star Project of Guangzhou City [2014J2200060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Technology Programs; Pearl River Science and Technology New Star Project of Guangzhou City	This study was supported by the National Natural Science Foundation of China (No. 81270980), the Guangdong Technology Programs (No. 2009B080701017) and the Pearl River Science and Technology New Star Project of Guangzhou City (2014J2200060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2011, CLIN IMMUNOL, V139, P177, DOI 10.1016/j.clim.2011.01.014; Akdeniz N, 2004, ANN ACAD MED SINGAP, V33, P596; CASPI RR, 1994, J IMMUNOL, V152, P890; Chi W, 2008, INVEST OPHTH VIS SCI, V49, P3058, DOI 10.1167/iovs.07-1390; Commodaro AG, 2010, SCAND J IMMUNOL, V72, P31, DOI 10.1111/j.1365-3083.2010.02401.x; Damico FM, 2009, ARQ BRAS OFTALMOL, V72, P413, DOI 10.1590/S0004-27492009000300028; DEBOER JH, 1992, CURR EYE RES, V11, P181, DOI 10.3109/02713689208999530; Evereklioglu C, 2002, MEDIAT INFLAMM, V11, P87, DOI 10.1080/09629350220131935; Fang W, 2008, BRIT J OPHTHALMOL, V92, P182, DOI 10.1136/bjo.2007.128967; Hamzaoui K, 2002, SCAND J RHEUMATOL, V31, P205, DOI 10.1080/030097402320318387; Hamzaoui K, 2011, MED SCI MONITOR, V17, pCR227, DOI 10.12659/MSM.881720; Imai Yumi, 2002, International Ophthalmology Clinics, V42, P25; Jager A, 2010, SCAND J IMMUNOL, V72, P173, DOI 10.1111/j.1365-3083.2010.02432.x; Li B, 2005, BRIT J OPHTHALMOL, V89, P1410, DOI 10.1136/bjo.2005.074062; Liu XL, 2009, CLIN IMMUNOL, V131, P333, DOI 10.1016/j.clim.2008.12.007; Lohmann T, 2002, DIABETES, V51, P2474, DOI 10.2337/diabetes.51.8.2474; Matsuoka K, 2004, GUT, V53, P1303, DOI 10.1136/gut.2003.024190; Misumi M, 2003, CYTOKINE, V24, P210, DOI 10.1016/j.cyto.2003.09.003; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; OSHIKA T, 1989, Nippon Ganka Gakkai Zasshi, V93, P1032; Raziuddin S, 1998, J RHEUMATOL, V25, P329; Read RW, 2001, AM J OPHTHALMOL, V131, P647, DOI 10.1016/S0002-9394(01)00925-4; ROMAGNANI S, 1995, J CLIN IMMUNOL, V15, P121, DOI 10.1007/BF01543103; SILMAN AJ, 1990, LANCET, V335, P1078; Sugita S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3824; Wang CK, 2012, INVEST OPHTH VIS SCI, V53, P4668, DOI 10.1167/iovs.12-9863; Zhou ZY, 2012, AUTOIMMUN REV, V11, P699, DOI 10.1016/j.autrev.2011.12.005	27	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109647	10.1371/journal.pone.0109647	http://dx.doi.org/10.1371/journal.pone.0109647			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303043	Green Published, Green Submitted, gold			2022-12-27	WOS:000343730400072
J	Petrovici, MA; Vogginger, B; Muller, P; Breitwieser, O; Lundqvist, M; Muller, L; Ehrlich, M; Destexhe, A; Lansner, A; Schuffny, R; Schemmel, J; Meier, K				Petrovici, Mihai A.; Vogginger, Bernhard; Mueller, Paul; Breitwieser, Oliver; Lundqvist, Mikael; Muller, Lyle; Ehrlich, Matthias; Destexhe, Alain; Lansner, Anders; Schueffny, Rene; Schemmel, Johannes; Meier, Karlheinz			Characterization and Compensation of Network-Level Anomalies in Mixed-Signal Neuromorphic Modeling Platforms	PLOS ONE			English	Article							HORIZONTAL SYNAPTIC CONNECTIONS; HIGH-CONDUCTANCE STATE; SYNCHRONOUS SPIKING; INTEGRATIVE PROPERTIES; PYRAMIDAL NEURONS; PROPAGATION; RAT; SIMULATION; CORTEX; ORGANIZATION	Advancing the size and complexity of neural network models leads to an ever increasing demand for computational resources for their simulation. Neuromorphic devices offer a number of advantages over conventional computing architectures, such as high emulation speed or low power consumption, but this usually comes at the price of reduced configurability and precision. In this article, we investigate the consequences of several such factors that are common to neuromorphic devices, more specifically limited hardware resources, limited parameter configurability and parameter variations due to fixed-pattern noise and trial-to-trial variability. Our final aim is to provide an array of methods for coping with such inevitable distortion mechanisms. As a platform for testing our proposed strategies, we use an executable system specification (ESS) of the BrainScaleS neuromorphic system, which has been designed as a universal emulation back-end for neuroscientific modeling. We address the most essential limitations of this device in detail and study their effects on three prototypical benchmark network models within a well-defined, systematic workflow. For each network model, we start by defining quantifiable functionality measures by which we then assess the effects of typical hardware-specific distortion mechanisms, both in idealized software simulations and on the ESS. For those effects that cause unacceptable deviations from the original network dynamics, we suggest generic compensation mechanisms and demonstrate their effectiveness. Both the suggested workflow and the investigated compensation mechanisms are largely back-end independent and do not require additional hardware configurability beyond the one required to emulate the benchmark networks in the first place. We hereby provide a generic methodological environment for configurable neuromorphic devices that are targeted at emulating large-scale, functional neural networks.	[Petrovici, Mihai A.; Mueller, Paul; Breitwieser, Oliver; Schemmel, Johannes; Meier, Karlheinz] Heidelberg Univ, Kirchhoff Inst Phys, Heidelberg, Germany; [Vogginger, Bernhard; Ehrlich, Matthias; Schueffny, Rene] Tech Univ Dresden, Inst Circuits & Syst, D-01062 Dresden, Germany; [Lundqvist, Mikael; Lansner, Anders] Stockholm Univ, Sch Comp Sci & Commun, Dept Computat Biol, S-10691 Stockholm, Sweden; [Lundqvist, Mikael; Lansner, Anders] Royal Inst Technol, Stockholm, Sweden; [Muller, Lyle; Destexhe, Alain] CNRS, Unite Neurosci Informat & Complex, Gif Sur Yvette, France	Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Royal Institute of Technology; Stockholm University; Royal Institute of Technology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Petrovici, MA (corresponding author), Heidelberg Univ, Kirchhoff Inst Phys, Heidelberg, Germany.	mpedro@kip.uni-heidelberg.de	; Lansner, Anders/E-4824-2016	Lundqvist, Mikael/0000-0003-1011-5234; Petrovici, Mihai Alexandru/0000-0003-2632-0427; Muller, Lyle/0000-0001-5165-9890; Schemmel, Johannes/0000-0003-1440-4375; Lansner, Anders/0000-0002-2358-7815; Destexhe, Alain/0000-0001-7405-0455	EU [269921]; Manfred Stark Foundation	EU(European Commission); Manfred Stark Foundation	This research was supported by EU grant #269921 (BrainScaleS) and the Manfred Stark Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles M, 2004, J COMPUT NEUROSCI, V17, P179, DOI 10.1023/B:JCNS.0000037682.18051.5f; Aertsen A, 1996, J PHYSIOLOGY-PARIS, V90, P243, DOI 10.1016/S0928-4257(97)81432-5; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; [Anonymous], FRONT NEUROINFORM; Berge HKO, 2007, IEEE INT SYMP CIRC S, P857, DOI 10.1109/ISCAS.2007.378041; Bergman K., 2008, EXASCALE COMPUTING S; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bill J, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00129; BONTORIN G, 2007, P 29 ANN INT C IEEE; Brette R, 2005, J NEUROPHYSIOL, V94, P3637, DOI 10.1152/jn.00686.2005; Brette R, 2007, J COMPUT NEUROSCI, V23, P349, DOI 10.1007/s10827-007-0038-6; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Bruderle D, 2009, FRONT NEUROINFORM, V3, P2009; Bruderle D, 2011, BIOL CYBERN, V104, P263, DOI 10.1007/s00422-011-0435-9; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Buxhoeveden DP, 2002, BRAIN BEHAV EVOLUT, V60, P125, DOI 10.1159/000065935; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Costas-Santos J, 2007, IEEE T CIRCUITS-I, V54, P1444, DOI 10.1109/TCSI.2007.900179; Delbruck T, 2004, VISION RES, V44, P2083, DOI 10.1016/j.visres.2004.03.021; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Destexhe A, 2006, SCIENCE, V314, P85, DOI 10.1126/science.1127241; Destexhe A, 2009, J COMPUT NEUROSCI, V27, P493, DOI 10.1007/s10827-009-0164-4; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Diesmann M, 2001, NEUROCOMPUTING, V38, P565, DOI 10.1016/S0925-2312(01)00409-X; Diesmann M, 2002, FORSCHUNG WISSCHENSC, V58, P43; Diesmann M., 2002, THESIS RUHR U BOCHUM; Djurfeldt M, 2008, IBM J RES DEV, V52, P31, DOI 10.1147/rd.521.0031; Ehrlich M., 2007, P INT C SENS CIRC IN; Ehrlich M, 2010, ARTIFICIAL NEURAL NETWORKS AND INTELLIGENT INFORMATION PROCESSING, P43; El Boustani S, 2009, NEURAL COMPUT, V21, P46, DOI 10.1162/neco.2009.02-08-710; Eppler JM, 2008, FRONT NEUROINFORM, V2; Fieres J., 2008, P 2008 INT JOINT C N; Furber S. B., 2012, IEEE T COMPUTERS, V99; Galluppi F, 2010, LECT NOTES COMPUT SC, V6443, P58, DOI 10.1007/978-3-642-17537-4_8; Giulioni M, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2011.00149; Gonzalez-Burgos G, 2000, CEREB CORTEX, V10, P82, DOI 10.1093/cercor/10.1.82; Hafliger P, 2007, IEEE T NEURAL NETWOR, V18, P551, DOI 10.1109/TNN.2006.884676; Hartmann S., 2010, Proceedings of the 2010 17th IEEE International Conference on Electronics, Circuits and Systems (ICECS 2010), P950, DOI 10.1109/ICECS.2010.5724670; Hasler J, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00118; Helias M, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00026; Hellwig B, 2000, BIOL CYBERN, V82, P111, DOI 10.1007/PL00007964; Hines M., 2003, NEURON SIMULATION EN, P769; Hines ML, 2009, FRONT NEUROINFORM; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; Indiveri G, 2006, IEEE T NEURAL NETWOR, V17, P211, DOI 10.1109/TNN.2005.860850; Indiveri G., 2011, FRONTIERS NEUROSCIEN, V5; Indiveri G, 2008, SENSORS-BASEL, V8, P5352, DOI 10.3390/s8095352; Indiveri G, 2009, COGN COMPUT, V1, P119, DOI 10.1007/s12559-008-9003-6; Kampa BM, 2006, NAT NEUROSCI, V9, P1472, DOI 10.1038/nn1798; Kremkow J, 2010, J NEUROSCI, V30, P15760, DOI 10.1523/JNEUROSCI.3874-10.2010; Kremkow J, 2010, J COMPUT NEUROSCI, V28, P579, DOI 10.1007/s10827-010-0240-9; Kumar A, 2008, NEURAL COMPUT, V20, P1, DOI 10.1162/neco.2008.20.1.1; Laing C., 2009, STOCHASTIC METHODS N; Lande T. S., 1996, Proceedings of the Fifth International Conference on Microelectronics for Neural Networks and Fuzzy Systems. MicroNeuro'96, P271, DOI 10.1109/MNNFS.1996.493802; LEWIS MA, 2000, P INT C ROB AUT; Lundqvist M, 2006, NETWORK-COMP NEURAL, V17, P253, DOI 10.1080/09548980600774619; Lundqvist M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000803; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Markram H, 1998, NEUROBIOL LEARN MEM, V70, P101, DOI 10.1006/nlme.1998.3841; McDonnell MD, 2014, P IEEE, V102, P646, DOI 10.1109/JPROC.2014.2314776; MEAD C, 1990, P IEEE, V78, P1629, DOI 10.1109/5.58356; Mead C.A., 1989, ANALOG VLSI NEURAL S; MEAD CA, 1988, NEURAL NETWORKS, V1, P91, DOI 10.1016/0893-6080(88)90024-X; MEROLLA PA, 2006, P 2006 IEEE INT S CI; Millner S, 2010, ADV NEURAL INFORM PR, V23, P1642; Mitra S, 2009, IEEE T BIOMED CIRC S, V3, P32, DOI 10.1109/TBCAS.2008.2005781; Morrison A, 2005, NEURAL COMPUT, V17, P1776, DOI 10.1162/0899766054026648; Morrison A, 2008, BIOL CYBERN, V98, P459, DOI 10.1007/s00422-008-0233-1; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Muller L, 2012, J PHYSIOL-PARIS, V106, P222, DOI 10.1016/j.jphysparis.2012.06.005; MURAKOSHI T, 1993, NEUROSCI LETT, V163, P211, DOI 10.1016/0304-3940(93)90385-X; Netter T, 2002, 2002 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-3, PROCEEDINGS, P129, DOI 10.1109/IRDS.2002.1041376; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Peters A, 1997, J NEUROCYTOL, V26, P779, DOI 10.1023/A:1018518515982; Pfeil T, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00011; Pfeil T, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00090; RENAUD S, 2007, P 2007 IEEE S CIRC S; Rieke F., 1997, SPIKES EXPLORING NEU; Rocke P, 2008, LECT NOTES COMPUT SC, V5216, P118; Roxin A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.238103; Schemmel J., 2008, P 2008 INT JOINT C N; Schemmel J., 2006, P 2006 INT JOINT C N; Schemmel J, 2007, IEEE INT SYMP CIRC S, P3367, DOI 10.1109/ISCAS.2007.378289; Schemmel J, 2010, IEEE INT SYMP CIRC S, P1947, DOI 10.1109/ISCAS.2010.5536970; Scholze S., 2010, 2010 MIXDES - 17th International Conference "Mixed Design of Integrated Circuits & Systems", P316; Scholze S, 2011, INTEGRATION VLSI J; Scholze S, 2011, FRONT NEUROSCI, V5, P1; Schrader S, 2010, FRONTIERS COMPUTATIO, V4; Serrano-Gotarredona R., 2006, ADV NEURAL INFORM PR, V18, P1217; Serrano-Gotarredona R, 2009, IEEE T NEURAL NETWOR, V20, P1417, DOI 10.1109/TNN.2009.2023653; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Telfeian AE, 2003, NEUROSCI LETT, V343, P121, DOI 10.1016/S0304-3940(03)00379-3; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Vogels TP, 2005, J NEUROSCI, V25, P10786, DOI 10.1523/JNEUROSCI.3508-05.2005; Vogelstein RJ, 2007, IEEE T NEURAL NETWOR, V18, P253, DOI 10.1109/TNN.2006.883007; Zou Q, 2006, NEUROCOMPUTING, V69, P1137, DOI 10.1016/j.neucom.2005.12.061	98	31	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108590	10.1371/journal.pone.0108590	http://dx.doi.org/10.1371/journal.pone.0108590			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303102	Green Submitted, gold, Green Published			2022-12-27	WOS:000343730400017
J	Qin, L; Wu, Y; Liu, YT; Chen, YM; Zhang, P				Qin, Liang; Wu, Yang; Liu, Youting; Chen, Yiming; Zhang, Peng			Dual Effects of Alpha-Arbutin on Monophenolase and Diphenolase Activities of Mushroom Tyrosinase	PLOS ONE			English	Article							SODIUM DODECYL-SULFATE; SUICIDE-INACTIVATION; POLYPHENOL OXIDASE; INHIBITION; MECHANISM; ACTIVATION; KINETICS; AUTOACTIVATION; OXYGENASES; CATALYSIS	The effects of alpha-arbutin on the monophenolase and diphenolase activities of mushroom tyrosinase were investigated. The results showed that alpha-arbutin inhibited monophenolase activity but it activated diphenolase activity. For monophenolase activity, IC50 value was 4.5 mmol.L-1 and 4.18 mmol.L-1 of alpha-arbutin could extend the lag time from 40.5 s to 167.3 s. Alpha-arbutin is proposed to be regarded as a triphenolic substrate by the enzyme during catalyzation, leading to the suicide inactivation of the active site of tyrosinase. For diphenolase activity, alpha-arbutin acted as an activator and its activation mechanism was mixed type activation. To reveal such activation, it should be mainly refered to the conformational changes in tyrosinase caused by the interaction of alpha-arbutin with residues located at the entrance to the active site, and the decrease of the effect of suicide inactivation.	[Qin, Liang; Wu, Yang; Liu, Youting; Chen, Yiming; Zhang, Peng] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Bioproc Key Lab, Beijing 100029, Peoples R China	Beijing University of Chemical Technology	Zhang, P (corresponding author), Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Bioproc Key Lab, Beijing 100029, Peoples R China.	zhangpengmark@163.com			Beijing Bioprocess Key Laboratory, Beijing University of Chemical Technology	Beijing Bioprocess Key Laboratory, Beijing University of Chemical Technology	The authors express our gratitude for financial support from Beijing Bioprocess Key Laboratory, Beijing University of Chemical Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASADA N, 1993, INSECT BIOCHEM MOLEC, V23, P515, DOI 10.1016/0965-1748(93)90060-6; ASIMOV I, 1950, J AM CHEM SOC, V72, P820, DOI 10.1021/ja01158a045; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burton SG, 2003, TRENDS BIOTECHNOL, V21, P543, DOI 10.1016/j.tibtech.2003.10.006; BURTON SG, 1994, CATAL TODAY, V22, P459, DOI 10.1016/0920-5861(94)80118-5; Chen QX, 2002, J AGR FOOD CHEM, V50, P4108, DOI 10.1021/jf011378z; Cooksey CJ, 1997, J BIOL CHEM, V272, P26226, DOI 10.1074/jbc.272.42.26226; Cornish-Bowden A, 1995, FUNDAMENTALS ENZYME, P203; Decker H, 2007, GENE, V398, P183, DOI 10.1016/j.gene.2007.02.051; Espin JC, 1999, J AGR FOOD CHEM, V47, P2638, DOI 10.1021/jf981055b; FUNAYAMA M, 1995, BIOSCI BIOTECH BIOCH, V59, P143, DOI 10.1271/bbb.59.143; Goldfeder M, 2013, APPL MICROBIOL BIOT, V97, P1953, DOI 10.1007/s00253-012-4050-z; Halaouli S, 2006, J APPL MICROBIOL, V100, P219, DOI 10.1111/j.1365-2672.2006.02866.x; Hernandez-Romero D, 2006, FEBS J, V273, P257, DOI 10.1111/j.1742-4658.2005.05038.x; INGRAHAM LL, 1952, J AM CHEM SOC, V74, P2623, DOI 10.1021/ja01130a047; Jimenez M, 1996, PHYTOCHEMISTRY, V42, P1503, DOI 10.1016/0031-9422(96)00175-6; Jimenez M, 2001, J AGR FOOD CHEM, V49, P4060, DOI 10.1021/jf010194h; JIMENEZCERVANTES C, 1995, BBA-GEN SUBJECTS, V1243, P421, DOI 10.1016/0304-4165(94)00169-X; JOLLEY RL, 1974, J BIOL CHEM, V249, P335; Kahn V, 1997, J AGR FOOD CHEM, V45, P4460, DOI 10.1021/jf9702858; Kanteev M, 2013, J BIOL INORG CHEM, V18, P895, DOI 10.1007/s00775-013-1034-0; Kawamura-Konishi Y, 2007, BIOSCI BIOTECH BIOCH, V71, P1752, DOI 10.1271/bbb.70171; KORNER A, 1982, SCIENCE, V217, P1163, DOI 10.1126/science.6810464; Kubo I, 1999, J AGR FOOD CHEM, V47, P4121, DOI 10.1021/jf990201q; Land EJ, 2007, TOHOKU J EXP MED, V212, P341, DOI 10.1620/tjem.212.341; Land EJ, 2003, ACCOUNTS CHEM RES, V36, P300, DOI 10.1021/ar020062p; LERCH K, 1981, MET IONS BIOL SYST, V13, P143; Munoz-Munoz JL, 2010, IUBMB LIFE, V62, P539, DOI 10.1002/iub.348; Munoz-Munoz JL, 2009, BBA-PROTEINS PROTEOM, V1794, P244, DOI 10.1016/j.bbapap.2008.10.002; MAEDA K, 1991, J SOC COSMET CHEM, V42, P361; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Mosher DB, 1983, UPDATE DERMATOLOGY G, P205; Munoz-Munoz JL, 2010, BBA-PROTEINS PROTEOM, V1804, P1467, DOI 10.1016/j.bbapap.2010.02.015; Munoz-Munoz JL, 2008, BIOCHEM J, V416, P431, DOI 10.1042/BJ20080892; NISHIMURA T, 1995, YAKUGAKU ZASSHI, V115, P626, DOI 10.1248/yakushi1947.115.8_626; Nolan LC, 2007, BIOTECHNOL LETT, V29, P1045, DOI 10.1007/s10529-007-9365-y; Priestly G. C, 1993, MOL ASPECTS DERMATOL, V3; Ramsden CA, 2010, ARKIVOC, P260, DOI 10.3998/ark.5550190.0011.107; ROBB DA, 1984, COPPER PROTEINS COPP, V2, P207; Robert C, 1997, FOOD CHEM, V59, P355, DOI 10.1016/S0308-8146(96)00179-3; ROSMARTINEZ JR, 1993, BIOCHEM J, V294, P621, DOI 10.1042/bj2940621; SANCHEZFERRER A, 1995, BBA-PROTEIN STRUCT M, V1247, P1; SEIJI M, 1978, TOHOKU J EXP MED, V125, P233, DOI 10.1620/tjem.125.233; SolerRivas C, 1997, MYCOL RES, V101, P375, DOI 10.1017/S0953756296002729; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Sugimoto K, 2003, CHEM PHARM BULL, V51, P798; Taylor SC, 2002, J AM ACAD DERMATOL, V46, pS41, DOI 10.1067/mjd.2002.120790; Tomita Y, 1977, DERMATOLOGY, V4, P245; Wang GL, 2000, FEMS MICROBIOL LETT, V185, P23, DOI 10.1111/j.1574-6968.2000.tb09035.x; Xie LP, 2003, INT J BIOCHEM CELL B, V35, P1658, DOI 10.1016/S1357-2725(03)00006-2	51	17	18	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109398	10.1371/journal.pone.0109398	http://dx.doi.org/10.1371/journal.pone.0109398			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303458	Green Published, gold, Green Submitted			2022-12-27	WOS:000343730400054
J	Su, MI; Tsai, CT; Yeh, HI; Chen, CY				Su, Min-I; Tsai, Cheng-Ting; Yeh, Hung-I; Chen, Chun-Yen			The Impact of SYNTAX Score of Non-Infarct-Related Artery on Long-Term Outcome among Patients with Acute ST Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention	PLOS ONE			English	Article							CHRONIC TOTAL OCCLUSION; PRIMARY ANGIOPLASTY; MULTIVESSEL DISEASE; CLINICAL-OUTCOMES; PROGNOSTIC IMPACT; MEDICAL THERAPY; REPERFUSION; MANAGEMENT; MORTALITY; VESSEL	Objective: We investigated the impact of the severity of stenosis in a non-infarct-related artery (IRA) on the long-term prognosis of patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Methods: Three hundred one consecutive patients (age: 59.7 +/- 13.2 years, 85.5% men) underwent primary PCI during 2009-2012. Receiver operating characteristic curve analysis found the optimal cutoff for non-IRA SYNTAX score (SS) to be 2.5. We divided the patients into two groups according to this cutoff value. Results: By multivariable analysis, non-IRA SS (>= 2.5) was an independent predictor of major adverse cardiac events (hazard ratio [HR]: 2.15, 95% confidence interval [CI]: 1.21-3.79, P = 0.008) and all-cause mortality (HR: 3.49, 95% CI: 1.13-10.8, P = 0.03). However, the prediction of cardiovascular mortality had only borderline significance (HR: 3.29, 95% CI: 0.90-12.08, P = 0.07). Conclusion: STEMI patients treated with primary PCI and moderate to severe non-IRA stenosis (SS >= 2.5) have more subsequent cardiac events. Those populations should be treated with more aggressive preventive and medical management.	[Su, Min-I; Tsai, Cheng-Ting; Yeh, Hung-I; Chen, Chun-Yen] Mackay Mem Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Yeh, Hung-I; Chen, Chun-Yen] Mackay Med Coll, New Taipei City, Taiwan	Mackay Memorial Hospital; Mackay Medical College	Chen, CY (corresponding author), Mackay Mem Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan.	mwplasma@ms9.hinet.net		Su, Min-I/0000-0002-9523-9676				Biondi-Zoccai G, 2010, AM HEART J, V160, DOI 10.1016/j.ahj.2010.10.013; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Brown AJ, 2013, ANGIOLOGY; Claessen BE, 2012, EUR HEART J, V33, P768, DOI 10.1093/eurheartj/ehr471; Claessen BEPM, 2010, HEART, V96, P1968, DOI 10.1136/hrt.2010.197673; Claessen BEPM, 2009, JACC-CARDIOVASC INTE, V2, P1128, DOI 10.1016/j.jcin.2009.08.024; DAVIES MJ, 1976, BRIT HEART J, V38, P659; Garg S, 2011, JACC-CARDIOVASC INTE, V4, P66, DOI 10.1016/j.jcin.2010.09.017; Goldstein JA, 2000, NEW ENGL J MED, V343, P915, DOI 10.1056/NEJM200009283431303; Head SJ, 2012, JACC-CARDIOVASC INTE, V5, P618, DOI 10.1016/j.jcin.2012.02.013; KAHN JK, 1990, J AM COLL CARDIOL, V16, P1089, DOI 10.1016/0735-1097(90)90537-Y; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Kornowski R, 2011, J AM COLL CARDIOL, V58, P704, DOI 10.1016/j.jacc.2011.02.071; Lemesle G, 2009, AM J CARDIOL, V103, P1189, DOI 10.1016/j.amjcard.2009.01.029; Lexis CPH, 2011, CATHETER CARDIO INTE, V77, P484, DOI 10.1002/ccd.22664; Magro M, 2011, AM HEART J, V161, P771, DOI 10.1016/j.ahj.2011.01.004; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Moreno R, 1998, REV ESP CARDIOL, V51, P547, DOI 10.1016/S0300-8932(98)74788-8; MULLER DWM, 1991, AM HEART J, V121, P1042, DOI 10.1016/0002-8703(91)90661-Z; O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84; PARISI AF, 1992, NEW ENGL J MED, V326, P10, DOI 10.1056/NEJM199201023260102; Sianos Georgios, 2005, EuroIntervention, V1, P219; Sorajja P, 2007, EUR HEART J, V28, P1709, DOI 10.1093/eurheartj/ehm184; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Schaaf RJD, 2006, HEART, V92, P1760, DOI [10.1136/hrt.2005.086058, 10.1136/hrt.2004.059675]; Vlaar PJ, 2011, J AM COLL CARDIOL, V58, P692, DOI 10.1016/j.jacc.2011.03.046; Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520; Yang CH, 2013, HEART LUNG CIRC, V22, P341, DOI 10.1016/j.hlc.2012.12.003; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109828	10.1371/journal.pone.0109828	http://dx.doi.org/10.1371/journal.pone.0109828			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303079	Green Published, gold, Green Submitted			2022-12-27	WOS:000343730400083
J	Suzuki, T; Kazuki, Y; Oshimura, M; Hara, T				Suzuki, Teruhiko; Kazuki, Yasuhiro; Oshimura, Mitsuo; Hara, Takahiko			A Novel System for Simultaneous or Sequential Integration of Multiple Gene-Loading Vectors into a Defined Site of a Human Artificial Chromosome	PLOS ONE			English	Article							HAC VECTOR; CONDITIONAL CENTROMERE; GERMLINE TRANSMISSION; EXPRESSION; RECOMBINASES; FIBROBLASTS; DELIVERY; MOUSE; CELLS	Human artificial chromosomes (HACs) are gene-delivery vectors suitable for introdLicing large DNA fragments mammalian cells. A thou h a HAC theoretically incorporates multiple gene expression cassettes of unlimited DNA size, t application has been limited because the conventional gene-loading system accepts only one gene-loading vector (GLV) into a I-IAC. We report a novel method for the simultaneous or sequential integration of multiple GLVs into a HAC vector (designated as the SIM system) via combined usage of Cre, FLP, Bxb1, and (pC31 recombinase/integrase. As a proof of principle, we first attempted simu i ltaneous ntegration of three GLVs encoding EGFP, Venus, and TdTomata into a geneloading site of a HAC in CHO cells. These cells successfully expressed all three fluorescent proteins. Furthermore, nlicrocell mediated transfer of HACs enabled the expression of those fluorescent proteins in recipient cells. We next demonstrated hat GLVs could be introduced into a HAC cane-by-one via reciprocal usage of recombinase/integrase. Lastly, we introduced a fourth GLV into a HAC after simultaneous integration of three GLVs by FLP-mediated DNA recombination. The SIM system expands the applicability of HAC vectors and is useful for various biomedical studies, including cell reporgramming.	[Suzuki, Teruhiko; Hara, Takahiko] Tokyo Metropolitan Inst Med Sci, Stem Cell Project, Setagaya Ku, Tokyo 113, Japan; [Kazuki, Yasuhiro] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Dept Biomed Sci, Yonago, Tottori, Japan; [Kazuki, Yasuhiro; Oshimura, Mitsuo] Tottori Univ, Chromosome Engn Res Ctr, Yonago, Tottori, Japan; [Hara, Takahiko] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo, Japan	Tokyo Metropolitan Institute of Medical Science; Tottori University; Tottori University; Tokyo Medical & Dental University (TMDU)	Suzuki, T (corresponding author), Tokyo Metropolitan Inst Med Sci, Stem Cell Project, Setagaya Ku, Tokyo 113, Japan.	suzuki-tr@igakuken.or.jp			Japan Society for the Promotion of Science KAKENHI [23390256, 24790696]; Grants-in-Aid for Scientific Research [24790696] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Japan Society for the Promotion of Science KAKENHI Grant numbers 23390256 (T.H.) and 24790696 (T.S.) (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008; Esposito D, 1997, NUCLEIC ACIDS RES, V25, P3605, DOI 10.1093/nar/25.18.3605; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Hiratsuka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025961; Hoshiya H, 2009, MOL THER, V17, P309, DOI 10.1038/mt.2008.253; Iida Y, 2014, ACS SYNTH BIOL, V3, P83, DOI 10.1021/sb400166j; Iida Y, 2010, DNA RES, V17, P293, DOI 10.1093/dnares/dsq020; Kakeda M, 2011, BIOCHEM BIOPH RES CO, V415, P439, DOI 10.1016/j.bbrc.2011.10.088; Kazuki Y, 2011, GENE THER, V18, P384, DOI 10.1038/gt.2010.147; Kazuki Y, 2010, MOL THER, V18, P386, DOI 10.1038/mt.2009.274; Kim JH, 2011, P NATL ACAD SCI USA, V108, P20048, DOI 10.1073/pnas.1114483108; Kitajima K, 2011, BLOOD, V117, P3748, DOI 10.1182/blood-2010-07-298596; Kouprina N, 2014, EXPERT OPIN DRUG DEL, V11, P517, DOI 10.1517/17425247.2014.882314; Kouprina N, 2012, ACS SYNTH BIOL, V1, P590, DOI 10.1021/sb3000436; Kuroiwa Y, 2002, NAT BIOTECHNOL, V20, P889, DOI 10.1038/nbt727; Kurosaki H, 2011, J HUM GENET, V56, P727, DOI 10.1038/jhg.2011.88; Miyamoto K, 2014, TRANSGENIC RES, V23, P317, DOI 10.1007/s11248-013-9772-x; Nakano M, 2008, DEV CELL, V14, P507, DOI 10.1016/j.devcel.2008.02.001; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Takiguchi M., 2012, ACS SYNTH BIOL; Thyagarajan B, 2001, MOL CELL BIOL, V21, P3926, DOI 10.1128/MCB.21.12.3926-3934.2001; Tomizuka K, 1997, NAT GENET, V16, P133, DOI 10.1038/ng0697-133; Toth A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085565; Voet T, 2001, GENOME RES, V11, P124, DOI 10.1101/gr.159901; Yamaguchi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017267; Yoshimi K, 2000, NAT BIOTECHNOL, V18, P1086, DOI 10.1038/80287	29	30	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110404	10.1371/journal.pone.0110404	http://dx.doi.org/10.1371/journal.pone.0110404			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303219	gold, Green Published, Green Submitted			2022-12-27	WOS:000343730400128
J	Szalai, B; Hoffmann, P; Prokop, S; Erdelyi, L; Varnai, P; Hunyady, L				Szalai, Bence; Hoffmann, Peter; Prokop, Susanne; Erdelyi, Laszlo; Varnai, Peter; Hunyady, Laszlo			Improved Methodical Approach for Quantitative BRET Analysis of G Protein Coupled Receptor Dimerization	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; CALCIUM-SENSING RECEPTOR; MEMBRANE MICRODOMAINS; ENDOPLASMIC-RETICULUM; ANGIOTENSIN RECEPTOR; IN-VIVO; OLIGOMERIZATION; AGONIST; AT(1); HETERODIMERS	G Protein Coupled Receptors (GPCR) can form dimers or higher ordered oligomers, the process of which can remarkably influence the physiological and pharmacological function of these receptors. Quantitative Bioluminescence Resonance Energy Transfer (qBRET) measurements are the gold standards to prove the direct physical interaction between the protomers of presumed GPCR dimers. For the correct interpretation of these experiments, the expression of the energy donor Renilla luciferase labeled receptor has to be maintained constant, which is hard to achieve in expression systems. To analyze the effects of non-constant donor expression on qBRET curves, we performed Monte Carlo simulations. Our results show that the decrease of donor expression can lead to saturation qBRET curves even if the interaction between donor and acceptor labeled receptors is non-specific leading to false interpretation of the dimerization state. We suggest here a new approach to the analysis of qBRET data, when the BRET ratio is plotted as a function of the acceptor labeled receptor expression at various donor receptor expression levels. With this method, we were able to distinguish between dimerization and non-specific interaction when the results of classical qBRET experiments were ambiguous. The simulation results were confirmed experimentally using rapamycin inducible heterodimerization system. We used this new method to investigate the dimerization of various GPCRs, and our data have confirmed the homodimerization of V-2 vasopressin and CaSR calcium sensing receptors, whereas our data argue against the heterodimerization of these receptors with other studied GPCRs, including type I and II angiotensin, beta(2) adrenergic and CB1 cannabinoid receptors.	[Szalai, Bence; Hoffmann, Peter; Prokop, Susanne; Erdelyi, Laszlo; Varnai, Peter; Hunyady, Laszlo] Semmelweis Univ, Fac Med, Dept Physiol, H-1085 Budapest, Hungary; [Szalai, Bence; Erdelyi, Laszlo; Varnai, Peter; Hunyady, Laszlo] MTA SE Lab Mol Physiol, Budapest, Hungary	Semmelweis University	Hunyady, L (corresponding author), Semmelweis Univ, Fac Med, Dept Physiol, H-1085 Budapest, Hungary.	Hunyady@eok.sote.hu		Szalai, Bence/0000-0002-9320-5704	Hungarian Scientific Research Fund OTKA [100883]	Hungarian Scientific Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the Hungarian Scientific Research Fund OTKA 100883 (LH; http://www.otka.hu/en). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/nchembio.396, 10.1038/NCHEMBIO.396]; Balla A, 2012, J BIOL CHEM, V287, P9090, DOI 10.1074/jbc.M111.293944; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Cottet M, 2010, CURR OPIN PHARMACOL, V10, P59, DOI 10.1016/j.coph.2009.10.003; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Drinovec Luka, 2012, Front Endocrinol (Lausanne), V3, P104, DOI 10.3389/fendo.2012.00104; Fallahi-Sichani M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006604; Ferre S, 2010, CURR OPIN PHARMACOL, V10, P1, DOI 10.1016/j.coph.2009.11.002; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Granier S, 2004, J BIOL CHEM, V279, P50904, DOI 10.1074/jbc.M405089200; Gyombolai P, 2013, MOL CELL ENDOCRINOL, V372, P116, DOI 10.1016/j.mce.2013.03.013; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Jensen AA, 2002, EUR J BIOCHEM, V269, P5076, DOI 10.1046/j.1432-1033.2002.03218.x; Jiang YF, 2004, J BIOL CHEM, V279, P14147, DOI 10.1074/jbc.M307422200; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Khan MA, 2010, BRIT J PHARMACOL, V159, P1039, DOI 10.1111/j.1476-5381.2009.00603.x; Kufareva Irina, 2013, Methods Mol Biol, V1013, P93, DOI 10.1007/978-1-62703-426-5_7; Loison S, 2012, J MED CHEM, V55, P8588, DOI 10.1021/jm3006146; Marullo S, 2007, TRENDS PHARMACOL SCI, V28, P362, DOI 10.1016/j.tips.2007.06.007; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Milligan G, 2013, MOL PHARMACOL, V84, P158, DOI 10.1124/mol.113.084780; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Pidasheva S, 2006, HUM MOL GENET, V15, P2200, DOI 10.1093/hmg/ddl145; Ray K, 1999, J BIOL CHEM, V274, P27642, DOI 10.1074/jbc.274.39.27642; Rivero-Muller A, 2010, P NATL ACAD SCI USA, V107, P2319, DOI 10.1073/pnas.0906695106; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; Szalai B, 2012, BIOCHEM PHARMACOL, V84, P477, DOI 10.1016/j.bcp.2012.04.014; Szidonya L, 2008, J ENDOCRINOL, V196, P435, DOI 10.1677/JOE-07-0573; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; Toke J, 2007, CLIN ENDOCRINOL, V67, P385, DOI 10.1111/j.1365-2265.2007.02896.x; Turu G, 2006, FEBS LETT, V580, P41, DOI 10.1016/j.febslet.2005.11.044; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Waldhoer M, 2005, P NATL ACAD SCI USA, V102, P9050, DOI 10.1073/pnas.0501112102; Wilson PC, 2013, J BIOL CHEM, V288, P18872, DOI 10.1074/jbc.M113.472381; Woo J, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-23; Woolf PJ, 2003, BIOPHYS CHEM, V104, P217, DOI 10.1016/S0301-4622(02)00369-1; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	38	26	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e109503	10.1371/journal.pone.0109503	http://dx.doi.org/10.1371/journal.pone.0109503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329164	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000345204100016
J	Tan, LBG; Lo, BCY; Macrae, CN				Tan, Lucy B. G.; Lo, Barbara C. Y.; Macrae, C. Neil			Brief Mindfulness Meditation Improves Mental State Attribution and Empathizing	PLOS ONE			English	Article							MIND; MECHANISMS; ATTENTION	The ability to infer and understand the mental states of others (i.e., Theory of Mind) is a cornerstone of human interaction. While considerable efforts have focused on explicating when, why and for whom this fundamental psychological ability can go awry, considerably less is known about factors that may enhance theory of mind. Accordingly, the current study explored the possibility that mindfulness-based meditation may improve people's mindreading skills. Following a 5-minute mindfulness induction, participants with no prior meditation experience completed tests that assessed mindreading and empathic understanding. The results revealed that brief mindfulness meditation enhanced both mental state attribution and empathic concern, compared to participants in the control group. These findings suggest that mindfulness may be a powerful technique for facilitating core aspects of social-cognitive functioning.	[Tan, Lucy B. G.] Univ Queensland, Sch Med, Psychiat Discipline, Brisbane, Qld, Australia; [Lo, Barbara C. Y.] Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Macrae, C. Neil] Univ Aberdeen, Sch Psychol, Aberdeen AB9 1FX, Scotland	University of Queensland; University of Hong Kong; University of Aberdeen	Tan, LBG (corresponding author), Univ Queensland, Sch Med, Psychiat Discipline, Brisbane, Qld, Australia.	lucy.tan@uq.edu.au			Australia Prime Minister's Endeavour Asia Award	Australia Prime Minister's Endeavour Asia Award(Australian GovernmentDepartment of Industry, Innovation and Science)	LBGT was supported by an Australia Prime Minister's Endeavour Asia Award. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baer Ruth A., 2009, Cognitive Behaviour Therapy, V38, P15, DOI 10.1080/16506070902980703; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Creswell JD, 2007, PSYCHOSOM MED, V69, P560, DOI 10.1097/PSY.0b013e3180f6171f; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Dekeyser M, 2008, PERS INDIV DIFFER, V44, P1235, DOI 10.1016/j.paid.2007.11.018; Farb NAS, 2007, SOC COGN AFFECT NEUR, V2, P313, DOI 10.1093/scan/nsm030; Frith CD, 2012, ANNU REV PSYCHOL, V63, P287, DOI 10.1146/annurev-psych-120710-100449; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Guastella AJ, 2010, BIOL PSYCHIAT, V67, P692, DOI 10.1016/j.biopsych.2009.09.020; HAPPE FGE, 1995, CHILD DEV, V66, P843, DOI 10.2307/1131954; Holzel BK, 2011, PERSPECT PSYCHOL SCI, V6, P537, DOI 10.1177/1745691611419671; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Ickes, 2010, EVERYDAY MIND READIN; Kabat-Zinn J, 2003, CLIN PSYCHOL-SCI PR, V10, P144, DOI 10.1093/clipsy/bpg016; Kidd DC, 2013, SCIENCE, V342, P377, DOI 10.1126/science.1239918; Mascaro JS, 2013, SOC COGN AFFECT NEUR, V8, P48, DOI 10.1093/scan/nss095; Masten CL, 2011, NEUROIMAGE, V55, P381, DOI 10.1016/j.neuroimage.2010.11.060; Mrazek MD, 2012, EMOTION, V12, P442, DOI 10.1037/a0026678; Papies EK, 2012, SOC PSYCHOL PERS SCI, V3, P291, DOI 10.1177/1948550611419031; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Siegel DJ, 2007, SOC COGN AFFECT NEUR, V2, P259, DOI 10.1093/scan/nsm034; Tan L, 2015, CHILD ADOL MENT H-UK, V20, P49, DOI 10.1111/camh.12057; Tan L, 2013, CLIN CHILD PSYCHOL P, V18, P300, DOI 10.1177/1359104512455182; Tang YY, 2009, P NATL ACAD SCI USA, V106, P8865, DOI 10.1073/pnas.0904031106; van Beest I, 2006, J PERS SOC PSYCHOL, V91, P918, DOI 10.1037/0022-3514.91.5.918; Vellante M, 2013, COGN NEUROPSYCHIATRY, V18, P326, DOI 10.1080/13546805.2012.721728; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Zeidan F, 2010, CONSCIOUS COGN, V19, P597, DOI 10.1016/j.concog.2010.03.014	32	60	60	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110510	10.1371/journal.pone.0110510	http://dx.doi.org/10.1371/journal.pone.0110510			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TF	25329321	Green Published, gold			2022-12-27	WOS:000345204100086
J	Bernardoni, JL; Sousa, LF; Wermelinger, LS; Lopes, AS; Prezoto, BC; Serrano, SMT; Zingali, RB; Moura-da-Silva, AM				Bernardoni, Juliana L.; Sousa, Leijiane F.; Wermelinger, Luciana S.; Lopes, Aline S.; Prezoto, Benedito C.; Serrano, Solange M. T.; Zingali, Russolina B.; Moura-da-Silva, Ana M.			Functional Variability of Snake Venom Metalloproteinases: Adaptive Advantages in Targeting Different Prey and Implications for Human Envenomation	PLOS ONE			English	Article							BOTHROPS-JARARACA VENOM; PROTEOMIC ANALYSIS; JARARHAGIN; EVOLUTION; INSIGHTS; RATTLESNAKE; EXPRESSION; DIVERSITY; PROTEINS; CLONING	Snake venom metalloproteinases (SVMPs) are major components in most viperid venoms that induce disturbances in the hemostatic system and tissues of animals envenomated by snakes. These disturbances are involved in human pathology of snake bites and appear to be essential for the capture and digestion of snake's prey and avoidance of predators. SVMPs are a versatile family of venom toxins acting on different hemostatic targets which are present in venoms in distinct structural forms. However, the reason why a large number of different SVMPs are expressed in some venoms is still unclear. In this study, we evaluated the interference of five isolated SVMPs in blood coagulation of humans, birds and small rodents. P-III class SVMPs (fractions Ic, IIb and IIc) possess gelatinolytic and hemorrhagic activities, and, of these, two also show fibrinolytic activity. P-I class SVMPs (fractions IVa and IVb) are only fibrinolytic. P-III class SVMPs reduced clotting time of human plasma. Fraction IIc was characterized as prothrombin activator and fraction Ic as factor X activator. In the absence of Ca2+, a firm clot was observed in chicken blood samples with fractions Ic, IIb and partially with fraction IIc. In contrast, without Ca2+, only fraction IIc was able to induce a firm clot in rat blood. In conclusion, functionally distinct forms of SVMPs were found in B. neuwiedi venom that affect distinct mechanisms in the coagulation system of humans, birds and small rodents. Distinct SVMPs appear to be more specialized to rat or chicken blood, strengthening the current hypothesis that toxin diversity enhances the possibilities of the snakes for hunting different prey or evading different predators. This functional diversity also impacts the complexity of human envenoming since different hemostatic mechanisms will be targeted by SVMPs accounting for the complexity of the response of humans to venoms.	[Bernardoni, Juliana L.; Sousa, Leijiane F.; Moura-da-Silva, Ana M.] Inst Butantan, Lab Imunopatol, Sao Paulo, Brazil; [Wermelinger, Luciana S.; Zingali, Russolina B.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Lab Hemostasia & Venenos, Rio Do Janeiro, RJ, Brazil; [Lopes, Aline S.; Serrano, Solange M. T.] Inst Butantan, Lab Especial Toxinol Aplicada, Sao Paulo, Brazil; [Prezoto, Benedito C.] Inst Butantan, Farmacol Lab, Sao Paulo, Brazil; [Wermelinger, Luciana S.] Univ Fed Rio de Janeiro, Fac Farm, Lab Fisiopatol Trombose, Rio Do Janeiro, RJ, Brazil; [Lopes, Aline S.; Serrano, Solange M. T.] FAPESP, Ctr Toxins Immune Response & Cell Signaling CeTIC, Sao Paulo, Brazil	Instituto Butantan; Universidade Federal do Rio de Janeiro; Instituto Butantan; Instituto Butantan; Universidade Federal do Rio de Janeiro; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Moura-da-Silva, AM (corresponding author), Inst Butantan, Lab Imunopatol, Sao Paulo, Brazil.	ana.moura@butantan.gov.br	Serrano, Solange/ABB-7569-2021; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; Serrano, Solange M. T./A-7132-2008; Moura-da-Silva, Ana M/A-5247-2008; Prezoto, Benedito C/A-5488-2018; da Silva, Ana/GXH-4851-2022; de Sousa, Leijiane/ABC-7626-2021; de Sousa, Leijiane Figueira/F-8735-2017	Serrano, Solange/0000-0001-8994-1904; Serrano, Solange M. T./0000-0001-8994-1904; Moura-da-Silva, Ana M/0000-0003-1787-6634; de Sousa, Leijiane/0000-0001-6303-0897; Zingali, Russolina/0000-0003-3156-6923	FAPESP [2012/16277-9, 2012/23018-0, 2013-07467-1]; CAPES [063/2010 1519/2011]; FAPERJ [E-26/110.319/2010]; CNPq [483642/2012-6, 569312010-7]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by FAPESP (2012/16277-9; 2012/23018-0; 2013-07467-1), CAPES (Edict 063/2010 1519/2011, Toxinology), FAPERJ (E-26/110.319/2010) and CNPq (grant numbers 483642/2012-6 and 569312010-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade DV, 1999, HERPETOLOGICA, V55, P200; Assakura MT, 2003, TOXICON, V41, P217, DOI 10.1016/S0041-0101(02)00279-9; Baldo C, 2008, TOXICON, V51, P54, DOI 10.1016/j.toxicon.2007.08.005; BARAMOVA EN, 1989, ARCH BIOCHEM BIOPHYS, V275, P63, DOI 10.1016/0003-9861(89)90350-0; Brust A, 2013, MOL CELL PROTEOMICS, V12, P1488, DOI [10.1074/mcp.A112.023135, 10.1074/mcp.M112.023135]; Calvete JJ, 2005, TOXICON, V45, P1063, DOI 10.1016/j.toxicon.2005.02.024; Calvete JJ, 2013, SNAKE VENOMICS INVEN; Calvete JJ, 2011, J PROTEOMICS, V74, P510, DOI 10.1016/j.jprot.2011.01.003; Calvete JJ, 2010, TOXICON, V56, P1284, DOI 10.1016/j.toxicon.2009.12.015; Campbell J. A., 2004, VENOMOUS REPTILES W; CARDOSO JLC, 1993, Q J MED, V86, P315; Casewell NR, 2014, P NATL ACAD SCI USA, V111, P9205, DOI 10.1073/pnas.1405484111; Clissa PB, 2001, TOXICON, V39, P1567, DOI 10.1016/S0041-0101(01)00131-3; Dagda RK, 2013, BIOCHEM RES INT, V2013, DOI 10.1155/2013/251474; Deshimaru M, 1996, FEBS LETT, V397, P83, DOI 10.1016/S0014-5793(96)01144-1; Diaz C, 2005, J CELL BIOCHEM, V94, P520, DOI 10.1002/jcb.20322; Fernandes CM, 2006, TOXICON, V47, P549, DOI 10.1016/j.toxicon.2006.01.009; Fox JW, 2008, FEBS J, V275, P3016, DOI 10.1111/j.1742-4658.2008.06466.x; Fry BG, 2012, TOXICON, V60, P434, DOI 10.1016/j.toxicon.2012.02.013; Gibbs HL, 2011, J PROTEOMICS, V74, P2169, DOI 10.1016/j.jprot.2011.06.013; Gibbs HL, 2009, TOXICON, V53, P672, DOI 10.1016/j.toxicon.2009.01.034; GREENE HW, 1997, SNAKES EVOLUTION MIS; JESPERSEN J, 1983, HAEMOSTASIS, V13, P301; Kamiguti AS, 1996, BIOCHEM J, V320, P635, DOI 10.1042/bj3200635; KAMIGUTI AS, 1994, THROMB HAEMOSTASIS, V72, P244; Kini RM, 2005, PATHOPHYSIOL HAEMO T, V34, P200, DOI 10.1159/000092424; Kini RM, 2001, HAEMOSTASIS, V31, P218; Laing GD, 2005, TOXICON, V45, P987, DOI 10.1016/j.toxicon.2005.02.013; Lopes DS, 2012, TOXICON, V60, P1072, DOI 10.1016/j.toxicon.2012.07.004; Mackessy SP, 2010, TOXICON, V55, P1463, DOI 10.1016/j.toxicon.2010.02.028; Gutierrez JM, 2009, TOXICON, V54, P958, DOI 10.1016/j.toxicon.2009.01.038; Martins M, 2002, BIOL PIT VIPERS, P45; Massey DJ, 2012, J PROTEOMICS, V75, P2576, DOI 10.1016/j.jprot.2012.02.035; Modesto JCD, 2005, BIOL CHEM, V386, P589, DOI 10.1515/BC.2005.069; Moura-Da-Silva AM, 2007, CURR PHARM DESIGN, V13, P2893, DOI 10.2174/138161207782023711; Moura-da-Silva AM, 2003, ARCH BIOCHEM BIOPHYS, V409, P395, DOI 10.1016/S0003-9861(02)00598-2; Moura-da-Silva AM, 2001, THROMB RES, V102, P153, DOI 10.1016/S0049-3848(01)00216-X; Moura-da-Silva AM, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-94; MOURADASILVA AM, 1991, TOXICON, V29, P713, DOI 10.1016/0041-0101(91)90063-W; MouradaSilva AM, 1996, J MOL EVOL, V43, P263, DOI 10.1007/PL00006085; Oliveira AK, 2010, THROMB HAEMOSTASIS, V104, P485, DOI 10.1160/TH09-12-0855; Leme AFP, 2012, J PROTEOME RES, V11, P279, DOI 10.1021/pr2006439; PAINE MJI, 1992, J BIOL CHEM, V267, P22869; Rodrigues RS, 2012, J PROTEOMICS, V75, P2707, DOI 10.1016/j.jprot.2012.03.028; Siigur E, 2001, GENE, V263, P199, DOI 10.1016/S0378-1119(00)00571-0; Lopes DS, 2009, TOXICON, V54, P42, DOI 10.1016/j.toxicon.2009.03.007; Sousa LF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002442; Tanjoni I, 2005, APOPTOSIS, V10, P851, DOI 10.1007/s10495-005-2945-1; THOMAS RG, 1979, TOXICON, V17, P221, DOI 10.1016/0041-0101(79)90211-3; Zelanis A, 2010, J PROTEOME RES, V9, P2278, DOI 10.1021/pr901027r	50	45	45	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109651	10.1371/journal.pone.0109651	http://dx.doi.org/10.1371/journal.pone.0109651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313513	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500064
J	Chen, J; Ma, WT; Zhang, Y; Wu, XQ; Wei, DH; Liu, GX; Deng, ZH; Yang, LQ; Zhang, ZJ				Chen, Jiu; Ma, Wentao; Zhang, Yan; Wu, Xingqu; Wei, Dunhong; Liu, Guangxiong; Deng, Zihe; Yang, Laiqi; Zhang, Zhijun			Distinct Facial Processing Related Negative Cognitive Bias in First-Episode and Recurrent Major Depression: Evidence from the N170 ERP Component	PLOS ONE			English	Article							EMOTIONAL EXPRESSION; SELECTIVE ATTENTION; ASSOCIATION; EPISODES; STIMULI; NUMBER; FACES; VULNERABILITY; MODULATION; RESPONSES	Background: States of depression are associated with increased sensitivity to negative events. For this novel study, we have assessed the relationship between the number of depressive episodes and the dysfunctional processing of emotional facial expressions. Methodology/Principal Findings: We used a visual emotional oddball paradigm to manipulate the processing of emotional information while event-related brain potentials were recorded in 45 patients with first episode major depression (F-MD), 40 patients with recurrent major depression (R-MD), and 46 healthy controls (HC). Compared with the HC group, F-MD patients had lower N170 amplitudes when identifying happy, neutral, and sad faces; R-MD patients had lower N170 amplitudes when identifying happy and neutral faces, but higher N170 amplitudes when identifying sad faces. F-MD patients had longer N170 latencies when identifying happy, neutral, and sad faces relative to the HC group, and R-MD patients had longer N170 latencies when identifying happy and neutral faces, but shorter N170 latencies when identifying sad faces compared with F-MD patients. Interestingly, a negative relationship was observed between N170 amplitude and the depressive severity score for identification of happy faces in R-MD patients while N170 amplitude was positively correlated with the depressive severity score for identification of sad faces in F-MD and R-MD patients. Additionally, the deficits of N170 amplitude for sad faces positively correlated with the number of depressive episodes in R-MD patients. Conclusion/Significance: These results provide new evidence that having more recurrent depressive episodes and serious depressive states are likely to aggravate the already abnormal processing of emotional facial expressions in patients with depression. Moreover, it further suggests that the impaired processing as indexed by N170 amplitude for positive face identification may be a potentially useful biomarker for predicting propagation of depression while N170 amplitude for negative face identification could be a potential biomarker for depression recurrence.	[Chen, Jiu; Zhang, Zhijun] Southeast Univ, Neuropsychiatr Inst, Affiliated ZhongDa Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Chen, Jiu; Zhang, Zhijun] Southeast Univ, Sch Med, Nanjing, Jiangsu, Peoples R China; [Ma, Wentao; Zhang, Yan; Wu, Xingqu; Wei, Dunhong; Liu, Guangxiong; Deng, Zihe; Yang, Laiqi] Third Hosp Peoples Liberat Army, Ctr Mental Dis Control & Prevent, Baoji, Shaanxi Provinc, Peoples R China	Southeast University - China; Southeast University - China	Zhang, ZJ (corresponding author), Southeast Univ, Neuropsychiatr Inst, Affiliated ZhongDa Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China.	yanglaiqi6666@163.com; janemengzhang@vip.163.com		Chen, Jiu/0000-0001-8185-8575	Special Research Fund for Traditional Chinese Medicine in Chinese Army [10ZYX108]; Key Program for Clinical Medicine and Science and Tochnology: Jiangsu Provence Clinical Medical Research Center [BL2013025]; National Natural Science Foundation of China [91132000]	Special Research Fund for Traditional Chinese Medicine in Chinese Army; Key Program for Clinical Medicine and Science and Tochnology: Jiangsu Provence Clinical Medical Research Center; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Special Research Fund for Traditional Chinese Medicine in Chinese Army (Grant no. 10ZYX108); the Key Program for Clinical Medicine and Science and Tochnology: Jiangsu Provence Clinical Medical Research Center (Grant no. BL2013025); the National Natural Science Foundation of China (Grant no. 91132000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; Arnone D, 2012, AM J PSYCHIAT, V169, P841, DOI 10.1176/appi.ajp.2012.11121774; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Beck A, 1979, COGNITIVE THERAPY DE; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; BLACKBURN IM, 1990, PSYCHOL MED, V20, P95, DOI 10.1017/S003329170001326X; Blau VC, 2007, BEHAV BRAIN FUNCT, V3; Bulloch A, 2014, DEPRESS ANXIETY, V31, P72, DOI 10.1002/da.22173; Caharel S, 2005, BRAIN COGNITION, V59, P96, DOI 10.1016/j.bandc.2005.05.005; Calvo MG, 2014, NEUROIMAGE, V92, P237, DOI 10.1016/j.neuroimage.2014.01.048; Campanella S, 2004, NEUROSCI LETT, V367, P14, DOI 10.1016/j.neulet.2004.05.097; Campanella S, 2012, PSYCHIAT RES, V197, P145, DOI 10.1016/j.psychres.2011.12.026; Celik C, 2010, PROG NEURO-PSYCHOPH, V34, P372, DOI 10.1016/j.pnpbp.2010.01.002; Chen J, 2013, J AFFECT DISORDERS, V150, P337, DOI 10.1016/j.jad.2013.04.015; Dai Q, 2012, CLIN NEUROPHYSIOL, V123, P2172, DOI 10.1016/j.clinph.2012.04.018; Dai Q, 2011, INT J PSYCHOPHYSIOL, V79, P249, DOI 10.1016/j.ijpsycho.2010.10.016; Demenescu LR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015058; Dietrich DE, 2000, PSYCHIAT RES, V96, P15, DOI 10.1016/S0165-1781(00)00187-6; Fossati P, 2004, J PSYCHIATR RES, V38, P137, DOI 10.1016/j.jpsychires.2003.08.002; Frodl T, 2003, BIOL PSYCHIAT, V53, P338, DOI 10.1016/S0006-3223(02)01474-9; Gotlib IH, 2000, STRESS, COPING, AND DEPRESSION, P117; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P127, DOI 10.1037/0021-843X.113.1.121; Hankin BL, 2010, J ABNORM PSYCHOL, V119, P491, DOI 10.1037/a0019609; Hietanen JK, 2013, BIOL PSYCHOL, V92, P114, DOI 10.1016/j.biopsycho.2012.10.005; Hurtado E, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-69; Ibanez A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00188; Ibanez A, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-8; Japee S, 2009, EMOTION, V9, P59, DOI 10.1037/a0014487; Joiner TE, 2000, CLIN PSYCHOL-SCI PR, V7, P203, DOI 10.1093/clipsy/7.2.203; Joormann J, 2007, J ABNORM PSYCHOL, V116, P80, DOI 10.1037/0021-843X.116.1.80; Joormann J, 2006, J ABNORM PSYCHOL, V115, P705, DOI 10.1037/0021-843X.115.4.705; Just N, 2001, CLIN PSYCHOL REV, V21, P63, DOI 10.1016/S0272-7358(99)00035-5; Karabekiroglu A, 2010, TURK PSIKIYATR DERG, V21, P280; Kim EY, 2013, PSYCHIAT INVEST, V10, P164, DOI 10.4306/pi.2013.10.2.164; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kronmuller KT, 2009, PSYCHIAT RES-NEUROIM, V174, P62, DOI 10.1016/j.pscychresns.2008.08.001; Kujawa A, 2012, J CHILD PSYCHOL PSYC, V53, P207, DOI 10.1111/j.1469-7610.2011.02461.x; Leppanen JM, 2006, CURR OPIN PSYCHIATR, V19, P34, DOI 10.1097/01.yco.0000191500.46411.00; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; Meng C, 2014, BRAIN, V137, P598, DOI 10.1093/brain/awt290; Mitchell PB, 2003, J AFFECT DISORDERS, V73, P245, DOI 10.1016/S0165-0327(01)00479-7; Nandrino JL, 2002, PSYCHOPATHOLOGY, V35, P335, DOI 10.1159/000068591; Nandrino JL, 2004, J PSYCHIAT RES, V38, P475, DOI 10.1016/j.jpsychires.2004.03.002; Roca M, 2011, COMPR PSYCHIAT, V52, P26, DOI 10.1016/j.comppsych.2010.04.011; Rossignol M, 2008, NEUROPHYSIOL CLIN, V38, P267, DOI 10.1016/j.neucli.2008.07.007; Sloan DM, 2001, J ABNORM PSYCHOL, V110, P488, DOI 10.1037//0021-843X.110.3.488; Stefanescu C, 2012, J AFFECT DISORDERS, V143, P34, DOI 10.1016/j.jad.2012.05.022; Stuhrmann A, 2013, J PSYCHIATR NEUROSCI, V38, P249, DOI 10.1503/jpn.120060; Vanderhasselt MA, 2012, J PSYCHIATR NEUROSCI, V37, P250, DOI 10.1503/jpn.110089; [王妍 Wang Yan], 2005, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V13, P396; Wronka E, 2011, PSYCHOPHYSIOLOGY, V48, P1047, DOI 10.1111/j.1469-8986.2011.01180.x; Yoon KL, 2009, J ABNORM PSYCHOL, V118, P223, DOI 10.1037/a0014658; ZHENG YP, 1988, BRIT J PSYCHIAT, V152, P660, DOI 10.1192/bjp.152.5.660; Zhong MT, 2011, CLIN NEUROPHYSIOL, V122, P1371, DOI 10.1016/j.clinph.2010.09.016	54	33	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109176	10.1371/journal.pone.0109176	http://dx.doi.org/10.1371/journal.pone.0109176			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR5ZW	25314024	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662500025
J	Denessiouk, K; Permyakov, S; Denesyuk, A; Permyakov, E; Johnson, MS				Denessiouk, Konstantin; Permyakov, Sergei; Denesyuk, Alexander; Permyakov, Eugene; Johnson, Mark S.			Two Structural Motifs within Canonical EF-Hand Calcium-Binding Domains Identify Five Different Classes of Calcium Buffers and Sensors	PLOS ONE			English	Article							CARDIAC TROPONIN-C; CRYSTAL-STRUCTURE; REGULATORY DOMAIN; ATOMIC-RESOLUTION; CA2+ BINDING; N-DOMAIN; PROTEIN; CALMODULIN; DIVERSITY; SUBSTITUTIONS	Proteins with EF-hand calcium-binding motifs are essential for many cellular processes, but are also associated with cancer, autism, cardiac arrhythmias, and Alzheimer's, skeletal muscle and neuronal diseases. Functionally, all EF-hand proteins are divided into two groups: (1) calcium sensors, which function to translate the signal to various responses; and (2) calcium buffers, which control the level of free Ca2+ ions in the cytoplasm. The borderline between the two groups is not clear, and many proteins cannot be described as definitive buffers or sensors. Here, we describe two highly-conserved structural motifs found in all known different families of the EF-hand proteins. The two motifs provide a supporting scaffold for the DxDxDG calcium binding loop and contribute to the hydrophobic core of the EF hand domain. The motifs allow more precise identification of calcium buffers and calcium sensors. Based on the characteristics of the two motifs, we could classify individual EF-hand domains into five groups: (1) Open static; (2) Closed static; (3) Local dynamic; (4) Dynamic; and (5) Local static EF-hand domains.	[Denessiouk, Konstantin; Denesyuk, Alexander; Johnson, Mark S.] Abo Akad Univ, Dept Biosci, Turku, Finland; [Permyakov, Sergei; Permyakov, Eugene] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142292, Russia	Abo Akademi University; Russian Academy of Sciences	Denessiouk, K (corresponding author), Abo Akad Univ, Dept Biosci, Turku, Finland.	kdenessi@abo.fi	Permyakov, Sergei/O-1386-2019; Permyakov, Sergei E./B-8156-2011; Permyakov, Eugene A./M-8707-2014	Permyakov, Sergei/0000-0003-4086-3137; Permyakov, Sergei E./0000-0003-4086-3137; Permyakov, Eugene A./0000-0002-9099-1148	Stiftelsens for Abo Akademi Forskningsinstitut; Abo Akademi University Center of Excellence Program in Cell Stress and Aging; Sigrid Juselius Foundation; Joe, Pentti and Tor Borg Memorial Fund; Academy of Finland (Bioinformatics Infrastructure Program of Biocenter Finland and FIRI program); Molecular and Cellular Biology Program of the Russian Academy of Sciences	Stiftelsens for Abo Akademi Forskningsinstitut; Abo Akademi University Center of Excellence Program in Cell Stress and Aging; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Joe, Pentti and Tor Borg Memorial Fund; Academy of Finland (Bioinformatics Infrastructure Program of Biocenter Finland and FIRI program); Molecular and Cellular Biology Program of the Russian Academy of Sciences(Russian Academy of Sciences)	This work was supported in part by grants from the Stiftelsens for Abo Akademi Forskningsinstitut, Abo Akademi University Center of Excellence Program in Cell Stress and Aging, the Sigrid Juselius Foundation, the Joe, Pentti and Tor Borg Memorial Fund, the Academy of Finland (Bioinformatics Infrastructure Program of Biocenter Finland and FIRI program), and by a grant from the Molecular and Cellular Biology Program of the Russian Academy of Sciences (EP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Andersson M, 1997, PROTEIN SCI, V6, P1139, DOI 10.1002/pro.5560060602; Andreeva A, 2014, NUCLEIC ACIDS RES, V42, pD310, DOI 10.1093/nar/gkt1242; Babini E, 2011, J BIOL INORG CHEM, V16, P243, DOI 10.1007/s00775-010-0721-3; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Baylor SM, 2012, J GEN PHYSIOL, V139, P261, DOI 10.1085/jgp.201210773; Blanchard H, 1997, NAT STRUCT BIOL, V4, P532, DOI 10.1038/nsb0797-532; Bluhm WF, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar003; Brandl M, 2001, J MOL BIOL, V307, P357, DOI 10.1006/jmbi.2000.4473; Braunewell KH, 2005, TRENDS PHARMACOL SCI, V26, P345, DOI 10.1016/j.tips.2005.04.008; Brodersen DE, 1998, STRUCTURE, V6, P477, DOI 10.1016/S0969-2126(98)00049-5; Chen YY, 2010, SCI CHINA CHEM, V53, P52, DOI 10.1007/s11426-010-0011-5; Chouhan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025069; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; DASILVA ACR, 1991, TRENDS BIOCHEM SCI, V16, P53, DOI 10.1016/0968-0004(91)90024-P; de Beer T, 2000, NAT STRUCT BIOL, V7, P1018, DOI 10.1038/80924; Declercq JP, 1999, PROTEIN SCI, V8, P2194, DOI 10.1110/ps.8.10.2194; DEREWENDA ZS, 1995, J MOL BIOL, V252, P248, DOI 10.1006/jmbi.1995.0492; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; Emberley ED, 2004, BIOCHEM CELL BIOL, V82, P508, DOI 10.1139/O04-052; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Glaaser IW, 2006, J BIOL CHEM, V281, P24015, DOI 10.1074/jbc.M605473200; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; Himmel DM, 2009, J MOL BIOL, V394, P496, DOI 10.1016/j.jmb.2009.09.035; Hohenester E, 1996, NAT STRUCT BIOL, V3, P67, DOI 10.1038/nsb0196-67; Hubner CA, 2002, HUM MOL GENET, V11, P2435, DOI 10.1093/hmg/11.20.2435; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; Iwasaki W, 2003, STRUCTURE, V11, P75, DOI 10.1016/S0969-2126(02)00932-2; Jia J, 2001, ACTA CRYSTALLOGR D, V57, P1843, DOI 10.1107/S0907444901016511; Jiang L, 2010, ADV EXP MED BIOL, V664, P273, DOI 10.1007/978-1-4419-1399-9_31; Kawasaki H, 1998, BIOMETALS, V11, P277, DOI 10.1023/A:1009282307967; Kawasaki H, 2012, PROTEINS, V80, P2592, DOI 10.1002/prot.24143; Kobayashi N, SOLUTION STRUCTURE O; Koltzscher M, 2000, BIOCHEMISTRY-US, V39, P9533, DOI 10.1021/bi000257+; Kragelund BB, 1998, BIOCHEMISTRY-US, V37, P8926, DOI 10.1021/bi9726436; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krebs J, 2007, CALCIUM A MATTER OF; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; Lakowski TM, 2007, PROTEIN SCI, V16, P1119, DOI 10.1110/ps.072777107; Lee YC, 2004, J BIOMOL NMR, V29, P399, DOI 10.1023/B:JNMR.0000032617.88899.4b; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Machaca K, 2011, CELL CALCIUM, V49, P323, DOI 10.1016/j.ceca.2011.05.004; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Marchand A, 2012, ADV EXP MED BIOL, V740, P795, DOI 10.1007/978-94-007-2888-2_35; Mazumder M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096202; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mikhaylova M, 2011, J NEUROCHEM, V118, P695, DOI 10.1111/j.1471-4159.2011.07372.x; MONCRIEF ND, 1990, J MOL EVOL, V30, P522, DOI 10.1007/BF02101108; Nakayama N, 2000, TOP BIOL INORG CHEM, V3, P29; Naranjo JR, 2012, J BIOL CHEM, V287, P31674, DOI 10.1074/jbc.R112.384982; Nelson MR, 1998, BIOMETALS, V11, P297, DOI 10.1023/A:1009253808876; Nelson MR, 2002, PROTEIN SCI, V11, P198, DOI 10.1110/ps.33302; Ng C, 2008, EMBO J, V27, P804, DOI 10.1038/emboj.2008.18; Nishiguchi KM, 2004, INVEST OPHTH VIS SCI, V45, P3863, DOI 10.1167/iovs.04-0590; Oleszczuk M, 2010, J MOL CELL CARDIOL, V48, P925, DOI 10.1016/j.yjmcc.2010.01.016; Permyakov, 2011, CALCIUM BINDING PROT; Permyakov E. Y., 2009, METALLOPROTEOMICS; Permyakov SE, 2012, CELL CALCIUM, V52, P366, DOI 10.1016/j.ceca.2012.06.002; Permyakov SE, 2011, MOL BIOSYST, V7, P2164, DOI 10.1039/c0mb00305k; Permyakov SE, 2009, CELL CALCIUM, V46, P163, DOI 10.1016/j.ceca.2009.07.001; Permyakoy SE, 2008, PROTEINS, V72, P822, DOI 10.1002/prot.21974; Rigden DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021507; Rigden DJ, 2004, J MOL BIOL, V343, P971, DOI 10.1016/j.jmb.2004.08.077; Robertson IM, 2014, ARCH BIOCHEM BIOPHYS, V552, P40, DOI 10.1016/j.abb.2013.12.003; Santamaria-Hernando S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040698; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Schwaller B, 2009, CELL MOL LIFE SCI, V66, P275, DOI 10.1007/s00018-008-8564-6; Seaton G, 2011, SEMIN CELL DEV BIOL, V22, P530, DOI 10.1016/j.semcdb.2011.07.014; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Sillitoe I, 2013, NUCLEIC ACIDS RES, V41, pD490, DOI 10.1093/nar/gks1211; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Sokal I, 1998, MOL CELL, V2, P129, DOI 10.1016/S1097-2765(00)80121-5; Spyracopoulos L, 1997, BIOCHEMISTRY-US, V36, P12138, DOI 10.1021/bi971223d; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Subramanian L, 2004, BIOCHEM BIOPH RES CO, V322, P1153, DOI 10.1016/j.bbrc.2004.07.109; Takahashi T, 2012, INT J MOL SCI, V13, P7532, DOI 10.3390/ijms13067532; TANAKA T, 1995, NATURE, V376, P444, DOI 10.1038/376444a0; Tikunova SB, 2002, BIOCHEMISTRY-US, V41, P6697, DOI 10.1021/bi011763h; Verdino P, 2002, EMBO J, V21, P5007, DOI 10.1093/emboj/cdf526; Wang X, 2002, J BIOL CHEM, V277, P31124, DOI 10.1074/jbc.M203896200; Wilson MA, 2000, J MOL BIOL, V301, P1237, DOI 10.1006/jmbi.2000.4029; Wolf S, 2011, AMINO ACIDS, V41, P849, DOI 10.1007/s00726-010-0623-2; Woods NK, 2012, ADV EXP MED BIOL, V740, P1193, DOI 10.1007/978-94-007-2888-2_54; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Zhou Y, 2006, PROTEINS, V65, P643, DOI 10.1002/prot.21139; Zhou YB, 2009, CELL CALCIUM, V46, P1, DOI 10.1016/j.ceca.2009.05.005	88	43	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109287	10.1371/journal.pone.0109287	http://dx.doi.org/10.1371/journal.pone.0109287			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313560	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662500029
J	Dinis, TM; Vidal, G; Jose, RR; Vigneron, P; Bresson, D; Fitzpatrick, V; Marin, F; Kaplan, DL; Egles, C				Dinis, Tony M.; Vidal, Guillaume; Jose, Rodrigo R.; Vigneron, Pascale; Bresson, Damien; Fitzpatrick, Vincent; Marin, Frederic; Kaplan, David L.; Egles, Christophe			Complementary Effects of Two Growth Factors in Multifunctionalized Silk Nanofibers for Nerve Reconstruction	PLOS ONE			English	Article							CILIARY NEUROTROPHIC FACTOR; SCHWANN-CELLS; ELECTROSPUN NANOFIBERS; FACTOR DELIVERY; REGENERATION; GRAFTS; CNTF; REMYELINATION; EXPRESSION; ALIGNMENT	With the aim of forming bioactive guides for peripheral nerve regeneration, silk fibroin was electrospun to obtain aligned nanofibers. These fibers were functionalized by incorporating Nerve Growth Factor (NGF) and Ciliary NeuroTrophic Factor (CNTF) during electrospinning. PC12 cells grown on the fibers confirmed the bioavailability and bioactivity of the NGF, which was not significantly released from the fibers. Primary neurons from rat dorsal root ganglia (DRGs) were grown on the nanofibers and anchored to the fibers and grew in a directional fashion based on the fiber orientation, and as confirmed by growth cone morphology. These biofunctionalized nanofibers led to a 3-fold increase in neurite length at their contact, which was likely due to the NGF. Glial cell growth, alignment and migration were stimulated by the CNTF in the functionalized nanofibers. Organotypic culture of rat fetal DRGs confirmed the complementary effect of both growth factors in multifunctionalized nanofibers, which allowed glial cell migration, alignment and parallel axonal growth in structures resembling the 'bands of Bungner' found in situ. Graftable multi-channel conduits based on biofunctionalized aligned silk nanofibers were developed as an organized 3D scaffold. Our bioactive silk tubes thus represent new options for a biological and biocompatible nerve guidance conduit.	[Dinis, Tony M.; Vidal, Guillaume; Vigneron, Pascale; Bresson, Damien; Fitzpatrick, Vincent; Marin, Frederic; Egles, Christophe] Univ Technol Compiegne, CNRS UMR BioMecan & BioIngn 7338, Ctr Rech, Compiegne, France; [Dinis, Tony M.; Jose, Rodrigo R.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Egles, Christophe] Tufts Univ, Sch Dent Med, Dept Oral & Maxillofacial Pathol, Boston, MA 02111 USA	Picardie Universites; Universite de Technologie de Compiegne; Tufts University; Tufts University	Egles, C (corresponding author), Univ Technol Compiegne, CNRS UMR BioMecan & BioIngn 7338, Ctr Rech, Compiegne, France.	Christophe.egles@utc.fr	Marin, Frederic/B-3757-2010	Marin, Frederic/0000-0003-0440-4849; EGLES, Christophe/0000-0003-0982-7752; Fitzpatrick, Vincent/0000-0002-0556-1179; Bresson, Damien/0000-0001-6250-8932	NIH [p41(EB002520)]; french Region Picardie; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); french Region Picardie(Region Hauts-de-France); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by NIH grant p41(EB002520) and by a grant of the french Region Picardie (grant SilkNerve). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler R, 1993, Curr Opin Neurobiol, V3, P785, DOI 10.1016/0959-4388(93)90154-Q; Al-Majed AA, 2000, J NEUROSCI, V20, P2602; Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8; Ashammakhi N, 2008, REGEN MED, V3, P547, DOI 10.2217/17460751.3.4.547; Berrocal YA, 2013, J NEUROSURG, V119, P720, DOI 10.3171/2013.4.JNS121189; Biazar E, 2010, INT J NANOMED, V5, P839, DOI 10.2147/IJN.S11883; Bozkurt A, 2009, BIOMATERIALS, V30, P169, DOI 10.1016/j.biomaterials.2008.09.017; Brunetti V, 2010, P NATL ACAD SCI USA, V107, P6264, DOI 10.1073/pnas.0914456107; Bungner O., 1891, BEITR PATHOL ANAT, V10, P321; Campbell WW, 2008, CLIN NEUROPHYSIOL, V119, P1951, DOI 10.1016/j.clinph.2008.03.018; Chew SY, 2007, ADV FUNCT MATER, V17, P1288, DOI 10.1002/adfm.200600441; DEGROOT P, 1994, PROC SPIE, P101, DOI 10.1117/12.194308; FRIEDMAN B, 1992, NEURON, V9, P295, DOI 10.1016/0896-6273(92)90168-D; Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F; GUENARD V, 1992, J NEUROSCI, V12, P3310; Hiruma S, 1997, EXP MOL PATHOL, V64, P23, DOI 10.1006/exmp.1997.2206; Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a; Jesuraj NJ, 2014, MUSCLE NERVE, V49, P267, DOI 10.1002/mus.23885; Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u; Jose RR, 2012, J MATER SCI-MATER M, V23, P2679, DOI 10.1007/s10856-012-4739-7; Kang SS, 2012, J NEUROSCI, V32, P9277, DOI 10.1523/JNEUROSCI.1746-12.2012; Keilhoff G, 2003, BIOMATERIALS, V24, P2779, DOI 10.1016/S0142-9612(03)00084-X; Kemp SWP, 2011, EXP NEUROL, V229, P460, DOI 10.1016/j.expneurol.2011.03.017; KIM DH, 1994, J NEUROSURG, V80, P254, DOI 10.3171/jns.1994.80.2.0254; Krick K, 2011, CURR OPIN BIOTECH, V22, P741, DOI 10.1016/j.copbio.2011.04.002; Lang EM, 2008, J NEUROTRAUM, V25, P384, DOI 10.1089/neu.2007.0396; Lee JY, 2012, IEEE T NANOBIOSCI, V11, P15, DOI 10.1109/TNB.2011.2159621; Levi ADO, 1997, EXP NEUROL, V143, P25, DOI 10.1006/exnr.1996.6344; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Liu WY, 2012, ADV HEALTHC MATER, V1, P10, DOI 10.1002/adhm.201100021; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Midha Rajiv, 2006, Clin Neurosurg, V53, P185; Neal RA, 2012, J BIOMED MATER RES A, V100A, P406, DOI 10.1002/jbm.a.33204; Nectow AR, 2012, TISSUE ENG PART B-RE, V18, P40, DOI [10.1089/ten.teb.2011.0240, 10.1089/ten.TEB.2011.0240]; Perez RA, 2013, ADV DRUG DELIVER REV, V65, P471, DOI 10.1016/j.addr.2012.03.009; Pfister LA, 2007, J PERIPHER NERV SYST, V12, P65, DOI 10.1111/j.1529-8027.2007.00125.x; RAJARAMAN R, 1974, EXP CELL RES, V88, P327, DOI 10.1016/0014-4827(74)90248-1; RENDE M, 1992, GLIA, V5, P25, DOI 10.1002/glia.440050105; Robson RM, 1985, FIBER CHEMISTRY HAND; Sahoo S, 2010, J BIOMED MATER RES A, V93A, P1539, DOI 10.1002/jbm.a.32645; SANDROCK AW, 1987, BRAIN RES, V425, P360, DOI 10.1016/0006-8993(87)90520-8; Schneider A, 2009, ACTA BIOMATER, V5, P2570, DOI 10.1016/j.actbio.2008.12.013; Stoll G, 2002, J PERIPHER NERV SYST, V7, P13, DOI 10.1046/j.1529-8027.2002.02002.x; Tang X, 2012, BIOMATERIALS, V33, P3860, DOI 10.1016/j.biomaterials.2012.02.008; Teng KK, 1994, CELL BIOL LAB HDB, P218; Thoenen H, 1981, Adv Biochem Psychopharmacol, V28, P263; Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034; Vernerey J, 2013, J NEUROSCI, V33, P3240, DOI 10.1523/JNEUROSCI.2579-12.2013; Vidal G, 2013, ACTA BIOMATER, V9, P4935, DOI 10.1016/j.actbio.2012.09.003; Waller A., 1850, PHIL T R SOC, V140, P423, DOI DOI 10.1098/RSTL.1850.0021; Wang CY, 2012, J BIOMAT SCI-POLYM E, V23, P167, DOI 10.1163/092050610X545805; Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002; Wittmer CR, 2011, ADV FUNCT MATER, V21, P4232, DOI 10.1002/adfm.201100755; Xu JJ, 2009, J CLIN NEUROSCI, V16, P812, DOI 10.1016/j.jocn.2008.08.035; Xu WJ, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014104; Yang YM, 2009, POLYM DEGRAD STABIL, V94, P2213, DOI 10.1016/j.polymdegradstab.2009.09.002; Yao M, 1999, LARYNGOSCOPE, V109, P1263, DOI 10.1097/00005537-199908000-00015	57	52	53	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109770	10.1371/journal.pone.0109770	http://dx.doi.org/10.1371/journal.pone.0109770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313579	gold, Green Published, Green Submitted			2022-12-27	WOS:000343662500074
J	Islam, FMA; Chakrabarti, R; Dirani, M; Islam, MT; Ormsby, G; Wahab, M; Critchley, C; Finger, RP				Islam, Fakir M. Amirul; Chakrabarti, Rahul; Dirani, Mohamed; Islam, M. Tauhidul; Ormsby, Gail; Wahab, Mohamed; Critchley, Christine; Finger, Robert P.			Knowledge, Attitudes and Practice of Diabetes in Rural Bangladesh: The Bangladesh Population Based Diabetes and Eye Study (BPDES)	PLOS ONE			English	Article							IMPAIRED FASTING GLYCEMIA; TYPE-2; MANAGEMENT; TRIAL; INDIA	Background: To assess the Knowledge, Attitudes and Practice (KAP) amongst the general community regarding type 2 diabetes mellitus (DM) in rural Bangladesh. Methods: Data was collected using cluster random sampling from 3104 adults residing in a rural district in Bangladesh. Participants underwent a KAP questionnaire survey regarding assessing diabetes, socio-demographic and medical history. Descriptive, Chi-square and regression analyses were performed. Results: Participants were aged between 30 and 89 years (M = 51, SD = 11.8) and 65.5% were female. The prevalence of diabetes was found to be 8.3%. The majority (93%) reported to have heard of diabetes, yet only 4% knew what a glucose tolerance test was. Only 50% reported that they knew physical inactivity was a risk factor. Age, gender, level of education and socio-economic status (SES) were significantly associated with KAP. A lower proportion (41%) of older participants (aged >= 65 years) reported that they knew that dietary modifications assist in diabetes control compared to those aged less than 35 years (69%), p, 0.001. Males (beta = 0.393, 95% CI = 0.142-0.643), and any level of education compared to no schooling (beta = 0.726, 95% CI = 0.596, 0.857) reported significantly more knowledge, after multivariate adjustments for covariates. Participants aged under 35 years, (odds ratio (OR) = 1.73, 95% CI = 1.22-2.43) had significantly higher positive attitudes towards treatments of diabetes compared to those aged >= 65 years. Of the 99 people with known diabetes, more than 50% (n = 52) never had their blood sugar levels checked since diagnosis. Conclusions: Knowledge of diabetes and its risk factors is very limited in rural Bangladesh, even in persons diagnosed with type 2 DM. The development of public health programmes to increase knowledge of diabetes and its complications is required to assist people living in rural Bangladesh to control and management of diabetes.	[Islam, Fakir M. Amirul; Critchley, Christine] Swinburne Univ Technol, Dept Stat Data Sci & Epidemiol, Fac Hlth Arts & Design, Melbourne, Vic, Australia; [Islam, Fakir M. Amirul; Chakrabarti, Rahul; Islam, M. Tauhidul; Wahab, Mohamed] Org Rural Community Dev, Dariapur, Narail, Bangladesh; [Chakrabarti, Rahul; Dirani, Mohamed; Ormsby, Gail; Finger, Robert P.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Islam, M. Tauhidul] Univ Melbourne, Dept Phys, Melbourne, Vic, Australia; [Ormsby, Gail] Avondale Coll Higher Educ, Sydney, NSW, Australia; [Wahab, Mohamed] Narail Diabet Hosp & Narail Diabet Sham, Narail, Bangladesh	Swinburne University of Technology; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Melbourne	Islam, FMA (corresponding author), Swinburne Univ Technol, Dept Stat Data Sci & Epidemiol, Fac Hlth Arts & Design, Melbourne, Vic, Australia.	fislam@swin.edu.au	Islam, Fakir M Amirul/P-6665-2015	Islam, Fakir M Amirul/0000-0003-3897-3302; Finger, Robert P/0000-0003-4253-7597				Abu Sayeed M, 2004, DIABETES CARE, V27, P1054, DOI 10.2337/diacare.27.5.1054; Al-Adsani AMS, 2009, DIABETES METAB, V35, P121, DOI 10.1016/j.diabet.2008.09.005; Al-Maskari F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052857; ANDRICH D, 1978, PSYCHOMETRIKA, V43, P561, DOI 10.1007/BF02293814; Basgram Union Parisad Office, 2011, EL LIST; Bhowmik B, 2013, DIABETES METAB J, V37, P46, DOI 10.4093/dmj.2013.37.1.46; Bhowmik B, 2012, DIABETES METAB J, V36, P422, DOI 10.4093/dmj.2012.36.6.422; Chakrabarti R, 2014, BANGLADESH IN PRESS; Critchley CR, 2012, DIABETES CARE, V35, P699, DOI 10.2337/dc11-1183; Demaio AR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-236; Fitzgerald JT, 1998, DIABETES CARE, V21, P706, DOI 10.2337/diacare.21.5.706; He X, 2007, INT NURS REV, V54, P280, DOI 10.1111/j.1466-7657.2007.00570.x; IDF, 2012, INT DIAB ATL; Kamel N M, 1999, East Mediterr Health J, V5, P967; MAZZUCA SA, 1986, DIABETES CARE, V9, P1, DOI 10.2337/diacare.9.1.1; Mohan Deepa, 2005, J Assoc Physicians India, V53, P283; Moore SM, 2011, PSYCHOL HEALTH, V26, P485, DOI 10.1080/08870440903548749; Mushtaque A, 2002, INTERNATIONAL JOURNA, V22, P191; Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561; Rahim MA, 2007, DIABETES RES CLIN PR, V77, P300, DOI 10.1016/j.diabres.2006.11.010; Rani PK, 2008, RURAL REMOTE HEALTH, V8; Saleh F, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1112; Sayeed MA, 2003, DIABETES CARE, V26, P1034, DOI 10.2337/diacare.26.4.1034; Shah VN, 2009, INT J DIABETES DEV C, V29, P118, DOI 10.4103/0973-3930.54288; Tricco AC, 2012, LANCET, V379, P2252, DOI 10.1016/S0140-6736(12)60480-2; World Health Organization, 2008, ADVOCACY COMMUNICATI; Wright BD, 1982, RATING SCALE ANAL RA; Zaman MJ, 2012, INT J EPIDEMIOL, V41, P1302, DOI 10.1093/ije/dyr226	28	79	79	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110368	10.1371/journal.pone.0110368	http://dx.doi.org/10.1371/journal.pone.0110368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR5ZW	25313643	Green Published, gold			2022-12-27	WOS:000343662500111
J	Ter Maat, A; Trost, L; Sagunsky, H; Seltmann, S; Gahr, M				Ter Maat, Andries; Trost, Lisa; Sagunsky, Hannes; Seltmann, Susanne; Gahr, Manfred			Zebra Finch Mates Use Their Forebrain Song System in Unlearned Call Communication	PLOS ONE			English	Article							VOCAL CONTROL-SYSTEM; BEHAVIOR; DIFFERENTIATION; PATHWAYS; PREMOTOR; GUTTATA	Unlearned calls are produced by all birds whereas learned songs are only found in three avian taxa, most notably in songbirds. The neural basis for song learning and production is formed by interconnected song nuclei: the song control system. In addition to song, zebra finches produce large numbers of soft, unlearned calls, among which "stack" calls are uttered frequently. To determine unequivocally the calls produced by each member of a group, we mounted miniature wireless microphones on each zebra finch. We find that group living paired males and females communicate using bilateral stack calling. To investigate the role of the song control system in call-based male female communication, we recorded the electrical activity in a premotor nucleus of the song control system in freely behaving male birds. The unique combination of acoustic monitoring together with wireless brain recording of individual zebra finches in groups shows that the neuronal activity of the song system correlates with the production of unlearned stack calls. The results suggest that the song system evolved from a brain circuit controlling simple unlearned calls to a system capable of producing acoustically rich, learned vocalizations.	[Ter Maat, Andries; Trost, Lisa; Sagunsky, Hannes; Seltmann, Susanne; Gahr, Manfred] Max Planck Inst Ornithol, Seewiesen, Germany	Max Planck Society	Ter Maat, A (corresponding author), Max Planck Inst Ornithol, Eberhard Gwinner Str, Seewiesen, Germany.	termaat@orn.mpg.de		Seltmann, Susanne/0000-0001-6311-8215	Max Planck Society	Max Planck Society(Max Planck Society)	The study was undertaken with the budget of the Max Planck Society (www.mpg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1982, J NEUROSCI METH, V5, P317, DOI 10.1016/0165-0270(82)90002-4; Amy M, 2010, P ROY SOC B-BIOL SCI, V277, P3685, DOI 10.1098/rspb.2010.0598; Beckers GJL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011129; CARYL PG, 1976, ANIM BEHAV, V24, P93, DOI 10.1016/S0003-3472(76)80103-0; Elie JE, 2010, ANIM BEHAV, V80, P597, DOI 10.1016/j.anbehav.2010.06.003; Fee MS, 2001, J NEUROSCI METH, V112, P83, DOI 10.1016/S0165-0270(01)00426-5; Gahr M, 2007, ADV GENET, V59, P67, DOI 10.1016/S0065-2660(07)59003-6; Garamszegi LZ, 2007, BEHAV ECOL, V18, P86, DOI 10.1093/beheco/arl047; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hahnloser RHR, 2006, J NEUROPHYSIOL, V96, P794, DOI 10.1152/jn.01064.2005; KROODSMA DE, 1991, ANIM BEHAV, V42, P477, DOI 10.1016/S0003-3472(05)80047-8; Liu WC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3082; Lohmann R, 2000, J NEUROBIOL, V42, P220, DOI 10.1002/(SICI)1097-4695(20000205)42:2<220::AID-NEU6>3.0.CO;2-E; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Margoliash D, 1997, J NEUROBIOL, V33, P671, DOI 10.1002/(SICI)1097-4695(19971105)33:5<671::AID-NEU12>3.0.CO;2-C; Marler P, 2004, ANN NY ACAD SCI, V1016, P31, DOI 10.1196/annals.1298.034; Miller CT, 2009, J COMP PHYSIOL A, V195, P783, DOI 10.1007/s00359-009-0456-1; MORRIS D, 1954, BEHAVIOUR, V6, P271, DOI 10.1163/156853954X00130; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; Poesel A, 2006, BEHAVIOUR, V143, P1529, DOI 10.1163/156853906779366973; Price JJ, 2009, P ROY SOC B-BIOL SCI, V276, P1971, DOI 10.1098/rspb.2008.1626; Riebel K, 2005, TRENDS ECOL EVOL, V20, P419, DOI 10.1016/j.tree.2005.04.024; Schmidt MF, 1998, NAT NEUROSCI, V1, P513, DOI 10.1038/2232; Schregardus DS, 2006, J NEUROSCI METH, V155, P62, DOI 10.1016/j.jneumeth.2005.12.028; Seyfarth RM, 2010, BRAIN LANG, V115, P92, DOI 10.1016/j.bandl.2009.10.003; SILCOX AP, 1982, ANIM BEHAV, V30, P1237, DOI 10.1016/S0003-3472(82)80216-9; SIMPSON HB, 1990, J NEUROSCI, V10, P1541; Soltis J, 2005, ANIM BEHAV, V70, P579, DOI 10.1016/j.anbehav.2004.11.015; SPEIRS EAH, 1991, ANIM BEHAV, V41, P937, DOI 10.1016/S0003-3472(05)80631-1; Spiro JE, 1999, J NEUROPHYSIOL, V81, P3007, DOI 10.1152/jn.1999.81.6.3007; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Team RC, 2013, R LANGUAGE ENV STAT; Vignal C, 2008, BEHAV PROCESS, V77, P191, DOI 10.1016/j.beproc.2007.09.003; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871; ZANN R, 1996, ZEBRA FINCH	35	56	56	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109334	10.1371/journal.pone.0109334	http://dx.doi.org/10.1371/journal.pone.0109334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313846	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500032
J	Warepam, M; Sharma, GS; Dar, TA; Khan, MKA; Singh, LR				Warepam, Marina; Sharma, Gurumayum Suraj; Dar, Tanveer Ali; Khan, Md. Khurshid Alam; Singh, Laishram Rajendrakumar			Structural Characteristic of the Initial Unfolded State on Refolding Determines Catalytic Efficiency of the Folded Protein in Presence of Osmolytes	PLOS ONE			English	Article							DENATURED RIBONUCLEASE-A; TRIMETHYLAMINE-N-OXIDE; CHEMICAL CHAPERONES; SECONDARY STRUCTURE; ENZYME-ACTIVITY; GIBBS ENERGY; UREA; STABILIZATION; CONFORMATION; STABILITY	Osmolytes are low molecular weight organic molecules accumulated by organisms to assist proper protein folding, and to provide protection to the structural integrity of proteins under denaturing stress conditions. It is known that osmolyte-induced protein folding is brought by unfavorable interaction of osmolytes with the denatured/unfolded states. The interaction of osmolyte with the native state does not significantly contribute to the osmolyte-induced protein folding. We have therefore investigated if different denatured states of a protein (generated by different denaturing agents) interact differently with the osmolytes to induce protein folding. We observed that osmolyte-assisted refolding of protein obtained from heat-induced denatured state produces native molecules with higher enzyme activity than those initiated from GdmCl- or urea-induced denatured state indicating that the structural property of the initial denatured state during refolding by osmolytes determines the catalytic efficiency of the folded protein molecule. These conclusions have been reached from the systematic measurements of enzymatic kinetic parameters (K-m and k(cat)), thermodynamic stability (T-m and Delta H-m) and secondary and tertiary structures of the folded native proteins obtained from refolding of various denatured states (due to heat-, urea- and GdmCl-induced denaturation) of RNase-A in the presence of various osmolytes.	[Warepam, Marina; Sharma, Gurumayum Suraj; Singh, Laishram Rajendrakumar] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India; [Dar, Tanveer Ali] Univ Kashmir, Dept Clin Biochem, Srinagar 190006, Jammu & Kashmir, India; [Khan, Md. Khurshid Alam] BS Abdur Rahman Univ, Sch Life Sci, Chennai, Tamil Nadu, India	University of Delhi; University of Kashmir; B. S. Abdur Rahman Crescent Institute of Science & Technology	Singh, LR (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India.	lairksingh@gmail.com	Dar, Tanveer/F-3738-2019; Khan, Khurshid/AAG-3807-2020	Dar, Tanveer/0000-0002-1574-9036; Sharma, Gurumayum Suraj/0000-0002-7924-2031	Department of Science and Technology [SR/SO/BB-0003/2011]; Council of Scientific and Industrial Research (CSIR) [37(1597)/13/EMR-II]; CSIR [09/045(0992)/2010-EMR-1]	Department of Science and Technology(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the grants from the Department of Science and Technology (grant no: SR/SO/BB-0003/2011) and Council of Scientific and Industrial Research (CSIR) (grant no: 37(1597)/13/EMR-II). LRS and MW also acknowledge CSIR for the financial assistance provided to MW in the form of research fellowship (File. no. 09/045(0992)/2010-EMR-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD F, 1983, J BIOL CHEM, V258, P7960; Baskakov I, 1998, BIOPHYS J, V74, P2666, DOI 10.1016/S0006-3495(98)77972-X; BIGELOW C C, 1960, C R Trav Lab Carlsberg, V31, P305; Bolen DW, 2001, J MOL BIOL, V310, P955, DOI 10.1006/jmbi.2001.4819; Chang JY, 1999, J BIOL CHEM, V274, P123, DOI 10.1074/jbc.274.1.123; CROOK EM, 1960, BIOCHEM J, V74, P234, DOI 10.1042/bj0740234; Dar TA, 2011, BIOCHEMISTRY-US, V50, P1029, DOI 10.1021/bi101551h; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Fields PA, 2001, EUR J BIOCHEM, V268, P4497, DOI 10.1046/j.1432-1327.2001.02374.x; Gulotta M, 2007, BIOCHEMISTRY-US, V46, P10055, DOI 10.1021/bi700990d; Hagihara Y, 1998, FOLD DES, V3, P195, DOI 10.1016/S1359-0278(98)00027-3; Haque I, 2005, FEBS LETT, V579, P3891, DOI 10.1016/j.febslet.2005.06.005; Haque I, 2005, BIOPHYS CHEM, V117, P1, DOI 10.1016/j.bpc.2005.04.004; Howard Marybeth, 2002, Methods Mol Med, V70, P267; Kim YS, 2003, PROTEIN SCI, V12, P1252, DOI 10.1110/ps.0242603; Kumar R, 2005, ARCH BIOCHEM BIOPHYS, V436, P78, DOI 10.1016/j.abb.2005.01.008; Kumar R, 2001, J BIOL CHEM, V276, P18146, DOI 10.1074/jbc.M100825200; KUMAR TKS, 1994, INT J BIOL MACROMOL, V16, P171; Leandro P, 2001, MOL GENET METAB, V73, P173, DOI 10.1006/mgme.2001.3172; MASHINO T, 1987, ARCH BIOCHEM BIOPHYS, V258, P356, DOI 10.1016/0003-9861(87)90355-9; Pace C N, 1986, Methods Enzymol, V131, P266; Powell K, 2002, ADV DRUG DELIVER REV, V54, P1395, DOI 10.1016/S0169-409X(02)00148-5; Reinstadler D, 1996, BIOCHEMISTRY-US, V35, P15822, DOI 10.1021/bi961810j; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; SESHADRI S, 1994, BIOCHEMISTRY-US, V33, P1351, DOI 10.1021/bi00172a010; Singh LR, 2007, MOL GENET METAB, V91, P335, DOI 10.1016/j.ymgme.2007.04.011; Singh LR, 2007, BBA-PROTEINS PROTEOM, V1774, P1555, DOI 10.1016/j.bbapap.2007.09.006; Singh R, 2008, BIOPHYS CHEM, V133, P81, DOI 10.1016/j.bpc.2007.12.006; Sinha A, 2000, BIOCHEM J, V345, P711, DOI 10.1042/0264-6021:3450711; SOSNICK TR, 1992, BIOCHEMISTRY-US, V31, P8329, DOI 10.1021/bi00150a029; Tamarappoo BK, 1999, J BIOL CHEM, V274, P34825, DOI 10.1074/jbc.274.49.34825; Tanaka M, 2005, J MOL MED, V83, P343, DOI 10.1007/s00109-004-0632-2; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5; Timasheff SN, 2002, P NATL ACAD SCI USA, V99, P9721, DOI 10.1073/pnas.122225399; Uversky VN, 2001, FEBS LETT, V509, P31, DOI 10.1016/S0014-5793(01)03121-0; Yancey Paul H., 2004, Science Progress, V87, P1, DOI 10.3184/003685004783238599; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Yancey PH, 2003, BIOLOGIST, V50, P126; Yang DS, 1999, J BIOL CHEM, V274, P32970, DOI 10.1074/jbc.274.46.32970; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Yoshida H, 2002, NEUROBIOL DIS, V10, P88, DOI 10.1006/nbdi.2002.0502	42	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109408	10.1371/journal.pone.0109408	http://dx.doi.org/10.1371/journal.pone.0109408			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313668	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500039
J	You, XL; Li, YB; Zhang, M; Yan, HQ; Zhao, RQ				You, Xiaolin; Li, Yibo; Zhang, Min; Yan, Huoqi; Zhao, Ruqian			A Survey of Chinese Citizens' Perceptions on Farm Animal Welfare	PLOS ONE			English	Article								Farm animal welfare has been gradually recognized as an important issue in most parts of the world. In China, domestic animals were traditionally raised in backyard and treated as an important component of family wealth. Industrialization of animal production brings forth the farm animal welfare concerns recently in China, yet the modern concept of animal welfare has not been publicized and a comprehensive recognition on how consumers and farmers perceive animal welfare is lacking. Therefore, we conducted a survey on public opinions toward farm animal welfare in China, based on pigs (including sows, piglets, and fattening pigs), domestic fowls (including layers and broilers) and their products. From 6,006 effective questionnaires approximately two thirds of the respondents had never heard of 'animal welfare'; 72.9% of the respondents claimed that, for the sake of animal derived food safety, human beings should improve the rearing conditions for pigs and domestic fowls; 65.8% of the respondents totally or partly agreed on establishing laws to improve animal welfare; more than half of the respondents were willing, or to some extent willing, to pay more for high-welfare animal products, whereas 45.5% of the respondents were not willing or reluctant to pay more. In summary, farm animal welfare is still in its early stage of development and more efforts are needed to improve the public conception to animal welfare in the process of establishing farm animal welfare standards and legislations in China.	[You, Xiaolin; Yan, Huoqi] Nanjing Agr Univ, Nanjing, Jiangsu, Peoples R China; [Li, Yibo] Nanjing Agr Univ, Dept Sociol, Nanjing, Jiangsu, Peoples R China; [Zhang, Min] Nanjing Agr Univ, Dept Laws, Nanjing, Jiangsu, Peoples R China; [Zhao, Ruqian] Nanjing Agr Univ, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University; Nanjing Agricultural University; Nanjing Agricultural University	Yan, HQ (corresponding author), Nanjing Agr Univ, Nanjing, Jiangsu, Peoples R China.	yhq@njau.edu.cn; zhao.ruqian@gmail.com						Communication from the Commission to the European Parliament the Council and the European Economic and Social Committee, 2012, EUR UN STRAT PROT WE, P4; Duncan IJH, 2010, ANIM WELFARE, V9, P279, DOI [10.1007/978-90-481-3650-6_12, DOI 10.1007/978-90-481-3650-6_12]; Kj?rnes U., 2007, WELFARE QUALITY REPO, V2; Lusk JL, 2010, SOC INDIC RES, V96, P551, DOI 10.1007/s11205-009-9492-z; Radford Mike, 2001, ANIMAL WELFARE LAW B, P127; Roex J, 2005, RETAILERS PRODUCERS, V1, P42; Vanhonacker F, 2012, J AGR ENVIRON ETHIC, V25, P79, DOI 10.1007/s10806-010-9299-6	7	45	45	5	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109177	10.1371/journal.pone.0109177	http://dx.doi.org/10.1371/journal.pone.0109177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25314159	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500026
J	Jiang, CM; Cui, CY; Li, L; Shao, YZ				Jiang, Chongming; Cui, Chunyan; Li, Li; Shao, Yuanzhi			The Anomalous Diffusion of a Tumor Invading with Different Surrounding Tissues	PLOS ONE			English	Article							MATHEMATICAL-MODEL; MATRIX METALLOPROTEINASES; DICTYOSTELIUM-DISCOIDEUM; INDUCED ANGIOGENESIS; CANCER INVASION; GROWTH DYNAMICS; CELL-ADHESION; METASTASIS; CHEMOTAXIS; COLLAGEN	We simulated the invasion of a proliferating, diffusing tumor within different surrounding tissue conditions using a hybrid mathematical model. The in silico invasion of a tumor was addressed systematically for the first time within the framework of a generalized diffusion theory. Our results reveal that a tumor not only migrates using typical Fickian diffusion, but also migrates more generally using subdiffusion, superdiffusion, and even ballistic diffusion, with increasing mobility of the tumor cell when haptotaxis and chemotaxis toward the host tissue surrounding the proliferative tumor are involved. Five functional terms were included in the hybrid model and their effects on a tumor's invasion were investigated quantitatively: haptotaxis toward the extracellular matrix tissue that is degraded by matrix metalloproteinases; chemotaxis toward nutrients; cell-cell adhesion; the proliferation of the tumor; and the immune response toward the tumor. Haptotaxis and chemotaxis, which are initiated by extracellular matrix and nutrient supply (i.e., glucose) respectively, as well as cell-cell adhesions all drastically affect a tumor's diffusion mode when a tumor invades its surrounding host tissue and proliferates. We verified the in silico invasive behavior of a tumor by analyzing experimental data gathered from the in vitro culturing of different tumor cells and clinical imaging observations that used the same approach as was used to process the simulation data. The different migration modes of a tumor suggested by the simulations generally conform to the results observed in cell cultures and in clinical imaging. Our study not only discloses some migration modes of a tumor that proliferates and invades under different host tissues conditions, but also provides a heuristic method to characterize the invasion of a tumor in clinical medical imaging analysis.	[Jiang, Chongming; Shao, Yuanzhi] Sun Yat Sen Univ, Sch Phys & Engn, Guangzhou 510275, Guangdong, Peoples R China; [Cui, Chunyan; Li, Li] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Shao, Yuanzhi] Sun Yat Sen Univ, Inst Franco Chinois Energie Nucl, Zhuhai, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Shao, YZ (corresponding author), Sun Yat Sen Univ, Sch Phys & Engn, Guangzhou 510275, Guangdong, Peoples R China.	stssyz@mail.sysu.edu.cn	Jiang, Chongming/AFQ-0011-2022	Jiang, Chongming/0000-0003-2566-3313	National Natural Science Foundation of China [11274394]; Natural Science Foundation of Guangdong Province [S2012010010542]; Fundamental Research Funds for the Central Universities [11lgjc12]; Specialized Research Fund for the Doctoral Program of Higher Education [20110171110023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (Grant No. 11274394), the Natural Science Foundation of Guangdong Province (Grant No. S2012010010542), the Fundamental Research Funds for the Central Universities (Grant No. 11lgjc12), and the Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 20110171110023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amblard F, 1996, PHYS REV LETT, V77, P4470, DOI 10.1103/PhysRevLett.77.4470; Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; AndersonAR ChaplainMA, 2000, J THEORETICAL MED, V2, P129, DOI DOI 10.1080/10273660008833042; Araujo RP, 2004, B MATH BIOL, V66, P1039, DOI 10.1016/j.bulm.2003.11.002; Armstrong NJ, 2006, J THEOR BIOL, V243, P98, DOI 10.1016/j.jtbi.2006.05.030; Baish JW, 2000, CANCER RES, V60, P3683; Bellomo N, 2010, MATH MOD METH APPL S, V20, P1179, DOI 10.1142/S0218202510004568; BERNSTEIN JJ, 1995, NEUROSURGERY, V36, P124, DOI 10.1227/00006123-199501000-00016; Bru A, 1998, PHYS REV LETT, V81, P4008, DOI 10.1103/PhysRevLett.81.4008; Carslaw H. S., 1973, CONDUCTION HEAT SOLI; Chaplain MAJ, 2004, MATH MODELLING TISSU; Chavanis PH, 2006, EUR PHYS J B, V52, P433, DOI 10.1140/epjb/e2006-00310-y; Crank J., 1975, MATH DIFFUSION; Dallon JC, 2004, J THEOR BIOL, V231, P203, DOI 10.1016/j.jtbi.2004.06.015; Darnell JE, 1986, MOL CELL BIOL; Debruyne PR, 2002, ONCOGENE, V21, P6740, DOI 10.1038/sj.onc.1205729; Deisboeck TS, 2001, CELL PROLIFERAT, V34, P115, DOI 10.1046/j.1365-2184.2001.00202.x; DUFFY MJ, 1992, CLIN EXP METASTAS, V10, P145, DOI 10.1007/BF00132746; Eikenberry S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000362; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Friedman A, 2011, TUMOR CELLS, V8, P371; Galle J, 2005, BIOPHYS J, V88, P62, DOI 10.1529/biophysj.104.041459; GAO J, 1982, PATHOL RES PRACT, V174, P325; Gatenby RA, 1996, CANCER RES, V56, P5745; Gerlee P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002556; Hillen T, 2009, J MATH BIOL, V58, P183, DOI 10.1007/s00285-008-0201-3; Ji RC, 2014, CANCER LETT, V346, P6, DOI 10.1016/j.canlet.2013.12.001; Jiao Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002314; Johansson N, 2000, CELL MOL LIFE SCI, V57, P5, DOI 10.1007/s000180050495; Kikuchi A, 2006, EUR J GYNAECOL ONCOL, V27, P561; Kikuchi A, 2008, GYNECOL OBSTET INVES, V66, P127, DOI 10.1159/000129671; Kim Y, 2011, PROG BIOPHYS MOL BIO, V106, P353, DOI 10.1016/j.pbiomolbio.2011.06.006; Kim Y, 2009, J THEOR BIOL, V260, P359, DOI 10.1016/j.jtbi.2009.06.025; KLOMINEK J, 1993, CANCER RES, V53, P4376; Kuntz M, 2004, J PHYS D APPL PHYS, V37, pL5, DOI 10.1088/0022-3727/37/1/L02; Kuntz M, 2001, J PHYS D APPL PHYS, V34, P2547, DOI 10.1088/0022-3727/34/16/322; LI CKN, 1982, CANCER-AM CANCER SOC, V50, P2066, DOI 10.1002/1097-0142(19821115)50:10<2066::AID-CNCR2820501017>3.0.CO;2-X; Li L, 2014, BIO-MED MATER ENG, V24, P163, DOI 10.3233/BME-130796; Liu LY, 2013, P NATL ACAD SCI USA, V110, P1686, DOI 10.1073/pnas.1221147110; LUDWIG D, 1978, J ANIM ECOL, V47, P315, DOI 10.2307/3939; MATRISIAN LM, 1992, BIOESSAYS, V14, P455, DOI 10.1002/bies.950140705; McDougall SR, 2002, B MATH BIOL, V64, P673, DOI 10.1006/bulm.2002.0293; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; Murray J. D., 1989, MATH BIOL, DOI DOI 10.1007/978-3-662-08539-4; Orme ME, 1996, MATH COMPUT MODEL, V23, P43, DOI 10.1016/0895-7177(96)00053-2; Palsson E, 2000, P NATL ACAD SCI USA, V97, P10448, DOI 10.1073/pnas.97.19.10448; Pekalski A., 1999, ANOMALOUS DIFFUSION; Perumpanani AJ, 1996, INVAS METAST, V16, P209; Philip J.R., 1969, ADV HYDROSCI, V5, P215, DOI [DOI 10.1016/B978-1-4831-9936-8.50010-6, 10.1016/B978-1-4831-9936-8.50010-6]; Rong ZM, 2006, ANALYST, V131, P816, DOI 10.1039/b600334f; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; Sander LM, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051901; Saragosti J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000890; Schein PSC, 1993, MED ONCOLOGY; SHERRATT JA, 1992, P ROY SOC B-BIOL SCI, V248, P261, DOI 10.1098/rspb.1992.0071; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; StetlerStevenson WG, 1996, SEMIN CANCER BIOL, V7, P147, DOI 10.1006/scbi.1996.0020; TEAD SF, 1988, MACROMOLECULES, V21, P1513, DOI 10.1021/ma00183a048; TERRANOVA VP, 1985, J CELL BIOL, V101, P2330, DOI 10.1083/jcb.101.6.2330; THORGEIRSSON UP, 1994, J NEURO-ONCOL, V18, P89, DOI 10.1007/BF01050415; Verbeni M, 2013, PHYS LIFE REV, V10, P457, DOI 10.1016/j.plrev.2013.06.004; Ward JP, 1999, IMA J MATH APPL MED, V16, P171; Weeks ER, 2002, CHEM PHYS, V284, P361, DOI 10.1016/S0301-0104(02)00667-5; Wu PH, 2014, P NATL ACAD SCI USA, V111, P3949, DOI 10.1073/pnas.1318967111; Zhong WR, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011916	67	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109784	10.1371/journal.pone.0109784	http://dx.doi.org/10.1371/journal.pone.0109784			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310134	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210300074
J	Liu, YY; Li, LF; Fu, JY; Kao, KC; Huang, CC; Chien, Y; Liao, YW; Chiou, SH; Chang, YL				Liu, Yung-Yang; Li, Li-Fu; Fu, Jui-Ying; Kao, Kuo-Chin; Huang, Chung-Chi; Chien, Yueh; Liao, Yi-Wen; Chiou, Shih-Hwa; Chang, Yuh-Lih			Induced Pluripotent Stem Cell Therapy Ameliorates Hyperoxia-Augmented Ventilator-Induced Lung Injury through Suppressing the Src Pathway	PLOS ONE			English	Article							VOLUME MECHANICAL VENTILATION; C-SRC; EXPRESSION; INCREASES; ACTIVATION; GENERATION; STRESS; GENE	Background: High tidal volume (V-T) mechanical ventilation (MV) can induce the recruitment of neutrophils, release of inflammatory cytokines and free radicals, and disruption of alveolar epithelial and endothelial barriers. It is proposed to be the triggering factor that initiates ventilator-induced lung injury (VILI) and concomitant hyperoxia further aggravates the progression of VILI. The Src protein tyrosine kinase (PTK) family is one of the most critical families to intracellular signal transduction related to acute inflammatory responses. The anti-inflammatory abilities of induced pluripotent stem cells (iPSCs) have been shown to improve acute lung injuries (ALIs); however, the mechanisms regulating the interactions between MV, hyperoxia, and iPSCs have not been fully elucidated. In this study, we hypothesize that Src PTK plays a critical role in the regulation of oxidants and inflammation-induced VILI during hyperoxia. iPSC therapy can ameliorate acute hyperoxic VILI by suppressing the Src pathway. Methods: Male C57BL/6 mice, either wild-type or Src-deficient, aged between 2 and 3 months were exposed to high V-T (30 mL/kg) ventilation with or without hyperoxia for 1 to 4 h after the administration of Oct4/Sox2/Parp1 iPSCs at a dose of 5 x 10(7) cells/kg of mouse. Nonventilated mice were used for the control groups. Results: High V-T ventilation during hyperoxia further aggravated VILI, as demonstrated by the increases in microvascular permeability, neutrophil infiltration, macrophage inflammatory protein-2 (MIP-2) and plasminogen activator inhibitor-1 (PAI-1) production, Src activation, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, and malaldehyde (MDA) level. Administering iPSCs attenuated ALI induced by MV during hyperoxia, which benefited from the suppression of Src activation, oxidative stress, acute inflammation, and apoptosis, as indicated by the Src-deficient mice. Conclusion: The data suggest that iPSC-based therapy is capable of partially suppressing acute inflammatory and oxidant responses that occur during hyperoxia-augmented VILI through the inhibition of Src-dependent signaling pathway.	[Liu, Yung-Yang] Taipei Vet Gen Hosp, Chest Dept, Taipei, Taiwan; [Liu, Yung-Yang; Chiou, Shih-Hwa] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Li, Li-Fu; Fu, Jui-Ying; Kao, Kuo-Chin; Huang, Chung-Chi] Chang Gung Mem Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taoyuan, Taiwan; [Li, Li-Fu; Fu, Jui-Ying; Kao, Kuo-Chin; Huang, Chung-Chi] Chang Gung Univ, Taoyuan, Taiwan; [Li, Li-Fu; Kao, Kuo-Chin; Huang, Chung-Chi] Chang Gung Mem Hosp, Dept Resp Therapy, Taoyuan, Taiwan; [Chien, Yueh; Liao, Yi-Wen; Chiou, Shih-Hwa; Chang, Yuh-Lih] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Chien, Yueh; Liao, Yi-Wen; Chiou, Shih-Hwa; Chang, Yuh-Lih] Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Li, LF (corresponding author), Chang Gung Mem Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taoyuan, Taiwan.	lfp3434@adm.cgmh.org.tw; ylchang@vghtpe.gov.tw	Fu, JY/GRR-6179-2022		National Science Council [101-2314-B-182A-088-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	This research was supported by a grant from the National Science Council (No. 101-2314-B-182A-088-MY3). http://web.nsc.gov.tw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Allen GL, 2000, AM J PHYSIOL-LUNG C, V278, pL253, DOI 10.1152/ajplung.2000.278.2.L253; Altemeier WA, 2007, CURR OPIN CRIT CARE, V13, P73, DOI 10.1097/MCC.0b013e32801162cb; Barazzone C, 1996, J CLIN INVEST, V98, P2666, DOI 10.1172/JCI119089; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Carnesecchi S, 2009, AM J RESP CRIT CARE, V180, P972, DOI 10.1164/rccm.200902-0296OC; Chang YS, 2011, CELL TRANSPLANT, V20, P1843, DOI 10.3727/096368911X565038; Chapman KE, 2005, AM J PHYSIOL-LUNG C, V289, pL834, DOI 10.1152/ajplung.00069.2005; Chen SJ, 2010, STEM CELLS DEV, V19, P1757, DOI 10.1089/scd.2009.0452; Chiang CH, 2011, INTENS CARE MED, V37, P1360, DOI 10.1007/s00134-011-2251-z; Chimenti L, 2012, EUR RESPIR J, V40, P939, DOI 10.1183/09031936.00153211; Chiou SH, 2013, J EXP MED, V210, P85, DOI 10.1084/jem.20121044; Chowdhury AK, 2005, J BIOL CHEM, V280, P20700, DOI 10.1074/jbc.M411722200; Dahlem P, 2005, INTENS CARE MED, V31, P724, DOI 10.1007/s00134-005-2588-2; Davis ME, 2003, AM J PHYSIOL-HEART C, V284, pH1449, DOI 10.1152/ajpheart.00918.2002; Desai LP, 2007, AM J PHYSIOL-LUNG C, V293, pL769, DOI 10.1152/ajplung.00127.2007; Dos Santos CC, 2007, CRIT CARE, V11, DOI 10.1186/cc5733; Fung SY, 2011, BIOMATERIALS, V32, P4000, DOI 10.1016/j.biomaterials.2011.02.005; Gore A, 2010, J IMMUNOTOXICOL, V7, P239, DOI 10.3109/1547691X.2010.492254; Held HD, 2001, AM J RESP CRIT CARE, V163, P711, DOI 10.1164/ajrccm.163.3.2003001; Horinouchi H, 1996, AM J RESP CELL MOL, V14, P548, DOI 10.1165/ajrcmb.14.6.8652183; Kallet RH, 2013, RESP CARE, V58, P123, DOI 10.4187/respcare.01963; Kamao H, 2014, STEM CELL REP, V2, P205, DOI 10.1016/j.stemcr.2013.12.007; Lachmann N, 2014, AM J RESP CRIT CARE, V189, P167, DOI 10.1164/rccm.201306-1012OC; Lee IT, 2012, BIOCHEM PHARMACOL, V84, P581, DOI 10.1016/j.bcp.2012.05.005; Li HY, 2011, BIOMATERIALS, V32, P5994, DOI 10.1016/j.biomaterials.2011.05.009; Li LF, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-90; Li LF, 2011, TRANSL RES, V157, P293, DOI 10.1016/j.trsl.2010.12.009; Liu YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066760; Liu YY, 2009, TRANSL RES, V154, P228, DOI 10.1016/j.trsl.2009.06.006; Makena PS, 2011, J APPL PHYSIOL, V111, P1467, DOI 10.1152/japplphysiol.00539.2011; Miyahara T, 2007, AM J PHYSIOL-LUNG C, V293, pL11, DOI 10.1152/ajplung.00279.2005; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Okutani D, 2006, AM J PHYSIOL-LUNG C, V291, pL129, DOI 10.1152/ajplung.00261.2005; Oyaizu T, 2012, INTENS CARE MED, V38, P894, DOI 10.1007/s00134-012-2498-z; Park HS, 2009, RESPIROLOGY, V14, P27, DOI 10.1111/j.1440-1843.2008.01447.x; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Phua J, 2009, AM J RESP CRIT CARE, V179, P220, DOI 10.1164/rccm.200805-722OC; Quinn DA, 2002, J APPL PHYSIOL, V93, P517, DOI 10.1152/japplphysiol.00570.2001; Rachmale S, 2012, RESP CARE, V57, P1887, DOI 10.4187/respcare.01696; Ricard J D, 2003, Eur Respir J Suppl, V42, p2s; Sinclair SE, 2004, CRIT CARE MED, V32, P2496, DOI 10.1097/01.CCM.0000148231.04642.8D; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Syrkina O, 2008, RESPIROLOGY, V13, P333, DOI 10.1111/j.1440-1843.2008.01279.x; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tremblay LN, 2006, INTENS CARE MED, V32, P24, DOI 10.1007/s00134-005-2817-8; Wen ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075383; Yang KY, 2011, CHEST, V140, P1243, DOI 10.1378/chest.11-0539; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	49	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109953	10.1371/journal.pone.0109953	http://dx.doi.org/10.1371/journal.pone.0109953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310015	Green Submitted, gold, Green Published			2022-12-27	WOS:000343210300081
J	Nakamoto-Matsubara, R; Sakata-Yanagimoto, M; Enami, T; Yoshida, K; Yanagimoto, S; Shiozawa, Y; Nanmoku, T; Satomi, K; Muto, H; Obara, N; Kato, T; Kurita, N; Yokoyama, Y; Izutsu, K; Ota, Y; Sanada, M; Shimizu, S; Komeno, T; Sato, Y; Ito, T; Kitabayashi, I; Takeuchi, K; Nakamura, N; Ogawa, S; Chiba, S				Nakamoto-Matsubara, Rie; Sakata-Yanagimoto, Mamiko; Enami, Terukazu; Yoshida, Kenichi; Yanagimoto, Shintaro; Shiozawa, Yusuke; Nanmoku, Tohru; Satomi, Kaishi; Muto, Hideharu; Obara, Naoshi; Kato, Takayasu; Kurita, Naoki; Yokoyama, Yasuhisa; Izutsu, Koji; Ota, Yasunori; Sanada, Masashi; Shimizu, Seiichi; Komeno, Takuya; Sato, Yuji; Ito, Takayoshi; Kitabayashi, Issay; Takeuchi, Kengo; Nakamura, Naoya; Ogawa, Seishi; Chiba, Shigeru			Detection of the G17V RHOA Mutation in Angioimmunoblastic T-Cell Lymphoma and Related Lymphomas Using Quantitative Allele-Specific PCR	PLOS ONE			English	Article							TET2; LEUKEMIA	Angioimmunoblastic T-cell lymphoma (AITL) and peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) are subtypes of T-cell lymphoma. Due to low tumor cell content and substantial reactive cell infiltration, these lymphomas are sometimes mistaken for other types of lymphomas or even non-neoplastic diseases. In addition, a significant proportion of PTCL-NOS cases reportedly exhibit features of AITL (AITL-like PTCL-NOS). Thus disagreement is common in distinguishing between AITL and PTCL-NOS. Using whole-exome and subsequent targeted sequencing, we recently identified G17V RHOA mutations in 60-70% of AITL and AITL-like PTCL-NOS cases but not in other hematologic cancers, including other T-cell malignancies. Here, we establish a sensitive detection method for the G17V RHOA mutation using a quantitative allele-specific polymerase chain reaction (qAS-PCR) assay. Mutated allele frequencies deduced from this approach were highly correlated with those determined by deep sequencing. This method could serve as a novel diagnostic tool for 60-70% of AITL and AITL-like PTCL-NOS.	[Nakamoto-Matsubara, Rie; Sakata-Yanagimoto, Mamiko; Enami, Terukazu; Muto, Hideharu; Obara, Naoshi; Kato, Takayasu; Kurita, Naoki; Yokoyama, Yasuhisa; Chiba, Shigeru] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Hematol, Tsukuba, Ibaraki, Japan; [Sakata-Yanagimoto, Mamiko; Muto, Hideharu; Obara, Naoshi; Kato, Takayasu; Kurita, Naoki; Yokoyama, Yasuhisa; Chiba, Shigeru] Univ Tsukuba, Fac Med, Dept Hematol, Tsukuba, Ibaraki, Japan; [Sakata-Yanagimoto, Mamiko; Muto, Hideharu; Obara, Naoshi; Kato, Takayasu; Kurita, Naoki; Yokoyama, Yasuhisa; Shimizu, Seiichi; Komeno, Takuya; Chiba, Shigeru] Univ Tsukuba Hosp, Dept Hematol, Tsukuba, Ibaraki, Japan; [Yoshida, Kenichi; Shiozawa, Yusuke; Sanada, Masashi; Ogawa, Seishi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Sakyo Ku, Kyoto, Japan; [Yanagimoto, Shintaro] Univ Tokyo, Div Hlth Serv Promot, Bunkyo Ku, Tokyo 113, Japan; [Nanmoku, Tohru] Univ Tsukuba Hosp, Dept Clin Lab, Tsukuba, Ibaraki, Japan; [Satomi, Kaishi] Univ Tsukuba Hosp, Dept Pathol, Tsukuba, Ibaraki, Japan; [Kato, Takayasu; Chiba, Shigeru] Univ Tsukuba, Life Sci Ctr, Tsukuba Adv Res Ctr, Tsukuba, Ibaraki, Japan; [Izutsu, Koji] Toranomon Gen Hosp, Dept Hematol, Minato Ku, Tokyo, Japan; [Izutsu, Koji] Okinaka Mem Inst Med Res, Minato Ku, Tokyo, Japan; [Ota, Yasunori] Toranomon Gen Hosp, Dept Pathol, Minato Ku, Tokyo, Japan; [Shimizu, Seiichi] Tsuchiura Kyodo Gen Hosp, Dept Hematol, Tsuchiura, Ibaraki, Japan; [Komeno, Takuya] Natl Hosp Org, Mito Med Ctr, Dept Hematol, Ibaraki, Japan; [Sato, Yuji] Tsukuba Mem Hosp, Dept Hematol, Tsukuba, Ibaraki, Japan; [Ito, Takayoshi] JA Toride Med Ctr, Dept Hematol, Ibaraki, Japan; [Kitabayashi, Issay] Natl Canc Ctr, Res Inst, Div Hematol Malignancy, Chuo Ku, Tokyo 104, Japan; [Takeuchi, Kengo] Japanese Fdn Canc Res, Inst Canc, Pathol Project Mol Targets, Koto Ku, Tokyo 170, Japan; [Nakamura, Naoya] Tokai Univ, Sch Med, Dept Pathol, Isehara, Kanagawa 25911, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba; Kyoto University; University of Tokyo; University of Tsukuba; University of Tsukuba; University of Tsukuba; Toranomon Hospital; Toranomon Hospital; Tsuchiura Kyodo Hospital; National Cancer Center - Japan; Japanese Foundation for Cancer Research; Tokai University	Chiba, S (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Hematol, Tsukuba, Ibaraki, Japan.	schiba-tky@umin.net	Yokoyama, Yasuhisa/AAG-1070-2020; Izutsu, Koji/AAI-1125-2019; Ogawa, Seishi/AAE-7088-2019; Kitabayashi, Issay/G-2204-2017; Mamiko, Sakata-yanagimoto/AAP-3298-2020; Takeuchi, Kengo/C-3614-2008	Yokoyama, Yasuhisa/0000-0003-0366-4147; Izutsu, Koji/0000-0001-9129-8057; Takeuchi, Kengo/0000-0002-1599-5800; Kitabayashi, Issay/0000-0002-8409-0407; Yoshida, Kenichi/0000-0003-4612-2778; Muto, Hideharu/0000-0002-9146-012X	Ministry of Education, Culture, Sports, Science and Technology of Japan [24390241, 23659482, 23118503, 22130002, 25461407]; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [24390241] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) (24390241, 23659482, 23118503, and 22130002 to S. C.; 25461407 to M.S.-Y.), and the Adaptable and Seamless Technology Transfer Program through target-driven R and D (A-STEP) to M. S.-Y. from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This work was also supported by the Mochida Memorial Foundation for Medical and Pharmaceutical Research, and the Uehara Memorial Foundation to M. S.-Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cairns RA, 2012, BLOOD, V119, P1901, DOI 10.1182/blood-2011-11-391748; Couronne L, 2012, NEW ENGL J MED, V366, P95, DOI 10.1056/NEJMc1111708; de Leval L, 2007, BLOOD, V109, P4952, DOI 10.1182/blood-2006-10-055145; de Leval L, 2010, BRIT J HAEMATOL, V148, P673, DOI 10.1111/j.1365-2141.2009.08003.x; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Dogan A, 2003, BRIT J HAEMATOL, V121, P681, DOI 10.1046/j.1365-2141.2003.04335.x; Frantz C, 2007, AM J CLIN PATHOL, V128, P865, DOI 10.1309/LW7Q3739RBRMBXXP; FRIZZERA G, 1974, LANCET, V1, P1070; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Papadi B, 2012, VIRCHOWS ARCH, V461, P323, DOI 10.1007/s00428-012-1280-5; Piccaluga PP, 2013, J CLIN ONCOL, V31, P3019, DOI 10.1200/JCO.2012.42.5611; Sakata-Yanagimoto M, 2014, NAT GENET, V46, P171, DOI 10.1038/ng.2872; Shammaa D, 2010, GENET TEST MOL BIOMA, V14, P13, DOI 10.1089/gtmb.2009.0119; Swerdlow S.H., 2008, WHO CLASSIFICATION T, P306; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Treon SP, 2013, BLOOD, V121, P4434, DOI 10.1182/blood-2013-04-494849; Wangkumhang P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-275; Wu ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026534; Zapparoli GV, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-206	21	15	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109714	10.1371/journal.pone.0109714	http://dx.doi.org/10.1371/journal.pone.0109714			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310466	gold, Green Published			2022-12-27	WOS:000343210300069
J	Tsai, JC; Lin, YH; Lu, PL; Shen, NJ; Yang, CJ; Lee, NY; Tang, HJ; Liu, YM; Huang, WC; Lee, CH; Ko, WC; Chen, YH; Lin, HH; Chen, TC; Hung, CC				Tsai, Jen-Chih; Lin, Yu-Huei; Lu, Po-Liang; Shen, Ni-Jiin; Yang, Chia-Jui; Lee, Nan-Yao; Tang, Hung-Jen; Liu, Yuag-Meng; Huang, Wen-Chi; Lee, Chen-Hsiang; Ko, Wen-Chien; Chen, Yen-Hsu; Lin, Hsi-Hsun; Chen, Tun-Chieh; Hung, Chien-Ching			Comparison of Serological Response to Doxycycline versus Benzathine Penicillin G in the Treatment of Early Syphilis in HIV-Infected Patients: A Multi-Center Observational Study	PLOS ONE			English	Article							TREPONEMA-PALLIDUM; ASSOCIATION; PREVALENCE; GUIDELINES; MANAGEMENT; TAIWAN	Background: While doxycycline is recommended as an alternative treatment of syphilis in patients with penicillin allergy or intolerance, clinical studies to compare serological response to doxycycline versus benzathine penicillin in treatment of early syphilis among HIV-infected patients remain sparse. Methods: We retrospectively reviewed the medical records of HIV-infected patients with early syphilis who received doxycycline 100 mg twice daily for 14 days (doxycycline group) and those who received 1 dose of benzathine penicillin (2.4 million units) (penicillin group) between 2007 and 2013. Serological responses defined as a decline of rapid plasma reagin titer by 4-fold or greater at 6 and 12 months of treatment were compared between the two groups. Results: During the study period, 123 and 271 patients in the doxycycline and penicillin group, respectively, completed 6 months or longer follow-up. Ninety-one and 271 patients in the doxycycline and penicillin group, respectively, completed 12 months or longer follow-up. Clinical characteristics were similar between the two groups, except that, compared with penicillin group, doxycycline group had a lower proportion of patients with secondary syphilis (65.4% versus 41.5%, P<0.0001) and a higher proportion of patients with early latent syphilis (25.3% versus 49.6%, P<0.0001). No statistically significant differences were found in the serological response rates to doxycycline versus benzathine penicillin at 6 months (63.4% versus 72.3%, P = 0.075) and 12 months of treatment (65.9% versus 68.3%, P = 0.681). In multivariate analysis, secondary syphilis, but not treatment regimen, was consistently associated with serological response at 6 and 12 months of follow-up. Conclusions: The serological response rates to a 14-day course of doxycycline and a single dose of benzathine penicillin were similar in HIV-infected patients with early syphilis at 6 and 12 months of follow-up. Patients with secondary syphilis were more likely to achieve serological response than those with other stages.	[Tsai, Jen-Chih; Shen, Ni-Jiin; Hung, Chien-Ching] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Tsai, Jen-Chih; Shen, Ni-Jiin; Hung, Chien-Ching] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Tsai, Jen-Chih] Tzu Chi Hosp, Dept Internal Med, Hualien, Taiwan; [Tsai, Jen-Chih] Tzu Chi Univ, Coll Med, Hualien, Taiwan; [Lin, Yu-Huei] Taichung Vet Gen Hosp, Dept Internal Med, Taichung, Taiwan; [Lu, Po-Liang; Chen, Yen-Hsu; Chen, Tun-Chieh] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Lu, Po-Liang; Chen, Yen-Hsu; Chen, Tun-Chieh] Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan; [Shen, Ni-Jiin] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Internal Med, Yunlin, Taiwan; [Yang, Chia-Jui] Far Eastern Mem Hosp, Dept Internal Med, New Taipei City, Taiwan; [Lee, Nan-Yao; Ko, Wen-Chien] Natl Cheng Kung Univ, Coll Med & Hosp, Dept Internal Med, Tainan 70101, Taiwan; [Tang, Hung-Jen] Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Liu, Yuag-Meng] Changhua Christian Hosp, Dept Internal Med, Changhua, Taiwan; [Huang, Wen-Chi; Lee, Chen-Hsiang] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Lin, Hsi-Hsun] I Shou Univ, E Da Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Tun-Chieh] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Hung, Chien-Ching] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Hung, Chien-Ching] China Med Univ, Taichung, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Taichung Veterans General Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; National Cheng Kung University; Chi Mei Hospital; Changhua Christian Hospital; Chang Gung Memorial Hospital; Chang Gung University; E-Da Hospital; I Shou University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Chen, TC (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan.	dalechen.chen@gmail.com; hcc0401@ntu.edu.tw	Ko, Wen-Chien/ABG-4316-2020; Lu, Po-Liang/D-4499-2009; Chen, Tun-Chieh/J-2877-2013	Ko, Wen-Chien/0000-0001-7497-149X; Lu, Po-Liang/0000-0002-7423-6783; Chen, Tun-Chieh/0000-0002-9258-0692; Chen, Yen-hsu/0000-0002-8667-4844; Hung, Chien-Ching/0000-0001-7345-0836	Centers for Disease Control, Taiwan [DOH102-DC-1401]	Centers for Disease Control, Taiwan	This study was supported by a grant from the Centers for Disease Control, Taiwan (grant number DOH102-DC-1401 to C.-C. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centers for Disease Control and Prevention, 2006, MMWR Recomm Rep, V55, P1; Farhi D, 2009, MEDICINE, V88, P331, DOI 10.1097/MD.0b013e3181c2af86; Flood JM, 1998, J INFECT DIS, V177, P931, DOI 10.1086/515245; Ghanem KG, 2007, SEX TRANSM INFECT, V83, P97, DOI 10.1136/sti.2006.021402; Ghanem KG, 2006, CLIN INFECT DIS, V42, pE45, DOI 10.1086/500406; Ghanem KG, 2011, CLIN INFECT DIS, V53, pS110, DOI 10.1093/cid/cir701; Gonzalez-Lopez JJ, 2009, CLIN INFECT DIS, V49, P1505, DOI 10.1086/644618; Hung CC, 2014, CLIN INFECT DIS, V58, P1625, DOI 10.1093/cid/ciu127; Kim JH, 2011, CHINESE MED J-PEKING, V124, P2123, DOI 10.3760/cma.j.issn.0366-6999.2011.14.008; Kingston M, 2008, INT J STD AIDS, V19, P729, DOI 10.1258/ijsa.2008.008279; Knaute DF, 2012, CLIN INFECT DIS, V55, P1615, DOI 10.1093/cid/cis757; Paz-Bailey G, 2004, SEX TRANSM DIS, V31, P581, DOI 10.1097/01.olq.0000140009.28121.0f; Psomas KC, 2012, MED MALADIES INFECT, V42, P15, DOI 10.1016/j.medmal.2011.10.003; Reynolds SJ, 2006, SEX TRANSM INFECT, V82, P121, DOI 10.1136/sti.2005.015040; ROMPALO AM, 1992, J INFECT DIS, V165, P1124, DOI 10.1093/infdis/165.6.1124; Rompalo AM, 2001, SEX TRANSM DIS, V28, P158, DOI 10.1097/00007435-200103000-00007; Savage EJ, 2012, EUROSURVEILLANCE, V17; Sun HY, 2012, J CLIN MICROBIOL, V50, P781, DOI 10.1128/JCM.06014-11; U. S. Department of Health and Human Services, 2009, SEX TRANSM DIS SURV; van de Laar T, 2009, GASTROENTEROLOGY, V136, P1609, DOI 10.1053/j.gastro.2009.02.006; Wong T, 2008, AM J MED, V121, P903, DOI 10.1016/j.amjmed.2008.04.042; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; Wu BR, 2014, CLIN MICROBIOL INFEC, V20, pO524, DOI 10.1111/1469-0691.12504; Wu BR, 2014, CLIN MICROBIOL INFEC, V20, P802, DOI 10.1111/1469-0691.12529; Wu H, 2012, SEX TRANSM INFECT, V88, P612, DOI 10.1136/sextrans-2011-050354; Zetola NM, 2007, CLIN INFECT DIS, V44, P1222, DOI 10.1086/513427	26	23	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109813	10.1371/journal.pone.0109813	http://dx.doi.org/10.1371/journal.pone.0109813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310367	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210300076
J	van Donkelaar, EL; Vaessen, KRD; Pawluski, JL; Sierksma, AS; Blokland, A; Canete, R; Steinbusch, HWM				van Donkelaar, Eva L.; Vaessen, Koen R. D.; Pawluski, Jodi L.; Sierksma, Annerieke S.; Blokland, Arjan; Canete, Ramon; Steinbusch, Harry W. M.			Long-Term Corticosterone Exposure Decreases Insulin Sensitivity and Induces Depressive-Like Behaviour in the C57BL/6NCrl Mouse	PLOS ONE			English	Article							FORCED SWIMMING TEST; ALZHEIMERS-DISEASE; METABOLIC SYNDROME; ANIMAL-MODEL; GLUCOSE-TOLERANCE; IN-VIVO; RESISTANCE; STRESS; MICE; ANTIDEPRESSANTS	Chronic stress or long-term administration of glucocorticoids disrupts the hypothalamus-pituitary-adrenal system leading to continuous high levels of glucocorticoids and insulin resistance (IR). This pre-diabetic state can eventually develop into type 2 diabetes mellitus and has been associated with a higher risk to develop depressive disorders. The mechanisms underlying the link between chronic stress, IR and depression remains unclear. The present study aimed to establish a stress-depression model in mice to further study the effects of stress-induced changes upon insulin sensitivity and behavioural consequences. A pilot study was conducted to establish the optimal administration route and a pragmatic measurement of IR. Subsequently, 6-month-old C57BL/6NCrl mice were exposed to long-term oral corticosterone treatment via the drinking water. To evaluate insulin sensitivity changes, blood glucose and plasma insulin levels were measured at different time-points throughout treatment and mice were behaviourally assessed in the elevated zero maze (EZM), forced swimming test (FST) and open field test to reveal behavioural changes. Long-term corticosterone treatment increased body weight and decreased insulin sensitivity. The latter was revealed by a higher IR index and increased insulin in the plasma, whereas blood glucose levels remained unchanged. Corticosterone treatment induced longer immobility times in the FST, reflecting depressive-like behaviour. No effects were observed upon anxiety as measured in the EZM. The effect of the higher body weight of the CORT treated animals at time of testing did not influence behaviour in the EZM or FST, as no differences were found in general locomotor activity. Long-term corticosterone treatment via the drinking water reduces insulin sensitivity and induces depressive-like behaviour in the C57BL/6 mouse. This mouse model could thus be used to further explore the underlying mechanisms of chronic stress-induced T2DM and its association with increased prevalence of major depressive disorder on the short-term and other behavioural adaptations on the longer term.	[van Donkelaar, Eva L.; Vaessen, Koen R. D.; Pawluski, Jodi L.; Sierksma, Annerieke S.; Steinbusch, Harry W. M.] Maastricht Univ, Fac Hlth Med & Life Sci, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [Vaessen, Koen R. D.] Univ Utrecht, Fac Vet Med, Cent Lab Anim Res Facil, Utrecht, Netherlands; [Pawluski, Jodi L.] Univ Liege, GIGA Neurosci, Liege, Belgium; [Pawluski, Jodi L.] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA; [Sierksma, Annerieke S.] VIB Ctr Biol Dis, Leuven, Belgium; [Sierksma, Annerieke S.] Katholieke Univ Leuven, Ctr Human Genet, Leuven, Belgium; [Blokland, Arjan] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands; [Canete, Ramon] Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba IMIBIC, Unidad Endocrinol Pediat, Cordoba, Spain	Maastricht University; Utrecht University; University of Liege; University System of Ohio; Ohio University; Flanders Institute for Biotechnology (VIB); KU Leuven; Maastricht University	van Donkelaar, EL (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Sch Mental Hlth & Neurosci, Maastricht, Netherlands.	eva.vandonkelaar@maastrichtuniversity.nl	Steinbusch, Heinrich/L-6950-2017; Pawluski, Jodi L/K-5801-2015; Sierksma, Annerieke/L-7990-2016	Pawluski, Jodi L/0000-0002-8240-8178; 	Internationale Stichting Alzheimer Onderzoek (ISAO) [09551]; ZonNW [114024017]	Internationale Stichting Alzheimer Onderzoek (ISAO); ZonNW	EVD was financially supported by the Internationale Stichting Alzheimer Onderzoek (ISAO, grant number 09551; https://www.alzheimer.nl/) and ZonNW (grant number 114024017; http://www.zonmw.nl/nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Aznar S, 2011, J ALZHEIMERS DIS, V23, P177, DOI 10.3233/JAD-2010-100390; Bao AM, 2008, BRAIN RES REV, V57, P531, DOI 10.1016/j.brainresrev.2007.04.005; Biessels GJ, 2005, BIOCHEM SOC T, V33, P1041, DOI 10.1042/BST0331041; BINDRA D, 1953, J COMP PHYSIOL PSYCH, V46, P43, DOI 10.1037/h0057952; Briones A, 2011, BRIT J PHARMACOL, V165, P897; Budas G, 1999, NEUROSCI LETT, V276, P61, DOI 10.1016/S0304-3940(99)00790-9; Caraci F, 2010, EUR J PHARMACOL, V626, P64, DOI 10.1016/j.ejphar.2009.10.022; Craft S, 2005, NEUROBIOL AGING, V26, pS65, DOI 10.1016/j.neurobiolaging.2005.08.021; Cryan JF, 2007, CURR OPIN PSYCHIATR, V20, P1, DOI 10.1097/YCO.0b013e3280117733; Dallman MF, 2003, P NATL ACAD SCI USA, V100, P11696, DOI 10.1073/pnas.1934666100; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Detke MJ, 1996, BEHAV BRAIN RES, V73, P43; ELLIOTT EM, 1993, J NEUROCHEM, V61, P57, DOI 10.1111/j.1471-4159.1993.tb03537.x; Ennaceur A, 2006, BEHAV BRAIN RES, V171, P26, DOI 10.1016/j.bbr.2006.03.016; Ferrannini E, 1998, J HYPERTENS, V16, P895, DOI 10.1097/00004872-199816070-00001; Gardier AM, 2001, PSYCHOPHARMACOLOGY, V153, P393, DOI 10.1007/s002130000560; Gasparini L, 2001, J NEUROSCI, V21, P2561, DOI 10.1523/JNEUROSCI.21-08-02561.2001; GAVARD JA, 1993, DIABETES CARE, V16, P1167, DOI 10.2337/diacare.16.8.1167; Gillespie CF, 2005, PSYCHOSOM MED, V67, pS26, DOI 10.1097/01.psy.0000163456.22154.d2; Gounarides JS, 2008, ENDOCRINOLOGY, V149, P758, DOI 10.1210/en.2007-1214; Gourley SL, 2008, BIOL PSYCHIAT, V64, P884, DOI 10.1016/j.biopsych.2008.06.016; Grundy SM, 2004, ENDOCRIN METAB CLIN, V33, pIX, DOI 10.1016/S0889-8529(04)00035-0; Haan MN, 2006, NAT CLIN PRACT NEURO, V2, P159, DOI 10.1038/ncpneuro0124; Haas JT, 2009, CURR OPIN LIPIDOL, V20, P206, DOI 10.1097/MOL.0b013e32832b2024; Hem A, 1998, LAB ANIM-UK, V32, P364, DOI 10.1258/002367798780599866; Herrmann M, 2009, STEROIDS, V74, P245, DOI 10.1016/j.steroids.2008.11.009; Karatsoreos IN, 2010, ENDOCRINOLOGY, V151, P2117, DOI 10.1210/en.2009-1436; Lee S, 2008, AM J PHYSIOL-ENDOC M, V294, pE261, DOI 10.1152/ajpendo.00676.2007; Lucki I, 1997, BEHAV PHARMACOL, V8, P523, DOI 10.1097/00008877-199711000-00010; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nandi A, 2004, PHYSIOL REV, V84, P623, DOI 10.1152/physrev.00032.2003; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Reagan LP, 2008, EUR J PHARMACOL, V585, P64, DOI 10.1016/j.ejphar.2008.02.050; Reus VI, 2001, EXPERT OPIN INV DRUG, V10, P1789, DOI 10.1517/13543784.10.10.1789; Riederer P, 2011, NEUROTOX RES, V19, P253, DOI 10.1007/s12640-010-9203-1; Severino C, 2002, AM J PHYSIOL-ENDOC M, V283, pE367, DOI 10.1152/ajpendo.00185.2001; SHEPHERD JK, 1994, PSYCHOPHARMACOLOGY, V116, P56, DOI 10.1007/BF02244871; Sierksma ASR, 2013, NEUROBIOL AGING, V34, P319, DOI 10.1016/j.neurobiolaging.2012.05.012; Sierksma ASR, 2010, EUR J PHARMACOL, V626, P72, DOI 10.1016/j.ejphar.2009.10.021; Solas M, 2013, BBA-MOL BASIS DIS, V1832, P2332, DOI 10.1016/j.bbadis.2013.09.013; Solas M, 2010, NEUROPSYCHOPHARMACOL, V35, P1664, DOI 10.1038/npp.2010.13; Stoothoff WH, 2005, BBA-MOL BASIS DIS, V1739, P280, DOI 10.1016/j.bbadis.2004.06.017; Stranahan AM, 2008, HIPPOCAMPUS, V18, P1085, DOI 10.1002/hipo.20470; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Zhao LX, 2004, J NEUROSCI, V24, P11120, DOI 10.1523/JNEUROSCI.2860-04.2004; Zhao Y, 2008, EUR J PHARMACOL, V581, P113, DOI 10.1016/j.ejphar.2007.12.005	49	41	41	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e106960	10.1371/journal.pone.0106960	http://dx.doi.org/10.1371/journal.pone.0106960			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310187	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210300003
J	Bossa, AS; Salemi, VMC; Ribeiro, SP; Rosa, DS; Ferreira, LRP; Ferreira, SC; Nishiya, AS; Mady, C; Kalil, J; Cunha-Neto, E				Bossa, Aline S.; Salemi, Vera M. C.; Ribeiro, Susan P.; Rosa, Daniela S.; Pinto Ferreira, Ludmila Rodrigues; Ferreira, Suzete C.; Nishiya, Anna Shoko; Mady, Charles; Kalil, Jorge; Cunha-Neto, Edecio			Plasma Cytokine Profile in Tropical Endomyocardial Fibrosis: Predominance of TNF-a, IL-4 and IL-10	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; NECROSIS-FACTOR-ALPHA; DISEASE; EOSINOPHILIA; ACTIVATION; CARDIOMYOPATHY; INTERLEUKIN-10; ASSOCIATION; MORTALITY	Background: The participation of immune/inflammatory mechanisms in the pathogenesis of tropical endomyocardial fibrosis (EMF) has been suggested by the finding of early blood and myocardial eosinophilia. However, the inflammatory activation status of late-stage EMF patients is still unknown. Methodology/Principal findings: We evaluated pro- and anti-inflammatory cytokine levels in plasma samples from late stage EMF patients. Cytokine levels of Tumor Necrosis Factor (TNF)-alpha, Interferon (IFN)-gamma, Interleukin (IL)-2, IL-4, IL-6, and IL-10 were assayed in plasma samples from 27 EMF patients and compared with those of healthy control subjects. All EMF patients displayed detectable plasma levels of at least one of the cytokines tested. We found that TNF-alpha, IL-6, IL-4, and IL-10 were each detected in at least 74% of tested sera, and plasma levels of IL-10, IL-4, and TNF-alpha were significantly higher than those of controls. Plasma levels of such cytokines positively correlated with each other. Conclusions/Significance: The mixed pro-and anti-inflammatory/Th2circulating cytokine profile in EMF is consistent with the presence of a persistent inflammatory stimulus. On the other hand, the detection of increased levels of TNF-alpha may be secondary to the cardiovascular involvement observed in these patients, whereas IL-4 and IL-10 may have been upregulated as a homeostatic mechanism to buffer both production and deleterious cardiovascular effects of pro-inflammatory cytokines. Further studies might establish whether these findings play a role in disease pathogenesis.	[Bossa, Aline S.; Pinto Ferreira, Ludmila Rodrigues; Kalil, Jorge; Cunha-Neto, Edecio] Univ Sao Paulo, Sch Med, Inst Heart InCor, Immunol Lab, Sao Paulo, Brazil; [Bossa, Aline S.; Ribeiro, Susan P.; Pinto Ferreira, Ludmila Rodrigues; Kalil, Jorge; Cunha-Neto, Edecio] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Salemi, Vera M. C.; Ferreira, Suzete C.; Mady, Charles] Univ Sao Paulo, Sch Med, Inst Heart InCor, Cardiomyopathy Unit, Sao Paulo, Brazil; [Nishiya, Anna Shoko] ProSangue Fdn, Sao Paulo, Brazil; [Nishiya, Anna Shoko] Inst Investigat Immunol, INCT, Sao Paulo, Brazil; [Rosa, Daniela S.] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Div Immunol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Cunha-Neto, E (corresponding author), Univ Sao Paulo, Sch Med, Inst Heart InCor, Immunol Lab, Sao Paulo, Brazil.	edecunha@usp.br	Salemi, Vera MC/C-9104-2013; Nishiya, Anna/Q-8156-2016; KALIL, JORGE/C-8029-2012; Ferreira, Ludmila Rodrigues Pinto/AAO-7540-2021; Ferreira, Ludmila Rodrigues Pinto/B-4955-2015; Cunha-Neto, Edecio/B-4157-2009; Mady, Charles/C-8870-2012; Ferreira, Ludmila/C-4100-2012; Rosa, Daniela S/D-2190-2012; Salemi, Vera/AAY-5024-2020	Salemi, Vera MC/0000-0002-7152-1810; KALIL, JORGE/0000-0001-8415-4274; Ferreira, Ludmila Rodrigues Pinto/0000-0001-9944-6691; Ferreira, Ludmila Rodrigues Pinto/0000-0001-9944-6691; Cunha-Neto, Edecio/0000-0002-3699-3345; Mady, Charles/0000-0002-8838-199X; Ferreira, Ludmila/0000-0001-9944-6691; Rosa, Daniela S/0000-0003-4536-891X; 	Brazilian Council for Scientific and Technological Development - CNPq; Sao Paulo State Research Funding Agency - FAPESP; Sao Paulo State Research Funding Agency - FAPESP fellowship	Brazilian Council for Scientific and Technological Development - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo State Research Funding Agency - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Sao Paulo State Research Funding Agency - FAPESP fellowship	This research was supported by the Brazilian Council for Scientific and Technological Development - CNPq and the Sao Paulo State Research Funding Agency - FAPESP. ASB is recipient of a Sao Paulo State Research Funding Agency - FAPESP fellowship. ECN and JK are recipients of Brazilian Council for Scientific and Technological Development - CNPq productivity awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir O, 2010, ISR MED ASSOC J, V12, P158; Andy JJ, 1998, ACTA TROP, V69, P127, DOI 10.1016/S0001-706X(97)00125-3; Anker SD, 2004, HEART, V90, P464, DOI 10.1136/hrt.2002.007005; Aukrust P, 2005, ANN MED, V37, P74, DOI 10.1080/07853890510007232; BROCKING.IF, 1972, POSTGRAD MED J, V48, P740, DOI 10.1136/pgmj.48.566.740; DAVIES J N P, 1948, East Afr Med J, V25, P454; Gage JR, 2004, NEUROIMMUNOMODULAT, V11, P173, DOI 10.1159/000076766; Guinjoan SM, 2009, WORLD J BIOL PSYCHIA, V10, P913, DOI 10.1080/15622970802432153; Haudek SB, 2007, J CLIN INVEST, V117, P2692, DOI 10.1172/JCI29134; Iglezias SD, 2008, VIRCHOWS ARCH, V453, P233, DOI 10.1007/s00428-008-0652-3; IVE FA, 1967, Q J MED, V36, P495; MacDonald AS, 2002, INFECT IMMUN, V70, P427, DOI 10.1128/IAI.70.2.427-433.2002; Mann DL, 2003, ANNU REV PHYSIOL, V65, P81, DOI 10.1146/annurev.physiol.65.092101.142249; Mehra VC, 2005, J LEUKOCYTE BIOL, V78, P805, DOI 10.1189/jlb.0405182; Mocelin AO, 2005, EUR J HEART FAIL, V7, P869, DOI 10.1016/j.ejheart.2004.10.014; Muller-Werdan U, 1998, EUR CYTOKINE NETW, V9, P689; Orus J, 2000, J HEART LUNG TRANSPL, V19, P419, DOI 10.1016/S1053-2498(00)00083-8; PATEL AK, 1977, BRIT HEART J, V39, P238; Rauchhaus M, 2000, CIRCULATION, V102, P3060; ROBERTS WC, 1969, AM J MED, V46, P28, DOI 10.1016/0002-9343(69)90055-2; Salemi VMC, 2011, CIRC-CARDIOVASC IMAG, V4, P304, DOI 10.1161/CIRCIMAGING.110.950675; Salemi VM, 2009, EUR J ECHOCARDIOGR, V10, P400, DOI 10.1093/ejechocard/jen297; Salemi VMC, 2004, ARTIF ORGANS, V28, P343, DOI 10.1111/j.1525-1594.2004.47352.x; Sato Y, 1999, CLIN CARDIOL, V22, P811, DOI 10.1002/clc.4960221211; Satoh Mamoru, 2008, Curr Heart Fail Rep, V5, P69, DOI 10.1007/s11897-008-0012-2; Schopf LR, 2002, J IMMUNOL, V168, P2383, DOI 10.4049/jimmunol.168.5.2383; Sliwa K, 2010, CLIN RES CARDIOL, V99, P65, DOI 10.1007/s00392-009-0094-1; Sun L, 2011, AM J PHYSIOL-LUNG C, V300, pL341, DOI 10.1152/ajplung.00122.2010; TorreAmione G, 1996, J AM COLL CARDIOL, V27, P1201, DOI 10.1016/0735-1097(95)00589-7; Yamaoka M, 1999, JPN CIRC J, V63, P951, DOI 10.1253/jcj.63.951; Yu LP, 2012, PARASITOL RES, V110, P1547, DOI 10.1007/s00436-011-2661-4	32	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108984	10.1371/journal.pone.0108984	http://dx.doi.org/10.1371/journal.pone.0108984			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303100	Green Published, gold, Green Submitted			2022-12-27	WOS:000343730400039
J	Colvin, CJ; Konopka, S; Chalker, JC; Jonas, E; Albertini, J; Amzel, A; Fogg, K				Colvin, Christopher J.; Konopka, Sarah; Chalker, John C.; Jonas, Edna; Albertini, Jennifer; Amzel, Anouk; Fogg, Karen			A Systematic Review of Health System Barriers and Enablers for Antiretroviral Therapy (ART) for HIV-Infected Pregnant and Postpartum Women	PLOS ONE			English	Article							SINGLE-DOSE NEVIRAPINE; TO-CHILD TRANSMISSION; FOLLOW-UP; ADDIS-ABABA; CAPE-TOWN; ADHERENCE; PREVENTION; PMTCT; INITIATION; MORTALITY	Background: Despite global progress in the fight to reduce maternal mortality, HIV-related maternal deaths remain persistently high, particularly in much of Africa. Lifelong antiretroviral therapy (ART) appears to be the most effective way to prevent these deaths, but the rates of three key outcomes-ART initiation, retention in care, and long-term ART adherence-remain low. This systematic review synthesized evidence on health systems factors affecting these outcomes in pregnant and postpartum women living with HIV. Methods: Searches were conducted for studies addressing the population of interest (HIV-infected pregnant and postpartum women), the intervention of interest (ART), and the outcomes of interest (initiation, adherence, and retention). Quantitative and qualitative studies published in English since January 2008 were included. A four-stage narrative synthesis design was used to analyze findings. Review findings from 42 included studies were categorized according to five themes: 1) models of care, 2) service delivery, 3) resource constraints and governance challenges, 4) patient-health system engagement, and 5) maternal ART interventions. Results: Low prioritization of maternal ART and persistent dropout along the maternal ART cascade were key findings. Service delivery barriers included poor communication and coordination among health system actors, poor clinical practices, and gaps in provider training. The few studies that assessed maternal ART interventions demonstrated the importance of multi-pronged, multi-leveled interventions. Conclusions: There has been a lack of emphasis on the experiences, needs and vulnerabilities particular to HIV-infected pregnant and postpartum women. Supporting these women to successfully traverse the maternal ART cascade requires carefully designed and targeted interventions throughout the steps. Careful design of integrated service delivery models is of critical importance in this effort. Key knowledge gaps and research priorities were also identified, including definitions and indicators of adherence rates, and the importance of cumulative measures of dropout along the maternal ART cascade.	[Colvin, Christopher J.] Univ Cape Town, Sch Publ Hlth & Family Med, Div Social & Behav Sci, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; [Konopka, Sarah; Jonas, Edna] Management Sci Hlth, Ctr Hlth Serv, Arlington, VA USA; [Chalker, John C.] Management Sci Hlth, Ctr Pharmaceut Management, Arlington, VA USA; [Albertini, Jennifer] US Agcy Int Dev, Africa Bur, Washington, DC 20523 USA; [Amzel, Anouk] USAID, Bur Global Hlth, Off HIV AIDS, Washington, DC USA; [Fogg, Karen] USAID, BGH, Off Hlth Infect Dis & Nutr, Washington, DC USA	University of Cape Town; United States Agency for International Development (USAID); United States Agency for International Development (USAID); United States Agency for International Development (USAID)	Colvin, CJ (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Div Social & Behav Sci, Ctr Infect Dis Epidemiol & Res, Med Sch Campus, ZA-7925 Cape Town, South Africa.	cj.colvin@uct.ac.za	Colvin, Christopher/AAB-8276-2019; Colvin, Christopher/AAQ-1607-2021	Colvin, Christopher/0000-0002-8930-7863; 	Africa Bureau of USAID	Africa Bureau of USAID(United States Agency for International Development (USAID))	This review was supported by funding from the Africa Bureau of USAID. Three co-authors on the paper are from USAID. They played a role in designing the review questions and methods, and contributed to revisions of the manuscript. They were not involved in data collection and analysis or drafting of the initial manuscript.	Abdool Karim Q, 2010, LANCET, V375, P1948, DOI 10.1016/S0140-6736(10)60747-7; Addala A, 2010, 18 INT AIDS C RIGHTS; Ayuo P, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17994; Barr BT, 2013, C RETR PREGN LACT WO; Bullo M, 2009, 18 ISSTDR LOND UK; Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Chinkonde JR, 2009, REPROD HEALTH MATTER, V17, P143, DOI 10.1016/S0968-8080(09)33440-0; Clouse K, 2013, TROP MED INT HEALTH, V18, P451, DOI 10.1111/tmi.12072; Colvin CJ, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-31; Coria A, 2012, JAIDS-J ACQ IMM DEF, V61, P636, DOI 10.1097/QAI.0b013e31826abdd1; Coutsoudis A, 2013, LANCET, V381, P269, DOI 10.1016/S0140-6736(12)61807-8; Dean AL, 2012, J TELEMED TELECARE, V18, P399, DOI 10.1258/jtt.2012.120118; Delvaux T, 2009, JAIDS-J ACQ IMM DEF, V50, P223, DOI 10.1097/QAI.0b013e31819001a3; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Esiru G, 2013, C PREGN WOM THEIR HI; Ferguson L, 2012, JAIDS-J ACQ IMM DEF, V60, pE90, DOI 10.1097/QAI.0b013e318253258a; Hodgson I, 2014, PLOS MED UNPUB; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Jerome JS, 2012, AIDS CARE, V24, P491, DOI 10.1080/09540121.2011.613906; Kagee A, 2011, GLOB PUBLIC HEALTH, V6, P83, DOI 10.1080/17441691003796387; Kasenga F, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.1882; Killam WP, 2010, AIDS, V24, P85, DOI 10.1097/QAD.0b013e32833298be; Kim MH, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17389; Kirsten I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021020; Kuonza LR, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-218; Liotta G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071653; Makadzange AT, 2010, CLIN INFECT DIS, V50, P1532, DOI 10.1086/652652; Mandala J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-314; Mellins CA, 2008, AIDS CARE, V20, P958, DOI 10.1080/09540120701767208; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mirkuzie AH, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-50; Mirkuzie AH, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-267; Moodley J, 2011, BJOG-INT J OBSTET GY, V118, P219, DOI 10.1111/j.1471-0528.2010.02726.x; Muchedzi A, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-38; Myer L, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-94; Myer L, 2012, AIDS CARE, V24, P986, DOI 10.1080/09540121.2012.668173; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Nassali M, 2009, AIDS CARE, V21, P1124, DOI 10.1080/09540120802707467; Ngidi W, 2013, J ACQUIR IMMUNE DEFI; O'Gorman DA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-354; Pai NP, 2012, INT J STD AIDS, V23, P319, DOI 10.1258/ijsa.2011.011139; Peltzer K, 2011, ACTA PAEDIATR, V100, P1253, DOI 10.1111/j.1651-2227.2011.02253.x; Peltzer K, 2010, ACTA PAEDIATR, V99, P699, DOI 10.1111/j.1651-2227.2010.01699.x; Popay J., 2006, GUIDANCE CONDUCT NAR; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Ramers C, 2010, 18 INT AIDS C RIGHTS; Scanlon ML, 2013, HIV AIDS-RES PALLIAT, V5, P1, DOI 10.2147/HIV.S28912; Sprague C, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-10; Stinson K, 2014, LAY HLTH WORK SUPP S; Stinson K, 2010, TROP MED INT HEALTH, V15, P825, DOI 10.1111/j.1365-3156.2010.02538.x; SURE Collaboration, 2011, ID ADDR BARR IMPL PO; Thetard RHS, 2014, PLOS MED UNPUB; Tsague L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-753; Tshabalala MF, 2010, 18 INT AIDS C RIGHTS; Ujiji OA, 2011, CULT HEALTH SEX, V13, P829, DOI 10.1080/13691058.2011.583682; Van Schalkwyk M, 2013, J ACQUIR IMMUNE DEFI; Varga C, 2008, QUAL HEALTH RES, V18, P786, DOI 10.1177/1049732308318449; Watson-Jones D, 2012, PLOS ONE US; Weigel R, 2012, TROP MED INT HEALTH, V17, P751, DOI 10.1111/j.1365-3156.2012.02980.x; WHO, 2010, TRENDS MAT MORT 1990; WHO, 2007, EV BUS STRENGTH HLTH; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Winestone LE, 2010, 18 INT AIDS C RIGHTS; World Health Organization, 2011, GLOB HLTH SECT STRAT; Zaba B, 2013, LANCET, V381, P1763, DOI 10.1016/S0140-6736(13)60803-X	65	87	87	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108150	10.1371/journal.pone.0108150	http://dx.doi.org/10.1371/journal.pone.0108150			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6ZS	25303241	Green Published, gold, Green Submitted			2022-12-27	WOS:000343730400008
J	Lee, JY; Divaris, K; DeWalt, DA; Baker, AD; Gizlice, Z; Rozier, RG; Vann, WF				Lee, Jessica Y.; Divaris, Kimon; DeWalt, Darren A.; Baker, A. Diane; Gizlice, Ziya; Rozier, R. Gary; Vann, William F., Jr.			Caregivers' Health Literacy and Gaps in Children's Medicaid Enrollment: Findings from the Carolina Oral Health Literacy Study	PLOS ONE			English	Article							NEWEST VITAL SIGN; INSURANCE-COVERAGE; UNITED-STATES; ELIGIBLE CHILDREN; PREVENTIVE CARE; UNINSURED CHILDREN; FEMALE CAREGIVERS; WIC PARTICIPATION; ADULT LITERACY; POOR CHILDREN	Background and Objectives: Recent evidence supports a link between caregivers' health literacy and their children's health and use of health services. Disruptions in children's health insurance coverage have been linked to poor health care and outcomes. We examined young children's Medicaid enrollment patterns in a well-characterized cohort of child/caregivers dyads and investigated the association of caregivers' low health literacy with the incidence of enrollment gaps. Methods: We relied upon Medicaid enrollment data for 1208 children (mean age = 19 months) enrolled in the Carolina Oral Health Literacy project during 2008-09. The median follow-up was 25 months. Health literacy was measured using the Newest Vital Sign (NVS). Analyses relied on descriptive, bivariate, and multivariate methods based on Poisson modeling. Findings: One-third of children experienced one or more enrollment gaps; most were short in duration (median = 5 months). The risk of gaps was inversely associated with caregivers' age, with a 2% relative risk decrease for each added year. Low health literacy was associated with a modestly elevated risk increase [Incidence Rate Ratio (IRR) = 1.17 (95% confidence interval (CI) 0.88-1.57)] for enrollment disruptions; however, this estimate was substantially elevated among caregivers with less than a high school education [IRR = 1.52 (95% CI 0.99-2.35); homogeneity p<0.2]. Conclusions: Our findings provide initial support for a possible role of caregivers' health literacy as a determinant of children's Medicaid enrollment gaps. Although the association between health literacy and enrollment gaps was not confirmed statistically, we found that it was markedly stronger among caregivers with low educational attainment. This population, as well as young caregivers, may be the most vulnerable to the negative effects of low health literacy.	[Lee, Jessica Y.; Divaris, Kimon; Baker, A. Diane; Vann, William F., Jr.] Univ N Carolina, Sch Dent, Dept Pediat Dent, Chapel Hill, NC 27514 USA; [Lee, Jessica Y.; Rozier, R. Gary] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC USA; [Divaris, Kimon] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [DeWalt, Darren A.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [DeWalt, Darren A.] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA; [Gizlice, Ziya] Univ N Carolina, Ctr Hlth Promot & Dis Prevent, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Lee, JY (corresponding author), Univ N Carolina, Sch Dent, Dept Pediat Dent, Chapel Hill, NC 27514 USA.	Jessica_Lee@unc.edu	Divaris, Kimon/AAU-8735-2021; Divaris, Kimon/E-4706-2011	Divaris, Kimon/0000-0003-1290-7251; Divaris, Kimon/0000-0003-1290-7251; DeWalt, Darren/0000-0003-2270-751X	National Institute of Dental and Craniofacial Research of the National Institutes of Health [RO1DE018045]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018045] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The Carolina Oral Health Literacy Study is supported by a grant from the National Institute of Dental and Craniofacial Research of the National Institutes of Health (RO1DE018045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baicker K, 2012, MILBANK Q, V90, P107, DOI 10.1111/j.1468-0009.2011.00656.x; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; Chatterji P, 2004, AM J PUBLIC HEALTH, V94, P1324, DOI 10.2105/AJPH.94.8.1324; Christakis DA, 1999, PEDIATRICS, V103, P738, DOI 10.1542/peds.103.4.738; Chung PJ, 2006, ANNU REV PUBL HEALTH, V27, P491, DOI 10.1146/annurev.publhealth.27.021405.102155; Cooper WO, 2005, MED CARE, V43, P718, DOI 10.1097/01.mlr.0000167174.05861.3d; Devoe JE, 2008, AMBUL PEDIATR, V8, P129, DOI 10.1016/j.ambp.2007.10.003; Devoe JE, 2008, HEALTH SERV RES, V43, P401, DOI 10.1111/j.1475-6773.2007.00764.x; DeVoe JE, 2012, FAM MED, V44, P39; DeWalt Darren A, 2009, Pediatrics, V124 Suppl 3, pS265, DOI 10.1542/peds.2009-1162B; Divaris K, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-108; Fairbrother G, 2011, ACAD PEDIATR, V11, P318, DOI 10.1016/j.acap.2011.05.004; Fairbrother GL, 2007, HEALTH AFFAIR, V26, P520, DOI 10.1377/hlthaff.26.2.520; Federico SG, 2007, PEDIATRICS, V120, pe1009, DOI 10.1542/peds.2006-3094; Ferguson Barbara, 2008, Nurs Womens Health, V12, P286, DOI 10.1111/j.1751-486X.2008.00343.x; Fisher MA, 2007, COMMUNITY DENT ORAL, V35, P263, DOI 10.1111/j.1600-0528.2007.00341.x; Fisher MA, 2009, J AM DENT ASSOC, V140, P1403, DOI 10.14219/jada.archive.2009.0078; Flores G, 2005, AMBUL PEDIATR, V5, P332, DOI 10.1367/A04-067R2.1; Freed GL, 1999, PEDIATRICS, V103, P864; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Greenland S, 2008, MODERN EPIDEMIOLOGY, P258; Hakim RB, 2001, PEDIATRICS, V108, P90, DOI 10.1542/peds.108.1.90; Heinrich C, 2012, J AM ACAD NURSE PRAC, V24, P218, DOI 10.1111/j.1745-7599.2012.00698.x; KALTON G, 1983, INT STAT REV, V51, P175, DOI 10.2307/1402747; Kronebusch K, 2004, HEALTH AFFAIR, V23, P233, DOI 10.1377/hlthaff.23.3.233; Landers RM, 2012, NEW ENGL J MED, V367, P198, DOI 10.1056/NEJMp1206847; Lee JY, 2012, AM J PUBLIC HEALTH, V102, P923, DOI 10.2105/AJPH.2011.300291; Lee JY, 2011, J PUBLIC HEALTH DENT, V71, P152, DOI 10.1111/j.1752-7325.2011.00244.x; Lee JY, 2004, AM J PUBLIC HEALTH, V94, P772, DOI 10.2105/AJPH.94.5.772; Lillie-Blanton M, 2005, HEALTH AFFAIR, V24, P398, DOI 10.1377/hlthaff.24.2.398; National Association of Pediatric Nurse Practitioners, 2003, J Pediatr Health Care, V17, pA22; NEWACHECK PW, 1988, PEDIATRICS, V82, P462; Newacheck PW, 1998, NEW ENGL J MED, V338, P513, DOI 10.1056/NEJM199802193380806; Olson LM, 2005, NEW ENGL J MED, V353, P382, DOI 10.1056/NEJMsa043878; Osborn CY, 2007, AM J HEALTH BEHAV, V31, pS36; Parker RM, 2003, HEALTH AFFAIR, V22, P147, DOI 10.1377/hlthaff.22.4.147; Pati S, 2014, MATERN CHILD HLTH J, V18, P1176, DOI 10.1007/s10995-013-1348-0; Pati S, 2012, ACAD PEDIATR, V12, P297, DOI 10.1016/j.acap.2012.04.008; PEIXOTO JL, 1987, AM STAT, V41, P311, DOI 10.2307/2684752; Price J., 2006, J APPL SOCIAL SCI, V23, P92; Ross DC, 2003, FUTURE CHILD, V13, P81; Sanders LM, 2007, PEDIATRICS, V119, pE86, DOI 10.1542/peds.2005-1738; Sanders LM, 2009, ARCH PEDIAT ADOL MED, V163, P131, DOI 10.1001/archpediatrics.2008.539; Satchell M, 2005, PEDIATRICS, V116, P1155, DOI 10.1542/peds.2004-2403; Savage MF, 2004, PEDIATRICS, V114, pE418, DOI 10.1542/peds.2003-0469-F; Selden TM, 2006, PEDIATRICS, V118, pE1766, DOI 10.1542/peds.2006-0286; Sentell T, 2012, HEALTH AFFAIR, V31, P1039, DOI 10.1377/hlthaff.2011.0954; Sentell TL, 2006, J GEN INTERN MED, V21, P862, DOI 10.1111/j.1525-1497.2006.00538.x; Sheridan SL, 2011, J HEALTH COMMUN, V16, P30, DOI 10.1080/10810730.2011.604391; Sommers BD, 2012, HEALTH AFFAIR, V31, P909, DOI 10.1377/hlthaff.2011.0977; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; Starfield B, 2004, PEDIATRICS, V113, P1493; STPETER RF, 1992, JAMA-J AM MED ASSOC, V267, P2760, DOI 10.1001/jama.267.20.2760; Strickland BB, 2011, PEDIATRICS, V127, P604, DOI 10.1542/peds.2009-3555; Summer L, 2006, INSTABILITY PUBLIC H; Tang SFS, 2003, PEDIATRICS, V112, pE168, DOI 10.1542/peds.112.2.e168; Vann WF, 2010, J DENT RES, V89, P1395, DOI 10.1177/0022034510379601; Wachino V, 2009, MAXIMIZING KIDS ENRO; Weiss BD, 2005, ANN FAM MED, V3, P514, DOI 10.1370/afm.405; Welch VL, 2011, J AM BOARD FAM MED, V24, P281, DOI 10.3122/jabfm.2011.03.100212; Wilson JM, 2009, J HEALTH CARE POOR U, V20, P423, DOI 10.1353/hpu.0.0127; Wise PH, 2002, AM J PUBLIC HEALTH, V92, P1458, DOI 10.2105/AJPH.92.9.1458; Yin H Shonna, 2009, Pediatrics, V124 Suppl 3, pS289, DOI 10.1542/peds.2009-1162E; Yu JB, 2011, MED CARE RES REV, V68, P56, DOI 10.1177/1077558710374620	65	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110178	10.1371/journal.pone.0110178	http://dx.doi.org/10.1371/journal.pone.0110178			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6ZS	25303271	Green Published, gold, Green Submitted			2022-12-27	WOS:000343730400118
J	Munoz, IM; Szyniarowski, P; Toth, R; Rouse, J; Lachaud, C				Munoz, Ivan M.; Szyniarowski, Piotr; Toth, Rachel; Rouse, John; Lachaud, Christophe			Improved Genome Editing in Human Cell Lines Using the CRISPR Method	PLOS ONE			English	Article							TAL EFFECTORS; DNA; SYSTEMS; CAS9; SPECIFICITY; NUCLEASES; NICKASES	The Cas9/CRISPR system become a popular choice for genome editing. In this system, binding of a single guide (sg) RNA to a cognate genomic sequence enables the Cas9 nuclease to induce a double-strand break at that locus. This break is next repaired by an error-prone mechanism, leading to mutation and gene disruption. In this study we describe a range of refinements of the method, including stable cell lines expressing Cas9, and a PCR based protocol for the generation of the sgRNA. We also describe a simple methodology that allows both elimination of Cas9 from cells after gene disruption and re-intoduction of the disrupted gene. This advance enables easy assessment of the off target effects associated with gene disruption, as well as phenotype-based structure-function analysis. In our study, we used the Fan1 DNA repair gene as control in these experiments. Cas9/CRISPR-mediated Fanl disruption occurred at frequencies of around 29%, and resulted in the anticipated spectrLlm of genotoxin hypersensitivity, which was rescued by re-introduction of Fan1.	[Munoz, Ivan M.; Szyniarowski, Piotr; Toth, Rachel; Rouse, John; Lachaud, Christophe] Univ Dundee, Coll Life Sci, Med Res Council Prot Phosphorylat Unit, Dundee, Scotland	University of Dundee	Rouse, J (corresponding author), Univ Dundee, Coll Life Sci, Med Res Council Prot Phosphorylat Unit, Dundee, Scotland.	j.rouse@dundee.ac.uk; c.lachaud@dundee.ac.uk	Perez, Franck/A-1558-2014; Lachaud, Christophe/ABC-8596-2021	Perez, Franck/0000-0002-9129-9401; Lachaud, Christophe/0000-0003-2762-1619; Munoz Munoz, Ivan/0000-0002-1606-5445	Marie Curie Intra-European fellowship (FanDamAge); Medical Research Council (MRC); Medical Research Council [MC_U127070192, MC_UU_12016/1] Funding Source: researchfish; MRC [MC_U127070192, MC_UU_12016/1] Funding Source: UKRI	Marie Curie Intra-European fellowship (FanDamAge); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Marie Curie Intra-European fellowship (FanDamAge) and the Medical Research Council (MRC). The pharmaceutical companies supporting the Division of Signal Transduction Therapy Unit (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck KgaA, Janssen Pharmaceutica and Pfizer) associated with the MRC PPU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briggs AW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks624; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Makarova KS, 2011, J BACTERIOL, V193, P6039, DOI 10.1128/JB.05535-11; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Schmid-Burgk JL, 2013, NAT BIOTECHNOL, V31, P76, DOI 10.1038/nbt.2460; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	17	34	37	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e109752	10.1371/journal.pone.0109752	http://dx.doi.org/10.1371/journal.pone.0109752			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303670	Green Published, gold, Green Submitted			2022-12-27	WOS:000343730400077
J	Thanh, HN; Zhao, LJ; Liu, QG				Hai Nguyen Thanh; Zhao, Liangjie; Liu, Qigen			De Novo Transcriptome Sequencing Analysis and Comparison of Differentially Expressed Genes (DEGs) in Macrobrachium rosenbergii in China	PLOS ONE			English	Article							RNA-SEQ DATA; KYOTO ENCYCLOPEDIA; LITOPENAEUS-VANNAMEI; MICROSATELLITE LOCI; KEGG; IDENTIFICATION; PATHWAYS; PROFILIN; GENOMICS; BINDING	Giant freshwater prawn (GFP; Macrobrachium rosenbergii) is an exotic species that was introduced into China in 1976 and thereafter it became a major species in freshwater aquaculture. However the gene discovery in this species has been limited to small-scale data collection in China. We used the next generation sequencing technology for the experiment; the transcriptome was sequenced of samples of hepatopancreas organ in individuals from 4 GFP groups (A1, A2, B1 and B2). De novo transcriptome sequencing generated 66,953 isogenes. Using BLASTX to search the Non-redundant (NR), Search Tool for the Retrieval of Interacting Genes (STRING), and Kyoto Encyclopedia of Genes and Genome (KEGG) databases; 21,224 unigenes were annotated, 9,552 matched unigenes with the Gene Ontology (GO) classification; 5,782 matched unigenes in 25 categories of Clusters of Orthologous Groups of proteins (COG) and 20,859 unigenes were consequently assigned to 312 KEGG pathways. Between the A and B groups 147 differentially expressed genes (DEGs) were identified; between the A1 and A2 groups 6,860 DEGs were identified and between the B1 and B2 groups 5,229 DEGs were identified. After enrichment, the A and B groups identified 38 DEGs, but none of them were significantly enriched. The A1 and A2 groups identified 21,856 DEGs in three main categories based on functional groups: biological process, cellular_component and molecular function and the KEGG pathway defined 2,459 genes had a KEGG Ortholog - ID (KO-ID) and could be categorized into 251 pathways, of those, 9 pathways were significantly enriched. The B1 and B2 groups identified 5,940 DEGs in three main categories based on functional groups: biological process, cellular_component and molecular function, and the KEGG pathway defined 1,543 genes had a KO-ID and could be categorized into 240 pathways, of those, 2 pathways were significantly enriched. We investigated 99 queries (GO) which related to growth of GFP in 4 groups. After enrichment we identified 23 DEGs and 1 KEGG PATHWAY 'ko04711' relation with GFP growth.	[Hai Nguyen Thanh; Zhao, Liangjie; Liu, Qigen] Shanghai Ocean Univ, Key Lab Freshwater Fishery Germplasm Resources, Minist Agr, Shanghai, Peoples R China; [Hai Nguyen Thanh] Minist Agr & Rural Dev Viet Nam, Directorate Fisheries, Vietnam Inst Fisheries Econ & Planning, Hanoi, Vietnam	Ministry of Agriculture & Rural Affairs; Shanghai Ocean University	Liu, QG (corresponding author), Shanghai Ocean Univ, Key Lab Freshwater Fishery Germplasm Resources, Minist Agr, Shanghai, Peoples R China.	qgliu@shou.edu.cn			Special Fund for Agro-scientific Research in the Public Interest, State Agriculture Ministry of China [201203083]; Shanghai University Knowledge Service Platform Project [ZF1206]; Shanghai Universities First-class Disciplines Project of Fisheries	Special Fund for Agro-scientific Research in the Public Interest, State Agriculture Ministry of China; Shanghai University Knowledge Service Platform Project; Shanghai Universities First-class Disciplines Project of Fisheries	This study was supported by Special Fund for Agro-scientific Research in the Public Interest, State Agriculture Ministry of China (201203083), by Shanghai University Knowledge Service Platform Project (ZF1206) and by Shanghai Universities First-class Disciplines Project of Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermann E, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-60; Asusens ACJ, 2012, AQUACULTURE RES DEV, V3, P1; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Brady P, 2012, INT J BIOL SCI, V8, P328, DOI 10.7150/ijbs.3517; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carlson Joe, 2009, Mod Healthc, V39, P17; CARLSSON L, 1977, J MOL BIOL, V115, P465, DOI 10.1016/0022-2836(77)90166-8; Chand V, 2005, MOL ECOL NOTES, V5, P308, DOI 10.1111/j.1471-8286.2005.00910.x; Chareontawee K, 2007, AQUACULTURE, V271, P121, DOI 10.1016/j.aquaculture.2007.07.001; Chen JM, 1998, FEBS LETT, V441, P361, DOI 10.1016/S0014-5793(98)01574-9; Chen JM, 1997, J BIOL CHEM, V272, P8090, DOI 10.1074/jbc.272.12.8090; Chen S, 2003, J BIOL CHEM, V278, P20029, DOI 10.1074/jbc.M300818200; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa A, 2009, BLAST2GO TUTORIAL; Di Nardo A, 2000, J CELL SCI, V113, P3795; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Erlich Y, 2008, NAT METHODS, V5, P679, DOI 10.1038/nmeth.1230; FAO, 2012, FISH STAT DAT GLOB A; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hara-Nishimura I, 1998, HDB PROTEOLYTIC ENZY, P746; HernandezSanchez C, 1997, J BIOL CHEM, V272, P4663, DOI 10.1074/jbc.272.8.4663; Hoare S, 1999, ENDOCRINOLOGY, V140, P2268, DOI 10.1210/en.140.5.2268; Hochberg YY, 2005, J ROYAL STAT SOC, V57; INABA T, 1992, SCIENCE, V257, P531, DOI 10.1126/science.1386162; Jianguo LEP, 2012, BMC GENOMICS, V13; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Keyi M, 2012, PLOS ONE, V7; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Liang HY, 2008, TREE GENET GENOMES, V4, P419, DOI 10.1007/s11295-007-0120-2; Maizatul IM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060839., DOI 10.1371/JOURNAL.PONE.0060839]; Manna PR, 2002, MOL ENDOCRINOL, V16, P184, DOI 10.1210/me.16.1.184; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mckernan K, 2006, US patent application, Patent No. 20080003571; MikelAickin P, 1996, AM J PUBLIC HLTH, V86; Minet-Quinared R, 2004, AM J PHYSIOL-ENDOC M, V287, pE671, DOI 10.1152/ajpendo.00185.2003; MINTON AP, 1992, BIOPHYS J, V63, P1090, DOI 10.1016/S0006-3495(92)81663-6; Mitchell SG, 2009, CHEM COMMUN, P2712, DOI 10.1039/b903206a; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakazato T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077910; Nguyen MT, 2010, AQUACULTURE, V301, P7, DOI 10.1016/j.aquaculture.2010.02.001; Nhan DT, 2010, AQUACULTURE, V300, P80, DOI 10.1016/j.aquaculture.2009.12.012; Nhan DT, 2009, AQUACULTURE, V298, P36, DOI 10.1016/j.aquaculture.2009.09.011; Nunan LM, 2001, J WORLD AQUACULT SOC, V32, P330, DOI 10.1111/j.1749-7345.2001.tb00456.x; Phuong NT, 2006, FISHERIES SCI, V72, P1, DOI 10.1111/j.1444-2906.2006.01109.x; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schwantes VS, 2009, AQUACULTURE, V287, P120, DOI 10.1016/j.aquaculture.2008.10.017; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Siddle K, 2001, BIOCHEM SOC T, V29, P513, DOI 10.1042/BST0290513; Sookruksawong S, 2013, FISH SHELLFISH IMMUN, V35, P1395, DOI 10.1016/j.fsi.2013.08.003; Sookruksawong S, 2013, DEV COMP IMMUNOL, V41, P523, DOI 10.1016/j.dci.2013.07.020; Stanewsky R, 2003, J NEUROBIOL, V54, P111, DOI 10.1002/neu.10164; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Thanh NM, 2010, AQUACULTURE, V299, P30, DOI 10.1016/j.aquaculture.2009.12.011; Thanh NM, 2009, AQUACULTURE, V287, P75, DOI 10.1016/j.aquaculture.2008.10.051; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Uawisetwathana U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024427; Vigouroux Y, 2002, MOL BIOL EVOL, V19, P1251, DOI 10.1093/oxfordjournals.molbev.a004186; Vlahopoulos SA, 2008, BIOESSAYS, V30, P314, DOI 10.1002/bies.20734; Wang JPZ, 2004, BIOINFORMATICS, V20, P2973, DOI 10.1093/bioinformatics/bth342; WESTFALL PH, 1989, J AM STAT ASSOC, V84, P780, DOI 10.2307/2289666; Woessner J. F., 1998, HDB PROTEOLYTIC ENZY, P749; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yang GL, 2012, AQUAC RES, V43, P1049, DOI 10.1111/j.1365-2109.2011.03009.x; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zara FJ, 2013, ACTA ZOOL-STOCKHOLM, V94, P134, DOI 10.1111/j.1463-6395.2011.00537.x	77	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e109656	10.1371/journal.pone.0109656	http://dx.doi.org/10.1371/journal.pone.0109656			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329319	Green Published, Green Submitted, gold			2022-12-27	WOS:000343942100033
J	Lee, S; Page-McCaw, P; Gamse, JT				Lee, Stacey; Page-McCaw, Patrick; Gamse, Joshua T.			Kctd12 and Ulk2 Partner to Regulate Dendritogenesis and Behavior in the Habenular Nuclei	PLOS ONE			English	Article							ZEBRAFISH; MORPHOGENESIS; ASYMMETRY	The habenular nuclei of the limbic system regulate responses, such as anxiety, to aversive stimuli in the environment. The habenulae receive inputs from the telencephalon via elaborate dendrites that form in the center of the nuclei. The kinase Ulk2 positively regulates dendritogenesis on habenular neurons, and in turn is negatively regulated by the cytoplasmic protein Kctd12. Given that the habenulae are a nexus in the aversive response circuit, we suspected that incomplete habenular dendritogenesis would have profound implications for behavior. We find that Ulk2, which interacts with Kctd12 proteins via a small proline-serine rich domain, promotes branching and elaboration of dendrites. Loss of Kctd12 results in increased branching/elaboration and decreased anxiety. We conclude that fine-tuning of habenular dendritogenesis during development is essential for appropriate behavioral responses to negative stimuli.	[Lee, Stacey; Gamse, Joshua T.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Page-McCaw, Patrick] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University	Gamse, JT (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	josh.gamse@vanderbilt.edu		Page-McCaw, Patrick/0000-0002-4139-9770	Vanderbilt University Discovery Grant; NIH [R01 HD054534]; Vanderbilt University Program in Developmental Biology Training grant NIH [T32 HD007502]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007502] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD054534] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593, P60DK020593, P30DK058404, U24DK059637, U2CDK059637] Funding Source: NIH RePORTER	Vanderbilt University Discovery Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University Program in Developmental Biology Training grant NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by a Vanderbilt University Discovery Grant and by NIH R01 HD054534 to J.T.G. S. L. was supported by the Vanderbilt University Program in Developmental Biology Training grant NIH T32 HD007502. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00138; Bianco IH, 2009, PHILOS T R SOC B, V364, P1005, DOI 10.1098/rstb.2008.0213; Bianco IH, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-9; Caputo A, 1998, EUR ARCH PSY CLIN N, V248, P272, DOI 10.1007/s004060050049; Choe SK, 2011, DEV BIOL, V358, P356, DOI 10.1016/j.ydbio.2011.05.676; Colombo A, 2013, DEVELOPMENT, V140, P3997, DOI 10.1242/dev.091934; Gamse JT, 2005, DEVELOPMENT, V132, P4869, DOI 10.1242/dev.02046; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Klee EW, 2012, HUM GENET, V131, P977, DOI 10.1007/s00439-011-1128-0; Klee EW, 2011, NICOTINE TOB RES, V13, P301, DOI 10.1093/ntr/ntr010; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lee A, 2010, CURR BIOL, V20, P2211, DOI 10.1016/j.cub.2010.11.025; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Maximino C, 2010, NAT PROTOC, V5, P209, DOI 10.1038/nprot.2009.225; Metz M, 2011, J COMP NEUROL, V519, P1435, DOI 10.1002/cne.22610; Miklosi A, 2006, ZEBRAFISH, V3, P227, DOI 10.1089/zeb.2006.3.227; Morris JS, 1999, NEUROIMAGE, V10, P163, DOI 10.1006/nimg.1999.0455; Okamoto H, 2012, DEV NEUROBIOL, V72, P386, DOI 10.1002/dneu.20913; Ranft K, 2010, PSYCHOL MED, V40, P557, DOI 10.1017/S0033291709990821; Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027; Savitz JB, 2011, BIOL PSYCHIAT, V69, P336, DOI 10.1016/j.biopsych.2010.09.027; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schnorr SJ, 2012, BEHAV BRAIN RES, V228, P367, DOI 10.1016/j.bbr.2011.12.016; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Shepard PD, 2006, SCHIZOPHRENIA BULL, V32, P417, DOI 10.1093/schbul/sbj083; Shumake J, 2003, Behav Cogn Neurosci Rev, V2, P198, DOI 10.1177/1534582303259057; Taylor RW, 2011, J NEUROSCI, V31, P9869, DOI 10.1523/JNEUROSCI.0435-11.2011; Thisse B, 2001, ZFIN DIRECT DATA SUB; Tomoda T, 2004, GENE DEV, V18, P541, DOI 10.1101/gad.1151204; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; Yan J, 1999, ONCOGENE, V18, P5850, DOI 10.1038/sj.onc.1202988; Zhou X, 2007, P NATL ACAD SCI USA, V104, P5842, DOI 10.1073/pnas.0701402104	34	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2014	9	10							e110280	10.1371/journal.pone.0110280	http://dx.doi.org/10.1371/journal.pone.0110280			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0AY	25329151	Green Published, Green Submitted, gold			2022-12-27	WOS:000343942100050
J	Dabundo, R; Lehmann, MF; Treibergs, L; Tobias, CR; Altabet, MA; Moisander, PH; Granger, J				Dabundo, Richard; Lehmann, Moritz F.; Treibergs, Lija; Tobias, Craig R.; Altabet, Mark A.; Moisander, Pia H.; Granger, Julie			The Contamination of Commercial N-15(2) Gas Stocks with N-15-Labeled Nitrate and Ammonium and Consequences for Nitrogen Fixation Measurements	PLOS ONE			English	Article							ACETYLENE-REDUCTION ASSAY; ISOTOPIC COMPOSITION; FRESH; MARINE; CYANOBACTERIA; ASSIMILATION; DIAZOTROPHS; SEAWATER; NITRITE; RATES	We report on the contamination of commercial 15-nitrogen (N-15) N-2 gas stocks with N-15-enriched ammonium, nitrate and/or nitrite, and nitrous oxide. N-15(2) gas is used to estimate N-2 fixation rates from incubations of environmental samples by monitoring the incorporation of isotopically labeled N-15(2) into organic matter. However, the microbial assimilation of bioavailable N-15-labeled N-2 gas contaminants, nitrate, nitrite, and ammonium, is liable to lead to the inflation or false detection of N-2 fixation rates. N-15(2) gas procured from three major suppliers was analyzed for the presence of these N-15-contaminants. Substantial concentrations of N-15-contaminants were detected in four Sigma-Aldrich N-15(2) lecture bottles from two discrete batch syntheses. Per mole of N-15(2) gas, 34 to 1900 mmoles of N-15-ammonium, 1.8 to 420 mmoles of (15)Nnitrate/nitrite, and >= 21 mmoles of N-15-nitrous oxide were detected. One N-15(2) lecture bottle from Campro Scientific contained >= 11 mmoles of N-15-nitrous oxide per mole of N-15(2) gas, and no detected N-15-nitrate/nitrite at the given experimental N-15(2) tracer dilutions. Two Cambridge Isotopes lecture bottles from discrete batch syntheses contained >= 0.81 mu moles N-15-nitrous oxide per mole (15)N2, and trace concentrations of N-15-ammonium and N-15-nitrate/nitrite. N-15(2) gas equilibrated cultures of the green algae Dunaliella tertiolecta confirmed that the N-15-contaminants are assimilable. A finite-differencing model parameterized using oceanic field conditions typical of N-2 fixation assays suggests that the degree of detected N-15-ammonium contamination could yield inferred N-2 fixation rates ranging from undetectable, <0.01 nmoles N L-1 d(-1), to 530 nmoles N L-1 d(-1), contingent on experimental conditions. These rates are comparable to, or greater than, N-2 fixation rates commonly detected in field assays. These results indicate that past reports of N-2 fixation should be interpreted with caution, and demonstrate that the purity of commercial N-15(2) gas must be ensured prior to use in future N-2 fixation rate determinations.	[Dabundo, Richard; Treibergs, Lija; Tobias, Craig R.; Granger, Julie] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Lehmann, Moritz F.] Univ Basel, Inst Environm Geosci, Basel, Switzerland; [Altabet, Mark A.] Univ Massachusetts, Dept Estuarine & Ocean Sci, N Dartmouth, MA USA; [Moisander, Pia H.] Univ Massachusetts, Dept Biol, N Dartmouth, MA USA	University of Connecticut; University of Basel; University of Massachusetts System; University Massachusetts Dartmouth; University of Massachusetts System; University Massachusetts Dartmouth	Dabundo, R (corresponding author), Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA.	richard.dabundo@uconn.edu	Mourino, Beatriz/E-8635-2016; Lehmann, Moritz F/A-3301-2014	Lehmann, Moritz F/0000-0003-0626-5942; Moisander, Pia/0000-0002-3262-3662	National Science Foundation Ocean Sciences [1233897, 1130495]; University of Connecticut Research Funding Large Grant [461510]; Swiss National Science Foundation R'Equip [121258]; Directorate For Geosciences [1233897] Funding Source: National Science Foundation	National Science Foundation Ocean Sciences(National Science Foundation (NSF)); University of Connecticut Research Funding Large Grant; Swiss National Science Foundation R'Equip; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the following sources of funding: National Science Foundation Ocean Sciences, 1233897, JG; National Science Foundation Ocean Sciences, 1130495, PHM, MAA (http://www.nsf.gov/div/index.jsp?div = OCE); University of Connecticut Research Funding Large Grant, 461510, JG (http://research.uconn.edu); and Swiss National Science Foundation R'Equip 121258, MFL (http://www.snf.ch/en/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison SL, 2010, APPL MICROBIOL BIOT, V87, P2313, DOI 10.1007/s00253-010-2731-z; ALTABET MA, 1988, DEEP-SEA RES, V35, P535, DOI 10.1016/0198-0149(88)90130-6; ASHMORE PG, 1962, T FARADAY SOC, V58, P685, DOI 10.1039/tf9625800685; BELAY N, 1988, BIOCHIM BIOPHYS ACTA, V971, P233; Bergersen FJ, 1980, METHOD EVALUATING BI, P5; Blais M, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004096; Bohlke J.K., 1993, REF INT MAT STABL IS; Bohlke JK, 2003, RAPID COMMUN MASS SP, V17, P1835, DOI 10.1002/rcm.1123; BOHLKE JK, 1993, GEOSTANDARD NEWSLETT, V17, P159, DOI 10.1111/j.1751-908X.1993.tb00131.x; BRAMAN RS, 1989, ANAL CHEM, V61, P2715, DOI 10.1021/ac00199a007; Burris RH, 1941, SCIENCE, V93, P114, DOI 10.1126/science.93.2405.114; Casciotti KL, 2002, ANAL CHEM, V74, P4905, DOI 10.1021/ac020113w; CORDOBA F, 1986, PLANT PHYSIOL, V82, P904, DOI 10.1104/pp.82.4.904; Dekaezemacker J, 2013, GLOBAL BIOGEOCHEM CY, V27, P768, DOI 10.1002/gbc.20063; DEPOLLI H, 1977, SOIL BIOL BIOCHEM, V9, P119, DOI 10.1016/0038-0717(77)90047-5; Dore JE, 2002, LIMNOL OCEANOGR, V47, P1595, DOI 10.4319/lo.2002.47.6.1595; Fawcett SE, 2011, NAT GEOSCI, V4, P717, DOI [10.1038/ngeo1265, 10.1038/NGEO1265]; Fernandez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020539; GILLER KE, 1987, SOIL BIOL BIOCHEM, V19, P783, DOI 10.1016/0038-0717(87)90066-6; Gonfiantini R., 1984, ADV GROUP M STABL IS; Grosskopf T, 2012, NATURE, V488, P361, DOI 10.1038/nature11338; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Halm H, 2012, ISME J, V6, P1238, DOI 10.1038/ismej.2011.182; Hamersley MR, 2011, AQUAT MICROB ECOL, V63, P193, DOI 10.3354/ame01494; HARDY R W F, 1973, Soil Biology and Biochemistry, V5, P47, DOI 10.1016/0038-0717(73)90093-X; HARDY RWF, 1968, PLANT PHYSIOL, V43, P1185, DOI 10.1104/pp.43.8.1185; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; ILCHENKO NI, 1976, USP KHIM+, V45, P2168; KENDALL C, 1990, ANAL CHEM, V62, P526, DOI 10.1021/ac00204a019; McIlvin MR, 2011, ANAL CHEM, V83, P1850, DOI 10.1021/ac1028984; Mohr W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012583; Montoya JP, 2004, NATURE, V430, P1027, DOI 10.1038/nature02824; Montoya JP, 1996, APPL ENVIRON MICROB, V62, P986, DOI 10.1128/AEM.62.3.986-993.1996; Needoba JA, 2007, LIMNOL OCEANOGR, V52, P1317, DOI 10.4319/lo.2007.52.4.1317; OHYAMA T, 1981, SOIL SCI PLANT NUTR, V27, P263, DOI 10.1080/00380768.1981.10431278; Qi HP, 2003, RAPID COMMUN MASS SP, V17, P2483, DOI 10.1002/rcm.1219; Scharff AM, 2003, PLANT PHYSIOL, V131, P367, DOI 10.1104/pp.015156; Sigman DM, 2001, ANAL CHEM, V73, P4145, DOI 10.1021/ac010088e; Staal M, 2001, ENVIRON MICROBIOL, V3, P343, DOI 10.1046/j.1462-2920.2001.00201.x; STAM H, 1987, FEMS MICROBIOL LETT, V46, P73, DOI 10.1016/0378-1097(87)90187-X; STEWART WDP, 1967, P NATL ACAD SCI USA, V58, P2071, DOI 10.1073/pnas.58.5.2071; Wilson ST, 2012, APPL ENVIRON MICROB, V78, P6516, DOI 10.1128/AEM.01146-12; Zhang L, 2007, ANAL CHEM, V79, P5297, DOI 10.1021/ac070106d	43	167	169	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110335	10.1371/journal.pone.0110335	http://dx.doi.org/10.1371/journal.pone.0110335			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	25329300	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204100064
J	Jiang, B; Huang, YD				Jiang, Bo; Huang, Yu Dong			Non-Contact Analysis of the Adsorptive Ink Capacity of Nano Silica Pigments on a Printing Coating Base	PLOS ONE			English	Article							SPECTROSCOPY	Near infrared spectra combined with partial least squares were proposed as a means of non-contact analysis of the adsorptive ink capacity of recording coating materials in ink jet printing. First, the recording coating materials were prepared based on nano silica pigments. 80 samples of the recording coating materials were selected to develop the calibration of adsorptive ink capacity against ink adsorption (g/m(2)). The model developed predicted samples in the validation set with r(2) = 0.80 and SEP = 1.108, analytical results showed that near infrared spectra had significant potential for the adsorption of ink capacity on the recording coating. The influence of factors such as recording coating thickness, mass ratio silica: binder-polyvinyl alcohol and the solution concentration on the adsorptive ink capacity were studied. With the help of the near infrared spectra, the adsorptive ink capacity of a recording coating material can be rapidly controlled.	[Jiang, Bo; Huang, Yu Dong] Harbin Inst Technol, Sch Chem Engn & Technol, Polymer Mat & Engn Dept, Harbin 150006, Peoples R China	Harbin Institute of Technology	Jiang, B (corresponding author), Harbin Inst Technol, Sch Chem Engn & Technol, Polymer Mat & Engn Dept, Harbin 150006, Peoples R China.	jiangbo5981@hit.edu.cn			National Natural Science Foundation of China [50903025]; Fundamental Research Funds for the Central Universities [HIT.IBRSEM.201318]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Funding from Grant No. 50903025 from the National Natural Science Foundation of China and Grant No. HIT.IBRSEM.201318 from the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chae SS, 2013, ADV MATER, V25, P1408, DOI 10.1002/adma.201202927; Chung JW, 2004, APPL PHYS LETT, V84, P801, DOI 10.1063/1.1644907; de Gans BJ, 2004, ADV MATER, V16, P203, DOI 10.1002/adma.200300385; de Gans BJ, 2007, ADV FUNCT MATER, V17, P23; Jiang B, 2008, ANAL CHIM ACTA, V616, P103, DOI 10.1016/j.aca.2008.04.013; Kim YH, 2012, ADV MATER, V24, P497, DOI 10.1002/adma.201103032; Lee KJ, 2006, NANOTECHNOLOGY, V17, P2424, DOI 10.1088/0957-4484/17/9/060; Moraes IR, 2011, CHEMPHYSCHEM, V12, P2920, DOI 10.1002/cphc.201100567; Sirringhaus H, 2000, SCIENCE, V290, P2123, DOI 10.1126/science.290.5499.2123; Fernandes DDS, 2011, TALANTA, V87, P30, DOI 10.1016/j.talanta.2011.09.025; Wu JT, 2012, J MATER CHEM, V22, P15599, DOI [10.1039/c2jm31761c, 10.1039/c2jm31761]; Yoshioka Y, 2006, ADV MATER, V18, P1307, DOI 10.1002/adma.200502362	12	0	0	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109918	10.1371/journal.pone.0109918	http://dx.doi.org/10.1371/journal.pone.0109918			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329464	Green Published, Green Submitted, gold			2022-12-27	WOS:000343210800046
J	Li, BYS; Zhan, CJ; Yeung, LF; Ko, KT; Yang, GK				Li, Benjamin Y. S.; Zhan, Choujun; Yeung, Lam F.; Ko, King T.; Yang, Genke			A Low Dimensional Approach on Network Characterization	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; ALIGNMENT	In many applications, one may need to characterize a given network among a large set of base networks, and these networks are large in size and diverse in structure over the search space. In addition, the characterization algorithms are required to have low volatility and with a small circle of uncertainty. For large datasets, these algorithms are computationally intensive and inefficient. However, under the context of network mining, a major concern of some applications is speed. Hence, we are motivated to develop a fast characterization algorithm, which can be used to quickly construct a graph space for analysis purpose. Our approach is to transform a network characterization measure, commonly formulated based on similarity matrices, into simple vector form signatures. We shall show that the N x N similarity matrix can be represented by a dyadic product of two N-dimensional signature vectors; thus the network alignment process, which is usually solved as an assignment problem, can be reduced into a simple alignment problem based on separate signature vectors.	[Li, Benjamin Y. S.; Yeung, Lam F.; Ko, King T.] City Univ Hong Kong, Dept Elect Engn, Hong Kong, Hong Kong, Peoples R China; [Zhan, Choujun] Hong Kong Polytech Univ, Dept Elect & Informat Engn, Hong Kong, Hong Kong, Peoples R China; [Yang, Genke] Shanghai Jiao Tong Univ, Dept Automat, Shanghai 200030, Peoples R China	City University of Hong Kong; Hong Kong Polytechnic University; Shanghai Jiao Tong University	Li, BYS (corresponding author), City Univ Hong Kong, Dept Elect Engn, Hong Kong, Hong Kong, Peoples R China.	yeesli2-c@my.cityu.edu.hk		YEUNG, Lam Fat/0000-0001-6462-7855; KO, King Tim/0000-0002-6412-1026	CityU Strategic Research Grant [7003016]	CityU Strategic Research Grant	This project is supported by CityU Strategic Research Grant 7003016. http://www.cityu.edu.hk/ro/dlSRG.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Blondel VD, 2004, SIAM REV, V46, P647, DOI 10.1137/S0036144502415960; Brandes U., 2005, NETWORK ANAL METHODO, V3418; Bunke H, 1998, PATTERN RECOGN LETT, V19, P255, DOI 10.1016/S0167-8655(97)00179-7; Cha S, 2007, CITY, V1, DOI DOI 10.1007/S00167-009-0884-Z; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chartrand G, 1998, AEQUATIONES MATH, V55, P129, DOI DOI 10.1007/s000100050025; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Fossum E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000570; Hardy GH., 1952, INEQUALITIES; Hayes W, 2013, BIOINFORMATICS, V29, P483, DOI 10.1093/bioinformatics/bts729; Kuchaiev O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-24; Milenkovic T, 2008, CANCER INFORM, V6, P257; Milenkovic T, 2010, CANCER INFORM, V9, P121, DOI 10.4137/CIN.S4744; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mises RV, 1929, ZAMM J APPL MATH MEC, V9, P152, DOI [10.1002/zamm.19290090206, DOI 10.1002/ZAMM.19290090105, DOI 10.1002/ZAMM.19290090206]; Papadopoulos A. N., 1999, Proceedings. Tenth International Workshop on Database and Expert Systems Applications. DEXA 99, P174, DOI 10.1109/DEXA.1999.795162; Penrose M., 2003, RANDOM GEOMETRIC GRA; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; Przulj N, 2006, J R SOC INTERFACE, V3, P711, DOI 10.1098/rsif.2006.0147; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Rito T, 2010, BIOINFORMATICS, V26, pi611, DOI 10.1093/bioinformatics/btq386; Singh R, 2008, P NATL ACAD SCI USA, V105, P12763, DOI 10.1073/pnas.0806627105; Takigawa I, 2013, DRUG DISCOV TODAY, V18, P50, DOI 10.1016/j.drudis.2012.07.016; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; UMEYAMA S, 1988, IEEE T PATTERN ANAL, V10, P695, DOI 10.1109/34.6778; Vishwanathan SVN, 2010, J MACH LEARN RES, V11, P1201; Wegner JK, 2012, COMMUN ACM, V55, P65, DOI 10.1145/2366316.2366334; Zhenping L, 2007, BIOINFORMATICS, V23, P1631, DOI 10.1093/bioinformatics/btm156	30	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2014	9	10							e109383	10.1371/journal.pone.0109383	http://dx.doi.org/10.1371/journal.pone.0109383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9XC	25329146	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210800022
J	Bellamy, LM; Joanisse, S; Grubb, A; Mitchell, CJ; McKay, BR; Phillips, SM; Baker, S; Parise, G				Bellamy, Leeann M.; Joanisse, Sophie; Grubb, Amanda; Mitchell, Cameron J.; McKay, Bryon R.; Phillips, Stuart M.; Baker, Steven; Parise, Gianni			The Acute Satellite Cell Response and Skeletal Muscle Hypertrophy following Resistance Training	PLOS ONE			English	Article							OLDER MEN; MYONUCLEAR ADDITION; REGULATORY FACTORS; TRAPEZIUS MUSCLE; MYOSTATIN; STRENGTH; EXERCISE; YOUNG; EXPRESSION; INCREASE	The extent of skeletal muscle hypertrophy in response to resistance training is highly variable in humans. The main objective of this study was to explain the nature of this variability. More specifically, we focused on the myogenic stem cell population, the satellite cell (SC) as a potential mediator of hypertrophy. Twenty-three males (aged 18-35 yrs) participated in 16 wk of progressive, whole body resistance training, resulting in changes of 7.9 +/- 1.6% (range of -1.9-24.7%) and 21.0 +/- 4.0% (range of -7.0 to 51.7%) in quadriceps volume and myofibre cross-sectional area (CSA), respectively. The SC response to a single bout of resistance exercise (80% 1RM), analyzed via immunofluorescent staining resulted in an expansion of type II fibre associated SC 72 h following exercise (pre: 11.3 +/- 0.9; 72 h: 14.8 +/- 1.4 SC/type II fibre; p<0.05). Training resulted in an expansion of the SC pool associated with type I (pre: 10.7 +/- 1.1; post: 12.1 +/- 1.2 SC/type I fibre; p<0.05) and type II fibres (pre: 11.3 +/- 0.9; post: 13.0 +/- 1.2 SC/type II fibre; p<0.05). Analysis of individual SC responses revealed a correlation between the relative change in type I associated SC 24 to 72 hours following an acute bout of resistance exercise and the percentage increase in quadriceps lean tissue mass assessed by MRI (r(2) = 0.566, p = 0.012) and the relative change in type II associated SC following 16 weeks of resistance training and the percentage increase in quadriceps lean tissue mass assessed by MRI (r(2) = 0.493, p = 0.027). Our results suggest that the SC response to resistance exercise is related to the extent of muscular hypertrophy induced by training.	[Bellamy, Leeann M.; Joanisse, Sophie; Grubb, Amanda; Mitchell, Cameron J.; McKay, Bryon R.; Phillips, Stuart M.; Parise, Gianni] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada; [Parise, Gianni] McMaster Univ, Dept Med Phys & Appl Radiat Sci, Hamilton, ON, Canada; [Baker, Steven] McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Parise, G (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.	pariseg@mcmaster.ca	Mitchell, Cameron/I-4423-2019; Phillips, Stuart/B-2343-2009	Mitchell, Cameron/0000-0003-3843-6806; Phillips, Stuart/0000-0002-1956-4098; Joanisse, Sophie/0000-0001-9983-9401	Natural Science and Engineering Research Council Discovery grant	Natural Science and Engineering Research Council Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by a Natural Science and Engineering Research Council Discovery grant awarded to GP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 1999, MUSCLE NERVE, V22, P1350, DOI 10.1002/(SICI)1097-4598(199910)22:10<1350::AID-MUS3>3.0.CO;2-8; Arnold HH, 1998, CURR OPIN GENET DEV, V8, P539, DOI 10.1016/S0959-437X(98)80008-7; Clarkson PM, 2005, J APPL PHYSIOL, V99, P154, DOI 10.1152/japplphysiol.01139.2004; Crameri RM, 2004, J PHYSIOL-LONDON, V558, P333, DOI 10.1113/jphysiol.2004.061846; Davidsen PK, 2011, J APPL PHYSIOL, V110, P309, DOI 10.1152/japplphysiol.00901.2010; Dreyer HC, 2006, MUSCLE NERVE, V33, P242, DOI 10.1002/mus.20461; Eriksson A, 2005, HISTOCHEM CELL BIOL, V124, P167, DOI 10.1007/s00418-005-0029-5; Hubal MJ, 2005, MED SCI SPORT EXER, V37, P964, DOI 10.1249/01.mss.0000170469.90461.5f; Jackson JR, 2012, AM J PHYSIOL-CELL PH, V303, pC854, DOI 10.1152/ajpcell.00207.2012; Jones SW, 2004, FASEB J, V18, P1025, DOI 10.1096/fj.03-1228fje; Kadi F, 1999, HISTOCHEM CELL BIOL, V111, P189, DOI 10.1007/s004180050348; Kim JS, 2005, AM J PHYSIOL-ENDOC M, V288, pE1110, DOI 10.1152/ajpendo.00464.2004; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Lee SJ, 2012, P NATL ACAD SCI USA, V109, pE2353, DOI 10.1073/pnas.1206410109; Mackey AL, 2011, J PHYSIOL-LONDON, V589, P5503, DOI 10.1113/jphysiol.2011.217885; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McKay BR, 2012, FASEB J, V26, P2509, DOI 10.1096/fj.11-198663; McKay BR, 2010, J PHYSIOL-LONDON, V588, P3307, DOI 10.1113/jphysiol.2010.190876; Mckay BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006027; McKay BR, 2008, J PHYSIOL-LONDON, V586, P5549, DOI 10.1113/jphysiol.2008.160176; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Mitchell CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078636; Nana A, 2012, MED SCI SPORT EXER, V44, P180, DOI 10.1249/MSS.0b013e318228b60e; O'Connor RS, 2007, J APPL PHYSIOL, V103, P1099, DOI 10.1152/japplphysiol.00101.2007; Pescatello LS, 2006, MED SCI SPORT EXER, V38, P1074, DOI 10.1249/01.mss.0000222835.28273.80; Petrella JK, 2008, J APPL PHYSIOL, V104, P1736, DOI 10.1152/japplphysiol.01215.2007; Petrella JK, 2006, AM J PHYSIOL-ENDOC M, V291, pE937, DOI 10.1152/ajpendo.00190.2006; Phillips BE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003389; Raue U, 2006, J APPL PHYSIOL, V101, P53, DOI 10.1152/japplphysiol.01616.2005; Riechman SE, 2004, J APPL PHYSIOL, V97, P2214, DOI 10.1152/japplphysiol.00491.2004; Rudnicki MA, 2008, COLD SH Q B, V73, P323, DOI 10.1101/sqb.2008.73.064; Sinha-Hikim I, 2003, AM J PHYSIOL-ENDOC M, V285, pE197, DOI 10.1152/ajpendo.00370.2002; Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127; Terzis G, 2008, EUR J APPL PHYSIOL, V102, P145, DOI 10.1007/s00421-007-0564-y; Timmons JA, 2011, J APPL PHYSIOL, V110, P846, DOI 10.1152/japplphysiol.00934.2010; Toth KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017392; Verdijk LB, 2009, J GERONTOL A-BIOL, V64, P332, DOI 10.1093/gerona/gln050; Wang Q, 2012, J PHYSIOL-LONDON, V590, P2151, DOI 10.1113/jphysiol.2011.226001; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011	40	102	104	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109739	10.1371/journal.pone.0109739	http://dx.doi.org/10.1371/journal.pone.0109739			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313863	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000343662500068
J	Gidoin, C; Babin, R; Beilhe, LB; Cilas, C; ten Hoopen, GM; Bieng, MAN				Gidoin, Cynthia; Babin, Regis; Beilhe, Leila Bagny; Cilas, Christian; ten Hoopen, Gerben Martijn; Bieng, Marie Ange Ngo			Tree Spatial Structure, Host Composition and Resource Availability Influence Mirid Density or Black Pod Prevalence in Cacao Agroforests in Cameroon	PLOS ONE			English	Article							PLANT-SPECIES DIVERSITY; CONSERVATION BIOLOGY; SHADE TREES; COCOA; DISEASE; PATHOGEN; BEHAVIOR; ROT; MANAGEMENT; REGRESSION	Combining crop plants with other plant species in agro-ecosystems is one way to enhance ecological pest and disease regulation mechanisms. Resource availability and microclimatic variation mechanisms affect processes related to pest and pathogen life cycles. These mechanisms are supported both by empirical research and by epidemiological models, yet their relative importance in a real complex agro-ecosystem is still not known. Our aim was thus to assess the independent effects and the relative importance of different variables related to resource availability and microclimatic variation that explain pest and disease occurrence at the plot scale in real complex agro-ecosystems. The study was conducted in cacao (Theobroma cacao) agroforests in Cameroon, where cocoa production is mainly impacted by the mirid bug, Sahlbergella singularis, and black pod disease, caused by Phytophthora megakarya. Vegetation composition and spatial structure, resource availability and pest and disease occurrence were characterized in 20 real agroforest plots. Hierarchical partitioning was used to identify the causal variables that explain mirid density and black pod prevalence. The results of this study show that cacao agroforests can be differentiated on the basis of vegetation composition and spatial structure. This original approach revealed that mirid density decreased when a minimum number of randomly distributed forest trees were present compared with the aggregated distribution of forest trees, or when forest tree density was low. Moreover, a decrease in mirid density was also related to decreased availability of sensitive tissue, independently of the effect of forest tree structure. Contrary to expectations, black pod prevalence decreased with increasing cacao tree abundance. By revealing the effects of vegetation composition and spatial structure on mirids and black pod, this study opens new perspectives for the joint agro-ecological management of cacao pests and diseases at the plot scale, through the optimization of the spatial structure and composition of the vegetation.	[Gidoin, Cynthia] Supagro, UMR Syst, Montpellier, France; [Gidoin, Cynthia; Babin, Regis; Beilhe, Leila Bagny; Cilas, Christian; ten Hoopen, Gerben Martijn] CIRAD, UPR Bioagresseurs, Montpellier, France; [Babin, Regis] ICIPE, Plant Hlth Div, Coffee Pest Project, Nairobi, Kenya; [Beilhe, Leila Bagny; ten Hoopen, Gerben Martijn] IRAD, Yaounde, Cameroon; [Bieng, Marie Ange Ngo] CIRAD, UMR Syst, Montpellier, France	Institut Agro; Montpellier SupAgro; CIRAD; International Centre of Insect Physiology & Ecology (ICIPE); CIRAD	Gidoin, C (corresponding author), Supagro, UMR Syst, Montpellier, France.	gidoin@supagro.inra.fr	cilas, christian/C-3450-2008; Babin, Régis/D-5322-2014; Babin, Régis/N-3682-2019; Hoopen, Gerben Martijn ten/AAU-9466-2021	cilas, christian/0000-0001-7658-1866; Babin, Régis/0000-0002-3753-1193; 	West African Scientific Partnership Platform on diversity of production systems and agroecological management of pests and diseases of the French Agricultural Research Centre for International Development (CIRAD); research project "Search for trade-offs between production and other ecosystem services provided by tropical agroforestry systems" (SAFSE)	West African Scientific Partnership Platform on diversity of production systems and agroecological management of pests and diseases of the French Agricultural Research Centre for International Development (CIRAD); research project "Search for trade-offs between production and other ecosystem services provided by tropical agroforestry systems" (SAFSE)	The authors thank the West African Scientific Partnership Platform on diversity of production systems and agroecological management of pests and diseases of the French Agricultural Research Centre for International Development (CIRAD) and the research project "Search for trade-offs between production and other ecosystem services provided by tropical agroforestry systems" (SAFSE) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akrofi AY, 2003, CROP PROT, V22, P469, DOI 10.1016/S0261-2194(02)00193-X; ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; [Anonymous], AGROFORESTERIA AM; Avelino J., 2011, ECOSYSTEMS SERVICES, P91; Babin R., 2010, P 16 INT COC RES C 1, P683; Babin R, 2010, AGR FOREST ENTOMOL, V12, P69, DOI 10.1111/j.1461-9563.2009.00453.x; Bartels SF, 2010, ECOLOGY, V91, P1931, DOI 10.1890/09-1376.1; Beer J., 1998, AGROFOREST SYST, V38, P139, DOI [10.1023/A:1005956528316, DOI 10.1023/A:1005956528316]; BERRY D, 1994, AGRONOMIE, V14, P599, DOI 10.1051/agro:19940904; Bieng MAN, 2013, BASIC APPL ECOL, V14, P329, DOI 10.1016/j.baae.2013.03.003; BURDON JJ, 1982, ANNU REV PHYTOPATHOL, V20, P143, DOI 10.1146/annurev.py.20.090182.001043; Burdon JJ., 1987, DIS PLANT POPULATION; Calonnec A, 2013, EUR J PLANT PATHOL, V135, P479, DOI 10.1007/s10658-012-0111-5; Chevassus au Louis B, 2008, DEMETER ECONOMIE STR, V14, P7; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Despreaux D, 2004, IMPROVEMENT COCOA TR; Despreaux D., 1988, P 10 INT COC RES C S, P407; Entwistle P.F., 1972, PESTS OF COCOA; Evans H.C., 1998, SUST COC WORKSH 30 M; Evans HC, 1998, P 1 INT WORKSH SUST, P12; FAO, 2013, PROD PART FAOSTAT FA; Gaba S, 2010, AGR ECOSYST ENVIRON, V138, P318, DOI 10.1016/j.agee.2010.06.005; Garrett KA, 1999, PHYTOPATHOLOGY, V89, P984, DOI 10.1094/PHYTO.1999.89.11.984; Gidoin C, 2014, PHYTOPATHOLOGY, V104, P275, DOI 10.1094/PHYTO-07-13-0216-R; Goreaud F, 2000, THESIS ENGREF; Holmes KA, 2003, PLANT PATHOL, V52, P486, DOI 10.1046/j.1365-3059.2003.00869.x; Jagoret P, 2011, THESIS MONTPELLIER S; Jagoret P, 2011, AGROFOREST SYST, V81, P267, DOI 10.1007/s10457-010-9368-x; KAISER HF, 1991, PSYCHOL REP, V68, P855, DOI 10.2466/pr0.1991.68.3.855; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Konam JK, 2004, AUSTRALAS PLANT PATH, V33, P55, DOI 10.1071/AP03082; Lebart L, 1994, CORRES ANAL SOCIAL S, P162; Leprieur F, 2008, PLOS BIOL, V6, P404, DOI 10.1371/journal.pbio.0060028; LESTON D, 1973, ENTOMOL EXP APPL, V16, P91, DOI 10.1007/BF00333554; Mac Nally R, 2000, BIODIVERS CONSERV, V9, P655, DOI 10.1023/A:1008985925162; Mac Nally R, 2002, BIODIVERS CONSERV, V11, P1397, DOI 10.1023/A:1016250716679; Malezieux E, 2009, AGRON SUSTAIN DEV, V29, P43, DOI 10.1051/agro:2007057; Bieng MAN, 2013, EUR J FOREST RES, V132, P841, DOI 10.1007/s10342-013-0716-z; Martens SN, 2000, ECOL MODEL, V126, P79, DOI 10.1016/S0304-3800(99)00188-X; Mfegue CV, 2012, THESIS MONTPELLIER S; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; Mpe JM, 2001, W AFR REG COC IPM WO, P39; Opoku IY, 2002, CROP PROT, V21, P629, DOI 10.1016/S0261-2194(02)00013-3; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ratnadass A, 2012, AGRON SUSTAIN DEV, V32, P273, DOI 10.1007/s13593-011-0022-4; Richard FJ, 2001, J INSECT BEHAV, V14, P271, DOI 10.1023/A:1007845929801; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Sabatier R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080352; Schroth G, 2000, AGROFOREST SYST, V50, P199, DOI 10.1023/A:1006468103914; Schroth Gotz, 2004, P227; Sonwa DJ, 2007, BIODIVERS CONSERV, V16, P2385, DOI 10.1007/s10531-007-9187-1; Tadu Z, 2014, AGROFOREST SYST, V88, P1067, DOI 10.1007/s10457-014-9676-7; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Walsh C, 2009, PACKAGE HIER PART DO	55	31	31	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109405	10.1371/journal.pone.0109405	http://dx.doi.org/10.1371/journal.pone.0109405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313514	gold, Green Published			2022-12-27	WOS:000343662500037
J	Zhang, DD; Tao, XQ; Jiang, HY; Wen, K; Shen, JZ; Cao, XY				Zhang, Dongdong; Tao, Xiaoqi; Jiang, Haiyang; Wen, Kai; Shen, Jianzhong; Cao, Xingyuan			Simultaneous Detection of Forbidden Chemical Residues in Milk Using Dual-Label Time-Resolved Reverse Competitive Chemiluminescent Immunoassay Based on Amine Group Functionalized Surface	PLOS ONE			English	Article							ANALYTICAL STRATEGIES; CHLORAMPHENICOL; CHROMATOGRAPHY; CLENBUTEROL; ELISA	In this study, a sensitive dual-label time-resolved reverse competitive chemiluminescent immunoassay was developed for simultaneous detection of chloramphenicol (CAP) and clenbuterol (CLE) in milk. The strategy was performed based on the distinction of the kinetic characteristics of horseradish peroxidase (HRP) and alkaline phosphatase (ALP) in chemiluminesecence (CL) systems and different orders of magnitude in HRP CL value for CAP and ALP CL value for CLE in the chemiluminescent immunoassay. Capture antibodies were covalently bound to the amine group functionalized chemiluminescent microtiter plate (MTP) for efficient binding of detection antibodies for the enzymes labeled CAP (HRP-CAP) and CLE (ALP-CLE). The CL signals were recorded at different time points by the automatic luminometers with significant distinction in the dynamic curves. When we considered the ALP CL value (about 10(5)) of CLE as background for HRP CL signal value (about 10(7)) of CAP, there was no interaction from ALP CL background of CLE and the differentiation of CAP and CLE can be easily achieved. The 50% inhibition concentration (IC50) values of CAP and CLE in milk samples were 0.00501 mu g L-1 and 0.0128 mu g L-1, with the ranges from 0.0003 mu g L-1 to 0.0912 mu g L-1 and from 0.00385 mu g L-1 to 0.125 mu g L-1, respectively. The developed method is more sensitive and of less duration than the commercial ELISA kits, suitable for simultaneous screening of CAP and CLE.	[Zhang, Dongdong; Tao, Xiaoqi; Jiang, Haiyang; Wen, Kai; Shen, Jianzhong; Cao, Xingyuan] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; [Tao, Xiaoqi] Southwest Univ, Coll Food Sci, Chongqing, Peoples R China	China Agricultural University; Southwest University - China	Cao, XY (corresponding author), China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China.	06046@cau.edu.cn	Shen, Jianzhong/AAH-8184-2019; Mochel, Jonathan Paul/AAR-3496-2021	Mochel, Jonathan Paul/0000-0002-0997-3111	Technology Pillar Program in the Twentieth Five-Year Plan Period [2011BAK10B01, 2011BAZ0319816]	Technology Pillar Program in the Twentieth Five-Year Plan Period	This study was supported by Technology Pillar Program in the Twentieth Five-Year Plan Period (2011BAK10B01, 2011BAZ0319816). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berlina AN, 2013, ANAL BIOANAL CHEM, V405, P4997, DOI 10.1007/s00216-013-6876-3; Capriotti AL, 2013, J CHROMATOGR A, V1313, P62, DOI 10.1016/j.chroma.2013.06.054; Davis F, 2010, PEDIATR RES, V67, P476, DOI 10.1203/PDR.0b013e3181d61c0c; Festing MFW, 2001, FOOD CHEM TOXICOL, V39, P375, DOI 10.1016/S0278-6915(00)00149-6; Ge L, 2012, BIOMATERIALS, V33, P1024, DOI 10.1016/j.biomaterials.2011.10.065; Guo XW, 2012, J BIOPHOTONICS, V5, P483, DOI 10.1002/jbio.201200015; Han J, 2013, BIOSENS BIOELECTRON, V48, P39, DOI 10.1016/j.bios.2013.03.033; Holford TRJ, 2012, BIOSENS BIOELECTRON, V34, P12, DOI 10.1016/j.bios.2011.10.023; Huet AC, 2010, TRAC-TREND ANAL CHEM, V29, P1281, DOI 10.1016/j.trac.2010.07.017; Li SX, 2013, ELECTROANAL, V25, P867, DOI 10.1002/elan.201200166; Moragues F, 2012, FOOD ANAL METHOD, V5, P416, DOI 10.1007/s12161-011-9261-x; Ren XF, 2009, FOOD AGR IMMUNOL, V20, P333, DOI 10.1080/09540100903365852; Sai N, 2010, TALANTA, V82, P1113, DOI 10.1016/j.talanta.2010.06.018; Shen JZ, 2009, J CHROMATOGR B, V877, P1523, DOI 10.1016/j.jchromb.2009.03.040; Stolker AAM, 2005, J CHROMATOGR A, V1067, P15, DOI 10.1016/j.chroma.2005.02.037; Tao XQ, 2014, FOOD AGR IMMUNOL, V25, P137, DOI 10.1080/09540105.2012.753513; Tao XQ, 2013, DRUG TEST ANAL, V5, P346, DOI 10.1002/dta.1465; Vashist SK, 2012, DIAGNOSTICS, V2, P23, DOI 10.3390/diagnostics2030023; Vashist SK, 2013, BIOSENS BIOELECTRON, V40, P297, DOI 10.1016/j.bios.2012.07.067; Vashist SK, 2011, ANALYST, V136, P4431, DOI 10.1039/c1an15325k; Wu ML, 2013, AM J EMERG MED, V31, P1501, DOI 10.1016/j.ajem.2013.07.001; Zhang MZ, 2009, ANAL BIOANAL CHEM, V395, P2591, DOI 10.1007/s00216-009-3181-2; Zhang SX, 2006, J AGR FOOD CHEM, V54, P5718, DOI 10.1021/jf060275j; Zheng D, 2012, TALANTA, V99, P22, DOI 10.1016/j.talanta.2012.05.014; Zheng D, 2012, ANALYST, V137, P3800, DOI 10.1039/c2an35128e; Zhou Y, 2011, BIOSENS BIOELECTRON, V30, P310, DOI 10.1016/j.bios.2011.08.034	26	4	4	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e109509	10.1371/journal.pone.0109509	http://dx.doi.org/10.1371/journal.pone.0109509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313517	Green Published, gold, Green Submitted			2022-12-27	WOS:000343662500046
J	Dong, YZ; Zhang, LJ; Wu, ZM; Gao, L; Yao, YS; Tan, NZ; Wu, JY; Ni, LQ; Zhu, JS				Dong, Yun-Zi; Zhang, Li-Juan; Wu, Zi-Mei; Gao, Ling; Yao, Yi-Sang; Tan, Ning-Zhi; Wu, Jian-Yong; Ni, Luqun; Zhu, Jia-Shi			Altered Proteomic Polymorphisms in the Caterpillar Body and Stroma of Natural Cordyceps sinensis during Maturation	PLOS ONE			English	Article							OPHIOCORDYCEPS-SINENSIS; SCIENTIFIC REDISCOVERY; PAECILOMYCES-HEPIALI; FUNGUS; EXPRESSIONS; DNA	Objective: To examine the maturational changes in proteomic polymorphisms resulting from differential expression by multiple intrinsic fungi in the caterpillar body and stroma of natural Cordyceps sinensis (Cs), an integrated micro-ecosystem. Methods: The surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) biochip technique was used to profile the altered protein compositions in the caterpillar body and stroma of Cs during its maturation. The MS chromatograms were analyzed using density-weighted algorithms to examine the similarities and cluster relationships among the proteomic polymorphisms of the Cs compartments and the mycelial products Hirsutella sinensis (Hs) and Paecilomyces hepiali (Ph). Results: SELDI-TOF MS chromatograms displayed dynamic proteomic polymorphism alterations among samples from the different Cs compartments during maturation. More than 1,900 protein bands were analyzed using density-weighted ZUNIX similarity equations and clustering methods, revealing integral polymorphism similarities of 57.4% between the premature and mature stromata and 42.8% between the premature and mature caterpillar bodies. The across-compartment similarity was low, ranging from 10.0% to 18.4%. Consequently, each Cs compartment (i.e., the stroma and caterpillar body) formed a clustering clade, and the 2 clades formed a Cs cluster. The polymorphic similarities ranged from 0.51% to 1.04% between Hs and the Cs compartments and were 2.8- to 4.8-fold higher (1.92%-4.34%) between Ph and the Cs compartments. The Hs and Ph mycelial samples formed isolated clades outside of the Cs cluster. Conclusion: Proteomic polymorphisms in the caterpillar body and stroma of Cs change dynamically during maturation. The proteomic polymorphisms in Hs and Ph differ from those in Cs, suggesting the presence of multiple Cs-associated fungi and multiple Ophiocordyceps sinensis genotypes with altered differential protein expression in the Cs compartments during maturation. In conjunction with prior mycological and molecular observations, the findings from this proteomic study support the integrated micro-ecosystem hypothesis for natural Cs.	[Dong, Yun-Zi; Zhang, Li-Juan; Wu, Zi-Mei; Gao, Ling; Yao, Yi-Sang; Tan, Ning-Zhi] Pharmanex Beijing Clin Pharmacol Ctr, Beijing, Peoples R China; [Wu, Jian-Yong; Zhu, Jia-Shi] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China; [Wu, Jian-Yong; Zhu, Jia-Shi] Hong Kong Polytech Univ, Shenzhen TCM Pharm & Mol Pharmacol Kay Lab, Shenzhen, Guangdong, Peoples R China; [Ni, Luqun] Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA; [Zhu, Jia-Shi] NS Ctr Antiaging Res, Provo, UT USA	Hong Kong Polytechnic University; Hong Kong Polytechnic University; University of California System; University of California San Diego	Zhu, JS (corresponding author), Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China.	zhujosh@gmail.com	Wu, JY/F-4406-2014; Zhang, Li/GWM-7501-2022	Wu, JY/0000-0002-5392-5686; 	Pharmanex Cordyceps sinensis Research Fund	Pharmanex Cordyceps sinensis Research Fund	This study was supported by the Pharmanex Cordyceps sinensis Research Fund. The funder provided support in the form of full or partial salaries for the authors [YZD, LJZ, ZMW, LG, YSY, NZT, JSZ], the purchase of research materials and the payment of SELDI-TOF MS service fees. The funder did not have any additional role in the study design, data collection and analyses, decision to publish or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Chen JP, 2006, LIFE SCI, V78, P2742, DOI 10.1016/j.lfs.2005.10.047; Chen YQ, 2001, BIOCHEM SYST ECOL, V29, P597, DOI 10.1016/S0305-1978(00)00100-9; Chen YQ, 2004, FEMS MICROBIOL LETT, V230, P153, DOI 10.1016/S0378-1097(03)00889-9; Dai Ruqin, 1989, Acta Agriculturae Universitatis Pekinensis, V15, P221; Gao Ling, 2012, Beijing Da Xue Xue Bao Yi Xue Ban, V44, P454; Gao Ling, 2011, Beijing Da Xue Xue Bao Yi Xue Ban, V43, P259; Guo YL, 2010, MODERN CHIN MED, V12, P3; Hu X, 2013, CHINESE SCI BULL, V58, P2846, DOI 10.1007/s11434-013-5929-5; Hu Zheng, 2004, Edible Fungi of China, V23, P37; Issaq HJ, 2002, BIOCHEM BIOPH RES CO, V292, P587, DOI 10.1006/bbrc.2002.6678; Jin ZX, 2005, J TIANJIN MED U, V11, P137; Lai Yu-hong, 2008, Zhong Yao Cai, V31, P1142; Leung PH, 2006, J APPL MICROBIOL, V101, P275, DOI 10.1111/j.1365-2672.2006.02930.x; Li SP, 2004, PHYTOMEDICINE, V11, P684, DOI 10.1016/j.phymed.2003.07.011; Li YL, 2014, 10 INT MYC C BANGK T; Li Z.Z., 2000, MYCOSYSTEMA, V19, P60; [梁宗琦 Liang Zongqi], 2010, [微生物学通报, Microbiology], V37, P1692; Lu Yan-Yan, 2011, Food Science and Technology, V36, P250; Ma SL, 2010, CHIN J GRASSLAND S, V32, P63; Ni LQ, 2014, AM J BIOMED SCI, V6, P82; Shen NY, 1983, MONOGRAPH CORDYCEPS, P1; Stensrud O, 2007, MYCOL RES, V111, P409, DOI 10.1016/j.mycres.2007.01.015; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; Tan NZ, 2011, FASEB J, V25, P5991; Wang S, 2009, J SEP SCI, V32, P4069, DOI 10.1002/jssc.200900570; [魏鑫丽 Wei Xinli], 2006, [菌物学报, Mygosystema], V25, P192; Wu Yan-Shu, 2008, Zhongguo Zhong Yao Za Zhi, V33, P2212; [肖薇 XIAO Wei], 2009, [菌物学报, Mygosystema], V28, P724; Xiao YanYan, 2011, Journal of Anhui Agricultural University, V38, P587; Yang Jin-Ling, 2008, Yao Xue Xue Bao, V43, P421; Yang ML, 2011, J NAT PROD, V74, P1996, DOI 10.1021/np100902f; Yao Yi-sang, 2014, Beijing Da Xue Xue Bao Yi Xue Ban, V46, P618; Yao Yi-sang, 2011, Journal of Fungal Research, V9, P37; Ye MQ, 2004, J BIOCHEM MOL BIOL, V37, P466; YUE D, 1995, ADV STUDY TRADITIONA, V1, P91; Zeidan BA, 2009, CLIN PROTEOM, V5, P133; Zhang P, 2003, J BIOL, V20, P43; Zhang YJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015570; Zhang YongJie, 2010, Mycosystema, V29, P518; Zhao J, 1999, ACTA SCI NATURAL U S, V38, P122; Zhu Jia-shi, 2012, Journal of Fungal Research, V10, P100; Zhu Jia-shi, 2007, Journal of Fungal Research, V5, P214; Zhu JS, 1998, J ALTERN COMPLEM MED, V4, P289, DOI 10.1089/acm.1998.4.3-289; Zhu JS, 1998, J ALTERN COMPLEM MED, V4, P429, DOI 10.1089/acm.1998.4.429; Zhu JS, 2010, AM J BIOMED SCI, V2, P217, DOI DOI 10.5099/AJ100300217	45	4	10	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109083	10.1371/journal.pone.0109083	http://dx.doi.org/10.1371/journal.pone.0109083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310818	Green Submitted, Green Published, gold			2022-12-27	WOS:000343210300032
J	Shmueli, MD; Schnaider, L; Herzog, G; Gazit, E; Segal, D				Shmueli, Merav D.; Schnaider, Lee; Herzog, Gal; Gazit, Ehud; Segal, Daniel			Computational and Experimental Characterization of dVHL Establish a Drosophila Model of VHL Syndrome	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; HIPPEL-LINDAU GENE; INTRINSICALLY DISORDERED PROTEINS; ENDOTHELIAL GROWTH-FACTOR; EVOLUTIONARY CONSERVATION; STRUCTURE PREDICTION; MOLTEN GLOBULE; HIF-ALPHA; ELONGIN-B; SEQUENCE	The von Hippel-Lindau (VHL) cancer syndrome is associated with mutations in the VHL gene. The pVHL protein is involved in response to changes in oxygen availability as part of an E3-ligase that targets the Hypoxia-Inducible Factor for degradation. pVHL has a molten globule configuration with marginal thermodynamic stability. The cancer-associated mutations further destabilize it. The Drosophila homolog, dVHL, has relatively low sequence similarity to pVHL, and is also involved in regulating HIF1-alpha. Using in silico, in vitro and in vivo approaches we demonstrate high similarity between the structure and function of dVHL and pVHL. These proteins have a similar fold, secondary and tertiary structures, as well as thermodynamic stability. Key functional residues in dVHL are evolutionary conserved. This structural homology underlies functional similarity of both proteins, evident by their ability to bind their reciprocal partner proteins, and by the observation that transgenic pVHL can fully maintain normal dVHL-HIF1-alpha downstream pathways in flies. This novel transgenic Drosophila model is thus useful for studying the VHL syndrome, and for testing drug candidates to treat it.	[Shmueli, Merav D.; Schnaider, Lee; Herzog, Gal; Gazit, Ehud; Segal, Daniel] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Segal, D (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	dsegal@post.tau.ac.il	Shmueli, Merav/HDM-9859-2022; Gazit, Ehud/M-8026-2019; Gazit, Ehud/C-3715-2011; Gazit, Ehud/AHE-9332-2022	Shmueli, Merav/0000-0002-9196-7633; Gazit, Ehud/0000-0001-5764-1720; Gazit, Ehud/0000-0001-5764-1720; Segal, Daniel/0000-0002-6777-505X	Israel Cancer Association; The Israel Cancer Research Fund; The Cancer Biology Research Center in Tel Aviv University	Israel Cancer Association; The Israel Cancer Research Fund; The Cancer Biology Research Center in Tel Aviv University	This work was supported in part by a grant from the Israel Cancer Association to DS (http://ica.cancer.org.il/english/) and in part by a grant from The Israel Cancer Research Fund to DS (http://www.icrfonline.org/). A travel fellowship from The Cancer Biology Research Center in Tel Aviv University was awarded to MDS (http://www.tau.ac.il/institutes/cbrc/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Adryan B, 2000, ONCOGENE, V19, P2803, DOI 10.1038/sj.onc.1203611; Arquier N, 2006, BIOCHEM J, V393, P471, DOI 10.1042/BJ20050675; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Aso T, 2000, BIOCHEM BIOPH RES CO, V276, P355, DOI 10.1006/bbrc.2000.3451; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beroud C, 1998, NUCLEIC ACIDS RES, V26, P256, DOI 10.1093/nar/26.1.256; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Celniker G, 2013, ISR J CHEM; Cho NK, 2002, CELL, V108, P865, DOI 10.1016/S0092-8674(02)00676-1; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; Dammai V, 2003, GENE DEV, V17, P2812, DOI 10.1101/gad.1096903; Dar AC, 2012, NATURE, V486, P80, DOI 10.1038/nature11127; DUAN DR, 1995, SCIENCE, V269, P1402, DOI 10.1126/science.7660122; DUAN DR, 1995, P NATL ACAD SCI USA, V92, P6459, DOI 10.1073/pnas.92.14.6459; Duchi S, 2010, DEVELOPMENT, V137, P1493, DOI 10.1242/dev.042804; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Escher SA, 1999, HEREDITAS, V130, P95, DOI 10.1111/j.1601-5223.1999.00095.x; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gnarra JR, 1996, P NATL ACAD SCI USA, V93, P10589, DOI 10.1073/pnas.93.20.10589; Groulx I, 2002, MOL CELL BIOL, V22, P5319, DOI 10.1128/MCB.22.15.5319-5336.2002; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Herzog G, 2012, J BIOL CHEM, V287, P44330, DOI 10.1074/jbc.M112.417980; Hsu T, 2006, J BIOL CHEM, V281, P12069, DOI 10.1074/jbc.M511621200; Hsu T, 2011, ONCOGENE; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; Iliopoulos O, 1998, P NATL ACAD SCI USA, V95, P11661, DOI 10.1073/pnas.95.20.11661; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Irisarri M, 2009, MOL BIOL CELL, V20, P3878, DOI 10.1091/mbc.E09-01-0038; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kessel A, 2002, CURRENT TOPICS MEMBR; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Lewis MD, 2003, ONCOGENE, V22, P3992, DOI 10.1038/sj.onc.1206683; Maher ER, 1997, MEDICINE, V76, P381, DOI 10.1097/00005792-199711000-00001; Mahrour N, 2008, J BIOL CHEM, V283, P8005, DOI 10.1074/jbc.M706987200; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Miller F, 2005, J BIOL CHEM, V280, P7985, DOI 10.1074/jbc.M413160200; Ohh M, 1999, J CLIN INVEST, V104, P1583, DOI 10.1172/JCI8161; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohh M, 2006, NEOPLASIA, V8, P623, DOI 10.1593/neo.06442; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Rudrapatna VA, 2012, DEV DYNAM, V241, P107, DOI 10.1002/dvdy.22771; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schoenfeld AR, 2001, INT J CANCER, V91, P457, DOI 10.1002/1097-0215(20010215)91:4<457::AID-IJC1072>3.0.CO;2-P; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Shiao YH, 2000, CANCER RES, V60, P2816; Shmueli MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066333; Siemeister G, 1996, CANCER RES, V56, P2299; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Stratmann R, 1997, J NEUROPATH EXP NEUR, V56, P1242, DOI 10.1097/00005072-199711000-00009; Sutovsky H, 2004, J BIOL CHEM, V279, P17190, DOI 10.1074/jbc.M311225200; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; Wang Y, 2009, NAT MED, V15, P319, DOI 10.1038/nm.1922; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Williams R M, 2001, Pac Symp Biocomput, P89; Wolff T, 2000, HISTOLOGICAL TECHN 1; Wolff T, 2000, HISTOLOGICAL TECHN 2; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	79	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109864	10.1371/journal.pone.0109864	http://dx.doi.org/10.1371/journal.pone.0109864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310726	Green Published, gold, Green Submitted			2022-12-27	WOS:000343210300079
J	Wang, B; Jedlicka, S; Cheng, XH				Wang, Bu; Jedlicka, Sabrina; Cheng, Xuanhong			Maintenance and Neuronal Cell Differentiation of Neural Stem Cells C17.2 Correlated to Medium Availability Sets Design Criteria in Microfluidic Systems	PLOS ONE			English	Article							GAMMA PROMOTES DIFFERENTIATION; BRAIN INTERSTITIAL FLUID; BETA-TUBULIN ISOTYPE; PROGENITOR CELLS; GENE-EXPRESSION; NEUROTROPHIC FACTOR; DENTATE GYRUS; RADIAL GLIA; NEUROGENESIS; TRANSPLANTATION	Background: Neural stem cells (NSCs) play an important role in developing potential cell-based therapeutics for neurodegenerative disease. Microfluidics has proven a powerful tool in mechanistic studies of NSC differentiation. However, NSCs are prone to differentiate when the nutrients are limited, which occurs unfavorable by fast medium consumption in miniaturized culture environment. For mechanistic studies of NSCs in microfluidics, it is vital that neuronal cell differentiation is triggered by controlled factors only. Thus, we studied the correlation between available cell medium and spontaneous neuronal cell differentiation of C17.2 NSCs in standard culture medium, and proposed the necessary microfluidic design criteria to prevent undesirable cell phenotype changes. Methodology/Principal Findings: A series of microchannels with specific geometric parameters were designed to provide different amount of medium to the cells over time. A medium factor (MF, defined as the volume of stem cell culture medium divided by total number of cells at seeding and number of hours between medium replacement) successfully correlated the amount of medium available to each cell averaged over time to neuronal cell differentiation. MF smaller than 8.3 x 10(4) mu m(3)/cell.hour produced significant neuronal cell differentiation marked by cell morphological change and significantly more cells with positive beta-tubulin-III and MAP2 staining than the control. When MF was equal or greater than 8.3 x 10(4) mu m(3)/cell.hour, minimal spontaneous neuronal cell differentiation happened relative to the control. MF had minimal relation with the average neurite length. Significance: MFs can be controlled easily to maintain the stem cell status of C17.2 NSCs or to induce spontaneous neuronal cell differentiation in standard stem cell culture medium. This finding is useful in designing microfluidic culture platforms for controllable NSC maintenance and differentiation. This study also offers insight about consumption rate of serum molecules involved in maintaining the stemness of NSCs.	[Wang, Bu; Jedlicka, Sabrina; Cheng, Xuanhong] Lehigh Univ, Dept Mat Sci & Engn, Bethlehem, PA 18015 USA; [Jedlicka, Sabrina; Cheng, Xuanhong] Lehigh Univ, Bioengn Program, Bethlehem, PA 18015 USA	Lehigh University; Lehigh University	Cheng, XH (corresponding author), Lehigh Univ, Dept Mat Sci & Engn, Bethlehem, PA 18015 USA.	xuc207@lehigh.edu			National Science Foundation [1014957]; Div Of Chem, Bioeng, Env, & Transp Sys [1014957] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Funding for the research is provided by National Science Foundation (http://www.nsf.gov/) under Grant No. 1014957. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2004, NEUROCHEM INT, V45, P545, DOI 10.1016/j.neuint.2003.11.006; Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Akerud P, 2001, J NEUROSCI, V21, P8108, DOI 10.1523/JNEUROSCI.21-20-08108.2001; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Anton ES, 1997, DEVELOPMENT, V124, P3501; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; BASSER PJ, 1992, MICROVASC RES, V44, P143, DOI 10.1016/0026-2862(92)90077-3; Bechara S, 2011, ACTA BIOMATER, V7, P2892, DOI 10.1016/j.actbio.2011.04.009; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Blagovic K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022892; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Chang YJ, 2013, NANOMED-NANOTECHNOL, V9, P345, DOI 10.1016/j.nano.2012.07.008; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chung BG, 2005, LAB CHIP, V5, P401, DOI 10.1039/b417651k; Chung C, 2013, BIOMATER SCI-UK, V1, P1082, DOI 10.1039/c3bm60139k; Cimetta E, 2009, METHODS, V47, P81, DOI 10.1016/j.ymeth.2008.10.015; Colleen T, 2012, MAT RES SOC S P, V1498; CULICAN SM, 1990, J NEUROSCI, V10, P684; Cullen DK, 2007, J NEURAL ENG, V4, P159, DOI 10.1088/1741-2560/4/2/015; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; Deguchi Y, 1995, PHARM RES-DORDR, V12, P1838, DOI 10.1023/A:1016263032765; Diers-Fenger M, 2001, GLIA, V34, P213, DOI 10.1002/glia.1055; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dugan LL, 1997, P NATL ACAD SCI USA, V94, P9434, DOI 10.1073/pnas.94.17.9434; Ellison D, 2009, MOL BIOSYST, V5, P1004, DOI 10.1039/b905602e; Fan YW, 2002, J NEUROSCI METH, V120, P17, DOI 10.1016/S0165-0270(02)00181-4; Fanarraga ML, 1999, EUR J NEUROSCI, V11, P517; Flanagan LA, 2008, STEM CELLS, V26, P656, DOI 10.1634/stemcells.2007-0810; Garcez RC, 2009, CELL MOL NEUROBIOL, V29, P1087, DOI 10.1007/s10571-009-9406-2; Geer CP, 1997, J NEURO-ONCOL, V32, P193, DOI 10.1023/A:1005761031077; Gierdalski M, 2003, CEREB CORTEX, V13, P572, DOI 10.1093/cercor/13.6.572; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; Hemmingsen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063638; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Horie N, 2008, CELL MOL NEUROBIOL, V28, P833, DOI 10.1007/s10571-007-9237-y; Huang CP, 2009, LAB CHIP, V9, P1740, DOI 10.1039/b818401a; Huang NF, 2013, AM J TRANSL RES, V5, P510; Iwai M, 2002, J CEREBR BLOOD F MET, V22, P411, DOI 10.1097/00004647-200204000-00005; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Jung DJ, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-23; KATSETOS CD, 1994, ARCH PATHOL LAB MED, V118, P1002; Keenan TM, 2012, INTEGR BIOL-UK, V4, P1522, DOI 10.1039/c2ib20074k; Khetani SR, 2006, CURR OPIN BIOTECH, V17, P524, DOI 10.1016/j.copbio.2006.08.009; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kim SJ, 2007, NEUROCHEM RES, V32, P1399, DOI 10.1007/s11064-007-9323-z; King JA, 2007, CURR OPIN CHEM BIOL, V11, P394, DOI 10.1016/j.cbpa.2007.05.034; King KR, 2008, LAB CHIP, V8, P107, DOI 10.1039/b716962k; King KR, 2007, LAB CHIP, V7, P77, DOI 10.1039/b612516f; KITCHENS DL, 1994, J NEUROBIOL, V25, P797, DOI 10.1002/neu.480250705; Kraus T, 2006, LAB CHIP, V6, P218, DOI 10.1039/b511768b; Kurbel S, 2005, MED HYPOTHESES, V64, P375, DOI 10.1016/j.mehy.2004.02.059; Labeed FH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025458; Lanfer B, 2010, TISSUE ENG PT A, V16, P1103, DOI [10.1089/ten.tea.2009.0282, 10.1089/ten.TEA.2009.0282]; Li M, 2011, CHEMBIOCHEM, V12, P449, DOI 10.1002/cbic.201000570; Liu JL, 1998, J NEUROSCI, V18, P7768; Liu WG, 2007, PARKINSONISM RELAT D, V13, P77, DOI 10.1016/j.parkreldis.2006.07.015; Liu XZ, 1997, J NEUROSCI, V17, P5395; Loewke KE, 2011, IEEE T BIO-MED ENG, V58, P159, DOI 10.1109/TBME.2010.2085082; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; Lu W, 2008, MOL CELL BIOCHEM, V311, P233, DOI 10.1007/s11010-008-9713-9; Lundqvist J, 2013, TOXICOL IN VITRO, V27, P1565, DOI 10.1016/j.tiv.2012.04.020; MASUI H, 1993, J CELL BIOL, V120, P85, DOI 10.1083/jcb.120.1.85; Millet LJ, 2007, LAB CHIP, V7, P987, DOI 10.1039/b705266a; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Oh JE, 2009, FASEB J, V23, P2088, DOI 10.1096/fj.08-119255; Park JY, 2010, INTEGR BIOL-UK, V2, P229, DOI 10.1039/c000442a; Park JY, 2009, STEM CELLS, V27, P2646, DOI 10.1002/stem.202; Park TH, 2003, BIOTECHNOL PROGR, V19, P243, DOI 10.1021/bp020143k; Pearce TM, 2005, LAB CHIP, V5, P97, DOI 10.1039/b407871c; Pineda JR, 2007, GENE THER, V14, P118, DOI 10.1038/sj.gt.3302847; Qazi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020348; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; Rajaraman S, 2007, J MICROMECH MICROENG, V17, P163, DOI 10.1088/0960-1317/17/1/021; Roskams AJI, 1998, NEUROSCIENCE, V83, P191, DOI 10.1016/S0306-4522(97)00344-8; Roy NS, 2000, NAT MED, V6, P271; Ryu MY, 2005, CELL TRANSPLANT, V14, P193, DOI 10.3727/000000005783983133; Schmetsdorf S, 2005, INT J DEV NEUROSCI, V23, P101, DOI 10.1016/j.ijdevneu.2004.07.019; Schwindt TT, 2009, AN ACAD BRAS CIENC, V81, P443, DOI 10.1590/S0001-37652009000300009; Sevc J, 2009, CELL MOL NEUROBIOL, V29, P927, DOI 10.1007/s10571-009-9377-3; Shamloo A, 2013, INTEGR BIOL-UK, V5, P1076, DOI 10.1039/c3ib40025e; Sharma R, 2008, J PINEAL RES, V45, P277, DOI 10.1111/j.1600-079X.2008.00587.x; Sinden JD, 1997, NEUROSCIENCE, V81, P599, DOI 10.1016/S0306-4522(97)00330-8; Singh A, 2013, NAT METHODS, V10, P438, DOI [10.1038/nmeth.2437, 10.1038/NMETH.2437]; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Solanki A, 2013, ADV MATER, V25, P5477, DOI 10.1002/adma.201302219; Sun JQ, 2010, BRAIN DEV-JPN, V32, P191, DOI 10.1016/j.braindev.2009.01.004; Tang FJ, 2005, J NEUROSCI, V25, P6702, DOI 10.1523/JNEUROSCI.0871-05.2005; Tavana H, 2011, BIOTECHNOL BIOENG, V108, P2509, DOI 10.1002/bit.23190; Trkov S, 2010, J TISSUE ENG REGEN M, V4, P205, DOI 10.1002/term.231; Wan CR, 2011, ANN BIOMED ENG, V39, P1840, DOI 10.1007/s10439-011-0275-8; Wang HF, 2012, J NEURAL TRANSM, V119, P1307, DOI 10.1007/s00702-012-0786-y; Wang JY, 2009, LAB CHIP, V9, P644, DOI 10.1039/b813495b; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051; Yang M, 2002, EXP NEUROL, V177, P50, DOI 10.1006/exnr.2002.7989; Yang Y, 2006, NEUROREPORT, V17, P235, DOI 10.1097/01.wnr.0000199470.29357.8f; Yang Y, 2007, BBA-MOL BASIS DIS, V1772, P457, DOI 10.1016/j.bbadis.2006.10.002; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Yu HM, 2005, LAB CHIP, V5, P1089, DOI 10.1039/b504403k; Yu ZF, 1999, EXP NEUROL, V155, P302, DOI 10.1006/exnr.1998.7002; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhang H, 2008, J R SOC INTERFACE, V5, P671, DOI 10.1098/rsif.2008.0052; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8; Zhang Y, 2010, BRAIN STRUCT FUNCT, V215, P115, DOI 10.1007/s00429-010-0278-5; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhong JF, 2008, LAB CHIP, V8, P68, DOI 10.1039/b712116d; Zhong WL, 2013, STEM CELLS DEV, V22, P2083, DOI 10.1089/scd.2012.0685; Zhu JM, 2011, J INT MED RES, V39, P488, DOI 10.1177/147323001103900216	113	16	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109815	10.1371/journal.pone.0109815	http://dx.doi.org/10.1371/journal.pone.0109815			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	25310508	Green Submitted, gold, Green Published			2022-12-27	WOS:000343210300077
J	Dunkel, IJ; Shi, WJ; Salvaggio, K; Marr, BP; Brodie, SE; Gobin, YP; Abramson, DH				Dunkel, Ira J.; Shi, Weiji; Salvaggio, Kim; Marr, Brian P.; Brodie, Scott E.; Gobin, Y. Pierre; Abramson, David H.			Risk Factors for Severe Neutropenia following Intra-Arterial Chemotherapy for Intra-Ocular Retinoblastoma	PLOS ONE			English	Article								Purpose: Intra-arterial chemotherapy is a promising strategy for intra-ocular retinoblastoma. Neutropenia is the most commonly encountered systemic toxicity and in this study we aimed to determine the risk factors associated with the development of severe (>= grade 3) neutropenia. Methods: Retrospective review of 187 evaluable cycles of melphalan-containing intra-arterial chemotherapy from the first three cycles administered to 106 patients with intra-ocular retinoblastoma from May 2006 to June 2011. Cycles were considered to be evaluable if (1) blood count results were available in the 7 to 14 days post-treatment interval and (2) concurrent intravenous chemotherapy was not administered. Toxicity was assessed via the Common Terminology Criteria for Adverse Events version 4.0. Results: 54 cycles (29%) were associated with grade 3 (n = 43) or grade 4 (n = 11) neutropenia. Multivariate stepwise logistic regression revealed that a higher melphalan dose (>0.40 mg/kg) was significantly associated with severe neutropenia during all 3 cycles (odds ratio during cycle one 4.11, 95% confidence interval 1.33-12.73, p = 0.01), but the addition of topotecan and/or carboplatin were not. Prior treatment with systemic chemotherapy was not associated with severe neutropenia risk in any analysis. Conclusions: Intra-arterial melphalan-based chemotherapy can cause severe neutropenia, especially when a dose of greater than 0.40 mg/kg is administered. Further study with a larger sample may be warranted.	[Dunkel, Ira J.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Dunkel, Ira J.] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Pediat, New York, NY USA; [Shi, Weiji] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Salvaggio, Kim; Gobin, Y. Pierre] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Neurosurg, New York, NY USA; [Marr, Brian P.; Abramson, David H.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Marr, Brian P.; Abramson, David H.] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Ophthalmol, New York, NY USA; [Brodie, Scott E.] Mt Sinai Med Ctr, Dept Ophthalmol, New York, NY 10029 USA	Memorial Sloan Kettering Cancer Center; Cornell University; NewYork-Presbyterian Hospital; Memorial Sloan Kettering Cancer Center; Cornell University; NewYork-Presbyterian Hospital; Memorial Sloan Kettering Cancer Center; Cornell University; NewYork-Presbyterian Hospital; Icahn School of Medicine at Mount Sinai	Dunkel, IJ (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA.	dunkeli@mskcc.org		Dunkel, Ira/0000-0001-8091-6067	Perry's Promise Fund	Perry's Promise Fund	This work was supported by Perry's Promise Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; Gobin YP, 2011, ARCH OPHTHALMOL-CHIC, V129, P732, DOI 10.1001/archophthalmol.2011.5; MILLER R, 1982, BIOMETRICS, V38, P1011, DOI 10.2307/2529881; REESE AB, 1955, ARCH OPHTHALMOL-CHIC, V53, P505; Schaiquevich P, 2012, INVEST OPHTH VIS SCI, V53, P4205, DOI 10.1167/iovs.12-9501; Suzuki S, 2011, OPHTHALMOLOGY, V118, P2081, DOI 10.1016/j.ophtha.2011.03.013	6	27	29	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108692	10.1371/journal.pone.0108692	http://dx.doi.org/10.1371/journal.pone.0108692			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303673	Green Published, gold, Green Submitted			2022-12-27	WOS:000343730400022
J	Kan, YJ; Danner, EW; Israelachvili, JN; Chen, YF; Waite, JH				Kan, Yajing; Danner, Eric W.; Israelachvili, Jacob N.; Chen, Yunfei; Waite, J. Herbert			Boronate Complex Formation with Dopa Containing Mussel Adhesive Protein Retards pH-Induced Oxidation and Enables Adhesion to Mica	PLOS ONE			English	Article							CROSS-LINKING; STRUCTURAL PROTEINS; CATECHOL; SURFACES; CHEMISTRY; MECHANISM; DYNAMICS; COATINGS; DENSITY; BORATE	The biochemistry of mussel adhesion has inspired the design of surface primers, adhesives, coatings and gels for technological applications. These mussel-inspired systems often focus on incorporating the amino acid 3,4-dihydroxyphenyl-L-alanine (Dopa) or a catecholic analog into a polymer. Unfortunately, effective use of Dopa is compromised by its susceptibility to auto-oxidation at neutral pH. Oxidation can lead to loss of adhesive function and undesired covalent cross-linking. Mussel foot protein 5 (Mfp-5), which contains similar to 30 mole % Dopa, is a superb adhesive under reducing conditions but becomes nonadhesive after pH-induced oxidation. Here we report that the bidentate complexation of borate by Dopa to form a catecholato-boronate can be exploited to retard oxidation. Although exposure of Mfp-5 to neutral pH typically oxidizes Dopa, resulting in a>95% decrease in adhesion, inclusion of borate retards oxidation at the same pH. Remarkably, this Dopa-boronate complex dissociates upon contact with mica to allow for a reversible Dopa-mediated adhesion. The borate protection strategy allows for Dopa redox stability and maintained adhesive function in an otherwise oxidizing environment.	[Kan, Yajing; Chen, Yunfei] Southeast Univ, Jiangsu Key Lab Design & Mfg Micronano Biomed Ins, Nanjing, Jiangsu, Peoples R China; [Kan, Yajing; Chen, Yunfei] Southeast Univ, Sch Mech Engn, Nanjing, Jiangsu, Peoples R China; [Danner, Eric W.; Waite, J. Herbert] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA; [Kan, Yajing; Israelachvili, Jacob N.] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA	Southeast University - China; Southeast University - China; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Chen, YF (corresponding author), Southeast Univ, Jiangsu Key Lab Design & Mfg Micronano Biomed Ins, Nanjing, Jiangsu, Peoples R China.	yunfeichen@seu.edu.cn; waite@lifesci.ucsb.edu	wang, xingsong/C-5189-2009; Chen, Yunfei/H-7820-2014; Kan, Yajing/A-9249-2015	Chen, Yunfei/0000-0002-8682-868X; , Eric/0000-0003-3277-5727	National Institutes of Health [R01 DE018468]; Materials Research Science and Engineering Centers Program of the National Science Foundation [DMR 1121053]; National Basic Research Program of China [2011CB707605]; MRSEC Program of the National Science Foundation [DMR 1121053]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018468] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Materials Research Science and Engineering Centers Program of the National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); National Basic Research Program of China(National Basic Research Program of China); MRSEC Program of the National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by the National Institutes of Health (R01 DE018468), Materials Research Science and Engineering Centers Program of the National Science Foundation under Award DMR 1121053, and the National Basic Research Program of China (2011CB707605). This work was partially supported by the MRSEC Program of the National Science Foundation under Award No. DMR 1121053. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdogan Y, 2014, ANGEW CHEM INT EDIT, V53, P11253, DOI 10.1002/anie.201406858; Argust P, 1998, BIOL TRACE ELEM RES, V66, P131, DOI 10.1007/BF02783133; BABCOCK L, 1980, INORG CHEM, V19, P56, DOI 10.1021/ic50203a013; BABCOCK L, 1983, INORG CHEM, V22, P174, DOI 10.1021/ic00143a038; BOLT GH, 1957, J PHYS CHEM-US, V61, P1166, DOI 10.1021/j150555a007; Chough S.K., 2000, MARINE GEOLOGY KOREA; Danner EW, 2012, BIOCHEMISTRY-US, V51, P6511, DOI 10.1021/bi3002538; EASTERDAY O, 1961, J PHARMACOL EXP THER, V132, P392; Faghihnejad A, 2013, LANGMUIR, V29, P12443, DOI 10.1021/la402244h; Haemers S, 2003, BIOMACROMOLECULES, V4, P632, DOI 10.1021/bm025707n; Harrington MJ, 2010, SCIENCE, V328, P216, DOI 10.1126/science.1181044; He LH, 2011, CHEM COMMUN, V47, P7497, DOI 10.1039/c1cc11928a; Israelachvili J, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/3/036601; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; ISRAELACHVILI JN, 1978, J CHEM SOC FARAD T 1, V74, P975, DOI 10.1039/f19787400975; JANG HG, 1991, J AM CHEM SOC, V113, P9200, DOI 10.1021/ja00024a028; Joslyn MA, 1935, J AM CHEM SOC, V57, P1779, DOI 10.1021/ja01313a007; Kosmulski M, 2009, J COLLOID INTERF SCI, V337, P439, DOI 10.1016/j.jcis.2009.04.072; Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429; Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103; Li SC, 2010, SCIENCE, V328, P882, DOI 10.1126/science.1188328; Liu B, 2006, J AM CHEM SOC, V128, P15228, DOI 10.1021/ja065794h; Lu QY, 2013, ANGEW CHEM INT EDIT, V52, P3944, DOI 10.1002/anie.201210365; Lu QY, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0759; McDowell LM, 1999, J BIOL CHEM, V274, P20293, DOI 10.1074/jbc.274.29.20293; Menyo MS, 2013, SOFT MATTER, V9, P10314, DOI [10.1039/C3SM51824H, 10.1039/c3sm51824h]; Miserez A, 2010, J BIOL CHEM, V285, P38115, DOI 10.1074/jbc.M110.161174; Nakahata M, 2014, ACS MACRO LETT, V3, P337, DOI 10.1021/mz500035w; PIZER R, 1977, INORG CHEM, V16, P1677, DOI 10.1021/ic50173a021; Sedo J, 2013, ADV MATER, V25, P653, DOI 10.1002/adma.201202343; Shafiq Z, 2012, ANGEW CHEM INT EDIT, V51, P4332, DOI 10.1002/anie.201108629; Su J, 2011, J AM CHEM SOC, V133, P11850, DOI 10.1021/ja203077x; Vatankhah-Varnoosfaderani M, 2014, POLYM CHEM-UK, V5, P512, DOI 10.1039/c3py00788j; Vatankhah-Varnoosfaderani M, 2013, CHEM COMMUN, V49, P4685, DOI 10.1039/c3cc41332b; WAITE JH, 1985, BIOCHEMISTRY-US, V24, P5010, DOI 10.1021/bi00340a008; Waite JH, 2001, BIOCHEMISTRY-US, V40, P2887, DOI 10.1021/bi002718x; WAITE JH, 1984, METHOD ENZYMOL, V107, P397; Wang DW, 2011, J AM CHEM SOC, V133, P2192, DOI 10.1021/ja108154a; Wang JJ, 2008, ADV MATER, V20, P3872, DOI 10.1002/adma.200801140; YATES DE, 1980, J CHEM SOC FARAD T 1, V76, P9, DOI 10.1039/f19807600009; YOSHINO K, 1979, B CHEM SOC JPN, V52, P3005, DOI 10.1246/bcsj.52.3005; Young GA, 1982, APPL SCI, V6, P13; Yu J, 2013, BIOMACROMOLECULES, V14, P1072, DOI 10.1021/bm301908y; Yu J, 2011, NAT CHEM BIOL, V7, P588, DOI [10.1038/NCHEMBIO.630, 10.1038/nchembio.630]; Yu J, 2011, ADV MATER, V23, P2362, DOI 10.1002/adma.201003580; Zhao H, 2006, J BIOL CHEM, V281, P26150, DOI 10.1074/jbc.M604357200	46	38	40	9	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e108869	10.1371/journal.pone.0108869	http://dx.doi.org/10.1371/journal.pone.0108869			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	25303409	Green Published, gold			2022-12-27	WOS:000343730400032
J	Wang, Y; Jin, S; Sonobe, Y; Cheng, Y; Horiuchi, H; Parajuli, B; Kawanokuchi, J; Mizuno, T; Takeuchi, H; Suzumura, A				Wang, Yue; Jin, Shijie; Sonobe, Yoshifumi; Cheng, Yi; Horiuchi, Hiroshi; Parajuli, Bijay; Kawanokuchi, Jun; Mizuno, Tetsuya; Takeuchi, Hideyuki; Suzumura, Akio			Interleukin-1 beta Induces Blood-Brain Barrier Disruption by Downregulating Sonic Hedgehog in Astrocytes	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; MULTIPLE-SCLEROSIS; ENDOTHELIAL-CELLS; NEUROLOGICAL DISEASES; MOLECULAR-MECHANISMS; MAGNETIC-RESONANCE; ALZHEIMERS-DISEASE; CNS	The blood-brain barrier (BBB) is composed of capillary endothelial cells, pericytes, and perivascular astrocytes, which regulate central nervous system homeostasis. Sonic hedgehog (SHH) released from astrocytes plays an important role in the maintenance of BBB integrity. BBB disruption and microglial activation are common pathological features of various neurologic diseases such as multiple sclerosis, Parkinson's disease, amyotrophic lateral sclerosis, and Alzheimer's disease. Interleukin-1 beta (IL-1 beta), a major pro-inflammatory cytokine released from activated microglia, increases BBB permeability. Here we show that IL-1 beta abolishes the protective effect of astrocytes on BBB integrity by suppressing astrocytic SHH production. Astrocyte conditioned media, SHH, or SHH signal agonist strengthened BBB integrity by upregulating tight junction proteins, whereas SHH signal inhibitor abrogated these effects. Moreover, IL-1 beta increased astrocytic production of pro-inflammatory chemokines such as CCL2, CCL20, and CXCL2, which induce immune cell migration and exacerbate BBB disruption and neuroinflammation. Our findings suggest that astrocytic SHH is a potential therapeutic target that could be used to restore disrupted BBB in patients with neurologic diseases.	[Wang, Yue; Jin, Shijie; Sonobe, Yoshifumi; Cheng, Yi; Horiuchi, Hiroshi; Parajuli, Bijay; Kawanokuchi, Jun; Mizuno, Tetsuya; Takeuchi, Hideyuki; Suzumura, Akio] Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Nagoya, Aichi 464, Japan	Nagoya University	Takeuchi, H (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Nagoya, Aichi 464, Japan.	htake@riem.nagoya-u.ac.jp	Antaki, James/S-3051-2016; Vandenberghe, Stijn/T-9364-2019; Antaki, James Francis/AAC-5331-2020; Vandenberghe, Stijn/G-9038-2016; Bijay, Parajuli/AAT-5590-2021; Parajuli, Bijay/G-2961-2015	Antaki, James/0000-0002-5430-7353; Vandenberghe, Stijn/0000-0003-1464-0597; Antaki, James Francis/0000-0002-5430-7353; Vandenberghe, Stijn/0000-0003-1464-0597; Parajuli, Bijay/0000-0003-3813-113X; Horiuchi, Hiroshi/0000-0001-9008-2027; Takeuchi, Hideyuki/0000-0001-5912-7581	Ministry of Education, Culture, Sports, Science and Technology of Japan; Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO) of Japan; Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO) of Japan; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a grant from the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO) of Japan; and grants from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Alvarez JI, 2013, GLIA, V61, P1939, DOI 10.1002/glia.22575; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Araujo GLL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00077; Argaw AT, 2006, J IMMUNOL, V177, P5574, DOI 10.4049/jimmunol.177.8.5574; Aronica E, 2012, GLIA, V60, P1258, DOI 10.1002/glia.22312; Blamire AM, 2000, J NEUROSCI, V20, P8153; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Carvey PM, 2009, J NEUROCHEM, V111, P291, DOI 10.1111/j.1471-4159.2009.06319.x; Chakraborty S, 2010, J NEUROSCI RES, V88, P1615, DOI 10.1002/jnr.22343; Cheng Y, 2014, J NEUROIMMUNOL, V269, P38, DOI 10.1016/j.jneuroim.2014.02.001; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Doi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061988; Erickson MA, 2013, J CEREBR BLOOD F MET, V33, P1500, DOI 10.1038/jcbfm.2013.135; FREQUIN STFM, 1992, J NEUROIMMUNOL, V40, P265, DOI 10.1016/0165-5728(92)90142-8; Friedman WJ, 1996, J BIOL CHEM, V271, P31115, DOI 10.1074/jbc.271.49.31115; Glazner GW, 2000, J NEUROCHEM, V75, P101, DOI 10.1046/j.1471-4159.2000.0750101.x; Grammas P, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001918; Hayashi Y, 1997, GLIA, V19, P13, DOI 10.1002/(SICI)1098-1136(199701)19:1<13::AID-GLIA2>3.3.CO;2-E; Herx LM, 2001, J NEUROPATH EXP NEUR, V60, P961, DOI 10.1093/jnen/60.10.961; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Kempermann G, 2003, SCIENCE, V302, P1689, DOI 10.1126/science.1092864; Kraus J, 2006, DRUG DISCOV TODAY, V11, P755, DOI 10.1016/j.drudis.2006.06.008; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Laflamme N, 1999, J NEUROSCI, V19, P10923, DOI 10.1523/JNEUROSCI.19-24-10923.1999; Liang JF, 2008, BRAIN RES, V1210, P11, DOI 10.1016/j.brainres.2008.03.012; Luissint AC, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-23; MARTINEY JA, 1990, AM J PATHOL, V137, P1411; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Mastronardi FG, 2004, J IMMUNOL, V172, P6418, DOI 10.4049/jimmunol.172.10.6418; Mastronardi FG, 2003, MULT SCLER, V9, P362, DOI 10.1191/1352458503ms924oa; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Minagar A, 2003, MULT SCLER J, V9, P540, DOI 10.1191/1352458503ms965oa; Muldoon LL, 2013, J CEREBR BLOOD F MET, V33, P13, DOI 10.1038/jcbfm.2012.153; Nachtergaele S, 2012, NAT CHEM BIOL, V8, P211, DOI 10.1038/nchembio.765; Osterlund T, 2006, TRENDS CELL BIOL, V16, P176, DOI 10.1016/j.tcb.2006.02.004; Parajuli B, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.503; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Sonobe Y, 2009, J BIOL CHEM, V284, P31834, DOI 10.1074/jbc.M109.025940; SUZUMURA A, 1986, SCIENCE, V232, P991, DOI 10.1126/science.3010460; TATSUTA T, 1992, J BIOL CHEM, V267, P20383; Traiffort E, 2010, J NEUROCHEM, V113, P576, DOI 10.1111/j.1471-4159.2010.06642.x; Walsh JG, 2014, NAT REV NEUROSCI, V15, P84, DOI 10.1038/nrn3638; Wang JY, 2008, P NATL ACAD SCI USA, V105, P3915, DOI 10.1073/pnas.0709592105; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Yousry TA, 2006, NEW ENGL J MED, V354, P924, DOI 10.1056/NEJMoa054693; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	47	247	256	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110024	10.1371/journal.pone.0110024	http://dx.doi.org/10.1371/journal.pone.0110024			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313834	Green Submitted, Green Published, gold			2022-12-27	WOS:000343662500094
J	Wang, YJ; Loghmanpour, N; Vandenberghe, S; Ferreira, A; Keller, B; Gorcsan, J; Antaki, J				Wang, Yajuan; Loghmanpour, Natasha; Vandenberghe, Stijn; Ferreira, Antonio; Keller, Bradley; Gorcsan, John; Antaki, James			Simulation of Dilated Heart Failure with Continuous Flow Circulatory Support	PLOS ONE			English	Article							VENTRICULAR ASSIST DEVICE; PRESSURE-VOLUME RELATIONS; TURBODYNAMIC BLOOD PUMPS; MYOCARDIAL RECOVERY; FILLING PRESSURES; RISK SCORE; IN-VIVO; EXERCISE; MODEL; REST	Lumped parameter models have been employed for decades to simulate important hemodynamic couplings between a left ventricular assist device (LVAD) and the native circulation. However, these studies seldom consider the pathological descending limb of the Frank-Starling response of the overloaded ventricle. This study introduces a dilated heart failure model featuring a unimodal end systolic pressure-volume relationship (ESPVR) to address this critical shortcoming. The resulting hemodynamic response to mechanical circulatory support are illustrated through numerical simulations of a rotodynamic, continuous flow ventricular assist device (cfVAD) coupled to systemic and pulmonary circulations with baroreflex control. The model further incorporated septal interaction to capture the influence of left ventricular (LV) unloading on right ventricular function. Four heart failure conditions were simulated (LV and bi-ventricular failure with/without pulmonary hypertension) in addition to normal baseline. Several metrics of LV function, including cardiac output and stroke work, exhibited a unimodal response whereby initial unloading improved function, and further unloading depleted preload reserve thereby reducing ventricular output. The concept of extremal loading was introduced to reflect the loading condition in which the intrinsic LV stroke work is maximized. Simulation of bi-ventricular failure with pulmonary hypertension revealed inadequacy of LV support alone. These simulations	[Wang, Yajuan; Loghmanpour, Natasha; Ferreira, Antonio; Antaki, James] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Vandenberghe, Stijn] Univ Bern, Bern, Switzerland; [Ferreira, Antonio] Univ Fed Maranhao, Maranhao, Brazil; [Keller, Bradley] Univ Louisville, Cardiovasc Innovat Inst, Louisville, KY 40292 USA; [Gorcsan, John] Univ Pittsburgh, Med Ctr, Inst Heart & Vasc, Pittsburgh, PA USA	Carnegie Mellon University; University of Bern; Universidade Federal do Maranhao; University of Louisville; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Antaki, J (corresponding author), Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.	antaki@cmu.edu	Antaki, James/S-3051-2016; Vandenberghe, Stijn/T-9364-2019; Antaki, James Francis/AAC-5331-2020; Vandenberghe, Stijn/G-9038-2016; Bijay, Parajuli/AAT-5590-2021; Parajuli, Bijay/G-2961-2015	Antaki, James/0000-0002-5430-7353; Vandenberghe, Stijn/0000-0003-1464-0597; Antaki, James Francis/0000-0002-5430-7353; Vandenberghe, Stijn/0000-0003-1464-0597; Parajuli, Bijay/0000-0003-3813-113X; Horiuchi, Hiroshi/0000-0001-9008-2027; Takeuchi, Hideyuki/0000-0001-5912-7581	NIH [1R01HL086918]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The research was supported by NIH grant 1R01HL086918. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURKHOFF D, 1987, AM J PHYSIOL, V252, pH1218, DOI 10.1152/ajpheart.1987.252.6.H1218; CAREY CF, 1998, WASHINGTON MANUAL ME; Choi S., 1998, THESIS U PITTSBURGH; Chung DC, 1997, AM J PHYSIOL-HEART C, V272, pH2942, DOI 10.1152/ajpheart.1997.272.6.H2942; Dang NC, 2006, J HEART LUNG TRANSPL, V25, P1, DOI 10.1016/j.healun.2005.07.008; EHRSAM RE, 1983, CLIN SCI, V65, P653, DOI 10.1042/cs0650653; FARRAR DJ, 1985, WORLD J SURG, V9, P89, DOI 10.1007/BF01656260; Ferreira A, 2007, P ANN INT IEEE EMBS, P3978, DOI 10.1109/IEMBS.2007.4353205; Ferreira A, 2009, IEEE T BIO-MED ENG, V56, P656, DOI 10.1109/TBME.2008.2005960; Fitzpatrick JR, 2009, J THORAC CARDIOV SUR, V137, P971, DOI 10.1016/j.jtcvs.2008.09.021; Fitzpatrick JR, 2008, J HEART LUNG TRANSPL, V27, P1286, DOI 10.1016/j.healun.2008.09.006; Gorcsan J, 2003, J HEART LUNG TRANSPL, V22, P1304, DOI 10.1016/S1053-2498(03)00056-1; Gwak KW, 2004, IEEE DECIS CONTR P, P1069, DOI 10.1109/CDC.2004.1428833; Gwak KW, 2007, ASAIO J, V53, P403, DOI 10.1097/MAT.0b013e31806ada0a; Gwak KW, 2011, ARTIF ORGANS, V35, P725, DOI 10.1111/j.1525-1594.2011.01230.x; Hall JE, 2010, GUYTON HALL TXB MED, P110; KASS DA, 1989, CIRCULATION, V79, P167, DOI 10.1161/01.CIR.79.1.167; Katz AM, 2008, CIRC-HEART FAIL, V1, P63, DOI 10.1161/CIRCHEARTFAILURE.108.772756; Kinoshita M, 1988, ASAIO Trans, V34, P208; KORMOS RL, 1990, ANN THORAC SURG, V49, P261, DOI 10.1016/0003-4975(90)90148-Y; Kormos RL, 2010, J THORAC CARDIOV SUR, V139, P1316, DOI 10.1016/j.jtcvs.2009.11.020; Kovacs G, 2009, EUR RESPIR J, V34, P888, DOI 10.1183/09031936.00145608; Lisy O, 2000, CIRCULATION, V102, P338; LITTLE WC, 1988, CIRCULATION, V78, P736, DOI 10.1161/01.CIR.78.3.736; Matthews JC, 2008, J AM COLL CARDIOL, V51, P2163, DOI 10.1016/j.jacc.2008.03.009; Maybaum S, 2011, CIRCULATION, V123, P355, DOI 10.1161/CIRCULATIONAHA.110.005199; Morley D, 2007, J THORAC CARDIOV SUR, V133, P21, DOI 10.1016/j.jtcvs.2006.07.037; Moscato F, 2010, ARTIF ORGANS, V34, P736, DOI 10.1111/j.1525-1594.2010.01066.x; Nair PK, 2010, J HEART LUNG TRANSPL, V29, P201, DOI 10.1016/j.healun.2009.09.013; Nakatani S, 1996, J AM COLL CARDIOL, V27, P894, DOI 10.1016/0735-1097(95)00555-2; NORDENFELT I, 1985, CLIN PHYSIOL, V5, P161, DOI 10.1111/j.1475-097X.1985.tb00592.x; Palardy M, 2009, CIRC-HEART FAIL, V2, P181, DOI 10.1161/CIRCHEARTFAILURE.108.822999; Rose AG, 2000, ANN THORAC SURG, V70, P1270, DOI 10.1016/S0003-4975(00)01929-9; ROSS J, 1964, CIRCULATION, V29, P739, DOI 10.1161/01.CIR.29.5.739; SARNOFF SJ, 1954, CIRCULATION, V9, P706, DOI 10.1161/01.CIR.9.5.706; Schima H, 2004, J THORAC CARDIOV SUR, V127, P1743, DOI 10.1016/j.jtcvs.2003.09.029; Shi YB, 2006, ARTIF ORGANS, V30, P929, DOI 10.1111/j.1525-1594.2006.00326.x; SHROFF SG, 1985, AM J PHYSIOL, V249, pH358, DOI 10.1152/ajpheart.1985.249.2.H358; Simon MA, 2010, J CARD FAIL, V16, P99, DOI 10.1016/j.cardfail.2009.10.018; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; Soloff LA, 1999, CIRCULATION, V100, P1012, DOI 10.1161/circ.100.9.1011/-b; Starling E. H., 1918, LINACRE LECT LAW HEA; STEVENSON LW, 1986, CIRCULATION, V74, P1303, DOI 10.1161/01.CIR.74.6.1303; SUGA H, 1974, CIRC RES, V35, P117, DOI 10.1161/01.RES.35.1.117; THADANI U, 1978, AM J CARDIOL, V41, P52, DOI 10.1016/0002-9149(78)90131-5; Ursino M, 1998, AM J PHYSIOL-HEART C, V275, pH1733, DOI 10.1152/ajpheart.1998.275.5.H1733; Vandenberghe S, 2003, ARTIF ORGANS, V27, P1094, DOI 10.1111/j.1525-1594.2003.07198.x; Vollkron M, 2002, ARTIF ORGANS, V26, P349, DOI 10.1046/j.1525-1594.2002.06870.x; ZARET BL, 1984, EUR HEART J, V5, P850, DOI 10.1093/oxfordjournals.eurheartj.a061576	49	247	256	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85234	10.1371/journal.pone.0085234	http://dx.doi.org/10.1371/journal.pone.0085234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	25313834	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000330237000027
J	Liang, WF; Zhao, YL; Liu, LQ; Wang, YC; Dong, ZL; Li, WJ; Lee, GB; Xiao, XB; Zhang, WJ				Liang, Wenfeng; Zhao, Yuliang; Liu, Lianqing; Wang, Yuechao; Dong, Zaili; Li, Wen Jung; Lee, Gwo-Bin; Xiao, Xiubin; Zhang, Weijing			Rapid and Label-Free Separation of Burkitt's Lymphoma Cells from Red Blood Cells by Optically-Induced Electrokinetics	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; DIELECTROPHORESIS; MANIPULATION; SYSTEM	Early stage detection of lymphoma cells is invaluable for providing reliable prognosis to patients. However, the purity of lymphoma cells in extracted samples from human patients' marrow is typically low. To address this issue, we report here our work on using optically-induced dielectrophoresis (ODEP) force to rapidly purify Raji cells' (a type of Burkitt's lymphoma cell) sample from red blood cells (RBCs) with a label-free process. This method utilizes dynamically moving virtual electrodes to induce negative ODEP force of varying magnitudes on the Raji cells and RBCs in an optically-induced electrokinetics (OEK) chip. Polarization models for the two types of cells that reflect their discriminate electrical properties were established. Then, the cells' differential velocities caused by a specific ODEP force field were obtained by a finite element simulation model, thereby established the theoretical basis that the two types of cells could be separated using an ODEP force field. To ensure that the ODEP force dominated the separation process, a comparison of the ODEP force with other significant electrokinetics forces was conducted using numerical results. Furthermore, the performance of the ODEP-based approach for separating Raji cells from RBCs was experimentally investigated. The results showed that these two types of cells, with different concentration ratios, could be separated rapidly using externally-applied electrical field at a driven frequency of 50 kHz at 20 V-pp. In addition, we have found that in order to facilitate ODEP-based cell separation, Raji cells' adhesion to the OEK chip's substrate should be minimized. This paper also presents our experimental results of finding the appropriate bovine serum albumin concentration in an isotonic solution to reduce cell adhesion, while maintaining suitable medium conductivity for electrokinetics-based cell separation. In short, we have demonstrated that OEK technology could be a promising tool for efficient and effective purification of Raji cells from RBCs.	[Liang, Wenfeng; Liu, Lianqing; Wang, Yuechao; Dong, Zaili; Li, Wen Jung] Chinese Acad Sci, Shenyang Inst Automat, State Key Lab Robot, Shenyang 110016, Peoples R China; [Liang, Wenfeng] Univ Chinese Acad Sci, Beijing, Peoples R China; [Liang, Wenfeng; Zhao, Yuliang; Li, Wen Jung] City Univ Hong Kong, Dept Mech & Biomed Engn, Kowloon, Hong Kong, Peoples R China; [Lee, Gwo-Bin] Natl Tsing Hua Univ, Dept Power Mech Engn, Hsinchu, Taiwan; [Xiao, Xiubin; Zhang, Weijing] Acad Mil Med Sci, Affiliated Hosp, Dept Lymphoma, Beijing, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Automation, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; City University of Hong Kong; National Tsing Hua University; Academy of Military Medical Sciences - China	Liu, LQ (corresponding author), Chinese Acad Sci, Shenyang Inst Automat, State Key Lab Robot, Shenyang 110016, Peoples R China.	lqliu@sia.cn; wenjli@cityu.edu.hk	Zhang, Weijing/GQA-9455-2022; Lee, Gwo-Bin Vincent/D-3032-2012; Li, Wen Jung/A-6153-2010	Lee, Gwo-Bin Vincent/0000-0001-6910-9133; Li, Wen Jung/0000-0001-9616-6213; Wenhua, Liang/0000-0002-1391-8238; Liang, Wenfeng/0000-0002-6605-2511	National Natural Science Foundation of China [61107043]; CAS-Croucher Joint Lab Scheme [9500011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS-Croucher Joint Lab Scheme	The work was supported by National Natural Science Foundation of China (Project No. 61107043) http://www.nsfc.gov.cn; CAS-Croucher Joint Lab Scheme (Project No. 9500011) http://www.croucher.org.hk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustsson P, 2012, ANAL CHEM, V84, P7954, DOI 10.1021/ac301723s; BOYUM A, 1976, SCAND J IMMUNOL, P9, DOI 10.1111/j.1365-3083.1976.tb03851.x; Castellanos A, 2003, J PHYS D APPL PHYS, V36, P2584, DOI 10.1088/0022-3727/36/20/023; Chau LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051577; Chiou PY, 2005, NATURE, V436, P370, DOI [10.1038/nature03831, 10.1038/nature0383l]; Gao J, 2012, ANALYST, V137, P5215, DOI 10.1039/c2an35707k; Hsu HY, 2010, LAB CHIP, V10, P165, DOI 10.1039/b906593h; Huang CJ, 2011, MICROFLUID NANOFLUID, V10, P37, DOI 10.1007/s10404-010-0644-x; Huang SB, 2013, LAB CHIP, V13, P1371, DOI 10.1039/c3lc41256c; Huang SB, 2012, INT J ELECTROCHEM SC, V7, P12656; Hwang H, 2009, BIOMICROFLUIDICS, V3, DOI 10.1063/1.3086600; Janeway CA, 2001, IMMUNOBIOLOGY; Jones T. B., 1995, ELECTROMECHANICS PAR; KAKUTANI T, 1993, BIOELECTROCH BIOENER, V31, P131, DOI 10.1016/0302-4598(93)80002-C; Lau ANK, 2009, LAB CHIP, V9, P2952, DOI 10.1039/b907840a; Li M, 2012, SCI CHINA LIFE SCI, V55, P968, DOI 10.1007/s11427-012-4399-3; Li M, 2011, BIOCHEM BIOPH RES CO, V404, P689, DOI 10.1016/j.bbrc.2010.12.043; Liang WF, 2012, MICROMACHINES-BASEL, V3, P492, DOI 10.3390/mi3020492; Liang WF, 2013, SENSOR ACTUAT A-PHYS, V193, P103, DOI 10.1016/j.sna.2013.01.020; Lin YH, 2010, SENSOR ACTUAT B-CHEM, V145, P854, DOI 10.1016/j.snb.2010.01.019; Lin YH, 2009, OPT EXPRESS, V17, P15318, DOI 10.1364/OE.17.015318; Mikolajczyk S. D., 2011, J ONCOL, V2011, P1, DOI [DOI 10.1186/1477-7819-4-67, 10.1186/1477-7819-4-67]; Moon HS, 2011, LAB CHIP, V11, P1118, DOI [10.1039/c0lc00345j, 10.1039/c01c00345j]; Morgan H., 2003, AC ELECTROKINETICS C, Vfirst; Ohta AT, 2007, IEEE J SEL TOP QUANT, V13, P235, DOI 10.1109/JSTQE.2007.893558; Ohta AT, 2010, LAB CHIP, V10, P3213, DOI [10.1039/c0lc00072h, 10.1039/C0LC00072H]; Polevaya Y, 1999, BBA-BIOMEMBRANES, V1419, P257, DOI 10.1016/S0005-2736(99)00072-3; Rosenberg R, 2002, CYTOMETRY, V49, P150, DOI 10.1002/cyto.10161; Ryu BY, 2005, P NATL ACAD SCI USA, V102, P14302, DOI 10.1073/pnas.0506970102; Sun JS, 2012, LAB CHIP, V12, P3952, DOI 10.1039/c2lc40679a; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106; Valley JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010160; VETTORE L, 1980, AM J HEMATOL, V8, P291, DOI 10.1002/ajh.2830080307; Wang S, 2011, MICROMACHINES-BASEL, V2, P431, DOI 10.3390/mi2040431; Yang J, 1999, ANAL CHEM, V71, P911, DOI 10.1021/ac981250p	35	115	117	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90827	10.1371/journal.pone.0090827	http://dx.doi.org/10.1371/journal.pone.0090827			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	25329056	gold, Green Submitted, Green Published			2022-12-27	WOS:000332485800056
J	Zheng, YL; Kwong, MT; MacCormick, IJC; Beare, NAV; Harding, SP				Zheng, Yalin; Kwong, Man Ting; MacCormick, Ian J. C.; Beare, Nicholas A. V.; Harding, Simon P.			A Comprehensive Texture Segmentation Framework for Segmentation of Capillary Non-Perfusion Regions in Fundus Fluorescein Angiograms	PLOS ONE			English	Article							CEREBRAL MALARIA; IMAGE-ANALYSIS; MINIMIZATION; RETINOPATHY; COMPETITION; CHILDREN; DENSITY; COLOR	Capillary non-perfusion (CNP) in the retina is a characteristic feature used in the management of a wide range of retinal diseases. There is no well-established computation tool for assessing the extent of CNP. We propose a novel texture segmentation framework to address this problem. This framework comprises three major steps: pre-processing, unsupervised total variation texture segmentation, and supervised segmentation. It employs a state-of-the-art multiphase total variation texture segmentation model which is enhanced by new kernel based region terms. The model can be applied to texture and intensity-based multiphase problems. A supervised segmentation step allows the framework to take expert knowledge into account, an AdaBoost classifier with weighted cost coefficient is chosen to tackle imbalanced data classification problems. To demonstrate its effectiveness, we applied this framework to 48 images from malarial retinopathy and 10 images from ischemic diabetic maculopathy. The performance of segmentation is satisfactory when compared to a reference standard of manual delineations: accuracy, sensitivity and specificity are 89.0%, 73.0%, and 90.8% respectively for the malarial retinopathy dataset and 80.8%, 70.6%, and 82.1% respectively for the diabetic maculopathy dataset. In terms of region-wise analysis, this method achieved an accuracy of 76.3% (45 out of 59 regions) for the malarial retinopathy dataset and 73.9% (17 out of 26 regions) for the diabetic maculopathy dataset. This comprehensive segmentation framework can quantify capillary non-perfusion in retinopathy from two distinct etiologies, and has the potential to be adopted for wider applications.	[Zheng, Yalin; Kwong, Man Ting; MacCormick, Ian J. C.; Beare, Nicholas A. V.; Harding, Simon P.] Univ Liverpool, Dept Eye & Vision Sci, Liverpool L69 3BX, Merseyside, England; [Zheng, Yalin; Kwong, Man Ting; Beare, Nicholas A. V.; Harding, Simon P.] Royal Liverpool Univ Hosp, St Pauls Eye Unit, Liverpool, Merseyside, England; [MacCormick, Ian J. C.] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi	University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; University of Malawi	Zheng, YL (corresponding author), Univ Liverpool, Dept Eye & Vision Sci, Liverpool L69 3BX, Merseyside, England.	yalin.zheng@liverpool.ac.uk	Zheng, Yalin/N-6432-2017; MacCormick, Ian/GPW-8622-2022; Beare, Nicholas/AAG-4946-2019; MacCormick, Ian JC/AFW-1885-2022	Zheng, Yalin/0000-0002-7873-0922; MacCormick, Ian/0000-0002-8171-0332; MacCormick, Ian JC/0000-0002-8171-0332; Harding, Simon/0000-0003-4676-1158; Beare, Nicholas/0000-0001-8086-990X	Wellcome Trust [092668/Z/10/Z]; Foundation for the Prevention of Blindness	Wellcome Trust(Wellcome TrustEuropean Commission); Foundation for the Prevention of Blindness	This work was supported by the Wellcome Trust (grant number 092668/Z/10/Z) and the Foundation for the Prevention of Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHTON N, 1953, BRIT J OPHTHALMOL, V37, P282, DOI 10.1136/bjo.37.5.282; Beare NAV, 2009, J INFECT DIS, V199, P263, DOI 10.1086/595735; Buchanan CR, 2008, IEEE ENG MED BIO, P5437, DOI 10.1109/IEMBS.2008.4650444; Chambolle A, 2004, J MATH IMAGING VIS, V20, P89; Chan TF, 2005, IMAGE PROCESSING AND ANALYSIS, P1, DOI 10.1137/1.9780898717877; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Choy SK, 2011, IEEE T IMAGE PROCESS, V20, P1473, DOI 10.1109/TIP.2010.2095023; Cree MJ, 1999, PHYS MED BIOL, V44, P293, DOI 10.1088/0031-9155/44/1/021; Cremers D, 2007, INT J COMPUT VISION, V72, P195, DOI 10.1007/s11263-006-8711-1; Dithmar S., 2008, FLUORESCENCE ANGIOGR; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Garcia Sevilla P., 2006, IMAGE PROCESSING DEA; Gardiner TA, 2007, MICROCIRCULATION, V14, P25, DOI 10.1080/10739680601072123; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hijazi MHA, 2012, KNOWL-BASED SYST, V29, P83, DOI 10.1016/j.knosys.2011.07.002; JASIOBEDZKI P, 1993, IMAGE VISION COMPUT, V11, P139, DOI 10.1016/0262-8856(93)90052-I; JASIOBEDZKI P, 1991, COMPUTER-BASED MEDICA SYSTEMS, P162, DOI 10.1109/CBMS.1991.128960; Nguyen K, 2012, PATTERN RECOGN LETT, V33, P951, DOI 10.1016/j.patrec.2011.10.001; Kim JM, 2005, IEEE T IMAGE PROCESS, V14, P1486, DOI 10.1109/TIP.2005.854442; Li CM, 2008, IEEE T IMAGE PROCESS, V17, P1940, DOI 10.1109/TIP.2008.2002304; Li F, 2010, COMMUN COMPUT PHYS, V8, P623, DOI 10.4208/cicp.160609.311209a; Mabrouk M.S., 2006, ICGST INT J GRAPH VI, V6, P1; Maude RJ, 2009, T ROY SOC TROP MED H, V103, P661, DOI 10.1016/j.trstmh.2008.11.003; Mirmehdi M., 2008, HDB TEXTURE ANAL; Narasimha-Iyer H, 2006, IEEE T BIO-MED ENG, V53, P1084, DOI 10.1109/TBME.2005.863971; Ni K, 2009, INT J COMPUT VISION, V84, P97, DOI 10.1007/s11263-009-0234-0; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Patton N, 2006, PROG RETIN EYE RES, V25, P99, DOI 10.1016/j.preteyeres.2005.07.001; Patton N, 2005, J ANAT, V206, P319, DOI 10.1111/j.1469-7580.2005.00395.x; Rousson M, 2003, PROC CVPR IEEE, P699; Sandberg B, 2002, 0239 CAM UCLA DEP MA; Saxena Sandeep, 2007, Indian Journal of Ophthalmology, V55, P267; Sivaswamy J, 2008, COMM COM INF SC, V25, P176; Sonka M., 2006, IMAGE PROCESSING ANA; TALBOT JF, 1982, BRIT J OPHTHALMOL, V66, P149, DOI 10.1136/bjo.66.3.149; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Trucco E, 2007, P ANN INT IEEE EMBS, P6740; Winder RJ, 2009, COMPUT MED IMAG GRAP, V33, P608, DOI 10.1016/j.compmedimag.2009.06.003; WOLF S, 1994, HYPERTENSION, V23, P464, DOI 10.1161/01.HYP.23.4.464; Zheng Y., 2012, ISRN SIGNAL PROCESS, V2012, P1; Zheng YL, 2007, P ANN INT IEEE EMBS, P4433, DOI 10.1109/IEMBS.2007.4353322; Zheng YL, 2013, BIOMED SIGNAL PROCES, V8, P374, DOI 10.1016/j.bspc.2013.02.004; Zheng YL, 2013, AM J OPHTHALMOL, V155, P277, DOI 10.1016/j.ajo.2012.07.030; Zheng YL, 2010, INVEST OPHTH VIS SCI, V51, P3653, DOI 10.1167/iovs.09-4935; Zhu SC, 1996, IEEE T PATTERN ANAL, V18, P884, DOI 10.1109/34.537343	45	73	78	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e93624	10.1371/journal.pone.0093624	http://dx.doi.org/10.1371/journal.pone.0093624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	25314156	Green Published, gold			2022-12-27	WOS:000335226500010
J	Zhao, JP; Levy, E; Fraser, WD; Julien, P; Delvin, E; Montoudis, A; Spahis, S; Garofalo, C; Nuyt, AM; Luo, ZC				Zhao, Jin-Ping; Levy, Emile; Fraser, William D.; Julien, Pierre; Delvin, Edgard; Montoudis, Alain; Spahis, Schohraya; Garofalo, Carole; Nuyt, Anne Monique; Luo, Zhong-Cheng			Circulating Docosahexaenoic Acid Levels Are Associated with Fetal Insulin Sensitivity	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; GESTATIONAL DIABETES-MELLITUS; ALPHA-LINOLENIC ACID; PHOSPHOLIPID-COMPOSITION; DESATURASE ACTIVITIES; ARACHIDONIC-ACID; PREGNANCY; GLUCOSE; SECRETION; OBESITY	Background: Arachidonic acid (AA; C20: 4 n-6) and docosahexaenoic acid (DHA; C22: 6 n-3) are important long-chain polyunsaturated fatty acids (LC-PUFA) in maintaining pancreatic beta-cell structure and function. Newborns of gestational diabetic mothers are more susceptible to the development of type 2 diabetes in adulthood. It is not known whether low circulating AA or DHA is involved in perinatally "programming'' this susceptibility. This study aimed to assess whether circulating concentrations of AA, DHA and other fatty acids are associated with fetal insulin sensitivity or beta-cell function, and whether low circulating concentrations of AA or DHA are involved in compromised fetal insulin sensitivity in gestational diabetic pregnancies. Methods and Principal Findings: In a prospective singleton pregnancy cohort, maternal (32-35 weeks gestation) and cord plasma fatty acids were assessed in relation to surrogate indicators of fetal insulin sensitivity (cord plasma glucose-to-insulin ratio, proinsulin concentration) and beta-cell function (proinsulin-to-insulin ratio) in 108 mother-newborn pairs. Cord plasma DHA levels (in percentage of total fatty acids) were lower comparing newborns of gestational diabetic (n = 24) vs. nondiabetic pregnancies (2.9% vs. 3.5%, P = 0.01). Adjusting for gestational age at blood sampling, lower cord plasma DHA levels were associated with lower fetal insulin sensitivity (lower glucose-to-insulin ratio, r = 0.20, P = 0.036; higher proinsulin concentration, r = 20.37, P<0.0001). The associations remained after adjustment for maternal and newborn characteristics. Cord plasma saturated fatty acids C18:0 and C20:0 were negatively correlated with fetal insulin sensitivity, but their levels were not different between gestational diabetic and non-diabetic pregnancies. Cord plasma AA levels were not correlated with fetal insulin sensitivity. Conclusion: Low circulating DHA levels are associated with compromised fetal insulin sensitivity, and may be involved in perinatally "programming'' the susceptibility to type 2 diabetes in the offspring of gestational diabetic mothers.	[Zhao, Jin-Ping; Fraser, William D.; Luo, Zhong-Cheng] Univ Montreal, Dept Obstet & Gynecol, Montreal, PQ, Canada; [Levy, Emile; Montoudis, Alain; Spahis, Schohraya; Garofalo, Carole] Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada; [Julien, Pierre] Laval Univ Hosp Res Ctr, Quebec City, PQ, Canada; [Julien, Pierre] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Delvin, Edgard] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Nuyt, Anne Monique] Univ Montreal, Dept Pediat, St Justine Hosp Res Ctr, Montreal, PQ H3C 3J7, Canada; [Luo, Zhong-Cheng] Shanghai Jiao Tong Univ, Minist Educ, Shanghai Key Lab Childrens Environm Hlth, Xinhua Hosp,Sch Med, Shanghai 200030, Peoples R China	Universite de Montreal; Universite de Montreal; Laval University; Laval University; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Shanghai Jiao Tong University	Luo, ZC (corresponding author), Univ Montreal, Dept Obstet & Gynecol, Montreal, PQ, Canada.	zc_luo@yahoo.com	Julien, Pierre/AGO-7542-2022; Luo, Zhong-Cheng/T-3882-2017	Julien, Pierre/0000-0002-9247-6676; Luo, Zhong-Cheng/0000-0002-1794-1312	Canadian Institutes of Health Research (CIHR) [79896, 78879]; Quebec Training Network in Perinatal Research (QTNPR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Quebec Training Network in Perinatal Research (QTNPR)	This work was supported by the Canadian Institutes of Health Research (CIHR grant no. 79896 and 78879). J-P Zhao is the recipient of a Postdoctoral Scholarship from Quebec Training Network in Perinatal Research (QTNPR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardenheier BH, 2013, DIABETES CARE, V36, P1209, DOI 10.2337/dc12-0901; Baur LA, 1998, METABOLISM, V47, P106, DOI 10.1016/S0026-0495(98)90202-5; Bergeron K, 2007, J LIPID RES, V48, P2396, DOI 10.1194/jlr.M700166-JLR200; Bitsanis D, 2006, LIPIDS, V41, P341, DOI 10.1007/s11745-006-5104-8; Brenner RR, 2003, PROSTAG LEUKOTR ESS, V68, P151, DOI 10.1016/S0952-3278(02)00265-X; Burdge GC, 2008, PROSTAG LEUKOTR ESS, V78, P73, DOI 10.1016/j.plefa.2007.10.028; Burdge GC, 2002, BRIT J NUTR, V88, P411, DOI 10.1079/BJN2002689; Burdge GC, 2006, NUTR RES REV, V19, P26, DOI 10.1079/NRR2005113; CLANDININ MT, 1991, FASEB J, V5, P2761, DOI 10.1096/fasebj.5.13.1916101; Clausen TD, 2008, DIABETES CARE, V31, P340, DOI 10.2337/dc07-1596; Dabelea D, 2008, DIABETES CARE, V31, P1422, DOI 10.2337/dc07-2417; Decsi T, 2000, LIPIDS, V35, P1179, DOI 10.1007/s11745-000-0634-7; Dixon G, 2004, CLIN SCI, V106, P191, DOI 10.1042/CS20030261; FAAS FH, 1983, LIPIDS, V18, P339, DOI 10.1007/BF02534712; FIELD CJ, 1990, J BIOL CHEM, V265, P11143; Gibson RA, 2011, MATERN CHILD NUTR, V7, P17, DOI 10.1111/j.1740-8709.2011.00299.x; Innis SM, 2003, AM J CLIN NUTR, V77, P473, DOI 10.1093/ajcn/77.2.473; Kaushik M, 2009, AM J CLIN NUTR, V90, P613, DOI 10.3945/ajcn.2008.27424; Konrad RJ, 1996, PANCREAS, V13, P253, DOI 10.1097/00006676-199610000-00007; KONRAD RJ, 1994, BIOCHEMISTRY-US, V33, P13284, DOI 10.1021/bi00249a015; Korotkova M, 2005, AM J PHYSIOL-REG I, V288, pR575, DOI 10.1152/ajpregu.00342.2004; Lambert M, 2004, INT J OBESITY, V28, P833, DOI 10.1038/sj.ijo.0802694; LEPAGE G, 1989, J LIPID RES, V30, P1483; Luo ZC, 2010, DIABETES CARE, V33, P2055, DOI 10.2337/dc10-0819; Luoto R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001036; Makrides M, 2000, AM J CLIN NUTR, V71, p307S, DOI 10.1093/ajcn/71.1.307S; Miller MR, 2012, J CLIN ENDOCR METAB, V97, P3285, DOI 10.1210/jc.2012-1318; Min Y, 2005, DIABETIC MED, V22, P914, DOI 10.1111/j.1464-5491.2005.01556.x; Min Y, 2004, DIABETOLOGIA, V47, P75, DOI 10.1007/s00125-003-1275-5; MONTELONGO A, 1992, DIABETES, V41, P1651, DOI 10.2337/diabetes.41.12.1651; Ortega-Senovilla H, 2009, DIABETES CARE, V32, P120, DOI 10.2337/dc08-0679; Resnick HE, 2000, DIABETES CARE, V23, P176, DOI 10.2337/diacare.23.2.176; Setia S, 2006, PATHOLOGY, V38, P236, DOI 10.1080/00313020600696256; Spahis S, 2008, PROSTAG LEUKOTR ESS, V79, P47, DOI 10.1016/j.plefa.2008.07.005; Steffen LM, 2008, INT J OBESITY, V32, P1297, DOI 10.1038/ijo.2008.89; Thomas BA, 2005, PROSTAG LEUKOTR ESS, V72, P335, DOI 10.1016/j.plefa.2005.01.001; Wang QW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059845; Warensjo E, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-37; Welch AA, 2010, AM J CLIN NUTR, V92, P1040, DOI 10.3945/ajcn.2010.29457; Whelan J, 2009, PROSTAG LEUKOTR ESS, V81, P133, DOI 10.1016/j.plefa.2009.05.008; Wijendran V, 2000, LIPIDS, V35, P927, DOI 10.1007/S11745-000-0602-2; Zhang G, 2012, J CLIN ENDOCR METAB, V97, pE973, DOI 10.1210/jc.2011-2997	42	252	260	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85054	10.1371/journal.pone.0085054	http://dx.doi.org/10.1371/journal.pone.0085054			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	25303175	Green Published, Green Submitted, gold			2022-12-27	WOS:000329922500037
J	Chen, Y; Yang, J; Shu, HZ; Shi, LY; Wu, JS; Luo, LM; Coatrieux, JL; Toumoulin, C				Chen, Yang; Yang, Jian; Shu, Huazhong; Shi, Luyao; Wu, Jiasong; Luo, Limin; Coatrieux, Jean-Louis; Toumoulin, Christine			2-D Impulse Noise Suppression by Recursive Gaussian Maximum Likelihood Estimation	PLOS ONE			English	Article							MEDIAN FILTER; TOMOGRAPHIC RECONSTRUCTION; REMOVAL; DETECTOR; SIMILARITY; ALGORITHM; WEIGHTS	An effective approach termed Recursive Gaussian Maximum Likelihood Estimation (RGMLE) is developed in this paper to suppress 2-D impulse noise. And two algorithms termed RGMLE-C and RGMLE-CS are derived by using spatially-adaptive variances, which are respectively estimated based on certainty and joint certainty & similarity information. To give reliable implementation of RGMLE-C and RGMLE-CS algorithms, a novel recursion stopping strategy is proposed by evaluating the estimation error of uncorrupted pixels. Numerical experiments on different noise densities show that the proposed two algorithms can lead to significantly better results than some typical median type filters. Efficient implementation is also realized via GPU (Graphic Processing Unit)-based parallelization techniques.	[Chen, Yang; Shu, Huazhong; Shi, Luyao; Wu, Jiasong; Luo, Limin] Southeast Univ, Lab Image Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Chen, Yang; Shu, Huazhong; Shi, Luyao; Wu, Jiasong; Luo, Limin] Southeast Univ, Minist Educ, Key Lab Comp Network & Informat Integrat, Beijing, Peoples R China; [Chen, Yang; Shu, Huazhong; Shi, Luyao; Wu, Jiasong; Luo, Limin; Coatrieux, Jean-Louis; Toumoulin, Christine] Ctr Rech Informat Biomed Sino Francais LIA CRIBs, Rennes, France; [Yang, Jian] Beijing Inst Technol, Res Ctr Mixed Real & Adv Display, Beijing 100081, Peoples R China; [Coatrieux, Jean-Louis; Toumoulin, Christine] INSERM, U1099, Rennes, France; [Coatrieux, Jean-Louis; Toumoulin, Christine] Univ Rennes 1, LTSI, Rennes, France	Southeast University - China; Southeast University - China; Beijing Institute of Technology; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Luo, LM (corresponding author), Southeast Univ, Lab Image Sci & Technol, Nanjing, Jiangsu, Peoples R China.	luo.list@seu.edu.cn	Coatrieux, Jean-Louis/ABC-8154-2020; Shi, Luyao/AAH-1342-2019	CHEN, YI-KUAN/0000-0002-0219-4756	National Basic Research Program of China [2010CB732503]; National Natural Science Foundation [81000636, 81370040]; Natural Science Foundations of Jiangsu Province [BK2011593]; Key Laboratory of Computer Network and Information Integration (Southeast University), Ministry of Education	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundations of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Key Laboratory of Computer Network and Information Integration (Southeast University), Ministry of Education	This research was supported by National Basic Research Program of China under grant (2010CB732503), National Natural Science Foundation under grants (81000636, 81370040), and the Project supported by Natural Science Foundations of Jiangsu Province (BK2011593). This work was also supported by the Key Laboratory of Computer Network and Information Integration (Southeast University), Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS DF, 1974, J ROY STAT SOC B MET, V36, P99; [Anonymous], NVIDIA CUDATM PROGR; Arce GR, 1998, IEEE T SIGNAL PROCES, V46, P3195, DOI 10.1109/78.735296; Astola J., 1997, FUNDAMENTALS NONLINE; Bovik A., 2000, HDB IMAGE VIDEO PROC; Buades A, 2005, PROC CVPR IEEE, P60, DOI 10.1109/cvpr.2005.38; Cai JF, 2011, INVERSE PROBL IMAG, V2, P187; Chan RH, 2005, IEEE T IMAGE PROCESS, V14, P1479, DOI 10.1109/TIP.2005.852196; Chaudhury KN, 2012, IEEE SIGNAL PROC LET, V19, P745, DOI 10.1109/LSP.2012.2217329; Chen Y, 2008, J MATH IMAGING VIS, V30, P133, DOI 10.1007/s10851-007-0042-5; Chen Y, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/9/2667; Chen Y, 2011, MULTISCALE MODEL SIM, V9, P1399, DOI 10.1137/100814184; Deledalle CA, 2009, IEEE T IMAGE PROCESS, V18, P2661, DOI 10.1109/TIP.2009.2029593; Dong YQ, 2007, IEEE T IMAGE PROCESS, V16, P1112, DOI 10.1109/TIP.2006.891348; Elad M, 2006, IEEE T IMAGE PROCESS, V15, P3736, DOI 10.1109/TIP.2006.881969; Esakkirajan S, 2011, IEEE SIGNAL PROC LET, V18, P287, DOI 10.1109/LSP.2011.2122333; Harris JW, 1998, HDB MATH COMPUTATION, P824; HWANG H, 1995, IEEE T IMAGE PROCESS, V4, P499, DOI 10.1109/83.370679; Justusson BI, 1981, P 2 DIM DIG SIGN PRO; LEE YH, 1991, IEEE T SIGNAL PROCES, V39, P984, DOI 10.1109/78.80931; Lin CH, 2010, IEEE T IMAGE PROCESS, V19, P2307, DOI 10.1109/TIP.2010.2047906; Ng PE, 2006, IEEE T IMAGE PROCESS, V15, P1506, DOI 10.1109/TIP.2005.871129; Sree PSJ, 2013, SIGNAL IMAGE VIDEO P, V7, P111, DOI 10.1007/s11760-011-0210-3; Srinivasan KS, 2007, IEEE SIGNAL PROC LET, V14, P189, DOI 10.1109/LSP.2006.884018; Takeda H, 2007, IEEE T IMAGE PROCESS, V16, P349, DOI 10.1109/TIP.2006.888330; Ville DVD, 2011, IEEE T IMAGE PROCESS, V20, P2683; Wainwright MJ, ADV NEUROALINFORMATI; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Zhang SQ, 2002, IEEE SIGNAL PROC LET, V9, P360, DOI 10.1109/LSP.2002.805310; Zhang XM, 2009, IEEE SIGNAL PROC LET, V16, P295, DOI 10.1109/LSP.2009.2014293	30	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e96386	10.1371/journal.pone.0096386	http://dx.doi.org/10.1371/journal.pone.0096386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836960	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800016
J	Chen, YK; Han, LZ; Xue, F; Shen, CH; Lu, J; Yang, TH; Zhang, JJ; Xia, Q				Chen, Yi-kuan; Han, Long-zhi; Xue, Feng; Shen, Cong-huan; Lu, Jun; Yang, Tai-hua; Zhang, Jian-jun; Xia, Qiang			Personalized Tacrolimus Dose Requirement by CYP3A5 but Not ABCB1 or ACE Genotyping in Both Recipient and Donor after Pediatric Liver Transplantation	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; ATP-BINDING CASSETTE; RENAL-TRANSPLANTATION; DOSAGE REQUIREMENTS; DOSING REQUIREMENTS; SUBFAMILY B; PHARMACOKINETICS; IMPACT; PHARMACOGENETICS; AGE	Tacrolimus (TAC) is the backbone of an immunosuppressive drug used in most solid organ transplant recipients. A single nucleotide polymorphism (SNP) at position 6986G>A in CYP3A5 has been notably involved in the pharmacokinetic variability of TAC. It is hypothesized that CYP3A5 genotyping in patients may provide a guideline for TAC therapeutic regimen. To further evaluate the impact of CYP3A5 variants in donors and recipients, ABCB1 and ACE SNPs in recipients on TAC disposition, clinical and laboratory data were retrospectively reviewed from 90 pediatric patients with liver transplantation and their corresponding donors after 1 year of transplantation. The recipients with CYP3A5 *1/*1 or *1/*3 required more time to achieve TAC therapeutic range during the induction phase, and needed more upward dose during the late induction and the maintained phases, with lower C/D ratio, compared with those with CYP3A5 *3/*3. And donor CYP3A5 genotypes were found to impact on TAC trough concentrations after liver transplantation. No association between ABCB1 or ACE genotypes and TAC disposition post-transplantation was found. These results strongly suggest that CYP3A5 genotyping both in recipient and donor, not ABCB1 or ACE is necessary for establishing a personalized TAC dosage regimen in pediatric liver transplant patients.	[Chen, Yi-kuan; Han, Long-zhi; Xue, Feng; Shen, Cong-huan; Lu, Jun; Yang, Tai-hua; Zhang, Jian-jun; Xia, Qiang] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Liver Surg & Liver Transplantat, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Xue, F (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Liver Surg & Liver Transplantat, Shanghai 200030, Peoples R China.	fengxue6879@163.com; xiaqiang@medmail.com.cn	Coatrieux, Jean-Louis/ABC-8154-2020; Shi, Luyao/AAH-1342-2019	CHEN, YI-KUAN/0000-0002-0219-4756	National Ministry of Public Health [IHECCO8-201213]; Shanghai Science and Technology Committee [12ZR1418300]	National Ministry of Public Health; Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This project was supported by National Ministry of Public Health grant (IHECCO8-201213) (http://www.nhfpc.gov.cn/gjhzs/index.shtml) and Shanghai Science and Technology Committee grant (12ZR1418300) (http://www.stcsm.gov.cn/). The funders had roles in study design, data collection and analysis.	Gomez-Bravo MA, 2013, J CLIN PHARMACOL, V53, P1146, DOI 10.1002/jcph.154; Chen DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073405; Cho JH, 2012, TRANSPL P, V44, P109, DOI 10.1016/j.transproceed.2011.11.004; de Wildt SN, 2011, EUR J CLIN PHARMACOL, V67, P1231, DOI 10.1007/s00228-011-1083-7; Ferraris JR, 2011, PEDIATR TRANSPLANT, V15, P525, DOI 10.1111/j.1399-3046.2011.01513.x; Fukudo M, 2006, CLIN PHARMACOL THER, V80, P331, DOI 10.1016/j.clpt.2006.06.008; Gijsen V, 2011, J HEART LUNG TRANSPL, V30, P1352, DOI 10.1016/j.healun.2011.08.001; Gijsen VMGJ, 2012, ANN TRANSPL, V17, P111; Glowacki F, 2011, NEPHROL DIAL TRANSPL, V26, P3046, DOI 10.1093/ndt/gfr253; Grenda R, 2009, ANN TRANSPL, V14, P18; Hawwa AF, 2011, EXPERT OPIN DRUG SAF, V10, P9, DOI 10.1517/14740338.2010.505600; Hawwa AF, 2009, BRIT J CLIN PHARMACO, V68, P413, DOI 10.1111/j.1365-2125.2009.03461.x; Hesselink DA, 2014, CLIN PHARMACOKINET, V53, P123, DOI 10.1007/s40262-013-0120-3; Hosohata K, 2009, DRUG METAB PHARMACOK, V24, P458, DOI 10.2133/dmpk.24.458; Hosohata K, 2009, DRUG METAB DISPOS, V37, P821, DOI 10.1124/dmd.108.025833; Iwasaki K, 2007, DRUG METAB PHARMACOK, V22, P328, DOI 10.2133/dmpk.22.328; Jacobson PA, 2011, TRANSPLANTATION, V91, P300, DOI 10.1097/TP.0b013e318200e991; Kausman JY, 2008, PEDIATR TRANSPLANT, V12, P329, DOI 10.1111/j.1399-3046.2007.00821.x; Kim JS, 2005, PEDIATR TRANSPLANT, V9, P162, DOI 10.1111/j.1399-3046.2005.00263.x; Li L, 2011, EUR J CLIN PHARMACOL, V67, P787, DOI 10.1007/s00228-011-1010-y; MacPhee IAM, 2005, TRANSPLANTATION, V79, P499, DOI 10.1097/01.TP.0000151766.73249.12; Min SI, 2010, TRANSPLANTATION, V90, P1394, DOI 10.1097/TP.0b013e3181fa93a4; Penninga L, 2010, EUR J CLIN PHARMACOL, V66, P1177, DOI 10.1007/s00228-010-0902-6; Provenzani A, 2009, ANN TRANSPL, V14, P23; SAEKI T, 1993, J BIOL CHEM, V268, P6077; Satoh S, 2008, BRIT J CLIN PHARMACO, V66, P207, DOI 10.1111/j.1365-2125.2008.03188.x; Shilbayeh Sireen, 2013, Saudi J Kidney Dis Transpl, V24, P1125, DOI 10.4103/1319-2442.121268; Staatz CE, 2010, CLIN PHARMACOKINET, V49, P207, DOI 10.2165/11317550-000000000-00000; Uesugi M, 2013, BIOL PHARM BULL, V36, P1814; Vannaprasaht S, 2013, CLIN THER, V35, P1762, DOI 10.1016/j.clinthera.2013.08.019; Wang WL, 2006, LIVER TRANSPLANT, V12, P775, DOI 10.1002/lt.20709; Xue F, 2010, TRANSPLANTATION, V89, P620, DOI 10.1097/TP.0b013e3181c690fa; Yu SF, 2006, TRANSPLANTATION, V81, P46, DOI 10.1097/01.tp.0000188118.34633.bf	33	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2014	9	10							e109464	10.1371/journal.pone.0109464	http://dx.doi.org/10.1371/journal.pone.0109464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ9WZ	24836960	gold, Green Published, Green Submitted			2022-12-27	WOS:000343210300051
J	Wang, ZT; Akamatsu, T; Wang, KX; Wang, D				Wang, Zhitao; Akamatsu, Tomonari; Wang, Kexiong; Wang, Ding			The Diel Rhythms of Biosonar Behavior in the Yangtze Finless Porpoise (Neophocaena asiaeorientalis asiaeorientalis) in the Port of the Yangtze River: The Correlation between Prey Availability and Boat Traffic	PLOS ONE			English	Article							PANTROPICAL SPOTTED DOLPHINS; PHOCAENOIDES-ASIAEORIENTALIS; ECHOLOCATION BEHAVIOR; TEMPORAL PATTERNS; BEAKED-WHALES; FOOD-HABITS; CONSERVATION; SIGNALS; SONAR; MOVEMENTS	Information on the habitat use of the critically endangered Yangtze finless porpoise (Neophocaena asiaeorientalis asiaeorientalis) is critical for its conservation. The diel biosonar behavior of the porpoise in the port areas of the Yangtze River was examined along with simultaneous observations of fish density and boat traffic. Biosonar pulses from the porpoises were detected for 1233 min (5.77%) over a 21,380 min duration of effective observations. In total, 190 (5.63%) buzzes (an indication of prey capture attempts) were recorded among the 3372 identified click trains. Of the 168 echolocation encounters (bouts of click trains less than eight min apart), 150 (89.3%) involved single animals, indicating that solitary porpoises were frequently present and feeding in the port areas. Significant diel patterns were evident involving the biosonar behavior of the porpoises (including click trains and buzzes), fish density and boat traffic. The frequencies of the click trains and buzzes were significantly lower during the day than in the evening and at night, which suggests that porpoises in this region are primarily engaged in crepuscular and nocturnal foraging. The lack of a significant diel pattern in the echolocation encounters indicates the importance of the port in porpoise conservation. A forced feeding schedule may be associated with the lack of a significant correlation between porpoise acoustics and boat traffic. Overall, prey availability appears to be the primary factor that attracts porpoises. Additionally, porpoises tend to migrate or remain downstream in the morning and migrate or remain upstream in the evening, most likely to follow their prey. The findings of this study can be used to improve the conservation of the Yangtze finless porpoise.	[Wang, Zhitao; Wang, Kexiong; Wang, Ding] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China; [Wang, Zhitao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Akamatsu, Tomonari] Natl Res Inst Fisheries Engn, Fisheries Res Agcy, Ibaraki, Japan	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Japan Fisheries Research & Education Agency (FRA)	Wang, KX (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China.	wangk@ihb.ac.cn; wangd@ihb.ac.cn	Wang, Zhi-Tao/F-1176-2015; zhang, lingling/HDM-2189-2022; meng, li/GVT-2063-2022	Wang, Zhi-Tao/0000-0002-5734-7385; Chen, Hou-Zao/0000-0001-6805-3182; Zhang, Tong/0000-0003-1148-4322	Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-Z-4]; National Natural Science Foundation of China [31170501, 31070347]; Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China [201203086]; Ministry of Science and Technology of China [2011BAG07B05-3]; State Oceanic Administration of China [201105011-3]; CREST, Japan Science and Technology Agency; Ocean Park Conservation Foundation, Hong Kong; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA026114] Funding Source: NIH RePORTER	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China; Ministry of Science and Technology of China(Ministry of Science and Technology, China); State Oceanic Administration of China; CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ocean Park Conservation Foundation, Hong Kong; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-4), the National Natural Science Foundation of China (31170501 and 31070347), the Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China (201203086), Ministry of Science and Technology of China (2011BAG07B05-3), State Oceanic Administration of China (201105011-3), CREST, Japan Science and Technology Agency and the Ocean Park Conservation Foundation, Hong Kong (There is no grant code). The funders had no roles in designing the study, collecting and analyzing data or preparing and deciding where to publish the manuscript.	Akamatsu T, 2008, J ACOUST SOC AM, V123, P4403, DOI 10.1121/1.2912449; Akamatsu T, 2000, J ACOUST SOC AM, V108, P1353, DOI 10.1121/1.1287841; Akamatsu T, 2005, MAR TECHNOL SOC J, V39, P3, DOI 10.4031/002533205787443980; Akamatsu T, 2005, J ACOUST SOC AM, V117, P3325, DOI 10.1121/1.1893325; Akamatsu T, 2010, J EXP BIOL, V213, P146, DOI 10.1242/jeb.037655; Akamatsu T, 2007, DEEP-SEA RES PT II, V54, P290, DOI 10.1016/j.dsr2.2006.11.006; Au W.W, 2008, PRINCIPLES MARINE BI; Au WWL, 2013, J ACOUST SOC AM, V133, P3119, DOI 10.1121/1.4798360; Baird RW, 2001, CAN J ZOOL, V79, P988, DOI 10.1139/cjz-79-6-988; Barros NB, 2002, RAFFLES B ZOOL, P115; Benoit-Bird KJ, 2004, MAR MAMMAL SCI, V20, P215, DOI 10.1111/j.1748-7692.2004.tb01152.x; Benoit-Bird KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P364, DOI 10.1007/s00265-003-0585-4; Carlstrom J, 2005, MAR MAMMAL SCI, V21, P1, DOI 10.1111/j.1748-7692.2005.tb01204.x; Dawson S, 2013, ENDANGER SPECIES RES, V21, P45, DOI 10.3354/esr00508; Dong Shou-Yue, 2012, Acta Hydrobiologica Sinica, V36, P246; Evans W.E., 1974, P385; Fabi G, 2002, ICES J MAR SCI, V59, pS309, DOI 10.1006/jmsc.2002.1194; FOOTE KG, 1987, J ACOUST SOC AM, V82, P981, DOI 10.1121/1.395298; Gannier Alexandre, 1999, Aquatic Mammals, V25, P123; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Henderson EE, 2012, MAR MAMMAL SCI, V28, P439, DOI 10.1111/j.1748-7692.2011.00498.x; Johnston DW, 2008, BIOL LETTERS, V4, P208, DOI 10.1098/rsbl.2007.0614; Kajimura H., 1981, FISH B-NOAA, V78, P951; Keenan SE, 2003, AM FISH S S, V36, P167; Kimura S, 2013, J ACOUST SOC AM, V133, P3128, DOI 10.1121/1.4796129; Kimura S, 2012, MAR MAMMAL SCI, V28, P308, DOI 10.1111/j.1748-7692.2011.00490.x; Kimura S, 2009, J ACOUST SOC AM, V125, P547, DOI 10.1121/1.3021302; Leeney RH, 2011, AQUAT MAMM, V37, P151, DOI 10.1578/AM.37.2.2011.151; Li S., 2008, BIOACOUSTICS, V17, P174, DOI [10.1080/09524622.2008.9753806, DOI 10.1080/09524622.2008.9753806]; Li SH, 2006, J ACOUST SOC AM, V120, P1803, DOI 10.1121/1.2335674; Li SH, 2010, WILDL PROT DESTR EXT, P343; Lin PC, 2013, J APPL ICHTHYOL, V29, P1402, DOI 10.1111/jai.12342; Linnenschmidt M, 2013, MAR MAMMAL SCI, V29, pE77, DOI 10.1111/j.1748-7692.2012.00592.x; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Madsen PT, 2005, J EXP BIOL, V208, P181, DOI 10.1242/jeb.01327; Miller PJO, 2004, P ROY SOC B-BIOL SCI, V271, P2239, DOI 10.1098/rspb.2004.2863; Payne NL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2363; Pilleri G., 1970, P27; Rasmussen MH, 2013, DEEP-SEA RES PT II, V88-89, P97, DOI 10.1016/j.dsr2.2012.07.011; Reubens JT, 2014, J SEA RES, V85, P214, DOI 10.1016/j.seares.2013.05.005; Richard S, 2010, SCIENCE, V329, P378; Robertson KM, 1997, FISH B-NOAA, V95, P334; Sasaki-Yamamoto Y, 2013, MAR MAMMAL SCI, V29, P589, DOI 10.1111/j.1748-7692.2012.00590.x; Scott MD, 2009, MAR MAMMAL SCI, V25, P137, DOI 10.1111/j.1748-7692.2008.00241.x; Shirakihara M, 2008, J MAMMAL, V89, P1248, DOI 10.1644/07-MAMM-A-264.1; Soldevilla MS, 2010, J ACOUST SOC AM, V127, P124, DOI 10.1121/1.3257586; Todd VLG, 2009, ICES J MAR SCI, V66, P734, DOI 10.1093/icesjms/fsp035; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Wang D., 2013, NEOPHOCAENA ASIAEORI, V2013, DOI DOI 10.2305/IUCN.UK.2013-1.RLTS.T43205774A45893487.EN; Wang D, 2009, CHINESE SCI BULL, V54, P3473, DOI 10.1007/s11434-009-0522-7; Wang KX, 2005, J ACOUST SOC AM, V118, P1180, DOI 10.1121/1.1945487; Wang ZT, 2014, INTEGRATIVE ZOOLOGY, V9; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; Wei Zhou, 2003, Acta Zoologica Sinica, V49, P163; Xiao JQ, 2005, ZOO BIOL, V24, P531, DOI 10.1002/zoo.20070; Yerushalmi S, 2009, ECOL LETT, V12, P970, DOI 10.1111/j.1461-0248.2009.01343.x; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zhao XJ, 2008, BIOL CONSERV, V141, P3006, DOI 10.1016/j.biocon.2008.09.005; Zimmer WM., 2011, PASSIVE ACOUSTIC MON, DOI 10.1017/CBO9780511977107	59	444	463	25	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97907	10.1371/journal.pone.0097907	http://dx.doi.org/10.1371/journal.pone.0097907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	25116432	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200137
J	Wang, ZL; Luo, XF; Li, MT; Xu, D; Zhou, S; Chen, HZ; Gao, N; Chen, Z; Zhang, LL; Zeng, XF				Wang, Zhuo-Long; Luo, Xiao-Fang; Li, Meng-Tao; Xu, Dong; Zhou, Shuang; Chen, Hou-Zao; Gao, Na; Chen, Zhen; Zhang, Ling-Ling; Zeng, Xiao-Feng			Resveratrol Possesses Protective Effects in a Pristane-Induced Lupus Mouse Model	PLOS ONE			English	Article							INDUCED APOPTOSIS; BALB/C MICE; AUTOANTIBODIES; MECHANISMS; DIFFERENTIATION; DISEASE; CELLS; SIRT1	Background: Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease characterized by the production of autoantibodies. To date, no therapy has been found to satisfactorily treat SLE. SIRT1 deficiency results in the development of an autoimmune syndrome in mice, including a high titer of anti-nuclear antibody in serum, immunoglobulin deposition in the kidney, and immune complex glomerulonephritis. Resveratrol is an activator of SIRT1 and possesses anti-inflammation and immune-regulatory properties. Objective: To evaluate the preventative effects of resveratrol on a pristane-induced lupus animal model and assess its putative immune modulation effects. Methods: BALB/c mice received a single intraperitoneal injection of 0.5 ml of pristane on day 1 and then various doses of resveratrol were given to the mice daily starting on day 2 and continuing for seven months. The autoantibodies in serum and supernatants were measured. Single cells isolated from spleen, isolated CD4+ T cells, and CD19+ B cells were cultured with or without resveratrol in vitro and assessed by flow cytometry. Results: Resveratrol attenuated proteinuria, immunoglobuin depositon in kidney, and glomerulonephritis as well as IgG1 and IgG2a in serum in pristane-induced lupus mice. Resveratrol also suppressed CD69 and CD71 expression on CD4+ T cells as well as CD4+ T cell proliferation, induced CD4+ T cell apoptosis, and decreased CD4 IFN gamma(+) Th1 cells and the ratio of Th1/Th2 cells in vitro. In vitro antibody production and proliferation of B cells were also inhibited. Conclusion: Resveratrol possesses protective effects in pristane-induced lupus mice and may represent a novel approach for the management of SLE.	[Wang, Zhuo-Long; Luo, Xiao-Fang; Li, Meng-Tao; Xu, Dong; Zhou, Shuang; Gao, Na; Chen, Zhen; Zhang, Ling-Ling; Zeng, Xiao-Feng] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100021, Peoples R China; [Wang, Zhuo-Long; Luo, Xiao-Fang; Li, Meng-Tao; Xu, Dong; Zhou, Shuang; Gao, Na; Chen, Zhen; Zhang, Ling-Ling; Zeng, Xiao-Feng] Chinese Acad Med Sci, Key Lab Rheumatol & Clin Immunol, Minist Educ, Beijing 100730, Peoples R China; [Chen, Hou-Zao] Peking Union Med Coll, Natl Lab Med Mol Biol, Inst Basic Med Sci, Beijing 100021, Peoples R China; [Chen, Hou-Zao] Chinese Acad Med Sci, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College	Zeng, XF (corresponding author), Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100021, Peoples R China.	zengxfpumc@gmail.com	Wang, Zhi-Tao/F-1176-2015; zhang, lingling/HDM-2189-2022; meng, li/GVT-2063-2022	Wang, Zhi-Tao/0000-0002-5734-7385; Chen, Hou-Zao/0000-0001-6805-3182; Zhang, Tong/0000-0003-1148-4322	Chinese National Key Technology R&D Program, Ministry of Science and Technology [2008BAI59B02]; Chinese National High Technology Research and Development Program, Ministry of Science and Technology [2012AA02A513]; Young Investigator Project, Peking Union Medical College Hospital [I457200]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA026114] Funding Source: NIH RePORTER	Chinese National Key Technology R&D Program, Ministry of Science and Technology; Chinese National High Technology Research and Development Program, Ministry of Science and Technology(National High Technology Research and Development Program of China); Young Investigator Project, Peking Union Medical College Hospital; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the Chinese National Key Technology R&D Program, Ministry of Science and Technology (2008BAI59B02); the Chinese National High Technology Research and Development Program, Ministry of Science and Technology (2012AA02A513) and the Young Investigator Project, Peking Union Medical College Hospital (I457200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bereswill S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015099; Csiszar A, 2009, HYPERTENSION, V54, P668, DOI 10.1161/HYPERTENSIONAHA.109.133397; Cui XL, 2010, CANCER PREV RES, V3, P549, DOI 10.1158/1940-6207.CAPR-09-0117; Danila MI, 2009, RHEUMATOLOGY, V48, P542, DOI 10.1093/rheumatology/kep012; Dorrie J, 2001, CANCER RES, V61, P4731; Gao XZ, 2012, ANN RHEUM DIS, V71, P129, DOI 10.1136/ard.2011.149831; He MX, 2013, CELL DEATH DIFFER, V20, P188, DOI 10.1038/cdd.2012.148; Hoffman RW, 2004, CLIN IMMUNOL, V113, P4, DOI 10.1016/j.clim.2004.05.001; Imler TJ, 2009, INT IMMUNOPHARMACOL, V9, P134, DOI 10.1016/j.intimp.2008.10.015; Izawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048798; Ko YC, 2011, CANCER LETT, V309, P46, DOI 10.1016/j.canlet.2011.05.014; Kuo PL, 2002, LIFE SCI, V72, P23, DOI 10.1016/S0024-3205(02)02177-X; Kwon HS, 2008, CELL HOST MICROBE, V3, P158, DOI 10.1016/j.chom.2008.02.002; Lee PY, 2008, J EXP MED, V205, P2995, DOI 10.1084/jem.20080462; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Miyake K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/980286; Monneaux F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2711; Nakata R, 2012, BIOL PHARM BULL, V35, P273, DOI 10.1248/bpb.35.273; Padayatty SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011414, 10.1371/journal.pone.0015288]; Pervaiz S, 2003, FASEB J, V17, P1975, DOI 10.1096/fj.03-0168rev; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Richards HB, 1999, CLIN EXP IMMUNOL, V115, P547; Roman V, 2002, BRIT J HAEMATOL, V117, P842, DOI 10.1046/j.1365-2141.2002.03520.x; SATOH M, 1995, P NATL ACAD SCI USA, V92, P10934, DOI 10.1073/pnas.92.24.10934; SATOH M, 1994, J EXP MED, V180, P2341, DOI 10.1084/jem.180.6.2341; Savarese E, 2008, ARTHRITIS RHEUM, V58, P1107, DOI 10.1002/art.23407; Sequeira J, 2008, EXP CELL RES, V314, P3069, DOI 10.1016/j.yexcr.2008.07.011; Sestak AL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2176; Sharma S, 2007, CLIN EXP IMMUNOL, V147, P155, DOI 10.1111/j.1365-2249.2006.03257.x; Singh UP, 2010, J PHARMACOL EXP THER, V332, P829, DOI 10.1124/jpet.109.160838; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Svajger U, 2010, IMMUNOLOGY, V129, P525, DOI 10.1111/j.1365-2567.2009.03205.x; Takahashi S, 1996, J CLIN INVEST, V97, P1597, DOI 10.1172/JCI118584; Wallace DJ, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-77; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhu X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017783, 10.1371/journal.pone.0027081]; Zou T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075139; Zunino SJ, 2009, J NUTR, V139, P1603, DOI 10.3945/jn.109.105064	39	444	463	25	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114792	10.1371/journal.pone.0114792	http://dx.doi.org/10.1371/journal.pone.0114792			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25116432	Green Submitted, gold, Green Published			2022-12-27	WOS:000347146700054
J	Wang, Z; Li, Y; Childress, AR; Detre, JA				Wang, Ze; Li, Yin; Childress, Anna Rose; Detre, John A.			Brain Entropy Mapping Using fMRI	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; APPROXIMATE ENTROPY; COMPLEXITY ANALYSIS; SAMPLE ENTROPY; FUNCTIONAL MRI; DEFAULT MODE; NETWORKS; DISEASE; NOVELTY	Entropy is an important trait for life as well as the human brain. Characterizing brain entropy (BEN) may provide an informative tool to assess brain states and brain functions. Yet little is known about the distribution and regional organization of BEN in normal brain. The purpose of this study was to examine the whole brain entropy patterns using a large cohort of normal subjects. A series of experiments were first performed to validate an approximate entropy measure regarding its sensitivity, specificity, and reliability using synthetic data and fMRI data. Resting state fMRI data from a large cohort of normal subjects (n = 1049) from multi-sites were then used to derive a 3-dimensional BEN map, showing a sharp low-high entropy contrast between the neocortex and the rest of brain. The spatial heterogeneity of resting BEN was further studied using a data-driven clustering method, and the entire brain was found to be organized into 7 hierarchical regional BEN networks that are consistent with known structural and functional brain parcellations. These findings suggest BEN mapping as a physiologically and functionally meaningful measure for studying brain functions.	[Wang, Ze; Li, Yin; Childress, Anna Rose] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Wang, Ze; Detre, John A.] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Detre, John A.] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Wang, Z (corresponding author), Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA.	zewang@mail.med.upenn.edu	Wang, Zhi-Tao/F-1176-2015; zhang, lingling/HDM-2189-2022; meng, li/GVT-2063-2022	Wang, Zhi-Tao/0000-0002-5734-7385; Chen, Hou-Zao/0000-0001-6805-3182; Zhang, Tong/0000-0003-1148-4322	National Institutes of Health [R21DC011074, 8P41-EB015893, 5R33DA026114-04]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA026114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants: R21DC011074, and 8P41-EB015893, and 5R33DA026114-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2008, HUM BRAIN MAP POSTER, P496; Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; Baumgartner R, 2000, MAGN RESON IMAGING, V18, P845, DOI 10.1016/S0730-725X(00)00171-5; BERGSTROM R M, 1969, Developmental Psychobiology, V2, P139, DOI 10.1002/dev.420020304; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bruna R, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036007; Buxton R., 2002, INTRO FUNCTIONAL MAG; Chen CH, 2012, SCIENCE, V335, P1634, DOI 10.1126/science.1215330; Chen X, 2005, P ANN INT IEEE EMBS, P4212; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Araujo DB, 2003, NEUROIMAGE, V20, P311, DOI 10.1016/S1053-8119(03)00306-9; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fernandez A, 2010, ALZ DIS ASSOC DIS, V24, P182, DOI 10.1097/WAD.0b013e3181c727f7; Frith CD, 1995, HUM BRAIN MAPP, V3, P153, DOI 10.1002/hbm.460030209; HITCHCOCK DR, 1967, ICARUS, V7, P149, DOI 10.1016/0019-1035(67)90059-0; Hu ZH, 2006, IEEE IMAGE PROC, P2861, DOI 10.1109/ICIP.2006.313026; Hyvarinen A, 1998, ADV NEUR IN, V10, P273; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Kolmogorov AN, 1998, THEOR COMPUT SCI, V207, P387, DOI 10.1016/S0304-3975(98)00075-9; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; Li Z, 2012, JMRI; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044556; Liu CY, 2013, J MAGN RESON IMAGING, V38, P36, DOI 10.1002/jmri.23961; Lovelock James, 1979, GAIA NEW LOOK LIFE E; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Palazzolo JA, 1998, AM J PHYSIOL-HEART C, V274, pH1099, DOI 10.1152/ajpheart.1998.274.4.H1099; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Pinker S., 1997, MIND WORKS; Poza J, 2008, ANN BIOMED ENG, V36, P141, DOI 10.1007/s10439-007-9402-y; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rezek IA, 1998, IEEE T BIO-MED ENG, V45, P1186, DOI 10.1109/10.709563; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rosso OA, 2001, J NEUROSCI METH, V105, P65, DOI 10.1016/S0165-0270(00)00356-3; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sandler S.I, 2006, CHEM ENG THERMODYNAM; Schrodinger E., 1944, WHAT IS LIFE PHYS AS; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Singer W, 2009, EUR REV, V17, P321, DOI 10.1017/S1062798709000751; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; Sokunbi MO, 2011, IEEE T BIO-MED ENG, V58, P3206, DOI 10.1109/TBME.2011.2164793; Strange BA, 2005, NEURAL NETWORKS, V18, P225, DOI 10.1016/j.neunet.2004.12.004; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang Z., 2012, 3 BIENN C REST STAT, P208; Wang Z, 2012, 2012 ANN M ORG HUM B; Wang Z, 2007, NEUROIMAGE, V36, P1139, DOI 10.1016/j.neuroimage.2007.03.072; Wang Z, 2009, NEUROIMAGE, V46, P608, DOI 10.1016/j.neuroimage.2009.03.016; Yang AC, 2013, NEUROBIOL AGING, V34, P428, DOI 10.1016/j.neurobiolaging.2012.05.004; Ze Wang A.M., 2013, 2013 ANN M INT SOC M, P4861; Ze Wang JS, 2013, 2013 ANN M SOC NEUR, P7491; Zhu HT, 2006, 9 INT C CONTR AUT RO, P1	57	444	463	25	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e89948	10.1371/journal.pone.0089948	http://dx.doi.org/10.1371/journal.pone.0089948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	25116432	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300008
